Citrus Sinensis ID: 018734

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-
Protein Sequence
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS
Secondary Structure (PSIPRED)
cccEEEEEEEcccccEEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHccccccccEEEEEccccEEEEEEEEcccccHHHHHHHHccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccccccccccccccccccccccHHcccccccccccccHHHHHHHHHHHHcccccccccccHHHHHHHccccEEEEEccccccccHHHHHHHHHHHcccccccccHHHHHcccccccccccccHHHHHHHHHcccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEcccccccEEEEEEEcccccEEEEEEEccccccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccccEEEEEccccEEEccccccccccccHHHHcHHHHcccccccccEEHHHHHHHHHHHHccccccccccccHHHHHHHHHHHcccccccccccccHHHHHHHHHHHcccHHHcccHHHHHcccHHHHcccccccccHHHHHHHccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHcHHHcccccHHHHHHHHHHHHcccccEEcc
Coil and Loop (DISEMBL)
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINhkqlrhpniirfkevvltpTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLentlldgspaprlkicdfgyskssllhsrpkstvgtpayiapevlsrreydgkladVWSCGVTLYVMLVgaypfedqedpknFRKTISRIMAVQykipdyvhiSQDCRNLLSRIfvanpsrritikeikshpwflknlpRELTETAQAIYYrkenptfslqSVEEITKIVEeakvpppvsrsiggfgwggeedgdekeeetdadeedEYEKTVKEAQQSGEVSVS
Flexible Loop (DISEMBL)
mekyelmkdigsgnfgvarlmrNKNTKELVAMKYIERGHKIDANVAREIINhkqlrhpniirFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSsllhsrpkstvgtpayiapevlSRREYDGKLADVWSCGVTLYVMLVGAypfedqedpkNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIfvanpsrritikeikshpwflknlPRELTETAQAIYYRKENPTFSLQSVEEITKIveeakvpppvsrsiggfgwggeedgdEKEEEtdadeedeyeKTVKeaqqsgevsvs
Low Complexity Region (SEG)
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIggfgwggeedgdekeeetdadeedeyeKTVKEAQQSGEVSVS
Disordered region (IsUnstruct)
***********SGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH*****TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVE******************************************************
Disordered Region (DISOPRED)
*EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET********************************************************************************
Disordered Region (DISEMBL)
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIGGFGWG************************************
Disordered Region (DISPRO)
*EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP***LQSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSV*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	351	2.2.26 [Sep-21-2011]
Q9C958	361	Serine/threonine-protein	yes	no	1.0	0.972	0.831	1e-172
P43291	363	Serine/threonine-protein	no	no	1.0	0.966	0.840	1e-172
Q7XQP4	359	Serine/threonine-protein	yes	no	1.0	0.977	0.791	1e-167
Q6ZI44	365	Serine/threonine-protein	no	no	0.917	0.882	0.836	1e-165
Q9FFP9	360	Serine/threonine-protein	no	no	0.888	0.866	0.833	1e-158
Q5N942	360	Serine/threonine-protein	no	no	0.988	0.963	0.761	1e-156
P43292	353	Serine/threonine-protein	no	no	0.985	0.980	0.771	1e-155
Q7XKA8	370	Serine/threonine-protein	no	no	1.0	0.948	0.728	1e-155
O64812	339	Serine/threonine-protein	no	no	0.951	0.985	0.736	1e-145
P0C5D6	334	Serine/threonine-protein	no	no	0.945	0.994	0.730	1e-143

>sp|Q9C958|SRK2B_ARATH Serine/threonine-protein kinase SRK2B OS=Arabidopsis thaliana GN=SRK2B PE=1 SV=1

 Score =  603 bits (1556), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 300/361 (83%), Positives = 322/361 (89%), Gaps = 10/361 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KYEL+KDIG+GNFGVARLMR KN+KELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MDKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTH+AI MEYAAGGELFERIC+AGRFSEDEARYFFQQLISGVSYCH+MQIC
Sbjct: 61  IRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS PKSTVGTPAYIAPEVLSR EYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNF+KTI RIMAV+YKIPDYVHISQDC++LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FV N ++RITI +IK HPWFLKNLPRELTE AQA Y+RKENPTFSLQSVEEI KIVEEAK
Sbjct: 241 FVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEEAK 300

Query: 301 VPPPVSRSIGGFGWGGEEDG---------DEKEEETDADEEDEYEKTVKEAQQS-GEVSV 350
            P  VSRSIG FGWGG ED          + +E E + DEEDEY+KTVK+   S GEV V
Sbjct: 301 TPARVSRSIGAFGWGGGEDAEGKEEDAEEEVEEVEEEEDEEDEYDKTVKQVHASMGEVRV 360

Query: 351 S 351
           S
Sbjct: 361 S 361

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1

 Score =  603 bits (1555), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 305/363 (84%), Positives = 325/363 (89%), Gaps = 12/363 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KYEL+KDIG+GNFGVARLM+ KN+KELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MDKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHLAI MEYAAGGELFERIC+AGRFSEDEARYFFQQLISGVSYCH+MQIC
Sbjct: 61  IRFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI +IMAVQYKIPDYVHISQDC+NLLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIQKIMAVQYKIPDYVHISQDCKNLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVAN  +RITI EIK H WFLKNLPRELTETAQA Y++KENPTFSLQ+VEEI KIV +AK
Sbjct: 241 FVANSLKRITIAEIKKHSWFLKNLPRELTETAQAAYFKKENPTFSLQTVEEIMKIVADAK 300

Query: 301 VPPPVSRSIGGFGWGGEEDGDEK------------EEETDADEEDEYEKTVKEAQQSGEV 348
            PPPVSRSIGGFGWGG  D D K            E E + D+EDEY+KTVKE   SGEV
Sbjct: 301 TPPPVSRSIGGFGWGGNGDADGKEEDAEDVEEEEEEVEEEEDDEDEYDKTVKEVHASGEV 360

Query: 349 SVS 351
            +S
Sbjct: 361 RIS 363

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7XQP4|SAPK7_ORYSJ Serine/threonine-protein kinase SAPK7 OS=Oryza sativa subsp. japonica GN=SAPK7 PE=2 SV=2

 Score =  587 bits (1513), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 284/359 (79%), Positives = 318/359 (88%), Gaps = 8/359 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           ME+YEL+KDIG+GNFGVARLMRNK TKELVAMKYI RG KID NVAREIINH+ LRHPNI
Sbjct: 1   MERYELLKDIGAGNFGVARLMRNKETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVV+TPTHLAIVMEYAAGGELF+RICNAGRFSEDEARYFFQQLI GVSYCH MQIC
Sbjct: 61  IRFKEVVVTPTHLAIVMEYAAGGELFDRICNAGRFSEDEARYFFQQLICGVSYCHFMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS+PKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKT 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFED +DPKNFRKTI RIM++QYKIP+YVH+SQDCR LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIMSIQYKIPEYVHVSQDCRQLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN--PTFSLQSVEEITKIVEE 298
           FVANP++RITI+EI++HPWFLKNLPRELTE AQA+YY+K+N  PT+S+QSVEEI KIVEE
Sbjct: 241 FVANPAKRITIREIRNHPWFLKNLPRELTEAAQAMYYKKDNSAPTYSVQSVEEIMKIVEE 300

Query: 299 AKVPPPVSRSIGGFGWGGEEDGDEKEEE------TDADEEDEYEKTVKEAQQSGEVSVS 351
           A+ PP  S  + GFGW  E++ ++  ++       + D EDEY+K VK+   SGE  +S
Sbjct: 301 ARTPPRSSTPVAGFGWQEEDEQEDNSKKPEEEQEEEEDAEDEYDKQVKQVHASGEFQLS 359

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZI44|SAPK6_ORYSJ Serine/threonine-protein kinase SAPK6 OS=Oryza sativa subsp. japonica GN=SAPK6 PE=2 SV=1

 Score =  580 bits (1495), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 271/324 (83%), Positives = 299/324 (92%), Gaps = 2/324 (0%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRN+ TKELVAMKYI RG KID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELLKDIGSGNFGVARLMRNRETKELVAMKYIPRGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELF+RIC+AGRFSEDE+RYFFQQLI GVSYCH MQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFDRICSAGRFSEDESRYFFQQLICGVSYCHFMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS+PKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSKPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFED +DPKNFRKTI RI+++QYKIP+YVHISQDCR LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPDDPKNFRKTIGRIVSIQYKIPEYVHISQDCRQLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP--TFSLQSVEEITKIVEE 298
           FVANP++RITI+EI++HPWF+KNLPRELTE AQA YY+K+N   TFS Q+V+EI KIV+E
Sbjct: 241 FVANPAKRITIREIRNHPWFMKNLPRELTEAAQAKYYKKDNSARTFSDQTVDEIMKIVQE 300

Query: 299 AKVPPPVSRSIGGFGWGGEEDGDE 322
           AK PPP S  + GFGW  EE+ ++
Sbjct: 301 AKTPPPSSTPVAGFGWTEEEEQED 324

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFP9|SRK2H_ARATH Serine/threonine-protein kinase SRK2H OS=Arabidopsis thaliana GN=SRK2H PE=1 SV=1

 Score =  558 bits (1439), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 260/312 (83%), Positives = 287/312 (91%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KYE++KD+G+GNFGVARL+R+K TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSE EARYFFQQLI GV YCHS+QIC
Sbjct: 61  IRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAP LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVG YPFED +DP+NFRKTI RIMAVQYKIPDYVHISQ+CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FV N ++RIT+KEIK HPW+LKNLP+ELTE AQA YY++E P+FSLQSVE+I KIV EA+
Sbjct: 241 FVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKIVGEAR 300

Query: 301 VPPPVSRSIGGF 312
            P P S ++ GF
Sbjct: 301 NPAPSSNAVKGF 312

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5N942|SAPK4_ORYSJ Serine/threonine-protein kinase SAPK4 OS=Oryza sativa subsp. japonica GN=SAPK4 PE=2 SV=2

 Score =  552 bits (1423), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 274/360 (76%), Positives = 309/360 (85%), Gaps = 13/360 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE ++DIGSGNFGVARLMRN+ T+ELVA+K IERGH+ID NV REIINH+ LRHPNI
Sbjct: 1   MEKYEAVRDIGSGNFGVARLMRNRETRELVAVKCIERGHRIDENVYREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEV+LTPTHL IVME+AAGGELF+RIC+ GRFSEDEARYFFQQLI GVSYCH MQIC
Sbjct: 61  IRFKEVILTPTHLMIVMEFAAGGELFDRICDRGRFSEDEARYFFQQLICGVSYCHHMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLEN LLDGSPAPRLKICDFGYSKSS+LHSRPKS VGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENVLLDGSPAPRLKICDFGYSKSSVLHSRPKSAVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQ+DPKN RKTI RIM+VQYKIPDYVHIS +C+ L++RI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQDDPKNIRKTIQRIMSVQYKIPDYVHISAECKQLIARI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN--PTFSLQSVEEITKIVEE 298
           FV NP RRIT+KEIKSHPWFLKNLPRELTETAQA+YYR++N  P+FS Q+ EEI KIV+E
Sbjct: 241 FVNNPLRRITMKEIKSHPWFLKNLPRELTETAQAMYYRRDNSVPSFSDQTSEEIMKIVQE 300

Query: 299 AKVPPPVSRSIGGFGWGGEEDGD-------EKEEETDADEEDEYEKTVKEAQQSGEVSVS 351
           A+  P  SR+    G+  +   D       E+ EE + +EEDEY+K VKE   SGE+ +S
Sbjct: 301 ARTMPKSSRT----GYWSDAGSDEEEKEEEERPEENEEEEEDEYDKRVKEVHASGELRMS 356

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43292|SRK2G_ARATH Serine/threonine-protein kinase SRK2G OS=Arabidopsis thaliana GN=SRK2G PE=1 SV=2

 Score =  546 bits (1407), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 270/350 (77%), Positives = 308/350 (88%), Gaps = 4/350 (1%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KY+++KD+G+GNFGVARL+R+K+TKELVAMKYIERG KID NVAREIINH+ L+HPNI
Sbjct: 1   MDKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEV+LTPTHLAIVMEYA+GGELF+RIC AGRFSE EARYFFQQLI GV YCHS+QIC
Sbjct: 61  IRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFED  DPKNFRKTI RIMAVQYKIPDYVHISQ+C++LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FV N ++RIT+KEIK+HPW+LKNLP+EL E+AQA YY+++  +FSLQSVE+I KIV EA+
Sbjct: 241 FVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDT-SFSLQSVEDIMKIVGEAR 299

Query: 301 VPPPVSRSIGGFGWG---GEEDGDEKEEETDADEEDEYEKTVKEAQQSGE 347
            P P + ++   G G    EE+  E E E + D+EDEYEK VKEAQ   E
Sbjct: 300 NPAPSTSAVKSSGSGADEEEEEDVEAEVEEEEDDEDEYEKHVKEAQSCQE 349

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7XKA8|SAPK5_ORYSJ Serine/threonine-protein kinase SAPK5 OS=Oryza sativa subsp. japonica GN=SAPK5 PE=2 SV=1

 Score =  546 bits (1407), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 266/365 (72%), Positives = 310/365 (84%), Gaps = 14/365 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE +++IG+GNFGVA+LMRNK T+ELVAMK+IERG++ID NV REI+NH+ LRHPNI
Sbjct: 1   MEKYEPVREIGAGNFGVAKLMRNKETRELVAMKFIERGNRIDENVFREIVNHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVV+T  HLAIVMEYAAGGELFERIC AGRF EDEARYFFQQL+ GVSYCH+MQIC
Sbjct: 61  IRFKEVVVTGRHLAIVMEYAAGGELFERICEAGRFHEDEARYFFQQLVCGVSYCHAMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFED +DPKNFRKTISRIM+VQYKIP+YVH+SQ CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDPKDPKNFRKTISRIMSVQYKIPEYVHVSQPCRHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP--------------TFSL 286
           FVANP +RI++ EIKSHPWFLKNLPREL E AQA+YY +                  FS 
Sbjct: 241 FVANPYKRISMGEIKSHPWFLKNLPRELKEEAQAVYYNRRGADHAASSASSAAAAAAFSP 300

Query: 287 QSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSG 346
           QSVE+I +IV+EA+  P   + + G+GWG ++D D+++   + DEED+Y++TV+E   S 
Sbjct: 301 QSVEDIMRIVQEAQTVPKPDKPVSGYGWGTDDDDDDQQPAEEEDEEDDYDRTVREVHASV 360

Query: 347 EVSVS 351
           ++ +S
Sbjct: 361 DLDMS 365

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64812|SRK2J_ARATH Serine/threonine-protein kinase SRK2J OS=Arabidopsis thaliana GN=SRK2J PE=1 SV=1

 Score =  515 bits (1327), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 249/338 (73%), Positives = 282/338 (83%), Gaps = 4/338 (1%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE++KD+G GNFG+ARLMRNK T ELVA+K+I+RG+KID NVAREIINH+ L HPNI
Sbjct: 1   MEKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +RFKEVVLTPTHL IVMEYAAGGELFERI + GRFSE EARYFFQQLI GV Y H++QIC
Sbjct: 61  VRFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEV  R EYDGK 
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKS 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWSCGV LYVMLVGAYPFED +DP+NFRKT+ +IMAV YKIP YVHIS+DCR LLSRI
Sbjct: 181 VDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP--TFSLQSVEEITKIVEE 298
           FVANP  R T+KEIKSH WFLKNLPREL E AQAIYY++      FS Q VEEI KIV E
Sbjct: 241 FVANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIVGE 300

Query: 299 AKVPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYE 336
           A+  P +SR +     G ++  D++EE  DA++E+ Y+
Sbjct: 301 ARTIPNLSRPVESL--GSDKKDDDEEEYLDANDEEWYD 336

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P0C5D6|SAPK3_ORYSJ Serine/threonine-protein kinase SAPK3 OS=Oryza sativa subsp. japonica GN=SAPK3 PE=1 SV=1

 Score =  509 bits (1311), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 244/334 (73%), Positives = 283/334 (84%), Gaps = 2/334 (0%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E+YE +K++G+GNFGVARL+R+K +KELVA+KYIERG KID NV REIINH+ LRHPNII
Sbjct: 3   ERYEALKELGAGNFGVARLVRDKRSKELVAVKYIERGKKIDENVQREIINHRSLRHPNII 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           RFKEV LTPTHLAIVMEYAAGGELFE+IC AGRFSEDEARYFFQQLISGVSYCHS++ICH
Sbjct: 63  RFKEVCLTPTHLAIVMEYAAGGELFEQICTAGRFSEDEARYFFQQLISGVSYCHSLEICH 122

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RDLKLENTLLDGSP PR+KICDFGYSKS+LLHS+PKSTVGTPAYIAPEVLSR+EYDGK+A
Sbjct: 123 RDLKLENTLLDGSPTPRVKICDFGYSKSALLHSKPKSTVGTPAYIAPEVLSRKEYDGKVA 182

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           DVWSCGVTLYVMLVG+YPFED  DP+NFRKTISRI+ VQY IPDYV +S DCR LLS+IF
Sbjct: 183 DVWSCGVTLYVMLVGSYPFEDPGDPRNFRKTISRILGVQYSIPDYVRVSSDCRRLLSQIF 242

Query: 242 VANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKV 301
           VA+PS+RITI EIK H WFLKNLP+E++E  +A  Y+  +     Q+VEEI +I++EAKV
Sbjct: 243 VADPSKRITIPEIKKHTWFLKNLPKEISEREKAD-YKDTDAAPPTQAVEEIMRIIQEAKV 301

Query: 302 PPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEY 335
           P  ++ +         E   + EEE  ADE D Y
Sbjct: 302 PGDMAAADPALLAELAELKSDDEEEA-ADEYDTY 334

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	351
356543422	359	PREDICTED: serine/threonine-protein kina	0.997	0.974	0.888	0.0
357445405	351	Serine/threonine protein kinase [Medicag	1.0	1.0	0.886	0.0
388490962	351	unknown [Medicago truncatula]	0.991	0.991	0.890	0.0
225448215	356	PREDICTED: serine/threonine-protein kina	1.0	0.985	0.898	0.0
224118462	353	predicted protein [Populus trichocarpa]	1.0	0.994	0.903	0.0
147864363	357	hypothetical protein VITISV_028464 [Viti	1.0	0.983	0.885	1e-180
297739581	335	unnamed protein product [Vitis vinifera]	0.900	0.943	0.939	1e-179
255579673	357	Serine/threonine-protein kinase ASK1, pu	1.0	0.983	0.910	1e-179
356525969	352	PREDICTED: serine/threonine-protein kina	1.0	0.997	0.900	1e-179
441433481	352	sucrose non-fermenting-1-related protein	0.997	0.994	0.872	1e-178

>gi|356543422|ref|XP_003540159.1| PREDICTED: serine/threonine-protein kinase SRK2B-like [Glycine max]

 Score =  647 bits (1668), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/360 (88%), Positives = 334/360 (92%), Gaps = 10/360 (2%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+KYEL+KDIGSGNFGVARLMR+K+TKELVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MDKYELVKDIGSGNFGVARLMRHKDTKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHL IVMEYAAGGELFERIC+AGRFSEDEARYFFQQLISGVSYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLGIVMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQDCR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQDCRHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVANP+RRITIKEIKSHPWFLKNLPRELTE AQA YYRKENPTFSLQS+E I  IVEEAK
Sbjct: 241 FVANPARRITIKEIKSHPWFLKNLPRELTEVAQAAYYRKENPTFSLQSIEGIMNIVEEAK 300

Query: 301 VPPPVSRSIGGFGWGGEEDGDEKEEE---------TDADEEDEYEKTVKEAQQSGEVSVS 351
            PPP SRSIGGFGWGGEE+ DE +EE         T+A EEDEYEK VKEAQ SGE  VS
Sbjct: 301 TPPPASRSIGGFGWGGEEEEDETKEEEDETKEEAVTEA-EEDEYEKRVKEAQASGEFHVS 359

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357445405|ref|XP_003592980.1| Serine/threonine protein kinase [Medicago truncatula] gi|55140609|gb|AAV41842.1| stress kinase [Medicago truncatula] gi|55140611|gb|AAV41843.1| stress kinase [Medicago truncatula] gi|355482028|gb|AES63231.1| Serine/threonine protein kinase [Medicago truncatula]

 Score =  642 bits (1655), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/351 (88%), Positives = 333/351 (94%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE++KDIGSGNFGVARLMR+K+TK+LVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYEVVKDIGSGNFGVARLMRHKDTKQLVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHL IVMEYAAGGELF+RIC+AGRFSEDEARYFFQQLISGVSYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLGIVMEYAAGGELFDRICSAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQ+CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQECRHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVA+P+RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPT+SLQS+E+I KIVEEAK
Sbjct: 241 FVASPARRITIKEIKSHPWFLKNLPRELTEMAQAVYYRKENPTYSLQSIEDIMKIVEEAK 300

Query: 301 VPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 351
            PP  SRS+GGFGWGGEED DE  E     EEDEYEK VKEAQ+SGE+ V+
Sbjct: 301 NPPQASRSVGGFGWGGEEDDDEINEAEAELEEDEYEKRVKEAQESGEIHVN 351

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388490962|gb|AFK33547.1| unknown [Medicago truncatula]

 Score =  640 bits (1650), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 310/348 (89%), Positives = 331/348 (95%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE++KDIGSGNFGVARLMR+K+TK+LVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYEVVKDIGSGNFGVARLMRHKDTKQLVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHL IVMEYAAGGELF+RIC+AGRFSEDEARYFFQQLISGVSYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLGIVMEYAAGGELFDRICSAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQ+DPKNFRKTI+RIMAVQYKIPDYVHISQ+CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQDDPKNFRKTINRIMAVQYKIPDYVHISQECRHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVA+P+RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPT+SLQS+E+I KIVEEAK
Sbjct: 241 FVASPARRITIKEIKSHPWFLKNLPRELTEMAQAVYYRKENPTYSLQSIEDIMKIVEEAK 300

Query: 301 VPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKTVKEAQQSGEV 348
            PP  SRS+GGFGWGGEED DE  E     EEDEYEK VKEAQ+SGE+
Sbjct: 301 NPPQASRSVGGFGWGGEEDDDEINEAEAELEEDEYEKRVKEAQESGEI 348

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225448215|ref|XP_002269221.1| PREDICTED: serine/threonine-protein kinase SRK2B isoform 1 [Vitis vinifera]

 Score =  640 bits (1650), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/356 (89%), Positives = 336/356 (94%), Gaps = 5/356 (1%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRNK TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR+LL+RI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRHLLARI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVANPSRR+TIK+IK+HPWFLKNLPRELTE AQA+YYR+ENPTFSLQS+E+I KIV+EAK
Sbjct: 241 FVANPSRRVTIKDIKNHPWFLKNLPRELTEAAQALYYRRENPTFSLQSIEDIMKIVDEAK 300

Query: 301 VPPPVSRSIGGFGWGG-----EEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 351
            PPPVSRSIGGFGWGG     EE+  E+E ET+ +EEDEYEK VKEA  SGEV VS
Sbjct: 301 TPPPVSRSIGGFGWGGEEEEEEEEEKEEEVETEEEEEDEYEKQVKEAHASGEVHVS 356

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118462|ref|XP_002331488.1| predicted protein [Populus trichocarpa] gi|222873566|gb|EEF10697.1| predicted protein [Populus trichocarpa]

 Score =  639 bits (1648), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/353 (90%), Positives = 334/353 (94%), Gaps = 2/353 (0%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           ME+YEL+KDIGSGNFGVARLMR+K TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MERYELVKDIGSGNFGVARLMRHKQTKELVAMKYIERGLKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVV+TPTHLAI+MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC
Sbjct: 61  IRFKEVVVTPTHLAIIMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI+RIMAVQYKIPDYVHISQDCR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTINRIMAVQYKIPDYVHISQDCRHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVANP RRITIKEIKSHPWFLKNLPRELTE AQA+YYRKENPTFSLQSVEEI KIVEEAK
Sbjct: 241 FVANPIRRITIKEIKSHPWFLKNLPRELTEAAQAMYYRKENPTFSLQSVEEIMKIVEEAK 300

Query: 301 VPPPVSRSIGGFGWGG--EEDGDEKEEETDADEEDEYEKTVKEAQQSGEVSVS 351
           +PPPVSRSIGGFGW G  ++D  E + E + +EEDEYEK VKEAQ SGEV VS
Sbjct: 301 IPPPVSRSIGGFGWVGEEDDDVKEDDAEEEEEEEDEYEKRVKEAQASGEVHVS 353

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147864363|emb|CAN78793.1| hypothetical protein VITISV_028464 [Vitis vinifera]

 Score =  637 bits (1643), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 316/357 (88%), Positives = 333/357 (93%), Gaps = 6/357 (1%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRNK TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR+LL+RI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRHLLARI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVANPSRR+TIK+IK+HPWFLKNLPRELTE AQA+YYR+ENPTFSLQS+E+I KIV+EAK
Sbjct: 241 FVANPSRRVTIKDIKNHPWFLKNLPRELTEAAQALYYRRENPTFSLQSIEDIMKIVDEAK 300

Query: 301 VPPPVSRSIGGFGWGGEEDGDEKEEETDADEEDEYEKT------VKEAQQSGEVSVS 351
            PPPVSRSIGGFGWGGEE  +E+EEE + + E E E+       VKEA  SGEV VS
Sbjct: 301 TPPPVSRSIGGFGWGGEEKKEEEEEEKEEEVETEEEEEDEYEKQVKEAHASGEVHVS 357

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297739581|emb|CBI29763.3| unnamed protein product [Vitis vinifera]

 Score =  634 bits (1635), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 297/316 (93%), Positives = 309/316 (97%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRNK TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGQKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR+LL+RI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRHLLARI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVANPSRR+TIK+IK+HPWFLKNLPRELTE AQA+YYR+ENPTFSLQS+E+I KIV+EAK
Sbjct: 241 FVANPSRRVTIKDIKNHPWFLKNLPRELTEAAQALYYRRENPTFSLQSIEDIMKIVDEAK 300

Query: 301 VPPPVSRSIGGFGWGG 316
            PPPVSRSIGGFGWGG
Sbjct: 301 TPPPVSRSIGGFGWGG 316

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255579673|ref|XP_002530676.1| Serine/threonine-protein kinase ASK1, putative [Ricinus communis] gi|223529769|gb|EEF31707.1| Serine/threonine-protein kinase ASK1, putative [Ricinus communis]

 Score =  633 bits (1632), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 325/357 (91%), Positives = 337/357 (94%), Gaps = 6/357 (1%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMRNK TKELVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRNKETKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS+QIC
Sbjct: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSLQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK+
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKM 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI+RIMAVQYKIPDYVHISQDCR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTINRIMAVQYKIPDYVHISQDCRHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVANPSRR+TIK+IKSHPWFLKNLPRELTE AQA+YYRKENPTFSLQ+ EEI KIVEEAK
Sbjct: 241 FVANPSRRVTIKDIKSHPWFLKNLPRELTEAAQAMYYRKENPTFSLQTAEEIMKIVEEAK 300

Query: 301 VPPPVSRSIGGFGWGGEEDGDEK------EEETDADEEDEYEKTVKEAQQSGEVSVS 351
           +PPPVSRSIGGFGWGGEEDGD K      EEE +  EEDEYEK VKEAQ SGE  VS
Sbjct: 301 IPPPVSRSIGGFGWGGEEDGDGKEDDTEAEEEEEVGEEDEYEKRVKEAQASGEFHVS 357

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356525969|ref|XP_003531593.1| PREDICTED: serine/threonine-protein kinase SRK2B-like [Glycine max]

 Score =  632 bits (1630), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 317/352 (90%), Positives = 334/352 (94%), Gaps = 1/352 (0%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYEL+KDIGSGNFGVARLMR+K+TKELVAMKYIERGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYELVKDIGSGNFGVARLMRHKDTKELVAMKYIERGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRFKEVVLTPTHL IVMEYAAGGELFERIC+AGRFSEDEARYFFQQLISGVSYCHSMQIC
Sbjct: 61  IRFKEVVLTPTHLGIVMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHSMQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI+RIMAVQYKIPDYVHISQDCR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTINRIMAVQYKIPDYVHISQDCRHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVANP+RRITIKEIKSHPWF+KNLPRELTE AQA YYRKENPTFSLQS+E+I  IVEEAK
Sbjct: 241 FVANPARRITIKEIKSHPWFVKNLPRELTEVAQAAYYRKENPTFSLQSIEDIMNIVEEAK 300

Query: 301 VPPPVSRSIGGFGWGGEEDGDEKEEETDAD-EEDEYEKTVKEAQQSGEVSVS 351
            PPP SRSIGGFGWGGEE+ +++ +E  A+ EEDEYEK VKEAQ SGE  VS
Sbjct: 301 APPPASRSIGGFGWGGEEEEEDETKEAVAETEEDEYEKRVKEAQASGEFHVS 352

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|441433481|gb|AGC31662.1| sucrose non-fermenting-1-related protein kinase [Malus x domestica]

 Score =  631 bits (1627), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 308/353 (87%), Positives = 328/353 (92%), Gaps = 3/353 (0%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           MEKYE++KDIGSGNFGVARLMRNK TKELVAMKYI+RGHKID NVAREIINH+ LRHPNI
Sbjct: 1   MEKYEVVKDIGSGNFGVARLMRNKETKELVAMKYIDRGHKIDENVAREIINHRSLRHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IRF+EVVLTPTHL IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS+QIC
Sbjct: 61  IRFREVVLTPTHLGIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSLQIC 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGS APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL
Sbjct: 121 HRDLKLENTLLDGSAAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT+ +IM V YKIPD+VH+SQ+CR+LLSRI
Sbjct: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTMKKIMGVHYKIPDHVHMSQECRHLLSRI 240

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVANP+RRITIK+IK+HPWFLKNLPRELTE AQ IYYRKENPTFS Q+VE+I KIVEEAK
Sbjct: 241 FVANPARRITIKDIKNHPWFLKNLPRELTEAAQIIYYRKENPTFSPQTVEDIMKIVEEAK 300

Query: 301 VPPPVSRSIGGFGWGGEEDGDEK--EEETDADEEDEYEKTVKEAQQSGEVSVS 351
           +PPPVSRSIGGF W GEEDGD K   E  + +EEDEY KTVKE   SGEVSVS
Sbjct: 301 IPPPVSRSIGGFSW-GEEDGDTKEEVEGEEEEEEDEYVKTVKEVHASGEVSVS 352

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	351
TAIR|locus:2206046	361	SNRK2.10 "SNF1-related protein	0.880	0.855	0.886	1.2e-147
TAIR|locus:2160559	360	SNRK2.5 "SNF1-related protein	0.880	0.858	0.834	7.8e-142
TAIR|locus:2159597	353	SNRK2.1 "SNF1-related protein	0.877	0.872	0.809	1.3e-137
TAIR|locus:2045319	339	SNRK2.9 "SNF1-related protein	0.880	0.911	0.778	8.4e-129
TAIR|locus:2118929	362	OST1 "OPEN STOMATA 1" [Arabido	0.868	0.842	0.758	4.6e-128
TAIR|locus:2174999	361	SNRK2.3 "sucrose nonfermenting	0.874	0.850	0.730	5.7e-123
TAIR|locus:2032075	343	SNRK2-8 "SNF1-RELATED PROTEIN	0.863	0.883	0.731	7.4e-121
TAIR|locus:2140104	350	SNRK2.7 "SNF1-related protein	0.854	0.857	0.719	4.7e-119
DICTYBASE|DDB_G0277905	727	snfA "AMP-activated protein ki	0.735	0.354	0.446	1.5e-53
POMBASE|SPCC74.03c	576	ssp2 "serine/threonine protein	0.752	0.458	0.444	4.9e-53

TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1442 (512.7 bits), Expect = 1.2e-147, P = 1.2e-147
 Identities = 274/309 (88%), Positives = 291/309 (94%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             M+KYEL+KDIG+GNFGVARLMR KN+KELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct:     1 MDKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
             IRFKEVVLTPTH+AI MEYAAGGELFERIC+AGRFSEDEARYFFQQLISGVSYCH+MQIC
Sbjct:    61 IRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQIC 120

Query:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
             HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS PKSTVGTPAYIAPEVLSR EYDGK+
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKM 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
             ADVWSCGVTLYVMLVGAYPFEDQEDPKNF+KTI RIMAV+YKIPDYVHISQDC++LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRI 240

Query:   241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
             FV N ++RITI +IK HPWFLKNLPRELTE AQA Y+RKENPTFSLQSVEEI KIVEEAK
Sbjct:   241 FVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEEAK 300

Query:   301 VPPPVSRSI 309
              P  VSRSI
Sbjct:   301 TPARVSRSI 309

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA;RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0048527 "lateral root development" evidence=IMP

GO:0070300 "phosphatidic acid binding" evidence=IDA

TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1387 (493.3 bits), Expect = 7.8e-142, P = 7.8e-142
 Identities = 258/309 (83%), Positives = 285/309 (92%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             M+KYE++KD+G+GNFGVARL+R+K TKELVAMKYIERG KID NVAREIINH+ LRHPNI
Sbjct:     1 MDKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
             IRFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSE EARYFFQQLI GV YCHS+QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
             HRDLKLENTLLDGSPAP LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
             ADVWSCGVTLYVMLVG YPFED +DP+NFRKTI RIMAVQYKIPDYVHISQ+CR+LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRI 240

Query:   241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
             FV N ++RIT+KEIK HPW+LKNLP+ELTE AQA YY++E P+FSLQSVE+I KIV EA+
Sbjct:   241 FVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKRETPSFSLQSVEDIMKIVGEAR 300

Query:   301 VPPPVSRSI 309
              P P S ++
Sbjct:   301 NPAPSSNAV 309

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1347 (479.2 bits), Expect = 1.3e-137, P = 1.3e-137
 Identities = 250/309 (80%), Positives = 285/309 (92%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             M+KY+++KD+G+GNFGVARL+R+K+TKELVAMKYIERG KID NVAREIINH+ L+HPNI
Sbjct:     1 MDKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
             IRFKEV+LTPTHLAIVMEYA+GGELF+RIC AGRFSE EARYFFQQLI GV YCHS+QIC
Sbjct:    61 IRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
             HRDLKLENTLLDGSPAP LKICDFGYSKSS+LHSRPKSTVGTPAYIAPEVLSRREYDGK 
Sbjct:   121 HRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKH 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
             ADVWSCGVTLYVMLVGAYPFED  DPKNFRKTI RIMAVQYKIPDYVHISQ+C++LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRI 240

Query:   241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
             FV N ++RIT+KEIK+HPW+LKNLP+EL E+AQA YY+++  +FSLQSVE+I KIV EA+
Sbjct:   241 FVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKRDT-SFSLQSVEDIMKIVGEAR 299

Query:   301 VPPPVSRSI 309
              P P + ++
Sbjct:   300 NPAPSTSAV 308

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1264 (450.0 bits), Expect = 8.4e-129, P = 8.4e-129
 Identities = 242/311 (77%), Positives = 267/311 (85%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             MEKYE++KD+G GNFG+ARLMRNK T ELVA+K+I+RG+KID NVAREIINH+ L HPNI
Sbjct:     1 MEKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
             +RFKEVVLTPTHL IVMEYAAGGELFERI + GRFSE EARYFFQQLI GV Y H++QIC
Sbjct:    61 VRFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQIC 120

Query:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
             HRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEV  R EYDGK 
Sbjct:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKS 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
              DVWSCGV LYVMLVGAYPFED +DP+NFRKT+ +IMAV YKIP YVHIS+DCR LLSRI
Sbjct:   181 VDVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRI 240

Query:   241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE-NP-TFSLQSVEEITKIVEE 298
             FVANP  R T+KEIKSH WFLKNLPREL E AQAIYY++  N   FS Q VEEI KIV E
Sbjct:   241 FVANPLHRSTLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIVGE 300

Query:   299 AKVPPPVSRSI 309
             A+  P +SR +
Sbjct:   301 ARTIPNLSRPV 311

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=IGI

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1257 (447.5 bits), Expect = 4.6e-128, P = 4.6e-128
 Identities = 235/310 (75%), Positives = 274/310 (88%)

Query:     2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct:    19 DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78

Query:    62 RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct:    79 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138

Query:   122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
             RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct:   139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198

Query:   182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
             DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct:   199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258

Query:   242 VANPSRRITIKEIKSHPWFLKNLPRELTE--TAQAIYYRKENPTFSLQSVEEITKIVEEA 299
             VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct:   259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315

Query:   300 KVPPPVSRSI 309
              VPP  ++++
Sbjct:   316 TVPPAGTQNL 325

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=IGI;IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IDA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0009931 "calcium-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:2000377 "regulation of reactive oxygen species metabolic process" evidence=IMP

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010118 "stomatal movement" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005985 "sucrose metabolic process" evidence=IMP

GO:0006636 "unsaturated fatty acid biosynthetic process" evidence=IMP

GO:0019432 "triglyceride biosynthetic process" evidence=IMP

GO:0040007 "growth" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0042744 "hydrogen peroxide catabolic process" evidence=RCA

TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1209 (430.6 bits), Expect = 5.7e-123, P = 5.7e-123
 Identities = 225/308 (73%), Positives = 269/308 (87%)

Query:     2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             ++Y+ +KDIGSGNFGVARLMR+K TKELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct:    20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 79

Query:    62 RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             RFKEV+LTPTHLAI+MEYA+GGEL+ERICNAGRFSEDEAR+FFQQL+SGVSYCHSMQICH
Sbjct:    80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139

Query:   122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
             RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R+EYDGK+A
Sbjct:   140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199

Query:   182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
             DVWSCGVTLYVMLVGAYPFED E+P+++RKTI RI++V+Y IPD + IS +C +L+SRIF
Sbjct:   200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259

Query:   242 VANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKV 301
             VA+P+ RI+I EIK+H WFLKNLP +L   +      +E P   +QS++ I +I+ EA +
Sbjct:   260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE-PEQPMQSLDTIMQIISEATI 318

Query:   302 PPPVSRSI 309
             P   +R +
Sbjct:   319 PAVRNRCL 326

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IGI

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0009739 "response to gibberellin stimulus" evidence=IGI

GO:0010029 "regulation of seed germination" evidence=IGI;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009414 "response to water deprivation" evidence=IGI

TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1189 (423.6 bits), Expect = 7.4e-121, P = 7.4e-121
 Identities = 226/309 (73%), Positives = 266/309 (86%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             ME+YE++KDIGSGNFGVA+L+R+K +KEL A+K+IERG KID +V REI+NH+ L HPNI
Sbjct:     1 MERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
             IRFKEV+LT THLA+VMEYAAGGELF RIC+AGRFSEDEAR+FFQQLISGV+YCHS+QIC
Sbjct:    61 IRFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQIC 120

Query:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
             HRDLKLENTLLDGS APR+KICDFGYSKS +LHS+PK+TVGTPAYIAPEVLS +EYDGK+
Sbjct:   121 HRDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKI 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
             ADVWSCGVTLYVMLVGAYPFED  DPK+FRKTI RI+  QY IPDYV +S +CR+LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRI 240

Query:   241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
             FVANP +RITI+EIK+H WFLKNLP E+ E +  +      P  S Q+VEEI  I+EEA+
Sbjct:   241 FVANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMM----NGP--STQTVEEIVWIIEEAR 294

Query:   301 VPPPVSRSI 309
              P  V+  +
Sbjct:   295 KPITVATGL 303

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0080167 "response to karrikin" evidence=IEP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IGI

TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1172 (417.6 bits), Expect = 4.7e-119, P = 4.7e-119
 Identities = 218/303 (71%), Positives = 257/303 (84%)

Query:     1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
             ME+Y++++D+GSGNFGVA+L+R K   E  A+KYIERG KID +V REIINH+ L+HPNI
Sbjct:     1 MERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNI 60

Query:    61 IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
             IRFKEV +TPTHLAIVMEYAAGGELFERICNAGRFSEDE RY+F+QLISGVSYCH+MQIC
Sbjct:    61 IRFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQIC 120

Query:   121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
             HRDLKLENTLLDGSP+  LKICDFGYSKSS+LHS+PKSTVGTPAY+APEVLSR+EY+GK+
Sbjct:   121 HRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKI 180

Query:   181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
             ADVWSCGVTLYVMLVGAYPFED EDP+N R TI RI++V Y IPDYV IS +C++LLSRI
Sbjct:   181 ADVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRI 240

Query:   241 FVANPSRRITIKEIKSHPWFLKN---LPRELTETAQAIYYRKENPTFSLQSVEEITKIVE 297
             FVA+P +RIT+ EI+ HPWFLK    +P E  +    +   +E      QSVEEI KI+E
Sbjct:   241 FVADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEIVKIIE 300

Query:   298 EAK 300
             EA+
Sbjct:   301 EAR 303

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)]

 Score = 554 (200.1 bits), Expect = 1.5e-53, P = 1.5e-53
 Identities = 121/271 (44%), Positives = 161/271 (59%)

Query:     4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPN 59
             Y L K +G G+FG  +L  +  T   VA+K + R      K+D  + REI N K  RHP+
Sbjct:    31 YRLDKTLGIGSFGKVKLAEHIRTGVKVAIKILNRTKIKNLKMDEKIRREIQNMKLFRHPH 90

Query:    60 IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
             II+  EV+ T T + +VMEY  GGELFE I   G+  EDE+R  FQQ+ISGV YCH   +
Sbjct:    91 IIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDESRRLFQQMISGVDYCHHHMV 150

Query:   120 CHRDLKLENTLLDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
              HRDLK EN LLD  P  + +KI DFG S         K++ G+P Y APEV+S + Y G
Sbjct:   151 VHRDLKPENLLLD--PINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAAPEVISGKLYAG 208

Query:   179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 238
                DVWSCGV LY  L    PF+D+  P  F+K    +    + IPD+V  S  C +L+ 
Sbjct:   209 PEVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGV----FSIPDFV--SPSCADLIK 262

Query:   239 RIFVANPSRRITIKEIKSHPWFLKNLPRELT 269
             ++ V +P +RITI EI++HPWF   LP+ L+
Sbjct:   263 KMLVVDPVKRITIHEIRNHPWFQVKLPKYLS 293

GO:0046956 "positive phototaxis" evidence=IMP

GO:0008283 "cell proliferation" evidence=IMP

GO:0007005 "mitochondrion organization" evidence=IMP

GO:0006754 "ATP biosynthetic process" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007165 "signal transduction" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=ISS

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

POMBASE|SPCC74.03c ssp2 "serine/threonine protein kinase Ssp2" [Schizosaccharomyces pombe (taxid:4896)]

 Score = 549 (198.3 bits), Expect = 4.9e-53, P = 4.9e-53
 Identities = 124/279 (44%), Positives = 172/279 (61%)

Query:     4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDAN--VAREIINHKQLRHPN 59
             Y + + +G G+FG  +L  +  T++ VA+K+I R    K D +  V REI   K LRHP+
Sbjct:    34 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 93

Query:    60 IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
             II+  +V+ TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I  + YCH  +I
Sbjct:    94 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 152

Query:   120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
              HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV++ + Y G 
Sbjct:   153 VHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 210

Query:   180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
               DVWSCG+ LYVMLVG  PF+D+  P  F+K  S +    Y +PD+  +S   ++L+ R
Sbjct:   211 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV----YVMPDF--LSPGAQSLIRR 264

Query:   240 IFVANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIY 276
             + VA+P +RITI+EI+  PWF  NLP  L   E  Q  Y
Sbjct:   265 MIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 303

GO:0004674 "protein serine/threonine kinase activity" evidence=ISM

GO:0005524 "ATP binding" evidence=ISM

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISM

GO:0007165 "signal transduction" evidence=IC

GO:0031593 "polyubiquitin binding" evidence=TAS

GO:0044732 "mitotic spindle pole body" evidence=IDA

GO:0046015 "regulation of transcription by glucose" evidence=ISO

GO:0051519 "activation of bipolar cell growth" evidence=IMP

GO:2000766 "negative regulation of cytoplasmic translation" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9C958	SRK2B_ARATH	2, ., 7, ., 1, 1, ., 1	0.8310	1.0	0.9722	yes	no
Q9FFP9	SRK2H_ARATH	2, ., 7, ., 1, 1, ., 1	0.8333	0.8888	0.8666	no	no
A2ZAB5	SAPK3_ORYSI	2, ., 7, ., 1, 1, ., 1	0.7305	0.9458	0.9940	N/A	no
P0C5D6	SAPK3_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7305	0.9458	0.9940	no	no
O64812	SRK2J_ARATH	2, ., 7, ., 1, 1, ., 1	0.7366	0.9515	0.9852	no	no
Q5N942	SAPK4_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7611	0.9886	0.9638	no	no
Q02066	AAIP_WHEAT	2, ., 7, ., 1, 1, ., 1	0.7441	0.8547	0.9036	N/A	no
Q9M9E9	SRK2C_ARATH	2, ., 7, ., 1, 1, ., 1	0.7385	0.8547	0.8746	no	no
Q7XQP4	SAPK7_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7910	1.0	0.9777	yes	no
Q75LR7	SAPK1_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7715	0.8575	0.8801	no	no
P43292	SRK2G_ARATH	2, ., 7, ., 1, 1, ., 1	0.7714	0.9857	0.9801	no	no
P43291	SRK2A_ARATH	2, ., 7, ., 1, 1, ., 1	0.8402	1.0	0.9669	no	no
Q39193	SRK2I_ARATH	2, ., 7, ., 1, 1, ., 1	0.7266	0.8831	0.8587	no	no
Q39192	SRK2D_ARATH	2, ., 7, ., 1, 1, ., 1	0.7170	0.8831	0.8563	no	no
Q7XKA8	SAPK5_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7287	1.0	0.9486	no	no
Q940H6	SRK2E_ARATH	2, ., 7, ., 1, 1, ., 1	0.7337	0.9059	0.8784	no	no
Q75H77	SAPKA_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7491	0.8831	0.8563	no	no
A2YNT8	SAPK2_ORYSI	2, ., 7, ., 1, 1, ., 1	0.7492	0.9031	0.9351	N/A	no
Q6ZI44	SAPK6_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8364	0.9173	0.8821	no	no
Q0D4J7	SAPK2_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7523	0.9031	0.9351	no	no
Q7Y0B9	SAPK8_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7483	0.8689	0.8221	no	no
Q75V57	SAPK9_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7363	0.8831	0.8587	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	351
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-101
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-87
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-67
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-66
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-64
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-60
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-59
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-54
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-54
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-52
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-51
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-48
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-47
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-46
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-46
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-46
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-46
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	5e-45
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-44
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-44
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-43
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-43
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-43
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-42
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-41
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-41
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-41
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-40
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-40
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-39
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-39
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-39
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-39
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-39
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-39
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-39
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-39
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-38
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-38
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-38
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-38
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-37
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-37
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-37
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-36
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-36
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-36
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-36
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-36
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-36
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-35
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-35
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-35
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-35
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-34
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-34
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-34
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-34
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-34
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-34
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-34
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-33
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-33
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-33
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-33
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-33
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-33
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-33
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-33
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-33
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-32
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-32
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-32
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-32
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-32
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-32
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-31
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-31
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-31
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-31
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-31
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-31
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-30
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-30
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-30
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-30
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-30
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-30
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-30
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-30
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-29
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-29
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-29
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-29
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-29
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-28
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-28
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-28
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-28
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-28
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-28
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-28
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-28
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-27
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-27
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-27
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-27
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-27
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-27
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-27
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-27
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-26
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-26
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-26
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-26
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-26
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-25
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-25
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-25
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-25
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-25
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-25
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-25
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-25
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-25
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-24
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-24
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-24
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-24
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-24
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-24
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-24
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	7e-24
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-24
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-24
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-23
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-23
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-23
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-23
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-23
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-23
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-22
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-22
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-22
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-22
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-22
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-21
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-21
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-21
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-21
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-20
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-20
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-20
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-19
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-19
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-19
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-18
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-18
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-18
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-18
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-18
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-18
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-18
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-17
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-17
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-17
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-17
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-16
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-16
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-16
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-15
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-15
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-14
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-13
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-11
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-11
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-09
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	9e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-08
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.003
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  298 bits (766), Expect = e-101
 Identities = 98/260 (37%), Positives = 148/260 (56%), Gaps = 9/260 (3%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNII 61
           YE+++ +G G+FG   L R+K T +LVA+K I++         + REI   K+L+HPNI+
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           R  +V      L +VMEY  GG+LF+ +   GR SEDEAR++ +Q++S + Y HS  I H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RDLK EN LLD      +K+ DFG ++      +  + VGTP Y+APEVL  + Y     
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA-V 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVHISQDCRNLLSRI 240
           D+WS GV LY +L G  PF   +      +   +I   +   P     IS + ++L+ ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 241 FVANPSRRITIKEIKSHPWF 260
            V +P +R+T +E   HP+F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  262 bits (671), Expect = 6e-87
 Identities = 104/263 (39%), Positives = 147/263 (55%), Gaps = 9/263 (3%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPNI 60
           YEL++ +GSG+FG     ++K T ++VA+K +       K D    REI   ++L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +R  +      HL +VMEY  GG+LF+ +   G  SEDEA+    Q++ G+ Y HS  I 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGK 179
           HRDLK EN LLD +    +KI DFG +K  L  S   +T VGTP Y+APEVL      G 
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH--ISQDCRNLL 237
             DVWS GV LY +L G  PF   E+  +  + I RI+    +  +      S++ ++L+
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 238 SRIFVANPSRRITIKEIKSHPWF 260
            +    +PS+R T +EI  HPWF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  211 bits (540), Expect = 1e-67
 Identities = 88/253 (34%), Positives = 125/253 (49%), Gaps = 42/253 (16%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPNIIRFKEVV 67
           +G G FG   L R+K T + VA+K I++         + REI   K+L HPNI++   V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 68  LTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKL 126
               HL +VMEY  GG L + +  N G+ SEDE      Q++ G+ Y HS  I HRDLK 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 127 ENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
           EN LLD S   ++K+ DFG SK  +   S  K+ VGTPAY+APEVL  + Y  + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            GV LY +                                      + ++L+ ++   +P
Sbjct: 180 LGVILYEL-------------------------------------PELKDLIRKMLQKDP 202

Query: 246 SRRITIKEIKSHP 258
            +R + KEI  H 
Sbjct: 203 EKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  208 bits (531), Expect = 9e-66
 Identities = 92/262 (35%), Positives = 138/262 (52%), Gaps = 20/262 (7%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           KYE++K IG G+FG   L+R K+  +L  +K I       K   +   E+   K+L HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSYCH 115
           II++ E       L IVMEYA GG+L ++I    +    F E++   +F QL   + Y H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KSTVGTPAYIAPEVLSR 173
           S +I HRD+K +N  L       +K+ DFG SK  L  +    K+ VGTP Y++PE+   
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISK-VLSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQD 232
           + Y+ K +D+WS G  LY +    +PFE +    N  +   +I+  QY  IP     S +
Sbjct: 178 KPYNYK-SDIWSLGCVLYELCTLKHPFEGE----NLLELALKILKGQYPPIPS--QYSSE 230

Query: 233 CRNLLSRIFVANPSRRITIKEI 254
            RNL+S +   +P  R +I +I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  204 bits (522), Expect = 2e-64
 Identities = 96/261 (36%), Positives = 145/261 (55%), Gaps = 21/261 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LRHPNIIRFKE 65
           +G G+FG   L+R K+T +L AMK +++   I        +  +     + HP I++   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
              T   L +V+EYA GGELF  +   GRFSE+ AR++  +++  + Y HS+ I +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 126 LENTLLD--GSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
            EN LLD  G     +K+ DFG +K      SR  +  GTP Y+APEVL  + Y GK  D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175

Query: 183 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 242
            WS GV LY ML G  PF   ED K   +   +I+    + P+++  S + R+L+S +  
Sbjct: 176 WWSLGVLLYEMLTGKPPFYA-EDRK---EIYEKILKDPLRFPEFL--SPEARDLISGLLQ 229

Query: 243 ANPSRRIT---IKEIKSHPWF 260
            +P++R+     +EIK+HP+F
Sbjct: 230 KDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  194 bits (495), Expect = 2e-60
 Identities = 86/268 (32%), Positives = 133/268 (49%), Gaps = 32/268 (11%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNIIRFK-- 64
           +G G+FG   L  +K+T EL+A+K +E     +  +    REI     L+HPNI+R+   
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           E       L I +EY +GG L   +   G+  E   R + +Q++ G++Y HS  I HRD+
Sbjct: 68  ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127

Query: 125 KLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           K  N L+D      +K+ DFG +K            S  GTP ++APEV+ R E  G+ A
Sbjct: 128 KGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGEEYGRAA 184

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI---------PDYVHISQD 232
           D+WS G T+  M  G  P+ +  +P          MA  YKI         P+  H+S++
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNP----------MAALYKIGSSGEPPEIPE--HLSEE 232

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWF 260
            ++ L +    +P +R T  E+  HP+ 
Sbjct: 233 AKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  192 bits (490), Expect = 3e-59
 Identities = 89/281 (31%), Positives = 148/281 (52%), Gaps = 50/281 (17%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--------- 54
           +E +K +G+G+FG   L+R+K + +  A+K + +          +I+  KQ         
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK---------AKIVKLKQVEHVLNEKR 53

Query: 55  ----LRHPNIIR----FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ 106
               +RHP ++     F++     ++L +VMEY  GGELF  +  +GRF E  AR++  Q
Sbjct: 54  ILQSIRHPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ 109

Query: 107 LISGVSYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 164
           ++  + Y HS+ I +RDLK EN LLD  G     +KI DFG++K   +  R  +  GTP 
Sbjct: 110 VVLALEYLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPE 163

Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 224
           Y+APE++  + Y GK  D W+ G+ +Y ML G  PF D    + + K    I+  + + P
Sbjct: 164 YLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK----ILEGKVRFP 218

Query: 225 DYVHISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
                S D ++L+  +   + ++R+      + +IK+HPWF
Sbjct: 219 --SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  179 bits (457), Expect = 2e-54
 Identities = 84/291 (28%), Positives = 137/291 (47%), Gaps = 47/291 (16%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-----RHP 58
           ++  K IG G+F    L + K T +  A+K +++   I     + +   K++      HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 59  NIIR----FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
            II+    F++      +L  V+EYA  GEL + I   G   E   R++  +++  + Y 
Sbjct: 63  GIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSLLH 153
           HS  I HRDLK EN LLD      +KI DFG +K                          
Sbjct: 119 HSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 213
            R  S VGT  Y++PE+L+ +   GK +D+W+ G  +Y ML G  PF    +   F+K  
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK-- 233

Query: 214 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK----EIKSHPWF 260
             I+ ++Y  P   +   D ++L+ ++ V +P  R+ +     E+K+HP+F
Sbjct: 234 --ILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  178 bits (455), Expect = 2e-54
 Identities = 87/267 (32%), Positives = 139/267 (52%), Gaps = 23/267 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPNIIRFKE 65
           I  G +G   L + K+T ++ A+K I++   I  N   +++  +    Q + P +++   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                 +L +VMEY  GG+L   + N G   ED AR +  +++  + Y HS  I HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 126 LENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKST---VGTPAYIAPEVLSRREY 176
            +N L+D +    LK+ DFG SK  L      L+   K     VGTP YIAPEV+  + +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
             K  D WS G  LY  LVG  PF      +   +    I+  + + P+ V +S +  +L
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG----ETPEEIFQNILNGKIEWPEDVEVSDEAIDL 233

Query: 237 LSRIFVANPSRRI---TIKEIKSHPWF 260
           +S++ V +P +R+   +I+EIK+HP+F
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  173 bits (441), Expect = 2e-52
 Identities = 80/262 (30%), Positives = 133/262 (50%), Gaps = 14/262 (5%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNII 61
            +E+++ IG G FG     R+K T + VA+K I     +    +  EI   K+ +HPNI+
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQIC 120
           ++    L    L IVME+ +GG L + + +  +  +E +  Y  ++L+ G+ Y HS  I 
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGII 120

Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRD+K  N LL  DG     +K+ DFG S          + VGTP ++APEV++ + YD 
Sbjct: 121 HRDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIPDYVHISQDCRNLL 237
           K AD+WS G+T   +  G  P+ +        K + +I       + +    S + ++ L
Sbjct: 177 K-ADIWSLGITAIELAEGKPPYSEL----PPMKALFKIATNGPPGLRNPEKWSDEFKDFL 231

Query: 238 SRIFVANPSRRITIKEIKSHPW 259
            +    NP +R T +++  HP+
Sbjct: 232 KKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  169 bits (431), Expect = 9e-51
 Identities = 83/263 (31%), Positives = 136/263 (51%), Gaps = 20/263 (7%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LRHPNIIRFKE 65
           +G G FG   L++ K+     A+K +++ H ++      I + K+      HP I++   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                 ++ ++MEY  GGEL+  + + G F E  AR++   ++    Y H+  I +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 126 LENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            EN LLD +    +K+ DFG++K      +  +  GTP Y+APE++  + YD    D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177

Query: 186 CGVTLYVMLVGAYPF-EDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLSRIFV 242
            G+ LY +L G  PF ED EDP    +  + I+    K+  P+Y  I +  ++L+ ++  
Sbjct: 178 LGILLYELLTGRPPFGEDDEDP---MEIYNDILKGNGKLEFPNY--IDKAAKDLIKQLLR 232

Query: 243 ANPSRRI-----TIKEIKSHPWF 260
            NP  R+      IK+IK H WF
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  163 bits (414), Expect = 3e-48
 Identities = 83/269 (30%), Positives = 137/269 (50%), Gaps = 18/269 (6%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERG-HKIDANVAREIINHKQLRHPN 59
           +++    IG G FG      N +T EL+A+K I  +    K    +A E+   + L+HPN
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEA--RYFFQQLISGVSYCHSM 117
           ++++  V +    + I MEY +GG L E +   GR   DE   R +  QL+ G++Y HS 
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSH 118

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLS 172
            I HRD+K  N  LD +    +K+ DFG +      ++ +    +S  GTPAY+APEV++
Sbjct: 119 GIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 173 RREYDGKL--ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
             +  G    AD+WS G  +  M  G  P+ + ++   F+         +  IPD + +S
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGHKPPIPDSLQLS 234

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPW 259
            + ++ L R   ++P +R T  E+  HP+
Sbjct: 235 PEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  163 bits (414), Expect = 1e-47
 Identities = 98/298 (32%), Positives = 144/298 (48%), Gaps = 34/298 (11%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--------KQLRHPN 59
           K +G G FG   L+R K T +  AMK +    K +  +A++ + H        +  RHP 
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKIL----KKEVIIAKDEVAHTLTESRVLQNTRHPF 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S + Y HS  +
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDG 178
            +RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL   +Y G
Sbjct: 117 VYRDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 173

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 238
           +  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    +S + ++LL+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLSPEAKSLLA 227

Query: 239 RIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEE 291
            +   +P +R+       KEI  H +F        +   Q +  +K  P F  Q   E
Sbjct: 228 GLLKKDPKQRLGGGPEDAKEIMEHRFF-------ASINWQDVVQKKLEPPFKPQVTSE 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  164 bits (416), Expect = 2e-47
 Identities = 89/331 (26%), Positives = 148/331 (44%), Gaps = 30/331 (9%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHP 58
            Y +++ +G G+FG   L R++   +LVA+K + +  +  +       REI     L HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 59  -NIIRFKEVVLTPTHLAIVMEYAAGGELFERICN---AGRFSEDEARYFFQQLISGVSYC 114
            NI++  +       L +VMEY  GG L + +      G  SE EA +   Q++S + Y 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSLLHSRPKSTVGTPAYIA 167
           HS  I HRD+K EN LLD      +K+ DFG +K       +S + + P ++VGTP Y+A
Sbjct: 118 HSKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 168 PEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-------MA 218
           PEVL      Y    +D+WS G+TLY +L G  PFE +++     +T+  I       +A
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYR 278
                 +   IS+   +LL ++   +P  R++     SH        +        +   
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL--AHLKLKESDLSDLLKP 294

Query: 279 KENPTFSLQSVEEITKIVEEAKVPPPVSRSI 309
            ++    L     +  ++            +
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDL 325

Length = 384

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  159 bits (405), Expect = 1e-46
 Identities = 84/286 (29%), Positives = 134/286 (46%), Gaps = 33/286 (11%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNI 60
           YE ++ +G G +GV    R+K T E+VA+K I   ++ +   +   REI   K+L+HPNI
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQI 119
           ++  +V+ T   L +V EY    +L + +    G  S +  +    QL+ G++YCHS +I
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRREYD 177
            HRDLK +N L++      LK+ DFG +++  +  R  +  V T  Y APE+L   + Y 
Sbjct: 120 LHRDLKPQNILINRD--GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYS 177

Query: 178 GKLADVWSCGVTLYVMLVGAYPF-----EDQ-------------EDPKNFRK--TISRIM 217
             + D+WS G     M+ G   F      DQ             E      K        
Sbjct: 178 TAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236

Query: 218 AVQYKIPDYVHIS---QDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                      +     +  +LLS++   NP++RI+ KE   HP+F
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  158 bits (402), Expect = 1e-46
 Identities = 75/267 (28%), Positives = 138/267 (51%), Gaps = 20/267 (7%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LRHPN 59
           +EL++ IG G FG   +++ ++TK++ AMKY+ +   ++    R ++N ++    L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           ++          ++ +V++   GG+L   +    +FSE++ +++  +++  + Y HS  I
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 177
            HRD+K +N LLD      + I DF    ++ +     +T   GTP Y+APEVL R+ Y 
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNI--ATKVTPDTLTTSTSGTPGYMAPEVLCRQGY- 176

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDY-VHISQDCRN 235
               D WS GVT Y  L G  P+       + R    +I A Q      Y    S +  +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQIRAKQETADVLYPATWSTEAID 231

Query: 236 LLSRIFVANPSRRI--TIKEIKSHPWF 260
            ++++   +P +R+   +K++K+HP+F
Sbjct: 232 AINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  160 bits (407), Expect = 3e-46
 Identities = 90/308 (29%), Positives = 140/308 (45%), Gaps = 69/308 (22%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + +E++K IG G FG   L+R+K+T ++ AMK + +          ++I   Q+ H   +
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK---------SDMIKRNQIAH---V 48

Query: 62  RFKEVVLTPT----------------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQ 105
           R +  +L                   HL +VMEY  GG+L   +     F E+ AR++  
Sbjct: 49  RAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA 108

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----------------- 148
           +L+  +   H +   HRD+K +N L+D      +K+ DFG  K                 
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 149 -----SSLLHSRPK--------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV 195
                + L+  R          STVGTP YIAPEVL    Y G   D WS GV LY ML 
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLY 225

Query: 196 GAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDCRNLLSRIFVANPSRRIT-IK 252
           G  PF         ++T ++I+  +   + P    +S +  +L+ R  + +P  R+   +
Sbjct: 226 GFPPFYSD----TLQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFE 280

Query: 253 EIKSHPWF 260
           EIKSHP+F
Sbjct: 281 EIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  156 bits (397), Expect = 7e-46
 Identities = 88/274 (32%), Positives = 130/274 (47%), Gaps = 36/274 (13%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHP 58
            Y+L   IG G FGV     N  T + VA+K I    KI     + I+      K L+HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISL-EKIKEEALKSIMQEIDLLKNLKHP 59

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE-ARYFFQQLISGVSYCHSM 117
           NI+++   + T   L I++EYA  G L + I   G F E   A Y +Q L  G++Y H  
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-QGLAYLHEQ 118

Query: 118 QICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRR 174
            + HRD+K  N L   DG     +K+ DFG + K + +     S VGTP ++APEV+   
Sbjct: 119 GVIHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--------PDY 226
                 +D+WS G T+  +L G  P+ D              MA  ++I        P+ 
Sbjct: 175 GASTA-SDIWSLGCTVIELLTGNPPYYDLNP-----------MAALFRIVQDDHPPLPE- 221

Query: 227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             IS + ++ L + F  +P+ R T K++  HPW 
Sbjct: 222 -GISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  156 bits (396), Expect = 5e-45
 Identities = 88/262 (33%), Positives = 136/262 (51%), Gaps = 20/262 (7%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-----RHPNIIRFK 64
           +G G+FG   L   K T EL A+K +++   +  +     +  K++     +HP + +  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I  +GRF E  AR++  +++ G+ + H   I +RDL
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 183
           KL+N LLD      +KI DFG  K  +L     ST  GTP YIAPE+LS + Y G   D 
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179

Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 243
           W+ GV LY ML G  PFE  ++ + F+     I+  + + P    +S++ +++L      
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELFQS----ILEDEVRYP--RWLSKEAKSILKSFLTK 233

Query: 244 NPSRRITI-----KEIKSHPWF 260
           NP +R+       ++IK HP+F
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFF 255

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  154 bits (390), Expect = 1e-44
 Identities = 87/286 (30%), Positives = 134/286 (46%), Gaps = 32/286 (11%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVA-REIINHKQLRHPNI 60
           Y+ +  IG G +GV    R+K T E+VA+K I+     +     A REI   K+L HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQI 119
           I+  +V      L +V E+    +L++ I +  R   E   + +  QL+ G+++CHS  I
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDG 178
            HRDLK EN L++      LK+ DFG ++S     RP +  V T  Y APE+L   +   
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYS 177

Query: 179 KLADVWSCGVTLYVMLVGAYPFE-----DQ----------EDPKNFRKTISRIMAVQYKI 223
              D+WS G     +L     F      DQ           DP+ + K  S     ++  
Sbjct: 178 TPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF 237

Query: 224 PDYVHI---------SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           P    +         S    +LLS++   +P +RIT ++  +HP+F
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  153 bits (390), Expect = 2e-44
 Identities = 88/281 (31%), Positives = 142/281 (50%), Gaps = 20/281 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E Y+ ++ IG G  G      ++ T + VA+K +    +    +  EI+  K  +HPNI+
Sbjct: 19  ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIV 78

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + +  L    L +VMEY  GG L + I  N  R +E +  Y  ++++ G+ Y HS  + 
Sbjct: 79  DYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138

Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG++ + +   S+  S VGTP ++APEV+ R++Y 
Sbjct: 139 HRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYG 194

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI---SQDCR 234
            K  D+WS G+    M  G  P+   E P      I+        IP   +    S + +
Sbjct: 195 PK-VDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLIT-----TKGIPPLKNPEKWSPEFK 247

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 275
           + L++  V +P +R + +E+  HP FLK       E A  I
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHP-FLKK-ACPKEEFAPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 4e-43
 Identities = 85/268 (31%), Positives = 140/268 (52%), Gaps = 20/268 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRH 57
           +  E +K +G+G FG   L+R++ ++   A+K +     I     + + N K    ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P IIR          L ++MEY  GGELF  + N+GRFS     ++  +++  + Y HS 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           +I +RDLK EN LLD      +K+ DFG++K   L  R  +  GTP Y+APEV+  + + 
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            K  D W+ G+ +Y MLVG  PF D     N      +I+A + + P   H+    ++L+
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYEKILAGKLEFPR--HLDLYAKDLI 229

Query: 238 SRIFVANPSRRI-----TIKEIKSHPWF 260
            ++ V + +RR+        ++K+H WF
Sbjct: 230 KKLLVVDRTRRLGNMKNGADDVKNHRWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  150 bits (382), Expect = 5e-43
 Identities = 90/295 (30%), Positives = 140/295 (47%), Gaps = 43/295 (14%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LRHPN 59
           ++ +K +G G+ G   L+R K T +L A+K +++   I  N  + ++  ++    L HP 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           +        T T+L +VM+Y  GGELF   +       SE+ AR++  +++  + Y H +
Sbjct: 63  LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122

Query: 118 QICHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSLLHS------ 154
            I +RDLK EN LL  S                 P P  K    G  +SS+         
Sbjct: 123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS 182

Query: 155 -----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF 209
                R  S VGT  YIAPEV+S   +   + D W+ G+ LY ML G  PF+      N 
Sbjct: 183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG----SNR 237

Query: 210 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK----EIKSHPWF 260
            +T S I+  +   P    +S   R+L+ ++ V +PS+R+  K    EIK HP+F
Sbjct: 238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  150 bits (381), Expect = 9e-43
 Identities = 84/277 (30%), Positives = 144/277 (51%), Gaps = 30/277 (10%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPN 59
           ++++  +G G +G   L + K+T E+VA+K +++      N  R ++  +      +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +++         +L + MEY  GG+    + N G  SED AR++  ++   V   H +  
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN L+D S    +K+ DFG SK  +  +   S VG+P Y+APEVL  + YD  
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178

Query: 180 LADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAVQYKIPDYV----HI 229
           + D WS G  LY  L G  PF      E  E+ K +++T+ R        P Y     ++
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR--------PVYDDPRFNL 229

Query: 230 SQDCRNLLSRIFVANPSRRI-TIKEIKSHPWFLKNLP 265
           S +  +L++++ + +PSRR  ++++IK+HP+F K + 
Sbjct: 230 SDEAWDLITKL-INDPSRRFGSLEDIKNHPFF-KEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  146 bits (371), Expect = 4e-42
 Identities = 93/261 (35%), Positives = 130/261 (49%), Gaps = 12/261 (4%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIIN-HKQLRHPN 59
           KYE ++ +G G FG+  L R K  ++LV +K I  E+  K +   A+      K L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSM 117
           II + E  L    L IVMEYA GG L E I         ED   +FF Q++  + + H+ 
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I HRDLK +N LLD      +KI DFG SK     S+  + VGTP YI+PE+   + Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            K +D+W+ G  LY +      FE    P    K +S   A     P     S D R L+
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA-----PISDRYSPDLRQLI 233

Query: 238 SRIFVANPSRRITIKEIKSHP 258
             +   +PS+R  + +I + P
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  146 bits (370), Expect = 1e-41
 Identities = 77/275 (28%), Positives = 137/275 (49%), Gaps = 31/275 (11%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHP 58
            YE+++ IG G+FG  R +R K+  +++  K I+ G+ +     +++++     ++L+HP
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59

Query: 59  NIIRF--KEVVLTPTHLAIVMEYAAGGELFERICNA----GRFSEDEARYFFQQLISGVS 112
           NI+R+  + +  +   L IVMEY  GG+L + I           E+       QL+  + 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 113 YCH-----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPA 164
            CH        + HRDLK  N  LD +    +K+ DFG +K  +L       K+ VGTP 
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAK--ILGHDSSFAKTYVGTPY 175

Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI 223
           Y++PE L+   YD K +D+WS G  +Y +   + PF      +N  +  S+I   ++ +I
Sbjct: 176 YMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFT----ARNQLQLASKIKEGKFRRI 230

Query: 224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           P     S +   ++  +   +P +R + +E+   P
Sbjct: 231 PY--RYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  145 bits (368), Expect = 3e-41
 Identities = 78/293 (26%), Positives = 128/293 (43%), Gaps = 43/293 (14%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           +Y+++  IG G  G+    +++ T E VA+K +        I     REI   +  +HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQ 118
           +++  +V    +   +VMEY     L E + +  R   E + + + + L+ GV+Y H+  
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVL-SRRE 175
           I HRDLK  N L+  S    LKI DFG ++  S          V T  Y APE+L   R+
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------QYK-IP 224
           YD    D+W+ G     +L G+  F  + D +     ++ +                 +P
Sbjct: 178 YDP-GVDLWAVGCIFAELLNGSPLFPGENDIEQ----LAIVFRTLGTPNEETWPGLTSLP 232

Query: 225 DYVHISQ-------------DCR----NLLSRIFVANPSRRITIKEIKSHPWF 260
           DY  I+              D      +LL  + V +PS+R++  E   HP+F
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  145 bits (368), Expect = 4e-41
 Identities = 97/325 (29%), Positives = 159/325 (48%), Gaps = 33/325 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK--------QLRHPNII 61
           IG G+FG    +R ++T+ + A+K I + H     V+R  + H         Q+  P I+
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI----VSRSEVTHTLAERTVLAQVNCPFIV 56

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             K    +P  L +V+ +  GGELF  +   GRF    AR++  +L+  +   H   + +
Sbjct: 57  PLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIY 116

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKL 180
           RDLK EN LLD      + +CDFG  K ++      +T  GTP Y+APE+L    Y  K 
Sbjct: 117 RDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KA 173

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            D W+ GV LY ML G  PF D+   + +RK    I+    + PD     +D ++LL  +
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPD--GFDRDAKDLLIGL 227

Query: 241 FVANPSRRITI---KEIKSHPWFLK-NLPRELTETAQ-----AIYYRKENPTFSLQSVEE 291
              +P+RR+     +EIK+HP+F + +  + L +  Q     A+    +   F  +   E
Sbjct: 228 LSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTRE 287

Query: 292 --ITKIVEEAKVPPPVSRSIGGFGW 314
             I  +V+++ +   V +  GG+ +
Sbjct: 288 KPIDSVVDDSHLSETVQQQFGGWSY 312

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  143 bits (363), Expect = 3e-40
 Identities = 89/261 (34%), Positives = 141/261 (54%), Gaps = 18/261 (6%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQL----RHPNIIR 62
           K +G G+FG   L   K T E  A+K +++     D +V   ++  + L     HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                 T  HL  VMEY  GG+L   I ++GRF E  AR++  ++I G+ + H   I +R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 181
           DLKL+N LLD      +KI DFG  K ++      ST  GTP YIAPE+L  ++Y+  + 
Sbjct: 121 DLKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV- 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHISQDCRNLLSRI 240
           D WS GV LY ML+G  PF  +++ + F        ++    P +   IS++ ++ LS++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFD-------SILNDRPHFPRWISKEAKDCLSKL 230

Query: 241 FVANPSRRITIK-EIKSHPWF 260
           F  +P++R+ +  +I+ HP+F
Sbjct: 231 FERDPTKRLGVDGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  143 bits (363), Expect = 3e-40
 Identities = 88/275 (32%), Positives = 144/275 (52%), Gaps = 38/275 (13%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--------- 54
           +E+ + +G+G+FG  R+ ++K T E  A+K +++         REI+  KQ         
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKK---------REILKMKQVQHVAQEKS 70

Query: 55  ----LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
               L HP I+           +  ++E+  GGELF  +  AGRF  D A+++  +L+  
Sbjct: 71  ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA 130

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
             Y HS  I +RDLK EN LLD      +K+ DFG++K   +  R  +  GTP Y+APEV
Sbjct: 131 FEYLHSKDIIYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEV 186

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           +  + + GK  D W+ GV LY  + G  PF D + P  FR    +I+A + K P++    
Sbjct: 187 IQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWF--D 239

Query: 231 QDCRNLLSRIFVANPSRRI-TIK----EIKSHPWF 260
              R+L+  +   + ++R+ T+K    ++K+HP+F
Sbjct: 240 GRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  142 bits (359), Expect = 1e-39
 Identities = 100/298 (33%), Positives = 147/298 (49%), Gaps = 34/298 (11%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--------KQLRHPN 59
           K +G G FG   L+R K + +  AMK +++    +  +A++ + H        K  RHP 
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKK----EVIIAKDEVAHTLTESRVLKNTRHPF 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +   K    T   L  VMEY  GGELF  +     FSED  R++  +++S + Y HS +I
Sbjct: 57  LTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRREYDG 178
            +RDLKLEN +LD      +KI DFG  K  +  +   K+  GTP Y+APEVL   +Y G
Sbjct: 117 VYRDLKLENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-G 173

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 238
           +  D W  GV +Y M+ G  PF +Q+  K F      I+    K P    +S D ++LLS
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEDIKFPRT--LSADAKSLLS 227

Query: 239 RIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEE 291
            + + +P++R+       KEI  H +F            Q +Y +K  P F  Q   E
Sbjct: 228 GLLIKDPNKRLGGGPDDAKEIMRHSFFTG-------VNWQDVYDKKLVPPFKPQVTSE 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  140 bits (356), Expect = 1e-39
 Identities = 81/274 (29%), Positives = 130/274 (47%), Gaps = 30/274 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPN 59
           E + L++ IG G+FG      +K T ++VA+K I+     D   ++ +EI    Q R P 
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           I ++    L  + L I+MEY  GG   + +   G+  E    +  ++++ G+ Y H    
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEGK 119

Query: 120 CHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREY 176
            HRD+K  N LL  +G     +K+ DFG S   +   S+  + VGTP ++APEV+ +  Y
Sbjct: 120 IHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-------DYVHI 229
           D K AD+WS G+T   +  G  P  D   P          M V + IP       +    
Sbjct: 176 DEK-ADIWSLGITAIELAKGEPPLSDL-HP----------MRVLFLIPKNNPPSLEGNKF 223

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           S+  ++ +S     +P  R + KE+  H  F+K 
Sbjct: 224 SKPFKDFVSLCLNKDPKERPSAKELLKHK-FIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  140 bits (355), Expect = 2e-39
 Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 18/264 (6%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLR---HPN 59
           E +K +G G+ GV   +R+K T ++ A+K I      +    + RE+   K LR    P 
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLREL---KTLRSCESPY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM-Q 118
           +++          ++IV+EY  GG L + +   G+  E    Y  +Q++ G+ Y H+   
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 119 ICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRRE 175
           I HRD+K  N L+   G      KI DFG SK         +T VGT  Y++PE + + E
Sbjct: 121 IIHRDIKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
                AD+WS G+TL    +G +PF     P +F + +  I             S + R+
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPAEEFSPEFRD 234

Query: 236 LLSRIFVANPSRRITIKEIKSHPW 259
            +S     +P +R +  E+  HP+
Sbjct: 235 FISACLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  141 bits (358), Expect = 2e-39
 Identities = 82/264 (31%), Positives = 132/264 (50%), Gaps = 19/264 (7%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIR 62
           K IG G+FG   L ++K   +  A+K +++   +     + I+       K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E  AR++  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 181
           DLK EN LLD      L   DFG  K  + HS+  ST  GTP Y+APEVL ++ YD +  
Sbjct: 121 DLKPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           D W  G  LY ML G  PF  ++  + +   +++ + ++       +IS   R+LL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP------NISVSARHLLEGLL 231

Query: 242 VANPSRRI----TIKEIKSHPWFL 261
             + ++R+       EIK+H +F 
Sbjct: 232 QKDRTKRLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  141 bits (358), Expect = 2e-39
 Identities = 95/311 (30%), Positives = 154/311 (49%), Gaps = 32/311 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-------RHPNIIR 62
           +G G+FG   L   K T EL A+K +++G  I  +    ++  K++       RHP ++ 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                 T  H+  VMEYAAGG+L   I +   FSE  A ++   ++ G+ Y H  +I +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 181
           DLKL+N LLD      +KI DFG  K  +      ST  GTP ++APEVL+   Y  +  
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           D W  GV +Y MLVG  PF   ++ + F   ++    V+Y       +S++  +++ R+ 
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN--DEVRYPR----FLSREAISIMRRLL 236

Query: 242 VANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF--SLQSVEEITK 294
             NP RR+       +++K  P+F +++          +  RK  P F  +++  E+++ 
Sbjct: 237 RRNPERRLGSGEKDAEDVKKQPFF-RDI------NWDDLLARKIKPPFVPTIKGPEDVSN 289

Query: 295 IVEEAKVPPPV 305
             EE     PV
Sbjct: 290 FDEEFTSEAPV 300

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  142 bits (360), Expect = 2e-39
 Identities = 92/276 (33%), Positives = 140/276 (50%), Gaps = 28/276 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E ++++K IG G FG  +L+R+K++K++ AMK + +   I  ++ A     R+I+ H   
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN- 101

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
               I++         +L +VMEY  GG+L   + N     E  AR++  +++  +   H
Sbjct: 102 -SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIH 159

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVL 171
           SM   HRD+K +N LLD S    LK+ DFG       + ++     + VGTP YI+PEVL
Sbjct: 160 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRC--DTAVGTPDYISPEVL 215

Query: 172 SRREYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--AVQYKIPDY 226
             +  D   G+  D WS GV LY MLVG  PF       +   T S+IM        PD 
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMDHKNSLTFPDD 271

Query: 227 VHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
           + IS+  ++L+         R  R  + EIKSHP+F
Sbjct: 272 IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  139 bits (351), Expect = 3e-39
 Identities = 84/265 (31%), Positives = 140/265 (52%), Gaps = 20/265 (7%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           KY  +K IG G+FG A L+++K   +   +K I   +   K      +E+     ++HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARYFFQQLISGVSYCHS 116
           I++++E      +L IVM+Y  GG+L+++I NA R   F ED+   +F Q+   + + H 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSR 173
            +I HRD+K +N  L       +K+ DFG ++  +L+S     ++ +GTP Y++PE+   
Sbjct: 120 RKILHRDIKSQNIFLTKDGT--IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEICEN 175

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           R Y+ K +D+W+ G  LY M    + FE      N +  + +I+   Y  P   H S D 
Sbjct: 176 RPYNNK-SDIWALGCVLYEMCTLKHAFE----AGNMKNLVLKIIRGSYP-PVSSHYSYDL 229

Query: 234 RNLLSRIFVANPSRRITIKEIKSHP 258
           RNL+S++F  NP  R ++  I    
Sbjct: 230 RNLVSQLFKRNPRDRPSVNSILEKN 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  139 bits (352), Expect = 6e-39
 Identities = 82/273 (30%), Positives = 136/273 (49%), Gaps = 21/273 (7%)

Query: 4   YELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERGHKID-ANVAREIINHKQL---- 55
           +EL++ +G+G +G   L+R     +  +L AMK +++   +  A  A      +Q+    
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 56  -RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
            R P ++       T T L ++++Y  GGELF  +     F+E E R +  +++  + + 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPAYIAPEVLS 172
           H + I +RD+KLEN LLD      + + DFG SK  L     R  S  GT  Y+APEV+ 
Sbjct: 122 HQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 173 RREYD-GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-RIMAVQYKIPDYVHIS 230
                  K  D WS GV  + +L GA PF   +  +N +  IS RI+  +   P    +S
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFT-VDGEQNSQSEISRRILKSKPPFPK--TMS 236

Query: 231 QDCRNLLSRIFVANPSRRI---TIKEIKSHPWF 260
            + R+ + ++   +P +R+      EIK+HP+F
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  137 bits (347), Expect = 1e-38
 Identities = 85/266 (31%), Positives = 125/266 (46%), Gaps = 24/266 (9%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRHPNI 60
           ++++K +G G++G    ++  +  +  A+K ++ G        +   EI     + HPNI
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSYCHS 116
           I +KE  L    L IVMEYA  G+L + I    +      E E    F QL+ G+   H 
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKSTVGTPAYIAPEVLSRRE 175
            +I HRDLK  N LL       +KI D G SK  +L     K+ +GTP Y+APEV   R 
Sbjct: 122 QKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRP 177

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFE--DQEDPKNFRKTISRIMAVQY-KIPDYVHISQD 232
           Y  K +D+WS G  LY M   A PFE    +D +       ++   +Y  IP     SQD
Sbjct: 178 YSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRY------KVQRGKYPPIPP--IYSQD 228

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHP 258
            +N +  +    P  R    +I + P
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  138 bits (350), Expect = 2e-38
 Identities = 84/268 (31%), Positives = 151/268 (56%), Gaps = 25/268 (9%)

Query: 7   MKDIGSGNFGVARLMRN---KNTKELVAMKYIERG-----HKIDANVAREIINHKQLRHP 58
           +K +G G+FG   L+R     +  +L AMK +++       ++   + R+I+    + HP
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHP 58

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
            I++      T   L +++++  GG+LF R+     F+E++ +++  +L   + + HS+ 
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      +K+ DFG SK S+ H  +  S  GT  Y+APEV++RR + 
Sbjct: 119 IIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            + AD WS GV ++ ML G+ PF+     K+ ++T++ I+  +  +P +  +S + ++LL
Sbjct: 177 -QSADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLL 229

Query: 238 SRIFVANPSRRI-----TIKEIKSHPWF 260
             +F  NP+ R+      ++EIK HP+F
Sbjct: 230 RALFKRNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 3e-38
 Identities = 89/309 (28%), Positives = 141/309 (45%), Gaps = 60/309 (19%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMK------YIERGHKIDANVAREIINHKQL 55
           + +E +K IG G FG  RL++ K+T  + AMK       +E+         R+I+   + 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL--AEA 58

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            +P +++         +L ++MEY  GG++   +     F+E+E R++  + I  +   H
Sbjct: 59  DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH 118

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SLLHSRPK------- 157
            +   HRD+K +N LLD      +K+ DFG                L H+ P        
Sbjct: 119 KLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 158 ---------------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG 196
                                STVGTP YIAPEV  +  Y  K  D WS GV +Y MLVG
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVG 235

Query: 197 AYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDCRNLLSRIFVANPSRRI---TI 251
             PF   ++P   ++T  +I+  +   + PD V +S + ++L+ R       RR+    +
Sbjct: 236 YPPFC-SDNP---QETYRKIINWKETLQFPDEVPLSPEAKDLIKR-LCCEAERRLGNNGV 290

Query: 252 KEIKSHPWF 260
            EIKSHP+F
Sbjct: 291 NEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  135 bits (342), Expect = 9e-38
 Identities = 77/255 (30%), Positives = 127/255 (49%), Gaps = 12/255 (4%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQLRHPNIIRF 63
           +GSG+FG      N +  +  A+K +      + G +    + +EI    +L+HPNI+++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRD 123
                   +L I +E   GG L + +   G F E   R + +Q++ G+ Y H     HRD
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 124 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 183
           +K  N L+D +    +K+ DFG +K  +  S  KS  G+P ++APEV++++   G  AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 243
           WS G T+  M  G  P+   E      K I R   +   IPD  H+S + ++ + +    
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELP-PIPD--HLSDEAKDFILKCLQR 241

Query: 244 NPSRRITIKEIKSHP 258
           +PS R T  E+  HP
Sbjct: 242 DPSLRPTAAELLEHP 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  137 bits (346), Expect = 1e-37
 Identities = 95/295 (32%), Positives = 146/295 (49%), Gaps = 26/295 (8%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQL---RHPNIIRF 63
           K +G G FG   L+R K T    AMK + +   I  + VA  +   + L   RHP +   
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRD 123
           K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + Y HS  + +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 124 LKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           +KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y G+  D
Sbjct: 121 IKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 183 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 242
            W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S + ++LL+ +  
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAKSLLAGLLK 231

Query: 243 ANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEI 292
            +P +R+       KE+  H +F       L+   Q +  +K  P F  Q   E+
Sbjct: 232 KDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKPQVTSEV 279

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  136 bits (344), Expect = 2e-37
 Identities = 86/272 (31%), Positives = 135/272 (49%), Gaps = 37/272 (13%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH------------ 57
           IG G FG    +R K+T+ + AMK + +         +EI+  K++ H            
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK---------KEIVAKKEVAHTIGERNILVRTL 51

Query: 58  ----PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
               P I+  K    T + L +V +Y +GGELF  +   GRFSED A+++  +L+  + +
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEH 111

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLS 172
            H   I +RDLK EN LLD +    + +CDFG SK++L  ++  +T  GT  Y+APEVL 
Sbjct: 112 LHKYDIVYRDLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL 169

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
             +   K  D WS GV ++ M  G  PF  ++  + +R     I   + + P  V +S +
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----IAFGKVRFPKNV-LSDE 224

Query: 233 CRNLLSRIFVANPSRRI----TIKEIKSHPWF 260
            R  +  +   NP  R+       E+K HP+F
Sbjct: 225 GRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 9e-37
 Identities = 80/262 (30%), Positives = 126/262 (48%), Gaps = 16/262 (6%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-----VAREIINHKQLRHPNII 61
           +K I  G FG   L + ++T +  A+K +++   I  N      A   I   Q   P + 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           +      +  +L +VMEY  GG+    I   G   ED A+ +  +++ GV   H   I H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RD+K EN L+D      LK+ DFG S++ L     K  VGTP Y+APE +     D K++
Sbjct: 121 RDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMS 174

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           D WS G  ++  L G  PF  +     F   +SR   + +        S +  +L++R+ 
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR--INWPEEVKEFCSPEAVDLINRLL 232

Query: 242 VANPSRRI---TIKEIKSHPWF 260
             +P++R+     +EIKSHP+F
Sbjct: 233 CMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  133 bits (335), Expect = 1e-36
 Identities = 91/269 (33%), Positives = 137/269 (50%), Gaps = 29/269 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE----------RGHKIDANVAREIINHKQLRHPN 59
           IGSG+FG   L  N ++ EL+A+K +E          R   +   +AREI   K+L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           I+++    L   HL I +EY  GG +   + N G F E   R F +Q++ G++Y H+  I
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--------RPKSTVGTPAYIAPEVL 171
            HRD+K  N L+D      +KI DFG SK    +S        RP S  G+  ++APEV+
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARP-SLQGSVFWMAPEVV 184

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHIS 230
            +  Y  K AD+WS G  +  ML G +PF D        + I +I      +IP   +IS
Sbjct: 185 KQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDC----TQLQAIFKIGENASPEIPS--NIS 237

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPW 259
            +  + L + F  + ++R T  E+  HP+
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 1e-36
 Identities = 87/271 (32%), Positives = 132/271 (48%), Gaps = 33/271 (12%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERG-------HKIDANVAREIINHKQLRHPNI 60
           K +G G FG   L  + +T   +A+K +           +++A +  EI   K L+H  I
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNA-LECEIQLLKNLQHERI 66

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +++   +     L+I MEY  GG + +++   G  +E   R + +Q++ GV Y HS  I 
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSR---PKSTVGTPAYIAPEVLSRREY 176
           HRD+K  N L D   A  +K+ DFG SK    + S     KS  GTP +++PEV+S   Y
Sbjct: 127 HRDIKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY 184

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI----PDYV---HI 229
            G+ ADVWS G T+  ML    P+ + E            MA  +KI     +     H+
Sbjct: 185 -GRKADVWSVGCTVVEMLTEKPPWAEFEA-----------MAAIFKIATQPTNPQLPSHV 232

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           S D RN L R FV N  +R + +E+  H + 
Sbjct: 233 SPDARNFLRRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  133 bits (336), Expect = 2e-36
 Identities = 84/261 (32%), Positives = 140/261 (53%), Gaps = 18/261 (6%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHPNIIR 62
           K +G G+FG   L   K T +  A+K +++   + D +V   ++  + L     HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                 T  +L  VMEY  GG+L   I +  +F    A ++  ++I G+ + HS  I +R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           DLKL+N LLD      +KI DFG  K ++L  ++  +  GTP YIAPE+L  ++Y     
Sbjct: 121 DLKLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDCRNLLSRI 240
           D WS GV LY ML+G  PF   ++ + F+       +++   P Y   ++++ +++L ++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQ-------SIRMDNPCYPRWLTREAKDILVKL 230

Query: 241 FVANPSRRITIK-EIKSHPWF 260
           FV  P RR+ +K +I+ HP+F
Sbjct: 231 FVREPERRLGVKGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  133 bits (335), Expect = 3e-36
 Identities = 83/261 (31%), Positives = 137/261 (52%), Gaps = 18/261 (6%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQL----RHPNIIR 62
           K +G G+FG   L   K   E  A+K +++    ID +V   ++  + L     +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                 T  HL  VME+  GG+L   I + GRF    A ++  +++ G+ + HS  I +R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           DLKL+N +LD      +KI DFG  K ++   +R  +  GTP YIAPE+L   +Y   + 
Sbjct: 121 DLKLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDCRNLLSRI 240
           D WS GV LY ML+G  PF   ++ + F        +++   P Y   I+++ +++L ++
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKL 230

Query: 241 FVANPSRRITIK-EIKSHPWF 260
           F  +P+RR+ +   I+ HP+F
Sbjct: 231 FERDPTRRLGVVGNIRGHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  132 bits (333), Expect = 7e-36
 Identities = 99/299 (33%), Positives = 146/299 (48%), Gaps = 35/299 (11%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--------KQLRHPN 59
           K +G G FG   L++ K T    AMK +++    +  VA++ + H        +  RHP 
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVLQNSRHPF 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQ 118
           +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S + Y HS   
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRREYD 177
           + +RDLKLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +Y 
Sbjct: 117 VVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY- 173

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    +S + ++LL
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPRT--LSPEAKSLL 227

Query: 238 SRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEE 291
           S +   +P +R+       KEI  H +F            Q +Y +K  P F  Q   E
Sbjct: 228 SGLLKKDPKQRLGGGPDDAKEIMQHKFF-------AGIVWQDVYEKKLVPPFKPQVTSE 279

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  131 bits (330), Expect = 7e-36
 Identities = 86/268 (32%), Positives = 129/268 (48%), Gaps = 23/268 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-----------RGHKIDANVAREIINHKQLRHP 58
           IG G +G   L  N  T E++A+K +E           R   +   +  EI   K L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI+++     T  +L+I +EY  GG +   +   GRF E   R+F +Q++ G++Y HS  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---LLHSRPKSTVGTPAYIAPEV--LSR 173
           I HRDLK +N L+D       KI DFG SK S     + +  S  G+  ++APEV     
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HISQ 231
           + Y  K+ D+WS G  +  M  G  P+ D+E      K  ++  A    IP  V  ++S 
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP--PIPPDVSMNLSP 243

Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPW 259
              + L+  F  NP  R T +E+  HP+
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  130 bits (330), Expect = 1e-35
 Identities = 84/304 (27%), Positives = 130/304 (42%), Gaps = 68/304 (22%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG-HKIDANVA-REIINHKQLR----H 57
           Y+++K +G G FG   L RNK T ELVA+K +++  +  +  +  RE+   K LR    H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISGVSYCH 115
           PNI++ KEV      L  V EY   G L++ +       FSE   R    Q++ G+++ H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 173
                HRDLK EN L+  S    +KI DFG ++   + SRP  T  V T  Y APE+L R
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE---------DQEDPKNFRKTISRIMAV----- 219
                   D+W+ G     ++   Y            DQ         + +I +V     
Sbjct: 173 STSYSSPVDIWALG----CIMAELYTLRPLFPGSSEIDQ---------LYKICSVLGTPT 219

Query: 220 --------------QYKIPDYVHI---------SQDCRNLLSRIFVANPSRRITIKEIKS 256
                          ++ P +            S +  +L+  +   +P +R T  +   
Sbjct: 220 KQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Query: 257 HPWF 260
           HP+F
Sbjct: 280 HPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  131 bits (332), Expect = 1e-35
 Identities = 100/341 (29%), Positives = 167/341 (48%), Gaps = 43/341 (12%)

Query: 4   YELMKDIGSGNFGVARLMRN---KNTKELVAMKYIERGHKID-------ANVAREIINHK 53
           +EL+K +G+G +G   L+R     +T +L AMK +++   +            R ++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           + + P ++       T   L ++++Y +GGE+F  +     FSEDE R++  ++I  + +
Sbjct: 62  R-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAYIAPEVL 171
            H + I +RD+KLEN LLD      + + DFG SK  L     R  S  GT  Y+APE++
Sbjct: 121 LHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-RIMAVQYKIPDYVHIS 230
             +   GK  D WS G+ ++ +L GA PF   E  +N +  +S RI+      P +  I 
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFT-LEGERNTQSEVSRRILKCDPPFPSF--IG 235

Query: 231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF- 284
            + ++LL ++   +P +R+        EIK HP+F K L  E      A+  RK NP F 
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF-KGLDWE------ALALRKVNPPFR 288

Query: 285 -SLQSVEEITKIVEE----------AKVPPPVSRSIGGFGW 314
            S+++  ++    EE          A  PP  +R   G+ +
Sbjct: 289 PSIRNELDVGNFAEEFTNLEPVYSPAGTPPSGARVFQGYSF 329

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  129 bits (326), Expect = 2e-35
 Identities = 85/255 (33%), Positives = 139/255 (54%), Gaps = 21/255 (8%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPN 59
           +Y +++ +G G+FG A L+++ N+ +  AMK I R  K  + V    +E +   +++HPN
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDSRKEAVLLAKMKHPN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGR-FSEDEARYFFQQLISGVSYCHSM 117
           I+ FKE      HL IVMEY  GG+L ++I    G+ F ED    +F Q+  GV + H  
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS----TVGTPAYIAPEVLSR 173
           ++ HRD+K +N  L  +   ++K+ DFG   S+ L + P +     VGTP Y+ PE+   
Sbjct: 120 RVLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWEN 174

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
             Y+ K +D+WS G  LY +    +PF+      +++  I ++    YK P   H S + 
Sbjct: 175 MPYNNK-SDIWSLGCILYELCTLKHPFQ----ANSWKNLILKVCQGSYK-PLPSHYSYEL 228

Query: 234 RNLLSRIFVANPSRR 248
           R+L+ ++F  NP  R
Sbjct: 229 RSLIKQMFKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 3e-35
 Identities = 85/296 (28%), Positives = 131/296 (44%), Gaps = 48/296 (16%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ER-GHKIDANVAREIINHKQLRHP 58
           YE +  IG G +G     RNK T ELVA+K I    E+ G  I A   REI   ++LRHP
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA--IREIKLLQKLRHP 58

Query: 59  NIIRFKEVVLTPTHLAI--VMEYA----AGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           NI+R KE+V +    +I  V EY      G  L +      +F+E + + + +QL+ G+ 
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQ 114

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRD+K  N L++      LK+ DFG ++     +    T  V T  Y  PE+
Sbjct: 115 YLHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 171 L-SRREYDGKLADVWSCGVTLYVMLVGAYPFE---DQE------------DPKNFRKTIS 214
           L     Y  ++ D+WS G  L  + +G   F+   + E              +N+     
Sbjct: 173 LLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231

Query: 215 RIMAVQYKIP--------DYVH--ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                  K          ++    I     +LL ++   +P +RI+  +   H +F
Sbjct: 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  128 bits (324), Expect = 1e-34
 Identities = 92/286 (32%), Positives = 138/286 (48%), Gaps = 35/286 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------VAREIINHKQL 55
           E +E +K I +G +G   L+R+K T++  AMK I + + I  N      V R+I+   + 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            +P ++       T  HL +VMEY  GG+    + N G    D AR +F + +  + Y H
Sbjct: 60  -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----------------KST 159
           +  I HRDLK +N L+  +    +K+ DFG SK  L+                    K  
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            GTP YIAPEV+ R+ Y GK  D W+ G+ LY  LVG  PF      + F + IS     
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS----D 231

Query: 220 QYKIPDYVH-ISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFL 261
             + P+    +  D ++L+SR+   NP  R+      E+K H +FL
Sbjct: 232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  128 bits (324), Expect = 2e-34
 Identities = 81/267 (30%), Positives = 129/267 (48%), Gaps = 25/267 (9%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA------REIINHKQLRHPNIIRF 63
           +G G+FG  +++R K T ++ AMK +++   +           R+I++      P I + 
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS--ISNSPWIPQL 66

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
           +       +L +VMEY  GG+L   +     +F ED A+++  +L+  +   H M   HR
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHR 126

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           D+K EN L+D +    +K+ DFG +   ++      K  VGTP YIAPEVL+    DGK 
Sbjct: 127 DIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKG 184

Query: 181 A-----DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHISQDC 233
                 D WS GV  Y M+ G  PF   E      KT + IM  Q   K P+   +S D 
Sbjct: 185 TYGVECDWWSLGVIAYEMIYGRSPFH--EG--TSAKTYNNIMNFQRFLKFPEDPKVSSDF 240

Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWF 260
            +L+  + +     R+  + +  HP+F
Sbjct: 241 LDLIQSL-LCGQKERLGYEGLCCHPFF 266

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  128 bits (324), Expect = 2e-34
 Identities = 89/268 (33%), Positives = 136/268 (50%), Gaps = 23/268 (8%)

Query: 7   MKDIGSGNFG---VARLMRNKNTKELVAMKY-----IERGHKIDANVAREIINHKQLRHP 58
           +K +G G +G     R +   +T ++ AMK      I R  K  A+   E    + ++HP
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
            I+       T   L +++EY +GGELF  +   G F ED A ++  ++   + + H   
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      +K+ DFG  K S+       T  GT  Y+APE+L R  + 
Sbjct: 121 IIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH- 177

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           GK  D WS G  +Y ML GA PF  +    N +KTI +I+  +  +P Y  ++ + R+LL
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAE----NRKKTIDKILKGKLNLPPY--LTPEARDLL 231

Query: 238 SRIFVANPSRRI-----TIKEIKSHPWF 260
            ++   NPS R+        E++SHP+F
Sbjct: 232 KKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  127 bits (320), Expect = 4e-34
 Identities = 77/205 (37%), Positives = 105/205 (51%), Gaps = 17/205 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVA---MKYIERGHKIDANVAREIINHKQLRHP 58
            KYE++  +G G +GV    RNK T E+VA    K  E    +     RE+   +QLRH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           NI+  KE       L +V EY      EL E   + G    D  R +  QL+  ++YCHS
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEVL- 171
             I HRD+K EN L+  S +  LK+CDFG++++  L +RP S     V T  Y APE+L 
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174

Query: 172 SRREYDGKLADVWSCGVTLYVMLVG 196
               Y GK  DVW+ G  +  +L G
Sbjct: 175 GDTNY-GKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  125 bits (316), Expect = 5e-34
 Identities = 83/252 (32%), Positives = 125/252 (49%), Gaps = 16/252 (6%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPN 59
           +E++  IG G+FGV   +  K  K + AMK I+   K++     E I+      +L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGR-FSEDEARYFFQQLISGVSYCHSM 117
           IIR+ E  L    L IVMEYA  G+L + +    GR   ED+   FF Q++ G+++ HS 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREY 176
           +I HRD+K  N  LD      +KI D G +K  S   +   + VGTP Y++PE+   + Y
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K +DVW+ GV LY    G +PF    D  N    I +I+   +  P     SQ    L
Sbjct: 179 NEK-SDVWALGVVLYECCTGKHPF----DANNQGALILKIIRGVFP-PVSQMYSQQLAQL 232

Query: 237 LSRIFVANPSRR 248
           + +    +  +R
Sbjct: 233 IDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 7e-34
 Identities = 87/271 (32%), Positives = 131/271 (48%), Gaps = 26/271 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-----ANVAREIINHKQLR 56
           E YEL++ IGSG +G     R+  T ELVA+K I    K++       + +EI   K+ R
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVI----KLEPGDDFEIIQQEISMLKECR 58

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCH 115
           HPNI+ +    L    L IVMEY  GG L +      G  SE +  Y  ++ + G++Y H
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH 118

Query: 116 SMQICHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEV 170
                HRD+K  N LL  DG     +K+ DFG S    +++  ++ KS +GTP ++APEV
Sbjct: 119 ETGKIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEV 172

Query: 171 L---SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
                +  YDGK  D+W+ G+T   +     P  D   P      IS+      K+ D  
Sbjct: 173 AAVERKGGYDGK-CDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPPPKLKDKE 230

Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
             S    + + +    +P +R T  ++  HP
Sbjct: 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  125 bits (315), Expect = 7e-34
 Identities = 90/268 (33%), Positives = 139/268 (51%), Gaps = 21/268 (7%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           +YE++K IG G+FG   L + K+  E   +K I   +   K      +E+I   +++HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARYFFQQLISGVSYCHS 116
           I+ F         L IVMEY  GG+L +RI N  R   FSED+   +F Q+  G+ + H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 117 MQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPAYIAPEVLS 172
            +I HRD+K +N  L  +G  A   K+ DFG ++  L  S     + VGTP Y++PE+  
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
            R Y+ K  D+WS G  LY +    +PFE      N  + + +I    +  P   + S+D
Sbjct: 176 NRPYNNK-TDIWSLGCVLYELCTLKHPFEGN----NLHQLVLKICQGYFA-PISPNFSRD 229

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWF 260
            R+L+S++F  +P  R +I  I   P+ 
Sbjct: 230 LRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  124 bits (314), Expect = 1e-33
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 13/263 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E +++++ +G G++G      +K T ++VA+K +     +   + +EI   KQ   P I+
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-EIIKEISILKQCDSPYIV 61

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           ++       T L IVMEY   G + +  +I N    +E+E      Q + G+ Y HS + 
Sbjct: 62  KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNKK 120

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREYD 177
            HRD+K  N LL+       K+ DFG S   L  +  K  + +GTP ++APEV+    Y+
Sbjct: 121 IHRDIKAGNILLNEEGQA--KLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            K AD+WS G+T   M  G  P+ D   P      I          P+    S +  + +
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSDIH-PMRAIFMIPNKPPPTLSDPE--KWSPEFNDFV 233

Query: 238 SRIFVANPSRRITIKEIKSHPWF 260
            +  V +P  R +  ++  HP+ 
Sbjct: 234 KKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  125 bits (317), Expect = 1e-33
 Identities = 85/308 (27%), Positives = 131/308 (42%), Gaps = 62/308 (20%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLR 56
           +YE  K +G G + V    R+K T  +VA+K I+ G +      I+    REI   ++L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYC 114
           HPNII   +V    +++ +V E+    +L E++        +  + + +    + G+ Y 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMET-DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----STVGTPAYIAPEV 170
           HS  I HRDLK  N L+       LK+ DFG ++S      P       V T  Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV----- 219
           L    + G   D+WS G     +L+   PF       DQ         + +I        
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQ---------LGKIFEALGTPT 223

Query: 220 ------QYKIPDYV---------------HISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
                    +PDYV                 S D  +LL R+   NP++RIT ++   HP
Sbjct: 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283

Query: 259 WFLKNLPR 266
           +F  N P 
Sbjct: 284 YF-SNDPA 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  126 bits (319), Expect = 1e-33
 Identities = 88/300 (29%), Positives = 132/300 (44%), Gaps = 50/300 (16%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHPN 59
           +YEL+K IGSG +GV     +K T   VA+K I       IDA  + REI   + LRH N
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 60  IIRFKEVVLTPT-----HLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSY 113
           II   +++  P+      + IV E     +L  ++  + +  ++D  +YF  Q++ G+ Y
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELM-ETDL-HKVIKSPQPLTDDHIQYFLYQILRGLKY 118

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPE 169
            HS  + HRDLK  N L++ +    LKICDFG ++        K      V T  Y APE
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Query: 170 V-LSRREYDGKLADVWSCGVTLYVML---------------------VGAYPFED--QED 205
           + LS   Y  K  D+WS G     +L                     +G    ED     
Sbjct: 177 LLLSSSRYT-KAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235

Query: 206 PKNFRKTISRIMAVQYK-----IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +  R  +  +     K      P     S +  +LL ++ V +P +RIT  E  +HP+ 
Sbjct: 236 SEKARNYLKSLPKKPKKPLSKLFPG---ASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  124 bits (313), Expect = 1e-33
 Identities = 67/266 (25%), Positives = 112/266 (42%), Gaps = 26/266 (9%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
            L K +G G FG         +    K  VA+K + +    +  +    RE    ++L H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
           PN+++   V      L IVMEY  GG+L   +  N  + S  +   F  Q+  G+ Y  S
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSLLHSRPKSTVGTPAYIAPEVL 171
               HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L
Sbjct: 121 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESL 175

Query: 172 SRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
              ++  K +DVWS GV L+ +  +G  P+       +  + +  +    Y++P   +  
Sbjct: 176 KEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPG----MSNEEVLEYLKN-GYRLPQPPNCP 229

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKS 256
            +  +L+ + +  +P  R T  E+  
Sbjct: 230 PELYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  126 bits (317), Expect = 2e-33
 Identities = 95/318 (29%), Positives = 148/318 (46%), Gaps = 34/318 (10%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERG-----HKIDANVAREIINHKQLRHPNIIRFK 64
           +G G+FG   L R K +  L A+K +++        ++  +  + I      HP + +  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
               TP  L  VME+  GG+L   I  + RF E  AR++  ++ S + + H   I +RDL
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 183
           KL+N LLD       K+ DFG  K  + + +  ST  GTP YIAPE+L    Y G   D 
Sbjct: 123 KLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179

Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 243
           W+ GV LY ML G  PFE + +   F      I+  +   P ++   QD  ++L      
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTWLS--QDAVDILKAFMTK 233

Query: 244 NPSRRITI------KEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS--LQSVEEITK- 294
           NP+ R+        + I  HP+F K L  E       +  R+  P F   ++S E+++  
Sbjct: 234 NPTMRLGSLTLGGEEAILRHPFF-KELDWEK------LNRRQIEPPFRPRIKSREDVSNF 286

Query: 295 ---IVEEAKVPPPVSRSI 309
               ++E  V  P+  S+
Sbjct: 287 DPDFIKEDPVLTPIEESL 304

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (313), Expect = 2e-33
 Identities = 67/264 (25%), Positives = 108/264 (40%), Gaps = 25/264 (9%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
            L K +G G FG         +    +  VA+K ++            RE    ++L HP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           NI++   V      L IVMEY  GG+L  + R       S  +   F  Q+  G+ Y  S
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSLLHSRPKSTVGTPAYIAPEVL 171
               HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L
Sbjct: 122 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESL 176

Query: 172 SRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
              ++  K +DVWS GV L+ +  +G  P+       +  + +  +    Y++P   +  
Sbjct: 177 KEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPG----MSNAEVLEYLKK-GYRLPKPPNCP 230

Query: 231 QDCRNLLSRIFVANPSRRITIKEI 254
            +   L+ + +  +P  R T  E+
Sbjct: 231 PELYKLMLQCWAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  124 bits (312), Expect = 3e-33
 Identities = 81/261 (31%), Positives = 137/261 (52%), Gaps = 21/261 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +  +K+T   VA+K ++ R  +    +  E++  +  +HPNI+      L
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S+ H+  + HRD+K ++
Sbjct: 87  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDS 145

Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    R KS VGTP ++APEV+SR  Y G   D+WS
Sbjct: 146 ILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200

Query: 186 CGVTLYVMLVGAYPFEDQEDP----KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
            G+ +  M+ G  P+ + E P    K  R  +        K+ +   +S   R+ L R+ 
Sbjct: 201 LGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPP------KLKNLHKVSPRLRSFLDRML 253

Query: 242 VANPSRRITIKEIKSHPWFLK 262
           V +P++R T  E+ +HP+  K
Sbjct: 254 VRDPAQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  123 bits (311), Expect = 4e-33
 Identities = 75/264 (28%), Positives = 121/264 (45%), Gaps = 20/264 (7%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQLRHPNIIRF 63
           +G G FG     + K T ++ A K ++      R  +  A   ++I+  +++    I+  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL--EKVSSRFIVSL 58

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICH 121
                T   L +VM    GG+L   I N G   F E  A ++  Q+I G+ + H  +I +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RDLK EN LLD     R  I D G +       + K   GTP Y+APEVL    YD    
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           D ++ G TLY M+ G  PF  +++     +   R + +  + PD    S + ++L   + 
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALL 233

Query: 242 VANPSRRI-----TIKEIKSHPWF 260
             +P +R+     +  E++ HP F
Sbjct: 234 QKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  126 bits (317), Expect = 4e-33
 Identities = 92/316 (29%), Positives = 133/316 (42%), Gaps = 73/316 (23%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA------REIINHKQLRH 57
           +  +K IG G FG   L+R  +T  L AMK + +   +  N A      R+I+   +  +
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDIL--AEADN 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             +++         +L  VM+Y  GG++   +   G F ED AR++  +L   +   H M
Sbjct: 61  EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------S 149
              HRD+K +N L+D      +K+ DFG             Y K               S
Sbjct: 121 GFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 150 SLLHSRPK----------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM 193
            +   R K                S VGTP YIAPEVL R  Y  +L D WS GV LY M
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 237

Query: 194 LVGAYPF------EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSR 247
           LVG  PF      E Q    N+  T+         IP    +S++  +L+ R+       
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTL--------HIPSQAKLSREASDLILRL-CCGAED 288

Query: 248 RI---TIKEIKSHPWF 260
           R+      EIK+HP+F
Sbjct: 289 RLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  124 bits (312), Expect = 7e-33
 Identities = 82/263 (31%), Positives = 136/263 (51%), Gaps = 19/263 (7%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIR 62
           K IG G+FG   L R+K  ++  A+K +++   +     + I++      K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E  AR++  ++ S + Y HS+ I +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 181
           DLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL ++ YD +  
Sbjct: 121 DLKPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           D W  G  LY ML G  PF  +   + +   +++ + ++   P+   I+   R+LL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNSARHLLEGLL 231

Query: 242 VANPSRRITIK----EIKSHPWF 260
             + ++R+  K    EIK+H +F
Sbjct: 232 QKDRTKRLGAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  122 bits (307), Expect = 1e-32
 Identities = 77/268 (28%), Positives = 134/268 (50%), Gaps = 19/268 (7%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREI-INHKQLRHPNII 61
           E + ++G+GN GV   + ++ T +++A+K I       I   + RE+ I HK    P I+
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSPYIV 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHS-MQ 118
            F         ++I MEY  GG L    +    GR  E         ++ G++Y H   +
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK 121

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRD+K  N L++     ++K+CDFG S   L++S  K+ VGT +Y+APE +   +Y  
Sbjct: 122 IIHRDVKPSNILVNSR--GQIKLCDFGVSG-QLVNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 179 KLADVWSCGVTLYVMLVGAYPF-EDQEDPKNFRKTISRIMAVQY---KIPDYVHISQDCR 234
           K +D+WS G++L  +  G +P+  + + P    + +  I  V     ++P     S D +
Sbjct: 179 K-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI--VNEPPPRLPSGKF-SPDFQ 234

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLK 262
           + ++   + +P  R + KE+  HP+  K
Sbjct: 235 DFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  123 bits (311), Expect = 1e-32
 Identities = 91/291 (31%), Positives = 137/291 (47%), Gaps = 31/291 (10%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHPNIIR 62
           K +G G+FG   L   K T E+ A+K +++   + D +V   +   + L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                 T   L  VMEY  GG+L  +I  + +F E  +R++  ++   + + H   + +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 181
           DLKL+N LLD       K+ DFG  K  +L+    +T  GTP YIAPE+L   EY G   
Sbjct: 121 DLKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177

Query: 182 DVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           D W+ GV +Y M+ G  PFE D ED          I+      P  V +S++  ++L   
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDDVLYP--VWLSKEAVSILKAF 230

Query: 241 FVANPSRRI-------TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
              NP++R+           IK HP+F K +   L E       RK  P F
Sbjct: 231 MTKNPNKRLGCVASQGGEDAIKQHPFF-KEIDWVLLEQ------RKIKPPF 274

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  121 bits (307), Expect = 1e-32
 Identities = 67/268 (25%), Positives = 110/268 (41%), Gaps = 26/268 (9%)

Query: 8   KDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPNIIR 62
           K +G G FG     +L         VA+K ++     +      +E    K+L HPN++R
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLIS-------GVSY 113
              V      L +V+EY  GG+L  + R       S +++    + L+S       G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEV 170
             S +  HRDL   N L+       +KI DFG S+        +   G    I   APE 
Sbjct: 121 LASKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 171 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 229
           L    +  K +DVWS GV L+ +  +GA P+      +   + + +     Y++P   + 
Sbjct: 179 LKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRK----GYRLPKPEYC 232

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSH 257
             +   L+   +  +P  R T  E+   
Sbjct: 233 PDELYELMLSCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  121 bits (306), Expect = 2e-32
 Identities = 82/266 (30%), Positives = 127/266 (47%), Gaps = 24/266 (9%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQLRH 57
           Y  ++ +G G FG A L R      LV  K +      E+  +   N   EI+    L+H
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALN---EIVILSLLQH 58

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISGVSYCH 115
           PNII +    +    L I MEYA GG L+++I       F E+   ++  Q++S VSY H
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLS 172
              I HRD+K  N  L  + A  +K+ DFG SK   S    +  ++ VGTP Y++PE+  
Sbjct: 119 KAGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMA--ETVVGTPYYMSPELCQ 174

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
             +Y+ K +D+W+ G  LY +L     F    D  N    + +I+   Y     V+ S +
Sbjct: 175 GVKYNFK-SDIWALGCVLYELLTLKRTF----DATNPLNLVVKIVQGNYTPVVSVY-SSE 228

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHP 258
             +L+  +   +P +R T  E+   P
Sbjct: 229 LISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 3e-32
 Identities = 79/264 (29%), Positives = 131/264 (49%), Gaps = 18/264 (6%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRH--- 57
           + EL   IG G +G     ++  T  +VA+K I      D  +++ RE+    QLR    
Sbjct: 5   RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI ++    L    L I+MEYA GG +   +  AG  +E       ++++  + Y H +
Sbjct: 62  PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKV 120

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSR-RE 175
            + HRD+K  N L+  +    +K+CDFG +     +S  +ST VGTP ++APEV++  + 
Sbjct: 121 GVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           YD K AD+WS G+T+Y M  G  P+ D +    FR  +    +   ++ D    S+  R 
Sbjct: 179 YDTK-ADIWSLGITIYEMATGNPPYSDVD---AFRAMMLIPKSKPPRLEDN-GYSKLLRE 233

Query: 236 LLSRIFVANPSRRITIKEIKSHPW 259
            ++      P  R++ +E+    W
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKW 257

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  122 bits (308), Expect = 6e-32
 Identities = 88/272 (32%), Positives = 139/272 (51%), Gaps = 20/272 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E YE++K IG G FG  +L+R+K+T+++ AMK + +   I  + +      + +      
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P +++         +L +VMEY  GG+L   + N     E  AR++  +++  +   HSM
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 161

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 162 GFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 217

Query: 174 R---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           +    Y G+  D WS GV LY MLVG  PF        + K ++   ++ +  PD   IS
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDIS 275

Query: 231 QDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
           ++ +NL+         R  R  ++EIK H +F
Sbjct: 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  121 bits (305), Expect = 7e-32
 Identities = 81/268 (30%), Positives = 136/268 (50%), Gaps = 20/268 (7%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHP 58
           +  +  +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
            + +      T   L  VMEY  GG+L   I   G+F E  A ++  ++  G+ + HS  
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 177
           I +RDLKL+N +LD      +KI DFG  K ++   +   T  GTP YIAPE+++ + Y 
Sbjct: 122 IIYRDLKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY- 178

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           GK  D W+ GV LY ML G  PF+ +++ + F+     IM      P    +S++  ++ 
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAVSIC 232

Query: 238 SRIFVANPSRRITI-----KEIKSHPWF 260
             +   +P++R+       ++I+ H +F
Sbjct: 233 KGLLTKHPAKRLGCGPTGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  119 bits (301), Expect = 1e-31
 Identities = 82/290 (28%), Positives = 132/290 (45%), Gaps = 40/290 (13%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------VAREIINHKQLRH 57
           ++ ++ +G G +      RN+ T E+VA+K I     +DA         REI   K+L+H
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEI----HLDAEEGTPSTAIREISLMKELKH 57

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            NI+R  +V+ T   L +V EY      +  +     G    +  + F  QL+ G+++CH
Sbjct: 58  ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVL-SR 173
             ++ HRDLK +N L++      LK+ DFG +++  +  +   + V T  Y AP+VL   
Sbjct: 118 ENRVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 174 REYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDP--KNFR----------KTISRIMAV 219
           R Y   + D+WS G  +  M+ G   +P  + ED   K FR            IS++   
Sbjct: 176 RTYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234

Query: 220 QYKIPDYVHISQ---------DCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +   P Y                 +LL R+   NP  RI+  +   HPWF
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  118 bits (298), Expect = 2e-31
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 33/272 (12%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDAN-----VAREIINHKQLRHPNIIR 62
           +G+G F      R+  T  L+A+K +   R    +       + +EI    +L HP+IIR
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                   +H  + +E+ AGG +   +   G F E     + +QL+ G+SY H  QI HR
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPEVLSRRE 175
           D+K  N L+D S   RL+I DFG   ++ L ++           +GT A++APEVL   +
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI------PDY-VH 228
           Y G+  DVWS G  +  M     P+  ++         S  +A+ +KI      P    H
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEK--------HSNHLALIFKIASATTAPSIPEH 235

Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +S   R++  R     P  R   +E+  HP F
Sbjct: 236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  118 bits (299), Expect = 2e-31
 Identities = 85/279 (30%), Positives = 126/279 (45%), Gaps = 32/279 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRHP 58
           + YEL++ IG G   V          E VA+K I+       +D  + +E+    Q  HP
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHP 59

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFE---RICNAGRFSEDEARYFFQQLISGVSYCH 115
           N++++    +    L +VM Y +GG L +        G   E       ++++ G+ Y H
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 116 SMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SLLHSRPKSTVGTPAYIAP 168
           S    HRD+K  N LL  DGS    +KI DFG S S            K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Query: 169 EVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--- 224
           EV+     YD K AD+WS G+T   +  GA P+      K    T+      Q   P   
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTL------QNDPPSLE 228

Query: 225 ---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              DY   S+  R ++S     +PS+R T +E+  H +F
Sbjct: 229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  120 bits (301), Expect = 3e-31
 Identities = 84/268 (31%), Positives = 135/268 (50%), Gaps = 20/268 (7%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHP 58
           +  +  +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
            + +      T   L  VMEY  GG+L  +I   GRF E  A ++  ++  G+ + HS  
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLKL+N +LD      +KI DFG  K ++      K+  GTP YIAPE+++ + Y 
Sbjct: 122 IIYRDLKLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY- 178

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           GK  D W+ GV LY ML G  PFE +++ + F+     IM      P    +S++   + 
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPK--SMSKEAVAIC 232

Query: 238 SRIFVANPSRRITI-----KEIKSHPWF 260
             +   +P +R+       ++IK H +F
Sbjct: 233 KGLMTKHPGKRLGCGPEGERDIKEHAFF 260

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 3e-31
 Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 47/287 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNI 60
             +EL++ IG G +G     R+K T +LVA+K ++     +  +  E  I  K   HPNI
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65

Query: 61  IRFKEVVLTPTH------LAIVMEYAAGG---ELFERICNAG-RFSEDEARYFFQQLISG 110
             F    +          L +VME   GG   +L + +   G R  E+   Y  ++ + G
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125

Query: 111 VSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAY 165
           ++Y H  ++ HRD+K +N LL  +      +K+ DFG S    S+L   R  + +GTP +
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVSAQLDSTL--GRRNTFIGTPYW 179

Query: 166 IAPEVLS-----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 220
           +APEV++        YD + +DVWS G+T   +  G  P  D   P          M   
Sbjct: 180 MAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMH-P----------MRAL 227

Query: 221 YKIPDYV--------HISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
           +KIP           + S+   + +S   + N  +R  ++E+  HP+
Sbjct: 228 FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  118 bits (298), Expect = 9e-31
 Identities = 80/271 (29%), Positives = 136/271 (50%), Gaps = 25/271 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTK-ELVAMKYIERGHKIDANVA------REIINHKQ 54
           E +  ++ +G+G+FG   L   KN     VA+K  E+   I           R+I+N+  
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-- 87

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           + HP  +         ++L +V+E+  GGE F  +    RF  D   ++  Q++    Y 
Sbjct: 88  INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
            S+ I +RDLK EN LLD      +K+ DFG++K  ++ +R  +  GTP YIAPE+L   
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNV 203

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            + GK AD W+ G+ +Y +LVG  PF   E    ++K +  I+      P +  +  +C+
Sbjct: 204 GH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIY----FPKF--LDNNCK 256

Query: 235 NLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           +L+ ++   + ++R        + +K HPWF
Sbjct: 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  118 bits (297), Expect = 1e-30
 Identities = 80/263 (30%), Positives = 122/263 (46%), Gaps = 19/263 (7%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIR 62
           K IG G+FG   L + K+     A+K +++   +       I+       K L+HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                 T   L  V++Y  GGELF  +     F E  AR++  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 181
           DLK EN LLD      + + DFG  K  +      ST  GTP Y+APEVL +  YD +  
Sbjct: 121 DLKPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           D W  G  LY ML G  PF  ++  + +   + + + +             C +LL  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA-----C-DLLVGLL 231

Query: 242 VANPSRRITIK----EIKSHPWF 260
             +  RR+  K    EIK+H +F
Sbjct: 232 HKDQRRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  117 bits (294), Expect = 1e-30
 Identities = 81/289 (28%), Positives = 138/289 (47%), Gaps = 36/289 (12%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           KYE ++ IG G +G     +N+ T E+VA+K +   +    + ++  REI   K+L+H N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSM 117
           I+R  +V+ +   L +V EY    +  ++  ++  G    +  + F  QL+ G+++CHS 
Sbjct: 61  IVRLYDVLHSDKKLTLVFEYC--DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRRE 175
            + HRDLK +N L++ +    LK+ DFG +++  +  R  S  V T  Y  P+VL   + 
Sbjct: 119 NVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPDYV 227
           Y   + D+WS G     +     P     D  +  K I R++            K+PDY 
Sbjct: 177 YSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 228 ----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            ++   R+LL  + V NP +RI+ +E   HP+F
Sbjct: 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  117 bits (294), Expect = 2e-30
 Identities = 81/262 (30%), Positives = 133/262 (50%), Gaps = 20/262 (7%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL----RHPNIIRFK 64
           +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    + P + +  
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
               T   L  VMEY  GG+L   I   G+F E +A ++  ++  G+ + H   I +RDL
Sbjct: 68  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 183
           KL+N +LD      +KI DFG  K  ++      T  GTP YIAPE+++ + Y GK  D 
Sbjct: 128 KLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 243
           W+ GV LY ML G  PF+ +++ + F+     IM      P    +S++  ++   +   
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAVSICKGLMTK 238

Query: 244 NPSRRITI-----KEIKSHPWF 260
           +PS+R+       ++I+ H +F
Sbjct: 239 HPSKRLGCGPEGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  115 bits (291), Expect = 3e-30
 Identities = 69/267 (25%), Positives = 110/267 (41%), Gaps = 25/267 (9%)

Query: 5   ELMKDIGSGNFGV---ARL-MRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
           EL K +G G FG      L    + T+  VA+K ++ G   +       E    K+L HP
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           NI+R   V      L IV EY  GG+L  F R  +  + +  +      Q+  G+ Y  S
Sbjct: 62  NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 171
               HRDL   N L+  +    +KI DFG S+   ++            +     APE L
Sbjct: 121 KNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 172 SRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
              ++  K +DVWS GV L+ +  +G  P+    + +             Y++P   +  
Sbjct: 177 KDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-----YRLPRPENCP 230

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSH 257
            +   L+ + +  +P  R T  E+   
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  118 bits (296), Expect = 3e-30
 Identities = 85/274 (31%), Positives = 140/274 (51%), Gaps = 24/274 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E Y+++K IG G FG  +L+R+K+++++ AMK + +   I  + +      + +      
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P +++         +L +VMEY  GG+L   + N     E  A+++  +++  +   HSM
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            + HRD+K +N LLD      LK+ DFG      ++ ++     + VGTP YI+PEVL  
Sbjct: 162 GLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRC--DTAVGTPDYISPEVLKS 217

Query: 174 R---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVH 228
           +    Y G+  D WS GV L+ MLVG  PF       +   T S+IM  +  +  P+ V 
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFY----ADSLVGTYSKIMDHKNSLNFPEDVE 273

Query: 229 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
           IS+  +NL+         R  R  ++EIK HP+F
Sbjct: 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  116 bits (291), Expect = 3e-30
 Identities = 83/287 (28%), Positives = 136/287 (47%), Gaps = 34/287 (11%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRHPNI 60
           ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L HPNI
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           ++  +V+ T   L +V E+     + F              + +  QL+ G+++CHS ++
Sbjct: 62  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRREYDG 178
            HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L   +Y  
Sbjct: 122 LHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 179

Query: 179 KLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQ--------YKIPDYV-- 227
              D+WS G     M+     F  D E  + FR  I R +             +PDY   
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTPDEVVWPGVTSLPDYKPS 237

Query: 228 --------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                          + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  116 bits (291), Expect = 3e-30
 Identities = 78/278 (28%), Positives = 140/278 (50%), Gaps = 25/278 (8%)

Query: 4   YELMKDIGSGNFGVARLMRN---KNTKELVAMKYIERGHKID-------ANVAREIINHK 53
           +EL+K +G+G +G   L+R     ++ +L AMK +++   +            R+++ H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           + + P ++       T T L ++++Y  GGELF  +    RF E E + +  +++  + +
Sbjct: 62  R-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTVGTPAYIAPEVL 171
            H + I +RD+KLEN LLD +    + + DFG SK        R  S  GT  Y+AP+++
Sbjct: 121 LHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 172 SRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 229
              +  +D K  D WS GV +Y +L GA PF    +  +  +   RI+  +   P    +
Sbjct: 179 RGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EM 235

Query: 230 SQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLK 262
           S   ++++ R+ + +P +R+        EIK HP+F K
Sbjct: 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 4e-30
 Identities = 86/302 (28%), Positives = 129/302 (42%), Gaps = 60/302 (19%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR-- 56
           YE + +IG G +G     R+ NT   VA+K +     E G  I  +  REI   KQL   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58

Query: 57  -HPNIIRFKEVVLTP-----THLAIVMEYA----AGGELFERICNAGRFSEDEARYFFQQ 106
            HPNI+R  +V   P       L +V E+     A    +   C       +  +   +Q
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLAT---YLSKCPKPGLPPETIKDLMRQ 115

Query: 107 LISGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 164
           L+ GV + HS +I HRDLK +N L+  DG    ++KI DFG ++         S V T  
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLW 171

Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLYVM--LVGAYP-----------FE-----DQED- 205
           Y APEVL +  Y   + D+WS G     +      +            F+      +E+ 
Sbjct: 172 YRAPEVLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230

Query: 206 PKN-------FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           P+N       F     R       +P+   I ++  +LL ++   NP +RI+  E   HP
Sbjct: 231 PRNVSLPRSSFPSYTPRSFKSF--VPE---ICEEGLDLLKKMLTFNPHKRISAFEALQHP 285

Query: 259 WF 260
           +F
Sbjct: 286 YF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  115 bits (291), Expect = 6e-30
 Identities = 91/301 (30%), Positives = 139/301 (46%), Gaps = 54/301 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ER-GHKIDANVAREIINHKQLR 56
           ++YE +  I  G +GV    R+K T E+VA+K +    E+ G  I +   REI    +L+
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--LREINILLKLQ 62

Query: 57  HPNIIRFKEVVL--TPTHLAIVMEYAAGGE-----LFERICNAGRFSEDEARYFFQQLIS 109
           HPNI+  KEVV+      + +VMEY    E     L E +     F + E +    QL+S
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQLLS 117

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIA 167
           GV++ H   I HRDLK  N LL  +    LKICDFG ++   S L    +  V T  Y A
Sbjct: 118 GVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174

Query: 168 PEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFR----------- 210
           PE+L   +EY   + D+WS G     +L     F      DQ + K F+           
Sbjct: 175 PELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLN-KIFKLLGTPTEKIWP 232

Query: 211 --KTISRIMAVQYKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
               +       +    Y         + +S +  +LL+R+   +P++RI+ ++   HP+
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Query: 260 F 260
           F
Sbjct: 293 F 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 2e-29
 Identities = 78/280 (27%), Positives = 125/280 (44%), Gaps = 40/280 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHP 58
           + +E++ ++G G FG     ++K T    A K I+   +    D  V  +I++  + +HP
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSM 117
           NI+   E       L I++E+  GG L   +    R  +E + RY  +Q++  +++ HS 
Sbjct: 63  NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 118 QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVL-- 171
           ++ HRDLK  N LL  DG     +K+ DFG S +    +  K  + +GTP ++APEV+  
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVS-AKNKSTLQKRDTFIGTPYWMAPEVVAC 177

Query: 172 ---SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-- 226
                  YD K AD+WS G+TL  +     P  +              M V  KI     
Sbjct: 178 ETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELN-----------PMRVLLKILKSEP 225

Query: 227 ------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                    S    + L    V +P  R T  E+  HP+ 
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  113 bits (285), Expect = 2e-29
 Identities = 84/264 (31%), Positives = 127/264 (48%), Gaps = 11/264 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           E +EL++ IGSG +G     RN NT EL A+K I  E G      V +EII  K  +H N
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           I+ +    L    L I ME+  GG L +     G  SE +  Y  ++ + G+ Y HS   
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEV--LSRREY 176
            HRD+K  N LL  +    +K+ DFG S   +   ++ KS +GTP ++APEV  + R+  
Sbjct: 128 MHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYKIPDYVHISQDCRN 235
             +L D+W+ G+T   +     P  D    +  F  T S       K+ D +  S    +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP--KLKDKMKWSNSFHH 243

Query: 236 LLSRIFVANPSRRITIKEIKSHPW 259
            +      NP +R T +++  HP+
Sbjct: 244 FVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  113 bits (285), Expect = 2e-29
 Identities = 81/268 (30%), Positives = 123/268 (45%), Gaps = 24/268 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-----EIINHKQL 55
           +  +++ K IG G F V           +VA+K ++    +DA  AR     EI   KQL
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK-ARQDCLKEIDLLKQL 59

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGV 111
            HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S +
Sbjct: 60  DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYI 166
            + HS +I HRD+K  N  +  +    +K+ D G      SK++  HS     VGTP Y+
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYM 173

Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 226
           +PE +    Y+ K +D+WS G  LY M     PF    D  N      +I    Y     
Sbjct: 174 SPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPA 230

Query: 227 VHISQDCRNLLSRIFVANPSRRITIKEI 254
            H S++ R+L+SR    +P +R  I  +
Sbjct: 231 DHYSEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  113 bits (285), Expect = 4e-29
 Identities = 82/292 (28%), Positives = 145/292 (49%), Gaps = 37/292 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           M++YE ++ IG G +GV    R++ T E +A+K I   +    + +   REI   K+++H
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQQLISGVSYCH 115
            NI+R ++VV +   L +V EY    +L + + ++  F+++    + +  Q++ G++YCH
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 174
           S ++ HRDLK +N L+D      LK+ DFG +++  +  R  +  V T  Y APE+L   
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGS 178

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPF--EDQEDPKNFRKTISRIMAVQYK--------IP 224
            +     D+WS G  ++  +V   P    D E  + F+  I RI+    +        +P
Sbjct: 179 RHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFK--IFRILGTPNEETWPGVTSLP 235

Query: 225 DYVH----------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           DY                  +     +LLS++   +PS+RIT +    H +F
Sbjct: 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  113 bits (285), Expect = 5e-29
 Identities = 85/304 (27%), Positives = 128/304 (42%), Gaps = 66/304 (21%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ERGHKIDANVAREIINHKQLRHPN 59
           +E +  IG G +G+    R+  + E+VA+K +    ER   I  +  REI     LRHPN
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPN 67

Query: 60  IIRFKEVVLTPTHLA---IVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           I+  KEVV    HL    +VMEY       L + +     FSE + +    QL+ G+ Y 
Sbjct: 68  IVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYL 124

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL-S 172
           H   I HRDLK+ N LL       LKI DFG +++  L ++P +  V T  Y APE+L  
Sbjct: 125 HENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182

Query: 173 RREYDGKLADVWSCG---------------------VTLYVMLVGA-----YP------- 199
              Y     D+W+ G                     + L + L+G      +P       
Sbjct: 183 CTTYT-TAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 200 ---FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
              F   + P N  K              +  +S+    LL+ + + +P +R T +E   
Sbjct: 242 VGKFTLPKQPYNNLK------------HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289

Query: 257 HPWF 260
             +F
Sbjct: 290 SSYF 293

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  112 bits (281), Expect = 7e-29
 Identities = 81/272 (29%), Positives = 128/272 (47%), Gaps = 27/272 (9%)

Query: 4   YELMKDIGSGNFGVARLMRNKNT-KELVAMKYI------------ERGHKIDANVAREII 50
           Y +++ +GSG FG    +R KN  + L+A+K I            ER   I   V+   I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN----AGRFSEDEARYFFQQ 106
             +QLRHPNI+R+ +  L    L IVM+   G  L E   +      RF+E+     F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 107 LISGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY 165
           ++  + Y H   +I HRDL   N +L      ++ I DFG +K     S+  S VGT  Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IP 224
             PE++    Y G+ ADVW+ G  LY M     PF       N     ++I+   Y+ +P
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYST----NMLSLATKIVEAVYEPLP 234

Query: 225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
           + ++ S+D  ++++     +   R  I ++ +
Sbjct: 235 EGMY-SEDVTDVITSCLTPDAEARPDIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  113 bits (284), Expect = 1e-28
 Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 43/307 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHP 58
            +Y+ +++IGSG +GV     +  + + VA+K I        +     RE+   +  +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 59  NIIRFKEVVLTP----THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           NII  ++++  P      + +VM+     +L   I +    +E+  RYF  QL+ G+ Y 
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSR-PKSTVGTPAYIAPE 169
           HS  + HRDLK  N L++      L+I DFG     S S   H       V T  Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 170 VL-SRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTIS 214
           +L S  EY   + D+WS G     ML     +P ++                +     I 
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240

Query: 215 --RIMAVQYKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
             R+      +P          +   S +  +LLS++   +P  RIT+++   HP FL  
Sbjct: 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP-FLAQ 299

Query: 264 LPRELTE 270
                 E
Sbjct: 300 YHDPDDE 306

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  113 bits (284), Expect = 1e-28
 Identities = 80/274 (29%), Positives = 133/274 (48%), Gaps = 23/274 (8%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIR 62
           E +  IGSG  G    + ++ T  L A+K I   H+  +   + REI   + + HPN+++
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
             ++      + +++E+  GG L        +F  D AR    Q++SG++Y H   I HR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHR 192

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV----LSRREYD 177
           D+K  N L++   A  +KI DFG S+       P  S+VGT AY++PE     L+   YD
Sbjct: 193 DIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 178 GKLADVWSCGVTLYVMLVGAYPFE--DQEDPKNFRKTISRIMAVQYKIPDY--VHISQDC 233
           G   D+WS GV++    +G +PF    Q D        S + A+    P       S++ 
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCAICMSQPPEAPATASREF 304

Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
           R+ +S      P++R +  ++  HP+ L+  P +
Sbjct: 305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ 338

Length = 353

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  111 bits (278), Expect = 1e-28
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 28/272 (10%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTK---ELVAMKYIERG-----HKIDANVAREIINHKQ 54
           +Y L + +G G+FG   L+++K       L  +K I  G       + AN   ++++  +
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS--K 58

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI----CNAGRFSEDEARYFFQQLISG 110
           L HP I++F    L      I+ EY  G +L  ++          SE++   +F QL+ G
Sbjct: 59  LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAP 168
           V Y H  +I HRDLK +N  L  +    LKI DFG S+  L+ S   +T   GTP Y++P
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSR-LLMGSCDLATTFTGTPYYMSP 174

Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYV 227
           E L  + YD K +D+WS G  LY M   A+ FE Q    NF   + RI+      +P+  
Sbjct: 175 EALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQ----NFLSVVLRIVEGPTPSLPE-- 227

Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
             S+   +++  +   +PS R +  EI  +P+
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  111 bits (278), Expect = 2e-28
 Identities = 75/259 (28%), Positives = 132/259 (50%), Gaps = 16/259 (6%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G +G+    R+ +T+  +A+K I ER  +    +  EI  H  L+H NI+++     
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 69  TPTHLAIVMEYAAGGEL---FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                 I ME   GG L           + +E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135

Query: 126 LENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR--REYDGKLAD 182
            +N L++ + +  +KI DFG SK  + ++   ++  GT  Y+APEV+ +  R Y G  AD
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY-GAPAD 193

Query: 183 VWSCGVTLYVMLVGAYPFEDQEDPKN--FRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           +WS G T+  M  G  PF +  +P+   F+  + +I     +IP+   +S + +N + R 
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP---EIPE--SLSAEAKNFILRC 248

Query: 241 FVANPSRRITIKEIKSHPW 259
           F  +P +R +  ++   P+
Sbjct: 249 FEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  112 bits (281), Expect = 3e-28
 Identities = 92/295 (31%), Positives = 139/295 (47%), Gaps = 43/295 (14%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDA-NVAREIINHKQLRHPN 59
           KY  +K IG G +G+    +N  T E VA+K I     ++IDA    REI   + L H N
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 60  IIRFKEVVLTPTH------LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           +I  K+++  P H      + IV E     +L + I ++   S+D  +YF  QL+ G+ Y
Sbjct: 66  VIAIKDIM-PPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEV-L 171
            HS  + HRDLK  N LL+ +    LKICDFG ++ +S         V T  Y APE+ L
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 172 SRREYDGKLADVWSCG---------------------VTLYVMLVGAYPFEDQE--DPKN 208
           +  EY     DVWS G                     + L   L+G+   ED      + 
Sbjct: 182 NCSEY-TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 209 FRKTISRIMAVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            R+ I R +    +      + H +    +LL ++ V +PS+RIT++E  +HP+ 
Sbjct: 241 ARRYI-RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 6e-28
 Identities = 93/291 (31%), Positives = 145/291 (49%), Gaps = 42/291 (14%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHPN 59
           Y+ ++ IG G +GV    R+K T E+VA+K I R    D  V     REI   K+L HPN
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEA--RYFFQQLISGVSYCHSM 117
           I+R  +VV +   L +V E+    +L + + ++     D    + +  QL+ G++YCHS 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEV-LSRRE 175
           ++ HRDLK +N L+D   A  LK+ DFG +++  +  R  +  V T  Y APE+ L  R+
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMA---------VQYKIPD 225
           Y   + D+WS G     M+     F  D E  + FR  I R +          V   +PD
Sbjct: 177 YSTPV-DIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGTPDEDVWPGVTS-LPD 232

Query: 226 YV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           Y                 ++ +D  +LLS++ V +P++RI+ K    HP+F
Sbjct: 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  110 bits (277), Expect = 6e-28
 Identities = 77/263 (29%), Positives = 127/263 (48%), Gaps = 19/263 (7%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIR 62
           K IG G+FG   L + K   +  A+K +++   ++    + I+       K ++HP ++ 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
                 T   L  V+++  GGELF  +     F E  AR++  ++ S + Y HS+ I +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLA 181
           DLK EN LLD      + + DFG  K  +  S   +T  GTP Y+APEV+ ++ YD    
Sbjct: 121 DLKPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYD-NTV 177

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           D W  G  LY ML G  PF  ++  + +   + + + ++   P     S    ++L  + 
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR---PG---ASLTAWSILEELL 231

Query: 242 VANPSRRITIK----EIKSHPWF 260
             +  RR+  K    EI+ HP+F
Sbjct: 232 EKDRQRRLGAKEDFLEIQEHPFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  110 bits (276), Expect = 8e-28
 Identities = 89/307 (28%), Positives = 135/307 (43%), Gaps = 59/307 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           ++K++++  IG G +G     R+K+T ELVA+K +     + G  I A   REI   +QL
Sbjct: 6   VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA--IREIKILRQL 63

Query: 56  RHPNIIRFKEVVLTPTH----------LAIVMEYAAG---GELFERICNAGRFSEDEARY 102
            H NI+  KE+V                 +V EY      G L   + +   FSED  + 
Sbjct: 64  NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKS 120

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKS 158
           F +QL+ G++YCH     HRD+K  N LL+     ++K+ DFG    Y+      SRP +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEE---SRPYT 175

Query: 159 T-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI- 216
             V T  Y  PE+L   E  G   DVWSCG  L  +      F+  ++     + ISR+ 
Sbjct: 176 NKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLC 234

Query: 217 ---------------------MAVQYK---IPDYVHISQDCRNLLSRIFVANPSRRITIK 252
                                   QY+     ++  I     +LL  +   +PS+R T +
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 253 EIKSHPW 259
           E  + PW
Sbjct: 295 EALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  109 bits (274), Expect = 1e-27
 Identities = 84/279 (30%), Positives = 142/279 (50%), Gaps = 16/279 (5%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  + R K++   VA+K ++ R  +    +  E++  +  +H N++   +  L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L ++ME+  GG L + I +  R +E++     + ++  + Y HS  + HRD+K ++
Sbjct: 89  VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147

Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+SR  Y G   D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWS 202

Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+   + P    K +    +   K+ +   IS   R+ L R+    P
Sbjct: 203 LGIMVIEMVDGEPPYF-SDSPVQAMKRLRD--SPPPKLKNAHKISPVLRDFLERMLTREP 259

Query: 246 SRRITIKEIKSHPWFLK-NLPRELTETAQAIYYRKENPT 283
             R T +E+  HP+ L+  LP  L    Q   YRK   T
Sbjct: 260 QERATAQELLDHPFLLQTGLPECLVPLIQQ--YRKRTST 296

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  110 bits (277), Expect = 1e-27
 Identities = 82/302 (27%), Positives = 138/302 (45%), Gaps = 49/302 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN-- 59
           + +E +K IG G FG  RL++ K+T  + AMK + +   ++      I   + +      
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 60  --IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             +++         +L ++ME+  GG++   +      SE+  +++  + +  +   H +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SLLHSRPK--------- 157
              HRD+K +N LLD      +K+ DFG               +L H+ P          
Sbjct: 121 GFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 158 ----------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE 201
                           STVGTP YIAPEV  +  Y+ KL D WS GV +Y ML+G  PF 
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237

Query: 202 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHP 258
            +   + +RK ++    + +  P  V IS+  ++L+ R F  +   RI    ++EIKSHP
Sbjct: 238 SETPQETYRKVMNWKETLVF--PPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHP 294

Query: 259 WF 260
           +F
Sbjct: 295 FF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 1e-27
 Identities = 83/322 (25%), Positives = 137/322 (42%), Gaps = 77/322 (23%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           E +  +K IG G FG  RL++ K+T ++ AMK +         +  E+    QL H    
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL---------LKSEMFKKDQLAHVKAE 51

Query: 58  ---------PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI 108
                    P ++          +L ++ME+  GG+L   +     FSED  R++  + +
Sbjct: 52  RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV 111

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-------------------- 148
             +   H +   HRD+K +N L+D      +K+ DFG S                     
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169

Query: 149 ---------------SSLLHSRPK-------------STVGTPAYIAPEVLSRREYDGKL 180
                          +  + S+ +             STVGTP YIAPE+  ++ Y G+ 
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQE 228

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            D WS G  ++  L+G  PF  +   + +RK I+    + +  PD +H+S +  +L+ R+
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF--PDDIHLSVEAEDLIRRL 286

Query: 241 FVANPSR--RITIKEIKSHPWF 260
                +R  R    EIKSHP+F
Sbjct: 287 ITNAENRLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 2e-27
 Identities = 87/270 (32%), Positives = 136/270 (50%), Gaps = 22/270 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
             + L K +G G FG   L  + +T   +A+K +       E   +++A +  EI   K 
Sbjct: 2   VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKN 60

Query: 55  LRHPNIIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           LRH  I+++   +  P    L+I +EY  GG + +++   G  +E+  R + +Q++ GVS
Sbjct: 61  LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS 120

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAP 168
           Y HS  I HRD+K  N L D   A  +K+ DFG SK      +  +  KS  GTP +++P
Sbjct: 121 YLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
           EV+S   Y G+ ADVWS   T+  ML    P+ + E      K  ++    +  +PD   
Sbjct: 179 EVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTKPMLPD--G 233

Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           +S  CR+ L +IFV    RR T + +  HP
Sbjct: 234 VSDACRDFLKQIFVEE-KRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  108 bits (272), Expect = 2e-27
 Identities = 79/290 (27%), Positives = 125/290 (43%), Gaps = 41/290 (14%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKY-IERGHKID-ANVAREIINHKQLR-HPNI 60
           Y+++  IG G F      +++ T +  A+K   +    ++  N  REI   ++L  HPNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 61  IRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSM 117
           +R  EV+       LA+V E      L+E I    R   E   + +  QL+  + + H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRRE 175
            I HRD+K EN L+       LK+ DFG  +   ++S+P  T  + T  Y APE L    
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 176 YDGKLADVWSCGVTLYVM--LVGAYPFEDQED-----------PK---NFRKTISRIMAV 219
           Y G   D+W+ G   + +  L   +P  ++ D           P      +   SR M  
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM-- 232

Query: 220 QYKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            Y  P            + S +  +LL ++   +P  RIT K+   HP+F
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  109 bits (273), Expect = 2e-27
 Identities = 84/292 (28%), Positives = 135/292 (46%), Gaps = 29/292 (9%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQLRHPNIIRFK 64
           IG G++    L+R K T+ + AMK +++        ID     + +  +   HP ++   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
               T + L  V+EY  GG+L   +    +  E+ AR++  ++   ++Y H   I +RDL
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAYIAPEVLSRREYDGKL 180
           KL+N LLD      +K+ D+G  K  L   RP  T     GTP YIAPE+L   +Y G  
Sbjct: 123 KLDNVLLDSE--GHIKLTDYGMCKEGL---RPGDTTSTFCGTPNYIAPEILRGEDY-GFS 176

Query: 181 ADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
            D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP    +S    +
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAAS 234

Query: 236 LLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 281
           +L      +P  R+         +I+ HP+F +N+  +L E  Q +   K N
Sbjct: 235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDLMEQKQVVPPFKPN 285

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  107 bits (269), Expect = 6e-27
 Identities = 84/294 (28%), Positives = 146/294 (49%), Gaps = 45/294 (15%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLRH 57
            Y  ++ IG G +GV    RNK T ++VAMK I     E G  + +   REI   K+L+H
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG--VPSTAIREISLLKELQH 58

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNI+  ++V++  + L ++ E+ +    +  + +        +  + +  Q++ G+ +CH
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL--S 172
           S ++ HRDLK +N L+D      +K+ DFG +++  +  R  +  V T  Y APEVL  S
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGS 176

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPF--EDQEDPKNFRKTISRIMAVQ--------YK 222
            R Y   + D+WS G T++  +    P    D E  + FR  I RI+             
Sbjct: 177 PR-YSTPV-DIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVTS 231

Query: 223 IPDY----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +PDY                 ++ +D  +LL ++ + +P++RI+ K+  +HP+F
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  107 bits (270), Expect = 7e-27
 Identities = 79/281 (28%), Positives = 132/281 (46%), Gaps = 23/281 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQLRHPNIIRFK 64
           IG G++    L+  K T+ + AMK I++        ID     + +      HP ++   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
               T + L  V+E+ +GG+L   +    +  E+ AR++  ++   +++ H   I +RDL
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 183
           KL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   +Y   + D 
Sbjct: 123 KLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV-DW 179

Query: 184 WSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 238
           W+ GV ++ M+ G  PF+     D  D          I+  Q +IP    +S    ++L 
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKASSVLK 237

Query: 239 RIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQ 273
                +P  R+        ++IKSHP+F +N+  +L E  Q
Sbjct: 238 GFLNKDPKERLGCHPQTGFRDIKSHPFF-RNIDWDLLEQKQ 277

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  107 bits (268), Expect = 8e-27
 Identities = 80/277 (28%), Positives = 128/277 (46%), Gaps = 24/277 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPN 59
           EK   +  +G G  G     R KNT  + A+K I       +   + RE+  +K  + P 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 60  IIRFKEVVLTP--THLAIVMEYAAGGELFERI-----CNAGRFSEDEARYFFQQLISGVS 112
           I+++    L    + + I MEY  GG L + I        GR  E       + ++ G+S
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           Y HS +I HRD+K  N LL       +K+CDFG S   L++S   +  GT  Y+APE + 
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVS-GELVNSLAGTFTGTSFYMAPERIQ 176

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQYKIP------- 224
            + Y    +DVWS G+TL  +    +PF  + E P    + +S I  V    P       
Sbjct: 177 GKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI--VNMPNPELKDEPG 233

Query: 225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
           + +  S++ ++ + +    +P+RR T  ++  HPW  
Sbjct: 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  105 bits (264), Expect = 1e-26
 Identities = 83/257 (32%), Positives = 129/257 (50%), Gaps = 21/257 (8%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQLR 56
           + L K +G G FG   L  + +T   +A+K +       E   +++A +  EI   K L 
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKNLL 62

Query: 57  HPNIIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           H  I+++   +  P    L+I ME+  GG + +++ + G  +E+  R + +Q++ GVSY 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEV 170
           HS  I HRD+K  N L D      +K+ DFG SK      L  +  KS  GTP +++PEV
Sbjct: 123 HSNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEV 180

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           +S   Y G+ AD+WS G T+  ML    P+ + E      K  ++       +P   H+S
Sbjct: 181 ISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ--PTNPVLP--PHVS 235

Query: 231 QDCRNLLSRIFVANPSR 247
             CR+ L RIFV    R
Sbjct: 236 DHCRDFLKRIFVEAKLR 252

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  105 bits (265), Expect = 2e-26
 Identities = 77/271 (28%), Positives = 131/271 (48%), Gaps = 26/271 (9%)

Query: 2   EKYELMKDIGS--GNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HP 58
           +  E++K +    G FG   ++++K T++L   K I+  +    N A E + H+ ++ +P
Sbjct: 14  KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN---FN-AIEPMVHQLMKDNP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N I+    V T     ++M+Y   G+LF+ +   G+ SE E +   +QL+  ++  H   
Sbjct: 70  NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN 129

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRREYD 177
           I H D+KLEN L D +   R+ +CD+G  K         S   GT  Y +PE +    YD
Sbjct: 130 IIHNDIKLENVLYDRA-KDRIYLCDYGLCK----IIGTPSCYDGTLDYFSPEKIKGHNYD 184

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQED----PKNFRKTISRIMAVQYKIPDYVHISQDC 233
               D W+ GV  Y +L G +PF++ ED     ++  K   +      K+P   ++S++ 
Sbjct: 185 VSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------KLPFIKNVSKNA 237

Query: 234 RNLLSRIFVANPSRR-ITIKEIKSHPWFLKN 263
            + +  +   N + R     EI  HP FLK 
Sbjct: 238 NDFVQSMLKYNINYRLTNYNEIIKHP-FLKI 267

Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  106 bits (265), Expect = 2e-26
 Identities = 78/260 (30%), Positives = 135/260 (51%), Gaps = 13/260 (5%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   K++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146

Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    R KS VGTP ++APE++SR  Y G   D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201

Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPKLK--NLHKVSPSLKGFLDRLLVRDP 258

Query: 246 SRRITIKEIKSHPWFLKNLP 265
           ++R T  E+  HP+  K  P
Sbjct: 259 AQRATAAELLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  105 bits (264), Expect = 3e-26
 Identities = 80/265 (30%), Positives = 133/265 (50%), Gaps = 14/265 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA+K +    +     +  EI+  ++ +HPNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVI 137

Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV++R+ Y 
Sbjct: 138 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 249

Query: 238 SRIFVANPSRRITIKEIKSHPWFLK 262
           +R    +  +R + KE+  HP FLK
Sbjct: 250 NRCLEMDVEKRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 5e-26
 Identities = 85/282 (30%), Positives = 137/282 (48%), Gaps = 36/282 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           + +E++K IG G FG   +++ KNT ++ AMK + +   +  A  A     R+++ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYC 114
           R   I           +L +VM+Y  GG+L   +     R  ED AR++  +++  +   
Sbjct: 61  RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST------VGTPAYIAP 168
           H +   HRD+K +N LLD +   RL   DFG    S L      T      VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172

Query: 169 EVLSRREYDGK-----LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI 223
           E+L   E DGK       D WS GV +Y ML G  PF  +    +  +T  +IM  +   
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKEHF 227

Query: 224 ---PDYVHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
              PD   +S++ ++L+ R+  +  +R  R  +++ K HP+F
Sbjct: 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  104 bits (260), Expect = 1e-25
 Identities = 84/283 (29%), Positives = 143/283 (50%), Gaps = 15/283 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA+K +    +     +  EI+  ++ ++PNI
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVI 137

Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ Y 
Sbjct: 138 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--RLSAVFRDFL 249

Query: 238 SRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE 280
           +R    +  RR + KE+  HP FLK L + L+     I   KE
Sbjct: 250 NRCLEMDVDRRGSAKELLQHP-FLK-LAKPLSSLTPLIIAAKE 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  103 bits (259), Expect = 1e-25
 Identities = 78/257 (30%), Positives = 133/257 (51%), Gaps = 14/257 (5%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   K+T + VA+K ++ R  +    +  E++  +   H N++      L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +SY H+  + HRD+K ++
Sbjct: 90  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148

Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+SR  Y G   D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203

Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+ ++   +  R+    +     ++ D   +S   R  L  + V  P
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP---RVKDSHKVSSVLRGFLDLMLVREP 260

Query: 246 SRRITIKEIKSHPWFLK 262
           S+R T +E+  HP FLK
Sbjct: 261 SQRATAQELLQHP-FLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  102 bits (256), Expect = 2e-25
 Identities = 79/258 (30%), Positives = 127/258 (49%), Gaps = 7/258 (2%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIR 62
           YEL++ +GSG +G     RN +T EL A+K I+     D + + +EI   K+ +H NI+ 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
           +    L+   L I MEY  GG L +     G  SE +  Y  ++ + G++Y HS    HR
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130

Query: 123 DLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG--K 179
           D+K  N LL  +    +K+ DFG  +K +   ++ KS +GTP ++APEV +  +  G  +
Sbjct: 131 DIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
           L D+W+ G+T   +     P  D   P      +S+      K+ D    S    N +  
Sbjct: 189 LCDIWAVGITAIELAELQPPMFDLH-PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKI 247

Query: 240 IFVANPSRRITIKEIKSH 257
               NP +R T + + +H
Sbjct: 248 SLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  102 bits (255), Expect = 3e-25
 Identities = 83/265 (31%), Positives = 127/265 (47%), Gaps = 22/265 (8%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQLRHPNI 60
           K +G G FG   L  + +T   +A K +       E   ++ A +  EI   K L+H  I
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKNLQHERI 66

Query: 61  IRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +++   +       L I MEY  GG + +++   G  +E   R + +Q++ G+SY HS  
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEVLSRR 174
           I HRD+K  N L D   A  +K+ DFG SK      +  +  +S  GTP +++PEV+S  
Sbjct: 127 IVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            Y G+ ADVWS G T+  ML    P+ + E        I +I           HIS+  R
Sbjct: 185 GY-GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHAR 239

Query: 235 NLLSRIFVANPSRRITIKEIKSHPW 259
           + L  IFV     R + +E+  HP+
Sbjct: 240 DFLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  104 bits (260), Expect = 3e-25
 Identities = 82/306 (26%), Positives = 141/306 (46%), Gaps = 57/306 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E +E +K IG G FG  RL++ K+T  + AMK + +   ++    +E + H +     ++
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE----KEQVGHIRAERDILV 56

Query: 62  RFKEVVLTPT--------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
               + +           +L ++ME+  GG++   +      +E+E +++  + +  +  
Sbjct: 57  EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SLLHSRPK----- 157
            H +   HRD+K +N LLD      +K+ DFG               +L HS P      
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 158 --------------------STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA 197
                               STVGTP YIAPEV  +  Y+ KL D WS GV +Y ML+G 
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGY 233

Query: 198 YPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEI 254
            PF  +   + ++K ++    + +  P  V IS+  ++L+ R F      RI    ++EI
Sbjct: 234 PPFCSETPQETYKKVMNWKETLIF--PPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEI 290

Query: 255 KSHPWF 260
           K++P+F
Sbjct: 291 KTNPFF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  102 bits (256), Expect = 3e-25
 Identities = 86/283 (30%), Positives = 144/283 (50%), Gaps = 15/283 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA+K I    +     +  EI+  K+L++PNI
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + F +  L    L +VMEY AGG L + +       E +     ++ +  + + H+ Q+ 
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEAQIAAVCRECLQALEFLHANQVI 137

Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ Y 
Sbjct: 138 HRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSPIFRDFL 249

Query: 238 SRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKE 280
           +R    +  +R + KE+  HP FLK L + L+     I   KE
Sbjct: 250 NRCLEMDVEKRGSAKELLQHP-FLK-LAKPLSSLTPLILAAKE 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  103 bits (258), Expect = 4e-25
 Identities = 83/326 (25%), Positives = 155/326 (47%), Gaps = 29/326 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           + +E++K IG G FG   +++ K+T+ + AMK + +   +  A  A     R ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYC 114
           +    + +        +L +VM+Y  GG+L   +     R  ED AR++  +++  +   
Sbjct: 61  QWITTLHY--AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLS 172
           H +   HRD+K +N LLD +   RL   DFG           +S+  VGTP YI+PE+L 
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRL--ADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 173 RREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--AVQYKIPDY 226
             E      G   D WS GV +Y ML G  PF  +    +  +T  +IM    +++ P +
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHEERFQFPSH 232

Query: 227 V-HISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRELTETAQAIYYRKENP 282
           +  +S++ ++L+ R+ + +  RR+    I++ K H +F + +  E     +A Y    + 
Sbjct: 233 ITDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHAFF-EGIDWENIRNLEAPYIPDVSS 290

Query: 283 TFSLQSVEEITKIVEEAKVPPPVSRS 308
                + +    ++   ++ PP S +
Sbjct: 291 PSDTSNFDVDDDVLRNPEIAPPSSHT 316

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  102 bits (255), Expect = 5e-25
 Identities = 74/292 (25%), Positives = 136/292 (46%), Gaps = 26/292 (8%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PNI 60
           E++ ++G GN+G    + ++ T   +AMK I    ++D +   +II    + H    P I
Sbjct: 4   EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVSPYI 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           + F         + + MEY   G   +L+          ED  R     ++ G+ +    
Sbjct: 62  VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
             I HRD+K  N L++G+   ++K+CDFG S  +L+ S  K+ +G  +Y+APE +     
Sbjct: 122 HNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGP 178

Query: 177 DGKL-----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HI 229
           +        +DVWS G+++  M +G YP+     P+ +    +++ A+    P  +    
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYP----PETYANIFAQLSAIVDGDPPTLPSGY 234

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK--NLPRELTETAQAIYYRK 279
           S D ++ +++     P+RR T  ++  HPW +K  N   ++ E       RK
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGALKRK 286

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  101 bits (254), Expect = 9e-25
 Identities = 68/197 (34%), Positives = 100/197 (50%), Gaps = 17/197 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
           + +  +++IG G+FG     R+  T E+VA+K +    K      ++II      +QLRH
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PN I +K   L      +VMEY  G   ++ E   +     E E        + G++Y H
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LS 172
           S +  HRD+K  N LL  +    +K+ DFG   S+ L S   S VGTP ++APEV   + 
Sbjct: 133 SHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMD 187

Query: 173 RREYDGKLADVWSCGVT 189
             +YDGK  DVWS G+T
Sbjct: 188 EGQYDGK-VDVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  102 bits (255), Expect = 9e-25
 Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 37/288 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
            +Y  ++ +G G FG+    R++ T + VA+K I +            RE+   K LRH 
Sbjct: 10  NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69

Query: 59  NIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           NII   ++ ++P   +  V E    G    R+  +    +   +YF  Q++ G+ Y HS 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV-LSRREY 176
            + HRDLK  N L++ +    LKICDFG ++  +   +    V T  Y APE+ L+ ++Y
Sbjct: 128 GVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQKY 183

Query: 177 DGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTISRIMAVQY- 221
           D ++ D+WS G     ML G   +P +D  +            P +   TI     +++ 
Sbjct: 184 DVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242

Query: 222 -------KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                   +P    + +      +LL ++ V +P +RI+  E  +HP+
Sbjct: 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  101 bits (253), Expect = 1e-24
 Identities = 85/294 (28%), Positives = 131/294 (44%), Gaps = 43/294 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMK-YIERG-----HKIDANVAREIINHKQL 55
           EKYE +  IG G++GV    RN+ T ++VA+K ++E        KI     REI   KQL
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI---ALREIRMLKQL 57

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           +HPN++   EV      L +V EY     L E   N     E   +    Q +  V++CH
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEVL 171
                HRD+K EN L+  +   ++K+CDFG+++   + + P       V T  Y APE+L
Sbjct: 118 KHNCIHRDVKPENILI--TKQGQIKLCDFGFAR---ILTGPGDDYTDYVATRWYRAPELL 172

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDP-----KNFRKTISRIMAV----Q 220
                 G   DVW+ G     +L G   +P +   D      K     I R   +    Q
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232

Query: 221 Y----KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +     IP+          + +IS    + L      +P+ R++ +E+  HP+F
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  102 bits (254), Expect = 1e-24
 Identities = 78/275 (28%), Positives = 135/275 (49%), Gaps = 22/275 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E +E++K IG G FG   +++ KN  ++ AMK + +   +  A  A     R+++ +   
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYC 114
           +    + +        +L +VM+Y  GG+L   +     R  ED AR++  +++  +   
Sbjct: 61  QWITTLHY--AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLS 172
           H +   HRD+K +N L+D +   RL   DFG     +     +S+  VGTP YI+PE+L 
Sbjct: 119 HQLHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 173 RREYDGK-----LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
             E DGK       D WS GV +Y ML G  PF  +   + + K ++     Q+      
Sbjct: 177 AME-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP-AQVT 234

Query: 228 HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
            +S+D ++L+ R+  +   R  +  I++ K HP+F
Sbjct: 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  100 bits (250), Expect = 2e-24
 Identities = 79/271 (29%), Positives = 128/271 (47%), Gaps = 24/271 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+     D   ++ +EI    Q   P 
Sbjct: 4   ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +  AG F E +     ++++ G+ Y HS + 
Sbjct: 64  VTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 122

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG + + +    +  + VGTP ++APEV+ +  YD 
Sbjct: 123 IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV------HISQD 232
           K AD+WS G+T   +  G  P  D              M V + IP           S+ 
Sbjct: 181 K-ADIWSLGITAIELAKGEPPNSDMHP-----------MRVLFLIPKNNPPTLTGEFSKP 228

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
            +  +      +PS R T KE+  H + +KN
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  100 bits (251), Expect = 2e-24
 Identities = 70/202 (34%), Positives = 108/202 (53%), Gaps = 12/202 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMK-YIER-GHKIDANVA-REIINHKQLRHP 58
           EKYE +  +G G++G+    ++K T ++VA+K ++E    K+   +A REI   KQLRH 
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           N++   EV      L +V E+     L   E+  N G       +Y FQ ++ G+ +CHS
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQ-ILRGIEFCHS 118

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRR 174
             I HRD+K EN L+  S +  +K+CDFG+++ +L       T  V T  Y APE+L   
Sbjct: 119 HNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGD 175

Query: 175 EYDGKLADVWSCGVTLYVMLVG 196
              G+  D+W+ G  +  ML G
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  100 bits (251), Expect = 3e-24
 Identities = 82/313 (26%), Positives = 134/313 (42%), Gaps = 70/313 (22%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLRH 57
           KYE +  IG G FG     R+K TK++VA+K +     + G  I A   REI   + L+H
Sbjct: 13  KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA--LREIKILQLLKH 70

Query: 58  PNIIRFKEVVLTPT--------HLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLI 108
            N++   E+  T             +V E+    +L   + N   +F+  E +   + L+
Sbjct: 71  ENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLL 129

Query: 109 SGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKST-----VG 161
           +G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L    K       V 
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 162 TPAYIAPEV-LSRREYDGKLADVWSCG---------------------VTLYVMLVGA-- 197
           T  Y  PE+ L  R+Y G   D+W  G                     +TL   L G+  
Sbjct: 186 TLWYRPPELLLGERDY-GPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244

Query: 198 ---YP-------FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSR 247
              +P       F+  E P+  ++       V+ ++  YV       +L+ ++ V +P++
Sbjct: 245 PEVWPGVDKLELFKKMELPQGQKR------KVKERLKPYVK-DPHALDLIDKLLVLDPAK 297

Query: 248 RITIKEIKSHPWF 260
           RI      +H +F
Sbjct: 298 RIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  100 bits (251), Expect = 3e-24
 Identities = 78/281 (27%), Positives = 132/281 (46%), Gaps = 21/281 (7%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQLRHPNIIRFK 64
           IG G++    L+R K   ++ AMK +++        ID     + +  +   +P ++   
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
               T + L +V+EY  GG+L   +    +  E+ AR++  ++   +++ H   I +RDL
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADV 183
           KL+N LLD      +K+ D+G  K  L      ST  GTP YIAPE+L   EY G   D 
Sbjct: 123 KLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179

Query: 184 WSCGVTLYVMLVGAYPFE---DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           W+ GV ++ M+ G  PF+   D  D          I+    +IP +  +S    ++L   
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGF 237

Query: 241 FVANPSRRITIK------EIKSHPWFLKNLPRELTETAQAI 275
              +P  R+  +      +IKSH +F +++  +L E  Q  
Sbjct: 238 LNKDPKERLGCQPQTGFSDIKSHTFF-RSIDWDLLEKKQVT 277

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 5e-24
 Identities = 82/296 (27%), Positives = 126/296 (42%), Gaps = 44/296 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
            +Y+ +  IG G +G+     +K T   VA+K I             REI   ++ +H N
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCH 115
           II   ++ + P       +     EL E    ++      S D  +YF  Q++ G+ Y H
Sbjct: 65  IIGILDI-IRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEV- 170
           S  + HRDLK  N LL+      LKICDFG ++ +             V T  Y APE+ 
Sbjct: 124 SANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGA--YPFED----------------QEDPKNFRKT 212
           L+ + Y  K  D+WS G  L  ML     +P +D                QED       
Sbjct: 182 LNSKGYT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240

Query: 213 ISR--IMAVQYKIPDYVHISQDCRN-------LLSRIFVANPSRRITIKEIKSHPW 259
            +R  I ++ +K    V  ++   N       LL ++   NP +RIT++E  +HP+
Sbjct: 241 RARNYIKSLPFK--PKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  100 bits (251), Expect = 7e-24
 Identities = 89/314 (28%), Positives = 130/314 (41%), Gaps = 65/314 (20%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQLRH 57
           +  +K +G G FG   L R  +TK L AMK +       R         R+I+   +  +
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDIL--AEADN 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             ++R         +L  VM+Y  GG++   +   G F ED AR++  +L   V   H M
Sbjct: 61  EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYS------------------------------ 147
              HRD+K +N L+D      +K+ DFG                                
Sbjct: 121 GFIHRDIKPDNILIDRD--GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 148 ----------------KSSLLHSR--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVT 189
                           +++  H R    S VGTP YIAPEVL R  Y  +L D WS GV 
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVI 237

Query: 190 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI 249
           LY MLVG  PF  Q   +   K I+   ++   IP    +S +  +L+ ++    P  R+
Sbjct: 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLH--IPPQAKLSPEASDLIIKL-CRGPEDRL 294

Query: 250 ---TIKEIKSHPWF 260
                 EIK+HP+F
Sbjct: 295 GKNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 98.6 bits (245), Expect = 7e-24
 Identities = 78/265 (29%), Positives = 121/265 (45%), Gaps = 24/265 (9%)

Query: 1   MEKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQL 55
           +  +++ K IG G F  V R     + K  VA+K ++    +DA   ++ +      KQL
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKP-VALKKVQIFEMMDAKARQDCVKEIDLLKQL 59

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGV 111
            HPN+I++ +  +    L IV+E A  G+L + I    +      E     +F QL S V
Sbjct: 60  NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYI 166
            + HS ++ HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y+
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYM 173

Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 226
           +PE +    Y+ K +D+WS G  LY M     PF    D  N      +I    Y     
Sbjct: 174 SPERIHENGYNFK-SDIWSLGCLLYEMAALQSPF--YGDKMNLFSLCQKIEQCDYPPLPT 230

Query: 227 VHISQDCRNLLSRIFVANPSRRITI 251
            H S+  R L+S     +P +R  I
Sbjct: 231 EHYSEKLRELVSMCIYPDPDQRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =   99 bits (250), Expect = 8e-24
 Identities = 91/307 (29%), Positives = 138/307 (44%), Gaps = 61/307 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DA--NVA------REIIN 51
           + KYE+++ +G G +G+     ++ TKE+VA+K      KI DA  N        REI+ 
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------KIFDAFRNATDAQRTFREIMF 59

Query: 52  HKQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQ 106
            ++L  HPNI++   V+       I + +    E  E     +  A    +   RY   Q
Sbjct: 60  LQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQ 115

Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKST--V 160
           L+  + Y HS  + HRDLK  N LL+     R+K+ DFG ++S          P  T  V
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYV 173

Query: 161 GTPAYIAPEVL--SRREYDGKLADVWSCGVTLYVMLVGAYPF------------------ 200
            T  Y APE+L  S R Y  K  D+WS G  L  ML+G   F                  
Sbjct: 174 ATRWYRAPEILLGSTR-YT-KGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 201 ---EDQEDPK-NFRKTISRIMAVQYK--IPDYV-HISQDCRNLLSRIFVANPSRRITIKE 253
              ED E  K  F  T+   +  + +  + + +   S D  +LL ++ V NP++R+T +E
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291

Query: 254 IKSHPWF 260
              HP+ 
Sbjct: 292 ALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 97.7 bits (243), Expect = 2e-23
 Identities = 78/269 (28%), Positives = 128/269 (47%), Gaps = 30/269 (11%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRH-------PNII 61
           IG G FG     R  +T ++ AMK +++  +I       + +N + +         P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
                  TP  L+ +++   GG+L   +   G FSE E R++  ++I G+ + H+  + +
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 122 RDLKLENTLLDGSPAPRLK----ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR-REY 176
           RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   Y
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAY 173

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D   AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S + R+L
Sbjct: 174 DSS-ADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSPELRSL 229

Query: 237 LSRIFVANPSRRITI-----KEIKSHPWF 260
           L  +   + +RR+       +E+K HP+F
Sbjct: 230 LEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 97.6 bits (243), Expect = 3e-23
 Identities = 68/275 (24%), Positives = 133/275 (48%), Gaps = 24/275 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           E  E + D+G+GN G    +++  T  ++A K +  G K  ++V ++I+   Q+ H    
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRS 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P I+ F    L   ++ + ME+   G L       G    +        ++ G++Y +++
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 118 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++     ++K+CDFG S   L++S   + VGT  Y++PE +   +Y
Sbjct: 123 HRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKY 179

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-------- 228
             K +DVWS G+++  + +G +PF       + +     I+ +  +I   V         
Sbjct: 180 TVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI---VQEPPPRLPS 235

Query: 229 --ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
               +D R+ +    + +P+ R T +++ + P F+
Sbjct: 236 SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 98.9 bits (246), Expect = 3e-23
 Identities = 88/325 (27%), Positives = 130/325 (40%), Gaps = 93/325 (28%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN------- 59
           +K +G G FG   L    +T  L AMK + +         ++++N  Q+ H         
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRK---------KDVLNRNQVAHVKAERDILA 56

Query: 60  ------IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
                 +++         +L  VM+Y  GG++   +     F E  AR++  +L   +  
Sbjct: 57  EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIES 116

Query: 114 CHSMQICHRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSS-------- 150
            H M   HRD+K +N L  LDG     +K+ DFG             Y K S        
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172

Query: 151 ------------------LLHSRPK---------STVGTPAYIAPEVLSRREYDGKLADV 183
                              L  R           S VGTP YIAPEVL R+ Y  +L D 
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDW 231

Query: 184 WSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           WS GV L+ MLVG  PF      E Q    N+  T+         IP  V +S +  +L+
Sbjct: 232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL--------HIPPQVKLSPEAVDLI 283

Query: 238 SRIFVANPSR--RITIKEIKSHPWF 260
           +++  +   R  R    +IK+HP+F
Sbjct: 284 TKLCCSAEERLGRNGADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 96.5 bits (240), Expect = 5e-23
 Identities = 76/268 (28%), Positives = 122/268 (45%), Gaps = 25/268 (9%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG     + + T +L A K + +       G++  A V + I+     R   I+ 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYE-GAMVEKRILAKVHSRF--IVS 57

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSYCHSMQ 118
                 T T L +VM    GG+L   I N       F E  A ++  Q+ISG+ + H  +
Sbjct: 58  LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      ++I D G +       S+ K   GTP ++APE+L   EYD
Sbjct: 118 IIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
             + D ++ GVTLY M+    PF  + +    ++   RI+      PD    S   ++  
Sbjct: 176 FSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASKSFC 232

Query: 238 SRIFVANPSRRITIK-----EIKSHPWF 260
             +   +P +R+  +      +++HP F
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLF 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 96.7 bits (240), Expect = 6e-23
 Identities = 76/265 (28%), Positives = 135/265 (50%), Gaps = 14/265 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ Y 
Sbjct: 139 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 250

Query: 238 SRIFVANPSRRITIKEIKSHPWFLK 262
           +R    +  +R + KE+  H  FLK
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQ-FLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 96.2 bits (239), Expect = 8e-23
 Identities = 85/291 (29%), Positives = 131/291 (45%), Gaps = 38/291 (13%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRHPN 59
           K+E++  +G G +GV    R+K TKE+VA+K     E   ++     RE+   + L+  N
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           I+  KE       L +V EY      EL E + N      ++ R +  QLI  + +CH  
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHKN 119

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRRE 175
            I HRD+K EN L+  S    LK+CDFG++++    S    T  V T  Y +PE+L    
Sbjct: 120 DIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 176 YDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPK-NFRKTISRIMAVQYKI--------- 223
           Y GK  D+WS G  L  +  G   +P E + D     +K +  + A Q K+         
Sbjct: 178 Y-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 224 ---PDYVH-----------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              P   H           +S    +L+  +   NP+ R   ++  +HP F
Sbjct: 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 95.9 bits (238), Expect = 8e-23
 Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 21/286 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           E +E++ ++G G FG     +NK T  L A K I+   + +  +   EI       HPNI
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQI 119
           ++  +      +L I++E+ AGG +   +    R  +E + R   +Q +  ++Y H  +I
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124

Query: 120 CHRDLKLENTL--LDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVL----- 171
            HRDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+     
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
             R YD K ADVWS G+TL + +    P   + +P      I++        P     S 
Sbjct: 181 KDRPYDYK-ADVWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS--RWSS 236

Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWFL--KNLP-RELTETAQA 274
           + ++ L +    N   R T  ++  HP+     N P REL   A+A
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAKA 282

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 96.4 bits (240), Expect = 9e-23
 Identities = 78/300 (26%), Positives = 138/300 (46%), Gaps = 47/300 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRH--- 57
           + +E + ++G+GN GV   + ++ +  ++A K I   H +I   +  +II   ++ H   
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLI---HLEIKPAIRNQIIRELKVLHECN 57

Query: 58  -PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P I+ F     +   ++I ME+  GG L + +  AGR  E+        ++ G++Y   
Sbjct: 58  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117

Query: 117 -MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
             +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    
Sbjct: 118 KHKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTH 174

Query: 176 YDGKLADVWSCGVTLYVMLVGAYP------------FEDQEDP---KNFRKTIS------ 214
           Y    +D+WS G++L  M +G YP            F         K   + +S      
Sbjct: 175 Y-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233

Query: 215 -RIMAVQYKIPDYV-----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
            R MA+ +++ DY+             S + ++ + +    NP  R  +KE+  HP+  +
Sbjct: 234 PRPMAI-FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 99.0 bits (246), Expect = 1e-22
 Identities = 81/255 (31%), Positives = 122/255 (47%), Gaps = 49/255 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHK--------IDANVAREIIN 51
           + +YE++K IG+G FG   L+++K T+E    K I  RG K        I+ NV RE   
Sbjct: 12  LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRE--- 68

Query: 52  HKQLRHPNIIRFKEVVLTPTH--LAIVMEYAAGGELFERICNA----GRFSEDEARYFFQ 105
              L+H NI+R+ +  L   +  L I+ME+   G+L   I       G+  E       +
Sbjct: 69  ---LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125

Query: 106 QLISGVSYCHSMQ-------ICHRDLKLENTLLDG---------------SPAPRLKICD 143
           QL+  ++YCH+++       + HRDLK +N  L                 +  P  KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 144 FGYSKSSLLHSRPKSTVGTPAYIAPEVL--SRREYDGKLADVWSCGVTLYVMLVGAYPFE 201
           FG SK+  + S   S VGTP Y +PE+L    + YD K +D+W+ G  +Y +  G  PF 
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFH 244

Query: 202 DQEDPKNFRKTISRI 216
                 NF + IS +
Sbjct: 245 KA---NNFSQLISEL 256

Length = 1021

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 98.2 bits (244), Expect = 1e-22
 Identities = 89/299 (29%), Positives = 142/299 (47%), Gaps = 31/299 (10%)

Query: 21  MRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY 79
            R  + KE V  K++    +  A  AR E+       H  I++  +   +   L ++MEY
Sbjct: 87  TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146

Query: 80  AAGGELFERICNAGR----FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP 135
            +GG+L ++I    +    F E E    F Q++  +   HS ++ HRDLK  N  L   P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204

Query: 136 APRLKICDFGYSKS---SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYV 192
              +K+ DFG+SK    S+      S  GTP Y+APE+  R+ Y  K AD+WS GV LY 
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263

Query: 193 MLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK 252
           +L    PF+        R+ + +++  +Y  P    +S   + LL  +   NP+ R T +
Sbjct: 264 LLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQ 318

Query: 253 EIKSHPWFLK---NLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEE--AKVPPPVS 306
           ++  H  FLK   NL +++   ++ I         S    EEI + ++E   + PPP S
Sbjct: 319 QL-LHTEFLKYVANLFQDIVRHSETI---------SPHDREEILRQLQESGERAPPPSS 367

Length = 478

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 95.2 bits (237), Expect = 1e-22
 Identities = 67/222 (30%), Positives = 100/222 (45%), Gaps = 20/222 (9%)

Query: 6   LMKDIGSGNFGVARLMR----NKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPN 59
            +K +G G+FG   L R      NT E VA+K +      +  ++  REI   + L H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
           I+++K V   P    L ++MEY   G L + +  +  + +      F  Q+  G+ Y  S
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++      +KI DFG +K  L   +    V  P      + APE L
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 213
              ++    +DVWS GVTLY +    Y    Q  P  F + I
Sbjct: 185 RTSKFSSA-SDVWSFGVTLYELF--TYGDPSQSPPAEFLRMI 223

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 94.8 bits (235), Expect = 2e-22
 Identities = 76/273 (27%), Positives = 125/273 (45%), Gaps = 28/273 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+     D   ++ +EI    Q   P 
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 64  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 177
            HRD+K  N LL  S    +K+ DFG +   L  ++ K    VGTP ++APEV+ +  YD
Sbjct: 123 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 230
            K AD+WS G+T   +  G  P  +          PKN   T+              + S
Sbjct: 180 SK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG------------NYS 226

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           +  +  +       PS R T KE+  H + ++ 
Sbjct: 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 94.0 bits (233), Expect = 4e-22
 Identities = 83/271 (30%), Positives = 124/271 (45%), Gaps = 26/271 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  TKE+VA+K I+     D   ++ +EI    Q   P 
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           I R+    L  T L I+MEY  GG   + +   G   E       ++++ G+ Y HS + 
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERK 122

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD 
Sbjct: 123 IHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHISQ 231
           K AD+WS G+T   +  G  P  D          PKN   T+      QY  P +    +
Sbjct: 181 K-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG----QYSKP-FKEFVE 234

Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
            C N        +P  R T KE+  H +  +
Sbjct: 235 ACLN-------KDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 92.8 bits (230), Expect = 1e-21
 Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 30/269 (11%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRH-------PNII 61
           IG G FG     R  +T ++ AMK +++  +I       + +N + +         P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDK-KRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
                  TP  L  +++   GG+L   +   G FSE E R++  ++I G+ + H+  + +
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 122 RDLKLENTLLDGSPAPRLK----ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR-REY 176
           RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   Y
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAY 173

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D   AD +S G  L+ +L G  PF  Q   K+  +     + V  ++PD    S + ++L
Sbjct: 174 DSS-ADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTVNVELPD--SFSPELKSL 229

Query: 237 LSRIFVANPSRRITI-----KEIKSHPWF 260
           L  +   + S+R+       +E+K H +F
Sbjct: 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 92.8 bits (230), Expect = 1e-21
 Identities = 87/289 (30%), Positives = 133/289 (46%), Gaps = 26/289 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHP 58
           E +E++ ++G G FG     +NK T  L A K IE   +    D  V  EI+      HP
Sbjct: 12  EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEIL--ATCNHP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSM 117
            I++          L I++E+  GG +   +    R  +E + +   +Q++  + Y HSM
Sbjct: 70  YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129

Query: 118 QICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEV---- 170
           +I HRDLK  N LL  DG     +K+ DFG S K+     R  S +GTP ++APEV    
Sbjct: 130 KIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 171 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 229
            +    YD K AD+WS G+TL + +    P   + +P      I++        P     
Sbjct: 186 TMKDTPYDYK-ADIWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS--KW 241

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK---NLP-RELTETAQA 274
           S + R+ L      +P  R +  ++  HP+      N P REL   A+A
Sbjct: 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVAEAKA 290

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 65/192 (33%), Positives = 102/192 (53%), Gaps = 17/192 (8%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYI----ERGHKIDANVAREIINHKQLRHPNIIR 62
           + +IG G+FG      N +T E+VA+K +    ++ ++   ++ +E+   +QL+HPN I 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 63  FKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +K   L      +VMEY  G   +L E   +     E E        + G++Y HS  + 
Sbjct: 86  YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 177
           HRD+K  N LL  +   ++K+ DFG   S+   S   S VGTP ++APEV   +   +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 178 GKLADVWSCGVT 189
           GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 91.6 bits (227), Expect = 3e-21
 Identities = 73/261 (27%), Positives = 114/261 (43%), Gaps = 22/261 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLR 56
           +  + + K IG G F              VA+K ++    +DA    + I      KQL 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVS 112
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIA 167
           + HS ++ HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y++
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 174

Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
           PE +    Y+ K +D+WS G  LY M     PF    D  N      +I    Y      
Sbjct: 175 PERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSD 231

Query: 228 HISQDCRNLLSRIFVANPSRR 248
           H S++ R L++     +P +R
Sbjct: 232 HYSEELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 78/302 (25%), Positives = 128/302 (42%), Gaps = 58/302 (19%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVA-REIINHKQLRHP 58
           ++Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K + H 
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           N+I   +V    + L       +V     G +L   I    + S+D  ++   Q++ G+ 
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGLK 132

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE+
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEI 186

Query: 171 -LSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISRIMAV-------- 219
            L+   Y+ +  D+WS G  +  +L G   +P  D  D       + RIM +        
Sbjct: 187 MLNWMHYN-QTVDIWSVGCIMAELLTGKTLFPGSDHID------QLKRIMNLVGTPDEEL 239

Query: 220 -----------------QYKIPDYVHI----SQDCRNLLSRIFVANPSRRITIKEIKSHP 258
                            Q    D+  +    +    +LL ++ V +P +RIT  E  +HP
Sbjct: 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299

Query: 259 WF 260
           + 
Sbjct: 300 YL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 36/292 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E Y+ +  +G G++      R+K T +LVA+K I   H+  A     RE    K L+H 
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSM 117
           NI+   +++ T   L +V EY    +L + + + G   S    R F  QL+ G++YCH  
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRRE 175
           ++ HRDLK +N L+  S    LK+ DFG +++  + S+  S  V T  Y  P+VL    E
Sbjct: 123 RVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------------V 219
           Y   L D+W  G   Y M  G   F    D ++    I R++                  
Sbjct: 181 YSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239

Query: 220 QYKIPDY------VHISQ-----DCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            Y  P Y       H  +         L  +     P +RI+  E   HP+F
Sbjct: 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 94.2 bits (234), Expect = 3e-21
 Identities = 70/239 (29%), Positives = 125/239 (52%), Gaps = 30/239 (12%)

Query: 73  LAIVMEYAAGGELFERICN---AGR-FSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
           +A+V++YA  G+L + I +     R F E EA   F Q++  V + HS  + HRD+K  N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 129 TLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  +    +K+ DFG+SK   +++     ++  GTP Y+APE+  R+ Y  K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230

Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDCRNLLSRIFVAN 244
            GV LY +L    PF    D +N  + + + +A +Y  +P    IS + + +++ +  ++
Sbjct: 231 LGVLLYELLTLKRPF----DGENMEEVMHKTLAGRYDPLPP--SISPEMQEIVTALLSSD 284

Query: 245 PSRRITIKEIKSHP---WFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           P RR +  ++ + P    F+  L  E+ +T          P FS    + I++ +++ K
Sbjct: 285 PKRRPSSSKLLNMPICKLFISGL-LEIVQTQ---------PGFSGPLRDTISRQIQQTK 333

Length = 496

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.1 bits (226), Expect = 4e-21
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 18/205 (8%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-------RGHKIDANVAREIINHKQLRHPNIIR 62
           +G G +G        N  +L+A+K +E          K    +  E+   K L+H NI++
Sbjct: 8   LGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
           +    L    ++I ME+  GG +   +   G   E     + +Q++ GV+Y H+  + HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKS------SLLHSRP-KSTVGTPAYIAPEVLSRRE 175
           D+K  N +L   P   +K+ DFG ++          HS   KS  GTP ++APEV++   
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPF 200
           Y G+ +D+WS G T++ M  G  P 
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 91.2 bits (226), Expect = 4e-21
 Identities = 67/201 (33%), Positives = 102/201 (50%), Gaps = 9/201 (4%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E Y  +  +G G +      R+K T+ LVA+K I   H+  A     RE+   K L+H 
Sbjct: 4   LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSM 117
           NI+   +++ T   L +V EY    +L + + N G   S    + F  QL+ G+SYCH  
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRRE 175
           +I HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+V L   E
Sbjct: 123 KILHRDLKPQNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 176 YDGKLADVWSCGVTLYVMLVG 196
           Y   + D+W  G  LY M  G
Sbjct: 181 YSTPI-DMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 90.0 bits (223), Expect = 1e-20
 Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 21/271 (7%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG    ++ KNT ++ A K +++       G K+ A + +EI+  +++  P I+ 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQLISGVSYCHSMQIC 120
                 + THL +VM    GG+L   I N G    +  R  ++  Q+  G+ + HSM I 
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           +RD+K EN LLD     RL   D G +             GT  Y+APE+L    Y   +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            D ++ G ++Y M+ G  PF+D ++     +   R +  + K  ++ + +++ +++    
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLF 233

Query: 241 FVANPSRRITIKEIKSHP---WFLK--NLPR 266
               P  R+  +E    P    F K  N PR
Sbjct: 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 90.1 bits (223), Expect = 1e-20
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 39/293 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E Y  +  +G G +      R+K T  LVA+K I   H+  A     RE+   K L+H 
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSM 117
           NI+   +++ T   L +V EY    +L + + + G   +    + F  QL+ G++YCH  
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRRE 175
           ++ HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P++ L   +
Sbjct: 124 KVLHRDLKPQNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181

Query: 176 YDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISRIMA--------------- 218
           Y  ++ D+W  G   Y M  G   +P    E+  +F   I RI+                
Sbjct: 182 YSTQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEE 237

Query: 219 -VQYKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
              Y  P Y           +  D   LLS++      +RI+ +E   HP+F 
Sbjct: 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 72/319 (22%), Positives = 118/319 (36%), Gaps = 64/319 (20%)

Query: 3   KYELMKDIGSGNFGVARLMRNKN--TKELVAMKYIE----RGHKIDANVAREIINHKQLR 56
           KYE+   IG G +G     + KN    +  A+K  +    +   I  +  REI   ++L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 57  HPNIIRFKEVVLTPTHLAIVM--EYAAGGEL----FERICNAGRFSEDEARYFFQQLISG 110
           H N++   EV L     ++ +  +YA         F R            +    Q+++G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 111 VSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKS------TVGT 162
           V Y HS  + HRDLK  N L+  +G     +KI D G ++  L ++  K        V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178

Query: 163 PAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPK------------- 207
             Y APE+ L  R Y  K  D+W+ G     +L     F+  +   K             
Sbjct: 179 IWYRAPELLLGARHYT-KAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237

Query: 208 ----------------------NFRKTISRIMAVQYKIPDYVHI----SQDCRNLLSRIF 241
                                    K           +  ++           +LL ++ 
Sbjct: 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297

Query: 242 VANPSRRITIKEIKSHPWF 260
             +P++RIT +E   HP+F
Sbjct: 298 EYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 89.8 bits (222), Expect = 2e-20
 Identities = 65/192 (33%), Positives = 100/192 (52%), Gaps = 17/192 (8%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           +++IG G+FG     R+  T E+VA+K +    K      ++II      ++++HPN I 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 63  FKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +K   L      +VMEY  G   +L E   +     E E        + G++Y HS  + 
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 177
           HRD+K  N LL  +   ++K+ DFG   S+ + S   S VGTP ++APEV   +   +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202

Query: 178 GKLADVWSCGVT 189
           GK+ DVWS G+T
Sbjct: 203 GKV-DVWSLGIT 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 88.5 bits (219), Expect = 3e-20
 Identities = 71/269 (26%), Positives = 131/269 (48%), Gaps = 27/269 (10%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLRHP 58
           Y  ++ +G G++G   L+R++   +   +K +      R  +  A    ++++  QL+HP
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLS--QLKHP 59

Query: 59  NIIRFKEVVL-TPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLISGVSYCH 115
           NI+ ++E        L IVM +  GG+L+ ++         E++   +F Q+   + Y H
Sbjct: 60  NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 174
              I HRDLK +N  L  +    +K+ D G ++         ST +GTP Y++PE+ S +
Sbjct: 120 EKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP----DYVHIS 230
            Y+ K +DVW+ G  +Y M    + F    + K+    + RI  ++ K+P    DY   S
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPKDY---S 227

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPW 259
            +   L++ +    P +R ++K I   P+
Sbjct: 228 PELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 17/192 (8%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           +++IG G+FG     R+    E+VA+K +    K      ++II      ++LRHPN I+
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 63  FKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++   L      +VMEY  G   +L E   +     E E        + G++Y HS  + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 177
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192

Query: 178 GKLADVWSCGVT 189
           GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 89.0 bits (220), Expect = 5e-20
 Identities = 62/203 (30%), Positives = 106/203 (52%), Gaps = 11/203 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   +++K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P I+ F     +   ++I ME+  GG L + +  A R  E+        ++ G++Y    
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 118 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            QI HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Query: 177 DGKLADVWSCGVTLYVMLVGAYP 199
             + +D+WS G++L  + +G YP
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 88.1 bits (218), Expect = 6e-20
 Identities = 78/278 (28%), Positives = 130/278 (46%), Gaps = 29/278 (10%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIR 62
           +E+++ IG G +G    + NK    L A+K ++    +D  +  E    + L  HPN+++
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83

Query: 63  FKEVVLTPTHLA-----IVMEYAAGG---ELFERICNAG-RFSEDEARYFFQQLISGVSY 113
           F  +      L      +V+E   GG   EL + +   G R  E    Y     + G+ +
Sbjct: 84  FYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQH 143

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVL 171
            H+ +I HRD+K  N LL       +K+ DFG S + L  +R +  ++VGTP ++APEV+
Sbjct: 144 LHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPEVI 200

Query: 172 S-RREYDGKL---ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
           +  ++YD       DVWS G+T   +  G  P  D    K   K I R        P  +
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK-IPRNPP-----PTLL 254

Query: 228 HISQDCR---NLLSRIFVANPSRRITIKEIKSHPWFLK 262
           H  + CR   + +S+  + +   R ++  +  HP F+K
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 74/314 (23%), Positives = 120/314 (38%), Gaps = 69/314 (21%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ER-GHKIDANVAREIINHKQLRHP 58
           YE++  +G G FG     R   T  +VA+K I    E+ G  I A   REI   K+L+HP
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILKKLKHP 67

Query: 59  NIIRFKEVVL--------TPTHLAIVMEYA----AGGELFE--RICNAGRFSEDEARYFF 104
           N++   ++ +            + +V  Y     +G  L E   +    + +E + + + 
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCYM 121

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY------SKSSLLHSRPKS 158
            QL+ G++Y H   I HRD+K  N L+D      LKI DFG          +        
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 159 T------VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK 211
           T      V T  Y  PE +L  R Y     D+W  G     M       + + D      
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238

Query: 212 TISRIMAV-----------------QYKIPDYV--------HISQDCRNLLSRIFVANPS 246
            I ++                     +   +Y          +  +  +LLS++   +P 
Sbjct: 239 -IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPY 297

Query: 247 RRITIKEIKSHPWF 260
           +R+T  +   HP+F
Sbjct: 298 KRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 64/203 (31%), Positives = 105/203 (51%), Gaps = 11/203 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 118 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Query: 177 DGKLADVWSCGVTLYVMLVGAYP 199
             + +D+WS G++L  M +G YP
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 85.9 bits (212), Expect = 3e-19
 Identities = 75/271 (27%), Positives = 130/271 (47%), Gaps = 22/271 (8%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR 62
           +EL++ +G+G +G     R+  T +L A+K ++     +  + +EI +  K   H NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 63  FKEVVLTPT------HLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYC 114
           +    +          L +VME+   G + + I N       E+   Y  ++++ G+S+ 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR 173
           H  ++ HRD+K +N LL  +    +K+ DFG S        R  + +GTP ++APEV++ 
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 174 RE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
            E     YD K +D+WS G+T   M  GA P  D   P      I R  A + K   +  
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW-- 241

Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
            S+  ++ +    V N S+R T +++  HP+
Sbjct: 242 -SKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 11/212 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           ME Y  ++ +G G +      R+K T+ LVA+K I   H+  A     RE+   K L+H 
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSM 117
           NI+   ++V T   L +V EY    +L + + + G   S    + F  Q++ G++YCH  
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRRE 175
           ++ HRDLK +N L++      LK+ DFG +++  + ++  S  V T  Y  P+V L   E
Sbjct: 124 KVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181

Query: 176 YDGKLADVWSCGVTLYVMLVGA--YPFEDQED 205
           Y  ++ D+W  G   + M  G   +P    ED
Sbjct: 182 YSTQI-DMWGVGCIFFEMASGRPLFPGSTVED 212

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 85.9 bits (212), Expect = 5e-19
 Identities = 86/307 (28%), Positives = 133/307 (43%), Gaps = 46/307 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ERGHKIDANVAREIINHKQLRH 57
           + YE ++ +G G++      ++K   +LVA+K I    E G    A   RE    K L+H
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA--IREASLLKGLKH 62

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
            NI+   +++ T   L +V EY           + G    +  + F  QL+ G+SY H  
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-LSRRE 175
            I HRDLK +N L+  S    LK+ DFG +++  + S   S  V T  Y  P+V L   E
Sbjct: 123 YILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 176 YDGKLADVWSCGVTLYVML--VGAYP----FEDQ------------ED------------ 205
           Y   L D+W  G     M+  V A+P     +DQ            ED            
Sbjct: 181 YSTCL-DMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK 239

Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
           P+ F     + +   +    YV+ ++D   L S++    P  R++ +   SH +F    P
Sbjct: 240 PERFTLYSPKNLRQAWNKLSYVNHAED---LASKLLQCFPKNRLSAQAALSHEYFSDLPP 296

Query: 266 R--ELTE 270
           R  ELT+
Sbjct: 297 RLWELTD 303

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 85.0 bits (210), Expect = 7e-19
 Identities = 74/271 (27%), Positives = 132/271 (48%), Gaps = 26/271 (9%)

Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L R      NT E VA+K +  E G    A++ +EI   + L H NI
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSM 117
           +++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  S 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPAY-IAPEVLSR 173
           Q  HRDL   N L++     ++KI DFG +K+      +   K  + +P +  APE L +
Sbjct: 129 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 174 REYDGKLADVWSCGVTLYVMLV----GAYP---FEDQEDPKNFRKTISRIMAV---QYKI 223
            ++    +DVWS GVTLY +L      + P   F     P + + T++R++ V     ++
Sbjct: 187 SKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 224 PDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           P   +  ++   L+ + +   PS+R T + +
Sbjct: 246 PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 84.9 bits (210), Expect = 8e-19
 Identities = 59/199 (29%), Positives = 105/199 (52%), Gaps = 22/199 (11%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PNIIRFKE 65
           +G GN G      +  T+ ++A+K I     I   + ++I++  ++ +    P II F  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 66  VVLTPTHLAIVMEYAAGGEL--FERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICH 121
                  ++I  E+  GG L  + +I     GR +          ++ G++Y  S++I H
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RD+K  N L++     ++K+CDFG S + L++S  K+ VGT AY+APE +S  +Y G  +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVS-TQLVNSIAKTYVGTNAYMAPERISGEQY-GIHS 174

Query: 182 DVWSCGVTLYVMLVGAYPF 200
           DVWS G++   + +G +P+
Sbjct: 175 DVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 18/214 (8%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR 62
           +EL++ +G+G +G     R+  T +L A+K ++     +  +  EI +  K   H NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 63  FKEVVLT---PTH---LAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYC 114
           +    +    P H   L +VME+   G + + + N       ED   Y  ++++ G+++ 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR 173
           H+ ++ HRD+K +N LL  +    +K+ DFG S        R  + +GTP ++APEV++ 
Sbjct: 138 HAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 174 RE-----YDGKLADVWSCGVTLYVMLVGAYPFED 202
            E     YD + +D+WS G+T   M  GA P  D
Sbjct: 196 DENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 16/262 (6%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RHPNIIRFKE 65
           +G G FG     + + T ++ A K +E+            +N KQ+        ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRD 123
              T   L +V+    GG+L   I N G   F E+ A ++  ++  G+   H  +I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127

Query: 124 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 183
           LK EN LLD      ++I D G +         +  VGT  Y+APEV+    Y     D 
Sbjct: 128 LKPENILLDDY--GHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDW 184

Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 243
           W  G  +Y M+ G  PF  +++     +   R+   Q +  +    S+  R++  ++   
Sbjct: 185 WGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSICRQLLTK 242

Query: 244 NPSRRITIK-----EIKSHPWF 260
           +P  R+  +     E+K+HP+F
Sbjct: 243 DPGFRLGCRGEGAEEVKAHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 76/299 (25%), Positives = 121/299 (40%), Gaps = 55/299 (18%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ---------- 54
           E  + IG G FGV   + +    + VA+K +        NV + +++ K+          
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-------PNVFQNLVSCKRVFRELKMLCF 55

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFER-----ICNAGRFSEDEARYFFQQLIS 109
            +H N++   ++ L P H+    E     EL +      I +    S D  + F  Q++ 
Sbjct: 56  FKHDNVLSALDI-LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIA 167
           G+ Y HS  I HRD+K  N L++ +    LKICDFG ++          T  V T  Y A
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 168 PEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------- 217
           PE+L   R Y   + D+WS G     +L     F+ Q   +        +          
Sbjct: 173 PEILMGSRHYTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231

Query: 218 ----AVQY------KIPD----YVHISQDCR---NLLSRIFVANPSRRITIKEIKSHPW 259
               A  +      K P     Y   SQ      +LL R+ V +P +RI+  +  +HP+
Sbjct: 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 74/273 (27%), Positives = 124/273 (45%), Gaps = 24/273 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNI 60
           + +E+++ IG G +G    + NK      A+K ++  H ID  +  E    K L  HPN+
Sbjct: 18  DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77

Query: 61  IRF-----KEVVLTPTHLAIVMEYAAGG---ELFERICNAG-RFSEDEARYFFQQLISGV 111
           ++F     K+ V     L +V+E   GG   +L +     G R  E    Y   + + G+
Sbjct: 78  VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPE 169
            + H  +  HRD+K  N LL  +    +K+ DFG S   +S    R  ++VGTP ++APE
Sbjct: 138 QHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAPE 194

Query: 170 VLSRRE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 224
           V++  +     YD +  DVWS G+T   +  G  P  D    +   K I R        P
Sbjct: 195 VIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPTLHQP 252

Query: 225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 257
           +    S +  + + +    +  +R T+ ++  H
Sbjct: 253 EL--WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 78/295 (26%), Positives = 127/295 (43%), Gaps = 44/295 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHP 58
           ++Y  +K +GSG +G      ++ T   VA+K + R  + +       RE+   K ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 59  NIIRFKEVVLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
           N+I   +V  TP           +VM +   G    ++    + SED  ++   Q++ G+
Sbjct: 75  NVIGLLDV-FTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
            Y H+  I HRDLK  N  L  +    LKI DFG ++ +   S     V T  Y APEV+
Sbjct: 132 KYIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVI 187

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQ---------------------ED 205
               +  +  D+WS G  +  ML G   F+     DQ                     ED
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247

Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            KN+ K + R     ++     + +    N+L ++ V +   RIT  E  +HP+F
Sbjct: 248 AKNYVKKLPRFRKKDFRSL-LPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF 301

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 82.4 bits (204), Expect = 4e-18
 Identities = 73/268 (27%), Positives = 115/268 (42%), Gaps = 33/268 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPN 59
            ++ +L   IG G FG   L   +  K  VA+K ++       A +A E      LRHPN
Sbjct: 5   SKELKLGATIGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLA-EASVMTTLRHPN 61

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSM 117
           +++   VVL    L IV EY A G L + + + GR   +  +   F   +  G+ Y    
Sbjct: 62  LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEVLSRREY 176
              HRDL   N L+        K+ DFG +K +S      K  V    + APE L  +++
Sbjct: 122 NFVHRDLAARNVLVSEDLVA--KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKF 176

Query: 177 DGKLADVWSCGVTLY-VMLVG--AYPFEDQED-----PKNFRKTISRIMAVQYKIPDYVH 228
             K +DVWS G+ L+ +   G   YP    +D      K +R      M      P  V+
Sbjct: 177 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR------MEAPEGCPPEVY 229

Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKS 256
                  ++   +  +P++R T K+++ 
Sbjct: 230 ------KVMKDCWELDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 88/316 (27%), Positives = 140/316 (44%), Gaps = 51/316 (16%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHPN 59
           +Y++ + IG G++GV     + +T E VA+K I     H  DA  + REI   + LRHP+
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 60  IIRFKEVVLTPTH-----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           I+  K ++L P+      + +V E     +L + I      + +  ++F  QL+  + Y 
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----STVGTPAYIAPEV 170
           H+  + HRDLK +N L +     +LKICDFG ++ +   +         V T  Y APE+
Sbjct: 120 HTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 171 LSRREYDGKLA---DVWSCGVTLYVMLVGAYPFEDQEDPKNFR-----------KTISRI 216
                +  K     D+WS G     +L G   F  +                  +TISR+
Sbjct: 178 CG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235

Query: 217 ---------MAVQYKIPDYVHISQDCRN-------LLSRIFVANPSRRITIKEIKSHPWF 260
                     +++ K P  V  SQ   N       LL R+   +P  R T +E  + P+F
Sbjct: 236 RNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293

Query: 261 LKNLPRELTE-TAQAI 275
            K L +   E +AQ I
Sbjct: 294 -KGLAKVEREPSAQPI 308

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 80/301 (26%), Positives = 126/301 (41%), Gaps = 49/301 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR 56
           + YE ++ IG G +G     R+KNT +LVA+K       E G  I     REI   + L 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG--IPPTALREISLLQMLS 58

Query: 57  H-PNIIRFKEVVLTPTH-----LAIVMEYAAGGELFERICNAGR-----FSEDEARYFFQ 105
               I+R  +V           L +V EY    +L + + + GR           + F  
Sbjct: 59  ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMY 117

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPA 164
           QL+ GV++CH   + HRDLK +N L+D      LKI D G  ++ S+        + T  
Sbjct: 118 QLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLW 176

Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF----EDQEDPKNFR-------KTI 213
           Y APEVL    +     D+WS G     M      F    E Q+    F+       +  
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236

Query: 214 SRIMAVQ--------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
             +  ++                +PD   +S +  +LL ++   +P++RI+ K   +HP+
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Query: 260 F 260
           F
Sbjct: 294 F 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 82.4 bits (204), Expect = 8e-18
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 21/272 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--VAREI-INHKQLRHP 58
              E + +IGSG  G    MR K T  ++A+K + R    + N  +  ++ +  K    P
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYC-H 115
            I++     +T + + I ME  +    +L +RI   G   ED        ++  + Y   
Sbjct: 75  YIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE 132

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL--- 171
              + HRD+K  N LLD S    +K+CDFG S   L+ S+ K+ + G  AY+APE +   
Sbjct: 133 KHGVIHRDVKPSNILLDASG--NVKLCDFGIS-GRLVDSKAKTRSAGCAAYMAPERIDPP 189

Query: 172 -SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHI 229
               +YD + ADVWS G++L  +  G +P+++ +    F + +++I+  +          
Sbjct: 190 DPNPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQEEPPSLPPNEGF 245

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
           S D  + +      +  +R   +E+  HP+  
Sbjct: 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 69/265 (26%), Positives = 101/265 (38%), Gaps = 63/265 (23%)

Query: 47  REIINHKQLRHPNIIRFKEV-----------VLTPTHLA---IVMEYAAGGELFERICNA 92
           REI   ++L H NI++  EV           V + T L    IV EY         +   
Sbjct: 51  REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQ 108

Query: 93  GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG------- 145
           G  SE+ AR F  QL+ G+ Y HS  + HRDLK  N  ++ +    LKI DFG       
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDP 167

Query: 146 -YSKSSLLHSRPKSTVGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVMLVG------- 196
            YS    L       + T  Y +P  +LS   Y  K  D+W+ G     ML G       
Sbjct: 168 HYSHKGYL----SEGLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGA 222

Query: 197 -----------AYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVH---------ISQDCRN 235
                      + P   +ED    R  +  ++    +                ++ +  +
Sbjct: 223 HELEQMQLILESVPVVREED----RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALD 278

Query: 236 LLSRIFVANPSRRITIKEIKSHPWF 260
            L +I   NP  R+T +E   HP+ 
Sbjct: 279 FLEQILTFNPMDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 82.6 bits (204), Expect = 9e-18
 Identities = 80/297 (26%), Positives = 128/297 (43%), Gaps = 49/297 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVA-REIINHKQLRHP 58
           E+Y  +K +GSG +G      +K T E VA+K + R    +I A  A RE+   K ++H 
Sbjct: 15  ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           N+I   +V  +           +VM Y       ++I      SED+ +Y   Q++ G+ 
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLK 131

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           Y HS  I HRDLK  N  L  +    LKI DFG ++ +   +     V T  Y APEV+ 
Sbjct: 132 YIHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVIL 187

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVH--- 228
              +  +  D+WS G  +  ML G   F+     K++   +++I+ V     P++V    
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGPEFVQKLE 243

Query: 229 -------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                                     S    +LL ++   +  +R+T  E   HP+F
Sbjct: 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 81.3 bits (201), Expect = 1e-17
 Identities = 64/197 (32%), Positives = 93/197 (47%), Gaps = 15/197 (7%)

Query: 8   KDIGSGNFGVAR--LMRNKNTKEL-VAMKYIERG--HKIDANVAREIINHKQLRHPNIIR 62
           K +G G+FGV R         K + VA+K ++      I  +  +E      L H N+IR
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERI-CNA-GRFSEDEARYFFQQLISGVSYCHSMQIC 120
              VVLT   L +V E A  G L +R+  +A G F       +  Q+ +G+ Y  S +  
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTP-AYIAPEVLSRREY 176
           HRDL   N LL  +   ++KI DFG  ++      H   +  +  P A+ APE L  R +
Sbjct: 120 HRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 177 DGKLADVWSCGVTLYVM 193
               +DVW  GVTL+ M
Sbjct: 178 S-HASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 70/222 (31%), Positives = 105/222 (47%), Gaps = 20/222 (9%)

Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHP 58
           + ++ +G G+FG   L      N  T E+VA+K ++R  G +  +   +EI   K L H 
Sbjct: 7   KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66

Query: 59  NIIRFKEVVLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           NI+++K          L ++MEY   G L + +    + +  +   F QQ+  G++Y HS
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPAY-IAPEVLS 172
               HRDL   N LLD      +KI DFG +K+      + R +    +P +  A E L 
Sbjct: 126 QHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL- 182

Query: 173 RREYDGKLA-DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 213
            +E     A DVWS GVTLY +L        Q  PK F + I
Sbjct: 183 -KENKFSYASDVWSFGVTLYELLTHCDSK--QSPPKKFEEMI 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 1e-17
 Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 24/210 (11%)

Query: 8   KDIGSGNFGVAR--LMRNKNTKEL-VAMKYIERGHKIDANVA---REIINHKQLRHPNII 61
           K++G GNFG     +   K+ KE+ VA+K +++ H I A      RE     QL HP I+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH-IAAGKKEFLREASVMAQLDHPCIV 59

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           R   V      L +VME A  G L + +         + +    Q+  G++Y  S    H
Sbjct: 60  RLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIAPEVLSR 173
           RDL   N LL      + KI DFG S++        S              + APE ++ 
Sbjct: 119 RDLAARNVLLVNR--HQAKISDFGMSRA----LGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 174 REYDGKLADVWSCGVTLYVML-VGAYPFED 202
            ++  K +DVWS GVTL+     GA P+ +
Sbjct: 173 GKFSSK-SDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 56/205 (27%), Positives = 105/205 (51%), Gaps = 14/205 (6%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIR 62
           Y ++K +  G+ G   +       + V +K  ++G   I+A + + +       HP++IR
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNV------NHPSVIR 121

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
            K+ +++     +V+ + +  +L+  +   +     D+A    +Q++ G+ Y H+ +I H
Sbjct: 122 MKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIH 180

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RD+K EN  ++     ++ I D G ++  ++        GT    APEVL+R +Y+ K A
Sbjct: 181 RDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK-A 237

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDP 206
           D+WS G+ L+ ML  AYP    EDP
Sbjct: 238 DIWSAGIVLFEML--AYPSTIFEDP 260

Length = 357

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 75/263 (28%), Positives = 115/263 (43%), Gaps = 18/263 (6%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF----KE 65
           +G G FG     + + T ++ A K +E+            +N KQ+      RF      
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRD 123
              T   L +V+    GG+L   I + G   F E  A ++  ++  G+   H  +I +RD
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127

Query: 124 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 183
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y     D 
Sbjct: 128 LKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 184

Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHISQDCRNLLSRIFV 242
           W+ G  LY M+ G  PF+ Q   K  R+ + R++  VQ +  +    S D R+L   +  
Sbjct: 185 WALGCLLYEMIAGQSPFQ-QRKKKIKREEVERLVKEVQEEYSE--KFSPDARSLCKMLLC 241

Query: 243 ANPSRRI-----TIKEIKSHPWF 260
            +P  R+       +E+K HP F
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 86/309 (27%), Positives = 126/309 (40%), Gaps = 69/309 (22%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTK--ELVAMKYIER--GHKIDANVA-REIINHKQLR-H 57
           YEL+K++G G +G+    RN  T   E VA+K I      KI A  A RE+   +  R H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 58  PNII-----------RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQ 106
            NI             F E+ L       +ME     +L + I +    ++   + F  Q
Sbjct: 62  KNITCLYDMDIVFPGNFNELYLYEE----LMEA----DLHQIIRSGQPLTDAHFQSFIYQ 113

Query: 107 LISGVSYCHSMQICHRDLKLENTL--LDGSPAPRLKICDFGYSKSSLLHSRPKST----- 159
           ++ G+ Y HS  + HRDLK  N L   D      LKICDFG ++       P        
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARG--FSENPGENAGFMT 167

Query: 160 --VGTPAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED----------- 205
             V T  Y APE+ LS + Y  K  DVWS G  L   L+G  P    +D           
Sbjct: 168 EYVATRWYRAPEIMLSFQSYT-KAIDVWSVGCIL-AELLGRKPVFKGKDYVDQLNQILQV 225

Query: 206 ----PKNFRKTISRIMAVQY--KIPDYVHI---------SQDCRNLLSRIFVANPSRRIT 250
                +     I    A  Y   +P+             +    +LL ++   +P++RI+
Sbjct: 226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS 285

Query: 251 IKEIKSHPW 259
           ++E   HP+
Sbjct: 286 VEEALEHPY 294

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 79.0 bits (195), Expect = 7e-17
 Identities = 64/263 (24%), Positives = 106/263 (40%), Gaps = 20/263 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-NVAREIINHKQLRHPNI 60
           E++ L + +GSG FG       KN    VA+K ++    +   +  +E+   K+LRH ++
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQLISGVSYCHSMQ 118
           I    V      + I+ E    G L   + +        A       Q+  G++Y     
Sbjct: 65  ISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVLSRR 174
             HRDL   N L+        K+ DFG ++       L S  K       + APE  S  
Sbjct: 125 SIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHG 179

Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +  K +DVWS G+ LY +   G  P+       N  +   +I A  Y++P      Q+ 
Sbjct: 180 TFSTK-SDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQITA-GYRMPCPAKCPQEI 233

Query: 234 RNLLSRIFVANPSRRITIKEIKS 256
             ++   + A P  R + K ++ 
Sbjct: 234 YKIMLECWAAEPEDRPSFKALRE 256

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 74/288 (25%), Positives = 121/288 (42%), Gaps = 34/288 (11%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           Y  ++ +G G++       ++   +LVA+K I  +    +     RE    K L+H NI+
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
              +++ T   L  V EY         I + G       R F  QL+ G++Y H   I H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRREYDGK 179
           RDLK +N L+  S    LK+ DFG +++  + S+  S+ V T  Y  P+VL    +Y   
Sbjct: 127 RDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------KIPDY----- 226
           L D+W  G     ML G   F    D     + I  ++ V          K+P+Y     
Sbjct: 185 L-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243

Query: 227 -------VHISQD-------CRNLLSRIFVANPSRRITIKEIKSHPWF 260
                  + +            +L S++ +  P  RI+ ++   HP+F
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 93/358 (25%), Positives = 145/358 (40%), Gaps = 88/358 (24%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA------REIINHKQLR 56
           +Y+ +K IGSG  G+     +  T + VA+K + R  +   NV       RE++  K + 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ---NVTHAKRAYRELVLMKLVN 73

Query: 57  HPNIIRFKEVVLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQL 107
           H NII    V  TP         + +VME      +   +C   +   D  R  Y   Q+
Sbjct: 74  HKNIIGLLNV-FTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLLYQM 127

Query: 108 ISGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY 165
           + G+ + HS  I HRDLK  N ++  D +    LKI DFG ++++         V T  Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKNFRKTISR-------- 215
            APEV+    Y   + D+WS G  +  M+ G   +P  D  D  N  K I +        
Sbjct: 184 RAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWN--KIIEQLGTPSDEF 240

Query: 216 IMAVQYKIPDYVH-----------------------------ISQDCRNLLSRIFVANPS 246
           +  +Q  + +YV                               +   R+LLS++ V +P 
Sbjct: 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300

Query: 247 RRITIKEIKSHP----WFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           +RI++ +   HP    W+    P E+     A Y           S++E    VEE K
Sbjct: 301 KRISVDDALQHPYINVWY---DPSEVEAPPPAPYD---------HSIDEREHTVEEWK 346

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 22/214 (10%)

Query: 10  IGSGNFG--VARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHPNIIRFK 64
           IG       +  L ++K T  LVA+K I        ++     EII  +QL+HPNI+ + 
Sbjct: 6   IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65

Query: 65  EVVLTPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
              +  + L +V    A G   +L +     G   E    +  + +++ + Y HS    H
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKGFIH 124

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYS--------KSSLLHSRPKSTVGTPAYIAPEVLSR 173
           R +K  + LL G    ++ +    YS        +  ++H  PKS+V    +++PEVL +
Sbjct: 125 RSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 174 --REYDGKLADVWSCGVTLYVMLVGAYPFEDQED 205
             + Y+ K +D++S G+T   +  G  PF+D   
Sbjct: 183 NLQGYNEK-SDIYSVGITACELANGHVPFKDMPA 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 77.3 bits (190), Expect = 3e-16
 Identities = 67/266 (25%), Positives = 117/266 (43%), Gaps = 17/266 (6%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-LRHPN---IIRFKE 65
           +G G FG     + + T ++ A K +E+            +N KQ L   N   ++    
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRD 123
              T   L +V+    GG+L   I N G   F E+ A ++  +++ G+   H     +RD
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127

Query: 124 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 183
           LK EN LLD      ++I D G +         +  VGT  Y+APEVL+ + Y     D 
Sbjct: 128 LKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDY 184

Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 243
           W  G  +Y M+ G  PF  +++     +   R++  +         S++ +++   +   
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTK 242

Query: 244 NPSRRITIK-----EIKSHPWFLKNL 264
           +P +R+  +     E+K HP F +N+
Sbjct: 243 DPKQRLGCQEEGAGEVKRHP-FFRNM 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 73/301 (24%), Positives = 127/301 (42%), Gaps = 45/301 (14%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C       D  R  Y   Q++ G+ + 
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 139

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 197

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------ 216
            Y   + D+WS G  +  ++ G+  F+  +    + K I ++                  
Sbjct: 198 GYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256

Query: 217 ---------MAVQYKIPDYVHISQD---------CRNLLSRIFVANPSRRITIKEIKSHP 258
                    ++ +   PD++  S+           R+LLS++ V +P +RI++ E   HP
Sbjct: 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316

Query: 259 W 259
           +
Sbjct: 317 Y 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 4e-16
 Identities = 57/201 (28%), Positives = 90/201 (44%), Gaps = 10/201 (4%)

Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++GSG FGV  L + +   + VA+K I  G   + +   E     +L HPN+++   
Sbjct: 8   FLKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V      + IV EY A G L   +    G+   +        +   + Y  S    HRDL
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRREYDGKLA 181
              N L+       +K+ DFG ++  +L  +  S+ GT   +    PEV     +  K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182

Query: 182 DVWSCGVTLY-VMLVGAYPFE 201
           DVWS GV ++ V   G  P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 83/299 (27%), Positives = 125/299 (41%), Gaps = 54/299 (18%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y+L   IG+G+FGV       +T E VA+K + +  +      RE++  K L H NII  
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN---RELLIMKNLNHINIIFL 124

Query: 64  KEVVLTPT--------HLAIVMEYAAGG-----ELFERICNAGRFSEDEARYFFQQLISG 110
           K+   T           L +VME+         + + R  N         + +  QL   
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRA 182

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPR---LKICDFGYSKSSLLHSRPKSTVGTPAYIA 167
           ++Y HS  ICHRDLK +N L+D    P    LK+CDFG +K+ L   R  S + +  Y A
Sbjct: 183 LAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRA 238

Query: 168 PEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS----------RI 216
           PE+ L    Y   + D+WS G  +  M++G   F  Q       + I           + 
Sbjct: 239 PELMLGATNYTTHI-DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297

Query: 217 MAVQY---KIPDYVHISQDCR------------NLLSRIFVANPSRRITIKEIKSHPWF 260
           M   Y   K PD     +D +            N +S+     P +R+   E  + P+F
Sbjct: 298 MNPNYADIKFPDVK--PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354

Length = 440

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 76.1 bits (187), Expect = 6e-16
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 10/201 (4%)

Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E     +L H  +++   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V      + IV EY + G L   +   G RF   +     + +  G++Y  S Q  HRDL
Sbjct: 67  VCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDL 126

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 181
              N L+D      +K+ DFG S+  +L     S+VG+     +  PEVL   ++  K +
Sbjct: 127 AARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK-S 182

Query: 182 DVWSCGVTLY-VMLVGAYPFE 201
           DVW+ GV ++ V  +G  P+E
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 76.2 bits (188), Expect = 6e-16
 Identities = 65/269 (24%), Positives = 116/269 (43%), Gaps = 32/269 (11%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L + +G+G FG V     N  TK  VA+K ++ G        +E    K+LRH  +
Sbjct: 6   ESLKLERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF-FQQLI-------SGVS 112
           ++   V      + IV EY + G L + +         E +     QL+        G++
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTP-AYIAP 168
           Y  S    HRDL   N L+  +     KI DFG ++  L+       +     P  + AP
Sbjct: 118 YLESRNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAP 173

Query: 169 EVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
           E  +   +  K +DVWS G+ L  ++  G  P+         R+ + ++    Y++P   
Sbjct: 174 EAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGM----TNREVLEQVER-GYRMPRPP 227

Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKS 256
           +  ++  +L+ + +  +P  R T + ++S
Sbjct: 228 NCPEELYDLMLQCWDKDPEERPTFEYLQS 256

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 75/270 (27%), Positives = 120/270 (44%), Gaps = 34/270 (12%)

Query: 6   LMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNI 60
           + K IG G FG     RL      +  VA+K ++ G   K   +   E     Q  HPNI
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           IR + VV     + I+ EY   G L  F R  N G+F+  +     + + SG+ Y   M 
Sbjct: 68  IRLEGVVTKSRPVMIITEYMENGSLDKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN 126

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-----PA-YIAPEVLS 172
             HRDL   N L++ +     K+ DFG S+        ++T  T     P  + APE ++
Sbjct: 127 YVHRDLAARNILVNSN--LVCKVSDFGLSR---RLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 173 RREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            R++    +DVWS G+ ++ VM  G  P+ D  +    +  I  +    Y++P  +    
Sbjct: 182 YRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAVED-GYRLPPPM---- 231

Query: 232 DCRNLLSRIFV----ANPSRRITIKEIKSH 257
           DC + L ++ +     + + R T  +I S 
Sbjct: 232 DCPSALYQLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 76.2 bits (188), Expect = 9e-16
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 42/219 (19%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--------- 57
           + +IG G FG    M +K +  ++A+K      +I + V  +    K+L           
Sbjct: 9   LGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEK--EQKRLLMDLDVVMRSS 60

Query: 58  --PNIIRFKEVVLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISGVSYC 114
             P I++F   +       I ME      + F +        E       ++++  ++  
Sbjct: 61  DCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY-----EVLKSVIPEEILGKIAVA 115

Query: 115 ---------HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPA 164
                      ++I HRD+K  N LLD +    +K+CDFG S   L+ S  K+   G   
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGIS-GQLVDSIAKTRDAGCRP 172

Query: 165 YIAPEVL--SRRE-YDGKLADVWSCGVTLYVMLVGAYPF 200
           Y+APE +  S R+ YD + +DVWS G+TLY +  G +P+
Sbjct: 173 YMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 68/263 (25%), Positives = 113/263 (42%), Gaps = 18/263 (6%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G FG     + + T ++ A K +E+            +N K++      RF  V L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV-VSLA 66

Query: 70  PTH-----LAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
             +     L +V+    GG+L   I N G   F E  A ++  +L  G+      +I +R
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR 126

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           DLK EN LLD      ++I D G +         +  VGT  Y+APEV++  +Y     D
Sbjct: 127 DLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PD 183

Query: 183 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 242
            W  G  +Y M+ G  PF  +++     +   R+   Q +  +    S+D +++   +  
Sbjct: 184 WWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSICRMLLT 241

Query: 243 ANPSRRITIK-----EIKSHPWF 260
            NP  R+  +      +K HP F
Sbjct: 242 KNPKERLGCRGNGAAGVKQHPIF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 70/318 (22%), Positives = 121/318 (38%), Gaps = 68/318 (21%)

Query: 2   EKYE-LMKDIGSGNFGVARLMRNKNTKELVAMKYI----------ERGHKIDA-----NV 45
           E+Y      +G G +G      +  T ++VA+K +          +    +         
Sbjct: 8   ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67

Query: 46  AREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQ 105
            RE+    +++H NI+   +V +    + +VM+  A  +L + +    R +E + +    
Sbjct: 68  LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILL 126

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----------SSLLHS 154
           Q+++G++  H     HRDL   N  ++       KI DFG ++           S     
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 155 RPK----STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQEDPKN 208
           + +    S V T  Y APE+L   E      D+WS G     +L G   +P E++ D   
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID--- 241

Query: 209 FRKTISRIMAV-----------QYKIPDYV---------------HISQDCRNLLSRIFV 242
               + RI  +             K+P Y                + S D  +LL  +  
Sbjct: 242 ---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298

Query: 243 ANPSRRITIKEIKSHPWF 260
            NP  RI+ KE   H +F
Sbjct: 299 LNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 75/294 (25%), Positives = 127/294 (43%), Gaps = 42/294 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTISRIM 217
               +  +  D+WS G  +  +L G   +P  D  D                 K IS   
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249

Query: 218 AVQY-----KIPD------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           A  Y     ++P       ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 74.4 bits (183), Expect = 3e-15
 Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 17/198 (8%)

Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNII 61
           ++ +G GNFG   L R      NT E+VA+K ++        +  REI   K L+H NI+
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFER-ICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           ++K V  +    +L +VMEY   G L +    +  R    +   +  Q+  G+ Y  S +
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE L+ 
Sbjct: 129 YVHRDLATRNILVESEN--RVKIGDFGLTKV-LPQDKEYYKVREPGESPIFWYAPESLTE 185

Query: 174 REYDGKLADVWSCGVTLY 191
            ++    +DVWS GV LY
Sbjct: 186 SKFS-VASDVWSFGVVLY 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 82/319 (25%), Positives = 135/319 (42%), Gaps = 65/319 (20%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           +YE  K +G G +G     + K+ K+    A+K IE G  I  +  REI   ++L+HPN+
Sbjct: 3   EYEGCK-VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACREIALLRELKHPNV 60

Query: 61  IRFKEVVLTPT--HLAIVMEYAAGGEL----FERICNAGR----FSEDEARYFFQQLISG 110
           I  ++V L+ +   + ++ +YA         F R   A +          +    Q++ G
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 111 VSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK------STVGT 162
           + Y H+  + HRDLK  N L+  +G    R+KI D G+++  L +S  K        V T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVT 178

Query: 163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKN----FRKTISRIM 217
             Y APE+L    +  K  D+W+ G     +L     F   QED K         + RI 
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238

Query: 218 AVQ-----------YKIPDYVHISQDCRN-------------------------LLSRIF 241
           +V             K+P+Y  + +D R                          LL ++ 
Sbjct: 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLL 298

Query: 242 VANPSRRITIKEIKSHPWF 260
             +P++RIT ++    P+F
Sbjct: 299 TMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 79/325 (24%), Positives = 136/325 (41%), Gaps = 38/325 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +   ++ VA+K + R  +  I A    RE+   K ++H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           N+I   +V    T +     + +     G     I    + S++  ++   QL+ G+ Y 
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++   
Sbjct: 135 HSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLNW 190

Query: 175 EYDGKLADVWSCGVTLYVMLVGA--YPFEDQED------------PKNFRKTISRIMAVQ 220
            +  +  D+WS G  +  +L G   +P  D  D                 K IS   A +
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250

Query: 221 YKIPDYVHISQD------------CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
           Y I    H+ Q               +LL ++ V +  +RI+  E  +HP+F +    E 
Sbjct: 251 Y-IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPED 309

Query: 269 TETAQAIYYRKENPTFSLQSVEEIT 293
              A+      EN   +++  +E+T
Sbjct: 310 EPEAEPYDESPENKERTIEEWKELT 334

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 6/155 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +E++ ++K I  G FG   L R KN  +L A+K +++   I+ N+  ++   +      +
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P I+     + +  ++ +VMEY  GG++   +   G F E+ A  +  ++   + Y H 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR 122

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 151
             I HRDLK +N L+  S    +K+ DFG SK +L
Sbjct: 123 HGIIHRDLKPDNMLI--SNEGHIKLTDFGLSKVTL 155

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 41/281 (14%)

Query: 1   MEKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--- 52
            EK  L++++G G+FG     +A+ +     +  VA+K +      +    RE I     
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN-----ENASMRERIEFLNE 59

Query: 53  ----KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERIC-----NAGRFSEDEAR 101
               K+    +++R   VV T     +VME  A G+L  + R       N         +
Sbjct: 60  ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119

Query: 102 YFFQ---QLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RP 156
            F Q   ++  G++Y  + +  HRDL   N ++       +KI DFG ++        R 
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRK 177

Query: 157 KSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTIS 214
                 P  ++APE L    +  K +DVWS GV L+ M  +   P++   + +  +  I 
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID 236

Query: 215 R-IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
              + +    PD          L+   +  NP  R T  EI
Sbjct: 237 GGHLDLPENCPDK------LLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 10/200 (5%)

Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEV 66
           MK++GSG FGV  L + +   + VA+K I  G   + +   E     +L HP +++   V
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 67  VLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                 L IV E+   G L   +    G+ S+D      Q +  G+ Y       HRDL 
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127

Query: 126 LENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLAD 182
             N L+  S    +K+ DFG ++  +L     S+ G      +  PEV +  +Y  K +D
Sbjct: 128 ARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-SD 183

Query: 183 VWSCGVTLY-VMLVGAYPFE 201
           VWS GV ++ V   G  PFE
Sbjct: 184 VWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 77/307 (25%), Positives = 126/307 (41%), Gaps = 57/307 (18%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82

Query: 58  PNIIRFKEVVLTPTH-------LAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQLI 108
            NII    V  TP         + IVME      +   +C   +   D  R  Y   Q++
Sbjct: 83  KNIIGLLNV-FTPQKSLEEFQDVYIVMEL-----MDANLCQVIQMELDHERMSYLLYQML 136

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
            G+ + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------MAVQ 220
           EV+    Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253

Query: 221 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 252
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313

Query: 253 EIKSHPW 259
           E   HP+
Sbjct: 314 EALQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 72/299 (24%), Positives = 115/299 (38%), Gaps = 59/299 (19%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKE----------------LVAMKYIERGHKIDANV 45
           +    ++ +G G FG   L      ++                LVA+K +    + DA+ 
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL----RPDASD 60

Query: 46  A------REIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FER--------- 88
                  +E+    +L  PNI R   V      L ++MEY   G+L  F +         
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 89  ICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 148
            CN+   S     Y   Q+ SG+ Y  S+   HRDL   N L+       +KI DFG S+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSR 178

Query: 149 SSLLHSRPKSTVG--TPAYI---APEVLSRREYDGKLADVWSCGVTLY--VMLVGAYPFE 201
           +  L+S     V    P  I   A E +   ++  K +DVW+ GVTL+  + L    P+E
Sbjct: 179 N--LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYE 235

Query: 202 DQEDPKNFRKTISRIMAVQYKIPDYVHISQ------DCRNLLSRIFVANPSRRITIKEI 254
              D     + I             +++ +      D   L+   +  +   R T +EI
Sbjct: 236 HLTDQ----QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 76/299 (25%), Positives = 122/299 (40%), Gaps = 52/299 (17%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR- 56
           +YE + +IG G +G     R+ ++   VA+K +     E G  +  +  RE+   K+L  
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL--STVREVALLKRLEA 58

Query: 57  --HPNIIRFKEVVLT-----PTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQL 107
             HPNI+R  +V  T      T + +V E+         +++   G    +  +   +Q 
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIA 167
           + G+ + H+  I HRDLK EN L+  +   ++K+ DFG ++           V T  Y A
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 168 PEVLSRREYDGKLADVWSCGVTLYVML--------------------VGAYPFEDQ---- 203
           PEVL +  Y     D+WS G     M                     +   P ED     
Sbjct: 176 PEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234

Query: 204 -EDPK-NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              P+  F     R   VQ  +P+   I +    LL  +   NP +RI+      HP+F
Sbjct: 235 VTLPRGAFSPRGPR--PVQSVVPE---IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 18/208 (8%)

Query: 8   KDIGSGNFG-VAR-LMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG+G FG V R +++    KE+ VA+K ++ G+  K   +   E     Q  H NIIR
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
            + VV       I+ EY   G L + +  + G FS  +     + + +G+ Y   M   H
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRRE 175
           RDL   N L++ +     K+ DFG S+  +L   P+ T  T        + APE ++ R+
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFED 202
           +    +DVWS G+ ++ VM  G  P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 70.7 bits (173), Expect = 6e-14
 Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)

Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG+G FG     RL      +  VA+K ++ G+  K   +   E     Q  HPNII 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  + G+F+  +     + + SG+ Y   M   
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFED 202
           ++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 185 KFTSA-SDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 70.4 bits (172), Expect = 6e-14
 Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 10/205 (4%)

Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           L+++IGSG FG+  L      ++ VA+K I  G   + +   E     +L HP +++   
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V    + + +V E+   G L + +    G+FS++        +  G++Y  S  + HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 181
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S  +Y  K +
Sbjct: 127 AARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK-S 182

Query: 182 DVWSCGVTLY-VMLVGAYPFEDQED 205
           DVWS GV ++ V   G  P+E++ +
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSN 207

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.4 bits (172), Expect = 6e-14
 Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 13/195 (6%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 61

Query: 61  IRFKEVVLTP-THLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSM 117
           ++   V++     L IV EY A G L + + + GR     D    F   +   + Y  + 
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  +++
Sbjct: 122 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 176

Query: 177 DGKLADVWSCGVTLY 191
             K +DVWS G+ L+
Sbjct: 177 STK-SDVWSFGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 61/235 (25%), Positives = 105/235 (44%), Gaps = 23/235 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E+ E  + + S N G  +       + L+A K ++ G +    +  EI+   +L H NI+
Sbjct: 174 EEAEARRGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENIL 226

Query: 62  RFKEVVLTPTH-LAIVMEYAAGGELFERICNAGRFSED-----EARYFFQQLISGVSYCH 115
           + +E++ +  +   I  +Y    +L+  + +     +D     + R   +QL+  V Y H
Sbjct: 227 KIEEILRSEANTYMITQKYDF--DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 173
             ++ HRD+KLEN  L+      L   DFG +              VGT A  +PE+L+ 
Sbjct: 285 DKKLIHRDIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342

Query: 174 REYDGKLADVWSCGVTLYVMLVGAY-PFED--QEDPKNFRKTISRIMAVQYKIPD 225
             Y  ++ D+WSCG+ L  ML   + P  D   +  K   K I  +     + PD
Sbjct: 343 DGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPD 396

Length = 501

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 71.3 bits (174), Expect = 8e-14
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------MAVQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 194 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252

Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ E   HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312

Query: 259 W 259
           +
Sbjct: 313 Y 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.7 bits (168), Expect = 2e-13
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)

Query: 10  IGSGNFG---VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPNIIR 62
           IG+G FG     RL      +  VA+K ++ G+       R+ ++      Q  HPNII 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIH 69

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIAPEVLS 172
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE ++
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 173 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
            R++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 55/188 (29%), Positives = 79/188 (42%), Gaps = 21/188 (11%)

Query: 26  TKELVAMKYI-----ERGHKIDANVAREIINHKQLRHPNIIRF-KEVVLTPTHLAIVMEY 79
           T   VA+K +     E  H+  A   RE     +L HPNI+         P  L  V EY
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQR-ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 80  AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APR 138
             G  L E +   G     E      Q++  ++  H+  I HRDLK +N ++  +   P 
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 139 LKICDFGYSKSSLLH----------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGV 188
            K+ DFG    +LL           +R    +GTP Y APE L R E     +D+++ G+
Sbjct: 121 AKVLDFGI--GTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGL 177

Query: 189 TLYVMLVG 196
                L G
Sbjct: 178 IFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 81/319 (25%), Positives = 133/319 (41%), Gaps = 65/319 (20%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           +YE  K +G G +G     + K+ K+    A+K IE G  I  +  REI   ++L+HPN+
Sbjct: 3   EYEGCK-VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNV 60

Query: 61  IRFKEVVLTPT--HLAIVMEYAAGGEL----FERICNAGR----FSEDEARYFFQQLISG 110
           I  ++V L+     + ++ +YA         F R   A +          +    Q++ G
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 111 VSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK------STVGT 162
           + Y H+  + HRDLK  N L+  +G    R+KI D G+++  L +S  K        V T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLKPLADLDPVVVT 178

Query: 163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKN----FRKTISRIM 217
             Y APE+L    +  K  D+W+ G     +L     F   QED K         + RI 
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238

Query: 218 AVQ-----------YKIPDYVHISQDCR-------------------------NLLSRIF 241
            V             K+P++  + +D R                         +LL ++ 
Sbjct: 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298

Query: 242 VANPSRRITIKEIKSHPWF 260
             +P +RIT ++    P+F
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 68/276 (24%), Positives = 127/276 (46%), Gaps = 35/276 (12%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH------- 57
           E+++++G G +GV   MR+  T  ++A+K      +I A V       K+L         
Sbjct: 4   EVIEELGRGAYGVVDKMRHVPTGTIMAVK------RIRATV--NSQEQKRLLMDLDISMR 55

Query: 58  ----PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRF-SEDEARYFFQQLISG 110
               P  + F   +     + I ME       + ++++ + G    ED        ++  
Sbjct: 56  SVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA 115

Query: 111 VSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAP 168
           + Y HS + + HRD+K  N L++     ++K+CDFG S   L+ S  K+   G   Y+AP
Sbjct: 116 LEYLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGIS-GYLVDSVAKTIDAGCKPYMAP 172

Query: 169 E----VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 224
           E     L+++ YD K +DVWS G+T+  +  G +P++  + P  F++    +     ++P
Sbjct: 173 ERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLP 229

Query: 225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                S + ++ +++    N   R    E+  HP+F
Sbjct: 230 AE-KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 67.7 bits (165), Expect = 5e-13
 Identities = 69/246 (28%), Positives = 103/246 (41%), Gaps = 15/246 (6%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFKEVV 67
           IG GNFG     R +     VA+K        D  A   +E    KQ  HPNI+R   V 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 68  LTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKL 126
                + IVME   GG+    +   G R    E     +   +G+ Y  S    HRDL  
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAA 122

Query: 127 ENTLLDGSPAPRLKICDFGYSKSSL--LHSRPKSTVGTPA-YIAPEVLSRREYDGKLADV 183
            N L+       LKI DFG S+     +++        P  + APE L+   Y  + +DV
Sbjct: 123 RNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-SDV 179

Query: 184 WSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 242
           WS G+ L+    +GA P+ +  + +  R+ I +   V+   P+          L+ R + 
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQT-REAIEQ--GVRLPCPE--LCPDAVYRLMERCWE 234

Query: 243 ANPSRR 248
            +P +R
Sbjct: 235 YDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 49/299 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           ++YE + +IG G +G     R+ KN    VA+K +     E G  +  +  RE+   + L
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL--STIREVAVLRHL 58

Query: 56  R---HPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQ 105
               HPN++R  +V         T L +V E+         +++   G  +E   +    
Sbjct: 59  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE-TIKDMMF 117

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY 165
           QL+ G+ + HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWY 175

Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------- 216
            APEVL +  Y     D+WS G     M      F    D     K +  I         
Sbjct: 176 RAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234

Query: 217 ---------------MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            ++  + D   + +D   LL +    NP++RI+     SHP+F
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 66.5 bits (162), Expect = 1e-12
 Identities = 69/259 (26%), Positives = 115/259 (44%), Gaps = 19/259 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           ++K  L + IG G FG   +++ + T + VA+K I+      A +    +  K L H N+
Sbjct: 5   LQKLTLGEIIGEGEFGA--VLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTK-LHHKNL 61

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVSYCHSMQ 118
           +R   V+L    L IVME  + G L   +   GR      +   F   +  G+ Y  S +
Sbjct: 62  VRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           + HRDL   N L+  S     K+ DFG ++   + S        P  + APE L  +++ 
Sbjct: 121 LVHRDLAARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFS 175

Query: 178 GKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS GV L+ V   G  P+     PK   K +   +   Y++        D   L
Sbjct: 176 SK-SDVWSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229

Query: 237 LSRIFVANPSRRITIKEIK 255
           ++  +   P +R +  +++
Sbjct: 230 MTSCWETEPKKRPSFHKLR 248

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 72/273 (26%), Positives = 124/273 (45%), Gaps = 36/273 (13%)

Query: 2   EKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGHKIDANVAR------EIINH 52
           E   L + IG G FG       M  +N K  VA+K      K   + +       E    
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTC----KNCTSPSVREKFLQEAYIM 61

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           +Q  HP+I++   V+ T   + IVME A  GEL   +  N           +  QL + +
Sbjct: 62  RQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-P-AYIAPE 169
           +Y  S +  HRD+   N L+  SP   +K+ DFG S+     S  K++ G  P  ++APE
Sbjct: 121 AYLESKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 170 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRI-----MAVQYKI 223
            ++ R +    +DVW  GV ++ ++++G  PF+  ++       I RI     + +    
Sbjct: 179 SINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRIENGERLPMPPNC 233

Query: 224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
           P  ++      +L+++ +  +PS+R    E+K+
Sbjct: 234 PPTLY------SLMTKCWAYDPSKRPRFTELKA 260

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 19/211 (9%)

Query: 5   ELMKDIGSGNFGVAR----LMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHP 58
           E +K +GSG FG       +   +  K  VA+K +  E   K +  +  E      + HP
Sbjct: 10  EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSM 117
           +++R   + L+     ++ +    G L + +  +           +  Q+  G+SY    
Sbjct: 70  HVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLS 172
           ++ HRDL   N L+  +P   +KI DFG +K  LL    K            ++A E + 
Sbjct: 129 RLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLDVDEKEYHAEGGKVPIKWMALESIL 184

Query: 173 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
            R Y  K +DVWS GVT++ +M  GA P+E 
Sbjct: 185 HRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 58/246 (23%), Positives = 109/246 (44%), Gaps = 24/246 (9%)

Query: 20  LMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY 79
           L+ +  T++   +K + +  +        II H     PN++   + +++   + +V+++
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66

Query: 80  AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRL 139
           A GG+L+  I       E+  + +  +++  +   H   I  RDL   N LLD     +L
Sbjct: 67  AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126

Query: 140 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP 199
                 +S+ S +            Y APEV    E + +  D WS G  L+ +L G   
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTL 181

Query: 200 FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI-----TIKEI 254
            E      N   T++        IP+   +S++ R+LL ++   NP+ R+      +++I
Sbjct: 182 VECHPSGINTHTTLN--------IPE--WVSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231

Query: 255 KSHPWF 260
           KSHP+F
Sbjct: 232 KSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 28/219 (12%)

Query: 5   ELMKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPN 59
           EL+  IG G  +     L R K T E V ++ I      +  V     E+   K   HPN
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSM 117
           I+ ++   +    L +V  + A G   + IC       SE    Y  Q ++  + Y H M
Sbjct: 61  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120

Query: 118 QICHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSSLLHSRPKSTVGTPAY 165
              HR +K  + L  +DG      K+   G            +  ++H  PK +V    +
Sbjct: 121 GYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174

Query: 166 IAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED 202
           ++PEVL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 175 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 5e-11
 Identities = 70/258 (27%), Positives = 107/258 (41%), Gaps = 28/258 (10%)

Query: 10  IGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG GNFG V + +   NT+  V          +     +E    KQ  HPNI++   V +
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 69  TPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
               + IVME   GG L   +     R +  +         +G+ Y  S    HRDL   
Sbjct: 63  QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAAR 122

Query: 128 NTLLDGSPAPRLKICDFG---------YSKSSLLHSRP-KSTVGTPAYIAPEVLSRREYD 177
           N L+  +    LKI DFG         Y+ S  L   P K T       APE L+   Y 
Sbjct: 123 NCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT-------APEALNYGRYT 173

Query: 178 GKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            + +DVWS G+ L+    +G  P+    +    ++T  RI +  Y++P      ++   L
Sbjct: 174 SE-SDVWSYGILLWETFSLGDTPYPGMSN----QQTRERIES-GYRMPAPQLCPEEIYRL 227

Query: 237 LSRIFVANPSRRITIKEI 254
           + + +  +P  R +  EI
Sbjct: 228 MLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 80/290 (27%), Positives = 124/290 (42%), Gaps = 54/290 (18%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDAN------VAREII 50
           ++  L K +G G FG      A  + N N    VA+K +    K DA       +  E+ 
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML----KDDATEKDLSDLVSEME 67

Query: 51  NHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY------- 102
             K + +H NII    V      L +V+EYAA G L + +  A R   + A         
Sbjct: 68  MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126

Query: 103 ----------FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL 152
                     F  Q+  G+ +  S +  HRDL   N L+  +    +KI DFG ++   +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182

Query: 153 HSRP---KSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDP 206
           H      K+T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+      
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVE 241

Query: 207 KNFR--KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           + F+  K   R+   Q    +  H+ +DC       +   PS+R T K++
Sbjct: 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDC-------WHEVPSQRPTFKQL 284

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 68/264 (25%), Positives = 120/264 (45%), Gaps = 23/264 (8%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L+K +G+G FG V     N +TK  VA+K +++G         E    KQL+HP +
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGHTK--VAIKSLKQGSMSPEAFLAEANLMKQLQHPRL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +     + + ++      Q+  G+++     
Sbjct: 64  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 123 YIHRDLRAANILV--SETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINY 177

Query: 174 REYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
             +  K +DVWS G+ L  ++  G  P+    +P+     + + +   Y++P   +  ++
Sbjct: 178 GTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNLERGYRMPRPDNCPEE 231

Query: 233 CRNLLSRIFVANPSRRITIKEIKS 256
              L+   +   P  R T + ++S
Sbjct: 232 LYELMRLCWKEKPEERPTFEYLRS 255

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 34/225 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----------KIDAN------V 45
           ++  L + +G G FG   L   +   E +     E             + D         
Sbjct: 5   QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 46  AREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL------------FERICNAG 93
            +EI    +L++PNIIR   V ++   L ++ EY   G+L            F    N  
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 94  RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SL 151
             S     Y   Q+ SG+ Y  S+   HRDL   N L+       +KI DFG S++  S 
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSG 182

Query: 152 LHSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLYVMLV 195
            + R +     P  ++A E +   ++    +DVW+ GVTL+ M  
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 69/276 (25%), Positives = 113/276 (40%), Gaps = 37/276 (13%)

Query: 6   LMKDIGSGNFGVARL-----MRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           L +++G G FG   L     +  +N KELVA+K ++     DA  +  RE       +H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERI--------------CNAGRFSEDEARYFF 104
           NI++F  V        +V EY   G+L + +                 G  +  +     
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SLLHSRPKSTVGT 162
            Q+ SG+ Y  S    HRDL   N L+       +KI DFG S+   +  + R       
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 163 PA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQ 220
           P  ++ PE +  R++  + +DVWS GV L+ +   G  P+    + +         +  +
Sbjct: 187 PIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245

Query: 221 YKI-PDYV-HISQDCRNLLSRIFVANPSRRITIKEI 254
            +  P  V  I   C       +  +P +RI IK+I
Sbjct: 246 PRTCPSEVYDIMLGC-------WKRDPQQRINIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 70/315 (22%), Positives = 121/315 (38%), Gaps = 68/315 (21%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHK 53
           M++Y++++ IG G  G   L  +      VA+K I           K      RE     
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLREAKIAA 57

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARY-------- 102
            L HP I+    +      +   M Y  G     L + +      S++ A          
Sbjct: 58  DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG----------------Y 146
            F ++ + + Y HS  + HRDLK +N LL       + I D+G                 
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 147 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ 203
            + ++ +S    P   VGTP Y+APE L          D+++ GV LY ML  ++P+   
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233

Query: 204 EDPKNFRKTISRIMAVQYKIPDYVHIS--QDCRNLLSRI----FVANPSRRIT-----IK 252
              K  RK     ++ +  I   + ++  ++    LS+I       +P+ R +      +
Sbjct: 234 ---KKGRK-----ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285

Query: 253 EIKSH-----PWFLK 262
           +++ H      W +K
Sbjct: 286 DLEPHLQGSPEWTVK 300

Length = 932

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 58.9 bits (142), Expect = 6e-10
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 11/205 (5%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L+K +G+G FG V     N +TK  VA+K ++ G         E    K L+H  +
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV     + I+ EY A G L  F +    G+    +   F  Q+  G++Y     
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREY 176
             HRDL+  N L+  S +   KI DFG ++      ++  +       + APE ++   +
Sbjct: 124 YIHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181

Query: 177 DGKLADVWSCGVTLY-VMLVGAYPF 200
             K +DVWS G+ LY ++  G  P+
Sbjct: 182 TIK-SDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 58.6 bits (142), Expect = 7e-10
 Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 51/292 (17%)

Query: 1   MEKYELMKDIGSGNFG-VAR----LMRNKNTKELVAMKYIERGHKIDA--NVAREIINHK 53
           +     ++++G G FG V +        + +   VA+K ++   +        +E     
Sbjct: 4   LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE------RICNAGRFSED-------EA 100
            L+HPNI+    V        ++ EY A G+L E         + G  S D       + 
Sbjct: 64  DLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123

Query: 101 RYFFQ---QLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHS 154
             F     Q+ +G+ Y  S    HRDL   N L+       +KI DFG S+   S+  + 
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYR 181

Query: 155 RPKSTVGTPAYIAPE-VLSRREYDGKL---ADVWSCGVTLY-VMLVGAYP---FEDQEDP 206
               ++    ++ PE +L      GK    +D+WS GV L+ +   G  P   F +QE  
Sbjct: 182 VQSKSLLPVRWMPPEAILY-----GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236

Query: 207 KNFRKTISRIMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSH 257
           +  R     ++      P  V+ +  +C N +       P+RR   K+I + 
Sbjct: 237 EMIRSRQ--LLPCPEDCPARVYALMIECWNEI-------PARRPRFKDIHTR 279

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 58.6 bits (142), Expect = 8e-10
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 5   ELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           +L++ +G+G FG V   + N  T   VA+K ++ G     +   E    K+LRHP +I+ 
Sbjct: 9   QLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL 66

Query: 64  KEVVLTPTHLAIVMEYAAGGELFE-------RICNAGRFSEDEARYFFQQLISGVSYCHS 116
             V      + IV E    G L E       R     +  +  A     Q+ SG++Y  +
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA-----QVASGMAYLEA 121

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEVLSR 173
               HRDL   N L+  +     K+ DFG +   K  +  +R  +      + APE    
Sbjct: 122 QNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEAREGAKFPI-KWTAPEAALY 178

Query: 174 REYDGKLADVWSCGVTLY-VMLVGAYPF 200
             +  K +DVWS G+ L  ++  G  P+
Sbjct: 179 NRFSIK-SDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 58.1 bits (140), Expect = 9e-10
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 36/219 (16%)

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI---- 108
           KQ  HPNI++   V      + IVME   GG+    +    R  +DE +   +QL+    
Sbjct: 47  KQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFAL 100

Query: 109 ---SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSLLHSRPK 157
              +G++Y  S    HRDL   N L+  +    LKI DFG S+        SS L   P 
Sbjct: 101 DAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPI 158

Query: 158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRI 216
                  + APE L+   Y  + +DVWS G+ L+    +G  P+    + +  R+ + + 
Sbjct: 159 K------WTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVEK- 209

Query: 217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 255
               Y++        D   ++ R +   P  R    E++
Sbjct: 210 ---GYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ 245

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 42/235 (17%)

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERIC--------------NAGRFS 96
           KQ+ HP++I+          L +++EYA  G L  F R                N+    
Sbjct: 58  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 97  EDEAR--------YFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 148
             + R         F  Q+  G+ Y   M++ HRDL   N L+  +   ++KI DFG S+
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSR 175

Query: 149 ------SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
                 S +  S+ +  V    ++A E L    Y  + +DVWS GV L+ ++ +G  P+ 
Sbjct: 176 DVYEEDSYVKRSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY- 230

Query: 202 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
               P    + +  ++   Y++    + S++  NL+   +   P +R T  +I  
Sbjct: 231 ----PGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 54/194 (27%), Positives = 89/194 (45%), Gaps = 15/194 (7%)

Query: 8   KDIGSGNFGVAR--LMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNII 61
            ++GSGNFG  +  + + K +++ VA+K I +    D  +  E++      +QL +P I+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           R   +        +VME A  G L + +      +E        Q+  G+ Y       H
Sbjct: 60  RMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVH 118

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPA-YIAPEVLSRREYD 177
           RDL   N LL        KI DFG SK   +   + + K+    P  + APE ++  ++ 
Sbjct: 119 RDLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 178 GKLADVWSCGVTLY 191
            K +DVWS GV ++
Sbjct: 177 SK-SDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 22/213 (10%)

Query: 9   DIGSGNFGVARL----MRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PNI 60
           ++GSGNFG  +     MR K     VA+K ++  +  + +V  E++   ++ H    P I
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQID--VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYI 57

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +R   V      L +VME A+GG L + +       +         Q+  G+ Y      
Sbjct: 58  VRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTP-AYIAPEVLSRRE 175
            HRDL   N LL        KI DFG SK   +   + + +S    P  + APE ++ R+
Sbjct: 117 VHRDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 176 YDGKLADVWSCGVTLYVML-VGAYPFEDQEDPK 207
           +  + +DVWS G+T++     G  P++  + P+
Sbjct: 175 FSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 69/275 (25%), Positives = 111/275 (40%), Gaps = 42/275 (15%)

Query: 10  IGSGNFG-----VARLMRNKNTKEL-VAMKYIERGHKIDANVAREIINHKQL----RHPN 59
           +GSG FG      A  +    +  + VA+K + +G         E +    L     HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GVS 112
           I++   V L      I+ME   GG+L   + +A            ++L+        G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 113 YCHSMQICHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSLLHSRPKSTVGTPAYI 166
           Y   M   HRDL   N L+   G  A R +KI DFG ++    S  + +    +    ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 167 APEVLSRREYDGKL---ADVWSCGVTLY-VMLVG--AYPFEDQEDPKNFRKTISRIMAVQ 220
           APE L     DGK    +DVWS GV ++ ++ +G   YP  + ++         R+   +
Sbjct: 181 APESL----LDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236

Query: 221 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 255
              PD          L++  +  +PS R T   I+
Sbjct: 237 -NCPD------KIYQLMTNCWAQDPSERPTFDRIQ 264

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 67/261 (25%), Positives = 119/261 (45%), Gaps = 17/261 (6%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L K +G+G FG V     NK+TK  VA+K ++ G         E    K L+H  +
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           ++   VV T   + I+ E+ A G L  F +     +    +   F  Q+  G+++     
Sbjct: 64  VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREY 176
             HRDL+  N L+  S +   KI DFG ++      ++  +       + APE ++   +
Sbjct: 123 YIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 180

Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
             K +DVWS G+ L  ++  G  P+    +P+     + R +   Y++P   +  ++  N
Sbjct: 181 TIK-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYN 234

Query: 236 LLSRIFVANPSRRITIKEIKS 256
           ++ R +   P  R T + I+S
Sbjct: 235 IMMRCWKNRPEERPTFEYIQS 255

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 44/281 (15%)

Query: 6   LMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREI-------INHKQL 55
           L K +G G FG     +L ++  ++  VA+K +    K+D +   EI          K  
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDF 58

Query: 56  RHPNIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI- 108
            HPN+++   V    + L       +++ +   G+L   +    R      +   Q L+ 
Sbjct: 59  DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLK 117

Query: 109 ------SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC--DFGYSKS--SLLHSRPKS 158
                  G+ Y  +    HRDL   N +L       + +C  DFG SK   S  + R   
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGR 173

Query: 159 TVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRI 216
               P  +IA E L+ R Y  K +DVW+ GVT++ +   G  P+   E+ + +       
Sbjct: 174 IAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH-- 230

Query: 217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 257
              + K P+      +  +L+   + A+P  R T  +++  
Sbjct: 231 -GNRLKQPE--DCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 13/146 (8%)

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR--YFFQQLISG 110
           K+++HPN+++   V        I+ E+   G L + +    R   +     Y   Q+ S 
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAY 165
           + Y       HRDL   N L+       +K+ DFG S+     +   H+  K  +    +
Sbjct: 117 MEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KW 171

Query: 166 IAPEVLSRREYDGKLADVWSCGVTLY 191
            APE L+  ++  K +DVW+ GV L+
Sbjct: 172 TAPESLAYNKFSIK-SDVWAFGVLLW 196

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 54/187 (28%), Positives = 84/187 (44%), Gaps = 29/187 (15%)

Query: 29  LVAMKYIERGHKIDAN------VAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG 82
           LVA+K +    + DAN        +EI    +L+ PNIIR   V +T   L ++ EY   
Sbjct: 48  LVAVKML----REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMEN 103

Query: 83  GELFERIC-----------NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLL 131
           G+L + +            +    S     +   Q+ SG+ Y  S+   HRDL   N L+
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163

Query: 132 DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE-YDGKL---ADVWSCG 187
             +    +KI DFG S++  L+S     +   A +    +S      GK    +DVW+ G
Sbjct: 164 GKNYT--IKIADFGMSRN--LYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG 219

Query: 188 VTLYVML 194
           VTL+ +L
Sbjct: 220 VTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 35/218 (16%)

Query: 10  IGSGNFG-VARLMRNKNTKEL-VAMKYI-----ERGHKIDANVAREI-INHKQLRHPNII 61
           IG GNFG V R M  K+  ++  A+K +     E  H+   + A E+ +  K   HPNII
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR---DFAGELEVLCKLGHHPNII 66

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE-----RIC-----------NAGRFSEDEARYFFQ 105
                     +L I +EYA  G L +     R+             A   +  +   F  
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-PA 164
            + +G+ Y    Q  HRDL   N L+  + A   KI DFG S+   ++   K T+G  P 
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPV 182

Query: 165 -YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
            ++A E L+   Y  K +DVWS GV L+ ++ +G  P+
Sbjct: 183 RWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 32/217 (14%)

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGV 111
           Q  H NI+R + V+     + IV EY + G L  F R  + G+    +       L SG+
Sbjct: 62  QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGM 120

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG---YSKSSLLHS--RPKSTVGTPAYI 166
            Y   M   H+ L     L++       KI  F      KS  +++    KS V    + 
Sbjct: 121 KYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWA 175

Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKI 223
           APE +    +    +DVWS G+ ++ VM  G  P+ D             I AV+  +++
Sbjct: 176 APEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQ-------DVIKAVEDGFRL 227

Query: 224 PDYVHISQDCRNLLSRIFV----ANPSRRITIKEIKS 256
           P   +    C NLL ++ +         R    +I S
Sbjct: 228 PAPRN----CPNLLHQLMLDCWQKERGERPRFSQIHS 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 45/174 (25%), Positives = 69/174 (39%), Gaps = 42/174 (24%)

Query: 55  LRHPNIIRFKEVVLTPTHLAI--------VMEYAAGGEL--FERIC------NAGRFSED 98
           L H NI       L   H+ I        +  Y   G L  F + C      N    S  
Sbjct: 65  LSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 99  EARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHS- 154
           +  +   Q+  G+SY H   + H+D+   N ++D     ++KI D   S+       H  
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYHCL 175

Query: 155 -----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
                RP        ++A E L  +EY    +DVWS GV L+ +M +G  P+ +
Sbjct: 176 GDNENRPVK------WMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 35/218 (16%)

Query: 10  IGSGNFG-VARLMRNKNTKEL-VAMKYI-----ERGHKIDANVAREI-INHKQLRHPNII 61
           IG GNFG V +    K+   +  A+K +     +  H+   + A E+ +  K   HPNII
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 59

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE-----RIC-----------NAGRFSEDEARYFFQ 105
                     +L + +EYA  G L +     R+             A   S  +  +F  
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 106 QLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-PA 164
            +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P 
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPV 175

Query: 165 -YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
            ++A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 176 RWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR----HP 58
           +K +GSG FG       +   +N K  VA+K +       AN  +EI++   +      P
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSM 117
            + R   + LT T + +V +    G L + +  N  R    +   +  Q+  G+SY   +
Sbjct: 70  YVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRR 174
           ++ HRDL   N L+  SP   +KI DFG ++   +        G      ++A E +  R
Sbjct: 129 RLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186

Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFE 201
            +  + +DVWS GVT++ +M  GA P++
Sbjct: 187 RFTHQ-SDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 53/170 (31%), Positives = 79/170 (46%), Gaps = 22/170 (12%)

Query: 97  EDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 156
           ED   Y FQ +  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P
Sbjct: 179 EDLICYSFQ-VAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDP 233

Query: 157 ----KSTVGTP-AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNF- 209
               K     P  ++APE +  R Y  + +DVWS GV L+ +  +GA P+   +  + F 
Sbjct: 234 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 292

Query: 210 --RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 257
              K  +R+ A  Y  P+      DC +         PS+R T  E+  H
Sbjct: 293 RRLKEGTRMRAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 26/218 (11%)

Query: 6   LMKDIGSGNFGVARLMRNKN-----TKELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L +++G G FG   L    N      K LVA+K + +       +  RE      L+H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-------------RFSEDEARYFFQQ 106
           I++F  V +    L +V EY   G+L + +   G               ++ +  +  QQ
Sbjct: 69  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128

Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTP 163
           + +G+ Y  S    HRDL   N L+  +    +KI DFG S+   S+  +     T+   
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 164 AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
            ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 187 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 64/282 (22%), Positives = 107/282 (37%), Gaps = 44/282 (15%)

Query: 22  RNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM-EYA 80
                ++ V +K +  G        REI   K + H  II         + + +VM +Y 
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169

Query: 81  AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLK 140
              +LF  +  +G    ++A    ++L+  ++Y H   I HRD+K EN  LD      L 
Sbjct: 170 C--DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG 227

Query: 141 ICDFGYS-KSSLLHSRPKST--VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA 197
             DFG + K       P+     GT    +PE+L+   Y  K  D+WS G+ L+ M V  
Sbjct: 228 --DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKN 284

Query: 198 YPFEDQEDPKNFRKTISRIMAVQ----------------------------YKIPDYVH- 228
                ++   +  +  S I  +Q                            Y IP  +  
Sbjct: 285 VTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK 344

Query: 229 --ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
             +  D   L++++   +   R + ++I S P F K     L
Sbjct: 345 YGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL 386

Length = 392

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 71/283 (25%), Positives = 117/283 (41%), Gaps = 48/283 (16%)

Query: 6   LMKDIGSGNFGVARL-----MRNKNTKELVAMKYIERGHKIDANVA------REIINHKQ 54
           L +++G G FG   L     +     K LVA+K ++     D  +A      RE      
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTN 63

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FER--------------ICNAGRFSED 98
           L+H +I++F  V      L +V EY   G+L  F R                  G     
Sbjct: 64  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 99  EARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSR 155
           +  +   Q+ SG+ Y  S    HRDL   N L+  +    +KI DFG S+   S+  +  
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRV 181

Query: 156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 214
              T+    ++ PE +  R++  + +DVWS GV L+ +   G  P+  Q       + I+
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWF-QLSNTEVIECIT 239

Query: 215 --RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 255
             R++      P  V+      +++   +   P +R+ IKEI 
Sbjct: 240 QGRVLERPRVCPKEVY------DIMLGCWQREPQQRLNIKEIY 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 10/104 (9%)

Query: 160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
           +GTP Y+APE+L  + + G   D W+ GV L+  L G  PF D+   + F+  ++R    
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNR---- 595

Query: 220 QYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              IP       +S + +N +  +   +P++R  +KE+K HP F
Sbjct: 596 --DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 52.4 bits (126), Expect = 9e-08
 Identities = 56/248 (22%), Positives = 95/248 (38%), Gaps = 35/248 (14%)

Query: 5   ELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRH 57
            L++ +G G FG     + R       +  VA+K +      + +++   E +   +  H
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH 68

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERIC--NAGRFSE---DEARYFFQQLISG 110
            NI+R   V        I++E  AGG+L  F R       R S     +  +  + +  G
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SLLHSRPKSTVGTPAYI 166
             Y       HRD+   N LL      R+ KI DFG ++    +  + +    +    ++
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQ---------------EDPKNFR 210
            PE      +  K  DVWS GV L+ +  +G  P+  +               + PK   
Sbjct: 189 PPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCP 247

Query: 211 KTISRIMA 218
             + RIM 
Sbjct: 248 GPVYRIMT 255

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 32/225 (14%)

Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQLRHP 58
           L K +G G FG   +M  +  ++   +K   +  KI         +   E +  K+  HP
Sbjct: 3   LGKTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60

Query: 59  NIIRFKEVVLTPTHL------AIVMEYAAGGEL-----FERICNAGRFSEDEARY-FFQQ 106
           N++R   V L            +++ +   G+L     + R+ +  ++   +    F   
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC--DFGYSKS--SLLHSRPKSTVGT 162
           + SG+ Y  S    HRDL   N +L+ +    + +C  DFG SK   +  + R       
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 163 PA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 205
           P  +IA E L+ R Y  K +DVWS GVT++ +   G  P+   E+
Sbjct: 177 PVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVEN 220

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 46/305 (15%)

Query: 3   KYELMKDIGSGNFG---------VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK 53
           +  L K +G G FG         + +   NK     V M   +   K  +++  E+   K
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72

Query: 54  QL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-----FSED-----EARY 102
            + +H NII           L +++EYA+ G L E +  A R     +S D     E + 
Sbjct: 73  MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQL 131

Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    +  
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDY 189

Query: 155 RPKSTVGT-PA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    +
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGIPVE 243

Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL------VEDLDRVLTVT 297

Query: 272 AQAIY 276
           +   Y
Sbjct: 298 STDEY 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 47/239 (19%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKY---IERGHKI---------DAN------VAREIIN 51
           +G G FG   L    N ++L  +++   + +G  +         DAN        +E+  
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEAR---------- 101
             +L+ PNIIR   V +    L ++ EY   G+L  +  ++    + E            
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 102 ----------YFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL 151
                     +   Q+ SG+ Y  S+   HRDL   N L+  +    +KI DFG S++  
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRNLY 189

Query: 152 L--HSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY--VMLVGAYPFEDQED 205
              + R +     P  ++A E +   ++    +DVW+ GVTL+  +ML    P+ +  D
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPYGELTD 247

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 75/275 (27%), Positives = 121/275 (44%), Gaps = 45/275 (16%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L+K +G+G FG V     N NTK  VA+K ++ G     +   E    K+LRH  +
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED-EARYF--------FQQLISGV 111
           ++   VV +   + IV EY + G L +       F +D E R            Q+ +G+
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YI 166
           +Y   M   HRDL+  N L+        KI DFG ++   L    + T    A     + 
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWT 170

Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           APE      +  K +DVWS G+ L  ++  G  P+       N R+ + ++    Y++P 
Sbjct: 171 APEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGM----NNREVLEQV-ERGYRMP- 223

Query: 226 YVHISQDC----RNLLSRIFVANPSRRITIKEIKS 256
                QDC      L+ + +  +P  R T + ++S
Sbjct: 224 ---CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)

Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   +  K  VA+K +    G K +     E +    + HP++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +R   V L+PT + +V +    G L + +  +           +  Q+  G+ Y    ++
Sbjct: 72  VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 174
            HRDL   N L+  SP   +KI DFG ++  LL    K            ++A E +  R
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           ++  + +DVWS GVT++ +M  G  P++
Sbjct: 187 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 53/245 (21%), Positives = 95/245 (38%), Gaps = 42/245 (17%)

Query: 8   KDIGSGNFG------VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
            +IG+G FG        R M     K  V +K +      D  +   +E+  +++L HPN
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMS----KARVVVKELRASATPDEQLLFLQEVQPYRELNHPN 56

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGEL-----FERICNAGRFSEDEARYFFQQLISGVSYC 114
           +++     +      +V+E+   G+L       R   A    +D  +    ++ SG+ + 
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YI 166
           H     H DL L N  L    +  +KI D+G     L   +                 ++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYG-----LALEQYPEDYYITKDCHAVPLRWL 169

Query: 167 APEVLSRREYDGKLAD------VWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAV 219
           APE++  R  D    D      +WS GVT++ +      P+ D  D +  ++    +   
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV---VREQ 226

Query: 220 QYKIP 224
             K+P
Sbjct: 227 DIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 22/209 (10%)

Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ +   K   A+K + R   ++      +E I  K   HPN++   
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 65  EVVLTPTHLA-IVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L       +V+ Y   G+L   I +     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHR 122

Query: 123 DLKLENTLLDGSPAPRLKICDFG-----YSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
           DL   N +LD S    +K+ DFG     Y K   S   H+  K  V    ++A E L  +
Sbjct: 123 DLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQTQ 177

Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFED 202
           ++  K +DVWS GV L+ +M  GA P+ D
Sbjct: 178 KFTTK-SDVWSFGVLLWELMTRGAPPYPD 205

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 61/237 (25%), Positives = 111/237 (46%), Gaps = 36/237 (15%)

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-----FSEDEAR-----YFFQ 105
           +H NII           L +++EYA+ G L E +  A R     +S D AR       F+
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFK 137

Query: 106 QLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRP 156
            L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  +++ + + 
Sbjct: 138 DLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKK 195

Query: 157 KSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 214
            +    P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    + + 
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVEELF 249

Query: 215 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
           +++   +++    + + +   ++   + A PS R T K++      +++L R LT T
Sbjct: 250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL------VEDLDRILTLT 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 24/171 (14%)

Query: 97  EDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 156
           ED   Y FQ +  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P
Sbjct: 173 EDLISYSFQ-VARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDP 227

Query: 157 ----KSTVGTP-AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE----DQEDP 206
               K     P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+     D+E  
Sbjct: 228 DYVRKGDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFC 286

Query: 207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 257
           +  ++  +R+ A +Y  P+   I  DC       +  NP  R T  E+   
Sbjct: 287 RRLKEG-TRMRAPEYATPEIYSIMLDC-------WHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 40/175 (22%), Positives = 69/175 (39%), Gaps = 23/175 (13%)

Query: 30  VAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---- 85
           V +K +   H+             QL H ++++   V +   ++ +V EY   G L    
Sbjct: 33  VVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFL 91

Query: 86  -FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLL-----DGSPAPRL 139
             E+   +  +  D A    +QL S + Y    ++ H ++  +N L+     +    P +
Sbjct: 92  HREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI 147

Query: 140 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL---ADVWSCGVTLY 191
           K+ D G   + L        +    +IAPE +  R     L   AD WS G TL 
Sbjct: 148 KLSDPGIPITVLSREERVERI---PWIAPECI--RNGQASLTIAADKWSFGTTLL 197

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 31/218 (14%)

Query: 3   KYELMKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 66  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 120

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 164
           G++Y    ++ HRDL   N L+       +KI DFG +K  LL +  K            
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIK 176

Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 177 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 17/147 (11%)

Query: 97  EDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 156
           ED   Y FQ +  G+ +  S +  HRDL   N LL  S    +KICDFG ++   ++  P
Sbjct: 174 EDLICYSFQ-VARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDP 228

Query: 157 ----KSTVGTP-AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE----DQEDP 206
               K +   P  ++APE +  + Y  + +DVWS GV L+ +  +GA P+     ++E  
Sbjct: 229 DYVRKGSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFC 287

Query: 207 KNFRKTISRIMAVQYKIPDYVHISQDC 233
           +  +   +R+ A +   P+   I   C
Sbjct: 288 QRLKDG-TRMRAPENATPEIYRIMLAC 313

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 49.6 bits (118), Expect = 8e-07
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 19/207 (9%)

Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +    + K  VA+K I+   G +    +   ++    L H  I
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +R   +    + L +V + +  G L + +  +           +  Q+  G+ Y    ++
Sbjct: 72  VRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----STVGTP-AYIAPEVLSRR 174
            HR+L   N LL  S +  ++I DFG +   LL+   K    S   TP  ++A E +   
Sbjct: 131 VHRNLAARNILLK-SDS-IVQIADFGVA--DLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 175 EYDGKLADVWSCGVTLYVMLV-GAYPF 200
            Y  + +DVWS GVT++ M+  GA P+
Sbjct: 187 RYTHQ-SDVWSYGVTVWEMMSYGAEPY 212

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 13/206 (6%)

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYC 114
           H NI+           + ++ EY   G+L  F R       + ++   F  Q+  G+++ 
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPA-YIAPEVL 171
            S    HRDL   N LL  +    +KICDFG ++  +  S    K     P  ++APE +
Sbjct: 158 ASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 172 SRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
               Y    +DVWS G+ L+ +  +G+ P+        F K I       Y++    H  
Sbjct: 216 FNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQPEHAP 270

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKS 256
            +  +++   + A+P +R T K+I  
Sbjct: 271 AEIYDIMKTCWDADPLKRPTFKQIVQ 296

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 70/282 (24%), Positives = 114/282 (40%), Gaps = 44/282 (15%)

Query: 4   YELMKDIGSGNFGVAR---LMRNKNTKELVAMKYIERGHKIDANVA-------REIINHK 53
           + L + +G G FG  R   L     + + VA+K +    K D   +       RE    K
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML----KADIFSSSDIEEFLREAACMK 56

Query: 54  QLRHPNIIRFKEVVL---TPTHLAIVM---EYAAGGELFERICNAGRFSEDEARYFFQQL 107
           +  HPN+I+   V L       L I M    +   G+L   +    R  E+      Q L
Sbjct: 57  EFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTL 115

Query: 108 I-------SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC--DFGYSKS--SLLHSRP 156
           +       SG+ Y  S    HRDL   N +L+ +    + +C  DFG SK   S  + R 
Sbjct: 116 VRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQ 171

Query: 157 KSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 214
                 P  ++A E L+   Y    +DVW+ GVT++ +M  G  P+   E+ + +   I 
Sbjct: 172 GCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK 230

Query: 215 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
                + K P      +D   L+ + +   P  R + + ++ 
Sbjct: 231 ---GNRLKQP--PDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 21/192 (10%)

Query: 11  GSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLT 69
           G+  F  A  + NK T E V +K  +RG    +A++ R I       HP+II+ K     
Sbjct: 103 GAEGFAFA-CIDNK-TCEHVVIKAGQRGGTATEAHILRAI------NHPSIIQLKGTFTY 154

Query: 70  PTHLAIVM-EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
                +++  Y    +L+  +      +  +     + ++  + Y H  +I HRD+K EN
Sbjct: 155 NKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAEN 212

Query: 129 TLLDGSPAPRLKIC--DFGYS--KSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 184
             ++  P     +C  DFG +     +  ++     GT A  APE+L+R  Y G   D+W
Sbjct: 213 IFIN-HPG---DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIW 267

Query: 185 SCGVTLYVMLVG 196
           S G+ L+ M   
Sbjct: 268 SAGIVLFEMATC 279

Length = 391

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 31/209 (14%)

Query: 9   DIGSGNFGVARLMRNKN-----TKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNIIR 62
           ++G G FG   L    N      K LVA+K + E       +  RE      L+H +I+R
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FER-------------ICNAGRFSEDEARYFFQQL 107
           F  V      L +V EY   G+L  F R                 G+ +  +      Q+
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--- 164
            SG+ Y  S+   HRDL   N L+       +KI DFG S+   ++S     VG      
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTMLP 187

Query: 165 --YIAPEVLSRREYDGKLADVWSCGVTLY 191
             ++ PE +  R++  + +D+WS GV L+
Sbjct: 188 IRWMPPESILYRKFTTE-SDIWSFGVVLW 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 35/95 (36%), Positives = 48/95 (50%), Gaps = 16/95 (16%)

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSLLHSRP 156
           +QL+S + Y H   I HRD+K EN L++G       IC  DFG       S S+  H   
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322

Query: 157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY 191
             TV T    APEVL+   Y   + D+WS G+ ++
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIF 353

Length = 461

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 39/232 (16%)

Query: 2   EKYELMKDIGSGNFG-VARL------MRNKNTKELVAMKYIERGHKIDANVAREIINHKQ 54
           ++  L K +G G FG V R           +    VA+K + + +  D ++A ++I+  +
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLA-DLISEME 69

Query: 55  L-----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-----FSED-----E 99
           L     +H NII    V      L +++EYAA G L E +  A R     ++ D     E
Sbjct: 70  LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPE 128

Query: 100 ARYFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 150
            +  F+ L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHD 186

Query: 151 LLHSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
           + + +  S    P  ++APE L  R Y  + +DVWS G+ ++ +  +G  P+
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 35/221 (15%)

Query: 3   KYELMKDIGSGNFGV---ARLMRNKNTKE--LVAMKYIERGHKID--ANVAREIINHKQL 55
             E ++DIG G FG    AR       +   +VA+K ++     D  A+  RE     + 
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 65

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--------------------RICNAGR- 94
            HPNI++   V      + ++ EY A G+L E                    R C     
Sbjct: 66  DHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 95  -FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SL 151
             S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S++  S 
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYSA 183

Query: 152 LHSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY 191
            + +       P  ++ PE +    Y  + +DVW+ GV L+
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 36/274 (13%)

Query: 7   MKDIGSGNFGVARLMRNKNTKE-----LVAMKYIERGHKIDANVA----REIINHKQLRH 57
           +  +G G FG   L + K  +E     LV +K ++     D N+     RE+   ++L H
Sbjct: 10  ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ--KTKDENLQSEFRRELDMFRKLSH 67

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGR-------FSEDEARYFFQQLI 108
            N++R   +        +++EY   G+L  F R   +          S  +      Q+ 
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSLLHSRPKSTVGTP 163
            G+ +  + +  HRDL   N L+            L      Y+            +   
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL--- 182

Query: 164 AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 222
            ++APE +   ++  K +DVWS GV ++ V   G  PF    D     + ++R+ A + +
Sbjct: 183 RWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNRLQAGKLE 237

Query: 223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
           +P           L++R +  NP  R +  E+ S
Sbjct: 238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 39/151 (25%), Positives = 70/151 (46%), Gaps = 13/151 (8%)

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT 162
           F  Q+  G+ +  S    HRDL   N LL  +    +KICDFG ++  ++H     + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298

Query: 163 P----AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIM 217
                 ++APE +    Y   L+DVWS G+ L+ +  +G  P+        F   I    
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-- 355

Query: 218 AVQYKIPDYVHISQDCRNLLSRIFVANPSRR 248
              Y++    H +Q+  +++ + + + P +R
Sbjct: 356 --GYRMAKPDHATQEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 72/280 (25%), Positives = 122/280 (43%), Gaps = 40/280 (14%)

Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   +           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY----------FFQ 105
           +H NII           L +++EYA+ G L E +  A R    E  Y           F+
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 106 QLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 157
            L+S       G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 141 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 198

Query: 158 STVGT-PA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 214
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 252

Query: 215 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 11/141 (7%)

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKST 159
           F  Q+ +G+ +  S    HRDL   N L+       +KICDFG ++  +  S      ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMA 218
                ++APE +    Y   L+DVWS G+ L+ +  +G  P+ +    + F   I R   
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR--- 357

Query: 219 VQYKIPDYVHISQDCRNLLSR 239
             Y++    H S +   ++ +
Sbjct: 358 -GYRMAKPAHASDEIYEIMQK 377

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 29/215 (13%)

Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID-ANVAREI-INHKQLRHPNIIRFK 64
           IG GNFG    AR+ ++    +    +  E   K D  + A E+ +  K   HPNII   
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 65  EVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDEARYFFQQLI 108
                  +L + +EYA  G L + +                  A   S  +  +F   + 
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-PA-YI 166
            G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 190

Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
           A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 191 AIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 16/213 (7%)

Query: 5   ELMKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHKIDANV---AREIINHKQLRHPN 59
           EL  +IG G  N     L R+  T  LV ++  +  +  + ++     E++     RHPN
Sbjct: 1   ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60

Query: 60  IIRFKEVVLTPTHLAIV---MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I+    V  T + L ++   M Y +   L +     G  SE          + G++Y H 
Sbjct: 61  IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQ 119

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYS------KSSLLHSRPKSTVGTPAYIAPEV 170
               HR++K  + L+ G     L      YS      K+ +++  P+ +     +++PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 171 LSRREYDGKL-ADVWSCGVTLYVMLVGAYPFED 202
           L +  Y   + +D++S G+T   +  G  PF+D
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 46.2 bits (109), Expect = 8e-06
 Identities = 52/196 (26%), Positives = 85/196 (43%), Gaps = 15/196 (7%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E   L   +G G FG V     N  T+  VA+K ++ G        +E    K+LRH  +
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE----DEARYFFQQLISGVSYCHS 116
           ++   VV +   + IV EY + G L + +   G   +     +      Q+ SG++Y   
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVER 120

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRR 174
           M   HRDL+  N L+  +     K+ DFG ++      ++  +       + APE     
Sbjct: 121 MNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 175 EYDGKLADVWSCGVTL 190
            +  K +DVWS G+ L
Sbjct: 179 RFTIK-SDVWSFGILL 193

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 17/159 (10%)

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKSTV 160
           F  Q+  G+S+  S    HRDL   N LL  +     KICDFG ++     S    K   
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 161 GTPA-YIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTIS---R 215
             P  ++APE +    Y  + +DVWS G+ L+ +  +G+ P+        F K I    R
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335

Query: 216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           +++ +    +   I + C +       A+P +R T K+I
Sbjct: 336 MLSPECAPSEMYDIMKSCWD-------ADPLKRPTFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 56/229 (24%), Positives = 95/229 (41%), Gaps = 43/229 (18%)

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI------CNAGRFSEDEAR------ 101
           +L HPNI+    VV     + ++ EY   G+L E +       + G  S+++        
Sbjct: 63  ELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122

Query: 102 -----YFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SLLHS 154
                +   Q+ +G+ Y  S    H+DL   N L+       +KI D G S+   S  + 
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI--GEQLHVKISDLGLSREIYSADYY 180

Query: 155 RPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLYVM----LVGAYPFEDQEDPKNF 209
           R +     P  ++ PE +   ++    +D+WS GV L+ +    L   Y F +QE  +  
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239

Query: 210 RKTISRIMAVQYKIPDYVHISQDC----RNLLSRIFVANPSRRITIKEI 254
           RK               +  S+DC     +L++  +   PSRR   K+I
Sbjct: 240 RKR------------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 61/241 (25%), Positives = 105/241 (43%), Gaps = 31/241 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++++++  +G G FG      ++  KE  A+K +    K   +   EI   +++R  +  
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPA 188

Query: 62  -RFKEVVLT------PTHLAIVM-EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
            RF  + +         H+ IVM +Y  G  L + I   G FS         Q    + Y
Sbjct: 189 DRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDY 246

Query: 114 CHS-MQICHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSLLHSRPKS 158
            H+ + + H DLK EN L++ S             P P R++ICD G       HSR  +
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR-TA 304

Query: 159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF---RKTISR 215
            V T  Y +PEV+    +     D+WS G  +Y +  G   ++  ++ ++     KT+ R
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363

Query: 216 I 216
           +
Sbjct: 364 L 364

Length = 467

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.5 bits (105), Expect = 5e-05
 Identities = 48/162 (29%), Positives = 70/162 (43%), Gaps = 23/162 (14%)

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSR--PKST 159
           F  Q+  G+ +  S    HRD+   N LL DG  A   KICDFG ++  +  S    K  
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSNYVVKGN 273

Query: 160 VGTPA-YIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIM 217
              P  ++APE +    Y  + +DVWS G+ L+ +  +G  P+        F K + R  
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR-- 330

Query: 218 AVQYKIPDYV-----HISQDCRNLLSRIFVANPSRRITIKEI 254
             Q   PD+       I + C NL        P+ R T  +I
Sbjct: 331 GYQMSRPDFAPPEIYSIMKMCWNL-------EPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 43.9 bits (103), Expect = 5e-05
 Identities = 62/266 (23%), Positives = 107/266 (40%), Gaps = 27/266 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G  +     +E    K+LRH  ++
Sbjct: 6   ESLRLDVKLGQGCFGEV-WMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLV 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYF--------FQQLISGVSY 113
               VV +   + IV E+   G L + +       E + +Y           Q+  G++Y
Sbjct: 65  PLYAVV-SEEPIYIVTEFMGKGSLLDFL------KEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVL 171
              M   HRDL+  N L+  +     KI DFG ++      ++  +       + APE  
Sbjct: 118 IERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 175

Query: 172 SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
               +  K +DVWS G+ L  ++  G  P+     P    + +   +   Y++P      
Sbjct: 176 LYGRFTIK-SDVWSFGILLTELVTKGRVPY-----PGMVNREVLEQVERGYRMPCPQGCP 229

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKS 256
           +    L+   +  +P  R T + I+S
Sbjct: 230 ESLHELMKLCWKKDPDERPTFEYIQS 255

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 39/226 (17%)

Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA------REIINHKQLRHPNII 61
           K+IG+G FG  +++  +        + + +  ++ A+V        E   ++ L+H N++
Sbjct: 1   KEIGNGWFG--KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQ---QLISGVSYCHS 116
           +        T   +VME+   G+L  + R C        +     +   ++  G+ + H 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIAP 168
               H DL L N LL       +KI D+G S     H++ K               +IAP
Sbjct: 119 NNFIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAP 171

Query: 169 EVLSRREYDGKL--------ADVWSCGVTLYVML-VGAYPFEDQED 205
           E++   E  G L        ++VWS GVT++ +  +G+ P+    D
Sbjct: 172 ELVD--EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 39/167 (23%), Positives = 67/167 (40%), Gaps = 20/167 (11%)

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQ----QLISG 110
           L+HPNI++     +      +V EY   G+L   +        +      Q    ++ +G
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYI 166
           V++ H     H DL L N  L       +K+ D+G      K   + +     V    ++
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL-RWL 168

Query: 167 APEVLSRREYDG-------KLADVWSCGVTLYVML-VGAYPFEDQED 205
           APE++      G       K ++VW+ GVTL+ +    A P+    D
Sbjct: 169 APELVGEFH-GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 41/183 (22%)

Query: 47  REIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC------NAGRFSED-- 98
            E +   +L+HPNI+    VV     L+++  Y +  +L E +       + G   +D  
Sbjct: 57  HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 99  -----EARYFFQ---QLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG----- 145
                E   F     Q+ +G+ +  S  + H+DL   N L+       +KI D G     
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDKLNVKISDLGLFREV 174

Query: 146 ----YSK---SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGA 197
               Y K   +SLL  R         +++PE +   ++    +D+WS GV L+ V   G 
Sbjct: 175 YAADYYKLMGNSLLPIR---------WMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGL 224

Query: 198 YPF 200
            P+
Sbjct: 225 QPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 21/159 (13%)

Query: 48  EIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQL 107
           EI +  +L+HPNI++   +  +     ++ EY  G  L E + N       E R   +++
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSW----ERR---RKI 785

Query: 108 ISGVS------YCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 160
             G++      +C  S  +   +L  E  ++DG   P L++     S   LL +  K  +
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFI 840

Query: 161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP 199
            + AY+APE    ++   K +D++  G+ L  +L G  P
Sbjct: 841 SS-AYVAPETRETKDITEK-SDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 37.4 bits (87), Expect = 0.004
 Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 14/95 (14%)

Query: 114 CHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
             +++  HR  K  N LL  DG           G    S+    P+ +   P ++APEV+
Sbjct: 27  LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP 206
             + Y  K AD++S G+TLY  L    P  ++E  
Sbjct: 77  QGQSYTEK-ADIYSLGITLYEALDYELP-YNEERE 109

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	351
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
PRK10345	210	hypothetical protein; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
smart00090	237	RIO RIO-like kinase.	99.86
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.67
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
KOG1243	690	consensus Protein kinase [General function predict	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.54
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.53
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.37
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.35
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.31
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
COG4248	637	Uncharacterized protein with protein kinase and he	99.19
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.12
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.92
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.9
PRK09902	216	hypothetical protein; Provisional	98.85
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.73
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.7
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.64
PF01636	239	APH: Phosphotransferase enzyme family This family	98.53
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.48
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.46
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.44
PLN02876	822	acyl-CoA dehydrogenase	98.42
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.4
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.22
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.2
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.19
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.12
PRK10593	297	hypothetical protein; Provisional	98.09
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.05
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.91
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.9
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.86
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.69
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.67
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.65
PRK05231	319	homoserine kinase; Provisional	97.63
KOG2270	520	consensus Serine/threonine protein kinase involved	97.56
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.51
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.36
PLN02236	344	choline kinase	97.3
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.24
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.08
PLN02756	418	S-methyl-5-thioribose kinase	96.98
PTZ00384	383	choline kinase; Provisional	96.94
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.87
PRK12396	409	5-methylribose kinase; Reviewed	96.87
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.84
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.59
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.5
PRK11768	325	serine/threonine protein kinase; Provisional	96.34
PTZ00296	442	choline kinase; Provisional	96.3
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.18
PRK06148	1013	hypothetical protein; Provisional	96.1
COG2334	331	Putative homoserine kinase type II (protein kinase	95.89
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.52
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.36
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	94.78

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-64  Score=444.84  Aligned_cols=261  Identities=36%  Similarity=0.602  Sum_probs=229.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~   73 (351)
                      +.|.+.+.||+|+||.|.+|..++|++.||||++++...        ....+.+|+++|++|+|||||+++++|..+...
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            468899999999999999999999999999999976432        123467999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEeccCCCcccCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~~~vkL~DFg~a~~~~~  152 (351)
                      |+||||+.||+|++.+..++.+.+..-+.+++|++.|+.|||+.||+||||||+|||+..+ ....+||+|||+|+....
T Consensus       252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~  331 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE  331 (475)
T ss_pred             EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence            9999999999999999999999999999999999999999999999999999999999765 334589999999998877


Q ss_pred             CCCCCCcccCCCccCcccccCCcC--CCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC--CCCccC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVH  228 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  228 (351)
                      .....+.||||.|.|||++.+.++  ++.++|||||||++|.+++|.+||........+.+   ++....|.  .+.|..
T Consensus       332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---QI~~G~y~f~p~~w~~  408 (475)
T KOG0615|consen  332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---QILKGRYAFGPLQWDR  408 (475)
T ss_pred             ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH---HHhcCcccccChhhhh
Confidence            788889999999999999976654  34568999999999999999999988765543333   33444443  456778


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      +|.++.+||.+||..||++|||++++|+||||.....
T Consensus       409 Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~  445 (475)
T KOG0615|consen  409 ISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC  445 (475)
T ss_pred             hhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence            9999999999999999999999999999999986543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-62  Score=450.47  Aligned_cols=252  Identities=36%  Similarity=0.638  Sum_probs=233.1

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEecc----CcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +|+.++.||+|||+.||.+++..+|+.||+|++.+    .......+.+||++++.|+|||||+++++|++.+++|||.|
T Consensus        19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE   98 (592)
T KOG0575|consen   19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence            69999999999999999999999999999999987    34455789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC-CCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~-~~~~~~  157 (351)
                      +|..++|..++++.++++|.+++.+++||+.||.|||+++|+|||||..|+|++.+.+  |||+|||+|.... ...+..
T Consensus        99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccccc
Confidence            9999999999999999999999999999999999999999999999999999988875  9999999998765 447778


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      +.||||.|.|||++...+.. ..+||||+||+||.||.|++||..    ..+.++..++....|.+|.  .+|.++++||
T Consensus       177 TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dLI  249 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDLI  249 (592)
T ss_pred             eecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHHH
Confidence            88999999999999977765 449999999999999999999976    4567788888888998888  7999999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+||++||.+|||+++||.|+||...
T Consensus       250 ~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  250 RKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             HHHhcCCcccCCCHHHHhcCHhhhCC
Confidence            99999999999999999999999443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-60  Score=417.63  Aligned_cols=259  Identities=35%  Similarity=0.618  Sum_probs=225.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +.|++++.||+|+||+||+++.+.|++.+|+|++++...    ..+....|..++..++||+||+++..|++..++|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            679999999999999999999999999999999987543    2356778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~  156 (351)
                      ||+.||.|+.+|++.+.|+|..++.++..|+.||.|||++|||||||||+|||+|.+|  +++|+|||+++..... ...
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G--Hi~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG--HIKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC--cEEEeccccchhcccCCCcc
Confidence            9999999999999999999999999999999999999999999999999999997766  5999999999965444 444


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      .+.|||+.|||||++.+.+|+ +++|+||||+++|+|++|.+||...+.    .++..++.......+. ..++.+++++
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~----~~~~~~I~~~k~~~~p-~~ls~~ardl  256 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDV----KKMYDKILKGKLPLPP-GYLSEEARDL  256 (357)
T ss_pred             ccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccH----HHHHHHHhcCcCCCCC-ccCCHHHHHH
Confidence            556999999999999999886 559999999999999999999988654    3444444444422222 2489999999


Q ss_pred             HHHhcccCCCCCC----ChHHHhcCcccccCCChhh
Q 018734          237 LSRIFVANPSRRI----TIKEIKSHPWFLKNLPREL  268 (351)
Q Consensus       237 i~~~L~~~P~~Rp----s~~eil~hp~~~~~~~~~~  268 (351)
                      |+++|+.+|.+|.    ++.+|.+||||....+..+
T Consensus       257 l~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  257 LKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             HHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence            9999999999996    7889999999987655443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-60  Score=418.17  Aligned_cols=259  Identities=29%  Similarity=0.477  Sum_probs=226.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC--cccCHHHHHHHHHHhcCCCCCcceEEEEEEcCC-EEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQLRHPNIIRFKEVVLTPT-HLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-~~~lv~e~   79 (351)
                      +.+.++.||+|..|+||+|+++.|++.+|+|++...  .....++.+|+++++.++|||||++|++|..++ .++|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            456678999999999999999999999999999543  334567899999999999999999999999999 49999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |+||+|...+...++++|..+..++.+|++||.|||+ ++||||||||+||||+..+.  |||||||.++..... ...+
T Consensus       160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~t  236 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IANT  236 (364)
T ss_pred             cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hccc
Confidence            9999999999999999999999999999999999995 99999999999999987765  999999999865544 6678


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCC-CChhHHHHHHHHHHhh-ccCCCCccCCCHhHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ-EDPKNFRKTISRIMAV-QYKIPDYVHISQDCRNL  236 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  236 (351)
                      .+||..|||||.+.+..|.-+ +||||||++++||++|+.||... .........+..+... .-.+|.- .+|+++++|
T Consensus       237 fvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~F  314 (364)
T KOG0581|consen  237 FVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSF  314 (364)
T ss_pred             ccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHH
Confidence            899999999999999998766 99999999999999999999875 2233445555555542 2234432 489999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      |..||++||.+|||+.|+++|||+++....
T Consensus       315 V~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  315 VSCCLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            999999999999999999999999876553

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-58  Score=392.67  Aligned_cols=254  Identities=34%  Similarity=0.646  Sum_probs=229.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|+.++.||.|+||.|.+++.+.+|..+|+|++.+....    .+...+|..+++.+.||+++++++.+.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            46899999999999999999999999999999999875432    34567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||++||.|++++++.++|++..++.++.||+.||+|||+++|++|||||+|||+|.+|.  +||+|||+|+..  ..+.
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v--~~rT  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRV--SGRT  198 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEe--cCcE
Confidence            999999999999999999999999999999999999999999999999999999988875  999999999854  3346


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      .+.||||.|+|||++...+|+ +++|+||||+++|||++|.+||...+.    .++..++....+.+|.  .+++++++|
T Consensus       199 ~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~--~fs~~~kdL  271 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPS--YFSSDAKDL  271 (355)
T ss_pred             EEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCc--ccCHHHHHH
Confidence            678999999999999999885 669999999999999999999998766    5566677788888887  589999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccCCC
Q 018734          237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLP  265 (351)
Q Consensus       237 i~~~L~~~P~~Rp-----s~~eil~hp~~~~~~~  265 (351)
                      |+++|+.|-.+|.     ...+|..||||.....
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W  305 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW  305 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCcccccccH
Confidence            9999999999994     5789999999986543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-59  Score=401.22  Aligned_cols=260  Identities=28%  Similarity=0.485  Sum_probs=226.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |++|+.+.++|+|+||+||+|+++.||+.||||++.-+..   ...-.++||+++++|+|||+|.++++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            8999999999999999999999999999999999866544   2355789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC-CCCC
Q 018734           78 EYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~-~~~~  155 (351)
                      |||+. ++.+-|...+ -++...++.+++|+++|+.|+|++++|||||||+||||..++.  +||||||+|+... .+..
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~  157 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDN  157 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcch
Confidence            99976 6666666544 5899999999999999999999999999999999999987775  9999999999766 5666


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hc
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQ  220 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~  220 (351)
                      .+.++.|.||+|||++.+...+++.+||||+||++.||++|.+.|.+.++.+++..+...+..               ..
T Consensus       158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            788999999999999999877788899999999999999999999999998887766543321               01


Q ss_pred             cCCCC----------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          221 YKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       221 ~~~~~----------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..+|.          ++.++.-+.+|+++||+.||.+|++.+++|.||||...
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence            11222          34567789999999999999999999999999999543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-57  Score=420.68  Aligned_cols=255  Identities=52%  Similarity=0.852  Sum_probs=231.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC----c--ccCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----H--KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~--~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~   74 (351)
                      .+|++++.||+|+||+|+.+.+..+++.||+|++.+.    .  .....+.+|+.+++.++ ||||+++++++.+...+|
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            5899999999999999999999999999999987764    1  23456778999999999 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc-CCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLH  153 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~-~~~  153 (351)
                      +|||||.||+|++++.+.+++.|..++.+++|++.|+.|+|++||+||||||+|||++.+. +++||+|||++... ...
T Consensus        97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~  175 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGED  175 (370)
T ss_pred             EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCC
Confidence            9999999999999999999999999999999999999999999999999999999998873 45999999999877 456


Q ss_pred             CCCCCcccCCCccCcccccCCc-CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          154 SRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      ......||||.|+|||++.+.. |.++++||||+|++||.|++|+.||.+...    ..+...+....+.+|.+.. |++
T Consensus       176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~----~~l~~ki~~~~~~~p~~~~-S~~  250 (370)
T KOG0583|consen  176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV----PNLYRKIRKGEFKIPSYLL-SPE  250 (370)
T ss_pred             CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH----HHHHHHHhcCCccCCCCcC-CHH
Confidence            6778899999999999999988 999999999999999999999999988443    3444457778888888644 999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      +++|+.+||..+|.+|+|+.+|+.||||+.
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999987

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-59  Score=420.24  Aligned_cols=261  Identities=29%  Similarity=0.498  Sum_probs=231.9

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc--CHHHHHHHHHHhcCC-CCCcceEEEEEEcCC-EEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLR-HPNIIRFKEVVLTPT-HLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~-~~~lv   76 (351)
                      |+||.++++||.|+||.||+|+...++..||||.+++....  +..-++|+..+++|+ |||||++.+++.+.. .+|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            68999999999999999999999999999999999875443  334678999999999 999999999999887 99999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||||+ .+|+.+++..+ .|++..++.|++||++||+|+|.+|+.|||+||+|||+.++..  |||+|||+|+.......
T Consensus        89 fE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKPP  165 (538)
T ss_pred             HHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCCC
Confidence            99995 59999998654 5999999999999999999999999999999999999975544  99999999999988899


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hc
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQ  220 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~  220 (351)
                      .+.++-|.||+|||++.+..+++...|+||+|||++|+.+-++.|.+.++.+++.++..-+..               .+
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            999999999999999999888888899999999999999999999999988888877654422               23


Q ss_pred             cCCCCc---------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          221 YKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       221 ~~~~~~---------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      +.+|..         +.++.++.+||.+||.+||.+||||.++|+||||+...
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            333332         23688999999999999999999999999999997543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-57  Score=402.54  Aligned_cols=259  Identities=37%  Similarity=0.601  Sum_probs=227.4

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +.+|.+.+.||+|+||+||+++++.++..||||.+.+..   +..+.+..|+.+++.++|||||++++++..++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            358999999999999999999999999999999997753   23456789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CC---CCEEEeccCCCcccCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSLLH  153 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~---~~vkL~DFg~a~~~~~~  153 (351)
                      |||.||+|..++++.+.+++..++.++.||+.||++||+++||||||||+||||... ..   ..+||+|||+|+.....
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999999999999999999999999999999999999999999999999999764 22   56999999999988877


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc-cCCCHh
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHISQD  232 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  232 (351)
                      ....+.||+|.|||||+++...|+.+ +|+||+|+|+|+|++|++||......+.+.    .+.......|.. ..+++.
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~----~~~k~~~~~~~~~~~~s~~  243 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL----YIKKGNEIVPVLPAELSNP  243 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhccccccCchhhhccCc
Confidence            77888999999999999999999877 899999999999999999998765543333    333333333332 246778


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      +.+|+...|+.+|.+|.+..+-+.|+++....
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            88999999999999999999999999987654

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.8e-57  Score=414.26  Aligned_cols=262  Identities=33%  Similarity=0.578  Sum_probs=228.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++++.||+|+||.||+|+.+.||..+|+|+++++.-.    -+.++.|-.+|....+|+||+++.+|.+..++|+|
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            47899999999999999999999999999999999886432    24577788888889999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC----
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL----  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~----  152 (351)
                      |||++||++..+|.+.+.|++..++.++.+++.|+..||+.|+|||||||+|+|||..|  ++||+|||+++....    
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G--HiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG--HIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC--CEeeccccccchhhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999998776  599999999852110    


Q ss_pred             ---------------------CC----C-------------------CCCcccCCCccCcccccCCcCCCcchhHHHHHH
Q 018734          153 ---------------------HS----R-------------------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGV  188 (351)
Q Consensus       153 ---------------------~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  188 (351)
                                           ..    .                   ..+.+|||.|||||++.+.+|... +|+|||||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG~  376 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLGC  376 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHHH
Confidence                                 00    0                   024579999999999999997544 99999999


Q ss_pred             HHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCC---ChHHHhcCcccccCCC
Q 018734          189 TLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLP  265 (351)
Q Consensus       189 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp---s~~eil~hp~~~~~~~  265 (351)
                      |+||||.|.+||....+...+.+++...  ..+.+|....+++++.|||.+||+ ||++|.   +++||..||||....+
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr--~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W  453 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWR--ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW  453 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHh--hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence            9999999999999988777666665432  345677777899999999999999 999998   5899999999987765


Q ss_pred             hhh
Q 018734          266 REL  268 (351)
Q Consensus       266 ~~~  268 (351)
                      ..+
T Consensus       454 ~~l  456 (550)
T KOG0605|consen  454 DHL  456 (550)
T ss_pred             chh
Confidence            443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-57  Score=413.29  Aligned_cols=257  Identities=35%  Similarity=0.576  Sum_probs=224.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|.+++.||.|+|++|++|+++.+++.||||++.+....    ..-+.+|-..|.+| .||.|++++..|.++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            5799999999999999999999999999999998774332    23355677788888 899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC---
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---  153 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~---  153 (351)
                      +||+++|+|.++|.+.+.|++...+.++.||+.||+|||++|||||||||+|||+|+++  ++||+|||.|+.....   
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm--hikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG--HIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC--cEEEeeccccccCChhhcc
Confidence            99999999999999999999999999999999999999999999999999999998776  5999999998743211   


Q ss_pred             -----------CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC
Q 018734          154 -----------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK  222 (351)
Q Consensus       154 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (351)
                                 .+..+++||..|.+||++..... ++.+|||+||||+|.|++|.+||...+..    .+.++++...+.
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~Ney----liFqkI~~l~y~  305 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEY----LIFQKIQALDYE  305 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHH----HHHHHHHHhccc
Confidence                       11245789999999999977665 45599999999999999999999987764    445566777887


Q ss_pred             CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      +|.  ++++.+++||+++|..||++|+|+.+|.+||||..-....
T Consensus       306 fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  306 FPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             CCC--CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            776  7899999999999999999999999999999997654433

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-57  Score=420.39  Aligned_cols=255  Identities=40%  Similarity=0.755  Sum_probs=239.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC----cccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      =|++++.||.|+.|.|.+|++..||+.+|||++.+.    ......+.+||.+|+.+.||||+++++++.+..++|+|.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            489999999999999999999999999999999775    2334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |++||.|++++...+++++.+..++++||+.|+.|+|..+|+||||||+|+|+|..++  |||+|||+|.....+....+
T Consensus        93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLeT  170 (786)
T KOG0588|consen   93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLET  170 (786)
T ss_pred             ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccccc
Confidence            9999999999999999999999999999999999999999999999999999988776  99999999998888888899


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      .||+|.|.|||++.+..|++.++||||.|||||.||+|+.||.+    +++..++.++..+.+..|.  .+|+++.+||.
T Consensus       171 SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLLr  244 (786)
T KOG0588|consen  171 SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLLR  244 (786)
T ss_pred             cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHHH
Confidence            99999999999999999999999999999999999999999985    5667888888889999886  69999999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCCC
Q 018734          239 RIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      +||..||.+|+|.++|++|||+.+...
T Consensus       245 ~ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  245 RMLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HHhccCccccccHHHHhhCchhhcCCC
Confidence            999999999999999999999987643

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.6e-56  Score=374.26  Aligned_cols=260  Identities=30%  Similarity=0.483  Sum_probs=226.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++||...++||+|.||.||+|++..||+.||||++......   +...++||..++.++||||+.++++|...+.+.+|+
T Consensus         1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            57899999999999999999999999999999999875443   578899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           78 EYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      ||++. +|...++... .++..+++.|+.++++||+|||++.|+||||||+|+||+.++.  +||+|||+|+........
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRI  157 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCcc
Confidence            99965 8988887654 6899999999999999999999999999999999999987775  999999999976544433


Q ss_pred             -CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-CCC---------
Q 018734          157 -KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD---------  225 (351)
Q Consensus       157 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~---------  225 (351)
                       +..+-|.||+|||++.|...++..+|+||+|||+.||+.|.+-|.+.++.+++..+.......... +|.         
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence             334899999999999998888888999999999999999999999999988888777655432211 221         


Q ss_pred             ------------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          226 ------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       226 ------------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                  +...++++.+|+.+||.+||.+|+|+.|+|+|+||...
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence                        12246788999999999999999999999999999764

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-56  Score=392.06  Aligned_cols=267  Identities=30%  Similarity=0.453  Sum_probs=224.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~~   74 (351)
                      +|..++.||+|+||.|+.+.++.+|+.||||++.+...   ...+..+|+.+++.++|+||+.+.+++..+     ..+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            46667999999999999999999999999999985443   346788999999999999999999999762     5799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC--
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~--  152 (351)
                      +|+|+| +.+|...++....+++.+++.+++||++||+|+|+.+|+||||||+|+|++.+..  +||||||+|+....  
T Consensus       103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFF  179 (359)
T ss_pred             EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccccC
Confidence            999999 5689999988888999999999999999999999999999999999999987776  99999999997653  


Q ss_pred             -CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH-----------H---
Q 018734          153 -HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-----------M---  217 (351)
Q Consensus       153 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----------~---  217 (351)
                       ....+..+-|.||+|||++.....++++.||||+|||++||++|++.|.+.+...++..++..+           .   
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             4445677899999999999877777888999999999999999999999887666555443211           1   


Q ss_pred             ------hhccCC--C---CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChhhHHHH
Q 018734          218 ------AVQYKI--P---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA  272 (351)
Q Consensus       218 ------~~~~~~--~---~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~~~~~~  272 (351)
                            ......  |   .+++.++.+.+|+.+||..||.+|+|++|+|.||||..-..+.-.+.+
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~  325 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC  325 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC
Confidence                  011100  0   134678999999999999999999999999999999887665544433

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.8e-56  Score=406.58  Aligned_cols=253  Identities=34%  Similarity=0.627  Sum_probs=226.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC---HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |++|-+.+.||+|+||.||+++.+.+.+.||+|.+.+.....   ..+.+|+++++.++|||||.++++|++..++|+|+
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            799999999999999999999999999999999998765544   56889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~  156 (351)
                      |||.| +|+.++...+.++|+.++.++.+++.||.|||+++|+|||+||.|||+++++.  +|+||||+|+.+..... .
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vl  157 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVL  157 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceee
Confidence            99977 99999999999999999999999999999999999999999999999987765  99999999997655443 3


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ++..|||.|||||++.+..|+.. +|+||||||+|||++|++||...    .+...+..+...+...|.  ..|..+..|
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~----si~~Lv~~I~~d~v~~p~--~~S~~f~nf  230 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYAR----SITQLVKSILKDPVKPPS--TASSSFVNF  230 (808)
T ss_pred             eeccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHH----HHHHHHHHHhcCCCCCcc--cccHHHHHH
Confidence            45579999999999998888766 99999999999999999999763    345555666666655555  789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +..+|.+||.+|+|..+++.|||..+.
T Consensus       231 l~gLL~kdP~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  231 LQGLLIKDPAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             HHHHhhcChhhcccHHHHhcChHHhhh
Confidence            999999999999999999999997543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-55  Score=390.14  Aligned_cols=258  Identities=32%  Similarity=0.490  Sum_probs=213.1

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc-CHHHHHHHHHHhcCCCCCcceEEEEEEcCC--EEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~--~~~lv~e~   79 (351)
                      +|..++.||+|+||.||++.+.++|+.+|+|.+...... ...+.+|+.++++++|||||++++......  .++++|||
T Consensus        18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy   97 (313)
T KOG0198|consen   18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY   97 (313)
T ss_pred             hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence            578899999999999999999999999999988765221 345889999999999999999999854444  79999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEeccCCCcccCC----C
Q 018734           80 AAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLL----H  153 (351)
Q Consensus        80 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~-~~~~~vkL~DFg~a~~~~~----~  153 (351)
                      +++|+|.+++.+.+ .+++..++.+.+||++||.|||++||+||||||+|||++. ++.  +||+|||+++....    .
T Consensus        98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~  175 (313)
T KOG0198|consen   98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKS  175 (313)
T ss_pred             cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccccc
Confidence            99999999999877 8999999999999999999999999999999999999987 444  99999999886543    2


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                      .......|||.|||||++.......+++|||||||++.||+||..||....  .. ...+..+.......+.+..+|.++
T Consensus       176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~~-~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--EE-AEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--ch-HHHHHHHhccCCCCCCCcccCHHH
Confidence            223456899999999999864444456999999999999999999998741  11 111222222222223344689999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ++||.+||+.+|++|||+.++|+|||......
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999876644

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-55  Score=393.80  Aligned_cols=257  Identities=36%  Similarity=0.624  Sum_probs=222.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---------------cCHHHHHHHHHHhcCCCCCcceEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------------IDANVAREIINHKQLRHPNIIRFKE   65 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~e~~~~~~l~hp~Iv~~~~   65 (351)
                      +++|++++.||+|.||+|.+|++..+++.||||++.+...               ..+.+.+||.+|++|.|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            6899999999999999999999999999999999875321               1257889999999999999999999


Q ss_pred             EEEcC--CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 018734           66 VVLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD  143 (351)
Q Consensus        66 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~D  143 (351)
                      +..++  +.+|||+|||..|.+...=.....+++.+++.|+++++.||+|||.+|||||||||+|+||+.++  ++||+|
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIsD  253 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKISD  253 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEeec
Confidence            98765  68999999999988754433334489999999999999999999999999999999999998775  599999


Q ss_pred             cCCCcccCCC------CCCCCcccCCCccCcccccC---CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHH
Q 018734          144 FGYSKSSLLH------SRPKSTVGTPAYIAPEVLSR---REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS  214 (351)
Q Consensus       144 Fg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  214 (351)
                      ||.+......      ......+|||.|+|||.+.+   ..+.+++.||||+|++||.|+.|+.||.+..    ......
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----~~~l~~  329 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----ELELFD  329 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----HHHHHH
Confidence            9988754222      11234689999999999977   5577888999999999999999999998744    345566


Q ss_pred             HHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          215 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ++......+|..+.++..+++||.+||++||++|+++.+|..|||..+.
T Consensus       330 KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  330 KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            6777788899988899999999999999999999999999999998765

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.8e-55  Score=376.30  Aligned_cols=260  Identities=29%  Similarity=0.424  Sum_probs=224.4

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTP--THLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~l   75 (351)
                      +++|+.++.|++|+||.||+++|+.|++.||+|+++.....   .-..++||.++.+++|||||.+.++....  +.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            46799999999999999999999999999999999876542   35678999999999999999999998755  67999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-
Q 018734           76 VMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-  153 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-  153 (351)
                      |||||+. +|.+++.+.+ +|+..+++.++.|+++||+|||.+.|+||||||+|+|++..|.  +||+|||+|+..... 
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPL  231 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCc
Confidence            9999976 8999998765 8999999999999999999999999999999999999976664  999999999975544 


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-CCCc------
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDY------  226 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~------  226 (351)
                      ...+..+-|.||+|||++.+...++.++|+||+|||+.||+++++.|.+.+..+++.++...+...... +|.+      
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            335667899999999999998888888999999999999999999999999988888877654332111 1110      


Q ss_pred             -------------------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          227 -------------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       227 -------------------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                         ..++....+|+.++|.+||.+|.|+.+.|+|+||.+.
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                               0145888999999999999999999999999999874

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-55  Score=393.96  Aligned_cols=258  Identities=27%  Similarity=0.479  Sum_probs=222.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~lv   76 (351)
                      +.|+.+++||+|+||.||+|++..+|+.||+|++.....   ......+||.+|++|+||||+++.+...+.  +.+|+|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            468889999999999999999999999999999976543   335677999999999999999999999877  789999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC--
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--  153 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~--  153 (351)
                      +|||+. +|.-++... -.|++.+|+.++.||+.||.|+|++||+|||||.+|||||.++.  +||+|||+|+.....  
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGS  273 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCC
Confidence            999976 787777664 37999999999999999999999999999999999999987765  999999999954433  


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc------CCCC--
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY------KIPD--  225 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~--  225 (351)
                      ...+..+-|.||+|||++.+...++.++|+||+||||.||++|++.|.+..+.+++..+.........      ++|.  
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence            34677889999999999999988888899999999999999999999999988888777654432111      1121  


Q ss_pred             ---------------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          226 ---------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       226 ---------------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                                     +..+++.+.+|+..||+.||.+|.|+.++|.|+||..
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence                           1236788999999999999999999999999999943

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-56  Score=379.05  Aligned_cols=241  Identities=33%  Similarity=0.528  Sum_probs=206.4

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC---cccCHHHHHHHHHHhcCCCCCcceEEE-EEEcCCE-EEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKE-VVLTPTH-LAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~~~~l~hp~Iv~~~~-~~~~~~~-~~lv~   77 (351)
                      .|++.++||+|+||.||++++..+|..||.|.+.-.   .+....+..|+.+|++|+|||||++++ .|..++. ++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            589999999999999999999999999999998743   223356889999999999999999999 5555554 89999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           78 EYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHS--MQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        78 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~--~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      |||.+|+|...++.    ...++|..+|.++.|++.||..+|+  .+  |+||||||.||+++.++.  +||+|||+++.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~  177 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRF  177 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHhH
Confidence            99999999988864    3569999999999999999999999  45  999999999999987765  99999999986


Q ss_pred             cCCC-CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-CCCcc
Q 018734          150 SLLH-SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYV  227 (351)
Q Consensus       150 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~  227 (351)
                      .... ....+.+|||+||+||++.+.+|+.+ |||||+||++|||++-++||.+.    ++.....++....+. .|. .
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~-~  251 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPD-E  251 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcH-H
Confidence            5433 33456799999999999999999766 99999999999999999999986    455566666666554 332 4


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCCh
Q 018734          228 HISQDCRNLLSRIFVANPSRRITI  251 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~  251 (351)
                      .+|.++..||..|+.+||.+||+.
T Consensus       252 ~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  252 HYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HhhhHHHHHHHHHccCCcccCCCc
Confidence            689999999999999999999985

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-56  Score=368.96  Aligned_cols=257  Identities=34%  Similarity=0.626  Sum_probs=225.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC---cccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||+|.|+.|+++.+..||+.+|+|.++..   ...-+.+.+|+++-+.|+|||||++++.+...+..|+|+|
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe   90 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   90 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence            5789999999999999999999999999999988642   2233678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ++.|++|..-+.+.-.++|..+..+++||+.||.|+|.+||||||+||.|+|+.+. ...-+||+|||+|.....+....
T Consensus        91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~  170 (355)
T KOG0033|consen   91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWH  170 (355)
T ss_pred             cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccc
Confidence            99999998777766778999999999999999999999999999999999999532 23359999999999877666677


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC--CCCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  235 (351)
                      ..+|||.|||||++....|..+ +|||+.|+|+|-|+.|++||.+.+...    +..+++...++  .|.|..+++++++
T Consensus       171 G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~r----lye~I~~g~yd~~~~~w~~is~~Ak~  245 (355)
T KOG0033|consen  171 GFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHR----LYEQIKAGAYDYPSPEWDTVTPEAKS  245 (355)
T ss_pred             cccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHH----HHHHHhccccCCCCcccCcCCHHHHH
Confidence            7899999999999998888555 999999999999999999998865443    34445555555  4568899999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      |+.+||..||.+|+|+.|+|+|||+.+.
T Consensus       246 LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  246 LIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999999999764

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-54  Score=396.25  Aligned_cols=257  Identities=30%  Similarity=0.523  Sum_probs=221.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ..|....+||+|+.|.||.|+...+++.||||.+..... ..+-+++|+.+|+..+|+|||.+++.|.-.+.+|+||||+
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            468888999999999999999999999999999987544 3456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  159 (351)
                      +||+|.+.+... .++|.+|..+.+.++.||+|||.+||+|||||.+|||++.++.  +||+|||++....... ...+.
T Consensus       353 ~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~Tm  429 (550)
T KOG0578|consen  353 EGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTM  429 (550)
T ss_pred             CCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccc
Confidence            999998888654 5899999999999999999999999999999999999977765  9999999998655444 45567


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      +|||+|||||++....|..+ +||||||++++||+-|.+||....+... ...+.  ......+.....+|+.+++||.+
T Consensus       430 VGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrA-lyLIa--~ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  430 VGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIA--TNGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             cCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHH-HHHHh--hcCCCCcCCccccCHHHHHHHHH
Confidence            89999999999998888655 9999999999999999999987443222 22222  23333455556899999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ||+.||.+|+++.+||+||||....+
T Consensus       506 cL~~dv~~RasA~eLL~HpFl~~a~p  531 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLEHPFLKMAKP  531 (550)
T ss_pred             HhhcchhcCCCHHHHhcChhhhhcCC
Confidence            99999999999999999999965544

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-53  Score=379.71  Aligned_cols=264  Identities=29%  Similarity=0.444  Sum_probs=220.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +.|++...||.|..++||+|+...+++.||||++......  -..+++|+..++.++||||++++.+|..+..+|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            5799999999999999999999999999999999865443  35789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC-
Q 018734           80 AAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-  156 (351)
Q Consensus        80 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~-  156 (351)
                      |.+|+++++++..-  -++|..|..+++++++||.|||.+|.||||||+.||||+.+|.  |||+|||.+......... 
T Consensus       106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCcee
Confidence            99999999998643  3899999999999999999999999999999999999988776  999999987654333211 


Q ss_pred             ----CCcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh----hccCCCCc
Q 018734          157 ----KSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----VQYKIPDY  226 (351)
Q Consensus       157 ----~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~~~  226 (351)
                          +..+|||+|||||++..  .+|+ .++||||||++..||.+|+.||....+.+.+...++.-..    ........
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~  262 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDED  262 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHh
Confidence                44589999999999533  3555 4499999999999999999999988765544333221100    00011122


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChhh
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL  268 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~~  268 (351)
                      ..++..++.++..||+.||.+|||+.++|+|+||++...+..
T Consensus       263 k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~  304 (516)
T KOG0582|consen  263 KKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY  304 (516)
T ss_pred             hhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence            346788999999999999999999999999999998877654

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-54  Score=356.20  Aligned_cols=253  Identities=36%  Similarity=0.662  Sum_probs=228.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++++.||+|.||.||+++.+.++-.||+|++.+++-    ....+.+|+++.+.|+||||+++|++|.+...+|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            5789999999999999999999999999999999987653    345788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           77 MEYAAGGELFERIC--NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +||..+|+|+..|+  ...++++...+.++.|++.||.|+|.+++|||||||+|+|++..+.  +||+|||.+.... ..
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~  177 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SN  177 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CC
Confidence            99999999999999  6678999999999999999999999999999999999999976665  9999999987554 55


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      ...+.|||..|.+||+..+..++.. +|+|++|++.||++.|.+||.....    .+..+++.+..+.+|  ..++..+.
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~----~etYkrI~k~~~~~p--~~is~~a~  250 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSH----SETYKRIRKVDLKFP--STISGGAA  250 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhh----HHHHHHHHHccccCC--cccChhHH
Confidence            6677899999999999999998766 9999999999999999999987653    455666777777777  47999999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      |+|.+||..+|.+|++..|++.|||+...
T Consensus       251 dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  251 DLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            99999999999999999999999998654

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-53  Score=371.97  Aligned_cols=258  Identities=31%  Similarity=0.495  Sum_probs=222.1

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcC--C---EEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP--T---HLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~---~~~lv~   77 (351)
                      +|+..+.+|.|+||.||++....+++.||||++-.......   +|+++|+.+.|||||++..+|...  +   ...+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~kn---rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKN---RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCc---HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            47888999999999999999999999999998876655433   799999999999999999998654  2   356899


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           78 EYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        78 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ||++. +|...++.    +.+++.-.++.+++||++||.|||++||+||||||.|+|||.+ .+.+||||||.|+....+
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~-tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD-TGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC-CCeEEeccCCcceeeccC
Confidence            99965 89888874    5779999999999999999999999999999999999999865 357999999999999889


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh----------hc---
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------VQ---  220 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----------~~---  220 (351)
                      ....++..|.+|+|||.+.+...++.+.||||.||++.||+-|++.|.+.+..+++..++.-+..          ..   
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            98899999999999999999888888899999999999999999999998888888777654321          11   


Q ss_pred             cCCC----------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          221 YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       221 ~~~~----------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ..+|          .....++++.+|+.++|+++|.+|.++.+++.||||.....
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            1111          12346889999999999999999999999999999976543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=392.68  Aligned_cols=256  Identities=33%  Similarity=0.593  Sum_probs=222.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|.+++.||+|+||+|+++..+.+++.+|||++++....    -+....|-+++... +||.+++++.+|.+..++|+
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f  446 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF  446 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence            57899999999999999999999999999999999885432    24566777777766 59999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC-CCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~-~~~  154 (351)
                      ||||+.||+ ...+++.+.|++..++.|+..|+.||+|||++|||+||||.+|||+|..|.  +||+|||+++... .+.
T Consensus       447 vmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  447 VMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCC
Confidence            999999999 555667789999999999999999999999999999999999999987764  9999999999765 455


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .+.+.||||.|||||++.+..|+ .++|+|||||+||||+.|..||.+.+..+.+..    +.......|.  .+|.++.
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds----I~~d~~~yP~--~ls~ea~  596 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS----IVNDEVRYPR--FLSKEAI  596 (694)
T ss_pred             ccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HhcCCCCCCC--cccHHHH
Confidence            56678999999999999999985 559999999999999999999998776555444    4445555555  5899999


Q ss_pred             HHHHHhcccCCCCCCC-----hHHHhcCcccccCCCh
Q 018734          235 NLLSRIFVANPSRRIT-----IKEIKSHPWFLKNLPR  266 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps-----~~eil~hp~~~~~~~~  266 (351)
                      +++.++|.++|++|..     +.+|..||||+.....
T Consensus       597 ~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~  633 (694)
T KOG0694|consen  597 AIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD  633 (694)
T ss_pred             HHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence            9999999999999995     5789999999876543

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-52  Score=383.79  Aligned_cols=258  Identities=37%  Similarity=0.648  Sum_probs=227.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +.|++.+.||+|.||.||.|..+.+|+.+|+|++.+....    ...+.+|+.+|+++. |||||+++++|.+...+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            4799999999999999999999999999999999775432    257889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCCEEEeccCCCcccCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~--~~~vkL~DFg~a~~~~~~~  154 (351)
                      ||+|.||.|++.+.+. .+++..+..++.|++.|+.|||+.||+||||||+|+|+....  .+.+|++|||++.......
T Consensus       115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~  193 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE  193 (382)
T ss_pred             EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence            9999999999999877 499999999999999999999999999999999999996553  3579999999998766656


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+|||+|+|||++....|... +||||+|+++|.|++|.+||........+..+..  ....+..+.|..+|..++
T Consensus       194 ~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~--~~~~f~~~~w~~is~~ak  270 (382)
T KOG0032|consen  194 RLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILR--GDFDFTSEPWDDISESAK  270 (382)
T ss_pred             eEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc--CCCCCCCCCccccCHHHH
Confidence            6777899999999999988887655 9999999999999999999999876555543222  222345567788999999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ++|.+||..||.+|+|+.++|+|||+...
T Consensus       271 d~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  271 DFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.6e-52  Score=365.78  Aligned_cols=261  Identities=29%  Similarity=0.446  Sum_probs=221.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCC-cceEEEEEEcCC------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPN-IIRFKEVVLTPT------   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~-Iv~~~~~~~~~~------   71 (351)
                      ..|..+++||+|+||+||+|+...+|+.||+|+++....   ......+|+-+++.|+|+| ||.+++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            457778899999999999999999999999999987655   3467889999999999999 999999998877      


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           72 HLAIVMEYAAGGELFERICNAG----RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      .+++|+||++ .+|..++...+    .++...++.+++||+.||.|||+++|+||||||+||||+.++.  +||+|||+|
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlA  167 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLA  167 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchH
Confidence            8999999995 48999987765    4778899999999999999999999999999999999987654  999999999


Q ss_pred             cccCCCCC-CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CC--
Q 018734          148 KSSLLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI--  223 (351)
Q Consensus       148 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~--  223 (351)
                      +....... .+..++|.+|+|||++.+...++...||||+|||++||+++++.|.+.++.+++..+...+..... .+  
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            96654433 566789999999999999876677699999999999999999999999887777666654432211 11  


Q ss_pred             -----------CCc----------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          224 -----------PDY----------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       224 -----------~~~----------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                                 +.+          +..+++..+++.+||+.+|.+|.|+..+|.||||...-.
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence                       111          112358899999999999999999999999999987633

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.6e-53  Score=357.50  Aligned_cols=254  Identities=35%  Similarity=0.600  Sum_probs=223.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---------cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      +.|.-.+.||+|..++|.++..+.++..+|+|++.....         ..+.-.+|+.+++++ .||+|+++.++|.++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            467788899999999999999999999999999864211         123456799999988 6999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      .+++|+|.|+.|.|+++|...-.+++...+.+++|++.|+.|||.++|+||||||+|||++++.+  +||+|||+|+...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence            99999999999999999999888999999999999999999999999999999999999998875  9999999999988


Q ss_pred             CCCCCCCcccCCCccCccccc------CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc--CC
Q 018734          152 LHSRPKSTVGTPAYIAPEVLS------RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KI  223 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~  223 (351)
                      .+......||||+|+|||.+.      ..+| ++.+|+||+|+|+|.|+.|.+||...    ...-++..++..++  ..
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHR----kQmlMLR~ImeGkyqF~s  249 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHR----KQMLMLRMIMEGKYQFRS  249 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHH----HHHHHHHHHHhcccccCC
Confidence            888888999999999999974      2334 45599999999999999999999653    23445556666555  46


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      |.|.++|...++||.+||+.||.+|+|++|+|.||||.+
T Consensus       250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            888999999999999999999999999999999999954

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-52  Score=368.76  Aligned_cols=257  Identities=30%  Similarity=0.495  Sum_probs=223.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +.|++++.||.|.-|+||+|....++..+|+|++.+...    ...++..|-.+|+.+.||.++.+|..|.++...|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            467889999999999999999999999999999987543    2345667889999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC----
Q 018734           78 EYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL----  151 (351)
Q Consensus        78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~----  151 (351)
                      |||+||+|..++++.  +.|++..++.++..++.||+|||-.|||.|||||+||||.++|  +|.|+||.++....    
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG--HIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG--HIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC--cEEeeeccccccCCCCCe
Confidence            999999999998764  4699999999999999999999999999999999999997666  59999999763100    


Q ss_pred             ------------------------------C-----------------------CCCCCCcccCCCccCcccccCCcCCC
Q 018734          152 ------------------------------L-----------------------HSRPKSTVGTPAYIAPEVLSRREYDG  178 (351)
Q Consensus       152 ------------------------------~-----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~  178 (351)
                                                    .                       ..+..+.+||-.|+|||++.+.+.. 
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg-  313 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG-  313 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC-
Confidence                                          0                       0112345799999999999998874 


Q ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCC----hHHH
Q 018734          179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT----IKEI  254 (351)
Q Consensus       179 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps----~~ei  254 (351)
                      .++|||+|||.+|||+.|..||.+.+..+.    +.++...+..+|..+.++..++|||+++|.+||.+|+.    +.||
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T----l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI  389 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET----LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI  389 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhh----HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHh
Confidence            559999999999999999999999877544    44566677788888889999999999999999999998    9999


Q ss_pred             hcCcccccCCC
Q 018734          255 KSHPWFLKNLP  265 (351)
Q Consensus       255 l~hp~~~~~~~  265 (351)
                      .+||||..-.+
T Consensus       390 K~HpFF~gVnW  400 (459)
T KOG0610|consen  390 KRHPFFEGVNW  400 (459)
T ss_pred             hcCccccCCCh
Confidence            99999977544

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-53  Score=372.21  Aligned_cols=251  Identities=38%  Similarity=0.696  Sum_probs=231.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      .||++.+.||+|+||+|-+|.+...|+.||||.++++....    ..+.+||++|..|+||||+++|++|.+.+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            47999999999999999999999999999999998765433    45889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||..+|.|++++...+.+++.+.+.+++||+.|+.|+|.++++|||||.+|||+|.+++  +||+|||++..........
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHH
Confidence            99999999999999999999999999999999999999999999999999999998876  9999999998777777778


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ++||+|.|.+||++++..|.++.+|.||||++||.|+.|..||.+.    +...++.++....|..|.   .+.++.-||
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~----Dhk~lvrQIs~GaYrEP~---~PSdA~gLI  283 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR----DHKRLVRQISRGAYREPE---TPSDASGLI  283 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc----hHHHHHHHhhcccccCCC---CCchHHHHH
Confidence            8999999999999999999999999999999999999999999874    345667777778887664   567889999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccc
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      +.||-.||.+|-|+.+|-.|=|+.
T Consensus       284 RwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  284 RWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHhcCcccchhHHHHhhhheee
Confidence            999999999999999999998853

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.6e-51  Score=379.14  Aligned_cols=253  Identities=32%  Similarity=0.591  Sum_probs=217.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++++..+++.||+|++....    .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999987532    2234578899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+.|++|.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....  ..
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~~--~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG--HVKVTDFGFAKKVPD--RT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC--CEEEeeccCceEcCC--Cc
Confidence            99999999999999888999999999999999999999999999999999999998766  499999999875422  23


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|.  .++..+.+|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l  245 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFR----IYEKILAGRLKFPN--WFDGRARDL  245 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCcCCCC--CCCHHHHHH
Confidence            345799999999999887765 55999999999999999999997654322    23333334434443  478899999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 018734          237 LSRIFVANPSRRIT-----IKEIKSHPWFLKNL  264 (351)
Q Consensus       237 i~~~L~~~P~~Rps-----~~eil~hp~~~~~~  264 (351)
                      |.+||+.||.+||+     +.++++||||.+..
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence            99999999999997     79999999998643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-51  Score=371.93  Aligned_cols=251  Identities=33%  Similarity=0.602  Sum_probs=215.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            58999999999999999999999999999999986532    12345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||+.+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....  ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RTW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Ccc
Confidence            9999999999999888999999999999999999999999999999999999997665  499999999875432  233


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......+|.  .++..+++||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li  229 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGI----YEKILAGKLEFPR--HLDLYAKDLI  229 (291)
T ss_pred             cccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCcCCCc--cCCHHHHHHH
Confidence            45799999999999877765 559999999999999999999987654332    2233333333333  5688999999


Q ss_pred             HHhcccCCCCCCC-----hHHHhcCcccccC
Q 018734          238 SRIFVANPSRRIT-----IKEIKSHPWFLKN  263 (351)
Q Consensus       238 ~~~L~~~P~~Rps-----~~eil~hp~~~~~  263 (351)
                      .+||+.||.+||+     ++++++||||...
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence            9999999999995     9999999999753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1e-50  Score=366.98  Aligned_cols=257  Identities=29%  Similarity=0.476  Sum_probs=210.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      |++|++.+.||.|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            6799999999999999999999999999999999865432  23467799999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CC
Q 018734           79 YAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~  156 (351)
                      |+.+ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...... ..
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG--ELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEECcCcceeeccCCCccc
Confidence            9975 8988887654 579999999999999999999999999999999999997765  49999999987543222 22


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hcc
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQY  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (351)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|++||......+.+..+......               ..+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY  240 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence            34578999999999876554456699999999999999999999876654444333221110               000


Q ss_pred             CCCC---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          222 KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       222 ~~~~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+|.         ...++.++.+||.+||++||.+|||++|+|+||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            1111         12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2e-50  Score=367.68  Aligned_cols=261  Identities=26%  Similarity=0.440  Sum_probs=209.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||.|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            689999999999999999999999999999999875432  234577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCC
Q 018734           80 AAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPK  157 (351)
Q Consensus        80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~  157 (351)
                      +. ++|.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++..... ....
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG--ELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECCCCcceeccCCCccCC
Confidence            95 577777655 45689999999999999999999999999999999999997665  4999999998743222 2234


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc--------CCC-----
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------KIP-----  224 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~-----  224 (351)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||....+.......+........        ..+     
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            4578999999999876554556699999999999999999999876543222221111110000        000     


Q ss_pred             --------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          225 --------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       225 --------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                                    ....+++.+.+||.+||+.||.+|||+.++++||||....+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                          00124567899999999999999999999999999976533

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-50  Score=378.20  Aligned_cols=258  Identities=28%  Similarity=0.482  Sum_probs=213.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            589999999999999999999999999999999875321    2245678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---  154 (351)
                      |||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999998765  49999999986432110   


Q ss_pred             ---------------------------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCC
Q 018734          155 ---------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE  201 (351)
Q Consensus       155 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  201 (351)
                                                       .....+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~-~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC-chhhhhhHHHHHHHHhCCCCCC
Confidence                                             012357999999999998877764 4999999999999999999998


Q ss_pred             CCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCC---CCCChHHHhcCcccccCCC
Q 018734          202 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPS---RRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~---~Rps~~eil~hp~~~~~~~  265 (351)
                      .......+..+..  ......+|....++++++++|.+|+. +|.   .||++++|++||||.....
T Consensus       238 ~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         238 SETPQETYKKVMN--WKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CCCHHHHHHHHHc--CcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence            7654333332221  01223355555689999999999875 444   4589999999999987543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.3e-50  Score=365.70  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=214.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999998865321    22356789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           79 YAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |+.+|+|...+...  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.  ++|+|||++.........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence            99999998877543  36899999999999999999999999999999999999986654  999999998764333334


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....||+.|+|||++.+..++.. +|||||||++|+|++|+.||...............+.....  .....++..+.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l  235 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAKSI  235 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc--cCCccCCHHHHHH
Confidence            45679999999999988777544 99999999999999999999876543332333333322222  2233588999999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 018734          237 LSRIFVANPSRRIT-----IKEIKSHPWFLKNL  264 (351)
Q Consensus       237 i~~~L~~~P~~Rps-----~~eil~hp~~~~~~  264 (351)
                      +.+||+.||.+||+     ++++++||||....
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            99999999999997     89999999997754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.8e-51  Score=374.10  Aligned_cols=248  Identities=36%  Similarity=0.598  Sum_probs=210.6

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+.+|+||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999875321    2245678999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCcccC
Q 018734           84 ELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGT  162 (351)
Q Consensus        84 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt  162 (351)
                      +|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ......+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~--~~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--CEEEeeCCCCcccccCCCcccceecC
Confidence            9999999888999999999999999999999999999999999999998765  4999999998753222 223446799


Q ss_pred             CCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcc
Q 018734          163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  242 (351)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  242 (351)
                      +.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|  ..+++.+.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~~~~~~~~~p--~~~~~~~~~li~~~L~  231 (323)
T cd05571         159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEEIRFP--RTLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHHHHHHHcc
Confidence            999999999887775 45999999999999999999997654322    2223333333333  3689999999999999


Q ss_pred             cCCCCCC-----ChHHHhcCcccccCC
Q 018734          243 ANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       243 ~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      .||.+||     ++.++++||||....
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999     899999999997753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-51  Score=379.82  Aligned_cols=256  Identities=34%  Similarity=0.584  Sum_probs=214.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||||++....    .....+.+|+.+++.++||||+++++++.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            58999999999999999999999999999999987532    22245678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---  154 (351)
                      |||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||+++......   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence            99999999999998889999999999999999999999999999999999999987664  9999999986432110   


Q ss_pred             ------------------------------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCC
Q 018734          155 ------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAY  198 (351)
Q Consensus       155 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  198 (351)
                                                          .....+||+.|+|||++.+..++ .++|||||||++|+|++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCC
Confidence                                                01134699999999999887775 44999999999999999999


Q ss_pred             CCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCC---hHHHhcCcccccC
Q 018734          199 PFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKN  263 (351)
Q Consensus       199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps---~~eil~hp~~~~~  263 (351)
                      ||...........+..  .......|....+++.+.+||.+||. +|.+|++   +.+++.||||...
T Consensus       238 Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         238 PFCSDNPQETYRKIIN--WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCHHHHHHHHHc--CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9987654333222211  11222344545689999999999997 9999998   9999999999765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.3e-51  Score=381.10  Aligned_cols=257  Identities=28%  Similarity=0.408  Sum_probs=219.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-C-----CCcceEEEEEEcCCEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-H-----PNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-h-----p~Iv~~~~~~~~~~~~~lv   76 (351)
                      ||++.+.||+|+||.|.+|.|..|++.||||++++......+...|+.+|..|+ |     -|||+++++|...+++|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            799999999999999999999999999999999998888788889999999997 4     3899999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           77 MEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +|++ ..+|+++++.+.  .|+...++.++.||+.||.+||+.||||+||||+||||......+|||+|||+|...... 
T Consensus       267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~-  344 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQR-  344 (586)
T ss_pred             ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCc-
Confidence            9999 569999998764  489999999999999999999999999999999999998777678999999998743322 


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh----------------
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------------  218 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----------------  218 (351)
                       ....+.+.+|+|||++.+..|+.. .||||||||++||++|.+.|.+.+..+++..++.-+..                
T Consensus       345 -vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff  422 (586)
T KOG0667|consen  345 -VYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF  422 (586)
T ss_pred             -ceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence             237789999999999999999766 99999999999999999999998877776655442200                


Q ss_pred             --------------------------------hccCCC-Ccc--------CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          219 --------------------------------VQYKIP-DYV--------HISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       219 --------------------------------~~~~~~-~~~--------~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                                                      .....| .-.        .-...+.+||++||.+||.+|+|+.++|+|
T Consensus       423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH  502 (586)
T ss_pred             hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                                            000011 000        012357899999999999999999999999


Q ss_pred             cccccC
Q 018734          258 PWFLKN  263 (351)
Q Consensus       258 p~~~~~  263 (351)
                      |||...
T Consensus       503 pfl~~~  508 (586)
T KOG0667|consen  503 PFLTGT  508 (586)
T ss_pred             cccccc
Confidence            999743

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.7e-50  Score=362.91  Aligned_cols=256  Identities=28%  Similarity=0.440  Sum_probs=209.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||+|+||.||++++..+++.||+|++.....   ....+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            589999999999999999999999999999999875432   23567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--CC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~~  156 (351)
                      |+.++.+..+......+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND--VLKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEEeeccCcccccccccccc
Confidence            999877665555556799999999999999999999999999999999999997665  49999999987543222  22


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hcc
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQY  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (351)
                      ....||+.|+|||++.+..++ .++|||||||++|+|++|++||......+....+......               ...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            345799999999999887765 4599999999999999999999876544333222111000               000


Q ss_pred             CCCC-----------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          222 KIPD-----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       222 ~~~~-----------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ..+.           ...+|..+.+||.+||++||.+|||++++|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1111           11367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-53  Score=375.90  Aligned_cols=253  Identities=30%  Similarity=0.446  Sum_probs=219.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .|...+.||+|+||.||++.+..+++.||+|++......  .+.+.+|+.++.+++++||.++|+.+..+..+|++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            578889999999999999999999999999999875543  367889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  159 (351)
                      .||++.+.++..+.+.+..+..++++++.||.|||..+.+|||||+.|||+...+.  +||+|||.+...... ......
T Consensus        94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhccccc
Confidence            99999999999888899999999999999999999999999999999999987754  999999998765433 334678


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC-ccCCCHhHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQDCRNLLS  238 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~  238 (351)
                      +|||+|||||++.+..|+.+ +||||||++.+||++|.+||....+...+..    +.+.  ..|. -..+|+.+++||.
T Consensus       172 vGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlfl----Ipk~--~PP~L~~~~S~~~kEFV~  244 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLFL----IPKS--APPRLDGDFSPPFKEFVE  244 (467)
T ss_pred             cccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEEe----ccCC--CCCccccccCHHHHHHHH
Confidence            99999999999998888777 8999999999999999999988665221111    1110  1111 1258899999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCC
Q 018734          239 RIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      .||.+||+.||+|.++|+|+|++...
T Consensus       245 ~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            99999999999999999999997743

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-50  Score=373.31  Aligned_cols=252  Identities=31%  Similarity=0.538  Sum_probs=214.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCC-cEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTK-ELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++.+.||+|+||.||+|.+..++ ..||+|++....    .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            367999999999999999999876654 689999886532    223457789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...  ..
T Consensus       109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~ikL~DFG~a~~~~--~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG--FIKMTDFGFAKVVD--TR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEecCCCCeecC--CC
Confidence            999999999999999888999999999999999999999999999999999999997665  49999999987542  22


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.......    ....+......+|.  .+++.+.+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~  257 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLL----IYQKILEGIIYFPK--FLDNNCKH  257 (340)
T ss_pred             cceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHH----HHHHHhcCCCCCCC--CCCHHHHH
Confidence            3456799999999999877765 55999999999999999999998755432    23333333334443  57899999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 018734          236 LLSRIFVANPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       236 li~~~L~~~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      +|++||+.+|.+|+     +++++++||||...
T Consensus       258 li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        258 LMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999996     89999999999764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-50  Score=371.80  Aligned_cols=255  Identities=29%  Similarity=0.523  Sum_probs=216.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999987542    12245778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.....  ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG--HIKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--CEEEEeCcCCccccc--ccC
Confidence            9999999999999888999999999999999999999999999999999999998765  499999999875432  344


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc----cCCCHhH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY----VHISQDC  233 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~  233 (351)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|..||........+..+...  ......|..    ..++.++
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--KETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             CcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--cccccCCCCCccccccCHHH
Confidence            56799999999999888765 4599999999999999999999876543333322211  111112222    2568999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+||.+||+.+|.+||++.++++||||...
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            999999999999999999999999999754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-51  Score=369.60  Aligned_cols=253  Identities=36%  Similarity=0.699  Sum_probs=231.0

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      |.+.+.||+|.|++|.+|++.-||+.||||++.+...   ....+.+|++.|+.++|||||++|++..++..+|+|+|+-
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG   99 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG   99 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence            7888999999999999999999999999999987543   2356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           81 AGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      .+|+|+++|-+. .-+.|...++|++||+.|+.|+|+..+|||||||+|+.+-.. .|-|||+|||++.....+...+..
T Consensus       100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~kL~Ts  178 (864)
T KOG4717|consen  100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKKLTTS  178 (864)
T ss_pred             CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcchhhcc
Confidence            999999998654 469999999999999999999999999999999999987543 346999999999988888888999


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      ||+..|.|||++.+..|+.+++||||||+|||-|+||++||+..++.+    .+..++...|..|.  .+|.+|++||..
T Consensus       179 CGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----TLTmImDCKYtvPs--hvS~eCrdLI~s  252 (864)
T KOG4717|consen  179 CGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----TLTMIMDCKYTVPS--HVSKECRDLIQS  252 (864)
T ss_pred             cchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----hhhhhhcccccCch--hhhHHHHHHHHH
Confidence            999999999999999999999999999999999999999999887754    45566778888887  689999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ||+.||.+|-+.++|..++|++..
T Consensus       253 MLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  253 MLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             HHhcCchhhccHHHHhccccccCC
Confidence            999999999999999999998754

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-50  Score=377.81  Aligned_cols=256  Identities=31%  Similarity=0.532  Sum_probs=212.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+...    ....+.+|+.+++.++|||||++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            589999999999999999999999999999999865321    2245678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---  154 (351)
                      ||++||+|..++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~--~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC--CEEEeecccccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999997665  49999999985211100   


Q ss_pred             ---------------------------------------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHH
Q 018734          155 ---------------------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVT  189 (351)
Q Consensus       155 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  189 (351)
                                                                   .....+||+.|+|||++.+..++ .++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvi  237 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAI  237 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchh
Confidence                                                         00124799999999999887775 45999999999


Q ss_pred             HHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCC---CChHHHhcCcccccC
Q 018734          190 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRR---ITIKEIKSHPWFLKN  263 (351)
Q Consensus       190 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R---ps~~eil~hp~~~~~  263 (351)
                      +|+|++|.+||........+..+...  .....+|....++.++.+||.+||+ +|.+|   +++.+++.||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            99999999999876543333322211  1223345555689999999999998 67765   599999999999764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6e-50  Score=375.90  Aligned_cols=256  Identities=30%  Similarity=0.483  Sum_probs=212.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .|++++.||+|+||+||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            69999999999999999999999999999999875432    22457789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-----
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-----  153 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-----  153 (351)
                      |++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCccccccccccc
Confidence            999999999999888899999999999999999999999999999999999997665  5999999987532100     


Q ss_pred             -------------------------------------------CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHH
Q 018734          154 -------------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTL  190 (351)
Q Consensus       154 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  190 (351)
                                                                 ......+||+.|+|||++.+..++ .++|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHH
Confidence                                                       001235799999999999887775 459999999999


Q ss_pred             HHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhccc--CCCCCCChHHHhcCcccccC
Q 018734          191 YVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA--NPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       191 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~--~P~~Rps~~eil~hp~~~~~  263 (351)
                      |+|++|..||...........++.  .......|....+++++.+||.+||..  +|..|+++.+++.||||...
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999987654333222211  122234555556899999999996654  45559999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-50  Score=373.91  Aligned_cols=254  Identities=34%  Similarity=0.585  Sum_probs=217.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            58999999999999999999999999999999987532    22345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---  154 (351)
                      ||+.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......   
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence            99999999999988888999999999999999999999999999999999999987664  9999999987543332   


Q ss_pred             ---------------------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh
Q 018734          155 ---------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK  207 (351)
Q Consensus       155 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  207 (351)
                                                 ......||+.|+|||++.+..++. ++|||||||++|+|++|+.||.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCC-ceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                       223457999999999998887654 4999999999999999999998766433


Q ss_pred             HHHHHHHHHHh--hccCCCCccCCCHhHHHHHHHhcccCCCCCCC-hHHHhcCcccccC
Q 018734          208 NFRKTISRIMA--VQYKIPDYVHISQDCRNLLSRIFVANPSRRIT-IKEIKSHPWFLKN  263 (351)
Q Consensus       208 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps-~~eil~hp~~~~~  263 (351)
                      ...    .+..  .....|....+++.+.+||.+||+ +|.+||+ +.++++||||...
T Consensus       238 ~~~----~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         238 TYN----KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHH----HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            322    2332  333455555679999999999997 9999999 9999999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=6.4e-50  Score=381.57  Aligned_cols=257  Identities=30%  Similarity=0.427  Sum_probs=208.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcC--------CEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP--------THL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--------~~~   73 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....   ...+|+.+++.++|||||++++++...        ..+
T Consensus        66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            479999999999999999999999999999998865432   345799999999999999999887532        247


Q ss_pred             EEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           74 AIVMEYAAGGELFERIC----NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      ++||||+++ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++ +.+||+|||+|+.
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~  220 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKN  220 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-Cceeeeccccchh
Confidence            799999975 6766654    346799999999999999999999999999999999999997543 2499999999986


Q ss_pred             cCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh----------
Q 018734          150 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------  219 (351)
Q Consensus       150 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------  219 (351)
                      ..........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+....+.+..++......          
T Consensus       221 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~  300 (440)
T PTZ00036        221 LLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP  300 (440)
T ss_pred             ccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence            6555555567899999999998766544566999999999999999999998876655555544322110          


Q ss_pred             ---ccCCCC----------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          220 ---QYKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       220 ---~~~~~~----------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                         ...+|.          +...+.++.+||.+||+++|.+|||+.++|.||||...
T Consensus       301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence               011111          12367899999999999999999999999999999653

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-50  Score=366.26  Aligned_cols=245  Identities=33%  Similarity=0.608  Sum_probs=208.4

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734           10 IGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus        10 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ||+|+||.||++.+..+++.||+|++....    .....+.+|+.++++++||||+++++++...+.+|+||||+.+++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999986532    2224567899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCcccCCC
Q 018734           86 FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPA  164 (351)
Q Consensus        86 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt~~  164 (351)
                      .+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ......+||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG--HIALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC--cEEEEECcccccCccCCCccccccCCcc
Confidence            99998888999999999999999999999999999999999999997766  4999999998753222 22334579999


Q ss_pred             ccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccC
Q 018734          165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN  244 (351)
Q Consensus       165 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~  244 (351)
                      |+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|  ..+++.+.+||.+||+.|
T Consensus       159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKILQEPLRFP--DGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCCCCCC--CcCCHHHHHHHHHHcCCC
Confidence            9999999887775 44999999999999999999998754433    2333333333343  368899999999999999


Q ss_pred             CCCCC---ChHHHhcCcccccC
Q 018734          245 PSRRI---TIKEIKSHPWFLKN  263 (351)
Q Consensus       245 P~~Rp---s~~eil~hp~~~~~  263 (351)
                      |.+||   ++.++++||||.+.
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCC
Confidence            99997   57999999999775

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.9e-50  Score=368.06  Aligned_cols=258  Identities=30%  Similarity=0.542  Sum_probs=213.2

Q ss_pred             CeeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCcc-----cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHK-----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-----~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      +|++++.||+|+||.||++++.   .+++.||+|++.+...     ....+.+|+.+++.+ .||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999998874   4789999999865321     224567899999999 489999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ++||||+.+|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~--~~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG--HVVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC--CEEEeeCcCCcccccc
Confidence            99999999999999998888899999999999999999999999999999999999998765  4999999998754322


Q ss_pred             C--CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          154 S--RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       154 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      .  .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||...............+......+  ...+++
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  236 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF--PSFIGP  236 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCH
Confidence            2  223457999999999998765455669999999999999999999975443333333333333333223  336889


Q ss_pred             hHHHHHHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 018734          232 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      .+.++|.+||+.||.+||     ++.++++||||....
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            999999999999999999     788999999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.9e-50  Score=376.75  Aligned_cols=256  Identities=34%  Similarity=0.537  Sum_probs=213.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      .+|++++.||+|+||.||++++..+++.||+|++.....    ....+.+|+.+++.++|||||++++++.+...+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            479999999999999999999999999999999875422    2245778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC----
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH----  153 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~----  153 (351)
                      |||++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++......    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g--~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEeECCCCcccccccccc
Confidence            9999999999998888899999999999999999999999999999999999998766  4999999997521100    


Q ss_pred             --------------------------------------------CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHH
Q 018734          154 --------------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVT  189 (351)
Q Consensus       154 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  189 (351)
                                                                  ......+||+.|+|||++.+..++. ++|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~DiwSlGvi  237 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ-LCDWWSVGVI  237 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC-eeeEEechHH
Confidence                                                        0012347999999999998888764 4999999999


Q ss_pred             HHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCC---hHHHhcCcccccC
Q 018734          190 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKN  263 (351)
Q Consensus       190 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps---~~eil~hp~~~~~  263 (351)
                      +|+|++|++||...........+..  .......|....+++++.++|.+|+ .+|.+|++   +.++++||||...
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            9999999999987654333322221  1123345555678999999999986 59999997   9999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.6e-50  Score=368.52  Aligned_cols=248  Identities=34%  Similarity=0.595  Sum_probs=209.9

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+.+|+||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            469999999999999999999999999875322    2235668999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCcccC
Q 018734           84 ELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGT  162 (351)
Q Consensus        84 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt  162 (351)
                      +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ......+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC--CEEecccHHhccccCCCCccccccCC
Confidence            9999998888899999999999999999999999999999999999998765  4999999998753222 222345799


Q ss_pred             CCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcc
Q 018734          163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  242 (351)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  242 (351)
                      +.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......+|  ..+++.+.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~----~~~~~~~~~~~p--~~~~~~~~~li~~~L~  231 (323)
T cd05595         159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFP--RTLSPEAKSLLAGLLK  231 (323)
T ss_pred             cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHHHHHHHcc
Confidence            999999999877765 459999999999999999999977544322    222333333344  3689999999999999


Q ss_pred             cCCCCCC-----ChHHHhcCcccccCC
Q 018734          243 ANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       243 ~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      .+|.+||     ++.++++||||.+..
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            9999998     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-51  Score=372.27  Aligned_cols=256  Identities=32%  Similarity=0.497  Sum_probs=226.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCE-EEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTH-LAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~-~~lv   76 (351)
                      |++|..++.+|+|+||.+++++++..++.+++|.+.....   ......+|+.++++++|||||.+.++|..++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            6899999999999999999999999999999999976543   23467899999999999999999999998887 9999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           77 MEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      |+||+||+|.+.+...  ..|+++.+..|+.|++.|+.|||+++|+|||||++|||+..++.  |||+|||+|+......
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence            9999999999998653  46999999999999999999999999999999999999987775  8999999999877766


Q ss_pred             -CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          155 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                       ...+.+|||.||.||++.+..|..+ +|||||||++|||++-+++|...+......++..    .. ..|.+..++.++
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~----~~-~~Plp~~ys~el  234 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINR----GL-YSPLPSMYSSEL  234 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhh----cc-CCCCCccccHHH
Confidence             6677899999999999999999766 9999999999999999999988765544444433    22 346666899999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      +.||+.||..+|..||++.++|.+|.++..+
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            9999999999999999999999999876544

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.1e-49  Score=362.33  Aligned_cols=259  Identities=26%  Similarity=0.447  Sum_probs=213.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++++.||+|+||.||++.+..++..||+|++.....  ....+.+|+.+++.++||||+++++++...+.+++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            689999999999999999999999999999999876432  235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      +++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++  .+||+|||++..... .....
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~-~~~~~  161 (331)
T cd06649          85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SMANS  161 (331)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC--cEEEccCcccccccc-ccccc
Confidence            99999999998888899999999999999999999986 699999999999997765  499999999875432 23345


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHH------------------------
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS------------------------  214 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------------------------  214 (351)
                      ..||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... +...+.                        
T Consensus       162 ~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCccccccccc
Confidence            5799999999999877765 45999999999999999999996543211 111110                        


Q ss_pred             -------------------HHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          215 -------------------RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       215 -------------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                                         .+............+++++.+||.+||+.||++|||+.++++||||.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                               011000000011236789999999999999999999999999999976544

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.5e-50  Score=372.88  Aligned_cols=257  Identities=34%  Similarity=0.542  Sum_probs=214.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.++..+|+||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            57999999999999999999999999999999986532    12234678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~  155 (351)
                      ||++||+|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.......  .
T Consensus       123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~~kL~DfG~~~~~~~~~~~~  199 (370)
T cd05596         123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMDANGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC--CEEEEeccceeeccCCCccc
Confidence            99999999998865 4689999999999999999999999999999999999998766  49999999987543222  2


Q ss_pred             CCCcccCCCccCcccccCCc---CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      ....+||+.|+|||++.+..   ..+.++|||||||++|+|++|+.||........+.++...  .....+|....+|..
T Consensus       200 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~  277 (370)
T cd05596         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISKQ  277 (370)
T ss_pred             CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCCHH
Confidence            23457999999999986543   2356699999999999999999999876654333332211  122345665578999


Q ss_pred             HHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 018734          233 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  263 (351)
Q Consensus       233 ~~~li~~~L~~~P~~--Rps~~eil~hp~~~~~  263 (351)
                      +.+||.+||+.+|.+  |+|+.++++||||...
T Consensus       278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            999999999999988  9999999999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-51  Score=349.84  Aligned_cols=257  Identities=36%  Similarity=0.591  Sum_probs=222.8

Q ss_pred             CCeeEe-eeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcC----CEEEE
Q 018734            2 EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTP----THLAI   75 (351)
Q Consensus         2 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~----~~~~l   75 (351)
                      ++|.+- .+||-|-.|.|..|.++.|++.+|+|++..+    ...++|++.+-.. .|||||+++++|.+.    ..+.+
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi  136 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI  136 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence            455554 6799999999999999999999999987654    3567888887665 699999999998654    46789


Q ss_pred             EEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEeccCCCcccCC
Q 018734           76 VMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~~~vkL~DFg~a~~~~~  152 (351)
                      |||.++||.|++.++..+.  |+|.++..|++||..|+.|||+.+|.||||||+|+|.... .+..+||+|||+|+....
T Consensus       137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9999999999999998765  9999999999999999999999999999999999998543 345699999999998777


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC--ccCCC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS  230 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (351)
                      .....+.|-||+|.|||++...+|+ +.+|+||+|+++|.|+||.+||...........+-.++...+|.+|.  |..+|
T Consensus       217 ~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VS  295 (400)
T KOG0604|consen  217 PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVS  295 (400)
T ss_pred             CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHH
Confidence            7777888999999999999777765 55999999999999999999998776544445566677888887764  66789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..++++|+++|..+|.+|+|+.++++|||+.+.
T Consensus       296 e~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  296 EAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            999999999999999999999999999999764

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.1e-50  Score=375.36  Aligned_cols=256  Identities=33%  Similarity=0.544  Sum_probs=213.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      .+|++++.||+|+||.||++++..+++.||+|++....    .....+.+|+.+++.++||||+++++.+.+.+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999986532    22345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC----
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH----  153 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~----  153 (351)
                      |||++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+|......    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~--~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC--CEEEEeCCCCcccccccccc
Confidence            9999999999999888899999999999999999999999999999999999998665  4999999997421100    


Q ss_pred             ----------------------------------------CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHH
Q 018734          154 ----------------------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM  193 (351)
Q Consensus       154 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  193 (351)
                                                              ......+||+.|||||++.+..++ .++|||||||++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeeh
Confidence                                                    001234799999999999887775 449999999999999


Q ss_pred             HcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCC---ChHHHhcCcccccC
Q 018734          194 LVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKN  263 (351)
Q Consensus       194 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp---s~~eil~hp~~~~~  263 (351)
                      ++|+.||...........+..  .......+....+++.+.++|.+|+ .+|.+|+   ++.++++||||...
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            999999987654333222211  1122334555568999999999977 5999999   99999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-49  Score=366.40  Aligned_cols=248  Identities=37%  Similarity=0.607  Sum_probs=209.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+.+|+||||+.++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999875422    2245678999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCcccC
Q 018734           84 ELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGT  162 (351)
Q Consensus        84 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt  162 (351)
                      +|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ......+||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG--HIKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC--cEEEecCcCCccCCCcccccccccCC
Confidence            9999998888899999999999999999999999999999999999998665  4999999998753222 222345799


Q ss_pred             CCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcc
Q 018734          163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  242 (351)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  242 (351)
                      +.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|  ..++.++.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~~p--~~~~~~~~~li~~~L~  231 (328)
T cd05593         159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEDIKFP--RTLSADAKSLLSGLLI  231 (328)
T ss_pred             cCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHH----HHHHhccCCccCC--CCCCHHHHHHHHHHcC
Confidence            999999999877765 45999999999999999999997654322    2222333333333  3689999999999999


Q ss_pred             cCCCCCC-----ChHHHhcCcccccCC
Q 018734          243 ANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       243 ~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      .||.+|+     ++.++++||||....
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999997     899999999997643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-49  Score=366.01  Aligned_cols=258  Identities=27%  Similarity=0.477  Sum_probs=206.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~~   74 (351)
                      ||++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            79999999999999999999999999999998865322   224577899999999999999999988643     3589


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +|||||. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC--KLKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEccCcccccccccc
Confidence            9999995 68999998888899999999999999999999999999999999999997765  49999999987532222


Q ss_pred             C----CCCcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHH-----------HH-
Q 018734          155 R----PKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-----------RI-  216 (351)
Q Consensus       155 ~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-----------~~-  216 (351)
                      .    ....+||+.|+|||++.+  ..+ +.++|||||||++|+|++|++||........+..+..           .+ 
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            1    134579999999999865  344 4559999999999999999999976553322211100           00 


Q ss_pred             -------Hh---hccCC---CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          217 -------MA---VQYKI---PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       217 -------~~---~~~~~---~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                             ..   .....   ..+..+++.+.++|.+||+.+|++|||+.++++||||....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                   00   00000   11234678899999999999999999999999999997643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-49  Score=362.42  Aligned_cols=245  Identities=33%  Similarity=0.493  Sum_probs=205.3

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCC-EEEEEEecc
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPT-HLAIVMEYA   80 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-~~~lv~e~~   80 (351)
                      .+.+.||.|+||+||.+....+ ..||+|++......   ...+.+|+.++++++|||||++++++..+. .+++||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            4456799999999999998753 22999998764433   347999999999999999999999998887 799999999


Q ss_pred             CCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCC
Q 018734           81 AGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  156 (351)
Q Consensus        81 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~-iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~  156 (351)
                      ++|+|..++.+  ...++...+..++.||++||.|||+++ ||||||||.|||++.+. .++||||||+++..... ...
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~~~  201 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKTSM  201 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccccccc
Confidence            99999999988  678999999999999999999999999 99999999999998775 24999999999865544 344


Q ss_pred             CCcccCCCccCccccc--CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          157 KSTVGTPAYIAPEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      +...||+.|||||++.  ...|+.+ +||||||+++|||+||+.||......    .....+.....+.+.+...++.+.
T Consensus       202 ~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~----~~~~~v~~~~~Rp~~p~~~~~~l~  276 (362)
T KOG0192|consen  202 TSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPV----QVASAVVVGGLRPPIPKECPPHLS  276 (362)
T ss_pred             cCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCccCCHHHH
Confidence            5578999999999998  4466555 99999999999999999999887652    222233333333333445899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhc
Q 018734          235 NLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .|+.+||..||.+||++.+++.
T Consensus       277 ~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  277 SLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHhCCCCCCcCCCHHHHHH
Confidence            9999999999999999999875

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-49  Score=369.05  Aligned_cols=253  Identities=20%  Similarity=0.301  Sum_probs=205.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .+|++++.||+|+||.||+|.+..+++.||+|....     ..+.+|+.++++++|||||+++++|......++|+|++.
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            579999999999999999999999999999997532     346789999999999999999999999999999999995


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC--CCCCCc
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKST  159 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~--~~~~~~  159 (351)
                       ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+.....  ......
T Consensus       167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccccc
Confidence             689999888888999999999999999999999999999999999999976654  999999998643221  223345


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------hhHHHHHHHHHH---------------
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIM---------------  217 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~---------------  217 (351)
                      +||+.|+|||++.+..++ .++|||||||++|+|++|..||.....       ...+..++....               
T Consensus       244 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~  322 (391)
T PHA03212        244 AGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD  322 (391)
T ss_pred             cCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence            799999999999887765 559999999999999999988754321       111111111110               


Q ss_pred             -------hhccC----CCC---ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          218 -------AVQYK----IPD---YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       218 -------~~~~~----~~~---~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                             .....    .+.   ...++.++.+||.+||+.||.+|||+.++|+||||...
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                   00000    011   11246689999999999999999999999999999764

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.9e-50  Score=368.12  Aligned_cols=257  Identities=29%  Similarity=0.501  Sum_probs=214.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            579999999999999999999999999999999876432    2345678899999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      ||+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||++........ 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG--HIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC--CEEeccCCCCeECCCCCce
Confidence            999999999999876 6799999999999999999999999999999999999998665  499999999875433222 


Q ss_pred             -CCCcccCCCccCcccccC-----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCC
Q 018734          156 -PKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                       .....||+.|+|||++..     ....+.++|||||||++|+|++|+.||........+..+...  .....+|....+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~  236 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPKV  236 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCC
Confidence             223479999999999863     222345599999999999999999999876554433332211  112234555568


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ++.+.+||.+||+ +|.+||++.++++||||...
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            9999999999998 99999999999999999764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-49  Score=369.59  Aligned_cols=258  Identities=30%  Similarity=0.524  Sum_probs=214.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++....    .....+.+|+.++..++||||+++++.+.+...+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999986532    22345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---  154 (351)
                      ||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++  +++|+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCcccccccccc
Confidence            9999999999999888999999999999999999999999999999999999997665  59999999986432110   


Q ss_pred             ---------------------------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCC
Q 018734          155 ---------------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE  201 (351)
Q Consensus       155 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  201 (351)
                                                       .....+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~-~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC-cceeccccceeeecccCCCCCC
Confidence                                             012357999999999998887764 4999999999999999999998


Q ss_pred             CCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCC---ChHHHhcCcccccCCC
Q 018734          202 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLP  265 (351)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp---s~~eil~hp~~~~~~~  265 (351)
                      .......+..+..  ......+|....+++.+++||.+|+. +|.+|+   ++.++++||||.....
T Consensus       238 ~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         238 SETPQETYRKVMN--WKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             CCCHHHHHHHHHc--CCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCH
Confidence            7655433322221  01223345444589999999999874 999998   4799999999987533

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.6e-49  Score=369.70  Aligned_cols=257  Identities=33%  Similarity=0.528  Sum_probs=212.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.++..+|+||
T Consensus        43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999986522    12234678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~  155 (351)
                      ||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......  .
T Consensus       123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~  199 (370)
T cd05621         123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMVR  199 (370)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCcee
Confidence            999999999988654 6899999999999999999999999999999999999987654  9999999987543222  1


Q ss_pred             CCCcccCCCccCcccccCCc---CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      ....+||+.|+|||++.+..   +.+.++|||||||++|+|++|+.||........+..+...  .....+|....++..
T Consensus       200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~  277 (370)
T cd05621         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEISKH  277 (370)
T ss_pred             cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCCHH
Confidence            23567999999999987643   2355699999999999999999999876543333322211  122345555568999


Q ss_pred             HHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 018734          233 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  263 (351)
Q Consensus       233 ~~~li~~~L~~~P~~--Rps~~eil~hp~~~~~  263 (351)
                      +++++.+||+.+|.+  |+++.++++||||...
T Consensus       278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999866544  8999999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.3e-49  Score=361.64  Aligned_cols=247  Identities=32%  Similarity=0.536  Sum_probs=207.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++....    .....+..|..++..+ +||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987532    1223456777777766 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  161 (351)
                      ++|..++.....+++..+..++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++..... ......+|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence            999999988889999999999999999999999999999999999999987664  999999998753322 22344579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|+.||.......    ....+.......|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~li~~~L  231 (320)
T cd05590         159 TPDYIAPEILQEMLYGP-SVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAILNDEVVYPT--WLSQDAVDILKAFM  231 (320)
T ss_pred             CccccCHHHHcCCCCCC-ccchhhhHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence            99999999998777654 4999999999999999999998765432    23333333333333  57899999999999


Q ss_pred             ccCCCCCCCh------HHHhcCcccccC
Q 018734          242 VANPSRRITI------KEIKSHPWFLKN  263 (351)
Q Consensus       242 ~~~P~~Rps~------~eil~hp~~~~~  263 (351)
                      +.||.+||++      +++++||||...
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            9999999998      899999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.1e-49  Score=362.52  Aligned_cols=251  Identities=28%  Similarity=0.498  Sum_probs=207.2

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++.+...    ....+.+|..+++.+ +||||+++++++.+...+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            469999999999999999999999999976432    123466788888888 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  161 (351)
                      ++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEECcCccccccccCCCccccccC
Confidence            99999998888999999999999999999999999999999999999998765  499999999874322 222344679


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh-----HHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----NFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|+.||.......     ........+......+|.  .++..+.++
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~l  235 (329)
T cd05588         159 TPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSV  235 (329)
T ss_pred             CccccCHHHHcCCCCCC-ccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence            99999999998877654 5999999999999999999996422111     111122233333444443  578999999


Q ss_pred             HHHhcccCCCCCCC------hHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRIT------IKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps------~~eil~hp~~~~~  263 (351)
                      |.+||+.||.+|++      +.++++||||...
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            99999999999997      7899999999653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8.4e-49  Score=360.39  Aligned_cols=252  Identities=30%  Similarity=0.558  Sum_probs=211.6

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCC-CcceEEEEEEcCCEEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHP-NIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp-~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +|++++.||+|+||.||++.+..+++.||+|++....    .....+..|..+++.++|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5899999999999999999999999999999987532    1224567788888888765 5888999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~  156 (351)
                      ||+.|++|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||++..... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG--HIKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC--CEEEeecCcceecCCCCCce
Confidence            9999999999998888899999999999999999999999999999999999998765  499999999874322 2223


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........+    ..+......+|  ..++..+.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~l  231 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYP--KSLSKEAVSI  231 (324)
T ss_pred             eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHH
Confidence            345799999999999887765 4499999999999999999999876543322    23333333333  3688999999


Q ss_pred             HHHhcccCCCCCCCh-----HHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITI-----KEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~-----~eil~hp~~~~~  263 (351)
                      +.+||+.+|.+|++.     .++++||||...
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999986     899999999764

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-48  Score=353.42  Aligned_cols=255  Identities=28%  Similarity=0.444  Sum_probs=204.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-CCcEEEEEEeccCcc---cCHHHHHHHHHHhcC---CCCCcceEEEEEEc-----
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-TKELVAMKYIERGHK---IDANVAREIINHKQL---RHPNIIRFKEVVLT-----   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l---~hp~Iv~~~~~~~~-----   69 (351)
                      ++|++.+.||+|+||.||+|.+.. +++.||+|++.....   ......+|+.+++.+   +||||+++++++..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            589999999999999999999854 468899998865332   223456677776655   69999999998852     


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           70 PTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        70 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      ...+++||||+. ++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~--~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC--CEEEccccce
Confidence            456899999996 5898888653  3589999999999999999999999999999999999997765  4999999998


Q ss_pred             cccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh-ccCCC--
Q 018734          148 KSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIP--  224 (351)
Q Consensus       148 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~--  224 (351)
                      +............||+.|+|||++.+..++.+ +|||||||++|+|++|++||........+..++...... ...++  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            76544444455679999999999987776544 999999999999999999999877655555544322100 00000  


Q ss_pred             ------------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          225 ------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       225 ------------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                                        ....++..+.+|+.+||+.+|++|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              012467788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-49  Score=363.70  Aligned_cols=249  Identities=36%  Similarity=0.586  Sum_probs=209.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+.+|+||||+.++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            469999999999999999999999999875321    2245678899999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCccc
Q 018734           84 ELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  161 (351)
Q Consensus        84 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  161 (351)
                      +|..++.....+++..++.++.||+.||.|||+ +||+||||||+|||++.++  .+||+|||+++..... ......+|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC--CEEEecCCCCeecCCCCcccccccC
Confidence            999999888889999999999999999999997 7999999999999998766  4999999998743222 22234579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......+|  ..+++++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~li~~~L  231 (325)
T cd05594         159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFP--RTLSPEAKSLLSGLL  231 (325)
T ss_pred             CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHHHHHHHh
Confidence            9999999999877765 459999999999999999999977543222    222333333333  358899999999999


Q ss_pred             ccCCCCCC-----ChHHHhcCcccccCCC
Q 018734          242 VANPSRRI-----TIKEIKSHPWFLKNLP  265 (351)
Q Consensus       242 ~~~P~~Rp-----s~~eil~hp~~~~~~~  265 (351)
                      +.||.+|+     ++.++++||||.....
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~  260 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVW  260 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCCCH
Confidence            99999997     8999999999987543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-48  Score=351.86  Aligned_cols=256  Identities=25%  Similarity=0.407  Sum_probs=213.6

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++..+..+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999865322    22346789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           79 YAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |+.+++|..++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCCCcc
Confidence            99999998887543  4689999999999999999999999999999999999997665  4999999998764433333


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+|++.|+|||++.+..++. ++||||+||++|+|++|+.||...............+.......  ...++..+.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~-~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  235 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTF-SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSEAARSI  235 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCc-cccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc--CcccCHHHHHH
Confidence            4567999999999998777654 48999999999999999999987654333333333333222222  23578999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      +.+||+.||.+||     +++++++||||...
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            9999999999999     89999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-48  Score=359.59  Aligned_cols=249  Identities=33%  Similarity=0.559  Sum_probs=209.3

Q ss_pred             eeeecccCceEEEEEEEc---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            7 MKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++.||+|+||.||++.+.   .+++.||+|++....     .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            368999999999999874   468899999987532     222456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~  157 (351)
                      |+.+++|...+.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEeeCcCCeecccCCCccc
Confidence            999999999999888899999999999999999999999999999999999997665  4999999998743322 2233


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|  ..+++.+.+||
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~li  231 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKK----TIDKILKGKLNLP--PYLTPEARDLL  231 (323)
T ss_pred             ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHHHH
Confidence            45799999999999877765 55999999999999999999998755432    2333333333333  35789999999


Q ss_pred             HHhcccCCCCCC-----ChHHHhcCcccccCC
Q 018734          238 SRIFVANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       238 ~~~L~~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      .+||+.+|.+||     ++.++++||||....
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999999     899999999997653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.2e-48  Score=355.28  Aligned_cols=260  Identities=26%  Similarity=0.451  Sum_probs=211.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      |++|++.+.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.+++.++||||+++++++..++..++|||
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            6789999999999999999999999999999999875432  23457789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CC
Q 018734           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~  156 (351)
                      |+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++....... ..
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG--ELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECccccceecCCCcccc
Confidence            9975 888777654 4589999999999999999999999999999999999998765  49999999987533222 22


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hcc
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQY  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (351)
                      ....+|+.|+|||++.+....+.++|||||||++|+|++|++||......+.+..+......               ...
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            34568999999999876554456699999999999999999999876654443333221100               001


Q ss_pred             CCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          222 KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       222 ~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..+         ....++.++.+||.+||+.||.+|||+.++++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            111         112468899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.1e-48  Score=362.68  Aligned_cols=256  Identities=28%  Similarity=0.448  Sum_probs=205.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCC------
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPT------   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~------   71 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            478999999999999999999999999999999986542   22346778999999999999999999986543      


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      .+|+||||+.+ +|...+..  .+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~--~~kl~Dfg~a~~~~  174 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAC  174 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEecCCCccccc
Confidence            57999999965 66666543  478999999999999999999999999999999999998765  49999999997654


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH---------------
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI---------------  216 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  216 (351)
                      .........||+.|+|||++.+..+..+ +|||||||++|+|++|+.||........+.......               
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            4444455689999999999988777655 999999999999999999998765433322222111               


Q ss_pred             ---HhhccCC---------CC---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          217 ---MAVQYKI---------PD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       217 ---~~~~~~~---------~~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                         .......         +.         ....++.+++||.+||+.||.+|||+.|+|+||||..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence               0000000         00         0123578899999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-48  Score=358.38  Aligned_cols=251  Identities=33%  Similarity=0.593  Sum_probs=207.8

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHH---HhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIIN---HKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~---~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      |++.+.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+   ++.++||||+++++++.....+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999987532    122345556554   4567899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~  155 (351)
                      |||+.|++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ...
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence            999999999887754 57999999999999999999999999999999999999987664  99999999874322 222


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........+    ..+.......|  ..++..+.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~  230 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVF----DSIVNDEVRYP--RFLSREAIS  230 (324)
T ss_pred             ccccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHHHH
Confidence            3446799999999999887765 4499999999999999999999875543322    23333333333  357899999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 018734          236 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       236 li~~~L~~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      +|.+||+.||.+||     ++.++++||||....
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            99999999999999     699999999997653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.2e-48  Score=360.08  Aligned_cols=251  Identities=29%  Similarity=0.506  Sum_probs=206.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++.+...    ....+.+|+.++.++ +||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999876432    123466788777666 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  161 (351)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~--~~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--CEEEeeCCccccccCCCCccccccC
Confidence            99999998888999999999999999999999999999999999999998766  499999999875322 222344579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----hhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----PKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|+.||.....     ..........+......+|  ..++..+.++
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~l  235 (329)
T cd05618         159 TPNYIAPEILRGEDYGF-SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASV  235 (329)
T ss_pred             CccccCHHHHcCCCCCC-ccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC--CCCCHHHHHH
Confidence            99999999998877654 49999999999999999999963211     1111122223333333444  3678999999


Q ss_pred             HHHhcccCCCCCCC------hHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRIT------IKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps------~~eil~hp~~~~~  263 (351)
                      |.+||+.||.+||+      +.++++||||...
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            99999999999998      5799999999654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.1e-48  Score=359.40  Aligned_cols=253  Identities=32%  Similarity=0.545  Sum_probs=211.9

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +|++.+.||+|+||.||++.+..+++.||+|++.+....    ......|..++..+ .||+|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999999998764321    12355677777666 5899999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~  156 (351)
                      ||+.+|+|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~--~~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC--cEEEccCCCceecCCCCCcc
Confidence            9999999999998888899999999999999999999999999999999999998766  499999999875332 2233


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......+|  ..++.++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~l  231 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYP--KSMSKEAVAI  231 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCC--CcCCHHHHHH
Confidence            456799999999999887775 449999999999999999999987654332    233333333344  3689999999


Q ss_pred             HHHhcccCCCCCCCh-----HHHhcCcccccCC
Q 018734          237 LSRIFVANPSRRITI-----KEIKSHPWFLKNL  264 (351)
Q Consensus       237 i~~~L~~~P~~Rps~-----~eil~hp~~~~~~  264 (351)
                      +.+||+.+|.+|++.     .++++||||....
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999999984     8999999997643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-48  Score=358.59  Aligned_cols=248  Identities=31%  Similarity=0.511  Sum_probs=207.8

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++.....    ....+..|..+++.+ +||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999875321    223456778887765 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  161 (351)
                      ++|...+.+...+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||++...... ......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG--HCKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeecccceecccCCcccccccc
Confidence            99999998888899999999999999999999999999999999999998766  4999999998753222 22344579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|+.||........    ...+.......|.  .++.++.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~el~tg~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~~~ll~~~L  231 (321)
T cd05591         159 TPDYIAPEILQELEYGP-SVDWWALGVLMYEMMAGQPPFEADNEDDL----FESILHDDVLYPV--WLSKEAVSILKAFM  231 (321)
T ss_pred             CccccCHHHHcCCCCCC-ccceechhHHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence            99999999998777754 49999999999999999999987654333    2333333333343  47899999999999


Q ss_pred             ccCCCCCC-------ChHHHhcCcccccCC
Q 018734          242 VANPSRRI-------TIKEIKSHPWFLKNL  264 (351)
Q Consensus       242 ~~~P~~Rp-------s~~eil~hp~~~~~~  264 (351)
                      +.+|.+||       ++.++++||||....
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            99999999       899999999996643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-48  Score=356.19  Aligned_cols=248  Identities=32%  Similarity=0.553  Sum_probs=205.5

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhc-CCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQ-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~-l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++....    ........|..++.. ++||||+++++++.+.+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            47999999999999999999999999987532    122345567777765 4899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  161 (351)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .++|+|||+++.... .......+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG--HIKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEeCccCCCeecccCCCceeccCC
Confidence            99999998888899999999999999999999999999999999999998766  499999999874322 222345679


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+.......|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05620         159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDEL----FESIRVDTPHYPR--WITKESKDILEKLF  231 (316)
T ss_pred             CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHHHHHHc
Confidence            9999999999887775 449999999999999999999987554322    2222222222333  47899999999999


Q ss_pred             ccCCCCCCCh-HHHhcCcccccCC
Q 018734          242 VANPSRRITI-KEIKSHPWFLKNL  264 (351)
Q Consensus       242 ~~~P~~Rps~-~eil~hp~~~~~~  264 (351)
                      +.||.+||++ +++++||||....
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCCC
Confidence            9999999998 5899999997753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.1e-48  Score=356.38  Aligned_cols=258  Identities=26%  Similarity=0.458  Sum_probs=210.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.++||.|+||.||++.+..++..+|+|++.....  ....+.+|+.+++.++||||+++++++...+.+++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            689999999999999999999999999999998876432  234688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      +.+++|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.  +||+|||++.... ......
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~-~~~~~~  161 (333)
T cd06650          85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLI-DSMANS  161 (333)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhh-hhcccc
Confidence            99999999999888899999999999999999999975 7999999999999976654  9999999986432 222344


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHH-------------------------
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI-------------------------  213 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-------------------------  213 (351)
                      ..||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... .....                         
T Consensus       162 ~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         162 FVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKE-LELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             CCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhH-HHHHhcCcccCCccccccCcccCCccchhh
Confidence            5799999999999877665 44999999999999999999997543211 11100                         


Q ss_pred             ----------------HHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          214 ----------------SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       214 ----------------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                                      ..+............++.++.+||.+||+.||++|||+.+++.||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence                            000000000000113578899999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2e-48  Score=374.81  Aligned_cols=259  Identities=22%  Similarity=0.383  Sum_probs=202.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC------CCcceEEEEEEcC-CEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH------PNIIRFKEVVLTP-THLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h------p~Iv~~~~~~~~~-~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+..+++.||||++............|+.+++.++|      ++++++++++... .++|
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            57999999999999999999999999999999987644434455667777666644      5688999988765 5799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCC--------------CCE
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPA--------------PRL  139 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~--------------~~v  139 (351)
                      +||+++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++..+.              .++
T Consensus       209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v  287 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV  287 (467)
T ss_pred             EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence            999998 77999999888899999999999999999999998 59999999999999975542              249


Q ss_pred             EEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-
Q 018734          140 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-  218 (351)
Q Consensus       140 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-  218 (351)
                      ||+|||++...  .......+||+.|+|||++.+..+.. ++|||||||++|||++|++||........+..+...... 
T Consensus       288 kl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~-~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        288 RICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMY-STDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             EECCCCccccC--ccccccccCCccccCcHHhhcCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence            99999987532  22334568999999999998887754 499999999999999999999876543333222111000 


Q ss_pred             ------------------hccC-CCC----------------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          219 ------------------VQYK-IPD----------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       219 ------------------~~~~-~~~----------------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                        .... .+.                ....++.+.+||.+||++||.+|||+.|+|+||||.+.
T Consensus       365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence                              0000 000                00013567899999999999999999999999999765


Q ss_pred             C
Q 018734          264 L  264 (351)
Q Consensus       264 ~  264 (351)
                      .
T Consensus       445 ~  445 (467)
T PTZ00284        445 Y  445 (467)
T ss_pred             C
Confidence            3

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.8e-48  Score=356.76  Aligned_cols=248  Identities=32%  Similarity=0.546  Sum_probs=205.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHH-HHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~-~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++.....    ....+..|.. +++.++||||+++++++.....+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            479999999999999999999999999875321    1123444444 46789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  161 (351)
                      ++|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC--cEEEeccCCCcccccCCCccccccC
Confidence            99999999888999999999999999999999999999999999999997766  4999999998753222 22334579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|..||.......    ....+.......+  ..++..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (323)
T cd05575         159 TPEYLAPEVLRKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRDTAE----MYDNILNKPLRLK--PNISVSARHLLEGLL  231 (323)
T ss_pred             ChhhcChhhhcCCCCCc-cccccccchhhhhhhcCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHHHHHHHh
Confidence            99999999998877654 5999999999999999999998754332    2233333333332  357999999999999


Q ss_pred             ccCCCCCCCh----HHHhcCcccccCC
Q 018734          242 VANPSRRITI----KEIKSHPWFLKNL  264 (351)
Q Consensus       242 ~~~P~~Rps~----~eil~hp~~~~~~  264 (351)
                      +.+|.+||++    .++++||||....
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            9999999987    6999999997653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-48  Score=363.64  Aligned_cols=255  Identities=35%  Similarity=0.539  Sum_probs=211.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++.++..+|+||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            689999999999999999999999999999999865221    2234668899999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~  155 (351)
                      ||++||+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.......  .
T Consensus       123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~--~ikL~DfG~a~~~~~~~~~~  199 (371)
T cd05622         123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVR  199 (371)
T ss_pred             cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC--CEEEEeCCceeEcCcCCccc
Confidence            999999999988654 589999999999999999999999999999999999998765  49999999987543222  2


Q ss_pred             CCCcccCCCccCcccccCCc---CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh--ccCCCCccCCC
Q 018734          156 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--QYKIPDYVHIS  230 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  230 (351)
                      ....+||+.|+|||++.+..   ..+.++|||||||++|+|++|..||...+....+    ..+...  ...+|....++
T Consensus       200 ~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s  275 (371)
T cd05622         200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY----SKIMNHKNSLTFPDDNDIS  275 (371)
T ss_pred             ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCcccCCCcCCCC
Confidence            23567999999999986543   2355699999999999999999999875543333    233322  23456656789


Q ss_pred             HhHHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 018734          231 QDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  263 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~--Rps~~eil~hp~~~~~  263 (351)
                      ..++++|.+||..+|.+  |+++.++++||||.+.
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            99999999999854443  7899999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.2e-48  Score=361.68  Aligned_cols=256  Identities=27%  Similarity=0.484  Sum_probs=207.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|+.++.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+.+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            468889999999999999999999999999999865432  235678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~  158 (351)
                      +.+++|...    ...++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...... ....
T Consensus       154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~~~  227 (353)
T PLN00034        154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK--NVKIADFGVSRILAQTMDPCNS  227 (353)
T ss_pred             CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEcccccceecccccccccc
Confidence            999988542    3457888999999999999999999999999999999998765  49999999987543222 2244


Q ss_pred             cccCCCccCcccccC----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          159 TVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .+||+.|+|||++..    ..+.+.++|||||||++|+|++|+.||....... +......+. ..........++..+.
T Consensus       228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~  305 (353)
T PLN00034        228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAIC-MSQPPEAPATASREFR  305 (353)
T ss_pred             cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHh-ccCCCCCCCccCHHHH
Confidence            579999999998743    2344456999999999999999999997433222 222222221 1112222346789999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      +||.+||+.+|++|||+.++++||||.+...
T Consensus       306 ~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        306 HFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            9999999999999999999999999988644

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-50  Score=345.92  Aligned_cols=257  Identities=37%  Similarity=0.625  Sum_probs=225.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      |++|..++.||+|.||+|-+|+.+.+++.+|||++++.-...    +.-+.|-++++..+||.+..+..+|++.+++|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            688999999999999999999999999999999988754322    3455688899999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      |||..||.|+-+|.+...|++...+.+...|+.||.|||+++||.||||.+|+|+|.++.  +||+|||+++....... 
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence            999999999999999999999999999999999999999999999999999999988775  99999999986554443 


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....||||.|+|||++....| ++++|+|.+|+++|||+||+.||...+-...+    .-++....++|.  .++++++.
T Consensus       325 ~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLF----eLIl~ed~kFPr--~ls~eAkt  397 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF----ELILMEDLKFPR--TLSPEAKT  397 (516)
T ss_pred             eccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHH----HHHHhhhccCCc--cCCHHHHH
Confidence            456799999999999988887 56699999999999999999999876543333    334445555665  79999999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccCCCh
Q 018734          236 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       236 li~~~L~~~P~~Rp-----s~~eil~hp~~~~~~~~  266 (351)
                      |+..+|.+||.+|.     .+.+|..|+||....+.
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence            99999999999998     58899999999876543

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-48  Score=365.05  Aligned_cols=259  Identities=26%  Similarity=0.400  Sum_probs=211.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC-----EEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT-----HLA   74 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-----~~~   74 (351)
                      +|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            48899999999999999999999999999998865322   2246788999999999999999999998776     899


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +||||+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~--~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC--VLKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC--CEEeccccceeecccCc
Confidence            9999996 58888888888899999999999999999999999999999999999998765  49999999987543222


Q ss_pred             --CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHH-----------------
Q 018734          155 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR-----------------  215 (351)
Q Consensus       155 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-----------------  215 (351)
                        ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+...                 
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence              2234568999999999987654556699999999999999999999876654443332211                 


Q ss_pred             --HHhhccCCC-------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          216 --IMAVQYKIP-------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       216 --~~~~~~~~~-------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                        +.......+       .....++.+.+||.+||+.||.+|||+.++++||||.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence              001111111       1123578899999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.2e-48  Score=348.43  Aligned_cols=254  Identities=27%  Similarity=0.430  Sum_probs=204.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcC---CCCCcceEEEEEEc-----CC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQL---RHPNIIRFKEVVLT-----PT   71 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l---~hp~Iv~~~~~~~~-----~~   71 (351)
                      +|++.+.||+|+||.||++.+..+++.||+|.+.....   ......+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            69999999999999999999999999999998875322   223455677766655   79999999998864     34


Q ss_pred             EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           72 HLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      .++++|||+.+ +|..++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~--~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--QVKLADFGLARI  157 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccCcccc
Confidence            68999999975 888888764  3489999999999999999999999999999999999997665  499999999876


Q ss_pred             cCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc-cCCC----
Q 018734          150 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIP----  224 (351)
Q Consensus       150 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~----  224 (351)
                      ...........||+.|+|||++.+..++. ++|||||||++|+|++|++||........+.++........ ..++    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCC-cchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            54444445567899999999998777654 49999999999999999999987665554444433221000 0000    


Q ss_pred             ----------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          225 ----------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       225 ----------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                                      ....++..+.+||.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                            012467788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.3e-48  Score=348.45  Aligned_cols=249  Identities=28%  Similarity=0.423  Sum_probs=204.6

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus        10 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ||+|+||+||++.+..+++.||+|++......    ...+..|+.+++.++||||+++.+++.....+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999998653221    13466899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCcc
Q 018734           86 FERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTV  160 (351)
Q Consensus        86 ~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~  160 (351)
                      ...+..    ...+++..+..++.||+.||.|||++||+||||||+||+++.++  .++|+|||++....... ......
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG--NVRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCccceecCCCCccccccC
Confidence            877743    35689999999999999999999999999999999999997665  49999999986433222 223457


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHh
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  240 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (351)
                      ||+.|+|||++.+..++ .++|||||||++|+|++|+.||...............+.......  ...++..+.+++.+|
T Consensus       159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~  235 (280)
T cd05608         159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY--PDKFSPASKSFCEAL  235 (280)
T ss_pred             CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCC--cccCCHHHHHHHHHH
Confidence            99999999999887775 459999999999999999999986543322222233332222222  235889999999999


Q ss_pred             cccCCCCCC-----ChHHHhcCcccccC
Q 018734          241 FVANPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       241 L~~~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      |+.+|.+||     +++++++||||...
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            999999999     78999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.1e-48  Score=360.76  Aligned_cols=256  Identities=28%  Similarity=0.427  Sum_probs=206.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC------C
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------T   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~   71 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++...      .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            4799999999999999999999999999999999875432   234677899999999999999999987643      3


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      .+|+||||+.+ +|...+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~  177 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAG  177 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC--cEEEEeCCCccccC
Confidence            57999999965 77776653  478999999999999999999999999999999999998765  49999999998654


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-------------
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------------  218 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------------  218 (351)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........+..++.....             
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            4444455679999999999988777554 99999999999999999999876654444433321100             


Q ss_pred             --hccCCCC---------------------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          219 --VQYKIPD---------------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       219 --~~~~~~~---------------------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                        .....|.                     ....+..+++||.+||+.||.+|||+.++|+||||..
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence              0000000                     0113467899999999999999999999999999954

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-48  Score=356.97  Aligned_cols=258  Identities=29%  Similarity=0.534  Sum_probs=208.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.+...    ....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            589999999999999999999999999999999875221    2234678899999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      ||+.|++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++........ 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG--HIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC--CEEEEECCceeecCCCCCc
Confidence            99999999999976 45799999999999999999999999999999999999997665  499999999865433222 


Q ss_pred             -CCCcccCCCccCcccccC----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC-CccCC
Q 018734          156 -PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVHI  229 (351)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  229 (351)
                       ....+||+.|+|||++..    ....+.++|||||||++|+|++|+.||...........+...  .....++ ....+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~  236 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTDV  236 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCCC
Confidence             123469999999999863    233345699999999999999999999875543333222211  1112222 22347


Q ss_pred             CHhHHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 018734          230 SQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  263 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~--Rps~~eil~hp~~~~~  263 (351)
                      +..++++|.+||+.++.+  |+++.++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            899999999999765544  7899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.5e-48  Score=359.98  Aligned_cols=257  Identities=27%  Similarity=0.422  Sum_probs=206.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC------C
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------T   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~   71 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            4789999999999999999999999999999999875432   234577899999999999999999998654      3


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      ..|+||||+.+ +|...+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~--~~kl~Dfg~~~~~~  170 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAG  170 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC--CEEEeeCcccccCC
Confidence            57999999965 67666643  578999999999999999999999999999999999998765  49999999998654


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-------------
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------------  218 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------------  218 (351)
                      .........||+.|+|||++.+..+..+ +|||||||++|+|++|+.||........+...+.....             
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            4444455689999999999988777554 99999999999999999999876544443333221100             


Q ss_pred             -----hc-----cCCC-------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          219 -----VQ-----YKIP-------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       219 -----~~-----~~~~-------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                           ..     ..++             .....+..+++||.+||+.||.+|||+.++|+||||...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                 00     0000             011235678999999999999999999999999999644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.4e-48  Score=355.39  Aligned_cols=247  Identities=34%  Similarity=0.598  Sum_probs=207.9

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++.+..    .....+.+|..+++.+ +||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987542    1223456788888777 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  161 (351)
                      ++|...+.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence            999999988889999999999999999999999999999999999999987664  999999998743222 22334579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|+.||........    ...+.......|  ..++..+.+||.+||
T Consensus       159 ~~~y~aPE~~~~~~~~~-~~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (318)
T cd05570         159 TPDYIAPEILSYQPYGP-AVDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSILEDEVRYP--RWLSKEAKSILKSFL  231 (318)
T ss_pred             CccccCHHHhcCCCCCc-chhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCCCC--CcCCHHHHHHHHHHc
Confidence            99999999998877754 49999999999999999999976553322    223333333333  357899999999999


Q ss_pred             ccCCCCCCCh-----HHHhcCcccccC
Q 018734          242 VANPSRRITI-----KEIKSHPWFLKN  263 (351)
Q Consensus       242 ~~~P~~Rps~-----~eil~hp~~~~~  263 (351)
                      +.||.+||++     .+++.||||...
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999     999999999764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.5e-48  Score=354.29  Aligned_cols=247  Identities=35%  Similarity=0.609  Sum_probs=203.5

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhc-CCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQ-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~-l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++.....    .......|..++.. .+||||+++++++.....+|+||||+.|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999875321    12334456666554 4899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  161 (351)
                      ++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++..... ......+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG--HIKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC--CEEEccCcCCeECCCCCCccccccC
Confidence            99999998888999999999999999999999999999999999999997665  4999999998753322 23344579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|+.||........+    ..+......+|  ..++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~ll~~~l  231 (316)
T cd05592         159 TPDYIAPEILKGQKYNE-SVDWWSFGVLLYEMLIGQSPFHGEDEDELF----DSILNDRPHFP--RWISKEAKDCLSKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCC-cccchhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHc
Confidence            99999999998877654 499999999999999999999876543222    22222222223  357889999999999


Q ss_pred             ccCCCCCCChH-HHhcCcccccC
Q 018734          242 VANPSRRITIK-EIKSHPWFLKN  263 (351)
Q Consensus       242 ~~~P~~Rps~~-eil~hp~~~~~  263 (351)
                      +.+|.+||++. +++.||||...
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCCC
Confidence            99999999874 88899999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.8e-48  Score=354.05  Aligned_cols=248  Identities=33%  Similarity=0.561  Sum_probs=205.5

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhc-CCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQ-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~-l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++....    ........|..+++. ++||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999987642    222345567777765 5899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  161 (351)
                      |+|...+.....+++..+..++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++..... ......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG--HIKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC--CEEEccCCcceECCCCCCceeeecC
Confidence            99999998888899999999999999999999999999999999999998766  4999999998743222 22344579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|..||........    ...+.......|  ..++..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (316)
T cd05619         159 TPDYIAPEILLGQKYNT-SVDWWSFGVLLYEMLIGQSPFHGHDEEEL----FQSIRMDNPCYP--RWLTREAKDILVKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCc-hhhhhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCC--ccCCHHHHHHHHHHh
Confidence            99999999998777654 49999999999999999999987553322    222222222233  247889999999999


Q ss_pred             ccCCCCCCChH-HHhcCcccccCC
Q 018734          242 VANPSRRITIK-EIKSHPWFLKNL  264 (351)
Q Consensus       242 ~~~P~~Rps~~-eil~hp~~~~~~  264 (351)
                      +.+|.+||++. +++.||||....
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCCC
Confidence            99999999996 899999997754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-48  Score=345.27  Aligned_cols=254  Identities=35%  Similarity=0.590  Sum_probs=209.8

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCH---HHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      |++++.||+|+||+||++++..+++.||+|++........   ...+|+.++++++||||+++++++......++||+++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            8999999999999999999999999999999987654333   2345999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc-CCCCCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLHSRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~-~~~~~~~~~  159 (351)
                      .+++|..++...+.+++..+..++.||+.||.+||++|++|+||||+||+++.++.  ++|+|||++... .........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence            99999999998888999999999999999999999999999999999999986654  999999998742 223334556


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc--CCCCccCCCHhHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRNLL  237 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li  237 (351)
                      .+|+.|+|||++......+.++||||||+++|+|++|..||........ ............  ........+..+.++|
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccchhh-hhhhhhcccccccccccccchhHHHHHHHH
Confidence            7999999999997333345569999999999999999999987632222 222222222111  1111112347999999


Q ss_pred             HHhcccCCCCCCChHHHhcCccc
Q 018734          238 SRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+||+.+|++|||+.++++||||
T Consensus       238 ~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-49  Score=340.58  Aligned_cols=259  Identities=30%  Similarity=0.525  Sum_probs=221.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      +.||+|+||.|--|....++..||||++.+... ...++.+|++++.++ .|+||++++++|+++.++|+|||.|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            679999999999999999999999999987533 346789999999998 599999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCCCEEEeccCCCcccCCC--------CCC
Q 018734           86 FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLLH--------SRP  156 (351)
Q Consensus        86 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~-~~~~~~vkL~DFg~a~~~~~~--------~~~  156 (351)
                      ..+|++...|+|.++..++.+|+.||.|||.+||.||||||+|||-. .+...-||||||.+.......        ...
T Consensus       164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L  243 (463)
T KOG0607|consen  164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL  243 (463)
T ss_pred             HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence            99999999999999999999999999999999999999999999974 333445899999987532111        122


Q ss_pred             CCcccCCCccCcccc----cCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh-----------HHHHHHHHHHhhcc
Q 018734          157 KSTVGTPAYIAPEVL----SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----------NFRKTISRIMAVQY  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~----~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----------~~~~~~~~~~~~~~  221 (351)
                      .+.+|+..|||||+.    ....++.+.+|.||||+|+|.|++|.+||.+....+           ...+....+....|
T Consensus       244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY  323 (463)
T KOG0607|consen  244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY  323 (463)
T ss_pred             cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCC
Confidence            345799999999986    234455677999999999999999999998765321           33456667777777


Q ss_pred             CCCC--ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          222 KIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       222 ~~~~--~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      .+|+  |..+|.++++|++.+|..+|.+|.++.++++|||++...+.
T Consensus       324 eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  324 EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            7774  78899999999999999999999999999999999876543

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-48  Score=360.31  Aligned_cols=257  Identities=24%  Similarity=0.424  Sum_probs=206.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC------CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~   72 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            689999999999999999999999999999999875432   224567899999999999999999988543      45


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +|++++++ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++... 
T Consensus        95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~-  169 (343)
T cd07878          95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQAD-  169 (343)
T ss_pred             EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecC-
Confidence            78999998 778877664 457999999999999999999999999999999999999987664  9999999987543 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh-------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------  219 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------  219 (351)
                       ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.......             
T Consensus       170 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07878         170 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHA  248 (343)
T ss_pred             -CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhH
Confidence             233456799999999999775545566999999999999999999998755433332222110000             


Q ss_pred             ---ccCCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          220 ---QYKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       220 ---~~~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                         ....+         .+...++.+.+||.+||+.||.+|||+.++|.||||.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         249 RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence               00000         0123566789999999999999999999999999997653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.1e-48  Score=355.06  Aligned_cols=252  Identities=29%  Similarity=0.488  Sum_probs=207.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++......    ...+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999764321    23466788888777 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  161 (351)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence            999999988888999999999999999999999999999999999999987664  99999999875322 223344679


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh---hHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      |+.|+|||++.+..++ .++|||||||++|+|++|+.||......   .........+......+|  ..++..+.++|.
T Consensus       159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~  235 (327)
T cd05617         159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVKASHVLK  235 (327)
T ss_pred             CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC--CCCCHHHHHHHH
Confidence            9999999999887775 4599999999999999999999643221   111122233333333344  357899999999


Q ss_pred             HhcccCCCCCCC------hHHHhcCcccccCC
Q 018734          239 RIFVANPSRRIT------IKEIKSHPWFLKNL  264 (351)
Q Consensus       239 ~~L~~~P~~Rps------~~eil~hp~~~~~~  264 (351)
                      +||+.||.+|++      +.++++||||....
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            999999999998      56999999997653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-48  Score=356.93  Aligned_cols=249  Identities=33%  Similarity=0.590  Sum_probs=208.7

Q ss_pred             eeeecccCceEEEEEEE---cCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            7 MKDIGSGNFGVARLMRN---KNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++.||+|+||.||++++   ..+++.||+|++.....   ......+|+.++++++||||+++++++..++.+|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999886   35789999999875332   2234667999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  159 (351)
                      .+++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ......
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence            99999999988888999999999999999999999999999999999999987664  999999998754333 223345


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      +||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......+|  ..+++.+.+||.+
T Consensus       159 ~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~li~~  231 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKET----MTMILKAKLGMP--QFLSPEAQSLLRA  231 (318)
T ss_pred             cCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHHHHH
Confidence            799999999999877765 459999999999999999999987554322    223333333333  3578999999999


Q ss_pred             hcccCCCCCCC-----hHHHhcCcccccCC
Q 018734          240 IFVANPSRRIT-----IKEIKSHPWFLKNL  264 (351)
Q Consensus       240 ~L~~~P~~Rps-----~~eil~hp~~~~~~  264 (351)
                      ||+.||.+||+     +.+++.||||....
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            99999999999     77799999998653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.5e-47  Score=351.86  Aligned_cols=253  Identities=30%  Similarity=0.540  Sum_probs=211.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.+...    ....+..|..+++.+. ||+|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            47899999999999999999999999999999875321    1234667888888775 577889999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~  156 (351)
                      ||++|++|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~--~ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG--HIKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEeccccccccCCCCccc
Confidence            9999999999998888999999999999999999999999999999999999998766  49999999987533222 23


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+.......|  ..++..+.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~----~~~~i~~~~~~~p--~~~~~~~~~l  231 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQSIMEHNVSYP--KSLSKEAVSI  231 (323)
T ss_pred             cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCC--ccCCHHHHHH
Confidence            345699999999999877765 45999999999999999999998765432    2333333343344  3578999999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 018734          237 LSRIFVANPSRRIT-----IKEIKSHPWFLKNL  264 (351)
Q Consensus       237 i~~~L~~~P~~Rps-----~~eil~hp~~~~~~  264 (351)
                      +.+||+.+|.+|++     ..++++||||....
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            99999999999997     47899999998653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-49  Score=352.87  Aligned_cols=261  Identities=27%  Similarity=0.442  Sum_probs=228.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++.|+.-+.||+|+||.||.++.+.||+.+|+|++.+...    ...-.++|-+++.+++.|.||.+-..|.+.+.+|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            3568888999999999999999999999999998865322    234577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           77 MEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +..|.||+|..+|-+.+  .|++..++.++.+|+.||++||+.+||.|||||+|||+|+.+.  ++|+|+|+|.......
T Consensus       264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~  341 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGK  341 (591)
T ss_pred             EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCC
Confidence            99999999988887655  6999999999999999999999999999999999999987765  9999999999877777


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||.+|||||++.+..|+.. .|+|||||++|||+.|+.||..........++-.++.......++  .+|++++
T Consensus       342 ~~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eak  418 (591)
T KOG0986|consen  342 PIRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAK  418 (591)
T ss_pred             ccccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHH
Confidence            7778899999999999999887655 899999999999999999998766544444555556666666664  7999999


Q ss_pred             HHHHHhcccCCCCCC-----ChHHHhcCcccccCCCh
Q 018734          235 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       235 ~li~~~L~~~P~~Rp-----s~~eil~hp~~~~~~~~  266 (351)
                      +|...+|++||.+|.     .++++.+||||...-.+
T Consensus       419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             HHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence            999999999999998     57899999999875443

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.9e-48  Score=356.45  Aligned_cols=257  Identities=29%  Similarity=0.528  Sum_probs=209.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.++..++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            58999999999999999999999999999999986422    12234677888999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      ||+.+|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~--~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC--CEEEeecchheecccCCcc
Confidence            99999999999977 46799999999999999999999999999999999999997665  499999999875332221 


Q ss_pred             -CCCcccCCCccCcccccC----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc--cCCCC-cc
Q 018734          156 -PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD-YV  227 (351)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~-~~  227 (351)
                       ....+||+.|+|||++..    ....+.++|||||||++|+|++|+.||........+..    +....  ..+|. ..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~----i~~~~~~~~~p~~~~  234 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK----IMNHKERFQFPAQVT  234 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH----HhCCCccccCCCccc
Confidence             223579999999999863    22334569999999999999999999987654333332    22222  12222 23


Q ss_pred             CCCHhHHHHHHHhcccCCCC--CCChHHHhcCcccccCC
Q 018734          228 HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKNL  264 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~--Rps~~eil~hp~~~~~~  264 (351)
                      .++..+.+||.+||+.+|.+  |+++.++++||||....
T Consensus       235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            57899999999999775555  68999999999997643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.7e-48  Score=355.00  Aligned_cols=249  Identities=30%  Similarity=0.498  Sum_probs=205.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHH-HHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~-~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++.....    ....+..|.. +++.++||||+++++.+...+.+|+||||+.|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            469999999999999999999999999865321    1233445544 46789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  161 (351)
                      ++|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~--~~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG--HVVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEeecCCcccCCCCCCCcccccC
Confidence            99999998888999999999999999999999999999999999999998766  499999999875322 222345579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|+.||........+    ..+.......  ....+..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DvwslG~il~el~~G~~pf~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~~ll~~ll  231 (325)
T cd05604         159 TPEYLAPEVIRKQPYDN-TVDWWCLGAVLYEMLYGLPPFYCRDVAEMY----DNILHKPLVL--RPGASLTAWSILEELL  231 (325)
T ss_pred             ChhhCCHHHHcCCCCCC-cCccccccceehhhhcCCCCCCCCCHHHHH----HHHHcCCccC--CCCCCHHHHHHHHHHh
Confidence            99999999998877754 499999999999999999999876543322    2233322222  2357899999999999


Q ss_pred             ccCCCCCCCh----HHHhcCcccccCCC
Q 018734          242 VANPSRRITI----KEIKSHPWFLKNLP  265 (351)
Q Consensus       242 ~~~P~~Rps~----~eil~hp~~~~~~~  265 (351)
                      +.+|.+||++    .++++||||.....
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~  259 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFESLSW  259 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence            9999999977    58999999976543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=367.70  Aligned_cols=254  Identities=28%  Similarity=0.430  Sum_probs=214.1

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEecc-CcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      |.|+..||.|+||.||+|..+.++-..|.|++.. +....+.++-||.+|..+.||+||++++.|..++.+||+.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            6788899999999999999999998889999865 334456788999999999999999999999999999999999999


Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc-CCCCCCCCcc
Q 018734           83 GELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLHSRPKSTV  160 (351)
Q Consensus        83 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~-~~~~~~~~~~  160 (351)
                      |.+...+-. ...+++.+|+.+.+|++.||.|||+++|||||||..|||+.-+|.  |+|+|||.+... .......+++
T Consensus       114 GAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDsFI  191 (1187)
T KOG0579|consen  114 GAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDSFI  191 (1187)
T ss_pred             chHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhcccc
Confidence            999877655 456999999999999999999999999999999999999987776  999999987532 2223446788


Q ss_pred             cCCCccCccccc-----CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          161 GTPAYIAPEVLS-----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       161 gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      |||+|||||+..     ..+|+. ++||||||++|.||..+.+|....+....+.++.   ...+-.+-.+.+++..+.|
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDy-kaDiWSlGITLIEMAqiEPPHhelnpMRVllKia---KSePPTLlqPS~Ws~~F~D  267 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLLQPSHWSRSFSD  267 (1187)
T ss_pred             CCcccccchheeeccccCCCchh-hhhHHhhhhHHHHHhccCCCccccchHHHHHHHh---hcCCCcccCcchhhhHHHH
Confidence            999999999863     445554 4899999999999999999988766544333322   1222234445679999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ++++||.+||..||++.++|+||||...
T Consensus       268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  268 FLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            9999999999999999999999999754

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-48  Score=357.30  Aligned_cols=248  Identities=33%  Similarity=0.542  Sum_probs=204.1

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcC---CCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQL---RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus        10 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l---~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      ||+|+||.||++.+..+++.||+|++.+....    ......|..++..+   .||||+++++++.....+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999998653211    12334455555544   699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~g  161 (351)
                      ++|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++...... ......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG--HIALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEecCCcCcCCCCCCCCccCccC
Confidence            99999999888999999999999999999999999999999999999998765  4999999998753322 22345679


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+....+.++|||||||++|+|++|+.||......    .....+......++.. .+++.+.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L  233 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMYRNIAFGKVRFPKN-VLSDEGRQFVKGLL  233 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----HHHHHHHcCCCCCCCc-cCCHHHHHHHHHHc
Confidence            999999999976554456699999999999999999999775432    2233333334444432 47899999999999


Q ss_pred             ccCCCCCC----ChHHHhcCcccccCC
Q 018734          242 VANPSRRI----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       242 ~~~P~~Rp----s~~eil~hp~~~~~~  264 (351)
                      +.+|.+||    ++.++++||||....
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            99999998    689999999997654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.5e-47  Score=346.01  Aligned_cols=260  Identities=27%  Similarity=0.466  Sum_probs=211.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +++|++.+.||.|+||.||++.+..+++.||+|.+.....  ....+.+|+.+++.++||||+++++++..+..+++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            5789999999999999999999999999999998865332  23467789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-C
Q 018734           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~  156 (351)
                      |+. ++|...+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.  ++|+|||++........ .
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCcc
Confidence            997 5888887653 56899999999999999999999999999999999999987654  99999999875433222 2


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hcc
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQY  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (351)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|++||......+....+......               ...
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            33468999999999876655556699999999999999999999876543333222211100               000


Q ss_pred             CCCC---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          222 KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       222 ~~~~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..+.         ...+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            1111         12467889999999999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1e-47  Score=353.30  Aligned_cols=247  Identities=32%  Similarity=0.556  Sum_probs=204.1

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHH-HHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREI-INHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~-~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++.....    ....+..|. .+++.++||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            479999999999999999999999999875321    122344444 346788999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  161 (351)
                      ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCCcccccC
Confidence            99999998888899999999999999999999999999999999999997665  499999999875322 222345679


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|..||........+.    .+......  ....++..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~----~i~~~~~~--~~~~~~~~~~~li~~~l  231 (325)
T cd05602         159 TPEYLAPEVLHKQPYDR-TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQ--LKPNITNSARHLLEGLL  231 (325)
T ss_pred             CccccCHHHHcCCCCCC-ccccccccHHHHHHhcCCCCCCCCCHHHHHH----HHHhCCcC--CCCCCCHHHHHHHHHHc
Confidence            99999999998877654 4999999999999999999998755433322    22222222  23368999999999999


Q ss_pred             ccCCCCCCChH----HHhcCcccccC
Q 018734          242 VANPSRRITIK----EIKSHPWFLKN  263 (351)
Q Consensus       242 ~~~P~~Rps~~----eil~hp~~~~~  263 (351)
                      +.+|.+||++.    ++++|+||...
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccCCC
Confidence            99999999876    89999999654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-49  Score=360.91  Aligned_cols=254  Identities=29%  Similarity=0.452  Sum_probs=213.0

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .|.-++.||.|+||.||-|++..+.+.||||++.-+.+..    ..+++|+..+++++|||+|.+.+||..+...|+|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3566788999999999999999999999999998655433    468899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||-| +-.+++. ..+++.+.+|..|..+.+.||.|||+++.||||||..|||+...+.  |||+|||.|...   .+.+
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~---~PAn  180 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIM---APAN  180 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhc---Cchh
Confidence            9965 6666664 4567999999999999999999999999999999999999987765  999999987643   4567


Q ss_pred             CcccCCCccCccccc---CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          158 STVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      +++|||+|||||++.   .+.|+++ +|||||||++.||.-.++|+...+.    ...+..+....-..-....+|..++
T Consensus       181 sFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNA----MSALYHIAQNesPtLqs~eWS~~F~  255 (948)
T KOG0577|consen  181 SFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPTLQSNEWSDYFR  255 (948)
T ss_pred             cccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchH----HHHHHHHHhcCCCCCCCchhHHHHH
Confidence            899999999999985   3567777 9999999999999999999876543    2223333322222112346899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      .|+..||++-|..|||.+++|.|+|.....+..
T Consensus       256 ~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~t  288 (948)
T KOG0577|consen  256 NFVDSCLQKIPQERPTSEELLKHRFVLRERPPT  288 (948)
T ss_pred             HHHHHHHhhCcccCCcHHHHhhcchhccCCCch
Confidence            999999999999999999999999998776654

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=385.84  Aligned_cols=260  Identities=32%  Similarity=0.512  Sum_probs=222.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||.|.+++.+.|++.||+|++++-.    ...+-+..|-.+|..-+.+=|++++..|.++.++|+||
T Consensus        75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM  154 (1317)
T KOG0612|consen   75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM  154 (1317)
T ss_pred             HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence            57999999999999999999999999999999987722    22344667778888888999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--  155 (351)
                      ||++||+|..++.+..++|+..++.|+..|+.||..||+.|+|||||||+|||||..|  ++||+|||.+-.....+.  
T Consensus       155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G--HikLADFGsClkm~~dG~V~  232 (1317)
T KOG0612|consen  155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG--HIKLADFGSCLKMDADGTVR  232 (1317)
T ss_pred             ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC--cEeeccchhHHhcCCCCcEE
Confidence            9999999999999999999999999999999999999999999999999999998766  599999998765543332  


Q ss_pred             CCCcccCCCccCcccccCC----cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh--ccCCCCccCC
Q 018734          156 PKSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--QYKIPDYVHI  229 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  229 (351)
                      ....+|||.|.+||++...    +.+++.+|+||+||++|||++|..||...+    +..+..+|+..  .+.+|+...+
T Consensus       233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHHHHHhchhhhcCCCccccc
Confidence            3456899999999998532    445667999999999999999999998744    45555555544  5567766789


Q ss_pred             CHhHHHHHHHhcccCCCCCCC---hHHHhcCcccccCCChhh
Q 018734          230 SQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKNLPREL  268 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps---~~eil~hp~~~~~~~~~~  268 (351)
                      |.++++||.++|+ +|..|..   ++++..||||.+..+..+
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~i  349 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNI  349 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhh
Confidence            9999999999886 7888887   999999999988766443

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.5e-47  Score=343.44  Aligned_cols=256  Identities=25%  Similarity=0.422  Sum_probs=209.4

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .|++.+.||+|+||.||++.+..+++.||+|.+......    ...+.+|+.+++.++|+||+.+++.+.+...+++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            488899999999999999999999999999988654221    2346689999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           79 YAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |+.|++|...+...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++  .++|+|||++.........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC--CEEEeeccceeecCCCccc
Confidence            99999998888643  3589999999999999999999999999999999999998765  4999999998754433333


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......... ....... .........+++.+.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVK-EVQEEYSEKFSPDARSL  235 (285)
T ss_pred             cCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhh-hhhhhcCccCCHHHHHH
Confidence            445799999999999877765 45999999999999999999998654321111 1111111 01111223578899999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRIT-----IKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps-----~~eil~hp~~~~~  263 (351)
                      +.+||+.+|.+|||     +.++++||||.+.
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            99999999999999     8999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.4e-47  Score=342.05  Aligned_cols=250  Identities=24%  Similarity=0.400  Sum_probs=204.4

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus        10 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ||+|+||.||++.+..+++.||+|.+.....    ....+..|+.+++.++||||+++++++.....+|+||||+.|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999864321    123455799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCC
Q 018734           86 FERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP  163 (351)
Q Consensus        86 ~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~  163 (351)
                      ...+...+  .+++..+..++.|++.||.|||+.||+||||||+||+++.++  .++|+|||++.............||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG--NCRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC--CEEEeeceeeeecCCCceeeccCCCC
Confidence            88876543  488999999999999999999999999999999999998765  49999999987544333334457999


Q ss_pred             CccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhccc
Q 018734          164 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA  243 (351)
Q Consensus       164 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  243 (351)
                      .|+|||++.+..++ .++|||||||++|+|++|+.||.......................+ ...+++++.+||.+||+.
T Consensus       159 ~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         159 GYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhcc
Confidence            99999999887765 4599999999999999999999765432222233333332222222 235789999999999999


Q ss_pred             CCCCCCCh----HHHhcCcccccC
Q 018734          244 NPSRRITI----KEIKSHPWFLKN  263 (351)
Q Consensus       244 ~P~~Rps~----~eil~hp~~~~~  263 (351)
                      ||.+||++    .+++.||||...
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    678899999753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.6e-47  Score=351.39  Aligned_cols=248  Identities=31%  Similarity=0.515  Sum_probs=204.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHH-HHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~-~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..+++.||+|++.+...    ....+..|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            479999999999999999999999999875321    1233445543 57889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~g  161 (351)
                      ++|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG--HVVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC--CEEEccCCCCccCCCCCCccccccC
Confidence            99999998888899999999999999999999999999999999999998766  499999999875322 222344579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+...    ....+......+|  ...+..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNILHKPLQLP--GGKTVAACDLLVGLL  231 (321)
T ss_pred             CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHH----HHHHHhcCCCCCC--CCCCHHHHHHHHHHc
Confidence            999999999987776544 999999999999999999998754322    2233333333333  357889999999999


Q ss_pred             ccCCCCCCCh----HHHhcCcccccCC
Q 018734          242 VANPSRRITI----KEIKSHPWFLKNL  264 (351)
Q Consensus       242 ~~~P~~Rps~----~eil~hp~~~~~~  264 (351)
                      +.+|.+||++    .++++||||....
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            9999999976    4999999997543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-47  Score=354.08  Aligned_cols=252  Identities=25%  Similarity=0.427  Sum_probs=199.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .+|++++.||+|+||.||++.+..+++.||+|+....     ....|+.++++++||||+++++++......++||+++.
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            3699999999999999999999999999999975432     33568999999999999999999999999999999995


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcc
Q 018734           82 GGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV  160 (351)
Q Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~  160 (351)
                       ++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++..+.  +||+|||+++............
T Consensus       141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~  217 (357)
T PHA03209        141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLA  217 (357)
T ss_pred             -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCccccccc
Confidence             588887765 457999999999999999999999999999999999999976654  9999999987544444444567


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCC-CCCCCh---------hHHHHHHHHHHhhccCCC------
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF-EDQEDP---------KNFRKTISRIMAVQYKIP------  224 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~---------~~~~~~~~~~~~~~~~~~------  224 (351)
                      ||+.|+|||++.+..++.+ +|||||||++|+|+++..|+ ......         ..+...+.........++      
T Consensus       218 gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  296 (357)
T PHA03209        218 GTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR  296 (357)
T ss_pred             ccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence            9999999999988777544 99999999999999865544 332111         011111111100000011      


Q ss_pred             ----------------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          225 ----------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       225 ----------------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                                            ....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                  01135667888999999999999999999999999975

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.5e-47  Score=340.55  Aligned_cols=256  Identities=24%  Similarity=0.414  Sum_probs=212.9

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .|+..+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++|+||+.+.+.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            48889999999999999999999999999999865422    12346789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           79 YAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |+.+++|...+...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCCcc
Confidence            99999998887643  3699999999999999999999999999999999999997665  4999999998754333333


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....|++.|+|||++.+..++. ++|+|||||++|+|++|..||...............+.......  ...++..+.+|
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  235 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTL-SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSEEAKSI  235 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc--CccCCHHHHHH
Confidence            4567999999999998777654 48999999999999999999987554333333333332222222  23578899999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRIT-----IKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps-----~~eil~hp~~~~~  263 (351)
                      +.+||+.+|.+||+     +.+++.||||...
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            99999999999999     8899999999765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-46  Score=334.70  Aligned_cols=252  Identities=32%  Similarity=0.467  Sum_probs=211.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +.|++.+.||.|++|.||.+.+..+++.||+|++.....      ....+.+|+.++++++||||+++++++.....+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            579999999999999999999999999999998865322      12357789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ++||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++  +++|+|||+++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~--~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccceecccccc
Confidence            999999999999998888899999999999999999999999999999999999998665  499999999875332211


Q ss_pred             C----CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          156 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       156 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      .    ....|++.|+|||++.+..++ .++|||||||++|+|++|+.||...........    ........+....++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  234 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSP  234 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCH
Confidence            1    235688999999999877754 559999999999999999999976544332222    2222222233346789


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+.++|.+||..+|.+|||+.++++||||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.6e-47  Score=351.45  Aligned_cols=256  Identities=28%  Similarity=0.501  Sum_probs=208.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+...    ....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            689999999999999999999999999999999865321    2234667889999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      ||+.||+|..++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||++........ 
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG--HIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC--CEEEEeccceeeccCCCce
Confidence            99999999999987 46799999999999999999999999999999999999997665  499999999875432222 


Q ss_pred             -CCCcccCCCccCcccccCC----cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc--cCCCC-cc
Q 018734          156 -PKSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD-YV  227 (351)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~-~~  227 (351)
                       ....+||+.|+|||++.+.    ...+.++|||||||++|+|++|+.||........+.    .+....  ..+|. ..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~~~p~~~~  234 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG----KIMNHEERFQFPSHIT  234 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH----HHHcCCCcccCCCccc
Confidence             1235699999999998652    223455999999999999999999998755433322    222222  22222 23


Q ss_pred             CCCHhHHHHHHHhcccCCCC--CCChHHHhcCcccccC
Q 018734          228 HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKN  263 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~--Rps~~eil~hp~~~~~  263 (351)
                      .++..+.++|.+||+..+.+  |++++++++||||...
T Consensus       235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            47899999999999976655  5689999999999754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-46  Score=363.35  Aligned_cols=252  Identities=28%  Similarity=0.425  Sum_probs=209.6

Q ss_pred             CeeEeeeecccCceEEEEEEEcCC-CcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNT-KELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .|.+.+.||+|+||.||+|.+..+ ++.||+|++..... ....+.+|+.+++.++|||||++++++...+.+|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            499999999999999999998877 78899997654332 2245678999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--
Q 018734           81 AGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  154 (351)
Q Consensus        81 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--  154 (351)
                      .||+|.+.+..    ..++++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......  
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~--~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG--IIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC--cEEEEeCcCceecCCcccc
Confidence            99999887753    45689999999999999999999999999999999999998765  49999999997543222  


Q ss_pred             -CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          155 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                       .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    .+..+...... +.+..++..+
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~----~~~~~~~~~~~-~~~~~~s~~~  299 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQRE----IMQQVLYGKYD-PFPCPVSSGM  299 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCC-CCCccCCHHH
Confidence             23445799999999999877765 45999999999999999999997654322    22333322222 3334688999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      .++|.+||+.+|++||++.+++.|||+..
T Consensus       300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        300 KALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            99999999999999999999999999854

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.7e-47  Score=378.05  Aligned_cols=258  Identities=28%  Similarity=0.468  Sum_probs=211.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~~l   75 (351)
                      +++|++++.||.|+||.||++.+..++..||+|++.....   ....+..|+.+++.|+|||||+++++|..  ...+||
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            4789999999999999999999999999999999875322   23467889999999999999999999854  367999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeecCCCCCcEEecCC----------
Q 018734           76 VMEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSM-------QICHRDLKLENTLLDGS----------  134 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-------~iiH~Dikp~NIll~~~----------  134 (351)
                      ||||+.+++|..+|..    .+.+++..++.|+.||+.||.|||+.       +||||||||+||||+..          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999999999998865    35799999999999999999999984       49999999999999642          


Q ss_pred             -----CCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCC-cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhH
Q 018734          135 -----PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN  208 (351)
Q Consensus       135 -----~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  208 (351)
                           +.+.+||+|||++............+||+.|+|||++.+. ...+.++||||||||+|+|++|..||........
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~q  251 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ  251 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHH
Confidence                 2335899999999865444444556799999999998643 2234559999999999999999999987654433


Q ss_pred             HHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          209 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +...+.   . ...++ ....+.++.+||.+||+.+|.+||++.++|.||||...
T Consensus       252 li~~lk---~-~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        252 LISELK---R-GPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             HHHHHh---c-CCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            322221   1 11122 23468899999999999999999999999999999744

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.1e-46  Score=345.16  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=193.0

Q ss_pred             eeeecccCceEEEEEEEc--CCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEEEEEEeccCC
Q 018734            7 MKDIGSGNFGVARLMRNK--NTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVMEYAAG   82 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~~lv~e~~~~   82 (351)
                      .++||+|+||.||+|.+.  .+++.||+|.+.... ....+.+|+.++++++||||+++++++..  +..+|++|||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            568999999999999965  467899999886543 33567899999999999999999999854  467899999995 


Q ss_pred             CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCCEEEeccCCCcccC
Q 018734           83 GELFERICNA---------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKICDFGYSKSSL  151 (351)
Q Consensus        83 ~~L~~~l~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~--~~~~vkL~DFg~a~~~~  151 (351)
                      ++|..++...         ..+++..++.++.||+.||.|||++||+||||||+|||+...  ..+++||+|||+++...
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            5887776532         258999999999999999999999999999999999999432  23469999999997543


Q ss_pred             CCC----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh---------hHHHHHHHHHH-
Q 018734          152 LHS----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTISRIM-  217 (351)
Q Consensus       152 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~~~~~~~~-  217 (351)
                      ...    .....+||+.|+|||++.+....+.++|||||||++|+|++|++||......         ..+..+..... 
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF  243 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence            221    2234578999999999987655566699999999999999999999754321         11111111000 


Q ss_pred             ----------h-------------hccCC--------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          218 ----------A-------------VQYKI--------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       218 ----------~-------------~~~~~--------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                                .             .....        ......+..+.+||.+||++||.+|||++|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                      0             00000        0001234578999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.7e-46  Score=337.15  Aligned_cols=257  Identities=30%  Similarity=0.483  Sum_probs=211.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            589999999999999999999999999999998865322   23457789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~  157 (351)
                      |+++++|..++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++  .++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCccccc
Confidence            999988887777777899999999999999999999999999999999999998665  49999999987543332 223


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh---------------ccC
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QYK  222 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  222 (351)
                      ...++..|+|||.+.+....+.++|||||||++|+|++|+.||......+....+.......               ...
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            45688999999998765544556999999999999999999998766544333322211100               000


Q ss_pred             CCC----------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          223 IPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       223 ~~~----------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .|.          ...++..+.+|+.+||+.+|++||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            111          12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.3e-47  Score=347.49  Aligned_cols=287  Identities=26%  Similarity=0.384  Sum_probs=213.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEecc-Cc--ccCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GH--KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~--~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ..|+++++||.||.+.||++.....+ .||+|++.. ..  .....+.+|+..|.+|+ |.+||+++++-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            36999999999999999999988754 566655443 22  22356889999999995 899999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           78 EYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      ||- ..+|..+|++... ++...++.+..|++.|+.++|.+||||.||||+|+|+-   .|++||+|||+|........ 
T Consensus       440 E~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             ecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE---eeeEEeeeechhcccCccccc
Confidence            986 4689999988765 44468999999999999999999999999999999984   34699999999986544332 


Q ss_pred             --CCCcccCCCccCcccccCCcCC----------CcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-
Q 018734          156 --PKSTVGTPAYIAPEVLSRREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-  222 (351)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  222 (351)
                        ..+.+||+.||+||.+....+.          ++++||||||||||+|+.|++||....   +...-+..+...... 
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~P~~~I  592 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITDPNHEI  592 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcCCCccc
Confidence              2456899999999998554432          456999999999999999999997532   223334445544443 


Q ss_pred             -CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc-CCChhhHHHHHHhhhh-ccCCCCCCCCHHHHHHHHH
Q 018734          223 -IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTETAQAIYYR-KENPTFSLQSVEEITKIVE  297 (351)
Q Consensus       223 -~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  297 (351)
                       +|.... ..++.++++.||++||.+||++.++|+|||++- .++-...........+ .+.+.....+...+.+.+.
T Consensus       593 efp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~~~m~~~~~~~~k~~e~~~v~~d~~n~i~~ql~  669 (677)
T KOG0596|consen  593 EFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPVEQMAKLTTNEMKYVEGQLVDLDSPNSILKQLK  669 (677)
T ss_pred             cccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccchHHHHHHHHHHHhcccCCCCcccHHHHHHHHH
Confidence             333221 123899999999999999999999999999977 3332222222111111 1444555555555555443

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-46  Score=354.24  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=205.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEc--CCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK--NTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      .+|++++.||.|+||.||++...  .+++.||+|.+...    ....+|+.+++.++|||||++++++.....+|++|++
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            36999999999999999999754  45678999987653    2356899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC---C
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---P  156 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---~  156 (351)
                      +. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .++|+|||++........   .
T Consensus       168 ~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~--~~~l~DfG~a~~~~~~~~~~~~  244 (392)
T PHA03207        168 YK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE--NAVLGDFGAACKLDAHPDTPQC  244 (392)
T ss_pred             cC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEccCccccccCcccccccc
Confidence            95 68989887778899999999999999999999999999999999999998665  499999999875433222   2


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh---hHHHHHHHHHHhhc-------------
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQ-------------  220 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~-------------  220 (351)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......   ..+..++..+....             
T Consensus       245 ~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        245 YGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             cccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence            24579999999999988777544 99999999999999999999765432   12222221111000             


Q ss_pred             ------------cCCCCc---cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          221 ------------YKIPDY---VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       221 ------------~~~~~~---~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                                  +..|..   ..++.++.++|.+||+.+|.+|||+.++|.||||.+.-
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                        001110   13466889999999999999999999999999997653

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.2e-46  Score=337.67  Aligned_cols=255  Identities=27%  Similarity=0.476  Sum_probs=206.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|++.+.||.|++|.||++.+..++..||+|++.....   ....+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            58999999999999999999999999999999865322   235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-C
Q 018734           80 AAGGELFERICNA---GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R  155 (351)
Q Consensus        80 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~  155 (351)
                      +. ++|.+++...   ..+++..++.++.||+.||.|||++|++||||||+||+++.++.  ++|+|||++....... .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence            97 5888887543   46899999999999999999999999999999999999987664  9999999987543222 1


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh--------------hcc
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------------VQY  221 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~  221 (351)
                      .....+++.|+|||++.+....+.++|||||||++|+|++|++||..................              ...
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            233467899999999876554455699999999999999999999876543333222211100              000


Q ss_pred             CC---------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          222 KI---------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       222 ~~---------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ..         .....+++++.++|.+||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            00         0122478899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-50  Score=342.79  Aligned_cols=255  Identities=22%  Similarity=0.411  Sum_probs=216.7

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      |.++++||+|+||.||+|.++.+|..+|||.+...... .++.+|+.++++++.|++|++|+.+.....+|+|||||..|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDL-QEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDL-QEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchH-HHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            56789999999999999999999999999998775443 46889999999999999999999999999999999999999


Q ss_pred             ChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCccc
Q 018734           84 ELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVG  161 (351)
Q Consensus        84 ~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~g  161 (351)
                      ++.+.+. +++++++.++..+++..++||+|||...-||||||..|||++.++  ..||+|||.|....... ..+.++|
T Consensus       114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G--~AKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T KOG0574|consen  114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG--IAKLADFGVAGQLTDTMAKRNTVIG  191 (502)
T ss_pred             cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc--hhhhhhccccchhhhhHHhhCcccc
Confidence            9999986 456799999999999999999999999999999999999997665  59999999987643332 3356789


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      ||.|||||++..-+|+.. +||||||++..||..|++||.+..+...   +...-.+.+-.+..+..+|+++.+++++||
T Consensus       192 TPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRA---IFMIPT~PPPTF~KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  192 TPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRA---IFMIPTKPPPTFKKPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             CcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccce---eEeccCCCCCCCCChHhhhhHHHHHHHHHh
Confidence            999999999999999877 8999999999999999999987554221   111111112223334458999999999999


Q ss_pred             ccCCCCCCChHHHhcCcccccCCC
Q 018734          242 VANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       242 ~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      .++|++|-|+-++++|||++....
T Consensus       268 iK~PE~R~TA~~L~~H~FiknA~g  291 (502)
T KOG0574|consen  268 IKKPEERKTALRLCEHTFIKNAPG  291 (502)
T ss_pred             cCCHHHHHHHHHHhhhhhhcCCCc
Confidence            999999999999999999876644

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-46  Score=363.92  Aligned_cols=254  Identities=28%  Similarity=0.421  Sum_probs=209.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC-------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT-------   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-------   71 (351)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+..+..++|+||++++..+....       
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            689999999999999999999999999999999875432   2245678999999999999999988775432       


Q ss_pred             -EEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           72 -HLAIVMEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        72 -~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                       .+++||||+.+|+|.+.+..    ...+++..+..++.|++.||.|||++||+||||||+|||++.++  .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~--~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC--CEEEEeccc
Confidence             47899999999999998864    34689999999999999999999999999999999999998765  499999999


Q ss_pred             CcccCCC---CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC
Q 018734          147 SKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI  223 (351)
Q Consensus       147 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (351)
                      ++.....   ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    .+..+..... .
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~----~~~~~~~~~~-~  263 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEE----VMHKTLAGRY-D  263 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCCC-C
Confidence            8753321   223346799999999999887765 45999999999999999999997654322    2223332222 2


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +.+..+++.+.+++.+||+.+|.+||++.++++|||+...
T Consensus       264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        264 PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            3344689999999999999999999999999999998653

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-46  Score=339.47  Aligned_cols=255  Identities=29%  Similarity=0.512  Sum_probs=204.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+....   .....+.+|+.+++.++||||+++++++.+...+++++||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            6999999999999999999999999999999986532   2234677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CC
Q 018734           80 AAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PK  157 (351)
Q Consensus        80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~  157 (351)
                      +.+ +|...+.+ .+.+++..++.++.||+.||.|||++|++||||||+||+++.++  +++|+|||+++....... ..
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC--cEEECccchhhccCCCCCCcC
Confidence            964 78777754 56799999999999999999999999999999999999998665  499999999875432222 23


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh-HHHHHHHHHHh------------hcc-CC
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-NFRKTISRIMA------------VQY-KI  223 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~------------~~~-~~  223 (351)
                      ...+++.|+|||++.+....+.++|||||||++|+|++|..||....+.. .+..+......            ..+ ..
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            35688999999998776554566999999999999999988865444322 22221111100            000 00


Q ss_pred             ----------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          224 ----------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       224 ----------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                                +....+++.+.+||.+||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                      0112467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-47  Score=355.15  Aligned_cols=254  Identities=40%  Similarity=0.686  Sum_probs=232.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC---HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .-|.+.++||+|.|++|.++++..++..||||.+.+.....   ..+.+|+.+|+.|+|||||+++.+..++..+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            35899999999999999999999999999999998865432   457899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |+.+|.+++++.+.+++.+...+.++.|++.|++|||+++|+|||||++|||++.+.+  +||+|||++..........+
T Consensus       136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccc
Confidence            9999999999999999999999999999999999999999999999999999988775  99999999998888888889


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      .||++.|.|||++.+..|+++.+|+||+|+++|.|++|.+||.+..    +...-.+.....+++|.  .++-++.++|+
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~----lk~Lr~rvl~gk~rIp~--~ms~dce~lLr  287 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN----LKELRPRVLRGKYRIPF--YMSCDCEDLLR  287 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc----cccccchheeeeecccc--eeechhHHHHH
Confidence            9999999999999999999999999999999999999999998754    23344456667777777  47889999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccC
Q 018734          239 RIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ++|..+|.+|++.+++.+|.|....
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccchh
Confidence            9999999999999999999997543

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5e-46  Score=336.64  Aligned_cols=252  Identities=33%  Similarity=0.636  Sum_probs=215.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.++++++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            58999999999999999999999999999999987533    22345778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||+.+++|.+++...+.+++..+..++.||+.||.|||++|++|+||+|.||+++.++  .+||+|||++......  ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG--YIKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC--CEEEeeCCCccccCCC--CC
Confidence            9999999999999888999999999999999999999999999999999999998765  4999999998754333  34


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ...|++.|+|||.+.+...+ .++||||||+++|+|++|+.||.......    ....+......+|  ..++..+.++|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~--~~~~~~l~~li  229 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFP--SFFSPDAKDLI  229 (290)
T ss_pred             CCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCccCC--ccCCHHHHHHH
Confidence            45799999999998776654 55999999999999999999997655322    2222233333333  35789999999


Q ss_pred             HHhcccCCCCCC-----ChHHHhcCcccccCC
Q 018734          238 SRIFVANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       238 ~~~L~~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      .+||+.+|.+|+     +++++++||||....
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            999999999999     899999999996643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.1e-46  Score=334.71  Aligned_cols=254  Identities=24%  Similarity=0.409  Sum_probs=206.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            578999999999999999999999999999999865432  234577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      +++++|...    ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.  ++|+|||++..... ......
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~-~~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVN-SIAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceeccc-ccccCC
Confidence            999988544    35789999999999999999999999999999999999987664  99999999875432 233446


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhH---HHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN---FRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      +||+.|+|||.+.+..++ .++|+|||||++|+|++|+.||........   .......+.............++++.++
T Consensus       154 ~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         154 VGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            799999999999877765 459999999999999999999965332111   1111111111111111123477899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +.+||+.+|.+||++++++.||||...
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCcccccc
Confidence            999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=302.80  Aligned_cols=260  Identities=29%  Similarity=0.514  Sum_probs=219.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |.+|.-+++||+|.||+||++++..+++.||+|.++.....   ....++|+-+++.|+|.|||+++++..++..+.+|+
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            67888899999999999999999999999999998765443   367899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-C
Q 018734           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~  155 (351)
                      |||. .+|..+... ++.+....++.++.|+++||.++|+++++||||||.|.||+.++.  +||+|||+++.....- .
T Consensus        81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrc  157 (292)
T KOG0662|consen   81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRC  157 (292)
T ss_pred             HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEe
Confidence            9995 488777755 577999999999999999999999999999999999999987775  9999999998654443 2


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhcc-C------CCCc-
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY-K------IPDY-  226 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~-~------~~~~-  226 (351)
                      ....+-|.+|++|.++.+.+.++...|+||.|||+.|+.. |++.|.+.+-.+++..+......... .      +|++ 
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            3445789999999999998888877999999999999985 77888887776777766655433221 1      2222 


Q ss_pred             ---------------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          227 ---------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       227 ---------------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                     +.++..-++|+.++|..+|.+|++++.+++||||...
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                           1234567899999999999999999999999999764

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.2e-46  Score=333.63  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=207.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcC------CEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTP------THLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~------~~~~   74 (351)
                      .+|++.+.||+|+||.||++.+..+++.||+|++.........+.+|+.+++++ +||||+++++++...      ..+|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            368899999999999999999999999999999877665566788999999988 699999999998753      4689


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      ++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.  ++|+|||++.....
T Consensus        86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~  163 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceeccc
Confidence            999999999999998763  46899999999999999999999999999999999999987664  99999999875432


Q ss_pred             C-CCCCCcccCCCccCcccccC-----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc
Q 018734          153 H-SRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  226 (351)
Q Consensus       153 ~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (351)
                      . .......|++.|+|||++.+     ..+ +.++|||||||++|+|++|..||...........    ...........
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~  238 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKS  238 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCCC
Confidence            2 22334579999999999863     234 3459999999999999999999976543222211    11112222222


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ..++..+.+|+.+||+.+|.+|||+.++++||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            3578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-46  Score=354.08  Aligned_cols=252  Identities=21%  Similarity=0.304  Sum_probs=200.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ..|.+.+.||+|+||.||++.+..+++.||+|....     ....+|+.++++++|||||++++++...+..++||+++.
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~  243 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR  243 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence            369999999999999999999999999999996322     245689999999999999999999999999999999995


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC---CC
Q 018734           82 GGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PK  157 (351)
Q Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---~~  157 (351)
                       ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.......   ..
T Consensus       244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~--~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC--CEEEcccCCceeccccccccccc
Confidence             6888887654 4699999999999999999999999999999999999997665  499999999875322211   22


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-------hhHHHHHHHHHHhh--c--------
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAV--Q--------  220 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~~~--~--------  220 (351)
                      ..+||+.|+|||++.+..++. ++|||||||++|||++|..|+.....       ...+..++......  .        
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~-~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~  399 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTP-SVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR  399 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence            356999999999998877754 49999999999999998766543221       11222222211000  0        


Q ss_pred             ----------------cCC---CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          221 ----------------YKI---PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       221 ----------------~~~---~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                                      ...   ..+..++..+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                            000   111235668999999999999999999999999999964

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-45  Score=337.32  Aligned_cols=256  Identities=28%  Similarity=0.499  Sum_probs=209.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+.....  ....+.+|+.++++++||||+++++++..++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            579999999999999999999999999999998865432  234577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      +++++|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||.|||++.++  .+||+|||++..... .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~~~~  157 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLID-SMANS  157 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC--cEEEccCCCcccccc-ccccc
Confidence            9999999999888889999999999999999999997 5999999999999998765  499999999864322 22345


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHH------------------------
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS------------------------  214 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------------------------  214 (351)
                      ..|++.|+|||.+.+..+. .++|+|||||++|+|++|+.||...... .......                        
T Consensus       158 ~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             CCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccc
Confidence            6789999999998776654 4599999999999999999999654321 1111110                        


Q ss_pred             ---------HHHhh-ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          215 ---------RIMAV-QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       215 ---------~~~~~-~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                               .+... ....|. ..++.++.+|+.+||..+|++|||+.++++||||.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                     00000 000111 1267789999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-46  Score=345.25  Aligned_cols=248  Identities=22%  Similarity=0.385  Sum_probs=197.7

Q ss_pred             CCeeEeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcC-CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTP-TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~-~~   72 (351)
                      ++|++.+.||+|+||.||++.+     ..+++.||+|++.....  ....+.+|+.+++.+ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            5899999999999999999975     24457899999875432  224678899999999 899999999988654 46


Q ss_pred             EEEEEeccCCCChHHHHHhc------------------------------------------------------------
Q 018734           73 LAIVMEYAAGGELFERICNA------------------------------------------------------------   92 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~------------------------------------------------------------   92 (351)
                      ++++|||+++|+|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            89999999999999888642                                                            


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---CCCCcccCCCccC
Q 018734           93 --GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIA  167 (351)
Q Consensus        93 --~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~a  167 (351)
                        ..+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......   ......+++.|+|
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCccccC
Confidence              2377888999999999999999999999999999999998665  49999999987542221   1123346788999


Q ss_pred             cccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCC
Q 018734          168 PEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPS  246 (351)
Q Consensus       168 PE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~  246 (351)
                      ||++.+..++.+ +|||||||++|+|++ |..||........+...   +.. .........+++.+.+|+.+||+.+|.
T Consensus       245 PE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         245 PESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR---LKD-GTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             cHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---Hhc-CCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            999987776544 999999999999997 99999875543332222   111 112223346788999999999999999


Q ss_pred             CCCChHHHhc
Q 018734          247 RRITIKEIKS  256 (351)
Q Consensus       247 ~Rps~~eil~  256 (351)
                      +|||+.++++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=356.23  Aligned_cols=252  Identities=30%  Similarity=0.481  Sum_probs=212.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCChH
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELF   86 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~   86 (351)
                      -.||+|+||+||.++|..|+...|||.+.-.. ....-+..||...++|+|.|||++++++..++.+-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            37999999999999999999999999886433 23334778999999999999999999999999999999999999999


Q ss_pred             HHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCCCCcccC
Q 018734           87 ERICNA-GRF--SEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGT  162 (351)
Q Consensus        87 ~~l~~~-~~l--~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~~~~~gt  162 (351)
                      ++|... +++  .|..+..+..||++||+|||++.|||||||-.|+||+. ..|.+||+|||-++.... .....++.||
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~TETFTGT  739 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPCTETFTGT  739 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCccccccccc
Confidence            999764 666  89999999999999999999999999999999999974 456799999998876443 3444556799


Q ss_pred             CCccCcccccC-CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          163 PAYIAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       163 ~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      .-|||||++.. ..-+++++|||||||++.||.||++||.....+....   -++.....-.|.+..+|.+++.+|.+|+
T Consensus       740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---FkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            99999999954 3445788999999999999999999998776543321   1222222234445578999999999999


Q ss_pred             ccCCCCCCChHHHhcCcccccC
Q 018734          242 VANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       242 ~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .++|.+||++.++|..||++..
T Consensus       817 epd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCCcccCccHHHhccCcccccC
Confidence            9999999999999999999766

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.6e-46  Score=330.63  Aligned_cols=254  Identities=30%  Similarity=0.453  Sum_probs=211.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||.|+||.||++....++..+|+|++.....  ....+.+|+..++.++||||+++++.+......+++||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            589999999999999999999998999999999865332  335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           80 AAGGELFERICNA---GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        80 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      +.+++|.+++...   ..+++..++.++.|++.||.|||++|++||||+|+||+++.++  .++|+|||++.........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~--~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG--SVKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEcccchHHHhccCccc
Confidence            9999999999764   4589999999999999999999999999999999999998765  4999999988754433222


Q ss_pred             -----CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC---ccC
Q 018734          157 -----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD---YVH  228 (351)
Q Consensus       157 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  228 (351)
                           ....|++.|+|||++......+.++|+|||||++|+|++|+.||........+.+....   .....+.   +..
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKK  235 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcccccc
Confidence                 33468999999999877634456699999999999999999999876554333332221   1111111   235


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +++.+.+++.+||+.+|++||++.++++||||
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         236 YSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             ccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            78899999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-48  Score=348.88  Aligned_cols=250  Identities=34%  Similarity=0.618  Sum_probs=218.0

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccC---cccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~   84 (351)
                      +.||.|-||+||-++++++|+.||||++.+-   .+....+++|+.+++.+.||.||.+...|++..++++|||.+.| +
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-D  648 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-D  648 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-h
Confidence            7899999999999999999999999999763   34456788999999999999999999999999999999999965 6


Q ss_pred             hHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEeccCCCcccCCCCCCCCccc
Q 018734           85 LFERIC--NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVG  161 (351)
Q Consensus        85 L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~~~vkL~DFg~a~~~~~~~~~~~~~g  161 (351)
                      +.+.|-  ..+++++...+.++.||+.||.|||-++|+|+||||+|||+.+. .-..+||||||+|+.........+.+|
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG  728 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG  728 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence            666653  46789999999999999999999999999999999999999643 335799999999998887788889999


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      ||.|+|||++..++|+.. -|+||+|+|+|.-++|..||....+....   + +.....|....|..+++.+.+||..+|
T Consensus       729 TPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdIndQ---I-QNAaFMyPp~PW~eis~~AidlIn~LL  803 (888)
T KOG4236|consen  729 TPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDINDQ---I-QNAAFMYPPNPWSEISPEAIDLINNLL  803 (888)
T ss_pred             CccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccchhHH---h-hccccccCCCchhhcCHHHHHHHHHHH
Confidence            999999999999999766 79999999999999999999876543221   1 112334444567789999999999999


Q ss_pred             ccCCCCCCChHHHhcCcccccC
Q 018734          242 VANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       242 ~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +..-.+|.|++..|.|||++..
T Consensus       804 qVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  804 QVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHhcchHhhccchhhhcc
Confidence            9999999999999999999875

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.7e-46  Score=333.21  Aligned_cols=251  Identities=32%  Similarity=0.494  Sum_probs=207.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc-CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++...... ...+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            4788999999999999999999999999999998754322 235678999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  159 (351)
                      ++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++  .++|+|||++...... ......
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG--HVKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEECcceeeeEccCcccccccc
Confidence            9999999998888999999999999999999999999999999999999997665  4999999998644322 122345


Q ss_pred             ccCCCccCccccc---CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC---CccCCCHhH
Q 018734          160 VGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYVHISQDC  233 (351)
Q Consensus       160 ~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  233 (351)
                      .|++.|+|||++.   ...+ +.++|+|||||++|+|++|..||............    .......+   ....++..+
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM----TKSNFQPPKLKDKMKWSNSF  241 (267)
T ss_pred             cCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh----hccCCCCCcccccCCCCHHH
Confidence            7999999999974   2334 45599999999999999999999765433222111    11111111   222467889


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcc
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPW  259 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~  259 (351)
                      .+++.+||+.+|++||+++++++|||
T Consensus       242 ~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         242 HHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=344.77  Aligned_cols=242  Identities=26%  Similarity=0.454  Sum_probs=209.1

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +++++.||+|-||.||.+....+ ..||+|.+.........+.+|+++|++|+|+|||++++++..+..+|||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            45678999999999999999863 47999998876666678899999999999999999999999988999999999999


Q ss_pred             ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcc-
Q 018734           84 ELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-  160 (351)
Q Consensus        84 ~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~-  160 (351)
                      +|.++|+.  ...+...+...++.||++|++||+++++|||||-..||||+.+..  +||+|||+|+... ........ 
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~-d~~Y~~~~~  363 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIG-DDEYTASEG  363 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccC-CCceeecCC
Confidence            99999987  567999999999999999999999999999999999999987764  9999999999332 22222222 


Q ss_pred             --cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          161 --GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       161 --gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                        -...|.|||.+....++.+ ||||||||+||||+| |+.||......+.+     ......+++|.+..+|+.+.+++
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~-----~~le~GyRlp~P~~CP~~vY~lM  437 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVL-----ELLERGYRLPRPEGCPDEVYELM  437 (468)
T ss_pred             CCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHH-----HHHhccCcCCCCCCCCHHHHHHH
Confidence              3345999999999998766 999999999999998 88998877654333     23556788899999999999999


Q ss_pred             HHhcccCCCCCCChHHHh
Q 018734          238 SRIFVANPSRRITIKEIK  255 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil  255 (351)
                      ..||..+|++|||++.+.
T Consensus       438 ~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  438 KSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHHhhCCcccCCCHHHHH
Confidence            999999999999999664

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-45  Score=333.10  Aligned_cols=256  Identities=27%  Similarity=0.453  Sum_probs=210.7

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|++.+.||.|+||.||++.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++.....+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            69999999999999999999999999999999876432   235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--C
Q 018734           80 AAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--P  156 (351)
Q Consensus        80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~  156 (351)
                      + +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++  .++|+|||++........  .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC--cEEEeeeeecccccCCCCCcc
Confidence            9 9999998865 45689999999999999999999999999999999999998765  499999999875543321  3


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh---------------cc
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QY  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~  221 (351)
                      ....|+..|+|||.+.+....+.++|||||||++|+|++|.+||........+...+......               ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            345789999999998766655667999999999999999988887665544433333221100               00


Q ss_pred             CCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          222 KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       222 ~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      ..+         .....+..+.+||.+||+.+|++|||++++++||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            000         1124568899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.2e-46  Score=332.21  Aligned_cols=252  Identities=29%  Similarity=0.427  Sum_probs=206.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            579999999999999999999999999999999865432 2245778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  159 (351)
                      .+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++....... .....
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06646          89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKSF  166 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCcc
Confidence            99999999988888999999999999999999999999999999999999976654  9999999987543222 22345


Q ss_pred             ccCCCccCcccccCC--cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC---CCccCCCHhHH
Q 018734          160 VGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI---PDYVHISQDCR  234 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  234 (351)
                      .|++.|+|||.+...  ...+.++|+|||||++|+|++|+.||..........    .+.......   +....++..+.
T Consensus       167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF----LMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe----eeecCCCCCCCCccccccCHHHH
Confidence            789999999998532  222455999999999999999999996543221111    111111111   12234688999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcc
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPW  259 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~  259 (351)
                      ++|.+||+.+|++|||++++++|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=337.03  Aligned_cols=255  Identities=34%  Similarity=0.547  Sum_probs=214.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+......    ...+.+|+.+++.++||||+++++.+......|++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            5899999999999999999999999999999998764322    245778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           78 EYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||+.|++|.+++.+.  ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++  +++|+|||++........
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG--HIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC--CEEEeecchhhccccccc
Confidence            999999999998754  5689999999999999999999999999999999999998765  499999998764322111


Q ss_pred             ------------------------------CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q 018734          156 ------------------------------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED  205 (351)
Q Consensus       156 ------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  205 (351)
                                                    .....||..|+|||++.+..++ .++|||||||++|+|++|..||.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCC-chHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                          1123689999999999877664 559999999999999999999987655


Q ss_pred             hhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCC----hHHHhcCcccccC
Q 018734          206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT----IKEIKSHPWFLKN  263 (351)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps----~~eil~hp~~~~~  263 (351)
                      ...+..    +.......+....++..+.++|.+||+.+|.+|||    +.++|.||||...
T Consensus       238 ~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         238 DETFSN----ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHH----HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            433332    23333344444447899999999999999999999    9999999999764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.7e-46  Score=342.02  Aligned_cols=256  Identities=23%  Similarity=0.373  Sum_probs=200.2

Q ss_pred             Eeeeeccc--CceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            6 LMKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         6 ~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +++.||+|  +||+||++.+..+++.||+|.+.....   ....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56889999  678999999999999999999876432   2245667999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC----
Q 018734           81 AGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS----  154 (351)
Q Consensus        81 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~----  154 (351)
                      ++++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.  ++++||+.+.......    
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccccccc
Confidence            999999998653  45899999999999999999999999999999999999987664  9999998654321111    


Q ss_pred             ----CCCCcccCCCccCcccccCC-cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh----------
Q 018734          155 ----RPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------  219 (351)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------  219 (351)
                          ......++..|+|||++.+. ...+.++|||||||++|+|++|+.||...................          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE  239 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence                11223577889999999763 223455999999999999999999997654332222111100000          


Q ss_pred             c------------------------------cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          220 Q------------------------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       220 ~------------------------------~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .                              ...+....+++.+.+||.+||+.||.+|||++++++||||.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence            0                              0001112356789999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.8e-45  Score=328.60  Aligned_cols=250  Identities=34%  Similarity=0.501  Sum_probs=208.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----------CHHHHHHHHHHhcCCCCCcceEEEEEEcCCE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------DANVAREIINHKQLRHPNIIRFKEVVLTPTH   72 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~   72 (351)
                      +|.+...||.|+||.||.+.+..+++.||+|.+......          ...+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            688999999999999999999989999999988653321          1356789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      .+++|||+++++|..++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++  .++|+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~--~~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG--GIKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC--CEEecccCCCccccc
Confidence            999999999999999998888899999999999999999999999999999999999997665  499999999875432


Q ss_pred             CC-------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC
Q 018734          153 HS-------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD  225 (351)
Q Consensus       153 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (351)
                      ..       ......|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||..........    .+... .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~-~~~~~  232 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF----KIGEN-ASPEI  232 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHH----HHhcc-CCCcC
Confidence            11       11234588999999999877665 44999999999999999999998754332221    11111 11122


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ...++..+.++|.+||+.+|.+||++.++++||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            23578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-47  Score=319.87  Aligned_cols=257  Identities=24%  Similarity=0.398  Sum_probs=211.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc--CHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++.+++..||.|+.|.|++++...+|...|||.+.+....  ..+++..+.++... .+|+||+.+++|..+..+++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            3456678899999999999999999999999999876543  34566677665554 48999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH-~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      .|.. .+..+++. .++++|..+-++...+++||.||. .+||+|||+||+|||+|..++  +||||||++.........
T Consensus       172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccccc
Confidence            9943 45555543 467999999999999999999998 579999999999999988876  999999999887777777


Q ss_pred             CCcccCCCccCcccccC---CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-hccCCCCccCCCHh
Q 018734          157 KSTVGTPAYIAPEVLSR---REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHISQD  232 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  232 (351)
                      +...|.+.|||||.+.-   ..|+-+ +||||||++++||.||+.||......-   ..+..+++ .+-.+|....+|++
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdF---e~ltkvln~ePP~L~~~~gFSp~  324 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDF---EVLTKVLNEEPPLLPGHMGFSPD  324 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccH---HHHHHHHhcCCCCCCcccCcCHH
Confidence            88899999999999843   345545 899999999999999999998865432   22333332 22234555569999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      +.+|+..||++|+.+||...++|+|||+.....
T Consensus       325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~  357 (391)
T KOG0983|consen  325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET  357 (391)
T ss_pred             HHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence            999999999999999999999999999976543

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.6e-46  Score=334.57  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=211.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.++++++||||+++++++...+.+++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            579999999999999999999999999999998865322  224678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           80 AAGGELFERICNA---GRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        80 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      +++++|..++...   ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++  .++|+|||++..... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA-SL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC-Cc
Confidence            9999998888763   378999999999999999999996 5999999999999998754  599999999875422 22


Q ss_pred             CCCcccCCCccCcccccCCcC-----CCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          156 PKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .....+++.|+|||.+.+...     .+.++|+|||||++|+|++|+.||......... ..+..+.... ....+..++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~  235 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDGD-PPTLPSGYS  235 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhcC-CCCCCcccC
Confidence            334568899999999855432     245599999999999999999999765433222 2222222211 112223578


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      .++.++|.+||+.+|.+||++.+++.||||.....
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         236 DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            99999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-45  Score=331.39  Aligned_cols=257  Identities=29%  Similarity=0.506  Sum_probs=205.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +++|++.+.||.|++|.||++.+..+++.||+|.+.....  ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999999999999999999865432  22456789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-C
Q 018734           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~  156 (351)
                      |+.+ +|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++  ++||+|||+++....... .
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG--ELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC--CEEECccccccccCCCCccc
Confidence            9975 898888664 4689999999999999999999999999999999999998766  499999999875432221 2


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh----------------c
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------------Q  220 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------------~  220 (351)
                      ....+++.|+|||++.+....+.++||||+||++|+|++|+.||............+......                .
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            234578899999998765544556999999999999999999997655322221111111000                0


Q ss_pred             cCCC---------CccCCC--HhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          221 YKIP---------DYVHIS--QDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       221 ~~~~---------~~~~~~--~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ...+         ....++  ..+.+++.+||+.+|.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0000         011233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.3e-45  Score=331.55  Aligned_cols=257  Identities=25%  Similarity=0.436  Sum_probs=212.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .+|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++.+......|+||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            589999999999999999999999999999998875433 2356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  159 (351)
                      .+++|..++.. ..+++.++..++.|++.||.|||+.||+||||||+||+++.++  .++|+|||++........ ....
T Consensus       100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~--~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEECccccchhccccccccCcc
Confidence            99999998864 4689999999999999999999999999999999999997765  499999998875432222 2334


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .|++.|+|||.+.+..++ .++|||||||++|+|++|+.||............   ........+....++..+.+++.+
T Consensus       177 ~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~  252 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNR  252 (296)
T ss_pred             cCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHHHHHH
Confidence            789999999999776664 4599999999999999999999765542222211   111111223334678899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ||..+|.+||++.++++||||....+
T Consensus       253 ~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         253 CLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HCcCCcccCcCHHHHhhChhhhccCC
Confidence            99999999999999999999976533

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.2e-45  Score=335.41  Aligned_cols=260  Identities=29%  Similarity=0.466  Sum_probs=208.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~l   75 (351)
                      +++|++.+.||.|+||.||++.+..+++.||+|++.....   ......+|+.++++++||||+++++++...  +.+++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            5789999999999999999999999999999999865332   223466899999999999999999998765  57899


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      ||||+.+ +|.+.+.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++  .+||+|||++.......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeeecCCcc
Confidence            9999965 78888765 36789999999999999999999999999999999999997665  49999999987543322


Q ss_pred             -CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------
Q 018734          155 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------  218 (351)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------  218 (351)
                       ......+++.|+|||++.+....+.++|||||||++|+|++|++||........+..+......               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence             2233456889999999876554556699999999999999999999876655444433322110               


Q ss_pred             hccCCCC---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          219 VQYKIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       219 ~~~~~~~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..+..+.         ....++.+.+||.+||++||.+|||+.+++.||||.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            0000110         11257889999999999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.6e-45  Score=334.34  Aligned_cols=259  Identities=29%  Similarity=0.437  Sum_probs=211.6

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc------CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI------DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +|++.+.||.|+||.||++.+..+++.||+|.+......      ...+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            689999999999999999999999999999998764322      34567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      |||+ +++|..++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++  .++|+|||++....... 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~--~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC--CEEEccceeeeeccCCCc
Confidence            9999 889999998776 799999999999999999999999999999999999998765  49999999987543332 


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-------CC----
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------KI----  223 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~----  223 (351)
                      ......+++.|+|||.+.+....+.++|+|||||++|+|++|.+||........+.+..........       ..    
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            2233467889999999866555566699999999999999998888776654443333221100000       00    


Q ss_pred             -----------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          224 -----------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       224 -----------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                                 ......+..+.++|.+||+++|.+|||+.+++.||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~  289 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP  289 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence                       00123578899999999999999999999999999997753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.8e-46  Score=329.82  Aligned_cols=252  Identities=29%  Similarity=0.516  Sum_probs=213.9

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +|++.+.||.|+||.||++.+..+++.||+|++.+...    ....+.+|+.++++++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999875432    23567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |+.|++|...+.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.  ++|+|||++...........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence            9999999999988778999999999999999999999999999999999999987664  99999999876544444455


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      ..|+..|+|||.+.+..+. .++|+||||+++|+|++|..||...... ...........  ...+.+..++..+.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~  234 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET--ADVLYPATWSTEAIDAIN  234 (258)
T ss_pred             cCCChhhcCHHHHcccCCC-CcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc--ccccCcccCcHHHHHHHH
Confidence            6789999999999777754 4599999999999999999999876542 11111221111  222333467899999999


Q ss_pred             HhcccCCCCCCCh--HHHhcCccc
Q 018734          239 RIFVANPSRRITI--KEIKSHPWF  260 (351)
Q Consensus       239 ~~L~~~P~~Rps~--~eil~hp~~  260 (351)
                      +||+.+|.+||++  .++++||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.9e-45  Score=330.99  Aligned_cols=253  Identities=28%  Similarity=0.474  Sum_probs=204.7

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCC-CCCcceEEEEEEcC--CEEEEEEe
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLR-HPNIIRFKEVVLTP--THLAIVME   78 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~--~~~~lv~e   78 (351)
                      |++.+.||+|+||.||++.+..+++.||+|++.....  ......+|+..++++. ||||+++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            7899999999999999999999999999998876432  2234457888888885 99999999999987  89999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |+.+ +|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.   +.+||+|||++..........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCCcC
Confidence            9974 88887765 457899999999999999999999999999999999999987   469999999987654444444


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHH--------------hhccCC
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------------AVQYKI  223 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------------~~~~~~  223 (351)
                      ...+++.|+|||.+......+.++|||||||++|+|++|..||...+..+.+........              ...+.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            567899999999876655556679999999999999999999987654333322221100              011111


Q ss_pred             CC---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          224 PD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       224 ~~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +.         ...++..+.++|.+||+++|.+||++.++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11         12467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.9e-45  Score=329.30  Aligned_cols=258  Identities=27%  Similarity=0.387  Sum_probs=210.0

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      -|++.+.||.|+||.||++.+..++..+++|.+.... .....+.+|+.+++.++||||+++++++......|+||||+.
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3688899999999999999999999999999886543 223467789999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCc
Q 018734           82 GGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  159 (351)
Q Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  159 (351)
                      +++|...+.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.++  +++|+|||++...... ......
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG--DIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC--CEEEccccccccccccccccccc
Confidence            9999887754 45789999999999999999999999999999999999997665  4999999998653222 122345


Q ss_pred             ccCCCccCcccccC----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          160 VGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       160 ~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      .|++.|+|||++..    ....+.++|||||||++|+|++|++||.............   .......+....++..+.+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh---hcCCCCCCCccccCHHHHH
Confidence            68999999999842    1222345999999999999999999997755433222221   1111122333457889999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      +|.+||+.+|.+||++.++++||||.....
T Consensus       241 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            999999999999999999999999987644

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-45  Score=327.35  Aligned_cols=256  Identities=28%  Similarity=0.457  Sum_probs=213.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||.|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++..+..+|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            589999999999999999999999999999999875432  224577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~  158 (351)
                      +.+++|.+++... ++++..+..++.|++.||.|||+++++||||+|+||+++.++.  ++|+|||+++..... .....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence            9999999998765 8899999999999999999999999999999999999987664  999999998765433 22344


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li  237 (351)
                      ..|++.|+|||.+.+..++ .++|||||||++|+|++|+.||........    ...+..... ..+. ..++..+.+++
T Consensus       158 ~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~l  231 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRV----LFLIPKNNPPSLEG-NKFSKPFKDFV  231 (274)
T ss_pred             ccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHH----HHHhhhcCCCCCcc-cccCHHHHHHH
Confidence            5789999999999877754 559999999999999999999976543222    111111111 1111 12788999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      .+||..+|++|||+.++++||||.+....
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence            99999999999999999999999876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-45  Score=327.82  Aligned_cols=256  Identities=29%  Similarity=0.463  Sum_probs=211.0

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +|+..+.||+|+||.||.+.+..+++.||+|++.....       ....+.+|+.++++++||||+++++++...+.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            58899999999999999999999999999999865331       22467889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||||+.|++|.+++.+.+++++..+..++.||+.||.|||++|++|+||+|+||+++.++. .++|+|||++........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence            9999999999999988888999999999999999999999999999999999999975542 489999999865432211


Q ss_pred             -----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          156 -----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       156 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                           .....|+..|+|||.+.+..++ .++|+|||||++|+|++|..||.......... .................++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHHhccCCCCCCchhhC
Confidence                 1234688999999999776664 45999999999999999999997554322222 2222222222222233578


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      +.+.+++.+||+.+|.+||++.++++||||.
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            8999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.6e-45  Score=330.35  Aligned_cols=255  Identities=27%  Similarity=0.452  Sum_probs=212.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+|+..++.++||||+++++++.....+|+|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            479999999999999999999999999999998865432 3356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  159 (351)
                      .+++|..++.. ..+++.++..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++........ ....
T Consensus        99 ~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655          99 AGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG--SVKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             CCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccchhcccccccCCCc
Confidence            99999988865 4689999999999999999999999999999999999997665  499999998875433222 2334


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .|++.|+|||.+.+..++. ++|+|||||++|+|++|+.||.............   .........+..+++.+.++|.+
T Consensus       176 ~~~~~y~aPE~~~~~~~~~-~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCCccccCcchhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHHHHHH
Confidence            6899999999998777654 4999999999999999999998765433322211   11111223344678899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ||..+|.+||++.+++.||||...
T Consensus       252 ~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         252 CLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HhhcChhhCCCHHHHhhChHhhhc
Confidence            999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.1e-45  Score=330.91  Aligned_cols=256  Identities=27%  Similarity=0.412  Sum_probs=208.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +.|++++.||.|+||.||++.+..+++.|++|++..... ....+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            469999999999999999999999999999999875432 2345778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCC
Q 018734           81 AGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKS  158 (351)
Q Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~  158 (351)
                      .+++|..++.+ ...+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++...... .....
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~  169 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQRRDS  169 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceeccccccccce
Confidence            99999887754 45689999999999999999999999999999999999997655  4999999988643222 12234


Q ss_pred             cccCCCccCcccccCCc----CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CCCCccCCCHhH
Q 018734          159 TVGTPAYIAPEVLSRRE----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQDC  233 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  233 (351)
                      ..+++.|+|||.+.+..    ..+.++|+|||||++|+|++|.+||..........    .+..... ..+....++..+
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  245 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL----KIAKSEPPTLSQPSKWSMEF  245 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHH----HHhcCCCccCCCCcccCHHH
Confidence            56899999999985322    12345999999999999999999997654322222    1211111 222334578899


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .++|.+||+.+|++||++.++++||||...
T Consensus       246 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         246 RDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             HHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            999999999999999999999999999653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-45  Score=325.90  Aligned_cols=252  Identities=27%  Similarity=0.445  Sum_probs=210.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||.|+||.||++....+++.|++|.+..... ...+.+|+.+++.++||||+++++++.....+|+++||+.
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            689999999999999999999999899999999876543 5678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCc
Q 018734           82 GGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  159 (351)
Q Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  159 (351)
                      +++|.+++.. ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.  ++|+|||++....... .....
T Consensus        82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCccccccc
Confidence            9999999875 456899999999999999999999999999999999999987664  9999999987544332 22344


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .|+..|+|||++.+..++ .++||||||+++|+|++|+.||.............   ............++..+.++|.+
T Consensus       160 ~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NKPPPTLSDPEKWSPEFNDFVKK  235 (256)
T ss_pred             cCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cCCCCCCCchhhcCHHHHHHHHH
Confidence            689999999999877765 45999999999999999999997654332211110   00111122233567899999999


Q ss_pred             hcccCCCCCCChHHHhcCccc
Q 018734          240 IFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ||+.+|.+|||+.+++.||||
T Consensus       236 ~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         236 CLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-45  Score=330.64  Aligned_cols=256  Identities=26%  Similarity=0.423  Sum_probs=210.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||.|+||.||++.+..++..||+|.+..... ....+.+|+.+++.++||||+++++.+..+...|+||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            579999999999999999999998999999999865432 2245778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCC
Q 018734           81 AGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  158 (351)
Q Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~  158 (351)
                      .+++|..++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++  .++|+|||++....... ....
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG--DVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC--CEEEccCccchhhcccccccce
Confidence            999999998764 5699999999999999999999999999999999999997765  49999999876433222 2234


Q ss_pred             cccCCCccCcccccCC----cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CCCCccCCCHhH
Q 018734          159 TVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQDC  233 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  233 (351)
                      ..|++.|+|||.+...    ...+.++|+|||||++|+|++|+.||..........    .+..... .+.....++..+
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL----KILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH----HHhcCCCCCcCCcccCCHHH
Confidence            5689999999998532    222345999999999999999999997754332222    2222111 122233578899


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .++|.+||+.+|.+||++.++++||||...
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.1e-45  Score=323.98  Aligned_cols=254  Identities=31%  Similarity=0.504  Sum_probs=212.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ||.+.+.||+|+||.||++.+..+++.|++|++.....   ....+.+|+.+++.++||||+++++++.....+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            79999999999999999999998999999999876544   345688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC--
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--  157 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~--  157 (351)
                      +.+++|.+++.+...+++..++.++.|++.||.|||++|++|+||+|.||+++.++  .+||+|||++..........  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~--~~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG--VIKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEcccccccccCCCCCcccc
Confidence            99999999998887899999999999999999999999999999999999998765  49999999987543332221  


Q ss_pred             ---CcccCCCccCcccccCCc--CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          158 ---STVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       158 ---~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                         ...+++.|+|||.+.+..  ....++||||||+++|+|++|+.||............  ........+|....++..
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGHKPPIPDSLQLSPE  236 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--HhcCCCCCCCcccccCHH
Confidence               246889999999987655  1345599999999999999999999765432221111  111222334555556889


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +.++|.+||+.+|.+|||+.+++.|||+
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-45  Score=324.15  Aligned_cols=251  Identities=31%  Similarity=0.466  Sum_probs=209.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||.|+||.||++.+..+++.+++|++..... ....+.+|+.+++.++||||+++++++.....+|++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            689999999999999999999999999999999876433 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCC
Q 018734           81 AGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  158 (351)
Q Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~  158 (351)
                      .+++|..++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++....... ....
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhcccc
Confidence            999999988776 78999999999999999999999999999999999999987654  9999999987543322 2234


Q ss_pred             cccCCCccCcccccCC---cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC---CCCccCCCHh
Q 018734          159 TVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK---IPDYVHISQD  232 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (351)
                      ..++..|+|||.+.+.   .++ .++|+|||||++|+|++|..||............    ....+.   ......++..
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  235 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLI----SKSNFPPPKLKDKEKWSPV  235 (262)
T ss_pred             ccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhccCCCccccchhhhhHH
Confidence            5789999999998765   554 4599999999999999999999876543332221    111111   1112245778


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPW  259 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~  259 (351)
                      +.+++.+||+.+|.+|||+.+++.|||
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         236 FHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.4e-45  Score=327.87  Aligned_cols=254  Identities=32%  Similarity=0.473  Sum_probs=206.7

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-----------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----------IDANVAREIINHKQLRHPNIIRFKEVVLTPT   71 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~   71 (351)
                      +|.+.+.||.|+||.||++.+..+++.||+|.+.....           ..+.+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68999999999999999999999999999998753211           1134678999999999999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      ..++||||+.+++|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.  ++|+|||++....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999986654  9999999987533


Q ss_pred             CCC---CCCCcccCCCccCcccccCCc-CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--C
Q 018734          152 LHS---RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--D  225 (351)
Q Consensus       152 ~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~  225 (351)
                      ...   ......|+..|+|||.+.... ..+.++|+||||+++|+|++|..||...............  .....++  .
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~  237 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--RSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--ccCCcCCccc
Confidence            211   123346889999999987654 2345599999999999999999999754432222211111  1111111  1


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ...++..+.++|.+||..+|.+|||++++++||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            23468899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.7e-45  Score=332.02  Aligned_cols=257  Identities=28%  Similarity=0.466  Sum_probs=209.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++..+...|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            589999999999999999999999999999998765332   23457789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~  157 (351)
                      |+.+++|..+......+++..+..++.||+.||.|||+.|++|+||+|+||+++.++  .++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC--cEEEEeeeeeeeccCCccccC
Confidence            999988888777666799999999999999999999999999999999999998765  49999999987543322 223


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hccC
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQYK  222 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~  222 (351)
                      ...++..|+|||++.+....+.++|||||||++|+|++|++||......+....+......               ....
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            4568999999999876554456699999999999999999999765543332222211000               0000


Q ss_pred             CC----------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          223 IP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       223 ~~----------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+          ..+.++..+.+|+.+||+.+|.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            11          123568889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.5e-45  Score=325.96  Aligned_cols=249  Identities=30%  Similarity=0.538  Sum_probs=209.1

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus        10 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ||.|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++.+.++..++++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            7999999999999999999999999876432    235688899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCc
Q 018734           86 FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY  165 (351)
Q Consensus        86 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y  165 (351)
                      .+++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++  .++|+|||++.............|++.|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG--YVKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC--CEEEeeCCcccccCcccccccccCCcCc
Confidence            99998888899999999999999999999999999999999999998765  4999999998865444334455789999


Q ss_pred             cCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCC
Q 018734          166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP  245 (351)
Q Consensus       166 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P  245 (351)
                      +|||.+.+..++.+ +|+||||+++|+|++|..||......  .......+.......+.....++.+.++|.+||+.+|
T Consensus       159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            99999877776544 89999999999999999999876521  1222223332222223333458899999999999999


Q ss_pred             CCCCC-----hHHHhcCcccccC
Q 018734          246 SRRIT-----IKEIKSHPWFLKN  263 (351)
Q Consensus       246 ~~Rps-----~~eil~hp~~~~~  263 (351)
                      .+||+     +.++++||||...
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhCC
Confidence            99999     9999999999753

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=316.27  Aligned_cols=252  Identities=26%  Similarity=0.423  Sum_probs=206.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~~l   75 (351)
                      +||++.+.||.|||+.||+++...+++.||+|++..+. ...+..++|+...++++|||+++++++...+     ...|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            68999999999999999999999999999999987655 4456788999999999999999998876443     45999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           76 VMEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      +++|+..|+|.+.+..    +..++|.++.+|+.+|++||++||+..  +.||||||.|||+.+.+.  ++|.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCccc
Confidence            9999999999988864    336999999999999999999999998  999999999999987554  99999999875


Q ss_pred             cCCCCCCC----------CcccCCCccCcccccCCcCC--CcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHH
Q 018734          150 SLLHSRPK----------STVGTPAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM  217 (351)
Q Consensus       150 ~~~~~~~~----------~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  217 (351)
                      ....-...          ....|..|+|||++.-+...  +.++|||||||++|.|+.|..||...-..-.  ...-.+.
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg--SlaLAv~  256 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG--SLALAVQ  256 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--eEEEeee
Confidence            44332221          12368899999998544332  4559999999999999999999964211000  0011234


Q ss_pred             hhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          218 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.++.+|....+|..+.++|+.||++||.+||++.+++.+
T Consensus       257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            4566778777899999999999999999999999999874

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.1e-45  Score=336.46  Aligned_cols=252  Identities=25%  Similarity=0.410  Sum_probs=191.4

Q ss_pred             eeeecccCceEEEEEEEcC--CCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEEEEEEeccCC
Q 018734            7 MKDIGSGNFGVARLMRNKN--TKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVMEYAAG   82 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~~lv~e~~~~   82 (351)
                      ..+||+|+||.||+|....  ++..||+|.+.... ....+.+|+.+++.++||||+++++++..  +..+++||||+.+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            4689999999999999654  56889999886543 33467889999999999999999999854  5688999999964


Q ss_pred             CChHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCCEEEeccCCCcccC
Q 018734           83 GELFERICN---------AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKICDFGYSKSSL  151 (351)
Q Consensus        83 ~~L~~~l~~---------~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~--~~~~vkL~DFg~a~~~~  151 (351)
                       +|...+..         ...+++..++.++.||+.||.|||++||+||||||+|||+...  ..+++||+|||+++...
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence             77777642         1248899999999999999999999999999999999999432  23469999999997543


Q ss_pred             CCC----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh---------hHHHHHHHHHH-
Q 018734          152 LHS----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTISRIM-  217 (351)
Q Consensus       152 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~~~~~~~~-  217 (351)
                      ...    ......||+.|+|||++.+....+.++|||||||++|+|++|++||......         ..+........ 
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF  243 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence            221    1234578999999999977655566699999999999999999999754321         01111110000 


Q ss_pred             ------------------hhccCC-------------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          218 ------------------AVQYKI-------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       218 ------------------~~~~~~-------------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                                        ...+..             ......+..+.+||.+||+.||.+|||+.|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                              000000             0001234578899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.1e-45  Score=329.23  Aligned_cols=260  Identities=28%  Similarity=0.454  Sum_probs=208.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |++|++.+.||+|++|.||++.+..+++.||+|.+.....   ....+.+|+.++++++||||+++++++......|+||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            6899999999999999999999999999999998865432   2346778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           78 EYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      ||+. ++|...+.....  +++..++.++.||+.||.|||++|++||||+|+||+++..+. .+||+|||++....... 
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVR  158 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCcc
Confidence            9996 588877765443  578899999999999999999999999999999999975432 48999999987543222 


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh--------------c
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------Q  220 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------~  220 (351)
                      ......+++.|+|||.+.+....+.++|||||||++|+|++|++||......+...+........              .
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence            12344688999999998765544566999999999999999999998765544433332211000              0


Q ss_pred             cCCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          221 YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       221 ~~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      ...+         ....++..+.+++.+||+.+|.+||++.++++||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence            0000         01346788999999999999999999999999999964

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.5e-45  Score=322.97  Aligned_cols=252  Identities=29%  Similarity=0.453  Sum_probs=210.9

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +|+..+.||+|+||.||++.+..+++.|++|.+.....      ....+.+|+.+++.++||||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            68899999999999999999998899999998865331      224677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      +||+++++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++  .+||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~--~~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG--VVKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEccCccceeccccccc
Confidence            99999999999998888899999999999999999999999999999999999998665  4999999998765444334


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....|++.|+|||.+......+.++|+|||||++|+|++|+.||...........    .............++..+.++
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l  234 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKDF  234 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHHH
Confidence            5567999999999987665234559999999999999999999977553222211    111111112223578899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +.+||+.+|++||++.+++.|||+
T Consensus       235 i~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         235 ILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.7e-45  Score=328.55  Aligned_cols=255  Identities=25%  Similarity=0.420  Sum_probs=206.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcC-----CEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTP-----THLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~-----~~~~l   75 (351)
                      ++|.+.+.||+|+||.||++.+..+++.+|+|++.........+.+|+.+++++ +||||+++++++...     ...|+
T Consensus        22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l  101 (291)
T cd06639          22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL  101 (291)
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence            579999999999999999999999999999999876554456677899999988 899999999998653     46899


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           76 VMEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      ||||+.+++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+||+++.++  ++||+|||++....
T Consensus       102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~--~~kl~dfg~~~~~~  179 (291)
T cd06639         102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG--GVKLVDFGVSAQLT  179 (291)
T ss_pred             EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC--CEEEeecccchhcc
Confidence            9999999999888753    45789999999999999999999999999999999999997665  49999999987543


Q ss_pred             CCC-CCCCcccCCCccCcccccCCcC----CCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc
Q 018734          152 LHS-RPKSTVGTPAYIAPEVLSRREY----DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  226 (351)
Q Consensus       152 ~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (351)
                      ... ......|+..|+|||.+.....    .+.++|||||||++|+|++|+.||..............   .........
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~  256 (291)
T cd06639         180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTLLHP  256 (291)
T ss_pred             cccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCCCcc
Confidence            222 2234568999999999854331    24559999999999999999999987544333222111   111112222


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      ..++..+.++|.+||+.+|++||++.+++.||||+
T Consensus       257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            34677899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.8e-45  Score=329.32  Aligned_cols=258  Identities=28%  Similarity=0.407  Sum_probs=205.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCE-----
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLR-HPNIIRFKEVVLTPTH-----   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~-----   72 (351)
                      ++|++.+.||.|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            589999999999999999999999999999998765432   2356788999999995 6999999999977655     


Q ss_pred             EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           73 LAIVMEYAAGGELFERICNA-----GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      .|++|||+.+ +|..++...     ..+++..++.++.||+.||.|||++||+||||||+||+++.+ .+.+||+|||++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~-~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ-KGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC-CCeEEEeecccc
Confidence            8999999986 788877542     357999999999999999999999999999999999999862 235999999998


Q ss_pred             cccCCC-CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-----
Q 018734          148 KSSLLH-SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-----  221 (351)
Q Consensus       148 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  221 (351)
                      ...... .......+++.|+|||++.+....+.++||||||+++|+|++|..||...........+.........     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            754322 22233467899999999876544456699999999999999999999876655444433322110000     


Q ss_pred             --------CCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          222 --------KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       222 --------~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                              ..+         ....++..+.+||.+||+++|.+||++.+++.||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                    000         0124788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-46  Score=358.76  Aligned_cols=247  Identities=28%  Similarity=0.474  Sum_probs=207.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCC-CCCcceEEEE-EEcC------CEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLR-HPNIIRFKEV-VLTP------THL   73 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~-hp~Iv~~~~~-~~~~------~~~   73 (351)
                      ++++.+.|.+|||+.||+|++...+..||+|++.... .....+.+||.+|+.|+ |||||.+++. ....      -.+
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            5788999999999999999999988999999876543 23456889999999996 9999999993 3221      358


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           74 AIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      +|+||||.||.|.+++...  ..|++.+|.+|++|+++|+.+||..+  |||||||-+||||+.++.  +||||||.|..
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt  195 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATT  195 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccccccc
Confidence            8999999999999998743  45999999999999999999999988  999999999999987765  99999999875


Q ss_pred             cCCCCCCC----------CcccCCCccCcccc---cCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH
Q 018734          150 SLLHSRPK----------STVGTPAYIAPEVL---SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI  216 (351)
Q Consensus       150 ~~~~~~~~----------~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  216 (351)
                      ........          ....|+.|+|||++   .+... +.++|||||||+||-|+....||......        +|
T Consensus       196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~l--------aI  266 (738)
T KOG1989|consen  196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGKL--------AI  266 (738)
T ss_pred             ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcce--------eE
Confidence            43333221          12479999999996   34444 45599999999999999999999876432        46


Q ss_pred             HhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +...|.+|.++.++..+.+||..||+.||.+||++-+++.+-+.
T Consensus       267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence            77899999999999999999999999999999999999876543

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-44  Score=321.37  Aligned_cols=250  Identities=26%  Similarity=0.478  Sum_probs=205.7

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc-CCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~-~~~~~lv~e   78 (351)
                      +|++.+.||+|++|.||++.+..+++.||+|++.....   ....+.+|+.++++++|||++++++.+.. ...+|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            59999999999999999999999999999999865332   22457789999999999999999998864 457899999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-C
Q 018734           79 YAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R  155 (351)
Q Consensus        79 ~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~  155 (351)
                      |+++++|.+++..  ...+++.+++.++.|++.||.+||++|++||||||+||+++.++  .++|+|||++....... .
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN--IIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC--cEEEecccceEEecccCCc
Confidence            9999999998876  34589999999999999999999999999999999999997665  49999999987543222 2


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      .....|++.|+|||++.+..++.+ +|+|||||++|+|++|+.||........    ...+..... .+....+++.+.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~  232 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSL----VYRIIEGKL-PPMPKDYSPELGE  232 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHHhcCC-CCCccccCHHHHH
Confidence            234468999999999987776544 8999999999999999999976443222    222222211 1222357899999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccc
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ++.+||+.+|.+||++.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.1e-45  Score=329.36  Aligned_cols=255  Identities=29%  Similarity=0.488  Sum_probs=207.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      .|++.+.||.|++|.||++.+..+++.||+|.+.....   ....+.+|+.++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48999999999999999999999999999998865332   224678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CC
Q 018734           80 AAGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  156 (351)
Q Consensus        80 ~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~  156 (351)
                      +. ++|..++..  ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.  +||+|||++....... ..
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence            96 588888765  356899999999999999999999999999999999999987664  9999999987543222 22


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh--------------ccC
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------------QYK  222 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~  222 (351)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|+.||...................              ...
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            334578999999998776655666999999999999999999998765544433332211100              000


Q ss_pred             CCC---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          223 IPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       223 ~~~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ++.         ...++..++++|.+||+.||.+|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            111         12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-44  Score=327.60  Aligned_cols=256  Identities=27%  Similarity=0.421  Sum_probs=202.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++|+||+++++++......|+||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            679999999999999999999999999999999865432  234577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCC
Q 018734           80 AAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPK  157 (351)
Q Consensus        80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~  157 (351)
                      +. ++|...+.. ...+++..++.++.|++.||.|||++||+|+||||+|||++.++  +++|+|||+++...... ...
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG--ELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC--cEEEeccccccccCCCCCCCC
Confidence            96 577666654 45688899999999999999999999999999999999997665  49999999987543222 223


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhH-HHHHHHHHH-----------hhccC---
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIM-----------AVQYK---  222 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~-----------~~~~~---  222 (351)
                      ...+++.|+|||.+.+....+.++|||||||++|+|++|..||........ +.+......           .....   
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE  241 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccch
Confidence            346899999999987654334559999999999999999999976543211 111111000           00000   


Q ss_pred             -C----C-------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          223 -I----P-------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       223 -~----~-------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                       .    +       .....+..+.+++.+||+.||.+|||+.+++.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence             0    0       000125688999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.4e-45  Score=331.05  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=211.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||.|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++++......|+||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            589999999999999999999999999999999875433 3355778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  159 (351)
                      ++++|..++.+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++  .++|+|||++........ ....
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~--~~~l~Dfg~~~~~~~~~~~~~~~  175 (297)
T cd06656          99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  175 (297)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEECcCccceEccCCccCcCcc
Confidence            99999998865 4689999999999999999999999999999999999997665  499999999875432222 2334


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .+++.|+|||.+.+..+. .++|+|||||++|+|++|..||.............   .........+..++..+.+|+.+
T Consensus       176 ~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~  251 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPERLSAVFRDFLNR  251 (297)
T ss_pred             cCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec---cCCCCCCCCccccCHHHHHHHHH
Confidence            689999999999877664 45999999999999999999997654322211110   11111122234578889999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ||..+|.+||++.++++||||....+
T Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         252 CLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             HccCChhhCcCHHHHhcCchhccccc
Confidence            99999999999999999999976544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.5e-47  Score=323.33  Aligned_cols=262  Identities=28%  Similarity=0.427  Sum_probs=207.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC----cEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc-CCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK----ELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT-PTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~-~~~~   73 (351)
                      ..|++++.||+|+||.||+|..++++    +.+|+|++..+..   ......+|+.+++.++|||++.+..+|.. +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            57999999999999999999665543    3789999876533   34678899999999999999999999977 8899


Q ss_pred             EEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCCEEEeccCC
Q 018734           74 AIVMEYAAGGELFERICN-----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKICDFGY  146 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~--~~~~vkL~DFg~  146 (351)
                      ++++||.+. +|...|.-     ...++...++.+++||+.|+.|||++-|+||||||+||||..+  ..|+|||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999976 88887753     2458999999999999999999999999999999999999654  236899999999


Q ss_pred             CcccCCCCC----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---------hhHHHHHH
Q 018734          147 SKSSLLHSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED---------PKNFRKTI  213 (351)
Q Consensus       147 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---------~~~~~~~~  213 (351)
                      ++.....-.    ...++-|.+|+|||++.+...++++.||||+|||+.||++-.+.|.+...         .+++..++
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            986433322    23467899999999999999889999999999999999999988876431         11112221


Q ss_pred             HHHHh-hccCCCC------c------------------------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          214 SRIMA-VQYKIPD------Y------------------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       214 ~~~~~-~~~~~~~------~------------------------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      .-+.. ....+|.      +                        ..-++...+|+.+||++||-+|+|+.++|+|+||..
T Consensus       263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~  342 (438)
T KOG0666|consen  263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE  342 (438)
T ss_pred             HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence            11110 0001111      1                        112455889999999999999999999999999987


Q ss_pred             CC
Q 018734          263 NL  264 (351)
Q Consensus       263 ~~  264 (351)
                      ..
T Consensus       343 d~  344 (438)
T KOG0666|consen  343 DP  344 (438)
T ss_pred             CC
Confidence            63

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-45  Score=329.05  Aligned_cols=257  Identities=32%  Similarity=0.505  Sum_probs=209.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||.|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++...+..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            58999999999999999999999999999999886532   233568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--CC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~~  156 (351)
                      |+.++.+..+..+...+++..+..++.||+.||.|||++|++||||+|+||+++.++  .+||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~--~~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG--VLKLCDFGFARALRARPASPL  158 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEEeeecccccCCCccccc
Confidence            999877766666667799999999999999999999999999999999999998765  49999999987654433  23


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh------------hcc---
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA------------VQY---  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------~~~---  221 (351)
                      ....+++.|+|||++.+....+.++||||||+++|+|++|++||......+.+.........            ..+   
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            34578999999999987734456699999999999999999999876544333222111100            000   


Q ss_pred             CCC-----------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          222 KIP-----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       222 ~~~-----------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ..+           ....++..+.+||.+||..+|++|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000           011247889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-45  Score=329.82  Aligned_cols=259  Identities=25%  Similarity=0.439  Sum_probs=212.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++.....+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            579999999999999999999999999999998765432  335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      +++++|..++...+.+++..++.++.|++.||.|||+ ++++||||||+||+++.++  .++|+|||++..... .....
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~-~~~~~  161 (284)
T cd06620          85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELIN-SIADT  161 (284)
T ss_pred             CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhh-hccCc
Confidence            9999999999888889999999999999999999996 6999999999999997665  499999998764322 22234


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh-------hHHHHHHHHHHhhccCCCCccCCCH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-------KNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      ..|+..|+|||++.+..++. ++|||||||++|+|++|+.||......       ..+......+............++.
T Consensus       162 ~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYTV-KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE  240 (284)
T ss_pred             cccCcccCCHHHHccCCCCc-cchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCH
Confidence            57999999999987776554 499999999999999999999865432       1111222222221111111123678


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      .+.+|+.+||+.+|.+|||+.++++||||.+..
T Consensus       241 ~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         241 DLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            899999999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-44  Score=320.87  Aligned_cols=251  Identities=36%  Similarity=0.532  Sum_probs=210.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+.....   ....+.+|+.+++.++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            69999999999999999999999999999999875432   234677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           80 AAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      +++++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. .++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCcccc
Confidence            9999999999763  35899999999999999999999999999999999999975442 48999999988655444444


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ...|++.|+|||.+.+...+ .++||||||+++|+|++|..||...........    +..... .+....++..+.+++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~l~~li  233 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLK----IMSGTF-APISDRYSPDLRQLI  233 (256)
T ss_pred             ccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHH----HHhcCC-CCCCCCcCHHHHHHH
Confidence            56789999999999876654 459999999999999999999977654332222    221111 122235788999999


Q ss_pred             HHhcccCCCCCCChHHHhcCccc
Q 018734          238 SRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+||+.+|.+|||+.+++.||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.7e-45  Score=328.73  Aligned_cols=254  Identities=25%  Similarity=0.415  Sum_probs=204.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEE-----cCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVL-----TPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~-----~~~~~~l   75 (351)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++.........+.+|+.+++.+ +||||+++++++.     .....++
T Consensus        18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l   97 (286)
T cd06638          18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL   97 (286)
T ss_pred             cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence            689999999999999999999999999999998876444446678899999998 6999999999874     3467999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           76 VMEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      ||||++|++|.+++..    ...+++..++.++.|++.||.|||+++++||||||+||+++.++.  ++|+|||++....
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~  175 (286)
T cd06638          98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLT  175 (286)
T ss_pred             EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeecc
Confidence            9999999999887642    356899999999999999999999999999999999999987654  9999999987543


Q ss_pred             CCC-CCCCcccCCCccCcccccCC----cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc
Q 018734          152 LHS-RPKSTVGTPAYIAPEVLSRR----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  226 (351)
Q Consensus       152 ~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (351)
                      ... ......|++.|+|||++...    ...+.++|||||||++|+|++|+.||..............   .........
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~  252 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NPPPTLHQP  252 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cCCCcccCC
Confidence            222 22345699999999998532    1124559999999999999999999976543332221110   011111222


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ..++..+.+++.+||+.+|++|||+.++++|+||
T Consensus       253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            3467889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.9e-45  Score=327.93  Aligned_cols=249  Identities=29%  Similarity=0.454  Sum_probs=205.4

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734           10 IGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus        10 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ||+|+||.||+|.+..+++.||+|.+....    .....+.+|+.+++.++||||+++++++...+.+|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            799999999999999999999999986532    1233456899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCC
Q 018734           86 FERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP  163 (351)
Q Consensus        86 ~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~  163 (351)
                      .+++.+..  .+++..+..++.|++.||.|||++|++||||+|.||+++.++  .++|+|||++.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG--NVRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC--CEEEccCcchhhhccCCccccccCCC
Confidence            99987765  799999999999999999999999999999999999998765  49999999887544333334556889


Q ss_pred             CccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhccc
Q 018734          164 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA  243 (351)
Q Consensus       164 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  243 (351)
                      .|+|||.+.+..++ .++|||||||++|+|++|+.||...........+........  .+....+++.+.++|.+||+.
T Consensus       159 ~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         159 GYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA--VEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc--ccCCccCCHHHHHHHHHHccC
Confidence            99999998777754 459999999999999999999976544222222222222222  222235789999999999999


Q ss_pred             CCCCCC-----ChHHHhcCcccccC
Q 018734          244 NPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       244 ~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      +|.+||     ++.+++.||||...
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhcC
Confidence            999999     88889999999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-44  Score=320.78  Aligned_cols=250  Identities=30%  Similarity=0.473  Sum_probs=208.7

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      .|.+.+.||+|++|.||++.+..+++.|++|.+....   .....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            5889999999999999999999999999999886432   2345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-C
Q 018734           80 AAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  156 (351)
Q Consensus        80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~  156 (351)
                      +.|++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++  .++|+|||+++....... .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~--~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC--CEEEcccccceeccCccchh
Confidence            9999999998764  5689999999999999999999999999999999999998665  499999999875433222 2


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....|++.|+|||++.+..++. ++|+|||||++|+|++|+.||........    ...+..... .+....++..+.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~  232 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNE-KSDVWALGVVLYECCTGKHPFDANNQGAL----ILKIIRGVF-PPVSQMYSQQLAQL  232 (256)
T ss_pred             hccccCccccCHHHhcCCCCCC-ccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCC-CCCccccCHHHHHH
Confidence            3346899999999998777654 49999999999999999999976553222    222222211 12222578899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +.+||+.+|++||++.++++|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.9e-45  Score=328.60  Aligned_cols=252  Identities=26%  Similarity=0.414  Sum_probs=204.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEc------CCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLT------PTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~------~~~~~   74 (351)
                      .+|++.+.||.|+||.||++.+..+++.||+|++.........+..|+.+++++ +||||+++++++..      ...+|
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            468999999999999999999999999999999876554456678899988888 69999999999853      46789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      ++|||+.+++|.+++...  ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.  ++|+|||++.....
T Consensus        96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~  173 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhc
Confidence            999999999999988653  45889999999999999999999999999999999999987664  99999999875432


Q ss_pred             C-CCCCCcccCCCccCcccccC-----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc
Q 018734          153 H-SRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  226 (351)
Q Consensus       153 ~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (351)
                      . .......|++.|+|||.+..     ..+ +.++|+|||||++|+|++|..||...........    +..........
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~  248 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKS  248 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCcc
Confidence            2 22344579999999999853     234 3459999999999999999999976543222211    11111111122


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ..++..+.+||.+||+.+|.+||++.++++||||
T Consensus       249 ~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         249 KKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            3578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=5.6e-45  Score=330.11  Aligned_cols=257  Identities=30%  Similarity=0.473  Sum_probs=208.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~l   75 (351)
                      +++|++.+.||.|+||.||+|.+..+++.+|+|.+.....   ....+.+|+.++++++||||+++++++...  ...|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            4679999999999999999999999999999999875432   223567899999999999999999998877  89999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-
Q 018734           76 VMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-  153 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-  153 (351)
                      ||||+.+ +|.+.+.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.  ++|+|||++...... 
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence            9999975 8988887644 5899999999999999999999999999999999999987654  999999998754433 


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------  218 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------  218 (351)
                      .......+++.|+|||.+.+....+.++|+||||+++|+|++|.+||..........++......               
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            22334568899999999876654456699999999999999999999876654443333221100               


Q ss_pred             --hccC-------CCCccC--CCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          219 --VQYK-------IPDYVH--ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       219 --~~~~-------~~~~~~--~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                        ....       ...+..  +++.+.++|.+||+.+|++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              0000       000111  47889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-44  Score=323.42  Aligned_cols=250  Identities=24%  Similarity=0.379  Sum_probs=206.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +|++.+.||.|+||.||++.+. +++.+|+|.+.....       ....+.+|+..++.++|+||+++++++.+....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            6899999999999999999874 688999998764321       12357789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC---
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---  152 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~---  152 (351)
                      ++||+.+++|.+++.+...+++..++.++.|++.||.|||+.+|+|+||+|+||+++.++  .++|+|||++.....   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC--eEEeccchhhHhhhhccc
Confidence            999999999999998888899999999999999999999999999999999999998665  499999998864321   


Q ss_pred             ----CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh-ccCCCCcc
Q 018734          153 ----HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIPDYV  227 (351)
Q Consensus       153 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  227 (351)
                          ........|+..|+|||.+.+..++. ++|+|||||++|+|++|..||...........    +... ....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~  232 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGR-KSDIWSIGCTVFEMATGKPPLASMDRLAAMFY----IGAHRGLMPRLPD  232 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcc-hhhHHHHHHHHHHHHhCCCccccCChHHHHHH----hhhccCCCCCCCC
Confidence                11122346899999999998777654 49999999999999999999976543322211    1111 11112233


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .++..+.++|.+||+.+|.+||++.++++||||
T Consensus       233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            578899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-45  Score=327.81  Aligned_cols=257  Identities=28%  Similarity=0.518  Sum_probs=212.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||.|+||.||++.+..+++.||+|.+.....  ....+.+|+.+++.++||||+++++.+.....+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            578999999999999999999999999999998876532  235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           80 AAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        80 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      +.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++  .++|+|||++........ .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~-~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSLA-K  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHHh-h
Confidence            9999999999876 789999999999999999999999 9999999999999998755  499999998864432222 2


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-hhHHHHHHHHHHhhcc-CCCCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-PKNFRKTISRIMAVQY-KIPDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (351)
                      ...++..|+|||.+.+..+. .++|||||||++|+|++|..||..... .......+..+..... ..+.. .++..+.+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  235 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG-KFSPDFQD  235 (265)
T ss_pred             cccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh-hcCHHHHH
Confidence            26789999999999877664 459999999999999999999976421 1122222333222211 11111 27889999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +|.+||..+|.+|||+.+++.||||++.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.5e-45  Score=324.07  Aligned_cols=252  Identities=30%  Similarity=0.441  Sum_probs=204.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc------cCHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~   73 (351)
                      ..|++.+.||+|+||.||++.+..++..||+|++.....      ....+.+|+.+++.++||||+++++++..  ...+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            368999999999999999999999999999998864321      12357789999999999999999999875  3678


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ++++||+.+++|.+.+.+.+.+++..++.++.|++.||.|||+++++||||||+||+++.++  .++|+|||++......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~--~~~l~dfg~~~~~~~~  159 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRLQTI  159 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCCCccccccc
Confidence            99999999999999998888899999999999999999999999999999999999997665  4999999998743221


Q ss_pred             ----CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCC
Q 018734          154 ----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       154 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                          .......++..|+|||.+.+..++ .++|||||||++|+|++|+.||...........    .............+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~  234 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLPSHI  234 (266)
T ss_pred             cccCCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCchhc
Confidence                111234588999999999876664 459999999999999999999986543332221    11111111112346


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      ++.+.+++ +||..+|.+||+++++++||||+
T Consensus       235 ~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         235 SEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            78889999 67778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-44  Score=329.99  Aligned_cols=255  Identities=33%  Similarity=0.541  Sum_probs=210.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +.|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            479999999999999999999999999999998875432    2245678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---  154 (351)
                      ||+.|++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||+++......   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~--~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC--CEEEeeCCCccccCcCcccc
Confidence            9999999999998888899999999999999999999999999999999999997665  49999999886321110   


Q ss_pred             -------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc
Q 018734          155 -------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY  221 (351)
Q Consensus       155 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (351)
                                   ......|+..|+|||.+.+..+. .++|+|||||++|+|++|..||.+.....    ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~vl~el~~g~~pf~~~~~~~----~~~~~~~~~~  233 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEE----LFGQVISDDI  233 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccc
Confidence                         01123578899999998877765 44999999999999999999997654322    2222222222


Q ss_pred             CCCCc-cCCCHhHHHHHHHhcccCCCCCCC---hHHHhcCcccccC
Q 018734          222 KIPDY-VHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKN  263 (351)
Q Consensus       222 ~~~~~-~~~~~~~~~li~~~L~~~P~~Rps---~~eil~hp~~~~~  263 (351)
                      ..|.. ..++..+.++|.+||+.+|.+||+   +.++++||||...
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            22221 257889999999999999999997   7899999999664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.8e-45  Score=338.77  Aligned_cols=255  Identities=28%  Similarity=0.429  Sum_probs=204.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC------CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~   72 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.+...   ....+.+|+.+++.++||||+++++++...      ..
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            689999999999999999999999999999999865322   224567899999999999999999998644      35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      .|+||||+. ++|...+...  +++..+..++.|++.||.|||++||+||||||+||+++.++  .+||+|||+++....
T Consensus        96 ~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~  170 (353)
T cd07850          96 VYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGT  170 (353)
T ss_pred             EEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEccCccceeCCC
Confidence            799999996 4888877654  89999999999999999999999999999999999998766  499999999986544


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh--------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------------  218 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------  218 (351)
                      ........+++.|+|||.+.+..+.. ++|||||||++|+|++|+.||...+....+..++.....              
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CCCCCCCcccccccCHHHHhCCCCCC-chhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            44444557899999999998877754 499999999999999999999866543333322211100              


Q ss_pred             ----hcc--------------CCCC-----ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          219 ----VQY--------------KIPD-----YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       219 ----~~~--------------~~~~-----~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                          ...              ..+.     ....++.+.++|.+||+.||.+|||+.++|.||||..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                000              0000     1124567899999999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-45  Score=326.82  Aligned_cols=254  Identities=27%  Similarity=0.448  Sum_probs=207.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC------EEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPT------HLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~------~~~   74 (351)
                      ++|++.+.||.|+||.||++.+..+++.+++|++.........+.+|+.+++++ .||||+++++++....      .++
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            689999999999999999999999999999999887665556788999999998 6999999999997644      589


Q ss_pred             EEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc
Q 018734           75 IVMEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  150 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~  150 (351)
                      +||||+.+++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++...
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~  163 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA--EVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC--eEEECCCccceec
Confidence            99999999999888765    35799999999999999999999999999999999999998765  4999999988643


Q ss_pred             CCC-CCCCCcccCCCccCcccccCCc----CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC
Q 018734          151 LLH-SRPKSTVGTPAYIAPEVLSRRE----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD  225 (351)
Q Consensus       151 ~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (351)
                      ... .......|++.|+|||++....    ..+.++|||||||++|+|++|+.||...........+..   ........
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~  240 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTLKS  240 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCCCc
Confidence            222 2223456899999999875432    223459999999999999999999976543333222211   11112222


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ...++..+.+||.+||..||++|||+.++++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            23477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9e-45  Score=326.69  Aligned_cols=249  Identities=28%  Similarity=0.436  Sum_probs=198.6

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHH---HhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIIN---HKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~---~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .||+|+||.||++.+..+++.+|+|.+......    .....++..+   +...+||||+.+++.+...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999988654321    1223344433   334579999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCccc
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  161 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  161 (351)
                      +++|..++...+.+++..+..++.|++.||.|||+++|+||||||+|||++.++  .++|+|||++...... ......|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~--~~~l~dfg~~~~~~~~-~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSKK-KPHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC--CEEEccCCcceecccc-CccCcCC
Confidence            999999998888899999999999999999999999999999999999998666  4999999998643322 2234579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||.+.+....+.++||||+||++|+|++|..||........ ...........  ...+..++..+.++|.+||
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l  234 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVN--VELPDSFSPELKSLLEGLL  234 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCC--cCCccccCHHHHHHHHHHh
Confidence            99999999986544344559999999999999999999976543221 11111111112  2223357899999999999


Q ss_pred             ccCCCCCC-----ChHHHhcCcccccC
Q 018734          242 VANPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       242 ~~~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      ..||.+||     ++.++++||||...
T Consensus       235 ~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         235 QRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             cCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            99999999     69999999999774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.2e-44  Score=319.59  Aligned_cols=250  Identities=30%  Similarity=0.507  Sum_probs=210.6

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|++++.||.|+||.||.+++..+++.+++|.+....   .....+.+|+.++++++||||+++++++.....++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            6999999999999999999999999999999876532   2234677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CC
Q 018734           80 AAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  156 (351)
Q Consensus        80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~  156 (351)
                      +.+++|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++  .+||+|||++....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~--~~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC--CEEECcCcceEEcccccccc
Confidence            9999999998764  4689999999999999999999999999999999999998765  49999999987543322 22


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....|++.|+|||.+.+..++ .++|+|||||++|+|++|..||.........    ..+...... +....++..+.++
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~  232 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLV----VKIVQGNYT-PVVSVYSSELISL  232 (256)
T ss_pred             cccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHcCCCC-CCccccCHHHHHH
Confidence            345689999999999877655 4499999999999999999999765443322    222222222 2224578899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +.+||+.+|.+||++.++++|||+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-44  Score=323.47  Aligned_cols=249  Identities=29%  Similarity=0.515  Sum_probs=200.9

Q ss_pred             CCeeEeeee--cccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDI--GSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~l--G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.+  |.|+||.||++.+..++..+|+|.+........    |+.....+ +||||+++++++...+..|+|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            457777776  999999999999999999999999865432211    22222222 79999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ +.++|+|||++....   ....
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~---~~~~  165 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIG---TPSC  165 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecC---CCcc
Confidence            999999999998888999999999999999999999999999999999999998765 259999999887442   2233


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      ..|++.|+|||++.+..++. ++|||||||++|+|++|..||........-...+....  ....+....+++.+.++|.
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDV-SFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             CCCCCcccChhhhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHH
Confidence            46899999999998777654 49999999999999999999985443221111111111  2223344468999999999


Q ss_pred             HhcccCCCCCCC-hHHHhcCcccc
Q 018734          239 RIFVANPSRRIT-IKEIKSHPWFL  261 (351)
Q Consensus       239 ~~L~~~P~~Rps-~~eil~hp~~~  261 (351)
                      +||+.+|.+||+ ++++|+||||.
T Consensus       243 ~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        243 SMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHhccChhhCCchHHHHhcCCccc
Confidence            999999999996 69999999995

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.9e-44  Score=321.80  Aligned_cols=252  Identities=32%  Similarity=0.477  Sum_probs=205.9

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc------cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTP--TH   72 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~   72 (351)
                      .+.|++.+.||+|+||.||.+.+..+++.||+|.+.....      ....+.+|+.++++++||||+++++++.+.  ..
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            3689999999999999999999999999999998754221      123567899999999999999999998764  56


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      ++++|||+++++|.+++.+.+.+++..+..++.|++.||.|||+++++|+||||+||+++.++  .++|+|||++.....
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~~l~Dfg~~~~~~~  158 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG--NVKLGDFGASKRLQT  158 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC--CEEECcCcccccccc
Confidence            889999999999999998878899999999999999999999999999999999999998665  499999998874322


Q ss_pred             C----CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          153 H----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       153 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                      .    .......|+..|+|||.+.+..++ .++|||||||++|+|++|+.||..........    ...........+..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~  233 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPH  233 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchh
Confidence            1    112334689999999999776654 55999999999999999999997654332221    22211112222335


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ++..+.++|.+||. +|.+||++++++.|||+
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence            77889999999995 99999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-44  Score=326.04  Aligned_cols=238  Identities=19%  Similarity=0.207  Sum_probs=197.6

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEc----CCEEEEEEec
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLT----PTHLAIVMEY   79 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~----~~~~~lv~e~   79 (351)
                      ..||+|++|.||++..  +++.||+|++.......    ..+.+|+.++++++|||||++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            5789999999999998  57899999987654433    456699999999999999999999876    3578999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      +.+|+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.++  .+||+|||+++....  ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~--~~kl~dfg~~~~~~~--~~~~  179 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY--KLKIICHGLEKILSS--PPFK  179 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC--cEEEcccchHhhhcc--cccc
Confidence            9999999999988889999999999999999999998 4999999999999998766  499999999874322  2234


Q ss_pred             cccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          159 TVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ..||+.|+|||++.+  ..+ +.++|||||||++|+|++|+.||........    ...+.......+.....++.+.+|
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~l~~l  254 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEI----YDLIINKNNSLKLPLDCPLEIKCI  254 (283)
T ss_pred             ccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcCCCCCCCCcCcHHHHHH
Confidence            578999999999976  444 4559999999999999999999987653322    222323333333334678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||+.||++|||+.++++
T Consensus       255 i~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        255 VEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999985

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-45  Score=354.32  Aligned_cols=261  Identities=23%  Similarity=0.380  Sum_probs=192.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC-cEEEEE------------------EeccCcccCHHHHHHHHHHhcCCCCCcce
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK-ELVAMK------------------YIERGHKIDANVAREIINHKQLRHPNIIR   62 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~   62 (351)
                      ++|++++.||+|+||.||+|...... ..++.|                  .+.........+.+|+.++++++|||||+
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            58999999999999999998764322 112222                  11111222345778999999999999999


Q ss_pred             EEEEEEcCCEEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 018734           63 FKEVVLTPTHLAIVMEYAAGGELFERICNA-----GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP  137 (351)
Q Consensus        63 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~  137 (351)
                      +++++...+..|+|++++. ++|..++...     .......++.++.||+.||.|||++||+||||||+|||++.++  
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~--  304 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG--  304 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--
Confidence            9999999999999999995 5777776442     2345677889999999999999999999999999999997665  


Q ss_pred             CEEEeccCCCcccCCCC--CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---hhHHHHH
Q 018734          138 RLKICDFGYSKSSLLHS--RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED---PKNFRKT  212 (351)
Q Consensus       138 ~vkL~DFg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~  212 (351)
                      .+||+|||+++......  .....+||+.|+|||++.+..++. ++|||||||++|+|++|..++.....   ...+.+.
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCE-ITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCc-HHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            49999999997543322  223457999999999998887754 49999999999999998764433221   1222222


Q ss_pred             HHHHHhhccCCCC--------------------------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          213 ISRIMAVQYKIPD--------------------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       213 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      +..+......+|.                          ...++.++.++|.+||++||.+|||+.|+|.||||.....+
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~  463 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE  463 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence            2211100000110                          11356678899999999999999999999999999776443

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-44  Score=328.15  Aligned_cols=256  Identities=26%  Similarity=0.441  Sum_probs=201.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC------
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT------   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~------   71 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+.....   ......+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            5789999999999999999999999999999998865322   2235668999999999999999999886543      


Q ss_pred             --EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           72 --HLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        72 --~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                        ..++||||+.+ +|...+... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++  .+||+|||++.
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~  167 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG--ILKLADFGLAR  167 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC--cEEECcCCCcc
Confidence              46999999964 787777654 3689999999999999999999999999999999999997665  49999999987


Q ss_pred             ccCCCCC-----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh----
Q 018734          149 SSLLHSR-----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----  219 (351)
Q Consensus       149 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----  219 (351)
                      .......     .....++..|+|||.+.+....+.++||||||+++|+|++|+.||........... +..+...    
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~-~~~~~~~~~~~  246 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL-ISQLCGSITPE  246 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChh
Confidence            5432221     12346788999999986655345569999999999999999999977554332221 1111100    


Q ss_pred             ------------ccCCCC-----------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          220 ------------QYKIPD-----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       220 ------------~~~~~~-----------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                                  ....+.           ....+..+.+||.+||+.||.+|||++++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                        000010           00135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-44  Score=328.75  Aligned_cols=252  Identities=23%  Similarity=0.345  Sum_probs=197.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC----------------CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN----------------TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRF   63 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~   63 (351)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|++.....  ....+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            489999999999999999998643                344799998876432  23467899999999999999999


Q ss_pred             EEEEEcCCEEEEEEeccCCCChHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 018734           64 KEVVLTPTHLAIVMEYAAGGELFERICNA-------------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDL  124 (351)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Di  124 (351)
                      ++++...+..++||||+.+++|.+++...                   ..++...+..++.||+.||.|||++||+||||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl  164 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL  164 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence            99999999999999999999999988643                   23677889999999999999999999999999


Q ss_pred             CCCcEEecCCCCCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc--CCCC
Q 018734          125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYP  199 (351)
Q Consensus       125 kp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~p  199 (351)
                      ||+|||++.++  .+||+|||+++.......   .....++..|+|||++.+..++ .++|||||||++|+|++  +..|
T Consensus       165 kp~Nill~~~~--~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         165 ATRNCLVGENL--TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             chhheEEcCCc--cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCCCC
Confidence            99999998765  499999999875432211   1233467889999998777765 45999999999999986  5678


Q ss_pred             CCCCCChhHHHHHHHHHHhh--ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          200 FEDQEDPKNFRKTISRIMAV--QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       200 f~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      |........+..........  .........++..+.+|+.+||+.+|.+|||+.+|..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            87655433322221111111  1111223357889999999999999999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.6e-44  Score=320.15  Aligned_cols=257  Identities=28%  Similarity=0.477  Sum_probs=215.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||.|++|.||++.+..+++.|++|++.....  ....+.+|+..+++++||||+++++++......+++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            479999999999999999999999999999999876543  345688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC-
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-  157 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~-  157 (351)
                      +++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++  .++|+|||++.......... 
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~--~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG--EVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC--CEEEccCccceecccCCCccc
Confidence            9999999999888889999999999999999999999 9999999999999998765  49999999987554333322 


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccC-CCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l  236 (351)
                      ...++..|+|||.+.+..++ .++|+||||+++|+|++|+.||...... ........+.... ..+.... ++..+.++
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l  235 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYS-YAADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGP-PPSLPAEEFSPEFRDF  235 (264)
T ss_pred             ceeecccccCHhhhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCC-CCCCCcccCCHHHHHH
Confidence            45689999999998777654 4599999999999999999999776521 1222233322211 1222223 78899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      |.+||..+|++||++.++++||||+..
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHhc
Confidence            999999999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-44  Score=324.61  Aligned_cols=257  Identities=22%  Similarity=0.400  Sum_probs=203.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHH-HhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIIN-HKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~-~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....  ....+..|+.. ++.+.||||+++++++..++.+|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            579999999999999999999999999999998876432  22345556654 667799999999999999999999999


Q ss_pred             ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           79 YAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        79 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |++ ++|.+++..    ...+++..++.++.||+.||.|||++ +++||||||+||+++.++  ++||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG--QVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecccccccccc
Confidence            996 577776653    34689999999999999999999997 999999999999998765  4999999998754333


Q ss_pred             CCCCCcccCCCccCcccccCCc---CCCcchhHHHHHHHHHHHHcCCCCCCCCCCh-hHHHHHHHHHHhhccCCCCccCC
Q 018734          154 SRPKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                      .......|+..|+|||.+.+..   ..+.++|+|||||++|+|++|+.||...... ......   ........+. ..+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-~~~  233 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---VEEPSPQLPA-EKF  233 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH---HhcCCCCCCc-ccc
Confidence            3334456899999999886422   1244599999999999999999999754321 221111   1111112221 247


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      |.++.++|.+||..+|.+||++.++++||||.+...
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            889999999999999999999999999999987643

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.1e-45  Score=336.11  Aligned_cols=258  Identities=31%  Similarity=0.490  Sum_probs=206.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~   73 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....   ....+.+|+.+++.++||||+++++++...     ..+
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            689999999999999999999999999999999865322   234567899999999999999999987654     358


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+|+||+. ++|.+.+...+++++..+..++.|++.||.|||+++++||||||+||+++.++  .+||+|||++......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~--~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARTTSEK  161 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECcCccccccCCC
Confidence            99999995 68999998888999999999999999999999999999999999999997665  4999999998754332


Q ss_pred             -CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH----------------
Q 018734          154 -SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI----------------  216 (351)
Q Consensus       154 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----------------  216 (351)
                       .......++..|+|||.+.+....+.++|||||||++|+|++|++||...+.......+....                
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence             222345689999999998754434566999999999999999999997654322221111100                


Q ss_pred             ---Hh-hccC-----CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          217 ---MA-VQYK-----IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       217 ---~~-~~~~-----~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                         .. ....     ......+++.+.++|.+||+.+|.+|||+.++++||||..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence               00 0000     0012357889999999999999999999999999999954

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.9e-44  Score=320.07  Aligned_cols=250  Identities=31%  Similarity=0.534  Sum_probs=208.7

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|++.+.||+|+||.||.+.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            6999999999999999999999999999999886432   2234678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-C
Q 018734           80 AAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  156 (351)
Q Consensus        80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~  156 (351)
                      +.+++|.+.+...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++........ .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence            9999999988654  35899999999999999999999999999999999999976654  99999999875433222 1


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....|++.|+|||++.+...+. ++|+|||||++|+|++|..||.........    ..+..... .+....++..+.++
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~-~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~l  232 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLV----LKIIRGSY-PPVSSHYSYDLRNL  232 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCC-ccchhHHHHHHHHHHcCCCCccCCCHHHHH----HHHhcCCC-CCCcccCCHHHHHH
Confidence            2345889999999998777654 499999999999999999999765433322    22222221 22334678899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      |.+||+.+|.+||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-45  Score=335.77  Aligned_cols=259  Identities=29%  Similarity=0.482  Sum_probs=203.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....  .....+.+|+.+++.++||||+++++++...     ..+|
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            68999999999999999999999999999999986422  2234577899999999999999999887644     3589


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +++||+.+ +|...+. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||++.......
T Consensus        85 lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~  160 (336)
T cd07849          85 IVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEH  160 (336)
T ss_pred             EEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccc
Confidence            99999964 7877764 457999999999999999999999999999999999999977654  9999999987543222


Q ss_pred             C----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH-----------H--
Q 018734          155 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-----------M--  217 (351)
Q Consensus       155 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----------~--  217 (351)
                      .    .....||+.|+|||.+.+....+.++|||||||++|+|++|+.||........+..+....           .  
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1    1234689999999987655444566999999999999999999997654322221111100           0  


Q ss_pred             -------hhcc--CCC---CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          218 -------AVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       218 -------~~~~--~~~---~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                             ....  ..+   .....++.+.++|.+||+.+|.+|||+.++++||||....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence                   0000  000   1124678899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-44  Score=323.92  Aligned_cols=261  Identities=29%  Similarity=0.493  Sum_probs=208.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~lv~   77 (351)
                      ++|+..+.||.|++|.||++.+..+++.||+|.+.....  ....+.+|+++++.++||||+++++++...  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            579999999999999999999999999999998875433  335688999999999999999999988654  4789999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           78 EYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        78 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ||+++++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.  ++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence            99999999887643    356899999999999999999999999999999999999987654  999999998654322


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh-hHHHHHHHHHHhhc-cCCCC----cc
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQ-YKIPD----YV  227 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~-~~~~~----~~  227 (351)
                      . .....++..|+|||.+.+..++.+ +|||||||++|+|++|..||...... ....+....+.... ...+.    -.
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             c-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence            2 224468889999999987776555 99999999999999999999865220 01111122111111 01111    12


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      .+++.+.++|.+||+.+|.+|||+.+++.||||.+...+
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  275 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK  275 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence            356789999999999999999999999999999665443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-44  Score=339.42  Aligned_cols=249  Identities=23%  Similarity=0.358  Sum_probs=199.8

Q ss_pred             CCeeEeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++.+.||+|+||.||++..     ..++..||+|++.....  ....+.+|+.+++.+ +|||||++++++......
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4799999999999999999974     34567899999865332  234678899999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC------------------------------------------------------------
Q 018734           74 AIVMEYAAGGELFERICNAG------------------------------------------------------------   93 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~------------------------------------------------------------   93 (351)
                      ++|||||++|+|.+++....                                                            
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            99999999999998886421                                                            


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC---
Q 018734           94 ---------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---  155 (351)
Q Consensus        94 ---------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---  155 (351)
                                     .+++..+..++.||+.||.|||++||+||||||+|||++.+.  .+||+|||+++.......   
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCcccccc
Confidence                           367888999999999999999999999999999999998655  499999999875432221   


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....++..|+|||++.+..++ .++|||||||++|+|++ |..||........+.+.+.    .......+...+.++.
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~  347 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYRMLSPECAPSEMY  347 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCccCCCCCCCCHHHH
Confidence            1123356679999999877765 45999999999999997 8999977654433333222    2222223335678999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcC
Q 018734          235 NLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +|+.+||+.+|++|||+.++++.
T Consensus       348 ~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         348 DIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3e-44  Score=323.65  Aligned_cols=255  Identities=29%  Similarity=0.497  Sum_probs=207.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +|++.+.||.|++|.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            58999999999999999999999999999999875432  2356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CC
Q 018734           81 AGGELFERICNA---GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  156 (351)
Q Consensus        81 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~  156 (351)
                      .+ +|.+++...   ..+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++....... ..
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~--~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG--ELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC--cEEEeecchhhhhcCCcccc
Confidence            75 888877654   3589999999999999999999999999999999999998665  49999999987543222 12


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHH-----------h---hccC
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-----------A---VQYK  222 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----------~---~~~~  222 (351)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|+.||......+....+.....           .   ....
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            3356889999999987655555669999999999999999999987765544443332110           0   0000


Q ss_pred             CCC---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          223 IPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       223 ~~~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+.         ....+..+.+++.+||+.+|.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            010         12357789999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.6e-44  Score=321.36  Aligned_cols=247  Identities=20%  Similarity=0.326  Sum_probs=201.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++...   ..+..||+|.+.....  ....+.+|+..++.++||||+++++++......++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            47999999999999999999765   4467899998876432  234678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++  .++|+|||.+........
T Consensus        85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCcccccccccch
Confidence            9999999999998764 5789999999999999999999999999999999999997765  499999998764322211


Q ss_pred             C--CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 P--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      .  ....++..|+|||.+.+..++. ++|||||||++|+|++ |..||.........    ..+ ......+.+..++..
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~ell~~g~~p~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~  236 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSS-ASDVWSFGIVMWEVMSYGERPYWDMSGQDVI----KAV-EDGFRLPAPRNCPNL  236 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccc-hhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH----HHH-HCCCCCCCCCCCCHH
Confidence            1  1233567899999998777654 4999999999999775 99999876543322    222 222334555578899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+++.+||+.+|.+||++.+|++
T Consensus       237 ~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         237 LHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.5e-45  Score=335.52  Aligned_cols=262  Identities=27%  Similarity=0.435  Sum_probs=209.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc----CCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT----PTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~----~~~~~   74 (351)
                      ++|++.+.||.|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++..    ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            479999999999999999999999999999999876432   23457789999999999999999998753    35789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +||||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++.......
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC--ELRIGDFGMARGLSSSP  161 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--cEEecccccceeecccC
Confidence            9999995 58999988778899999999999999999999999999999999999998766  49999999987543222


Q ss_pred             C-----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHH------------
Q 018734          155 R-----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM------------  217 (351)
Q Consensus       155 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------------  217 (351)
                      .     .....|+..|+|||.+.+....+.++|||||||++|+|++|+.||........+..+.....            
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~  241 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS  241 (334)
T ss_pred             cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence            1     12347899999999986644445669999999999999999999977654333222111100            


Q ss_pred             -------h-hccCCC-----CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          218 -------A-VQYKIP-----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       218 -------~-~~~~~~-----~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                             . .....+     .....+..+.++|.+||+.+|.+||++.+++.||||.+...+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence                   0 000000     013468899999999999999999999999999999765443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.3e-45  Score=339.91  Aligned_cols=248  Identities=22%  Similarity=0.343  Sum_probs=198.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++++.||+|+||.||++.+..+     +..||+|++.....  ....+.+|+.+++.+ +|||||++++++.....+
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            4699999999999999999986443     35799999875432  234577899999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-------------------------------------------------------------
Q 018734           74 AIVMEYAAGGELFERICNA-------------------------------------------------------------   92 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~-------------------------------------------------------------   92 (351)
                      ++|||||.+|+|.+++...                                                             
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            9999999999999888542                                                             


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC---CCcc
Q 018734           93 ---------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTV  160 (351)
Q Consensus        93 ---------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~---~~~~  160 (351)
                               .++++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++........   ....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeeccCCC
Confidence                     2467889999999999999999999999999999999998655  4999999998754332211   1223


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      +++.|||||++.+..++. ++|||||||++|+|++ |+.||........+...    .......+....+++++.+++.+
T Consensus       276 ~~~~y~aPE~~~~~~~~~-~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~  350 (374)
T cd05106         276 LPVKWMAPESIFDCVYTV-QSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM----VKRGYQMSRPDFAPPEIYSIMKM  350 (374)
T ss_pred             CccceeCHHHhcCCCCCc-cccHHHHHHHHHHHHhCCCCCCccccccHHHHHH----HHcccCccCCCCCCHHHHHHHHH
Confidence            566799999997777654 5999999999999997 99999875543332222    22222333333568999999999


Q ss_pred             hcccCCCCCCChHHHhc
Q 018734          240 IFVANPSRRITIKEIKS  256 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~  256 (351)
                      ||+.+|.+|||+.++++
T Consensus       351 cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         351 CWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=329.00  Aligned_cols=257  Identities=27%  Similarity=0.405  Sum_probs=201.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcC--CCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKN--TKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THLA   74 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~   74 (351)
                      +|++.+.||+|+||.||++.+..  +++.||+|.+....    .....+.+|+.+++.++||||+++++++.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            69999999999999999999988  89999999987632    2335678899999999999999999999988  8899


Q ss_pred             EEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCCEEEeccCCC
Q 018734           75 IVMEYAAGGELFERICNA-----GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKICDFGYS  147 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~--~~~~vkL~DFg~a  147 (351)
                      +||||+.+ +|...+...     ..+++..++.++.||+.||.|||+++|+||||||+||+++.+  ..+.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999965 676666432     368999999999999999999999999999999999999761  1345999999998


Q ss_pred             cccCCCCC----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh---------HHHHHHH
Q 018734          148 KSSLLHSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK---------NFRKTIS  214 (351)
Q Consensus       148 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------~~~~~~~  214 (351)
                      ........    .....+|+.|+|||++.+....+.++|||||||++|+|++|++||.......         .+...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            75432222    2334689999999998765544566999999999999999999997654321         1111111


Q ss_pred             HHH-----------------h--hccCCCCc------------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          215 RIM-----------------A--VQYKIPDY------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       215 ~~~-----------------~--~~~~~~~~------------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+.                 .  .......+            ...+..+.+++.+||+.+|.+|||+.+++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            000                 0  00000111            1456789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-44  Score=323.63  Aligned_cols=254  Identities=30%  Similarity=0.481  Sum_probs=206.9

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      |++.+.||.|++|.||++.+..+++.||+|++.....   ....+.+|+..++.++||||+++++++......|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            7889999999999999999999999999999875432   2346788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CC
Q 018734           81 AGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PK  157 (351)
Q Consensus        81 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~  157 (351)
                      . ++|.+++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.++  .++|+|||++........ ..
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCccccC
Confidence            5 68999887765  789999999999999999999999999999999999998755  599999999875432222 23


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHH--------------hhccCC
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------------AVQYKI  223 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------------~~~~~~  223 (351)
                      ...+++.|+|||++.+....+.++|+||||+++|+|++|++||..........+......              ......
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            346789999999887655445569999999999999999999987655443333222110              000000


Q ss_pred             ---------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          224 ---------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       224 ---------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                               .....++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                     1123567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=5.3e-44  Score=321.49  Aligned_cols=250  Identities=28%  Similarity=0.450  Sum_probs=200.4

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHH---HHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREI---INHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~---~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .||+|+||.||++.+..+++.||+|.+......    ......|.   ..++...||||+.+++.+.....+++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999988754221    11223333   34455689999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCccc
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  161 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  161 (351)
                      |++|..++...+.+++..++.++.|++.||.|||+++++||||||+||+++.++  .++|+|||++..... .......|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~--~~kl~dfg~~~~~~~-~~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSK-KKPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC--CEEEccCcCccccCc-cCCcCcCC
Confidence            999999998888899999999999999999999999999999999999998765  499999999874332 22334579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      +..|+|||.+.+....+.++||||+||++|+|++|+.||........ ..............|  ..++..+.+++.+||
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l  234 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP--DSFSPELRSLLEGLL  234 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCC--CcCCHHHHHHHHHHh
Confidence            99999999997554334559999999999999999999976532211 111122222222233  346899999999999


Q ss_pred             ccCCCCCC-----ChHHHhcCcccccCC
Q 018734          242 VANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       242 ~~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      ..+|.+||     ++.++++||||....
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            99999999     999999999997754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1e-44  Score=328.45  Aligned_cols=257  Identities=28%  Similarity=0.490  Sum_probs=209.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .|.....||.|+||.||++.+..++..||+|++..... ....+.+|+..++.++||||+++++.+...+..|+||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            35556789999999999999999999999998865332 23457789999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCcc
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTV  160 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~  160 (351)
                      +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++  .++|+|||++....... ......
T Consensus       103 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~--~~kL~dfg~~~~~~~~~~~~~~~~  179 (292)
T cd06658         103 GGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG--RIKLSDFGFCAQVSKEVPKRKSLV  179 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC--CEEEccCcchhhcccccccCceee
Confidence            9999887754 5689999999999999999999999999999999999998765  49999999886432222 223456


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHh
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  240 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (351)
                      |++.|+|||.+.+..++ .++|+||||+++|+|++|+.||........+.. +..  ......+....++..+.+++.+|
T Consensus       180 ~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~li~~~  255 (292)
T cd06658         180 GTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRD--NLPPRVKDSHKVSSVLRGFLDLM  255 (292)
T ss_pred             cCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh--cCCCccccccccCHHHHHHHHHH
Confidence            89999999999776665 459999999999999999999986554332221 111  11122233335788999999999


Q ss_pred             cccCCCCCCChHHHhcCcccccCCCh
Q 018734          241 FVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       241 L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      |+.+|.+|||+.++++||||....++
T Consensus       256 l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         256 LVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             ccCChhHCcCHHHHhhChhhhccCCc
Confidence            99999999999999999999865443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.1e-44  Score=316.86  Aligned_cols=250  Identities=30%  Similarity=0.523  Sum_probs=207.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~~lv~   77 (351)
                      +|++.+.||.|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            58999999999999999999999999999998865432   23457789999999999999999998764  45789999


Q ss_pred             eccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           78 EYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCH-----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        78 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH-----~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      ||+++++|.+++..    ..++++..++.++.||+.||.|||     +.+++|+||+|+||+++.++  .+||+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEecccccc
Confidence            99999999998865    357899999999999999999999     89999999999999998665  59999999988


Q ss_pred             ccCCCCC-CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCcc
Q 018734          149 SSLLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  227 (351)
Q Consensus       149 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (351)
                      ....... .....|++.|+|||.+.+..++ .++|+||||+++|+|++|+.||..... ..   ....+..... .+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~-~~---~~~~~~~~~~-~~~~~  232 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQ-LQ---LASKIKEGKF-RRIPY  232 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCH-HH---HHHHHhcCCC-CCCcc
Confidence            6544332 3345789999999999777654 459999999999999999999987652 22   2222222222 12233


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .++..+.+++.+||+.+|.+||++.+|++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            678999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3.3e-44  Score=323.26  Aligned_cols=249  Identities=22%  Similarity=0.372  Sum_probs=203.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCC-----cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTK-----ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~   73 (351)
                      +++|++.+.||+|+||.||++.+...+     ..||+|.+.....  ....+.+|+..++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            357999999999999999999986655     6899998865432  234578899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 018734           74 AIVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP  137 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~  137 (351)
                      +++|||+.+++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||+++.++  
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~--  161 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL--  161 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC--
Confidence            9999999999999998764                4578899999999999999999999999999999999998765  


Q ss_pred             CEEEeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHH
Q 018734          138 RLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  213 (351)
Q Consensus       138 ~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  213 (351)
                      .++|+|||+++......   ......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||......+..    
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~----  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI----  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----
Confidence            49999999987543221   22344678899999998777765 45999999999999998 99999876543222    


Q ss_pred             HHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          214 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+.. ....+....++..+.+|+.+||+.+|.+||++.+++++
T Consensus       237 ~~i~~-~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         237 EMIRS-RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHc-CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            22222 12223334688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-44  Score=319.12  Aligned_cols=246  Identities=32%  Similarity=0.507  Sum_probs=200.1

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHH-HHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~-~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||.|+||.||+|.+..+++.||+|++.+....    ......|.. .....+||||+++++++...+.+|+++||+.+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999999999999999998654321    122334443 34556899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccC
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT  162 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt  162 (351)
                      ++|..++...+.+++..+..++.|++.||.|||+.+++||||+|+||+++.++  .++|+|||++.....   .....|+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~---~~~~~~~  156 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG--HLKLTDFGLSRNGLE---NKKFVGT  156 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--cEEEeecccceeccc---cccCCCC
Confidence            99999998888899999999999999999999999999999999999998765  499999998874322   3345689


Q ss_pred             CCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--CCccCCCHhHHHHHHHh
Q 018734          163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLSRI  240 (351)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~  240 (351)
                      +.|+|||.+.+..+ +.++||||||+++|+|++|..||........+.    .+.......  .....+++.+.+++.+|
T Consensus       157 ~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~i~~~  231 (260)
T cd05611         157 PDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFD----NILSRRINWPEEVKEFCSPEAVDLINRL  231 (260)
T ss_pred             cCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcccCCCCcccccCCHHHHHHHHHH
Confidence            99999999987765 455999999999999999999997655433222    222222222  22235789999999999


Q ss_pred             cccCCCCCCC---hHHHhcCcccccC
Q 018734          241 FVANPSRRIT---IKEIKSHPWFLKN  263 (351)
Q Consensus       241 L~~~P~~Rps---~~eil~hp~~~~~  263 (351)
                      |+.+|++||+   +.+++.||||.+.
T Consensus       232 l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         232 LCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             ccCCHHHccCCCcHHHHHcChHhhcC
Confidence            9999999995   4799999999664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.5e-44  Score=330.44  Aligned_cols=260  Identities=24%  Similarity=0.366  Sum_probs=209.7

Q ss_pred             CCeeE-eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC---------------HHHHHHHHHHhcCCCCCcceEEE
Q 018734            2 EKYEL-MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---------------ANVAREIINHKQLRHPNIIRFKE   65 (351)
Q Consensus         2 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~e~~~~~~l~hp~Iv~~~~   65 (351)
                      +||.. .+.||.|+||.||++.+..+++.||+|++.......               ..+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            57765 477999999999999999999999999886533221               24678999999999999999999


Q ss_pred             EEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccC
Q 018734           66 VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG  145 (351)
Q Consensus        66 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg  145 (351)
                      ++......++||||+. ++|.+.+.....+++..+..++.|++.||.|||++|++||||+|+||+++.++  .++|+|||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~--~~kl~dfg  164 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG--ICKIADFG  164 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC--CEEECCcc
Confidence            9999999999999996 58999998888899999999999999999999999999999999999998766  49999999


Q ss_pred             CCcccCC---------------CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHH
Q 018734          146 YSKSSLL---------------HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR  210 (351)
Q Consensus       146 ~a~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  210 (351)
                      ++.....               ........+++.|+|||.+.+....+.++|+|||||++|+|++|.+||........+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            8864331               1111233578899999998776555666999999999999999999998776554443


Q ss_pred             HHHHHHHhhccC-CC---------------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          211 KTISRIMAVQYK-IP---------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       211 ~~~~~~~~~~~~-~~---------------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      .+.......... ++                     .....+..+.++|.+||+.+|.+|||++++|.||||....
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            333221110000 00                     0123578899999999999999999999999999997653

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1e-43  Score=314.79  Aligned_cols=252  Identities=31%  Similarity=0.511  Sum_probs=212.9

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~lv~   77 (351)
                      +|.+.+.||+|++|.||++.+..+++.|++|++....   .....+.+|+..+++++||||+++++++...  ..+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5899999999999999999999999999999987654   2345688999999999999999999999988  8999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--  155 (351)
                      ||+.+++|.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecccccccc
Confidence            9999999999998888999999999999999999999999999999999999998755  499999999876554443  


Q ss_pred             -CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          156 -PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                       .....++..|+|||.+.+.... .++||||||+++|+|++|..||........   .................++..+.
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYG-RAADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHH
Confidence             3456789999999999777654 459999999999999999999987652221   12222211112222335688999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCccc
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +++.+||+.+|++||++.+++.||||
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         235 DFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-46  Score=327.06  Aligned_cols=257  Identities=29%  Similarity=0.481  Sum_probs=213.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC--CC----cceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PN----IIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h--p~----Iv~~~~~~~~~~~~~l   75 (351)
                      +||.++..+|+|+||.|..+.|..++..||+|+++.-.+..+..+-|++++.++.+  |+    +|++.++|...+++||
T Consensus        89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi  168 (415)
T KOG0671|consen   89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI  168 (415)
T ss_pred             cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence            68999999999999999999999999999999999888777888899999999943  33    8899999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC----------C--------C
Q 018734           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG----------S--------P  135 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~----------~--------~  135 (351)
                      |+|.+ |.++++++..++  +++-.+++.+++|++.++.+||+.+++|.||||+|||+-+          .        .
T Consensus       169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k  247 (415)
T KOG0671|consen  169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK  247 (415)
T ss_pred             EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence            99999 679999998765  5889999999999999999999999999999999999831          1        1


Q ss_pred             CCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR  215 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  215 (351)
                      ...|+|+|||.|+..  .......+.|..|+|||++.+-+++.+ +||||+||||+|+++|...|+..++.+.+. ++.+
T Consensus       248 s~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHLa-MMer  323 (415)
T KOG0671|consen  248 STAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHLA-MMER  323 (415)
T ss_pred             CcceEEEecCCccee--ccCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHHH-HHHH
Confidence            235899999998743  344466789999999999999999877 999999999999999999999988766552 2222


Q ss_pred             HHh------------------hccCCCCc---------------cC--------CCHhHHHHHHHhcccCCCCCCChHHH
Q 018734          216 IMA------------------VQYKIPDY---------------VH--------ISQDCRNLLSRIFVANPSRRITIKEI  254 (351)
Q Consensus       216 ~~~------------------~~~~~~~~---------------~~--------~~~~~~~li~~~L~~~P~~Rps~~ei  254 (351)
                      +..                  ....+|..               ..        --.++.|||.+||..||.+|+|+.|+
T Consensus       324 IlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EA  403 (415)
T KOG0671|consen  324 ILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREA  403 (415)
T ss_pred             hhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHH
Confidence            211                  00111110               00        01258899999999999999999999


Q ss_pred             hcCcccccC
Q 018734          255 KSHPWFLKN  263 (351)
Q Consensus       255 l~hp~~~~~  263 (351)
                      |.||||...
T Consensus       404 L~HpFF~~~  412 (415)
T KOG0671|consen  404 LSHPFFARL  412 (415)
T ss_pred             hcCHHhhcC
Confidence            999999754

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.5e-44  Score=355.28  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=201.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      |++|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+..|++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            6899999999999999999999999999999999875432    234678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccC
Q 018734           77 MEYAAGGELFERICNA-----------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG  145 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-----------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg  145 (351)
                      |||++|++|.+++...           ..++...+..++.||+.||.|||++||+||||||+|||++.++.  ++|+|||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFG  158 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWG  158 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecC
Confidence            9999999999988642           23456778899999999999999999999999999999987664  9999999


Q ss_pred             CCcccCCC-------------------CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh
Q 018734          146 YSKSSLLH-------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP  206 (351)
Q Consensus       146 ~a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  206 (351)
                      +++.....                   ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            98754110                   011224699999999999887765 4599999999999999999999764432


Q ss_pred             hHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ....   ............+..+++.+.+++.+||+.+|.+||+..+.+.
T Consensus       238 ki~~---~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        238 KISY---RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK  284 (932)
T ss_pred             hhhh---hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2111   1111111122233467889999999999999999987665543

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.4e-44  Score=321.70  Aligned_cols=254  Identities=28%  Similarity=0.429  Sum_probs=209.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .|+..+.||.|+||.||.+.+..++..||+|++....  .....+.+|+.+++.++||||+++++++.+....|+||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            5788899999999999999999999999999887543  22346778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  159 (351)
                      .|++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.++  +++|+|||++........ ....
T Consensus        85 ~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06640          85 GGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG--DVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC--CEEEcccccceeccCCccccccc
Confidence            99999998865 5689999999999999999999999999999999999998665  499999999875433222 2334


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .++..|+|||.+.+...+ .++|+|||||++|+|++|..||..........    .+. ..........++..+.+++.+
T Consensus       162 ~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06640         162 VGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIP-KNNPPTLTGEFSKPFKEFIDA  235 (277)
T ss_pred             cCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhh-cCCCCCCchhhhHHHHHHHHH
Confidence            688999999999777664 44999999999999999999997654322211    111 111111222467889999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ||+.+|.+||++.+++.||||.+...
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         236 CLNKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             HcccCcccCcCHHHHHhChHhhhcch
Confidence            99999999999999999999976544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-44  Score=326.55  Aligned_cols=257  Identities=23%  Similarity=0.354  Sum_probs=203.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +.|...+.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.++.++. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            457778899999999999999999999999999875432  2345778999998886 9999999999999999999999


Q ss_pred             ccCCCChHHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           79 YAAGGELFERI---C--NAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        79 ~~~~~~L~~~l---~--~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |+.+ ++.++.   .  ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++  .++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG--NIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC--cEEEeecchhHHhcc
Confidence            9864 554432   1  24679999999999999999999997 4999999999999998665  499999999875443


Q ss_pred             CCCCCCcccCCCccCcccccCC--cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CC--CCcc
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI--PDYV  227 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~--~~~~  227 (351)
                      ........|++.|+|||++.+.  ...+.++|||||||++|+|++|+.||.....   ....+........ ..  ....
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCCCCcCCCcCCC
Confidence            3333445789999999998766  2334559999999999999999999976541   1122222221111 11  1123


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      .++..+.+|+.+||+.+|.+|||++++++||||....
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            4788999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-44  Score=332.16  Aligned_cols=258  Identities=31%  Similarity=0.462  Sum_probs=212.0

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCC-----EEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPT-----HLA   74 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-----~~~   74 (351)
                      +|++.+.||.|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6999999999999999999999999999999887643   23356888999999999999999999988775     789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      ++|+|+. ++|...+.+...+++..++.++.||+.||.|||++||+||||||.|||++.++  +++|+|||++.......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccc
Confidence            9999997 48999998878999999999999999999999999999999999999998765  59999999988654432


Q ss_pred             ----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc----------
Q 018734          155 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ----------  220 (351)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------  220 (351)
                          ......+++.|+|||++.+....+.++|+|||||++|+|++|++||......+.+..+........          
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence                234456899999999998774445669999999999999999999987765443333222110000          


Q ss_pred             ----------cC-----CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          221 ----------YK-----IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       221 ----------~~-----~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                ..     ......++..+.++|.+||+.+|.+||++.+++.||||.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                      00     00112367889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.9e-44  Score=315.63  Aligned_cols=246  Identities=25%  Similarity=0.413  Sum_probs=201.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.... +..+|+|.+.........+.+|+.+++.++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            579999999999999999998765 5679999887655555678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC--CC
Q 018734           82 GGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KS  158 (351)
Q Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~--~~  158 (351)
                      +++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||+++........  ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG--VVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC--eEEECCCCCccccCCCceeccCC
Confidence            9999999875 35689999999999999999999999999999999999998665  4999999988754322211  22


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..++..|+|||.+.+..+. .++|+||||+++|+|++ |+.||...........    +... ...+.....+..+.+++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~----i~~~-~~~~~~~~~~~~~~~li  234 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM----ISRG-FRLYRPKLASMTVYEVM  234 (256)
T ss_pred             CCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHCC-CCCCCCCCCCHHHHHHH
Confidence            2356689999999877765 45999999999999999 8999977554333222    2221 12222334678899999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 018734          238 SRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~  256 (351)
                      .+||+.+|.+|||+.++++
T Consensus       235 ~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-46  Score=338.71  Aligned_cols=237  Identities=31%  Similarity=0.472  Sum_probs=206.8

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      -++.||.|+.|.||+++..  ++.||||+++.-      ...+|.-|++|+||||+.+.+++....-+|||||||..|-|
T Consensus       128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhccCcccceeeeecc--CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            3578999999999999987  568999976432      23577889999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCc
Q 018734           86 FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY  165 (351)
Q Consensus        86 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y  165 (351)
                      ...|+....++......|..+|+.|+.|||.+.|||||||.-||||..+..  |||+|||-++.........+++||..|
T Consensus       200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaW  277 (904)
T KOG4721|consen  200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAW  277 (904)
T ss_pred             HHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhh
Confidence            999999999999999999999999999999999999999999999976665  999999988865555556678999999


Q ss_pred             cCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCC
Q 018734          166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP  245 (351)
Q Consensus       166 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P  245 (351)
                      ||||++.....+.+ +|||||||+|||||||..||.+....    .++-.+....+.+|.+..+++.++=||++||+-.|
T Consensus       278 MAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp  352 (904)
T KOG4721|consen  278 MAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP  352 (904)
T ss_pred             hCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence            99999988876555 99999999999999999999875432    23333444555677777889999999999999999


Q ss_pred             CCCCChHHHhcC
Q 018734          246 SRRITIKEIKSH  257 (351)
Q Consensus       246 ~~Rps~~eil~h  257 (351)
                      ..||++.+||.|
T Consensus       353 RNRPSFrqil~H  364 (904)
T KOG4721|consen  353 RNRPSFRQILLH  364 (904)
T ss_pred             CCCccHHHHHHH
Confidence            999999999998

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=319.93  Aligned_cols=254  Identities=31%  Similarity=0.511  Sum_probs=206.7

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEEEEEe
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAIVME   78 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~lv~e   78 (351)
                      |++.+.||.|+||.||++.+..+++.+|+|++....   .....+.+|+.+++.++|||++++++++...  ...++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            789999999999999999999999999999998753   2234677899999999999999999999888  89999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--C
Q 018734           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  155 (351)
Q Consensus        79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~  155 (351)
                      |+.+ +|...+.+. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.  ++|+|||++.......  .
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence            9975 888888765 57999999999999999999999999999999999999987664  9999999987554332  1


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc-cCCCC---------
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPD---------  225 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~---------  225 (351)
                      .....++..|+|||.+.+....+.++||||||+++|+|++|+.||...........+........ ..++.         
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            23346788999999887654445669999999999999999999987665444333322111000 00000         


Q ss_pred             --------------ccC-CCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          226 --------------YVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       226 --------------~~~-~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                                    ... .+..+.+++.+||+.+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                          111 37889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.5e-43  Score=319.66  Aligned_cols=255  Identities=29%  Similarity=0.513  Sum_probs=209.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      +|...+.||+|++|.||++.+..+++.+++|++..... ....+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            45556799999999999999999999999998864332 23457789999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCcc
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTV  160 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~  160 (351)
                      |++|.+++.. .++++..+..++.|++.||.|||++|++||||+|+||+++.++  .++|+|||++....... ......
T Consensus       100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648         100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG--RVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC--cEEEcccccchhhccCCccccccc
Confidence            9999998877 6789999999999999999999999999999999999998765  49999999876433222 123356


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc-cCCCCccCCCHhHHHHHHH
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~  239 (351)
                      |++.|+|||.+.+..+.. ++|||||||++|+|++|+.||..........    .+.... ........++..+.+++.+
T Consensus       177 ~~~~y~aPE~~~~~~~~~-~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~  251 (285)
T cd06648         177 GTPYWMAPEVISRLPYGT-EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK----RIRDNLPPKLKNLHKVSPRLRSFLDR  251 (285)
T ss_pred             CCccccCHHHhcCCCCCC-cccHHHHHHHHHHHHhCCCCCcCCCHHHHHH----HHHhcCCCCCcccccCCHHHHHHHHH
Confidence            899999999997776654 4999999999999999999997654322222    222111 1122223478899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ||+.+|.+||++.++++||||.+..+
T Consensus       252 ~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         252 MLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HcccChhhCcCHHHHccCcccccCCC
Confidence            99999999999999999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-43  Score=315.61  Aligned_cols=247  Identities=21%  Similarity=0.337  Sum_probs=204.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .+|.+.+.||+|+||.||++.+..+++.||+|.+.........+.+|+..++.++||||+++++++.....++++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            35889999999999999999999999999999987654444568899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC--C
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--K  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~--~  157 (351)
                      +++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||++.........  .
T Consensus        86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~df~~~~~~~~~~~~~~~  163 (263)
T cd05052          86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  163 (263)
T ss_pred             CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC--cEEeCCCccccccccceeeccC
Confidence            99999998754  3589999999999999999999999999999999999997665  4999999998754332211  1


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+++.|+|||.+.+..++.. +|||||||++|+|++ |..||...........    + ...+..+....++..+.++
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----L-EKGYRMERPEGCPPKVYEL  237 (263)
T ss_pred             CCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H-HCCCCCCCCCCCCHHHHHH
Confidence            2234668999999977776544 999999999999998 9999976543322221    1 1222334445688999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||+.+|++|||+.++++
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.4e-44  Score=323.97  Aligned_cols=257  Identities=30%  Similarity=0.496  Sum_probs=205.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCC------
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPT------   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~------   71 (351)
                      +++|++.+.||.|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            368999999999999999999999999999999986532   22345678999999999999999999987654      


Q ss_pred             ----EEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           72 ----HLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        72 ----~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                          .+++|+||+.+ ++...+... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.  +||+|||+
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~  162 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGL  162 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccc
Confidence                79999999976 676766653 46899999999999999999999999999999999999987664  99999999


Q ss_pred             CcccCCCC--CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CC
Q 018734          147 SKSSLLHS--RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI  223 (351)
Q Consensus       147 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  223 (351)
                      +.......  ......+++.|+|||.+.+....+.++|||||||++|+|++|++||........+..+......... ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            87543332  1223457889999998866544456699999999999999999999876554444333322111000 00


Q ss_pred             -----------------------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          224 -----------------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       224 -----------------------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                                             ..+..++..+.+++.+||+.+|.+||++.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                   1122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-43  Score=311.42  Aligned_cols=251  Identities=31%  Similarity=0.512  Sum_probs=211.1

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .|.+.+.||.|++|.||++.+..+++.+++|++..... ....+.+|+..++.++||||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            48899999999999999999998999999999877554 44678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcc
Q 018734           82 GGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV  160 (351)
Q Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~  160 (351)
                      +++|.+++... ..+++..+..++.|++.||.+||++|++||||+|+||+++.++  .++|+|||++.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG--EVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC--eEEEeecccccccccccccccee
Confidence            99999998776 5799999999999999999999999999999999999998765  49999999987554433234567


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHh
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  240 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (351)
                      ++..|+|||.+.+... +.++|+||||+++|+|++|+.||.............   .......+....++..+.++|.+|
T Consensus       159 ~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         159 GTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             cCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCCCCcCcccccCHHHHHHHHHH
Confidence            8999999999977665 455999999999999999999997654322222111   111112333333588999999999


Q ss_pred             cccCCCCCCChHHHhcCcc
Q 018734          241 FVANPSRRITIKEIKSHPW  259 (351)
Q Consensus       241 L~~~P~~Rps~~eil~hp~  259 (351)
                      |+.+|.+|||+.++++|||
T Consensus       235 l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         235 LQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCChhhCCCHHHHhcCCC
Confidence            9999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=318.68  Aligned_cols=253  Identities=28%  Similarity=0.487  Sum_probs=208.1

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCC---CCCcceEEEEEEcCCEEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~---hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      .|++.+.||.|+||.||++.+..+++.||+|.+.....  ....+.+|+.+++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            58899999999999999999999999999998865422  2345778999988886   999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~  156 (351)
                      ||+.+++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++  .++|+|||++........ .
T Consensus        82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCcccc
Confidence            99999999988865 4789999999999999999999999999999999999998755  599999999875443322 2


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc--cCCCHhHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY--VHISQDCR  234 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  234 (351)
                      ....|+..|+|||.+.+....+.++|+|||||++|+|++|..||..........    .+...  ..+..  ..++..+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~--~~~~~~~~~~~~~~~  232 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----LIPKS--KPPRLEDNGYSKLLR  232 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh----ccccC--CCCCCCcccCCHHHH
Confidence            334689999999998765544566999999999999999999997654322211    11111  11111  12678999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      +++.+||+.+|.+||++.+++.||||++..
T Consensus       233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         233 EFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.8e-43  Score=313.71  Aligned_cols=247  Identities=32%  Similarity=0.522  Sum_probs=205.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +|++.+.||.|+||.||++.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++.+.+...+|++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            6899999999999999999999999999999886432  23356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCC
Q 018734           81 AGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPK  157 (351)
Q Consensus        81 ~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~  157 (351)
                      ++++|.+++..  ...+++..+..++.|++.||.|||++|++|+||||+||+++.++  +++|+|||++....... ...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG--KVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC--cEEEcccCcceeecccccccc
Confidence            99999988864  34589999999999999999999999999999999999997665  49999999987543322 223


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ...|++.|+|||++.+..++ .++|+||||+++|+|++|..||.......    ....+..... .+....++..+.+||
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~li  232 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKN----LILKVCQGSY-KPLPSHYSYELRSLI  232 (255)
T ss_pred             cccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHH----HHHHHhcCCC-CCCCcccCHHHHHHH
Confidence            45689999999999777764 45999999999999999999997644322    2222222222 223345788999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.+|.+||++.+++..
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=5.1e-44  Score=324.69  Aligned_cols=253  Identities=27%  Similarity=0.496  Sum_probs=208.0

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      |+....||.|+||.||++.+..+++.||+|++.... .....+.+|+..++.++||||+++++++..+...|++|||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            555678999999999999999999999999986533 2335677899999999999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~g  161 (351)
                      ++|..++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .++|+|||++....... ......|
T Consensus       103 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~--~~kL~dfg~~~~~~~~~~~~~~~~~  179 (297)
T cd06659         103 GALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLVG  179 (297)
T ss_pred             CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC--cEEEeechhHhhcccccccccceec
Confidence            999887654 5689999999999999999999999999999999999998765  49999999886433222 2234579


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc-cCCCCccCCCHhHHHHHHHh
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHISQDCRNLLSRI  240 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~  240 (351)
                      ++.|+|||++.+..+. .++|||||||++|+|++|+.||...........    +.... ........++..+.++|.+|
T Consensus       180 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         180 TPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             CccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhccCCCCccccCCCCHHHHHHHHHH
Confidence            9999999999777664 459999999999999999999986554332221    11111 11222335788999999999


Q ss_pred             cccCCCCCCChHHHhcCcccccCC
Q 018734          241 FVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       241 L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      |+.+|.+||++.++++||||.+..
T Consensus       255 l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         255 LTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             hcCCcccCcCHHHHhhChhhccCC
Confidence            999999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-43  Score=314.71  Aligned_cols=251  Identities=33%  Similarity=0.529  Sum_probs=208.1

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|.+.+.||+|+||.||++.+..++..||+|.+....   .....+.+|+.+++.++||||+++++.+......++++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            6899999999999999999999999999999986532   2334677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC-
Q 018734           80 AAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-  156 (351)
Q Consensus        80 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~-  156 (351)
                      +.+++|.+++....  .+++..+..++.|++.||.|||+++++|+||||+||+++.++. .++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence            99999999887643  5799999999999999999999999999999999999986643 3799999988754332221 


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....|++.|+|||.+.+..++ .++|+||||+++|+|++|..||.........    ....... ..+....++..+.++
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~  233 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLV----LKICQGY-FAPISPNFSRDLRSL  233 (257)
T ss_pred             cccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHhccc-CCCCCCCCCHHHHHH
Confidence            234589999999998776654 4599999999999999999999765432222    2222211 122334578899999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccc
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      |.+||+.+|.+|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-45  Score=339.99  Aligned_cols=251  Identities=25%  Similarity=0.435  Sum_probs=208.9

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEec-----cCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCE--EEEEE
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-----RGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTH--LAIVM   77 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-----~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~--~~lv~   77 (351)
                      +....||+|+|-+||+|.|..+|..||.-.++     +......++..|+.+|+.|+|||||++++++.+..+  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34578999999999999999999999854332     222333679999999999999999999999988765  88999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |++..|+|+.++++.++.+...++.|++||++||.|||++.  |||||||.+||||+++ .|.|||+|+|+|+... ...
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl~r-~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATLLR-KSH  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHHhh-ccc
Confidence            99999999999999999999999999999999999999885  9999999999999865 4679999999998543 334


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ..+.+|||.|||||++. ..|+.. +||||||.++.||+|+..||.....+.++.+   ++..+........--.+++++
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK---KV~SGiKP~sl~kV~dPevr~  275 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYK---KVTSGIKPAALSKVKDPEVRE  275 (632)
T ss_pred             cceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHH---HHHcCCCHHHhhccCCHHHHH
Confidence            45589999999999996 556544 9999999999999999999998876655443   333322221111223578999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ||.+||.. .+.|||+.|+|+||||...
T Consensus       276 fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  276 FIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHhcC-chhccCHHHHhhChhhccc
Confidence            99999999 9999999999999999865

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.1e-43  Score=315.31  Aligned_cols=252  Identities=27%  Similarity=0.408  Sum_probs=203.9

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            5789999999999999999999999999999998764322    224577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +||+.+++|.+++..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.  ++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~  158 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccc
Confidence            999999999888753    345899999999999999999999999999999999999977654  99999998875432


Q ss_pred             CCC-CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          153 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       153 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      ... .....|++.|+|||.+.+..++. ++|+||||+++|+|++|+.||......  .......+............++.
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCc-hhhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCH
Confidence            221 22346889999999998777654 499999999999999999999654321  12222222222221111124678


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+.+++.+||+.+|++||++.++++.
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            89999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.1e-44  Score=324.84  Aligned_cols=257  Identities=25%  Similarity=0.430  Sum_probs=202.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC-------
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP-------   70 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-------   70 (351)
                      +++|++.+.||.|+||.||++.+..+++.||+|++.....   ......+|+.+++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            5789999999999999999999999999999998865322   224567899999999999999999987543       


Q ss_pred             -CEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           71 -THLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        71 -~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                       ..+++||+|+.+ +|...+.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||++.
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~  163 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR  163 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccch
Confidence             357999999965 67766654 457999999999999999999999999999999999999987664  9999999987


Q ss_pred             ccCCCCC------------CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH
Q 018734          149 SSLLHSR------------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI  216 (351)
Q Consensus       149 ~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  216 (351)
                      .......            .....+++.|+|||.+.+....+.++|||||||++|+|++|++||...........+....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~  243 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC  243 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            4332211            1233578999999998765444556999999999999999999998766544443333211


Q ss_pred             Hhhc----------------c---CCC-----CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          217 MAVQ----------------Y---KIP-----DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       217 ~~~~----------------~---~~~-----~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ....                .   ..+     .+..+++.+.++|.+||+.+|.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            1000                0   000     012345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.1e-43  Score=319.37  Aligned_cols=258  Identities=30%  Similarity=0.537  Sum_probs=210.8

Q ss_pred             CeeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      .|++.+.||.|+||.||.+.+.   .+++.||+|++....     .....+.+|+.+++++ +||||+++++++..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999885   478899999986532     2235577899999999 589999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++  ++||+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceecccc
Confidence            99999999999999998888899999999999999999999999999999999999998765  5999999998754322


Q ss_pred             C--CCCCcccCCCccCcccccCCc-CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          154 S--RPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       154 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .  ......|+..|+|||.+.+.. ..+.++||||||+++|+|++|..||...........+...+.....  +....++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  236 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMS  236 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCC
Confidence            1  123456899999999986532 2345599999999999999999999754433333333333333222  2233578


Q ss_pred             HhHHHHHHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 018734          231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      +.+.+++.+||+.+|.+||     ++.++++||||.+..
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            8999999999999999997     899999999997753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.7e-44  Score=316.99  Aligned_cols=247  Identities=34%  Similarity=0.572  Sum_probs=207.9

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus        10 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ||.|+||.||++.+..+++.+++|++.....    ....+.+|+.++++++||||+++++++......|++|||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999865432    335678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---------CC
Q 018734           86 FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---------RP  156 (351)
Q Consensus        86 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---------~~  156 (351)
                      .+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.  ++|+|||++.......         ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence            999988788999999999999999999999999999999999999987664  9999999987543321         12


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....+++.|+|||.+.+... +.++|+||||+++|+|++|..||........    ...+.......+....++..+.++
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEI----FQNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             cCcccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCcCCCccccCCHHHHHH
Confidence            33468899999999877665 4559999999999999999999976654322    222333334444443458999999


Q ss_pred             HHHhcccCCCCCCCh---HHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITI---KEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~---~eil~hp~~~~~  263 (351)
                      +.+||+.+|.+|||+   .++|+||||.+.
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            999999999999999   999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6e-44  Score=320.60  Aligned_cols=250  Identities=34%  Similarity=0.601  Sum_probs=211.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|.+.+.||.|+||.||++.+..+++.||+|++....    .....+.+|+.++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            58999999999999999999999999999999987632    22356778899999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--  154 (351)
                      ||++.+++|.+.+.+.+.+++..++.++.|++.||.+||++|++|+||+|+||+++.++  +++|+|||++.......  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~--~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEecCCccccccCCcccc
Confidence            99999999999999888999999999999999999999999999999999999997665  49999999887433222  


Q ss_pred             -------------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHH
Q 018734          155 -------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR  215 (351)
Q Consensus       155 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  215 (351)
                                         ......|+..|+|||++.+... +.++|+||||+++++|++|+.||........    ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~  233 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLT----FQK  233 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHH----HHH
Confidence                               1123357899999999877665 4459999999999999999999987653222    222


Q ss_pred             HHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCCh----HHHhcCccc
Q 018734          216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITI----KEIKSHPWF  260 (351)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~----~eil~hp~~  260 (351)
                      +......+|  ..+++.+.++|.+||+.+|.+||++    .++++||||
T Consensus       234 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         234 ILKLEYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHhcCCCCC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            333333333  3678999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.8e-43  Score=314.81  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=201.7

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      .....||+|+||.||++.+..++..||+|.+..... ....+.+|+.+++.++||||+++++++..+...++++||+.++
T Consensus        11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   90 (268)
T cd06624          11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG   90 (268)
T ss_pred             CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence            345689999999999999999999999998865433 2346789999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCc
Q 018734           84 ELFERICNA-GRF--SEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  159 (351)
Q Consensus        84 ~L~~~l~~~-~~l--~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  159 (351)
                      +|...+... ..+  ++..+..++.||+.||.|||++||+||||||+||+++... +.++|+|||++....... .....
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~  169 (268)
T cd06624          91 SLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTETF  169 (268)
T ss_pred             CHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCccccC
Confidence            999998764 445  8889999999999999999999999999999999997533 359999999886432221 12234


Q ss_pred             ccCCCccCcccccCCc-CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          160 VGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      .|++.|+|||.+.+.. ..+.++|+||||+++|+|++|+.||...........   ..............+++.+.+++.
T Consensus       170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~  246 (268)
T cd06624         170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF---KVGMFKIHPEIPESLSAEAKNFIL  246 (268)
T ss_pred             CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh---hhhhhccCCCCCcccCHHHHHHHH
Confidence            5899999999986543 234569999999999999999999976443221111   111111111122357889999999


Q ss_pred             HhcccCCCCCCChHHHhcCccc
Q 018734          239 RIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +||+.+|.+|||+.+++.||||
T Consensus       247 ~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         247 RCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.3e-44  Score=322.64  Aligned_cols=256  Identities=26%  Similarity=0.443  Sum_probs=210.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||.|+||.||++.+..++..||+|.+.... .....+.+|+.+++.++||||+++++.+......|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            58999999999999999999999889999999986433 23356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  159 (351)
                      .+++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++........ ....
T Consensus        99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~--~~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647          99 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC--CEEEccCcceecccccccccccc
Confidence            999999988653 578999999999999999999999999999999999997665  499999998764432222 2334


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||............   .......++....++..+.+++.+
T Consensus       176 ~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~  251 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNR  251 (293)
T ss_pred             cCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHHHHHH
Confidence            689999999999777664 4599999999999999999999765432221111   011111222333567889999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ||+.+|.+||++.+++.||||....
T Consensus       252 ~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         252 CLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.5e-43  Score=326.53  Aligned_cols=261  Identities=26%  Similarity=0.417  Sum_probs=205.1

Q ss_pred             CeeEeeeecccCceEEEEEEEcCC--CcEEEEEEeccCcc---cCHHHHHHHHHHhcC-CCCCcceEEEEEEc----CCE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNT--KELVAMKYIERGHK---IDANVAREIINHKQL-RHPNIIRFKEVVLT----PTH   72 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~----~~~   72 (351)
                      +|++.+.||+|+||.||++.+..+  +..||+|++.....   ....+.+|+.+++++ .||||+++++....    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            689999999999999999999988  89999998875322   234577899999998 59999999987532    246


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      ++++++++. ++|.+.+.....+++..++.++.||+.||.|||++|++||||||+|||++.++  .+||+|||+++....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~--~~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC--ELKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC--CEEeCcCCCceeccc
Confidence            889999985 68999998888899999999999999999999999999999999999998765  499999999875332


Q ss_pred             CC-----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHH----------
Q 018734          153 HS-----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM----------  217 (351)
Q Consensus       153 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----------  217 (351)
                      ..     ......||+.|+|||.+.+....+.++|||||||++|+|++|.+||........+...+....          
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            21     123357899999999886644345669999999999999999999987554332222211100          


Q ss_pred             -h------------hc-cCC-CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          218 -A------------VQ-YKI-PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       218 -~------------~~-~~~-~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                       .            .. ..+ ......+..+.+|+.+||+.+|.+|||+.+++.||||.+-..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence             0            00 000 0122357899999999999999999999999999999765433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-43  Score=328.23  Aligned_cols=258  Identities=24%  Similarity=0.413  Sum_probs=205.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC------CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~   72 (351)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++...      ..
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            689999999999999999999999999999999875322   234577899999999999999999988643      34


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      .|++++++ +++|...+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||++.... 
T Consensus        97 ~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--~~kl~dfg~~~~~~-  171 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTD-  171 (345)
T ss_pred             EEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC--CEEEeccccccccc-
Confidence            78888887 7788777754 4689999999999999999999999999999999999998766  49999999987532 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHH---------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM---------------  217 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~---------------  217 (351)
                       .......|++.|+|||.+.+....+.++|||||||++|+|++|+.||........+..+.....               
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (345)
T cd07877         172 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  250 (345)
T ss_pred             -ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhH
Confidence             2234457899999999987644345569999999999999999999976554333332221100               


Q ss_pred             ----hhccCCC------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          218 ----AVQYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       218 ----~~~~~~~------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                          ......+      .....++.+.++|.+||+.+|.+||++.+++.||||.+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         251 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence                0000001      01235788999999999999999999999999999986543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.2e-43  Score=320.11  Aligned_cols=255  Identities=27%  Similarity=0.394  Sum_probs=205.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++......    ...+.+|+.+++.++||||+++++++......|+||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            5789999999999999999999999999999988643221    235778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      ||+.| ++.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.  ++|+|||++....   ..
T Consensus        95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~---~~  168 (307)
T cd06607          95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVS---PA  168 (307)
T ss_pred             HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecC---CC
Confidence            99974 67666653 457899999999999999999999999999999999999987664  9999999886432   22


Q ss_pred             CCcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          157 KSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      ....|++.|+|||++.+  ....+.++||||||+++|+|++|+.||...........    +............++..+.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  244 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNDSPTLSSNDWSDYFR  244 (307)
T ss_pred             CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----HhcCCCCCCCchhhCHHHH
Confidence            34568899999999842  22234459999999999999999999976543222211    1111111111124678999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      ++|.+||+.+|.+||++.+++.||||.....+
T Consensus       245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  276 (307)
T cd06607         245 NFVDSCLQKIPQDRPSSEELLKHRFVLRERPP  276 (307)
T ss_pred             HHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence            99999999999999999999999999876554

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.5e-44  Score=329.63  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=205.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC------E
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT------H   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~------~   72 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++....      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            689999999999999999999999999999998865322   2245778999999999999999999987653      4


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +++||+|+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .++|+|||++.... 
T Consensus        95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~dfg~~~~~~-  169 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQTD-  169 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeecccccccc-
Confidence            68999999 7788877754 5789999999999999999999999999999999999997665  49999999987432 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh--------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------------  218 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------  218 (351)
                       .......+++.|+|||.+.+....+.++|+|||||++|+|++|+.||...........+......              
T Consensus       170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07880         170 -SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA  248 (343)
T ss_pred             -cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence             22334568999999999876444456699999999999999999999876543333222211000              


Q ss_pred             --hccCCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          219 --VQYKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       219 --~~~~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                        .....+         ....+++.+.++|.+||+.||.+|||+.+++.||||....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence              000000         1134678899999999999999999999999999997653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.9e-44  Score=324.33  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=199.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcE--EEEEEeccCc--ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~--~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++.+.||+|+||.||+|.+..++..  +|+|.+....  .....+.+|+.++.++ +||||+++++++...+.+|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            36899999999999999999998877654  5777665422  2234677899999999 89999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 018734           76 VMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRL  139 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~v  139 (351)
                      ||||+++++|.+++...+                .+++..++.++.||+.||.|||++|++||||||+|||++.++  .+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~--~~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC--cE
Confidence            999999999999986532                578999999999999999999999999999999999997665  49


Q ss_pred             EEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHh
Q 018734          140 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA  218 (351)
Q Consensus       140 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  218 (351)
                      ||+|||++.............++..|+|||.+.+..++ .++|||||||++|+|++ |..||..........    .+ .
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~-~  237 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-P  237 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCCc-ccccchhhhhHHHHHHhcCCCCcccCChHHHHH----HH-h
Confidence            99999998643222222223356779999998776654 55999999999999998 999997654432222    11 1


Q ss_pred             hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .....+....+++.+.+|+.+||+.+|.+||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222233334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-46  Score=368.44  Aligned_cols=254  Identities=30%  Similarity=0.440  Sum_probs=214.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC---cccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ||.-+.+||.|.||.||.|.+..+|+..|+|-+.-.   .+.-..+.+|..++..++|||+|+++++-.+...++|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            566778999999999999999999999999977543   22335678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-----
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-----  154 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-----  154 (351)
                      |.||+|.+.+..++-.++...+.+..|++.|+.|||++|||||||||+||+++.++.  +|++|||.|.......     
T Consensus      1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCCH
Confidence            999999999999888899999999999999999999999999999999999988775  9999999987543332     


Q ss_pred             CCCCcccCCCccCcccccCCcC--CCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          155 RPKSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      .....+|||.|||||++.+...  ...+.|||||||++.||+||+.||...+..-   .++-++.... ..+.+..+|++
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~~gh-~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVAAGH-KPQIPERLSSE 1469 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHhccC-CCCCchhhhHh
Confidence            1234679999999999976542  2456899999999999999999998765432   2333333332 22333469999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      .++||.+||+.||.+|+++.|+|+|.|-..
T Consensus      1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            999999999999999999999999988543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.3e-43  Score=310.75  Aligned_cols=250  Identities=35%  Similarity=0.550  Sum_probs=210.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|++.+.||.|+||.||++.+..++..||+|++.....   ....+.+|++.++.++|||++++.+.+......++++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            69999999999999999999999999999999876432   335678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           80 AAGGELFERICNA----GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        80 ~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      +++++|...+.+.    ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++  .++|+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~--~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG--LVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC--cEEECCccceeecccCcc
Confidence            9999999998763    6799999999999999999999999999999999999998655  49999999987543332 


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      ......|++.|+|||.+.+..+.. ++|+||+|+++++|++|..||.......    ......... ..+....++..+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~  232 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNY-KSDIWSLGCVLYELCTLKHPFEGENLLE----LALKILKGQ-YPPIPSQYSSELR  232 (258)
T ss_pred             eecceeeeecccChhHhccCCCCc-cccHHHHHHHHHHHHcCCCCCCCCcHHH----HHHHHhcCC-CCCCCCCCCHHHH
Confidence            223457899999999987777654 4999999999999999999997655322    222222221 1222236788999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCccc
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +++.+||..+|.+|||+.++|+||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-44  Score=332.08  Aligned_cols=259  Identities=24%  Similarity=0.399  Sum_probs=207.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCE------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTH------   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~------   72 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++.....      
T Consensus        15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07851          15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD   94 (343)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence            57999999999999999999999999999999886532   122456789999999999999999988866554      


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +++|++|+ +++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++  +++|+|||++.....
T Consensus        95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~--~~kL~dfg~~~~~~~  170 (343)
T cd07851          95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC--ELKILDFGLARHTDD  170 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEccccccccccc
Confidence            89999999 6699888865 5799999999999999999999999999999999999998665  599999999875432


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh--------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------------  218 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------  218 (351)
                        ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||........+..+......              
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  248 (343)
T cd07851         171 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA  248 (343)
T ss_pred             --cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence              2344578999999999866444456699999999999999999999876544333322211000              


Q ss_pred             ------hccC-C----CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          219 ------VQYK-I----PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       219 ------~~~~-~----~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                            .... .    ..+...+..+.++|.+||+.+|.+|||+.+|+.||||.+...+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                  0000 0    0112458899999999999999999999999999999876554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.3e-44  Score=321.69  Aligned_cols=252  Identities=28%  Similarity=0.412  Sum_probs=206.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .|+..+.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.+++.++||||+++++++......|+||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            57788999999999999999999999999998864332  2346788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~~~  159 (351)
                      ++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++........ ....
T Consensus        85 ~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          85 GGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhcc
Confidence            99999988754 56899999999999999999999999999999999999987654  99999999875432221 2234


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .|+..|+|||.+.+..++ .++|+|||||++|+|++|+.||..........    .+.. .........++..+.+++.+
T Consensus       162 ~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPK-NSPPTLEGQYSKPFKEFVEA  235 (277)
T ss_pred             cCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhc-CCCCCCCcccCHHHHHHHHH
Confidence            688999999999877665 44999999999999999999997654322211    1111 11111112467889999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ||+.+|++||++.+++.||||...
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         236 CLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             HccCCcccCcCHHHHHHhHHHHHH
Confidence            999999999999999999999654

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-43  Score=328.63  Aligned_cols=258  Identities=27%  Similarity=0.395  Sum_probs=203.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcC----------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTP----------   70 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~----------   70 (351)
                      .+|++.+.||.|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            589999999999999999999999999999998865443 234578899999999999999999876544          


Q ss_pred             ----CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           71 ----THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        71 ----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                          ...|+||||+. ++|...+.. +.+++..++.++.||+.||.|||++||+||||||+||+++..+ +.++|+|||+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~  161 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGL  161 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCccc
Confidence                35799999996 588877754 4689999999999999999999999999999999999997443 2489999999


Q ss_pred             CcccCCCCC----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH------
Q 018734          147 SKSSLLHSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------  216 (351)
Q Consensus       147 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------  216 (351)
                      +........    .....++..|+|||.+.+....+.++|||||||++|+|++|+.||............+...      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07854         162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE  241 (342)
T ss_pred             ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            864322111    1234688999999987664444566999999999999999999998765444333322210      


Q ss_pred             ------------Hh-hcc--CCC---CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          217 ------------MA-VQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       217 ------------~~-~~~--~~~---~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                                  .. ...  ..+   ....++.++.+||.+||+.+|.+|||+.+++.||||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                        00 000  000   01246788999999999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-43  Score=318.68  Aligned_cols=247  Identities=25%  Similarity=0.392  Sum_probs=202.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|.+.+.||+|+||.||++.+..     +++.||+|.+......  ...+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            578899999999999999998753     3678999998765433  357889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEE
Q 018734           75 IVMEYAAGGELFERICNAG--------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLK  140 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~--------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vk  140 (351)
                      +||||+.+++|.+++...+              .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~k  162 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL--VVK  162 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC--eEE
Confidence            9999999999999987542              378899999999999999999999999999999999998765  499


Q ss_pred             EeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHH
Q 018734          141 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI  216 (351)
Q Consensus       141 L~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  216 (351)
                      |+|||++.......   ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.........    ..+
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~----~~~  237 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVI----ECI  237 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHH
Confidence            99999987432221   1233456788999999988776544 999999999999998 99999776543322    222


Q ss_pred             HhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..... .+....++..+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         238 TQGRL-LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            22222 2223357899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-43  Score=309.57  Aligned_cols=250  Identities=32%  Similarity=0.491  Sum_probs=211.7

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|++.+.||+|++|.||++.+..+++.|++|.+.....   ....+.+|+.++++++|||++++++++.+....+++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            68999999999999999999999999999999876543   335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~~  158 (351)
                      +.+++|.+++.....+++..+..++.|++.||.+||++|++||||+|+||+++.++  .++|+|||++........ ...
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCcccccc
Confidence            99999999998888899999999999999999999999999999999999998754  599999999875443322 234


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      ..++..|+|||.+.+... +.++||||||+++|+|++|+.||............    .. ....+....++..+.+++.
T Consensus       159 ~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~i~  232 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI----VQ-DDHPPLPEGISPELKDFLM  232 (254)
T ss_pred             cccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----hc-cCCCCCCCCCCHHHHHHHH
Confidence            568999999999877664 45599999999999999999999765532222221    11 1112223357889999999


Q ss_pred             HhcccCCCCCCChHHHhcCccc
Q 018734          239 RIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +||..+|++|||+.+++.||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.4e-43  Score=313.01  Aligned_cols=246  Identities=24%  Similarity=0.395  Sum_probs=202.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|+++++||+|+||.||++.+.. +..||+|.+.........+.+|+.+++.++||||+++++++......+++|||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            689999999999999999999764 5679999887655445678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CC
Q 018734           82 GGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  157 (351)
Q Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~  157 (351)
                      +++|.+++..  ...++...+..++.|++.||.|||+++++||||||+||+++.++  .++|+|||++........  ..
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL--MCKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC--cEEECCCccceecCCCceeccC
Confidence            9999999865  34688999999999999999999999999999999999998765  499999999875432221  12


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...++..|+|||.+.+..++ .++|||||||++|+|++ |..||..........    .+ ......+....++..+.++
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS----AL-QRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             CCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH----HH-HcCCCCCCCCCCCHHHHHH
Confidence            23456789999999777665 44999999999999998 999997654332221    11 2223445555688999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||..+|++||+++++++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-43  Score=312.06  Aligned_cols=251  Identities=33%  Similarity=0.491  Sum_probs=205.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc------ccCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH------KIDANVAREIINHKQLRHPNIIRFKEVVLTP--THL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~   73 (351)
                      ..|++.+.||+|+||.||++.+..+++.||+|.+....      .....+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999875321      1123577899999999999999999998764  568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ++++||+++++|.+.+...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++  .++|+|||+++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG--NVKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--CEEECccccccccccc
Confidence            99999999999999998878899999999999999999999999999999999999998665  4999999998754221


Q ss_pred             ----CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCC
Q 018734          154 ----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       154 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                          .......|+..|+|||.+.+...+ .++|+|||||++|+|++|+.||..........    ...........+..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~p~~~  234 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIF----KIATQPTKPMLPDGV  234 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHH----HHHcCCCCCCCCccc
Confidence                112234689999999999877654 45999999999999999999997654332222    222222222223468


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ++.+.+++.+||+ +|.+||++.+++.|||.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            8999999999999 57999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.4e-43  Score=318.35  Aligned_cols=257  Identities=28%  Similarity=0.493  Sum_probs=214.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      +.|++.+.||.|+||.||.+.+..++..|++|++.........+.+|+..++.++||||+++++++......|+++||+.
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   98 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD   98 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence            46888899999999999999999889999999987655445568899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCc
Q 018734           82 GGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  159 (351)
Q Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  159 (351)
                      +++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++  .++|+|||++....... .....
T Consensus        99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614          99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG--SVKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC--CEEECccchhhhhccchhhhccc
Confidence            999999998876 899999999999999999999999999999999999998665  49999999876433222 12334


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .+++.|+|||.+.+..++ .++|+||||+++|+|++|+.||.............   .......+....++..+.++|.+
T Consensus       177 ~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~  252 (286)
T cd06614         177 VGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             cCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHHHHHHH
Confidence            588999999998877765 44999999999999999999997654432222111   11111223333478899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ||+.+|.+||++.++++||||.+.-
T Consensus       253 ~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         253 CLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HhccChhhCcCHHHHhhChHhhccC
Confidence            9999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.8e-44  Score=329.54  Aligned_cols=258  Identities=31%  Similarity=0.465  Sum_probs=206.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcC--CEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQL-RHPNIIRFKEVVLTP--THLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~--~~~~l   75 (351)
                      ++|++.+.||+|+||.||++.+..+++.+|+|++....   .....+.+|+.+++++ +||||+++++++...  ...|+
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            68999999999999999999999999999999885432   2234567899999999 999999999998654  46899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      ||||+. ++|...+... .+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||++....... 
T Consensus        87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEE  162 (337)
T ss_pred             Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccc
Confidence            999997 5898888765 7889999999999999999999999999999999999987664  9999999987543322 


Q ss_pred             -----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH-------------
Q 018734          155 -----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-------------  216 (351)
Q Consensus       155 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------------  216 (351)
                           ......||+.|+|||.+.+....+.++|||||||++|+|++|+.||................             
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 12234689999999988765555566999999999999999999997655443322221110             


Q ss_pred             ------Hh----hccC--CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          217 ------MA----VQYK--IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       217 ------~~----~~~~--~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                            ..    ....  ......++..+.++|.+||+.+|++|||+.++++||||.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                  00    0000  01122368899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-43  Score=327.65  Aligned_cols=256  Identities=29%  Similarity=0.439  Sum_probs=203.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcC------CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~   72 (351)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            68999999999999999999999999999999986532   2234577899999999999999999998654      35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +++|++|+.. +|...+  ...+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||+++... 
T Consensus        95 ~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~-  168 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHAD-  168 (342)
T ss_pred             EEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCC-
Confidence            7999999954 666554  34689999999999999999999999999999999999998765  59999999987532 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH----------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI----------------  216 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----------------  216 (351)
                       .......+++.|+|||.+.+....+.++|||||||++|+|++|+.||........+..++...                
T Consensus       169 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         169 -AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             -CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence             223445789999999998764444556999999999999999999998765433332222100                


Q ss_pred             ---HhhccCCC------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          217 ---MAVQYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       217 ---~~~~~~~~------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                         .......+      .++..+..+.+||.+||+.||.+||++.+++.||||....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence               00000000      1224677899999999999999999999999999997653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-46  Score=335.59  Aligned_cols=259  Identities=28%  Similarity=0.484  Sum_probs=229.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      .+.+.+..||-|+||.|-++........+|+|++++..    +..+.+..|-++|..++.|.||++|..|.++..+|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45667789999999999999988776679999887743    34466888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |-|-||.|...+...+.|.+...+.++.+++.|+.|||++|||.|||||+|++++.++.  +||.|||+|+....+..+.
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCcee
Confidence            99999999999999999999999999999999999999999999999999999998887  9999999999988888899


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      +.||||.|.|||++...+.+ .++|.||||+++|||++|.+||...++...+..+++.+-.    +..+..++..+.+||
T Consensus       578 TFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----i~~Pr~I~k~a~~Li  652 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----IEFPRRITKTATDLI  652 (732)
T ss_pred             eecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----hhcccccchhHHHHH
Confidence            99999999999999998876 4599999999999999999999998876666665554433    233357889999999


Q ss_pred             HHhcccCCCCCCC-----hHHHhcCcccccCCChh
Q 018734          238 SRIFVANPSRRIT-----IKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       238 ~~~L~~~P~~Rps-----~~eil~hp~~~~~~~~~  267 (351)
                      +++...+|.+|..     +.+|.+|.||.......
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg  687 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG  687 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence            9999999999985     89999999998765543

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.2e-43  Score=314.75  Aligned_cols=254  Identities=27%  Similarity=0.419  Sum_probs=207.9

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      -|++.+.||.|+||.||++.+..+++.||+|.+.....  ....+.+|+..++.++||||+++++++..+...|+||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            37788999999999999999998999999998764332  2246778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  159 (351)
                      .+++|..++.. ..+++..+..++.|++.||.+||++|++|+||+|.||+++.++  .++|+|||++....... .....
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~--~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC--CEEEeecccceecccchhhhccc
Confidence            99999988864 4689999999999999999999999999999999999997665  49999999886443221 12234


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .|+..|+|||.+.+...+ .++|+|||||++|+|++|..||.........    ..+.... .......++..+.+++.+
T Consensus       162 ~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~i~~  235 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVL----FLIPKNN-PPTLEGNYSKPLKEFVEA  235 (277)
T ss_pred             cCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHH----HHHhcCC-CCCCCcccCHHHHHHHHH
Confidence            688999999999776654 4499999999999999999999765432211    1111111 111223467899999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ||+.+|.+||++.++++||||.+...
T Consensus       236 ~l~~~p~~Rp~~~~~l~~~~~~~~~~  261 (277)
T cd06641         236 CLNKEPSFRPTAKELLKHKFIVRFAK  261 (277)
T ss_pred             HccCChhhCcCHHHHHhCHHHhhhhh
Confidence            99999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=8.6e-44  Score=327.65  Aligned_cols=255  Identities=21%  Similarity=0.329  Sum_probs=197.0

Q ss_pred             eeeeccc--CceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            7 MKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         7 ~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ...||+|  +||+||++.+..+++.||+|++......   ...+.+|+.+++.++||||++++++|......++||||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3467777  8999999999999999999998754322   2457789999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC----
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----  155 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~----  155 (351)
                      +++|.+++.+.  ..+++..+..++.|++.||.|||++|++||||||+|||++.++  .++++||+.+........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccCccccc
Confidence            99999988764  3589999999999999999999999999999999999997665  499999985432211111    


Q ss_pred             ----CCCcccCCCccCcccccCCcC-CCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH--------------
Q 018734          156 ----PKSTVGTPAYIAPEVLSRREY-DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------------  216 (351)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------------  216 (351)
                          .....++..|+|||++.+... .+.++|||||||++|+|++|+.||............+...              
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence                111235667999999876422 3456999999999999999999997654332221111000              


Q ss_pred             ---------------------------HhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          217 ---------------------------MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       217 ---------------------------~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                                 .......+....++..+.+||.+||+.||++|||+.++|+||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                       00000111122356789999999999999999999999999999554

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=336.43  Aligned_cols=244  Identities=33%  Similarity=0.543  Sum_probs=206.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHh-cCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK-QLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~-~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +.|++...+|.|+|++|..+.+..+++..++|++.+...   ...+|+.++. .-+||||+++++.+.+..+.|+|||++
T Consensus       322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhhccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            578899999999999999999999999999999987622   3335664444 447999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV  160 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~  160 (351)
                      .|+.+.+.+...+.+. ..+..|+++|+.|+.|||++|++||||||+|||++ +..++++|+|||+++.....  ....+
T Consensus       399 ~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~--~~tp~  474 (612)
T KOG0603|consen  399 DGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS--CDTPA  474 (612)
T ss_pred             cccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhhhCchh--hcccc
Confidence            9999999998877666 88889999999999999999999999999999995 33345999999998854333  34457


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHh
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  240 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (351)
                      -|..|.|||++....|+ .+|||||||++||+|++|+.||......   ..+..++....+.    ..+|..+++||.+|
T Consensus       475 ~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s----~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  475 LTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS----ECVSDEAKDLLQQL  546 (612)
T ss_pred             hhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc----cccCHHHHHHHHHh
Confidence            78899999999977775 5599999999999999999999887655   2333343333222    46899999999999


Q ss_pred             cccCCCCCCChHHHhcCccc
Q 018734          241 FVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       241 L~~~P~~Rps~~eil~hp~~  260 (351)
                      |+.||.+||++.+++.||||
T Consensus       547 L~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  547 LQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ccCChhhCcChhhhccCcch
Confidence            99999999999999999999

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.4e-43  Score=316.10  Aligned_cols=249  Identities=21%  Similarity=0.347  Sum_probs=200.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEc----CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNK----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++.|++.+.||+|+||.||++...    .++..||+|.+.....  ....+.+|+.+++.++||||+++++++......|
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            467999999999999999999853    4567899998865332  1245778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 018734           75 IVMEYAAGGELFERICNA-----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP  137 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~  137 (351)
                      ++|||+.+++|.+++...                 ..+++..+..++.|++.||.|||++|++||||||+|||++.++. 
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~-  162 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc-
Confidence            999999999999988532                 23788899999999999999999999999999999999987654 


Q ss_pred             CEEEeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHH
Q 018734          138 RLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  213 (351)
Q Consensus       138 ~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  213 (351)
                       +||+|||+++......   ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||...... ....  
T Consensus       163 -~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~-~~~~--  237 (283)
T cd05090         163 -VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-EVIE--  237 (283)
T ss_pred             -EEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHH--
Confidence             9999999987543221   12334467789999999777664 45999999999999998 99999765432 2122  


Q ss_pred             HHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          214 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                       .+. .....+.+..+++.+.+++.+||+.+|.+||++.+|+++
T Consensus       238 -~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         238 -MVR-KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             -HHH-cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence             111 122233444678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.6e-43  Score=311.54  Aligned_cols=247  Identities=23%  Similarity=0.389  Sum_probs=201.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||.+.... +..+|+|.+.........+.+|+.+++.++||||+++++++.....++++|||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            579999999999999999998765 4569999887655445678899999999999999999999998889999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC--CC
Q 018734           82 GGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KS  158 (351)
Q Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~--~~  158 (351)
                      +++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++  ++||+|||+++........  ..
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCceeecCC
Confidence            99999998764 4689999999999999999999999999999999999997665  5999999998754322211  12


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..++..|+|||.+.+..++. ++|||||||++|+|++ |..||..........    .+... ...+.....+..+.+++
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~-~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~li  234 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSS-KSDVWAFGVLMWEVYSLGKMPYERFNNSETVE----KVSQG-LRLYRPHLASEKVYAIM  234 (256)
T ss_pred             CccChhhCCHHHHhcCcccc-hhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH----HHhcC-CCCCCCCCCCHHHHHHH
Confidence            33567799999997776654 4999999999999998 999997655433222    22221 12222334688999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.+|.+||++.+++.+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-43  Score=316.09  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=196.4

Q ss_pred             CCe-eEeeeecccCceEEEEEE----EcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CE
Q 018734            2 EKY-ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP--TH   72 (351)
Q Consensus         2 ~~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~   72 (351)
                      +|| ++.+.||+|+||+||++.    ...++..||+|.+.....  ....+.+|+.+++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            577 999999999999998765    345678999999876432  345678899999999999999999987653  46


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      ++++|||+.+++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++  .++|+|||++.....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~  159 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC--cEEEeecccccccCC
Confidence            89999999999999988764 589999999999999999999999999999999999997665  499999999875432


Q ss_pred             CCC----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHH------------HHHH
Q 018734          153 HSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT------------ISRI  216 (351)
Q Consensus       153 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------------~~~~  216 (351)
                      ...    .....++..|+|||.+.+..++ .++|||||||++|+|++|..||......  +...            ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh
Confidence            221    1223466779999999776665 4599999999999999999998653321  1100            0111


Q ss_pred             HhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .......+....++..+.+++.+||+.+|++|||+++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1111223334457889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-43  Score=312.32  Aligned_cols=247  Identities=24%  Similarity=0.412  Sum_probs=202.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .+|++.+.||+|+||.||++.+.. +..+|+|++.........+.+|+.+++.++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            468899999999999999998864 6689999987655555678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC--CC
Q 018734           82 GGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KS  158 (351)
Q Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~--~~  158 (351)
                      |++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++........  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCC
Confidence            99999998753 46899999999999999999999999999999999999987664  999999998754322111  11


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..++..|+|||.+.+..++. ++|||||||++|+|++ |..||..........    .+. .....+.....+..+.+++
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSS-KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SVS-AGYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             CCCCccccCHHHhccCCCCc-hhhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HHH-cCCcCCCCCCCCHHHHHHH
Confidence            22345799999998777654 4999999999999998 899997654433222    211 2223333445789999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.+|.+|||+.++++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-43  Score=318.74  Aligned_cols=254  Identities=30%  Similarity=0.489  Sum_probs=207.1

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEEecc
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      |.+.+.||.|++|.||++....+++.|++|.+.....  ......+|+..+++++ ||||+++++++..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7889999999999999999999999999998865433  2234557889999999 999999999999999999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           81 AGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        81 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                       +++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|.||+++.++.  ++|+|||++...........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence             779988887654  7899999999999999999999999999999999999987654  99999999886544444455


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hccCC
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQYKI  223 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~  223 (351)
                      ..++..|+|||++.+....+.++|+||||+++++|++|++||......+.+.+.......               .....
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            678999999999865554456699999999999999999999876654444333221000               00000


Q ss_pred             C---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          224 P---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       224 ~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +         .....+..+.++|.+||+.+|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            0         011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-43  Score=311.55  Aligned_cols=242  Identities=26%  Similarity=0.428  Sum_probs=203.5

Q ss_pred             eeecccCceEEEEEEEcCC---CcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNT---KELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+...   +..|++|++......  ...+.+|+..++.++||||+++++++.....++++|||+.+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999866   889999998765443  35788899999999999999999999999999999999999


Q ss_pred             CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           83 GELFERICNA---------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        83 ~~L~~~l~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ++|.+++...         ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .++|+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~--~~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC--cEEEcccccccccccc
Confidence            9999999875         7799999999999999999999999999999999999998765  4999999998765433


Q ss_pred             C---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCC
Q 018734          154 S---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       154 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                      .   ......+++.|+|||.+....++ .++|||||||++|+|++ |..||...........    +.. ....+....+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~  232 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRK-GYRLPKPEYC  232 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCccC
Confidence            2   23345688999999999777654 45999999999999999 6999987644332222    221 2233444467


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.++.+++.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.7e-43  Score=322.63  Aligned_cols=247  Identities=21%  Similarity=0.354  Sum_probs=200.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcE----EEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKEL----VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      .+|++.+.||+|+||.||++.+..+++.    ||+|++....  .....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            5799999999999999999998665554    8999886432  2335678899999999999999999998764 5779


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +++|+.+|+|.+.+... ..++...+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~  163 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADE  163 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCCC
Confidence            99999999999998764 46889999999999999999999999999999999999976654  9999999998544332


Q ss_pred             CC---CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 RP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      ..   ....++..|+|||.+.+..++. ++|||||||++|+|++ |..||....... +.    .+.......+.....+
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~-~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~----~~~~~~~~~~~~~~~~  237 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTH-QSDVWSYGVTVWELMTFGSKPYDGIPASE-IS----SILEKGERLPQPPICT  237 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCc-hhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HH----HHHhCCCCCCCCCCCC
Confidence            21   1223467899999998777654 4999999999999997 999997654322 22    2223333445555678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+.+++.+||+.+|.+||++.+++.+
T Consensus       238 ~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         238 IDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.9e-43  Score=315.54  Aligned_cols=250  Identities=19%  Similarity=0.308  Sum_probs=202.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|.+.+.||+|+||.||++.+..     ++..||+|.+.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF   85 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence            478999999999999999999987     778899998764332  2346788999999999999999999999888999


Q ss_pred             EEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCC
Q 018734           75 IVMEYAAGGELFERICNAG-------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGY  146 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~  146 (351)
                      +||||+.|++|.+++....       .+++..+..++.||+.||.|||+++++||||||+||+++.++ ...+||+|||+
T Consensus        86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~  165 (277)
T cd05036          86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM  165 (277)
T ss_pred             EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence            9999999999999987643       488999999999999999999999999999999999997654 23589999999


Q ss_pred             CcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccC
Q 018734          147 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  222 (351)
Q Consensus       147 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (351)
                      ++.......   .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||........ ...   +. ....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~-~~~---~~-~~~~  239 (277)
T cd05036         166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-MEF---VT-GGGR  239 (277)
T ss_pred             ccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHH---HH-cCCc
Confidence            875422111   1122345679999999877765 45999999999999997 9999986544322 221   11 1222


Q ss_pred             CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+....++..+.+++.+||+.+|.+|||+.++++|
T Consensus       240 ~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         240 LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            23334678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-43  Score=314.91  Aligned_cols=251  Identities=27%  Similarity=0.400  Sum_probs=204.9

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++++..++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            5789999999999999999999999999999998765322    224677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |||+.+++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++  .++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~  158 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  158 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEECcchhhhcccc
Confidence            999999999988763    34689999999999999999999999999999999999997665  499999998875432


Q ss_pred             CCC-CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          153 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       153 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      ... .....|++.|+|||.+.+..++ .++|+||||+++|+|++|..||......  .......+....+.......++.
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccH
Confidence            222 2345789999999999877765 4499999999999999999999754321  12222333222222112235788


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhc
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .+.+++.+||+.+|++|||+.+|++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2e-43  Score=326.28  Aligned_cols=249  Identities=22%  Similarity=0.368  Sum_probs=198.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCccc--CHHHHHHHHHHhcC-CCCCcceEEEEEEcC-CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHKI--DANVAREIINHKQL-RHPNIIRFKEVVLTP-TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~-~~   72 (351)
                      +||++.+.||.|+||.||++...     .+++.||+|++......  ...+.+|+.+++++ +||||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            48999999999999999999754     34578999988754322  23567899999999 899999999987654 67


Q ss_pred             EEEEEeccCCCChHHHHHhc------------------------------------------------------------
Q 018734           73 LAIVMEYAAGGELFERICNA------------------------------------------------------------   92 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~------------------------------------------------------------   92 (351)
                      ++++|||+++++|.+++...                                                            
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            88999999999999888542                                                            


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC---CCCcccCCCccCc
Q 018734           93 -GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAP  168 (351)
Q Consensus        93 -~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aP  168 (351)
                       .++++..+..++.||+.||.|||++||+||||||+|||++.++  .++|+|||++........   .....++..|+||
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  244 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP  244 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence             2578899999999999999999999999999999999998765  499999999875432221   2233467789999


Q ss_pred             ccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCC
Q 018734          169 EVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSR  247 (351)
Q Consensus       169 E~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  247 (351)
                      |++.+..++.+ +|||||||++|+|++ |..||......+.+...+.    ...........++.+.+++.+||+.+|.+
T Consensus       245 E~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         245 ESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK----EGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             HHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh----ccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            99988877655 999999999999997 9999976544333332221    11122223357889999999999999999


Q ss_pred             CCChHHHhcC
Q 018734          248 RITIKEIKSH  257 (351)
Q Consensus       248 Rps~~eil~h  257 (351)
                      ||++.++++|
T Consensus       320 RPs~~ell~~  329 (337)
T cd05054         320 RPTFSELVEI  329 (337)
T ss_pred             CcCHHHHHHH
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.8e-43  Score=318.89  Aligned_cols=248  Identities=24%  Similarity=0.351  Sum_probs=198.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc--EEEEEEeccCc--ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE--LVAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++.+..++.  .+++|.+....  .....+.+|+.+++++ +||||+++++++...+.+|++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            689999999999999999999877664  46888776322  1224677899999999 799999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEE
Q 018734           77 MEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLK  140 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vk  140 (351)
                      |||+++++|.+++....                .+++..++.++.|++.||.|||++||+||||||+|||++.++  .+|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~--~~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL--ASK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC--eEE
Confidence            99999999999986532                478899999999999999999999999999999999997765  499


Q ss_pred             EeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhh
Q 018734          141 ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAV  219 (351)
Q Consensus       141 L~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  219 (351)
                      |+|||++..............+..|+|||.+.+..++ .++|||||||++|+|++ |..||...........    +. .
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----~~-~  233 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----LP-Q  233 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hh-c
Confidence            9999998643222122222335679999999777765 45999999999999997 9999977654332222    11 1


Q ss_pred             ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          220 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ....+....++..+.+|+.+||+.+|.+||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22233334588999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-43  Score=310.69  Aligned_cols=246  Identities=22%  Similarity=0.350  Sum_probs=202.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+.. ++.||+|.+.........+.+|+.++++++||||+++++++...+..+++|||+.
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            579999999999999999999765 5679999987655555678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC--C
Q 018734           82 GGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--K  157 (351)
Q Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~--~  157 (351)
                      +++|.+++....  .++...+..++.|++.||.+||++|++||||||+||+++.++.  ++|+|||+++........  .
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEARE  162 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccccC
Confidence            999999997654  6899999999999999999999999999999999999987664  999999998754322111  1


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...++..|+|||.+.+..++.+ +|||||||++|+|++ |+.||..........    .+ ...+..+.....+..+.++
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         163 GAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ----QV-DQGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             CCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HH-HcCCCCCCCCcCCHHHHHH
Confidence            1123457999999877766544 999999999999999 999997654332222    22 1223334445678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||+.+|.+||++.++++
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-43  Score=317.68  Aligned_cols=254  Identities=31%  Similarity=0.487  Sum_probs=207.3

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      |++.+.||.|++|.||++.+..+++.+++|.+.....   ....+.+|+.+++.++||||+++++++..+..+++++||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            6788999999999999999999999999998875433   2356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCC
Q 018734           81 AGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  158 (351)
Q Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~  158 (351)
                      .+ +|...+.. ...+++..+..++.|++.||.|||++||+|+||||+||+++.++  .++|+|||++....... ....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG--VLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC--cEEEeeeeeeEecCCCcccccC
Confidence            75 88887766 45789999999999999999999999999999999999998665  49999999887544332 2233


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh---------------ccCC
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---------------QYKI  223 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~  223 (351)
                      ..++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+.+..........               ...+
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            5688999999998776344566999999999999999999998766544443333221110               0000


Q ss_pred             C---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          224 P---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       224 ~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +         ....++..+.++|.+||+++|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            0         012367889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.8e-43  Score=311.13  Aligned_cols=245  Identities=23%  Similarity=0.355  Sum_probs=199.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.++||+|+||.||++.+..++ .||+|++.........+.+|+.+++.++||||+++++.+. ....++||||+.
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            58999999999999999999987654 5999998865554567889999999999999999999874 456899999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC--C
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--K  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~--~  157 (351)
                      +++|.+++.+.  ..+++..+..++.|++.||.|||+++++||||||.||+++.++  .++|+|||++.........  .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~--~~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC--cEEeccCCceeecccccccccc
Confidence            99999999753  3588999999999999999999999999999999999998665  4999999998754322211  2


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...++..|+|||.+.+..++ .++|||||||++|+|++ |..||..........    .+. .....+....++..+.++
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVE-RGYRMPCPPECPESLHDL  235 (262)
T ss_pred             CCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----HHh-cCCCCCCccccCHHHHHH
Confidence            23466789999998777765 44999999999999999 888997654432222    221 122233344678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||+.+|.+||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-43  Score=314.04  Aligned_cols=253  Identities=30%  Similarity=0.471  Sum_probs=203.6

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcC---CCCCcceEEEEEEcCCE-----
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQL---RHPNIIRFKEVVLTPTH-----   72 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l---~hp~Iv~~~~~~~~~~~-----   72 (351)
                      |++.+.||.|+||.||++.+..+++.||+|++......   ...+.+|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            78999999999999999999988999999998753322   23455677666555   69999999999987766     


Q ss_pred             EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc
Q 018734           73 LAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  150 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~  150 (351)
                      ++++|||+.+ +|.+++....  .+++..++.++.|++.||.|||+++++|+||+|+||+++.++  +++|+|||++...
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceec
Confidence            9999999975 8888887643  589999999999999999999999999999999999998775  5999999998765


Q ss_pred             CCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh-ccCCC-----
Q 018734          151 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-QYKIP-----  224 (351)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~-----  224 (351)
                      ..........+++.|+|||.+.+..+..+ +|+|||||++|+|++|++||......+.+..+....... ...++     
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            44444445568899999999987776544 999999999999999999998776655544443321100 00000     


Q ss_pred             ---------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          225 ---------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       225 ---------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                                     ....++..+.++|.+||+.+|.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                           011346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.7e-43  Score=329.88  Aligned_cols=248  Identities=23%  Similarity=0.379  Sum_probs=199.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCcc--cCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK--IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++++.||+|+||.||++.+...     +..||+|++.....  ....+.+|+.+++++. |||||++++++.....+
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            5788999999999999999987533     34699999865432  2346889999999996 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-------------------------------------------------------------
Q 018734           74 AIVMEYAAGGELFERICNA-------------------------------------------------------------   92 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~-------------------------------------------------------------   92 (351)
                      |+|||||++|+|.+++.+.                                                             
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            9999999999999887542                                                             


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 018734           93 -----------------------------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP  137 (351)
Q Consensus        93 -----------------------------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~  137 (351)
                                                         ..+++..+..++.||+.||.|||+++|+||||||+|||++.++  
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~--  274 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--  274 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC--
Confidence                                               2367788899999999999999999999999999999998765  


Q ss_pred             CEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHH
Q 018734          138 RLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  213 (351)
Q Consensus       138 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  213 (351)
                      .+||+|||+++.......   .....+++.|+|||.+.+..+. .++|||||||++|+|++ |..||........+..  
T Consensus       275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~--  351 (400)
T cd05105         275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN--  351 (400)
T ss_pred             EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH--
Confidence            499999999875432221   2234577889999999877765 45999999999999997 9999976543322222  


Q ss_pred             HHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          214 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                        ........+....++..+.+++.+||+.+|++||++.++.+
T Consensus       352 --~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 --KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             --HHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence              12222334444568899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.3e-43  Score=309.63  Aligned_cols=241  Identities=27%  Similarity=0.405  Sum_probs=194.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      +.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.+++.++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            469999999999999999999999998764322  235688999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC---Cccc
Q 018734           86 FERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVG  161 (351)
Q Consensus        86 ~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~---~~~g  161 (351)
                      .+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .+||+|||++..........   ...+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN--VLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC--cEEECccccCcccccccccccCCCCCC
Confidence            9998764 4689999999999999999999999999999999999997665  49999999987433211111   1123


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHh
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  240 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (351)
                      +..|+|||.+.+..+..+ +|||||||++|+|++ |..||....... ....+    ......+....++..+.+++.+|
T Consensus       159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAI----EQGVRLPCPELCPDAVYRLMERC  232 (252)
T ss_pred             ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHH----HcCCCCCCcccCCHHHHHHHHHH
Confidence            456999999987776544 999999999999997 888987644322 11111    11222333445788999999999


Q ss_pred             cccCCCCCCChHHHhc
Q 018734          241 FVANPSRRITIKEIKS  256 (351)
Q Consensus       241 L~~~P~~Rps~~eil~  256 (351)
                      |+.+|++|||+.++++
T Consensus       233 l~~~p~~Rps~~~~~~  248 (252)
T cd05084         233 WEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-42  Score=314.38  Aligned_cols=253  Identities=22%  Similarity=0.346  Sum_probs=200.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||++....     .+..||+|.+......  ...+.+|+..++.++||||+++++++......+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            589999999999999999987542     3458999987654322  235678999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           75 IVMEYAAGGELFERICNA----------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                      +||||+.+|+|.+++...          ..++...+..++.|++.||.|||+++|+||||||+||+++.++  .++|+||
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~--~~~L~Df  163 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF--TVKIGDF  163 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC--cEEECcC
Confidence            999999999999999652          2346778899999999999999999999999999999998765  4999999


Q ss_pred             CCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhc
Q 018734          145 GYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  220 (351)
Q Consensus       145 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (351)
                      |+++.......   .....++..|+|||.+.+..++ .++|+|||||++|+|++ |..||........    ...+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~~~~  238 (288)
T cd05061         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQV----LKFVMDGG  238 (288)
T ss_pred             CccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCC
Confidence            99874322211   1223457789999999877765 45999999999999998 7889976543322    22222211


Q ss_pred             cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc------Cccccc
Q 018734          221 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS------HPWFLK  262 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~------hp~~~~  262 (351)
                       ..+.....++.+.+++.+||+.+|.+|||+.++++      ||||..
T Consensus       239 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         239 -YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence             12223356789999999999999999999999986      788754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=319.79  Aligned_cols=254  Identities=31%  Similarity=0.576  Sum_probs=216.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +|-.+..||+|+||.|.++..+.+.+.+|||++++.-..+    +--..|-++|... +-|.+++++.+|.+-+++|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            5778899999999999999999999999999987743211    1123455666555 5789999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-P  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~  156 (351)
                      ||+.||+|...+++.++|.|..+..++..|+-||-+||++|||.||||..||+++..+  ++||+|||+++....... .
T Consensus       430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--HiKi~DFGmcKEni~~~~TT  507 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIFDGVTT  507 (683)
T ss_pred             EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC--ceEeeecccccccccCCcce
Confidence            9999999999999999999999999999999999999999999999999999997666  599999999987555544 3


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      .+.||||.|+|||++..++| ++++|+||+|++||||+.|++||.+.+..+.+..    ++..+...|.  .+|.++.++
T Consensus       508 kTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a----I~ehnvsyPK--slSkEAv~i  580 (683)
T KOG0696|consen  508 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA----IMEHNVSYPK--SLSKEAVAI  580 (683)
T ss_pred             eeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHHccCcCcc--cccHHHHHH
Confidence            45799999999999998887 4559999999999999999999998776555544    4444444554  689999999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccCCC
Q 018734          237 LSRIFVANPSRRIT-----IKEIKSHPWFLKNLP  265 (351)
Q Consensus       237 i~~~L~~~P~~Rps-----~~eil~hp~~~~~~~  265 (351)
                      .+.+|.+.|.+|..     -.+|..||||+...+
T Consensus       581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW  614 (683)
T KOG0696|consen  581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW  614 (683)
T ss_pred             HHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence            99999999999984     368999999976543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-44  Score=332.34  Aligned_cols=258  Identities=31%  Similarity=0.509  Sum_probs=214.4

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      |..++.||-|+||.|++++...|...||+|-+++.....    ..+..|-.+|..-..+-||++|..|.+.+.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            677899999999999999999999999999887754322    3455677888888999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-------
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-------  152 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-------  152 (351)
                      ++||++..+|.+.+-|.|..++.++..+.+|++++|..|+|||||||+|||||.++  +|||+||||++....       
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG--HIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC--ceeeeeccccccceeccccccc
Confidence            99999999999999999999999999999999999999999999999999998776  499999999862100       


Q ss_pred             -C--------------------C---------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcC
Q 018734          153 -H--------------------S---------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG  196 (351)
Q Consensus       153 -~--------------------~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  196 (351)
                       .                    +               ...+.+||+.|+|||++...+|+.. ||+||.|+|||||+.|
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLVG  867 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhhC
Confidence             0                    0               0023479999999999999998655 9999999999999999


Q ss_pred             CCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCC---ChHHHhcCcccccCCChh
Q 018734          197 AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp---s~~eil~hp~~~~~~~~~  267 (351)
                      ++||..........+++..  ...+.++...++|.++.+||.+++ ..++.|+   .++++..||||.......
T Consensus       868 ~~pf~~~tp~~tq~kv~nw--~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfss  938 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINW--RNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFSS  938 (1034)
T ss_pred             CCCccCCCCCcceeeeeeh--hhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchHh
Confidence            9999987665443332221  122345666689999999999865 5788888   467899999998765443

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=9e-43  Score=313.13  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=197.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||.+.+.     .++..||+|++.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            57999999999999999998864     2356799998764322  2245778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           75 IVMEYAAGGELFERICNAG----------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                      +||||+.+++|.+++.+..          .++...+..++.|++.||.|||++|++||||||+||+++.++  .++|+||
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~--~~~l~df  163 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC--CEEECCC
Confidence            9999999999999986532          356788999999999999999999999999999999998665  4999999


Q ss_pred             CCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhc
Q 018734          145 GYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  220 (351)
Q Consensus       145 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (351)
                      |+++.......   .....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||........    ...+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~----~~~~~~~~  238 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQV----LRFVMEGG  238 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----HHHHHcCC
Confidence            99874322211   1223467889999999877765 45999999999999998 7889976543322    22222221


Q ss_pred             cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          221 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      . .+.....+..+.+++.+||+.+|.+|||+.+++++
T Consensus       239 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         239 L-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            1 22234578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.8e-42  Score=308.96  Aligned_cols=251  Identities=29%  Similarity=0.435  Sum_probs=204.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+....    .....+.+|+.++++++|+||+++++++...+..++|
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            478999999999999999999999999999999886422    2235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |||+++++|..++.+    ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++  +++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~--~~~l~d~~~~~~~~~  158 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC--cEEEeccceeeeccC
Confidence            999999999988864    34589999999999999999999999999999999999998665  499999999875432


Q ss_pred             CC-CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          153 HS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       153 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      .. ......|++.|+|||.+.+..++.. +|+|||||++|+|++|+.||.....  ........+............++.
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEKCDYPPLPADHYSE  235 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCc--cHHHHHhhhhcCCCCCCChhhcCH
Confidence            22 2233568999999999987776544 9999999999999999999965432  112222222222221111125778


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhc
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .+.++|.+||..+|++|||+.+|++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.6e-43  Score=317.29  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=201.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC----------------cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK----------------ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRF   63 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~   63 (351)
                      ++|++++.||+|+||.||++.+..++                ..||+|++.....  ....+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            58999999999999999999876544                5689998875432  23567789999999999999999


Q ss_pred             EEEEEcCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 018734           64 KEVVLTPTHLAIVMEYAAGGELFERICNAG-----------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD  132 (351)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~  132 (351)
                      ++++..+...+++||++.+++|..++....           .+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~  164 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence            999999999999999999999999997765           689999999999999999999999999999999999998


Q ss_pred             CCCCCCEEEeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc--CCCCCCCCCChh
Q 018734          133 GSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPK  207 (351)
Q Consensus       133 ~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~  207 (351)
                      .++  .++|+|||++.......   ......+++.|+|||.+.+..+. .++|||||||++|+|++  |..||.......
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         165 KNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT-TKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             CCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC-ccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            765  49999999987533221   12234567889999998776654 55999999999999998  778887655433


Q ss_pred             HHHHHHHHHH--hhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          208 NFRKTISRIM--AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       208 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .+........  ......+.....+.++.+++.+||+.+|.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         242 VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            3222211100  111112333456789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-45  Score=324.74  Aligned_cols=263  Identities=26%  Similarity=0.435  Sum_probs=221.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc--------CHHHHHHHHHHhcCCCCCcceEEEEEEc-CCE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--------DANVAREIINHKQLRHPNIIRFKEVVLT-PTH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~e~~~~~~l~hp~Iv~~~~~~~~-~~~   72 (351)
                      +||-++..||+|||+.||+|.|...+++||+|+-......        -....+|..+.+.|.||.||++|++|.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            5788999999999999999999999999999975433221        1346689999999999999999999965 467


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEe-cCCCCCCEEEeccCCCcc
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM--QICHRDLKLENTLL-DGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--~iiH~Dikp~NIll-~~~~~~~vkL~DFg~a~~  149 (351)
                      +|-|+|||+|.+|.-+|+.+..+++.+++.|+.||+.||.||.+.  .|||-||||.|||+ +++..|.+||+|||+++.
T Consensus       543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI  622 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI  622 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence            899999999999999999999999999999999999999999976  59999999999997 455567799999999997


Q ss_pred             cCCCCCC--------CCcccCCCccCcccccCC---cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh
Q 018734          150 SLLHSRP--------KSTVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA  218 (351)
Q Consensus       150 ~~~~~~~--------~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  218 (351)
                      +......        ....||.||++||.+.-+   +..+.++||||+|+|+|.++.|+.||........+......+..
T Consensus       623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA  702 (775)
T KOG1151|consen  623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA  702 (775)
T ss_pred             ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence            6554432        234699999999997533   23345599999999999999999999887655554444444455


Q ss_pred             hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ....+|.-+.+++++.+||++||++.-..|..+.++-.||||.-..
T Consensus       703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence            6667888788999999999999999999999999999999997543

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.4e-43  Score=312.18  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=204.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .+|++.+.||.|+||.||++.+.. ++.+|+|++..... ....+.+|+.+++.++||||+++++++......++||||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            468899999999999999999988 88999999876544 3456888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-CC
Q 018734           81 AGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PK  157 (351)
Q Consensus        81 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-~~  157 (351)
                      ++++|.+++.+.  ..++...+..++.||+.||.|||++|++|+||||+||+++.++.  +||+|||++........ ..
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence            999999999753  46899999999999999999999999999999999999987654  99999999875432211 12


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...++..|+|||.+.+..+.. ++||||||+++|+|++ |+.||......+.+..    +. ..+..+....+++.+.++
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~-~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFST-KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQ----IT-AGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             CCCCceEecCHHHHccCCCCc-hhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH----HH-hCCcCCCCCCCCHHHHHH
Confidence            334667899999997776654 4999999999999998 8999976553333222    22 233444455788999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||+.+|.+|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-42  Score=319.67  Aligned_cols=257  Identities=27%  Similarity=0.478  Sum_probs=204.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEc-CCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~-~~~~~lv~   77 (351)
                      ++|++.+.||.|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++.. ....++++
T Consensus        10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            68999999999999999999999999999999875432   233567789999999999999999999876 46789999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||+ +++|...+.. ..+++..+..++.|++.||.|||++||+||||+|.||+++.++  .++|+|||++....  ....
T Consensus        90 e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~--~~~~  163 (328)
T cd07856          90 ELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARIQD--PQMT  163 (328)
T ss_pred             ehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccccC--CCcC
Confidence            999 5688777754 4688999999999999999999999999999999999998665  49999999987432  2233


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH--------------------H
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------------------M  217 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------------------~  217 (351)
                      ...+++.|+|||.+.+....+.++|||||||++|+|++|+.||........+.......                    .
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence            45688999999998664444566999999999999999999997654322211111100                    0


Q ss_pred             hhcc--CCC---CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          218 AVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       218 ~~~~--~~~---~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ....  ..|   ....++..+.++|.+||+.+|.+||++.+++.||||....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence            0000  011   1124678999999999999999999999999999996543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-42  Score=314.36  Aligned_cols=247  Identities=26%  Similarity=0.410  Sum_probs=200.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +.|.+.+.||+|+||.||++.+.     .++..+|+|.+..... ....+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            36899999999999999999863     3456789998865432 23468899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 018734           76 VMEYAAGGELFERICNAG-------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC  142 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~  142 (351)
                      ||||+.+++|.+++...+             .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~--~~kl~  162 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVKIG  162 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEEec
Confidence            999999999999987543             489999999999999999999999999999999999997765  49999


Q ss_pred             ccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHh
Q 018734          143 DFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA  218 (351)
Q Consensus       143 DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  218 (351)
                      |||++.......   ......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||........    ...+..
T Consensus       163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~----~~~i~~  237 (288)
T cd05093         163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEV----IECITQ  237 (288)
T ss_pred             cCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc
Confidence            999987543221   12233467889999999877665 45999999999999998 9999976654332    222222


Q ss_pred             hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ... .+....++..+.+|+.+||+.+|.+|||+.+++.
T Consensus       238 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         238 GRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            221 2223357889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=309.12  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=202.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC---CcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++....+   ...||+|.+.....  ....+.+|+.+++.++||||+++++++......+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5799999999999999999988644   45899998865432  234577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+.+++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+||+++.++.  ++|+|||++........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhccccccc
Confidence            9999999999998764 47899999999999999999999999999999999999987654  99999999886531111


Q ss_pred             ---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          156 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       156 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                         .....+++.|+|||.+.+..++. ++|||||||++|+|++ |..||........    ...+. .....+.....+.
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~-~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~----~~~~~-~~~~~~~~~~~~~  235 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTS-ASDVWSFGIVMWEVMSYGERPYWDMSNQDV----IKAVE-DGYRLPPPMDCPS  235 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCcc-ccchHHHHHHHHHHHccCCCCCCCCCHHHH----HHHHH-cCCCCCCCCCCCH
Confidence               11223567899999998777654 4999999999999998 9999976543322    12221 2233344456789


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+.+++.+||+.+|++||++.+++++
T Consensus       236 ~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         236 ALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9e-43  Score=315.72  Aligned_cols=252  Identities=28%  Similarity=0.501  Sum_probs=206.3

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ..+||+|+||.||++....+++.||+|++..... ....+.+|+.+++.++||||+++++.+......+++|||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            4579999999999999999999999998764332 334577899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCcccCCC
Q 018734           86 FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPA  164 (351)
Q Consensus        86 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~gt~~  164 (351)
                      .+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++  .++|+|||++....... ......|++.
T Consensus       105 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~  181 (292)
T cd06657         105 TDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSLVGTPY  181 (292)
T ss_pred             HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--CEEEcccccceecccccccccccccCcc
Confidence            887644 5689999999999999999999999999999999999998765  49999999876543222 1233568999


Q ss_pred             ccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccC
Q 018734          165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN  244 (351)
Q Consensus       165 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~  244 (351)
                      |+|||.+.+..++ .++|+||+|+++|+|++|..||.......... .+..  .....++....++..+.+++.+||+.+
T Consensus       182 y~~pE~~~~~~~~-~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         182 WMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK-MIRD--NLPPKLKNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             ccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHh--hCCcccCCcccCCHHHHHHHHHHHhCC
Confidence            9999998766654 45999999999999999999998654332221 1111  111222333457889999999999999


Q ss_pred             CCCCCChHHHhcCcccccCCC
Q 018734          245 PSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       245 P~~Rps~~eil~hp~~~~~~~  265 (351)
                      |.+||++.+++.||||.+..+
T Consensus       258 P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         258 PAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             cccCcCHHHHhcChHHhccCC
Confidence            999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.9e-42  Score=313.95  Aligned_cols=255  Identities=26%  Similarity=0.382  Sum_probs=205.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .|...+.||+|+||.||++.+..+++.|++|++......    ...+.+|+.+++.++|||++++++++.+....|+|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            366678899999999999999999999999998654322    2357789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |+. ++|...+.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.  ++|+|||++...   ....
T Consensus       102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~~~~  175 (313)
T cd06633         102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---SPAN  175 (313)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---CCCC
Confidence            996 477777654 456899999999999999999999999999999999999976654  999999987642   2233


Q ss_pred             CcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ...|+..|+|||++..  ....+.++|||||||++|+|++|..||.............    ...........++..+.+
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~  251 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNDSPTLQSNEWTDSFRG  251 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCccccCHHHHH
Confidence            4578999999999843  2223455999999999999999999997765433332221    111111112246778999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      |+.+||+.+|.+||++.+++.||||.......
T Consensus       252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~  283 (313)
T cd06633         252 FVDYCLQKIPQERPASAELLRHDFVRRDRPAR  283 (313)
T ss_pred             HHHHHccCChhhCcCHHHHhcCcccCCCchhH
Confidence            99999999999999999999999998765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.5e-42  Score=307.39  Aligned_cols=249  Identities=33%  Similarity=0.486  Sum_probs=208.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+.....   ....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            68999999999999999999999999999999875432   234567899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           80 AAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        80 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      +++++|..++.+    ...+++..++.++.|++.||.|||++|++|+||+|.||+++.++  ++||+|||++...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccC-C
Confidence            999999998866    35689999999999999999999999999999999999998755  5999999998765443 3


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      .....+++.|+|||.+.+..++. ++|+||||+++|+|++|+.||........    ...+....+ .+....++.++.+
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~-~~D~~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~  231 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSY-KSDIWSLGCLLYEMATFAPPFEARSMQDL----RYKVQRGKY-PPIPPIYSQDLQN  231 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCC-CCCchhhCHHHHH
Confidence            33456899999999998777654 49999999999999999999977653222    112222222 1222357889999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccc
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ++.+||+.+|++||++.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-42  Score=306.86  Aligned_cols=243  Identities=25%  Similarity=0.402  Sum_probs=202.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      +.|++.+.||.|+||.||++...  ++.||+|.+.........+.+|+.+++.++||||+++++++.+....++||||+.
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            57899999999999999999875  6789999987765545678899999999999999999999998999999999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           82 GGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      +++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||+++.....  ....
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~--~~~l~d~g~~~~~~~~--~~~~  159 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL--VAKVSDFGLAKEASQG--QDSG  159 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC--CEEEcccccccccccc--cccC
Confidence            999999997765  689999999999999999999999999999999999998665  4999999998755222  2233


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      .++..|+|||.+.+..+.. ++||||||+++|+|++ |+.||....... +..   .+ ...+.......+++.+.++|.
T Consensus       160 ~~~~~~~ape~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~---~~-~~~~~~~~~~~~~~~~~~li~  233 (256)
T cd05039         160 KLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVP---HV-EKGYRMEAPEGCPPEVYKVMK  233 (256)
T ss_pred             CCcccccCchhhcCCcCCc-HHHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHH---HH-hcCCCCCCccCCCHHHHHHHH
Confidence            4566799999987766654 5999999999999997 999997654322 211   11 112222333457899999999


Q ss_pred             HhcccCCCCCCChHHHhc
Q 018734          239 RIFVANPSRRITIKEIKS  256 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~  256 (351)
                      +||..+|.+|||+.++++
T Consensus       234 ~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         234 DCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHhccChhhCcCHHHHHH
Confidence            999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.2e-42  Score=346.40  Aligned_cols=146  Identities=30%  Similarity=0.477  Sum_probs=133.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      |++|.++++||+|+||.||++.+..+++.||||++......    ...+..|+.+++.++||||++++.++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            68999999999999999999999999999999998764322    24577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      |||+.|++|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++  ++||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCc
Confidence            99999999999998888899999999999999999999999999999999999997665  59999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=311.79  Aligned_cols=247  Identities=23%  Similarity=0.334  Sum_probs=200.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC-----cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK-----ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|.+.+.||+|+||.||++.+....     ..||+|.+.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            68999999999999999999987543     7899999865432  2245778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           75 IVMEYAAGGELFERICNA----------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                      +||||+.+++|.+++...          ..+++..+..++.|++.||.|||+++++||||||+||+++.++.  +||+||
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~df  163 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDF  163 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECCc
Confidence            999999999999998643          23678899999999999999999999999999999999987664  999999


Q ss_pred             CCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhc
Q 018734          145 GYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  220 (351)
Q Consensus       145 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (351)
                      |+++......   ......++..|+|||.+.+..++ .++|||||||++|+|++ |..||......... +   .+. ..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-~---~~~-~~  237 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL-K---FVI-DG  237 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHH-H---HHh-cC
Confidence            9987543221   12234578899999999776665 44999999999999998 99999765433222 2   222 11


Q ss_pred             cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          221 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...+.+..++..+.+++.+||+.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         238 GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            222233457899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-43  Score=313.63  Aligned_cols=254  Identities=32%  Similarity=0.525  Sum_probs=207.9

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      |++.+.||+|++|.||++....+++.||+|++....   .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            678899999999999999999999999999987642   23456778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCC
Q 018734           81 AGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  158 (351)
Q Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~  158 (351)
                      . ++|.+++.+. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++  .++|+|||++....... ....
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC--CEEEecCCcccccCCCccccCc
Confidence            7 5899999876 5799999999999999999999999999999999999998765  49999999987543332 2233


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHH-----------hh---ccCCC
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-----------AV---QYKIP  224 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----------~~---~~~~~  224 (351)
                      ..++..|+|||.+.+....+.++|+|||||++|+|++|++||........+.++.....           ..   ....+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            45788899999987764445669999999999999999999987655444333322110           00   00011


Q ss_pred             C---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          225 D---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       225 ~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .         .+.++..+.++|.+||+.+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            1         12347789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.1e-42  Score=314.84  Aligned_cols=248  Identities=23%  Similarity=0.377  Sum_probs=201.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|.+.+.||+|+||.||++.+.     .++..||+|++.....  ....+.+|+.+++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            47899999999999999999752     3456899998875432  224578899999999 799999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           74 AIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      +++|||+.+++|.+++....  .+++..+..++.|++.||.|||+++|+|+||||+|||++.++  .++|+|||+++...
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~  192 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIM  192 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCccccccc
Confidence            99999999999999987543  389999999999999999999999999999999999997655  49999999987543


Q ss_pred             CCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCcc
Q 018734          152 LHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  227 (351)
Q Consensus       152 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (351)
                      ....   .....+++.|+|||.+.+..++. ++|||||||++|+|++ |..||........+....    ......+...
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~  267 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYTF-ESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI----KEGYRMAQPE  267 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCCc-HhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH----HcCCcCCCCC
Confidence            2221   12234678899999998777654 5999999999999998 999998765443333222    2222233334


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+..+.+++.+||..+|++|||+.+++.
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            57889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=306.74  Aligned_cols=242  Identities=38%  Similarity=0.650  Sum_probs=205.2

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus        10 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ||.|+||.||.+.+..+++.||+|++......    ...+..|+.+++.++||||+++++.+..+...+++|||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            79999999999999988999999998765432    24677899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCcccCCC
Q 018734           86 FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPA  164 (351)
Q Consensus        86 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~~gt~~  164 (351)
                      .+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++  .++|+|||++...... .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG--HIKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC--cEEEeecCcceecccCCCcccCCcCCcc
Confidence            99998888899999999999999999999999999999999999998765  4999999998754333 22344568999


Q ss_pred             ccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccC
Q 018734          165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN  244 (351)
Q Consensus       165 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~  244 (351)
                      |+|||.+.+.... .++|+||||+++|+|++|..||......    .....+....  .+....++..+.+++.+||..+
T Consensus       159 ~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         159 YLAPEVLLGKGYG-KAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDP--LRFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             ccChHHhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCC
Confidence            9999999776654 4599999999999999999999765432    2222232222  3333456899999999999999


Q ss_pred             CCCCCCh---HHHhcCccc
Q 018734          245 PSRRITI---KEIKSHPWF  260 (351)
Q Consensus       245 P~~Rps~---~eil~hp~~  260 (351)
                      |.+||++   .++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3e-42  Score=310.10  Aligned_cols=246  Identities=21%  Similarity=0.361  Sum_probs=198.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc----EEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++.+.||.|+||.||++....+++    .||+|++.....  ....+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence            579999999999999999999876665    489998864322  235677899999999999999999988754 5779


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +++|+++|+|.+.+.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus        86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~--~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN--HVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC--cEEECCCCceeeccccc
Confidence            9999999999999876 45699999999999999999999999999999999999997655  49999999987543322


Q ss_pred             CC---CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 RP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      ..   ....+++.|+|||.+.+..++. ++|||||||++|||++ |..||....... ...    ........+....++
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~----~~~~~~~~~~~~~~~  237 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFTH-QSDVWSYGVTVWELMTFGAKPYDGIPARE-IPD----LLEKGERLPQPPICT  237 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCCc-hhHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH----HHHCCCcCCCCccCC
Confidence            21   1223567899999998777654 4999999999999998 899997644321 222    222223334445688


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.+++.+||+.+|++||++.+++.
T Consensus       238 ~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         238 IDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.4e-42  Score=313.40  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=204.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|.+.....  ....+..|+..+..+ .||||+++++++......|++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3679999999999999999999999999999999875432  223456677666555 5999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||+. ++|.+.+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++  .+||+|||++........
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccCCCc
Confidence            9985 477666654 4578999999999999999999997 5999999999999997665  499999999875433333


Q ss_pred             CCCcccCCCccCcccccCCc---CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc-cCCCCccCCCH
Q 018734          156 PKSTVGTPAYIAPEVLSRRE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHISQ  231 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (351)
                      .....+++.|+|||.+.+..   ..+.++||||||+++|+|++|+.||......   ...+..+.... ...+....++.
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  247 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPPSLPPNEGFSP  247 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCCCCCCCCCCCCH
Confidence            34456888999999986553   1234599999999999999999999653322   12222222222 22333334788


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      .+.+|+.+||+.+|.+||++.+++.||||.....
T Consensus       248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            9999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=322.80  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=198.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc-CHHHHHHHHHHhcCCCCCcceEEEEEEcCC-EEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPT-HLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-~~~lv~e~   79 (351)
                      +.|.-.+.||+|+||.||++....+ ..||||++...... ..++.+|+.++.+++|||+|++++++.+.+ ..++|+||
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy  153 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY  153 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence            4566678999999999999998875 88999988776554 567999999999999999999999999888 59999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-C
Q 018734           80 AAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-H  153 (351)
Q Consensus        80 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~  153 (351)
                      +.+|+|.++|....  .+++.....|+.++++||.|||+..   ||||||||+|||+|.+..  .||+|||+|+.... .
T Consensus       154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGD  231 (361)
T ss_pred             cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccc
Confidence            99999999997755  8999999999999999999999753   999999999999998776  99999999975544 3


Q ss_pred             CCCCCc-ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCC--ChhHHHHHHHHHHhh-cc---CCCCc
Q 018734          154 SRPKST-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE--DPKNFRKTISRIMAV-QY---KIPDY  226 (351)
Q Consensus       154 ~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~~~~-~~---~~~~~  226 (351)
                      ...... .||.+|+|||.+.....+.+ +||||||+++.||++|+.|.....  ....+.......... ..   -.|..
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            333333 89999999999988666555 999999999999999998887543  111122211111111 11   11111


Q ss_pred             --cCCC-----HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          227 --VHIS-----QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       227 --~~~~-----~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                        ...+     ..+..+..+|++.+|..||++.++++
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence              1122     23668889999999999999999754

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.4e-42  Score=306.05  Aligned_cols=239  Identities=23%  Similarity=0.343  Sum_probs=192.7

Q ss_pred             eecccCceEEEEEEE--cCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            9 DIGSGNFGVARLMRN--KNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      .||+|+||.||++..  ..++..+|+|++.....   ....+.+|+.+++.++||||+++++++. ....++||||+.++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999864  45678999998865432   2346778999999999999999999875 45678999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC----CCCc
Q 018734           84 ELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----PKST  159 (351)
Q Consensus        84 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~----~~~~  159 (351)
                      +|.+++.....+++..+..++.|++.||.|||++|++||||||.||+++.++  .+||+|||++........    ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCCC
Confidence            9999998888899999999999999999999999999999999999998765  499999999875433221    1222


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      .+++.|+|||.+....++ .++|+|||||++|+|++ |..||........    ...+.. ....+.+..+++++.++|.
T Consensus       159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----~~~i~~-~~~~~~~~~~~~~l~~li~  232 (257)
T cd05116         159 KWPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV----TQMIES-GERMECPQRCPPEMYDLMK  232 (257)
T ss_pred             CCCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHC-CCCCCCCCCCCHHHHHHHH
Confidence            346789999998766654 45999999999999997 9999976543222    222222 2223334468999999999


Q ss_pred             HhcccCCCCCCChHHHhc
Q 018734          239 RIFVANPSRRITIKEIKS  256 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~  256 (351)
                      +||+.+|++||++++|..
T Consensus       233 ~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         233 LCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHhccCchhCcCHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=314.24  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=197.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC--------------cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK--------------ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKE   65 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~   65 (351)
                      ++|++.+.||+|+||.||++.+..++              ..||+|.+.....  ....+.+|+.++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            48999999999999999999876432              3589998875422  2345788999999999999999999


Q ss_pred             EEEcCCEEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 018734           66 VVLTPTHLAIVMEYAAGGELFERICNAG------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG  133 (351)
Q Consensus        66 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~  133 (351)
                      ++......++||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+||+++.
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~  164 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN  164 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence            9999999999999999999999886432            3678899999999999999999999999999999999986


Q ss_pred             CCCCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc--CCCCCCCCCChhH
Q 018734          134 SPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPKN  208 (351)
Q Consensus       134 ~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~~  208 (351)
                      ++  .+||+|||++........   .....+++.|+|||.+.+..++ .++|||||||++|+|++  |..||........
T Consensus       165 ~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         165 HY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             CC--cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcC-chhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            65  499999999875432211   1223457789999998877764 55999999999999988  6678876554333


Q ss_pred             HHHHHHHHHh--hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          209 FRKTISRIMA--VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       209 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..........  ..........+++.+.+|+.+||+.+|.+|||+++|++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3222211111  11112223357889999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-42  Score=307.74  Aligned_cols=245  Identities=23%  Similarity=0.369  Sum_probs=199.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+.. +..||+|.+.........+.+|+.++++++||||+++++++. ....+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            689999999999999999998764 567999998765555567889999999999999999999874 456889999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CC
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~  157 (351)
                      +++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCccccccc
Confidence            99999998753  3589999999999999999999999999999999999998665  499999999875432221  11


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...++..|+|||.+.+..++ .++||||||+++|+|++ |.+||.........    ..+. .....+.....+..+.+|
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVL----EQVE-RGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             CCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHH-cCCCCCCCCcCCHHHHHH
Confidence            23356679999998776664 45999999999999999 89999765433222    2221 223334444678899999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||+.+|.+|||++++++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=8.5e-43  Score=318.90  Aligned_cols=252  Identities=24%  Similarity=0.407  Sum_probs=194.8

Q ss_pred             eeccc--CceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            9 DIGSG--NFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         9 ~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      .||+|  ++|.||.+++..+++.||+|++....   .....+.+|+..++.++||||+++++++......+++|||+.++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            34444  45567777778889999999987542   22356889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC------
Q 018734           84 ELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR------  155 (351)
Q Consensus        84 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~------  155 (351)
                      +|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++  .+||+|||.+........      
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~--~~kl~d~~~~~~~~~~~~~~~~~~  162 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG--KVVLSGLRYSVSMIKHGKRQRVVH  162 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC--ceEEecCccceeeccccccccccc
Confidence            999998753  4589999999999999999999999999999999999998665  499999998764322111      


Q ss_pred             --CCCcccCCCccCcccccCC--cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-------------
Q 018734          156 --PKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------------  218 (351)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------------  218 (351)
                        .....++..|+|||++...  .+ +.++|+|||||++|+|++|..||..................             
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         163 DFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             cccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence              2234578889999998653  34 45599999999999999999999875543322211110000             


Q ss_pred             ---------------hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          219 ---------------VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       219 ---------------~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                     .....+....++.++.+|+.+||+.||++|||++++|+||||.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence                           000000111235678999999999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-42  Score=313.33  Aligned_cols=248  Identities=22%  Similarity=0.354  Sum_probs=199.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      .+|++.+.||.|+||.||++.+..+     +..||+|++.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            4688899999999999999987543     57899999875432  2245778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 018734           75 IVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPR  138 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~  138 (351)
                      ++++|+.+++|..++...                ..++...+..++.|++.||.|||++||+||||||+||+++.++.  
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--
Confidence            999999999999988532                34788899999999999999999999999999999999976654  


Q ss_pred             EEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHH
Q 018734          139 LKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTIS  214 (351)
Q Consensus       139 vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  214 (351)
                      +||+|||+++.......   .....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.......    ...
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VIE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH
Confidence            99999999875432221   1233567899999999777765 44999999999999998 888987654432    222


Q ss_pred             HHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          215 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+..... .+....++..+.+|+.+||+.+|.+||++++|+..
T Consensus       238 ~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            2222222 22234688899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.3e-42  Score=315.23  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=198.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-------CCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      ++|.+.+.||+|+||.||++.+..       +...+|+|.+.....  ....+.+|+.+++.+ +||||+++++++...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            579999999999999999998643       235799998875422  224577899999999 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      ..|+||||+.+++|.+++....                .++...+..++.|++.||.|||++|++||||||+||+++.++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  177 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence            9999999999999999997532                478899999999999999999999999999999999998665


Q ss_pred             CCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                        .+||+|||+++.......   .....+++.|+|||.+.+..++ .++|||||||++|+|++ |..||..... ..+..
T Consensus       178 --~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~  253 (307)
T cd05098         178 --VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELFK  253 (307)
T ss_pred             --cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHH
Confidence              499999999875432111   1122345789999999877665 45999999999999998 8889866443 22222


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+    ......+.+..++.++.+|+.+||..+|.+|||+.+++++
T Consensus       254 ~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         254 LL----KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HH----HcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            21    1222233344678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.8e-42  Score=313.65  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=200.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++.+.||+|+||.||++.....     ...+|+|.+.....  ....+.+|+.+++++ +||||+++++++...+.+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            5799999999999999999987643     37899998875432  224577899999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 018734           74 AIVMEYAAGGELFERICN----------------AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP  137 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~----------------~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~  137 (351)
                      +++|||+.+++|..++..                ...+++..+..++.|++.||.|||++||+||||||+|||++.++  
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~--  169 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH--  169 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC--
Confidence            999999999999999854                24588999999999999999999999999999999999997665  


Q ss_pred             CEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHH
Q 018734          138 RLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  213 (351)
Q Consensus       138 ~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  213 (351)
                      .+||+|||+++.......   .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||...........  
T Consensus       170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--  246 (293)
T cd05053         170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL--  246 (293)
T ss_pred             eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH--
Confidence            499999999875432211   1222356789999998777765 44999999999999997 9999976554332221  


Q ss_pred             HHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          214 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                         .......+.....+..+.+|+.+||..+|++|||+.+++++
T Consensus       247 ---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         247 ---LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             ---HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence               11222233344678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=5.3e-42  Score=314.28  Aligned_cols=254  Identities=27%  Similarity=0.415  Sum_probs=206.1

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .|...+.||+|+||.||++.+..++..||+|++......    ...+.+|+.+++.++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            477889999999999999999999999999998754322    2357789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |+.| +|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++  .++|+|||++....   ...
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~--~~kl~dfg~~~~~~---~~~  179 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIAS---PAN  179 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC--CEEEecCCCccccC---Ccc
Confidence            9975 77776644 55689999999999999999999999999999999999997665  49999999876432   223


Q ss_pred             CcccCCCccCcccccC---CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          158 STVGTPAYIAPEVLSR---REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      ...|++.|+|||.+..   ..+ +.++|||||||++|+|++|+.||..........    .+............+++.++
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~  254 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPTLQSNEWSDYFR  254 (317)
T ss_pred             cccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhCCCCCCCccHHHHHH----HHHhccCCCCCCccccHHHH
Confidence            4578999999999742   333 455999999999999999999997654332222    22222222222335778899


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      +++.+||+.+|.+||++.++++|+|+....++.
T Consensus       255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         255 NFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             HHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence            999999999999999999999999997765543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3e-42  Score=306.77  Aligned_cols=245  Identities=23%  Similarity=0.403  Sum_probs=201.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|+++++||+|+||.||++.... ++.||+|.+.........+.+|+.++++++||||+++++++. ....+++|||+.
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME   83 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence            579999999999999999998765 678999998876555567889999999999999999999874 567899999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CC
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~  157 (351)
                      +++|.+++...  ..++...+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05067          84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTARE  161 (260)
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccccc
Confidence            99999988653  46899999999999999999999999999999999999987664  99999999875432221  12


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...++..|+|||.+.+..++ .++||||||+++|+|++ |++||........... +    ......+.....+.++.++
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         162 GAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-L----ERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             CCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH-H----HcCCCCCCCCCCCHHHHHH
Confidence            33467789999999777664 45999999999999998 9999987654332221 1    2223334445678899999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||..+|.+||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.3e-42  Score=311.24  Aligned_cols=258  Identities=29%  Similarity=0.521  Sum_probs=207.5

Q ss_pred             CeeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCcc-----cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHK-----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-----~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      +|++.+.||+|+||.||++.+.   .+++.||+|++.....     ....+.+|+.++.++ +||||+++++++......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999998864   4678899998865321     224567899999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ++||||+.+++|...+.....+++..++.++.|++.||.|||+.|++||||+|.||+++.++  +++|+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECccccccccc
Confidence            99999999999999998878899999999999999999999999999999999999997665  4999999998754332


Q ss_pred             CC--CCCcccCCCccCcccccCCc-CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          154 SR--PKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       154 ~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      ..  .....|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||...............+....  .+....++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  236 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMS  236 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCCcccC
Confidence            21  22346899999999986654 234559999999999999999999965433222223333333222  23333578


Q ss_pred             HhHHHHHHHhcccCCCCCCC---hHHHhcCcccccCC
Q 018734          231 QDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKNL  264 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps---~~eil~hp~~~~~~  264 (351)
                      ..+.++|.+||+.+|++|||   +.++|+||||+...
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            89999999999999999998   56779999996653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-42  Score=305.83  Aligned_cols=247  Identities=22%  Similarity=0.357  Sum_probs=203.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .++|++.+.||.|+||.||++.+.. +..||+|.+.........+.+|+.+++.++||||+++++++......+++|||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            3689999999999999999999765 577999998876555567889999999999999999999999889999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--C
Q 018734           81 AGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--P  156 (351)
Q Consensus        81 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~  156 (351)
                      .+++|.+++....  .++...+..++.|++.||.|||++|++|+||||+||+++.++  .++|+|||++........  .
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL--VCKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC--CEEECccccceeccchhhhhh
Confidence            9999999997643  689999999999999999999999999999999999998765  499999999875432111  1


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....++..|+|||.+.+..+. .++|+|||||++|+|++ |+.||...........    +. ..+..+.....+..+.+
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~  235 (261)
T cd05034         162 EGAKFPIKWTAPEAANYGRFT-IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ----VE-RGYRMPRPPNCPEELYD  235 (261)
T ss_pred             hccCCCccccCHHHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCHHHHH
Confidence            122345689999999876654 45999999999999998 9999976554332222    21 22333444456889999


Q ss_pred             HHHHhcccCCCCCCChHHHhc
Q 018734          236 LLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~  256 (351)
                      ++.+||+.+|.+||++++++.
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.6e-42  Score=305.67  Aligned_cols=245  Identities=23%  Similarity=0.355  Sum_probs=199.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||.|+||.||++.+..++ .+|+|.+.........+.+|+.+++.++||||+++++++. .+..+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            57999999999999999999987654 5999988765555567889999999999999999999875 456889999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CC
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~  157 (351)
                      +++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.  ++|+|||++........  ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccccC
Confidence            99999998754  34789999999999999999999999999999999999987654  99999999875432221  12


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...++..|+|||.+.+...+ .++|||||||++|+|++ |..||..........    .+ ......+....++..+.++
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLE----QV-ERGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             CCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HH-HcCCCCCCCcccCHHHHHH
Confidence            23466789999998776654 45999999999999999 999998755433222    11 1223334444678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||..+|.+||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.5e-42  Score=311.64  Aligned_cols=247  Identities=25%  Similarity=0.376  Sum_probs=199.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCccc-CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      .+|.+.+.||+|+||.||++.+.     .++..+++|.+...... ...+.+|+..+++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46899999999999999999854     34567889987654332 2457889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 018734           76 VMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRL  139 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~v  139 (351)
                      ||||+.+++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~~  162 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--LV  162 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cE
Confidence            999999999999986542                378999999999999999999999999999999999998765  49


Q ss_pred             EEeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHH
Q 018734          140 KICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISR  215 (351)
Q Consensus       140 kL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  215 (351)
                      +|+|||++.......   ......+++.|+|||.+.+..++. ++|||||||++|+|++ |+.||.........    ..
T Consensus       163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~t~g~~p~~~~~~~~~~----~~  237 (291)
T cd05094         163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT-ESDVWSFGVILWEIFTYGKQPWFQLSNTEVI----EC  237 (291)
T ss_pred             EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HH
Confidence            999999987543322   123345788999999998777654 4999999999999998 99999775543322    22


Q ss_pred             HHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.... .......++..+.+++.+||+.+|.+|||+.++++
T Consensus       238 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGR-VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCC-CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            22211 12223356889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-44  Score=330.61  Aligned_cols=245  Identities=25%  Similarity=0.360  Sum_probs=197.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++..++..||+|.||+||++++..+   ||||+++....   ..+.+.+|+.++++-+|-||+-+.+++..+.. .||+-
T Consensus       392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq  467 (678)
T KOG0193|consen  392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ  467 (678)
T ss_pred             HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence            3456889999999999999999864   99999876443   34578899999999999999999999988877 99999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--
Q 018734           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--  155 (351)
Q Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--  155 (351)
                      +|.|.+|+.+|.- ..+|.....+.|++||++|+.|||.++|||||||..|||+.+++  .|||+|||++........  
T Consensus       468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~--kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL--KVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC--cEEEecccceeeeeeecccc
Confidence            9999999999864 34688999999999999999999999999999999999998765  499999999875433322  


Q ss_pred             -CCCcccCCCccCcccccCCc--CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh---ccCCCCccCC
Q 018734          156 -PKSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---QYKIPDYVHI  229 (351)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  229 (351)
                       .....|...|||||++....  ..++.+|||||||++|||++|..||.. +..+++.   -.+..+   ..........
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIi---fmVGrG~l~pd~s~~~s~~  621 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQII---FMVGRGYLMPDLSKIRSNC  621 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheE---EEecccccCccchhhhccC
Confidence             23345888999999986432  235669999999999999999999984 3333222   111111   1111222346


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.++++|+..||.++|++||.+.+||.
T Consensus       622 pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  622 PKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            679999999999999999999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=306.95  Aligned_cols=257  Identities=29%  Similarity=0.532  Sum_probs=213.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHH----HHHHHHHH-hcCCCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINH-KQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----~~~e~~~~-~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|.+++.||+|+|++|.+++.++|.+.+|+|++++....+.+    ...|-.+. +.-+||.+|.++.+|.++.++++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            57899999999999999999999999999999998875432221    22333333 34489999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |.||++||+|.-.+++..++++++++.+...|+.||.|||+.|||.||||..|+|+|..+  ++||+|+|+++.......
T Consensus       329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg--hikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC--ceeecccchhhcCCCCCc
Confidence            999999999999999989999999999999999999999999999999999999998766  599999999987554444


Q ss_pred             C-CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCC---Ch-hHHHHHHHHHHhhccCCCCccCCC
Q 018734          156 P-KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE---DP-KNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       156 ~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      . .+.||||.|.|||++.+..| +..+|+|+||++++||++|+.||..-.   +. +.-.-....++..+.++|-  .+|
T Consensus       407 ~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--sls  483 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLS  483 (593)
T ss_pred             ccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eee
Confidence            4 45789999999999998887 455999999999999999999997421   11 1111223345556666665  577


Q ss_pred             HhHHHHHHHhcccCCCCCC------ChHHHhcCccccc
Q 018734          231 QDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLK  262 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rp------s~~eil~hp~~~~  262 (351)
                      -.+..+++..|.+||.+|.      .+.++..||||..
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            7889999999999999997      4789999999973

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-42  Score=304.25  Aligned_cols=240  Identities=27%  Similarity=0.375  Sum_probs=195.0

Q ss_pred             eeecccCceEEEEEEEcCCC---cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTK---ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++....++   ..||+|.+.....  ....+.+|+.+++.+.||||+++++++. ....++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876554   7899999876544  3456888999999999999999999876 4568999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC----C
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK----S  158 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~----~  158 (351)
                      ++|.+++.+.+.+++..+..++.|++.||.|||+++++||||||+|||++.++  .+||+|||+++.........    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~--~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH--QAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC--cEEeccccccceeecCCcccccccC
Confidence            99999998888899999999999999999999999999999999999997766  49999999987543322211    1


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..++..|+|||.+.+..++. ++|||||||++|+|++ |..||....... +...+    ......+....++..+.+++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~~~~~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSS-KSDVWSYGVTLWEAFSYGAKPYGEMKGAE-VIAML----ESGERLPRPEECPQEIYSIM  231 (257)
T ss_pred             ccccccccCHHHhcCCCCCc-cchHHHHHHHHHHHHcCCCCCcccCCHHH-HHHHH----HcCCcCCCCCCCCHHHHHHH
Confidence            12346799999997777654 5999999999999998 999997654422 22221    12223344456789999999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 018734          238 SRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~  256 (351)
                      .+||+.+|.+||++.++++
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         232 LSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-42  Score=307.69  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=201.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc---EEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ..|++.+.||+|+||.||++.+..+++   .||+|++.....  ....+..|+.+++.++||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            579999999999999999999887664   699998865422  235688899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+.+++|.+++.. .+.++...++.++.|++.||.|||++|++||||||+||+++.++  .+||+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCcc
Confidence            999999999998875 45689999999999999999999999999999999999997655  599999998864332221


Q ss_pred             C---CCcc---cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          156 P---KSTV---GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       156 ~---~~~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                      .   ....   ++..|+|||.+.+..++. ++|||||||++|+|++ |..||.........    ..+ ......|....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~----~~i-~~~~~~~~~~~  235 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----NAI-EQDYRLPPPMD  235 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccc-hhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH----HHH-HcCCcCCCccc
Confidence            1   1111   245799999998777654 4999999999999886 99999775543222    222 22334455556


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ++..+.+++.+||+.+|++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=332.24  Aligned_cols=256  Identities=27%  Similarity=0.463  Sum_probs=217.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEc-----CCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLT-----PTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~-----~~~~~l   75 (351)
                      +.|++.+.||.|.+|.||+++...+++.+|+|++......++++..|.++++.+ .|||++.++++|.-     ++.+|+
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL   98 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL   98 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence            468999999999999999999999999999999998888889999999999888 58999999999853     478999


Q ss_pred             EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           76 VMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |||||.||+..+++++  ..++.|..|..|++.+++||.+||.+.++|||||-.|||++.++.  |||+|||.+......
T Consensus        99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen   99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDST  176 (953)
T ss_pred             EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecc
Confidence            9999999999999875  457999999999999999999999999999999999999987664  999999998765444


Q ss_pred             -CCCCCcccCCCccCcccccC-----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCcc
Q 018734          154 -SRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  227 (351)
Q Consensus       154 -~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (351)
                       .+..+.+|||+|||||++.-     ..|+.. +|+||||++..||..|.+|+-+..+...+   +....+.+.++..+.
T Consensus       177 ~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraL---F~IpRNPPPkLkrp~  252 (953)
T KOG0587|consen  177 VGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNPPPKLKRPK  252 (953)
T ss_pred             cccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhh---ccCCCCCCccccchh
Confidence             34456789999999999842     234444 89999999999999999999876543322   222222333344456


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .++.++.++|..||.+|-.+||+..++|+|||+.+.
T Consensus       253 kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  253 KWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             hHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            789999999999999999999999999999999744

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.6e-42  Score=304.35  Aligned_cols=243  Identities=24%  Similarity=0.390  Sum_probs=197.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEE-cCCEEEEEEec
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVL-TPTHLAIVMEY   79 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~-~~~~~~lv~e~   79 (351)
                      +++|++.+.||+|+||.||++...  +..||+|.+.... ....+.+|+.++++++|||++++++++. .....+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            468999999999999999999765  6789999886543 2346889999999999999999999764 45679999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           80 AAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        80 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      +++++|.+++.+.+  .+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||++......  ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~--~~  157 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASST--QD  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC--cEEecCCccceecccc--CC
Confidence            99999999987644  488999999999999999999999999999999999998665  4999999998743222  23


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...++..|+|||++.+..++. ++|||||||++|+|++ |+.||.......    ....+. ..+.......+++.+.++
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~i~~~l~~~g~~p~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~~l  231 (256)
T cd05082         158 TGKLPVKWTAPEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVE-KGYKMDAPDGCPPVVYDV  231 (256)
T ss_pred             CCccceeecCHHHHccCCCCc-hhhhHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHh-cCCCCCCCCCCCHHHHHH
Confidence            344567899999997777654 4999999999999997 999997643322    222221 122223334678999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||+.+|.+|||+.++++
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.5e-42  Score=311.65  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC----------------CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN----------------TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRF   63 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~   63 (351)
                      ++|++.+.||+|+||.||++.+..                +...||+|++.....  ....+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            479999999999999999986542                345789998875432  23467899999999999999999


Q ss_pred             EEEEEcCCEEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 018734           64 KEVVLTPTHLAIVMEYAAGGELFERICNAG-----------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD  132 (351)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~  132 (351)
                      ++++......+++|||+.+++|.+++.+..           .+++..+..++.|++.||.|||++|++||||||+|||++
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~  164 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG  164 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence            999999999999999999999999987642           366788999999999999999999999999999999997


Q ss_pred             CCCCCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc--CCCCCCCCCChh
Q 018734          133 GSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFEDQEDPK  207 (351)
Q Consensus       133 ~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~  207 (351)
                      .++  .++|+|||+++.......   .....+++.|+|||...+..++ .++|||||||++|+|++  |..||......+
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         165 KNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             CCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCcc-chhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            655  599999999875432221   1223456789999988777664 45999999999999998  778987655433


Q ss_pred             HHHHHHHHHHh--hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          208 NFRKTISRIMA--VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       208 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...........  .....+....+++.+.+|+.+||+.+|.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            33222111111  11123444567889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.9e-42  Score=313.91  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=204.7

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +|...+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++|||++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            57788899999999999999999999999998864322    12356789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |+. ++|...+.. ...+++..+..++.|++.||.|||+++++||||+|+||+++.++  .++|+|||++.....   ..
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~---~~  169 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---AN  169 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeecC---cc
Confidence            996 577776643 45689999999999999999999999999999999999997665  599999998864322   23


Q ss_pred             CcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ...|++.|+|||.+.+  ....+.++|||||||++|+|++|..||...........    +............++..+.+
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06634         170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRN  245 (308)
T ss_pred             cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH----HhhcCCCCcCcccccHHHHH
Confidence            4568999999999753  22234559999999999999999999976543222221    11111111122357888999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      ||.+||+.+|.+||++.++++|||+....+..
T Consensus       246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~  277 (308)
T cd06634         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (308)
T ss_pred             HHHHHhhCCcccCCCHHHHhhCccccccCChh
Confidence            99999999999999999999999998865544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.5e-42  Score=323.91  Aligned_cols=249  Identities=23%  Similarity=0.377  Sum_probs=200.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCccc--CHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHKI--DANVAREIINHKQLR-HPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|.+.+.||+|+||.||++.+.     .+++.||+|++......  ...+.+|+.++.++. |||||++++++...+.+
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            46788899999999999999864     34578999999764322  235778999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC------------------------------------------------------------
Q 018734           74 AIVMEYAAGGELFERICNAG------------------------------------------------------------   93 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~------------------------------------------------------------   93 (351)
                      ++|||||.+|+|.+++...+                                                            
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            99999999999999886432                                                            


Q ss_pred             --------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           94 --------------------------------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        94 --------------------------------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                                                            .++...+..++.||+.||.|||+.+++||||||+|||++.++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence                                                  256677889999999999999999999999999999998655


Q ss_pred             CCCEEEeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                        .+||+|||+++......   ......+++.|+|||.+.+..+. .++|||||||++|||++ |..||......+....
T Consensus       277 --~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~  353 (401)
T cd05107         277 --LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN  353 (401)
T ss_pred             --EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHH
Confidence              49999999987532211   12234678899999999777664 45999999999999998 8999976544333222


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .    .......+.+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus       354 ~----~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         354 A----IKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             H----HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2    22233334444678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-42  Score=307.44  Aligned_cols=246  Identities=21%  Similarity=0.337  Sum_probs=195.9

Q ss_pred             eeEeeeecccCceEEEEEEEcC---CCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCE-----
Q 018734            4 YELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTH-----   72 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~-----   72 (351)
                      |.+++.||+|+||.||.+....   ++..||+|.+......   ...+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            6789999999999999998764   3478999998754322   2457889999999999999999998865543     


Q ss_pred             -EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccC
Q 018734           73 -LAIVMEYAAGGELFERICNA------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG  145 (351)
Q Consensus        73 -~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg  145 (351)
                       .+++|||+.+++|..++...      ..+++..+..++.|++.||.|||+++++||||||+||+++.++  .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCcc
Confidence             79999999999998887432      3589999999999999999999999999999999999998765  49999999


Q ss_pred             CCcccCCCCCC---CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhcc
Q 018734          146 YSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY  221 (351)
Q Consensus       146 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (351)
                      +++........   ....++..|+|||.+.+..++ .++|||||||++|+|++ |..||........+    ..+... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~----~~~~~~-~  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIY----DYLRHG-N  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcC-C
Confidence            98754332211   122356789999998766664 45999999999999999 89999765543322    222211 2


Q ss_pred             CCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          222 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+.+..++..+.+++.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            223334678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2e-42  Score=307.81  Aligned_cols=249  Identities=30%  Similarity=0.483  Sum_probs=201.6

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc------ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH------KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ||.+.+.||+|+||.||++.+..++..+++|++....      .....+..|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            7999999999999999999998887777777665321      1223456788999999999999999999988999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |||+.+++|...+..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.+   .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence            999999999888753    4568999999999999999999999999999999999999743   499999999875433


Q ss_pred             CCC-CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          153 HSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       153 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      ... .....|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.......    .......... ......++.
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~  231 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLS----VVLRIVEGPT-PSLPETYSR  231 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHcCCC-CCCcchhcH
Confidence            222 233468999999999877766545 999999999999999999997543322    2222222111 111235788


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+.++|.+||..+|.+||++.++++||||
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.2e-43  Score=310.24  Aligned_cols=244  Identities=31%  Similarity=0.500  Sum_probs=194.4

Q ss_pred             eEeeeecccCceEEEEEEEc----CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            5 ELMKDIGSGNFGVARLMRNK----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .+.+.||.|+||.||++...    ..+..|+||.+.....  ....+.+|+..+++++||||+++++++...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            57889999999999999988    4567899999965332  24678899999999999999999999998888999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--
Q 018734           79 YAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  154 (351)
Q Consensus        79 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--  154 (351)
                      |+.+|+|.+++...  ..++...+..++.||+.||.|||+++++|++|+++|||++.++.  +||+|||++.......  
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence            99999999999886  67999999999999999999999999999999999999987764  9999999987542111  


Q ss_pred             -CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          155 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                       ......+...|+|||.+....+ +.++||||||+++|||++ |+.||.......    ....+ ......+....++..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~  233 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----IIEKL-KQGQRLPIPDNCPKD  233 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----HHHHH-HTTEETTSBTTSBHH
T ss_pred             ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccc----ccccc-cccccceeccchhHH
Confidence             1233457788999999987776 455999999999999999 789987764322    22233 222334444568999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.++|.+||..+|.+|||+.+|++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.4e-42  Score=308.67  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=199.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++.+.||+|+||.||++...     .++..+|+|.+..... ....+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46889999999999999999753     3467899998765332 23568889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEE
Q 018734           76 VMEYAAGGELFERICNAG---------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLK  140 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~---------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vk  140 (351)
                      +|||+.+++|.+++...+               .+++..+..++.||+.||.|||++|++||||||+|||++.++  .+|
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~k  162 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VVK  162 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CEE
Confidence            999999999999987643               478999999999999999999999999999999999997655  499


Q ss_pred             EeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHH
Q 018734          141 ICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI  216 (351)
Q Consensus       141 L~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  216 (351)
                      |+|||++........   .....+++.|+|||.+.+..++. ++|||||||++|+|++ |.+||............    
T Consensus       163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----  237 (280)
T cd05092         163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT-ESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI----  237 (280)
T ss_pred             ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCc-hhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH----
Confidence            999999864332211   12234578899999998777654 4999999999999998 99999765543332221    


Q ss_pred             HhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .. ....+....+++.+.+++.+||+.+|.+||++.+++.
T Consensus       238 ~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 TQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             Hc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            11 1122333467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=332.79  Aligned_cols=246  Identities=31%  Similarity=0.437  Sum_probs=200.5

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC------EEEE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT------HLAI   75 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~------~~~l   75 (351)
                      |...+.||+|+||.||+++++.+|+.||||.++....  ..+..-+|++++++|+|||||++.++-.+..      .-.+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            5667899999999999999999999999999887433  3456789999999999999999999865443      4579


Q ss_pred             EEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC--CCCCCEEEeccCCCccc
Q 018734           76 VMEYAAGGELFERICNA---GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG--SPAPRLKICDFGYSKSS  150 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~--~~~~~vkL~DFg~a~~~  150 (351)
                      |||||.||+|+..+.+.   .-+++.++..++.+++.||.|||++||+||||||.||++-.  ++....||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            99999999999999753   35999999999999999999999999999999999999843  34445799999999988


Q ss_pred             CCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh------------
Q 018734          151 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA------------  218 (351)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  218 (351)
                      ..+..-.+.+||+.|++||++....+++..+|.|||||++|+++||..||.....+.....+...+..            
T Consensus       175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~  254 (732)
T KOG4250|consen  175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQE  254 (732)
T ss_pred             CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeec
Confidence            88888888999999999999986444455599999999999999999999887766543333222211            


Q ss_pred             -------hccCCCCccCCCHh----HHHHHHHhcccCCCCCC
Q 018734          219 -------VQYKIPDYVHISQD----CRNLLSRIFVANPSRRI  249 (351)
Q Consensus       219 -------~~~~~~~~~~~~~~----~~~li~~~L~~~P~~Rp  249 (351)
                             -...+|.+..+++.    +...+..+|..+|.+|.
T Consensus       255 ~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  255 EENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                   11123444445543    45678888999999999

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7e-42  Score=309.43  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=198.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +|++.+.||+|+||.||++.+..     ....+++|.+.....  ....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            58899999999999999998753     235688888765432  22467789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 018734           76 VMEYAAGGELFERICNA------------------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLL  131 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll  131 (351)
                      +|||+.+++|.+++...                        ..+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999999987642                        247888999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChh
Q 018734          132 DGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK  207 (351)
Q Consensus       132 ~~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  207 (351)
                      +.++  .+||+|||+++.......   .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||.......
T Consensus       161 ~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         161 AEGR--KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             cCCC--cEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            8665  499999999875432221   1233467789999998777665 55999999999999998 999997654322


Q ss_pred             HHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          208 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                       +...    .......+....++..+.+++.+||+.+|.+||++.++++
T Consensus       238 -~~~~----~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 -LFNL----LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             -HHHH----HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence             2221    2222333444568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-42  Score=307.39  Aligned_cols=241  Identities=24%  Similarity=0.365  Sum_probs=192.2

Q ss_pred             eeecccCceEEEEEEEcCCCc--EEEEEEeccCc--ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKE--LVAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+..++.  .+|+|.+....  .....+.+|+.+++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999988775  46888776432  2234677899999999 799999999999999999999999999


Q ss_pred             CChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           83 GELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        83 ~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                      ++|.+++....                .+++..+..++.|++.||.|||++|++||||||+||+++.++  ++||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~--~~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC--eEEECCCCC
Confidence            99999986532                478999999999999999999999999999999999998665  499999999


Q ss_pred             CcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCC
Q 018734          147 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD  225 (351)
Q Consensus       147 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (351)
                      +..............+..|+|||.+....++ .++|||||||++|+|++ |..||..........    .+ ...+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~----~~-~~~~~~~~  232 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-PQGYRLEK  232 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHH----HH-hCCCCCCC
Confidence            8643222222223346679999998776664 45999999999999997 999997654332222    22 12223333


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...++.++.+++.+||+.+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            3457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.9e-42  Score=319.39  Aligned_cols=249  Identities=23%  Similarity=0.372  Sum_probs=195.9

Q ss_pred             CCeeEeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcC-CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTP-TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~-~~   72 (351)
                      ++|++.+.||+|+||.||+|.+     ..+++.||||++.....  ....+.+|+.++.++ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5899999999999999999985     34678999999875432  224577899999999 689999999987654 56


Q ss_pred             EEEEEeccCCCChHHHHHhc------------------------------------------------------------
Q 018734           73 LAIVMEYAAGGELFERICNA------------------------------------------------------------   92 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~------------------------------------------------------------   92 (351)
                      ++++||||.+|+|.+++...                                                            
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            89999999999999988642                                                            


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC---CCCcccC
Q 018734           93 -------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGT  162 (351)
Q Consensus        93 -------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt  162 (351)
                             ..++...+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||++........   .....++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLP  244 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCCCCCC
Confidence                   1367778889999999999999999999999999999998665  499999999875322211   1223456


Q ss_pred             CCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      +.|+|||.+.+..++. ++|||||||++|+|++ |..||........+...+    ......+.....++.+.+++.+||
T Consensus       245 ~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         245 LKWMAPETIFDRVYTI-QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL----KEGTRMRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             cceECcHHhcCCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH----hccCCCCCCCCCCHHHHHHHHHHc
Confidence            7899999998777654 4999999999999996 999997654333322221    111122223346789999999999


Q ss_pred             ccCCCCCCChHHHhcC
Q 018734          242 VANPSRRITIKEIKSH  257 (351)
Q Consensus       242 ~~~P~~Rps~~eil~h  257 (351)
                      +.+|.+|||+.++++|
T Consensus       320 ~~~p~~Rps~~eil~~  335 (343)
T cd05103         320 HGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=9.1e-42  Score=304.97  Aligned_cols=247  Identities=25%  Similarity=0.388  Sum_probs=201.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC---cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK---ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      .+|++.+.||+|+||.||++.+..++   ..+|+|.+.....  ....+.+|+.++++++||||+++++++..++..|+|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57999999999999999999886444   3799998865432  234678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+++++|.+++... +.++...+..++.|++.||.|||++|++||||||+|||++.++  .++|+|||++........
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCcccccccccc
Confidence            9999999999998764 4689999999999999999999999999999999999997665  499999999875432211


Q ss_pred             C----CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          156 P----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       156 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .    ....++..|+|||.+.+..++. ++|+|||||++|++++ |..||..........    .+. .....|....++
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~-~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~  235 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTS-ASDVWSYGIVMWEVMSYGERPYWEMSNQDVIK----AIE-EGYRLPAPMDCP  235 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCc-hhhhHHHHHHHHHHhcCCCCCcccCCHHHHHH----HHh-CCCcCCCCCCCC
Confidence            1    1122356799999998777654 4999999999999886 999997765433222    222 223345555678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+.+++.+||+.+|.+||++.++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         236 AALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHHHHcccCchhCCCHHHHHH
Confidence            89999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-41  Score=306.31  Aligned_cols=246  Identities=20%  Similarity=0.322  Sum_probs=195.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc----EEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++.+.||+|+||.||++.+..+++    .+++|.+.....  ....+..|+..++.++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            579999999999999999999877766    467777653322  1245667888889999999999999875 456788


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      ++||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++  .+||+|||+++......
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYPDD  163 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccCCC
Confidence            9999999999999976 45689999999999999999999999999999999999998665  49999999987543222


Q ss_pred             C---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .   .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||....... ....    .......+.....+
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~~~~~~~~  237 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDL----LEKGERLAQPQICT  237 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH----HHCCCcCCCCCCCC
Confidence            1   1233567789999999877765 44999999999999998 999997654322 1222    22222333333467


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.+++.+||..+|++|||+.++++
T Consensus       238 ~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         238 IDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            78999999999999999999999975

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.5e-42  Score=311.38  Aligned_cols=248  Identities=24%  Similarity=0.347  Sum_probs=198.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-------CCCcEEEEEEeccCc--ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-------NTKELVAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      ++|.+.+.||+|+||.||+++..       ..+..||+|.+....  .....+.+|+.+++.+ +||||+++++++....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            47899999999999999999752       234579999886532  2235678899999999 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           72 HLAIVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      ..|++|||+.+++|.+++.+.                ..++...+..++.||+.||.|||++|++||||||+||+++.++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            999999999999999998753                2467888999999999999999999999999999999997665


Q ss_pred             CCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                        .+||+|||+++.......   .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......+.   
T Consensus       175 --~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~---  248 (304)
T cd05101         175 --VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEEL---  248 (304)
T ss_pred             --cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHH---
Confidence              499999999875432221   222346778999999987776544 999999999999998 7888876543222   


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                       ...+. ..........++..+.+|+.+||+.+|.+|||+.++++.
T Consensus       249 -~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         249 -FKLLK-EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             -HHHHH-cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence             22221 222223334678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.4e-42  Score=306.68  Aligned_cols=249  Identities=22%  Similarity=0.392  Sum_probs=203.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||.|+||.||+++...     +.+.|++|.+......  ...+.+|+.++++++||||+++++++......|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            579999999999999999999754     3467999987654332  356889999999999999999999999889999


Q ss_pred             EEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccC
Q 018734           75 IVMEYAAGGELFERICNAG---------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG  145 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg  145 (351)
                      +||||+++++|.+++....         .+++..+..++.|++.||.|||++||+||||||+||+++.++.  ++|+|||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~  162 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLS  162 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccc
Confidence            9999999999999997655         6899999999999999999999999999999999999987664  9999999


Q ss_pred             CCcccCCCC--CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccC
Q 018734          146 YSKSSLLHS--RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  222 (351)
Q Consensus       146 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (351)
                      ++.......  ......++..|+|||.+.+.... .++||||||+++|+|++ |..||.......    ...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~~~  237 (275)
T cd05046         163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGKLE  237 (275)
T ss_pred             cccccCcccccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCCcC
Confidence            986432221  22334577889999998776654 45999999999999998 888997654322    22233323333


Q ss_pred             CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+....++..+.+++.+||+.+|.+|||+.+++..
T Consensus       238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            44444678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-45  Score=302.59  Aligned_cols=262  Identities=26%  Similarity=0.403  Sum_probs=209.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcC--------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP--------   70 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--------   70 (351)
                      ..|+-+.+||+|.||.||+|+.+++++.||+|++....   -.....++|+.++..|+|+|++.+++++.+.        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666789999999999999999999999998765422   2346788999999999999999988876432        


Q ss_pred             CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           71 THLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        71 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      ..+|+||++|+. +|.-+|.+. .+++..+|+.++.+++.||.|+|++.|+|||+||+|+||+.++.  +||+|||+++.
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~  173 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARA  173 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccc
Confidence            358999999975 888888776 57999999999999999999999999999999999999987765  99999999964


Q ss_pred             cC-----CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CC
Q 018734          150 SL-----LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI  223 (351)
Q Consensus       150 ~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  223 (351)
                      ..     ...+.+..+-|.+|++||.+.+...+++..|||+.|||+.+|.+|.+.+++.....++..+-.-...... .+
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            32     2233455677999999999999888888899999999999999999999887655444322211100000 01


Q ss_pred             CCc----------------------------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          224 PDY----------------------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       224 ~~~----------------------------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      |..                            ..-.+++.+|+.+||..||.+|++++++|+|.||.+...+
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence            100                            0123578899999999999999999999999999876544

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.4e-41  Score=301.58  Aligned_cols=247  Identities=25%  Similarity=0.426  Sum_probs=201.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .+|++.+.||.|+||.||++.+.. +..+|+|.+.........+.+|+.++++++||||+++++++......++||||+.
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            478999999999999999998864 6689999887655555678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CCC
Q 018734           82 GGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKS  158 (351)
Q Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~~  158 (351)
                      +++|.+++... +.+++..++.++.|++.||.|||+++++||||||+||+++.++  .++|+|||++........  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcccccCC
Confidence            99999998764 5689999999999999999999999999999999999997655  499999998874432211  122


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..++..|+|||.+.+..+. .++||||||+++|+|++ |+.||........    ...+.. ..........+..+.+|+
T Consensus       161 ~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEV----VETINA-GFRLYKPRLASQSVYELM  234 (256)
T ss_pred             CccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH----HHHHhC-CCCCCCCCCCCHHHHHHH
Confidence            3356789999999776665 45999999999999998 9999976543222    222221 122222334688999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.+|.+|||+.+++++
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHcccChhhCCCHHHHHHh
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.4e-42  Score=306.09  Aligned_cols=246  Identities=23%  Similarity=0.365  Sum_probs=193.9

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCc--EEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcC------CE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKE--LVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~   72 (351)
                      |.+++.||+|+||.||++.+..++.  .||+|.+....   .....+.+|+.+++.++||||+++++.+...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578999999999999999887765  58999876542   2234677899999999999999999976432      25


Q ss_pred             EEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           73 LAIVMEYAAGGELFERICN------AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                      .+++|||+.+++|..++..      ...+++..+..++.|++.||.|||+++|+||||||+|||++.++  .+||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM--NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC--CEEECCCCc
Confidence            7899999999999887742      23488999999999999999999999999999999999997665  499999999


Q ss_pred             CcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccC
Q 018734          147 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  222 (351)
Q Consensus       147 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (351)
                      ++.......   .....+++.|+|||.+.+..++ .++|||||||++|+|++ |+.||.......    ....+... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~~~~~~~-~~  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSE----IYDYLRQG-NR  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHcC-CC
Confidence            885433221   1223467789999999877665 45999999999999999 899997654322    22222221 22


Q ss_pred             CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+....++..+.++|.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            23344678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-41  Score=306.80  Aligned_cols=252  Identities=26%  Similarity=0.409  Sum_probs=196.9

Q ss_pred             CCeeEeeeecccCceEEEEEE----EcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~~   74 (351)
                      ++|++.+.||+|+||.||.+.    +..+++.||+|++..... ....+.+|+.+++.++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            478999999999999999987    456788999999865433 23467889999999999999999998754  35689


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           75 IVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      +||||+++++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||++......
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~--~~~l~dfg~~~~~~~~  161 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN--RVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC--eEEECCCcccccccCC
Confidence            999999999999998764 4689999999999999999999999999999999999997665  4999999998854322


Q ss_pred             CCC----CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh-----------HHHHHHHHHHh
Q 018734          154 SRP----KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----------NFRKTISRIMA  218 (351)
Q Consensus       154 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----------~~~~~~~~~~~  218 (351)
                      ...    ....++..|+|||++.+..++ .++|||||||++|+|++|..|+.......           .....+.....
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            211    112234569999999776664 45999999999999999877764322100           00011112222


Q ss_pred             hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .....+....++..+.+|+.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            23334445567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.9e-42  Score=303.01  Aligned_cols=229  Identities=24%  Similarity=0.381  Sum_probs=188.9

Q ss_pred             cCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCChHHHHHhc
Q 018734           13 GNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA   92 (351)
Q Consensus        13 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   92 (351)
                      |.||.||++.+..+++.||+|++.....    ..++...+....||||+++++++......+++|||+.|++|.+++.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            8899999999999999999999876532    223444455567999999999999999999999999999999999887


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCccCccccc
Q 018734           93 GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS  172 (351)
Q Consensus        93 ~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~  172 (351)
                      ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++.....  ......++..|+|||.+.
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~--~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVED--SCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhcccc--ccccCCcCccccCCcccC
Confidence            78999999999999999999999999999999999999987664  99999998754322  223445678899999987


Q ss_pred             CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCCh-
Q 018734          173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITI-  251 (351)
Q Consensus       173 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~-  251 (351)
                      +..++ .++|+||+||++|+|++|+.||........        ......+|  ..+++.+.++|.+||+.||++||++ 
T Consensus       156 ~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~~--------~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         156 ISEET-EACDWWSLGAILFELLTGKTLVECHPSGIN--------THTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhcc--------cccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            76665 459999999999999999988764321100        00111233  3578899999999999999999986 


Q ss_pred             ----HHHhcCccc
Q 018734          252 ----KEIKSHPWF  260 (351)
Q Consensus       252 ----~eil~hp~~  260 (351)
                          +++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-41  Score=311.41  Aligned_cols=247  Identities=25%  Similarity=0.354  Sum_probs=196.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-------CCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      ++|.+.+.||+|+||.||++.+..       ....||+|.+.....  ....+.+|+.+++.+ +||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            479999999999999999998642       345789998775332  224577899999999 6999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           72 HLAIVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      .+|++|||+.+++|.+++...                ..++...+..++.||+.||.|||++|++||||||+|||++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence            999999999999999998653                3478899999999999999999999999999999999997665


Q ss_pred             CCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                        ++||+|||+++.......   .....+++.|+|||++.+..++ .++|||||||++|+|++ |..||........+. 
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-  247 (314)
T cd05099         172 --VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK-  247 (314)
T ss_pred             --cEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH-
Confidence              599999999975432211   1122345679999999877665 45999999999999999 899997654322222 


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                         .+.. ....+....++.++.+++.+||..+|.+|||+.++++
T Consensus       248 ---~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         248 ---LLRE-GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             ---HHHc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               1111 1222223457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-41  Score=302.27  Aligned_cols=246  Identities=24%  Similarity=0.398  Sum_probs=199.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .++|++.+.||+|+||.||++.+.. +..+|+|.+.........+.+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            4689999999999999999998654 5579999887654444678899999999999999999999877 7789999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--C
Q 018734           81 AGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--P  156 (351)
Q Consensus        81 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~  156 (351)
                      .+++|.+++.+.  ..++...+..++.|++.||.|||++|++||||||+||+++..+  .+||+|||++........  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCCcccc
Confidence            999999998763  4578889999999999999999999999999999999997665  499999998864322211  1


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....++..|+|||.+....++ .++|+|||||++|+|++ |+.||...........     ....+..+.....+..+.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05073         161 EGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-----LERGYRMPRPENCPEELYN  234 (260)
T ss_pred             cCCcccccccCHhHhccCCcC-ccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----HhCCCCCCCcccCCHHHHH
Confidence            223456779999999776654 44999999999999998 9999986544322221     1223333444567889999


Q ss_pred             HHHHhcccCCCCCCChHHHhc
Q 018734          236 LLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~  256 (351)
                      ++.+||+.+|++||++.++++
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-41  Score=304.27  Aligned_cols=247  Identities=24%  Similarity=0.369  Sum_probs=201.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc---EEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|+..+.||+|+||.||++.+..++.   .+|+|.+.....  ....+.+|+.+++.++||||+++.+++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            468899999999999999999876554   799998865432  234678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+.+++|..++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++  .+||+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceecccccc
Confidence            9999999999998764 5789999999999999999999999999999999999998665  499999999875432221


Q ss_pred             CC----CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          156 PK----STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       156 ~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      ..    ....++.|+|||++.+..++ .++|||||||++|+|++ |+.||.........    ..+. .....|.....+
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~----~~i~-~~~~~~~~~~~~  236 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVM----KAIN-DGFRLPAPMDCP  236 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH----HHHh-cCCCCCCCCCCC
Confidence            11    11234579999999877765 44999999999999997 99999765543222    2222 223445555678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         237 SAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.5e-42  Score=307.96  Aligned_cols=250  Identities=25%  Similarity=0.413  Sum_probs=197.0

Q ss_pred             eeEeeeecccCceEEEEEEE----cCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEEE
Q 018734            4 YELMKDIGSGNFGVARLMRN----KNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAI   75 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~l   75 (351)
                      |++++.||+|+||.||++..    ..++..||+|.+.....  ....+.+|+.+++.++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            68899999999999999974    45688999999865432  234678899999999999999999998775  57899


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      ||||++|++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||+++......
T Consensus        86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC--CEEECCCccccccccCc
Confidence            99999999999998765 3589999999999999999999999999999999999997665  49999999987543322


Q ss_pred             C----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----------hhHHHHHHHHHHhh
Q 018734          155 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----------PKNFRKTISRIMAV  219 (351)
Q Consensus       155 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~~~~~~~~~  219 (351)
                      .    .....++..|+|||.+.+..++ .++|||||||++|+|++++.|+.....           ......... ....
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  241 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VLEE  241 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HHHc
Confidence            1    1234567789999998777665 459999999999999998776532110           001111111 1112


Q ss_pred             ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          220 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ....+....++..+.+|+.+||+.+|.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            22334445688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.8e-41  Score=300.71  Aligned_cols=245  Identities=27%  Similarity=0.416  Sum_probs=201.2

Q ss_pred             eeEeeeecccCceEEEEEEEcCCC----cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTK----ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +++.+.||.|+||.||++.+...+    ..||+|++.....  ....+..|+..++.++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467889999999999999998766    8999999876543  3457888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           78 EYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||+++++|.+++.....  +++..+..++.|++.||.+||++|++||||||+||+++.++  .++|+|||++........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC--eEEEcccCCceecccccc
Confidence            99999999999876544  89999999999999999999999999999999999998766  499999999875443322


Q ss_pred             CC--CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 PK--STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      ..  ...+++.|+|||.+.+..+ +.++|+|||||++|+|++ |++||..........    .+.. ....+.....+..
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~  232 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE----YLKK-GYRLPKPENCPPE  232 (258)
T ss_pred             cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHhc-CCCCCCCCcCCHH
Confidence            11  2237789999999966555 455999999999999998 888887644322222    2221 1223333457899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+++.+||..+|.+|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.3e-41  Score=304.20  Aligned_cols=243  Identities=23%  Similarity=0.345  Sum_probs=188.2

Q ss_pred             eeecccCceEEEEEEEc--CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            8 KDIGSGNFGVARLMRNK--NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +.||+|+||.||++...  .++..+|+|.+.....  ....+.+|+.+++.++||||+++++++.+...+++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46999999999999754  3556799998865433  2246778999999999999999999999989999999999999


Q ss_pred             ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC---
Q 018734           84 ELFERICNAG-----RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---  155 (351)
Q Consensus        84 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---  155 (351)
                      +|.+++....     .++...++.++.|++.||.|||+.|++||||||+||+++.++  .+||+|||++........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceeec
Confidence            9999986532     356778889999999999999999999999999999998765  499999999864332211   


Q ss_pred             CCCcccCCCccCcccccCCc------CCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCc--
Q 018734          156 PKSTVGTPAYIAPEVLSRRE------YDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDY--  226 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  226 (351)
                      .....|++.|+|||++.+..      ..+.++|||||||++|+|++ |+.||............   +.......+..  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~  235 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---VREQQLKLPKPRL  235 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---hhcccCCCCCCcc
Confidence            22345788899999986432      12456999999999999996 99999765543322221   11111222211  


Q ss_pred             -cCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          227 -VHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       227 -~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                       ...+..+.+++.+|+ .+|++|||+++|+.
T Consensus       236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence             246788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.3e-43  Score=345.79  Aligned_cols=252  Identities=29%  Similarity=0.428  Sum_probs=197.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC--cccCHHHHHHHHHHhcCCCCCcceEEEEEEc----------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQLRHPNIIRFKEVVLT----------   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~----------   69 (351)
                      .+|+.++.||+||||.||+++++-+|+.||||+|...  .....++.+|+..+.+|+|||||+++..+..          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            4678889999999999999999999999999999765  4445679999999999999999998765430          


Q ss_pred             ---------------------------------------------C----------------------------------
Q 018734           70 ---------------------------------------------P----------------------------------   70 (351)
Q Consensus        70 ---------------------------------------------~----------------------------------   70 (351)
                                                                   .                                  
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                         0                                  


Q ss_pred             ------------------------------CEEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCC
Q 018734           71 ------------------------------THLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQI  119 (351)
Q Consensus        71 ------------------------------~~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~~~~qi~~aL~~lH~~~i  119 (351)
                                                    ..+||-||||+..+|.+++..+... .....++++++|+.||.|+|+.||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                          1268999999987777777665544 478899999999999999999999


Q ss_pred             eecCCCCCcEEecCCCCCCEEEeccCCCcccC-------------------CCCCCCCcccCCCccCcccccCCc--CCC
Q 018734          120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-------------------LHSRPKSTVGTPAYIAPEVLSRRE--YDG  178 (351)
Q Consensus       120 iH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~~~  178 (351)
                      |||||||.||+++.++.  |||+|||+|+...                   .....++.+||..|+|||++.+..  .+.
T Consensus       719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999997765  9999999997411                   011235568999999999997766  234


Q ss_pred             cchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC--ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       179 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .++|+||||+|++||+.   ||...-.-   ..++..+.......+.  +..--+.-..+|.+||+.||++||||.|+|+
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~TsMER---a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTSMER---ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCchHHH---HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            45999999999999994   67653321   2233333344443330  1112345679999999999999999999999


Q ss_pred             Ccccc
Q 018734          257 HPWFL  261 (351)
Q Consensus       257 hp~~~  261 (351)
                      +.||.
T Consensus       871 s~llp  875 (1351)
T KOG1035|consen  871 SELLP  875 (1351)
T ss_pred             ccCCC
Confidence            99987

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-41  Score=301.29  Aligned_cols=241  Identities=29%  Similarity=0.422  Sum_probs=196.3

Q ss_pred             eeecccCceEEEEEEEcC-CC--cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNKN-TK--ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|++|.||++.+.. .+  ..||+|.+.....  ....+.+|+..+++++||||+++++.+.. ...++||||+.+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 33  3689999876544  33567889999999999999999999988 899999999999


Q ss_pred             CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC----C
Q 018734           83 GELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----P  156 (351)
Q Consensus        83 ~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~----~  156 (351)
                      ++|.+.+.+..  .+++..++.++.|++.||.|||++|++||||||+||+++.++  .+||+|||++........    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccceecc
Confidence            99999997754  689999999999999999999999999999999999998775  499999999875433211    1


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||......+....    +.......+.....+..+.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  232 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK----IDKEGERLERPEACPQDIYN  232 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhcCCcCCCCccCCHHHHH
Confidence            22457788999999877776544 999999999999998 9999976544332222    22222233333457889999


Q ss_pred             HHHHhcccCCCCCCChHHHhc
Q 018734          236 LLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~  256 (351)
                      ++.+||+.+|.+|||+.+++.
T Consensus       233 li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         233 VMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHCCCCcccCCCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.8e-41  Score=306.22  Aligned_cols=248  Identities=16%  Similarity=0.178  Sum_probs=188.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC---CcEEEEEEeccCcccC------------HHHHHHHHHHhcCCCCCcceEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHKID------------ANVAREIINHKQLRHPNIIRFKEV   66 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~------------~~~~~e~~~~~~l~hp~Iv~~~~~   66 (351)
                      ++|++.+.||+|+||.||++.+..+   +..+|+|+........            .....++..+..+.|+||++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            5899999999999999999999877   6677888644322110            112233445567799999999998


Q ss_pred             EEcCC----EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 018734           67 VLTPT----HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC  142 (351)
Q Consensus        67 ~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~  142 (351)
                      +....    ..+++++++. .++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++.++  .++|+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l~  168 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYII  168 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEEE
Confidence            75543    4578888874 47777776666678999999999999999999999999999999999997665  49999


Q ss_pred             ccCCCcccCCCC--------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHH---
Q 018734          143 DFGYSKSSLLHS--------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK---  211 (351)
Q Consensus       143 DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---  211 (351)
                      |||+|+......        ......||+.|+|||++.+..++ .++|||||||++|+|++|..||...........   
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            999987543211        12234699999999999887775 559999999999999999999987643322221   


Q ss_pred             --HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          212 --TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       212 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                        .+.++.......   ...+..+.+++..|+..+|.+||++.++++
T Consensus       248 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              122222222222   346789999999999999999999999875

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-41  Score=312.73  Aligned_cols=248  Identities=24%  Similarity=0.353  Sum_probs=197.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-------CcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-------KELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      .+|++++.||+|+||.||.+.+...       ...||+|.+.....  ....+.+|+.+++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            3799999999999999999986432       23689998765332  234678899999999 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      .++++|||+.+++|.+++.+..                .++...+..++.|++.||.|||++|++||||||+|||++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            9999999999999999987532                367788999999999999999999999999999999997665


Q ss_pred             CCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                        .+||+|||+++.......   .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||......+... 
T Consensus       172 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~-  247 (334)
T cd05100         172 --VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFK-  247 (334)
T ss_pred             --cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH-
Confidence              499999999875432211   122234567999999987777555 999999999999998 889997654332222 


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                         .+. .....+.....+..+.+++.+||+.+|.+|||+.+++++
T Consensus       248 ---~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         248 ---LLK-EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             ---HHH-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence               111 222233334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=302.58  Aligned_cols=250  Identities=25%  Similarity=0.423  Sum_probs=203.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHH-hcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINH-KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~-~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +..||.|+||+|+++.++.+|+..|||.++....  ...+++.|.... +.-++||||++++....++..||.||+|. .
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence            4679999999999999999999999999976433  345677777664 55579999999999999999999999995 4


Q ss_pred             ChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           84 ELFERI-----CNAGRFSEDEARYFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        84 ~L~~~l-----~~~~~l~~~~~~~~~~qi~~aL~~lH-~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      +|..+.     .+..+++|+.+-.+....+.||.||- ...|||||+||+|||++..+.  +||||||++......-..+
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~SiAkT  225 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDSIAKT  225 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHHHHHhh
Confidence            664433     23567999999999999999999998 568999999999999987776  9999999998766666666


Q ss_pred             CcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--C--CccCCCH
Q 018734          158 STVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--P--DYVHISQ  231 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~  231 (351)
                      .-.|...|||||.+..  .+|+-+ ||+||||++|||+.||..|+....+   ....+..+.......  +  ...+++.
T Consensus       226 ~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~~~~~~s~  301 (361)
T KOG1006|consen  226 VDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDKECVHYSF  301 (361)
T ss_pred             hccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCcccccccCH
Confidence            7789999999999854  345545 9999999999999999999987653   233333333332221  1  1234788


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+..+|.-||.+|-+.||+..+++++||++..
T Consensus       302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             HHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            99999999999999999999999999998654

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.2e-41  Score=305.77  Aligned_cols=247  Identities=24%  Similarity=0.378  Sum_probs=199.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+..     ++..||+|++.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            579999999999999999998753     678999998875432  2345778999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 018734           75 IVMEYAAGGELFERICNA----------------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD  132 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~----------------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~  132 (351)
                      ++|||+.+++|.+++...                      ..+++..+..++.|++.||.|||+++++||||||+||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~  164 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG  164 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence            999999999999998643                      2367888999999999999999999999999999999997


Q ss_pred             CCCCCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhH
Q 018734          133 GSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKN  208 (351)
Q Consensus       133 ~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  208 (351)
                      .++  .++|+|||++........   .....++..|+|||.+.+..++. ++|||||||++|+|++ |..||......+ 
T Consensus       165 ~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~~~~~p~~~~~~~~-  240 (288)
T cd05050         165 ENM--VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTT-ESDVWAYGVVLWEIFSYGMQPYYGMAHEE-  240 (288)
T ss_pred             CCC--ceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCc-hhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            665  499999999874332211   12234567799999988777654 4999999999999997 888987654332 


Q ss_pred             HHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          209 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                         ....+.... ..+....++..+.+|+.+||+.+|.+|||+.++++
T Consensus       241 ---~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         241 ---VIYYVRDGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             ---HHHHHhcCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence               222222222 12223357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.8e-41  Score=303.31  Aligned_cols=243  Identities=21%  Similarity=0.378  Sum_probs=186.6

Q ss_pred             eeecccCceEEEEEEEcC--CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            8 KDIGSGNFGVARLMRNKN--TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +.||+|+||.||++....  ....+|+|.+.....  ....+.+|+..++.++||||+++++.+.....+++||||+.++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999986543  345788887654332  2245778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC---
Q 018734           84 ELFERICNAG-----RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---  155 (351)
Q Consensus        84 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---  155 (351)
                      +|.+++....     .+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence            9999987643     2467788999999999999999999999999999999987664  99999999864322211   


Q ss_pred             CCCcccCCCccCcccccCC------cCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCC---
Q 018734          156 PKSTVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD---  225 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  225 (351)
                      .....+++.|+|||++...      ...+.++|||||||++|+|++ |..||........+...+.   ......+.   
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR---EQDIKLPKPQL  235 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh---ccCccCCCCcc
Confidence            1233467789999997532      223456999999999999999 7888876654333332221   12222221   


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...++..+.+++..|+ .+|.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2257788899999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.9e-41  Score=299.36  Aligned_cols=239  Identities=25%  Similarity=0.388  Sum_probs=189.8

Q ss_pred             eecccCceEEEEEEEc--CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCC
Q 018734            9 DIGSGNFGVARLMRNK--NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~   84 (351)
                      .||+|+||.||++...  ..+..||+|++.....  ....+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999998765  4456799998865432  2345789999999999999999999875 457899999999999


Q ss_pred             hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC----CCCc
Q 018734           85 LFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----PKST  159 (351)
Q Consensus        85 L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~----~~~~  159 (351)
                      |.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++  .+||+|||++........    ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH--YAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC--cEEeccCCccccccCCccceeccCCC
Confidence            9998875 45789999999999999999999999999999999999997665  499999999874332211    1112


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      .+++.|+|||.+.+..++ .++|||||||++|+|++ |..||......... .   .+ ......+.....++++.+++.
T Consensus       159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~---~~-~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05115         159 KWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-S---FI-EQGKRLDCPAECPPEMYALMK  232 (257)
T ss_pred             CCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-H---HH-HCCCCCCCCCCCCHHHHHHHH
Confidence            345789999998776664 45999999999999996 99999876543221 1   11 112222333457899999999


Q ss_pred             HhcccCCCCCCChHHHhc
Q 018734          239 RIFVANPSRRITIKEIKS  256 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~  256 (351)
                      +||+.+|++||++.++++
T Consensus       233 ~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-41  Score=300.51  Aligned_cols=238  Identities=20%  Similarity=0.245  Sum_probs=191.4

Q ss_pred             eeecccCceEEEEEEEcCCC----------cEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            8 KDIGSGNFGVARLMRNKNTK----------ELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +.||+|+||.||++.+..++          ..+++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46999999999999998776          357888776554435678899999999999999999999887 7789999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC-----CEEEeccCCCcccC
Q 018734           78 EYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSL  151 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~-----~vkL~DFg~a~~~~  151 (351)
                      ||+.+++|..++...+ .++...+..++.||+.||.|||++||+||||||+|||++.++..     .+||+|||++....
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            9999999999998766 78999999999999999999999999999999999999766521     59999999987543


Q ss_pred             CCCCCCCcccCCCccCcccccCC-cCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCC
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                      .   .....++..|+|||.+.+. ...+.++|||||||++|+|++ |..||........ .....    .....+.  ..
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~-~~~~~----~~~~~~~--~~  229 (259)
T cd05037         160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK-ERFYQ----DQHRLPM--PD  229 (259)
T ss_pred             c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH-HHHHh----cCCCCCC--CC
Confidence            2   2344577889999998776 233555999999999999999 5788866543221 11111    1111222  22


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...+.+++.+||..+|.+|||+.++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHH
Confidence            478999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.9e-42  Score=304.71  Aligned_cols=240  Identities=18%  Similarity=0.245  Sum_probs=190.6

Q ss_pred             eeecccCceEEEEEEEcCCCc-------EEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            8 KDIGSGNFGVARLMRNKNTKE-------LVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +.||.|+||.||++.+...+.       .||+|.+..... ....+.+|+.+++.+.||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999999866543       388887755432 234677899999999999999999999998999999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC------CEEEeccCCCcccCC
Q 018734           80 AAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP------RLKICDFGYSKSSLL  152 (351)
Q Consensus        80 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~------~vkL~DFg~a~~~~~  152 (351)
                      +.+|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++..      .++++|||++.....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~  160 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP  160 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence            99999999997654 58999999999999999999999999999999999999765431      379999998764322


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCC-CCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA-YPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                         .....+++.|+|||++.+....+.++|||||||++|+|++|. .||........ ..    ........|.  ..+.
T Consensus       161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~----~~~~~~~~~~--~~~~  230 (258)
T cd05078         161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQ----FYEDRHQLPA--PKWT  230 (258)
T ss_pred             ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HH----HHHccccCCC--CCcH
Confidence               233568899999999977554456699999999999999984 66654333221 11    1122222332  4567


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ++.+|+.+||+.+|++|||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            89999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.3e-41  Score=303.35  Aligned_cols=247  Identities=19%  Similarity=0.288  Sum_probs=199.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC----CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEc-CCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~-~~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+..    ++..|++|.+.....  ....+.+|+.+++.++||||+++++++.. +...+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            589999999999999999999876    357899998765432  23457789999999999999999998765 46789


Q ss_pred             EEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           75 IVMEYAAGGELFERICNA--------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                      ++++|+.+++|..++...        ..+++..+..++.|++.||.|||+++++||||||+||+++.++  .+||+|||+
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d~g~  163 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITDNAL  163 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECCCCC
Confidence            999999999999998653        4589999999999999999999999999999999999997665  499999999


Q ss_pred             CcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccC
Q 018734          147 SKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  222 (351)
Q Consensus       147 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (351)
                      ++.......   .....++..|+|||.+.+..++.+ +|||||||++|++++ |+.||....... +..   . ......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~---~-~~~~~~  237 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE-MAA---Y-LKDGYR  237 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHH---H-HHcCCC
Confidence            875432211   122346678999999977766544 999999999999998 999997654322 211   1 222333


Q ss_pred             CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .+....+++.+.+++.+||+.+|++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         238 LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3444457889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-41  Score=301.71  Aligned_cols=246  Identities=23%  Similarity=0.369  Sum_probs=199.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc----EEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      .+|++.+.||+|+||.||++.+..+++    .+|+|++.....  ....+.+|+..++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            579999999999999999999876654    589998765533  23467789999999999999999999887 78899


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      ||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++  .+||+|||+++......
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC--eEEECCCcccccccCcc
Confidence            99999999999998764 4689999999999999999999999999999999999997665  49999999987543222


Q ss_pred             CCC---CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 RPK---STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      ...   ...++..|+|||.+....++ .++|+|||||++|+|++ |+.||....... +..   .+. .....+.+...+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~---~~~-~~~~~~~~~~~~  237 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPD---LLE-KGERLPQPPICT  237 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHH-HHH---HHh-CCCCCCCCCCCC
Confidence            211   12245679999998766665 44999999999999998 999997754322 222   122 222334444577


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.+++.+||..+|+.||++.++++
T Consensus       238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         238 IDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            89999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-41  Score=303.73  Aligned_cols=239  Identities=22%  Similarity=0.299  Sum_probs=188.4

Q ss_pred             eecccCceEEEEEEEcC------------------------CCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceE
Q 018734            9 DIGSGNFGVARLMRNKN------------------------TKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRF   63 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~~~------------------------~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~   63 (351)
                      .||+|+||.||++....                        ....||+|++..... ....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999987432                        124588888765432 23457788889999999999999


Q ss_pred             EEEEEcCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----CC
Q 018734           64 KEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-----AP  137 (351)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-----~~  137 (351)
                      ++++......++||||+++++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++..+     ..
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999888865 56789999999999999999999999999999999999997543     22


Q ss_pred             CEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHH-HcCCCCCCCCCChhHHHHHHHHH
Q 018734          138 RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM-LVGAYPFEDQEDPKNFRKTISRI  216 (351)
Q Consensus       138 ~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el-l~g~~pf~~~~~~~~~~~~~~~~  216 (351)
                      .+||+|||++.....   .....++..|+|||.+.+....+.++|||||||++|+| ++|..||........ ...    
T Consensus       162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~----  233 (274)
T cd05076         162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERF----  233 (274)
T ss_pred             eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHH----
Confidence            489999998753321   22346788899999987654445669999999999998 479999976543222 111    


Q ss_pred             HhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .......|.  ..++.+.++|.+||+.+|.+|||+.+++++
T Consensus       234 ~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         234 YEKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            112222232  356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.1e-41  Score=300.88  Aligned_cols=240  Identities=20%  Similarity=0.257  Sum_probs=187.7

Q ss_pred             eeecccCceEEEEEEEcC------------CCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            8 KDIGSGNFGVARLMRNKN------------TKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      +.||+|+||.||++....            ....|++|++..... ....+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532            233588898765433 2345678889999999999999999999988999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-----CCEEEeccCCCc
Q 018734           75 IVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA-----PRLKICDFGYSK  148 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~-----~~vkL~DFg~a~  148 (351)
                      ++|||+.+++|..++.. ...+++..+..++.||+.||.|||++||+||||||.|||++.++.     ..++++|||++.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            99999999999888765 456899999999999999999999999999999999999975442     138999999886


Q ss_pred             ccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHH-cCCCCCCCCCChhHHHHHHHHHHhhccCCCCcc
Q 018734          149 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  227 (351)
Q Consensus       149 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (351)
                      ...   ......++..|+|||.+......+.++|||||||++|+|+ .|..||........ .    .......  +...
T Consensus       161 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~----~~~~~~~--~~~~  230 (262)
T cd05077         161 TVL---SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-E----RFYEGQC--MLVT  230 (262)
T ss_pred             ccc---CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-H----HHHhcCc--cCCC
Confidence            432   2233568889999999875444456699999999999997 58888865432211 1    1111121  1222


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+.++.+||.+||+.+|.+||++.+|+++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.8e-41  Score=301.38  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=198.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC---CcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|.+.+.||+|+||.||++.+...   ...||+|.......  ....+.+|+.+++.++||||+++++++.. ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4689999999999999999987644   45689998765432  33468889999999999999999998865 457899


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+++++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++  .++|+|||+++.......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC--CeEEccCceeeecccccc
Confidence            99999999999997654 589999999999999999999999999999999999998765  499999999875433221


Q ss_pred             C--CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 P--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      .  ....+++.|+|||.+....+. .++|||||||++|+|++ |..||...........    +. .....+.+..++..
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~-~~~~~~~~~~~~~~  236 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IE-NGERLPMPPNCPPT  236 (270)
T ss_pred             eecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HH-cCCcCCCCCCCCHH
Confidence            1  122345679999998777665 45999999999999986 9999977654332222    11 22233444578899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.+++.+||..+|.+|||+.+++..
T Consensus       237 ~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         237 LYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.3e-41  Score=295.28  Aligned_cols=240  Identities=25%  Similarity=0.369  Sum_probs=193.6

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      +.||+|+||.||++... ++..+|+|++.....  ....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            46999999999999865 578899998875432  234577899999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC--CCcccC
Q 018734           86 FERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP--KSTVGT  162 (351)
Q Consensus        86 ~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~--~~~~gt  162 (351)
                      ..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||++.........  ....++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC--eEEECCCccceeccccccccCCCCCCc
Confidence            9988653 4689999999999999999999999999999999999997665  4999999998643222111  122346


Q ss_pred             CCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       163 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      ..|+|||++.+..++. ++||||||+++|+|++ |..||.........    ..+. ..........++..+.+++.+||
T Consensus       158 ~~y~aPE~~~~~~~~~-~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~li~~~l  231 (250)
T cd05085         158 IKWTAPEALNYGRYSS-ESDVWSYGILLWETFSLGVCPYPGMTNQQAR----EQVE-KGYRMSCPQKCPDDVYKVMQRCW  231 (250)
T ss_pred             ccccCHHHhccCCCCc-hhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH----HHHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence            6799999997776654 4999999999999998 99999765432221    1211 22223333467899999999999


Q ss_pred             ccCCCCCCChHHHhc
Q 018734          242 VANPSRRITIKEIKS  256 (351)
Q Consensus       242 ~~~P~~Rps~~eil~  256 (351)
                      +.+|.+||++.++++
T Consensus       232 ~~~p~~Rp~~~~l~~  246 (250)
T cd05085         232 DYKPENRPKFSELQK  246 (250)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.7e-41  Score=298.08  Aligned_cols=241  Identities=25%  Similarity=0.390  Sum_probs=195.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++..  +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..+++|||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5799999999999999998864  57789999886543 235688999999999999999999998655 4799999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           82 GGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      +++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++  .+||+|||++.....  .....
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~--~~kl~Dfg~~~~~~~--~~~~~  157 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSM--GVDNS  157 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--cEEECCCccceeccc--cCCCC
Confidence            999999987643  578999999999999999999999999999999999997665  499999999874322  12233


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      ..+..|+|||.+.+..++ .++|+|||||++|+|++ |+.||........ ..   .+ ......+....++..+.+++.
T Consensus       158 ~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~---~~-~~~~~~~~~~~~~~~~~~li~  231 (254)
T cd05083         158 KLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-KE---CV-EKGYRMEPPEGCPADVYVLMT  231 (254)
T ss_pred             CCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHH-HH---HH-hCCCCCCCCCcCCHHHHHHHH
Confidence            456789999998776665 44999999999999997 9999977553322 11   11 122333333467889999999


Q ss_pred             HhcccCCCCCCChHHHhc
Q 018734          239 RIFVANPSRRITIKEIKS  256 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~  256 (351)
                      +||+.+|.+||++++++.
T Consensus       232 ~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         232 SCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-41  Score=296.52  Aligned_cols=240  Identities=26%  Similarity=0.381  Sum_probs=195.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ++||.|+||.||++.+.. ++.||+|.+.....  ....+.+|+.++++++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999988 89999998876433  235688899999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC---CCccc
Q 018734           86 FERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVG  161 (351)
Q Consensus        86 ~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~---~~~~g  161 (351)
                      .+++.+. ..+++..+..++.|++.||.|||+++++||||||+||+++.++  .++|+|||++.........   ....+
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcceeccccCcc
Confidence            9998653 4689999999999999999999999999999999999997665  4999999998754321111   11234


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHh
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  240 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (351)
                      +..|+|||.+.+..++ .++|+|||||++|+|++ |..||...........     .......+....++..+.+++.+|
T Consensus       158 ~~~y~~PE~~~~~~~~-~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         158 PIKWTAPEALNYGRYT-SESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-----IESGYRMPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             eeccCChHhhccCCCC-cchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-----HhcCCCCCCCccCCHHHHHHHHHH
Confidence            5679999998777664 55999999999999998 8899976553222111     112223333446788999999999


Q ss_pred             cccCCCCCCChHHHhc
Q 018734          241 FVANPSRRITIKEIKS  256 (351)
Q Consensus       241 L~~~P~~Rps~~eil~  256 (351)
                      |+.+|.+|||+.++++
T Consensus       232 l~~~p~~Rp~~~ell~  247 (251)
T cd05041         232 WAYDPENRPSFSEIYN  247 (251)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-42  Score=319.79  Aligned_cols=246  Identities=28%  Similarity=0.411  Sum_probs=205.5

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCc---E-EEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKE---L-VAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      -.+.++||+|+||.||++.....+.   . ||+|....+.    .....+.+|.++|+.++|||||+++++......+++
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i  238 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML  238 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence            3456899999999999998775422   3 8999887522    233568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      |||+|.||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-..|+|++.+..  +||+|||+++......
T Consensus       239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~~  316 (474)
T KOG0194|consen  239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQYV  316 (474)
T ss_pred             EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCccee
Confidence            999999999999999987 4999999999999999999999999999999999999987664  7999999988554222


Q ss_pred             CCC-CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          155 RPK-STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       155 ~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      ... ...-...|+|||.+....++.+ +|||||||++||+++ |..||.+....    .....+....++.+.+...+..
T Consensus       317 ~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~~~~p~~  391 (474)
T KOG0194|consen  317 MKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIPSKTPKE  391 (474)
T ss_pred             eccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCCCCCHHH
Confidence            222 2234567999999988876555 999999999999998 78899886643    3344454566776766678899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +..++.+|+..+|++||++.++.+
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999999865

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-41  Score=303.61  Aligned_cols=252  Identities=25%  Similarity=0.407  Sum_probs=201.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEc----CCCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK----NTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLT--PTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~   73 (351)
                      +.|++.+.||+|+||.||++...    .+++.||+|++......  ...+.+|+..++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46888999999999999999864    34789999998765553  4678899999999999999999999877  5679


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           74 AIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +++|||+++++|.+++.... .++...+..++.|++.||.|||++|++|+||||+||+++.++  .++|+|||++.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEccccccccccc
Confidence            99999999999999997654 689999999999999999999999999999999999998765  599999999875432


Q ss_pred             CCC----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh----------HHHHHHHHHHh
Q 018734          153 HSR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK----------NFRKTISRIMA  218 (351)
Q Consensus       153 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------~~~~~~~~~~~  218 (351)
                      ...    .....++..|+|||.+.+..+. .++|||||||++|+|++|..||.......          .....+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            211    1122355679999998777664 44999999999999999999986543211          00111222222


Q ss_pred             hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .....+....++..+.+++.+||+.+|.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            33334444467789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=298.62  Aligned_cols=253  Identities=27%  Similarity=0.420  Sum_probs=210.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC------CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~   72 (351)
                      .||..++++|.|+- .|..|.|.-+++.||+|++.....   ...+..+|+..+..++|+||++++.+|.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            48899999999998 788899999999999998866432   235678999999999999999999999755      35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +|+|||+|. .+|...+.  -.+.-..+..+++|++.|++|||+.||+||||||+||+++.+..  +||+|||+|+....
T Consensus        96 ~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDT  170 (369)
T ss_pred             HHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccCc
Confidence            899999995 58887776  35678899999999999999999999999999999999987765  99999999997776


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh--------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------------  218 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------  218 (351)
                      ....+..+.|.+|+|||++.+.++... +||||+||++.||++|+..|.+..-.+++.+++.....              
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             ccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            667788899999999999999996555 99999999999999999999877655555544432211              


Q ss_pred             -------------hccCCCCc---------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          219 -------------VQYKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       219 -------------~~~~~~~~---------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                                   ....+|+.         ..-+..+++++.+||..||++|.|++++|+||||.
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                         00011211         11245789999999999999999999999999996

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-44  Score=301.91  Aligned_cols=256  Identities=25%  Similarity=0.425  Sum_probs=211.6

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC-----EEEEE
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT-----HLAIV   76 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-----~~~lv   76 (351)
                      +-.+.||-|+||+||.+.|..+|+.||+|++.+-+.   ....+.+|+.++...+|.|++..+++..-..     .+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            446899999999999999999999999999876433   3467889999999999999999999876553     46889


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      +|++. .+|.+.+.....++.+.++-+++||++||+|||+.+|+||||||.|.|++++..  +||||||+++....... 
T Consensus       136 TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhhh
Confidence            99995 489888888889999999999999999999999999999999999999987765  99999999986544433 


Q ss_pred             -CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHH-------------------
Q 018734          156 -PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR-------------------  215 (351)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-------------------  215 (351)
                       .+..+-|.+|+|||++++...++.++||||+|||+.||+.++..|...++..++..+..-                   
T Consensus       213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H  292 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH  292 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence             344578999999999999888888899999999999999999999988776665443321                   


Q ss_pred             HHhhccCCCCcc---------CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          216 IMAVQYKIPDYV---------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       216 ~~~~~~~~~~~~---------~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ++....+.|...         .-..+..+++.+||..+|.+|.+..+++.|+|+.+.
T Consensus       293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence            222222333221         123467899999999999999999999999997543

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=8e-41  Score=304.51  Aligned_cols=247  Identities=21%  Similarity=0.378  Sum_probs=197.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc----EEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|+..+.||+|+||.||++.+..++.    .||+|.+......  ...+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            578999999999999999999887775    4688877654321  23577899999999999999999988654 4679


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +++|+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++  .+||+|||+++......
T Consensus        86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~--~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN--HVKITDFGLARLLEGDE  163 (303)
T ss_pred             eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC--ceEEccccccccccCcc
Confidence            999999999999987654 689999999999999999999999999999999999997655  49999999987543222


Q ss_pred             C---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .   .....++..|+|||.+.+..++ .++|||||||++|+|++ |..||..... .....    ........+.....+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~----~~~~~~~~~~~~~~~  237 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPD----LLEKGERLPQPPICT  237 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH----HHHCCCCCCCCCCCC
Confidence            1   1223457789999999777765 44999999999999997 8999976432 22222    222333344445678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+.+++.+||..+|++||++.+++..
T Consensus       238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         238 IDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.5e-43  Score=317.54  Aligned_cols=257  Identities=26%  Similarity=0.412  Sum_probs=212.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC------CCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH------PNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h------p~Iv~~~~~~~~~~~~~l   75 (351)
                      .||.+....|+|-|++|..|.|...+..||||+|.+.......=+.|+++|++|+.      -|+++++..|...+++|+
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            58999999999999999999999999999999999988888888899999999963      589999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           76 VMEYAAGGELFERICNAGR---FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |+|-+ ..+|.+.|++.++   |....++.|+.|++.||..|-..||+|+||||.||||+.+.. .+||||||.|.... 
T Consensus       512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~-  588 (752)
T KOG0670|consen  512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS-  588 (752)
T ss_pred             Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc-
Confidence            99998 4699999998765   788899999999999999999999999999999999987665 59999999886432 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHH--------HHhhccCCC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR--------IMAVQYKIP  224 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~  224 (351)
                      ....+.+.-+..|+|||++.|..|+.. .|+||+||+||||.||+..|.+......+.-.+.-        +...++...
T Consensus       589 eneitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq  667 (752)
T KOG0670|consen  589 ENEITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ  667 (752)
T ss_pred             cccccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence            333344566778999999999999766 89999999999999999999987764433322110        000000000


Q ss_pred             Cc----------------------------------------------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCc
Q 018734          225 DY----------------------------------------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHP  258 (351)
Q Consensus       225 ~~----------------------------------------------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp  258 (351)
                      .+                                              ..+-.++++||.+||..||++|.|..++|.||
T Consensus       668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence            00                                              00123688999999999999999999999999


Q ss_pred             cccc
Q 018734          259 WFLK  262 (351)
Q Consensus       259 ~~~~  262 (351)
                      ||+.
T Consensus       748 Fi~~  751 (752)
T KOG0670|consen  748 FITE  751 (752)
T ss_pred             cccC
Confidence            9964

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.6e-41  Score=300.44  Aligned_cols=243  Identities=23%  Similarity=0.380  Sum_probs=194.3

Q ss_pred             eeecccCceEEEEEEEcCCC------cEEEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            8 KDIGSGNFGVARLMRNKNTK------ELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +.||+|+||.||++......      +.+|+|.+....  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46999999999999986543      689999876543  2345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CCCEEEeccCCCcc
Q 018734           80 AAGGELFERICNA-------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP---APRLKICDFGYSKS  149 (351)
Q Consensus        80 ~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~---~~~vkL~DFg~a~~  149 (351)
                      +++++|.+++.+.       ..+++..+..++.|++.||.|||+++++|+||||+||+++.+.   ...++|+|||++..
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999998642       3478899999999999999999999999999999999997655   12599999999875


Q ss_pred             cCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCC
Q 018734          150 SLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD  225 (351)
Q Consensus       150 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (351)
                      ......   .....++..|+|||.+.+..+. .++|||||||++|+|++ |..||.........    ..+ ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~----~~~-~~~~~~~~  234 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFT-TQSDVWSFGVLMWEILTLGQQPYPALNNQEVL----QHV-TAGGRLQK  234 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcc-cchhHHHHHHHHHHHHHcCCCCCcccCHHHHH----HHH-hcCCccCC
Confidence            432211   1223467889999999877764 55999999999999998 99999765433221    111 11222333


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...++..+.+++.+||+.+|.+||+++++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4467899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.7e-40  Score=297.08  Aligned_cols=246  Identities=22%  Similarity=0.313  Sum_probs=185.9

Q ss_pred             eeecccCceEEEEEEEcCC--CcEEEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            8 KDIGSGNFGVARLMRNKNT--KELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +.||+|+||.||++.....  ...+++|.+....  .....+.+|+..++.++||||+++++.+......|+||||+.++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999875433  3356677665432  23356888999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC---CCC
Q 018734           84 ELFERICNA----GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SRP  156 (351)
Q Consensus        84 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~---~~~  156 (351)
                      +|.+++.+.    ..++...++.++.||+.||.|||+++++||||||+|||++.++  .++|+|||++......   ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL--TVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc--cEEecccccccccCcchhhhcc
Confidence            999998753    3466778899999999999999999999999999999997665  4999999987643221   112


Q ss_pred             CCcccCCCccCcccccCCc------CCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCC
Q 018734          157 KSTVGTPAYIAPEVLSRRE------YDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                      ....+++.|+|||++....      ..+.++|||||||++|+|++ |..||......+.+...+...............+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            3456889999999985321      12455999999999999996 5778876554433333322211111111112347


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ++.+.+++..|| .+|.+||+++++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            888999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-40  Score=298.01  Aligned_cols=248  Identities=30%  Similarity=0.497  Sum_probs=199.4

Q ss_pred             CeeEeeeecccCceEEEEEEEcC-CCcEEEEEEeccCcc-----------cCHHHHHHHHHHh-cCCCCCcceEEEEEEc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKN-TKELVAMKYIERGHK-----------IDANVAREIINHK-QLRHPNIIRFKEVVLT   69 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-----------~~~~~~~e~~~~~-~l~hp~Iv~~~~~~~~   69 (351)
                      .|++.+.||+|+||.||++.+.. +++.+|+|.+.....           ....+.+|+.++. .++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999987 788999998753211           1134567777775 4799999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           70 PTHLAIVMEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        70 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                      .+..+++|||+.|++|.+++..    ...+++..++.++.|++.||.|||+ .+++|+||+|.||+++.++  .++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~--~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD--KVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC--cEEEecc
Confidence            9999999999999999887743    4568999999999999999999996 7899999999999997665  4999999


Q ss_pred             CCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC
Q 018734          145 GYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP  224 (351)
Q Consensus       145 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  224 (351)
                      |++.............|+..|+|||.+.+..+. .++|+||||+++|+|++|+.||.......    ....+....+...
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Dv~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~  233 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYG-EKADVWAFGCILYQMCTLQPPFYSTNMLS----LATKIVEAVYEPL  233 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCc-hHHHHHHHHHHHHHHHhCCCcccccCHHH----HHHHHhhccCCcC
Confidence            998765444334456789999999999876664 45999999999999999999997654322    2222222222222


Q ss_pred             CccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ....++..+.+++.+||+.||++||++.++..+
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            222578899999999999999999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.9e-40  Score=293.34  Aligned_cols=242  Identities=23%  Similarity=0.326  Sum_probs=187.4

Q ss_pred             eeecccCceEEEEEEEcC---CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEE-cCCEEEEEEeccC
Q 018734            8 KDIGSGNFGVARLMRNKN---TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVL-TPTHLAIVMEYAA   81 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~-~~~~~~lv~e~~~   81 (351)
                      +.||+|+||.||++.+..   .+..||+|.+.....  ....+.+|+.+++.++||||+++++++. .++..+++|+|+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998653   345799998754322  2346778999999999999999999765 4566889999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-----C
Q 018734           82 GGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-----R  155 (351)
Q Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-----~  155 (351)
                      +++|.+++.+. ..++...+..++.|++.||.|||+.+++||||||+|||++.++  .+||+|||+++......     .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF--TVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCccccccccCCcceeecc
Confidence            99999998764 3567888899999999999999999999999999999998765  49999999987433211     1


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcC-CCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+++.|+|||.+.+..++ .++|||||||++|+|++| .+||.......    ....+.. ....+....++..+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~  232 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFD----ITVYLLQ-GRRLLQPEYCPDPLY  232 (262)
T ss_pred             cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhc-CCCCCCCCcCCHHHH
Confidence            1233467789999998777665 459999999999999995 56665543222    2222221 112233335688999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcC
Q 018734          235 NLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +++.+||+.+|++||++.++++.
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-41  Score=326.06  Aligned_cols=245  Identities=27%  Similarity=0.411  Sum_probs=209.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      .-+..+.||+|+||+||++....     ....||||.++....  ...+|.+|+.++..|+|||||++++++..++-+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            34677899999999999998653     347899999876544  45789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEE
Q 018734           76 VMEYAAGGELFERICNA--------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI  141 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~--------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL  141 (351)
                      |+|||..|+|.++|...              ++++..+...++.||+.|+.||-++.+|||||-+.|+||..+..  |||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKI  644 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKI  644 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEe
Confidence            99999999999999642              12788999999999999999999999999999999999987775  999


Q ss_pred             eccCCCcccCCCCCCCC---cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHH
Q 018734          142 CDFGYSKSSLLHSRPKS---TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIM  217 (351)
Q Consensus       142 ~DFg~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  217 (351)
                      +|||+++..+.....+.   ..-..+|||||.|..+++++. |||||+||+|||+++ |..||.+....+.+    ..+.
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EVI----e~i~  719 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEVI----ECIR  719 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHHH----HHHH
Confidence            99999997665544432   345668999999999999777 999999999999997 99999988765433    3344


Q ss_pred             hhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHh
Q 018734          218 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK  255 (351)
Q Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil  255 (351)
                      ..+. ++-+...+.++.+|+..||+.+|.+||++.||-
T Consensus       720 ~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  720 AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            4444 666678999999999999999999999999984

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=300.44  Aligned_cols=258  Identities=25%  Similarity=0.419  Sum_probs=202.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-----C---CCcceEEEEEEcC---
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----H---PNIIRFKEVVLTP---   70 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-----h---p~Iv~~~~~~~~~---   70 (351)
                      .||.+.++||.|.|++||+|.|..+.+.||+|+.+......+..+.||.+|++++     |   .+||++++.|...   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            4899999999999999999999999999999999888888888999999998873     3   4699999999754   


Q ss_pred             -CEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEec--------------
Q 018734           71 -THLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCH-SMQICHRDLKLENTLLD--------------  132 (351)
Q Consensus        71 -~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH-~~~iiH~Dikp~NIll~--------------  132 (351)
                       .++|+|+|++ |.+|..+|+...  -++...++.|++||+.||.||| +.||||.||||+|||+.              
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~  236 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAG  236 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhc
Confidence             6899999999 789999998654  4899999999999999999999 56999999999999983              


Q ss_pred             --------------------------------------------------------------------------------
Q 018734          133 --------------------------------------------------------------------------------  132 (351)
Q Consensus       133 --------------------------------------------------------------------------------  132 (351)
                                                                                                      
T Consensus       237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v  316 (590)
T KOG1290|consen  237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV  316 (590)
T ss_pred             cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence                                                                                            


Q ss_pred             --------------------CC---------------------------C-----------------------CCCEEEe
Q 018734          133 --------------------GS---------------------------P-----------------------APRLKIC  142 (351)
Q Consensus       133 --------------------~~---------------------------~-----------------------~~~vkL~  142 (351)
                                          ..                           .                       .-++||+
T Consensus       317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa  396 (590)
T KOG1290|consen  317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA  396 (590)
T ss_pred             hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence                                00                           0                       0135666


Q ss_pred             ccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCC------ChhHHHHHHHHH
Q 018734          143 DFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE------DPKNFRKTISRI  216 (351)
Q Consensus       143 DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~~  216 (351)
                      |||.|....  ...+.-+.|..|+|||++.+.+|... +||||++|++|||+||...|...+      +.+.+..++.-.
T Consensus       397 DlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~-ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELL  473 (590)
T KOG1290|consen  397 DLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTS-ADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELL  473 (590)
T ss_pred             eccchhhhh--hhhchhhhhhhccCcceeecCCCCCc-hhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHH
Confidence            666665322  22244467889999999999999877 899999999999999999997654      223333332211


Q ss_pred             HhhccC-----------------------CCCc---------cCC----CHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          217 MAVQYK-----------------------IPDY---------VHI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       217 ~~~~~~-----------------------~~~~---------~~~----~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ...+..                       +..|         ..+    ..++.+||.-||+.+|.+||||.++|+|||+
T Consensus       474 G~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwL  553 (590)
T KOG1290|consen  474 GKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWL  553 (590)
T ss_pred             hhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccc
Confidence            110000                       0000         012    2468899999999999999999999999999


Q ss_pred             ccC
Q 018734          261 LKN  263 (351)
Q Consensus       261 ~~~  263 (351)
                      ...
T Consensus       554 n~~  556 (590)
T KOG1290|consen  554 NPV  556 (590)
T ss_pred             cCC
Confidence            654

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.6e-40  Score=294.62  Aligned_cols=246  Identities=22%  Similarity=0.364  Sum_probs=192.4

Q ss_pred             eeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC------
Q 018734            4 YELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT------   71 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~------   71 (351)
                      |++.+.||+|+||.||++...   .+++.||+|++.....   ....+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            678899999999999999864   3578999998875432   2345778999999999999999999886532      


Q ss_pred             EEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccC
Q 018734           72 HLAIVMEYAAGGELFERICNA------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG  145 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg  145 (351)
                      ..+++++|+.+++|..++...      ..++...+..++.|++.||.|||++||+||||||+||+++.++  .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~--~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM--TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC--CEEECccc
Confidence            347899999999998776432      2478899999999999999999999999999999999997655  49999999


Q ss_pred             CCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhcc
Q 018734          146 YSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY  221 (351)
Q Consensus       146 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (351)
                      +++.......   .....+++.|++||.+....++. ++|||||||++|+|++ |++||........    ...+... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~-~sDi~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~-~  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTT-HSDVWAFGVTMWEIMTRGQTPYAGVENSEI----YNYLIKG-N  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccch-hhhhHHHHHHHHHHhhCCCCCCCCCCHHHH----HHHHHcC-C
Confidence            9875432221   12234567899999997776654 5999999999999999 8899876543222    1111111 1


Q ss_pred             CCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          222 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+.....+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            222233577899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=329.41  Aligned_cols=245  Identities=24%  Similarity=0.398  Sum_probs=205.8

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCc-----EEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKE-----LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      -++.+.||+|+||.||.+.......     .||+|.+.+..+  ....+++|..+|+.++|||||++++++.+....+|+
T Consensus       694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~  773 (1025)
T KOG1095|consen  694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL  773 (1025)
T ss_pred             eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence            4678999999999999998765433     489998877543  446799999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           77 MEYAAGGELFERICNA-------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      +|||.||+|..+|++.       ..++..++..++.||++|+.||+++++|||||-..|+|++...  .+||+|||+|+.
T Consensus       774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r--~VKIaDFGlArD  851 (1025)
T KOG1095|consen  774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR--VVKIADFGLARD  851 (1025)
T ss_pred             ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC--cEEEcccchhHh
Confidence            9999999999999875       2488999999999999999999999999999999999998775  599999999994


Q ss_pred             cCCCCCCCC---cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCC
Q 018734          150 SLLHSRPKS---TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPD  225 (351)
Q Consensus       150 ~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (351)
                      .........   ..-...|||||.+....++++ +|||||||++||+++ |..||....+.+.+.    .+.... +++.
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~----~~~~gg-RL~~  925 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLL----DVLEGG-RLDP  925 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHH----HHHhCC-ccCC
Confidence            333222211   123457999999998888766 999999999999998 899998876543322    222233 6777


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+++..+.++|.+||+.+|++||++..|++
T Consensus       926 P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  926 PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            7789999999999999999999999999987

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.4e-41  Score=278.61  Aligned_cols=256  Identities=25%  Similarity=0.454  Sum_probs=209.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-CCCcceEEEEEEcC--CEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTP--THLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~--~~~~lv~   77 (351)
                      .++|++.+++|+|.|+.||.+.+..+++.++||+++.-.  ...+.+|+.+++.|+ ||||++++++..++  ....+++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            368999999999999999999999999999999886543  357889999999997 99999999999876  4577999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||+.+.+...+.   +.++..+++.++++++.||.|+|+.||+|||+||.|++||... ..++|+|+|+|...-.....+
T Consensus       115 E~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~-rkLrlIDWGLAEFYHp~~eYn  190 (338)
T KOG0668|consen  115 EYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL-RKLRLIDWGLAEFYHPGKEYN  190 (338)
T ss_pred             hhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh-ceeeeeecchHhhcCCCceee
Confidence            999886654443   4578899999999999999999999999999999999998554 369999999998766666677


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCC-CChhHHHHHHHHHHh---------hccCC----
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ-EDPKNFRKTISRIMA---------VQYKI----  223 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~~~~~~~~~---------~~~~~----  223 (351)
                      ..+.+.+|--||++..-..+...-|+|||||++..|+..+.||... ++.+++.++..-...         ....+    
T Consensus       191 VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~  270 (338)
T KOG0668|consen  191 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQF  270 (338)
T ss_pred             eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhH
Confidence            7789999999999977666666689999999999999999997644 455555554332211         00000    


Q ss_pred             -----------------CCccC-CCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          224 -----------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       224 -----------------~~~~~-~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                                       +...+ .++++.||+.++|..|..+|+|+.|++.||||..
T Consensus       271 ~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  271 EDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             hhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence                             11111 3689999999999999999999999999999954

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.9e-40  Score=323.42  Aligned_cols=259  Identities=19%  Similarity=0.218  Sum_probs=176.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCC----CcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEE------EEcC
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEV------VLTP   70 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~------~~~~   70 (351)
                      +++|++.+.||+|+||.||++.+..+    +..||+|++........ ...+  .++...+.+++.+...      ....
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-WMNE--RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-HHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence            36899999999999999999999988    89999998764332111 1111  1222223333332222      1345


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 018734           71 THLAIVMEYAAGGELFERICNAGR--------------------FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTL  130 (351)
Q Consensus        71 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIl  130 (351)
                      ..+++|++|+.+++|.+++.....                    ..+..+..++.||+.||.|||+++|+||||||+|||
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            689999999999999988865321                    123457789999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeccCCCcccCCC--CCCCCcccCCCccCcccccCCcCC---------------------CcchhHHHHH
Q 018734          131 LDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAYIAPEVLSRREYD---------------------GKLADVWSCG  187 (351)
Q Consensus       131 l~~~~~~~vkL~DFg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~DiwslG  187 (351)
                      ++.+. +++||+|||+|+.....  ......++|+.|||||.+......                     +.++||||||
T Consensus       288 l~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG  366 (566)
T PLN03225        288 FSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG  366 (566)
T ss_pred             EeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence            97532 35999999999753322  223456899999999976432211                     2236999999


Q ss_pred             HHHHHHHcCCCCCCCCCChhHHHHHHHHH----------HhhccC------CCCccCCCHhHHHHHHHhcccCCCCCCCh
Q 018734          188 VTLYVMLVGAYPFEDQEDPKNFRKTISRI----------MAVQYK------IPDYVHISQDCRNLLSRIFVANPSRRITI  251 (351)
Q Consensus       188 ~il~ell~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~------~~~~~~~~~~~~~li~~~L~~~P~~Rps~  251 (351)
                      |++|||+++..|+..  ....+...+...          ......      +...........+||.+||++||.+|||+
T Consensus       367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            999999997666432  111222211110          000000      00000112345689999999999999999


Q ss_pred             HHHhcCcccccCCC
Q 018734          252 KEIKSHPWFLKNLP  265 (351)
Q Consensus       252 ~eil~hp~~~~~~~  265 (351)
                      .++|+||||.....
T Consensus       445 ~e~L~Hpff~~~~~  458 (566)
T PLN03225        445 KAALAHPYFDREGL  458 (566)
T ss_pred             HHHhCCcCcCCCCc
Confidence            99999999987544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-39  Score=307.18  Aligned_cols=259  Identities=19%  Similarity=0.240  Sum_probs=187.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEc----------------CCCcEEEEEEeccCccc---------------CHHHHHHHH
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK----------------NTKELVAMKYIERGHKI---------------DANVAREII   50 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~---------------~~~~~~e~~   50 (351)
                      ++|++.++||+|+||.||++...                ..++.||||.+......               ......|+.
T Consensus       145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            68999999999999999998652                23567999998643211               122334666


Q ss_pred             HHhcCCCCC-----cceEEEEEEc--------CCEEEEEEeccCCCChHHHHHhcC------------------------
Q 018734           51 NHKQLRHPN-----IIRFKEVVLT--------PTHLAIVMEYAAGGELFERICNAG------------------------   93 (351)
Q Consensus        51 ~~~~l~hp~-----Iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~------------------------   93 (351)
                      ++.+++|.+     ++++++++..        .+..|+||||+.+++|.+++....                        
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            777776654     3666666543        356899999999999988886421                        


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC--cccCCCccCcccc
Q 018734           94 RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS--TVGTPAYIAPEVL  171 (351)
Q Consensus        94 ~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~--~~gt~~y~aPE~~  171 (351)
                      .++...++.++.|++.||.|||+++|+||||||+|||++.++  .+||+|||++...........  ..+|+.|+|||++
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l  382 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG--QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL  382 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC--cEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence            234567889999999999999999999999999999998765  499999999865433222222  3458999999998


Q ss_pred             cCCcCC---------------------CcchhHHHHHHHHHHHHcCCC-CCCCCCChhHH-------HHHHHHHHhhccC
Q 018734          172 SRREYD---------------------GKLADVWSCGVTLYVMLVGAY-PFEDQEDPKNF-------RKTISRIMAVQYK  222 (351)
Q Consensus       172 ~~~~~~---------------------~~~~DiwslG~il~ell~g~~-pf~~~~~~~~~-------~~~~~~~~~~~~~  222 (351)
                      ......                     ...+||||+||++|+|++|.. ||.........       ...........+.
T Consensus       383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~  462 (507)
T PLN03224        383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD  462 (507)
T ss_pred             cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence            543211                     123699999999999999875 76542211111       1111122233445


Q ss_pred             CCCccCCCHhHHHHHHHhcccCC---CCCCChHHHhcCccccc
Q 018734          223 IPDYVHISQDCRNLLSRIFVANP---SRRITIKEIKSHPWFLK  262 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P---~~Rps~~eil~hp~~~~  262 (351)
                      ++.+...++.+.+|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            55566788999999999999866   68999999999999954

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-38  Score=278.66  Aligned_cols=241  Identities=39%  Similarity=0.660  Sum_probs=202.7

Q ss_pred             CceEEEEEEEcCCCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCChHHHHHh
Q 018734           14 NFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN   91 (351)
Q Consensus        14 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   91 (351)
                      +||.||++....+++.+|+|++......  ...+.+|+..+++++|+||+++++++......++++|++.+++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            5899999999998999999998765443  36788999999999999999999999999999999999999999999987


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccc
Q 018734           92 AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL  171 (351)
Q Consensus        92 ~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~  171 (351)
                      ...++...+..++.+++.++.+||+.+++|+||+|.||+++.++  .++|+|||++.............++..|+|||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            76789999999999999999999999999999999999998765  5999999998865544444566789999999999


Q ss_pred             cCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccC-CCHhHHHHHHHhcccCCCCCCC
Q 018734          172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRIT  250 (351)
Q Consensus       172 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~~P~~Rps  250 (351)
                      .+..++. ++||||||+++++|++|..||..........   ............... ++..+.+++.+||..+|++||+
T Consensus       159 ~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      159 LGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELF---KKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             ccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            8777655 5999999999999999999997643333222   222222222222111 7889999999999999999999


Q ss_pred             hHHHhcCccc
Q 018734          251 IKEIKSHPWF  260 (351)
Q Consensus       251 ~~eil~hp~~  260 (351)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-39  Score=295.96  Aligned_cols=243  Identities=25%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             eEeeeecccCceEEEEEEEcCC----CcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            5 ELMKDIGSGNFGVARLMRNKNT----KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .+.+.||.|-||.||.+....-    +-.||||..+....  ..+.++.|..+|+.++|||||++++++.. ..+|||||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            3457899999999999876532    34688898776433  34679999999999999999999999964 57899999


Q ss_pred             ccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      +++.|.|..+|+.++ .++...+..+.+||+.||.|||++++|||||-..||||.+..  .|||+|||+++........+
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~--CVKLaDFGLSR~~ed~~yYk  548 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ--CVKLADFGLSRYLEDDAYYK  548 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc--eeeecccchhhhccccchhh
Confidence            999999999998764 689999999999999999999999999999999999997665  49999999999776666665


Q ss_pred             CcccC--CCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          158 STVGT--PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       158 ~~~gt--~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      ...|.  .-|||||-++-..++ .+||||.||+++||++. |..||.+-.+.+.+..     .....++|.++++++.+.
T Consensus       549 aS~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-----iEnGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  549 ASRGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-----IENGERLPCPPNCPPALY  622 (974)
T ss_pred             ccccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEE-----ecCCCCCCCCCCCChHHH
Confidence            55543  359999999888875 45999999999999875 9999998765443221     223446788889999999


Q ss_pred             HHHHHhcccCCCCCCChHHHhc
Q 018734          235 NLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .|+.+||.++|.+||.+.+|..
T Consensus       623 slmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHHH
Confidence            9999999999999999888754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=302.25  Aligned_cols=260  Identities=30%  Similarity=0.493  Sum_probs=219.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC-HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|+++..+|.|+||.||+++|+.+++..|+|+++...... ..+.+|+-+++.++|||||.+++.+.....+|+.||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            57999999999999999999999999999999998754433 45678999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc-CCCCCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-LLHSRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~-~~~~~~~~~  159 (351)
                      .||+|.+.-.-.+++++.++....+..++||+|||+.|-+|||||-.|||+++.++  +||+|||.+... ..-....++
T Consensus        95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen   95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhcc
Confidence            99999999988999999999999999999999999999999999999999987776  999999987643 233445678


Q ss_pred             ccCCCccCcccc---cCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC---CCCccCCCHhH
Q 018734          160 VGTPAYIAPEVL---SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK---IPDYVHISQDC  233 (351)
Q Consensus       160 ~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (351)
                      +|||+|||||+-   ...+|. ..+|||++|++..|+---++|-.+......+    .-+.+..++   ..+...+++.+
T Consensus       173 iGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l----~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRAL----FLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             cCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHH----HHhhccCCCCCcccCCccchHHH
Confidence            999999999985   344554 4599999999999998888886654432222    222233333   33445689999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccCCChhh
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL  268 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~~  268 (351)
                      .+|++.+|..+|.+||+++.+|.|||....+.+.+
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl  282 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRL  282 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccchhhHH
Confidence            99999999999999999999999999988766543

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=295.32  Aligned_cols=252  Identities=26%  Similarity=0.396  Sum_probs=207.6

Q ss_pred             CeeEeeeecccCceEEEEEEEcCC-C--cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNT-K--ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +..+.++||+|+||+|+++.+... |  -.||||++.....  ....+++|+..|.+|+|||+|++|++..+ ..+.+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            445678999999999999987643 2  4689999876443  34679999999999999999999999987 6788999


Q ss_pred             eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           78 EYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |++.+|+|.+.|.+  ...|.-..+..|+.||+.|+.||.++++|||||-..|+|+-...  .|||||||+.+.......
T Consensus       190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--tVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--TVKICDFGLMRALGENED  267 (1039)
T ss_pred             hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--eeeeecccceeccCCCCc
Confidence            99999999999987  34588899999999999999999999999999999999997654  499999999986655444


Q ss_pred             CCCc----ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          156 PKST----VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       156 ~~~~----~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      ....    .-...|+|||.+....++.. +|+|++|+++|||++ |..||.+.....    ++.++- ...+++-+..++
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~q----IL~~iD-~~erLpRPk~cs  341 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQ----ILKNID-AGERLPRPKYCS  341 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHH----HHHhcc-ccccCCCCCCCh
Confidence            3321    23446999999999998655 999999999999998 789998876533    333333 455677777899


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .++.++++.||..+|.+|||+..|.+.-++.+.
T Consensus       342 edIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             HHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence            999999999999999999999998765444433

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=288.29  Aligned_cols=249  Identities=23%  Similarity=0.376  Sum_probs=205.1

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC--HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +..++++||+|-||.|.+|.-.. ...||+|.++......  ..+.+|+++|.+|+|||||.+++++..++.+++++||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            45678999999999999998875 6899999988755433  57899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC-
Q 018734           81 AGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-  157 (351)
Q Consensus        81 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~-  157 (351)
                      +.|+|..++..+.  .+.......++.||+.|++||.+.++|||||-+.|+|++++..  +||+|||+++....+.... 
T Consensus       618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCceee
Confidence            9999999998763  3345566779999999999999999999999999999987765  9999999999776665543 


Q ss_pred             --CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHH--cCCCCCCCCCChhHHHHHHHHHHhhc---cCCCCccCCC
Q 018734          158 --STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML--VGAYPFEDQEDPKNFRKTISRIMAVQ---YKIPDYVHIS  230 (351)
Q Consensus       158 --~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  230 (351)
                        ..+-...|||||.+.-+++++. ||+|+||+++||++  |...||....+.....+.. .+...+   ..++.+.-++
T Consensus       696 qgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~-~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG-EFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh-hhcCCCCcceeccCCCcCc
Confidence              2356788999999988888655 99999999999985  5889998776544333222 222211   1234445678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.+++.+||..+-.+|||++++..
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            89999999999999999999999865

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=303.85  Aligned_cols=246  Identities=28%  Similarity=0.391  Sum_probs=192.8

Q ss_pred             eeeecccCce-EEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccCCCC
Q 018734            7 MKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (351)
Q Consensus         7 ~~~lG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~   84 (351)
                      -+.+|.|+-| .||++...  ++.||||.+-....  ..+.+|+..++.. .|||||++++.-.+++..||..|+|. .+
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~--~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFF--DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS  588 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHhhHhH--HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence            3578999999 57888875  67999998755433  3567899999888 69999999999999999999999995 69


Q ss_pred             hHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCCCEEEeccCCCcccCCCCC--
Q 018734           85 LFERICNAGR----FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG---SPAPRLKICDFGYSKSSLLHSR--  155 (351)
Q Consensus        85 L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~---~~~~~vkL~DFg~a~~~~~~~~--  155 (351)
                      |.+++.....    ...-..+..+.|++.||++||+.+||||||||.||||..   ++..+++|+|||+++....+..  
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~  668 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF  668 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence            9999977411    111356889999999999999999999999999999976   4556899999999987554432  


Q ss_pred             --CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcC-CCCCCCCCChhHHHHHHHHHHhhccCCCCccCC-CH
Q 018734          156 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI-SQ  231 (351)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (351)
                        .....||-+|+|||++...... +++|||||||++|+.++| ..||.+.-.      -...+...++........ ..
T Consensus       669 ~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~~------R~~NIl~~~~~L~~L~~~~d~  741 (903)
T KOG1027|consen  669 SRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSLE------RQANILTGNYTLVHLEPLPDC  741 (903)
T ss_pred             hcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchHH------hhhhhhcCccceeeeccCchH
Confidence              3345699999999999877654 469999999999988886 999976421      112233333332221111 11


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ++.+||.+||.++|..||++.++|.||||....
T Consensus       742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence            889999999999999999999999999997653

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.5e-37  Score=318.84  Aligned_cols=242  Identities=18%  Similarity=0.250  Sum_probs=184.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      .|...+.||+|+||.||++.+..++..||+|++.......   ..|+..+++++|||||++++++.+....|+||||+++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP---SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc---HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            3555678999999999999999899999999886543322   3568889999999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      |+|.+++..   +++..+..++.|++.||.|||   +.+|+||||||+||+++.+..  .++. ||.+....   .....
T Consensus       768 g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~  838 (968)
T PLN00113        768 KNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKC  838 (968)
T ss_pred             CcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCc
Confidence            999999853   789999999999999999999   669999999999999987765  4444 55443221   12334


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh-hHHHHHHHHHHhh----ccCCCC-------cc
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAV----QYKIPD-------YV  227 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~----~~~~~~-------~~  227 (351)
                      .||+.|+|||++.+..++.+ +|||||||++|||++|+.||...... .............    .+..|.       ..
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        839 FISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             cccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            78999999999988777554 99999999999999999999543211 1111111110000    000010       00


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ....++.+++.+||+.+|.+|||+.++++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            112356789999999999999999999863

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.7e-37  Score=276.38  Aligned_cols=256  Identities=27%  Similarity=0.416  Sum_probs=203.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC---CCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +.|.++.+||.|+|++||++.+..   .++.||+|.+...... ..+.+|+++|..+ .+.||+++.+++..++.+.+|+
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivl  114 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVL  114 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEe
Confidence            468899999999999999999988   7899999998765443 4688999999999 5899999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc-------
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS-------  150 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~-------  150 (351)
                      +|++..+..++...   ++-..++.+++.++.||.++|.+|||||||||+|+|.+... ++-.|+|||+|...       
T Consensus       115 p~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t-~rg~LvDFgLA~~~d~~~~~~  190 (418)
T KOG1167|consen  115 PYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT-QRGVLVDFGLAQRYDGYQQTE  190 (418)
T ss_pred             cccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc-CCceEEechhHHHHHhhhhhh
Confidence            99998887777754   56899999999999999999999999999999999998554 46899999998510       


Q ss_pred             ----------CC--CC--------------------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHH
Q 018734          151 ----------LL--HS--------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYV  192 (351)
Q Consensus       151 ----------~~--~~--------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e  192 (351)
                                ..  ..                          ......||++|+|||++..-+..+.++||||.|+|+..
T Consensus       191 ~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Ls  270 (418)
T KOG1167|consen  191 HSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLS  270 (418)
T ss_pred             hhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeeh
Confidence                      00  00                          00123599999999999888877888999999999999


Q ss_pred             HHcCCCCCCCCCChh-HHHHHHH--------HHHh--hc---------------------------cC--------CCCc
Q 018734          193 MLVGAYPFEDQEDPK-NFRKTIS--------RIMA--VQ---------------------------YK--------IPDY  226 (351)
Q Consensus       193 ll~g~~pf~~~~~~~-~~~~~~~--------~~~~--~~---------------------------~~--------~~~~  226 (351)
                      +++++.||....+.- .+.++..        +...  ..                           +.        ....
T Consensus       271 lls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~  350 (418)
T KOG1167|consen  271 LLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS  350 (418)
T ss_pred             hhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence            999999997654321 1111110        0000  00                           00        0001


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      ...+..+.+|+.+||..||.+|+|++++|+||||..
T Consensus       351 d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  351 DVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             ccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence            123457899999999999999999999999999974

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=250.82  Aligned_cols=197  Identities=25%  Similarity=0.431  Sum_probs=164.3

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCc--ccCHHHHHHHHHHhc-CCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQ-LRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~~~~-l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      -+..||+|++|.|-++++..+|...|+|.+...-  ....+.++++.+..+ ..+|.+|.+++.....+.+|+.||.|. 
T Consensus        50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-  128 (282)
T KOG0984|consen   50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-  128 (282)
T ss_pred             hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence            3567999999999999999999999999987543  334567788877554 479999999999999999999999995 


Q ss_pred             CChHHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           83 GELFER----ICNAGRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        83 ~~L~~~----l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      .+|..+    +.+++.++|..+-+++..++.||.|||++ .+||||+||+||||+..+  ++|+||||++......-..+
T Consensus       129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G--qVKiCDFGIsG~L~dSiAkt  206 (282)
T KOG0984|consen  129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG--QVKICDFGISGYLVDSIAKT  206 (282)
T ss_pred             hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC--cEEEcccccceeehhhhHHH
Confidence            477443    45678899999999999999999999965 899999999999997665  59999999987655555455


Q ss_pred             CcccCCCccCcccccC----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh
Q 018734          158 STVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP  206 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  206 (351)
                      ...|...|||||.+..    .+|+-+ |||||||++++||.+++.||.....+
T Consensus       207 ~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tp  258 (282)
T KOG0984|consen  207 MDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTP  258 (282)
T ss_pred             HhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCH
Confidence            5679999999999843    355444 99999999999999999999876543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=292.93  Aligned_cols=246  Identities=26%  Similarity=0.418  Sum_probs=210.4

Q ss_pred             eeEeeeecccCceEEEEEEEcCCC---cEEEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTK---ELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      -.+.+.||.|.||.|++++.+..+   ..||||-++...  +...+++.|..+|-++.||||+++.++.....-++||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            467899999999999999987655   579999887643  445789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-C-
Q 018734           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-R-  155 (351)
Q Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~-  155 (351)
                      ||++|+|..+|+. .++|+.-++.-+++.|+.|++||-+.++|||||-..||||+.+-.  .|++|||+++...... . 
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCCcc
Confidence            9999999999975 468999999999999999999999999999999999999987764  8999999998543332 1 


Q ss_pred             CCCccc--CCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 PKSTVG--TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 ~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      .++..|  ...|.|||.+...++++. |||||+|++|||.++ |..||.+.++.+.++.     ....|++|.+..++..
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-----Ie~gyRLPpPmDCP~a  862 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-----IEQGYRLPPPMDCPAA  862 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHHH-----HHhccCCCCCCCCcHH
Confidence            122222  357999999998888655 999999999998764 9999988776544433     4567889999999999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +..|+..||+++-++||.+.+|+.+
T Consensus       863 L~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  863 LYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999999998764

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=280.86  Aligned_cols=244  Identities=22%  Similarity=0.345  Sum_probs=208.1

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCC
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGE   84 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~   84 (351)
                      ....+||.|-||.||.+.+++-.-.||||.++-..-.-.+++.|..+|+.++|||+|+++++|..+.-+|||+|||..|+
T Consensus       270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN  349 (1157)
T KOG4278|consen  270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN  349 (1157)
T ss_pred             eeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence            44589999999999999999888899999887766666789999999999999999999999999999999999999999


Q ss_pred             hHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC--Ccc
Q 018734           85 LFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STV  160 (351)
Q Consensus        85 L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~--~~~  160 (351)
                      |.++|....+  ++.-.+.+++.||..|+.||..+++|||||-..|+||..+..  ||++|||+++.+.......  ...
T Consensus       350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAGAK  427 (1157)
T KOG4278|consen  350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAGAK  427 (1157)
T ss_pred             HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecccCcc
Confidence            9999987654  677778899999999999999999999999999999987765  9999999998654433321  122


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      -..-|.|||-+....+..+ +|||+||++|||+.| |-.||.+.+-.     .+..++...|+...+..+++.+.+|+..
T Consensus       428 FPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgyRM~~PeGCPpkVYeLMra  501 (1157)
T KOG4278|consen  428 FPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGYRMDGPEGCPPKVYELMRA  501 (1157)
T ss_pred             CcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccccccCCCCCCHHHHHHHHH
Confidence            3455999999988887666 999999999999987 77888775432     2334556677777778999999999999


Q ss_pred             hcccCCCCCCChHHHhc
Q 018734          240 IFVANPSRRITIKEIKS  256 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~  256 (351)
                      ||+++|.+||++.++.+
T Consensus       502 CW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  502 CWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HhcCCcccCccHHHHHH
Confidence            99999999999998854

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=279.94  Aligned_cols=198  Identities=30%  Similarity=0.478  Sum_probs=176.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCH---------HHHHHHHHHhcCC---CCCcceEEEEEEc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---------NVAREIINHKQLR---HPNIIRFKEVVLT   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~e~~~~~~l~---hp~Iv~~~~~~~~   69 (351)
                      ..|..+..||.|+||.|++|.++.....|+||.+.++.....         .+-.||++|..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            358999999999999999999999999999999988654322         2336999999997   9999999999999


Q ss_pred             CCEEEEEEeccC-CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           70 PTHLAIVMEYAA-GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        70 ~~~~~lv~e~~~-~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      ++++|++||... |.+|++++...+.++|.+...+++|++.|+++||+.||||||||-+|+.+++++.  +||+|||.|.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa  718 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAA  718 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchh
Confidence            999999999764 5689999999999999999999999999999999999999999999999987775  9999999876


Q ss_pred             ccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 018734          149 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFED  202 (351)
Q Consensus       149 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  202 (351)
                      . .....-...+||..|.|||++.+..|-++.-|||+||+++|.++....||..
T Consensus       719 ~-~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  719 Y-TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             h-hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            3 2334445678999999999999999999889999999999999999999863

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=263.01  Aligned_cols=247  Identities=27%  Similarity=0.360  Sum_probs=188.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHH--hcCCCCCcceEEEEEEcC----CEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--KQLRHPNIIRFKEVVLTP----THLAIV   76 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~--~~l~hp~Iv~~~~~~~~~----~~~~lv   76 (351)
                      +..+.+.||+|.||.||+++..  |+.||||++.....  ....+|-++.  ..|+|+||+.+++.-..+    ..+|+|
T Consensus       212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE--~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE--RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             eeEEEEEecCccccceeecccc--CCceEEEEecccch--hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            5678999999999999999987  67899999876544  4555555554  557999999999886543    479999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM--------QICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--------~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      ++|.+.|||+++|.. ..++-+...+++..++.||.+||..        .|.|||||..||||.+++.  .-|+|+|+|-
T Consensus       288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv  364 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAV  364 (513)
T ss_pred             eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeE
Confidence            999999999999988 5789999999999999999999952        4999999999999988776  8999999997


Q ss_pred             ccCCC-----CCCCCcccCCCccCcccccCCcC----C-CcchhHHHHHHHHHHHHcC----------CCCCCCCCChhH
Q 018734          149 SSLLH-----SRPKSTVGTPAYIAPEVLSRREY----D-GKLADVWSCGVTLYVMLVG----------AYPFEDQEDPKN  208 (351)
Q Consensus       149 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~----~-~~~~DiwslG~il~ell~g----------~~pf~~~~~~~~  208 (351)
                      .....     ...+..+||..|||||++.....    . -+.+||||||.++||++.+          ++||.+.-+.+.
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            54333     23456789999999999854321    1 2348999999999999853          678887655444


Q ss_pred             HHHHHHHHHhhccCCCCc-cCCC-----HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          209 FRKTISRIMAVQYKIPDY-VHIS-----QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.+..+.-.+..-|.. ..+.     ..+..|++.||..||.-|.|+=-|.+
T Consensus       445 s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  445 SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            344444333322222221 1221     24668899999999999999876643

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=266.66  Aligned_cols=245  Identities=23%  Similarity=0.293  Sum_probs=182.1

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHH--HhcCCCCCcceEEEEEEcCC----EEEEEE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIIN--HKQLRHPNIIRFKEVVLTPT----HLAIVM   77 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~--~~~l~hp~Iv~~~~~~~~~~----~~~lv~   77 (351)
                      ..+.+.||+|.||.||+++...  +.||||++.-...  +.+.+|-.+  +-.++|+||+++++.-....    .+++|+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~~k--qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQEK--QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhccC--ceeEEEecCHHHH--HHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            4567889999999999999874  7999999876554  344445444  44668999999999876554    899999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS---------MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---------~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      +|.+.|+|.++|..+ .+++....+++..+++||+|||+         ..|+|||||..||||..+..  .-|+|||+|.
T Consensus       288 ~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl  364 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLAL  364 (534)
T ss_pred             eeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccceeE
Confidence            999999999999764 67999999999999999999996         25999999999999987765  8999999997


Q ss_pred             ccCCC---CCCCCcccCCCccCcccccCCcCCC-----cchhHHHHHHHHHHHHcCCCCCCCC-------------CChh
Q 018734          149 SSLLH---SRPKSTVGTPAYIAPEVLSRREYDG-----KLADVWSCGVTLYVMLVGAYPFEDQ-------------EDPK  207 (351)
Q Consensus       149 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~ell~g~~pf~~~-------------~~~~  207 (351)
                      .....   ......+||..|||||++.+...-.     ++.||||+|.++|||+++..-+...             ....
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            65433   2334568999999999997654322     4589999999999999864333210             0111


Q ss_pred             HHHHHHHHHHhhcc--CCCCcc---CCCHhHHHHHHHhcccCCCCCCChHHHh
Q 018734          208 NFRKTISRIMAVQY--KIPDYV---HISQDCRNLLSRIFVANPSRRITIKEIK  255 (351)
Q Consensus       208 ~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~li~~~L~~~P~~Rps~~eil  255 (351)
                      .+..+...+.....  .+|+..   .--.-+.+.+..||..||+-|+|+.-+-
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence            12222222222111  122210   1224578999999999999999987654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=283.16  Aligned_cols=245  Identities=26%  Similarity=0.429  Sum_probs=200.3

Q ss_pred             eEeeeecccCceEEEEEEEcC-------CCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEE
Q 018734            5 ELMKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~   74 (351)
                      .+.+.||.|+||.|+++.-..       ....||||.......  ....+..|+.+|+.+ +||||+.+++++...+.++
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            566799999999999987431       146799998875443  346788999999998 5999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 018734           75 IVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPR  138 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~  138 (351)
                      +|+||+..|+|.+++.+..                .++..++..+++||+.|++||++.+++||||-..|||+..+..  
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~--  456 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV--  456 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE--
Confidence            9999999999999998765                3888999999999999999999999999999999999987754  


Q ss_pred             EEEeccCCCcccCCCCCCC--Cccc--CCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHH
Q 018734          139 LKICDFGYSKSSLLHSRPK--STVG--TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTI  213 (351)
Q Consensus       139 vkL~DFg~a~~~~~~~~~~--~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  213 (351)
                      +||+|||+|+.........  ...|  ...|||||.+....++.+ |||||+|+++||+++ |..||.+......+.+  
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~--  533 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEELLE--  533 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH--
Confidence            9999999998543333322  2223  234999999998777656 899999999999998 8899987443333322  


Q ss_pred             HHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          214 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                        .....++...+.+.++++.++++.||+.+|.+||++.++.+
T Consensus       534 --~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  534 --FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             --HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence              33445556666678999999999999999999999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=249.41  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=196.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEE-EEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEV-VLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~-~~~~~~~~lv~e~   79 (351)
                      +.|.+.+.||+|.||.+.+|.++.++..+++|.+.+.....+.+.+|..---.| .|.||+.-|+. |.+.+.+++++||
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            578999999999999999999999999999999999888888999998665555 48999987765 6777889999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      ++.|+|.+.+... .+.|...+.++.|++.|+.|||++++||||||.+||||-.....+|||||||..+.....-  ...
T Consensus       104 aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV--~~~  180 (378)
T KOG1345|consen  104 APRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV--KYL  180 (378)
T ss_pred             CccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee--hhh
Confidence            9999999888664 4688999999999999999999999999999999999955555589999999876432111  112


Q ss_pred             ccCCCccCcccccCCc----CCCcchhHHHHHHHHHHHHcCCCCCCCCCChh-HHHHHHHHHHhhccCCC-CccCCCHhH
Q 018734          160 VGTPAYIAPEVLSRRE----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-NFRKTISRIMAVQYKIP-DYVHISQDC  233 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~  233 (351)
                      -.+..|.|||++....    ...+.+|+|.||+++|.+++|.+||+.....+ .+.+...-.....-..| .+..+++.+
T Consensus       181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a  260 (378)
T KOG1345|consen  181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKA  260 (378)
T ss_pred             hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHH
Confidence            3566799999874332    22355899999999999999999998543222 12222211111111233 344589999


Q ss_pred             HHHHHHhcccCCCCCC---ChHHHhcCccc
Q 018734          234 RNLLSRIFVANPSRRI---TIKEIKSHPWF  260 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rp---s~~eil~hp~~  260 (351)
                      ..+.++-|.++|++|-   ++......-|.
T Consensus       261 ~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  261 LRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             HHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            9999999999999994   44444444443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=5.2e-33  Score=237.57  Aligned_cols=210  Identities=40%  Similarity=0.655  Sum_probs=183.3

Q ss_pred             ecccCceEEEEEEEcCCCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCChHH
Q 018734           10 IGSGNFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE   87 (351)
Q Consensus        10 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~   87 (351)
                      ||.|++|.||++.+..+++.+++|++......  ...+.+|+..++.++|++|+++++++......++++|++.|++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999988999999998765542  4578899999999999999999999999999999999999899999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEeccCCCcccCCCC-CCCCcccCCC
Q 018734           88 RICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS-RPKSTVGTPA  164 (351)
Q Consensus        88 ~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~-~~~~~vkL~DFg~a~~~~~~~-~~~~~~gt~~  164 (351)
                      ++... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. .+  +++|+|||.+....... ......+...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC--cEEEecCCceEEccCCcchhhcccCCCC
Confidence            98876 57899999999999999999999999999999999999986 44  59999999887543322 1334568889


Q ss_pred             ccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccC
Q 018734          165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN  244 (351)
Q Consensus       165 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~  244 (351)
                      |++||.+......+.++|+|++|+++++|                                     ..+.+++.+||+.+
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~  201 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKD  201 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCC
Confidence            99999997762345559999999999998                                     47789999999999


Q ss_pred             CCCCCChHHHhcCc
Q 018734          245 PSRRITIKEIKSHP  258 (351)
Q Consensus       245 P~~Rps~~eil~hp  258 (351)
                      |++||++.++++|+
T Consensus       202 p~~R~~~~~l~~~~  215 (215)
T cd00180         202 PEKRPSAKEILEHL  215 (215)
T ss_pred             cccCcCHHHHhhCC
Confidence            99999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=271.89  Aligned_cols=243  Identities=24%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             eEeeeecccCceEEEEEEEcCCCc----EEEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +..++||+|+||+||++.....++    +||+|++....  +...++++|...|.+|.|||++++++++..+. +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            446899999999999998865554    67888776543  33568999999999999999999999998766 889999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |+++|+|.++++. ...+.......|..||++|+.|||.++++||||-..||||..-..  +|++|||+|+.........
T Consensus       778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccccc
Confidence            9999999999875 457889999999999999999999999999999999999976654  9999999998755444332


Q ss_pred             Cc---ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          158 ST---VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       158 ~~---~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                      ..   .-.+-|||=|.+....+... +||||||+++||++| |..|+.+...     +.+...+....+++.++..+-++
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~-----~eI~dlle~geRLsqPpiCtiDV  929 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPA-----EEIPDLLEKGERLSQPPICTIDV  929 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCH-----HHhhHHHhccccCCCCCCccHHH
Confidence            22   23455999999988888655 999999999999987 8999987653     23334455556688888899999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhc
Q 018734          234 RNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .-++.+||..|+..||+++++..
T Consensus       930 y~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  930 YMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHHHHhccCcccCccHHHHHH
Confidence            99999999999999999988754

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=1e-33  Score=288.63  Aligned_cols=201  Identities=15%  Similarity=0.172  Sum_probs=147.9

Q ss_pred             cCCC-CCcceEEEEE-------EcCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 018734           54 QLRH-PNIIRFKEVV-------LTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDL  124 (351)
Q Consensus        54 ~l~h-p~Iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Di  124 (351)
                      .++| +||+++++.|       .....+++++|++ +++|.+++.. ...+++.+++.+++||+.||.|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            4456 5788888877       2234577889987 6699999975 345999999999999999999999999999999


Q ss_pred             CCCcEEecC-----------------CCCCCEEEeccCCCcccCCC-----------------CCCCCcccCCCccCccc
Q 018734          125 KLENTLLDG-----------------SPAPRLKICDFGYSKSSLLH-----------------SRPKSTVGTPAYIAPEV  170 (351)
Q Consensus       125 kp~NIll~~-----------------~~~~~vkL~DFg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~  170 (351)
                      ||+||||+.                 +..+.+|++|||+++.....                 ......+||++|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999953                 22335778888877632110                 00112468999999999


Q ss_pred             ccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCC
Q 018734          171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRIT  250 (351)
Q Consensus       171 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps  250 (351)
                      +.+..+. .++|||||||++|||++|.+|+.....  .+......     ...+......+...+++.+||+++|.+||+
T Consensus       187 ~~~~~~~-~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        187 DNGSSSN-CASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHR-----VLPPQILLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             hccCCCC-chhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHh-----hcChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence            9888875 559999999999999999888753211  11111111     111111122456779999999999999999


Q ss_pred             hHHHhcCcccccC
Q 018734          251 IKEIKSHPWFLKN  263 (351)
Q Consensus       251 ~~eil~hp~~~~~  263 (351)
                      +.++++||||.+.
T Consensus       259 ~~eil~h~~~~~~  271 (793)
T PLN00181        259 MSELLQSEFINEP  271 (793)
T ss_pred             hHHHhhchhhhhh
Confidence            9999999999763

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=6.9e-32  Score=234.00  Aligned_cols=196  Identities=42%  Similarity=0.712  Sum_probs=171.8

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      |.+.+.||.|++|.||++....+++.+|+|.+.....  ....+.+|+..++.++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6788999999999999999999899999999876543  34578889999999999999999999999899999999999


Q ss_pred             CCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--CCCC
Q 018734           82 GGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKS  158 (351)
Q Consensus        82 ~~~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~~~~  158 (351)
                      +++|.+++..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++  +++|+|||++.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG--LVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeCceeeEecCcccccccc
Confidence            9999999987766 89999999999999999999999999999999999998764  59999999887654332  3344


Q ss_pred             cccCCCccCcccc-cCCcCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 018734          159 TVGTPAYIAPEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPFED  202 (351)
Q Consensus       159 ~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~ell~g~~pf~~  202 (351)
                      ..++..|++||.+ ....+.. ++|+||||+++++|++|+.||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence            5788999999998 4445444 59999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=2e-30  Score=217.10  Aligned_cols=164  Identities=21%  Similarity=0.240  Sum_probs=125.3

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCccc
Q 018734           83 GELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  161 (351)
                      |+|.+++.. ...+++..++.++.||+.||.|||+++      ||+|||++.++.  +|+  ||++.....    ....|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~----~~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTP----EQSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeecc----ccCCC
Confidence            689999986 456999999999999999999999999      999999976654  888  998875432    22368


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHH-HHHHHHHhhccC-CCCccCCCH--hHHHHH
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR-KTISRIMAVQYK-IPDYVHISQ--DCRNLL  237 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~--~~~~li  237 (351)
                      |+.|||||++.+..++. ++|||||||++|+|++|+.||.......... ............ .+....++.  .+.+++
T Consensus        67 ~~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       67 DPYFMAPEVIQGQSYTE-KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             cccccChHHhcCCCCcc-hhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            99999999998888754 5999999999999999999997654322222 222111111000 011122333  699999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccc
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      .+||..+|.+||++.++++|+|+.
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHH
Confidence            999999999999999999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=5.7e-32  Score=263.41  Aligned_cols=256  Identities=32%  Similarity=0.525  Sum_probs=200.6

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEecc----Cc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ...+.+|.|++|.|+.+......+.++.|.+..    ..   .....+..|+-+-..|.|||++.....+.......-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            356789999999888888877777777775542    11   11123556777778899999988777776666566669


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---  154 (351)
                      |||++ +|+.++...+.++..++..++.|++.|+.|||+.||.||||||+|+++..++.  +||+|||.+.......   
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcchh
Confidence            99999 99999999889999999999999999999999999999999999999987764  9999999876433222   


Q ss_pred             --CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHH---HHhhccCCCCccCC
Q 018734          155 --RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR---IMAVQYKIPDYVHI  229 (351)
Q Consensus       155 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  229 (351)
                        .....+|+..|+|||++.+..|.++..||||.|++++.|.+|+.||......++.......   .....-..+.+..+
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  557 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL  557 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence              2345689999999999999999999999999999999999999999876544332100000   00000001122346


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +...+.+|.+||+++|.+|.|+++|++.+||+..
T Consensus       558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             hhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            7889999999999999999999999999999764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-28  Score=222.09  Aligned_cols=251  Identities=24%  Similarity=0.206  Sum_probs=193.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCC-cEEEEEEeccCcccC-HHHHHHHHHHhcCC----CCCcceEEEEE-EcCCEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTK-ELVAMKYIERGHKID-ANVAREIINHKQLR----HPNIIRFKEVV-LTPTHLAI   75 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~-~~~~~e~~~~~~l~----hp~Iv~~~~~~-~~~~~~~l   75 (351)
                      +|++.+.||+|+||.||.+.+..++ ..+|+|+........ ..+..|+.++..+.    .+++..+++.+ .....-|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999998874 678999877643322 25777888888876    36999999999 57788999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-C--CCEEEeccCCCc--
Q 018734           76 VMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-A--PRLKICDFGYSK--  148 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~--~~vkL~DFg~a~--  148 (351)
                      ||+.+ |.+|.++....  +.|+...+..++.|++.+|++||+.|++||||||+|+++.... .  ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99999 88999987554  5799999999999999999999999999999999999997543 1  359999999998  


Q ss_pred             ccCCCC-------C--CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh
Q 018734          149 SSLLHS-------R--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV  219 (351)
Q Consensus       149 ~~~~~~-------~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  219 (351)
                      ......       +  .....||..|.++.+..+.... +..|+||++.++.+|+.|..||..........+........
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~-r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQG-RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccC-CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence            321111       1  1234599999999999888865 55999999999999999999997766443332222211111


Q ss_pred             ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          220 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .. .......+..+..+...+-..+...+|....+..
T Consensus       257 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  257 LT-DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             cc-ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            11 1112234567778888777788899998887765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=3e-27  Score=215.14  Aligned_cols=255  Identities=34%  Similarity=0.575  Sum_probs=201.2

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCC-CcceEEEEEEcCCEEEEEEe
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHP-NIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp-~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      |.+...||.|+||.||.+.+.   ..+++|.+......    ...+.+|+..++.+.|+ +|+++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999998   67899988765443    45688899999999988 79999999988888999999


Q ss_pred             ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           79 YAAGGELFERICNAG---RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      ++.++++...+....   .++...+..++.|++.++.|+|+.+++|||+||+||+++.... .++++|||++....... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence            999999997777665   7999999999999999999999999999999999999976652 48999999987433222 


Q ss_pred             ------CCCCcccCCCccCcccccCC--cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-C--
Q 018734          155 ------RPKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-I--  223 (351)
Q Consensus       155 ------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~--  223 (351)
                            .....+||+.|+|||.+.+.  .......|+||+|++++++++|..||...............+...... .  
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  23566899999999999874  344556999999999999999999987665310111222222222211 1  


Q ss_pred             CCccCC----CHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          224 PDYVHI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       224 ~~~~~~----~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      +.....    ...+.+++.+++..+|..|.+..+...++|...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            111111    257899999999999999999999888866543

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-29  Score=220.30  Aligned_cols=247  Identities=15%  Similarity=0.232  Sum_probs=193.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC-----cEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcC-CEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK-----ELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTP-THL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-~~~   73 (351)
                      .|+++.-.+-+|.||.||.+......     +.|-+|-+.+....  -..++.|--.+..+.|||+.++.++...+ ...
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            35677778899999999999665332     34445655443322  23466777778888999999999987544 567


Q ss_pred             EEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccC
Q 018734           74 AIVMEYAAGGELFERICNA--------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG  145 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg  145 (351)
                      ++++.++.-|+|..++...        ..++..++..++.|++.|+.|||++|+||.||-..|++|++.-  ++||+|=.
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDsa  441 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDSA  441 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccch
Confidence            7888898889999998721        2367788999999999999999999999999999999998765  59999999


Q ss_pred             CCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhcc
Q 018734          146 YSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQY  221 (351)
Q Consensus       146 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  221 (351)
                      +++.......   ....-....||+||.+....|++. +|+||||+++|||+| |+.|+-..++.+.     ....+..+
T Consensus       442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm-----~~ylkdGy  515 (563)
T KOG1024|consen  442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEM-----EHYLKDGY  515 (563)
T ss_pred             hccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHH-----HHHHhccc
Confidence            9885433322   122334567999999988888654 999999999999987 8999977655332     23455677


Q ss_pred             CCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          222 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ++..+.++++++..++..||...|++||+++|+..
T Consensus       516 RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  516 RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            77777899999999999999999999999999853

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=4.5e-28  Score=222.33  Aligned_cols=160  Identities=16%  Similarity=0.122  Sum_probs=125.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcC-CCcEEEEEEeccCc------ccCHHHHHHHHHHhcCCCCCcce-EEEEEEcCCE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKN-TKELVAMKYIERGH------KIDANVAREIINHKQLRHPNIIR-FKEVVLTPTH   72 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~~~~e~~~~~~l~hp~Iv~-~~~~~~~~~~   72 (351)
                      +++|.+.+.||+|+||+||+|.+.. +++.||||++....      .....+.+|+.++++++|+||+. +++.    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            4689999999999999999999876 67788999865321      12345889999999999999985 4432    45


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL-KLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Di-kp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      .|+|||||.|++|.. +..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++  ++||+|||+|+...
T Consensus        93 ~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDFGlA~~~~  163 (365)
T PRK09188         93 DGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDFQLASVFR  163 (365)
T ss_pred             cEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEECccceecc
Confidence            799999999999963 211   11   2567899999999999999999999 99999997654  59999999998543


Q ss_pred             CCCC---------CCCcccCCCccCcccccC
Q 018734          152 LHSR---------PKSTVGTPAYIAPEVLSR  173 (351)
Q Consensus       152 ~~~~---------~~~~~gt~~y~aPE~~~~  173 (351)
                      ....         -...++++.|+|||.+..
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            2211         134468889999999854

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-29  Score=235.44  Aligned_cols=240  Identities=29%  Similarity=0.518  Sum_probs=199.0

Q ss_pred             eecccCceEEEEEEE---cCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEEeccC
Q 018734            9 DIGSGNFGVARLMRN---KNTKELVAMKYIERGHKI---DANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .+|.|+||.|++++.   ...+..+|+|+..+....   ......|-.++...+ ||.+|+++..|.+++..++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999987654   355788999988764321   113334556667775 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCccc
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  161 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  161 (351)
                      ||.|+..+.+...+.+...+.+...++.|+.++|+.+|+|||+|++||+++.+|.  +++.|||+++........   ||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhhc---cc
Confidence            9999999999999999999999999999999999999999999999999987764  999999998865444333   99


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |..|||||++.  +. ..++|+||+|+++++|++|..||..        .+..++.......|.  .++..+++++..++
T Consensus       156 t~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLF  222 (612)
T ss_pred             chhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHH
Confidence            99999999997  33 3448999999999999999999987        344455554544444  68899999999999


Q ss_pred             ccCCCCCCC-----hHHHhcCcccccCCCh
Q 018734          242 VANPSRRIT-----IKEIKSHPWFLKNLPR  266 (351)
Q Consensus       242 ~~~P~~Rps-----~~eil~hp~~~~~~~~  266 (351)
                      ..+|.+|.-     +.++++|+||+.....
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            999999984     5799999999877554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-26  Score=190.78  Aligned_cols=247  Identities=21%  Similarity=0.236  Sum_probs=190.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC-CCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h-p~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .+|+++++||.|+||.+|.+....+|+.||||+-.+.. ....+.-|..+.+.|++ ..|..+..++....+-.+||+++
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL   93 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL   93 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence            57999999999999999999999999999999765533 33467778888888875 77888888888888889999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccCCC-----
Q 018734           81 AGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH-----  153 (351)
Q Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~~~-----  153 (351)
                       |.+|.++..-. ..|+...+..++-|++.-++|+|.+++|||||||+|+|..-+. ..++.|+|||+|+.....     
T Consensus        94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~H  172 (341)
T KOG1163|consen   94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQH  172 (341)
T ss_pred             -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccccc
Confidence             88998887654 3589999999999999999999999999999999999984222 235899999999853322     


Q ss_pred             ---CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC---Ccc
Q 018734          154 ---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYV  227 (351)
Q Consensus       154 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~  227 (351)
                         .......||..|.+--...+...+ +..|+=|+|.++..+.-|..||++........+ ..++.......|   ...
T Consensus       173 Ipyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK-yEkI~EkK~s~~ie~LC~  250 (341)
T KOG1163|consen  173 IPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK-YEKISEKKMSTPIEVLCK  250 (341)
T ss_pred             CccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchhhHHHH-HHHHHHhhcCCCHHHHhC
Confidence               112345699999998887766654 448999999999999999999998654332221 222222222222   134


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChH
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIK  252 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~  252 (351)
                      .+|.++.-.+.-|-..--.+-|...
T Consensus       251 G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  251 GFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             CCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            5778888888888777666667654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-25  Score=195.18  Aligned_cols=200  Identities=27%  Similarity=0.343  Sum_probs=170.3

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEEeccC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .|+++++||.|+||+.+.+.+.-+++.||||.-... .....+..|.+..+.|. .++|.+.|.+.....+-.+|+|++ 
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            489999999999999999999999999999976543 33457888999999885 699999999998888888999999 


Q ss_pred             CCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CCCEEEeccCCCcccCCCC---
Q 018734           82 GGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP---APRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~---~~~vkL~DFg~a~~~~~~~---  154 (351)
                      |.+|.++..=++ +|+...+..++.|++.-++|+|++.+|.|||||+|+||...+   ...|.|+|||+|+......   
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq  186 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ  186 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence            889988876655 599999999999999999999999999999999999995332   2358999999998543221   


Q ss_pred             -----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q 018734          155 -----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED  205 (351)
Q Consensus       155 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  205 (351)
                           ..++..||..||+--...+...+.+ .|+=|||-+++..|-|..||.+...
T Consensus       187 HIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  187 HIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             cCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence                 2345679999999999988887544 9999999999999999999997653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=1.2e-26  Score=227.19  Aligned_cols=224  Identities=32%  Similarity=0.506  Sum_probs=168.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      +.|..++.|..|+||.||.++++.+.+.+|+| +++......   +   ++.....|.+|                    
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR---n---ilt~a~npfvv--------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR---N---ILTFAGNPFVV--------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh---c---cccccCCccee--------------------
Confidence            36788999999999999999999999999995 444322111   1   23333344443                    


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC--------
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--------  153 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~--------  153 (351)
                       |+-...++.-++++...        +.+++|||+.||+|||+||+|.+|..-+  ++|++|||+++.....        
T Consensus       136 -gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG--hiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 -GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             -chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc--cccccchhhhhhhhhhccchhhhc
Confidence             45556666666666544        8899999999999999999999996554  6999999987632111        


Q ss_pred             --------CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC
Q 018734          154 --------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD  225 (351)
Q Consensus       154 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (351)
                              ...+..+|||.|.|||++...+|. +.+|||++|+|+|+.+-|..||.+..+.+.+...+.....-..  . 
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE--~-  280 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE--E-  280 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc--c-
Confidence                    112456899999999999999985 5599999999999999999999998776666555543322111  1 


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCC---ChHHHhcCcccccCCChh
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rp---s~~eil~hp~~~~~~~~~  267 (351)
                      -..+++++++++.++|+.+|..|.   .+-++.+|+||+......
T Consensus       281 dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~  325 (1205)
T KOG0606|consen  281 DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKS  325 (1205)
T ss_pred             CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccch
Confidence            224788999999999999999996   567889999998765543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.7e-26  Score=202.68  Aligned_cols=191  Identities=26%  Similarity=0.380  Sum_probs=141.6

Q ss_pred             CCCCcceEEEEEEcC---------------------------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 018734           56 RHPNIIRFKEVVLTP---------------------------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI  108 (351)
Q Consensus        56 ~hp~Iv~~~~~~~~~---------------------------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~  108 (351)
                      +|||||++..+|.+.                           ..+|+||..++ .+|..++... ..+-...+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            699999999887642                           35899999985 5999998764 346777888999999


Q ss_pred             HHHHHHHHcCCeecCCCCCcEEe--cCCCCCCEEEeccCCCcccCC-------CCCCCCcccCCCccCcccccCCc----
Q 018734          109 SGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLL-------HSRPKSTVGTPAYIAPEVLSRRE----  175 (351)
Q Consensus       109 ~aL~~lH~~~iiH~Dikp~NIll--~~~~~~~vkL~DFg~a~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~----  175 (351)
                      +|+.|||.+||.|||+|.+||||  +++....+.|+|||++-....       .+..-...|...-||||+.....    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999998  556666789999998643222       11122345888999999985432    


Q ss_pred             -CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChH
Q 018734          176 -YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK  252 (351)
Q Consensus       176 -~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~  252 (351)
                       .+-.++|.|+.|.+.||++....||........-...   ....+. .+.+..+++.+++|+..+|+.||++|++.+
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qL-Palp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQL-PALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhC-CCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence             1223489999999999999999999874321100000   011111 122335788999999999999999999854

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=227.13  Aligned_cols=237  Identities=22%  Similarity=0.374  Sum_probs=182.7

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc--C---HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--D---ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~---~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +|...+.||.+.|=+|.+|++.+.  .|++|++-+....  .   .+.+.+++ ...+++||++.+.-.-.++...|+|.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            467889999999999999999873  4899998765421  1   23444555 56679999999998888888889999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      +|.. -+|++++...+-+..-+-++|+.|++.||..+|..||+|||||.+||||..-+-  +.|+||..-+..+......
T Consensus       101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCc
Confidence            9995 599999999888999999999999999999999999999999999999987776  8999999777655444332


Q ss_pred             Cc--------ccCCCccCcccccCCc----------CCCcchhHHHHHHHHHHHHc-CCCCCCCCC-------ChhHHHH
Q 018734          158 ST--------VGTPAYIAPEVLSRRE----------YDGKLADVWSCGVTLYVMLV-GAYPFEDQE-------DPKNFRK  211 (351)
Q Consensus       158 ~~--------~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~ell~-g~~pf~~~~-------~~~~~~~  211 (351)
                      ..        ..-.+|.|||.+....          .-.++-||||+||+++||++ |++||.-..       .......
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence            21        2345799999875422          12456899999999999988 688885311       0001111


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+..       ++     +..++.||..|++.+|.+|.++++.|+.
T Consensus       258 ~Le~-------Ie-----d~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEK-------IE-----DVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHh-------Cc-----CccHHHHHHHHHccCchhccCHHHHHHh
Confidence            1111       12     2368999999999999999999999875

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=4e-25  Score=186.81  Aligned_cols=137  Identities=21%  Similarity=0.202  Sum_probs=108.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----------CH-----------------HHHHHHHHHhcCCCCC
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------DA-----------------NVAREIINHKQLRHPN   59 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~-----------------~~~~e~~~~~~l~hp~   59 (351)
                      ...||+|+||.||.|.+. +|+.||+|+++.....          ..                 ...+|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 7999999998754211          01                 1234889999998877


Q ss_pred             cceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEecCCCCCC
Q 018734           60 IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HSMQICHRDLKLENTLLDGSPAPR  138 (351)
Q Consensus        60 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~l-H~~~iiH~Dikp~NIll~~~~~~~  138 (351)
                      +..........  .++||||++|+++.......+.++...+..++.|++.+|.++ |+.||+||||||+|||++.   ++
T Consensus        81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~~  155 (190)
T cd05147          81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---GK  155 (190)
T ss_pred             CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---Cc
Confidence            64433332222  379999999887765544556899999999999999999999 7999999999999999973   35


Q ss_pred             EEEeccCCCcc
Q 018734          139 LKICDFGYSKS  149 (351)
Q Consensus       139 vkL~DFg~a~~  149 (351)
                      ++|+|||+|..
T Consensus       156 v~LiDFG~a~~  166 (190)
T cd05147         156 LYIIDVSQSVE  166 (190)
T ss_pred             EEEEEcccccc
Confidence            99999999873

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=4e-25  Score=189.27  Aligned_cols=168  Identities=14%  Similarity=0.164  Sum_probs=128.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHH----------HHHHHHHHhcCCCCCcceEEEEEEcC-
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----------VAREIINHKQLRHPNIIRFKEVVLTP-   70 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~e~~~~~~l~hp~Iv~~~~~~~~~-   70 (351)
                      ++|++.+.||.|+||.||++.+  ++..+|+|++.......+.          +.+|+..+.++.||+|..+.+++... 
T Consensus        31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            5899999999999999999766  3567999998754433322          46888999999999999999886643 


Q ss_pred             -------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 018734           71 -------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD  143 (351)
Q Consensus        71 -------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~D  143 (351)
                             +..+++|||++|.+|.+..    .+++    ....+++.+|..||+.|++|||+||+||+++.++   ++|+|
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liD  177 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIID  177 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEE
Confidence                   3578999999999997763    2333    2466999999999999999999999999997654   99999


Q ss_pred             cCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHH
Q 018734          144 FGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML  194 (351)
Q Consensus       144 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  194 (351)
                      ||...........           .-++....+. .++|+||||+++..+.
T Consensus       178 fg~~~~~~e~~a~-----------d~~vler~y~-~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAK-----------DRIDLERHYG-IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhH-----------HHHHHHhHhc-ccccccceeEeehHHH
Confidence            9987643211110           0133445555 4589999999987644

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=6e-24  Score=180.11  Aligned_cols=139  Identities=19%  Similarity=0.156  Sum_probs=110.8

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---------------------------CHHHHHHHHHHhcCCCC
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------------------------DANVAREIINHKQLRHP   58 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~e~~~~~~l~hp   58 (351)
                      +.+.||+|+||.||+|.+. +|+.||||+++.....                           ......|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999988 8999999998764210                           01234788899999999


Q ss_pred             CcceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCC
Q 018734           59 NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAP  137 (351)
Q Consensus        59 ~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~  137 (351)
                      +|.....+....  .++||||++|+++.........++...+..++.|++.+|.+||+ +||+||||||+|||++ +  +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~--~  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D--G  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C--C
Confidence            876544443332  37999999988665443345678889999999999999999999 9999999999999997 3  3


Q ss_pred             CEEEeccCCCccc
Q 018734          138 RLKICDFGYSKSS  150 (351)
Q Consensus       138 ~vkL~DFg~a~~~  150 (351)
                      +++|+|||+++..
T Consensus       155 ~~~liDFG~a~~~  167 (190)
T cd05145         155 KPYIIDVSQAVEL  167 (190)
T ss_pred             CEEEEEcccceec
Confidence            5999999998743

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.1e-23  Score=176.85  Aligned_cols=185  Identities=17%  Similarity=0.164  Sum_probs=138.4

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCH-----HHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEEe
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-----NVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .+...|++|+||+|+.+..  .+..++.+.+........     .+.+|++++++|. |++|++++++    +..+++|+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4578899999999997776  466777776655443222     4678999999995 5889999886    34689999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCCCEEEeccCCCcccCCCCCC-
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL-KLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Di-kp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~-  156 (351)
                      |+.|.+|...+..      . ...++.|++.+|.++|++||+|||| ||+|||++.++  .++|+|||+|......... 
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcchHH
Confidence            9999988654321      1 2357889999999999999999999 79999997655  4999999999854332210 


Q ss_pred             -------------CCcccCCCccCcccccCCcC-CCcchhHHHHHHHHHHHHcCCCCCCCCC
Q 018734          157 -------------KSTVGTPAYIAPEVLSRREY-DGKLADVWSCGVTLYVMLVGAYPFEDQE  204 (351)
Q Consensus       157 -------------~~~~gt~~y~aPE~~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~  204 (351)
                                   .....++.|++|+...-... +-...++++.|+-+|.++|++.++....
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                         01236889999997533221 2234699999999999999998876543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=5.8e-24  Score=187.45  Aligned_cols=230  Identities=20%  Similarity=0.235  Sum_probs=144.2

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCC----------CCcceEEEEEEc
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRH----------PNIIRFKEVVLT   69 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~h----------p~Iv~~~~~~~~   69 (351)
                      +..++.||.|+++.||.+.+..|++.+|+|++......    -+++.+|......+.+          -.++-.++...-
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            45678999999999999999999999999988654321    1344445444433322          122222222221


Q ss_pred             ------------CC-----EEEEEEeccCCCChHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 018734           70 ------------PT-----HLAIVMEYAAGGELFERIC---NAGRF----SEDEARYFFQQLISGVSYCHSMQICHRDLK  125 (351)
Q Consensus        70 ------------~~-----~~~lv~e~~~~~~L~~~l~---~~~~l----~~~~~~~~~~qi~~aL~~lH~~~iiH~Dik  125 (351)
                                  ..     +.+++|+-+. ++|...+.   .....    .......+..|+++.+++||+.|++|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence                        11     2367888884 57866653   32222    122234556899999999999999999999


Q ss_pred             CCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCC-------cCCCcchhHHHHHHHHHHHHcCCC
Q 018734          126 LENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-------EYDGKLADVWSCGVTLYVMLVGAY  198 (351)
Q Consensus       126 p~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~ell~g~~  198 (351)
                      |+|++++.+|.  +.|+||+.........  .....+..|.+||.....       ...+.+.|.|+||+++|.|.|++.
T Consensus       173 ~~nfll~~~G~--v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGG--VFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS---EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCC--EEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999987765  9999999765332211  113456789999976432       122455899999999999999999


Q ss_pred             CCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCC
Q 018734          199 PFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRR  248 (351)
Q Consensus       199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  248 (351)
                      ||........          ....+....++++.+++||.+||++||.+|
T Consensus       249 Pf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9986543211          111233444688999999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.89  E-value=1.5e-22  Score=172.78  Aligned_cols=135  Identities=19%  Similarity=0.223  Sum_probs=107.6

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcC-----CCCCcceEEEEEEcCC---EEE-
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQL-----RHPNIIRFKEVVLTPT---HLA-   74 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l-----~hp~Iv~~~~~~~~~~---~~~-   74 (351)
                      .-...||+|+||.||.  +..+... +||++.... .....+.+|+..++.+     .||||+++++++.++.   .++ 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            3457899999999995  6666655 689886542 2345789999999999     5799999999998873   434 


Q ss_pred             EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCCcEEecCC--CCCCEEEeccC
Q 018734           75 IVMEY--AAGGELFERICNAGRFSEDEARYFFQQLISGV-SYCHSMQICHRDLKLENTLLDGS--PAPRLKICDFG  145 (351)
Q Consensus        75 lv~e~--~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL-~~lH~~~iiH~Dikp~NIll~~~--~~~~vkL~DFg  145 (351)
                      +|+||  +.+++|.+++.+. .+++.  ..++.|++.++ .|||+++|+||||||+|||++..  +..+++|+||+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            78999  5579999999764 56666  46688888888 99999999999999999999743  33469999955

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.1e-23  Score=176.81  Aligned_cols=239  Identities=21%  Similarity=0.322  Sum_probs=189.3

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEecc---CcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      .+..+|.....|..|+++...+  .++.|++.-   .......+..|.-.++-+.||||+.+++.+..+.++.++..||+
T Consensus       193 nl~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            4556788888999999988754  355566543   23344567788888999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           82 GGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      .|+|+..+....  .....++.+++.++++|+.|||+..  |.---|....++||.+...++-.+|--++..      ..
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------e~  344 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------EV  344 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee------cc
Confidence            999999997654  3577889999999999999999864  4455788999999998887777777655432      23


Q ss_pred             CcccCCCccCcccccCCcCC--CcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~--~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ...-.|.||+||.+.....+  -+++|+|||++++|||.|...||.+.++.+.=.++    .-...+...++.++..+..
T Consensus       345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----aleglrv~ippgis~hm~k  420 (448)
T KOG0195|consen  345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----ALEGLRVHIPPGISRHMNK  420 (448)
T ss_pred             ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----hhccccccCCCCccHHHHH
Confidence            34568899999999876644  35689999999999999999999987765443332    2223344445589999999


Q ss_pred             HHHHhcccCCCCCCChHHHh
Q 018734          236 LLSRIFVANPSRRITIKEIK  255 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil  255 (351)
                      |+.-|+..||.+||.++.+.
T Consensus       421 lm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  421 LMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHhcCCCCcCCCcceeh
Confidence            99999999999999998764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3e-22  Score=199.64  Aligned_cols=193  Identities=27%  Similarity=0.353  Sum_probs=156.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC---CCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~---hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +.|.|.+.||+|+||+||+|...+ ++.||+|+-......  ++.--.+++.+|+   -+.|..+..++...+..++|++
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e  774 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE  774 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence            468899999999999999999998 999999986654332  2222334444554   3566777777777788889999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-----CCCCCCEEEeccCCCcccCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD-----GSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~-----~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |.+.|+|.+++...+.+++..+..++.|++..++.||..+|||+||||+|.||.     +.+..-++|+|||.+-.+...
T Consensus       775 y~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lf  854 (974)
T KOG1166|consen  775 YSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLF  854 (974)
T ss_pred             ccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEc
Confidence            999999999999888999999999999999999999999999999999999983     222334999999987644322


Q ss_pred             CC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCC
Q 018734          154 SR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAY  198 (351)
Q Consensus       154 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  198 (351)
                      ..   -...++|-.+--+|+..+..++.. +|.|.|+.+++.|+.|+.
T Consensus       855 p~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  855 PDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHHH
Confidence            22   234578999999999999999755 899999999999999854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.1e-23  Score=205.58  Aligned_cols=259  Identities=32%  Similarity=0.513  Sum_probs=207.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-CCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-NTKELVAMKYIERGH---KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ..|.+.+.||+|+|+.|-.+... .....+|+|.+....   .....+..|..+.+.+. |+|++++++........++.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            46889999999999999887774 344566777665543   23344556888888887 99999999999999999999


Q ss_pred             EeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-
Q 018734           77 MEYAAGGELFERI-CNAG-RFSEDEARYFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l-~~~~-~l~~~~~~~~~~qi~~aL~~lH-~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-  152 (351)
                      +++..|++++..+ .... ..+......++.|+..++.|+| ..++.||||||+|.+++.++. .++++|||+|..... 
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNK  178 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccccc
Confidence            9999999999988 4444 5788899999999999999999 999999999999999987773 499999999986544 


Q ss_pred             CCC---CCCccc-CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          153 HSR---PKSTVG-TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       153 ~~~---~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                      ...   ....+| ++.|+|||...+..+..+..|+||.|+++..+++|..||................ ........+..
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  257 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN-KGRFTQLPWNS  257 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-ccccccCcccc
Confidence            222   233578 9999999999887777777999999999999999999997655433211111110 01222445667


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      ++....+++.++|..+|..|.+.+++..+||+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8899999999999999999999999999999977

>smart00090 RIO RIO-like kinase

Probab=99.86  E-value=1.1e-21  Score=171.32  Aligned_cols=138  Identities=17%  Similarity=0.121  Sum_probs=109.9

Q ss_pred             eeEeeeecccCceEEEEEE-EcCCCcEEEEEEeccCccc-------------------------CHHHHHHHHHHhcCCC
Q 018734            4 YELMKDIGSGNFGVARLMR-NKNTKELVAMKYIERGHKI-------------------------DANVAREIINHKQLRH   57 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~e~~~~~~l~h   57 (351)
                      |++.+.||+|+||.||+|. +..+|+.||+|++......                         ...+.+|+.+++++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            6788999999999999998 6678999999998753210                         0124579999999875


Q ss_pred             C--CcceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecCC
Q 018734           58 P--NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ-ICHRDLKLENTLLDGS  134 (351)
Q Consensus        58 p--~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~-iiH~Dikp~NIll~~~  134 (351)
                      .  .+.++++.    ...++||||+.|.+|.........+....+..++.|++.+|.+||++| ++||||||+||+++ +
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~  184 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D  184 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence            3  33444442    234799999999888766545556677778899999999999999999 99999999999997 3


Q ss_pred             CCCCEEEeccCCCc
Q 018734          135 PAPRLKICDFGYSK  148 (351)
Q Consensus       135 ~~~~vkL~DFg~a~  148 (351)
                        ++++|+|||++.
T Consensus       185 --~~i~LiDFg~a~  196 (237)
T smart00090      185 --GKVVIIDVSQSV  196 (237)
T ss_pred             --CCEEEEEChhhh
Confidence              359999999876

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.85  E-value=2.6e-22  Score=184.78  Aligned_cols=174  Identities=26%  Similarity=0.393  Sum_probs=132.7

Q ss_pred             EEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           72 HLAIVMEYAAGGELFERICNAG---RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      .+||.|++|...+|.++|.+..   ..+...+..++.|++.|++|   +|.+|+|+||.||+...+..  +||.|||+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh--hhhhhhhhee
Confidence            5899999999999999997543   35677899999999999999   99999999999999966654  9999999988


Q ss_pred             ccCCCC-------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhc
Q 018734          149 SSLLHS-------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  220 (351)
Q Consensus       149 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (351)
                      ......       ..+..+||.+||+||.+.+..|..+ +||||||++++||+. =..+|..       ......+....
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g~  476 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIRDGI  476 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcCC
Confidence            665554       4456689999999999999998655 999999999999996 2222211       11111222222


Q ss_pred             cCCC-CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          221 YKIP-DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       221 ~~~~-~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                        +| .+..-.+.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus       477 --ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  477 --IPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             --CChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence              22 111223455699999999999999977776666654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=5.7e-21  Score=178.84  Aligned_cols=203  Identities=23%  Similarity=0.345  Sum_probs=157.1

Q ss_pred             HhcCCCCCcceEEEEEEcCCEEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCC-eecCCCCCcE
Q 018734           52 HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQI-CHRDLKLENT  129 (351)
Q Consensus        52 ~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i-iH~Dikp~NI  129 (351)
                      |+.+.|.|+.++++.+.++..+++|.+||..|+|.+.+.. ...++......++++|+.||.|||...| .|+.++..|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999987 4468888899999999999999998766 9999999999


Q ss_pred             EecCCCCCCEEEeccCCCcccCCC---CCCCCcccCCCccCcccccCCcC------CCcchhHHHHHHHHHHHHcCCCCC
Q 018734          130 LLDGSPAPRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREY------DGKLADVWSCGVTLYVMLVGAYPF  200 (351)
Q Consensus       130 ll~~~~~~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~ell~g~~pf  200 (351)
                      +++....  +||+|||+.......   .......-..-|.|||.+.....      -+++.|+||+|++++|+++...||
T Consensus        81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9998886  999999987644221   11122234456999999976422      244589999999999999999999


Q ss_pred             CCCCChhHHHHHHHHHHh-hcc-CCCCc---cCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          201 EDQEDPKNFRKTISRIMA-VQY-KIPDY---VHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       201 ~~~~~~~~~~~~~~~~~~-~~~-~~~~~---~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..........+++.++.. ... ..|..   ....+.+..++.+||..+|..||+++++-.
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            875443332344444333 111 11211   135567999999999999999999998743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.5e-20  Score=158.47  Aligned_cols=134  Identities=24%  Similarity=0.223  Sum_probs=110.9

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---------CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++.||+|++|.||++..  .+..|++|+.......         ...+.+|+.++..+.|++|.....++......+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  4667999976532211         134668999999999999887777777777889999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      ||++|++|.+.+.....    ....++.+++.+|.+||++|++|||++|.|||++ +  +.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~--~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-G--GKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-C--CCEEEEECCcccC
Confidence            99999999998865432    8889999999999999999999999999999998 3  3499999998763

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.5e-19  Score=154.16  Aligned_cols=133  Identities=23%  Similarity=0.271  Sum_probs=104.5

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-----------------------cCHHHHHHHHHHhcCCCCC-
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----------------------IDANVAREIINHKQLRHPN-   59 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~e~~~~~~l~hp~-   59 (351)
                      |.+.+.||+|+||.||++... +++.||||++.....                       .......|+.++..+.|++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            778899999999999999875 689999998764321                       0112567888888887774 


Q ss_pred             -cceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 018734           60 -IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPR  138 (351)
Q Consensus        60 -Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~  138 (351)
                       +...++.    ...++||||+.|++|......      .....++.+++.++.++|+.|++||||||+||+++.++  .
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--~  163 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--K  163 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--c
Confidence             4444432    345899999999988655321      34677889999999999999999999999999998655  5


Q ss_pred             EEEeccCCCcc
Q 018734          139 LKICDFGYSKS  149 (351)
Q Consensus       139 vkL~DFg~a~~  149 (351)
                      ++|+|||++..
T Consensus       164 ~~liDfg~~~~  174 (198)
T cd05144         164 IYIIDWPQMVS  174 (198)
T ss_pred             EEEEECCcccc
Confidence            99999998863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.6e-19  Score=152.86  Aligned_cols=129  Identities=21%  Similarity=0.195  Sum_probs=103.2

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEeccCc-cc--------CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGH-KI--------DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~--------~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      .||+|+||.||++..  ++..|++|+..... ..        ..++.+|+.+++.+.|+++....-++......+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  46789999754321 11        14566899999999988766555555566677899999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      ++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|.||+++ +  ++++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~--~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D--DKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C--CcEEEEECCCCcC
Confidence            999999888755321       8899999999999999999999999999997 3  3599999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=7e-19  Score=171.95  Aligned_cols=133  Identities=21%  Similarity=0.197  Sum_probs=106.9

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEe-ccCcc--------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYI-ERGHK--------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~-~~~~~--------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      |...+.||+|+||.||++......  +++|+. .+...        ....+.+|+.+++.++|++|+....+.......+
T Consensus       335 ~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~  412 (535)
T PRK09605        335 KIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT  412 (535)
T ss_pred             cCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence            456789999999999998876543  343332 21111        1235778999999999999998877777777788


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      +||||++|++|.+.+.        ....++.|++.+|.+||++|++||||||+|||++ ++  +++|+|||+++.
T Consensus       413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~  476 (535)
T PRK09605        413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY  476 (535)
T ss_pred             EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence            9999999999988875        3567899999999999999999999999999994 33  499999999873

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=2.7e-18  Score=145.00  Aligned_cols=133  Identities=20%  Similarity=0.259  Sum_probs=95.1

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC---HH----------------------HHHHHHHHhcCCCC--C
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---AN----------------------VAREIINHKQLRHP--N   59 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~----------------------~~~e~~~~~~l~hp--~   59 (351)
                      .+.||+|+||.||.+.+. +++.||||++.......   ..                      ...|...+..+.+.  .
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999987 78899999886532211   00                      12455555555433  2


Q ss_pred             cceEEEEEEcCCEEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCC
Q 018734           60 IIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAP  137 (351)
Q Consensus        60 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~  137 (351)
                      +.+.+.+    ...++||||++|+++.. .+.... .. ..++.++.+++.++.++|. .||+||||||+||+++ +  +
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~--~  151 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D--G  151 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C--C
Confidence            4444443    23589999999854422 122111 11 6788999999999999999 9999999999999998 3  3


Q ss_pred             CEEEeccCCCcc
Q 018734          138 RLKICDFGYSKS  149 (351)
Q Consensus       138 ~vkL~DFg~a~~  149 (351)
                      .++|+|||.+..
T Consensus       152 ~~~liDfg~a~~  163 (187)
T cd05119         152 KVYIIDVPQAVE  163 (187)
T ss_pred             cEEEEECccccc
Confidence            599999998863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=2.9e-17  Score=143.74  Aligned_cols=132  Identities=19%  Similarity=0.247  Sum_probs=101.1

Q ss_pred             eeec-ccCceEEEEEEEcCCCcEEEEEEeccCc--------------ccCHHHHHHHHHHhcCCCCCc--ceEEEEEEcC
Q 018734            8 KDIG-SGNFGVARLMRNKNTKELVAMKYIERGH--------------KIDANVAREIINHKQLRHPNI--IRFKEVVLTP   70 (351)
Q Consensus         8 ~~lG-~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~~~~l~hp~I--v~~~~~~~~~   70 (351)
                      ..|| .|+.|+||.+...  +..+++|.+....              .....+.+|+.++..|.|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 7888889888775  5678998774311              122457789999999998875  6666664332


Q ss_pred             -C---EEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccC
Q 018734           71 -T---HLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG  145 (351)
Q Consensus        71 -~---~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg  145 (351)
                       .   ..++|||+++| .+|..++.. ..+++..    +.||+.+|.+||++||+||||||.|||++.++  .++|+|||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg  187 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFD  187 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECC
Confidence             2   23599999997 688887755 3556543    57899999999999999999999999997655  49999999


Q ss_pred             CCc
Q 018734          146 YSK  148 (351)
Q Consensus       146 ~a~  148 (351)
                      .+.
T Consensus       188 ~~~  190 (239)
T PRK01723        188 RGE  190 (239)
T ss_pred             Ccc
Confidence            876

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=4e-17  Score=132.24  Aligned_cols=131  Identities=25%  Similarity=0.284  Sum_probs=110.8

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC--CCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h--p~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      +++.||.|.++.||++....  ..+++|....... ...+.+|+..++.++|  +++++++.++...+..+++|||+.|+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            56889999999999999865  6799998866543 4578899999999976  58999999888888899999999987


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           84 ELFERICNAGRFSEDEARYFFQQLISGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        84 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      ++...       +......++.+++.+|.+||..   +++|+|++|.||+++..+  .++++|||.+.
T Consensus        79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~  137 (155)
T cd05120          79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAG  137 (155)
T ss_pred             ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEeccccc
Confidence            76543       5567778899999999999984   799999999999998643  59999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.67  E-value=1e-17  Score=164.99  Aligned_cols=259  Identities=27%  Similarity=0.388  Sum_probs=197.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +.+.+.+.+-.|+++.++.+....++...++|+........    +.+..+-.++-...+|.++.....+......++++
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~  883 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG  883 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence            46778889999999999999999888777777654432221    22223333333345577776665566667899999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC------
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL------  151 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~------  151 (351)
                      +|+.|++|...+++.+..++.-.+.++..+++++++||+..+.|+|++|.|+|+..++  +.+++|||......      
T Consensus       884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g--h~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG--HRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC--CcccCccccccccccccCcC
Confidence            9999999999999988889999999999999999999999999999999999996665  48999998322100      


Q ss_pred             -C---------------------C----CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Q 018734          152 -L---------------------H----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED  205 (351)
Q Consensus       152 -~---------------------~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  205 (351)
                       .                     .    .......||+.|.+||...+...... +|+|++|+++++.++|.+||.....
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcch
Confidence             0                     0    01223469999999999988876544 8999999999999999999988766


Q ss_pred             hhHHHHHHHHHHhhccCCCC-ccCCCHhHHHHHHHhcccCCCCCCChH---HHhcCcccccCCChh
Q 018734          206 PKNFRKTISRIMAVQYKIPD-YVHISQDCRNLLSRIFVANPSRRITIK---EIKSHPWFLKNLPRE  267 (351)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~Rps~~---eil~hp~~~~~~~~~  267 (351)
                      ...+..    +......+|. ....+..+.+++.++|..+|.+|..+.   ++..||||+...+..
T Consensus      1041 q~~f~n----i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1041 QQIFEN----ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             hhhhhc----cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccc
Confidence            554433    3333333333 234688999999999999999999887   899999998765543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=6.5e-17  Score=151.86  Aligned_cols=249  Identities=20%  Similarity=0.187  Sum_probs=188.6

Q ss_pred             CeeEeeeecc--cCceEEEEEEE--cCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEE
Q 018734            3 KYELMKDIGS--GNFGVARLMRN--KNTKELVAMKYIERGH---KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         3 ~y~~~~~lG~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~   74 (351)
                      .+-+...+|.  |.+|.||.+..  ..+...+|+|.-....   .....-.+++...+.+ .|+|.++.+..+...+..|
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3456678999  99999999998  8889999999743322   2223445677777777 4899999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHH----HHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           75 IVMEYAAGGELFERICNAG-RFSEDEARYFFQQLIS----GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~----aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      +-+|+| +.+|..+..... .++...++..+.+...    ||.++|+.+++|-|+||.||++..+. ...+++|||+...
T Consensus       195 iqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~  272 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSK  272 (524)
T ss_pred             eeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeEE
Confidence            999999 467877776544 4899999999999999    99999999999999999999998773 3489999998775


Q ss_pred             cCCCCCC------CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCC--CChhHHHHHHHHHHhhcc
Q 018734          150 SLLHSRP------KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ--EDPKNFRKTISRIMAVQY  221 (351)
Q Consensus       150 ~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--~~~~~~~~~~~~~~~~~~  221 (351)
                      .......      ....|...|++||...+..  +..+|+|++|.++.+..++..++...  .....+....       .
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-------i  343 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-------I  343 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------C
Confidence            4433322      1225777899999985543  55689999999999999887665443  2211111100       1


Q ss_pred             CCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          222 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      ........+..+...+..|++.+|-.|++...+++|+++..
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            11112245667777999999999999999999999998753

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.59  E-value=3.1e-14  Score=135.35  Aligned_cols=166  Identities=18%  Similarity=0.260  Sum_probs=128.2

Q ss_pred             EEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHH
Q 018734           21 MRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE   99 (351)
Q Consensus        21 ~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~   99 (351)
                      +..+.++..|.+.+...+.. ......+.+..++.++||||+++++.+...+.+|+|+|-+.  .|...+.+.   +...
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~  105 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEE  105 (690)
T ss_pred             cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHH
Confidence            45556678888888766544 22346788899999999999999999999999999999984  566666654   3778


Q ss_pred             HHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCcccCCCccCcccccCCcCC
Q 018734          100 ARYFFQQLISGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRREYD  177 (351)
Q Consensus       100 ~~~~~~qi~~aL~~lH-~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~  177 (351)
                      +..-++||+.||.||| ..+++|++|+.+.|+|+..+.  .||++|-++....... +.....---.|..|+.+....+ 
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~-  182 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEW-  182 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCcccc-
Confidence            8899999999999998 678999999999999977765  9999999875432222 1222233334677776643332 


Q ss_pred             CcchhHHHHHHHHHHHHcC
Q 018734          178 GKLADVWSCGVTLYVMLVG  196 (351)
Q Consensus       178 ~~~~DiwslG~il~ell~g  196 (351)
                        ..|.|.|||++++++.|
T Consensus       183 --s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  183 --SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --chhhhhHHHHHHHHhCc
Confidence              26999999999999998

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=3.2e-15  Score=130.60  Aligned_cols=203  Identities=18%  Similarity=0.306  Sum_probs=139.8

Q ss_pred             HHHHhcCCCCCcceEEEEEEcC-----CEEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-
Q 018734           49 IINHKQLRHPNIIRFKEVVLTP-----THLAIVMEYAAGGELFERICNA----GRFSEDEARYFFQQLISGVSYCHSMQ-  118 (351)
Q Consensus        49 ~~~~~~l~hp~Iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~-  118 (351)
                      +..+-++-|.|||+++.++.+.     ....++.||+..|+|..+|++.    ..+......+|+-||+.||.|||+.. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            3445666899999999988654     3578999999999999999763    35888999999999999999999874 


Q ss_pred             -CeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-----CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHH
Q 018734          119 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-----HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYV  192 (351)
Q Consensus       119 -iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e  192 (351)
                       |+|+++....|++..++.  +|+.--........     ........+-++|.|||.=.....++ ++|||++|....+
T Consensus       198 piihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~-a~dIy~fgmcAle  274 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTG-ASDIYKFGMCALE  274 (458)
T ss_pred             ccccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccccc-chhhhhhhHHHHH
Confidence             999999999999976553  66542111110000     00011224678999999754444444 4999999999999


Q ss_pred             HHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          193 MLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       193 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      |..+..--......-.....+.+..   .-..     ...-++++.+||+..|+.||++.+++.||.+.+
T Consensus       275 mailEiq~tnseS~~~~ee~ia~~i---~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENIANVI---IGLE-----NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             HHHheeccCCCcceeehhhhhhhhe---eecc-----CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            9887543222211111111111111   0011     122368899999999999999999999998654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.57  E-value=1.5e-15  Score=145.99  Aligned_cols=140  Identities=24%  Similarity=0.352  Sum_probs=95.0

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-----------------------------------cCH----
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----------------------------------IDA----   43 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------------------~~~----   43 (351)
                      .|+. ++||+|++|.||.|+.+.+|+.||||+++..-.                                   ...    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4565 789999999999999998899999999864310                                   001    


Q ss_pred             --HHHHHHHHHhcC----CCCCcceEEEEEEc-CCEEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 018734           44 --NVAREIINHKQL----RHPNIIRFKEVVLT-PTHLAIVMEYAAGGELFER--ICNAG----RFSEDEARYFFQQLISG  110 (351)
Q Consensus        44 --~~~~e~~~~~~l----~hp~Iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~--l~~~~----~l~~~~~~~~~~qi~~a  110 (351)
                        ++.+|...+.++    .+.+.+.+-.++.+ .+..++||||+.|+.+.+.  +...+    .+.+..+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence              123344343333    23333443333322 3456799999999999764  33333    245555566666654  


Q ss_pred             HHHHHHcCCeecCCCCCcEEecCCC--CCCEEEeccCCCccc
Q 018734          111 VSYCHSMQICHRDLKLENTLLDGSP--APRLKICDFGYSKSS  150 (351)
Q Consensus       111 L~~lH~~~iiH~Dikp~NIll~~~~--~~~vkL~DFg~a~~~  150 (351)
                           ..|++|+|+||.||+++.++  .++++++|||++...
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                 59999999999999997654  236999999987643

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.56  E-value=2e-14  Score=119.31  Aligned_cols=127  Identities=20%  Similarity=0.237  Sum_probs=96.0

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcc-eEEEEEEcCCEEEEEEeccCCCCh
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII-RFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv-~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ++.|+.|.++.||++...  +..|++|+............+|+.+++.+.+.+++ +++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            468899999999999875  67899998765543334567889999888655544 4555433  334799999999877


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           86 FERICNAGRFSEDEARYFFQQLISGVSYCHSMQI-----CHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        86 ~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i-----iH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      ...        ......++.+++.+|..||+.++     +|+|++|.||+++. +  +++++|||.+.
T Consensus        79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~-~--~~~liDf~~a~  135 (170)
T cd05151          79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD-G--RLWLIDWEYAG  135 (170)
T ss_pred             ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC-C--eEEEEeccccc
Confidence            543        11123467899999999999885     99999999999983 2  49999999765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.54  E-value=4.2e-14  Score=134.31  Aligned_cols=136  Identities=18%  Similarity=0.199  Sum_probs=91.6

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCccc-----------------------------------------CHHHH
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-----------------------------------------DANVA   46 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------------------------~~~~~   46 (351)
                      ++||.|++|.||+|+.. +|+.||||+.+.....                                         +-++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            68999999999999976 5889999997543100                                         00233


Q ss_pred             HHHHHHhcC----CCCCcceEEEEE-EcCCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcCC
Q 018734           47 REIINHKQL----RHPNIIRFKEVV-LTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLIS-GVSYCHSMQI  119 (351)
Q Consensus        47 ~e~~~~~~l----~hp~Iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~-aL~~lH~~~i  119 (351)
                      +|...+.++    ++.+-+.+-.++ ...+..++||||++|++|.+..... ..+   ....++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            344444443    232222322222 2234568999999999997765432 112   23445555555 4788999999


Q ss_pred             eecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734          120 CHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus       120 iH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      +|+|+||.||+++.++  +++|+|||++..
T Consensus       279 ~H~D~hPgNilv~~~g--~i~liDfG~~~~  306 (437)
T TIGR01982       279 FHADLHPGNIFVLKDG--KIIALDFGIVGR  306 (437)
T ss_pred             eeCCCCcccEEECCCC--cEEEEeCCCeeE
Confidence            9999999999997665  599999998864

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=6.8e-15  Score=138.37  Aligned_cols=248  Identities=20%  Similarity=0.197  Sum_probs=181.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-CCCcEEEEEEeccCccc---CHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-NTKELVAMKYIERGHKI---DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      -+|-++..||.|.|+.|+.+... .++..|++|...+....   +..-..|+.+...+ .|.++++++..+....+.|+-
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip  344 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP  344 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence            36778899999999999887765 67889999977654322   22344566666666 589999988888877788899


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      .|||.++++...+.-...+.+..++.+..|++.++.++|+..++|+|+||+||++..++ +..++.|||..+..  ....
T Consensus       345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~--~~~~  421 (524)
T KOG0601|consen  345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRL--AFSS  421 (524)
T ss_pred             hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhcccccccccc--ceec
Confidence            99999998876664445678889999999999999999999999999999999997653 34799999987642  1112


Q ss_pred             CCcccCCCcc-CcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          157 KSTVGTPAYI-APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       157 ~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....+.-+++ .+|++........+.|++|||..+.+.+++...-......   .    .+...  ..|.......++..
T Consensus       422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~---~----~i~~~--~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS---L----TIRSG--DTPNLPGLKLQLQV  492 (524)
T ss_pred             ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc---e----eeecc--cccCCCchHHhhhh
Confidence            2233444555 3566555544455589999999999999885433221110   0    11111  23333344578889


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccc
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      +.+.++..++..||.+.++..|+=|.
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhh
Confidence            99999999999999999988876553

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.53  E-value=1.5e-13  Score=115.51  Aligned_cols=136  Identities=15%  Similarity=0.179  Sum_probs=98.4

Q ss_pred             eeeecccCceEEEEEEEcC------CCcEEEEEEeccCc--------------c-------c--CHH----HHHHHHHHh
Q 018734            7 MKDIGSGNFGVARLMRNKN------TKELVAMKYIERGH--------------K-------I--DAN----VAREIINHK   53 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~--------------~-------~--~~~----~~~e~~~~~   53 (351)
                      ...||.|--+.||.+....      .+..+|+|+.+.+.              .       .  ...    ..+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998754      35789999864211              0       0  111    237888888


Q ss_pred             cCCC--CCcceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEE
Q 018734           54 QLRH--PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HSMQICHRDLKLENTL  130 (351)
Q Consensus        54 ~l~h--p~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~l-H~~~iiH~Dikp~NIl  130 (351)
                      ++..  -++..++++    ..-++||||+.+..+.....+...+++.....+..+++.+|..| |+.|++|+||+|.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8853  455566654    34569999997654433222333456677788899999999998 8999999999999999


Q ss_pred             ecCCCCCCEEEeccCCCcc
Q 018734          131 LDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus       131 l~~~~~~~vkL~DFg~a~~  149 (351)
                      ++.+   .+.|+|||.+..
T Consensus       158 ~~~~---~v~iIDF~qav~  173 (197)
T cd05146         158 WHDG---KVWFIDVSQSVE  173 (197)
T ss_pred             EECC---cEEEEECCCcee
Confidence            9643   499999997763

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=9.2e-12  Score=101.46  Aligned_cols=129  Identities=22%  Similarity=0.209  Sum_probs=96.3

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEe-ccCc---cc-----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYI-ERGH---KI-----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~-~~~~---~~-----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ..+++|+-+.++.+...  +..+++|.- .+.-   ..     ..+..+|..++++++--.|....-++.++....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            46889999999998664  334666642 2211   11     1345678888888876666555555667777889999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      |++|..|.+.+...       ...+++.+-.-+.-||.+||+|+||.++||++.+..   +.++|||++.
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~  139 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGE  139 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCccc
Confidence            99998888888665       245667777778889999999999999999997554   8999999986

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.35  E-value=4.1e-11  Score=111.15  Aligned_cols=212  Identities=19%  Similarity=0.276  Sum_probs=152.1

Q ss_pred             ce-EEEEEEEcCCCcEEEEEEeccCcccCH-HHHHHHHHHhcCCCCCcceEEEEEEc----CCEEEEEEeccCC-CChHH
Q 018734           15 FG-VARLMRNKNTKELVAMKYIERGHKIDA-NVAREIINHKQLRHPNIIRFKEVVLT----PTHLAIVMEYAAG-GELFE   87 (351)
Q Consensus        15 ~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~e~~~~~~l~hp~Iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~   87 (351)
                      |. +.|++....+|..|++|+++....... ..-.-+++++++.|+|||++.++|.+    +..+++|++|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            44 679999999999999999954333222 33356778899999999999999874    3578999999987 46766


Q ss_pred             HHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           88 RICN---------------AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        88 ~l~~---------------~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +.-.               +...+|..+|.++.|+..||.++|+.|+.-+-|.|.+||++++.  |++|...|+......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQE  445 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecC
Confidence            5421               23467899999999999999999999999999999999997654  588887776543322


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      ..      +       +.+.+    ..+-|.=.||.+++.|.||..--.........  .+.++.         ..++.+
T Consensus       446 d~------~-------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I~---------~~yS~D  497 (655)
T KOG3741|consen  446 DP------T-------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLTRIT---------TTYSTD  497 (655)
T ss_pred             CC------C-------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHH--HHHHhh---------hhhhHH
Confidence            22      1       11211    12358889999999999995442222211111  011111         146789


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ++++|.-+...+++. -++.+++.+
T Consensus       498 ~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  498 LRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHhcCccc-ccHHHHHHH
Confidence            999999999999886 678888765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.34  E-value=1e-11  Score=107.39  Aligned_cols=139  Identities=19%  Similarity=0.263  Sum_probs=103.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCC--CcceEEEEEEcC---CEEEEEEecc
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHP--NIIRFKEVVLTP---THLAIVMEYA   80 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp--~Iv~~~~~~~~~---~~~~lv~e~~   80 (351)
                      +.|+.|.++.||++...+ |+.+++|+......  ....+.+|..+++.+.+.  .+.+++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            678999999999998754 57899998766443  345678999999998763  456677766543   3678999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS--------------------------------------------  116 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--------------------------------------------  116 (351)
                      +|.++...+.. ..++......++.+++++|..||+                                            
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            99887665432 346666777777777777777773                                            


Q ss_pred             ------------cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 ------------MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 ------------~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                                  ..++|+|++|.||+++.+..+.+.|+||+.+.
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                        23699999999999987422347899999765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.31  E-value=8e-13  Score=126.31  Aligned_cols=157  Identities=16%  Similarity=0.275  Sum_probs=109.9

Q ss_pred             HHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC----------CCcccCCCccCcccccC
Q 018734          105 QQLISGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----------KSTVGTPAYIAPEVLSR  173 (351)
Q Consensus       105 ~qi~~aL~~lH-~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~~  173 (351)
                      .+++.||.|+| +.++||++|.|++|.++.++.  .||+.|+++.........          ....-...|.|||.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34559999999 569999999999999987776  999999987643321111          11235667999999987


Q ss_pred             CcCCCcchhHHHHHHHHHHHH-cCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChH
Q 018734          174 REYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIK  252 (351)
Q Consensus       174 ~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~  252 (351)
                      .. .+.++|+||+||++|.+. .|+..+......... .......... .+-....+++++++-|.++|..++..||++.
T Consensus       184 ~~-~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~~~~~~-~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  184 TT-NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRNLLNAG-AFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             cc-ccccccceeeeeEEEEEecCCcchhhccCCcchh-hhhhcccccc-cccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence            44 456699999999999998 455555443221111 1111000000 1111246889999999999999999999999


Q ss_pred             HHhcCcccccCCCh
Q 018734          253 EIKSHPWFLKNLPR  266 (351)
Q Consensus       253 eil~hp~~~~~~~~  266 (351)
                      .++..|||....-+
T Consensus       261 ~l~~~~ff~D~~~~  274 (700)
T KOG2137|consen  261 LLLSIPFFSDPGLK  274 (700)
T ss_pred             hhhcccccCCchhh
Confidence            99999999765433

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=3.3e-11  Score=97.86  Aligned_cols=141  Identities=17%  Similarity=0.102  Sum_probs=102.4

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEec-cCc--------ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGH--------KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~~~--------~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      .+..|.+|+-+.|+.+...  |+.+.||.-. +..        ....+..+|.+.+.++.--.|.-..-+|.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            4678899999999988876  6677777532 211        1224566788888888655655555555566666799


Q ss_pred             EeccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC-CEEEeccCCCc
Q 018734           77 MEYAAG-GELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP-RLKICDFGYSK  148 (351)
Q Consensus        77 ~e~~~~-~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~-~vkL~DFg~a~  148 (351)
                      |||++| .++.+++....  .....-...++.+|-..+.-||.++|+|+||.++||++...+.. .+.|+|||++.
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            999987 46777776532  22233347888999999999999999999999999999765542 34899999876

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.19  E-value=5e-10  Score=101.73  Aligned_cols=239  Identities=14%  Similarity=0.107  Sum_probs=152.6

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEE------EEcC-CEEEEEE
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEV------VLTP-THLAIVM   77 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~------~~~~-~~~~lv~   77 (351)
                      ..+.||+|+-+.+|-.-...+   .+.|+........  ..+.+..|... .||-+-.-+.+      .-+. ..+.++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~--~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAA--QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchhhc---hhheeecCCCchH--HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            467899999999887654432   3447776543321  11222333332 45543331111      1112 3378899


Q ss_pred             eccCCCCh-HHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc
Q 018734           78 EYAAGGEL-FERI------CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  150 (351)
Q Consensus        78 e~~~~~~L-~~~l------~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~  150 (351)
                      ..+.|..- ..++      ++.+.+....+.+..+.++.+...||.+|.+-+|+.++|+||.+.+.  |.|.|=..-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence            99887532 2222      23455778889999999999999999999999999999999976664  888886644434


Q ss_pred             CCCCCCCCcccCCCccCcccccC-----CcCCCcchhHHHHHHHHHHHHcC-CCCCCCCCC----hhHHHHHHHHH----
Q 018734          151 LLHSRPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVG-AYPFEDQED----PKNFRKTISRI----  216 (351)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~----~~~~~~~~~~~----  216 (351)
                      ..+......+|.+.|.+||.-.-     -..+.. .|.|.||+++++++.| +.||.+...    +......+...    
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            44555566789999999998642     222233 7999999999999887 999986421    11111111100    


Q ss_pred             ---HhhccC----CCCccCCCHhHHHHHHHhccc--CCCCCCChH
Q 018734          217 ---MAVQYK----IPDYVHISQDCRNLLSRIFVA--NPSRRITIK  252 (351)
Q Consensus       217 ---~~~~~~----~~~~~~~~~~~~~li~~~L~~--~P~~Rps~~  252 (351)
                         ....+.    .+.+.-+++.+..|..+|+..  +|.-|||++
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence               000111    112334788999999999876  456799865

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=4.4e-10  Score=99.65  Aligned_cols=129  Identities=15%  Similarity=0.050  Sum_probs=91.2

Q ss_pred             EEEEEEcCCCcEEEEEEeccCcc------------cCHHHHHHHHHHhcCCCCCcc--eEEEEEEc-----CCEEEEEEe
Q 018734           18 ARLMRNKNTKELVAMKYIERGHK------------IDANVAREIINHKQLRHPNII--RFKEVVLT-----PTHLAIVME   78 (351)
Q Consensus        18 V~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~e~~~~~~l~hp~Iv--~~~~~~~~-----~~~~~lv~e   78 (351)
                      |+.+..  .|+.|.||.......            ....+.+|+..+.+|..-+|.  ..+.++..     ....++|||
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            444433  366788896643221            112477888888777433322  33334332     235789999


Q ss_pred             ccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-----CCCCCEEEeccCCCc
Q 018734           79 YAAGG-ELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG-----SPAPRLKICDFGYSK  148 (351)
Q Consensus        79 ~~~~~-~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~-----~~~~~vkL~DFg~a~  148 (351)
                      ++++. +|.+++..  ....+......++.+++..+.-||.+||+|+|+++.|||++.     .+...+.|+||+.+.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99885 78888754  344567788899999999999999999999999999999974     234569999999764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.12  E-value=6.6e-10  Score=93.10  Aligned_cols=123  Identities=25%  Similarity=0.296  Sum_probs=79.0

Q ss_pred             EEEEEEEcCCCcEEEEEEeccCc--------------c-------------cCHHHHHHHHHHhcCCCC--CcceEEEEE
Q 018734           17 VARLMRNKNTKELVAMKYIERGH--------------K-------------IDANVAREIINHKQLRHP--NIIRFKEVV   67 (351)
Q Consensus        17 ~V~~~~~~~~~~~vaiK~~~~~~--------------~-------------~~~~~~~e~~~~~~l~hp--~Iv~~~~~~   67 (351)
                      .||.|.... +..+|+|+.....              .             ......+|.+.|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            488888865 6799999864310              0             013456799999999765  455666543


Q ss_pred             EcCCEEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           68 LTPTHLAIVMEYAA--GGELFERICNAGRFSEDEARYFFQQLISGVSY-CHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        68 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~-lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                        .  -++||||+.  |..+..+....  ++......++.+++..+.. +|..||+|+||.+.|||++.+   .+.|+||
T Consensus        80 --~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf  150 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDF  150 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--G
T ss_pred             --C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEec
Confidence              2  259999998  65554433221  1244567778888885555 589999999999999999866   3999999


Q ss_pred             CCCcc
Q 018734          145 GYSKS  149 (351)
Q Consensus       145 g~a~~  149 (351)
                      |.+..
T Consensus       151 ~qav~  155 (188)
T PF01163_consen  151 GQAVD  155 (188)
T ss_dssp             TTEEE
T ss_pred             Cccee
Confidence            97763

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.93  E-value=6.2e-09  Score=90.06  Aligned_cols=132  Identities=20%  Similarity=0.236  Sum_probs=95.7

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-----------------------ccCHHHHHHHHHHhcCCCC--C
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----------------------KIDANVAREIINHKQLRHP--N   59 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~~~~e~~~~~~l~hp--~   59 (351)
                      .++.+||-|--|.||.+.+.+ |..+|||.-+-..                       .......+|...|.+|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            467899999999999999985 7889999532110                       0123566899999988654  5


Q ss_pred             cceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 018734           60 IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRL  139 (351)
Q Consensus        60 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~v  139 (351)
                      +.+.+++    +.-.+|||++.|..|...-     ++......++..|+.-+.-+-..||||+|+++-||+++.++.  +
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~  241 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--I  241 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--E
Confidence            6666654    3456999999997664322     133445555556666555555899999999999999987765  9


Q ss_pred             EEeccCCCc
Q 018734          140 KICDFGYSK  148 (351)
Q Consensus       140 kL~DFg~a~  148 (351)
                      .++||--+.
T Consensus       242 ~vIDwPQ~v  250 (304)
T COG0478         242 VVIDWPQAV  250 (304)
T ss_pred             EEEeCcccc
Confidence            999998654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.92  E-value=1.7e-10  Score=109.57  Aligned_cols=240  Identities=20%  Similarity=0.191  Sum_probs=168.2

Q ss_pred             eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC-cceEEEEEEcCCEEEEEEeccCCC
Q 018734            5 ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         5 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~-Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      ....-.++|+++++++.+...+...+ .+++...    ....-++++|.+++||| .+..++.+..+...+++|+++.++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence            34456788999999999998876555 7776655    45667888999999999 777788787888999999999887


Q ss_pred             -Ch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCccc
Q 018734           84 -EL-FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  161 (351)
Q Consensus        84 -~L-~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  161 (351)
                       +. ...-...-.+.+-+.....+.-+++|.++|+.--+|+|    ||+.....   .++.||+...........+...+
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~~~  392 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTAIG  392 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCcccccccCCC
Confidence             21 11111111244456667777788999999998789999    88876543   79999998876554445667789


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC--CCCccCCCHhHH-HHHH
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCR-NLLS  238 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~li~  238 (351)
                      |+.++|||+.....+... .|.|++|.-..+|.-|.+|-....  ....    .+....-.  +.....++.... ++..
T Consensus       393 ~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~--~~~~----~~g~~p~s~~L~~~~aw~~~~~~~~~~  465 (829)
T KOG0576|consen  393 TPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPP--AVLP----MIGNGPNSPMLTDKSAWSPVFHRDFPA  465 (829)
T ss_pred             CCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCc--cccC----CCCCCCCccccchhhhcCcccccCCcc
Confidence            999999999988888766 799999987777777766643310  0000    00000000  000001122222 4778


Q ss_pred             HhcccCCCCCCChHHHhcCcccccC
Q 018734          239 RIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .|+..-|..|+....++.|.+|...
T Consensus       466 ~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  466 PCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             cccCCCCCCCcchhhHHHHHHhccC
Confidence            8999999999999999999998765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=1.8e-08  Score=86.35  Aligned_cols=107  Identities=19%  Similarity=0.203  Sum_probs=82.9

Q ss_pred             CHHHHHHHHHHhcCCCCC--cceEEEEEEcC----CEEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 018734           42 DANVAREIINHKQLRHPN--IIRFKEVVLTP----THLAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISGVSYC  114 (351)
Q Consensus        42 ~~~~~~e~~~~~~l~hp~--Iv~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~l  114 (351)
                      .....+|+..+..|..-+  +...+.+....    ...++|+|++++. +|.+++.....++......++.+++..+.-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            346778888877774322  33444444332    3568999999884 7888888755677888899999999999999


Q ss_pred             HHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCc
Q 018734          115 HSMQICHRDLKLENTLLDGSP-APRLKICDFGYSK  148 (351)
Q Consensus       115 H~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~  148 (351)
                      |.+||+|+|++|.|||++.+. ...+.|+||+-++
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            999999999999999997664 3458999999665

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.85  E-value=8e-08  Score=81.20  Aligned_cols=136  Identities=11%  Similarity=0.089  Sum_probs=98.7

Q ss_pred             cccCceEEEEEEEcCCCcEEEEEEeccC-------cccCHHHHHHHHHHhcCCCCC--cceEEEEE--EcC--CEEEEEE
Q 018734           11 GSGNFGVARLMRNKNTKELVAMKYIERG-------HKIDANVAREIINHKQLRHPN--IIRFKEVV--LTP--THLAIVM   77 (351)
Q Consensus        11 G~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~e~~~~~~l~hp~--Iv~~~~~~--~~~--~~~~lv~   77 (351)
                      |+||.+-|+.......  .+=+|...+.       ......+.+|+..+.+|..-+  +.+.....  ..+  ...+||+
T Consensus        27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            5688888988776533  5667765421       124578999999998885322  34444221  122  3478999


Q ss_pred             eccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           78 EYAAG-GELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        78 e~~~~-~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      |-+.| .+|.+++.+.  .+.+......++.+++.++.-||+.|+.|+|+.+.||+++..+...++++||--++
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97754 5787787653  35678888899999999999999999999999999999975554459999998655

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=1.2e-07  Score=80.48  Aligned_cols=133  Identities=16%  Similarity=0.178  Sum_probs=82.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----------HHHHHHHHHHhcC---CCCCcceEEEEEE-
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----------ANVAREIINHKQL---RHPNIIRFKEVVL-   68 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------~~~~~e~~~~~~l---~hp~Iv~~~~~~~-   68 (351)
                      +|++.+.+.......|.+..-  .++.+++|.........          ....+.+....++   .....+.++.+.. 
T Consensus        32 ~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek  109 (229)
T PF06176_consen   32 NYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK  109 (229)
T ss_pred             CceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence            566667776666665555544  35678888765422211          1122333333333   2233333222222 


Q ss_pred             ----cCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           69 ----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        69 ----~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                          -....+++|||++|..|.+...    +++    .+...++.++.-||+.|++|+|.+|.|+++..++   ++++||
T Consensus       110 k~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~  178 (229)
T PF06176_consen  110 KIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDT  178 (229)
T ss_pred             eeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEEC
Confidence                2245678999999988765432    222    2445677889999999999999999999998554   999999


Q ss_pred             CCCc
Q 018734          145 GYSK  148 (351)
Q Consensus       145 g~a~  148 (351)
                      +..+
T Consensus       179 ~~k~  182 (229)
T PF06176_consen  179 QGKR  182 (229)
T ss_pred             cccc
Confidence            8554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.73  E-value=1.2e-07  Score=96.12  Aligned_cols=199  Identities=21%  Similarity=0.295  Sum_probs=144.5

Q ss_pred             HHHHHHHhcCCCCCcceEEEEEEcCCE----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 018734           46 AREIINHKQLRHPNIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH  121 (351)
Q Consensus        46 ~~e~~~~~~l~hp~Iv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH  121 (351)
                      .-|+..+....|+|++.++.+......    +.+..++|.+.++...++..+..+....+.+..+++.||.|+|++...|
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~  309 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH  309 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence            346677788899999999988765533    3355779999999999999999999999999999999999999996666


Q ss_pred             cCCCCC---cEEecCCCCCCEEEe--ccCCCcccCCCCCCCCcccCCCccCcccccCCcCCC-cchhHHHHHHHHHHHHc
Q 018734          122 RDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG-KLADVWSCGVTLYVMLV  195 (351)
Q Consensus       122 ~Dikp~---NIll~~~~~~~vkL~--DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~ell~  195 (351)
                      .-+...   +--+++.  +.+..+  ||+.+.............-+..+.|||......... ...|+|.+|.....+..
T Consensus       310 v~L~~s~~~~~~~~~e--~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~  387 (1351)
T KOG1035|consen  310 VVLSASSSKESTVDGE--GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ  387 (1351)
T ss_pred             eEEecccccccccCcc--ceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence            655555   2223323  335555  888877665555555556777788999886655432 23699999999999998


Q ss_pred             CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          196 GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       196 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      |..+-.......       .++      +.  .......+++.+|+.-++.+|+++.+++.|||..
T Consensus       388 ~~~i~~~~~~~~-------~~l------~~--~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~  438 (1351)
T KOG1035|consen  388 GEDISEKSAVPV-------SLL------DV--LSTSELLDALPKCLDEDSEERLSALELLTHPFLR  438 (1351)
T ss_pred             cCcccccccchh-------hhh------cc--ccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence            755532211110       000      10  0111678899999999999999999999999964

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.70  E-value=2.9e-07  Score=79.96  Aligned_cols=72  Identities=15%  Similarity=0.182  Sum_probs=53.9

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC--cceEEEEEEcCCEEEEEEeccCCCC
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKEVVLTPTHLAIVMEYAAGGE   84 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~--Iv~~~~~~~~~~~~~lv~e~~~~~~   84 (351)
                      .+||+|..+.||+..    +..+++|...... ....+.+|.++++.+..-+  +.+.+.+....+...+||+++.|.+
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            578999999999842    4457788776533 3456789999998886433  4567777777788899999999863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.68  E-value=2.2e-07  Score=79.74  Aligned_cols=133  Identities=17%  Similarity=0.157  Sum_probs=88.9

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------------------cCH------HHHHHHHHHhcCC--CCC
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------------------IDA------NVAREIINHKQLR--HPN   59 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~------~~~~e~~~~~~l~--hp~   59 (351)
                      ...|..|--+.||+|... .+..+|+|++..+..                   ...      =..+|+..|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            346666777789998874 477899998754211                   011      1235777777773  344


Q ss_pred             cceEEEEEEcCCEEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCC
Q 018734           60 IIRFKEVVLTPTHLAIVMEYAAGGEL-FERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAP  137 (351)
Q Consensus        60 Iv~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~  137 (351)
                      +.+.+.+..    -.+||||+..... .-.|... .+...+...+..++++.+.-|-. .++||+||+.-|||+..+   
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~---  203 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDG---  203 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECC---
Confidence            445555542    2489999965421 1122222 22333688888889998888866 999999999999999733   


Q ss_pred             CEEEeccCCCc
Q 018734          138 RLKICDFGYSK  148 (351)
Q Consensus       138 ~vkL~DFg~a~  148 (351)
                      .+.++|||.|.
T Consensus       204 ~p~iID~~QaV  214 (268)
T COG1718         204 EPYIIDVSQAV  214 (268)
T ss_pred             eEEEEECcccc
Confidence            38999999776

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.64  E-value=1.9e-07  Score=89.82  Aligned_cols=136  Identities=19%  Similarity=0.223  Sum_probs=86.9

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcc--------------------------c---------------CHHHH
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--------------------------I---------------DANVA   46 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~---------------~~~~~   46 (351)
                      .+|+.++-|.||.|..++ |+.||||+.+..-.                          .               +-++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            678999999999999987 89999998753210                          0               01233


Q ss_pred             HHHHHHhcC-----CCCCcceEEEEEEcCCEEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 018734           47 REIINHKQL-----RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFER--ICNAGRFSEDEARYFFQQLISGVSYCHSMQI  119 (351)
Q Consensus        47 ~e~~~~~~l-----~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i  119 (351)
                      +|...+.++     +.|++.=..=+..-.+.-.++|||+.|..+.+.  +.. ..++...+...+.++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            444444443     234433222222234556799999999888776  333 3344333332222221  233335899


Q ss_pred             eecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734          120 CHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus       120 iH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      +|+|.+|.||+++.++  ++.+.|||+...
T Consensus       287 fHaDpHpGNi~v~~~g--~i~~lDfGi~g~  314 (517)
T COG0661         287 FHADPHPGNILVRSDG--RIVLLDFGIVGR  314 (517)
T ss_pred             cccCCCccceEEecCC--cEEEEcCcceec
Confidence            9999999999997765  599999998764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.53  E-value=7.5e-07  Score=77.41  Aligned_cols=78  Identities=15%  Similarity=0.180  Sum_probs=55.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC--cceEEEEEE---cCCEEEEEEeccC
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKEVVL---TPTHLAIVMEYAA   81 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~--Iv~~~~~~~---~~~~~~lv~e~~~   81 (351)
                      ++.|+.|..+.||.+....  ..+++|+.... .....+.+|..+++.+....  +.+++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            5789999999999999876  37899986655 33456778888887774332  445665432   2346799999999


Q ss_pred             CCChHH
Q 018734           82 GGELFE   87 (351)
Q Consensus        82 ~~~L~~   87 (351)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.48  E-value=1.5e-06  Score=83.54  Aligned_cols=135  Identities=19%  Similarity=0.243  Sum_probs=86.7

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCccc--------------------------------------CHHHHHHH
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--------------------------------------DANVAREI   49 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------~~~~~~e~   49 (351)
                      ++||.-+.|.||+|+.+. |+.||||+.+..-..                                      +-++.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            679999999999999998 999999986542110                                      01122333


Q ss_pred             HHHh----cCCCCC------cceEEEEEEcCCEEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHH-HHH
Q 018734           50 INHK----QLRHPN------IIRFKEVVLTPTHLAIVMEYAAGGELFER--ICNAGRFSEDEARYFFQQLISGVSY-CHS  116 (351)
Q Consensus        50 ~~~~----~l~hp~------Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~l~~~~~~~~~~qi~~aL~~-lH~  116 (351)
                      +...    .+.|-+      |.+++-.+  .....++||||+|..+.+.  +.+.+ ++...   ++..+.++... |=.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qIf~  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYLEQIFK  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHHHHHHh
Confidence            3322    233444      33443333  3456799999999877544  44433 34443   33333333222 336


Q ss_pred             cCCeecCCCCCcEEecCC--CCCCEEEeccCCCcc
Q 018734          117 MQICHRDLKLENTLLDGS--PAPRLKICDFGYSKS  149 (351)
Q Consensus       117 ~~iiH~Dikp~NIll~~~--~~~~vkL~DFg~a~~  149 (351)
                      .|++|+|=+|.||++..+  +..++.+.|||+...
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            789999999999999853  456799999998763

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.46  E-value=5e-06  Score=70.29  Aligned_cols=129  Identities=22%  Similarity=0.203  Sum_probs=91.6

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCc-----------------ccCHHHHHHHHHHhcCC------CCCcceE
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----------------KIDANVAREIINHKQLR------HPNIIRF   63 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~e~~~~~~l~------hp~Iv~~   63 (351)
                      ...||+|+.-.||.--+..   ..+||++....                 .......+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~HP~dp---~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPDDP---NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEECCCCC---CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3579999999888655443   46889887654                 12345566666655554      7899999


Q ss_pred             EEEEEcCCEEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 018734           64 KEVVLTPTHLAIVMEYAAG------GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP  137 (351)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~  137 (351)
                      +++..++....+|+|.+..      .+|.+++.+. .+++ .+...+.   .-..||-+++|+.+|++|.||++.....+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999998764      3567777443 4555 4444443   44667889999999999999999655543


Q ss_pred             --CEEEec
Q 018734          138 --RLKICD  143 (351)
Q Consensus       138 --~vkL~D  143 (351)
                        ++.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              366666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.44  E-value=3e-06  Score=74.58  Aligned_cols=75  Identities=11%  Similarity=0.043  Sum_probs=52.4

Q ss_pred             eecccCc-eEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEEeccCCCChH
Q 018734            9 DIGSGNF-GVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELF   86 (351)
Q Consensus         9 ~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~   86 (351)
                      .|..|.+ ..||++...  +..+.+|......  ...+.+|+.+++.+. +--+.+++.+....+..++||++++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4555666 688999764  3568888765543  335677888887774 334557777777667788999999997765


Q ss_pred             H
Q 018734           87 E   87 (351)
Q Consensus        87 ~   87 (351)
                      .
T Consensus        81 ~   81 (244)
T cd05150          81 A   81 (244)
T ss_pred             H
Confidence            3

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.42  E-value=3.9e-06  Score=86.52  Aligned_cols=143  Identities=17%  Similarity=0.278  Sum_probs=90.7

Q ss_pred             eeeecccCceEEEEEEEcCCC--cEEEEEEeccCcc--cCHHHHHHHHHHhcCC-CCCc--ceEEEEEEcC---CEEEEE
Q 018734            7 MKDIGSGNFGVARLMRNKNTK--ELVAMKYIERGHK--IDANVAREIINHKQLR-HPNI--IRFKEVVLTP---THLAIV   76 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~-hp~I--v~~~~~~~~~---~~~~lv   76 (351)
                      ++.|+.|.+..+|++.....+  ..+++|+......  ....+.+|+.+++.+. |+++  .+++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            577899999999998775432  3677777654322  2246789999999985 6665  6777776654   467899


Q ss_pred             EeccCCCChHH--------------------HH---HhcC----------C---CCHHHHHHHHHH--------------
Q 018734           77 MEYAAGGELFE--------------------RI---CNAG----------R---FSEDEARYFFQQ--------------  106 (351)
Q Consensus        77 ~e~~~~~~L~~--------------------~l---~~~~----------~---l~~~~~~~~~~q--------------  106 (351)
                      |||++|..+.+                    .+   +...          .   +...++..|..+              
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99999864321                    11   1100          0   112234333222              


Q ss_pred             -HHHHHHHHHH-----------cCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734          107 -LISGVSYCHS-----------MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus       107 -i~~aL~~lH~-----------~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                       +...+.+|..           ..+||+|+++.|||++......+-|.||.++..
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence             2233556632           249999999999999754333357999998763

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.40  E-value=2.2e-06  Score=69.86  Aligned_cols=126  Identities=21%  Similarity=0.191  Sum_probs=90.1

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcce-EEEEEEcCCEEEEEEeccCCCC
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR-FKEVVLTPTHLAIVMEYAAGGE   84 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~-~~~~~~~~~~~~lv~e~~~~~~   84 (351)
                      +.+.||+|++|.||++...  +..+|+|+-+. .....++..|.+++..+.--++-. ++.+.    ..++.|||+.|-+
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~-ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRR-DSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc--CceEEEEEecC-CcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence            4578999999999999886  45899996544 445568889999999888766654 33332    2346699999988


Q ss_pred             hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCC--CcEEecCCCCCCEEEeccCCCc
Q 018734           85 LFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKL--ENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        85 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp--~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      |.+.....   .    +.-+..++.+---|-..||-|+.|.-  .||+++..   .+.|+||..|+
T Consensus        99 L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~---~~~iIDFd~At  154 (201)
T COG2112          99 LGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR---DVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC---cEEEEEccchh
Confidence            86655432   1    23344555555557788999999975  47777543   39999999876

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.22  E-value=3.2e-05  Score=65.05  Aligned_cols=124  Identities=19%  Similarity=0.249  Sum_probs=87.7

Q ss_pred             CCeeEeeeecccCc-eEEEEEEEcCCCcEEEEEEecc---Cc-------------------ccCHHHHHHHHHHhcC---
Q 018734            2 EKYELMKDIGSGNF-GVARLMRNKNTKELVAMKYIER---GH-------------------KIDANVAREIINHKQL---   55 (351)
Q Consensus         2 ~~y~~~~~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~---~~-------------------~~~~~~~~e~~~~~~l---   55 (351)
                      ..++.++.||.|+- |.||+++-.  |+.||+|++..   ..                   ....-+..|.+...+|   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            36788999999999 999999986  56999999322   00                   0112355677776666   


Q ss_pred             CCCCc--ceEEEEEEcC------------------CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 018734           56 RHPNI--IRFKEVVLTP------------------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH  115 (351)
Q Consensus        56 ~hp~I--v~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH  115 (351)
                      .+.++  |+++++..-.                  ....||.||.....         .+    ...-+.+|.+-|..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence            45566  8888887322                  13467888776543         12    2233557777888999


Q ss_pred             HcCCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734          116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus       116 ~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      ..||+-+|+++.|..   +    -+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~---~----G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---G----GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---C----CEEEecccC
Confidence            999999999999988   3    389999964

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.20  E-value=3e-05  Score=67.73  Aligned_cols=75  Identities=17%  Similarity=0.259  Sum_probs=49.4

Q ss_pred             eeeecccCceEEEEEEEcC-CCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCc-ceEEEEEEcCCEEEEEEeccCCCC
Q 018734            7 MKDIGSGNFGVARLMRNKN-TKELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGE   84 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~I-v~~~~~~~~~~~~~lv~e~~~~~~   84 (351)
                      ++.|..|-...+|++.... .++.|++|+............+|+.+++.+...++ .+++..+.  +  .++|||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            4678888888999997654 35678899765443322344578888888854333 44444332  2  37999999866


Q ss_pred             h
Q 018734           85 L   85 (351)
Q Consensus        85 L   85 (351)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.19  E-value=8.8e-06  Score=71.19  Aligned_cols=73  Identities=10%  Similarity=-0.000  Sum_probs=46.1

Q ss_pred             eeeecccCce-EEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCC---CcceEEEEEEcC---CEEEEEEec
Q 018734            7 MKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---NIIRFKEVVLTP---THLAIVMEY   79 (351)
Q Consensus         7 ~~~lG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp---~Iv~~~~~~~~~---~~~~lv~e~   79 (351)
                      ++.|+.|+.. .||.+.     ..+++|+... ......+.+|..+++.+...   -+.+++......   ...|++|++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            4678877777 588772     2467786544 22345788899888777532   233444443322   245889999


Q ss_pred             cCCCCh
Q 018734           80 AAGGEL   85 (351)
Q Consensus        80 ~~~~~L   85 (351)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            999665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.12  E-value=3.6e-07  Score=94.90  Aligned_cols=203  Identities=13%  Similarity=0.041  Sum_probs=136.1

Q ss_pred             HHHHHHhcCCCCCcceEEEEEEc--CCEEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---
Q 018734           47 REIINHKQLRHPNIIRFKEVVLT--PTHLAIVMEYAAGGELFERICNA----GRFSEDEARYFFQQLISGVSYCHSM---  117 (351)
Q Consensus        47 ~e~~~~~~l~hp~Iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---  117 (351)
                      .|....+...|++++....=...  ....|..++++.+|.+++.+.++    +.+.+.-+.....+.+.+..-+|+.   
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            34444555689988776554432  34578999999999999998764    2333444444444447777777753   


Q ss_pred             --CCeecCCCCCcEEecCCCCCCEEEeccCCCcccC-CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHH
Q 018734          118 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML  194 (351)
Q Consensus       118 --~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  194 (351)
                        -.+|+++|+.|.+|..+.  ++|++++|+.+... ........++++.|++|++.+...++.+ +|+|..|+.+|.+.
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny--~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNY--NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRS 1434 (2724)
T ss_pred             CccchhhhhhhhccceecCC--cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHh
Confidence              268999999999997665  49999999998322 2222234568999999999988888665 99999999999999


Q ss_pred             cCCCCCCCCCChhHHHHHHHHHHhhccC---C-CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          195 VGAYPFEDQEDPKNFRKTISRIMAVQYK---I-PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       195 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      .|..+|..         .....++...+   . ....-.|.++......+|-+.-..||.-...+..+.|.
T Consensus      1435 ~~n~~fi~---------flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1435 DGNAYFIF---------FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             cccHHHHH---------HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            88777632         22222221111   1 11112345555666666666667899888888877764

>PRK10593 hypothetical protein; Provisional

Probab=98.09  E-value=8.4e-05  Score=67.36  Aligned_cols=76  Identities=11%  Similarity=0.070  Sum_probs=54.2

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC---CCcceEEEEEEc---CCEEEEEEecc
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---PNIIRFKEVVLT---PTHLAIVMEYA   80 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h---p~Iv~~~~~~~~---~~~~~lv~e~~   80 (351)
                      .+.||.|..+.||...... + .+.+|.. +.......+..|...++.|.-   -.+.++++++..   .+..++|||++
T Consensus        19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~-~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         19 VECISEQPYAALWALYDSQ-G-NPMPLMA-RSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeecCCccceeEEEEEcCC-C-CEEEEEe-cccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            4689999999999997654 3 4666763 332233578889988888743   356677776644   36689999999


Q ss_pred             CCCCh
Q 018734           81 AGGEL   85 (351)
Q Consensus        81 ~~~~L   85 (351)
                      +|.++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.05  E-value=2.8e-05  Score=68.89  Aligned_cols=131  Identities=14%  Similarity=0.095  Sum_probs=76.4

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEeccCcccC-HHHHHHHHHHhcCCCCCc-ceEEEEEEcCCEEEEEEeccCCCChH
Q 018734            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGELF   86 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~~~~l~hp~I-v~~~~~~~~~~~~~lv~e~~~~~~L~   86 (351)
                      .+..|-.+.+|++..  +++.+++|......... ....+|..+++.+...++ .+++...  .  -++||+|++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence            456688889998873  45678888765433221 245678888888854333 2344333  2  25899999986643


Q ss_pred             H--------------HH---HhcC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCCeecCCCCC
Q 018734           87 E--------------RI---CNAG----RFSE-DEARYFFQQL---------ISGVSYCHS--------MQICHRDLKLE  127 (351)
Q Consensus        87 ~--------------~l---~~~~----~l~~-~~~~~~~~qi---------~~aL~~lH~--------~~iiH~Dikp~  127 (351)
                      .              .+   .+.+    +++. ..+..+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            1              11   1111    1111 2222322222         111222222        24899999999


Q ss_pred             cEEecCCCCCCEEEeccCCCc
Q 018734          128 NTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       128 NIll~~~~~~~vkL~DFg~a~  148 (351)
                      ||++++++   +.|+||..|.
T Consensus       157 Nil~~~~~---~~lIDwE~a~  174 (256)
T TIGR02721       157 NLVVTPQG---LKLIDWEYAS  174 (256)
T ss_pred             cEEEeCCC---CEEEeccccC
Confidence            99997654   7899999775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.91  E-value=0.00051  Score=64.44  Aligned_cols=76  Identities=14%  Similarity=0.060  Sum_probs=52.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecc------C--cccCHHHHHHHHHHhcCC---CCCcceEEEEEEcCCEEEE
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIER------G--HKIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~------~--~~~~~~~~~e~~~~~~l~---hp~Iv~~~~~~~~~~~~~l   75 (351)
                      .+.||.|.+..||++.+...++.|+||.-..      .  .....+...|...|+.+.   ..++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4679999999999999976546899997431      1  112345666777777652   2456677766  4456789


Q ss_pred             EEeccCCCC
Q 018734           76 VMEYAAGGE   84 (351)
Q Consensus        76 v~e~~~~~~   84 (351)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.90  E-value=7.5e-05  Score=67.63  Aligned_cols=136  Identities=17%  Similarity=0.142  Sum_probs=79.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC--cceEEEE------EEcCCEEEEEEe
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKEV------VLTPTHLAIVME   78 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~--Iv~~~~~------~~~~~~~~lv~e   78 (351)
                      .+.|..|....+|++...  +..+++|+...  .....+..|+.++..+.+.+  +.+++..      ....+..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            567777877889988654  34688898764  22345667777777764322  3444331      233456789999


Q ss_pred             ccCCCChHH-----------HH---Hhc-CCCC--------HHHHH------------HHHHHHHHHHHHHHH-------
Q 018734           79 YAAGGELFE-----------RI---CNA-GRFS--------EDEAR------------YFFQQLISGVSYCHS-------  116 (351)
Q Consensus        79 ~~~~~~L~~-----------~l---~~~-~~l~--------~~~~~------------~~~~qi~~aL~~lH~-------  116 (351)
                      +++|..+..           .+   ... ..+.        .....            .....+..++.++.+       
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999866421           11   100 0000        00000            011112334444443       


Q ss_pred             cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 ~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      .+++|+|+.|.||+++++.  .+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~--~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDE--LSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCc--eEEEeehhhhc
Confidence            4799999999999998654  25799999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.86  E-value=0.00015  Score=65.89  Aligned_cols=75  Identities=12%  Similarity=0.179  Sum_probs=50.2

Q ss_pred             eeeecccCceEEEEEEEcC------CCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCc-ceEEEEEEcCCEEEEEEec
Q 018734            7 MKDIGSGNFGVARLMRNKN------TKELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~I-v~~~~~~~~~~~~~lv~e~   79 (351)
                      ++.|..|-...+|++....      .++.+++|+............+|..+++.+...++ .+++.++. +   .+|++|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            4567767777999998654      25789999876654443456788888887754333 34555553 2   258999


Q ss_pred             cCCCCh
Q 018734           80 AAGGEL   85 (351)
Q Consensus        80 ~~~~~L   85 (351)
                      ++|.++
T Consensus        79 i~G~~l   84 (302)
T cd05156          79 IPSRTL   84 (302)
T ss_pred             eCCCcC
Confidence            988665

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.69  E-value=3.1e-05  Score=69.16  Aligned_cols=132  Identities=14%  Similarity=0.171  Sum_probs=89.4

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-----------------c------cCHHHHHHHHHHhcCC-CCC
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----------------K------IDANVAREIINHKQLR-HPN   59 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~------~~~~~~~e~~~~~~l~-hp~   59 (351)
                      |.+++.||-|.-+.||.+-+.. |...++|.-+...                 .      ..-...+|+..|+.|. |-.
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            4578899999999999999876 6788888532110                 0      0123456787777774 222


Q ss_pred             -cceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 018734           60 -IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPR  138 (351)
Q Consensus        60 -Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~  138 (351)
                       +.+.+++    +.-++||+++.|-.|...-.-      ..+..+...+..-+.-|-.+|+||+|..--||+|+.++  +
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~--~  240 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD--K  240 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCC--C
Confidence             3333333    456799999998777543211      12333444555556778899999999999999998654  4


Q ss_pred             EEEeccCCCc
Q 018734          139 LKICDFGYSK  148 (351)
Q Consensus       139 vkL~DFg~a~  148 (351)
                      ++++||--..
T Consensus       241 i~vIDFPQmv  250 (465)
T KOG2268|consen  241 IVVIDFPQMV  250 (465)
T ss_pred             EEEeechHhh
Confidence            9999998543

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.67  E-value=0.00049  Score=62.74  Aligned_cols=137  Identities=16%  Similarity=0.174  Sum_probs=77.3

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC--cceEEEE------EEcCCEEEEEEe
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKEV------VLTPTHLAIVME   78 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~--Iv~~~~~------~~~~~~~~lv~e   78 (351)
                      ++.++.|....+|++... ++ .+++|+..... ....+..++.++..|...+  +.+++..      ....+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeC-CC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            566777777789988754 33 57788765422 2234556667666663222  3333331      122456789999


Q ss_pred             ccCCCChH-----------HHH---Hh-cCCC--------CHHH-----HH----------HHHHHHHHHHHHHHH----
Q 018734           79 YAAGGELF-----------ERI---CN-AGRF--------SEDE-----AR----------YFFQQLISGVSYCHS----  116 (351)
Q Consensus        79 ~~~~~~L~-----------~~l---~~-~~~l--------~~~~-----~~----------~~~~qi~~aL~~lH~----  116 (351)
                      |++|.++.           ..+   .. ...+        ....     ..          .....+...+.++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            99985431           111   11 0001        0000     00          001123334555542    


Q ss_pred             ---cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 ---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 ---~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                         .+++|+|+++.||+++.++  .+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDS--VKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence               6899999999999997664  35899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.65  E-value=0.00019  Score=60.39  Aligned_cols=96  Identities=16%  Similarity=0.096  Sum_probs=75.7

Q ss_pred             HHHHHHhcCCC-CCcceEEEEEEcCCEEEEEEeccCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCC
Q 018734           47 REIINHKQLRH-PNIIRFKEVVLTPTHLAIVMEYAAGGELFE---RICNAGRFSEDEARYFFQQLISGVSYCHS---MQI  119 (351)
Q Consensus        47 ~e~~~~~~l~h-p~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i  119 (351)
                      .|..+++.+.+ +++.++++++-    -++|.||...+++..   .+.+.-..++.....++.+++..+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57888888876 69999999982    247899998766542   12222345899999999999999999997   457


Q ss_pred             eecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          120 CHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       120 iH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      .-+|++|+|+-++.++  ++|++|...+.
T Consensus        84 ~lcDv~~~nfgv~~~~--~lk~iDld~v~  110 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDG--RLKLIDLDDVF  110 (188)
T ss_pred             EEeecchHHeEEeCCC--cEEEEechhcc
Confidence            8899999999998665  49999999654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=97.63  E-value=0.0015  Score=59.83  Aligned_cols=73  Identities=12%  Similarity=0.089  Sum_probs=42.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-----CCCCcceEE---EEEEcCCEEEEEEec
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-----RHPNIIRFK---EVVLTPTHLAIVMEY   79 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-----~hp~Iv~~~---~~~~~~~~~~lv~e~   79 (351)
                      +.|+.|....+|.+.... | .+++|++..  .....+..++..++.|     ..|.++.-.   .+....+..+++++|
T Consensus        28 ~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQ-G-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCC-C-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            556677777899887653 3 688898752  1223344455555444     233333210   012235678899999


Q ss_pred             cCCCC
Q 018734           80 AAGGE   84 (351)
Q Consensus        80 ~~~~~   84 (351)
                      ++|..
T Consensus       104 l~G~~  108 (319)
T PRK05231        104 LEGKW  108 (319)
T ss_pred             cCCCC
Confidence            99864

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.56  E-value=0.00056  Score=62.37  Aligned_cols=136  Identities=21%  Similarity=0.210  Sum_probs=90.8

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCc---------------------ccC-H-----HHHHHHHHHhcCCCCC
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---------------------KID-A-----NVAREIINHKQLRHPN   59 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~-~-----~~~~e~~~~~~l~hp~   59 (351)
                      -..|..|--+.||.|.... |..+|||++..+-                     ..+ .     =...|++.|++|+.-.
T Consensus       149 nGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            3456677778899988765 6779999864310                     001 1     1336888888876444


Q ss_pred             cceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEecCCCCCC
Q 018734           60 IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HSMQICHRDLKLENTLLDGSPAPR  138 (351)
Q Consensus        60 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~l-H~~~iiH~Dikp~NIll~~~~~~~  138 (351)
                      |.-.--+..  ..-.+||+|+.+.....-.-+.-.++...+..+-.|++.-+.-| |..++||.||.--|+|+..+   .
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG---~  302 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG---K  302 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC---E
Confidence            322111111  12248999996544433333445678888888888888888777 57899999999999999644   4


Q ss_pred             EEEeccCCCc
Q 018734          139 LKICDFGYSK  148 (351)
Q Consensus       139 vkL~DFg~a~  148 (351)
                      +.++|.+-+.
T Consensus       303 lyiIDVSQSV  312 (520)
T KOG2270|consen  303 LYIIDVSQSV  312 (520)
T ss_pred             EEEEEccccc
Confidence            9999998654

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.51  E-value=0.00026  Score=66.97  Aligned_cols=166  Identities=16%  Similarity=0.197  Sum_probs=102.6

Q ss_pred             HHHHHHHHHHhcCCCCCcceEEEEEEcC-CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 018734           43 ANVAREIINHKQLRHPNIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH  121 (351)
Q Consensus        43 ~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH  121 (351)
                      ..++-..++++.+.|+|..+++++.... .+..+|||++ +.+|.+.+..+. +-.....              .+++.|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~   90 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH   90 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence            4566778899999999999999988654 4578899999 668888876543 2111111              122211


Q ss_pred             cCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCC
Q 018734          122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE  201 (351)
Q Consensus       122 ~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  201 (351)
                           -|         +++.+| -++...      ....|                 +++||||+|.++.++..|...+.
T Consensus        91 -----~~---------~~~~td-~~~t~~------~~~~~-----------------pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   91 -----LN---------IIYITD-HFLTKY------PSPIG-----------------PKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             -----eh---------hhhccc-cccccC------CCCCC-----------------cchhhhhHHHHHHHHHHhhHHHH
Confidence                 11         134444 111100      11111                 25999999999999999987776


Q ss_pred             CCCChhHHHHHHHHHHhhccCC-------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          202 DQEDPKNFRKTISRIMAVQYKI-------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .....+....+.+ ....+...       -....++..+.+++.+|+-..|..||...++.+++-|.+.
T Consensus       133 ~~~~s~~l~~i~k-~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  133 ELTESEYLEILLK-YYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHH-hccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            5443333322211 11000000       0011245677899999999999999999999999988654

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.36  E-value=0.0021  Score=59.23  Aligned_cols=75  Identities=13%  Similarity=0.133  Sum_probs=47.3

Q ss_pred             eeeecccCceEEEEEEEcCC---CcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcc-eEEEEEEcCCEEEEEEeccCC
Q 018734            7 MKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHKIDANVAREIINHKQLRHPNII-RFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv-~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      ++.|..|=.-.+|++.....   +..|++|+........-...+|..+++.+..-++- ++++++. .+   +|.+|++|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            34555577778998875432   33788998765443333455788888888654443 5565553 22   58999987


Q ss_pred             CCh
Q 018734           83 GEL   85 (351)
Q Consensus        83 ~~L   85 (351)
                      .+|
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            654

>PLN02236 choline kinase

Probab=97.30  E-value=0.003  Score=58.52  Aligned_cols=137  Identities=15%  Similarity=0.187  Sum_probs=80.2

Q ss_pred             eeeecccCceEEEEEEEcC----CCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcc-eEEEEEEcCCEEEEEEeccC
Q 018734            7 MKDIGSGNFGVARLMRNKN----TKELVAMKYIERGHKIDANVAREIINHKQLRHPNII-RFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv-~~~~~~~~~~~~~lv~e~~~   81 (351)
                      +..|..|-.-.+|++....    .++.|++|+........-...+|..+++.+..-++. ++++.+.. +   .|.+|+.
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~  116 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH  116 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence            4456557777999987432    246789998765443333446788888888544433 45566533 2   5789998


Q ss_pred             CCChHHH----------H-------HhcC------CCCHHHHHHHHHHHH-----------------HHHHHH----H--
Q 018734           82 GGELFER----------I-------CNAG------RFSEDEARYFFQQLI-----------------SGVSYC----H--  115 (351)
Q Consensus        82 ~~~L~~~----------l-------~~~~------~l~~~~~~~~~~qi~-----------------~aL~~l----H--  115 (351)
                      |.+|...          +       .+..      ......+..++.++.                 ..+..|    .  
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7665311          1       1111      011233434432221                 111112    1  


Q ss_pred             --HcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          116 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       116 --~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                        ...++|+|+++.|||++... +.+.|+||..+.
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~  230 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS  230 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence              22589999999999997532 359999999765

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.24  E-value=0.006  Score=56.24  Aligned_cols=73  Identities=14%  Similarity=0.072  Sum_probs=46.7

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEec----c---C-cccCHHHHHHHHHHhcCC--CC-CcceEEEEEEcCCEEEEEE
Q 018734            9 DIGSGNFGVARLMRNKNTKELVAMKYIE----R---G-HKIDANVAREIINHKQLR--HP-NIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~----~---~-~~~~~~~~~e~~~~~~l~--hp-~Iv~~~~~~~~~~~~~lv~   77 (351)
                      .||.|....||++.+..+++.|+||.-.    .   + .....+..-|...|+...  .| .+.+++.+  ++....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            4799999999999986544689999532    1   1 112245556777776653  35 34444443  455566999


Q ss_pred             eccCCC
Q 018734           78 EYAAGG   83 (351)
Q Consensus        78 e~~~~~   83 (351)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.08  E-value=0.0051  Score=55.85  Aligned_cols=30  Identities=17%  Similarity=0.306  Sum_probs=26.0

Q ss_pred             CCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734          118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus       118 ~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      .++|+|+.+.||+++....  +-+.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~~--~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRP--TGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCe--eEEEecccccc
Confidence            4899999999999987665  89999998864

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.98  E-value=0.017  Score=54.34  Aligned_cols=72  Identities=15%  Similarity=0.164  Sum_probs=47.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecc-----Cc---ccCHHHHHHHHHHhcCC---CCCcceEEEEEEcCCEEEE
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GH---KIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~e~~~~~~l~---hp~Iv~~~~~~~~~~~~~l   75 (351)
                      .+.||.|....||++.+.  +..++||.-..     +.   ....+...|...|+.+.   ..++.+++.+..  ...++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            567899999999999874  34688886541     11   12234445566665553   246777777765  44568


Q ss_pred             EEeccCC
Q 018734           76 VMEYAAG   82 (351)
Q Consensus        76 v~e~~~~   82 (351)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            8999977

>PTZ00384 choline kinase; Provisional

Probab=96.94  E-value=0.013  Score=54.94  Aligned_cols=75  Identities=12%  Similarity=0.056  Sum_probs=46.0

Q ss_pred             eeeecccCceEEEEEEEcCCC------cEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcc-eEEEEEEcCCEEEEEEec
Q 018734            7 MKDIGSGNFGVARLMRNKNTK------ELVAMKYIERGHKIDANVAREIINHKQLRHPNII-RFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv-~~~~~~~~~~~~~lv~e~   79 (351)
                      ++.|..|-...+|++......      +.|.++........--...+|+.+++.+...++- ++++.+..    +++.||
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            455656888899998754321      2244444323222223445788999988655544 56666542    489999


Q ss_pred             cCCCCh
Q 018734           80 AAGGEL   85 (351)
Q Consensus        80 ~~~~~L   85 (351)
                      ++|-+|
T Consensus       131 IeGr~l  136 (383)
T PTZ00384        131 VEGNTM  136 (383)
T ss_pred             eccccC
Confidence            998765

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.87  E-value=0.0094  Score=53.41  Aligned_cols=30  Identities=23%  Similarity=0.336  Sum_probs=23.7

Q ss_pred             CCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       118 ~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      .++|+|++|.|||++.++. ..-|.||+.+.
T Consensus       186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~  215 (276)
T cd05152         186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK  215 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence            4899999999999985321 24699999775

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.87  E-value=0.012  Score=54.95  Aligned_cols=74  Identities=16%  Similarity=0.099  Sum_probs=48.6

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEec----c--C-cccCHHHHHHHHHHhcCC--CCC-cceEEEEEEcCCEEEEE
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIE----R--G-HKIDANVAREIINHKQLR--HPN-IIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~----~--~-~~~~~~~~~e~~~~~~l~--hp~-Iv~~~~~~~~~~~~~lv   76 (351)
                      .+.||.|.-..||++.+...++.|+||.-.    .  + .....+..-|...|+.+.  .|. +.+++.+  ++....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            568999999999999985445679998532    1  1 112345666777777663  354 4455544  44556689


Q ss_pred             EeccCC
Q 018734           77 MEYAAG   82 (351)
Q Consensus        77 ~e~~~~   82 (351)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999865

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.84  E-value=0.033  Score=50.67  Aligned_cols=29  Identities=31%  Similarity=0.651  Sum_probs=24.2

Q ss_pred             cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 ~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      .+++|+|+.+.||+++.+   .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~---~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKDN---EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeCC---cEEEEECcccc
Confidence            478999999999999762   38999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.59  E-value=0.034  Score=50.72  Aligned_cols=29  Identities=21%  Similarity=0.277  Sum_probs=25.2

Q ss_pred             CCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       118 ~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      +++|+|+.+.|+|+++++.  +.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence            7999999999999976654  8999999765

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.50  E-value=0.0044  Score=53.14  Aligned_cols=55  Identities=16%  Similarity=0.086  Sum_probs=33.3

Q ss_pred             CcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCc-ceEEEEEEcCCEEEEEEeccCCCCh
Q 018734           27 KELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus        27 ~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~I-v~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ++.|++++.......--....|..+++.+..-++ .++++++.. +   .|.+|+.|.+|
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~-g---~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN-G---RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT-E---EEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC-C---cEEEEeccccc
Confidence            4578889877765444567788888888864444 456665533 2   56689877554

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.34  E-value=0.1  Score=47.98  Aligned_cols=69  Identities=10%  Similarity=0.031  Sum_probs=41.3

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC--cceEE---E--EEEcCCEEEEEEeccCCCC
Q 018734           15 FGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFK---E--VVLTPTHLAIVMEYAAGGE   84 (351)
Q Consensus        15 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~--Iv~~~---~--~~~~~~~~~lv~e~~~~~~   84 (351)
                      -..||.+.... +..+++|+.+........+..|+..+..|....  ++...   +  ....++..+.++++++|..
T Consensus        38 eN~vy~v~~~~-~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         38 ENRVYQFGDED-GRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cceEEEEecCC-CCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            34689887643 557899987544334456667777776663211  22211   1  1223467888999998754

>PTZ00296 choline kinase; Provisional

Probab=96.30  E-value=0.054  Score=51.84  Aligned_cols=76  Identities=16%  Similarity=0.062  Sum_probs=47.3

Q ss_pred             EeeeecccCceEEEEEEEcCC--------CcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcc-eEEEEEEcCCEEEEE
Q 018734            6 LMKDIGSGNFGVARLMRNKNT--------KELVAMKYIERGHKIDANVAREIINHKQLRHPNII-RFKEVVLTPTHLAIV   76 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv-~~~~~~~~~~~~~lv   76 (351)
                      -++.|..|-.-.+|++.....        ++.|.+++.......--....|..+++.+..-+|- ++++.+. +   +.+
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I  184 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI  184 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence            345666677778888875422        46788998765443323455677777777544443 4555553 2   257


Q ss_pred             EeccCCCCh
Q 018734           77 MEYAAGGEL   85 (351)
Q Consensus        77 ~e~~~~~~L   85 (351)
                      .+|++|.+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            899987644

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.18  E-value=0.073  Score=47.89  Aligned_cols=74  Identities=11%  Similarity=0.034  Sum_probs=46.6

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC---CCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~---hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      -.+.++.|....+|.+.  .+++.+-+|+-.  ......+..|...|+.|.   .-.+.+.+.+....+.-|++|||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            45678889999999888  456778889765  223345777888887773   34566888888777777999999987


Q ss_pred             C
Q 018734           83 G   83 (351)
Q Consensus        83 ~   83 (351)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06148 hypothetical protein; Provisional

Probab=96.10  E-value=0.13  Score=54.68  Aligned_cols=32  Identities=31%  Similarity=0.481  Sum_probs=25.9

Q ss_pred             cCCeecCCCCCcEEecCCCCCCEE-EeccCCCc
Q 018734          117 MQICHRDLKLENTLLDGSPAPRLK-ICDFGYSK  148 (351)
Q Consensus       117 ~~iiH~Dikp~NIll~~~~~~~vk-L~DFg~a~  148 (351)
                      .++||+|+.+.|||++.+...++. |+|||-+.
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            579999999999999876533455 99999765

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.89  E-value=0.11  Score=47.58  Aligned_cols=130  Identities=18%  Similarity=0.185  Sum_probs=76.7

Q ss_pred             ceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC------cceE----EEEEEcCCEEEEEEeccCCCC
Q 018734           15 FGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN------IIRF----KEVVLTPTHLAIVMEYAAGGE   84 (351)
Q Consensus        15 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~------Iv~~----~~~~~~~~~~~lv~e~~~~~~   84 (351)
                      -..+|++...+.+  +++|+.+.. .....+.-|+..+..|.-..      +...    +.......+.+-+++|++|..
T Consensus        38 eN~~f~~~~~~g~--~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~  114 (331)
T COG2334          38 ENSNFRVQTEDGR--YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP  114 (331)
T ss_pred             cCceEEEEecCCC--eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence            3468888877643  488988776 55667778888887773211      1111    111111237888999999876


Q ss_pred             hHH------------HH---H----hcC-----C---CCHH----HH---------HHHHHHHHHHHHHHHH-------c
Q 018734           85 LFE------------RI---C----NAG-----R---FSED----EA---------RYFFQQLISGVSYCHS-------M  117 (351)
Q Consensus        85 L~~------------~l---~----~~~-----~---l~~~----~~---------~~~~~qi~~aL~~lH~-------~  117 (351)
                      +..            .+   .    ..+     .   ....    ..         .....++...+..+.+       .
T Consensus       115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~  194 (331)
T COG2334         115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA  194 (331)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence            651            11   0    000     0   1111    00         1123344455555553       2


Q ss_pred             -C--CeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          118 -Q--ICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       118 -~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                       +  +||+|+.|.||+++.... .+.+.||+-+.
T Consensus       195 ~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~  227 (331)
T COG2334         195 LGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG  227 (331)
T ss_pred             ccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence             3  999999999999987653 37899999654

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.52  E-value=0.064  Score=50.01  Aligned_cols=61  Identities=16%  Similarity=0.122  Sum_probs=44.8

Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH-SMQICHRDLKLENTLLDG  133 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH-~~~iiH~Dikp~NIll~~  133 (351)
                      ...++-+|..|.++..++...+ .++.....++.-.++||--+- --+.+|.|+.|.||++..
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            3457777888888888776543 356667777776677765544 568999999999999943

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.36  E-value=0.063  Score=49.31  Aligned_cols=71  Identities=25%  Similarity=0.293  Sum_probs=53.1

Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           71 THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        71 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      -..|++|++. |+++. .+.   .....++..++++.+..+.-+..+ ..=||++.-.||||+ .|  +|.|+||-+++.
T Consensus       299 ~y~yl~~kdh-gt~is-~ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G--nvtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPIS-IIK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG--NVTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceee-eee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC--ceEEEEeeeeec
Confidence            4567888886 44442 221   224678888999888888777754 689999999999998 44  499999999984

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=94.78  E-value=0.024  Score=51.52  Aligned_cols=54  Identities=24%  Similarity=0.273  Sum_probs=36.2

Q ss_pred             HHHHHHHHHHHHHHHHHH----HcCCeecCCCCCcEEecCCCC----------------CCEEEeccCCCcccC
Q 018734           98 DEARYFFQQLISGVSYCH----SMQICHRDLKLENTLLDGSPA----------------PRLKICDFGYSKSSL  151 (351)
Q Consensus        98 ~~~~~~~~qi~~aL~~lH----~~~iiH~Dikp~NIll~~~~~----------------~~vkL~DFg~a~~~~  151 (351)
                      +-++.++.||+.-.--+-    ....+|-||||.||||-++..                -+.+|.||.+|+...
T Consensus       275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~  348 (434)
T PF05445_consen  275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN  348 (434)
T ss_pred             HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence            446777788765542231    356899999999999843221                146788999887543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	351
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-143
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-143
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-142
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-142
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-137
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-137
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-57
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-53
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-53
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-52
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-52
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-52
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-52
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-52
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-52
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-51
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-51
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-51
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-51
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-49
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-48
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-48
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-48
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-47
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-43
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-43
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-43
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-43
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-43
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		8e-43
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		9e-43
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		9e-43
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-43
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-42
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-42
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-42
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-42
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-42
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-42
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-42
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-42
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-42
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-42
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-41
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-41
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-41
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-41
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-41
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-41
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-41
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-41
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-41
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-41
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-41
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-41
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-41
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-41
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-41
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-41
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-41
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-41
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-41
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-41
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-41
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-41
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-41
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-41
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-41
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-41
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-41
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-41
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-41
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-40
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-40
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-40
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-40
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-40
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-40
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-40
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-40
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-40
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-40
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-40
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-40
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-40
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-40
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-40
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-40
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-40
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-40
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-40
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-40
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-40
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-40
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-40
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-40
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-40
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-40
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-40
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-40
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-39
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-39
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-39
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-39
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-38
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-38
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-38
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-38
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-38
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-37
3soa_A	444	Full-Length Human Camkii Length = 444		2e-37
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-37
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-37
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-37
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-37
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-37
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-37
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-37
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-37
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-37
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-36
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-36
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-36
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-36
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-36
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-36
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-36
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-35
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-35
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-35
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-35
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-35
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-35
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-35
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-35
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-35
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-35
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-34
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-34
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-34
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-34
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-34
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-34
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-34
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-34
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-34
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-34
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-34
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-34
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-34
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-34
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-34
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		5e-34
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-34
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-34
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-34
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-34
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		9e-34
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-34
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-33
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-33
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-33
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-33
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-33
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-33
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-33
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-33
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-33
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-33
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-33
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-33
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-33
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-33
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-33
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-33
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-33
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-33
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-33
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-33
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-33
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-33
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-33
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-33
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-33
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-33
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-33
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-33
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-33
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-33
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-33
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-33
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-33
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-33
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-33
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-33
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-33
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-33
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-33
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-33
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-33
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-33
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		7e-33
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		7e-33
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-32
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-32
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-32
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-32
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-32
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-32
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-32
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-32
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-32
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-32
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-32
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-32
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-32
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-32
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-32
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-32
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-32
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-32
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-32
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-32
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-32
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-32
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-32
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-32
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-32
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-32
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-32
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-32
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-32
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-31
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-31
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-31
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-31
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-31
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-31
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-30
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-30
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-30
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-30
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-30
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-30
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-30
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-30
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-30
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-29
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-29
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-29
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-29
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-29
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		9e-29
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-29
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-28
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-28
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-28
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-28
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-28
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-28
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-27
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-27
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-27
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-27
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-27
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-27
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-27
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-27
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-27
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-27
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-27
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-27
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-27
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-27
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-27
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-27
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-26
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-26
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-26
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-26
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-26
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-26
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-26
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-26
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-26
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-26
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-26
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-26
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-26
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-26
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-26
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-26
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-26
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-26
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-26
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-26
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-26
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-25
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-25
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-25
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-25
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-25
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-25
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-25
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-25
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-25
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-25
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-25
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-24
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-24
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-24
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-24
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-24
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-24
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-24
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-24
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-24
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-24
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-24
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-24
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-24
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-24
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-24
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-24
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-24
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-24
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-24
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-24
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-24
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-24
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-24
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-24
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-24
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-24
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-24
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-24
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-24
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-24
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-24
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-24
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-24
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-24
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-24
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-24
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-24
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-24
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-24
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-24
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-24
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-24
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-24
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-24
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-24
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-24
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-24
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-24
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-24
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-24
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-24
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-24
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-24
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-24
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-24
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-24
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		7e-24
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-24
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-23
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-23
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-23
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-23
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-23
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-23
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-22
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-22
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-22
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-22
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-22
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-22
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-22
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		4e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-22
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-22
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-22
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-22
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-21
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-21
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-21
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-21
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-21
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-21
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-21
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-21
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-21
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-20
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-20
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-20
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-20
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-20
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-20
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-20
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-20
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-20
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-19
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-19
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-19
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-19
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-19
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-19
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-19
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-19
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-19
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-19
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-19
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-19
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-18
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-18
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-18
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-18
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-18
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-18
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-18
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-18
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-17
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-17
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-17
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-17
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-16
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-16
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-16
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-16
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-16
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-16
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-16
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-16
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-16
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-15
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-15
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		9e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		9e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-14
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-14
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-14
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-14
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-14
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-14
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-14
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-14
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-14
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-14
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-14
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-14
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-14
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-14
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		7e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-14
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		8e-14
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		8e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-13
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-13
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-13
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		8e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-12
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-12
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-12
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-11
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-11
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		7e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-11
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		9e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-11
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-10
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		1e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-10
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-10
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-10
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-10
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-10
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-10
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-10
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-10
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-10
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		2e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-10
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-10
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		4e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		5e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-09
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-09
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-09
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-09
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-09
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-09
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-09
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-09
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-09
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-09
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-09
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-09
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-08
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-08
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-08
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		6e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		9e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		1e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-07
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-07
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-07
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-07
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-07
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-07
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-06
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		2e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-06
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		2e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-06
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-06
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-06
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		8e-06
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		1e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-05
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-05
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		1e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  506 bits (1302), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 235/310 (75%), Positives = 274/310 (88%), Gaps = 5/310 (1%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 77
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 78  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 137
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct: 138 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 197
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 198 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 257
Query: 242 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 299
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 258 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFAASDQPG---QSIEEIMQIIAEA 314
Query: 300 KVPPPVSRSI 309
            VPP  ++++
Sbjct: 315 TVPPAGTQNL 324

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  504 bits (1297), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 235/310 (75%), Positives = 274/310 (88%), Gaps = 5/310 (1%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KI ANV REIINH+ LRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 242 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 299
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315
Query: 300 KVPPPVSRSI 309
            VPP  ++++
Sbjct: 316 TVPPAGTQNL 325

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  501 bits (1290), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 234/310 (75%), Positives = 273/310 (88%), Gaps = 5/310 (1%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RDLKLENTLLDGSPAPRLKIC FGYSKSS+LHS+PKSTVGTPAYIAPEVL ++EYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 242 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 299
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315
Query: 300 KVPPPVSRSI 309
            VPP  ++++
Sbjct: 316 TVPPAGTQNL 325

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  499 bits (1286), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 233/310 (75%), Positives = 272/310 (87%), Gaps = 5/310 (1%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIGSGNFGVARLMR+K + ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISGVSYCH+MQ+CH
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RDLKLENTLLDGSPAPRLKIC FGYSKSS+LHS+PK TVGTPAYIAPEVL ++EYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 242 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 299
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315
Query: 300 KVPPPVSRSI 309
            VPP  ++++
Sbjct: 316 TVPPAGTQNL 325

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  485 bits (1249), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 227/302 (75%), Positives = 263/302 (87%), Gaps = 5/302 (1%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++YEL+KDIG+GNFGVARLMR+K   ELVA+KYIERG KID NV REIINH+ LRHPNI+
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIV 78
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEAR+FFQQLISGVSY H+MQ+ H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAH 138
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RDLKLENTLLDGSPAPRLKI DFGYSK+S+LHS+PKS VGTPAYIAPEVL ++EYDGK+A
Sbjct: 139 RDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVA 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           DVWSCGVTLYVMLVGAYPFED E+PKNFRKTI RI+ VQY IPDYVHIS +CR+L+SRIF
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 242 VANPSRRITIKEIKSHPWFLKNLPRELT--ETAQAIYYRKENPTFSLQSVEEITKIVEEA 299
           VA+P++RI+I EI++H WFLKNLP +L    T    +   + P    QS+EEI +I+ EA
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPG---QSIEEIMQIIAEA 315
Query: 300 KV 301
            V
Sbjct: 316 TV 317

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  483 bits (1243), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 223/301 (74%), Positives = 265/301 (88%), Gaps = 1/301 (0%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++Y+ +KDIGSGNFGVARLMR+K TKELVA+KYIERG  ID NV REIINH+ LRHPNI+
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           RFKEV+LTPTHLAI+MEYA+GGEL+ERICNAGRFSEDEAR+FFQQL+SGVSYCHSMQICH
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICH 139
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R+EYDGK+A
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           DVWSCGVTLYVMLVGAYPFED E+P+++RKTI RI++V+Y IPD + IS +C +L+SRIF
Sbjct: 200 DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF 259
Query: 242 VANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKV 301
           VA+P+ RI+I EIK+H WFLKNLP +L   +      +E P   +QS++ I +I+ EA +
Sbjct: 260 VADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE-PEQPMQSLDTIMQIISEATI 318
Query: 302 P 302
           P
Sbjct: 319 P 319

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  218 bits (555), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 122/279 (43%), Positives = 170/279 (60%), Gaps = 15/279 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GHKIDANVAREIINHKQLRHPN 59
           Y + + +G G+FG  +L  +  T++ VA+K+I R       +   V REI   K LRHP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           II+  +V+ TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I  + YCH  +I
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV++ + Y G 
Sbjct: 130 VHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             DVWSCG+ LYVMLVG  PF+D+  P  F+K  S +    Y +PD+  +S   ++L+ R
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV----YVMPDF--LSPGAQSLIRR 241
Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPREL--TETAQAIY 276
           + VA+P +RITI+EI+  PWF  NLP  L   E  Q  Y
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  204 bits (520), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 111/269 (41%), Positives = 152/269 (56%), Gaps = 12/269 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GHKIDANVAREIINHKQLRHPN 59
           Y L   +G G FG  ++  ++ T   VA+K + R       +   + REI N K  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           II+  +V+ TPT   +VMEY +GGELF+ IC  GR  E EAR  FQQ++S V YCH   +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+S R Y G 
Sbjct: 133 VHRDLKPENVLLDAHMNA--KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             D+WSCGV LY +L G  PF+D+  P  F+K    I    + IP+Y  +++    LL  
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLLMH 244
Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPREL 268
           +   +P +R TIK+I+ H WF ++LP  L
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  204 bits (518), Expect = 8e-53,   Method: Compositional matrix adjust.
 Identities = 111/269 (41%), Positives = 151/269 (56%), Gaps = 12/269 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIER----GHKIDANVAREIINHKQLRHPN 59
           Y L   +G G FG  ++  ++ T   VA+K + R       +   + REI N K  RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           II+  +V+ TPT   +VMEY +GGELF+ IC  GR  E EAR  FQQ++S V YCH   +
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD       KI DFG S         + + G+P Y APEV+S R Y G 
Sbjct: 133 VHRDLKPENVLLDAHMNA--KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             D+WSCGV LY +L G  PF+D+  P  F+K    I    + IP+Y  +++    LL  
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLLMH 244
Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPREL 268
           +   +P +R TIK+I+ H WF ++LP  L
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  201 bits (512), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 106/259 (40%), Positives = 154/259 (59%), Gaps = 11/259 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANPSRRITIKEIKSHPW 259
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  201 bits (512), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 106/259 (40%), Positives = 154/259 (59%), Gaps = 11/259 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANPSRRITIKEIKSHPW 259
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  201 bits (511), Expect = 5e-52,   Method: Compositional matrix adjust.
 Identities = 112/292 (38%), Positives = 161/292 (55%), Gaps = 21/292 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPN 59
           Y L   +G G FG  ++ +++ T   VA+K + R       +   + REI N K  RHP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           II+  +V+ TP+ + +VMEY +GGELF+ IC  GR  E E+R  FQQ++SGV YCH   +
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD       KI DFG S         + + G+P Y APEV+S R Y G 
Sbjct: 138 VHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             D+WS GV LY +L G  PF+D   P  F+K    I    +  P Y++ S    +LL  
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----FYTPQYLNPS--VISLLKH 249
Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEE 291
           +   +P +R TIK+I+ H WF ++LP+         Y   E+P++S   +++
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDLPK---------YLFPEDPSYSSTMIDD 292

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  201 bits (510), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 106/259 (40%), Positives = 153/259 (59%), Gaps = 11/259 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANPSRRITIKEIKSHPW 259
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  200 bits (509), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 106/259 (40%), Positives = 152/259 (58%), Gaps = 11/259 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T   VA+K I++      ++    RE+   K L HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L ++MEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH  +I 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLD      +KI DFG+S    +  +  +  G+P Y APE+   ++YDG  
Sbjct: 134 HRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL R 
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKRF 245
Query: 241 FVANPSRRITIKEIKSHPW 259
            V NP +R T+++I    W
Sbjct: 246 LVLNPIKRGTLEQIMKDRW 264

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  200 bits (509), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 105/259 (40%), Positives = 154/259 (59%), Gaps = 11/259 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA++ I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANPSRRITIKEIKSHPW 259
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  199 bits (507), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 105/259 (40%), Positives = 153/259 (59%), Gaps = 11/259 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA++ I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLD      +KI DFG+S      ++     G+P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 241 FVANPSRRITIKEIKSHPW 259
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  199 bits (507), Expect = 1e-51,   Method: Compositional matrix adjust.
 Identities = 106/259 (40%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T   VA+K I++      ++    RE+   K L HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L ++MEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH  +I 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   ++YDG  
Sbjct: 137 HRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL R 
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKRF 248
Query: 241 FVANPSRRITIKEIKSHPW 259
            V NP +R T+++I    W
Sbjct: 249 LVLNPIKRGTLEQIMKDRW 267

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 105/259 (40%), Positives = 153/259 (59%), Gaps = 11/259 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+F+ +   G   E EAR  F+Q++S V YCH   I 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+   ++YDG  
Sbjct: 129 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL + 
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKF 240
Query: 241 FVANPSRRITIKEIKSHPW 259
            + NPS+R T+++I    W
Sbjct: 241 LILNPSKRGTLEQIMKDRW 259

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  197 bits (502), Expect = 6e-51,   Method: Compositional matrix adjust.
 Identities = 105/259 (40%), Positives = 151/259 (58%), Gaps = 11/259 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L+K IG GNF   +L R+  T + VA+K I++     +++    RE+   K L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L +V EYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+   ++YDG  
Sbjct: 136 HRDLKAENLLLDAD--XNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y   S DC NLL + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFYX--STDCENLLKKF 247
Query: 241 FVANPSRRITIKEIKSHPW 259
            + NPS+R T+++I    W
Sbjct: 248 LILNPSKRGTLEQIXKDRW 266

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  191 bits (485), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 109/271 (40%), Positives = 154/271 (56%), Gaps = 13/271 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPN 59
           Y+++K +G G+FG  +L  +  T + VA+K I +       +   + REI   + LRHP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 135 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             DVWSCGV LYVML    PF+D+  P  F+   + +    Y +P +  +S     L+ R
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 246
Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPRELTE 270
           + + NP  RI+I EI    WF  +LP  L E
Sbjct: 247 MLIVNPLNRISIHEIMQDDWFKVDLPEYLLE 277

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  189 bits (481), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 108/269 (40%), Positives = 153/269 (56%), Gaps = 13/269 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPN 59
           Y+++K +G G+FG  +L  +  T + VA+K I +       +   + REI   + LRHP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 134 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             DVWSCGV LYVML    PF+D+  P  F+   + +    Y +P +  +S     L+ R
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 245
Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPREL 268
           + + NP  RI+I EI    WF  +LP  L
Sbjct: 246 MLIVNPLNRISIHEIMQDDWFKVDLPEYL 274

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 108/269 (40%), Positives = 153/269 (56%), Gaps = 13/269 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPN 59
           Y+++K +G G+FG  +L  +  T + VA+K I +       +   + REI   + LRHP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 129 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             DVWSCGV LYVML    PF+D+  P  F+   + +    Y +P +  +S     L+ R
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 240
Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPREL 268
           + + NP  RI+I EI    WF  +LP  L
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFKVDLPEYL 269

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 108/269 (40%), Positives = 153/269 (56%), Gaps = 13/269 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPN 59
           Y+++K +G G+FG  +L  +  T + VA+K I +       +   + REI   + LRHP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           II+  +V+ +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  +I
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+S + Y G 
Sbjct: 125 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             DVWSCGV LYVML    PF+D+  P  F+   + +    Y +P +  +S     L+ R
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 236
Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPREL 268
           + + NP  RI+I EI    WF  +LP  L
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFKVDLPEYL 265

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  184 bits (468), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 106/260 (40%), Positives = 153/260 (58%), Gaps = 11/260 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
           Y L K IG GNF   +L R+  T   VA+K I++      ++    RE+   K L HPNI
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++  EV+ T   L +VMEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH   I 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK EN LLDG     +KI DFG+S    + ++  +  G+P Y APE+   ++YDG  
Sbjct: 137 HRDLKAENLLLDGD--MNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
            DVWS GV LY ++ G+ PF+ Q    N ++   R++  +Y+IP Y  +S DC NLL ++
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQ----NLKELRERVLRGKYRIPFY--MSTDCENLLKKL 248
Query: 241 FVANPSRRITIKEIKSHPWF 260
            V NP +R ++++I    W 
Sbjct: 249 LVLNPIKRGSLEQIMKDRWM 268

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 101/284 (35%), Positives = 165/284 (58%), Gaps = 17/284 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD + P PR+KI DFG +      +  K+  GTPA++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAI 275
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 101/288 (35%), Positives = 164/288 (56%), Gaps = 17/288 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAIYYRK 279
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+   K
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 100/284 (35%), Positives = 163/284 (57%), Gaps = 17/284 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAI 275
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  171 bits (434), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/284 (35%), Positives = 163/284 (57%), Gaps = 17/284 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAI 275
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 100/284 (35%), Positives = 164/284 (57%), Gaps = 17/284 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD + P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPRELTETAQAI 275
            ++ + R+ V +P +R+TI++   HPW   K+  + L+  A A+
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  170 bits (431), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 165/292 (56%), Gaps = 22/292 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 190
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 246
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 292

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 165/292 (56%), Gaps = 22/292 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 190
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 246
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 292

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 165/292 (56%), Gaps = 22/292 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 293

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 165/292 (56%), Gaps = 22/292 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 293

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 155/267 (58%), Gaps = 16/267 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            ++ + R+ V +P +R+TI++   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 155/267 (58%), Gaps = 16/267 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            ++ + R+ V +P +R+TI++   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 96/267 (35%), Positives = 155/267 (58%), Gaps = 16/267 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            ++ + R+ V +P +R+TI++   HPW
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 165/292 (56%), Gaps = 22/292 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 293

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 102/292 (34%), Positives = 164/292 (56%), Gaps = 22/292 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y+  +++GSG F V +  R K+T    A K+I++     +       ++ RE+   K+++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPN+I   EV    T + ++ E  AGGELF+ +      +E+EA  F +Q+++GV Y HS
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 117 MQICHRDLKLEN-TLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           +QI H DLK EN  LLD   P PR+KI DFG +      +  K+  GTP ++APE+++  
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN-Y 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ + AV Y+  D  + + S  
Sbjct: 192 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
            ++ + R+ V +P +R+TI++   HPW     P+   +T QA+     +P F
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPK---DTQQALSSAWSHPQF 293

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 151/267 (56%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  GE+++ +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 99/279 (35%), Positives = 156/279 (55%), Gaps = 13/279 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
           ++Y+ +K +GSG +G   L ++K T    A+K I++      + +  +++     KQL H
Sbjct: 4   DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG +Y H  
Sbjct: 64  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 123
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HRDLK EN LL+  S    +KI DFG S    +  + K  +GT  YIAPEVL R++Y
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKY 182
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCR 234
           D K  DVWSCGV LY++L G  PF  Q D    ++ + R+   ++    PD+  +S + +
Sbjct: 183 DEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEAK 237
Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 273
            L+  +    PS+RI+ +E  +HPW +K   ++ T+  +
Sbjct: 238 QLVKLMLTYEPSKRISAEEALNHPWIVKFCSQKHTDVGK 276

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 150/267 (56%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  GE+++ +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRXXLXGTLDYLPPEMIEGRMH 188
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 151/268 (56%), Gaps = 13/268 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
           ++Y+ +K +GSG +G   L ++K T    A+K I++      + +  +++     KQL H
Sbjct: 21  DRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG +Y H  
Sbjct: 81  PNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HRDLK EN LL+  S    +KI DFG S    +  + K  +GT  YIAPEVL R++Y
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKY 199
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCR 234
           D K  DVWSCGV LY++L G  PF  Q D    ++ + R+   ++    PD+  +S + +
Sbjct: 200 DEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEAK 254
Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLK 262
            L+  +    PS+RI+ +E  +HPW +K
Sbjct: 255 QLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R KN+K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KKVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMH 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       ++ T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQDTYKRISRVEFTFPDFV--TEGARDL 236
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 153 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 209
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 210 DEKV-DLWSLGVLCYEFLVGKPPFEAN----TYQETYKRISRVEFTFPDFV--TEGARDL 262
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 24  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 83
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 84  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 143
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 144 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 200
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 201 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 253
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 254 ISRLLKHNPSQRPMLREVLEHPWITAN 280

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 33  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 93  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 152
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 153 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEGRMH 209
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 210 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 262
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 263 ISRLLKHNPSQRPMLREVLEHPWITAN 289

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE +  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEXIEGRXH 188
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPXLREVLEHPWITAN 268

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 6   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 65
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 66  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 125
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 126 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 182
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 183 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 235
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 236 ISRLLKHNPSQRPMLREVLEHPWITAN 262

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRDTLCGTLDYLPPEMIEGRMH 184
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 237
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 104/290 (35%), Positives = 152/290 (52%), Gaps = 26/290 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    +K  + + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 235
            K  DVWS GV LY++L G  PF      KN    + R+   +Y   +P +  IS D ++
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 285
           L+ ++   +PS RIT  +   HPW  K              Y  E PT S
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK--------------YSSETPTIS 291

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 150/269 (55%), Gaps = 16/269 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQ 54
           + YE+ +++GSG F + R  R K T +  A K+I++     +        + RE+   ++
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           +RHPNII   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 115 HSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           HS +I H DLK EN +L     P PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 230
             E  G  AD+WS GV  Y++L GA PF  +      ++T++ I AV Y   +  + + S
Sbjct: 185 -YEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTS 239
Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPW 259
           +  ++ + R+ V +P RR+TI +   H W
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 11  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 188 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 240
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 241 ISRLLKHNPSQRPMLREVLEHPWITAN 267

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMH 186
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRAALCGTLDYLPPEMIEGRMH 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GS-AGELKIADFGWSCHA-PSSRRTTLSGTLDYLPPEMIEGRMH 184
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 237
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 185 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 237
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITAN 264

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 129 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRMH 185
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 186 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 238
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 12  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 71
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 72  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 131
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 132 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 188
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 189 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 241
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 242 ISRLLKHNPSQRPMLREVLEHPWITAN 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTELCGTLDYLPPEMIEGRMH 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTXLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 7   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 66
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 67  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 126
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 127 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRXXLCGTLDYLPPEMIEGRMH 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 184 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 236
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 237 ISRLLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K  K ++A+K + +       ++  + RE+     LR
Sbjct: 4   LEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 63
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 64  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 123
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 124 KRVIHRDIKPENLLL-GS-AGELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 181 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 233
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 234 ISRLLKHNPSQRPMLREVLEHPWITAN 260

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 9   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 68
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 69  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 128
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI +FG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 129 KRVIHRDIKPENLLL-GS-AGELKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 185
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 186 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 238
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 239 ISRLLKHNPSQRPMLREVLEHPWITAN 265

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 149/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 10  LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 70  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS A  LKI +FG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 130 KRVIHRDIKPENLLL-GS-AGELKIANFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 187 DEKV-DLWSLGVLCYEFLVGKPPFE----ANTYQETYKRISRVEFTFPDFV--TEGARDL 239
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 240 ISRLLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQ 54
           + YE+ +++GSG F + R  R K T +  A K+I++     +        + RE+   ++
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           +RHPNII   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 145
Query: 115 HSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           HS +I H DLK EN +L     P PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 146 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 205
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 230
             E  G  AD+WS GV  Y++L GA PF  +      ++T++ I AV Y   +  + + S
Sbjct: 206 -YEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTS 260
Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPW 259
           +  ++ + R+ V +P RR+ I +   H W
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 289

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 147/267 (55%), Gaps = 12/267 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    +K  + + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 235
            K  DVWS GV LY++L G  PF      KN    + R+   +Y   +P +  IS D ++
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLK 262
           L+ ++   +PS RIT  +   HPW  K
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQ 54
           + YE+ +++GSG F + R  R K T +  A K+I++     +        + RE+   ++
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           +RHPNII   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 131
Query: 115 HSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           HS +I H DLK EN +L     P PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 132 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 191
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 230
             E  G  AD+WS GV  Y++L GA PF  +      ++T++ I AV Y   +  + + S
Sbjct: 192 -YEPLGLEADMWSIGVITYILLSGASPFLGETK----QETLTNISAVNYDFDEEYFSNTS 246
Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPW 259
           +  ++ + R+ V +P RR+ I +   H W
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 147/267 (55%), Gaps = 12/267 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    +K  + + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 119 ICHRDLKLENTLLDGSPAP-RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  YD
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYD 200
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 235
            K  DVWS GV LY++L G  PF      KN    + R+   +Y   +P +  IS D ++
Sbjct: 201 EK-CDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLK 262
           L+ ++   +PS RIT  +   HPW  K
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/262 (37%), Positives = 147/262 (56%), Gaps = 14/262 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHPNIIR 62
           +E+  ++G G   +    + K T++  A+K +++   +D  + R EI    +L HPNII+
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
            KE+  TPT +++V+E   GGELF+RI   G +SE +A    +Q++  V+Y H   I HR
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 123 DLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           DLK EN LL  +PAP   LKI DFG SK        K+  GTP Y APE+L    Y G  
Sbjct: 173 DLKPEN-LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPE 230
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQE-DPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLL 237
            D+WS G+  Y++L G  PF D+  D   FR    RI+  +Y    P +  +S + ++L+
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQFMFR----RILNCEYYFISPWWDEVSLNAKDLV 286
Query: 238 SRIFVANPSRRITIKEIKSHPW 259
            ++ V +P +R+T  +   HPW
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPW 308

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 124 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNKPLKK 269

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 146/269 (54%), Gaps = 10/269 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNL 264
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 146/269 (54%), Gaps = 10/269 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNL 264
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 146/269 (54%), Gaps = 10/269 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNL 264
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 146/269 (54%), Gaps = 10/269 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNL 264
           LL +I V NPS RITI +IK   W+ K L
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  161 bits (407), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +++ + +G G FG   L R + +K ++A+K + +       ++  + RE+     LR
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLL-GSNG-ELKIADFGWSVHA-PSSRRDTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 188 DEKV-DLWSLGVLCYEFLVGMPPFEAH----TYQETYRRISRVEFTFPDFV--TEGARDL 240
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   N S+R+T+ E+  HPW   N
Sbjct: 241 ISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 147/271 (54%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 92/267 (34%), Positives = 148/267 (55%), Gaps = 14/267 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           +E +++ + +G G FG   L R + +K ++A+K + +       ++  + RE+     LR
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR 70
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCHS
Sbjct: 71  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL GS    LKI DFG+S  +   SR  +  GT  Y+ PE++  R +
Sbjct: 131 KRVIHRDIKPENLLL-GSNG-ELKIADFGWSVHA-PSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K+ D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD+V  ++  R+L
Sbjct: 188 DEKV-DLWSLGVLCYEFLVGMPPFEAH----TYQETYRRISRVEFTFPDFV--TEGARDL 240
Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   N S+R+T+ E+  HPW   N
Sbjct: 241 ISRLLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  160 bits (405), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 108/303 (35%), Positives = 151/303 (49%), Gaps = 63/303 (20%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----------------- 43
           + +Y L  +IG G++GV +L  N+N     AMK + +   I                   
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 44  ----------NVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICN 91
                      V +EI   K+L HPN+++  EV+  P   HL +V E    G + E +  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPT 130
Query: 92  AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSK- 148
               SED+AR++FQ LI G+ Y H  +I HRD+K  N L+  DG     +KI DFG S  
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNE 186
Query: 149 ---SSLLHSRPKSTVGTPAYIAPEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQ 203
              S  L S   +TVGTPA++APE LS  R+ + GK  DVW+ GVTLY  + G  PF D+
Sbjct: 187 FKGSDALLS---NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 204 EDPKNFRKTISRIMAVQYKI-------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
                      RIM +  KI       PD   I++D ++L++R+   NP  RI + EIK 
Sbjct: 244 -----------RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
Query: 257 HPW 259
           HPW
Sbjct: 293 HPW 295

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 97/271 (35%), Positives = 146/271 (53%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G  G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 125 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 239
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LLHKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 146/271 (53%), Gaps = 10/271 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +  L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           LL +I V NPS RITI +IK   W+ K L +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 90/278 (32%), Positives = 148/278 (53%), Gaps = 12/278 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQLRHPNII 61
           +E  + +G+G F    L   K T +L A+K I +      ++++  EI   ++++H NI+
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             +++  +P HL +VM+  +GGELF+RI   G ++E +A    +Q++  V Y H M I H
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 122 RDLKLENTL-LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           RDLK EN L        ++ I DFG SK         +  GTP Y+APEVL+++ Y  K 
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY-SKA 202
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLS 238
            D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ + 
Sbjct: 203 VDCWSIGVIAYILLCGYPPFYDENDSKLFE----QILKAEYEFDSPYWDDISDSAKDFIR 258
Query: 239 RIFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQA 274
            +   +P++R T ++   HPW   +  L + + E+  A
Sbjct: 259 NLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSA 296

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 96/284 (33%), Positives = 154/284 (54%), Gaps = 16/284 (5%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFK 64
            M+ +GSG F    L++ + T +L A+K I++     D+++  EI   K+++H NI+  +
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           ++  + TH  +VM+  +GGELF+RI   G ++E +A    QQ++S V Y H   I HRDL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 125 KLENTL-LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 183
           K EN L L      ++ I DFG SK    +    +  GTP Y+APEVL+++ Y  K  D 
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPY-SKAVDC 190
Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 243
           WS GV  Y++L G  PF ++ + K F K   +    +++ P +  IS+  ++ +  +   
Sbjct: 191 WSIGVITYILLCGYPPFYEETESKLFEKI--KEGYYEFESPFWDDISESAKDFICHLLEK 248
Query: 244 NPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQ 287
           +P+ R T ++  SHPW   N     T   + IY     P+ SLQ
Sbjct: 249 DPNERYTCEKALSHPWIDGN-----TALHRDIY-----PSVSLQ 282

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 141/263 (53%), Gaps = 14/263 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           Y+    +G+G F    L  +K T++LVA+K I  E     + ++  EI    +++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
              ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           RDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNL 236
           K  D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           +  +   +P +R T ++   HPW
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 141/263 (53%), Gaps = 14/263 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           Y+    +G+G F    L  +K T++LVA+K I  E     + ++  EI    +++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
              ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           RDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNL 236
           K  D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           +  +   +P +R T ++   HPW
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 141/263 (53%), Gaps = 14/263 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           Y+    +G+G F    L  +K T++LVA+K I  E     + ++  EI    +++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
              ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           RDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNL 236
           K  D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           +  +   +P +R T ++   HPW
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 141/263 (53%), Gaps = 14/263 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQLRHPNII 61
           Y+    +G+G F    L  +K T++LVA+K I +      + ++  EI    +++HPNI+
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
              ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I H
Sbjct: 80  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVH 139
Query: 122 RDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           RDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 140 RDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-S 196
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNL 236
           K  D WS GV  Y++L G  PF D+ D K F     +I+  +Y+   P +  IS   ++ 
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDF 252
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           +  +   +P +R T ++   HPW
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  154 bits (388), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 94/262 (35%), Positives = 143/262 (54%), Gaps = 8/262 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           E Y+ +K +GSG +G   L R+K T    A+K I +       ++ +  E+   K L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI++  +      +  +VME   GGELF+ I +  +F+E +A    +Q++SGV+Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 119 ICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+      L KI DFG S       + K  +GT  YIAPEVL R++YD
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYD 215
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            K  DVWS GV L+++L G  PF  Q D +  RK         +  P++ ++S+  ++L+
Sbjct: 216 EK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYTFDSPEWKNVSEGAKDLI 272
Query: 238 SRIFVANPSRRITIKEIKSHPW 259
            ++   +  RRI+ ++   HPW
Sbjct: 273 KQMLQFDSQRRISAQQALEHPW 294

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 90/267 (33%), Positives = 149/267 (55%), Gaps = 16/267 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNII   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I AV Y   +  +   S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITAVSYDFDEEFFSQTSEL 248
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 145/266 (54%), Gaps = 14/266 (5%)
Query: 2   EKYELMKDIGSGNFGVAR-LMRNKNTKELVAM-----KYIERGHKIDANVAREIINHKQL 55
           E+Y+L +++G G F V R  ++    +E  AM     K   R H+    + RE    + L
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRLL 67
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           +HPNI+R  + +    H  ++ +   GGELFE I     +SE +A +  QQ++  V +CH
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 116 SMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 173
            M + HR+LK EN LL        +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
             Y GK  D+W+CGV LY++LVG  PF D++  + +++   +  A  +  P++  ++ + 
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEA 244
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPW 259
           ++L++++   NPS+RIT  E   HPW
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPW 270

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/266 (34%), Positives = 141/266 (53%), Gaps = 14/266 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           ++Y+L +DIG G F V R      T    A K I       R H+    + RE    + L
Sbjct: 4   DEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQ---KLEREARICRLL 60
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           +H NI+R  + +       +V +   GGELFE I     +SE +A +  QQ++  V +CH
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 120
Query: 116 SMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 173
            M + HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL R
Sbjct: 121 QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVL-R 179
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           +E  GK  D+W+CGV LY++LVG  PF D++  K +++   +  A  +  P++  ++ + 
Sbjct: 180 KEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI--KAGAYDFPSPEWDTVTPEA 237
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPW 259
           +NL++++   NP++RIT  E   HPW
Sbjct: 238 KNLINQMLTINPAKRITAHEALKHPW 263

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 139/272 (51%), Gaps = 13/272 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIR 62
           Y L   IG G++G  ++   K T+   A K I +    D +   +EI   K L HPNIIR
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
             E     T + +VME   GGELFER+ +   F E +A    + ++S V+YCH + + HR
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 123 DLKLENTL-LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           DLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL      G   
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE--GLYGPEC 188
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLLSR 239
           D WS GV +YV+L G  PF    D     + + +I    +  P  D++++S    +L+ R
Sbjct: 189 DEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
Query: 240 IFVANPSRRITIKEIKSHPWFLKNL---PREL 268
           +   +P +RIT  +   H WF K L   PR L
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 143/269 (53%), Gaps = 24/269 (8%)
Query: 4   YELMKDIGSGNFGVAR-----------LMRNKNTKELVAMKYIERGHKIDANVAREIINH 52
           Y+L +++G G F V R             +  NTK+L A     R H+    + RE    
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA-----RDHQ---KLEREARIC 75
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           + L+HPNI+R  + +    H  ++ +   GGELFE I     +SE +A +  QQ++  V 
Sbjct: 76  RLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVL 135
Query: 113 YCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEV 170
           +CH M + HRDLK EN LL        +K+ DFG +       +      GTP Y++PEV
Sbjct: 136 HCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 195
Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           L +  Y GK  D+W+CGV LY++LVG  PF D++  + +++   +  A  +  P++  ++
Sbjct: 196 LRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVT 252
Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPW 259
            + ++L++++   NPS+RIT  E   HPW
Sbjct: 253 PEAKDLINKMLTINPSKRITAAEALKHPW 281

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 97/272 (35%), Positives = 139/272 (51%), Gaps = 13/272 (4%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIR 62
           Y L   IG G++G  ++   K T+   A K I +    D +   +EI   K L HPNIIR
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
             E     T + +VME   GGELFER+ +   F E +A    + ++S V+YCH + + HR
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 123 DLKLENTL-LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           DLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL      G   
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE--GLYGPEC 205
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLLSR 239
           D WS GV +YV+L G  PF    D     + + +I    +  P  D++++S    +L+ R
Sbjct: 206 DEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 261
Query: 240 IFVANPSRRITIKEIKSHPWFLKNL---PREL 268
           +   +P +RIT  +   H WF K L   PR L
Sbjct: 262 LLTKSPKQRITSLQALEHEWFEKQLSSSPRNL 293

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 149/267 (55%), Gaps = 16/267 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I +V Y   +  + H S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPF--LGDTK--QETLANITSVSYDFDEEFFSHTSEL 248
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 151/288 (52%), Gaps = 20/288 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           ++Y+L +++G G F V R      T +  A K I       R H+    + RE    + L
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLL 60
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           +HPNI+R  + +       +V +   GGELFE I     +SE +A +  QQ++  V++CH
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 116 SMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 173
              I HRDLK EN LL   S    +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
             Y GK  D+W+CGV LY++LVG  PF D++  + +++   +  A  +  P++  ++ + 
Sbjct: 181 DPY-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEA 237
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 281
           ++L++++   NP++RIT  E   HPW  +        T  ++ +R+E 
Sbjct: 238 KDLINKMLTINPAKRITASEALKHPWICQR------STVASMMHRQET 279

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 149/267 (55%), Gaps = 16/267 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I +V Y   +  + H S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITSVSYDFDEEFFSHTSEL 248
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 151/288 (52%), Gaps = 20/288 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           ++Y+L +++G G F V R      T +  A K I       R H+    + RE    + L
Sbjct: 4   DEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQ---KLEREARICRLL 60
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           +HPNI+R  + +       +V +   GGELFE I     +SE +A +  QQ++  V++CH
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 116 SMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 173
              I HRDLK EN LL   S    +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
             Y GK  D+W+CGV LY++LVG  PF D++  + +++   +  A  +  P++  ++ + 
Sbjct: 181 DPY-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEA 237
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 281
           ++L++++   NP++RIT  E   HPW  +        T  ++ +R+E 
Sbjct: 238 KDLINKMLTINPAKRITASEALKHPWICQR------STVASMMHRQET 279

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 149/267 (55%), Gaps = 16/267 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I +V Y   +  + H S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITSVSYDFDEEFFSHTSEL 248
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 142/263 (53%), Gaps = 9/263 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K  DVWS GV LY++L G  PF    +    +K         +++P +  +S+  ++L
Sbjct: 205 DEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSESAKDL 261
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           + ++    PS RI+ ++   H W
Sbjct: 262 IRKMLTYVPSMRISARDALDHEW 284

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 142/263 (53%), Gaps = 9/263 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 49  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 108
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 109 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 168
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 169 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 227
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K  DVWS GV LY++L G  PF    +    +K         +++P +  +S+  ++L
Sbjct: 228 DEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSESAKDL 284
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           + ++    PS RI+ ++   H W
Sbjct: 285 IRKMLTYVPSMRISARDALDHEW 307

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 142/263 (53%), Gaps = 9/263 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 50  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 109
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 110 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 169
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 170 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 228
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K  DVWS GV LY++L G  PF    +    +K         +++P +  +S+  ++L
Sbjct: 229 DEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSESAKDL 285
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           + ++    PS RI+ ++   H W
Sbjct: 286 IRKMLTYVPSMRISARDALDHEW 308

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 142/263 (53%), Gaps = 9/263 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 92  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 151
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 152 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 210
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K  DVWS GV LY++L G  PF    +    +K         +++P +  +S+  ++L
Sbjct: 211 DEK-CDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYTFELPQWKKVSESAKDL 267
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           + ++    PS RI+ ++   H W
Sbjct: 268 IRKMLTYVPSMRISARDALDHEW 290

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 148/267 (55%), Gaps = 16/267 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I AV Y   +  +   S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITAVSYDFDEEFFSQTSEL 248
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 148/267 (55%), Gaps = 16/267 (5%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-------NVAREIINHKQLR 56
           Y++ +++GSG F + +  R K+T    A K+I++     +        + RE+   +Q+ 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y H+
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 117 MQICHRDLKLEN-TLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
            +I H DLK EN  LLD + P P +K+ DFG +         K+  GTP ++APE+++  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN-Y 192
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQD 232
           E  G  AD+WS GV  Y++L GA PF    D K  ++T++ I AV Y   +  +   S+ 
Sbjct: 193 EPLGLEADMWSIGVITYILLSGASPFLG--DTK--QETLANITAVSYDFDEEFFSQTSEL 248
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            ++ + ++ V    +R+TI+E   HPW
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 93/265 (35%), Positives = 143/265 (53%), Gaps = 13/265 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDA-NVAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +     K D  ++ RE+   KQL H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI +  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 86  PNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN 145
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVL-HGTY 204
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCR 234
           D K  DVWS GV LY++L G  PF    +  N    + ++   +Y  ++P +  +S+  +
Sbjct: 205 DEK-CDVWSTGVILYILLSGCPPF----NGANEYDILKKVEKGKYTFELPQWKKVSESAK 259
Query: 235 NLLSRIFVANPSRRITIKEIKSHPW 259
           +L+ +     PS RI+ ++   H W
Sbjct: 260 DLIRKXLTYVPSXRISARDALDHEW 284

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 139/264 (52%), Gaps = 9/264 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLRH 57
           + Y++ +++G G F V R   +K T    A K I    K+ A     + RE    ++L+H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++  ++YCHS 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
             K  D+W+CGV LY++LVG  PF D++  + + +   +  A  Y  P++  ++ + ++L
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 264
Query: 237 LSRIFVANPSRRITIKEIKSHPWF 260
           +  +   NP +RIT  +    PW 
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWI 288

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 139/263 (52%), Gaps = 9/263 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLRH 57
           + Y++ +++G G F V R   +K T    A K I    K+ A     + RE    ++L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++  ++YCHS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
             K  D+W+CGV LY++LVG  PF D++  + + +   +  A  Y  P++  ++ + ++L
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 241
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           +  +   NP +RIT  +    PW
Sbjct: 242 IDSMLTVNPKKRITADQALKVPW 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 139/263 (52%), Gaps = 9/263 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLRH 57
           + Y++ +++G G F V R   +K T    A K I    K+ A     + RE    ++L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++  ++YCHS 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
             K  D+W+CGV LY++LVG  PF D++  + + +   +  A  Y  P++  ++ + ++L
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 241
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           +  +   NP +RIT  +    PW
Sbjct: 242 IDSMLTVNPKKRITADQALKVPW 264

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 139/263 (52%), Gaps = 9/263 (3%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLRH 57
           + Y++ +++G G F V R   +K T    A K I    K+ A     + RE    ++L+H
Sbjct: 5   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++  ++YCHS 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
             K  D+W+CGV LY++LVG  PF D++  + + +   +  A  Y  P++  ++ + ++L
Sbjct: 184 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 240
Query: 237 LSRIFVANPSRRITIKEIKSHPW 259
           +  +   NP +RIT  +    PW
Sbjct: 241 IDSMLTVNPKKRITADQALKVPW 263

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 139/266 (52%), Gaps = 14/266 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           + Y+L +++G G F V R    K   +  A K I       R H+    + RE    + L
Sbjct: 31  DDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQ---KLEREARICRLL 87
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           +HPNI+R  + +       +V +   GGELFE I     +SE +A +   Q++  V++ H
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH 147
Query: 116 SMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 173
              I HRDLK EN LL        +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK 207
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
             Y GK  D+W+CGV LY++LVG  PF D++  K +++   +  A  +  P++  ++ + 
Sbjct: 208 DPY-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI--KAGAYDFPSPEWDTVTPEA 264
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPW 259
           +NL++++   NP++RIT  +   HPW
Sbjct: 265 KNLINQMLTINPAKRITADQALKHPW 290

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 143/261 (54%), Gaps = 11/261 (4%)
Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEV 66
           K +G G+F + R   +K + +  A+K I +  +++AN  +EI   K    HPNI++  EV
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 67  VLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKL 126
                H  +VME   GGELFERI     FSE EA Y  ++L+S VS+ H + + HRDLK 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 127 ENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRREYDGKLADVW 184
           EN L  D +    +KI DFG+++     ++P K+   T  Y APE+L++  YD +  D+W
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLW 193
Query: 185 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-----YKIPDYVHISQDCRNLLSR 239
           S GV LY ML G  PF+  +        +  +  ++     ++   + ++SQ+ ++L+  
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253
Query: 240 IFVANPSRRITIKEIKSHPWF 260
           +   +P++R+ +  ++ + W 
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWL 274

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 147/281 (52%), Gaps = 20/281 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           ++ +++++ +G G FG   L R K  K ++A+K + +       ++  + REI     LR
Sbjct: 13  IDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSR 173
            ++ HRD+K EN L+       LKI DFG+S    +H+   R +   GT  Y+ PE++  
Sbjct: 133 RKVIHRDIKPENLLMGYKGE--LKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEG 186
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           + +D K+ D+W  GV  Y  LVG  PF    D  +  +T  RI+ V  K P +  +S   
Sbjct: 187 KTHDEKV-DLWCAGVLCYEFLVGMPPF----DSPSHTETHRRIVNVDLKFPPF--LSDGS 239
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQA 274
           ++L+S++   +P +R+ +K +  HPW   N  R L    Q+
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 280

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 146/281 (51%), Gaps = 20/281 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           ++ +++ + +G G FG   L R K  K ++A+K + +       ++  + REI     LR
Sbjct: 14  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH 
Sbjct: 74  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 133
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSR 173
            ++ HRD+K EN L+       LKI DFG+S    +H+   R +   GT  Y+ PE++  
Sbjct: 134 RKVIHRDIKPENLLM--GYKGELKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEG 187
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           + +D K+ D+W  GV  Y  LVG  PF    D  +  +T  RI+ V  K P +  +S   
Sbjct: 188 KTHDEKV-DLWCAGVLCYEFLVGMPPF----DSPSHTETHRRIVNVDLKFPPF--LSDGS 240
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQA 274
           ++L+S++   +P +R+ +K +  HPW   N  R L    Q+
Sbjct: 241 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQS 281

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  144 bits (363), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 94/278 (33%), Positives = 144/278 (51%), Gaps = 23/278 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDAN---------VAR 47
           E Y  ++ +GSG +G   L + KN     A+K I     ++G   D N         +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 48  EIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQL 107
           EI   K L HPNII+  +V     +  +V E+  GGELFE+I N  +F E +A    +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLLHSRPKSTVGTPAYI 166
           +SG+ Y H   I HRD+K EN LL+   +   +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIP 224
           APEVL +++Y+ K  DVWSCGV +Y++L G  PF  Q D    +  I ++   +Y     
Sbjct: 216 APEVL-KKKYNEK-CDVWSCGVIMYILLCGYPPFGGQND----QDIIKKVEKGKYYFDFN 269
Query: 225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
           D+ +IS + + L+  +   + ++R T +E  +  W  K
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 155/272 (56%), Gaps = 25/272 (9%)
Query: 3   KYELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERG-----HKIDANVAREIINHKQ 54
           ++EL+K +G G+FG   L++     + ++L AMK +++       ++   + R+I+   +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   + + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 143 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           R +  + AD WS GV ++ ML G  PF+     K+ ++T++ I+  +  +P +  +S + 
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 253
Query: 234 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           ++LL  +F  NP+ R+      ++EIK H +F
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 152/306 (49%), Gaps = 35/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 202
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S + 
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262
Query: 113 YCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 170
           Y HS + + +RDLKLEN +LD      +KI DFG  K  +      K+  GTP Y+APEV
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320
Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 321 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 373
Query: 231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 285
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 426
Query: 286 LQSVEE 291
            Q   E
Sbjct: 427 PQVTSE 432

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 155/272 (56%), Gaps = 25/272 (9%)
Query: 3   KYELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERG-----HKIDANVAREIINHKQ 54
           ++EL+K +G G+FG   L++     + ++L AMK +++       ++   + R+I+   +
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 82
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   + + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 143 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           R +  + AD WS GV ++ ML G  PF+     K+ ++T++ I+  +  +P +  +S + 
Sbjct: 201 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 253
Query: 234 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           ++LL  +F  NP+ R+      ++EIK H +F
Sbjct: 254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 152/306 (49%), Gaps = 35/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 150 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 205
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S + 
Sbjct: 206 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 265
Query: 113 YCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 170
           Y HS + + +RDLKLEN +LD      +KI DFG  K  +      K+  GTP Y+APEV
Sbjct: 266 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 323
Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 324 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 376
Query: 231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 285
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 377 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 429
Query: 286 LQSVEE 291
            Q   E
Sbjct: 430 PQVTSE 435

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 155/272 (56%), Gaps = 25/272 (9%)
Query: 3   KYELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERG-----HKIDANVAREIINHKQ 54
           ++EL+K +G G+FG   L++     + ++L AMK +++       ++   + R+I+   +
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILV--E 83
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           + HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   + + 
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSR 173
           HS+ I +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APEV++R
Sbjct: 144 HSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           R +  + AD WS GV ++ ML G  PF+     K+ ++T++ I+  +  +P +  +S + 
Sbjct: 202 RGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LSPEA 254
Query: 234 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           ++LL  +F  NP+ R+      ++EIK H +F
Sbjct: 255 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 134/264 (50%), Gaps = 9/264 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHPN 59
           ++ Y++ +++G+G FGV   +  + T    A K++   H+ D    R EI     LRHP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQ 118
           ++   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G+ + H   
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +   G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNL 236
              D+WS GV  Y++L G  PF  + D +  R     + +  + + D  +  IS+D ++ 
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDF 390
Query: 237 LSRIFVANPSRRITIKEIKSHPWF 260
           + ++ +A+P+ R+TI +   HPW 
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWL 414

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 135/264 (51%), Gaps = 9/264 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHPN 59
           ++ Y++ +++G+G FGV   +  + T    A K++   H+ D    R EI     LRHP 
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 109
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQ 118
           ++   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G+ + H   
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +   G
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 228
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNL 236
              D+WS GV  Y++L G  PF  + D     +T+  + +  + + D  +  IS+D ++ 
Sbjct: 229 YYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDF 284
Query: 237 LSRIFVANPSRRITIKEIKSHPWF 260
           + ++ +A+P+ R+TI +   HPW 
Sbjct: 285 IRKLLLADPNTRMTIHQALEHPWL 308

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/277 (31%), Positives = 146/277 (52%), Gaps = 36/277 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---------HKIDANVAREIIN 51
           ++ +++++ +G+G+FG   L+R+++     AMK +++          H  D  +   I+ 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
           H     P IIR          + ++M+Y  GGELF  +  + RF    A+++  ++   +
Sbjct: 65  H-----PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAP 168
            Y HS  I +RDLK EN LLD +    +KI DFG++K       P  T    GTP YIAP
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKN--GHIKITDFGFAKYV-----PDVTYXLCGTPDYIAP 172
Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
           EV+S + Y+ K  D WS G+ +Y ML G  PF D     N  KT  +I+  + + P +  
Sbjct: 173 EVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPPF-- 225
Query: 229 ISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
            ++D ++LLSR+   + S+R+       +++K+HPWF
Sbjct: 226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 152/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--- 57
           ++++E ++ +G+G+FG   L+++K T    AMK +++   +        +N K+++    
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVN 100
Query: 58  -PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +V+EYA GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 151/306 (49%), Gaps = 35/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 63
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S + 
Sbjct: 64  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 123
Query: 113 YCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 170
           Y HS + + +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEV
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 181
Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 182 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 234
Query: 231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 285
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 235 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 287
Query: 286 LQSVEE 291
            Q   E
Sbjct: 288 PQVTSE 293

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 151/306 (49%), Gaps = 35/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 62
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S + 
Sbjct: 63  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 122
Query: 113 YCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 170
           Y HS + + +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEV
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 180
Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 181 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 233
Query: 231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 285
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 234 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 286
Query: 286 LQSVEE 291
            Q   E
Sbjct: 287 PQVTSE 292

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/306 (32%), Positives = 151/306 (49%), Gaps = 35/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +++    +  VA++ + H        
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKK----EVIVAKDEVAHTLTENRVL 64
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S + 
Sbjct: 65  QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 124
Query: 113 YCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV 170
           Y HS + + +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEV
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 182
Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 183 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPR--TLG 235
Query: 231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS 285
            + ++LLS +   +P +R+       KEI  H +F   +        Q +Y +K +P F 
Sbjct: 236 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV-------WQHVYEKKLSPPFK 288
Query: 286 LQSVEE 291
            Q   E
Sbjct: 289 PQVTSE 294

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 150/306 (49%), Gaps = 34/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 171
           Y HS  + +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 232 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 286
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 287 QSVEEI 292
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 150/306 (49%), Gaps = 34/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 171
           Y HS  + +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 232 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 286
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 287 QSVEEI 292
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 150/306 (49%), Gaps = 34/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 7   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 62
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + 
Sbjct: 63  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 122
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 171
           Y HS  + +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL
Sbjct: 123 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 180
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 181 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 233
Query: 232 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 286
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 234 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 286
Query: 287 QSVEEI 292
           Q   E+
Sbjct: 287 QVTSEV 292

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   E  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  140 bits (354), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 149/306 (48%), Gaps = 34/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 171
           Y HS  + +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 232 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 286
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 287 QSVEEI 292
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 88/293 (30%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K IG+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 149/306 (48%), Gaps = 34/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 9   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 64
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + 
Sbjct: 65  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 124
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 171
           Y HS  + +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL
Sbjct: 125 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 182
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 183 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 235
Query: 232 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 286
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 236 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 288
Query: 287 QSVEEI 292
           Q   E+
Sbjct: 289 QVTSEV 294

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 149/306 (48%), Gaps = 34/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 171
           Y HS  + +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 232 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 286
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 287 QSVEEI 292
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 149/306 (48%), Gaps = 34/306 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK + +    +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRK----EVIIAKDEVAHTVTESRVL 59
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 171
           Y HS  + +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVL 177
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
              +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +S 
Sbjct: 178 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSP 230
Query: 232 DCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSL 286
           + ++LL+ +   +P +R+       KE+  H +F       L+   Q +  +K  P F  
Sbjct: 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF-------LSINWQDVVQKKLLPPFKP 283
Query: 287 QSVEEI 292
           Q   E+
Sbjct: 284 QVTSEV 289

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLXGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 237 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 289
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 335

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 209 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 261
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 307

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 86
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 147 LDLIYRDLKPENLLID--EQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 202
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 203 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 255
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 256 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 301

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLPNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 147/269 (54%), Gaps = 15/269 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIIN----HKQLR 56
           +E +++   +G G+F       + +T   VA+K I++     A + + + N    H QL+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCH 115
           HP+I+          ++ +V+E    GE+   + N  + FSE+EAR+F  Q+I+G+ Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           S  I HRDL L N LL  +    +KI DFG  ++  + H +  +  GTP YI+PE+ +R 
Sbjct: 130 SHGILHRDLTLSNLLL--TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            + G  +DVWS G   Y +L+G  PF    D    + T+++++   Y++P ++ I  + +
Sbjct: 188 AH-GLESDVWSLGCMFYTLLIGRPPF----DTDTVKNTLNKVVLADYEMPSFLSI--EAK 240
Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           +L+ ++   NP+ R+++  +  HP+  +N
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN 269

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 130/255 (50%), Gaps = 9/255 (3%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G FG         T   +A K I+ RG K    V  EI    QL H N+I+  +   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 69  TPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
           +   + +VMEY  GGELF+RI +     +E +   F +Q+  G+ + H M I H DLK E
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 128 NTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCG 187
           N L     A ++KI DFG ++      + K   GTP ++APEV++  ++     D+WS G
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN-YDFVSFPTDMWSVG 275
Query: 188 VTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSRIFVANP 245
           V  Y++L G  PF    D     +T++ I+A ++ + D  +  IS++ +  +S++ +   
Sbjct: 276 VIAYMLLSGLSPFLGDNDA----ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 246 SRRITIKEIKSHPWF 260
           S RI+  E   HPW 
Sbjct: 332 SWRISASEALKHPWL 346

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLIID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIIISKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF+E  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K IG+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GG++F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 92/275 (33%), Positives = 147/275 (53%), Gaps = 28/275 (10%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA------NVAREIINHKQLRH 57
           YEL + IG G F V R   N+ T +  A+K ++      +      ++ RE      L+H
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL-FERI--CNAGR-FSEDEARYFFQQLISGVSY 113
           P+I+   E   +   L +V E+  G +L FE +   +AG  +SE  A ++ +Q++  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 114 CHSMQICHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIA 167
           CH   I HRD+K EN LL    + AP +K+ DFG +    +S L+       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAP-VKLGDFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--D 225
           PEV+ R  Y GK  DVW CGV L+++L G  PF   ++     +    I+  +YK+    
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQ 255
Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           + HIS+  ++L+ R+ + +P+ RIT+ E  +HPW 
Sbjct: 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 85
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP Y+APE++  + Y
Sbjct: 146 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 202 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 254
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 255 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 300

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K IG+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GG++F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R  +  GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 92
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 153 LDLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 209 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 261
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 307

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 151/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +     +  GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGATWTLCGTPEYLAPEIILSKGY 236
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 237 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 289
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 335

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++K T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +I +H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIXNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 120
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 181 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 237 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 289
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 335

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG +K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMID--QQGYIKVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 94
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 155 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 210
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 211 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 263
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 264 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 309

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  137 bits (346), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+AP ++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPAIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++        + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKAFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 82/271 (30%), Positives = 152/271 (56%), Gaps = 25/271 (9%)
Query: 4   YELMKDIGSGNFGVARLMRN---KNTKELVAMKYIERG-----HKIDANVAREIINHKQL 55
           +EL+K +G G+FG   L+R     ++  L AMK +++       ++   + R+I+    +
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDIL--ADV 87
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP +++      T   L +++++  GG+LF R+     F+E++ +++  +L  G+ + H
Sbjct: 88  NHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLSRR 174
           S+ I +RDLK EN LLD      +K+ DFG SK ++ H +   S  GT  Y+APEV++R+
Sbjct: 148 SLGIIYRDLKPENILLD--EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQ 205
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            +    AD WS GV ++ ML G+ PF+     K+ ++T++ I+  +  +P +  +S + +
Sbjct: 206 GHSHS-ADWWSYGVLMFEMLTGSLPFQG----KDRKETMTLILKAKLGMPQF--LSTEAQ 258
Query: 235 NLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           +LL  +F  NP+ R+       +EIK H ++
Sbjct: 259 SLLRALFKRNPANRLGSGPDGAEEIKRHVFY 289

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 148/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P + + +      ++L +VMEYA GGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +K+ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLMID--QQGYIKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 161/312 (51%), Gaps = 32/312 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + Y + + IG G++   +   +K T    A+K I++  +  +     ++ + Q  HPNII
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ--HPNII 84
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             K+V     H+ +V E   GGEL ++I     FSE EA +    +   V Y HS  + H
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 122 RDLKLENTL-LDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAY----IAPEVLSRRE 175
           RDLK  N L +D S  P  L+ICDFG++K   L +     + TP Y    +APEVL R+ 
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQG 201
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFED--QEDPKNFRKTISRIMAVQYKIP--DYVHISQ 231
           YD +  D+WS G+ LY ML G  PF +   + P+     ++RI + ++ +   ++  +S+
Sbjct: 202 YD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEI---LTRIGSGKFTLSGGNWNTVSE 257
Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLK--NLPR--------ELTETAQAIYYRKEN 281
             ++L+S++   +P +R+T K++  HPW  +   LP+        +L + A A  Y   N
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALN 317
Query: 282 ---PTFSLQSVE 290
              PT  L+ +E
Sbjct: 318 SSKPTPQLKPIE 329

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 149/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEYA GGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN ++D      +++ DFG +K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLMIDQQ--GYIQVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 18/273 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187
Query: 172 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 244
Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 98/312 (31%), Positives = 161/312 (51%), Gaps = 32/312 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + Y + + IG G++   +   +K T    A+K I++  +  +     ++ + Q  HPNII
Sbjct: 27  DGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ--HPNII 84
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             K+V     H+ +V E   GGEL ++I     FSE EA +    +   V Y HS  + H
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 122 RDLKLENTL-LDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAY----IAPEVLSRRE 175
           RDLK  N L +D S  P  L+ICDFG++K   L +     + TP Y    +APEVL R+ 
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQG 201
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFED--QEDPKNFRKTISRIMAVQYKIP--DYVHISQ 231
           YD +  D+WS G+ LY ML G  PF +   + P+     ++RI + ++ +   ++  +S+
Sbjct: 202 YD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEI---LTRIGSGKFTLSGGNWNTVSE 257
Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLK--NLPR--------ELTETAQAIYYRKEN 281
             ++L+S++   +P +R+T K++  HPW  +   LP+        +L + A A  Y   N
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALN 317
Query: 282 ---PTFSLQSVE 290
              PT  L+ +E
Sbjct: 318 SSKPTPQLKPIE 329

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 150/293 (51%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K++     
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEALAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 18/273 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 172 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 18/273 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 172 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 18/273 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 172 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 161 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 217 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 269
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 315

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 87/268 (32%), Positives = 144/268 (53%), Gaps = 18/268 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +E +EL K +G G+FG   L   K T +  A+K +++   + D +V   ++  + L    
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP +        T  +L  VMEY  GG+L   I +  +F    A ++  ++I G+ + H
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 137 SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDC 233
           +Y+  + D WS GV LY ML+G  PF  Q++ + F        +++   P Y   + ++ 
Sbjct: 195 KYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMDNPFYPRWLEKEA 246
Query: 234 RNLLSRIFVANPSRRITIK-EIKSHPWF 260
           ++LL ++FV  P +R+ ++ +I+ HP F
Sbjct: 247 KDLLVKLFVREPEKRLGVRGDIRQHPLF 274

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 93/273 (34%), Positives = 137/273 (50%), Gaps = 18/273 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +     G   +A    NV  EI   
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194
Query: 172 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 251
Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 148/293 (50%), Gaps = 27/293 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----R 56
           ++++E +K +G+G+FG   L+++  T    AMK +++   +        +N K++     
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY  GGE+F  +   GRF E  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K   +  R     GTP Y+APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           + K  D W+ GV +Y M  G  PF   +  + + K +S     + + P   H S D ++L
Sbjct: 216 N-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPS--HFSSDLKDL 268
Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF 284
           L  +   + ++R       + +IK+H WF        T    AIY RK    F
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF-------ATTDWIAIYQRKVEAPF 314

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 146/283 (51%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+  H +    P+I+R    ++
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 131
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 132 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 191
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 192 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 250
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 251 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 310
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 311 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 353

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 148/283 (52%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 79
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 80  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 139
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 199 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 258
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 301

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 148/283 (52%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 80
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 81  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 140
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 141 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 199
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 200 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 259
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 260 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 302

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 146/283 (51%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+  H +    P+I+R    ++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 125
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 244
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 245 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 304
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 347

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 143/279 (51%), Gaps = 20/279 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLR 56
           ++ +E+ + +G G FG   L R K +  +VA+K + +       ++  + REI     L 
Sbjct: 22  IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R          + +++EYA  GEL++ +  +  F E       ++L   + YCH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSR 173
            ++ HRD+K EN LL       LKI DFG+S    +H+   R K+  GT  Y+ PE++  
Sbjct: 142 KKVIHRDIKPENLLLGLKGE--LKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           R ++ K+ D+W  GV  Y +LVG  PFE     + +R    RI+ V  K P    +    
Sbjct: 196 RMHNEKV-DLWCIGVLCYELLVGNPPFESASHNETYR----RIVKVDLKFP--ASVPTGA 248
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 272
           ++L+S++   NPS R+ + ++ +HPW   N  R L  +A
Sbjct: 249 QDLISKLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSA 287

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 148/283 (52%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 87
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 88  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 147
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 148 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 206
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 207 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 266
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 267 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 309

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 148/283 (52%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 85
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 86  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 145
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 146 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 204
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 205 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 264
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 265 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 307

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 148/283 (52%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 200
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 201 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 260
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 303

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 148/283 (52%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 86
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 87  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 146
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 147 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 205
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 206 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 265
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 266 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 308

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 146/283 (51%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+  H +    P+I+R    ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 200
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 201 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 260
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 303

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 146/283 (51%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+  H +    P+I+R    ++
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 95
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 96  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 155
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 156 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 214
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 215 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 274
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 275 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 317

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 147/283 (51%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I+R    ++
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 79
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 80  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 139
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+       TP Y+APEVL   +YD K  
Sbjct: 140 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYD-KSC 198
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 199 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 258
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 301

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 15/268 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + YE+ +DIG G++ V +   +K T    A+K I++  +        ++ + Q  HPNII
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNII 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y H+  + H
Sbjct: 80  TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 122 RDLKLENTL-LDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAY----IAPEVLSRRE 175
           RDLK  N L +D S  P  ++ICDFG++K           + TP Y    +APEVL R+ 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLMTPCYTANFVAPEVLERQG 196
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDC 233
           YD    D+WS GV LY ML G  PF +  D     + ++RI + ++ +    +  +S   
Sbjct: 197 YDAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFL 261
           ++L+S++   +P +R+T   +  HPW +
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 137/273 (50%), Gaps = 18/273 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA++ I +     G   +A    NV  EI   
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 209 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 172 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 384
Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 385 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 92/273 (33%), Positives = 137/273 (50%), Gaps = 18/273 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDA----NVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA++ I +     G   +A    NV  EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 172 SRREYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPD-YV 227
                 G  +  D WS GV L++ L G  PF +     + +    +I + +Y  IP+ + 
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 370
Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 143/268 (53%), Gaps = 18/268 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +E + L K +G G+FG   L   K T +  A+K +++   + D +V   ++  + L    
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP +        T  +L  VMEY  GG+L   I +  +F    A ++  ++I G+ + H
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+L  +
Sbjct: 136 SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ 193
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH-ISQDC 233
           +Y+  + D WS GV LY ML+G  PF  Q++ + F        +++   P Y   + ++ 
Sbjct: 194 KYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFH-------SIRMDNPFYPRWLEKEA 245
Query: 234 RNLLSRIFVANPSRRITIK-EIKSHPWF 260
           ++LL ++FV  P +R+ ++ +I+ HP F
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 96/321 (29%), Positives = 162/321 (50%), Gaps = 32/321 (9%)
Query: 2   EKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIE-----RGHKIDANVAREIINHK 53
           E +EL++ +G G +G     R +   NT ++ AMK ++     R  K  A+   E    +
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           +++HP I+       T   L +++EY +GGELF ++   G F ED A ++  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLS 172
            H   I +RDLK EN +L+      +K+ DFG  K S+       T  GT  Y+APE+L 
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
           R  ++ +  D WS G  +Y ML GA PF  +    N +KTI +I+  +  +P Y  ++Q+
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCKLNLPPY--LTQE 247
Query: 233 CRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS-- 285
            R+LL ++   N + R+        E+++HP+F     R +    + +  RK  P F   
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-----RHI--NWEELLARKVEPPFKPL 300
Query: 286 LQSVEEITKIVEEAKVPPPVS 306
           LQS E++++   +     PV 
Sbjct: 301 LQSEEDVSQFDSKFTRQTPVD 321

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 137/268 (51%), Gaps = 15/268 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + YE+ +DIG G++ V +   +K T    A+K I++  +        ++ + Q  HPNII
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQ--HPNII 79
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y H+  + H
Sbjct: 80  TLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139
Query: 122 RDLKLENTL-LDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAY----IAPEVLSRRE 175
           RDLK  N L +D S  P  ++ICDFG++K     +     + TP Y    +APEVL R+ 
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN---GLLXTPCYTANFVAPEVLERQG 196
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDC 233
           YD    D+WS GV LY  L G  PF +  D     + ++RI + ++ +    +  +S   
Sbjct: 197 YDAA-CDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTA 254
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFL 261
           ++L+S+    +P +R+T   +  HPW +
Sbjct: 255 KDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 95/321 (29%), Positives = 161/321 (50%), Gaps = 32/321 (9%)
Query: 2   EKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIE-----RGHKIDANVAREIINHK 53
           E +EL++ +G G +G     R +   NT ++ AMK ++     R  K  A+   E    +
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           +++HP I+       T   L +++EY +GGELF ++   G F ED A ++  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-PKSTVGTPAYIAPEVLS 172
            H   I +RDLK EN +L+      +K+ DFG  K S+          GT  Y+APE+L 
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
           R  ++ +  D WS G  +Y ML GA PF  +    N +KTI +I+  +  +P Y  ++Q+
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCKLNLPPY--LTQE 247
Query: 233 CRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS-- 285
            R+LL ++   N + R+        E+++HP+F     R +    + +  RK  P F   
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-----RHI--NWEELLARKVEPPFKPL 300
Query: 286 LQSVEEITKIVEEAKVPPPVS 306
           LQS E++++   +     PV 
Sbjct: 301 LQSEEDVSQFDSKFTRQTPVD 321

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 144/275 (52%), Gaps = 28/275 (10%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA------NVAREIINHKQLRH 57
           YEL + IG G F V R   N+ T +  A+K ++      +      ++ RE      L+H
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL-FERI--CNAG-RFSEDEARYFFQQLISGVSY 113
           P+I+   E   +   L +V E+  G +L FE +   +AG  +SE  A ++ +Q++  + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 114 CHSMQICHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIA 167
           CH   I HRD+K    LL    + AP +K+  FG +    +S L+       VGTP ++A
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 203
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--D 225
           PEV+ R  Y GK  DVW CGV L+++L G  PF   ++     +    I+  +YK+    
Sbjct: 204 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQ 257
Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           + HIS+  ++L+ R+ + +P+ RIT+ E  +HPW 
Sbjct: 258 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 132/272 (48%), Gaps = 21/272 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----- 55
           ++ +E ++ +G G+FG   L R K T +L A+K +++   +  +     +  K++     
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP + +      TP  L  VME+  GG+L   I  + RF E  AR++  ++IS + + H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 174
              I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L   
Sbjct: 142 DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            Y G   D W+ GV LY ML G  PFE + +   F      I+  +   P ++H  +D  
Sbjct: 200 LY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTWLH--EDAT 252
Query: 235 NLLSRIFVANPSRRITI------KEIKSHPWF 260
            +L      NP+ R+          I  HP+F
Sbjct: 253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 144/275 (52%), Gaps = 28/275 (10%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA------NVAREIINHKQLRH 57
           YEL + IG G F V R   N+ T +  A+K ++      +      ++ RE      L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGEL-FERI--CNAGR-FSEDEARYFFQQLISGVSY 113
           P+I+   E   +   L +V E+  G +L FE +   +AG  +SE  A ++ +Q++  + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 114 CHSMQICHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIA 167
           CH   I HRD+K    LL    + AP +K+  FG +    +S L+       VGTP ++A
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHFMA 201
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--D 225
           PEV+ R  Y GK  DVW CGV L+++L G  PF   ++     +    I+  +YK+    
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQ 255
Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           + HIS+  ++L+ R+ + +P+ RIT+ E  +HPW 
Sbjct: 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 90/283 (31%), Positives = 137/283 (48%), Gaps = 20/283 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREI---------I 50
           E YE  + +G G   V R   +K T +  A+K I+   G    A   +E+         I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             K   HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +S  GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEI 194
Query: 171 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R  +S     Q+  P+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 252
Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
           +   S   ++L+SR  V  P +R T +E  +HP+F + +  E+
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 141/283 (49%), Gaps = 17/283 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+  H +    P+I+R    ++
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 125
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IV E   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 126 NLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHR 185
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSC 244
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D WS GV  Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 245 DXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRN 304
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R TI E  +HPW  ++  +P+    T++ +   KE
Sbjct: 305 LLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTSRVLKEDKE 347

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 136/267 (50%), Gaps = 19/267 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHP 58
           +  +K IG G+FG   L R+K  +   A+K +++   +     + I++      K ++HP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
            ++       T   L  V++Y  GGELF  +     F E  AR++  ++ S + Y HS+ 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL ++ YD
Sbjct: 160 IVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            +  D W  G  LY ML G  PF  +   + +   +++ + ++       +I+   R+LL
Sbjct: 218 -RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK------PNITNSARHLL 270
Query: 238 SRIFVANPSRRITIK----EIKSHPWF 260
             +   + ++R+  K    EIKSH +F
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 135/280 (48%), Gaps = 10/280 (3%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-NVAREIINHKQLRHPNIIR 62
           Y++++++GSG FGV      K T  +   K+I   + +D   V  EI    QL HP +I 
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICH 121
             +       + +++E+ +GGELF+RI     + SE E   + +Q   G+ + H   I H
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVH 172
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
            D+K EN + +   A  +KI DFG +         K T  T  + APE++  RE  G   
Sbjct: 173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD-REPVGFYT 231
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+W+ GV  YV+L G  PF  ++D     +T+  +    ++  +  +  +S + ++ +  
Sbjct: 232 DMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN 287
Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRK 279
           +    P +R+T+ +   HPW LK     LT    +  Y K
Sbjct: 288 LLQKEPRKRLTVHDALEHPW-LKGDHSNLTSRIPSSRYNK 326

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 88/275 (32%), Positives = 132/275 (48%), Gaps = 20/275 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREI---------I 50
           E YE  + +G G   V R   +K T +  A+K I+   G    A   +E+         I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             K   HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 181
Query: 171 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R  +S     Q+  P+
Sbjct: 182 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 239
Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +   S   ++L+SR  V  P +R T +E  +HP+F
Sbjct: 240 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 89/283 (31%), Positives = 136/283 (48%), Gaps = 20/283 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREI---------I 50
           E YE  + +G G   V R   +K T +  A+K I+   G    A   +E+         I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             K   HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 171 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R  +S     Q+  P+
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 252
Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
           +   S   ++L+SR  V  P +R T +E  +HP+F + +  E+
Sbjct: 253 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 136/265 (51%), Gaps = 14/265 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           M++Y   + +G G F     + + +TKE+ A K + +   +  +    ++ EI  HK L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +P+++ F         + +V+E      L E        +E EARYF +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG  +K      R K+  GTP YIAPEVL ++ 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG 218
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI   +Y +P   HI+     
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETS----CLKETYIRIKKNEYSVPR--HINPVASA 271
Query: 236 LLSRIFVANPSRRITIKEIKSHPWF 260
           L+ R+  A+P+ R ++ E+ +  +F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           M++Y   + +G G F     + + +TKE+ A K + +   +  +    ++ EI  HK L 
Sbjct: 25  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +P+++ F         + +V+E      L E        +E EARYF +Q I GV Y H+
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++ 
Sbjct: 145 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI   +Y +P   HI+     
Sbjct: 203 HSFEV-DIWSLGCILYTLLVGKPPFETS----CLKETYIRIKKNEYSVPR--HINPVASA 255
Query: 236 LLSRIFVANPSRRITIKEIKSHPWF 260
           L+ R+  A+P+ R ++ E+ +  +F
Sbjct: 256 LIRRMLHADPTLRPSVAELLTDEFF 280

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 137/273 (50%), Gaps = 38/273 (13%)
Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           + +GSG FG   L+  +++     +K I  +R       +  EI   K L HPNII+  E
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNA---GR-FSEDEARYFFQQLISGVSYCHSMQICH 121
           V     ++ IVME   GGEL ERI +A   G+  SE       +Q+++ ++Y HS  + H
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVH 147
Query: 122 RDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYDG 178
           +DLK EN L  D SP   +KI DFG ++  L  S   ST   GT  Y+APEV  +R+   
Sbjct: 148 KDLKPENILFQDTSPHSPIKIIDFGLAE--LFKSDEHSTNAAGTALYMAPEVF-KRDVTF 204
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ----YKIPDYVHISQDCR 234
           K  D+WS GV +Y +L G  PF           T + +  VQ    YK P+Y   + +CR
Sbjct: 205 K-CDIWSAGVVMYFLLTGCLPF-----------TGTSLEEVQQKATYKEPNY---AVECR 249
Query: 235 -------NLLSRIFVANPSRRITIKEIKSHPWF 260
                  +LL ++   +P RR +  ++  H WF
Sbjct: 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           M++Y   + +G G F     + + +TKE+ A K + +   +  +    ++ EI  HK L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +P+++ F         + +V+E      L E        +E EARYF +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++ 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI   +Y +P   HI+     
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETS----CLKETYIRIKKNEYSVPR--HINPVASA 271
Query: 236 LLSRIFVANPSRRITIKEIKSHPWF 260
           L+ R+  A+P+ R ++ E+ +  +F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 85/265 (32%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           M++Y   + +G G F     + + +TKE+ A K + +   +  +    ++ EI  HK L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +P+++ F         + +V+E      L E        +E EARYF +Q I GV Y H+
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG  +K      R K   GTP YIAPEVL ++ 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  ++ D+WS G  LY +LVG  PFE        ++T  RI   +Y +P   HI+     
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETS----CLKETYIRIKKNEYSVPR--HINPVASA 271
Query: 236 LLSRIFVANPSRRITIKEIKSHPWF 260
           L+ R+  A+P+ R ++ E+ +  +F
Sbjct: 272 LIRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 87/283 (30%), Positives = 142/283 (50%), Gaps = 22/283 (7%)
Query: 8   KDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH-PNIIRF 63
           K++G G F V R   +K+T +  A K+++   RG    A +  EI   +  +  P +I  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICN---AGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            EV    + + +++EYAAGGE+F  +C    A   SE++     +Q++ GV Y H   I 
Sbjct: 95  HEVYENTSEIILILEYAAGGEIF-SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 121 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD-- 177
           H DLK +N LL    P   +KI DFG S+        +  +GTP Y+APE+L+   YD  
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN---YDPI 210
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
               D+W+ G+  Y++L    PF  +++ + +   IS++  V Y    +  +SQ   + +
Sbjct: 211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN-ISQV-NVDYSEETFSSVSQLATDFI 268
Query: 238 SRIFVANPSRRITIKEIKSHPWF----LKNL--PRELTETAQA 274
             + V NP +R T +   SH W      +NL  P E + ++Q 
Sbjct: 269 QSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQT 311

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 84/280 (30%), Positives = 149/280 (53%), Gaps = 24/280 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G+FG A L+++        +K I       K      RE+     ++H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARYFFQQLISGVSYC 114
           PNI++++E       L IVM+Y  GG+LF+RI NA +   F ED+   +F Q+   + + 
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 115 HSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPE 169
           H  +I HRD+K +N  L  DG+    +++ DFG ++  +L+S     ++ +GTP Y++PE
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGT----VQLGDFGIAR--VLNSTVELARACIGTPYYLSPE 195
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 229
           +   + Y+ K +D+W+ G  LY +    + FE      + +  + +I++  +  P  +H 
Sbjct: 196 ICENKPYNNK-SDIWALGCVLYELCTLKHAFE----AGSMKNLVLKIISGSFP-PVSLHY 249
Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 269
           S D R+L+S++F  NP  R ++  I    +  K + + L+
Sbjct: 250 SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLS 289

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 140/274 (51%), Gaps = 24/274 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E YE++K IG G FG  +L+R+K+T+++ AMK + +   I  + +      + +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P +++         +L +VMEY  GG+L   + N     E  AR++  +++  +   HSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 192
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 193 GFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 248
Query: 174 REYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVH 228
           +  D   G+  D WS GV LY MLVG  PF       +   T S+IM  +  +  PD   
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFY----ADSLVGTYSKIMNHKNSLTFPDDND 304
Query: 229 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
           IS++ +NL+         R  R  ++EIK H +F
Sbjct: 305 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 140/274 (51%), Gaps = 24/274 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E YE++K IG G FG  +L+R+K+T+++ AMK + +   I  + +      + +      
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P +++         +L +VMEY  GG+L   + N     E  AR++  +++  +   HSM
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 187
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 188 GFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 243
Query: 174 REYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVH 228
           +  D   G+  D WS GV LY MLVG  PF       +   T S+IM  +  +  PD   
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFY----ADSLVGTYSKIMNHKNSLTFPDDND 299
Query: 229 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
           IS++ +NL+         R  R  ++EIK H +F
Sbjct: 300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 140/274 (51%), Gaps = 24/274 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E YE++K IG G FG  +L+R+K+T+++ AMK + +   I  + +      + +      
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P +++         +L +VMEY  GG+L   + N     E  AR++  +++  +   HSM
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSM 192
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
              HRD+K +N LLD S    LK+ DFG     +K  ++  R  + VGTP YI+PEVL  
Sbjct: 193 GFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMV--RCDTAVGTPDYISPEVLKS 248
Query: 174 REYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVH 228
           +  D   G+  D WS GV LY MLVG  PF       +   T S+IM  +  +  PD   
Sbjct: 249 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFY----ADSLVGTYSKIMNHKNSLTFPDDND 304
Query: 229 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
           IS++ +NL+         R  R  ++EIK H +F
Sbjct: 305 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 137/272 (50%), Gaps = 22/272 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +  +  +  +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           + P + +      T   L  VMEY  GG+L   I   GRF E  A ++  ++  G+ +  
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N +LD      +KI DFG  K ++      K   GTP YIAPE+++ +
Sbjct: 139 SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ 196
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVHISQDC 233
            Y GK  D W+ GV LY ML G  PFE +++ + F+  +   +A    +  + V I   C
Sbjct: 197 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI---C 252
Query: 234 RNLLSRIFVANPSRRITI-----KEIKSHPWF 260
           + L+++    +P +R+       ++IK H +F
Sbjct: 253 KGLMTK----HPGKRLGCGPEGERDIKEHAFF 280

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 137/272 (50%), Gaps = 22/272 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +  +  +  +G G+FG   L   K T EL A+K +++   I D +V   ++  + L    
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           + P + +      T   L  VMEY  GG+L   I   GRF E  A ++  ++  G+ +  
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRR 174
           S  I +RDLKL+N +LD      +KI DFG  K ++      K   GTP YIAPE+++ +
Sbjct: 460 SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQ 517
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-DYVHISQDC 233
            Y GK  D W+ GV LY ML G  PFE +++ + F+  +   +A    +  + V I   C
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI---C 573
Query: 234 RNLLSRIFVANPSRRITI-----KEIKSHPWF 260
           + L+++    +P +R+       ++IK H +F
Sbjct: 574 KGLMTK----HPGKRLGCGPEGERDIKEHAFF 601

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 147/294 (50%), Gaps = 21/294 (7%)
Query: 2   EKYELMKDI-GSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--KQLRHP 58
           + Y+L K + G G  G      ++ T +  A+K +      D+  AR+ ++H  +    P
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGP 82
Query: 59  NIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVS 112
           +I+   +V     H    L I+ME   GGELF RI   G   F+E EA    + + + + 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           + HS  I HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEVL
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVL 201
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHI 229
              +YD K  D+WS GV +Y++L G  PF              RI   QY  P+  +  +
Sbjct: 202 GPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260
Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL--PRELTETAQAIYYRKEN 281
           S+D + L+  +   +P+ R+TI +  +HPW  +++  P+    TA+ +   K++
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH 314

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/294 (30%), Positives = 147/294 (50%), Gaps = 21/294 (7%)
Query: 2   EKYELMKDI-GSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH--KQLRHP 58
           + Y+L K + G G  G      ++ T +  A+K +      D+  AR+ ++H  +    P
Sbjct: 9   DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGP 63
Query: 59  NIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVS 112
           +I+   +V     H    L I+ME   GGELF RI   G   F+E EA    + + + + 
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 123
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPR-LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           + HS  I HRD+K EN L         LK+ DFG++K +  ++  ++   TP Y+APEVL
Sbjct: 124 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVL 182
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHI 229
              +YD K  D+WS GV +Y++L G  PF              RI   QY  P+  +  +
Sbjct: 183 GPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 241
Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL--PRELTETAQAIYYRKEN 281
           S+D + L+  +   +P+ R+TI +  +HPW  +++  P+    TA+ +   K++
Sbjct: 242 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH 295

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 139/283 (49%), Gaps = 20/283 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                  + +V+E      L E        +E EARY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 126 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 184
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++ +  ++ DVW
Sbjct: 145 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 185 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 244
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 202 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 255
Query: 245 PSRRITIKEIKSHPWFLKN-LPRELTETAQAIYYRKENPTFSL 286
           P+ R TI E+ +  +F    +P  L  T   I      P FS+
Sbjct: 256 PTARPTINELLNDEFFTSGYIPARLPITCLTI-----PPXFSI 293

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 15/272 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                  + +V+E      L E        +E EARY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 126 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 184
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++ +  ++ DVW
Sbjct: 149 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 205
Query: 185 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 244
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 206 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 259
Query: 245 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 275
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 260 PTARPTINELLNDEFFTSGYIPARLPITCLTI 291

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 135/272 (49%), Gaps = 15/272 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                  + +V+E      L E        +E EARY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 126 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 184
           L N  L+      +KI DFG  +K      R K+  GTP YIAPEVLS++ +  ++ DVW
Sbjct: 145 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 185 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 244
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 202 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 255
Query: 245 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 275
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 256 PTARPTINELLNDEFFTSGYIPARLPITCLTI 287

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 88/310 (28%), Positives = 137/310 (44%), Gaps = 54/310 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------VAREIINHKQL 55
           +KY L   IG G++GV R+     T+ + A+K + +      N      +  E+   K+L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFER--------------------ICNAGRF 95
            HPNI R  EV     ++ +VME   GG L ++                    IC     
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 96  SED----------EARYFFQ----------QLISGVSYCHSMQICHRDLKLENTLLDGSP 135
           +E+          E+  F Q          Q+ S + Y H+  ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 136 APRLKICDFGYSKSSLLHSRPK-----STVGTPAYIAPEVL-SRREYDGKLADVWSCGVT 189
           +  +K+ DFG SK     +  +     +  GTP ++APEVL +  E  G   D WS GV 
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 190 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI 249
           L+++L+GA PF    D     + +++ +   ++ P+Y  +S   R+LLS +   N   R 
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVDERF 323
Query: 250 TIKEIKSHPW 259
                  HPW
Sbjct: 324 DAMRALQHPW 333

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 137/271 (50%), Gaps = 20/271 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQL---- 55
           +  +  +  +G G+FG   L   K T+EL A+K +++   I D +V   ++  + L    
Sbjct: 18  LTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLD 77
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           + P + +      T   L  VMEY  GG+L   I   G+F E +A ++  ++  G+ + H
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRR 174
              I +RDLKL+N +LD      +KI DFG  K  ++     +   GTP YIAPE+++ +
Sbjct: 138 KRGIIYRDLKLDNVMLDSE--GHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQ 195
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            Y GK  D W+ GV LY ML G  PF+ +++ + F+     IM      P    +S++  
Sbjct: 196 PY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS----IMEHNVSYPK--SLSKEAV 248
Query: 235 NLLSRIFVANPSRRITI-----KEIKSHPWF 260
           ++   +   +P++R+       ++++ H +F
Sbjct: 249 SICKGLMTKHPAKRLGCGPEGERDVREHAFF 279

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 139/295 (47%), Gaps = 29/295 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQL 55
           ++ ++L++ IG G++    L+R K T  + AMK +++        ID     + +  +  
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++  ++   ++Y H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAYIAPEVL 171
              I +RDLKL+N LLD      +K+ D+G  K  L   RP  T     GTP YIAPE+L
Sbjct: 124 ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 178
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDY 226
              +Y G   D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP  
Sbjct: 179 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 235
Query: 227 VHISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAI 275
             +S    ++L      +P  R+         +I+ HP+F +N+  ++ E  Q +
Sbjct: 236 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMMEQKQVV 289

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 139/274 (50%), Gaps = 24/274 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----RH 57
           E Y+++K IG G FG  +L+R+K ++++ AMK + +   I  + +      + +      
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 134
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P +++         +L +VMEY  GG+L   + N     E  A+++  +++  +   HSM
Sbjct: 135 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM 193
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            + HRD+K +N LLD      LK+ DFG      ++ ++H    + VGTP YI+PEVL  
Sbjct: 194 GLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVHC--DTAVGTPDYISPEVLKS 249
Query: 174 REYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVH 228
           +  D   G+  D WS GV L+ MLVG  PF       +   T S+IM  +  +  P+   
Sbjct: 250 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFY----ADSLVGTYSKIMDHKNSLCFPEDAE 305
Query: 229 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
           IS+  +NL+         R  R  ++EIK HP+F
Sbjct: 306 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 339

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 15/272 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                  + +V+E      L E        +E EARY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 126 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 184
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++ +  ++ DVW
Sbjct: 143 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 199
Query: 185 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 244
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 200 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 253
Query: 245 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 275
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 254 PTARPTINELLNDEFFTSGYIPARLPITCLTI 285

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 139/295 (47%), Gaps = 29/295 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQL 55
           ++ ++L++ IG G++    L+R K T  + AMK +++        ID     + +  +  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++  ++   ++Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAYIAPEVL 171
              I +RDLKL+N LLD      +K+ D+G  K  L   RP  T     GTP YIAPE+L
Sbjct: 128 ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 182
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDY 226
              +Y G   D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP  
Sbjct: 183 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP-- 239
Query: 227 VHISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAI 275
             +S    ++L      +P  R+         +I+ HP+F +N+  ++ E  Q +
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMMEQKQVV 293

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 15/272 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                  + +V+E      L E        +E EARY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 126 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 184
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++ +  ++ DVW
Sbjct: 169 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 225
Query: 185 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 244
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 226 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 279
Query: 245 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 275
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 280 PTARPTINELLNDEFFTSGYIPARLPITCLTI 311

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 139/295 (47%), Gaps = 29/295 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQL 55
           ++ ++L++ IG G++    L+R K T  + AMK +++        ID     + +  +  
Sbjct: 19  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 78
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++  ++   ++Y H
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAYIAPEVL 171
              I +RDLKL+N LLD      +K+ D+G  K  L   RP  T     GTP YIAPE+L
Sbjct: 139 ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGL---RPGDTTSXFCGTPNYIAPEIL 193
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDY 226
              +Y G   D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP  
Sbjct: 194 RGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 252
Query: 227 VHISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAI 275
           + +     ++L      +P  R+         +I+ HP+F +N+  ++ E  Q +
Sbjct: 253 MSVK--AASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF-RNVDWDMMEQKQVV 304

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 85/272 (31%), Positives = 134/272 (49%), Gaps = 15/272 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRHPNIIRFKE 65
           +G G F     + + +TKE+ A K + +   +  +    ++ EI  H+ L H +++ F  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                  + +V+E      L E        +E EARY+ +Q++ G  Y H  ++ HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 126 LENTLLDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW 184
           L N  L+      +KI DFG  +K      R K   GTP YIAPEVLS++ +  ++ DVW
Sbjct: 167 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 223
Query: 185 SCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 244
           S G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +L+ ++   +
Sbjct: 224 SIGCIMYTLLVGKPPFETS----CLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 277
Query: 245 PSRRITIKEIKSHPWFLKN-LPRELTETAQAI 275
           P+ R TI E+ +  +F    +P  L  T   I
Sbjct: 278 PTARPTINELLNDEFFTSGYIPARLPITCLTI 309

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 122/275 (44%), Gaps = 36/275 (13%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIIN----------- 51
           +Y L   +G G FG          +  VA+K I R   +  +   + +            
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYA-AGGELFERICNAGRFSEDEARYFFQQLISG 110
                HP +IR  +   T     +V+E      +LF+ I   G   E  +R FF Q+++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 111 VSYCHSMQICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYI 166
           + +CHS  + HRD+K EN L+D   G      K+ DFG    +LLH  P +   GT  Y 
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGC----AKLIDFG--SGALLHDEPYTDFDGTRVYS 205
Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFRKTISRIMAVQYKIPD 225
            PE +SR +Y    A VWS G+ LY M+ G  PFE DQE           I+  +   P 
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----------ILEAELHFP- 253
Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             H+S DC  L+ R     PS R +++EI   PW 
Sbjct: 254 -AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 138/292 (47%), Gaps = 23/292 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-----GHKIDANVAREIINHKQL 55
           ++ ++L++ IG G++    L+R K T  + AM+ +++        ID     + +  +  
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++  ++   ++Y H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 174
              I +RDLKL+N LLD      +K+ D+G  K  L      ST  GTP YIAPE+L   
Sbjct: 171 ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFE-----DQEDPKNFRKTISRIMAVQYKIPDYVHI 229
           +Y G   D W+ GV ++ M+ G  PF+     D  D          I+  Q +IP    +
Sbjct: 229 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSL 285
Query: 230 SQDCRNLLSRIFVANPSRRI------TIKEIKSHPWFLKNLPRELTETAQAI 275
           S    ++L      +P  R+         +I+ HP+F +N+  ++ E  Q +
Sbjct: 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMMEQKQVV 336

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 136/276 (49%), Gaps = 23/276 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---------RGHKIDANVAREIINH 52
           +KY+    IG G   V R   ++ T    A+K +E         +  ++     RE    
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 53  KQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
           +Q+  HP+II   +   + + + +V +    GELF+ +      SE E R   + L+  V
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           S+ H+  I HRDLK EN LLD +   ++++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDN--MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 172 --SRREYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--P 224
             S  E     GK  D+W+CGV L+ +L G+ PF  +      R     IM  QY+   P
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSP 327
Query: 225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           ++   S   ++L+SR+   +P  R+T ++   HP+F
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  117 bits (294), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 144/280 (51%), Gaps = 23/280 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMR---NKNTKELVAMKYIERGHKID-------ANVAREII 50
           +E +EL+K +G+G +G   L+R     +T +L AMK +++   +            R+++
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
            H + + P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  
Sbjct: 113 EHIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAYIAP 168
           + + H + I +RD+KLEN LLD +    + + DFG SK  +     R     GT  Y+AP
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 169 EVLSRREYD-GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
           +++   +    K  D WS GV +Y +L GA PF   +  KN +  ISR + ++ + P   
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT-VDGEKNSQAEISRRI-LKSEPPYPQ 287
Query: 228 HISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLK 262
            +S   ++L+ R+ + +P +R+        EIK H +F K
Sbjct: 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 132/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 149 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 207 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 259
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 260 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 132/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 153 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 211 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 263
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 264 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 132/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  + VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 130 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 188 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 240
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 241 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 272

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F    ++I+ ++Y  P+        R
Sbjct: 210 SAX-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIF----AKIIKLEYDFPE--KFFPKAR 262
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 186 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 238
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 127 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 185 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 237
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 238 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 269

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 129 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 187 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 239
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 240 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 271

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 149 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 207 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 259
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 260 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 291

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 134 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 192 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 244
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 245 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 276

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 208 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 260
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 153 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 211 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 263
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 264 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 157 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 215 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 267
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 268 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 299

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F    ++I+ ++Y  P+        R
Sbjct: 210 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF----AKIIKLEYDFPE--KFFPKAR 262
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  G L + I   G F E   R++  +++S + Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R  S VGT  Y++PE+L+ +
Sbjct: 152 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        R
Sbjct: 210 S-ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKAR 262
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 294

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 130/272 (47%), Gaps = 22/272 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    V RE     +L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K        +R    VGT  Y++PE+L+ +
Sbjct: 155 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
               K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P         R
Sbjct: 213 S-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFP--AAFFPKAR 265
Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 266 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 297

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 137/290 (47%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           M+KYE ++ IG G +G     +N+ T E+VA+K +   +    + ++  REI   K+L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            NI+R  +V+ +   L +V E+      + F+  CN G    +  + F  QL+ G+ +CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CN-GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 174
           S  + HRDLK +N L++ +    LK+ DFG +++  +  R  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKIPDY 226
           +      D+WS G     +   A P     D  +  K I R++            K+PDY
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             ++   R+LL  +   NP +RI+ +E   HP+F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 131/281 (46%), Gaps = 8/281 (2%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           EKY + +D+G G FG+       ++K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
              E   +   L ++ E+ +G ++FERI  +A   +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           H D++ EN +     +  +KI +FG ++        +     P Y APEV  + +     
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV-HQHDVVSTA 183
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLS 238
            D+WS G  +YV+L G  PF  + +    ++ I  IM  +Y   +  +  IS +  + + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 239 RIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRK 279
           R+ V     R+T  E   HPW  + + R  T+  + + +R+
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRR 280

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+ +     ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 144/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+ +     ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 144/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 146/279 (52%), Gaps = 16/279 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  L R K++   VA+K ++ R  +    +  E++  +  +H N++   +  L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L ++ME+  GG L + I +  R +E++     + ++  ++Y H+  + HRD+K ++
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171
Query: 129 TL--LDGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            L  LDG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+SR  Y  ++ D+WS
Sbjct: 172 ILLTLDG----RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV-DIWS 226
Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+   + P    K +    +   K+ +   +S   R+ L R+ V +P
Sbjct: 227 LGIMVIEMVDGEPPYF-SDSPVQAMKRLRD--SPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 246 SRRITIKEIKSHPWFLK-NLPRELTETAQAIYYRKENPT 283
             R T +E+  HP+ L+  LP  L    Q   YRK+  T
Sbjct: 284 QERATAQELLDHPFLLQTGLPECLVPLIQ--LYRKQTST 320

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 144/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEA---RYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+S+C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/238 (33%), Positives = 120/238 (50%), Gaps = 29/238 (12%)
Query: 42  DANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVMEYAAGG--ELFERICNAGRFSE 97
           +ANV +EI   ++LRH N+I+  +V+       + +VMEY   G  E+ + +    RF  
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPV 108
Query: 98  DEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---- 153
            +A  +F QLI G+ Y HS  I H+D+K  N LL  +    LKI   G +++  LH    
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAEA--LHPFAA 164
Query: 154 -SRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK 211
               +++ G+PA+  PE+ +  + + G   D+WS GVTLY +  G YPFE      N  K
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYK 220
Query: 212 TISRIMAVQYKIPDYVHISQDC----RNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
               I    Y IP       DC     +LL  +    P++R +I++I+ H WF K  P
Sbjct: 221 LFENIGKGSYAIPG------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 235
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 144/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 56  R--HPNIIRFKEVVLTPTHLAIVME-YAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 234
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 273

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 144/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 250
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 251 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 249
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 250 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 288

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 235
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 187
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 235
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 236 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 274

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 144/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 144/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 144/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 245 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 144/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 9   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 68
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 69  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 128
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 234
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 235 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 273

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 8   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 67
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 68  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 127
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 185
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 233
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 234 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 272

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 277
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 278 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 230
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 136/290 (46%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           M+KYE ++ IG G +G     +N+ T E+VA+K +   +    + ++  REI   K+L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            NI+R  +V+ +   L +V E+      + F+  CN G    +  + F  QL+ G+ +CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS-CN-GDLDPEIVKSFLFQLLKGLGFCH 118
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 174
           S  + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKIPDY 226
           +      D+WS G     +     P     D  +  K I R++            K+PDY
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             ++   R+LL  +   NP +RI+ +E   HP+F
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 52  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 111
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 112 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 171
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 229
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 277
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 278 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 316

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 262
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 140/289 (48%), Gaps = 32/289 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNI++  +V+ T   L +V E+      +  +     G        Y FQ L+ G+++CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRR 174
           S ++ HRDLK EN L++   A  +K+ DFG +++  +  R     V T  Y APE+L   
Sbjct: 121 SHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 178
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY- 226
           +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY 
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 238
Query: 227 ---------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 24  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 83
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 84  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 143
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 201
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 249
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 250 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 288

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 141/289 (48%), Gaps = 32/289 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNI++  +V+ T   L +V E+ +    +  +     G        Y FQ L+ G+++CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRR 174
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L   
Sbjct: 124 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 181
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY- 226
           +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY 
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 227 ---------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 263
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 250
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 251 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 221
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 269
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 263
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 209
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 257
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 258 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 296

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 262
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSE 230
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 65
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 242 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHV--DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 141/289 (48%), Gaps = 32/289 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNI++  +V+ T   L +V E+ +    +  +     G        Y FQ L+ G+++CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRR 174
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L   
Sbjct: 123 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGC 180
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY- 226
           +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY 
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 240
Query: 227 ---------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 241 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 4   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 240 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SXE 263
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 62
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 132/279 (47%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 57  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 116
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 117 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 176
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 234
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 282
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 283 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 321

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 230
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SSE 262
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 38  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 97
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 98  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 157
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SXE 263
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 264 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 302

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 37  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 96
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 97  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 156
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q      V  S +
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQVFFRQRV--SXE 262
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 263 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 301

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 133/257 (51%), Gaps = 14/257 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   K+T + VA+K ++ R  +    +  E++  +   H N++      L
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +SY H+  + HRD+K ++
Sbjct: 113 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 171
Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+SR  Y G   D+WS
Sbjct: 172 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTEVDIWS 226
Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+ ++   +  R+      ++  ++ D   +S   R  L  + V  P
Sbjct: 227 LGIMVIEMIDGEPPYFNEPPLQAMRRIRD---SLPPRVKDLHKVSSVLRGFLDLMLVREP 283
Query: 246 SRRITIKEIKSHPWFLK 262
           S+R T +E+  HP FLK
Sbjct: 284 SQRATAQELLGHP-FLK 299

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 140/288 (48%), Gaps = 30/288 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           PNI++  +V+ T   L +V E+     + F              + +  QL+ G+++CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRRE 175
            ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L   +
Sbjct: 121 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY-- 226
           Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 227 --------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                           + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 139/288 (48%), Gaps = 30/288 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 5   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 64
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           PNI++  +V+ T   L +V E+     + F              + +  QL+ G+++CHS
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRRE 175
            ++ HRDLK +N L++   A  +K+ DFG +++  +  R     V T  Y APE+L   +
Sbjct: 125 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY-- 226
           Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 227 --------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                           + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 243 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 87/295 (29%), Positives = 138/295 (46%), Gaps = 34/295 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---------ANVAREIINH 52
           +KY  M  +GSG FG      +K   + V +K+I++   ++           V  EI   
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVME-YAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
            ++ H NII+  ++        +VME + +G +LF  I    R  E  A Y F+QL+S V
Sbjct: 84  SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK---STVGTPAYIAP 168
            Y     I HRD+K EN ++  +    +K+ DFG   S+    R K   +  GT  Y AP
Sbjct: 144 GYLRLKDIIHRDIKDENIVI--AEDFTIKLIDFG---SAAYLERGKLFYTFCGTIEYCAP 198
Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-PDYV 227
           EVL    Y G   ++WS GVTLY ++    PF + E+             V+  I P Y+
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TVEAAIHPPYL 246
Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP 282
            +S++  +L+S +    P RR T++++ + PW  +  P  L +      +R   P
Sbjct: 247 -VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ--PVNLADYTWEEVFRVNKP 298

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 91/315 (28%), Positives = 142/315 (45%), Gaps = 42/315 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKYE +  IG G++GV    RN++T ++VA+K     E    I     REI   KQL+H
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PN++   EV      L +V EY     L E         E   +    Q +  V++CH  
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----KSTVGTPAYIAPEVLSR 173
              HRD+K EN L+       +K+CDFG+++   L + P       V T  Y +PE+L  
Sbjct: 122 NCIHRDVKPENILITKHSV--IKLCDFGFAR---LLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF---RKTISRIM--------AVQY- 221
               G   DVW+ G     +L G   +  + D       RKT+  ++          QY 
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 222 ---KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF-----LKN 263
              KIPD          + +IS     LL      +P+ R+T +++  HP+F     +++
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296
Query: 264 LPRELTETAQAIYYR 278
           L +E  + A+ +Y++
Sbjct: 297 LAKEHDKPAENLYFQ 311

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+  I        + +   REI   K+L H
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 143/290 (49%), Gaps = 34/290 (11%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+  I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYC 114
           PNI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           HS ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L  
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY 226
            +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                             + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 25/279 (8%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 25  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 84
Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 85  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 144
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG S + L  +      GT  Y  PE + 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+             ++ ++     +S +
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXE 250
Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       P  R T +EI++HPW     LP+E  E
Sbjct: 251 CQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQETAE 289

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 134/260 (51%), Gaps = 13/260 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 219 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277
Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 278 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 332
Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 333 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 389
Query: 246 SRRITIKEIKSHPWFLKNLP 265
           ++R T  E+  HP+  K  P
Sbjct: 390 AQRATAAELLKHPFLAKAGP 409

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 143/289 (49%), Gaps = 34/289 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRHP 58
           E ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYCH 115
           NI++  +V+ T   L +V E+    +  ++  +A   +       + +  QL+ G+++CH
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 174
           S ++ HRDLK +N L++   A  +K+ DFG +++  +  R  +  V T  Y APE+L   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFE-DQEDPKNFR--KTISRIMAVQY----KIPDY- 226
           +Y     D+WS G     M+     F  D E  + FR  +T+     V +     +PDY 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 227 ---------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            + +D R+LLS++   +P++RI+ K   +HP+F
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 134/260 (51%), Gaps = 13/260 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 99  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 157
Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 158 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 212
Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 213 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 269
Query: 246 SRRITIKEIKSHPWFLKNLP 265
           ++R T  E+  HP+  K  P
Sbjct: 270 AQRATAAELLKHPFLAKAGP 289

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 134/260 (51%), Gaps = 13/260 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 97  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 155
Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 156 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 210
Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 211 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 267
Query: 246 SRRITIKEIKSHPWFLKNLP 265
           ++R T  E+  HP+  K  P
Sbjct: 268 AQRATAAELLKHPFLAKAGP 287

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 135/283 (47%), Gaps = 38/283 (13%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIR----FK 64
           +G G  G    + NK T+E  A+K ++   K      RE+  H +    P+I+R    ++
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
            +      L IVME   GGELF RI + G   F+E EA    + +   + Y HS+ I HR
Sbjct: 82  NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 141
Query: 123 DLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLA 181
           D+K EN L     P   LK+ DFG++K +                     +  +YD K  
Sbjct: 142 DVKPENLLYTSKRPNAILKLTDFGFAKET---------------------TGEKYD-KSC 179
Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLSR 239
           D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +S++ + L+  
Sbjct: 180 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 239
Query: 240 IFVANPSRRITIKEIKSHPWFLKN--LPRELTETAQAIYYRKE 280
           +    P++R+TI E  +HPW +++  +P+    T++ +   KE
Sbjct: 240 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 282

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 134/260 (51%), Gaps = 13/260 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 142 VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200
Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 201 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 255
Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 256 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 312
Query: 246 SRRITIKEIKSHPWFLKNLP 265
           ++R T  E+  HP+  K  P
Sbjct: 313 AQRATAAELLKHPFLAKAGP 332

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 134/260 (51%), Gaps = 13/260 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 146
Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 201
Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 202 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 258
Query: 246 SRRITIKEIKSHPWFLKNLP 265
           ++R T  E+  HP+  K  P
Sbjct: 259 AQRATAAELLKHPFLAKAGP 278

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 134/260 (51%), Gaps = 13/260 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           IG G+ G+  +   +++ +LVA+K ++ R  +    +  E++  +  +H N++      L
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 69  TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
               L +VME+  GG L + I    R +E++       ++  +S  H+  + HRD+K ++
Sbjct: 92  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 150
Query: 129 TLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
            LL  DG    R+K+ DFG+ ++ S    R K  VGTP ++APE++SR  Y G   D+WS
Sbjct: 151 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIWS 205
Query: 186 CGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANP 245
            G+ +  M+ G  P+ + E P    K I   +  + K  +   +S   +  L R+ V +P
Sbjct: 206 LGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDP 262
Query: 246 SRRITIKEIKSHPWFLKNLP 265
           ++R T  E+  HP+  K  P
Sbjct: 263 AQRATAAELLKHPFLAKAGP 282

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/331 (26%), Positives = 157/331 (47%), Gaps = 39/331 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E +E++K IG G FG   +++ KNT+ + AMK + +   +  A  A     R+++ +   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYC 114
           +    + +        HL +VM+Y  GG+L   +     +  ED AR++  +++  +   
Sbjct: 150 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 207
Query: 115 HSMQICHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSLLHSRPKSTVGTPAYIA 167
           H +   HRD+K +N LLD +   R       LK+ D G  +SS+        VGTP YI+
Sbjct: 208 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTPDYIS 260
Query: 168 PEVLSRREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--Y 221
           PE+L   E      G   D WS GV +Y ML G  PF      ++  +T  +IM  +  +
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHEERF 316
Query: 222 KIPDYV-HISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRELTETAQAIYY 277
           + P +V  +S++ ++L+ R+ + +  RR+    I++ K H  F + L  E     +A Y 
Sbjct: 317 QFPSHVTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHA-FFEGLNWENIRNLEAPYI 374
Query: 278 RKENPTFSLQSVEEITKIVEEAKVPPPVSRS 308
              +      + +    ++   ++ PP S +
Sbjct: 375 PDVSSPSDTSNFDVDDDVLRNTEILPPGSHT 405

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 88/331 (26%), Positives = 157/331 (47%), Gaps = 39/331 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E +E++K IG G FG   +++ KNT+ + AMK + +   +  A  A     R+++ +   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYC 114
           +    + +        HL +VM+Y  GG+L   +     +  ED AR++  +++  +   
Sbjct: 134 QWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSI 191
Query: 115 HSMQICHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSLLHSRPKSTVGTPAYIA 167
           H +   HRD+K +N LLD +   R       LK+ D G  +SS+        VGTP YI+
Sbjct: 192 HQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTPDYIS 244
Query: 168 PEVLSRREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--Y 221
           PE+L   E      G   D WS GV +Y ML G  PF      ++  +T  +IM  +  +
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHEERF 300
Query: 222 KIPDYV-HISQDCRNLLSRIFVANPSRRI---TIKEIKSHPWFLKNLPRELTETAQAIYY 277
           + P +V  +S++ ++L+ R+ + +  RR+    I++ K H  F + L  E     +A Y 
Sbjct: 301 QFPSHVTDVSEEAKDLIQRL-ICSRERRLGQNGIEDFKKHA-FFEGLNWENIRNLEAPYI 358
Query: 278 RKENPTFSLQSVEEITKIVEEAKVPPPVSRS 308
              +      + +    ++   ++ PP S +
Sbjct: 359 PDVSSPSDTSNFDVDDDVLRNTEILPPGSHT 389

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 31/280 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E YE++  IG+G++G  + +R K+  +++  K ++ G   +A    +  E+   ++L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVS 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCH-----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAY 165
            CH        + HRDLK  N  LDG     +K+ DFG ++  L H  S  K+ VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR-ILNHDTSFAKTFVGTPYY 182
Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP---FEDQEDPKNFRKTISRIMAVQYK 222
           ++PE ++R  Y+ K +D+WS G  LY +     P   F  +E     R+   R +  +Y 
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY- 240
Query: 223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
                  S +   +++R+       R +++EI  +P  L+
Sbjct: 241 -------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 138/280 (49%), Gaps = 31/280 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E YE++  IG+G++G  + +R K+  +++  K ++ G   +A    +  E+   ++L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVS 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCH-----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKSTVGTPAY 165
            CH        + HRDLK  N  LDG     +K+ DFG ++  L H  S  K+ VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR-ILNHDTSFAKAFVGTPYY 182
Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP---FEDQEDPKNFRKTISRIMAVQYK 222
           ++PE ++R  Y+ K +D+WS G  LY +     P   F  +E     R+   R +  +Y 
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY- 240
Query: 223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
                  S +   +++R+       R +++EI  +P  L+
Sbjct: 241 -------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 81/280 (28%), Positives = 136/280 (48%), Gaps = 31/280 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E YE++  IG+G++G  + +R K+  +++  K ++ G   +A    +  E+   ++L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVS 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 113 YCH-----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKSTVGTPAY 165
            CH        + HRDLK  N  LDG     +K+ DFG ++  L H     K  VGTP Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR-ILNHDEDFAKEFVGTPYY 182
Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP---FEDQEDPKNFRKTISRIMAVQYK 222
           ++PE ++R  Y+ K +D+WS G  LY +     P   F  +E     R+   R +  +Y 
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY- 240
Query: 223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
                  S +   +++R+       R +++EI  +P  L+
Sbjct: 241 -------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 121/252 (48%), Gaps = 25/252 (9%)
Query: 30  VAMKYIERGHKID-------ANVAREIINHKQLR--HPNIIRFKEVVLTPTHLAIVMEYA 80
           VA+K++E+    D         V  E++  K++      +IR  +    P    +++E  
Sbjct: 79  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 138
Query: 81  AG-GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRL 139
               +LF+ I   G   E+ AR FF Q++  V +CH+  + HRD+K EN L+D +    L
Sbjct: 139 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-EL 197
Query: 140 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP 199
           K+ DFG S + L  +      GT  Y  PE +    Y G+ A VWS G+ LY M+ G  P
Sbjct: 198 KLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 256
Query: 200 FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
           FE  E+             ++ ++     +S +C++L+       PS R T +EI++HPW
Sbjct: 257 FEHDEE------------IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 304
Query: 260 FLKN-LPRELTE 270
                LP+E  E
Sbjct: 305 MQDVLLPQETAE 316

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 130/252 (51%), Gaps = 12/252 (4%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G +G+    R+ + +  +A+K I ER  +    +  EI  HK L+H NI+++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 69  TPTHLAIVMEYAAGGELFERI-CNAGRFSEDEAR--YFFQQLISGVSYCHSMQICHRDLK 125
               + I ME   GG L   +    G   ++E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 126 LENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR--REYDGKLAD 182
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +  R Y GK AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAAD 207
Query: 183 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 242
           +WS G T+  M  G  PF +  +P+     +  +  V  +IP+   +S + +  + + F 
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPE--SMSAEAKAFILKCFE 264
Query: 243 ANPSRRITIKEI 254
            +P +R    ++
Sbjct: 265 PDPDKRACANDL 276

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 130/252 (51%), Gaps = 12/252 (4%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G +G+    R+ + +  +A+K I ER  +    +  EI  HK L+H NI+++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 69  TPTHLAIVMEYAAGGELFERI-CNAGRFSEDEAR--YFFQQLISGVSYCHSMQICHRDLK 125
               + I ME   GG L   +    G   ++E    ++ +Q++ G+ Y H  QI HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 126 LENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR--REYDGKLAD 182
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +  R Y GK AD
Sbjct: 136 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY-GKAAD 193
Query: 183 VWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV 242
           +WS G T+  M  G  PF +  +P+     +  +  V  +IP+   +S + +  + + F 
Sbjct: 194 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPE--SMSAEAKAFILKCFE 250
Query: 243 ANPSRRITIKEI 254
            +P +R    ++
Sbjct: 251 PDPDKRACANDL 262

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 138/293 (47%), Gaps = 36/293 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N N  E  A+K I   +    I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            NI++  +V+ T   L +V E+      +L + +C  G      A+ F  QL++G++YCH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 174
             ++ HRDLK +N L++      LKI DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPDY 226
           +      D+WS G     M+ GA  F    +     + I RI+            ++P Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKY 234
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
                             + +   +LLS++   +P++RIT K+   H +F +N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/269 (30%), Positives = 127/269 (47%), Gaps = 25/269 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR 56
           E+Y+++  +G G      L  +      VA+K I     E+   +     RE+ N  QL 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETL-KRFEREVHNSSQLS 69
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           H NI+   +V        +VMEY  G  L E I + G  S D A  F  Q++ G+ + H 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRR 174
           M+I HRD+K +N L+D +    LKI DFG +K  S    ++    +GT  Y +PE  ++ 
Sbjct: 130 MRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKG 186
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-RIMAVQYKIPDYV-----H 228
           E   +  D++S G+ LY MLVG  PF       N    +S  I  +Q  +P+        
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPF-------NGETAVSIAIKHIQDSVPNVTTDVRKD 239
Query: 229 ISQDCRNLLSRIFVANPSRRI-TIKEIKS 256
           I Q   N++ R    + + R  TI+E+K 
Sbjct: 240 IPQSLSNVILRATEKDKANRYKTIQEMKD 268

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 137/277 (49%), Gaps = 26/277 (9%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVA-----REIINHKQL 55
           E +E++K IG G FG   +++ KN  ++ AMK + +   +  A  A     R+++ +   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYC 114
           +    + +        +L +VM+Y  GG+L   +     R  E+ AR++  +++  +   
Sbjct: 134 KWITTLHY--AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLS 172
           H +   HRD+K +N L+D +   RL   DFG     +     +S+  VGTP YI+PE+L 
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLA--DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 173 RREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--AVQYKIPDY 226
             E      G   D WS GV +Y ML G  PF      ++  +T  +IM    +++ P  
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY----AESLVETYGKIMNHKERFQFPTQ 305
Query: 227 V-HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
           V  +S++ ++L+ R+  +   R  +  I++ K HP+F
Sbjct: 306 VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 139/279 (49%), Gaps = 19/279 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------KIPDYVHI 229
             + +D+WS G++L  M VG YP    +  ++ R  ++    + Y       K+P  V  
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGV-F 238
Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
           S + ++ +++  + NP+ R  +K++  H +  ++   E+
Sbjct: 239 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 277

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ Y 
Sbjct: 139 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 250
Query: 238 SRIFVANPSRRITIKEIKSHPWFLK 262
           +R    +  +R + KE+  H  FLK
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 89/299 (29%), Positives = 133/299 (44%), Gaps = 33/299 (11%)
Query: 4   YELMKDI-GSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLR-HPN 59
           Y+L +D+ G G     +   N  T +  A+K IE+  GH I + V RE+    Q + H N
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRN 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           ++   E         +V E   GG +   I     F+E EA    Q + S + + H+  I
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 120 CHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS--RPKST------VGTPAYIAPEV 170
            HRDLK EN L +  +    +KICDFG      L+    P ST       G+  Y+APEV
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 171 LSRRE-----YDGKLADVWSCGVTLYVMLVGAYPF-----------EDQEDPKNFRKTIS 214
           +         YD K  D+WS GV LY++L G  PF             +  P        
Sbjct: 193 VEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251
Query: 215 RIMAVQYKIP--DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            I   +Y+ P  D+ HIS   ++L+S++ V +  +R++  ++  HPW     P     T
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 84/293 (28%), Positives = 137/293 (46%), Gaps = 36/293 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N N  E  A+K I   +    I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            NI++  +V+ T   L +V E+      +L + +C  G      A+ F  QL++G++YCH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 174
             ++ HRDLK +N L++      LKI DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPDY 226
           +      D+WS G     M+ G   F    +     + I RI+            ++P Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKY 234
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
                             + +   +LLS++   +P++RIT K+   H +F +N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 134/287 (46%), Gaps = 34/287 (11%)
Query: 10  IGSGNFG-VARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLR-HPNIIRFKE 65
           +G G +  V   +  +N KE  A+K IE+  GH   + V RE+    Q + + NI+   E
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEY-AVKIIEKQAGHS-RSRVFREVETLYQCQGNKNILELIE 78
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLK 125
                T   +V E   GG +   I     F+E EA    + + + + + H+  I HRDLK
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLK 138
Query: 126 LENTLLDGSP--APRLKICDFGYSKSSLLH------SRPKSTV--GTPAYIAPEVL---- 171
            EN L + SP     +KICDF       L+      + P+ T   G+  Y+APEV+    
Sbjct: 139 PENILCE-SPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ--EDPKNFRKTISR---------IMAVQ 220
            +  +  K  D+WS GV LY+ML G  PF      D    R  + R         I   +
Sbjct: 198 DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 221 YKIP--DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
           Y+ P  D+ HIS + ++L+S++ V +  +R++  ++  HPW     P
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAP 304

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ Y 
Sbjct: 139 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY- 193
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 250
Query: 238 SRIFVANPSRRITIKEIKSHPWFLK 262
           +R    +  +R + KE+  H  FLK
Sbjct: 251 NRCLEMDVEKRGSAKELLQHQ-FLK 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ Y 
Sbjct: 139 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAY- 193
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 250
Query: 238 SRIFVANPSRRITIKEIKSHPWFLK 262
           +R    +  +R + KE+  H  FLK
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 139
Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV++R+ Y 
Sbjct: 140 HRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY- 194
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 251
Query: 238 SRIFVANPSRRITIKEIKSHPWFLK 262
           +R    +  +R + KE+  H  FLK
Sbjct: 252 NRCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 134/290 (46%), Gaps = 35/290 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           MEKY+ ++ +G G +GV    ++   + +VA+K I        I +   REI   K+L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCH 115
           PNI+   +V+ +   L +V E+       +++ +  +    + + + +  QL+ GV++CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 174
             +I HRDLK +N L++   A  LK+ DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-------------------- 214
           +      D+WS G     M+ G   F    D     K  S                    
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 215 -RIMAVQYKIPDYVHISQDCR---NLLSRIFVANPSRRITIKEIKSHPWF 260
            R   V  K P    I   C+   +LLS +   +P++RI+ ++  +HP+F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 128/266 (48%), Gaps = 12/266 (4%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LR 56
            + +E+++ IG G+FG   +++  +TK++ AMKY+ +   ++ N  R +    Q    L 
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HP ++           + +V++   GG+L   +     F E+  + F  +L+  + Y  +
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K +N LLD      + I DF  +      ++  +  GT  Y+APE+ S R+ 
Sbjct: 134 QRIIHRDMKPDNILLDEH--GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 177 DGK--LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            G     D WS GVT Y +L G  P+  +    + ++ +          P     SQ+  
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSA--WSQEMV 248
Query: 235 NLLSRIFVANPSRRIT-IKEIKSHPW 259
           +LL ++   NP +R + + ++++ P+
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPY 274

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 137/293 (46%), Gaps = 36/293 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N N  E  A+K I   +    I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            NI++  +V+ T   L +V E+      +L + +C  G      A+ F  QL++G++YCH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 174
             ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPDY 226
           +      D+WS G     M+ G   F    +     + I RI+            ++P Y
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR-IFRILGTPNSKNWPNVTELPKY 234
Query: 227 ----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
                             + +   +LLS++   +P++RIT K+   H +F +N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 134/290 (46%), Gaps = 35/290 (12%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
           MEKY+ ++ +G G +GV    ++   + +VA+K I        I +   REI   K+L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHH 78
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCH 115
           PNI+   +V+ +   L +V E+       +++ +  +    + + + +  QL+ GV++CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRR 174
             +I HRDLK +N L++   A  LK+ DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS-------------------- 214
           +      D+WS G     M+ G   F    D     K  S                    
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 215 -RIMAVQYKIPDYVHISQDCR---NLLSRIFVANPSRRITIKEIKSHPWF 260
            R   V  K P    I   C+   +LLS +   +P++RI+ ++  +HP+F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVI 139
Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGY-SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HR++K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV++R+ Y 
Sbjct: 140 HRNIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY- 194
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           G   D+WS G+    M+ G  P+ + E+P      I+     + + P+   +S   R+ L
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQNPE--KLSAIFRDFL 251
Query: 238 SRIFVANPSRRITIKEIKSHPWFLK 262
           +R    +  +R + KE+  H  FLK
Sbjct: 252 NRCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 21/284 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIR 62
           +E++ ++G G FG     +NK T  L A K I+ +  +   +   EI       HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  ++Y H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVL-----SR 173
           RDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           R YD K ADVWS G+TL + +    P   + +P      I++        P     S + 
Sbjct: 215 RPYDYK-ADVWSLGITL-IEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS--RWSSNF 270
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFL--KNLP-RELTETAQA 274
           ++ L +    N   R T  ++  HP+     N P REL   A+A
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKA 314

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 21/284 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIR 62
           +E++ ++G G FG     +NK T  L A K I+ +  +   +   EI       HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  ++Y H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVL-----SR 173
           RDLK  N L  LDG     +K+ DFG S K++    R  S +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 214
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           R YD K ADVWS G+TL + +    P   + +P      I++        P     S + 
Sbjct: 215 RPYDYK-ADVWSLGITL-IEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS--RWSSNF 270
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFL--KNLP-RELTETAQA 274
           ++ L +    N   R T  ++  HP+     N P REL   A+A
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKA 314

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/300 (28%), Positives = 135/300 (45%), Gaps = 44/300 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           + YEL + IGSG   V +       KE VA+K I  E+       + +EI    Q  HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICN--------AGRFSEDEARYFFQQLISGV 111
           I+ +    +    L +VM+  +GG + + I +        +G   E       ++++ G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 112 SYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSK-----SSLLHSRPKST-VGTP 163
            Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ + T VGTP
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 164 AYIAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFED-----------QEDPKNFRK 211
            ++APEV+ + R YD K AD+WS G+T   +  GA P+             Q DP +   
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249
Query: 212 TI-SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE 270
            +  + M  +Y         +  R ++S     +P +R T  E+  H +F K   +E  +
Sbjct: 250 GVQDKEMLKKY--------GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQ 301

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/273 (28%), Positives = 130/273 (47%), Gaps = 28/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q     
Sbjct: 23  ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           + ++    L  + L I+MEY  GG   + +  AG F E +     ++++ G+ Y HS + 
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKK 141
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREYD 177
            HRD+K  N LL  S    +K+ DFG +   L  ++ K  + VGTP ++APEV+ +  YD
Sbjct: 142 IHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD 198
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 230
            K AD+WS G+T   +  G  P  D          PKN   T+         + D+   +
Sbjct: 199 SK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTL---------VGDF---T 245
Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           +  +  +      +PS R T KE+  H + +KN
Sbjct: 246 KSFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 278

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 88/299 (29%), Positives = 132/299 (44%), Gaps = 33/299 (11%)
Query: 4   YELMKDI-GSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLR-HPN 59
           Y+L +D+ G G     +   N  T +  A+K IE+  GH I + V RE+    Q + H N
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRN 72
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           ++   E         +V E   GG +   I     F+E EA    Q + S + + H+  I
Sbjct: 73  VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 120 CHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHS--RPKST------VGTPAYIAPEV 170
            HRDLK EN L +  +    +KICDF       L+    P ST       G+  Y+APEV
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 171 LSRRE-----YDGKLADVWSCGVTLYVMLVGAYPF-----------EDQEDPKNFRKTIS 214
           +         YD K  D+WS GV LY++L G  PF             +  P        
Sbjct: 193 VEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251
Query: 215 RIMAVQYKIP--DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            I   +Y+ P  D+ HIS   ++L+S++ V +  +R++  ++  HPW     P     T
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 132/292 (45%), Gaps = 44/292 (15%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           + YEL + IGSG   V +       KE VA+K I  E+       + +EI    Q  HPN
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICN--------AGRFSEDEARYFFQQLISGV 111
           I+ +    +    L +VM+  +GG + + I +        +G   E       ++++ G+
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 112 SYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSK-----SSLLHSRPKST-VGTP 163
            Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ + T VGTP
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 164 AYIAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFED-----------QEDPKNFRK 211
            ++APEV+ + R YD K AD+WS G+T   +  GA P+             Q DP +   
Sbjct: 186 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 244
Query: 212 TI-SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
            +  + M  +Y         +  R ++S     +P +R T  E+  H +F K
Sbjct: 245 GVQDKEMLKKY--------GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 135/273 (49%), Gaps = 13/273 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 143 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 199
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-AVQYKIPDYVHISQDCRN 235
             + +D+WS G++L  M VG YP           + +  I+     K+P  V  S + ++
Sbjct: 200 SVQ-SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGV-FSLEFQD 257
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
            +++  + NP+ R  +K++  H +  ++   E+
Sbjct: 258 FVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 290

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 126/271 (46%), Gaps = 31/271 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E +++++ +G G++G      +K T ++VA+K +     +   + +EI   +Q   P+++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVV 87
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++       T L IVMEY   G + + I       +EDE     Q  + G+ Y H M+  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRD+K  N LL+       K+ DFG + + +   ++    +GTP ++APEV+    Y+  
Sbjct: 148 HRDIKAGNILLNTE--GHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC- 204
Query: 180 LADVWSCGVTLYVMLVGAYPFED-----------QEDPKNFRKTISRIMAVQYKIPDYVH 228
           +AD+WS G+T   M  G  P+ D              P  FRK            P+   
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK------------PEL-- 250
Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
            S +  + + +  V +P +R T  ++  HP+
Sbjct: 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHPF 281

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 134/284 (47%), Gaps = 21/284 (7%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLRHPNIIR 62
           +E++ ++G G FG     +NK T  L A K I+ +  +   +   EI       HPNI++
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQICH 121
             +      +L I++E+ AGG +   +    R  +E + +   +Q +  ++Y H  +I H
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 158
Query: 122 RDLKLENTL--LDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVL-----SR 173
           RDLK  N L  LDG     +K+ DFG S K++    R    +GTP ++APEV+       
Sbjct: 159 RDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKD 214
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           R YD K ADVWS G+TL + +    P   + +P      I++        P     S + 
Sbjct: 215 RPYDYK-ADVWSLGITL-IEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS--RWSSNF 270
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFL--KNLP-RELTETAQA 274
           ++ L +    N   R T  ++  HP+     N P REL   A+A
Sbjct: 271 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAKA 314

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 130/256 (50%), Gaps = 18/256 (7%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           E+ + +G G FGV  + + K   + VA+K IE   +  A +  E+    ++ HPNI++  
Sbjct: 12  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 68
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNA---GRFSEDEARYFFQQLISGVSYCHSMQ--- 118
              L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV+Y HSMQ   
Sbjct: 69  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           + HRDLK  N LL       LKICDFG +     H    +  G+ A++APEV     Y  
Sbjct: 127 LIHRDLKPPNLLLVAG-GTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSE 183
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 238
           K  DV+S G+ L+ ++    PF++   P  FR  I   +    + P   ++ +   +L++
Sbjct: 184 K-CDVFSWGIILWEVITRRKPFDEIGGPA-FR--IMWAVHNGTRPPLIKNLPKPIESLMT 239
Query: 239 RIFVANPSRRITIKEI 254
           R +  +PS+R +++EI
Sbjct: 240 RCWSKDPSQRPSMEEI 255

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 109/210 (51%), Gaps = 8/210 (3%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMK-YIERGH-KIDANVA-REIINHKQLRH 57
           MEKYE +  +G G++G+    RNK+T  +VA+K ++E    K+   +A REI   KQLRH
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARYFFQQLISGVSYCHS 116
            N++   EV        +V E+     L +  +   G   +   +Y FQ +I+G+ +CHS
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ-IINGIGFCHS 142
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRRE 175
             I HRD+K EN L+  S +  +K+CDFG++++           V T  Y APE+L    
Sbjct: 143 HNIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQED 205
             GK  DVW+ G  +  M +G   F    D
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 130/256 (50%), Gaps = 18/256 (7%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           E+ + +G G FGV  + + K   + VA+K IE   +  A +  E+    ++ HPNI++  
Sbjct: 11  EVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESESERKAFIV-ELRQLSRVNHPNIVKLY 67
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNA---GRFSEDEARYFFQQLISGVSYCHSMQ--- 118
              L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV+Y HSMQ   
Sbjct: 68  GACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           + HRDLK  N LL       LKICDFG +     H    +  G+ A++APEV     Y  
Sbjct: 126 LIHRDLKPPNLLLVAG-GTVLKICDFGTACDIQTHM--TNNKGSAAWMAPEVFEGSNYSE 182
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 238
           K  DV+S G+ L+ ++    PF++   P  FR  I   +    + P   ++ +   +L++
Sbjct: 183 K-CDVFSWGIILWEVITRRKPFDEIGGPA-FR--IMWAVHNGTRPPLIKNLPKPIESLMT 238
Query: 239 RIFVANPSRRITIKEI 254
           R +  +PS+R +++EI
Sbjct: 239 RCWSKDPSQRPSMEEI 254

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 130/274 (47%), Gaps = 22/274 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDAN--VAREIIN 51
           M  + + + IG G FG     R  +T ++ AMK +++       G  +  N  +   +++
Sbjct: 187 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 246
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
                 P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+
Sbjct: 247 TGDC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
            + H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL
Sbjct: 305 EHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVL 361
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            +       AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S 
Sbjct: 362 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSP 418
Query: 232 DCRNLLSRIFVANPSRRITI-----KEIKSHPWF 260
           + R+LL  +   + +RR+       +E+K  P+F
Sbjct: 419 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 452

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 130/274 (47%), Gaps = 22/274 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDAN--VAREIIN 51
           M  + + + IG G FG     R  +T ++ AMK +++       G  +  N  +   +++
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
                 P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+
Sbjct: 248 TGDC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
            + H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL
Sbjct: 306 EHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVL 362
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            +       AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSP 419
Query: 232 DCRNLLSRIFVANPSRRITI-----KEIKSHPWF 260
           + R+LL  +   + +RR+       +E+K  P+F
Sbjct: 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 130/274 (47%), Gaps = 22/274 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDAN--VAREIIN 51
           M  + + + IG G FG     R  +T ++ AMK +++       G  +  N  +   +++
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
                 P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+
Sbjct: 248 TGDC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
            + H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL
Sbjct: 306 EHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVL 362
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            +       AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSP 419
Query: 232 DCRNLLSRIFVANPSRRITI-----KEIKSHPWF 260
           + R+LL  +   + +RR+       +E+K  P+F
Sbjct: 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 130/274 (47%), Gaps = 22/274 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------GHKIDAN--VAREIIN 51
           M  + + + IG G FG     R  +T ++ AMK +++       G  +  N  +   +++
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
                 P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+
Sbjct: 248 TGDC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
            + H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL
Sbjct: 306 EHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVL 362
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            +       AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S 
Sbjct: 363 QKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKHEIDRMTLTMAVELPD--SFSP 419
Query: 232 DCRNLLSRIFVANPSRRITI-----KEIKSHPWF 260
           + R+LL  +   + +RR+       +E+K  P+F
Sbjct: 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q   P 
Sbjct: 27  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREYD 177
            HRD+K  N LL  S    +K+ DFG +   L  ++ K  + VGTP ++APEV+ +  YD
Sbjct: 146 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 202
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 230
            K AD+WS G+T   +  G  P  +          PKN   T+              + S
Sbjct: 203 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG------------NYS 249
Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           +  +  +       PS R T KE+  H + L+N
Sbjct: 250 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 282

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q   P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREYD 177
            HRD+K  N LL  S    +K+ DFG +   L  ++ K  + VGTP ++APEV+ +  YD
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 182
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 230
            K AD+WS G+T   +  G  P  +          PKN   T+              + S
Sbjct: 183 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG------------NYS 229
Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           +  +  +       PS R T KE+  H + L+N
Sbjct: 230 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 28/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q   P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 177
            HRD+K  N LL  S    +K+ DFG +   L  ++ K    VGTP ++APEV+ +  YD
Sbjct: 141 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 197
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 230
            K AD+WS G+T   +  G  P  +          PKN   T+              + S
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG------------NYS 244
Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           +  +  +       PS R T KE+  H + L+N
Sbjct: 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/296 (29%), Positives = 136/296 (45%), Gaps = 42/296 (14%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           +++ ++ +G+G +       NK T   VA+K +  +      +   REI   K+L+H NI
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65
Query: 61  IRFKEVVLTPTHLAIVMEYAAGG---ELFER-ICNAGRFSE-DEARYFFQQLISGVSYCH 115
           +R  +V+ T   L +V E+        +  R + N  R  E +  +YF  QL+ G+++CH
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVL-SR 173
             +I HRDLK +N L++     +LK+ DFG +++  +  +   S V T  Y AP+VL   
Sbjct: 126 ENKILHRDLKPQNLLIN--KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIPD 225
           R Y   + D+WSCG  L  M+ G   F    D +   K I  IM            K+P 
Sbjct: 184 RTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQL-KLIFDIMGTPNESLWPSVTKLPK 241
Query: 226 Y-VHISQ----DCR----------------NLLSRIFVANPSRRITIKEIKSHPWF 260
           Y  +I Q    D R                + L  +   NP  R++ K+   HPWF
Sbjct: 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 28/273 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I+         ++ +EI    Q   P 
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 177
            HRD+K  N LL  S    +K+ DFG +   L  ++ K    VGTP ++APEV+ +  YD
Sbjct: 126 IHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 182
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIMAVQYKIPDYVHIS 230
            K AD+WS G+T   +  G  P  +          PKN   T+              + S
Sbjct: 183 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG------------NYS 229
Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           +  +  +       PS R T KE+  H + L+N
Sbjct: 230 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 9/205 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPN 59
           E +  +  IG G+FG      + +TKE+VA+K I+         ++ +EI    Q   P 
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           I R+    L  T L I+MEY  GG   + +   G   E       ++++ G+ Y HS + 
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERK 137
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYD 177
            HRD+K  N LL  S    +K+ DFG +   L  ++ K    VGTP ++APEV+ +  YD
Sbjct: 138 IHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYD 194
Query: 178 GKLADVWSCGVTLYVMLVGAYPFED 202
            K AD+WS G+T   +  G  P  D
Sbjct: 195 FK-ADIWSLGITAIELAKGEPPNSD 218

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIRFKEVVL 68
           IG+G+FG         +   V +   +  H    N   RE+   K+LRHPNI+ F   V 
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 69  TPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQ--QLISGVSYCHSMQ--ICHRD 123
            P +L+IV EY + G L+  +  +G R   DE R       +  G++Y H+    I HR+
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164
Query: 124 LKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           LK  N L+D      +K+CDFG S+   S+ L S  KS  GTP ++APEVL R E   + 
Sbjct: 165 LKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVL-RDEPSNEK 219
Query: 181 ADVWSCGVTLYVMLVGAYPF 200
           +DV+S GV L+ +     P+
Sbjct: 220 SDVYSFGVILWELATLQQPW 239

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           +E+ + +G+G FG      +++T E VA+K    E   K       EI   K+L HPN++
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 62  RFKEV-----VLTPTHLAIV-MEYAAGGEL------FERICNAGRFSEDEARYFFQQLIS 109
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 133
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRL--KICDFGYSKSSLLHSRPKSTVGTPAYIA 167
            + Y H  +I HRDLK EN +L   P  RL  KI D GY+K           VGT  Y+A
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 200
           PE+L +++Y   + D WS G   +  + G  PF
Sbjct: 193 PELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/213 (33%), Positives = 101/213 (47%), Gaps = 21/213 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNII 61
           +E+ + +G+G FG      +++T E VA+K    E   K       EI   K+L HPN++
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 62  RFKEV-----VLTPTHLAIV-MEYAAGGEL------FERICNAGRFSEDEARYFFQQLIS 109
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 132
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRL--KICDFGYSKSSLLHSRPKSTVGTPAYIA 167
            + Y H  +I HRDLK EN +L   P  RL  KI D GY+K           VGT  Y+A
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF 200
           PE+L +++Y   + D WS G   +  + G  PF
Sbjct: 192 PELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 223

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 134/273 (49%), Gaps = 17/273 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 66
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+       VGT +Y++PE L    Y
Sbjct: 127 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDEMANEFVGTRSYMSPERLQGTHY 183
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-AVQYKIPDYVHISQDCRN 235
             + +D+WS G++L  M VG YP      P    + +  I+     K+P  V  S + ++
Sbjct: 184 SVQ-SDIWSMGLSLVEMAVGRYP----RPPMAIFELLDYIVNEPPPKLPSAV-FSLEFQD 237
Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
            +++  + NP+ R  +K++  H +  ++   E+
Sbjct: 238 FVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 270

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 101/200 (50%), Gaps = 14/200 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNIIRFKEVVL 68
           IG+G+FG         +   V +   +  H    N   RE+   K+LRHPNI+ F   V 
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 69  TPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQ--QLISGVSYCHSMQ--ICHRD 123
            P +L+IV EY + G L+  +  +G R   DE R       +  G++Y H+    I HRD
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRD 164
Query: 124 LKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           LK  N L+D      +K+CDFG S+   S  L S  K   GTP ++APEVL R E   + 
Sbjct: 165 LKSPNLLVDKKYT--VKVCDFGLSRLKASXFLXS--KXAAGTPEWMAPEVL-RDEPSNEK 219
Query: 181 ADVWSCGVTLYVMLVGAYPF 200
           +DV+S GV L+ +     P+
Sbjct: 220 SDVYSFGVILWELATLQQPW 239

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 130/291 (44%), Gaps = 37/291 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQL 55
           ++YE +  +G G F      R+KNT ++VA+K I+ GH+      I+    REI   ++L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISGVSY 113
            HPNII   +     +++++V ++       E I   N+   +    + +    + G+ Y
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLS 172
            H   I HRDLK  N LLD +    LK+ DFG +KS    +R     V T  Y APE+L 
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLF 185
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPF----EDQEDPKNFRKTISRIMAVQY----KIP 224
                G   D+W+ G  L  +L+   PF     D +      +T+      Q+     +P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244
Query: 225 DYV-----------HI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           DYV           HI      D  +L+  +F+ NP  RIT  +     +F
Sbjct: 245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/208 (35%), Positives = 107/208 (51%), Gaps = 25/208 (12%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-------LRHPNIIR 62
           IG G FG  ++ R     + VA+K     H  D ++++ I N +Q       L+HPNII 
Sbjct: 15  IGIGGFG--KVYRAFWIGDEVAVKAAR--HDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS---MQI 119
            + V L   +L +VME+A GG L  R+ +  R   D    +  Q+  G++Y H    + I
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 120 CHRDLKLENTLL-----DGSPAPR-LKICDFGYSKSSLLHSRPK-STVGTPAYIAPEVLS 172
            HRDLK  N L+     +G  + + LKI DFG ++    H   K S  G  A++APEV+ 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAAGAYAWMAPEVI- 186
Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPF 200
           R     K +DVWS GV L+ +L G  PF
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPF 214

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 39/293 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           ME Y  +  +G G +      ++K T  LVA+K I   H+  A     RE+   K L+H 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSM 117
           NI+   +++ T   L +V EY    +L + + + G   +    + F  QL+ G++YCH  
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEV-LSRRE 175
           ++ HRDLK +N L++      LK+ DFG +++  + ++   + V T  Y  P++ L   +
Sbjct: 120 KVLHRDLKPQNLLIN--ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177
Query: 176 YDGKLADVWSCGVTLYVMLVG--AYPFEDQEDPKNFRKTISRIMAV-------------- 219
           Y  ++ D+W  G   Y M  G   +P    E+  +F   I RI+                
Sbjct: 178 YSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSNEE 233
Query: 220 --QYKIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
              Y  P Y           +  D  +LL+++       RI+ ++   HP+FL
Sbjct: 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M +K T    A+K +    +++   A E++    L  P I+     V  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 156
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + +   G   ED A Y+  Q + G+ Y HS +I H D+K +N 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 130 LL--DGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLA 181
           LL  DGS A    +CDFG++         KS +      GT  ++APEV+  R  D K+ 
Sbjct: 217 LLSSDGSHA---ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV- 272
Query: 182 DVWSCGVTLYVMLVGAYPF 200
           DVWS    +  ML G +P+
Sbjct: 273 DVWSSCCMMLHMLNGCHPW 291

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 134/279 (48%), Gaps = 23/279 (8%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIR 62
           +EL++ +G+G +G     R+  T +L A+K ++     +  + +EI +  K   H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 63  FKEVVLTPT------HLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYC 114
           +    +          L +VME+   G + + I N       E+   Y  ++++ G+S+ 
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSR 173
           H  ++ HRD+K +N LL  +    +K+ DFG S        R  + +GTP ++APEV++ 
Sbjct: 146 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 174 RE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
            E     YD K +D+WS G+T   M  GA P  D   P      I R  A + K   +  
Sbjct: 204 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKW-- 259
Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
            S+  ++ +    V N S+R   +++  HP F+++ P E
Sbjct: 260 -SKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNE 296

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 125
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 186 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 242
Query: 177 DGKLADVWSCGVTLYVMLVGAYPF 200
             + +D+WS G++L  M VG YP 
Sbjct: 243 SVQ-SDIWSMGLSLVEMAVGRYPI 265

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 90
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 151 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 177 DGKLADVWSCGVTLYVMLVGAYP 199
             + +D+WS G++L  M VG YP
Sbjct: 208 SVQ-SDIWSMGLSLVEMAVGRYP 229

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M++K T    A+K +    +++     E++    L  P I+     V  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + I   G   ED A Y+  Q + G+ Y H+ +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 197
Query: 130 LLDGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLADV 183
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D K+ D+
Sbjct: 198 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 255
Query: 184 WSCGVTLYVMLVGAYPF 200
           WS    +  ML G +P+
Sbjct: 256 WSSCCMMLHMLNGCHPW 272

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 177 DGKLADVWSCGVTLYVMLVGAYPF 200
             + +D+WS G++L  M VG YP 
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 177 DGKLADVWSCGVTLYVMLVGAYPF 200
             + +D+WS G++L  M VG YP 
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPI 203

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M++K T    A+K +    +++     E++    L  P I+     V  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + I   G   ED A Y+  Q + G+ Y H+ +I H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 130 LLDGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLADV 183
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D K+ D+
Sbjct: 182 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 239
Query: 184 WSCGVTLYVMLVGAYPF 200
           WS    +  ML G +P+
Sbjct: 240 WSSCCMMLHMLNGCHPW 256

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 177 DGKLADVWSCGVTLYVMLVGAYP 199
             + +D+WS G++L  M VG YP
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 105/203 (51%), Gaps = 11/203 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   + +K +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 177 DGKLADVWSCGVTLYVMLVGAYP 199
             + +D+WS G++L  M VG YP
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYP 202

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 98/192 (51%), Gaps = 17/192 (8%)
Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           +++IG G+FG     R+    E+VA+K +    K      ++II      ++LRHPN I+
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 63  FKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++   L      +VMEY  G   +L E   +     E E        + G++Y HS  + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 177
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 178 GKLADVWSCGVT 189
           GK+ DVWS G+T
Sbjct: 193 GKV-DVWSLGIT 203

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 121/268 (45%), Gaps = 21/268 (7%)
Query: 7   MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           +++IG G+FG     R+    E+VA+K +    K      ++II      ++LRHPN I+
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 63  FKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++   L      +VMEY  G   +L E   +     E E        + G++Y HS  + 
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV---LSRREYD 177
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV   +   +YD
Sbjct: 177 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 231
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           GK+ DVWS G+T   +     P  +     N    +  I   +       H S+  RN +
Sbjct: 232 GKV-DVWSLGITCIELAERKPPLFNM----NAMSALYHIAQNESPALQSGHWSEYFRNFV 286
Query: 238 SRIFVANPSRRITIKEIKSHPWFLKNLP 265
                  P  R T + +  H + L+  P
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERP 314

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M +K T    A+K +    +++   A E++    L  P I+     V  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 137
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + +   G   ED A Y+  Q + G+ Y HS +I H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 130 LL--DGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLA 181
           LL  DGS A    +CDFG++         K  +      GT  ++APEV+  R  D K+ 
Sbjct: 198 LLSSDGSHA---ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV- 253
Query: 182 DVWSCGVTLYVMLVGAYPF 200
           DVWS    +  ML G +P+
Sbjct: 254 DVWSSCCMMLHMLNGCHPW 272

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G+FG    M++K T    A+K +    +++     E++    L  P I+     V  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 135
Query: 70  PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENT 129
              + I ME   GG L + I   G   ED A Y+  Q + G+ Y H+ +I H D+K +N 
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 130 LLDGSPAPRLKICDFGYSKSSLLHSRPKSTV------GTPAYIAPEVLSRREYDGKLADV 183
           LL  S   R  +CDFG++         KS +      GT  ++APEV+  +  D K+ D+
Sbjct: 196 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 253
Query: 184 WSCGVTLYVMLVGAYPF 200
           WS    +  ML G +P+
Sbjct: 254 WSSCCMMLHMLNGCHPW 270

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
           + +E + ++G+GN GV   ++++ +  ++A K I    +I   +  +II   Q+ H    
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 73
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-HS 116
           P I+ F     +   ++I ME+  GG L + +  A R  E+        ++ G++Y    
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            QI HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y+APE L    Y
Sbjct: 134 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMAPERLQGTHY 190
Query: 177 DGKLADVWSCGVTLYVMLVGAYPF 200
             + +D+WS G++L  + VG YP 
Sbjct: 191 SVQ-SDIWSMGLSLVELAVGRYPI 213

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 128/302 (42%), Gaps = 48/302 (15%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           +++Y  +  +G G +G      +  T E VA+K I   H+   +     RE+   K+L+H
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
            NII  K V+     L ++ EYA   +L + +      S    + F  QLI+GV++CHS 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 118 QICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSR 173
           +  HRDLK +N LL   D S  P LKI DFG +++  +  R  +  + T  Y  PE+L  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 174 REYDGKLADVWSCGVTLYVML--------------------------------VGAYPFE 201
             +     D+WS       ML                                V A P  
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW 271
Query: 202 DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
            Q  PK   KT+ R++              +  +LL+ +   +P +RI+ K    HP+F 
Sbjct: 272 KQSFPKFRGKTLKRVLGALL--------DDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323
Query: 262 KN 263
            N
Sbjct: 324 HN 325

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 116/261 (44%), Gaps = 22/261 (8%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLR 56
           +  + + K IG G F              VA+K ++    +DA    +  +EI   KQL 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVS 112
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIA 167
           + HS ++ HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y++
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMS 204
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
           PE +    Y+ K +D+WS G  LY M     PF    D  N      +I    Y      
Sbjct: 205 PERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPSD 261
Query: 228 HISQDCRNLLSRIFVANPSRR 248
           H S++ R L++     +P +R
Sbjct: 262 HYSEELRQLVNMCINPDPEKR 282

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 29/270 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVA-------MKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG     + K T +L A            +G++  A V ++I+     R   I+ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKVHSRF--IVS 249
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSYCHSMQ 118
                 T T L +VM    GG++   I N       F E  A ++  Q++SG+ + H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   EYD
Sbjct: 310 IIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQD-CRN 235
             + D ++ GVTLY M+    PF  + +    ++   R++      PD +   S+D C  
Sbjct: 368 FSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 236 LLSRIFVANPSRRITIKE-----IKSHPWF 260
           LL +    +P +R+  ++     +++HP F
Sbjct: 427 LLQK----DPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 29/270 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVA-------MKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG     + K T +L A            +G++  A V ++I+     R   I+ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKVHSRF--IVS 249
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSYCHSMQ 118
                 T T L +VM    GG++   I N       F E  A ++  Q++SG+ + H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   EYD
Sbjct: 310 IIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQD-CRN 235
             + D ++ GVTLY M+    PF  + +    ++   R++      PD +   S+D C  
Sbjct: 368 FSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 236 LLSRIFVANPSRRITIKE-----IKSHPWF 260
           LL +    +P +R+  ++     +++HP F
Sbjct: 427 LLQK----DPEKRLGFRDGSCDGLRTHPLF 452

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 29/270 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVA-------MKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG     + K T +L A            +G++  A V ++I+     R   I+ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKVHSRF--IVS 249
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSYCHSMQ 118
                 T T L +VM    GG++   I N       F E  A ++  Q++SG+ + H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   EYD
Sbjct: 310 IIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQD-CRN 235
             + D ++ GVTLY M+    PF  + +    ++   R++      PD +   S+D C  
Sbjct: 368 FSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 236 LLSRIFVANPSRRITIKE-----IKSHPWF 260
           LL +    +P +R+  ++     +++HP F
Sbjct: 427 LLQK----DPEKRLGFRDGSCDGLRTHPLF 452

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 135/291 (46%), Gaps = 30/291 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHP 58
           E +E++ ++G G FG     +NK T  L A K IE   +    D  V  EI+      HP
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEIL--ATCDHP 68
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSM 117
            I++          L I++E+  GG +   +    R  +E + +   +Q++  +++ HS 
Sbjct: 69  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 128
Query: 118 QICHRDLKLENTL--LDGSPAPRLKICDFGYSKSSL--LHSRPKSTVGTPAYIAPEV--- 170
           +I HRDLK  N L  L+G     +++ DFG S  +L  L  R  S +GTP ++APEV   
Sbjct: 129 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMC 183
Query: 171 --LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
             +    YD K AD+WS G+TL + +    P   + +P      I++        P    
Sbjct: 184 ETMKDTPYDYK-ADIWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--K 239
Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP-----RELTETAQA 274
            S + R+ L      NP  R +  ++  HP F+ ++      REL   A+A
Sbjct: 240 WSVEFRDFLKIALDKNPETRPSAAQLLEHP-FVSSITSNKALRELVAEAKA 289

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 30/281 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMK------YIERGHKIDANVAREIINHKQL 55
           + +E++K IG G F    +++ K T ++ AMK       ++RG        R+++ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYC 114
           R    + F        +L +VMEY  GG+L   +   G R   + AR++  +++  +   
Sbjct: 121 RWITQLHF--AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST------VGTPAYIAP 168
           H +   HRD+K +N LLD      +++ DFG    S L  R   T      VGTP Y++P
Sbjct: 179 HRLGYVHRDIKPDNILLD--RCGHIRLADFG----SCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 169 EVLSRREYDGKL------ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 222
           E+L                D W+ GV  Y M  G  PF      + + K +     +   
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292
Query: 223 IPDYVHISQDCRNLLSRIFVANPSR--RITIKEIKSHPWFL 261
           + D   + ++ R+ + R+     +R  R    + ++HP+F 
Sbjct: 293 LVDE-GVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFF 332

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 29/270 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVA-------MKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +G G FG     + K T +L A            +G++  A V ++I+     R   I+ 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ-GAMVEKKILAKVHSRF--IVS 249
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSYCHSMQ 118
                 T T L +VM    GG++   I N       F E  A ++  Q++SG+ + H   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+L   EYD
Sbjct: 310 IIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-YVHISQD-CRN 235
             + D ++ GVTLY M+    PF  + +    ++   R++      PD +   S+D C  
Sbjct: 368 FSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
Query: 236 LLSRIFVANPSRRITIKE-----IKSHPWF 260
           LL +    +P +R+  ++     +++HP F
Sbjct: 427 LLQK----DPEKRLGFRDGSCDGLRTHPLF 452

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 135/291 (46%), Gaps = 30/291 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHP 58
           E +E++ ++G G FG     +NK T  L A K IE   +    D  V  EI+      HP
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEIL--ATCDHP 76
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSM 117
            I++          L I++E+  GG +   +    R  +E + +   +Q++  +++ HS 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 118 QICHRDLKLENTL--LDGSPAPRLKICDFGYSKSSL--LHSRPKSTVGTPAYIAPEV--- 170
           +I HRDLK  N L  L+G     +++ DFG S  +L  L  R  S +GTP ++APEV   
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMC 191
Query: 171 --LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
             +    YD K AD+WS G+TL + +    P   + +P      I++        P    
Sbjct: 192 ETMKDTPYDYK-ADIWSLGITL-IEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--K 247
Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP-----RELTETAQA 274
            S + R+ L      NP  R +  ++  HP F+ ++      REL   A+A
Sbjct: 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHP-FVSSITSNKALRELVAEAKA 297

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 114/236 (48%), Gaps = 29/236 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHP 58
           ++YE+++ IG+G +GV    R + T + VA+K I     +  N  R   E+   K  +H 
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 59  NIIRFKEVVLTPT-------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
           NII  K++ L PT        + +V++     +L + I ++   + +  RYF  QL+ G+
Sbjct: 114 NIIAIKDI-LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGL 171
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPA 164
            Y HS Q+ HRDLK  N L++ +    LKI DFG ++   L + P          V T  
Sbjct: 172 KYMHSAQVIHRDLKPSNLLVNEN--CELKIGDFGMARG--LCTSPAEHQYFMTEYVATRW 227
Query: 165 YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
           Y APE+ LS  EY   + D+WS G     ML     F      KN+   +  IM V
Sbjct: 228 YRAPELMLSLHEYTQAI-DLWSVGCIFGEMLARRQLFPG----KNYVHQLQLIMMV 278

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 114/236 (48%), Gaps = 29/236 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHP 58
           ++YE+++ IG+G +GV    R + T + VA+K I     +  N  R   E+   K  +H 
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 59  NIIRFKEVVLTPT-------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
           NII  K++ L PT        + +V++     +L + I ++   + +  RYF  QL+ G+
Sbjct: 115 NIIAIKDI-LRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGL 172
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPA 164
            Y HS Q+ HRDLK  N L++ +    LKI DFG ++   L + P          V T  
Sbjct: 173 KYMHSAQVIHRDLKPSNLLVNEN--CELKIGDFGMARG--LCTSPAEHQYFMTEYVATRW 228
Query: 165 YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
           Y APE+ LS  EY   + D+WS G     ML     F      KN+   +  IM V
Sbjct: 229 YRAPELMLSLHEYTQAI-DLWSVGCIFGEMLARRQLFPG----KNYVHQLQLIMMV 279

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNII 61
           ++L   +G G +GV     +K T E+VA+K IE   K        REI   K  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHSM 117
               +   P       E     EL +    R+ +    S+D  +YF  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKS-------TVGTPAYI 166
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYR 189
Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFED-------------QEDPKNFRK 211
           APEV+       +  DVWSCG  L  + +    +P  D                  N  +
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 212 TISRIMAVQY--KIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            I    A +Y   +P Y           ++    +LL R+ V +P++RIT KE   HP+ 
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNII 61
           ++L   +G G +GV     +K T E+VA+K IE   K        REI   K  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHSM 117
               +   P       E     EL +    R+ +    S+D  +YF  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKST-------VGTPAYI 166
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYR 189
Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFED-------------QEDPKNFRK 211
           APEV+       +  DVWSCG  L  + +    +P  D                  N  +
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 212 TISRIMAVQY--KIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            I    A +Y   +P Y           ++    +LL R+ V +P++RIT KE   HP+ 
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNII 61
           ++L   +G G +GV     +K T E+VA+K IE   K        REI   K  +H NII
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHSM 117
               +   P       E     EL +    R+ +    S+D  +YF  Q +  V   H  
Sbjct: 73  TIFNIQ-RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKST-------VGTPAYI 166
            + HRDLK  N L++ +    LK+CDFG ++    S+  +S P          V T  Y 
Sbjct: 132 NVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189
Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLV--GAYPFED-------------QEDPKNFRK 211
           APEV+       +  DVWSCG  L  + +    +P  D                  N  +
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249
Query: 212 TISRIMAVQY--KIPDY---------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            I    A +Y   +P Y           ++    +LL R+ V +P++RIT KE   HP+ 
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 10/205 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E+  L+K++GSG FGV +L + K   + VA+K I+ G   +    +E     +L HP ++
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLISGVSYCHSMQIC 120
           +F  V      + IV EY + G L   + + G+  E  +       +  G+++  S Q  
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI 126
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYD 177
           HRDL   N L+D      +K+ DFG ++  +L  +  S+VGT     + APEV    +Y 
Sbjct: 127 HRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 178 GKLADVWSCGVTLY-VMLVGAYPFE 201
            K +DVW+ G+ ++ V  +G  P++
Sbjct: 184 SK-SDVWAFGILMWEVFSLGKMPYD 207

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +G    A   RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK---AFKNRELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 192
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +G    A   RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK---AFKNRELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 192
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 42/295 (14%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  ++ IG G +G+     +   K  VA+K I             REI    + RH N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I  ++++   T  A+   Y    +L E    ++  + + S D   YF  Q++ G+ Y HS
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQ-DLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N L++ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 163 ANVLHRDLKPSNLLINTTCD--LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQED--------P 206
             +   K  D+WS G  L  ML                  +G      QED         
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKA 280
Query: 207 KNFRKTI-SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +N+ +++ S+      K+  +        +LL R+   NP++RIT++E  +HP+ 
Sbjct: 281 RNYLQSLPSKTKVAWAKL--FPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYL 333

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +G    A   RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGK---AFKNRELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSED----EARYFFQQLISGVSY 113
           +    +        +L +V++Y     ++    +  R  +       + +  QL   ++Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE-VL 171
            HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE + 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPELIF 195
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG 196
              +Y   + DVWS G  L  +L+G
Sbjct: 196 GATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 20/266 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVL- 68
           +G G FG     + + T ++ A K +E+            +N KQ+      RF   +  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 69  ---TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRD 123
              T   L +V+    GG+L   I + G+  F E  A ++  ++  G+   H  +I +RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 124 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 183
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y     D 
Sbjct: 312 LKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 368
Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HISQDCRNLLSRIF 241
           W+ G  LY M+ G  PF+ Q   K  R+ + R++    ++P+      S   R+L S++ 
Sbjct: 369 WALGCLLYEMIAGQSPFQ-QRKKKIKREEVERLVK---EVPEEYSERFSPQARSLCSQLL 424
Query: 242 VANPSRRI-----TIKEIKSHPWFLK 262
             +P+ R+     + +E+K HP F K
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 121/266 (45%), Gaps = 20/266 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVL- 68
           +G G FG     + + T ++ A K +E+            +N KQ+      RF   +  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 69  ---TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRD 123
              T   L +V+    GG+L   I + G+  F E  A ++  ++  G+   H  +I +RD
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRD 311
Query: 124 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV 183
           LK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y     D 
Sbjct: 312 LKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDW 368
Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HISQDCRNLLSRIF 241
           W+ G  LY M+ G  PF+ Q   K  R+ + R++    ++P+      S   R+L S++ 
Sbjct: 369 WALGCLLYEMIAGQSPFQ-QRKKKIKREEVERLVK---EVPEEYSERFSPQARSLCSQLL 424
Query: 242 VANPSRRI-----TIKEIKSHPWFLK 262
             +P+ R+     + +E+K HP F K
Sbjct: 425 CKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 127/301 (42%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C       D  R  Y   Q++ G+ + 
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 140
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 141 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGM 198
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------ 216
            Y   + D+WS G  +  ++ G+  F+  +    + K I ++                  
Sbjct: 199 GYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNY 257
Query: 217 ---------MAVQYKIPDYVHISQD---------CRNLLSRIFVANPSRRITIKEIKSHP 258
                    +A +   PD++  S+           R+LLS++ V +P +RI++ E   HP
Sbjct: 258 VENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHP 317
Query: 259 W 259
           +
Sbjct: 318 Y 318

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 97
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 211
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 212 LIFGATDYTSSI-DVWSAGCVLAELLLG 238

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 226
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 227 LIFGATDYTSSI-DVWSAGCVLAELLLG 253

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 204
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 205 LIFGATDYTSSI-DVWSAGCVLAELLLG 231

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 90
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 204
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 205 LIFGATDYTSSI-DVWSAGCVLAELLLG 231

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 192
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 86
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 200
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 201 LIFGATDYTSSI-DVWSAGCVLAELLLG 227

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C       D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI--------MAVQYKI--- 223
            Y   + D+WS G  +  ++ G   F+  +    + K I ++         A+Q  +   
Sbjct: 201 GYAANV-DIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNY 259
Query: 224 ----------------PDYVHISQ---------DCRNLLSRIFVANPSRRITIKEIKSHP 258
                           PD++  S+           R+LLS++ V +P +RI++ E   HP
Sbjct: 260 VENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHP 319
Query: 259 W 259
           +
Sbjct: 320 Y 320

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 79
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 193
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 194 LIFGATDYTSSI-DVWSAGCVLAELLLG 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 192
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 192
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 82
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSXICSRYYRAPE 196
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 197 LIFGATDYTSSI-DVWSAGCVLAELLLG 223

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 112
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 226
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 227 LIFGATDYTSSI-DVWSAGCVLAELLLG 253

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 106
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 220
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 221 LIFGATDYTSSI-DVWSAGCVLAELLLG 247

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 114
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 228
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 229 LIFGATDYTSSI-DVWSAGCVLAELLLG 255

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 83
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 140 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 197
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 198 LIFGATDYTSSI-DVWSAGCVLAELLLG 224

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 78
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 192
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 193 LIFGATDYTSSI-DVWSAGCVLAELLLG 219

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 91
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 205
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 206 LIFGATDYTSSI-DVWSAGCVLAELLLG 232

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 116
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 230
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 231 LIFGATDYTSSI-DVWSAGCVLAELLLG 257

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 25/208 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN---RELQIMRKLDHCNIVRL 157
Query: 64  KEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDE-------ARYFFQQLISG 110
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAYIAPE 169
           ++Y HS  ICHRD+K +N LLD   A  LK+CDFG +K  L+   P  S + +  Y APE
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPE 271
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVG 196
            +    +Y   + DVWS G  L  +L+G
Sbjct: 272 LIFGATDYTSSI-DVWSAGCVLAELLLG 298

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 125/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT        ++ +  G +L+ ++      S D   YF  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 163 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 123/294 (41%), Gaps = 39/294 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYI-----ERGHKIDANVAREIINH-KQ 54
           ++YE + +IG G +G     R+ KN    VA+K +     E G  +       ++ H + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQL 107
             HPN++R  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIA 167
           + G+ + HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI----------- 216
           PEVL +  Y     D+WS G     M      F    D     K +  I           
Sbjct: 188 PEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 217 -----MAVQYK----IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                 A   K    I  +V  I +  ++LL +    NP++RI+     SHP+F
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 42/292 (14%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNI 60
           Y  ++ +GSG +G      +  T   VA+K + R  + +       RE+   K +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 61  IRFKEVVLTP-------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           I   +V  TP       T   +VM +   G    ++    +  ED  ++   Q++ G+ Y
Sbjct: 87  IGLLDV-FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            H+  I HRDLK  N  ++      LKI DFG ++ +   S     V T  Y APEV+  
Sbjct: 144 IHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQA--DSEMXGXVVTRWYRAPEVILN 199
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFE--DQED------------PKNFRKTISRIMAV 219
                +  D+WS G  +  M+ G   F+  D  D            P  F + +    A 
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 220 QY--KIP-----DYVHISQDCR----NLLSRIFVANPSRRITIKEIKSHPWF 260
            Y   +P     D+  I  +      NLL ++ V +  +R+T  E  +HP+F
Sbjct: 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 123/294 (41%), Gaps = 39/294 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYI-----ERGHKIDANVAREIINH-KQ 54
           ++YE + +IG G +G     R+ KN    VA+K +     E G  +       ++ H + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQL 107
             HPN++R  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIA 167
           + G+ + HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI----------- 216
           PEVL +  Y     D+WS G     M      F    D     K +  I           
Sbjct: 188 PEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 217 -----MAVQYK----IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                 A   K    I  +V  I +  ++LL +    NP++RI+     SHP+F
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 123/294 (41%), Gaps = 39/294 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYI-----ERGHKIDANVAREIINH-KQ 54
           ++YE + +IG G +G     R+ KN    VA+K +     E G  +       ++ H + 
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70
Query: 55  LRHPNIIRFKEVVLTP-----THLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQL 107
             HPN++R  +V         T L +V E+         +++   G  +E      FQ L
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-L 129
Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIA 167
           + G+ + HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y A
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI----------- 216
           PEVL +  Y     D+WS G     M      F    D     K +  I           
Sbjct: 188 PEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 217 -----MAVQYK----IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                 A   K    I  +V  I +  ++LL +    NP++RI+     SHP+F
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCAKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 251 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 73
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +A R    +   +  Q+  G+ Y 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYL 133
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 134 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 191 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 232

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  IGSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNED--XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 129/294 (43%), Gaps = 42/294 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  +   +A+K + R  +  I A    RE+   K ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V    T L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 170 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 223
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK-----------TISRIMAVQ 220
               +     D+WS G  +  +L G   F   +     ++            ISR+ + +
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHE 283
Query: 221 YK-----IPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +     +P          ++  +    +LL ++ V +  +RIT  E  +HP+F
Sbjct: 284 ARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF 337

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNED--SELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 137/306 (44%), Gaps = 56/306 (18%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVA-REIINHKQLRHPNIIRFKEV 66
           +GSG +G      +K + E VA+K + R  +  I A  A RE++  K ++H N+I   +V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 67  VLTPTHL------AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
               + L       +VM +       ++I    +FSE++ +Y   Q++ G+ Y HS  + 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYDG 178
           HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APEV+    +  
Sbjct: 149 HRDLKPGNLAVNED--CELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 202
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV------------------- 219
           +  D+WS G  +  ML G   F+     K++   +++I+ V                   
Sbjct: 203 QTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 258
Query: 220 ------QYKIPDYVHI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWF--LKNLPRE 267
                 Q    D+  +    S    +LL ++   +  +R+T  +  +HP+F   ++ P E
Sbjct: 259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD-PEE 317
Query: 268 LTETAQ 273
            TE  Q
Sbjct: 318 ETEAQQ 323

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSN--LAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 261 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 150
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 151 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 204
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 264
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 265 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 318

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 20/198 (10%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNIIRFKEVVL 68
           +G G FG A  + ++ T E++ MK + R   +      +E+   + L HPN+++F  V+ 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 69  TPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
               L  + EY  GG L   I +   ++   +   F + + SG++Y HSM I HRDL   
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137
Query: 128 NTLLDGSPAPRLKICDFGYSKSSL--------LHSRPK-------STVGTPAYIAPEVLS 172
           N L+  +    + + DFG ++  +        L S  K       + VG P ++APE+++
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195
Query: 173 RREYDGKLADVWSCGVTL 190
            R YD K+ DV+S G+ L
Sbjct: 196 GRSYDEKV-DVFSFGIVL 212

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 127/293 (43%), Gaps = 40/293 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++  
Sbjct: 161 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMXGXVATRWYRAPEIMLN 216
Query: 174 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 276
Query: 208 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 277 NYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 251 ARNYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNED--XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 274 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSNLAVNED--XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 266 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 275 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I  + + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKSQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG  +    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--SELKILDFGLCR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 261 ARNYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 262 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 267 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 267 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 136/306 (44%), Gaps = 56/306 (18%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVA-REIINHKQLRHPNIIRFKEV 66
           +GSG +G      +K + E VA+K + R  +  I A  A RE++  K ++H N+I   +V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 67  VLTPTHL------AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
               + L       +VM +       ++I     FSE++ +Y   Q++ G+ Y HS  + 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYDG 178
           HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APEV+    +  
Sbjct: 167 HRDLKPGNLAVNED--CELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 220
Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV------------------- 219
           +  D+WS G  +  ML G   F+     K++   +++I+ V                   
Sbjct: 221 QTVDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS 276
Query: 220 ------QYKIPDYVHI----SQDCRNLLSRIFVANPSRRITIKEIKSHPWF--LKNLPRE 267
                 Q    D+  +    S    +LL ++   +  +R+T  +  +HP+F   ++ P E
Sbjct: 277 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD-PEE 335
Query: 268 LTETAQ 273
            TE  Q
Sbjct: 336 ETEAQQ 341

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 127/293 (43%), Gaps = 40/293 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++  
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 174 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 208 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 NYIQSLAQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 127/293 (43%), Gaps = 40/293 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++  
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 174 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 208 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 266 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 319

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 262 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGXVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 140 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 193
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 253
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 254 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 307

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 127/293 (43%), Gaps = 40/293 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            HS  I HRDLK  N  ++      LKI DFG ++ +         V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 192
Query: 174 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 208 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 253 NYIQSLAQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTADEMTGYVATRWYRAPEIM 201
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 262 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 313

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 125/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 82  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G     +QED        +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 261 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 201
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 262 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 252 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 257 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 310

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 217
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 278 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 275 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 328

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 252 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 305

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 139 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 192
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 252
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 253 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 306

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 251 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 89  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 261 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 314

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 274 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 327

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 126/287 (43%), Gaps = 37/287 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           +E +  +G G FG     RN       A+K I    +  + +  E++    L H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  KEVVL-------------TPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLIS 109
               L               + L I MEY   G L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SL----LHSRP------ 156
            +SY HS  I HRDLK  N  +D S    +KI DFG +K+   SL    L S+       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 157 --KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
              S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    +  N  K + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL- 241
Query: 215 RIMAVQYKIPDYVHISQDCRNLLSRIFVA-NPSRRITIKEIKSHPWF 260
           R +++++  PD+          + R+ +  +P++R   + + +  W 
Sbjct: 242 RSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANV-AREIINHKQLRH 57
            E+ E+ + IG G FG     R       VA++ I  ER ++       RE++ ++Q RH
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLISGVSYCHS 116
            N++ F    ++P HLAI+     G  L+  + +A    + ++ R   Q+++ G+ Y H+
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFG-YSKSSLLHS-----RPKSTVGTPAYIAPEV 170
             I H+DLK +N   D     ++ I DFG +S S +L +     + +   G   ++APE+
Sbjct: 149 KGILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 171 LSRREYD--------GKLADVWSCGVTLYVMLVGAYPFEDQ 203
           + +   D         K +DV++ G   Y +    +PF+ Q
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 128/308 (41%), Gaps = 57/308 (18%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPT-------HLAIVMEY--AAGGELFERICNAGRFSEDEARYFFQQLI 108
            NII    V  TP         + IVME   A   ++ +   +  R S     Y   Q++
Sbjct: 83  KNIIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQML 136
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
            G+ + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQ 220
           EV+    Y   + D+WS GV +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 221 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 252
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 253 EIKSHPWF 260
           E   HP+ 
Sbjct: 314 EALQHPYI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 202 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 261 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320
Query: 259 WF 260
           + 
Sbjct: 321 YI 322

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 127/293 (43%), Gaps = 40/293 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            HS  I HRDLK  N  L  +    LKI DFG ++ +         V T  Y APE++  
Sbjct: 164 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHT--DDEMXGYVATRWYRAPEIMLN 219
Query: 174 REYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------EDPK 207
             +  +  D+WS G  +  +L G   +P  D                         E  +
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 279
Query: 208 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 280 NYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 331

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 117/270 (43%), Gaps = 30/270 (11%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA-REIINHKQLRHPNI 60
           + Y  ++ +G G F    L+   +     A+K I    + D   A RE   H+   HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 61  IRFKEVVL---TPTHLA-IVMEYAAGGELF---ERICNAGRF-SEDEARYFFQQLISGVS 112
           +R     L      H A +++ +   G L+   ER+ + G F +ED+  +    +  G+ 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SRPKSTVG-------T 162
             H+    HRDLK  N LL     P L   D G    + +H   SR   T+        T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVLM--DLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 163 PAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 220
            +Y APE+ S + +    +  DVWS G  LY M+ G  P++       F+K  S  +AVQ
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD-----MVFQKGDSVALAVQ 261
Query: 221 YK--IPDYVHISQDCRNLLSRIFVANPSRR 248
            +  IP     S     LL+ +   +P +R
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 104 IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 163 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 89  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 318

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 90  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 149 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 267 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 319

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 81  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 140 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 258 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 310

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 145 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 92  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 151 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 269 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 321

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 82  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 84
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 144
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 145 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM 202
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q  +  Y
Sbjct: 203 GYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 261
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 262 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 321
Query: 259 WF 260
           + 
Sbjct: 322 YI 323

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/308 (25%), Positives = 128/308 (41%), Gaps = 57/308 (18%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPT-------HLAIVMEY--AAGGELFERICNAGRFSEDEARYFFQQLI 108
            NII    V  TP         + IVME   A   ++ +   +  R S     Y   Q++
Sbjct: 83  KNIIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQML 136
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
            G+ + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQ 220
           EV+    Y   + D+WS GV +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 221 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 252
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 253 EIKSHPWF 260
           E   HP+ 
Sbjct: 314 EALQHPYI 321

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 11  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 68
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 69  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 129 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 186 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 227

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 123/293 (41%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI      RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 145 ANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + +  +  I A    RE+   K ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 267 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 320

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 120/294 (40%), Gaps = 40/294 (13%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI      RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 145 ANVLHRDLKPSNLLLNTT--SDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQED--------P 206
             +   K  D+WS G  L  ML                  +G      QED         
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +N+  ++     V +    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 263 RNYLLSLPHKNKVPWNRL-FPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 315

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 12  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 69
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 70  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 130 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 187 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 228

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 18  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 75
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 76  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 136 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 193 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 234

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 17  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 74
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 75  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 135 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 192 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 233

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 101
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 162 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 219 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 260

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 70
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 131 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 188 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 229

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 19  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 76
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 77  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 137 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 194 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 235

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 16  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 73
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 134 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 191 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 232

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 16  KFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 73
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++ME+   G L E +  +  R    +   +  Q+  G+ Y 
Sbjct: 74  DNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 134 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 191 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 232

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 20  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 77
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 78  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 138 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 195 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 236

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 70
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 131 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 188 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 229

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M+++++ +  G G FG  +L + K+T   VA+K + +  +      + + +   L HPNI
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 61  IRFKEVVLT-------PTHLAIVMEYAAGGELFERICNAGRFSEDEA------RYFFQQL 107
           ++ +    T         +L +VMEY    +   R C    +    A      + F  QL
Sbjct: 82  VQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCR-NYYRRQVAPPPILIKVFLFQL 138
Query: 108 ISGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPA 164
           I  +   H  S+ +CHRD+K  N L++ +    LK+CDFG +K  L  S P  + + +  
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAK-KLSPSEPNVAYICSRY 196
Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVG 196
           Y APE++   ++     D+WS G     M++G
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 130/295 (44%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D+G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDYGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 88
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 149 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 206 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 247

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 11  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 181
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 130 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 185
Query: 182 DVWSCGVTLY-VMLVGAYPFEDQEDPK 207
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA++ I             REI    + RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++ 
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 31  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 88
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 89  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 149 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 206 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 247

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 W 259
           +
Sbjct: 320 Y 320

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 123/294 (41%), Gaps = 47/294 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +   + E VA+K + +  +      RE+   + ++HPN++  
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN---RELQIMRIVKHPNVVDL 97
Query: 64  KEVVLT------PTHLAIVMEYAAGGELFERICNAGRFSEDEA--------RYFFQQLIS 109
           K    +         L +V+EY       E +  A R              + +  QL+ 
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 169
            ++Y HS+ ICHRD+K +N LLD  P+  LK+ DFG +K  +      S + +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLD-PPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPE 211
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-----VQYKIP 224
           ++          D+WS G  +  ++ G   F  +       + I  +       ++   P
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271
Query: 225 DYVH------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +Y+                      D  +L+SR+    PS R+T  E   HP+F
Sbjct: 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 10/207 (4%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I+ G   + +   E     +L HP +++   
Sbjct: 31  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRDL
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 181
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 150 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 205
Query: 182 DVWSCGVTLY-VMLVGAYPFEDQEDPK 207
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYENRSNSE 232

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/224 (33%), Positives = 107/224 (47%), Gaps = 26/224 (11%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K +  + G +  +   +EI   + L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVSYCHS 116
           I++K          L +VMEY   G L + +    R S   A+   F QQ+  G++Y H+
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 117 MQICHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SLLHSRPKSTVGTPA-YIAPEVL 171
               HRDL   N LLD     RL KI DFG +K+        R +    +P  + APE L
Sbjct: 153 QHYIHRDLAARNVLLDND---RLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 172 SRREYDGKLA-DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
             +EY    A DVWS GVTLY +L   +    Q  P  F + I 
Sbjct: 210 --KEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIG 249

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 48/285 (16%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 169
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 170 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 280
Query: 220 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 281 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 14  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRDL
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 181
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 133 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 188
Query: 182 DVWSCGVTLY-VMLVGAYPFEDQEDPK 207
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 189 DVWSFGVLMWEVFSEGKIPYENRSNSE 215

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 48/285 (16%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 30  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 169
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 170 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 252
Query: 220 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 253 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 9   FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRDL
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 181
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 128 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 183
Query: 182 DVWSCGVTLY-VMLVGAYPFEDQEDPK 207
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSE 210

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 11  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRDL
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 181
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 130 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 185
Query: 182 DVWSCGVTLY-VMLVGAYPFEDQEDPK 207
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 125/302 (41%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 48/285 (16%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 14  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 72  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 169
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 131 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 182
Query: 170 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 236
Query: 220 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 237 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 279

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L R      NT E VA+K +  E G    A++ +EI   + L H NI
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSM 117
           +++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  S 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAY-IAPEVLS 172
           Q  HRDL   N L++     ++KI DFG +K+ +   +   TV     +P +  APE L 
Sbjct: 146 QYVHRDLAARNVLVESEH--QVKIGDFGLTKA-IETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 173 RREYDGKLADVWSCGVTLYVMLV 195
           + ++    +DVWS GVTL+ +L 
Sbjct: 203 QSKF-YIASDVWSFGVTLHELLT 224

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +++IGSG FG+  L    N K+ VA+K I  G   + +   E     +L HP +++   
Sbjct: 12  FVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V L    + +V E+   G L + +    G F+ +        +  G++Y     + HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRREYDGKLA 181
              N L+  +    +K+ DFG ++  +L  +  S+ GT     + +PEV S   Y  K +
Sbjct: 131 AARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK-S 186
Query: 182 DVWSCGVTLY-VMLVGAYPFEDQEDPK 207
           DVWS GV ++ V   G  P+E++ + +
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSE 213

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 48/285 (16%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 11  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 169
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 170 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 233
Query: 220 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 234 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 276

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 70
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 71  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HRDL   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 131 GTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 188 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 229

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI DF  ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFYLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 30  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAPEVL-- 171
            I H DLK  N L+ DG     LK+ DFG +   +         S VGT  Y+ PE +  
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKD 202
Query: 172 --SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV---- 219
             S RE           +DVWS G  LY M  G  PF+           IS++ A+    
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAIIDPN 256
Query: 220 -QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
            + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 257 HEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 295

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 48/285 (16%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 10  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 68  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 169
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 127 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 170 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 179 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 232
Query: 220 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 233 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 275

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 48/285 (16%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 169
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VGT  Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 170 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 280
Query: 220 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 281 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI  FG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILGFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 57/308 (18%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPT-------HLAIVMEY--AAGGELFERICNAGRFSEDEARYFFQQLI 108
            NII    V  TP         + IVME   A   ++ +   +  R S     Y   Q++
Sbjct: 83  KNIIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQML 136
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
            G+ + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQ 220
           EV+    Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 221 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 252
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 253 EIKSHPWF 260
           E   HP+ 
Sbjct: 314 EALQHPYI 321

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 57/308 (18%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNH 82
Query: 58  PNIIRFKEVVLTPT-------HLAIVMEY--AAGGELFERICNAGRFSEDEARYFFQQLI 108
            NII    V  TP         + IVME   A   ++ +   +  R S     Y   Q++
Sbjct: 83  KNIIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQML 136
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
            G+ + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 VGIKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQ 220
           EV+    Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 221 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 252
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 253 EIKSHPWF 260
           E   HP+ 
Sbjct: 314 EALQHPYI 321

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 18/203 (8%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L R      NT E VA+K +  E G    A++ +EI   + L H NI
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 61  IRFKEVVLTP--THLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSM 117
           +++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  S 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV----GTPAY-IAPEVLS 172
           Q  HRDL   N L++     ++KI DFG +K+ +   +   TV     +P +  APE L 
Sbjct: 134 QYVHRDLAARNVLVESEH--QVKIGDFGLTKA-IETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 173 RREYDGKLADVWSCGVTLYVMLV 195
           + ++    +DVWS GVTL+ +L 
Sbjct: 191 QSKF-YIASDVWSFGVTLHELLT 212

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG G FG     RL      +  VA+K ++ G+  K   +   E     Q  HPNII 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M   
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMSAV 153
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R
Sbjct: 154 HRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 209
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 205
           ++    +DVWS G+ ++ VM  G  P+ D  +
Sbjct: 210 KFTSA-SDVWSYGIVMWEVMSYGERPYWDMSN 240

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 239 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 259 W 259
           +
Sbjct: 358 Y 358

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 194 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 259 W 259
           +
Sbjct: 313 Y 313

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 202 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 260
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 261 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 320
Query: 259 WF 260
           + 
Sbjct: 321 YI 322

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 84  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 202 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 260
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 261 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 320
Query: 259 WF 260
           + 
Sbjct: 321 YI 322

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG G FG     RL      +  VA+K ++ G+  K   +   E     Q  HPNII 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M   
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 138
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 205
           ++    +DVWS G+ ++ VM  G  P+ D  +
Sbjct: 195 KFTSA-SDVWSYGIVMWEVMSYGERPYWDMSN 225

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 195 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 253
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 254 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 313
Query: 259 W 259
           +
Sbjct: 314 Y 314

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 77  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 195 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 253
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 254 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 313
Query: 259 W 259
           +
Sbjct: 314 Y 314

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 81
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 82  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 141
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 142 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 199
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 200 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 258
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 259 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 318
Query: 259 WF 260
           + 
Sbjct: 319 YI 320

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 57/308 (18%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPT-------HLAIVMEY--AAGGELFERICNAGRFSEDEARYFFQQLI 108
            NII    V  TP         + IVME   A   ++ +   +  R S     Y   Q++
Sbjct: 83  KNIIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQML 136
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
            G+ + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQ 220
           EV+    Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 221 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 252
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 253 EIKSHPWF 260
           E   HP+ 
Sbjct: 314 EALQHPYI 321

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IG G FG     RL      +  VA+K ++ G+  K   +   E     Q  HPNII 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M   
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMSYV 132
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R
Sbjct: 133 HRDLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 205
           ++    +DVWS G+ ++ VM  G  P+ D  +
Sbjct: 189 KFTSA-SDVWSYGIVMWEVMSYGERPYWDMSN 219

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDAGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 239 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 298 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357
Query: 259 WF 260
           + 
Sbjct: 358 YI 359

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 120/300 (40%), Gaps = 44/300 (14%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA-REIINHKQLRHPNII 61
           +Y  +K +G G  G+     + +  + VA+K I          A REI   ++L H NI+
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL-------------FERICNAGRFSEDEARYFFQQLI 108
           +  E+ L P+   +  +  +  EL                +   G   E+ AR F  QL+
Sbjct: 72  KVFEI-LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG----TPA 164
            G+ Y HS  + HRDLK  N  ++      LKI DFG ++    H   K  +     T  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDL-VLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-- 222
           Y +P +L       K  D+W+ G     ML G   F    + +  +  +  I  V  +  
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 223 ------IPDYVH----------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                 IP Y+                 IS++  + L +I   +P  R+T +E  SHP+ 
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 19/192 (9%)
Query: 105 QQLISGVSYCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 163
           + +++  SY H+ + ICHRD+K  N L+D +   R+K+ DFG S+  ++  + K + GT 
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEY-MVDKKIKGSRGTY 214
Query: 164 AYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQ----EDPKNFR-KTISRIM 217
            ++ PE  S    Y+G   D+WS G+ LYVM     PF  +    E   N R K I   +
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 218 AVQYKIPDYVHISQDCRN---------LLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
              + +    +    C N          L      NP+ RIT ++   H W       +L
Sbjct: 275 DRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334
Query: 269 TETAQAIYYRKE 280
            E ++ +Y +++
Sbjct: 335 REFSKELYKKRK 346

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDGGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 107/223 (47%), Gaps = 24/223 (10%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K ++   G +  +   +EI   + L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVSYCHS 116
           I++K          L +VMEY   G L + +    R S   A+   F QQ+  G++Y HS
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPA-YIAPEVLS 172
               HR+L   N LLD      +KI DFG +K+      + R +    +P  + APE L 
Sbjct: 136 QHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 173 RREYDGKLA-DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            +EY    A DVWS GVTLY +L   +    Q  P  F + I 
Sbjct: 193 -KEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIG 232

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 38/293 (12%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +Y  +  IG G +G+     +   K  VA+K I             REI    + RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLISGVSYCHS 116
           I   +++  PT +  + +     +L E    ++      S D   YF  Q++ G+ Y HS
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSLLHSRP---KSTVGTPAYIAPEVLS 172
             + HRDLK  N LL+ +    LKI DFG ++ +   H         V T  Y APE++ 
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 173 RREYDGKLADVWSCGVTLYVML------------------VGAYPFEDQEDPKNFRKTIS 214
             +   K  D+WS G  L  ML                  +G      QED        +
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 215 R--IMAVQY--KIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           R  ++++ +  K+P    + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/295 (23%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +  I A    RE+   K ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 59  NIIRFKEVVLTPTHL-----AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G +L   I    + ++D  ++   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            HS  I HRDLK  N  ++      LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDRGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 172 SRREYDGKLADVWSCGVTLYVMLVG--AYPFEDQ------------------------ED 205
               +  +  D+WS G  +  +L G   +P  D                         E 
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 206 PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            +N+ ++++++  + +    ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 255 ARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 308

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 125/287 (43%), Gaps = 37/287 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           +E +  +G G FG     RN       A+K I    +  + +  E++    L H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 64  KEVVL-------------TPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLIS 109
               L               + L I MEY     L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SL----LHSRP------ 156
            +SY HS  I HRDLK  N  +D S    +KI DFG +K+   SL    L S+       
Sbjct: 128 ALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 157 --KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
              S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    +  N  K + 
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVNILKKL- 241
Query: 215 RIMAVQYKIPDYVHISQDCRNLLSRIFVA-NPSRRITIKEIKSHPWF 260
           R +++++  PD+          + R+ +  +P++R   + + +  W 
Sbjct: 242 RSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 124/302 (41%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  +  Y
Sbjct: 201 GYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 57/308 (18%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPT-------HLAIVMEY--AAGGELFERICNAGRFSEDEARYFFQQLI 108
            NII    V  TP         + IVME   A   ++ +   +  R S     Y   Q++
Sbjct: 83  KNIIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQML 136
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
            G+ + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y AP
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQ 220
           EV+    Y   + D+WS G  +  M+ G   F   +    + K I ++          +Q
Sbjct: 195 EVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 221 YKIPDYVH----------------------------ISQDCRNLLSRIFVANPSRRITIK 252
             +  YV                              +   R+LLS++ V + S+RI++ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 253 EIKSHPWF 260
           E   HP+ 
Sbjct: 314 EALQHPYI 321

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 115/264 (43%), Gaps = 31/264 (11%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--------VAREIINHKQLR 56
           E  K IG G FG+    R    K +VA+K +  G                RE+     L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-GVSYCH 115
           HPNI++   ++  P  +  VME+   G+L+ R+ +     +   +      I+ G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 116 SMQ--ICHRDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N     LD +     K+ DFG S+ S +HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-VHSV-SGLLGNFQWMAPET 197
Query: 171 LSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
           +   E  Y  K AD +S  + LY +L G  PF++    K     + R   ++  IP    
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP---- 252
Query: 229 ISQDC----RNLLSRIFVANPSRR 248
             +DC    RN++   +  +P +R
Sbjct: 253 --EDCPPRLRNVIELCWSGDPKKR 274

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 53/276 (19%)
Query: 8   KDIGSG-NFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRF-- 63
           +D+GSG  + + RL+ N+  K              +  + +E+   K+L  HPNI++F  
Sbjct: 48  QDVGSGREYALKRLLSNEEEK--------------NRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 64  ------KEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
                 +E         ++ E   G   E  +++ + G  S D     F Q    V + H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 116 SMQ--ICHRDLKLENTLLDGSPAPRLKICDFG----------YSKSSLLHSRPKSTVG-- 161
             +  I HRDLK+EN LL  S    +K+CDFG          YS S+   +  +  +   
Sbjct: 154 RQKPPIIHRDLKVENLLL--SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 162 -TPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 218
            TP Y  PE++        G+  D+W+ G  LY++    +PFED            RI+ 
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--------LRIVN 263
Query: 219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
            +Y IP +        +L+  +   NP  R++I E+
Sbjct: 264 GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 23/225 (10%)
Query: 5   ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHKIDANV---AREIINHKQLRH 57
           + ++ +G GNFG   + R      NT E+VA+K ++  H  + ++    REI   K L+H
Sbjct: 14  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ--HSTEEHLRDFEREIEILKSLQH 71
Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYC 114
            NI+++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y 
Sbjct: 72  DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPE 169
            + +  HR+L   N L++     R+KI DFG +K  L   +    V  P      + APE
Sbjct: 132 GTKRYIHRNLATRNILVENE--NRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            L+  ++    +DVWS GV LY +    Y  + +  P  F + I 
Sbjct: 189 SLTESKF-SVASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIG 230

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 115/264 (43%), Gaps = 31/264 (11%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--------VAREIINHKQLR 56
           E  K IG G FG+    R    K +VA+K +  G                RE+     L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-GVSYCH 115
           HPNI++   ++  P  +  VME+   G+L+ R+ +     +   +      I+ G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 116 SMQ--ICHRDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N     LD +     K+ DFG S+ S +HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-VHSV-SGLLGNFQWMAPET 197
Query: 171 LSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
           +   E  Y  K AD +S  + LY +L G  PF++    K     + R   ++  IP    
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP---- 252
Query: 229 ISQDC----RNLLSRIFVANPSRR 248
             +DC    RN++   +  +P +R
Sbjct: 253 --EDCPPRLRNVIELCWSGDPKKR 274

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 128/285 (44%), Gaps = 48/285 (16%)
Query: 4   YELMKDIGSGNFGVARLMRNKN-TKELVAMKYI---ERGHKIDANVAREI--INHKQLRH 57
           Y ++K IGSG  G +++ +  N  K++ A+KY+   E  ++   +   EI  +N  Q   
Sbjct: 58  YSILKQIGSG--GSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
             IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKST-------VGTPAYIAPE 169
            I H DLK  N L+ DG     LK+ DFG +       +P +T       VG   Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 170 VL----SRRE------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +    S RE           +DVWS G  LY M  G  PF+           IS++ A+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------QIINQISKLHAI 280
Query: 220 -----QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                + + PD     +D +++L      +P +RI+I E+ +HP+
Sbjct: 281 IDPNHEIEFPDIP--EKDLQDVLKCCLKRDPKQRISIPELLAHPY 323

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/302 (24%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 87
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 147
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 148 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 205
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  +  Y
Sbjct: 206 GYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 264
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V + S+RI++ E   HP
Sbjct: 265 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 324
Query: 259 WF 260
           + 
Sbjct: 325 YI 326

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 107/223 (47%), Gaps = 24/223 (10%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K ++   G +  +   +EI   + L H +I
Sbjct: 19  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVSYCHS 116
           I++K          L +VMEY   G L + +    R S   A+   F QQ+  G++Y H+
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPA-YIAPEVLS 172
               HR+L   N LLD      +KI DFG +K+      + R +    +P  + APE L 
Sbjct: 136 QHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL- 192
Query: 173 RREYDGKLA-DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
            +EY    A DVWS GVTLY +L   +    Q  P  F + I 
Sbjct: 193 -KEYKFYYASDVWSFGVTLYELLT--HCDSSQSPPTKFLELIG 232

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R  +   +  R   E++  K + H
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 76
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +C   +   D  R  Y   Q++ G+ + 
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 136
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 137 HSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI------------------ 216
            Y   + D+WS G  +  M+     F  ++    + K I ++                  
Sbjct: 195 GYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 253
Query: 217 ---------MAVQYKIPDYVHISQ---------DCRNLLSRIFVANPSRRITIKEIKSHP 258
                     + +   PD +  +            R+LLS++ V + S+RI++ E   HP
Sbjct: 254 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 313
Query: 259 WF 260
           + 
Sbjct: 314 YI 315

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPNIIR 62
           IG+G FG     RL      +  VA+K ++ G+       RE ++      Q  HPNIIR
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYT--ERQRREFLSEASIMGQFEHPNIIR 79
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPA---YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+    +S      S++G      + APE ++ R
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 205
           ++    +D WS G+ ++ VM  G  P+ D  +
Sbjct: 197 KFTSA-SDAWSYGIVMWEVMSFGERPYWDMSN 227

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 8   KDIGSGNFG---VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNII 61
           K IG+G FG      L  +   KE+ VA+K ++ G+  K   +   E     Q  H NII
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           R + V+     + I+ EY   G L  F R  + G FS  +     + + +G+ Y  +M  
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNY 168
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSR 173
            HRDL   N L++ +     K+ DFG S+  +L   P++T  T        + APE +S 
Sbjct: 169 VHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 174 REYDGKLADVWSCGVTLY-VMLVGAYPF 200
           R++    +DVWS G+ ++ VM  G  P+
Sbjct: 225 RKFTSA-SDVWSFGIVMWEVMTYGERPY 251

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHPNIIR 62
           IG+G FG     RL      +  VA+K ++ G+       RE ++      Q  HPNIIR
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYT--ERQRREFLSEASIMGQFEHPNIIR 81
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+    +S   +   +        + APE ++ R
Sbjct: 141 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQED 205
           ++    +D WS G+ ++ VM  G  P+ D  +
Sbjct: 199 KFTSA-SDAWSYGIVMWEVMSFGERPYWDMSN 229

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 115/246 (46%), Gaps = 14/246 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           IGSG+FG     +      +  +K ++   +       E+   ++ RH NI+ F    +T
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY-MT 102
Query: 70  PTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLEN 128
             +LAIV ++  G  L++ +     +F   +     +Q   G+ Y H+  I HRD+K  N
Sbjct: 103 KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN 162
Query: 129 TLLDGSPAPRLKICDFGYS--KSSLLHSRP-KSTVGTPAYIAPEVLSRREYD--GKLADV 183
             L       +KI DFG +  KS    S+  +   G+  ++APEV+  ++ +     +DV
Sbjct: 163 IFL--HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDV 220
Query: 184 WSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVA 243
           +S G+ LY ++ G  P+       N R  I  ++   Y  PD   + ++C   + R+ VA
Sbjct: 221 YSYGIVLYELMTGELPYSH----INNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRL-VA 275
Query: 244 NPSRRI 249
           +  +++
Sbjct: 276 DCVKKV 281

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 82/326 (25%), Positives = 137/326 (42%), Gaps = 74/326 (22%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           +KY L K +G+G+FG+   + +  + +  A+K + +  +      RE+   K L H NII
Sbjct: 7   KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN---RELDIMKVLDHVNII 63
Query: 62  RF-----------------------------------KEVVLTPT---HLAIVMEYAAGG 83
           +                                    K V++ P+   +L ++MEY    
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123
Query: 84  --ELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLK 140
             ++ +    +GR    +    +  QL   V + HS+ ICHRD+K +N L++ S    LK
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-SKDNTLK 182
Query: 141 ICDFGYSKSSLLHSRPK-STVGTPAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAY 198
           +CDFG +K  L+ S P  + + +  Y APE+ L   EY   + D+WS G     +++G  
Sbjct: 183 LCDFGSAK-KLIPSEPSVAXICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKP 240
Query: 199 PFEDQEDPKNFRKTISRIMAVQYK------IPDYVHI------SQDCR------------ 234
            F  +       + I +IM    K       P Y  +      ++D R            
Sbjct: 241 LFSGETSIDQLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 235 NLLSRIFVANPSRRITIKEIKSHPWF 260
           +LL +I    P  RI   E  +HP+F
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K ++ G   ++ +   REI   + L H +I
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGEL---FERICNAGRFSEDEARYFFQQLISGVSYCH 115
           +++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 129
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPA-YIAPEVL 171
           +    HR L   N LLD      +KI DFG +K+      + R +    +P  + APE L
Sbjct: 130 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 172 SRREYDGKLADVWSCGVTLYVMLV 195
              ++    +DVWS GVTLY +L 
Sbjct: 188 KECKFY-YASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 22/204 (10%)
Query: 7   MKDIGSGNFGVARLM----RNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNI 60
           ++D+G G+FG   L      N  T E+VA+K ++ G   ++ +   REI   + L H +I
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 61  IRFKEVV--LTPTHLAIVMEYAAGGEL---FERICNAGRFSEDEARYFFQQLISGVSYCH 115
           +++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 128
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTPA-YIAPEVL 171
           +    HR L   N LLD      +KI DFG +K+      + R +    +P  + APE L
Sbjct: 129 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 172 SRREYDGKLADVWSCGVTLYVMLV 195
              ++    +DVWS GVTLY +L 
Sbjct: 187 KECKFY-YASDVWSFGVTLYELLT 209

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGFV 169
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 W 259
           +
Sbjct: 320 Y 320

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 99  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 157
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 158 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 214 KFTSA-SDVWSYGIVLWEVMSYGERPY 239

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 13/195 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 5   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 61
Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSM 117
           ++   V++     L IV EY A G L + + + GR     D    F   +   + Y    
Sbjct: 62  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 121
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  +++
Sbjct: 122 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 176
Query: 177 DGKLADVWSCGVTLY 191
             K +DVWS G+ L+
Sbjct: 177 STK-SDVWSFGILLW 190

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 86/335 (25%), Positives = 131/335 (39%), Gaps = 87/335 (25%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHPNIIRFKEV 66
           IG G++G   L  +KNT++ VA+K + R  +  ID   + REI    +L+   IIR  ++
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 67  V-----LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           +     L    L IV+E  A  +L +        +E+  +     L+ G ++ H   I H
Sbjct: 94  IIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIH 152
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKS-----------------------SLLHSRPKS 158
           RDLK  N LL+   +  +K+CDFG +++                         L  +  S
Sbjct: 153 RDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML----------VGAYPF-------- 200
            V T  Y APE++  +E   K  D+WS G     +L             +P         
Sbjct: 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFP 270
Query: 201 ---------------EDQ-------------EDPKNFRK--TISRIMAVQYKIP-----D 225
                           DQ             +D KN  K   I  I    ++ P      
Sbjct: 271 LSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQK 330
Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           Y  IS D  NLL  +   NP++RITI +   HP+ 
Sbjct: 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 15/225 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           ++ + ++ +GSG +G      +   ++ VA+K + R  +  I A    RE+   K L+H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           N+I   +V    T +     + +     G     I  +   S++  ++   QL+ G+ Y 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYI 147
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++   
Sbjct: 148 HSAGIIHRDLKPSNVAVNED--SELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 203
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +  +  D+WS G  +  +L G   F       ++   + RIM V
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPG----SDYIDQLKRIMEV 244

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 141 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 197 KFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 13/195 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 76
Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSM 117
           ++   V++     L IV EY A G L + + + GR     D    F   +   + Y    
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  +++
Sbjct: 137 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 191
Query: 177 DGKLADVWSCGVTLY 191
             K +DVWS G+ L+
Sbjct: 192 STK-SDVWSFGILLW 205

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 109 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 167
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 168 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 224 KFTSA-SDVWSYGIVLWEVMSYGERPY 249

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 W 259
           +
Sbjct: 320 Y 320

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 92/195 (47%), Gaps = 13/195 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 248
Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSM 117
           ++   V++     L IV EY A G L + + + GR     D    F   +   + Y    
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L  +++
Sbjct: 309 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKF 363
Query: 177 DGKLADVWSCGVTLY 191
             K +DVWS G+ L+
Sbjct: 364 STK-SDVWSFGILLW 377

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 128/295 (43%), Gaps = 43/295 (14%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNI 60
           + Y+L++ +G G +       N    E V +K ++   K    + REI   + LR  PNI
Sbjct: 37  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--NKIKREIKILENLRGGPNI 94
Query: 61  IRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           I   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCHSM 
Sbjct: 95  ITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHSMG 151
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRREYD 177
           I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   + YD
Sbjct: 152 IMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 210
Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD---------- 225
             L D+WS G  L  M+    PF    D  +    I++++  +  Y   D          
Sbjct: 211 YSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 269
Query: 226 --------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                         +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 270 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 15/225 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           ++ + ++ +GSG +G      +   ++ VA+K + R  +  I A    RE+   K L+H 
Sbjct: 28  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 87
Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           N+I   +V    T +     + +     G     I      S++  ++   QL+ G+ Y 
Sbjct: 88  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 147
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++   
Sbjct: 148 HSAGIIHRDLKPSNVAVNED--SELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 203
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +  +  D+WS G  +  +L G   F       ++   + RIM V
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQGKALFPG----SDYIDQLKRIMEV 244

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 114/264 (43%), Gaps = 31/264 (11%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--------VAREIINHKQLR 56
           E  K IG G FG+    R    K +VA+K +  G                RE+     L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-GVSYCH 115
           HPNI++   ++  P  +  VME+   G+L+ R+ +     +   +      I+ G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 116 SMQ--ICHRDLKLENTL---LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N     LD +     K+ DF  S+ S +HS     +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-VHSV-SGLLGNFQWMAPET 197
Query: 171 LSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
           +   E  Y  K AD +S  + LY +L G  PF++    K     + R   ++  IP    
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP---- 252
Query: 229 ISQDC----RNLLSRIFVANPSRR 248
             +DC    RN++   +  +P +R
Sbjct: 253 --EDCPPRLRNVIELCWSGDPKKR 274

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +    +   D  R  Y   Q++ G+ + 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 143 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 201 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 259
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 260 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 319
Query: 259 WF 260
           + 
Sbjct: 320 YI 321

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 45/301 (14%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +  R   E++  K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEAR--YFFQQLISGVSYC 114
            NII    V      L    +     EL +  +    +   D  R  Y   Q++ G+ + 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHL 135
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+   
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------VQYKIPDY 226
            Y   + D+WS G  +  M+     F  ++    + K I ++          +Q  + +Y
Sbjct: 194 GYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 227 VH----------------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
           V                              +   R+LLS++ V +P++RI++ +   HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 259 W 259
           +
Sbjct: 313 Y 313

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 15/225 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           ++ + ++ +GSG +G      +   ++ VA+K + R  +  I A    RE+   K L+H 
Sbjct: 20  QRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHE 79
Query: 59  NIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           N+I   +V    T +     + +     G     I      S++  ++   QL+ G+ Y 
Sbjct: 80  NVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYI 139
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  I HRDLK  N  ++      L+I DFG ++ +         V T  Y APE++   
Sbjct: 140 HSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNW 195
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
            +  +  D+WS G  +  +L G   F       ++   + RIM V
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQGKALFPG----SDYIDQLKRIMEV 236

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 15/211 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           P I+   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPE 169
            H   I HRD+K  N L+  + A  +K+ DFG ++    S     +  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANILISATNA--VKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPE 189
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG ++  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLAR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 25/234 (10%)
Query: 6   LMKDI-GSGNFGVARLMRNKNTKELVAMKY---IERGHKIDANVAREIINHKQLRHPNII 61
           L+ DI G G        R+K T +L A+K    I     +D  + RE    K+L H NI+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 62  RF--KEVVLTPTHLAIVMEYAAGGELF---ERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +    E   T  H  ++ME+   G L+   E   NA    E E     + ++ G+++   
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 117 MQICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
             I HR++K  N +     DG      K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 173 R--------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 218
           R        ++Y G   D+WS GVT Y    G+ PF   E P+  ++ + +I+ 
Sbjct: 189 RAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 58/290 (20%)
Query: 31  AMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTH--LAIVMEYAAGGEL--- 85
           A+K IE G  I  +  REI   ++L+HPN+I  ++V L+     + ++ +YA        
Sbjct: 52  ALKQIE-GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII 110
Query: 86  -FERICNAGR----FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLL--DGSPAPR 138
            F R   A +          +    Q++ G+ Y H+  + HRDLK  N L+  +G    R
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170
Query: 139 LKICDFGYSKSSLLHSRPKS----TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML 194
           +KI D G+++      +P +     V T  Y APE+L    +  K  D+W+ G     +L
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
Query: 195 VGAYPFE-DQEDPKN----FRKTISRIMAVQ-----------YKIPDYVHISQDCR---- 234
                F   QED K         + RI  V             K+P++  + +D R    
Sbjct: 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 290
Query: 235 ---------------------NLLSRIFVANPSRRITIKEIKSHPWFLKN 263
                                +LL ++   +P +RIT ++    P+FL++
Sbjct: 291 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           P I+   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 4   YELMKDIGSG--NFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           YEL+  IG G  +     L R K T E V ++ I      +++   +  E+   K   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHS 116
           NI+ ++   +    L +V  + A G   + IC       +E    Y  Q ++  + Y H 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 117 MQICHRDLKLENTLL--DG-----SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 169
           M   HR +K  + L+  DG          L +   G  +  ++H  PK +V    +++PE
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 189
Query: 170 VLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED 202
           VL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 190 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 223

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           P I+   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG  +  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 18/215 (8%)
Query: 4   YELMKDIGSG--NFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           YEL+  IG G  +     L R K T E V ++ I      +++   +  E+   K   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHS 116
           NI+ ++   +    L +V  + A G   + IC       +E    Y  Q ++  + Y H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 117 MQICHRDLKLENTLL--DG-----SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 169
           M   HR +K  + L+  DG          L +   G  +  ++H  PK +V    +++PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 205
Query: 170 VLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED 202
           VL +  + YD K +D++S G+T   +  G  PF+D
Sbjct: 206 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 90/195 (46%), Gaps = 13/195 (6%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A +A   +   QLRH N+
Sbjct: 11  MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASV-MTQLRHSNL 67
Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSM 117
           ++   V++     L IV EY A G L + + + GR     D    F   +   + Y    
Sbjct: 68  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 127
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-YIAPEVLSRREY 176
              HRDL   N L+  S     K+ DFG +K +   S  + T   P  + APE L    +
Sbjct: 128 NFVHRDLAARNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREAAF 182
Query: 177 DGKLADVWSCGVTLY 191
             K +DVWS G+ L+
Sbjct: 183 STK-SDVWSFGILLW 196

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           P I+   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/328 (24%), Positives = 126/328 (38%), Gaps = 73/328 (22%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG--HKIDAN-VAREIINHKQLR- 56
           + KYEL+K +G G +G+     ++ T E+VA+K I     +  DA    REI+   +L  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           H NI+    V+       + + +         +  A        +Y   QLI  + Y HS
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--------------------SLLHSRP 156
             + HRD+K  N LL+      +K+ DFG S+S                    +    +P
Sbjct: 128 GGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 157 KST--VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML------------------VG 196
             T  V T  Y APE+L       K  D+WS G  L  +L                  +G
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
Query: 197 AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ---------------------DCR- 234
              F   ED ++ +   ++ M    K  + V I Q                     DC  
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLK--EKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 235 ---NLLSRIFVANPSRRITIKEIKSHPW 259
              +LL ++   NP++RI+  +   HP+
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPF 331

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GVSYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 67  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 121 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFE 201
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GVSYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSK 197
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFE 201
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNII 61
           +  +G GNFG   L R      NT  LVA+K ++  G     +  REI   K L    I+
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 71
Query: 62  RFKEVVLTPT--HLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +++ V   P    L +VMEY   G   +  +R  +  R        +  Q+  G+ Y  S
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGS 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++      +KI DFG +K   L  +    V  P      + APE L
Sbjct: 130 RRCVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDXXVVREPGQSPIFWYAPESL 186
Query: 172 SRREYDGKLADVWSCGVTLYVMLV 195
           S   +  + +DVWS GV LY +  
Sbjct: 187 SDNIFS-RQSDVWSFGVVLYELFT 209

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPN 59
           E   L + IG GNFG     R +    LVA+K        D  A   +E    KQ  HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQ 118
           I+R   V      + IVME   GG+    +   G R              +G+ Y  S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPA-YIAPEVLSRRE 175
             HRDL   N L+  +    LKI DFG S+  +  +++        P  + APE L+   
Sbjct: 234 CIHRDLAARNCLV--TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPF 200
           Y  + +DVWS G+ L+    +GA P+
Sbjct: 292 YSSE-SDVWSFGILLWETFSLGASPY 316

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 29  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 88
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           P I+   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 89  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 148
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y++PE
Sbjct: 149 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 206
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 207 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 236

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 123/263 (46%), Gaps = 31/263 (11%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPN 59
           E  +L K +G+G FG V     NK+TK  VA+K ++ G   ++A +A   +  K L+H  
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANV-MKTLQHDK 238
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVSYCHSM 117
           +++   VV T   + I+ E+ A G L + + +     +   +   F  Q+  G+++    
Sbjct: 239 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 297
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRR 174
              HRDL+  N L+  S     KI DFG ++           VG      + APE ++  
Sbjct: 298 NYIHRDLRAANILVSASLV--CKIADFGLAR-----------VGAKFPIKWTAPEAINFG 344
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +  K +DVWS G+ L  ++  G  P+    +P+     + R +   Y++P   +  ++ 
Sbjct: 345 SFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEEL 398
Query: 234 RNLLSRIFVANPSRRITIKEIKS 256
            N++ R +   P  R T + I+S
Sbjct: 399 YNIMMRCWKNRPEERPTFEYIQS 421

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GVSYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 71  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 125 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 181
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFE 201
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 182 FSSK-SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GVSYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 182
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFE 201
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 183 FSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 13/211 (6%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---- 58
           +YE++K IG G+FG      +    + VA+K +    +     A EI   + LR      
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 59  --NIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYC 114
             N+I   E      H+ +  E  +    EL ++    G FS    R F   ++  +   
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDAL 216
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           H  +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQED 205
            Y G   D+WS G  L  +L G YP    ED
Sbjct: 275 RY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 10  IGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFK 64
           IG+G FG   +  ++    +E+ VA+K ++ G+  K   +   E     Q  HPN+I  +
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 65  EVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
            VV   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   HR
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 159
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIAPEVLSRR 174
           DL   N L++ +     K+ DFG S+   L         T A        + APE +  R
Sbjct: 160 DLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFED 202
           ++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 216 KFTSA-SDVWSYGIVMWEVMSYGERPYWD 243

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 91/211 (43%), Gaps = 13/211 (6%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---- 58
           +YE++K IG G+FG      +    + VA+K +    +     A EI   + LR      
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 59  --NIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYC 114
             N+I   E      H+ +  E  +    EL ++    G FS    R F   ++  +   
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDAL 216
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           H  +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQSRFYRAPEVILGA 274
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQED 205
            Y G   D+WS G  L  +L G YP    ED
Sbjct: 275 RY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMK-----YIERGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K      + +   +D +  RE+     L H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
            N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 173 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 198 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 252
Query: 232 DCRNLLSRIFVANPSRRITIKEIKS 256
           D  N++ + +   P  R T   ++ 
Sbjct: 253 DIYNVMVQCWAHKPEDRPTFVALRD 277

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GVSYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 78  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 132 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 188
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFE 201
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 189 FSSK-SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 15/211 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANV----AREIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 58  PNIIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           P I+         T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 72  PAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPE 169
            H   I HRD+K  N ++  + A  +K+ DFG ++    S    ++  + +GT  Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPF 200
                  D + +DV+S G  LY +L G  PF
Sbjct: 190 QARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGAV 169
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GVSYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  +L     S+VG+     +  PEVL   +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFE 201
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 141 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 197 KFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 10  IGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFK 64
           IG+G FG   +  ++    +EL VA+K ++ G+  K   +   E     Q  HPNII  +
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 65  EVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRD 123
            VV     + IV EY   G L   +  N G+F+  +     + + +G+ Y   M   HRD
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRD 149
Query: 124 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRREYD 177
           L   N L++ +     K+ DFG S+  +L   P++   T        + APE ++ R++ 
Sbjct: 150 LAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFT 205
Query: 178 GKLADVWSCGVTLY-VMLVGAYPF 200
              +DVWS G+ ++ V+  G  P+
Sbjct: 206 SA-SDVWSYGIVMWEVVSYGERPY 228

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMK-----YIERGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K      + +   +D +  RE+     L H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
            N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 173 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 188 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 242
Query: 232 DCRNLLSRIFVANPSRRITIKEIKS 256
           D  N++ + +   P  R T   ++ 
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRD 267

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 8   KDIGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K +G+G FG   +  ++  + KE+ VA+K ++ G+  K   +   E     Q  HPNIIR
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L++ +     K+ DFG S+  +L   P++   T        + +PE ++ R
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPF 200
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 19/262 (7%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPN 59
           E  +L K +G+G FG V     NK+TK  VA+K ++ G   ++A +A   +  K L+H  
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANV-MKTLQHDK 71
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVSYCHSM 117
           +++   VV T   + I+ E+ A G L + + +     +   +   F  Q+  G+++    
Sbjct: 72  LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 130
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRRE 175
              HRDL+  N L+  S     KI DFG ++      ++  +       + APE ++   
Sbjct: 131 NYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 188
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
           +  K +DVWS G+ L  ++  G  P+    +P+     + R +   Y++P   +  ++  
Sbjct: 189 FTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELY 242
Query: 235 NLLSRIFVANPSRRITIKEIKS 256
           N++ R +   P  R T + I+S
Sbjct: 243 NIMMRCWKNRPEERPTFEYIQS 264

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPN 59
           E   L + IG GNFG     R +    LVA+K        D  A   +E    KQ  HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQ 118
           I+R   V      + IVME   GG+    +   G R              +G+ Y  S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPA-YIAPEVLSRRE 175
             HRDL   N L+  +    LKI DFG S+  +  + +        P  + APE L+   
Sbjct: 234 CIHRDLAARNCLV--TEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPF 200
           Y  + +DVWS G+ L+    +GA P+
Sbjct: 292 YSSE-SDVWSFGILLWETFSLGASPY 316

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMK-----YIERGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K      + +   +D +  RE+     L H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
            N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 173 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 192 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 246
Query: 232 DCRNLLSRIFVANPSRRITIKEIKS 256
           D  N++ + +   P  R T   ++ 
Sbjct: 247 DIYNVMVQCWAHKPEDRPTFVALRD 271

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 115/267 (43%), Gaps = 28/267 (10%)
Query: 9   DIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLRHPNIIRF 63
           +IG G+F    + +  +T+  V + + E   +      R+         K L+HPNI+RF
Sbjct: 33  EIGRGSFKT--VYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 64  ----KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ- 118
               +  V     + +V E    G L   +           R + +Q++ G+ + H+   
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 119 -ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I HRDLK +N  + G P   +KI D G + +    S  K+ +GTP + APE    + YD
Sbjct: 151 PIIHRDLKCDNIFITG-PTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXYEEK-YD 207
Query: 178 GKLADVWSCGVTLYVMLVGAYPF-EDQEDPKNFRKTISRIMAVQYK---IPDYVHISQDC 233
             + DV++ G          YP+ E Q   + +R+  S +    +    IP+   I + C
Sbjct: 208 ESV-DVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWF 260
                     N   R +IK++ +H +F
Sbjct: 267 -------IRQNKDERYSIKDLLNHAFF 286

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMK-----YIERGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K      + +   +D +  RE+     L H
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 80
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
            N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 140 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 173 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 198 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 252
Query: 232 DCRNLLSRIFVANPSRRITIKEIKS 256
           D  N++ + +   P  R T   ++ 
Sbjct: 253 DIYNVMVQCWAHKPEDRPTFVALRD 277

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNII 61
           +  +G GNFG   L R      NT  LVA+K ++  G     +  REI   K L    I+
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 74
Query: 62  RFKEVVLTPTH--LAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +++ V   P    L +VMEY   G   +  +R  +  R        +  Q+  G+ Y  S
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGS 132
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++      +KI DFG +K   L  +    V  P      + APE L
Sbjct: 133 RRCVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESL 189
Query: 172 SRREYDGKLADVWSCGVTLYVMLV 195
           S   +  + +DVWS GV LY +  
Sbjct: 190 SDNIFS-RQSDVWSFGVVLYELFT 212

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +     + G  I A   REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLL--HSRPK---ST 159
           L++G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L  +S+P    + 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 160 VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVM 193
           V T  Y  PE +L  R+Y G   D+W  G  +  M
Sbjct: 190 VVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 223

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 120/279 (43%), Gaps = 25/279 (8%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IGSG+ G     RL         VA+K ++ G+  +   +   E     Q  HPNIIR
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV       IV EY   G L  F R  + G+F+  +     + + +G+ Y   +   
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L+D +     K+ DFG S+  +L   P +   T        + APE ++ R
Sbjct: 174 HRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAXTTTGGKIPIRWTAPEAIAFR 229
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +    +DVWS GV ++ V+  G  P+ +  +    R  IS +    Y++P  +      
Sbjct: 230 TFS-SASDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEE-GYRLPAPMGCPHAL 283
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 272
             L+   +  + ++R    +I S    L   P  L  TA
Sbjct: 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMK-----YIERGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K      + +   +D +  RE+     L H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
            N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 173 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 188 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 242
Query: 232 DCRNLLSRIFVANPSRRITIKEIKS 256
           D  N++ + +   P  R T   ++ 
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRD 267

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNII 61
           +  +G GNFG   L R      NT  LVA+K ++  G     +  REI   K L    I+
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 75
Query: 62  RFKEVVLTPTH--LAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +++ V   P    L +VMEY   G   +  +R  +  R        +  Q+  G+ Y  S
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGS 133
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++      +KI DFG +K   L  +    V  P      + APE L
Sbjct: 134 RRCVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESL 190
Query: 172 SRREYDGKLADVWSCGVTLYVMLV 195
           S   +  + +DVWS GV LY +  
Sbjct: 191 SDNIFS-RQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 7   MKDIGSGNFGVARLMR----NKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNII 61
           +  +G GNFG   L R      NT  LVA+K ++  G     +  REI   K L    I+
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 62  RFKEVVLTPTH--LAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +++ V   P    L +VMEY   G   +  +R  +  R        +  Q+  G+ Y  S
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGS 145
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVL 171
            +  HRDL   N L++      +KI DFG +K   L  +    V  P      + APE L
Sbjct: 146 RRCVHRDLAARNILVESEA--HVKIADFGLAKLLPL-DKDYYVVREPGQSPIFWYAPESL 202
Query: 172 SRREYDGKLADVWSCGVTLYVMLV 195
           S   +  + +DVWS GV LY +  
Sbjct: 203 SDNIFS-RQSDVWSFGVVLYELFT 225

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMK-----YIERGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K      + +   +D +  RE+     L H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
            N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 173 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 188 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 242
Query: 232 DCRNLLSRIFVANPSRRITIKEIKS 256
           D  N++ + +   P  R T   ++ 
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALRD 267

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 120/279 (43%), Gaps = 25/279 (8%)
Query: 8   KDIGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIR 62
           K IGSG+ G     RL         VA+K ++ G+  +   +   E     Q  HPNIIR
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 63  FKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
            + VV       IV EY   G L  F R  + G+F+  +     + + +G+ Y   +   
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLGYV 173
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRR 174
           HRDL   N L+D +     K+ DFG S+  +L   P +   T        + APE ++ R
Sbjct: 174 HRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +    +DVWS GV ++ V+  G  P+ +  +    R  IS +    Y++P  +      
Sbjct: 230 TFS-SASDVWSFGVVMWEVLAYGERPYWNMTN----RDVISSVEE-GYRLPAPMGCPHAL 283
Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 272
             L+   +  + ++R    +I S    L   P  L  TA
Sbjct: 284 HQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATA 322

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 118/265 (44%), Gaps = 23/265 (8%)
Query: 6   LMKDIGSGNFGVARL--MRNKNTKEL-VAMK-----YIERGHKIDANVAREIINHKQLRH 57
           L++ +G G+FGV R       + K + VA+K      + +   +D +  RE+     L H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDH 74
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
            N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SLLHSRPKSTVGTP-AYIAPEVLS 172
            +  HRDL   N LL  +    +KI DFG  ++   +  H   +     P A+ APE L 
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 173 RREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
            R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P      Q
Sbjct: 192 TRTF-SHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPRPEDCPQ 246
Query: 232 DCRNLLSRIFVANPSRRITIKEIKS 256
           D  N++ + +   P  R T   ++ 
Sbjct: 247 DIYNVMVQCWAHKPEDRPTFVALRD 271

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +     + G  I A   REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLL--HSRPK---ST 159
           L++G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L  +S+P    + 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 160 VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVM 193
           V T  Y  PE +L  R+Y G   D+W  G  +  M
Sbjct: 190 VVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 223

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 25/234 (10%)
Query: 6   LMKDI-GSGNFGVARLMRNKNTKELVAMKY---IERGHKIDANVAREIINHKQLRHPNII 61
           L+ DI G G        R+K T +L A+K    I     +D  + RE    K+L H NI+
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM-REFEVLKKLNHKNIV 70
Query: 62  RF--KEVVLTPTHLAIVMEYAAGGELF---ERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +    E   T  H  ++ME+   G L+   E   NA    E E     + ++ G+++   
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 117 MQICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
             I HR++K  N +     DG      K+ DFG ++      +     GT  Y+ P++  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYE 188
Query: 173 R--------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 218
           R        ++Y G   D+WS GVT Y    G+ PF   E P+  ++ + +I+ 
Sbjct: 189 RAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 124/262 (47%), Gaps = 19/262 (7%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPN 59
           E  +L K +G+G FG V     NK+TK  VA+K ++ G   ++A +A   +  K L+H  
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANV-MKTLQHDK 244
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVSYCHSM 117
           +++   VV T   + I+ E+ A G L + + +     +   +   F  Q+  G+++    
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRRE 175
              HRDL+  N L+  S     KI DFG ++      ++  +       + APE ++   
Sbjct: 304 NYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
           +  K +DVWS G+ L  ++  G  P+    +P+     + R +   Y++P   +  ++  
Sbjct: 362 FTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELY 415
Query: 235 NLLSRIFVANPSRRITIKEIKS 256
           N++ R +   P  R T + I+S
Sbjct: 416 NIMMRCWKNRPEERPTFEYIQS 437

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +     + G  I A   REI   + L
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 74
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 133
Query: 107 LISGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLL--HSRPK---ST 159
           L++G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L  +S+P    + 
Sbjct: 134 LLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNR 189
Query: 160 VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVM 193
           V T  Y  PE +L  R+Y G   D+W  G  +  M
Sbjct: 190 VVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 223

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 9   DIGSGNFGVAR--LMRNKNTKELVAMKYIERG-HKIDAN-VAREIINHKQLRHPNIIRFK 64
           ++G GNFG  R  + R +  +  VA+K +++G  K D   + RE     QL +P I+R  
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYCHSMQICH 121
            V      L +VME A GG L + +   G+  E           Q+  G+ Y       H
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKS-----SLLHSRPKSTVGTPAYIAPEVLSRREY 176
           RDL   N LL        KI DFG SK+     S   +R         Y APE ++ R++
Sbjct: 134 RDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFRKF 190
Query: 177 DGKLADVWSCGVTLYVML-VGAYPFEDQEDPK 207
             + +DVWS GVT++  L  G  P++  + P+
Sbjct: 191 SSR-SDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +     + G  I A   REI   + L
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 73
Query: 56  RHPNIIRFKEVVLTPTH--------LAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQ 106
           +H N++   E+  T           + +V ++    +L   + N   +F+  E +   Q 
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 107 LISGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLL--HSRPK---ST 159
           L++G+ Y H  +I HRD+K  N L+  DG     LK+ DFG +++  L  +S+P    + 
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQPNRYXNR 188
Query: 160 VGTPAYIAPE-VLSRREYDGKLADVWSCGVTLYVM 193
           V T  Y  PE +L  R+Y G   D+W  G  +  M
Sbjct: 189 VVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEM 222

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 13/211 (6%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---- 58
           +YE++K IG G FG      +    + VA+K +    +     A EI   + LR      
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 59  --NIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYC 114
             N+I   E      H+ +  E  +    EL ++    G FS    R F   ++  +   
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDAL 216
Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           H  +I H DLK EN LL       +K+ DFG   S   H R    + +  Y APEV+   
Sbjct: 217 HKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQSRFYRAPEVILGA 274
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQED 205
            Y G   D+WS G  L  +L G YP    ED
Sbjct: 275 RY-GMPIDMWSLGCILAELLTG-YPLLPGED 303

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNI 60
           E + ++GSG  G    MR + T  ++A+K + R    + N  R +++     K    P I
Sbjct: 28  ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYI 86
Query: 61  IRFKEVVLTPTHLAIVMEYAAG----------GELFERICNAGRFSEDEARYFFQQLISG 110
           ++     +T T + I ME              G + ERI      +  +A Y+ ++    
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE---- 142
Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
                   + HRD+K  N LLD     ++K+CDFG S   +       + G  AY+APE 
Sbjct: 143 -----KHGVIHRDVKPSNILLD--ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPER 195
Query: 171 L-----SRREYDGKLADVWSCGVTLYVMLVGAYPFED 202
           +     ++ +YD + ADVWS G++L  +  G +P+++
Sbjct: 196 IDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKN 231

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 127/273 (46%), Gaps = 23/273 (8%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-----INHKQLR 56
           +  E + ++G G +GV   MR+  + +++A+K I     +++   + +     I+ + + 
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVD 108
Query: 57  HPNIIRFKEVVLTPTHLAIVMEY--AAGGELFERICNAGR-FSEDEARYFFQQLISGVSY 113
            P  + F   +     + I ME    +  + ++++ + G+   ED        ++  + +
Sbjct: 109 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 168
Query: 114 CHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPE-- 169
            HS + + HRD+K  N L++     ++K+CDFG S   L+ S  K+   G   Y+APE  
Sbjct: 169 LHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGIS-GYLVDSVAKTIDAGCKPYMAPERI 225
Query: 170 --VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
              L+++ Y  K +D+WS G+T+  + +  +P++    P    K +    + Q     + 
Sbjct: 226 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF- 283
Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             S +  +  S+    N   R T  E+  HP+F
Sbjct: 284 --SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 22/207 (10%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
            +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  +++   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 66  VVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS-------GVSYCHSMQ 118
           V      + I+ EY A G      C      E   R+  QQL+         + Y  S Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP---AYIAPEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  +L     S+ G+     +  PEVL   +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFE 201
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 183 FSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 121/287 (42%), Gaps = 37/287 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           +E +  +G G FG     RN       A+K I    +  + +  E+     L H  ++R+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 64  -------------KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSE-DEARYFFQQLIS 109
                           V   + L I  EY     L++ I +     + DE    F+Q++ 
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SL----LHSRP------ 156
            +SY HS  I HR+LK  N  +D S    +KI DFG +K+   SL    L S+       
Sbjct: 128 ALSYIHSQGIIHRNLKPXNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 157 --KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
              S +GT  Y+A EVL    +  +  D +S G+  +  +   YPF    +  N  K + 
Sbjct: 186 NLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVNILKKL- 241
Query: 215 RIMAVQYKIPDYVHISQDCRNLLSRIFVA-NPSRRITIKEIKSHPWF 260
           R +++++  PD+          + R+ +  +P++R   + + +  W 
Sbjct: 242 RSVSIEFP-PDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 10  IGSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           +G G FGV       NT    K+L AM  I    ++     +EI    + +H N++    
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
                  L +V  Y   G L +R+ C  G    S        Q   +G+++ H     HR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSS------LLHSRPKSTVGTPAYIAPEVLSRREY 176
           D+K  N LLD   A   KI DFG +++S      ++ SR    VGT AY+APE L R E 
Sbjct: 158 DIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXSR---IVGTTAYMAPEAL-RGEI 211
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPK 207
             K +D++S GV L  ++ G    ++  +P+
Sbjct: 212 TPK-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 43/229 (18%)
Query: 57  HPNIIRF--KEVVLTPTHLAIVMEYAAGGELFER--ICNAGRFSEDEARYFFQQLISGVS 112
           HPN+IR+   E      ++AI +  A   E  E+    + G     E     QQ  SG++
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL----EPITLLQQTTSGLA 132
Query: 113 YCHSMQICHRDLKLENTLLDGSPAP---RLKICDFGYSKSSLL----HSRPKSTVGTPAY 165
           + HS+ I HRDLK  N L+    A    +  I DFG  K   +     SR     GT  +
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 166 IAPEVLSR--REYDGKLADVWSCG-VTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 222
           IAPE+LS   +E      D++S G V  YV+  G++PF      K+ ++  + ++     
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF-----GKSLQRQANILLGA--- 244
Query: 223 IPDYVHISQDC-----------RNLLSRIFVANPSRRITIKEIKSHPWF 260
                  S DC           R L+ ++   +P +R + K +  HP+F
Sbjct: 245 ------CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 10  IGSGNFG---VARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFK 64
           IG+G FG     RL         VA+K ++ G+  K   +   E     Q  HPN++  +
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 65  EVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
            VV     + IV+E+   G L  F R  + G+F+  +     + + +G+ Y   M   HR
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRK-HDGQFTVIQLVGMLRGIAAGMRYLADMGYVHR 169
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA------YIAPEVLSRREY 176
           DL   N L++ +     K+ DFG S+  ++   P++   T        + APE +  R++
Sbjct: 170 DLAARNILVNSNLV--CKVSDFGLSR--VIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKF 225
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFEDQED 205
               +DVWS G+ ++ VM  G  P+ D  +
Sbjct: 226 TSA-SDVWSYGIVMWEVMSYGERPYWDMSN 254

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 10  IGSGNFG--VARLMRNKNTKEL-VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFK 64
           IG+G FG   +  ++    +E+ VA+K ++ G+  K   +   E     Q  HPN+I  +
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 65  EVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
            VV   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   HR
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR 133
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------YIAPEVLSRR 174
            L   N L++ +     K+ DFG S+   L         T A        + APE +  R
Sbjct: 134 ALAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFED 202
           ++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 190 KFTSA-SDVWSYGIVMWEVMSYGERPYWD 217

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N L+D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/272 (21%), Positives = 123/272 (45%), Gaps = 21/272 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-----INHKQLR 56
           +  E + ++G G +GV   MR+  + +++A+K I     +++   + +     I+ + + 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTVD 64
Query: 57  HPNIIRFKEVVLTPTHLAIVMEY--AAGGELFERICNAGR-FSEDEARYFFQQLISGVSY 113
            P  + F   +     + I ME    +  + ++++ + G+   ED        ++  + +
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 114 CHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE--- 169
            HS + + HRD+K  N L++     ++K+CDFG S   +         G   Y+APE   
Sbjct: 125 LHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN 182
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
             L+++ Y  K +D+WS G+T+  + +  +P++    P    K +    + Q     +  
Sbjct: 183 PELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF-- 239
Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            S +  +  S+    N   R T  E+  HP+F
Sbjct: 240 -SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 114/285 (40%), Gaps = 37/285 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQL-RH 57
           E +EL K IGSG FG       +    + A+K  ++   G   + N  RE+  H  L +H
Sbjct: 8   EFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 66
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSY 113
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y
Sbjct: 67  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 126
Query: 114 CHSMQICHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSLLHSRP 156
            HSM + H D+K  N  +  +  P                   KI D G+       S P
Sbjct: 127 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 183
Query: 157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 216
           +   G   ++A EVL         AD+++  +T+ V   GA P      P+N  +     
Sbjct: 184 QVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPL-----PRNGDQWHEIR 237
Query: 217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
                +IP    +SQ+   LL  +   +P RR +   +  H   L
Sbjct: 238 QGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 280

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 10  IGSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           +G G FGV       NT    K+L AM  I    ++     +EI    + +H N++    
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
                  L +V  Y   G L +R+ C  G    S        Q   +G+++ H     HR
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 157
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGK 179
           D+K  N LLD   A   KI DFG +++S   ++       VGT AY+APE L R E   K
Sbjct: 158 DIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL-RGEITPK 214
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPK 207
            +D++S GV L  ++ G    ++  +P+
Sbjct: 215 -SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 114/285 (40%), Gaps = 37/285 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQL-RH 57
           E +EL K IGSG FG       +    + A+K  ++   G   + N  RE+  H  L +H
Sbjct: 10  EFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSY 113
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y
Sbjct: 69  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 128
Query: 114 CHSMQICHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSLLHSRP 156
            HSM + H D+K  N  +  +  P                   KI D G+       S P
Sbjct: 129 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 185
Query: 157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 216
           +   G   ++A EVL         AD+++  +T+ V   GA P      P+N  +     
Sbjct: 186 QVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQWHEIR 239
Query: 217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
                +IP    +SQ+   LL  +   +P RR +   +  H   L
Sbjct: 240 QGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +  +  +F   +     +Q   G+
Sbjct: 75  RKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLS-GSILWMA 190
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPD 246
Query: 226 YVHISQDCRNLLSRIFV 242
              +  +C   + R+  
Sbjct: 247 LSKVRSNCPKRMKRLMA 263

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 37/227 (16%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           + YE+   IG G++G   L  +KN  + VA+K + R  +  ID   + REI    +L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 59  NIIRFKEVV-----LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
            IIR  +++     L    L IV+E  A  +L +        +E   +     L+ G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS------------------------ 149
            H   I HRDLK  N LL+   +  +KICDFG +++                        
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCS--VKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 150 --SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML 194
               L  +  S V T  Y APE++  +E      D+WS G     +L
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 10  IGSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           +G G FGV       NT    K+L AM  I    ++     +EI    + +H N++    
Sbjct: 33  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGR--FSEDEARYFFQQLISGVSYCHSMQICHR 122
                  L +V  Y   G L +R+ C  G    S        Q   +G+++ H     HR
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHR 151
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGK 179
           D+K  N LLD   A   KI DFG +++S   ++       VGT AY+APE L R E   K
Sbjct: 152 DIKSANILLD--EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL-RGEITPK 208
Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPK 207
            +D++S GV L  ++ G    ++  +P+
Sbjct: 209 -SDIYSFGVVLLEIITGLPAVDEHREPQ 235

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 114/285 (40%), Gaps = 37/285 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQL-RH 57
           E +EL K IGSG FG       +    + A+K  ++   G   + N  RE+  H  L +H
Sbjct: 10  EFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 68
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSY 113
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y
Sbjct: 69  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 128
Query: 114 CHSMQICHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSLLHSRP 156
            HSM + H D+K  N  +  +  P                   KI D G+       S P
Sbjct: 129 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 185
Query: 157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 216
           +   G   ++A EVL         AD+++  +T+ V   GA P      P+N  +     
Sbjct: 186 QVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQWHEIR 239
Query: 217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
                +IP    +SQ+   LL  +   +P RR +   +  H   L
Sbjct: 240 QGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 123/279 (44%), Gaps = 29/279 (10%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-----KQLR 56
           E  + + +IG G +G    M +K + +++A+K I     +D    ++++       +   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSD 79
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC-- 114
            P I++F   +       I ME  +    F++         D+     ++++  ++    
Sbjct: 80  CPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDV--IPEEILGKITLATV 135
Query: 115 -------HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYI 166
                   +++I HRD+K  N LLD S    +K+CDFG S   L+ S  K+   G   Y+
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGIS-GQLVDSIAKTRDAGCRPYM 192
Query: 167 APEVL----SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 222
           APE +    SR+ YD + +DVWS G+TLY +  G +P+       +    + +    Q  
Sbjct: 193 APERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLS 251
Query: 223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
             +    S    N ++     + S+R   KE+  HP+ L
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 105/237 (44%), Gaps = 40/237 (16%)
Query: 59  NIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           NII+  + V  P     A+V EY    + F+++      ++ + R++  +L+  + YCHS
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 150
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRRE 175
             I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   + 
Sbjct: 151 KGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 209
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIP--- 224
           YD  L D+WS G  L  M+    PF   +D  +    I++++  +        Y I    
Sbjct: 210 YDYSL-DMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDP 268
Query: 225 ---------------DYVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                          +++H      +S +  +LL ++   +  +R+T KE   HP+F
Sbjct: 269 HFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 105/237 (44%), Gaps = 40/237 (16%)
Query: 59  NIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           NII+  + V  P     A+V EY    + F+++      ++ + R++  +L+  + YCHS
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 155
Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRRE 175
             I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   + 
Sbjct: 156 KGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 214
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--------YKIP--- 224
           YD  L D+WS G  L  M+    PF   +D  +    I++++  +        Y I    
Sbjct: 215 YDYSL-DMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDP 273
Query: 225 ---------------DYVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                          +++H      +S +  +LL ++   +  +R+T KE   HP+F
Sbjct: 274 HFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 114/285 (40%), Gaps = 37/285 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQL-RH 57
           E +EL K IGSG FG       +    + A+K  ++   G   + N  RE+  H  L +H
Sbjct: 12  EFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSY 113
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 114 CHSMQICHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSLLHSRP 156
            HSM + H D+K  N  +  +  P                   KI D G+       S P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSP 187
Query: 157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 216
           +   G   ++A EVL         AD+++  +T+ V   GA P      P+N  +     
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-----PRNGDQWHEIR 241
Query: 217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
                +IP    +SQ+   LL  +   +P RR +   +  H   L
Sbjct: 242 QGRLPRIPQV--LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +  +  +F   +     +Q   G+
Sbjct: 75  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLS-GSILWMA 190
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPD 246
Query: 226 YVHISQDCRNLLSRIFV 242
              +  +C   + R+  
Sbjct: 247 LSKVRSNCPKRMKRLMA 263

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +  +  +F   +     +Q   G+
Sbjct: 63  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGM 121
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 122 DYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMA 178
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPD 234
Query: 226 YVHISQDCRNLLSRIFV 242
              +  +C   + R+  
Sbjct: 235 LSKVRSNCPKRMKRLMA 251

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 104/253 (41%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G FG       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 192
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+    DP      +  ++   Y++       +    L+   +
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGI-DPSQ----VYELLEKDYRMERPEGCPEKVYELMRACW 247
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 248 QWNPSDRPSFAEI 260

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR- 56
           +YE + +IG G +G     R+ ++   VA+K +     E G  I  +  RE+   ++L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGRFSEDEA----------RYF 103
             HPN++R  +V  T  T   I +       +FE +    R   D+A          +  
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTL-----VFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 163
            +Q + G+ + H+  I HRDLK EN L+  +    +K+ DFG ++           V T 
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALDPVVVTL 175
Query: 164 AYIAPEVLSRREYDGKLADVWSCGVTLYVML 194
            Y APEVL +  Y     D+WS G     M 
Sbjct: 176 WYRAPEVLLQSTY-ATPVDMWSVGCIFAEMF 205

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 59  RKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMA 174
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 230
Query: 226 YVHISQDCRNLLSRIF 241
              +  +C   + R+ 
Sbjct: 231 LSKVRSNCPKAMKRLM 246

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 153
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 213 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 271
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 272 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 206 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 98/212 (46%), Gaps = 20/212 (9%)
Query: 9   DIGSGNFGVAR--LMRNKNTKELVAMKYIERG-HKIDAN-VAREIINHKQLRHPNIIRFK 64
           ++G GNFG  R  + R +  +  VA+K +++G  K D   + RE     QL +P I+R  
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 65  EVVLTPTHLAIVMEYAAGGELFERICNAGRFSE---DEARYFFQQLISGVSYCHSMQICH 121
            V      L +VME A GG L + +   G+  E           Q+  G+ Y       H
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKS-----SLLHSRPKSTVGTPAYIAPEVLSRREY 176
           R+L   N LL        KI DFG SK+     S   +R         Y APE ++ R++
Sbjct: 460 RNLAARNVLLVNRH--YAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFRKF 516
Query: 177 DGKLADVWSCGVTLYVML-VGAYPFEDQEDPK 207
             + +DVWS GVT++  L  G  P++  + P+
Sbjct: 517 SSR-SDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR- 56
           +YE + +IG G +G     R+ ++   VA+K +     E G  I  +  RE+   ++L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGRFSEDEA----------RYF 103
             HPN++R  +V  T  T   I +       +FE +    R   D+A          +  
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTL-----VFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 163
            +Q + G+ + H+  I HRDLK EN L+  +    +K+ DFG ++           V T 
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALAPVVVTL 175
Query: 164 AYIAPEVLSRREYDGKLADVWSCGVTLYVML 194
            Y APEVL +  Y     D+WS G     M 
Sbjct: 176 WYRAPEVLLQSTY-ATPVDMWSVGCIFAEMF 205

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 11  GSGNFGVARLMRNKNT----KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEV 66
           G G FGV       NT    K+L AM  I    ++     +EI    + +H N++     
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITT-EELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 67  VLTPTHLAIVMEYAAGGELFERI-CNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRD 123
                 L +V  Y   G L +R+ C  G    S        Q   +G+++ H     HRD
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHRD 149
Query: 124 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKL 180
           +K  N LLD   A   KI DFG +++S   ++       VGT AY APE L R E   K 
Sbjct: 150 IKSANILLD--EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL-RGEITPK- 205
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPK 207
           +D++S GV L  ++ G    ++  +P+
Sbjct: 206 SDIYSFGVVLLEIITGLPAVDEHREPQ 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 15/197 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 87  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLS-GSILWMA 202
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 258
Query: 226 YVHISQDCRNLLSRIFV 242
              +  +C   + R+  
Sbjct: 259 LSKVRSNCPKAMKRLMA 275

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 86  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 144
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 145 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMA 201
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 257
Query: 226 YVHISQDCRNLLSRIF 241
              +  +C   + R+ 
Sbjct: 258 LSKVRSNCPKAMKRLM 273

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 79  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 137
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 138 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLS-GSILWMA 194
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 250
Query: 226 YVHISQDCRNLLSRIF 241
              +  +C   + R+ 
Sbjct: 251 LSKVRSNCPKAMKRLM 266

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 113/260 (43%), Gaps = 14/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E  +L+K +G+G FG   +    N+ + VA+K ++ G         E    K L+H  ++
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 71
Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           R   VV     + I+ EY A G L  F +    G+    +   F  Q+  G++Y      
Sbjct: 72  RLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 131
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  S +   KI DFG ++      ++  +       + APE ++   + 
Sbjct: 132 IHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 178 GKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ LY ++  G  P+     P      +   ++  Y++P   +   +  ++
Sbjct: 190 IK-SDVWSFGILLYEIVTYGKIPY-----PGRTNADVMTALSQGYRMPRVENCPDELYDI 243
Query: 237 LSRIFVANPSRRITIKEIKS 256
           +   +      R T   ++S
Sbjct: 244 MKMCWKEKAEERPTFDYLQS 263

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 87  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 145
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 146 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMA 202
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 258
Query: 226 YVHISQDCRNLLSRIF 241
              +  +C   + R+ 
Sbjct: 259 LSKVRSNCPKAMKRLM 274

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 61  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 119
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 120 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMA 176
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 232
Query: 226 YVHISQDCRNLLSRIF 241
              +  +C   + R+ 
Sbjct: 233 LSKVRSNCPKAMKRLM 248

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 59  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLS-GSILWMA 174
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 230
Query: 226 YVHISQDCRNLLSRIF 241
              +  +C   + R+ 
Sbjct: 231 LSKVRSNCPKAMKRLM 246

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 59  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 117
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 118 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMA 174
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 230
Query: 226 YVHISQDCRNLLSRIF 241
              +  +C   + R+ 
Sbjct: 231 LSKVRSNCPKAMKRLM 246

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 64  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMA 179
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 235
Query: 226 YVHISQDCRNLLSRIF 241
              +  +C   + R+ 
Sbjct: 236 LSKVRSNCPKAMKRLM 251

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGV 111
           ++ RH NI+ F      P  LAIV ++  G  L+  +     +F   +     +Q   G+
Sbjct: 64  RKTRHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGM 122
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY----SKSSLLHSRPKSTVGTPAYIA 167
            Y H+  I HRDLK  N  L       +KI DFG     S+ S  H   + + G+  ++A
Sbjct: 123 DYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLS-GSILWMA 179
Query: 168 PEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           PEV+  ++ +     +DV++ G+ LY ++ G  P+ +     N R  I  ++   Y  PD
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN----INNRDQIIFMVGRGYLSPD 235
Query: 226 YVHISQDCRNLLSRIF 241
              +  +C   + R+ 
Sbjct: 236 LSKVRSNCPKAMKRLM 251

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 58  PNIIRFKEVVLTPTHL--AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNII   ++V  P     A+V E+    + F+++      ++ + R++  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQT--LTDYDIRFYMYEILKALDYCH 148
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL-SRR 174
           SM I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPD------- 225
            YD  L D+WS G  L  M+    PF    D  +    I++++  +  Y   D       
Sbjct: 208 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 266
Query: 226 -----------------YVH------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                            +VH      +S +  + L ++   +   R+T +E   HP+F
Sbjct: 267 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/259 (24%), Positives = 115/259 (44%), Gaps = 27/259 (10%)
Query: 10  IGSGNFGVA------RLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           IG G+FGV          +N+    + ++  I    +++A + RE +  + L HPN++  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL-REGLLMRGLNHPNVLAL 87
Query: 64  KEVVLTPTHLA-IVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICH 121
             ++L P  L  +++ Y   G+L + I +  R  +  +   F  Q+  G+ Y    +  H
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147
Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSL--------LHSRPKSTVGTPAYIAPEVLSR 173
           RDL   N +LD S    +K+ DFG ++  L         H   +  V    + A E L  
Sbjct: 148 RDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPV---KWTALESLQT 202
Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
             +  K +DVWS GV L+ +L    P     DP +    ++  +A   ++P   +     
Sbjct: 203 YRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFD----LTHFLAQGRRLPQPEYCPDSL 257
Query: 234 RNLLSRIFVANPSRRITIK 252
             ++ + + A+P+ R T +
Sbjct: 258 YQVMQQCWEADPAVRPTFR 276

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 102/250 (40%), Gaps = 13/250 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 128 NTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
           N L+  +    +K+ DFG S+  +   ++ P        + APE L+  ++  K +DVW+
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK-SDVWA 198
Query: 186 CGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 244
            GV L+ +   G  P+     P      +  ++   Y++       +    L+   +  N
Sbjct: 199 FGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 253
Query: 245 PSRRITIKEI 254
           PS R +  EI
Sbjct: 254 PSDRPSFAEI 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 105/253 (41%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I++E+   G L +  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 192
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+    DP      +  ++   Y++       +    L+   +
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGI-DPSQ----VYELLEKDYRMERPEGCPEKVYELMRACW 247
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 248 QWNPSDRPSFAEI 260

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQLR- 56
           +YE + +IG G +G     R+ ++   VA+K +     E G  I  +  RE+   ++L  
Sbjct: 5   RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRLEA 62
Query: 57  --HPNIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGRFSEDEA----------RYF 103
             HPN++R  +V  T  T   I +       +FE +    R   D+A          +  
Sbjct: 63  FEHPNVVRLMDVCATSRTDREIKVTL-----VFEHVDQDLRTYLDKAPPPGLPAETIKDL 117
Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 163
            +Q + G+ + H+  I HRDLK EN L+  +    +K+ DFG ++           V T 
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILV--TSGGTVKLADFGLARIYSYQMALFPVVVTL 175
Query: 164 AYIAPEVLSRREYDGKLADVWSCGVTLYVML 194
            Y APEVL +  Y     D+WS G     M 
Sbjct: 176 WYRAPEVLLQSTY-ATPVDMWSVGCIFAEMF 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 102/250 (40%), Gaps = 13/250 (5%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 128 NTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWS 185
           N L+  +    +K+ DFG S+  +   ++ P        + APE L+  ++  K +DVW+
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK-SDVWA 199
Query: 186 CGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 244
            GV L+ +   G  P+     P      +  ++   Y++       +    L+   +  N
Sbjct: 200 FGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 254
Query: 245 PSRRITIKEI 254
           PS R +  EI
Sbjct: 255 PSDRPSFAEI 264

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I++E+   G L +  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 104/253 (41%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I++E+   G L +  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 16/224 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR------EIIN-HK 53
           M++YE+   IG G+FG      ++  +E VA+K I +  K   N A+      E++N H 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGV 111
                 I+  K   +   HL +V E  +   L++  R  N    S +  R F QQ+ + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 112 SYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 169
            +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 213
           VL    YD  + D+WS G  L  M  G   F    +     K +
Sbjct: 229 VLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 7   MKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLRHP 58
           +K +GSG FG       +   +N K  VA+K +       AN  +EI++       +  P
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 79
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSM 117
            + R   + LT T + +V +    G L + +  N GR    +   +  Q+  G+SY   +
Sbjct: 80  YVSRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDV 138
Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAPEVLSRR 174
           ++ HRDL   N L+  SP   +KI DFG ++   +        G      ++A E + RR
Sbjct: 139 RLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFE 201
            +  + +DVWS GVT++ +M  GA P++
Sbjct: 197 RFTHQ-SDVWSYGVTVWELMTFGAKPYD 223

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 16/224 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR------EIIN-HK 53
           M++YE+   IG G+FG      ++  +E VA+K I +  K   N A+      E++N H 
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 92
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGV 111
                 I+  K   +   HL +V E  +   L++  R  N    S +  R F QQ+ + +
Sbjct: 93  TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 151
Query: 112 SYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 169
            +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 152 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 209
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 213
           VL    YD  + D+WS G  L  M  G   F    +     K +
Sbjct: 210 VLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 252

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 41/230 (17%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDAN-VAREIINHKQLRHP 58
           ++YE+   IG+G++G      +K  K +VA+K I R  +  ID   + REI    +L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 59  NIIRFKEVVLTPT-----HLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVS 112
           ++++  ++V+         L +V+E A     F+++     + +E   +     L+ GV 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--------SLLHSRPKST----- 159
           Y HS  I HRDLK  N L++   +  +K+CDFG +++        S L   P+       
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 160 ---------------VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML 194
                          V T  Y APE++  +E   +  DVWS G     +L
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 16/224 (7%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR------EIIN-HK 53
           M++YE+   IG G+FG      ++  +E VA+K I +  K   N A+      E++N H 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHD 111
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGV 111
                 I+  K   +   HL +V E  +   L++  R  N    S +  R F QQ+ + +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 112 SYCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE 169
            +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PE
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPE 228
Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 213
           VL    YD  + D+WS G  L  M  G   F    +     K +
Sbjct: 229 VLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 104/253 (41%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I++E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 195
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 196 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 250
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 251 QWNPSDRPSFAEI 263

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 104/253 (41%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTFTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 192
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+    DP      +  ++   Y++       +    L+   +
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGI-DPSQ----VYELLEKDYRMERPEGCPEKVYELMRACW 247
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 248 QWNPSDRPSFAEI 260

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    S     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQLR 56
           +YE + +IG G +G     R+ ++   VA+K +        G  +  +  RE+   ++L 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 57  ---HPNIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGRFSEDEA----------RY 102
              HPN++R  +V  T  T   I +       +FE +    R   D+A          + 
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTL-----VFEHVDQDLRTYLDKAPPPGLPAETIKD 124
Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT 162
             +Q + G+ + H+  I HRDLK EN L+       +K+ DFG ++           V T
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVT 182
Query: 163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVML 194
             Y APEVL +  Y     D+WS G     M 
Sbjct: 183 LWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMF 213

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 104/253 (41%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I++E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 21/215 (9%)
Query: 1   MEKYEL------MK-DIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK 53
           M+K+E+      MK  +G G +G   +   K     VA+K ++          +E    K
Sbjct: 24  MDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 83
Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGV 111
           +++HPN+++   V        IV EY   G L +  R CN    +     Y   Q+ S +
Sbjct: 84  EIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAM 143
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYI 166
            Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  +    + 
Sbjct: 144 EYLEKKNFIHRDLAARNCLVGENHV--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWT 198
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
           APE L+   +  K +DVW+ GV L+ +   G  P+
Sbjct: 199 APESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPY 232

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 113/260 (43%), Gaps = 14/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E  +L+K +G+G FG   +    N+ + VA+K ++ G         E    K L+H  ++
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV 70
Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           R   VV     + I+ E+ A G L  F +    G+    +   F  Q+  G++Y      
Sbjct: 71  RLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 130
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  S +   KI DFG ++      ++  +       + APE ++   + 
Sbjct: 131 IHRDLRAANVLV--SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 178 GKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K ++VWS G+ LY ++  G  P+     P      +   ++  Y++P   +   +  ++
Sbjct: 189 IK-SNVWSFGILLYEIVTYGKIPY-----PGRTNADVMSALSQGYRMPRMENCPDELYDI 242
Query: 237 LSRIFVANPSRRITIKEIKS 256
           +   +      R T   ++S
Sbjct: 243 MKMCWKEKAEERPTFDYLQS 262

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 139/311 (44%), Gaps = 44/311 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDX 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 272 AQAIYYRKENP 282
               Y     P
Sbjct: 321 TNEEYLDLSQP 331

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 32/232 (13%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--------FFQQLI 108
           HPN+IR+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 109 SGVSYCHSMQICHRDLKLENTLLD-----------GSPAPRLKICDFGYSK-----SSLL 152
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 153 HSRPKSTVGTPAYIAPEVL--SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNF 209
                +  GT  + APE+L  S +    +  D++S G   Y +L  G +PF D+   ++ 
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 262
Query: 210 RKTISRIMAV-QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              I  I ++ + K      +  +  +L+S++   +P +R T  ++  HP F
Sbjct: 263 -NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 255 QWNPSDRPSFAEI 267

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 102/232 (43%), Gaps = 32/232 (13%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--------FFQQLI 108
           HPN+IR+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 109 SGVSYCHSMQICHRDLKLENTLLD-----------GSPAPRLKICDFGYSK-----SSLL 152
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 153 HSRPKSTVGTPAYIAPEVL--SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNF 209
                +  GT  + APE+L  S +    +  D++S G   Y +L  G +PF D+   ++ 
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 262
Query: 210 RKTISRIMAV-QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              I  I ++ + K      +  +  +L+S++   +P +R T  ++  HP F
Sbjct: 263 -NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 145 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 198
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 199 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 254 QWNPSDRPSFAEI 266

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 153
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 154 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 207
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 208 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 262
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 263 QWNPSDRPSFAEI 275

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 196
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 197 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 251
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 252 QWNPSDRPSFAEI 264

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 196
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 197 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 251
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 252 QWNPSDRPSFAEI 264

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/264 (24%), Positives = 117/264 (44%), Gaps = 21/264 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQL-RH 57
           + ++ +  +G G++G    +R+K    L A+K      RG K  A    E+ +H+++ +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVSYCH 115
           P  +R ++       L +  E    G   ++ C A   S  EA+   + +  +  +++ H
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC--GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
           S  + H D+K  N  L   P  R K+ DFG           +   G P Y+APE+L +  
Sbjct: 175 SQGLVHLDVKPANIFL--GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231
Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VHISQDCR 234
           Y G  ADV+S G+T+  +          E  +  R+         Y  P++   +S + R
Sbjct: 232 Y-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG--------YLPPEFTAGLSSELR 282
Query: 235 NLLSRIFVANPSRRITIKEIKSHP 258
           ++L  +   +P  R T + + + P
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALP 306

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF------ 63
           IGSG FG     +++   +   +K ++  ++      RE+    +L H NI+ +      
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 64  ---------KEVVLTPTH-LAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGV 111
                    K    + T  L I ME+   G L + I      +  +  A   F+Q+  GV
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
            Y HS ++ +RDLK  N  L      ++KI DFG   S     +   + GT  Y++PE +
Sbjct: 136 DYIHSKKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 172 SRREYDGKLADVWSCGVTLYVML 194
           S ++Y GK  D+++ G+ L  +L
Sbjct: 194 SSQDY-GKEVDLYALGLILAELL 215

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 195 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 249
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 250 QWNPSDRPSFAEI 262

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/124 (33%), Positives = 63/124 (50%), Gaps = 5/124 (4%)
Query: 73  LAIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTL 130
           L I ME+   G L + I      +  +  A   F+Q+  GV Y HS ++ HRDLK  N  
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 131 LDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTL 190
           L      ++KI DFG   S     +   + GT  Y++PE +S ++Y GK  D+++ G+ L
Sbjct: 169 L--VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLIL 225
Query: 191 YVML 194
             +L
Sbjct: 226 AELL 229

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/330 (22%), Positives = 123/330 (37%), Gaps = 68/330 (20%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQ 54
           E+YE++ ++G G FG V   + +   K  VA+K I          +++ NV ++I    +
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 110
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLISGVS 112
                 +   +      H+ I  E   G   FE +   N   +     R+   QL   + 
Sbjct: 111 ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 169
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-----------------KICDFGYSKSSLLHSR 155
           + H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H  
Sbjct: 170 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEH 227
Query: 156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF------ 209
             + V T  Y  PEV+    +  +  DVWS G  L+    G   F+  E+ ++       
Sbjct: 228 HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 286
Query: 210 -----RKTISRIMAVQY----------KIPDYVHISQDCR-----------------NLL 237
                   I R    +Y             D  ++ ++C+                 +L+
Sbjct: 287 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 346
Query: 238 SRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
            R+   +P++RIT+ E   HP+F    P E
Sbjct: 347 RRMLEFDPAQRITLAEALLHPFFAGLTPEE 376

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/330 (22%), Positives = 123/330 (37%), Gaps = 68/330 (20%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQ 54
           E+YE++ ++G G FG V   + +   K  VA+K I          +++ NV ++I    +
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLISGVS 112
                 +   +      H+ I  E   G   FE +   N   +     R+   QL   + 
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-----------------KICDFGYSKSSLLHSR 155
           + H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H  
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEH 195
Query: 156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF------ 209
             + V T  Y  PEV+    +  +  DVWS G  L+    G   F+  E+ ++       
Sbjct: 196 HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 254
Query: 210 -----RKTISRIMAVQY----------KIPDYVHISQDCR-----------------NLL 237
                   I R    +Y             D  ++ ++C+                 +L+
Sbjct: 255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314
Query: 238 SRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
            R+   +P++RIT+ E   HP+F    P E
Sbjct: 315 RRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 36/233 (15%)
Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +  +E ++ +G G FGV    +NK      A+K I   ++  A   V RE+    +L HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 59  NIIRFKEVVL-----------TP-THLAIVMEYAAGGELFERICNAGRFSEDE---ARYF 103
            I+R+    L           +P  +L I M+      L + +       E E     + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY--------SKSSLL--- 152
           F Q+   V + HS  + HRDLK  N          +K+ DFG          + ++L   
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 153 --HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ 203
             ++R    VGT  Y++PE +    Y  K+ D++S G+ L+ +L   YPF  Q
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKV-DIFSLGLILFELL---YPFSTQ 230

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/330 (22%), Positives = 123/330 (37%), Gaps = 68/330 (20%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQ 54
           E+YE++ ++G G FG V   + +   K  VA+K I          +++ NV ++I    +
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 87
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLISGVS 112
                 +   +      H+ I  E   G   FE +   N   +     R+   QL   + 
Sbjct: 88  ENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 146
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRL-----------------KICDFGYSKSSLLHSR 155
           + H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H  
Sbjct: 147 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEH 204
Query: 156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF------ 209
             + V T  Y  PEV+    +  +  DVWS G  L+    G   F+  E+ ++       
Sbjct: 205 HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 263
Query: 210 -----RKTISRIMAVQY----------KIPDYVHISQDCR-----------------NLL 237
                   I R    +Y             D  ++ ++C+                 +L+
Sbjct: 264 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 323
Query: 238 SRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
            R+   +P++RIT+ E   HP+F    P E
Sbjct: 324 RRMLEFDPAQRITLAEALLHPFFAGLTPEE 353

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/323 (23%), Positives = 130/323 (40%), Gaps = 70/323 (21%)
Query: 3   KYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHP 58
           +YE++  +G G FG V   + +K     VA+K ++   +     AR   +++ H     P
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-CEAARSEIQVLEHLNTTDP 73
Query: 59  N----IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVS 112
           N     ++  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V+
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 113 YCHSMQICHRDLKLENTLL---DGSPA--------------PRLKICDFGYSKSSLLHSR 155
           + HS ++ H DLK EN L    D + A              P +K+ DFG +     H  
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH- 191
Query: 156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTL--YVMLVGAYPFEDQED-------- 205
             + V T  Y APEV+    +  +  DVWS G  L  Y +    +P  D ++        
Sbjct: 192 -STLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 206 ----PKNFRKTISRIMAVQYKIPDYV-------HISQDCR-----------------NLL 237
               PK+  +   +     +   D+        ++S+ C+                 +L+
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 238 SRIFVANPSRRITIKEIKSHPWF 260
            ++   +P++RIT++E   HP+F
Sbjct: 310 QKMLEYDPAKRITLREALKHPFF 332

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 105/237 (44%), Gaps = 38/237 (16%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--------FFQQLI 108
           HPN+IR+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 109 SGVSYCHSMQICHRDLKLENTLLD-----------GSPAPRLKICDFGYSK-----SSLL 152
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K      S  
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 153 HSRPKSTVGTPAYIAPEVL-------SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQE 204
            +   +  GT  + APE+L       ++R     + D++S G   Y +L  G +PF D+ 
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKY 244
Query: 205 DPKNFRKTISRIMAV-QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             ++    I  I ++ + K      +  +  +L+S++   +P +R T  ++  HP F
Sbjct: 245 SRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/311 (24%), Positives = 136/311 (43%), Gaps = 44/311 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FERICNAGRFSEDEA 100
           K + +H NII           L +++EYA+ G L            E   +  R  E++ 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 101 RY-----FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            +        QL  G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDX 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 XKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 272 AQAIYYRKENP 282
               Y     P
Sbjct: 321 TNEEYLDLSQP 331

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 287
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    S     Y   Q+ S + Y       HR+L   
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 347
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 348 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 401
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 402 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 456
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 457 QWNPSDRPSFAEI 469

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/232 (23%), Positives = 104/232 (44%), Gaps = 36/232 (15%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQLRH 57
           + +++ +G G FG   L ++ + K+  A+K +       R  KI+A++ ++I  +  + +
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKI-QNDDINN 95
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISGVSYCH 115
            NI+++    +   H+ ++ E   G  L+E I   N   F  ++ + +  +++  ++Y  
Sbjct: 96  NNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 116 SMQICHRDLKLENTLLDG-----------------------SPAPRLKICDFGYSKSSLL 152
            M + H DLK EN LLD                        + +  +K+ DFG   ++  
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC--ATFK 212
Query: 153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 204
                S + T  Y APEV+    +D   +D+WS G  L  +  G+  F   E
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHE 263

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 40/274 (14%)
Query: 45  VAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---FERICNAGRF--SEDE 99
           V REI       HPNI+  +++ +     A+   Y     +     ++ +  R   S   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 100 ARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 159
            +YF   ++ G+   H   + HRDL   N LL  +    + ICDF  ++     +     
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDTADANKTHY 193
Query: 160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM-----LVGAYPFEDQ----------- 203
           V    Y APE++ + +   KL D+WS G  +  M     L     F +Q           
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 204 --EDPKNF---------RKTISRIMAVQYK--IPDYVHISQDCRNLLSRIFVANPSRRIT 250
             ED   F         R ++S + A  +   +P    ++ D   L++++   NP RRI+
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD---LIAKMLEFNPQRRIS 310
Query: 251 IKEIKSHPWFLKNL-PRELTETAQAIYYRKENPT 283
            ++   HP+F     P +LTE     ++  E+ T
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVT 344

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++  L      +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMLDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 216 TTK-SDVWSFGVLLWELMTRGAPPYPD 241

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/274 (23%), Positives = 111/274 (40%), Gaps = 40/274 (14%)
Query: 45  VAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---FERICNAGRF--SEDE 99
           V REI       HPNI+  +++ +     A+   Y     +     ++ +  R   S   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 100 ARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 159
            +YF   ++ G+   H   + HRDL   N LL  +    + ICDF  ++     +     
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDTADANKTHY 193
Query: 160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVM-----LVGAYPFEDQ----------- 203
           V    Y APE++ + +   KL D+WS G  +  M     L     F +Q           
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 204 --EDPKNF---------RKTISRIMAVQYK--IPDYVHISQDCRNLLSRIFVANPSRRIT 250
             ED   F         R ++S + A  +   +P    ++ D   L++++   NP RRI+
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD---LIAKMLEFNPQRRIS 310
Query: 251 IKEIKSHPWFLKNL-PRELTETAQAIYYRKENPT 283
            ++   HP+F     P +LTE     ++  E+ T
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVT 344

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLARDMYDKEXXSVHNKTGAKLPV-KWMALESLQTQKF 213
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 214 TTK-SDVWSFGVLLWELMTRGAPPYPD 239

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 272 AQ 273
Sbjct: 321 TN 322

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPD 240

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 176
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 177 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 233
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 234 TTK-SDVWSFGVLLWELMTRGAPPYPD 259

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 103/253 (40%), Gaps = 19/253 (7%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT 69
           +G G +G       K     VA+K ++          +E    K+++HPN+++   V   
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 326
Query: 70  PTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLE 127
                I+ E+   G L +  R CN    +     Y   Q+ S + Y       HR+L   
Sbjct: 327 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAAR 386
Query: 128 NTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L+  ++  K +D
Sbjct: 387 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 440
Query: 183 VWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
           VW+ GV L+ +   G  P+     P      +  ++   Y++       +    L+   +
Sbjct: 441 VWAFGVLLWEIATYGMSPY-----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 495
Query: 242 VANPSRRITIKEI 254
             NPS R +  EI
Sbjct: 496 QWNPSDRPSFAEI 508

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 156
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 157 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 213
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 214 TTK-SDVWSFGVLLWELMTRGAPPYPD 239

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 103/237 (43%), Gaps = 38/237 (16%)
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARY--------FFQQLI 108
           HPN+IR+     T   L I +E        + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 109 SGVSYCHSMQICHRDLKLENTLLD-----------GSPAPRLKICDFGYSK-----SSLL 152
           SGV++ HS++I HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 153 HSRPKSTVGTPAYIAPEVL-------SRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQE 204
                +  GT  + APE+L       ++R     + D++S G   Y +L  G +PF D+ 
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI-DIFSMGCVFYYILSKGKHPFGDKY 244
Query: 205 DPKNFRKTISRIMAV-QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             ++    I  I ++ + K      +  +  +L+S++   +P +R T  ++  HP F
Sbjct: 245 SRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 135/302 (44%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGHKIDA------NVAREIINH 52
           +K  L K +G G FG   +A  +     K   A+    +  K DA      ++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 272 AQ 273
Sbjct: 321 TN 322

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 175
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 176 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 232
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 233 TTK-SDVWSFGVLLWELMTRGAPPYPD 258

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 157
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPD 240

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 149
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 150 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 206
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 207 TTK-SDVWSFGVLLWELMTRGAPPYPD 232

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 155
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 212
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 213 TTK-SDVWSFGVLLWELMTRGAPPYPD 238

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 272 AQ 273
Sbjct: 321 TN 322

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 130 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 152
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 153 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 209
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 210 TTK-SDVWSFGVLLWELMTRGAPPYPD 235

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 14  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 71
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 72  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 130
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 131 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 185
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 186 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 219

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 15  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 72
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 73  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 131
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 132 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 186
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 187 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 220

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L+K +G+G FG V     N NTK  VA+K ++ G     +   E    K+L+H  +
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSPESFLEEAQIMKKLKHDKL 66
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GR-FSEDEARYFFQQLISGVSYCHSMQ 118
           ++   VV +   + IV EY   G L + + +  GR            Q+ +G++Y   M 
Sbjct: 67  VQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN 125
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+        KI DFG ++   L    + T    A     + APE    
Sbjct: 126 YIHRDLRSANILVGNGLI--CKIADFGLAR---LIEDNEXTARQGAKFPIKWTAPEAALY 180
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
             +  K +DVWS G+ L  ++  G  P+       N R+ + ++    Y++P      QD
Sbjct: 181 GRFTIK-SDVWSFGILLTELVTKGRVPYPGM----NNREVLEQV-ERGYRMP----CPQD 230
Query: 233 C----RNLLSRIFVANPSRRITIKEIKS 256
           C      L+   +  +P  R T + ++S
Sbjct: 231 CPISLHELMIHCWKKDPEERPTFEYLQS 258

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 144 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 201
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 202 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 255
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 256 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 309
Query: 272 AQ 273
Sbjct: 310 TN 311

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  S +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHR 154
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 155 DLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPV-KWMALESLQTQKF 211
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 212 TTK-SDVWSFGVLLWELMTRGAPPYPD 237

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 7   MKDIGSGNFGVA----RLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   +  K  VA+K +    G K +     E +    + HP++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +R   V L+PT + +V +    G L E +  +           +  Q+  G+ Y    ++
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 161
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 174
            HRDL   N L+  SP   +KI DFG ++  LL    K            ++A E +  R
Sbjct: 162 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           ++  + +DVWS GVT++ +M  G  P++
Sbjct: 218 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 244

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 22  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 80  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 138
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 139 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 193
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 194 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 227

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 21  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 78
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 79  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 137
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 138 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 192
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 193 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 226

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 7   MKDIGSGNFGVA----RLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   +  K  VA+K +    G K +     E +    + HP++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +R   V L+PT + +V +    G L E +  +           +  Q+  G+ Y    ++
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 138
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 174
            HRDL   N L+  SP   +KI DFG ++  LL    K            ++A E +  R
Sbjct: 139 VHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 175 EYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           ++  + +DVWS GVT++ +M  G  P++
Sbjct: 195 KFTHQ-SDVWSYGVTIWELMTFGGKPYD 221

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 258
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 312
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 313 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 366
Query: 272 AQ 273
Sbjct: 367 TN 368

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 77  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 136 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 190
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 191 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 142 TFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNV--MKIADFGLARDINNIDY 199
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 200 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 253
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 254 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 307
Query: 272 AQ 273
Sbjct: 308 TN 309

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 147 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 204
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 205 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 258
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 259 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 312
Query: 272 AQ 273
Sbjct: 313 TN 314

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 130 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEXTAREGAKFPIKWTAPEAINY 184
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 6   LMKDIGSGNFGVARLMRNKN-----TKELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L +++G G FG   L    N      K LVA+K + +       +  RE      L+H +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-------------RFSEDEARYFFQQ 106
           I++F  V +    L +V EY   G+L + +   G               ++ +  +  QQ
Sbjct: 77  IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQ 136
Query: 107 LISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTP 163
           + +G+ Y  S    HRDL   N L+  +    +KI DFG S+   S+  +     T+   
Sbjct: 137 IAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 164 AYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
            ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 195 RWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPW 231

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/302 (24%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLH 153
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  +++ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 154 SRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
            +  +    P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKNTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 272 AQ 273
Sbjct: 321 TN 322

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 75/323 (23%), Positives = 129/323 (39%), Gaps = 70/323 (21%)
Query: 3   KYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHP 58
           +YE++  +G G FG V   + +K     VA+K ++   +     AR   +++ H     P
Sbjct: 15  RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY-CEAARSEIQVLEHLNTTDP 73
Query: 59  N----IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVS 112
           N     ++  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V+
Sbjct: 74  NSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132
Query: 113 YCHSMQICHRDLKLENTLL---DGSPA--------------PRLKICDFGYSKSSLLHSR 155
           + HS ++ H DLK EN L    D + A              P +K+ DFG +     H  
Sbjct: 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH- 191
Query: 156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTL--YVMLVGAYPFEDQED-------- 205
             + V    Y APEV+    +  +  DVWS G  L  Y +    +P  D ++        
Sbjct: 192 -STLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 206 ----PKNFRKTISRIMAVQYKIPDYV-------HISQDCR-----------------NLL 237
               PK+  +   +     +   D+        ++S+ C+                 +L+
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 238 SRIFVANPSRRITIKEIKSHPWF 260
            ++   +P++RIT++E   HP+F
Sbjct: 310 QKMLEYDPAKRITLREALKHPFF 332

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 130 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 19  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 76
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 77  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 135
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 136 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINY 190
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 191 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 224

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 18  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 75
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 76  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 134
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 135 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINY 189
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 190 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 223

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 137/302 (45%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++EYA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    ++I DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MRIADFGLARDINNIDY 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 272 AQ 273
Sbjct: 321 TN 322

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 8   ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 65
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 66  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 124
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 125 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINY 179
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 180 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 12/212 (5%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 23  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 80
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 81  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 139
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREY 176
             HRDL+  N L+  S     KI DFG ++      ++  +       + APE ++   +
Sbjct: 140 YIHRDLRAANILV--SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 197
Query: 177 DGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 198 TIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 228

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 260 F 260
           F
Sbjct: 318 F 318

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 260 F 260
           F
Sbjct: 318 F 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 260 F 260
           F
Sbjct: 318 F 318

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/272 (20%), Positives = 117/272 (43%), Gaps = 21/272 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-----INHKQLR 56
           +  E + ++G G +GV    R+  + ++ A+K I     +++   + +     I+ + + 
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRA--TVNSQEQKRLLXDLDISXRTVD 91
Query: 57  HPNIIRFKEVVLTPTHLAIVMEY--AAGGELFERICNAGR-FSEDEARYFFQQLISGVSY 113
            P  + F   +     + I  E    +  + ++++ + G+   ED        ++  + +
Sbjct: 92  CPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 151
Query: 114 CHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPE--- 169
            HS + + HRD+K  N L++     ++K CDFG S   +         G   Y APE   
Sbjct: 152 LHSKLSVIHRDVKPSNVLINA--LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERIN 209
Query: 170 -VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
             L+++ Y  K +D+WS G+T   + +  +P++    P    K +    + Q     +  
Sbjct: 210 PELNQKGYSVK-SDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF-- 266
Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            S +  +  S+    N   R T  E+  HP+F
Sbjct: 267 -SAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 260 F 260
           F
Sbjct: 318 F 318

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 107 PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 160
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 161 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 219
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 220 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRI 278
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 279 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 338
Query: 260 F 260
           F
Sbjct: 339 F 339

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 140
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 200 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 258
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 259 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 318
Query: 260 F 260
           F
Sbjct: 319 F 319

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 38/283 (13%)
Query: 2   EKYELMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINH 52
           ++  L K +G G FG   L           N+ TK  V M   +   K  +++  E+   
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQL 107
           K + +H NII           L +++EYA+ G L E    R      FS + +    +QL
Sbjct: 88  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 108 IS------------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            S            G+ Y  S +  HRDL   N L+       +KI DFG ++    +  
Sbjct: 148 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDX 205
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    +
Sbjct: 206 XKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVE 259
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
            + +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 260 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 140
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 141 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 200 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 258
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 259 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 318
Query: 260 F 260
           F
Sbjct: 319 F 319

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 260 F 260
           F
Sbjct: 318 F 318

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 260 F 260
           F
Sbjct: 318 F 318

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/241 (22%), Positives = 103/241 (42%), Gaps = 46/241 (19%)
Query: 58  PNIIRFKEVVL-----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           PNI++  ++V      TP+   ++ EY    + F+ +      ++ + RY+  +L+  + 
Sbjct: 88  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 141
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL- 171
           YCHS  I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L 
Sbjct: 142 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 200
Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV--------QYKI 223
             ++YD  L D+WS G     M+    PF    D  +    I++++          +Y+I
Sbjct: 201 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 259
Query: 224 -----------------------PDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
                                   D  H +S +  + L ++   +   R+T  E  +HP+
Sbjct: 260 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 319
Query: 260 F 260
           F
Sbjct: 320 F 320

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 155
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 156 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 212
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 213 TTK-SDVWSFGVLLWELMTRGAPPYPD 238

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 216
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 217 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 273
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 274 TTK-SDVWSFGVLLWELMTRGAPPYPD 299

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 162
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 163 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 219
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 220 TTK-SDVWSFGVLLWELMTRGAPPYPD 245

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 158
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 159 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 215
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 216 TTK-SDVWSFGVLLWELMTRGAPPYPD 241

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPD 240

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 65  EVVL-TPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  S +  HR
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 157
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSL------LHSRPKSTVGTPAYIAPEVLSRREY 176
           DL   N +LD      +K+ DFG ++         +H++  + +    ++A E L  +++
Sbjct: 158 DLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQTQKF 214
Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV L+ +M  GA P+ D
Sbjct: 215 TTK-SDVWSFGVLLWELMTRGAPPYPD 240

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 112/260 (43%), Gaps = 50/260 (19%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------------DANVA 46
           +Y L++ +G G+F    L ++      VAMK I RG K+                DA+  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 47  RE----------IINHKQLRHPNIIRFKEV--VLTPTHLAIVMEYAAGGELFERICNAGR 94
           +E          +++H   + PN +    V  VL    LA++ +Y   G     +     
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV----- 133
Query: 95  FSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAP----RLKICDFGYSKS 149
                 +   +QL+ G+ Y H    I H D+K EN L++   +P    ++KI D G   +
Sbjct: 134 ------KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 150 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF 209
                   +++ T  Y +PEVL    + G  AD+WS    ++ ++ G + FE  E     
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
Query: 210 RKT--ISRIMAVQYKIPDYV 227
           +    I++I+ +  ++P Y+
Sbjct: 245 KDDDHIAQIIELLGELPSYL 264

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 112/260 (43%), Gaps = 50/260 (19%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------------DANVA 46
           +Y L++ +G G+F    L ++      VAMK I RG K+                DA+  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 47  RE----------IINHKQLRHPNIIRFKEV--VLTPTHLAIVMEYAAGGELFERICNAGR 94
           +E          +++H   + PN +    V  VL    LA++ +Y   G     +     
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV----- 133
Query: 95  FSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAP----RLKICDFGYSKS 149
                 +   +QL+ G+ Y H    I H D+K EN L++   +P    ++KI D G   +
Sbjct: 134 ------KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 150 SLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF 209
                   +++ T  Y +PEVL    + G  AD+WS    ++ ++ G + FE  E     
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT 244
Query: 210 RKT--ISRIMAVQYKIPDYV 227
           +    I++I+ +  ++P Y+
Sbjct: 245 KDDDHIAQIIELLGELPSYL 264

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 136/302 (45%), Gaps = 44/302 (14%)
Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKE--LVAMKYI--ERGHKIDANVAREIINH 52
           +K  L K +G G FG   +     +     KE   VA+K +  +   K  +++  E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSED-----EARY 102
           K + +H NII           L +++ YA+ G L E    R      +S D     E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHS 154
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++  + +  
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDY 212
Query: 155 RPKSTVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRK 211
             K+T G  P  ++APE L  R Y  + +DVWS GV ++ +  +G  P+     P    +
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY-----PGIPVE 266
Query: 212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
            + +++   +++    + + +   ++   + A PS+R T K++      +++L R LT T
Sbjct: 267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL------VEDLDRILTLT 320
Query: 272 AQ 273
Sbjct: 321 TN 322

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 100/242 (41%), Gaps = 29/242 (11%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREI-----INHKQL 55
           E+YE++  +G G FG V + + ++     VA+K I+   K       EI     IN K  
Sbjct: 33  ERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDP 92
Query: 56  RHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL-FERICNAGRFSEDEARYFFQQLISGVSY 113
            + N+ ++  +      H+ I  E        F +  N   +   + R+   QL   V +
Sbjct: 93  DNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKF 152
Query: 114 CHSMQICHRDLKLENTLLDGSP-----------------APRLKICDFGYSKSSLLHSRP 156
            H  ++ H DLK EN L   S                  +  +++ DFG   ++  H   
Sbjct: 153 LHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG--SATFDHEHH 210
Query: 157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI 216
            + V T  Y APEV+    +  +  DVWS G  ++   VG   F+  ++ ++    + RI
Sbjct: 211 STIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGFTLFQTHDNREHL-AMMERI 268
Query: 217 MA 218
           + 
Sbjct: 269 LG 270

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDA-NVAREI-INHKQLRHPNIIRFK 64
           IG GNFG    AR+ ++    +    +  E   K D  + A E+ +  K   HPNII   
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 65  EVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDEARYFFQQLI 108
                  +L + +EYA  G L + +                  A   S  +  +F   + 
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG-TPA-YI 166
            G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 143 RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 198
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
           A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 199 AIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 232

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDA-NVAREI-INHKQLRHPNIIRFK 64
           IG GNFG    AR+ ++    +    +  E   K D  + A E+ +  K   HPNII   
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 65  EVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDEARYFFQQLI 108
                  +L + +EYA  G L + +                  A   S  +  +F   + 
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG-TPA-YI 166
            G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 153 RGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 208
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
           A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 209 AIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 242

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLIS-- 109
           +H NII           L +++EYA+ G L E    R      +S + +    +QL S  
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 110 ----------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKS 158
                     G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K+
Sbjct: 141 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT 198
Query: 159 TVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISR 215
           T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + +
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELFK 252
Query: 216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           ++   +++    + + +   ++   + A PS+R T K++
Sbjct: 253 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 291

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLIS-- 109
           +H NII           L +++EYA+ G L E    R      +S + +    +QL S  
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 110 ----------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKS 158
                     G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K+
Sbjct: 144 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT 201
Query: 159 TVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISR 215
           T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + +
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELFK 255
Query: 216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           ++   +++    + + +   ++   + A PS+R T K++
Sbjct: 256 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 294

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLIS-- 109
           +H NII           L +++EYA+ G L E    R      +S + +    +QL S  
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 110 ----------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKS 158
                     G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K+
Sbjct: 145 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT 202
Query: 159 TVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISR 215
           T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + +
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELFK 256
Query: 216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           ++   +++    + + +   ++   + A PS+R T K++
Sbjct: 257 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 295

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 92/240 (38%), Gaps = 48/240 (20%)
Query: 4   YELMKDIGSGNFGVARLMRNK---NTKELVAMKY-IERGH--KIDANVAREIINHKQLRH 57
           +++   IG G F    L   +     +E +A+K+ I   H  +I A +    +   Q   
Sbjct: 23  FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQ--- 79
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
            N++  K       H+ I M Y    E F  I N+  F E   R +   L   +   H  
Sbjct: 80  DNVMGVKYCFRKNDHVVIAMPYLEH-ESFLDILNSLSFQE--VREYMLNLFKALKRIHQF 136
Query: 118 QICHRDLKLENTLLDGSPAPRLK---ICDFGYS--------------------------K 148
            I HRD+K  N L +     RLK   + DFG +                          K
Sbjct: 137 GIVHRDVKPSNFLYN----RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNK 192
Query: 149 SSLLHSRPKSTV---GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED 205
            S+  SR +      GTP + APEVL++        D+WS GV    +L G YPF    D
Sbjct: 193 CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   ++ K  V +K IE   G +    V   ++    L H +I
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 61  IRFKEVVLTP-THLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   + L P + L +V +Y   G L + +  + G         +  Q+  G+ Y     
Sbjct: 96  VRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPEVLS 172
           + HR+L   N LL  SP+ ++++ DFG +         LL+S  K+ +    ++A E + 
Sbjct: 154 MVHRNLAARNVLLK-SPS-QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIH 208
Query: 173 RREYDGKLADVWSCGVTLY-VMLVGAYPF 200
             +Y  + +DVWS GVT++ +M  GA P+
Sbjct: 209 FGKYTHQ-SDVWSYGVTVWELMTFGAEPY 236

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLIS-- 109
           +H NII           L +++EYA+ G L E    R      +S + +    +QL S  
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 110 ----------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKS 158
                     G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K+
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT 250
Query: 159 TVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISR 215
           T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + +
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELFK 304
Query: 216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           ++   +++    + + +   ++   + A PS+R T K++
Sbjct: 305 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLIS-- 109
           +H NII           L +++EYA+ G L E    R      +S + +    +QL S  
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 110 ----------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKS 158
                     G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K+
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT 209
Query: 159 TVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISR 215
           T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELFK 263
Query: 216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           ++   +++    + + +   ++   + A PS+R T K++
Sbjct: 264 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G  G V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 13  ETLKLVERLGAGQAGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSR 173
             HRDL+  N L+  S     KI DFG ++   L    + T    A     + APE ++ 
Sbjct: 130 YIHRDLRAANILV--SDTLSCKIADFGLAR---LIEDAEXTAREGAKFPIKWTAPEAINY 184
Query: 174 REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPK 207
             +  K +DVWS G+ L  ++  G  P+    +P+
Sbjct: 185 GTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 7   MKDIGSGNFGVAR----LMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNI 60
           +K +GSG FG       +   ++ K  V +K IE   G +    V   ++    L H +I
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 61  IRFKEVVLTP-THLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   + L P + L +V +Y   G L + +  + G         +  Q+  G+ Y     
Sbjct: 78  VRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPEVLS 172
           + HR+L   N LL  SP+ ++++ DFG +         LL+S  K+ +    ++A E + 
Sbjct: 136 MVHRNLAARNVLLK-SPS-QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIH 190
Query: 173 RREYDGKLADVWSCGVTLY-VMLVGAYPF 200
             +Y  + +DVWS GVT++ +M  GA P+
Sbjct: 191 FGKYTHQ-SDVWSYGVTVWELMTFGAEPY 218

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE----RICNAGRFSEDEARYFFQQLIS-- 109
           +H NII           L +++EYA+ G L E    R      +S + +    +QL S  
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 110 ----------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKS 158
                     G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K+
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT 209
Query: 159 TVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISR 215
           T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELFK 263
Query: 216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           ++   +++    + + +   ++   + A PS+R T K++
Sbjct: 264 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 119/280 (42%), Gaps = 40/280 (14%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-----------------FSED 98
           +H NII           L +++EYA+ G L E +  A R                  S  
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 99  EARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPK 157
           +      Q+  G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK 193
Query: 158 STVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTIS 214
           +T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + 
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELF 247
Query: 215 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           +++   +++    + + +   ++   + A PS+R T K++
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 111/260 (42%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IVMEY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 77  QLYAVV-SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 136 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 194 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 247
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +  +P  R T + +++
Sbjct: 248 MCQCWRKDPEERPTFEYLQA 267

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 21/263 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV+EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 77  QLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 174
            HRDL+  N L+  +     K+ DFG ++   L    + T    A     + APE     
Sbjct: 136 VHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEXTARQGAKFPIKWTAPEAALYG 190
Query: 175 EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +  K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +  
Sbjct: 191 RFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESL 244
Query: 234 RNLLSRIFVANPSRRITIKEIKS 256
            +L+ + +  +P  R T + +++
Sbjct: 245 HDLMCQCWRKDPEERPTFEYLQA 267

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 119/279 (42%), Gaps = 38/279 (13%)
Query: 6   LMKDIGSGNFGVARLMR---------NKNTKELVAMKYIERGHKIDANVAREIINHKQL- 55
           L K +G G FG   L           N+ TK  V M   +   K  +++  E+   K + 
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI----------C------NAGRFSEDE 99
           +H NII           L +++EYA+ G L E +          C         + S  +
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 100 ARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKS 158
                 Q+  G+ Y  S +  HRDL   N L+       +KI DFG ++    +    K+
Sbjct: 152 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT 209
Query: 159 TVG-TPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISR 215
           T G  P  ++APE L  R Y  + +DVWS GV L+ +  +G  P+     P    + + +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY-----PGVPVEELFK 263
Query: 216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           ++   +++    + + +   ++   + A PS+R T K++
Sbjct: 264 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 302

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 21/263 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 8   ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 66
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 67  QLYAVV-SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 125
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 174
            HRDL+  N L+  +     K+ DFG ++   L    + T    A     + APE     
Sbjct: 126 VHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEXTARQGAKFPIKWTAPEAALYG 180
Query: 175 EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +  K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +  
Sbjct: 181 RFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESL 234
Query: 234 RNLLSRIFVANPSRRITIKEIKS 256
            +L+ + +   P  R T + +++
Sbjct: 235 HDLMCQCWRKEPEERPTFEYLQA 257

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 111/260 (42%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV+EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 77  QLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 136 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 194 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 247
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +  +P  R T + +++
Sbjct: 248 MCQCWRKDPEERPTFEYLQA 267

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 31/218 (14%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 74
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 75  VDNPHVCRLLGICLTST-VQLIMQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAK 129
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 164
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 185
Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 186 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 9   ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 67
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 68  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 126
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 127 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 184
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 185 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 238
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +  +P  R T + +++
Sbjct: 239 MCQCWRKDPEERPTFEYLQA 258

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 7   ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 65
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 66  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 124
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 125 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 182
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 183 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 236
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +  +P  R T + +++
Sbjct: 237 MCQCWRKDPEERPTFEYLQA 256

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 37/221 (16%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTK-----ELVAMKYI--ERGHKIDANVAREIINHKQLRH 57
           E ++DIG G FG     R           +VA+K +  E    + A+  RE     +  +
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFE----------------------RICNAG-- 93
           PNI++   V      + ++ EY A G+L E                      R+ + G  
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 94  RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SL 151
             S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S++  S 
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSA 227
Query: 152 LHSRPKSTVGTPA-YIAPEVLSRREYDGKLADVWSCGVTLY 191
            + +       P  ++ PE +    Y  + +DVW+ GV L+
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 267

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 116/281 (41%), Gaps = 46/281 (16%)
Query: 6   LMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKIDANVA------REIINHKQ 54
           L +++G G FG   L    N      K LVA+K ++     D  +A      RE      
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-----DPTLAARKDFQREAELLTN 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICN--------------AGRFSED 98
           L+H +I++F  V      L +V EY   G+L  F R                  G     
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 99  EARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSR 155
           +  +   Q+ SG+ Y  S    HRDL   N L+  +    +KI DFG S+   S+  +  
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRV 191
Query: 156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFR-KTI 213
              T+    ++ PE +  R++  + +DVWS GV L+ +   G  P+    + +     T 
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 214 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
            R++      P  V+      +++   +   P +R+ IKEI
Sbjct: 251 GRVLERPRVCPKEVY------DVMLGCWQREPQQRLNIKEI 285

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDA-NVAREI-INHKQLRHPNIIRFK 64
           IG GNFG    AR+ ++    +    +  E   K D  + A E+ +  K   HPNII   
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 65  EVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDEARYFFQQLI 108
                  +L + +EYA  G L + +                  A   S  +  +F   + 
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG-TPA-YI 166
            G+ Y    Q  HR+L   N L+  +     KI DFG S+   ++   K T+G  P  ++
Sbjct: 150 RGMDYLSQKQFIHRNLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVRWM 205
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
           A E L+   Y    +DVWS GV L+ ++ +G  P+
Sbjct: 206 AIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 239

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 136 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 194 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 247
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +  +P  R T + +++
Sbjct: 248 MCQCWRKDPEERPTFEYLQA 267

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 77  QLYAVV-SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 136 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 194 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 247
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +  +P  R T + +++
Sbjct: 248 MCQCWRKDPEERPTFEYLQA 267

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 109/260 (41%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 11  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 69
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 70  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 128
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 129 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 186
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 187 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 240
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +   P  R T + +++
Sbjct: 241 MCQCWRKEPEERPTFEYLQA 260

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 111/263 (42%), Gaps = 21/263 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G+       +E    K+LRH  ++
Sbjct: 185 ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLV 243
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 244 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 302
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 174
            HRDL+  N L+  +     K+ DFG  +   L    + T    A     + APE     
Sbjct: 303 VHRDLRAANILVGENLV--CKVADFGLGR---LIEDNEYTARQGAKFPIKWTAPEAALYG 357
Query: 175 EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +  K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +  
Sbjct: 358 RFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESL 411
Query: 234 RNLLSRIFVANPSRRITIKEIKS 256
            +L+ + +  +P  R T + +++
Sbjct: 412 HDLMCQCWRKDPEERPTFEYLQA 434

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 77
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 78  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 132
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 74
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 75  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 129
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 130 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 188 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 189 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 76
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 77  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 131
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 69/154 (44%), Gaps = 14/154 (9%)
Query: 57  HPNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVS 112
           HPN++       +P   H  ++  +   G L+  +     F  D+++   F   +  G++
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 113 YCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           + H+++  I    L   + ++D     R+ + D  +S  S         +  PA++APE 
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPEA 179
Query: 171 LSRREYDG--KLADVWSCGVTLYVMLVGAYPFED 202
           L ++  D   + AD+WS  V L+ ++    PF D
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 77
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 78  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 132
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 133 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 103/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 189 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 109/260 (41%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL   N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 136 VHRDLAAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 194 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 247
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +  +P  R T + +++
Sbjct: 248 MCQCWRKDPEERPTFEYLQA 267

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/260 (22%), Positives = 110/260 (42%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K++RH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 136 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 194 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 247
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +  +P  R T + +++
Sbjct: 248 MCQCWRKDPEERPTFEYLQA 267

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 31/218 (14%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 164
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAK--LLGAEEKEYHAEGGKVPIK 186
Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 109/261 (41%), Gaps = 17/261 (6%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 15  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY   G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 74  QLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            HRDL+  N L+  +     K+ DFG ++    +   +R  +      + APE      +
Sbjct: 133 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEWTARQGAKFPI-KWTAPEAALYGRF 189
Query: 177 DGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
             K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +
Sbjct: 190 TIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHD 243
Query: 236 LLSRIFVANPSRRITIKEIKS 256
           L+ + +   P  R T + +++
Sbjct: 244 LMCQCWRKEPEERPTFEYLQA 264

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 18  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 76
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 77  QLYAVV-SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 135
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 136 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 193
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 194 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 247
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +  +P  R T + +++
Sbjct: 248 MCQCWRKDPEERPTFEYLQA 267

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 21/263 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 174
            HRDL+  N L+  +     K+ DFG ++   L    + T    A     + APE     
Sbjct: 302 VHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 175 EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +  K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +  
Sbjct: 357 RFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESL 410
Query: 234 RNLLSRIFVANPSRRITIKEIKS 256
            +L+ + +   P  R T + +++
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQA 433

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 21/263 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 174
            HRDL+  N L+  +     K+ DFG ++   L    + T    A     + APE     
Sbjct: 302 VHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 175 EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +  K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +  
Sbjct: 357 RFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESL 410
Query: 234 RNLLSRIFVANPSRRITIKEIKS 256
            +L+ + +   P  R T + +++
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQA 433

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 108/260 (41%), Gaps = 15/260 (5%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 15  ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 73
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY   G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 74  QLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNY 132
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 133 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 178 GKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
            K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +   +L
Sbjct: 191 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 244
Query: 237 LSRIFVANPSRRITIKEIKS 256
           + + +   P  R T + +++
Sbjct: 245 MCQCWRKEPEERPTFEYLQA 264

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 110/270 (40%), Gaps = 35/270 (12%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 267 ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQ---------QLISGVS 112
           +   VV +   + IV EY + G L +       F + E   + +         Q+ SG++
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMA 377
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIA 167
           Y   M   HRDL+  N L+  +     K+ DFG ++   L    + T    A     + A
Sbjct: 378 YVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWTA 432
Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 226
           PE      +  K +DVWS G+ L  +   G  P+     P    + +   +   Y++P  
Sbjct: 433 PEAALYGRFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCP 486
Query: 227 VHISQDCRNLLSRIFVANPSRRITIKEIKS 256
               +   +L+ + +   P  R T + +++
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFEYLQA 516

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 68/294 (23%)
Query: 6   LMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLR 56
           L K +G G FG      A  ++ +     VA+K ++       +  R++++     KQ+ 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--ENASPSELRDLLSEFNVLKQVN 84
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELF-----ERICNAGRFSE------------DE 99
           HP++I+          L +++EYA  G L       R    G                DE
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 100 ARYFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---- 148
                  LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+    
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRDVYE 202
Query: 149 --SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED--- 202
             S +  S+ +  V    ++A E L    Y  + +DVWS GV L+ ++ +G  P+     
Sbjct: 203 EDSXVKRSQGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 203 ------------QEDPKNFRKTISRIMAVQYKI-----PDYVHISQDCRNLLSR 239
                        E P N  + + R+M   +K      P +  IS+D   ++ +
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 21/263 (7%)
Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG    M   N    VA+K ++ G        +E    K+LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSE-DEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L + +    G++    +      Q+ SG++Y   M  
Sbjct: 243 QLYAVV-SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA-----YIAPEVLSRR 174
            HRDL+  N L+  +     K+ DFG ++   L    + T    A     + APE     
Sbjct: 302 VHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 175 EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
            +  K +DVWS G+ L  +   G  P+     P    + +   +   Y++P      +  
Sbjct: 357 RFTIK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESL 410
Query: 234 RNLLSRIFVANPSRRITIKEIKS 256
            +L+ + +   P  R T + +++
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQA 433

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 8   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 65
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM---- 117
              +   T T L +V +Y   G LF+ + N    + +          SG+++ H      
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 118 ----QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 169 EVL----SRREYDG-KLADVWSCGVTLY 191
           EVL    + + ++  K AD+++ G+  +
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFW 210

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 7   LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 64
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM---- 117
              +   T T L +V +Y   G LF+ + N    + +          SG+++ H      
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 118 ----QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 169 EVL----SRREYDG-KLADVWSCGVTLY 191
           EVL    + + ++  K AD+++ G+  +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFW 209

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 78/322 (24%), Positives = 117/322 (36%), Gaps = 74/322 (22%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----- 57
           +Y +++ +G G+F    L  +   K  VAMK ++           EI   K +R      
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 58  PN-------IIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLI 108
           PN       I  FK   +   H+ +V E   G  L + I   N         +   +Q++
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFE-VLGHHLLKWIIKSNYQGLPVRCVKSIIRQVL 150
Query: 109 SGVSYCHS-MQICHRDLKLENTLL-------------------DGSPAP----------- 137
            G+ Y HS  +I H D+K EN L+                    G+P P           
Sbjct: 151 QGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAA 210
Query: 138 ---------------RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLAD 182
                          R+KI D G   +  +H      + T  Y + EVL    Y    AD
Sbjct: 211 DLLVNPLDPRNADKIRVKIADLG--NACWVHKHFTEDIQTRQYRSIEVLIGAGYSTP-AD 267
Query: 183 VWSCGVTLYVMLVGAYPFEDQ--EDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           +WS     + +  G Y FE    ED       I+ I+ +   IP +  +S       SR 
Sbjct: 268 IWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALS----GKYSRE 323
Query: 241 FVANPSRRITIKEI-KSHPWFL 261
           F    +RR  ++ I K  PW L
Sbjct: 324 FF---NRRGELRHITKLKPWSL 342

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 106/286 (37%), Gaps = 68/286 (23%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PN- 59
           +Y +++ +G G+F    L  +   K+ VAMK ++           EI   K +R+  PN 
Sbjct: 22  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 81
Query: 60  ---------IIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLI 108
                    +  FK   +  TH+ +V E   G  L + I   N         +   QQ++
Sbjct: 82  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 140
Query: 109 SGVSYCHS-MQICHRDLKLENTLL-------------------DGSPAP----------- 137
            G+ Y H+  +I H D+K EN LL                    G+P P           
Sbjct: 141 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 200
Query: 138 -----------------RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
                            ++KI D G   +  +H      + T  Y + EVL    Y+   
Sbjct: 201 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 257
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT--ISRIMAVQYKIP 224
           AD+WS     + +  G Y FE     +  R    I+ I+ +  K+P
Sbjct: 258 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 303

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKN-----TKELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L  ++G G FG   L    N      K LVA+K + E       +  RE      L+H +
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 81
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG------RFSEDEA---------RYFF 104
           I+RF  V      L +V EY   G+L   + + G         ED A             
Sbjct: 82  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 164
            Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     VG   
Sbjct: 142 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRT 197
Query: 165 -----YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
                ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 198 MLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 238

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PN 59
           + + K IG GNFG  RL +N  T E VA+K +E        +  E   +KQL      P 
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           +  F        + A+V+E       +LF+ +C+   FS         QLIS + Y HS 
Sbjct: 70  VYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSK 124
Query: 118 QICHRDLKLENTLLDGSPAPR----LKICDFGY--------SKSSLLHSRPKSTVGTPAY 165
            + +RD+K EN L+ G P  +    + I DFG         +K  + +   KS  GT  Y
Sbjct: 125 NLIYRDVKPENFLI-GRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE 201
           ++      +E   +  D+ + G      L G+ P++
Sbjct: 184 MSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 117/294 (39%), Gaps = 68/294 (23%)
Query: 6   LMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLR 56
           L K +G G FG      A  ++ +     VA+K ++       +  R++++     KQ+ 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--ENASPSELRDLLSEFNVLKQVN 84
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELF-----ERICNAGRFSE------------DE 99
           HP++I+          L +++EYA  G L       R    G                DE
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 100 ARYFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---- 148
                  LIS       G+ Y   M + HRDL   N L+  +   ++KI DFG S+    
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILV--AEGRKMKISDFGLSRDVYE 202
Query: 149 --SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED--- 202
             S +  S+ +  V    ++A E L    Y  + +DVWS GV L+ ++ +G  P+     
Sbjct: 203 EDSXVKRSQGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 203 ------------QEDPKNFRKTISRIMAVQYKI-----PDYVHISQDCRNLLSR 239
                        E P N  + + R+M   +K      P +  IS+D   ++ +
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 106/286 (37%), Gaps = 68/286 (23%)
Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PN- 59
           +Y +++ +G G+F    L  +   K+ VAMK ++           EI   K +R+  PN 
Sbjct: 38  RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 60  ---------IIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLI 108
                    +  FK   +  TH+ +V E   G  L + I   N         +   QQ++
Sbjct: 98  PNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 109 SGVSYCHS-MQICHRDLKLENTLL-------------------DGSPAP----------- 137
            G+ Y H+  +I H D+K EN LL                    G+P P           
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 138 -----------------RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
                            ++KI D G   +  +H      + T  Y + EVL    Y+   
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP- 273
Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT--ISRIMAVQYKIP 224
           AD+WS     + +  G Y FE     +  R    I+ I+ +  K+P
Sbjct: 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVP 319

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 3   KYELMKDIGSGNFGVARLM--RNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +YE+   I  G  G   L   RN N + +V    +  G      +A   R+ +   ++ H
Sbjct: 81  QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFL--AEVVH 138
Query: 58  PNIIR-FKEVVLTPTHLA----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           P+I++ F  V  T  H      IVMEY  GG+  +R     +    EA  +  +++  +S
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKR-SKGQKLPVAEAIAYLLEILPALS 196
Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS---TVGTPAYIAPE 169
           Y HS+ + + DLK EN +L      +LK+ D G        SR  S     GTP + APE
Sbjct: 197 YLHSIGLVYNDLKPENIMLT---EEQLKLIDLGAV------SRINSFGYLYGTPGFQAPE 247
Query: 170 VLSRREYDGKLADVWSCGVTLYVM 193
           ++  R       D+++ G TL  +
Sbjct: 248 IV--RTGPTVATDIYTVGRTLAAL 269

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 68/294 (23%)
Query: 6   LMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLR 56
           L K +G G FG      A  ++ +     VA+K ++       +  R++++     KQ+ 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK--ENASPSELRDLLSEFNVLKQVN 84
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELF-----ERICNAGRFSE------------DE 99
           HP++I+          L +++EYA  G L       R    G                DE
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 100 ARYFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---- 148
                  LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+    
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRDVYE 202
Query: 149 --SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED--- 202
             S +  S+ +  V    ++A E L    Y  + +DVWS GV L+ ++ +G  P+     
Sbjct: 203 EDSYVKRSQGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPP 258
Query: 203 ------------QEDPKNFRKTISRIMAVQYKI-----PDYVHISQDCRNLLSR 239
                        E P N  + + R+M   +K      P +  IS+D   ++ +
Sbjct: 259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 46  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH------ 115
              +   T T L +V +Y   G LF+ + N    + +          SG+++ H      
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 116 --SMQICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 169 EVL----SRREYDG-KLADVWSCGVTLY 191
           EVL    + + ++  K AD+++ G+  +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFW 248

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKN-----TKELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L  ++G G FG   L    N      K LVA+K + E       +  RE      L+H +
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 75
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG------RFSEDEA---------RYFF 104
           I+RF  V      L +V EY   G+L   + + G         ED A             
Sbjct: 76  IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 164
            Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     VG   
Sbjct: 136 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRT 191
Query: 165 -----YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
                ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 192 MLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 232

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 119/295 (40%), Gaps = 57/295 (19%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           L++ +G G +G   + R     E VA+K      +       E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 66  VVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH------ 115
             +T  H    L ++  Y   G L++ +                 + SG+++ H      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 116 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--------VGTPAY 165
                I HRDLK +N L+  +   +  I D G +   ++HS+  +         VGT  Y
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 166 IAPEVLSRRE----YDG-KLADVWSCGVTLYVM--------LVGAY--PFED--QEDP-- 206
           +APEVL        +D  K  D+W+ G+ L+ +        +V  Y  PF D    DP  
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 207 KNFRKTIS------RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 255
           ++ RK +        I    +  P    +++    L+   +  NPS R+T   IK
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK----LMKECWYQNPSARLTALRIK 294

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 33  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 90
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM---- 117
              +   T T L +V +Y   G LF+ + N    + +          SG+++ H      
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 118 ----QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 169 EVL----SRREYDG-KLADVWSCGVTLY 191
           EVL    + + ++  K AD+++ G+  +
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFW 235

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/289 (22%), Positives = 125/289 (43%), Gaps = 43/289 (14%)
Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           +++K IG G +G   + + +  K  VA+K      +       EI     +RH NI+ F 
Sbjct: 40  QMVKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 65  EVVL----TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM--- 117
              +    + T L ++ +Y   G L++ + +    ++   +  +   +SG+ + H+    
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFS 156
Query: 118 -----QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +      I D G      S ++ +   P + VGT  Y+ 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 168 PEV----LSRREYDGK-LADVWSCGVTLYVM--------LVGAY--PFEDQEDPKNFRKT 212
           PEV    L+R  +    +AD++S G+ L+ +        +V  Y  P+ D        + 
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 213 ISRIMAVQYKIPDYVH--ISQDC----RNLLSRIFVANPSRRITIKEIK 255
           +  I+ ++   P + +   S +C      L++  +  NP+ R+T   +K
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 6   LMKDIGSGNFGVARLMRNKN-----TKELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           L  ++G G FG   L    N      K LVA+K + E       +  RE      L+H +
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG------RFSEDEA---------RYFF 104
           I+RF  V      L +V EY   G+L   + + G         ED A             
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 164
            Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     VG   
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRT 220
Query: 165 -----YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
                ++ PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 221 MLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 19/205 (9%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNIIRFKEVV 67
           +G G FG     R  +   LVA+K +  ER    +     E+       H N++R +   
Sbjct: 46  LGRGGFGKVYKGRLADGT-LVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 68  LTPTHLAIVMEYAAGGE----LFERICNAGRFSEDEARYFFQQLISGVSYCHSM---QIC 120
           +TPT   +V  Y A G     L ER  +       + +        G++Y H     +I 
Sbjct: 105 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 164
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----KSTVGTPAYIAPEVLSRREY 176
           HRD+K  N LLD        + DFG +K  L+  +      +  GT  +IAPE LS  + 
Sbjct: 165 HRDVKAANILLD--EEFEAVVGDFGLAK--LMDYKDXHVXXAVRGTIGHIAPEYLSTGKS 220
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFE 201
             K  DV+  GV L  ++ G   F+
Sbjct: 221 SEK-TDVFGYGVMLLELITGQRAFD 244

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 10  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 67
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM---- 117
              +   T T L +V +Y   G LF+ + N    + +          SG+++ H      
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 118 ----QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 169 EVL----SRREYDG-KLADVWSCGVTLY 191
           EVL    + + ++  K AD+++ G+  +
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFW 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++  
Sbjct: 152 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 209
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 210 K-SDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++  
Sbjct: 152 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 209
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 210 K-SDVWSFGVLMW 221

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF-- 63
           L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F  
Sbjct: 13  LQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIA 70
Query: 64  --KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM---- 117
              +   T T L +V +Y   G LF+ + N    + +          SG+++ H      
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 118 ----QICHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSLLHSRPKSTVGTPAYIAP 168
                I HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+AP
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 169 EVL----SRREYDG-KLADVWSCGVTLY 191
           EVL    + + ++  K AD+++ G+  +
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFW 215

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 119/295 (40%), Gaps = 57/295 (19%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           L++ +G G +G   + R     E VA+K      +       E+ N   LRH NI+ F  
Sbjct: 12  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 66  VVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH------ 115
             +T  H    L ++  Y   G L++ +                 + SG+++ H      
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 116 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--------VGTPAY 165
                I HRDLK +N L+  +   +  I D G +   ++HS+  +         VGT  Y
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRY 183
Query: 166 IAPEVLSRR----EYDG-KLADVWSCGVTLYVM--------LVGAY--PFED--QEDP-- 206
           +APEVL        +D  K  D+W+ G+ L+ +        +V  Y  PF D    DP  
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 207 KNFRKTIS------RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 255
           ++ RK +        I    +  P    +++    L+   +  NPS R+T   IK
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK----LMKECWYQNPSARLTALRIK 294

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 189 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 76
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 77  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 131
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 83
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 84  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 138
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 139 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 197 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 231

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 119/295 (40%), Gaps = 57/295 (19%)
Query: 6   LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKE 65
           L++ +G G +G   + R     E VA+K      +       E+ N   LRH NI+ F  
Sbjct: 41  LLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIA 98
Query: 66  VVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH------ 115
             +T  H    L ++  Y   G L++ +                 + SG+++ H      
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 116 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--------VGTPAY 165
                I HRDLK +N L+  +   +  I D G +   ++HS+  +         VGT  Y
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRY 212
Query: 166 IAPEVLSRR----EYDG-KLADVWSCGVTLYVM--------LVGAY--PFED--QEDP-- 206
           +APEVL        +D  K  D+W+ G+ L+ +        +V  Y  PF D    DP  
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 272
Query: 207 KNFRKTIS------RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 255
           ++ RK +        I    +  P    +++    L+   +  NPS R+T   IK
Sbjct: 273 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK----LMKECWYQNPSARLTALRIK 323

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 76
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 77  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 131
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 79
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 80  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 134
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 164
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 135 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 190
Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 191 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 227

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 98
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 99  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 153
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 164
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 154 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 209
Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 210 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 246

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 67
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 68  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 122
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 181 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 76
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 77  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 131
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 132 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 190 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 80
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 81  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 135
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 194 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++  
Sbjct: 142 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 200 K-SDVWSFGVLMW 211

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 91  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++  
Sbjct: 150 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 207
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 208 K-SDVWSFGVLMW 219

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 70
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 71  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAE 125
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 126 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 184 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 218

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 104/218 (47%), Gaps = 31/218 (14%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K + SG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 80
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++M+    G L + +    R  +D   ++Y      Q+  
Sbjct: 81  VDNPHVCRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 135
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA----- 164
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K  LL +  K            
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIK 191
Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           ++A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 192 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++  
Sbjct: 132 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 190 K-SDVWSFGVLMW 201

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTV-GTPAYI 166
           G+ Y H+  I HRD+K  N LLD +  P  KI DFG SK  + L  +     V GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 167 APEVLSRREYDGKLADVWSCGVTLYVML 194
            PE   +     K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++  
Sbjct: 136 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 193
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 194 K-SDVWSFGVLMW 205

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/88 (40%), Positives = 47/88 (53%), Gaps = 6/88 (6%)
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTV-GTPAYI 166
           G+ Y H+  I HRD+K  N LLD +  P  KI DFG SK  + L  +     V GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 167 APEVLSRREYDGKLADVWSCGVTLYVML 194
            PE   +     K +DV+S GV L+ +L
Sbjct: 209 DPEYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 75
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 76  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 130
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 131 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 189 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K +GSG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 80
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 81  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 135
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 194 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 71  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++  
Sbjct: 130 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 187
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 188 K-SDVWSFGVLMW 199

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+        + ++    P  + APE ++  ++  
Sbjct: 136 DLAARNVLL--VTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSS 193
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 194 K-SDVWSFGVLMW 205

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 435 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 493
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLL---HSRPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+      + + ++    P  + APE ++  ++  
Sbjct: 494 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 551
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 552 K-SDVWSFGVLMW 563

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 8   KDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRHPNIIR 62
           K++GSGNFG V +               I +    D  +  E++      +QL +P I+R
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 436 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 494
Query: 123 DLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPA-YIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK   +   + + ++    P  + APE ++  ++  
Sbjct: 495 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 552
Query: 179 KLADVWSCGVTLY 191
           K +DVWS GV ++
Sbjct: 553 K-SDVWSFGVLMW 564

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PN 59
           + + K IG GNFG  RL +N  T E VA+K +E        +  E   +KQL      P 
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           +  F        + A+V+E       +LF+ +C+   FS         QLIS + Y HS 
Sbjct: 70  VYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSK 124
Query: 118 QICHRDLKLENTLLDGSPAPR----LKICDFGY--------SKSSLLHSRPKSTVGTPAY 165
            + +RD+K EN L+ G P  +    + I DF          +K  + +   KS  GT  Y
Sbjct: 125 NLIYRDVKPENFLI-GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE 201
           ++      +E   +  D+ + G      L G+ P++
Sbjct: 184 MSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 218

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 26/216 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PN 59
           + + K IG GNFG  RL +N  T E VA+K +E        +  E   +KQL      P 
Sbjct: 32  FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 90
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           +  F        + A+V+E       +LF+ +C+   FS         QLIS + Y HS 
Sbjct: 91  VYYFGPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSK 145
Query: 118 QICHRDLKLENTLLDGSPAPR----LKICDFGY--------SKSSLLHSRPKSTVGTPAY 165
            + +RD+K EN L+ G P  +    + I DF          +K  + +   KS  GT  Y
Sbjct: 146 NLIYRDVKPENFLI-GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 204
Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE 201
           ++      +E   +  D+ + G      L G+ P++
Sbjct: 205 MSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 239

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 3   KYELMKDIGSGNFGVA--RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLR 56
           +++ +K +GSG FG     L   +  K  + +  +E          +EI++       + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLISGV 111
           +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  G+
Sbjct: 110 NPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGM 164
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YIAP 168
           +Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A 
Sbjct: 165 NYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 169 EVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 223 ESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 255

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 19/205 (9%)
Query: 10  IGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPNIIRFKEVV 67
           +G G FG     R  +   LVA+K +  ER    +     E+       H N++R +   
Sbjct: 38  LGRGGFGKVYKGRLADGX-LVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 68  LTPTHLAIVMEYAAGGE----LFERICNAGRFSEDEARYFFQQLISGVSYCHSM---QIC 120
           +TPT   +V  Y A G     L ER  +       + +        G++Y H     +I 
Sbjct: 97  MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKII 156
Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP----KSTVGTPAYIAPEVLSRREY 176
           HRD+K  N LLD        + DFG +K  L+  +      +  G   +IAPE LS  + 
Sbjct: 157 HRDVKAANILLD--EEFEAVVGDFGLAK--LMDYKDXHVXXAVRGXIGHIAPEYLSTGKS 212
Query: 177 DGKLADVWSCGVTLYVMLVGAYPFE 201
             K  DV+  GV L  ++ G   F+
Sbjct: 213 SEK-TDVFGYGVMLLELITGQRAFD 236

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----PN 59
           + + K IG GNFG  RL +N  T E VA+K +E        +  E   +KQL      P 
Sbjct: 6   FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPIKSRAPQLHLEYRFYKQLSATEGVPQ 64
Query: 60  IIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           +  F        + A+V+E       +LF+ +C+   F+         QLI+ + Y H+ 
Sbjct: 65  VYYFGP---XGKYNAMVLELLGPSLEDLFD-LCDR-TFTLKTVLMIAIQLITRMEYVHTK 119
Query: 118 QICHRDLKLENTLLDGSPAPR----LKICDFGY--------SKSSLLHSRPKSTVGTPAY 165
            + +RD+K EN L+ G P  +    + I DFG         +K  + +   KS  GT  Y
Sbjct: 120 SLIYRDVKPENFLV-GRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARY 178
Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE 201
           ++      +E   +  D+ + G      L G+ P++
Sbjct: 179 MSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 213

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K + SG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 74  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 128
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 187 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 3   KYELMKDIGSGNFGVA----RLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----Q 54
           +++ +K + SG FG       +   +  K  VA+K +       AN  +EI++       
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 80
Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE--ARYFFQ---QLIS 109
           + +P++ R   + LT T + ++ +    G L + +    R  +D   ++Y      Q+  
Sbjct: 81  VDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAK 135
Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA---YI 166
           G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++
Sbjct: 136 GMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFE 201
           A E +  R Y  + +DVWS GVT++ +M  G+ P++
Sbjct: 194 ALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 95/252 (37%), Gaps = 37/252 (14%)
Query: 6   LMKDIGSGNFG-----VARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHP 58
           L++ +G G FG         M N  +   VA+K +      + + +   E +   +L H 
Sbjct: 49  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ 108
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFE-------RICNAGRFSEDEARYFFQQLISGV 111
           NI+R   V L      I++E  AGG+L         R       +  +  +  + +  G 
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHS--RPKSTVGTPA-YI 166
            Y       HRD+   N LL   P P    KI DFG ++     S  R       P  ++
Sbjct: 169 QYLEENHFIHRDIAARNCLLT-CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQED---------------PKNFR 210
            PE      +  K  D WS GV L+ +  +G  P+  + +               PKN  
Sbjct: 228 PPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 286
Query: 211 KTISRIMAVQYK 222
             + RIM   ++
Sbjct: 287 GPVYRIMTQCWQ 298

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 94/252 (37%), Gaps = 37/252 (14%)
Query: 6   LMKDIGSGNFG-----VARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHP 58
           L++ +G G FG         M N  +   VA+K +      + + +   E +   +  H 
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFE-------RICNAGRFSEDEARYFFQQLISGV 111
           NI+R   V L      I+ME  AGG+L         R       +  +  +  + +  G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHS--RPKSTVGTPA-YI 166
            Y       HRD+   N LL   P P    KI DFG ++     S  R       P  ++
Sbjct: 154 QYLEENHFIHRDIAARNCLLT-CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQED---------------PKNFR 210
            PE      +  K  D WS GV L+ +  +G  P+  + +               PKN  
Sbjct: 213 PPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 271
Query: 211 KTISRIMAVQYK 222
             + RIM   ++
Sbjct: 272 GPVYRIMTQCWQ 283

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 95/252 (37%), Gaps = 37/252 (14%)
Query: 6   LMKDIGSGNFG-----VARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHP 58
           L++ +G G FG         M N  +   VA+K +      + + +   E +   +L H 
Sbjct: 35  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQ 94
Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFE-------RICNAGRFSEDEARYFFQQLISGV 111
           NI+R   V L      I++E  AGG+L         R       +  +  +  + +  G 
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHS--RPKSTVGTPA-YI 166
            Y       HRD+   N LL   P P    KI DFG ++     S  R       P  ++
Sbjct: 155 QYLEENHFIHRDIAARNCLLT-CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 167 APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQED---------------PKNFR 210
            PE      +  K  D WS GV L+ +  +G  P+  + +               PKN  
Sbjct: 214 PPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 272
Query: 211 KTISRIMAVQYK 222
             + RIM   ++
Sbjct: 273 GPVYRIMTQCWQ 284

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 63/154 (40%), Gaps = 14/154 (9%)
Query: 57  HPNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVS 112
           HPN++       +P   H  ++  +   G L+  +     F  D+++   F      G +
Sbjct: 66  HPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXA 125
Query: 113 YCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           + H+++  I    L   +  +D     R+   D  +S  S            PA++APE 
Sbjct: 126 FLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQS------PGRXYAPAWVAPEA 179
Query: 171 LSRREYDG--KLADVWSCGVTLYVMLVGAYPFED 202
           L ++  D   + AD WS  V L+ ++    PF D
Sbjct: 180 LQKKPEDTNRRSADXWSFAVLLWELVTREVPFAD 213
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	351
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	0.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-152
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-148
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-117
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-115
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-114
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-113
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-113
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-112
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-111
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-110
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-109
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-109
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-109
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-107
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-107
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-105
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-104
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-99
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-92
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-91
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-90
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-89
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-89
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-89
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-88
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-88
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-88
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-87
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-87
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-87
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-87
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-87
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-86
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-86
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-86
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-86
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-86
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-85
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-85
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-85
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-85
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-85
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-85
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-84
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-83
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-83
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-83
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-83
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	7e-83
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-82
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-81
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-81
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-81
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-81
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-81
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-80
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-80
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-80
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-75
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-75
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-74
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-73
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-71
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-69
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-68
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-66
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-66
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-66
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-64
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-64
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-63
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-62
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-62
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-62
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-62
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-61
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-61
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-61
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-61
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-60
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-60
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-60
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-60
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-60
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-59
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-59
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-59
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-59
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-58
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-57
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-56
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-56
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-55
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-53
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-48
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	9e-48
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-47
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-47
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-47
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-47
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-47
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-46
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-46
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-46
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-45
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-45
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-45
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-45
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-45
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-45
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-44
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-43
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-43
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-43
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-43
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-42
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-42
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-42
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-42
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-41
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-41
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-41
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-40
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-39
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-39
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-39
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-38
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-37
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-37
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-37
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-36
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-36
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-36
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-36
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-36
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-36
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-35
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-34
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-34
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-33
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-33
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-32
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-32
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-31
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-30
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-29
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-28
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-27
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-25
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	5e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-24
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-24
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-23
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-22
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-20
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-20
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-18
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-15
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-15
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-14
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-09
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  532 bits (1373), Expect = 0.0
 Identities = 228/333 (68%), Positives = 276/333 (82%), Gaps = 1/333 (0%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
            ++Y+ +KDIGSGNFGVARLMR+K TKELVA+KYIERG  ID NV REIINH+ LRHPNI
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +RFKEV+LTPTHLAI+MEYA+GGEL+ERICNAGRFSEDEAR+FFQQL+SGVSYCHSMQIC
Sbjct: 79  VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R+EYDGK+
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKI 198

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI 240
           ADVWSCGVTLYVMLVGAYPFED E+P+++RKTI RI++V+Y IPD + IS +C +L+SRI
Sbjct: 199 ADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI 258

Query: 241 FVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           FVA+P+ RI+I EIK+H WFLKNLP +L   +      +E P   +QS++ I +I+ EA 
Sbjct: 259 FVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE-PEQPMQSLDTIMQIISEAT 317

Query: 301 VPPPVSRSIGGFGWGGEEDGDEKEEETDADEED 333
           +P   +R +  F     +  D+ ++     E D
Sbjct: 318 IPAVRNRCLDDFMTDNLDLDDDMDDFDSESEID 350

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  431 bits (1110), Expect = e-152
 Identities = 105/328 (32%), Positives = 163/328 (49%), Gaps = 23/328 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R        GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYVHISQDCR 234
           +  +  DVWSCG+ L  ML G  P++   D  + +     +    +  +  +  I     
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPL 239

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTF---SLQSVEE 291
            LL +I V NPS RITI +IK   W+ K L +             E+P+     +QS  +
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLD 299

Query: 292 ITKIVEEAKVPPPVSRSIGGFGWGGEED 319
            + +   ++ P        G GW  E  
Sbjct: 300 FSPVNSASRTP--------GSGWSKEHH 319

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  417 bits (1074), Expect = e-148
 Identities = 96/274 (35%), Positives = 146/274 (53%), Gaps = 12/274 (4%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N+++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + 
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRRE 175
           I HRD+K EN LLD      LKI DFG +     ++R        GT  Y+APE+L RRE
Sbjct: 126 ITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-KNFRKTISRIMAVQYKIPDYVHISQDCR 234
           +  +  DVWSCG+ L  ML G  P++   D  + +     +    +  +  +  I     
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPWKKIDSAPL 239

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
            LL +I V NPS RITI +IK   W+ K L +  
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  339 bits (871), Expect = e-117
 Identities = 111/276 (40%), Positives = 153/276 (55%), Gaps = 20/276 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           +  Y L   +G G FG  ++  ++ T   VA+K + R      +    + REI N K  R
Sbjct: 10  IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HP+II+  +V+ TPT   +VMEY +GGELF+ IC  GR  E EAR  FQQ++S V YCH 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVLS 172
             + HRDLK EN LLD       KI DFG S        L     ++ G+P Y APEV+S
Sbjct: 130 HMVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLR----TSCGSPNYAAPEVIS 183

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
            R Y G   D+WSCGV LY +L G  PF+D+  P  F+K    I    + IP+  ++++ 
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPE--YLNRS 237

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
              LL  +   +P +R TIK+I+ H WF ++LP  L
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  333 bits (857), Expect = e-114
 Identities = 104/271 (38%), Positives = 151/271 (55%), Gaps = 11/271 (4%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHPN 59
            Y L+K IG GNF   +L R+  T   VA+K I++      +   + RE+   K L HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           I++  EV+ T   L ++MEYA+GGE+F+ +   GR  E EAR  F+Q++S V YCH  +I
Sbjct: 76  IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+   ++YDG 
Sbjct: 136 VHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             DVWS GV LY ++ G+ PF+ Q   +   +    ++  +Y+IP Y+  S DC NLL R
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFYM--STDCENLLKR 247

Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPRELTE 270
             V NP +R T+++I    W       +  +
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDELK 278

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  332 bits (854), Expect = e-113
 Identities = 118/274 (43%), Positives = 166/274 (60%), Gaps = 21/274 (7%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHP 58
            Y + + +G G+FG  +L  +  T++ VA+K+I R       +   V REI   K LRHP
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +II+  +V+ TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I  + YCH  +
Sbjct: 70  HIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           I HRDLK EN LLD +    +KI DFG S      + L     ++ G+P Y APEV++ +
Sbjct: 129 IVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLK----TSCGSPNYAAPEVINGK 182

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            Y G   DVWSCG+ LYVMLVG  PF+D+  P  F+K    + +  Y +PD   +S   +
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPD--FLSPGAQ 236

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
           +L+ R+ VA+P +RITI+EI+  PWF  NLP  L
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  337 bits (865), Expect = e-113
 Identities = 110/277 (39%), Positives = 155/277 (55%), Gaps = 22/277 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-----VAREIINHKQL 55
           +  Y L   +G G FG  ++ +++ T   VA+K + R  KI +      + REI N K  
Sbjct: 15  IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLF 73

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           RHP+II+  +V+ TP+ + +VMEY +GGELF+ IC  GR  E E+R  FQQ++SGV YCH
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYIAPEVL 171
              + HRDLK EN LLD       KI DFG S        L     ++ G+P Y APEV+
Sbjct: 134 RHMVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLR----TSCGSPNYAAPEVI 187

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
           S R Y G   D+WS GV LY +L G  PF+D   P  F+K    I    +  P   +++ 
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQ--YLNP 241

Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
              +LL  +   +P +R TIK+I+ H WF ++LP+ L
Sbjct: 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYL 278

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  327 bits (840), Expect = e-112
 Identities = 83/278 (29%), Positives = 132/278 (47%), Gaps = 15/278 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
             +Y   + +G G F     + + +TKE+ A K + +           ++ EI  H+ L 
Sbjct: 14  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           H +++ F         + +V+E      L E        +E EARY+ +Q++ G  Y H 
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG +         K  + GTP YIAPEVLS++ 
Sbjct: 134 NRVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 191

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWS G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +
Sbjct: 192 HSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAAS 244

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTETA 272
           L+ ++   +P+ R TI E+ +  +F    +P  L  T 
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 282

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  324 bits (833), Expect = e-111
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 30/283 (10%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----KIDANVAREIINHKQLRH 57
           KY +   +G G++G  + + +  T    A+K +++         +ANV +EI   ++LRH
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65

Query: 58  PNIIRFKEVVL--TPTHLAIVMEYAAGG--ELFERICNAGRFSEDEARYFFQQLISGVSY 113
            N+I+  +V+       + +VMEY   G  E+ + +    RF   +A  +F QLI G+ Y
Sbjct: 66  KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEY 124

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSLLHSRPKSTVGTPAYI 166
            HS  I H+D+K  N LL       LKI   G +                 ++ G+PA+ 
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCR----TSQGSPAFQ 178

Query: 167 APEVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
            PE+ +    + G   D+WS GVTLY +  G YPFE      N  K    I    Y IP 
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKLFENIGKGSYAIPG 234

Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
                    +LL  +    P++R +I++I+ H WF K  P   
Sbjct: 235 D--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAE 275

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  324 bits (833), Expect = e-110
 Identities = 83/278 (29%), Positives = 132/278 (47%), Gaps = 15/278 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
             +Y   + +G G F     + + +TKE+ A K + +           ++ EI  H+ L 
Sbjct: 40  RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           H +++ F         + +V+E      L E        +E EARY+ +Q++ G  Y H 
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRRE 175
            ++ HRDLKL N  L+      +KI DFG +         K  + GTP YIAPEVLS++ 
Sbjct: 160 NRVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           +  +  DVWS G  +Y +LVG  PFE        ++T  RI   +Y IP   HI+    +
Sbjct: 218 HSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPK--HINPVAAS 270

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTETA 272
           L+ ++   +P+ R TI E+ +  +F    +P  L  T 
Sbjct: 271 LIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 308

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  320 bits (823), Expect = e-109
 Identities = 102/296 (34%), Positives = 147/296 (49%), Gaps = 47/296 (15%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------------------- 42
           +Y L  +IG G++GV +L  N+N     AMK + +   I                     
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 43  -------ANVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICNAG 93
                    V +EI   K+L HPN+++  EV+  P   HL +V E    G + E +    
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132

Query: 94  RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-----K 148
             SED+AR++FQ LI G+ Y H  +I HRD+K  N L+       +KI DFG S      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190

Query: 149 SSLLHSRPKSTVGTPAYIAPEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP 206
            +LL     +TVGTPA++APE LS  R+ + GK  DVW+ GVTLY  + G  PF D+   
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
               K    I +   + PD   I++D ++L++R+   NP  RI + EIK HPW  +
Sbjct: 247 CLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  319 bits (819), Expect = e-109
 Identities = 79/278 (28%), Positives = 144/278 (51%), Gaps = 15/278 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
           +E +++   +G G+F       + +T   VA+K I++       +   V  E+  H QL+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCH 115
           HP+I+          ++ +V+E    GE+   + N    FSE+EAR+F  Q+I+G+ Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 174
           S  I HRDL L N LL  +    +KI DFG +    +      T+ GTP YI+PE+ +R 
Sbjct: 130 SHGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            +  + +DVWS G   Y +L+G  PF+        + T+++++   Y++P    +S + +
Sbjct: 188 AHGLE-SDVWSLGCMFYTLLIGRPPFDT----DTVKNTLNKVVLADYEMPS--FLSIEAK 240

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 272
           +L+ ++   NP+ R+++  +  HP+  +N   +  +  
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDEG 278

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  318 bits (818), Expect = e-109
 Identities = 84/279 (30%), Positives = 143/279 (51%), Gaps = 14/279 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
           ++ +++ + +G G FG   L R K  K ++A+K + +       ++  + REI     LR
Sbjct: 13  IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH 
Sbjct: 73  HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN L+       LKI DFG+S  +    R ++  GT  Y+ PE++  + +
Sbjct: 133 RKVIHRDIKPENLLMGYK--GELKIADFGWSVHA-PSLRRRTMCGTLDYLPPEMIEGKTH 189

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K  D+W  GV  Y  LVG  PF+     +  R+    I+ V  K P ++  S   ++L
Sbjct: 190 DEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPFL--SDGSKDL 242

Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 275
           +S++   +P +R+ +K +  HPW   N  R L    Q+ 
Sbjct: 243 ISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  315 bits (809), Expect = e-107
 Identities = 90/273 (32%), Positives = 145/273 (53%), Gaps = 14/273 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +       ++  + RE+     LR
Sbjct: 8   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 68  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S  +   SR     GT  Y+ PE++  R +
Sbjct: 128 KRVIHRDIKPENLLLGSA--GELKIADFGWSVHA-PSSRRTDLCGTLDYLPPEMIEGRMH 184

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K  D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD   +++  R+L
Sbjct: 185 DEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDL 237

Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 269
           +SR+   NPS+R  ++E+  HPW   N  +   
Sbjct: 238 ISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  314 bits (807), Expect = e-107
 Identities = 83/283 (29%), Positives = 130/283 (45%), Gaps = 33/283 (11%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--------VAREIINHKQ 54
           +Y++   +GSG FG        +    VA+K++E+  +I           V  E++  K+
Sbjct: 44  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKK 102

Query: 55  LRH--PNIIRFKEVVLTPTHLAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGV 111
           +      +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIAP 168
            +CH+  + HRD+K EN L+D +    LK+ DFG     K ++         GT  Y  P
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSPP 217

Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
           E +    Y G+ A VWS G+ LY M+ G  PFE  E           I+  Q        
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQ--R 265

Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTE 270
           +S +C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  311 bits (798), Expect = e-105
 Identities = 78/278 (28%), Positives = 114/278 (41%), Gaps = 32/278 (11%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-------ANVAREIINHKQL 55
           +Y L   +G G FG          +  VA+K I R   +             E+    ++
Sbjct: 32  EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91

Query: 56  R----HPNIIRFKEVVLTPTHLAIVMEYAA-GGELFERICNAGRFSEDEARYFFQQLISG 110
                HP +IR  +   T     +V+E      +LF+ I   G   E  +R FF Q+++ 
Sbjct: 92  GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS---KSSLLHSRPKSTVGTPAYIA 167
           + +CHS  + HRD+K EN L+D       K+ DFG                  GT  Y  
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVYSP 206

Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
           PE +SR +Y    A VWS G+ LY M+ G  PFE  +           I+  +   P   
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EILEAELHFPA-- 254

Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
           H+S DC  L+ R     PS R +++EI   PW      
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  309 bits (794), Expect = e-104
 Identities = 78/279 (27%), Positives = 123/279 (44%), Gaps = 32/279 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---------GHKIDANVAREIIN 51
            +KY  M  +GSG FG      +K   + V +K+I++                V  EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAA-GGELFERICNAGRFSEDEARYFFQQLISG 110
             ++ H NII+  ++        +VME    G +LF  I    R  E  A Y F+QL+S 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSLLHSRPKSTVGTPAYI 166
           V Y     I HRD+K EN ++       +K+ DFG +    +  L +    +  GT  Y 
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFY----TFCGTIEYC 196

Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 226
           APEVL    Y G   ++WS GVTLY ++    PF +          +   +      P  
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE----------LEETVEAAIHPPYL 246

Query: 227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
           V  S++  +L+S +    P RR T++++ + PW  + + 
Sbjct: 247 V--SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  297 bits (762), Expect = 1e-99
 Identities = 60/329 (18%), Positives = 118/329 (35%), Gaps = 59/329 (17%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER------------------GHKID 42
           +  Y +++ +  G F    L       +  A+K  E+                       
Sbjct: 30  INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87

Query: 43  ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG--------R 94
            +   E+     +++   +  + ++     + I+ EY     + +               
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147

Query: 95  FSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SS 150
                 +   + +++  SY H+   ICHRD+K  N L+D +   R+K+ DFG S+     
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDK 205

Query: 151 LLHSRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF 209
            +      + GT  ++ PE  S    Y+G   D+WS G+ LYVM     PF  +    + 
Sbjct: 206 KIK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SL 258

Query: 210 RKTISRIMAVQYKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIK 252
            +  + I     + P                     +S +  + L      NP+ RIT +
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 253 EIKSHPWFLKNLPRELTETAQAIYYRKEN 281
           +   H W       +L E ++ +Y +++ 
Sbjct: 319 DALKHEWLADTNIEDLREFSKELYKKRKK 347

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  276 bits (709), Expect = 1e-92
 Identities = 94/268 (35%), Positives = 135/268 (50%), Gaps = 10/268 (3%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           + Y L   IG G++G  ++   K T+   A K I +    D +   +EI   K L HPNI
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           IR  E     T + +VME   GGELFER+ +   F E +A    + ++S V+YCH + + 
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVA 128

Query: 121 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
           HRDLK EN L    SP   LK+ DFG +         ++ VGTP Y++P+VL    Y G 
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLY-GP 186

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLL 237
             D WS GV +YV+L G  PF    D +   K    I    +     D++++S    +L+
Sbjct: 187 ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESLI 242

Query: 238 SRIFVANPSRRITIKEIKSHPWFLKNLP 265
            R+   +P +RIT  +   H WF K L 
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWFEKQLS 270

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  275 bits (706), Expect = 2e-91
 Identities = 88/274 (32%), Positives = 129/274 (47%), Gaps = 20/274 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---------GHKIDANVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA+K I +               NV  EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 113 YCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 172 SRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYKIPDYV- 227
                    +  D WS GV L++ L G  PF +     +   +    I + +Y     V 
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITSGKYNFIPEVW 244

Query: 228 -HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             +S+   +L+ ++ V +P  R T +E   HPW 
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  275 bits (704), Expect = 3e-91
 Identities = 61/304 (20%), Positives = 114/304 (37%), Gaps = 39/304 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
             + L   +G G        R+K T +L A+K       +       RE    K+L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IIRFKEVV--LTPTHLAIVMEYAAGGELFERIC---NAGRFSEDEARYFFQQLISGVSYC 114
           I++   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+++ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 115 HSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
               I HR++K  N +       +   K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 173 RREYD-------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---- 221
           R           G   D+WS GVT Y    G+ PF   E P+  ++ + +I+  +     
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 222 ---------------KIPDYVHISQDCRN----LLSRIFVANPSRRITIKEIKSHPWFLK 262
                           +P    +S+  +     +L+ I  A+  +     +  +    + 
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308

Query: 263 NLPR 266
           +   
Sbjct: 309 HRGN 312

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  278 bits (713), Expect = 3e-91
 Identities = 85/278 (30%), Positives = 129/278 (46%), Gaps = 14/278 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---------GHKIDANVAREIINH 52
           ++Y + K +GSG  G  +L   + T + VA++ I +               NV  EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           K+L HP II+ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 113 YCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y H   I HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 172 SRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 229
                    +  D WS GV L++ L G  PF +     + +  I+      +    +  +
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKYNFIPEVWAEV 372

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
           S+   +L+ ++ V +P  R T +E   HPW      + 
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  274 bits (702), Expect = 6e-91
 Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 26/281 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
              Y ++K IGSG       + N+  K++ A+KY+      +    +   EI    +L+ 
Sbjct: 27  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85

Query: 58  PN--IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLS 172
              I H DLK  N L+       LK+ DFG +      +      S VGT  Y+ PE + 
Sbjct: 145 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 173 RREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 222
                             +DVWS G  LY M  G  PF+   +       +  I+   ++
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHE 258

Query: 223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           I       +D +++L      +P +RI+I E+ +HP+    
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  271 bits (696), Expect = 1e-90
 Identities = 84/271 (30%), Positives = 137/271 (50%), Gaps = 11/271 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           + Y++ +++G G F V R   +K T    A K I       +    + RE    ++L+HP
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++  ++YCHS  
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 119 ICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 184

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 235
            K  D+W+CGV LY++LVG  PF D++  + + +    I A  Y    P++  ++ + ++
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS 240

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           L+  +   NP +RIT  +    PW       
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWICNRERV 271

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  269 bits (689), Expect = 2e-89
 Identities = 77/267 (28%), Positives = 123/267 (46%), Gaps = 14/267 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDAN-VAREIINHKQLRHPN 59
           + +   + +GSG FG   L+  +++     +K I     ++    +  EI   K L HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERIC----NAGRFSEDEARYFFQQLISGVSYCH 115
           II+  EV     ++ IVME   GGEL ERI          SE       +Q+++ ++Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141

Query: 116 SMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           S  + H+DLK EN L    SP   +KI DFG ++         +  GT  Y+APEV  +R
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KR 200

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDC 233
           +      D+WS GV +Y +L G  PF      +  +K        +     +   ++   
Sbjct: 201 DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQA 255

Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWF 260
            +LL ++   +P RR +  ++  H WF
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWF 282

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  270 bits (693), Expect = 3e-89
 Identities = 66/282 (23%), Positives = 116/282 (41%), Gaps = 26/282 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRHP 58
             Y ++K IGSG       + N+  K++ A+KY+      +    +   EI    +L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 59  N--IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSR 173
             I H DLK  N L+       LK+ DFG +      +      S VGT  Y+ PE +  
Sbjct: 127 HGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 174 REYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI 223
                            +DVWS G  LY M  G  PF+   +  +    +  I+   ++I
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEI 240

Query: 224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
                  +D +++L      +P +RI+I E+ +HP+      
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  269 bits (689), Expect = 3e-89
 Identities = 89/285 (31%), Positives = 137/285 (48%), Gaps = 24/285 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----------ERGHKIDANVAREI-I 50
           E YE  + +G G   V R   +K T +  A+K I          E   ++     +E+ I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76

Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             K   HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 194

Query: 171 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-- 223
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R     IM+  Y+   
Sbjct: 195 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFGS 250

Query: 224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
           P++   S   ++L+SR  V  P +R T +E  +HP+F + +  E+
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  266 bits (682), Expect = 5e-88
 Identities = 89/267 (33%), Positives = 145/267 (54%), Gaps = 12/267 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           + +  M+ +GSG F    L++ + T +L A+K I++      +++  EI   K+++H NI
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +  +++  + TH  +VM+  +GGELF+RI   G ++E +A    QQ++S V Y H   I 
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128

Query: 121 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRREYDG 178
           HRDLK EN L        ++ I DFG SK  +  +    +  GTP Y+APEVL+++ Y  
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY-S 185

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNL 236
           K  D WS GV  Y++L G  PF ++ + K F K    I    Y+   P +  IS+  ++ 
Sbjct: 186 KAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDF 241

Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +  +   +P+ R T ++  SHPW   N
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGN 268

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  269 bits (689), Expect = 5e-88
 Identities = 70/318 (22%), Positives = 128/318 (40%), Gaps = 27/318 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
              Y ++K IGSG       + N+  K++ A+KY+      +    +   EI    +L+ 
Sbjct: 55  GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113

Query: 58  PN--IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            +  IIR  +  +T  ++ +VME     +L   +         E + +++ ++  V   H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLS 172
              I H DLK  N L+       LK+ DFG +      +      S VG   Y+ PE + 
Sbjct: 173 QHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229

Query: 173 RREYD----------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 222
                             +DVWS G  LY M  G  PF+   +  +    +  I+   ++
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHE 286

Query: 223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENP 282
           I       +D +++L      +P +RI+I E+ +HP+  +     + + A+      +  
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV-QIQTHPVNQMAKGTTEEMKYV 345

Query: 283 TFSLQSVEEITKIVEEAK 300
              L  +     I++ AK
Sbjct: 346 LGQLVGLNSPNSILKAAK 363

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  265 bits (679), Expect = 7e-88
 Identities = 89/270 (32%), Positives = 143/270 (52%), Gaps = 16/270 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
           + YE+ +++GSG F + R  R K T +  A K+I        R       + RE+   ++
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           +RHPNII   ++    T + +++E  +GGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124

Query: 115 HSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           HS +I H DLK EN +L     P PR+K+ DFG +      +  K+  GTP ++APE+++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN 184

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 230
                G  AD+WS GV  Y++L GA PF  +   +        I AV Y   +  + + S
Sbjct: 185 YEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNTS 239

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +  ++ + R+ V +P RR+TI +   H W 
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  268 bits (687), Expect = 1e-87
 Identities = 68/342 (19%), Positives = 126/342 (36%), Gaps = 45/342 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
             + L   +G G        R+K T +L A+K       +       RE    K+L H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 60  IIRFKEVV--LTPTHLAIVMEYAAGGELFERIC---NAGRFSEDEARYFFQQLISGVSYC 114
           I++   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+++ 
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 115 HSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
               I HR++K  N +       +   K+ DFG ++      +  S  GT  Y+ P++  
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188

Query: 173 RREYD-------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---- 221
           R           G   D+WS GVT Y    G+ PF   E P+  ++ + +I+  +     
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 222 ---------------KIPDYVHISQDCR----NLLSRIFVANPSRRITIKEIKSHPWFLK 262
                           +P    +S+  +     +L+ I  A+  +     +  +    + 
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308

Query: 263 NLP----RELTETAQAIYYRKENPTFS--LQSVEEITKIVEE 298
           +        L +      Y     T +   + V + TKI+  
Sbjct: 309 HRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISS 350

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  264 bits (678), Expect = 1e-87
 Identities = 95/272 (34%), Positives = 147/272 (54%), Gaps = 12/272 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    +K  + + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 119 ICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  Y 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY- 199

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 235
            +  DVWS GV LY++L G  PF  + +    ++    +   +Y   +P +  IS D ++
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAKD 255

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
           L+ ++   +PS RIT  +   HPW  K    E
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  263 bits (675), Expect = 4e-87
 Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 39/290 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             +E +  +G G FG     RN       A+K I    +  + +  E++    L H  ++
Sbjct: 6   SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65

Query: 62  RFKEV-------------VLTPTHLAIVMEYAAGGELFERICNAGRF-SEDEARYFFQQL 107
           R+                V   + L I MEY   G L++ I +       DE    F+Q+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SLL 152
           +  +SY HS  I HRDLK  N  +D S    +KI DFG +K+                  
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT 212
                S +GT  Y+A EVL    +  +  D++S G+  + M+         E     +K 
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK- 240

Query: 213 ISRIMAVQYKIPDYV--HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              + +V  + P     +  +  + ++  +   +P++R   + + +  W 
Sbjct: 241 ---LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  265 bits (680), Expect = 4e-87
 Identities = 81/278 (29%), Positives = 130/278 (46%), Gaps = 23/278 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---------GHKIDANVAREI-IN 51
           +KY+    IG G   V R   ++ T    A+K +E            ++     RE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 52  HKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
            +   HP+II   +   + + + +V +    GELF+ +      SE E R   + L+  V
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           S+ H+  I HRDLK EN LLD +    +++ DFG+S       + +   GTP Y+APE+L
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271

Query: 172 SRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 226
                +     GK  D+W+CGV L+ +L G+ PF  +      R     IM  QY+    
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSP 327

Query: 227 V--HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
                S   ++L+SR+   +P  R+T ++   HP+F +
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  264 bits (678), Expect = 8e-87
 Identities = 85/268 (31%), Positives = 138/268 (51%), Gaps = 11/268 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGHKID-ANVAREIINHKQLRHP 58
           + Y++ +++G G F V R   +K T    A K I   +    D   + RE    ++L+HP
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 88

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI+R  + +   +   +V +   GGELFE I     +SE +A +  QQ++  ++YCHS  
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148

Query: 119 ICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 207

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 235
            K  D+W+CGV LY++LVG  PF D++  + + +    I A  Y    P++  ++ + ++
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAKS 263

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKN 263
           L+  +   NP +RIT  +    PW    
Sbjct: 264 LIDSMLTVNPKKRITADQALKVPWICNR 291

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  263 bits (674), Expect = 2e-86
 Identities = 85/265 (32%), Positives = 133/265 (50%), Gaps = 11/265 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNI 60
           + YE+ +DIG G++ V +   +K T    A+K I+   K   +   EI I  +  +HPNI
Sbjct: 22  DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTEEIEILLRYGQHPNI 78

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           I  K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y H+  + 
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138

Query: 121 HRDLKLENTLLDGSP--APRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYD 177
           HRDLK  N L          ++ICDFG++K     +    T   T  ++APEVL R+ YD
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 235
               D+WS GV LY ML G  PF +  D     + ++RI + ++      +  +S   ++
Sbjct: 199 -AACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256

Query: 236 LLSRIFVANPSRRITIKEIKSHPWF 260
           L+S++   +P +R+T   +  HPW 
Sbjct: 257 LVSKMLHVDPHQRLTAALVLRHPWI 281

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  263 bits (673), Expect = 3e-86
 Identities = 82/316 (25%), Positives = 129/316 (40%), Gaps = 58/316 (18%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER------GHKIDANVAREIINHKQL 55
           +KY L   IG G++GV R+     T+ + A+K + +        K    +  E+   K+L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--------------------- 94
            HPNI R  EV     ++ +VME   GG L +++                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 95  -------------------FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP 135
                                E       +Q+ S + Y H+  ICHRD+K EN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 136 APRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYD-GKLADVWSCGVT 189
           +  +K+ DFG SK     ++  +    +  GTP ++APEVL+      G   D WS GV 
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 190 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLSRIFVANPSR 247
           L+++L+GA PF    D     +    ++  +     P+Y  +S   R+LLS +   N   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321

Query: 248 RITIKEIKSHPWFLKN 263
           R        HPW  + 
Sbjct: 322 RFDAMRALQHPWISQF 337

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  267 bits (684), Expect = 4e-86
 Identities = 92/268 (34%), Positives = 144/268 (53%), Gaps = 12/268 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E+Y ++  +G G+FG     +++ T++  A+K I +    + +   + RE+   K+L HP
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI++  E++   +   IV E   GGELF+ I    RFSE +A    +Q+ SG++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 119 ICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL R  Y 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTY- 199

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQDCRN 235
            +  DVWS GV LY++L G  PF  + +    ++    +      + +P +  IS D ++
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAKD 255

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKN 263
           L+ ++   +PS RIT  +   HPW  K 
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKY 283

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  261 bits (670), Expect = 4e-86
 Identities = 83/270 (30%), Positives = 139/270 (51%), Gaps = 16/270 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
           + Y++ +++GSG F + +  R K+T    A K+I        R       + RE+   +Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           + H N+I   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 115 HSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           H+ +I H DLK EN +L     P P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 230
                G  AD+WS GV  Y++L GA PF      +        I +V Y   +  + H S
Sbjct: 192 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVSYDFDEEFFSHTS 246

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +  ++ + ++ V    +R+TI+E   HPW 
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  262 bits (671), Expect = 4e-86
 Identities = 90/270 (33%), Positives = 145/270 (53%), Gaps = 16/270 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
           + Y+  +++GSG F V +  R K+T    A K+I        R      ++ RE+   K+
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           ++HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 115 HSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           HS+QI H DLK EN +L     P PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHIS 230
                G  AD+WS GV  Y++L GA PF      +        + AV Y  +   + + S
Sbjct: 191 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNTS 245

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              ++ + R+ V +P +R+TI++   HPW 
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  261 bits (670), Expect = 1e-85
 Identities = 85/270 (31%), Positives = 139/270 (51%), Gaps = 16/270 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-------ERGHKIDANVAREIINHKQ 54
           + Y++ +++GSG F + +  R K+T    A K+I        R       + RE+   +Q
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           + HPNII   +V    T + +++E  +GGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 115 HSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           H+ +I H DLK EN +L     P P +K+ DFG +         K+  GTP ++APE+++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 230
                G  AD+WS GV  Y++L GA PF      +        I AV Y   +  +   S
Sbjct: 192 YEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVSYDFDEEFFSQTS 246

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +  ++ + ++ V    +R+TI+E   HPW 
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  271 bits (693), Expect = 2e-85
 Identities = 79/337 (23%), Positives = 129/337 (38%), Gaps = 38/337 (11%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVAREIINHKQLRHPNI 60
            +E+ + +G+G FG      +++T E VA+K   +    K       EI   K+L HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 61  IRFKEVVLTPTHLA------IVMEYAAGGELFERIC---NAGRFSEDEARYFFQQLISGV 111
           +  +EV      LA      + MEY  GG+L + +    N     E   R     + S +
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 112 SYCHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
            Y H  +I HRDLK EN +L  G      KI D GY+K           VGT  Y+APE+
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPEL 194

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI--------------SRI 216
           L +++Y     D WS G   +  + G  PF     P  +   +              +  
Sbjct: 195 LEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253

Query: 217 MAVQYKIPDYVHISQDCRNLLSRIF----VANPSRRITIKEIKSHPWFLKNLPRELTETA 272
           +     +P   H+S      L R      + +  +R T  +  +   F + L   L+   
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCF-QALDSILSLKL 312

Query: 273 QAIYYRKENPTFSLQSVEEIT------KIVEEAKVPP 303
            ++         +    E          + ++  +P 
Sbjct: 313 LSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPE 349

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  265 bits (679), Expect = 2e-85
 Identities = 88/274 (32%), Positives = 141/274 (51%), Gaps = 13/274 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLRH 57
           ++Y+  + +G G+FG   L ++K T +  A+K I +           + RE+   KQL H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI++  E      +  +V E   GGELF+ I +  RFSE +A    +Q++SG++Y H  
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 118 QICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           +I HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    Y
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTY 204

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQDCR 234
             +  DVWS GV LY++L G  PF    +    +K    +      +++P +  +S+  +
Sbjct: 205 -DEKCDVWSTGVILYILLSGCPPFNGANEYDILKK----VEKGKYTFELPQWKKVSESAK 259

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
           +L+ ++    PS RI+ ++   H W       ++
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  260 bits (667), Expect = 3e-85
 Identities = 90/267 (33%), Positives = 140/267 (52%), Gaps = 8/267 (2%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           + +E+  ++G G   +    + K T++  A+K +++       V  EI    +L HPNII
Sbjct: 53  DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI-VRTEIGVLLRLSHPNII 111

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
           + KE+  TPT +++V+E   GGELF+RI   G +SE +A    +Q++  V+Y H   I H
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVH 171

Query: 122 RDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           RDLK EN L    +P   LKI DFG SK        K+  GTP Y APE+L    Y G  
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPE 230

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNLLS 238
            D+WS G+  Y++L G  PF D+   +       RI+  +Y    P +  +S + ++L+ 
Sbjct: 231 VDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNCEYYFISPWWDEVSLNAKDLVR 287

Query: 239 RIFVANPSRRITIKEIKSHPWFLKNLP 265
           ++ V +P +R+T  +   HPW      
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVTGKAA 314

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  265 bits (679), Expect = 3e-85
 Identities = 91/272 (33%), Positives = 145/272 (53%), Gaps = 12/272 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER---GHKIDANVAREIINHKQLRHP 58
           E Y+ +K +GSG +G   L R+K T    A+K I +       ++ +  E+   K L HP
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI++  +      +  +VME   GGELF+ I +  +F+E +A    +Q++SGV+Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 119 ICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK EN LL        +KI DFG S       + K  +GT  YIAPEVL R++Y 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKY- 214

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPDYVHISQDCRN 235
            +  DVWS GV L+++L G  PF  Q D +  RK    +      +  P++ ++S+  ++
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEKGKYTFDSPEWKNVSEGAKD 270

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
           L+ ++   +  RRI+ ++   HPW  +   ++
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKK 302

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  258 bits (662), Expect = 7e-85
 Identities = 88/273 (32%), Positives = 147/273 (53%), Gaps = 14/273 (5%)

Query: 2   EKYELM---KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-H 57
           + Y+L    K +G G+F + R   +K + +  A+K I +  +++AN  +EI   K    H
Sbjct: 8   QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGH 65

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PNI++  EV     H  +VME   GGELFERI     FSE EA Y  ++L+S VS+ H +
Sbjct: 66  PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDV 125

Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSRRE 175
            + HRDLK EN L  D +    +KI DFG+++     ++P K+   T  Y APE+L++  
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG 185

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPF---EDQEDPKNFRKTISRIMAVQY--KIPDYVHIS 230
           YD +  D+WS GV LY ML G  PF   +      +  + + +I    +  +   + ++S
Sbjct: 186 YD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS 244

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           Q+ ++L+  +   +P++R+ +  ++ + W    
Sbjct: 245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  257 bits (659), Expect = 2e-84
 Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 8/262 (3%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           EKY + +D+G G FG+       ++K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQIC 120
              E   +   L ++ E+ +G ++FERI  +    +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           H D++ EN +     +  +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STA 183

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRNLLS 238
            D+WS G  +YV+L G  PF  + +    ++ I  IM  +Y      +  IS +  + + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 239 RIFVANPSRRITIKEIKSHPWF 260
           R+ V     R+T  E   HPW 
Sbjct: 240 RLLVKERKSRMTASEALQHPWL 261

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  261 bits (669), Expect = 1e-83
 Identities = 90/279 (32%), Positives = 139/279 (49%), Gaps = 23/279 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--------------GHKIDANVAR 47
           E Y  ++ +GSG +G   L + KN     A+K I++                K    +  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 48  EIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQL 107
           EI   K L HPNII+  +V     +  +V E+  GGELFE+I N  +F E +A    +Q+
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 108 ISGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI 166
           +SG+ Y H   I HRD+K EN LL + +    +KI DFG S       + +  +GT  YI
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIP 224
           APEVL +++Y  +  DVWSCGV +Y++L G  PF  Q D    +K    +      +   
Sbjct: 216 APEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK----VEKGKYYFDFN 269

Query: 225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           D+ +IS + + L+  +   + ++R T +E  +  W  K 
Sbjct: 270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  257 bits (659), Expect = 2e-83
 Identities = 73/266 (27%), Positives = 127/266 (47%), Gaps = 9/266 (3%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           + Y++++++GSG FGV      K T  +   K+I   + +D   V  EI    QL HP +
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQI 119
           I   +       + +++E+ +GGELF+RI     + SE E   + +Q   G+ + H   I
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R    G 
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GF 229

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRNLL 237
             D+W+ GV  YV+L G  PF  ++D     +T+  +    +      +  +S + ++ +
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285

Query: 238 SRIFVANPSRRITIKEIKSHPWFLKN 263
             +    P +R+T+ +   HPW   +
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPWLKGD 311

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  255 bits (654), Expect = 3e-83
 Identities = 84/316 (26%), Positives = 149/316 (47%), Gaps = 23/316 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
           MEKY  ++ IG G+FG A L+++        +K I              RE+     ++H
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLISGVSYCH 115
           PNI++++E       L IVM+Y  GG+LF+RI       F ED+   +F Q+   + + H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRR 174
             +I HRD+K +N  L       +++ DFG ++  +      ++ +GTP Y++PE+   +
Sbjct: 143 DRKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDC 233
            Y+ K +D+W+ G  LY +    + FE      + +  + +I++  +  +    H S D 
Sbjct: 201 PYNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFPPVSL--HYSYDL 253

Query: 234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEIT 293
           R+L+S++F  NP  R ++  I    +  K + + L+    A         F L++  +  
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIA-------EEFCLKTFSKFG 306

Query: 294 KIVEEAKVPPPVSRSI 309
                AK P     SI
Sbjct: 307 SQPIPAKRPASGQNSI 322

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  258 bits (662), Expect = 3e-83
 Identities = 87/272 (31%), Positives = 141/272 (51%), Gaps = 18/272 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHKQLRHP 58
           E+Y+L +++G G F V R        +  A   I        +   + RE    + L+HP
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NI+R  + +    H  ++ +   GGELFE I     +SE +A +  QQ++  V +CH M 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 119 ICHRDLKLENTLL----DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVLSR 173
           + HR+LK EN LL     G+    +K+ DFG +       +      GTP Y++PEVL +
Sbjct: 131 VVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQ 231
             Y GK  D+W+CGV LY++LVG  PF D++  + +++    I A  Y    P++  ++ 
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTP 242

Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           + ++L++++   NPS+RIT  E   HPW    
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHR 274

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  253 bits (649), Expect = 7e-83
 Identities = 79/269 (29%), Positives = 128/269 (47%), Gaps = 15/269 (5%)

Query: 2   EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQLRH 57
             Y L  K++G G F V R   +K+T +  A K+++   RG    A +  EI   +  + 
Sbjct: 28  NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87

Query: 58  -PNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQLISGVSYC 114
            P +I   EV    + + +++EYAAGGE+F       A   SE++     +Q++ GV Y 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 115 HSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
           H   I H DLK +N LL    P   +KI DFG S+        +  +GTP Y+APE+L+ 
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQ 231
                   D+W+ G+  Y++L    PF  +++ + +      I  V     +  +  +SQ
Sbjct: 208 DPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVSQ 262

Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              + +  + V NP +R T +   SH W 
Sbjct: 263 LATDFIQSLLVKNPEKRPTAEICLSHSWL 291

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  258 bits (662), Expect = 6e-82
 Identities = 76/266 (28%), Positives = 133/266 (50%), Gaps = 9/266 (3%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           + Y++ +++G+G FGV   +  + T    A K++   H+ D   V +EI     LRHP +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G+ + H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +   G 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GY 335

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRNLL 237
             D+WS GV  Y++L G  PF  + D     +T+  + +  +      +  IS+D ++ +
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDFI 391

Query: 238 SRIFVANPSRRITIKEIKSHPWFLKN 263
            ++ +A+P+ R+TI +   HPW    
Sbjct: 392 RKLLLADPNTRMTIHQALEHPWLTPG 417

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  252 bits (645), Expect = 1e-81
 Identities = 86/286 (30%), Positives = 137/286 (47%), Gaps = 12/286 (4%)

Query: 2   EKYELMK--DIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHP 58
             Y + K   +G G FG         T   +A K I+     D   V  EI    QL H 
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSM 117
           N+I+  +   +   + +VMEY  GGELF+RI +     +E +   F +Q+  G+ + H M
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I H DLK EN L     A ++KI DFG ++      + K   GTP ++APEV+   ++ 
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFV 265

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN 235
               D+WS GV  Y++L G  PF    D     +T++ I+A ++  +  ++  IS++ + 
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWDLEDEEFQDISEEAKE 321

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 281
            +S++ +   S RI+  E   HPW L +       +AQ    R  +
Sbjct: 322 FISKLLIKEKSWRISASEALKHPW-LSDHKLHSRLSAQKKKNRGSD 366

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  251 bits (643), Expect = 1e-81
 Identities = 82/276 (29%), Positives = 133/276 (48%), Gaps = 20/276 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE------RGHKIDANVAREIINHKQL 55
           + YEL + IG G F V R   N+ T +  A+K ++             ++ RE      L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGV 111
           +HP+I+   E   +   L +V E+  G +L   I         +SE  A ++ +Q++  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143

Query: 112 SYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPE 169
            YCH   I HRD+K    LL     +  +K+  FG +             VGTP ++APE
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE 203

Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYV 227
           V+ R  Y GK  DVW CGV L+++L G  PF   ++     +    I+  +YK     + 
Sbjct: 204 VVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWS 257

Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           HIS+  ++L+ R+ + +P+ RIT+ E  +HPW  + 
Sbjct: 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  248 bits (636), Expect = 2e-81
 Identities = 78/280 (27%), Positives = 139/280 (49%), Gaps = 25/280 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
            E YE++  IG+G++G  + +R K+  +++  K ++ G   +A    +  E+   ++L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGV 111
           PNI+R+ + ++  T   L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 112 SYCHSM-----QICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAY 165
             CH        + HRDLK  N  LDG     +K+ DFG ++  +   S  K+ VGTP Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYY 182

Query: 166 IAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIP 224
           ++PE ++R  Y+ K +D+WS G  LY +     PF       + ++   +I   ++ +IP
Sbjct: 183 MSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIP 237

Query: 225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 264
                S +   +++R+       R +++EI  +P  L++ 
Sbjct: 238 Y--RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  249 bits (637), Expect = 4e-81
 Identities = 80/302 (26%), Positives = 126/302 (41%), Gaps = 31/302 (10%)

Query: 2   EKYELMKD-IGSGNFGVARLMRNKNTKELVAMKYIE-RGHKIDANVAREIINHKQLR-HP 58
           + Y+L +D +G G     +   N  T +  A+K IE +   I + V RE+    Q + H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           N++   E         +V E   GG +   I     F+E EA    Q + S + + H+  
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131

Query: 119 ICHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSLLHSRPKSTVGTPAYIAP 168
           I HRDLK EN L +     +P +KICDF            S +      +  G+  Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 169 EVLSRREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI- 223
           EV+     +     K  D+WS GV LY++L G  PF  +              A Q  + 
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250

Query: 224 ------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
                        D+ HIS   ++L+S++ V +  +R++  ++  HPW     P     T
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310

Query: 272 AQ 273
             
Sbjct: 311 PM 312

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  251 bits (643), Expect = 4e-81
 Identities = 89/273 (32%), Positives = 142/273 (52%), Gaps = 16/273 (5%)

Query: 2   EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPN 59
           + Y++  + +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+
Sbjct: 61  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPH 116

Query: 60  IIRFKEV----VLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSY 113
           I+R  +V          L IVME   GGELF RI + G   F+E EA    + +   + Y
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 114 CHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
            HS+ I HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL 
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHIS 230
             +YD K  D+WS GV +Y++L G  PF             +RI   QY    P++  +S
Sbjct: 237 PEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           ++ + L+  +    P++R+TI E  +HPW +++
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  248 bits (635), Expect = 1e-80
 Identities = 82/274 (29%), Positives = 130/274 (47%), Gaps = 19/274 (6%)

Query: 2   EKYELMKD-IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPN 59
           + Y+L K  +G G  G      ++ T +  A+K +    K      +E+  + +    P+
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPH 83

Query: 60  IIRFKEVVLTPTHLA----IVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSY 113
           I+   +V     H      I+ME   GGELF RI   G   F+E EA    + + + + +
Sbjct: 84  IVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQF 143

Query: 114 CHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYIAPEVL 171
            HS  I HRD+K EN L         LK+ DFG++K         ++   TP Y+APEVL
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVL 201

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHI 229
              +YD K  D+WS GV +Y++L G  PF              RI   QY    P++  +
Sbjct: 202 GPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV 260

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           S+D + L+  +   +P+ R+TI +  +HPW  ++
Sbjct: 261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  246 bits (629), Expect = 6e-80
 Identities = 64/283 (22%), Positives = 108/283 (38%), Gaps = 26/283 (9%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA-REIINHKQLRHPNI 60
           + Y  ++ +G G F    L+   +     A+K I    + D   A RE   H+   HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFERI----CNAGRFSEDEARYFFQQLISGVS 112
           +R     L          +++ +   G L+  I          +ED+  +    +  G+ 
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----------VGT 162
             H+    HRDLK  N LL      +  + D G    + +H                  T
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 163 PAYIAPEVLSRREYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ 220
            +Y APE+ S + +    +  DVWS G  LY M+ G  P++      +   +++  +  Q
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQNQ 263

Query: 221 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
             IP     S     LL+ +   +P +R  I  + S    L+ 
Sbjct: 264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  244 bits (626), Expect = 7e-80
 Identities = 62/283 (21%), Positives = 111/283 (39%), Gaps = 34/283 (12%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
              ++ ++ IGSG FG     +++   +   +K ++  ++      RE+    +L H NI
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNI 66

Query: 61  IRFKE----------------VVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARY 102
           + +                         L I ME+   G L + I      +  +  A  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT 162
            F+Q+  GV Y HS ++ +RDLK  N  L  +   ++KI DFG   S     +   + GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGT 184

Query: 163 PAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 222
             Y++PE +S ++Y  +  D+++ G+ L  +L       +        K  + +      
Sbjct: 185 LRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFETS------KFFTDLR--DGI 235

Query: 223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
           I D     +  + LL ++    P  R    EI       K  P
Sbjct: 236 ISD--IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  235 bits (600), Expect = 2e-75
 Identities = 67/292 (22%), Positives = 114/292 (39%), Gaps = 39/292 (13%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLR-HPNI 60
           +  + + +  G F      ++  +    A+K +    +     + +E+   K+L  HPNI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 61  IRF-------KEVVLTPTHLAIVMEYAAGGELFERICNA---GRFSEDEARYFFQQLISG 110
           ++F       KE   T     +++     G+L E +      G  S D     F Q    
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 111 VSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--------- 159
           V + H  +  I HRDLK+EN LL       +K+CDFG + +   +     +         
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 160 ----VGTPAYIAPEV--LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI 213
                 TP Y  PE+  L      G+  D+W+ G  LY++    +PFED           
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AK 258

Query: 214 SRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
            RI+  +Y IP +        +L+  +   NP  R++I E+      +    
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  233 bits (597), Expect = 3e-75
 Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 16/277 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA----NVAREIINHKQLR 56
           +  + + K IG G F              VA+K ++    +DA    +  +EI   KQL 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVS 112
           HPN+I++    +    L IV+E A  G+L   I +  +      E     +F QL S + 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVL 171
           + HS ++ HRD+K  N  +  +    +K+ D G  +  S   +   S VGTP Y++PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHIS 230
               Y+ K +D+WS G  LY M     PF    D  N      +I    Y  +P   H S
Sbjct: 209 HENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQCDYPPLPS-DHYS 264

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
           ++ R L++     +P +R  +  +      +      
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  231 bits (591), Expect = 2e-74
 Identities = 59/265 (22%), Positives = 110/265 (41%), Gaps = 17/265 (6%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQL-R 56
            + ++ +  +G G++G    +R+K    L A+K      RG K  A    E+ +H+++ +
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCH 115
           HP  +R ++       L +  E   G  L +     G    E +   + +  +  +++ H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
           S  + H D+K  N  L   P  R K+ DFG           +   G P Y+APE+L +  
Sbjct: 175 SQGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QGS 231

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           Y    ADV+S G+T+  +          E  +  R+          +      +S + R+
Sbjct: 232 YGTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP-----EFTA--GLSSELRS 283

Query: 236 LLSRIFVANPSRRITIKEIKSHPWF 260
           +L  +   +P  R T + + + P  
Sbjct: 284 VLVMMLEPDPKLRATAEALLALPVL 308

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  227 bits (580), Expect = 8e-73
 Identities = 80/272 (29%), Positives = 125/272 (45%), Gaps = 36/272 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNI 60
           +     + +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P+I
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHI 73

Query: 61  IRFKEV----VLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYC 114
           +R  +V          L IVME   GGELF RI + G   F+E EA    + +   + Y 
Sbjct: 74  VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133

Query: 115 HSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
           HS+ I HRD+K EN L     P   LK+ DFG                     A E    
Sbjct: 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-G 172

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--HISQ 231
            +YD K  D+WS GV +Y++L G  PF             +RI   QY+ P+     +S+
Sbjct: 173 EKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 231

Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
           + + L+  +    P++R+TI E  +HPW +++
Sbjct: 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  223 bits (569), Expect = 3e-71
 Identities = 66/304 (21%), Positives = 116/304 (38%), Gaps = 41/304 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHP 58
           +  +E ++ +G G FGV    +NK      A+K I   ++  A   V RE+    +L HP
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 59  NIIRFKEVVLT------------PTHLAIVMEYAAGGELFERI---CNAGRFSEDEARYF 103
            I+R+    L               +L I M+      L + +   C           + 
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SS 150
           F Q+   V + HS  + HRDLK  N          +K+ DFG                  
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 151 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR 210
             ++R    VGT  Y++PE +    Y  K  D++S G+ L+ +L   YPF  Q +     
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV--- 234

Query: 211 KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK-NLPRELT 269
           +T++ +  +++  P +         ++  +   +P  R     I  +  F   + P +  
Sbjct: 235 RTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293

Query: 270 ETAQ 273
              +
Sbjct: 294 LRQR 297

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  222 bits (568), Expect = 2e-69
 Identities = 66/301 (21%), Positives = 112/301 (37%), Gaps = 46/301 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNI 60
                 K +G G+ G     +       VA+K +            EI    +   HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSED-------EARYFFQQLISGVSY 113
           IR+     T   L I +E      L + + +     E+             +Q+ SGV++
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 114 CHSMQICHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSLLHSRPK 157
            HS++I HRDLK +N L+  S              R+ I DFG  K      S   +   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 158 STVGTPAYIAPEVLSRREYD------GKLADVWSCGVTLYVMLVGAY-PFEDQEDPKNFR 210
           +  GT  + APE+L             +  D++S G   Y +L     PF D+       
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245

Query: 211 KTISRIMAVQYKIPDYV-----HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
              S I+   + + +        +  +  +L+S++   +P +R T  ++  HP F     
Sbjct: 246 -RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304

Query: 266 R 266
           +
Sbjct: 305 K 305

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  216 bits (553), Expect = 1e-68
 Identities = 75/273 (27%), Positives = 129/273 (47%), Gaps = 22/273 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLR 56
            E ++  K +G G+F    L R   T    A+K +E+ H I  N    +   +    +L 
Sbjct: 29  PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HP  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLSR 173
             I HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L+ 
Sbjct: 149 KGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           +    K +D+W+ G  +Y ++ G  PF    +   F+K    I+ ++Y  P+        
Sbjct: 207 KSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLEYDFPE--KFFPKA 259

Query: 234 RNLLSRIFVANPSRRITIK------EIKSHPWF 260
           R+L+ ++ V + ++R+  +       +K+HP+F
Sbjct: 260 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  215 bits (550), Expect = 1e-66
 Identities = 66/271 (24%), Positives = 102/271 (37%), Gaps = 21/271 (7%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNII 61
            +     +G G  G     R       VA+K I    +  +   RE+   ++   HPN+I
Sbjct: 25  SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQIC 120
           R+           I +E      L E +          E     QQ  SG+++ HS+ I 
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 121 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVLSR 173
           HRDLK  N L+   +     +  I DFG  K         SR     GT  +IAPE+LS 
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 174 REYD--GKLADVWSCGVTLYVMLVGAY-PFEDQEDPKNFRKTISRIMAVQYKIPDY-VHI 229
              +      D++S G   Y ++     PF         R+    + A          H 
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLHPEKHE 256

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
               R L+ ++   +P +R + K +  HP+F
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  213 bits (543), Expect = 2e-66
 Identities = 40/313 (12%), Positives = 78/313 (24%), Gaps = 63/313 (20%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR-- 56
                  +G  +        ++ T E   +       +  +N    +  E++  + LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 57  -----------------------HPNIIRFKEVVLTPTHLAIVMEYAA--------GGEL 85
                                     +IR +        L+    Y          G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 86  FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG 145
                               Q+I  ++  H   + H  L+  + +LD      + +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251

Query: 146 YSKSSLLHSRPKSTVGTPAYIAPEVLSRRE----------YDGKLADVWSCGVTLYVMLV 195
           +            +  +  +  PE+ +RR                 D W+ G+ +Y +  
Sbjct: 252 HLVR---DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 196 GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 255
              P                            +I Q  R LL          R+   +  
Sbjct: 309 ADLPITKDAALGGSEWIFRSCK----------NIPQPVRALLEGFLRYPKEDRLLPLQAM 358

Query: 256 SHPWFLKNLPREL 268
             P + + L  EL
Sbjct: 359 ETPEY-EQLRTEL 370

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  212 bits (541), Expect = 5e-66
 Identities = 68/269 (25%), Positives = 128/269 (47%), Gaps = 16/269 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LR 56
            + +E+++ IG G+FG   +++  +TK++ AMKY+ +   ++ N  R +    Q    L 
Sbjct: 14  FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HP ++           + +V++   GG+L   +     F E+  + F  +L+  + Y  +
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133

Query: 117 MQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
            +I HRD+K +N LLD  G     + I DF  +      ++  +  GT  Y+APE+ S R
Sbjct: 134 QRIIHRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR 189

Query: 175 EYDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
           +  G     D WS GVT Y +L G  P+  +    + ++ +          P     SQ+
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQE 246

Query: 233 CRNLLSRIFVANPSRRI-TIKEIKSHPWF 260
             +LL ++   NP +R   + ++++ P+ 
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  205 bits (524), Expect = 4e-64
 Identities = 86/275 (31%), Positives = 144/275 (52%), Gaps = 32/275 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           ++ +++++ +G+G+FG   L+R+++     AMK +    K +  V  + + H        
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLML 60

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
             + HP IIR          + ++M+Y  GGELF  +  + RF    A+++  ++   + 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALE 120

Query: 113 YCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           Y HS  I +RDLK EN LLD  G     +KI DFG++K   +     +  GTP YIAPEV
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEV 174

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           +S + Y  K  D WS G+ +Y ML G  PF D  +     KT  +I+  + + P     +
Sbjct: 175 VSTKPY-NKSIDWWSFGILIYEMLAGYTPFYD-SNTM---KTYEKILNAELRFPP--FFN 227

Query: 231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           +D ++LLSR+   + S+R+       +++K+HPWF
Sbjct: 228 EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  205 bits (524), Expect = 8e-64
 Identities = 79/271 (29%), Positives = 144/271 (53%), Gaps = 24/271 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK----QLR 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +        +N K     + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 117 MQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           + + +RDLK EN L+D  G     +++ DFG++K   +  R  +  GTP  +APE++  +
Sbjct: 160 LDLIYRDLKPENLLIDQQG----YIQVTDFGFAKR--VKGRTWTLCGTPEALAPEIILSK 213

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            Y  K  D W+ GV +Y M  G  PF   + P    +   +I++ + + P   H S D +
Sbjct: 214 GY-NKAVDWWALGVLIYEMAAGYPPFFA-DQPI---QIYEKIVSGKVRFPS--HFSSDLK 266

Query: 235 NLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           +LL  +   + ++R       + +IK+H WF
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  203 bits (518), Expect = 3e-63
 Identities = 83/276 (30%), Positives = 154/276 (55%), Gaps = 29/276 (10%)

Query: 1   MEKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGHKIDANVA-----REIINH 52
             ++EL+K +G G+FG   + + +   + ++L AMK +++      +       R+I+  
Sbjct: 23  PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL-- 80

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
            ++ HP I++      T   L +++++  GG+LF R+     F+E++ +++  +L   + 
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140

Query: 113 YCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPE 169
           + HS+ I +RDLK EN LLD  G     +K+ DFG SK S+ H +   +  GT  Y+APE
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196

Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 229
           V++RR +  + AD WS GV ++ ML G  PF+     K+ ++T++ I+  +  +P +  +
Sbjct: 197 VVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--L 249

Query: 230 SQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           S + ++LL  +F  NP+ R+      ++EIK H +F
Sbjct: 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  202 bits (515), Expect = 1e-62
 Identities = 88/276 (31%), Positives = 139/276 (50%), Gaps = 31/276 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M  ++ +K +G G FG   L+R K T    AMK +    + +  +A++ + H        
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL----RKEVIIAKDEVAHTVTESRVL 59

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + 
Sbjct: 60  QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119

Query: 113 YCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPE 169
           Y HS  + +RD+KLEN +LD  G     +KI DFG  K  +       T  GTP Y+APE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 229
           VL   +Y G+  D W  GV +Y M+ G  PF +Q+  + F      I+  + + P    +
Sbjct: 176 VLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRT--L 228

Query: 230 SQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           S + ++LL+ +   +P +R+       KE+  H +F
Sbjct: 229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  203 bits (517), Expect = 1e-62
 Identities = 43/306 (14%), Positives = 84/306 (27%), Gaps = 45/306 (14%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHP 58
           K +L++ +  G+  V  L+R+    E  A+K    G +   +             +L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 59  NIIRFKEV--------------------------VLTPTHLAIVMEYAAG------GELF 86
           +    ++                                +  ++M  A+         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 87  ERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY 146
                 G            QLI   +   S  + H     +N  +      RL + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVSA 240

Query: 147 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYD-GKLADVWSCGVTLYVMLVGAYPFEDQED 205
                + +R  ++     Y   E L+          + W  G+++Y +     PF     
Sbjct: 241 LWK--VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298

Query: 206 PKNF---RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
                  R ++               +    + L+ R    +  RR+   E    P F  
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF-L 357

Query: 263 NLPREL 268
            L  E+
Sbjct: 358 QLQNEI 363

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  200 bits (512), Expect = 3e-62
 Identities = 85/278 (30%), Positives = 144/278 (51%), Gaps = 31/278 (11%)

Query: 1   MEKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGHKIDAN--VA-----REII 50
            E +EL++ +G G +G     R +   NT ++ AMK +++   +      A     R I+
Sbjct: 16  PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 51  NHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
             ++++HP I+       T   L +++EY +GGELF ++   G F ED A ++  ++   
Sbjct: 76  --EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133

Query: 111 VSYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIA 167
           + + H   I +RDLK EN +L+  G     +K+ DFG  K S+       T  GT  Y+A
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189

Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
           PE+L R  +  +  D WS G  +Y ML GA PF  +    N +KTI +I+  +  +P Y 
Sbjct: 190 PEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGE----NRKKTIDKILKCKLNLPPY- 243

Query: 228 HISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
            ++Q+ R+LL ++   N + R+        E+++HP+F
Sbjct: 244 -LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  198 bits (506), Expect = 6e-62
 Identities = 66/287 (22%), Positives = 109/287 (37%), Gaps = 38/287 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIE---RGHKIDANVAREIINHKQL-RH 57
            ++  ++ IGSG FG       +    + A+K  +    G   + N  RE+  H  L +H
Sbjct: 11  TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVSY 113
            +++R+        H+ I  EY  GG L + I    R    F E E +    Q+  G+ Y
Sbjct: 71  SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 114 CHSMQICHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSLLHSRP 156
            HSM + H D+K  N  +                   S     KI D G+       S P
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISSP 187

Query: 157 KSTVGTPAYIAPEVLS-RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR 215
           +   G   ++A EVL     +  K AD+++  +T+           + +     R+    
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP 246

Query: 216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
                 +IP    +SQ+   LL  +   +P RR +   +  H   L 
Sbjct: 247 ------RIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  198 bits (507), Expect = 3e-61
 Identities = 87/273 (31%), Positives = 135/273 (49%), Gaps = 28/273 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           +E + L K +G G+FG   L   K T +  A+K +    K D  +  + +          
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVL 71

Query: 53  -KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
                HP +        T  +L  VMEY  GG+L   I +  +F    A ++  ++I G+
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131

Query: 112 SYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAP 168
            + HS  I +RDLKL+N LLD  G     +KI DFG  K ++L     +T  GTP YIAP
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 187

Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
           E+L  ++Y     D WS GV LY ML+G  PF  Q++ + F      I       P +  
Sbjct: 188 EILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRW-- 240

Query: 229 ISQDCRNLLSRIFVANPSRRITIK-EIKSHPWF 260
           + ++ ++LL ++FV  P +R+ ++ +I+ HP F
Sbjct: 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  199 bits (507), Expect = 3e-61
 Identities = 48/298 (16%), Positives = 99/298 (33%), Gaps = 39/298 (13%)

Query: 2   EKYELMKDIGSGNFGVARL-----MRNKNTKELVAMKYIERGHKIDANVAREIIN-HKQL 55
           +   +   +G G F          + +   K+   +K  +  +  +  +  +++   K  
Sbjct: 65  KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-----NAGRFSEDEARYFFQQLISG 110
                ++F    L      +V E  + G L   I            +     F  +++  
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSLLHSRP---KS 158
           +   H  +I H D+K +N +L      +         L + D G S    L  +     +
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI----- 213
              T  +   E+LS + ++ +  D +    T+Y ML G Y     E  +   + +     
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLP 303

Query: 214 -----SRIMAVQYKIPDYVHIS--QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 264
                +    V   IPD  H+      R  L ++F  + + +I       +   +  L
Sbjct: 304 HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI---RALRNRLIVLLL 358

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  199 bits (508), Expect = 4e-61
 Identities = 83/276 (30%), Positives = 132/276 (47%), Gaps = 31/276 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
              +  +K IG G+FG   L R+K  +   A+K +    +  A + ++   H        
Sbjct: 37  PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL----QKKAILKKKEEKHIMSERNVL 92

Query: 53  -KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
            K ++HP ++       T   L  V++Y  GGELF  +     F E  AR++  ++ S +
Sbjct: 93  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 152

Query: 112 SYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAP 168
            Y HS+ I +RDLK EN LLD  G     + + DFG  K ++ H+   ST  GTP Y+AP
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208

Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
           EVL ++ Y  +  D W  G  LY ML G  PF  +   + +      I+    ++    +
Sbjct: 209 EVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQLKP--N 261

Query: 229 ISQDCRNLLSRIFVANPSRRI----TIKEIKSHPWF 260
           I+   R+LL  +   + ++R+       EIKSH +F
Sbjct: 262 ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  198 bits (506), Expect = 5e-61
 Identities = 85/276 (30%), Positives = 127/276 (46%), Gaps = 29/276 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           ++ +E ++ +G G+FG   L R K T +L A+K +    K D  +  + +          
Sbjct: 22  IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL----KKDVILQDDDVECTMTEKRIL 77

Query: 53  -KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
                HP + +      TP  L  VME+  GG+L   I  + RF E  AR++  ++IS +
Sbjct: 78  SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISAL 137

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV 170
            + H   I +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           L    Y G   D W+ GV LY ML G  PFE + +   F      I+  +   P    + 
Sbjct: 196 LQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPT--WLH 248

Query: 231 QDCRNLLSRIFVANPSRRI------TIKEIKSHPWF 260
           +D   +L      NP+ R+          I  HP+F
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  197 bits (502), Expect = 1e-60
 Identities = 82/273 (30%), Positives = 131/273 (47%), Gaps = 24/273 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-----L 55
           +  +  +  +G G+FG   L   K T EL A+K +++   I  +     +  K+      
Sbjct: 19  LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           + P + +      T   L  VMEY  GG+L   I   GRF E  A ++  ++  G+ +  
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138

Query: 116 SMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 172
           S  I +RDLKL+N +LD  G     +KI DFG  K ++       T  GTP YIAPE+++
Sbjct: 139 SKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIA 194

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
            + Y GK  D W+ GV LY ML G  PFE +++ + F+     IM      P    +S++
Sbjct: 195 YQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKE 247

Query: 233 CRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
              +   +   +P +R+       ++IK H +F
Sbjct: 248 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  198 bits (506), Expect = 2e-60
 Identities = 89/278 (32%), Positives = 133/278 (47%), Gaps = 30/278 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
            E YE++K IG G FG  +L+R+K+T+++ AMK +         + R             
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIM 123

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
                P +++         +L +VMEY  GG+L   + +     E  AR++  +++  + 
Sbjct: 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALD 182

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--HSRPKSTVGTPAYIAPEV 170
             HSM   HRD+K +N LLD S    LK+ DFG           R  + VGTP YI+PEV
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

Query: 171 LSRREYD---GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPD 225
           L  +  D   G+  D WS GV LY MLVG  PF       +   T S+IM        PD
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD----SLVGTYSKIMNHKNSLTFPD 296

Query: 226 YVHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWF 260
              IS++ +NL+   F+ +   R+    ++EIK H +F
Sbjct: 297 DNDISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  196 bits (500), Expect = 2e-60
 Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 26/279 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-----L 55
           ++ ++L++ IG G++    L+R K T  + AMK +++    D      +   K       
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++  ++   ++Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127

Query: 116 SMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 172
              I +RDLKL+N LLD  G     +K+ D+G  K  L      ST  GTP YIAPE+L 
Sbjct: 128 ERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 183

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIMAVQYKIPDYV 227
             +Y G   D W+ GV ++ M+ G  PF      D  D          I+  Q +IP   
Sbjct: 184 GEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS- 241

Query: 228 HISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWF 260
            +S    ++L      +P  R+         +I+ HP+F
Sbjct: 242 -LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  196 bits (501), Expect = 2e-60
 Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 33/283 (11%)

Query: 1   MEKYELMKDIGSGNFG---VARLMRNKNTKELVAMKYIERGHKI--DANVAR-------- 47
           +E +EL+K +G+G +G   + R +   +T +L AMK +++   +                
Sbjct: 53  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112

Query: 48  EIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQL 107
           E I       P ++       T T L ++++Y  GGELF  +    RF+E E + +  ++
Sbjct: 113 EHIRQ----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168

Query: 108 ISGVSYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLH--SRPKSTVGTP 163
           +  + + H + I +RD+KLEN LLD  G     + + DFG SK  +     R     GT 
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 164 AYIAPEVLSRREY-DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK 222
            Y+AP+++   +    K  D WS GV +Y +L GA PF    +  +  +   RI+  +  
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284

Query: 223 IPDYVHISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
            P    +S   ++L+ R+ + +P +R+        EIK H +F
Sbjct: 285 YPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  198 bits (504), Expect = 8e-60
 Identities = 94/275 (34%), Positives = 139/275 (50%), Gaps = 28/275 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------- 52
           M ++E +K +G G FG   L++ K T    AMK +    K +  VA++ + H        
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL----KKEVIVAKDEVAHTLTENRVL 202

Query: 53  KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           +  RHP +   K    T   L  VMEYA GGELF  +     FSED AR++  +++S + 
Sbjct: 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALD 262

Query: 113 YCHSMQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEV 170
           Y HS + + +RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEV
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           L   +Y G+  D W  GV +Y M+ G  PF +Q+  K F      I+  + + P    + 
Sbjct: 321 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LG 373

Query: 231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
            + ++LLS +   +P +R+       KEI  H +F
Sbjct: 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  195 bits (498), Expect = 2e-59
 Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 26/279 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-----L 55
           ++ ++L++ IG G++    L+R K T  + AM+ +++    D      +   K       
Sbjct: 51  LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS 110

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP ++       T + L  V+EY  GG+L   +    +  E+ AR++  ++   ++Y H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170

Query: 116 SMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLS 172
              I +RDLKL+N LLD  G     +K+ D+G  K  L      ST  GTP YIAPE+L 
Sbjct: 171 ERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIMAVQYKIPDYV 227
             +Y G   D W+ GV ++ M+ G  PF      D  D          I+  Q +IP   
Sbjct: 227 GEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR-- 283

Query: 228 HISQDCRNLLSRIFVANPSRRI------TIKEIKSHPWF 260
            +S    ++L      +P  R+         +I+ HP+F
Sbjct: 284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  193 bits (491), Expect = 3e-59
 Identities = 63/282 (22%), Positives = 101/282 (35%), Gaps = 31/282 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           +        +G G+FG    M++K T    A+K +     ++     E++    L  P I
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRI 112

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +     V     + I ME   GG L + I   G   ED A Y+  Q + G+ Y H+ +I 
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRIL 172

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPEVLSRR 174
           H D+K +N LL      R  +CDFG++                   GT  ++APEV+  +
Sbjct: 173 HGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV------- 227
             D K  D+WS    +  ML G +P+                  +  KI           
Sbjct: 232 PCDAK-VDIWSSCCMMLHMLNGCHPWTQYFR-----------GPLCLKIASEPPPIREIP 279

Query: 228 -HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
              +      +       P  R +  E++            L
Sbjct: 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  195 bits (498), Expect = 4e-59
 Identities = 76/278 (27%), Positives = 135/278 (48%), Gaps = 26/278 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVA-----REIINHKQ 54
            E +E++K IG G FG   +++ KN  ++ AMK + +   +  A  A     R+++    
Sbjct: 73  REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VN 130

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSY 113
                I           +L +VM+Y  GG+L   +     R  E+ AR++  +++  +  
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL 171
            H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE+L
Sbjct: 191 VHQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 172 SRREYD----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKIPD 225
              E      G   D WS GV +Y ML G  PF  +    +  +T  +IM    +++ P 
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKERFQFPT 304

Query: 226 YV-HISQDCRNLLSRIFVANPSR--RITIKEIKSHPWF 260
            V  +S++ ++L+ R+  +   R  +  I++ K HP+F
Sbjct: 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  194 bits (495), Expect = 7e-59
 Identities = 67/281 (23%), Positives = 121/281 (43%), Gaps = 30/281 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVA-----REIINHKQ 54
            + +E++K IG G F    +++ K T ++ AMK + +   +    V+     R+++    
Sbjct: 60  RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL--VN 117

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSY 113
                I +         +L +VMEY  GG+L   +   G R   + AR++  +++  +  
Sbjct: 118 GDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--HSRPKSTVGTPAYIAPEVL 171
            H +   HRD+K +N LLD      +++ DFG           R    VGTP Y++PE+L
Sbjct: 178 VHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235

Query: 172 SRREYD------GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--VQYKI 223
                       G   D W+ GV  Y M  G  PF       +  +T  +I+       +
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD----STAETYGKIVHYKEHLSL 291

Query: 224 PDY-VHISQDCRNLLSRIFVANPSRRIT---IKEIKSHPWF 260
           P     + ++ R+ + R  +  P  R+      + ++HP+F
Sbjct: 292 PLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  198 bits (504), Expect = 5e-58
 Identities = 81/271 (29%), Positives = 130/271 (47%), Gaps = 20/271 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ-----L 55
           +  +  +  +G G+FG   L   K T EL A+K +++   I  +     +  K+      
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           + P + +      T   L  VMEY  GG+L   I   GRF E  A ++  ++  G+ +  
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-GTPAYIAPEVLSRR 174
           S  I +RDLKL+N +LD      +KI DFG  K ++       T  GTP YIAPE+++ +
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            Y GK  D W+ GV LY ML G  PFE +++ + F+     IM      P    +S++  
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSKEAV 570

Query: 235 NLLSRIFVANPSRRI-----TIKEIKSHPWF 260
            +   +   +P +R+       ++IK H +F
Sbjct: 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  197 bits (502), Expect = 1e-57
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 18/272 (6%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL----- 55
           M  + + + IG G FG     R  +T ++ AMK +++            +N + +     
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 56  --RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
               P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+ +
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +
Sbjct: 308 MHNRFVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQK 364

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
                  AD +S G  L+ +L G  PF      K+  +     + +  ++PD    S + 
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPEL 421

Query: 234 RNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           R+LL  +   + +RR+       +E+K  P+F
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  192 bits (490), Expect = 1e-56
 Identities = 68/271 (25%), Positives = 116/271 (42%), Gaps = 16/271 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LR 56
              +   + +G G FG     + + T ++ A K +E+            +N KQ    + 
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYC 114
              ++       T   L +V+    GG+L   I + G+  F E  A ++  ++  G+   
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           H  +I +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+   
Sbjct: 303 HRERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE 360

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            Y     D W+ G  LY M+ G  PF+ ++      +    +  V  +  +    S   R
Sbjct: 361 RY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQAR 417

Query: 235 NLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           +L S++   +P+ R+     + +E+K HP F
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  190 bits (484), Expect = 4e-56
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 23/276 (8%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ----LR 56
            + +   + +G G FG     + K T +L A K + +         +  +  K+    + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVS 112
              I+       T T L +VM    GG++   I N       F E  A ++  Q++SG+ 
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 113 YCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPE 169
           + H   I +RDLK EN LLD  G     ++I D G +       ++ K   GTP ++APE
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPE 359

Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI 229
           +L   EY     D ++ GVTLY M+    PF  + +    ++   R++      PD    
Sbjct: 360 LLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--F 416

Query: 230 SQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
           S   ++    +   +P +R+     +   +++HP F
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  181 bits (461), Expect = 5e-55
 Identities = 68/267 (25%), Positives = 121/267 (45%), Gaps = 32/267 (11%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIE--RGHKIDANVAREIINHKQLRHPNIIRFKEVV 67
           +G G +G+    R+ + +  +A+K I           +  EI  HK L+H NI+++    
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP-LHEEIALHKHLKHKNIVQYLGSF 88

Query: 68  LTPTHLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
                + I ME   GG    L        + +E    ++ +Q++ G+ Y H  QI HRD+
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148

Query: 125 KLENTLLDGSPAPRLKICDFGYSK-SSLLHSRPKSTVGTPAYIAPEVL--SRREYDGKLA 181
           K +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++    R Y    A
Sbjct: 149 KGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-A 206

Query: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI---------PDYVHISQD 232
           D+WS G T+  M  G  PF +  +P           A  +K+         P+   +S +
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEP----------QAAMFKVGMFKVHPEIPE--SMSAE 254

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPW 259
            +  + + F  +P +R    ++    +
Sbjct: 255 AKAFILKCFEPDPDKRACANDLLVDEF 281

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  181 bits (459), Expect = 1e-53
 Identities = 40/308 (12%), Positives = 78/308 (25%), Gaps = 56/308 (18%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------------------------- 44
           +G  +        ++ T E   +       +  +N                         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 45  -VAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA-----------GGELFERICNA 92
              R I     ++ P   +   V L    + ++  +             G  L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 93  GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS--S 150
                        Q+I  ++  H   + H  L+  + +LD      + +  F +     +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRDGA 263

Query: 151 LLHSRPKSTVGTPAYIAPEVLSRREYDGKL----ADVWSCGVTLYVMLVGAYPFEDQEDP 206
              S        P   A  +L   ++   L     D W+ G+ +Y +     P  D    
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323

Query: 207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
                                +I Q  R LL          R+   +    P + + L  
Sbjct: 324 GGSEWIFRSC----------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRT 372

Query: 267 ELTETAQA 274
           EL+     
Sbjct: 373 ELSAALPL 380

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  164 bits (416), Expect = 4e-48
 Identities = 62/280 (22%), Positives = 121/280 (43%), Gaps = 22/280 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREI-INHKQLRH 57
           +   E + ++GSG  G    MR + T  ++A+K +      + +  +  ++ +  K    
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS- 116
           P I++     +T T + I ME         +    G   E         ++  + Y    
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRRE 175
             + HRD+K  N LLD     ++K+CDFG S   L+  + K    G  AY+APE +   +
Sbjct: 144 HGVIHRDVKPSNILLDER--GQIKLCDFGISG-RLVDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 176 -----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYV 227
                YD + ADVWS G++L  +  G +P+   ++ K   + ++++  +Q + P    ++
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPY---KNCKTDFEVLTKV--LQEEPPLLPGHM 254

Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
             S D ++ +      +  +R    ++  H +  +    E
Sbjct: 255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  162 bits (412), Expect = 9e-48
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 24/271 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           E +  ++ IG G+FG      +  T+++VA+K I  E       ++ +EI    Q   P 
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y HS + 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRD+K  N LL       +K+ DFG +   +    +  + VGTP ++APEV+ +  YD 
Sbjct: 141 IHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV------HISQD 232
           K AD+WS G+T   +  G  P  +   P          M V + IP         + S+ 
Sbjct: 199 K-ADIWSLGITAIELARGEPPHSE-LHP----------MKVLFLIPKNNPPTLEGNYSKP 246

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
            +  +       PS R T KE+  H + L+N
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFILRN 277

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  160 bits (408), Expect = 3e-47
 Identities = 77/283 (27%), Positives = 133/283 (46%), Gaps = 32/283 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K +N LL  DG     +K+ DFG+  + +   S+  + VGTP ++APEV++R+ Y 
Sbjct: 139 HRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--------DYVHI 229
            K  D+WS G+    M+ G  P+ + E+P          +   Y I         +   +
Sbjct: 195 PK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALYLIATNGTPELQNPEKL 242

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN--LPRELTE 270
           S   R+ L+R    +  +R + KE+  H  FLK       LT 
Sbjct: 243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQ-FLKIAKPLSSLTP 284

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  161 bits (409), Expect = 3e-47
 Identities = 76/283 (26%), Positives = 136/283 (48%), Gaps = 32/283 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
              +    IG G+ G+  L R K++   VA+K ++   +     +  E++  +  +H N+
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +   +  L    L ++ME+  GG L + I +  R +E++     + ++  ++Y H+  + 
Sbjct: 105 VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVI 163

Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           HRD+K ++ LL  DG    R+K+ DFG+  + S    + KS VGTP ++APEV+SR  Y 
Sbjct: 164 HRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--------DYVHI 229
            +  D+WS G+ +  M+ G  P+   + P          +    ++         +   +
Sbjct: 220 TE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHKV 267

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN--LPRELTE 270
           S   R+ L R+ V +P  R T +E+  HP FL    LP  L  
Sbjct: 268 SPVLRDFLERMLVRDPQERATAQELLDHP-FLLQTGLPECLVP 309

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  160 bits (407), Expect = 6e-47
 Identities = 77/298 (25%), Positives = 136/298 (45%), Gaps = 37/298 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E +++++ +G G++G      +K T ++VA+K +     +   + +EI   +Q   P+++
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVV 87

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           ++       T L IVMEY   G + + I       +EDE     Q  + G+ Y H M+  
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI 147

Query: 121 HRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPK--STVGTPAYIAPEVLSRREY 176
           HRD+K  N LL  +G      K+ DFG +   L  +  K  + +GTP ++APEV+    Y
Sbjct: 148 HRDIKAGNILLNTEG----HAKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--------DYVH 228
           +   AD+WS G+T   M  G  P+ D   P          M   + IP            
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD-IHP----------MRAIFMIPTNPPPTFRKPEL 250

Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP-----RELTETAQAIYYRKEN 281
            S +  + + +  V +P +R T  ++  HP F+++       R+L   A  +  +++ 
Sbjct: 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHP-FVRSAKGVSILRDLINEAMDVKLKRQE 307

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  159 bits (405), Expect = 7e-47
 Identities = 58/281 (20%), Positives = 118/281 (41%), Gaps = 33/281 (11%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--VAREI-INHKQLRH 57
            +  E + ++G G +GV   MR+  + +++A+K I           +  ++ I+ + +  
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICN-AGRFSEDEARYFFQQLISGVSYC 114
           P  + F   +     + I ME       + ++++ +      ED        ++  + + 
Sbjct: 66  PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 115 HS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEV-- 170
           HS + + HRD+K  N L++     ++K+CDFG S   L+    K    G   Y+APE   
Sbjct: 126 HSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISG-YLVDDVAKDIDAGCKPYMAPERIN 182

Query: 171 --LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-- 226
             L+++ Y  K +D+WS G+T+  + +  +P++    P               ++ +   
Sbjct: 183 PELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP----------FQQLKQVVEEPS 231

Query: 227 -----VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
                   S +  +  S+    N   R T  E+  HP+F  
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  159 bits (405), Expect = 8e-47
 Identities = 63/261 (24%), Positives = 111/261 (42%), Gaps = 18/261 (6%)

Query: 10  IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHPNIIRF--- 63
           IG G+F       +  T   VA   ++      +   R   E    K L+HPNI+RF   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 64  -KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ--IC 120
            +  V     + +V E    G L   +           R + +Q++ G+ + H+    I 
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++APE+    +YD   
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMY-EEKYDES- 209

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
            DV++ G+ +  M    YP+ + ++    +R+  S +               + + ++  
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDK--VAIPEVKEIIEG 265

Query: 240 IFVANPSRRITIKEIKSHPWF 260
               N   R +IK++ +H +F
Sbjct: 266 CIRQNKDERYSIKDLLNHAFF 286

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  161 bits (408), Expect = 1e-46
 Identities = 75/304 (24%), Positives = 126/304 (41%), Gaps = 47/304 (15%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN--VAREI-INHKQLRH 57
            + +E + ++G+GN GV   + +K +  ++A K I    K      + RE+ + H +   
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH-ECNS 90

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS- 116
           P I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            +I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y
Sbjct: 151 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY---------- 226
             + +D+WS G++L  M VG YP    +  +       ++     + P            
Sbjct: 208 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 227 ----VHISQDCRNLLSRI-------------------FVA-----NPSRRITIKEIKSHP 258
                        LL  I                   FV      NP+ R  +K++  H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326

Query: 259 WFLK 262
           +  +
Sbjct: 327 FIKR 330

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  159 bits (404), Expect = 2e-46
 Identities = 43/238 (18%), Positives = 83/238 (34%), Gaps = 26/238 (10%)

Query: 39  HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI---CNAGRF 95
                  + +I         N +   +      +L I M+      L + +   C+    
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 96  SEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 155
                 + F Q+   V + HS  + HRDLK  N          +K+ DFG   +      
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219

Query: 156 PKST-------------VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFED 202
            ++              VGT  Y++PE +    Y  K  D++S G+ L+ +L   Y F  
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275

Query: 203 QEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           Q       + I+ +  +++    +         ++  +   +P+ R    +I  +  F
Sbjct: 276 QM---ERVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  158 bits (401), Expect = 4e-46
 Identities = 80/292 (27%), Positives = 135/292 (46%), Gaps = 31/292 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
            ++ E+ + +G G FGV  + + K   + VA+K IE           E+    ++ HPNI
Sbjct: 7   YKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNI 63

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI---SGVSYCHSM 117
           ++     L P  + +VMEYA GG L+  +  A       A +     +    GV+Y HSM
Sbjct: 64  VKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 118 Q---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           Q   + HRDLK  N LL       LKICDFG +    + +   +  G+ A++APEV    
Sbjct: 122 QPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEGS 178

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDYVHI 229
            Y  K  DV+S G+ L+ ++    PF++   P        RIM   +      +   +  
Sbjct: 179 NYSEK-CDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHNGTRPPLIKNLP- 230

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKEN 281
            +   +L++R +  +PS+R +++EI      + +L R      + + Y  ++
Sbjct: 231 -KPIESLMTRCWSKDPSQRPSMEEIVKI---MTHLMRYFPGADEPLQYPCQH 278

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  155 bits (394), Expect = 8e-45
 Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 49/304 (16%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           +++Y  +  +G G +G      +  T E VA+K I   H+   +     RE+   K+L+H
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH 92

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
            NII  K V+     L ++ EYA   +L + +      S    + F  QLI+GV++CHS 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151

Query: 118 QICHRDLKLENTLLDGSPAPR---LKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-S 172
           +  HRDLK +N LL  S A     LKI DFG +++  +  R  +  + T  Y  PE+L  
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------A 218
            R Y   + D+WS       ML+    F      DQ         I  ++          
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLF------KIFEVLGLPDDTTWPG 264

Query: 219 VQYKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
           V   +PD+                   +  +  +LL+ +   +P +RI+ K    HP+F 
Sbjct: 265 VT-ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF- 322

Query: 262 KNLP 265
            +  
Sbjct: 323 SHND 326

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  155 bits (393), Expect = 8e-45
 Identities = 86/320 (26%), Positives = 134/320 (41%), Gaps = 54/320 (16%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           MEKYE +  IG G++GV    RN++T ++VA+K          I     REI   KQL+H
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PN++   EV      L +V EY         +R        E   +    Q +  V++CH
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 173
                HRD+K EN L+       +K+CDFG+++     S      V T  Y +PE+L   
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM----------- 217
            +Y G   DVW+ G     +L G   +      DQ         I + +           
Sbjct: 178 TQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ------LYLIRKTLGDLIPRHQQVF 230

Query: 218 -----AVQYKIPDYV----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF-- 260
                    KIPD            +IS     LL      +P+ R+T +++  HP+F  
Sbjct: 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290

Query: 261 ---LKNLPRELTETAQAIYY 277
              +++L +E  + A+ +Y+
Sbjct: 291 IREIEDLAKEHDKPAENLYF 310

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  154 bits (392), Expect = 8e-45
 Identities = 80/306 (26%), Positives = 136/306 (44%), Gaps = 55/306 (17%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           M+KYE ++ IG G +G     +N+ T E+VA+K +        + ++  REI   K+L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            NI+R  +V+ +   L +V E+      + F+     G    +  + F  QL+ G+ +CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 173
           S  + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV-------- 219
           + Y   + D+WS G     +     P       +DQ         + RI  +        
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQ---------LKRIFRLLGTPTEEQ 226

Query: 220 ---QYKIPDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                K+PDY                  ++   R+LL  +   NP +RI+ +E   HP+F
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

Query: 261 LKNLPR 266
             +   
Sbjct: 287 -SDFCP 291

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  155 bits (394), Expect = 9e-45
 Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 17/275 (6%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREI-INHKQLRH 57
            E  + + +IG G +G    M +K + +++A+K I      K    +  ++ +  +    
Sbjct: 21  AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGG--ELFERICNA--GRFSEDEARYFFQQLISGVSY 113
           P I++F   +       I ME  +    + ++ + +       E+         +  +++
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 114 CHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVL 171
               ++I HRD+K  N LLD S    +K+CDFG S   L+ S  K+   G   Y+APE +
Sbjct: 141 LKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISG-QLVDSIAKTRDAGCRPYMAPERI 197

Query: 172 ----SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
               SR+ YD + +DVWS G+TLY +  G +P+       +    + +    Q    +  
Sbjct: 198 DPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEER 256

Query: 228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
             S    N ++     + S+R   KE+  HP+ L 
Sbjct: 257 EFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  153 bits (388), Expect = 6e-44
 Identities = 81/315 (25%), Positives = 129/315 (40%), Gaps = 54/315 (17%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI-----ERGHKIDANVAREIINHKQL 55
           MEKYE +  +G G++G+    RNK+T  +VA+K       ++  K  A   REI   KQL
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MREIKLLKQL 81

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSY 113
           RH N++   EV        +V E+      +  E   N         + +  Q+I+G+ +
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYLFQIINGIGF 139

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLS 172
           CHS  I HRD+K EN L+  S    +K+CDFG++++           V T  Y APE+L 
Sbjct: 140 CHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV 197

Query: 173 R-REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM--------- 217
              +Y GK  DVW+ G  +  M +G   F      DQ         I   +         
Sbjct: 198 GDVKY-GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ------LYHIMMCLGNLIPRHQE 250

Query: 218 -------AVQYKIPDYVH----------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                      ++P+             +S+   +L  +    +P +R    E+  H +F
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

Query: 261 LK-NLPRELTETAQA 274
                    ++  Q 
Sbjct: 311 QMDGFAERFSQELQL 325

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  150 bits (382), Expect = 3e-43
 Identities = 79/296 (26%), Positives = 129/296 (43%), Gaps = 40/296 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           E +E++ ++G G FG     +NK T  L A K I  +   +++ +   EI       HP 
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPY 77

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQ 118
           I++          L I++E+  GG +   +       +E + +   +Q++  +++ HS +
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137

Query: 119 ICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
           I HRDLK  N L+  +G     +++ DFG S K+     +  S +GTP ++APEV+    
Sbjct: 138 IIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 176 -----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP------ 224
                YD K AD+WS G+TL  M     P  +  +P          M V  KI       
Sbjct: 194 MKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP----------MRVLLKIAKSDPPT 241

Query: 225 --DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP----RELTETAQA 274
                  S + R+ L      NP  R +  ++  HP+          REL   A+A
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKA 297

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  150 bits (382), Expect = 4e-43
 Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 41/290 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNI 60
             +EL++ +G+G +G     R+  T +L A+K ++     +  + +EI   K+   H NI
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI 83

Query: 61  IRF------KEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVS 112
             +      K        L +VME+   G + +  +        E+   Y  ++++ G+S
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 113 YCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSLLHSRPKSTVGTPAYIAPE 169
           + H  ++ HRD+K +N LL  +      +K+ DFG S +      R  + +GTP ++APE
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 199

Query: 170 VLSRRE-----YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 224
           V++  E     YD K +D+WS G+T   M  GA P  D   P          M   + IP
Sbjct: 200 VIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD-MHP----------MRALFLIP 247

Query: 225 -------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
                       S+  ++ +    V N S+R   +++  HP F+++ P E
Sbjct: 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNE 296

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  150 bits (382), Expect = 4e-43
 Identities = 76/303 (25%), Positives = 130/303 (42%), Gaps = 41/303 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHP 58
             +++ ++ +G+G +       NK T   VA+K ++   +    +   REI   K+L+H 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63

Query: 59  NIIRFKEVVLTPTHLAIVMEY-----AAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           NI+R  +V+ T   L +V E+         +             +  +YF  QL+ G+++
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL- 171
           CH  +I HRDLK +N L++     +LK+ DFG +++  +     S+ V T  Y AP+VL 
Sbjct: 124 CHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQ------------ED--P------ 206
             R Y   + D+WSCG  L  M+ G   F     E+Q            E   P      
Sbjct: 182 GSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240

Query: 207 ---KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
               N ++   R +    +      +  +  + L  +   NP  R++ K+   HPWF   
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF-AE 299

Query: 264 LPR 266
              
Sbjct: 300 YYH 302

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  149 bits (379), Expect = 7e-43
 Identities = 80/294 (27%), Positives = 129/294 (43%), Gaps = 31/294 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           + YEL + IGSG   V +       KE VA+K I  E+       + +EI    Q  HPN
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELF--------ERICNAGRFSEDEARYFFQQLISGV 111
           I+ +    +    L +VM+  +GG +         +    +G   E       ++++ G+
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS------KSSLLHSRPKSTVGTPAY 165
            Y H     HRD+K  N LL    +  ++I DFG S           +   K+ VGTP +
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 166 IAPEVLSR-REYDGKLADVWSCGVTLYVMLVGAYPFEDQED-------PKNFRKTISRIM 217
           +APEV+ + R YD K AD+WS G+T   +  GA P+             +N   ++   +
Sbjct: 193 MAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV 251

Query: 218 AVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE-LTE 270
             +  +  Y    +  R ++S     +P +R T  E+  H +F K   +E L E
Sbjct: 252 QDKEMLKKY---GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  149 bits (378), Expect = 7e-43
 Identities = 68/271 (25%), Positives = 108/271 (39%), Gaps = 33/271 (12%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA--------REIINHKQLR 56
           E  K IG G FG+    R    K +VA+K +  G                RE+     L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCH 115
           HPNI++   ++  P    +VME+   G+L+ R+ +                +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 116 SM--QICHRDLKLENTLLDG---SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +    I HRDL+  N  L     +     K+ DFG S+ S         +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS--VHSVSGLLGNFQWMAPET 197

Query: 171 LSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----I 223
           +   E  Y  K AD +S  + LY +L G  PF++    K     I  I  ++ +     I
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRPTI 251

Query: 224 PDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
           P+        RN++   +  +P +R     I
Sbjct: 252 PEDCP--PRLRNVIELCWSGDPKKRPHFSYI 280

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  149 bits (379), Expect = 1e-42
 Identities = 71/305 (23%), Positives = 126/305 (41%), Gaps = 50/305 (16%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHP 58
           ME Y  +  +G G +      ++K T  LVA+K I   H+        RE+   K L+H 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           NI+   +++ T   L +V EY      +  +        +    + F  QL+ G++YCH 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHR 118

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SRR 174
            ++ HRDLK +N L++      LK+ DFG +++  + ++     V T  Y  P++L    
Sbjct: 119 QKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST 176

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------AVQ 220
           +Y  ++ D+W  G   Y M  G   F     E+Q         I RI+          + 
Sbjct: 177 DYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLH------FIFRILGTPTEETWPGIL 229

Query: 221 YKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN 263
               ++                   +  D  +LL+++       RI+ ++   HP+F  +
Sbjct: 230 -SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF-LS 287

Query: 264 LPREL 268
           L   +
Sbjct: 288 LGERI 292

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  148 bits (376), Expect = 5e-42
 Identities = 77/300 (25%), Positives = 131/300 (43%), Gaps = 39/300 (13%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ERGHKIDANVAREIINHKQLRH 57
           + +  +++IG G+FG     R+    E+VA+K +    ++ ++   ++ +E+   ++LRH
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PN I+++   L      +VMEY  G        +     E E        + G++Y HS 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173

Query: 118 QICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS--- 172
            + HRD+K  N LL   G     +K+ DFG   +S++     S VGTP ++APEV+    
Sbjct: 174 NMIHRDVKAGNILLSEPG----LVKLGDFGS--ASIMAPA-NSFVGTPYWMAPEVILAMD 226

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP-------D 225
             +YDGK  DVWS G+T   +     P  +  +           M+  Y I         
Sbjct: 227 EGQYDGK-VDVWSLGITCIELAERKPPLFN-MNA----------MSALYHIAQNESPALQ 274

Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP----RELTETAQAIYYRKEN 281
             H S+  RN +       P  R T + +  H + L+  P     +L +  +      +N
Sbjct: 275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 334

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  146 bits (372), Expect = 6e-42
 Identities = 84/297 (28%), Positives = 136/297 (45%), Gaps = 50/297 (16%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N    E  A+K I    +   I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            NI++  +V+ T   L +V E+      +L +     G      A+ F  QL++G++YCH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 173
             ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL   
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------AV 219
           ++Y   + D+WS G     M+ G   F      DQ         I RI+          V
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLM------RIFRILGTPNSKNWPNV 228

Query: 220 QYKIPDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             ++P Y                  + +   +LLS++   +P++RIT K+   H +F
Sbjct: 229 T-ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  147 bits (373), Expect = 8e-42
 Identities = 81/306 (26%), Positives = 144/306 (47%), Gaps = 52/306 (16%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRH 57
           MEKY+ ++ +G G +GV    ++     +VA+K I    +   I +   REI   K+L H
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH 78

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           PNI+   +V+ +   L +V E+      ++ +   N     + + + +  QL+ GV++CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVL-SR 173
             +I HRDLK +N L++      LK+ DFG +++  +  R  +  V T  Y AP+VL   
Sbjct: 137 QHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISRIM---------AV 219
           ++Y   + D+WS G     M+ G   F     +DQ         I  I+          V
Sbjct: 195 KKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLP------KIFSILGTPNPREWPQV 247

Query: 220 QYKIPDYV-----------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
           Q ++P +                     Q+  +LLS +   +P++RI+ ++  +HP+F K
Sbjct: 248 Q-ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF-K 305

Query: 263 NLPREL 268
           +L  ++
Sbjct: 306 DLDPQI 311

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (369), Expect = 1e-41
 Identities = 65/281 (23%), Positives = 117/281 (41%), Gaps = 28/281 (9%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
             +  + + IGSG+FG     +       VA+K +         +     E+   ++ RH
Sbjct: 23  DGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
            NI+ F     T   LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y H+
Sbjct: 80  VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSR 173
             I HRDLK  N  L       +KI DFG +          + +   G+  ++APEV+  
Sbjct: 139 KSIIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196

Query: 174 RE---YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           ++   Y  + +DV++ G+ LY ++ G  P+ +     N R  I  ++      PD   + 
Sbjct: 197 QDSNPYSFQ-SDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVGRGSLSPDLSKVR 251

Query: 231 QDC----RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
            +C    + L++         R +   I +    ++ L RE
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRILAE---IEELARE 289

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  144 bits (365), Expect = 3e-41
 Identities = 74/272 (27%), Positives = 107/272 (39%), Gaps = 33/272 (12%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA-----NVAREIINHKQLRHPN 59
            L + IG G FG          +  VA+K        D      NV +E      L+HPN
Sbjct: 10  TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM-- 117
           II  + V L   +L +VME+A GG L   +    R   D    +  Q+  G++Y H    
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 118 -QICHRDLKLENTLLDGSPAPR------LKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
             I HRDLK  N L+             LKI DFG ++     +   S  G  A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPD 225
           +    +    +DVWS GV L+ +L G  PF   +        ++    V        IP 
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRGID-------GLAVAYGVAMNKLALPIPS 237

Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSH 257
                +    L+   +  +P  R +   I   
Sbjct: 238 TCP--EPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  146 bits (370), Expect = 4e-41
 Identities = 84/310 (27%), Positives = 132/310 (42%), Gaps = 62/310 (20%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQ 54
            ++YE +  +G G F      R+KNT ++VA+K I+ GH+      I+    REI   ++
Sbjct: 9   AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAG--GELFERICNAGRFSEDEARYFFQQLISGVS 112
           L HPNII   +     +++++V ++       + +   N+   +    + +    + G+ 
Sbjct: 69  LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLE 126

Query: 113 YCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPE 169
           Y H   I HRDLK  N LLD  G     LK+ DFG +KS    +R  +  V T  Y APE
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 182

Query: 170 VL-SRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMAV--- 219
           +L   R Y   + D+W+ G  L  +L+   PF       DQ         ++RI      
Sbjct: 183 LLFGARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLDQ---------LTRIFETLGT 231

Query: 220 --------QYKIPDYV---------------HISQDCRNLLSRIFVANPSRRITIKEIKS 256
                      +PDYV                   D  +L+  +F+ NP  RIT  +   
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291

Query: 257 HPWFLKNLPR 266
             +F  N P 
Sbjct: 292 MKYF-SNRPG 300

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  145 bits (367), Expect = 6e-41
 Identities = 60/289 (20%), Positives = 118/289 (40%), Gaps = 47/289 (16%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNII 61
           E+ + IG G FG     R       VA++ I+     +  +    RE++ ++Q RH N++
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQIC 120
            F    ++P HLAI+     G  L+  + +A      ++ R   Q+++ G+ Y H+  I 
Sbjct: 93  LFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGIL 152

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAPEVLSRR 174
           H+DLK +N   D     ++ I DFG         +     + +   G   ++APE++ + 
Sbjct: 153 HKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 175 E---------YDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-------KNFRKTISRIMA 218
                     +    +DV++ G   Y +    +PF+ Q             +  +S+I  
Sbjct: 210 SPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI-- 266

Query: 219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
                     + ++  ++L   +      R T  ++      L+ LP+ 
Sbjct: 267 ---------GMGKEISDILLFCWAFEQEERPTFTKLMDM---LEKLPKR 303

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  147 bits (372), Expect = 9e-41
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 48/297 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             Y   K IG+G+FGV    +  ++ ELVA+K +    K   N  RE+   ++L H NI+
Sbjct: 54  VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--RELQIMRKLDHCNIV 110

Query: 62  RFKEVVLTPT------HLAIVMEYAAGGELFERI----CNAGRFSEDEARYFFQQLISGV 111
           R +    +        +L +V++Y     ++                  + +  QL   +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 169

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPE 169
           +Y HS  ICHRD+K +N LLD   A  LK+CDFG +K   L     +   + +  Y APE
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPE 226

Query: 170 V-LSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED-----------PKNFRKTISR 215
           +     +Y   + DVWS G  L  +L+G   +P +   D           P   R+ I  
Sbjct: 227 LIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT--REQIRE 283

Query: 216 I--MAVQYKIPDYV----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +     ++K P                 +   L SR+    P+ R+T  E  +H +F
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  143 bits (364), Expect = 1e-40
 Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 33/284 (11%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNII 61
            + + IG+G+FG   + R +     VA+K +         V    RE+   K+LRHPNI+
Sbjct: 40  NIKEKIGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGR---FSEDEARYFFQQLISGVSYCHSM- 117
            F   V  P +L+IV EY + G L+  +  +G      E         +  G++Y H+  
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157

Query: 118 -QICHRDLKLENTLLDGSPAPRLKICDFGYS--KSSLLHSRPKSTVGTPAYIAPEVLSRR 174
             I HR+LK  N L+D      +K+CDFG S  K+S   S  KS  GTP ++APEVL   
Sbjct: 158 PPIVHRNLKSPNLLVDKK--YTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRDE 214

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDYVHI 229
             + K +DV+S GV L+ +     P+ +             + AV +K     IP  ++ 
Sbjct: 215 PSNEK-SDVYSFGVILWELATLQQPWGNLNP-------AQVVAAVGFKCKRLEIPRNLN- 265

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 273
                 ++   +   P +R +   I      L+ L +       
Sbjct: 266 -PQVAAIIEGCWTNEPWKRPSFATIMDL---LRPLIKSAVPPPN 305

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  140 bits (355), Expect = 3e-39
 Identities = 64/312 (20%), Positives = 111/312 (35%), Gaps = 61/312 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA------REIINHKQ 54
             +YE + +IG G +G     R+ ++   VA+K +   +             RE+   ++
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67

Query: 55  LR---HPNIIRFKEVVLTPTH-----LAIVMEYAAG--GELFERICNAGRFSEDEARYFF 104
           L    HPN++R  +V  T        + +V E+         ++         +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 164
           +Q + G+ + H+  I HRDLK EN L+       +K+ DFG ++           V T  
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARIYSYQMALTPVVVTLW 184

Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQEDPKNFRKTISRIMA 218
           Y APEVL +  Y   + D+WS G     M     P        DQ         + +I  
Sbjct: 185 YRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRK-PLFCGNSEADQ---------LGKIFD 233

Query: 219 V----------------QYKIPDYV---------HISQDCRNLLSRIFVANPSRRITIKE 253
           +                +   P             + +    LL  +   NP +RI+   
Sbjct: 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293

Query: 254 IKSHPWFLKNLP 265
              H +  K+  
Sbjct: 294 ALQHSYLHKDEG 305

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  142 bits (359), Expect = 3e-39
 Identities = 66/326 (20%), Positives = 113/326 (34%), Gaps = 61/326 (18%)

Query: 2   EKYELMKDIGSG--NFGVARLMRNKNTKELVAMKYI--ERGHKIDAN-VAREIINHKQLR 56
             YEL+  IG G  +     L R K T E V ++ I  E         +  E+   K   
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYC 114
           HPNI+ ++   +    L +V  + A G   + IC       +E    Y  Q ++  + Y 
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSLLHSRPKSTVGTPAYI 166
           H M   HR +K  + L+       + +     +        +  ++H  PK +V    ++
Sbjct: 145 HHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 167 APEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED-----------QEDP------- 206
           +PEVL +  + YD K +D++S G+T   +  G  PF+D                      
Sbjct: 203 SPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261

Query: 207 ----------------------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVAN 244
                                      T           P +   S    + + +    N
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321

Query: 245 PSRRITIKEIKSHPWFLKNLPRELTE 270
           P  R +   + +H  F K + R  +E
Sbjct: 322 PDARPSASTLLNHS-FFKQIKRRASE 346

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  140 bits (355), Expect = 4e-39
 Identities = 67/298 (22%), Positives = 125/298 (41%), Gaps = 47/298 (15%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPN 59
            + Y+L++ +G G +       N    E V +K ++   K      REI   + LR  PN
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK--REIKILENLRGGPN 92

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           II   ++V  P     A+V E+    +  +        ++ + R++  +++  + YCHSM
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVL-SRR 174
            I HRD+K  N ++D     +L++ D+G ++    H   +    V +  +  PE+L   +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPF------EDQ----------EDPKNFRKTISRIMA 218
            YD  L D+WS G  L  M+    PF       DQ          ED  ++    +  + 
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 219 VQYK--IPDY--------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            ++   +  +                +S +  + L ++   +   R+T +E   HP+F
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  140 bits (354), Expect = 2e-38
 Identities = 78/299 (26%), Positives = 124/299 (41%), Gaps = 51/299 (17%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
              Y   K IG+G+FGV    +   + E VA+K +    K   N  RE+   + ++HPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94

Query: 61  IRFKEVVLTPTH------LAIVMEYAAGGELFERIC-----NAGRFSEDEARYFFQQLIS 109
           +  K    +         L +V+EY    E   R                 + +  QL+ 
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIA 167
            ++Y HS+ ICHRD+K +N LLD      LK+ DFG +K   L +   +   + +  Y A
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKI--LIAGEPNVSYICSRYYRA 209

Query: 168 PEV-LSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED-----------PKNFRKTI 213
           PE+      Y   + D+WS G  +  ++ G   +P E   D           P   R+ I
Sbjct: 210 PELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS--REQI 266

Query: 214 SRIMA--VQYKIPDYV----------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             +    +++K P                 D  +L+SR+    PS R+T  E   HP+F
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  136 bits (345), Expect = 3e-38
 Identities = 47/266 (17%), Positives = 98/266 (36%), Gaps = 33/266 (12%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNII 61
             +  +   + G   L + +     + +K ++      +   +   E    +   HPN++
Sbjct: 13  NFLTKLNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 62  RFKEVVLTP--THLAIVMEYAAGGELFERICNAGRFSEDEARY--FFQQLISGVSYCHSM 117
                  +P   H  ++  +   G L+  +     F  D+++   F   +  G+++ H++
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL 130

Query: 118 Q--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
           +  I    L   + ++D       +I       S     +    +  PA++APE L ++ 
Sbjct: 131 EPLIPRHALNSRSVMIDEDM--TARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184

Query: 176 YDG--KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-----IPDYVH 228
            D   + AD+WS  V L+ ++    PF D          +   M V  +     IP    
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADL-------SNMEIGMKVALEGLRPTIPP--G 235

Query: 229 ISQDCRNLLSRIFVANPSRRITIKEI 254
           IS     L+      +P++R     I
Sbjct: 236 ISPHVSKLMKICMNEDPAKRPKFDMI 261

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  136 bits (344), Expect = 1e-37
 Identities = 74/302 (24%), Positives = 114/302 (37%), Gaps = 46/302 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA-REIINHKQLRHPNI 60
            +Y  +K +G G  G+     + +  + VA+K I          A REI   ++L H NI
Sbjct: 11  SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70

Query: 61  IRFKEVVLTPTHLAIVMEYAAGG--------ELFE----RICNAGRFSEDEARYFFQQLI 108
           ++  E++            +           E  E     +   G   E+ AR F  QL+
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPA 164
            G+ Y HS  + HRDLK  N  ++ +    LKI DFG ++    H   K      + T  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 165 YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED 205
           Y +P + LS   Y  K  D+W+ G     ML G   F                    +ED
Sbjct: 190 YRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEED 248

Query: 206 ----PKNFRKTISRIMAVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
                      I      +   P       IS++  + L +I   +P  R+T +E  SHP
Sbjct: 249 RQELLSVIPVYIRN-DMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHP 307

Query: 259 WF 260
           + 
Sbjct: 308 YM 309

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  137 bits (346), Expect = 2e-37
 Identities = 71/302 (23%), Positives = 123/302 (40%), Gaps = 47/302 (15%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPN 59
           M+++++ +  G G FG  +L + K+T   VA+K +        N   + + +   L HPN
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLHHPN 80

Query: 60  IIRFKEVVLTPTH-------LAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLI 108
           I++ +    T          L +VMEY     L     N  R          + F  QLI
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 109 SGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STVGTPAY 165
             +   H  S+ +CHRD+K  N L++ +    LK+CDFG +K  L  S P  + + +  Y
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAK-KLSPSEPNVAYICSRYY 197

Query: 166 IAPEV-LSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED----------------- 205
            APE+    + Y   + D+WS G     M++G   +  ++                    
Sbjct: 198 RAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256

Query: 206 ----PKNFRKTISRIMAVQYK--IPDYV-HISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
               P +    +     + +     D+    +++  +LLS +    P  R+   E   HP
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316

Query: 259 WF 260
           +F
Sbjct: 317 YF 318

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  135 bits (342), Expect = 5e-37
 Identities = 74/311 (23%), Positives = 126/311 (40%), Gaps = 62/311 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----ER-GHKIDANVAREIINHKQL 55
           + KYE +  IG G FG     R++ T + VA+K +    E+ G  I A   REI   + L
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLL 73

Query: 56  RHPNIIRFKEVVLTPTHLA--------IVMEYA----AGGELFERICNAGRFSEDEARYF 103
           +H N++   E+  T             +V ++     AG  L   +    +F+  E +  
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSEIKRV 129

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRP-KS 158
            Q L++G+ Y H  +I HRD+K  N L+       LK+ DFG    +S +         +
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 159 TVGTPAYIAPEVL-SRREYDGKLADVWSCGVTLYVMLVGAYPF------EDQ-------- 203
            V T  Y  PE+L   R+Y   + D+W  G  +  M   + P       + Q        
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLC 245

Query: 204 --------------EDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRI 249
                         E  +       +   V+ ++  YV       +L+ ++ V +P++RI
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYV-RDPYALDLIDKLLVLDPAQRI 304

Query: 250 TIKEIKSHPWF 260
              +  +H +F
Sbjct: 305 DSDDALNHDFF 315

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  135 bits (341), Expect = 1e-36
 Identities = 70/325 (21%), Positives = 120/325 (36%), Gaps = 66/325 (20%)

Query: 3   KYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN 59
           +YE  K +G G +G    A+  ++    +  A+K IE    I  +  REI   ++L+HPN
Sbjct: 23  EYEGCK-VGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKHPN 79

Query: 60  IIRFKEVVLTPTHLAI--VMEYA--------AGGELFERICNAGRFSEDEARYFFQQLIS 109
           +I  ++V L+     +  + +YA              +      +      +    Q++ 
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPR--LKICDFGYSKSSLLHSRPKST----VGTP 163
           G+ Y H+  + HRDLK  N L+ G    R  +KI D G+++      +P +     V T 
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 164 AYIAPEVL-SRREYDGKLADVWSCGVTLYVML---------------------------- 194
            Y APE+L   R Y  K  D+W+ G     +L                            
Sbjct: 200 WYRAPELLLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258

Query: 195 -------------VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF 241
                        +   P          R T +    ++Y     V       +LL ++ 
Sbjct: 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 318

Query: 242 VANPSRRITIKEIKSHPWFLKNLPR 266
             +P +RIT ++    P+F    P 
Sbjct: 319 TMDPIKRITSEQAMQDPYF-LEDPL 342

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  132 bits (335), Expect = 2e-36
 Identities = 65/290 (22%), Positives = 120/290 (41%), Gaps = 34/290 (11%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDANVAREIINHKQLRHPNIIRF 63
              + +G G FG A  + ++ T E++ MK + R   +      +E+   + L HPN+++F
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72

Query: 64  KEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQICHR 122
             V+     L  + EY  GG L   I +    +   +   F + + SG++Y HSM I HR
Sbjct: 73  IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSK---------------SSLLHSRPKSTVGTPAYIA 167
           DL   N L+  +    + + DFG ++                     +  + VG P ++A
Sbjct: 133 DLNSHNCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 168 PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
           PE+++ R YD K  DV+S G+ L  ++       D   P+           +  +     
Sbjct: 191 PEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPD-YLPRT------MDFGLNVRGFLDR 242

Query: 228 HISQDC----RNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQ 273
           +   +C      +  R    +P +R +  +++    +L+ L   L     
Sbjct: 243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE---HWLETLRMHLAGHLP 289

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  133 bits (338), Expect = 2e-36
 Identities = 78/296 (26%), Positives = 127/296 (42%), Gaps = 46/296 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
             Y  ++ +GSG +G      +  T   VA+K + R    ++ A    RE+   K +RH 
Sbjct: 25  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           N+I   +V      L       +VM +  G +L  ++    +  ED  ++   Q++ G+ 
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGLR 142

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 170
           Y H+  I HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APEV
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPEV 196

Query: 171 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISR 215
            L+   Y  +  D+WS G  +  M+ G   F+     DQ           P  F + +  
Sbjct: 197 ILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255

Query: 216 IMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             A  Y   +P+           + S    NLL ++ V +  +R+T  E  +HP+F
Sbjct: 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  132 bits (335), Expect = 3e-36
 Identities = 75/316 (23%), Positives = 124/316 (39%), Gaps = 70/316 (22%)

Query: 1   MEKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANV-------AREII 50
            ++YE + +IG G +G    AR    KN    VA+K +    ++            RE+ 
Sbjct: 10  DQQYECVAEIGEGAYGKVFKAR--DLKNGGRFVALKRV----RVQTGEEGMPLSTIREVA 63

Query: 51  NHKQLR---HPNIIRFKEVVLTP-----THLAIVMEYAAG--GELFERICNAGRFSEDEA 100
             + L    HPN++R  +V         T L +V E+         ++         +  
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETI 122

Query: 101 RYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 160
           +    QL+ G+ + HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVV 180

Query: 161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF-----EDQEDPKNFRKTISR 215
            T  Y APEVL +  Y   + D+WS G     M      F      DQ         + +
Sbjct: 181 VTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQ---------LGK 230

Query: 216 IMAV----------------QYKIPDYV---------HISQDCRNLLSRIFVANPSRRIT 250
           I+ V                +                 I +  ++LL +    NP++RI+
Sbjct: 231 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290

Query: 251 IKEIKSHPWFLKNLPR 266
                SHP+F ++L R
Sbjct: 291 AYSALSHPYF-QDLER 305

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  132 bits (335), Expect = 5e-36
 Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 47/296 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVA-REIINHKQLRHP 58
           + Y     +GSG +G      +K + E VA+K + R    +I A  A RE++  K ++H 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           N+I   +V    + L       +VM +    +L + +    +FSE++ +Y   Q++ G+ 
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGLK 140

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 170
           Y HS  + HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APEV
Sbjct: 141 YIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPEV 194

Query: 171 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISR 215
            LS   Y+ +  D+WS G  +  ML G   F+     DQ              F + ++ 
Sbjct: 195 ILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253

Query: 216 IMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             A  Y   +P          +   S    +LL ++   +  +R+T  +  +HP+F
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  132 bits (335), Expect = 6e-36
 Identities = 75/296 (25%), Positives = 123/296 (41%), Gaps = 46/296 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R     I A    RE+   K ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           N+I   +V      L       +V     G +L   I    + ++D  ++   Q++ G+ 
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGLK 146

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEV 170
           Y HS  I HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APE+
Sbjct: 147 YIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPEI 200

Query: 171 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISR 215
            L+   Y+ +  D+WS G  +  +L G   F      DQ                K IS 
Sbjct: 201 MLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259

Query: 216 IMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
             A  Y   +           ++  +    +LL ++ V +  +RIT  +  +H +F
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  128 bits (324), Expect = 6e-35
 Identities = 65/298 (21%), Positives = 104/298 (34%), Gaps = 59/298 (19%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF- 63
            L++ +G G +G   + R     E VA+K      +       E+ N   LRH NI+ F 
Sbjct: 11  TLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 64  ---KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ-- 118
                   + T L ++  Y   G L++ +                 + SG+++ H     
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 119 ------ICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +   +  I D G +      ++ L       VGT  Y+A
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 168 PEVL------SRREYDGKLADVWSCGVTLYVMLVGAY----------PFEDQ--EDP--- 206
           PEVL         +   +  D+W+ G+ L+ +               PF D    DP   
Sbjct: 186 PEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 207 --------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
                      R  I         +     + ++C          NPS R+T   IK 
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY-------QNPSARLTALRIKK 295

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  128 bits (325), Expect = 2e-34
 Identities = 79/296 (26%), Positives = 123/296 (41%), Gaps = 42/296 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDAN-VAREIINHKQLRHPN 59
            +Y  +  IG G +G+     +   K  VA+K I    H+       REI    + RH N
Sbjct: 27  PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86

Query: 60  IIRFKEVVLTPTH-----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           II   +++  PT      + IV +     +L  ++      S D   YF  Q++ G+ Y 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILRGLKYI 144

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST----VGTPAYIAPEV 170
           HS  + HRDLK  N LL+ +    LKICDFG ++ +             V T  Y APE+
Sbjct: 145 HSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202

Query: 171 -LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED---------PKNFRKTISR 215
            L+ + Y  K  D+WS G  L  ML     F      DQ +          +     I  
Sbjct: 203 MLNSKGYT-KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261

Query: 216 IMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           + A  Y   +P          + +      +LL ++   NP +RI +++  +HP+ 
Sbjct: 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  127 bits (321), Expect = 6e-34
 Identities = 84/304 (27%), Positives = 127/304 (41%), Gaps = 50/304 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER-GHKIDAN-VAREIINHKQLRHPN 59
             ++L   +G G +GV     +K T E+VA+K IE     + A    REI   K  +H N
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70

Query: 60  IIRFKEVVLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           II    +    +        I+ E     +L  R+ +    S+D  +YF  Q +  V   
Sbjct: 71  IITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAVKVL 128

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKST-------VGTP 163
           H   + HRDLK  N L++ +    LK+CDFG      +S+  +S P          V T 
Sbjct: 129 HGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186

Query: 164 AYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE-----DQED----------PK 207
            Y APEV L+  +Y  +  DVWSCG  L  + +    F       Q              
Sbjct: 187 WYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245

Query: 208 NFRKTISRIMAVQY--KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
           N  + I    A +Y   +P          +  ++    +LL R+ V +P++RIT KE   
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305

Query: 257 HPWF 260
           HP+ 
Sbjct: 306 HPYL 309

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  126 bits (319), Expect = 1e-33
 Identities = 75/305 (24%), Positives = 119/305 (39%), Gaps = 51/305 (16%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRH 57
           +++Y+ +K IGSG  G+     +   +  VA+K + R   ++  A    RE++  K + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 58  PNIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
            NII    V      L       IVME      L  ++        +   Y   Q++ G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
            + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED-------- 205
               Y  +  D+WS G  +  M+ G   F                     E         
Sbjct: 199 LGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257

Query: 206 -------PKNFRKTISRIMAVQYKIPDYVHISQ---DCRNLLSRIFVANPSRRITIKEIK 255
                  PK    +  ++        D  H        R+LLS++ V + S+RI++ E  
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317

Query: 256 SHPWF 260
            HP+ 
Sbjct: 318 QHPYI 322

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  124 bits (314), Expect = 3e-33
 Identities = 73/309 (23%), Positives = 112/309 (36%), Gaps = 62/309 (20%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF- 63
            L + IG G FG   + R K   E VA+K      +       EI     LRH NI+ F 
Sbjct: 45  VLQESIGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 64  ---KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS---- 116
               +   T T L +V +Y   G LF+ + N    + +          SG+++ H     
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 117 ----MQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +      I D G +      +  +   P   VGT  Y+A
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 168 PEVL------SRREYDGKLADVWSCGVTLYVMLVG----------AYPFEDQ--EDP--- 206
           PEVL         E   + AD+++ G+  + +               P+ D    DP   
Sbjct: 220 PEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 207 --------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP 258
                   +  R  I         +     I ++C       + AN + R+T   IK   
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMREC-------WYANGAARLTALRIKKT- 330

Query: 259 WFLKNLPRE 267
             L  L ++
Sbjct: 331 --LSQLSQQ 337

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  124 bits (314), Expect = 5e-33
 Identities = 62/304 (20%), Positives = 106/304 (34%), Gaps = 50/304 (16%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG-----------HKIDAN-VAREI 49
             Y + + I SG++G      +      VA+K +                     V REI
Sbjct: 22  SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 50  INHKQLRHPNIIRFKEVVLTPTH-----LAIVMEYAAGGELFERI-CNAGRFSEDEARYF 103
                  HPNI+  +++ +         L +V E     +L + I       S    +YF
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 163
              ++ G+   H   + HRDL   N LL  +    + ICDF  ++     +     V   
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYVTHR 197

Query: 164 AYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQE 204
            Y APE+ +  + +  KL D+WS G  +  M      F                     E
Sbjct: 198 WYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256

Query: 205 D-----PKNFRKTISRIMAVQYKIP---DYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
           D       + R  +   ++                   +L++++   NP RRI+ ++   
Sbjct: 257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316

Query: 257 HPWF 260
           HP+F
Sbjct: 317 HPYF 320

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  124 bits (312), Expect = 1e-32
 Identities = 71/329 (21%), Positives = 115/329 (34%), Gaps = 78/329 (23%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
            +KY L K +G+G+FG+   + +  + +  A+K + +      N  RE+   K L H NI
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAG--------------------------- 93
           I+  +   T                     N G                           
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 94  --------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRL 139
                             +    +  QL   V + HS+ ICHRD+K +N L++      L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181

Query: 140 KICDFGYSKSSLLHSRPKST--VGTPAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVG 196
           K+CDFG +K   L     S   + +  Y APE+ L   EY   + D+WS G     +++G
Sbjct: 182 KLCDFGSAKK--LIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILG 238

Query: 197 A--YPFEDQED-----------PKNFRKTISRI--MAVQYKIPDYVHIS----------Q 231
              +  E   D           P   ++ + R+     + + P                 
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPT--KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296

Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              +LL +I    P  RI   E  +HP+F
Sbjct: 297 LAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  124 bits (313), Expect = 3e-32
 Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 53/305 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
           ++Y+ +K IGSG  G+     +      VA+K + R   ++  A    RE++  K + H 
Sbjct: 62  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121

Query: 59  NIIRFKEVVLTPTHLA------IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           NII    V      L       +VME      L + I        +   Y   Q++ G+ 
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGIK 178

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+ 
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFE------------------DQED--------- 205
              Y  +  D+WS G  +  M+     F                     E          
Sbjct: 237 GMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 295

Query: 206 ----------PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 255
                        F K     +       +    +   R+LLS++ V +P++RI++ +  
Sbjct: 296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNK-LKASQARDLLSKMLVIDPAKRISVDDAL 354

Query: 256 SHPWF 260
            HP+ 
Sbjct: 355 QHPYI 359

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  122 bits (307), Expect = 4e-32
 Identities = 62/298 (20%), Positives = 109/298 (36%), Gaps = 59/298 (19%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           +++K IG G +G   +   K   E VA+K      +       EI     +RH NI+ F 
Sbjct: 40  QMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 65  EVVLTP----THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ-- 118
              +      T L ++ +Y   G L++ + +                +SG+ + H+    
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 119 ------ICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIA 167
                 I HRDLK +N L+  +      I D G +      ++ +   P + VGT  Y+ 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 168 PEVL------SRREYDGKLADVWSCGVTLYVMLVG----------AYPFED--QEDP--- 206
           PEVL      +  +     AD++S G+ L+ +               P+ D    DP   
Sbjct: 215 PEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273

Query: 207 --------KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS 256
                   K  R +     +    +     +  +C       +  NP+ R+T   +K 
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC-------WAHNPASRLTALRVKK 324

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  119 bits (301), Expect = 9e-31
 Identities = 78/344 (22%), Positives = 124/344 (36%), Gaps = 89/344 (25%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
           + Y +   IG G++G   L  +KNT++ VA+K + R     ID   + REI    +L+  
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
            IIR  ++++    L      IV+E A   +L +        +E+  +     L+ G ++
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------- 164
            H   I HRDLK  N LL+      +K+CDFG +++                        
Sbjct: 145 IHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 165 --------------YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVG------------- 196
                         Y APE+ L +  Y  K  D+WS G     +L               
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261

Query: 197 -----------AYPFEDQEDPKNFRKTISRIM------------------AVQY--KIPD 225
                            +   K+ R  ++ I                    ++Y    P 
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH 321

Query: 226 ---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                    Y  IS D  NLL  +   NP++RITI +   HP+ 
Sbjct: 322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  118 bits (298), Expect = 1e-30
 Identities = 77/329 (23%), Positives = 126/329 (38%), Gaps = 75/329 (22%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDANVA-REIINHKQLR-H 57
            KYEL+K +G G +G+     ++ T E+VA+K I     +  DA    REI+   +L  H
Sbjct: 9   RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68

Query: 58  PNIIRFKEVVLTPT--HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            NI+    V+       + +V +Y    +L   +  A        +Y   QLI  + Y H
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYLH 126

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---------------- 159
           S  + HRD+K  N LL+      +K+ DFG S+S +   R  +                 
Sbjct: 127 SGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 160 ------VGTPAYIAPEV-LSRREYDGKLADVWSCGVTLYVMLVG---------------- 196
                 V T  Y APE+ L   +Y  K  D+WS G  L  +L G                
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

Query: 197 -------------------------AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
                                    +   + +    N R   ++   +  KI      ++
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303

Query: 232 DCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +  +LL ++   NP++RI+  +   HP+ 
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFV 332

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  115 bits (290), Expect = 1e-29
 Identities = 67/330 (20%), Positives = 120/330 (36%), Gaps = 70/330 (21%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EI-----INHKQLR 56
           +Y L++ +G G+F    L ++      VAMK + RG K+    A  EI     +N     
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNT 78

Query: 57  HP------NIIRFKEV----VLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFF 104
                   +I++  +          H+ +V E   G  L    +            +   
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQIS 137

Query: 105 QQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPR----LKICDFGYSKSSLLHSRPKST 159
           +QL+ G+ Y H    I H D+K EN L++   +P     +KI D G   +        ++
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNS 195

Query: 160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT--ISRIM 217
           + T  Y +PEVL    +    AD+WS    ++ ++ G + FE  E     +    I++I+
Sbjct: 196 IQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254

Query: 218 AV------------------------------------QYKIPDYVHISQDCR----NLL 237
            +                                    +  + +    S+D      + L
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314

Query: 238 SRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
           S +   +P +R     + +HPW    L  E
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGME 344

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  114 bits (286), Expect = 2e-28
 Identities = 69/312 (22%), Positives = 123/312 (39%), Gaps = 55/312 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIER--GHKIDAN-VAREIINHKQLRHP 58
           ++YE+   IG+G++G      +K  K +VA+K I R     ID   + REI    +L H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112

Query: 59  NIIRFKEVVLTPT-----HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           ++++  ++V+         L +V+E A   +  +        +E   +     L+ GV Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA--------- 164
            HS  I HRDLK  N L++      +K+CDFG +++        S +             
Sbjct: 172 VHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229

Query: 165 -------------------YIAPEV-LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE 204
                              Y APE+ L +  Y  +  DVWS G     +L      ++  
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYT-EAIDVWSIGCIFAELLNMI---KENV 285

Query: 205 DPKNFRKTI------SRIMAVQYKIPDYVHISQDCRNLLSRIF--VANPSRRITIKEIKS 256
                R  +        +   Q    D+   ++  R+ L+ IF  +  PS    I+ ++ 
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEE-DIEALEK 344

Query: 257 HPW--FLKNLPR 266
                +++  P+
Sbjct: 345 EDAKRYIRIFPK 356

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  111 bits (279), Expect = 3e-28
 Identities = 68/346 (19%), Positives = 121/346 (34%), Gaps = 67/346 (19%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           ++  +L++ IG G +G   + +    +  VA+K     ++ +    + I     + H NI
Sbjct: 12  LDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI 69

Query: 61  IRF-----KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            RF     +          +VMEY   G L + + +        +      +  G++Y H
Sbjct: 70  ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLH 128

Query: 116 SM---------QICHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSLLHSRPK 157
           +           I HRDL   N L+         I DFG S               +   
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 158 STVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVML---VGAYPFEDQEDPKN 208
           S VGT  Y+APEVL         E   K  D+++ G+  + +       +P E   +   
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE--- 243

Query: 209 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKE-IKSHPWFLKNLPRE 267
                       Y++     +         ++ V+   +R    E  K +   +++L +E
Sbjct: 244 ------------YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL-KE 290

Query: 268 LTET-----AQAIYYRKENPTFS--LQSVEEITKIVEEAKVPPPVS 306
             E      A+A   R    T     + + E+  I E  K   P +
Sbjct: 291 TIEDCWDQDAEA---R---LTAQXAEERMAELMMIWERNKSVSPTA 330

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  110 bits (277), Expect = 3e-28
 Identities = 67/204 (32%), Positives = 95/204 (46%), Gaps = 9/204 (4%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHPN 59
           Y+++  +G G      L  +      VA+K I    +          RE+ N  QL H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           I+   +V        +VMEY  G  L E I + G  S D A  F  Q++ G+ + H M+I
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRD+K +N L+D      LKI DFG +K  S    ++    +GT  Y +PE       D
Sbjct: 133 VHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 178 GKLADVWSCGVTLYVMLVGAYPFE 201
               D++S G+ LY MLVG  PF 
Sbjct: 191 EC-TDIYSIGIVLYEMLVGEPPFN 213

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  109 bits (274), Expect = 1e-27
 Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 13/206 (6%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHPN 59
           Y L + +G G  G      +   + +VA+K +      D        RE     +L+ P+
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           ++   +       L + M    G +L   +   G  +   A    +Q+ S +   H+   
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTPAYIAPEVLSRRE 175
            HRD+K EN L+  S      + DFG     +   L  ++  +TVGT  Y+APE  S   
Sbjct: 156 THRDVKPENILV--SADDFAYLVDFGIASATTDEKL--TQLGNTVGTLYYMAPERFSESH 211

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFE 201
              + AD+++    LY  L G+ P++
Sbjct: 212 ATYR-ADIYALTCVLYECLTGSPPYQ 236

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  111 bits (279), Expect = 1e-27
 Identities = 71/336 (21%), Positives = 112/336 (33%), Gaps = 69/336 (20%)

Query: 3   KYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAR---EIINHKQLRHP 58
           +YE++K IG G+FG V +   +    + VA+K + R  K     A     I+ H + +  
Sbjct: 98  RYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDK 155

Query: 59  ----NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVS 112
               N+I   E      H+ +  E      L+E I       FS    R F   ++  + 
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
             H  +I H DLK EN LL       +K+ DFG   S   H R  + + +  Y APEV+ 
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTYIQSRFYRAPEVIL 272

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPF-------------------------------- 200
              Y   + D+WS G  L  +L G                                    
Sbjct: 273 GARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331

Query: 201 -------------EDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR--------NLLSR 239
                            D                  P+        +        + L +
Sbjct: 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391

Query: 240 IFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAI 275
               +P+ R+T  +   HPW  + LP+  T    ++
Sbjct: 392 CLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSV 427

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  112 bits (281), Expect = 2e-27
 Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 15/155 (9%)

Query: 54  QLRHPNIIRFKEVVLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLI 108
           ++ HP+I++    V            IVMEY  G  L        +    EA  +  +++
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEIL 192

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
             +SY HS+ + + DLK EN +L      +LK+ D G        +      GTP + AP
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAP 246

Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ 203
           E++          D+++ G TL  + +       +
Sbjct: 247 EIVRTGPTVA--TDIYTVGRTLAALTLDLPTRNGR 279

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  107 bits (269), Expect = 6e-27
 Identities = 57/300 (19%), Positives = 106/300 (35%), Gaps = 59/300 (19%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
              +L++    G FG     +  N    VA+K      K       E+ +   ++H NI+
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81

Query: 62  RF----KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           +F    K        L ++  +   G L + +  A   S +E  +  + +  G++Y H  
Sbjct: 82  QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHED 140

Query: 118 Q----------ICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPA 164
                      I HRD+K +N LL  +      I DFG +    +          VGT  
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGTRR 198

Query: 165 YIAPEVLS-----RREYDGKLADVWSCGVTL--------------------YVMLVGAYP 199
           Y+APEVL      +R+   +  D+++ G+ L                    +   +G +P
Sbjct: 199 YMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257

Query: 200 -FEDQED---PKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK 255
             ED ++    K  R  +         +       ++C +        +   R++   + 
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD-------HDAEARLSAGCVG 310

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  106 bits (266), Expect = 4e-26
 Identities = 69/275 (25%), Positives = 105/275 (38%), Gaps = 22/275 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
           E   L + IG GNFG     R +    LVA+K        D      +E    KQ  HPN
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           I+R   V      + IVME   GG+    +     R              +G+ Y  S  
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC 233

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVLSR 173
             HRDL   N L+       LKI DFG S+         +  G    +     APE L+ 
Sbjct: 234 CIHRDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNY 289

Query: 174 REYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
             Y  + +DVWS G+ L+    +GA P+ +     N ++T   +     ++P        
Sbjct: 290 GRYSSE-SDVWSFGILLWETFSLGASPYPNL---SN-QQTREFVEK-GGRLPCPELCPDA 343

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
              L+ + +   P +R +   I      L+++ + 
Sbjct: 344 VFRLMEQCWAYEPGQRPSFSTIY---QELQSIRKR 375

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  105 bits (263), Expect = 5e-26
 Identities = 65/231 (28%), Positives = 93/231 (40%), Gaps = 20/231 (8%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYI-ERGHKIDANVAREIINHKQLRHPN 59
           + +  +G GNFG   L        NT  LVA+K +   G     +  REI   K L    
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
           I++++ V   P    L +VMEY   G L + +  +  R        +  Q+  G+ Y  S
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYI-----APEV 170
            +  HRDL   N L+  S A  +KI DFG +K  LL        V  P        APE 
Sbjct: 146 RRCVHRDLAARNILV-ESEA-HVKIADFGLAK--LLPLDKDYYVVREPGQSPIFWYAPES 201

Query: 171 LSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTISRIMAVQ 220
           LS   +  + +DVWS GV LY +            +          + A+ 
Sbjct: 202 LSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  103 bits (260), Expect = 1e-25
 Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 31/218 (14%)

Query: 4   YELMKDIGSGNFGVA--------RLMRNKNTKELVAMKYIERGHKIDAN-VAR---EIIN 51
           YEL + +G G  G++        R  R+      VA+K +      D +   R   E  N
Sbjct: 14  YELGEILGFG--GMSEVHLARDLRDHRD------VAVKVLRADLARDPSFYLRFRREAQN 65

Query: 52  HKQLRHPNIIRF----KEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQL 107
              L HP I+      +          IVMEY  G  L + +   G  +   A       
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADA 125

Query: 108 ISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG----YSKSSLLHSRPKSTVGTP 163
              +++ H   I HRD+K  N ++  S    +K+ DFG     + S    ++  + +GT 
Sbjct: 126 CQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 164 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFE 201
            Y++PE       D + +DV+S G  LY +L G  PF 
Sbjct: 184 QYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFT 220

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  102 bits (257), Expect = 2e-25
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPN 59
           + ++ +G GNFG   +        NT E+VA+K ++    +   +  REI   K L+H N
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
           I+++K V  +     L ++MEY   G L + +  +  R    +   +  Q+  G+ Y  +
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 171
            +  HRDL   N L+  +   R+KI DFG +K  L   +    V  P        APE L
Sbjct: 133 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 172 SRREYDGKLADVWSCGVTLY 191
           +  ++    +DVWS GV LY
Sbjct: 190 TESKFSVA-SDVWSFGVVLY 208

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 2e-25
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPN 59
           + ++ +G GNFG   +        NT E+VA+K ++    +   +  REI   K L+H N
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
           I+++K V  +     L ++MEY   G L + +  +  R    +   +  Q+  G+ Y  +
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 171
            +  HRDL   N L+  +   R+KI DFG +K  L   +    V  P        APE L
Sbjct: 164 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 172 SRREYDGKLADVWSCGVTLY 191
           +  ++    +DVWS GV LY
Sbjct: 221 TESKFSVA-SDVWSFGVVLY 239

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  102 bits (256), Expect = 3e-25
 Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 19/212 (8%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
            L++ +G G+FGV               VA+K ++           + I        L H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHS 116
            N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  S
Sbjct: 81  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 139

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 171
            +  HRDL   N LL  +    +KI DFG  + +L  +     +     +     APE L
Sbjct: 140 KRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR-ALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 172 SRREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
             R +    +D W  GVTL+ +   G  P+  
Sbjct: 197 KTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  102 bits (256), Expect = 3e-25
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)

Query: 5   ELMKDIGSGNFGV---ARL-MRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
           + ++D+G G+FG     R      NT E VA+K ++     +      +EI   + L H 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCH 115
           NI+++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYI-----APE 169
           S Q  HRDL   N L+  S   ++KI DFG +K   + +  +  TV           APE
Sbjct: 144 SRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 170 VLSRREYDGKLADVWSCGVTLY 191
            L + ++    +DVWS GVTL+
Sbjct: 200 CLMQSKFYIA-SDVWSFGVTLH 220

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  102 bits (257), Expect = 5e-25
 Identities = 72/332 (21%), Positives = 114/332 (34%), Gaps = 72/332 (21%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHP- 58
           E+YE++ ++G G FG V   + +   K  VA+K I R        AR EI   K+++   
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEKD 77

Query: 59  -----NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGV 111
                  +   +      H+ I  E   G   FE +       +     R+   QL   +
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136

Query: 112 SYCHSMQICHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSLLHS 154
            + H  Q+ H DLK EN L   S                     +++ DFG   S+    
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDH 193

Query: 155 RPKST-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLY---------------------V 192
              +T V T  Y  PEV+    +     DVWS G  L+                      
Sbjct: 194 EHHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMME 252

Query: 193 MLVGAYP------------FEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD-----CRN 235
            ++G  P            F       +   +  R +    K      +          +
Sbjct: 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
           L+ R+   +P++RIT+ E   HP+F    P E
Sbjct: 313 LMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  102 bits (257), Expect = 2e-24
 Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 8/206 (3%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
               +   +G G +G       K     VA+K ++          +E    K+++HPN++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +   V        I+ E+   G L  + R CN    S     Y   Q+ S + Y      
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY--IAPEVLSRREYD 177
            HR+L   N L+  +    +K+ DFG S+     +              APE L+  ++ 
Sbjct: 340 IHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 178 GKLADVWSCGVTLY-VMLVGAYPFED 202
            K +DVW+ GV L+ +   G  P+  
Sbjct: 398 IK-SDVWAFGVLLWEIATYGMSPYPG 422

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 99.3 bits (248), Expect = 5e-24
 Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 18/200 (9%)

Query: 5   ELMKDIGSGNFGVARL----MRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
           + ++D+G G+FG   L      N  T E+VA+K ++            +EI   + L H 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 59  NIIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +II++K          L +VMEY   G L + +         +   F QQ+  G++Y H+
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 171
               HRDL   N LL  +    +KI DFG +K ++        V           APE L
Sbjct: 153 QHYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 172 SRREYDGKLADVWSCGVTLY 191
              ++    +DVWS GVTLY
Sbjct: 210 KEYKFYYA-SDVWSFGVTLY 228

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 99.2 bits (248), Expect = 6e-24
 Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 19/211 (9%)

Query: 5   ELMKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLR 56
           + +K +GSG FG       +   +  K  VA+K +           +EI++       + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVD 75

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCH 115
           +P++ R   + LT T + ++ +    G L + +  +           +  Q+  G++Y  
Sbjct: 76  NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT--P-AYIAPEVLS 172
             ++ HRDL   N L+  +P   +KI DFG +K      +     G   P  ++A E + 
Sbjct: 135 DRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 173 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
            R Y  + +DVWS GVT++ +M  G+ P++ 
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 73/333 (21%), Positives = 117/333 (35%), Gaps = 74/333 (22%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAR-EIINHKQLRHP-- 58
           ++YE+   IG G+FG      ++  +E VA+K I +  K   N A+ E+   + +     
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDT 112

Query: 59  ----NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVS 112
                I+  K   +   HL +V E      L++ + N      S +  R F QQ+ + + 
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171

Query: 113 YCHS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +  +  + I H DLK EN LL       +KI DFG   S  L  R    + +  Y +PEV
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQYIQSRFYRSPEV 229

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVG---------------------------------- 196
           L    YD  + D+WS G  L  M  G                                  
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

Query: 197 ----------AYPFEDQEDPKN-----FRKTISRIMAVQYKIPDYVHISQDCRN------ 235
                      +  +  +D K        + +  I+ V+   P      +          
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348

Query: 236 ---LLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
              L+ R+   +P  RI       H +F K   
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 97.7 bits (244), Expect = 3e-23
 Identities = 70/333 (21%), Positives = 117/333 (35%), Gaps = 73/333 (21%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHK 53
            +YE++  +G G FG V   + +K     VA+K + +           +  V   +    
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTD 72

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGV 111
                  ++  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 112 SYCHSMQICHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSLLHS 154
           ++ HS ++ H DLK EN L   S                   P +K+ DFG   S+    
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188

Query: 155 RPKST-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLY---------------------V 192
              ST V T  Y APEV+    +     DVWS G  L                       
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247

Query: 193 MLVGAYP-------------FEDQEDPKNFRKTISRIMAVQYKIPDYVHIS----QDCRN 235
            ++G  P               D+ D          +      + +++       +   +
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307

Query: 236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
           L+ ++   +P++RIT++E   HP+F   L + +
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF-DLLKKSI 339

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 96.2 bits (240), Expect = 5e-23
 Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 8/206 (3%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
               +   +G G +G       K     VA+K ++          +E    K+++HPN++
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 72

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +   V        I+ E+   G L  + R CN    S     Y   Q+ S + Y      
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT-PA-YIAPEVLSRREYD 177
            HRDL   N L+  +    +K+ DFG S+     +         P  + APE L+  ++ 
Sbjct: 133 IHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 178 GKLADVWSCGVTLY-VMLVGAYPFED 202
            K +DVW+ GV L+ +   G  P+  
Sbjct: 191 IK-SDVWAFGVLLWEIATYGMSPYPG 215

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 94.7 bits (236), Expect = 3e-22
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 19/211 (9%)

Query: 5   ELMKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
           + +K +GSG FG       +   +  K  VA+K +       AN     E      + +P
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSM 117
           ++ R   + LT T + ++ +    G L + +  +           +  Q+  G++Y    
Sbjct: 78  HVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVLS 172
           ++ HRDL   N L+  +P   +KI DFG +K  LL +  K        +     A E + 
Sbjct: 137 RLVHRDLAARNVLV-KTPQ-HVKITDFGLAK--LLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 173 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
            R Y  + +DVWS GVT++ +M  G+ P++ 
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 16/210 (7%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
            + K IGSG+ G     RL         VA+K ++ G+          E     Q  HPN
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           IIR + VV       IV EY   G L  F R  + G+F+  +     + + +G+ Y   +
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYI---APEVLSR 173
              HRDL   N L+D +     K+ DFG S+          +T G    I   APE ++ 
Sbjct: 171 GYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 174 REYDGKLADVWSCGVTLY-VMLVGAYPFED 202
           R +    +DVWS GV ++ V+  G  P+ +
Sbjct: 229 RTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 93.9 bits (234), Expect = 4e-22
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 18/207 (8%)

Query: 8   KDIGSGNFGVAR--LMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNIIR 62
           K++GSGNFG  +    + K   + VA+K ++      A       E    +QL +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGT--P-AYIAPEVLSRREY 176
           DL   N LL  +     KI DFG SK   L +     K+      P  + APE ++  ++
Sbjct: 142 DLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYYKF 197

Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS GV ++     G  P+  
Sbjct: 198 SSK-SDVWSFGVLMWEAFSYGQKPYRG 223

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 95.7 bits (238), Expect = 6e-22
 Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 10/206 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG   +     T   VA+K ++ G        +E    K+LRH  ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L  F +          +      Q+ SG++Y   M  
Sbjct: 326 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY--IAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++    +               APE      + 
Sbjct: 385 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 178 GKLADVWSCGVTLY-VMLVGAYPFED 202
            K +DVWS G+ L  +   G  P+  
Sbjct: 443 IK-SDVWSFGILLTELTTKGRVPYPG 467

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 10/206 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG   +     T   VA+K ++ G        +E    K+LRH  ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L  F +          +      Q+ SG++Y   M  
Sbjct: 243 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAY--IAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++    +               APE      + 
Sbjct: 302 VHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 178 GKLADVWSCGVTLY-VMLVGAYPFED 202
            K +DVWS G+ L  +   G  P+  
Sbjct: 360 IK-SDVWSFGILLTELTTKGRVPYPG 384

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 93.9 bits (234), Expect = 9e-22
 Identities = 63/333 (18%), Positives = 123/333 (36%), Gaps = 82/333 (24%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHK 53
             + +++ +G G FG V    ++ + K+  A+K + R  K       I+A++ ++I N  
Sbjct: 35  NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDD 92

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGV 111
              + NI+++    +   H+ ++ E   G  L+E I       F  ++ + +  +++  +
Sbjct: 93  INNN-NIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150

Query: 112 SYCHSMQICHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSK 148
           +Y   M + H DLK EN LLD                             +K+ DFG   
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG--- 207

Query: 149 SSLLHSRPKST-VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA--YPFEDQED 205
            +   S    + + T  Y APEV+    +D    D+WS G  L  +  G+  +   +  +
Sbjct: 208 CATFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHME 266

Query: 206 ------------PKNFRKTISRIMAVQY--------------KIPDYVHISQDCR----- 234
                       PKN     ++    +Y                 + +   + C      
Sbjct: 267 HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326

Query: 235 -------NLLSRIFVANPSRRITIKEIKSHPWF 260
                  + L  I   +P+ R +  E+  H + 
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 91.9 bits (229), Expect = 1e-21
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 14/205 (6%)

Query: 5   ELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
             +++IGSG FG V         K  VA+K I  G   + +   E     +L HP +++ 
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68

Query: 64  KEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             V L    + +V E+   G L  + R    G F+ +        +  G++Y     + H
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRREYDG 178
           RDL   N L+  +    +K+ DFG ++  +L  +  S+ GT   +   +PEV S   Y  
Sbjct: 128 RDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 179 KLADVWSCGVTLY-VMLVGAYPFED 202
           K +DVWS GV ++ V   G  P+E+
Sbjct: 185 K-SDVWSFGVLMWEVFSEGKIPYEN 208

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 91.9 bits (229), Expect = 2e-21
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 24/220 (10%)

Query: 2   EKYELMKD--------IGSGNFG-VAR-LMRNKNTKELVAMKYIERGHKIDANVA--REI 49
           +K  L +D        +G GNFG V + + R +  +  VA+K +++G +        RE 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61

Query: 50  INHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLI 108
               QL +P I+R   V      + +VME A GG L + +                 Q+ 
Sbjct: 62  QIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-- 166
            G+ Y       HRDL   N LL  +     KI DFG SK +L       T  +      
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK-ALGADDSYYTARSAGKWPL 177

Query: 167 ---APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
              APE ++ R++  + +DVWS GVT++  +  G  P++ 
Sbjct: 178 KWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 19/211 (9%)

Query: 5   ELMKDIGSGNFGVAR----LMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHP 58
             +K +GSG FG       +   ++ K  V +K IE      +  A    ++    L H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSM 117
           +I+R   +    + L +V +Y   G L + +  + G         +  Q+  G+ Y    
Sbjct: 76  HIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVLS 172
            + HR+L   N LL  SP+ ++++ DFG +   LL    K  + + A       A E + 
Sbjct: 135 GMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 173 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
             +Y  + +DVWS GVT++ +M  GA P+  
Sbjct: 191 FGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 91.0 bits (226), Expect = 4e-21
 Identities = 32/207 (15%), Positives = 58/207 (28%), Gaps = 35/207 (16%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRHPN 59
           Y L+   G           +      VA+ +++    +  +V        +   ++  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           + R  +VV T     +V E+  GG L E        S   A    Q L +     H   +
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
                      +  S    +                    +  PA +             
Sbjct: 151 ALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA--------NP 181

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDP 206
             D+   G +LY +LV  +P  +    
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVR 208

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.1 bits (231), Expect = 5e-21
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 18/205 (8%)

Query: 10  IGSGNFGVAR--LMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPNIIRFKE 65
           +G GNFG  R  + R +  +  VA+K +++G +        RE     QL +P I+R   
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 66  VVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V      + +VME A GG L + +                 Q+  G+ Y       HR+L
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNL 462

Query: 125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYI---APEVLSRREYDG 178
              N LL  +     KI DFG SK   L +      +       +   APE ++ R++  
Sbjct: 463 AARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518

Query: 179 KLADVWSCGVTLY-VMLVGAYPFED 202
           + +DVWS GVT++  +  G  P++ 
Sbjct: 519 R-SDVWSYGVTMWEALSYGQKPYKK 542

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 90.3 bits (225), Expect = 6e-21
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 20/211 (9%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E  +L++ +G+G FG V     N +TK  VA+K +++G         E    KQL+H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRL 70

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +R   VV T   + I+ EY   G L  F +  +  + + ++      Q+  G+++     
Sbjct: 71  VRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG------TPAYIAPEVLS 172
             HRDL+  N L+  + +   KI DFG ++    +              T    APE ++
Sbjct: 130 YIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183

Query: 173 RREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
              +  K +DVWS G+ L  ++  G  P+  
Sbjct: 184 YGTFTIK-SDVWSFGILLTEIVTHGRIPYPG 213

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 90.0 bits (224), Expect = 6e-21
 Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           ++ +L++ IG G FG   L   +  K  VA+K I+      A +  E     QLRH N++
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFL-AEASVMTQLRHSNLV 77

Query: 62  RFKEVVLTPT-HLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           +   V++     L IV EY A G L  + R         D    F   +   + Y     
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 137

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVLSR 173
             HRDL   N L+  S     K+ DFG        ++  S+      +     APE L  
Sbjct: 138 FVHRDLAARNVLV--SEDNVAKVSDFGL-------TKEASSTQDTGKLPVKWTAPEALRE 188

Query: 174 REYDGKLADVWSCGVTLY-VMLVGAYPFED 202
           +++  K +DVWS G+ L+ +   G  P+  
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 56/205 (27%), Positives = 84/205 (40%), Gaps = 18/205 (8%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFK 64
           +L++ IG G FG   L   +  K  VA+K I+      A    E     QLRH N+++  
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLL 252

Query: 65  EVVLT-PTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
            V++     L IV EY A G L  + R         D    F   +   + Y       H
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 312

Query: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRREYDG 178
           RDL   N L+        K+ DFG +K +       +       +   APE L  +++  
Sbjct: 313 RDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFST 365

Query: 179 KLADVWSCGVTLY-VMLVGAYPFED 202
           K +DVWS G+ L+ +   G  P+  
Sbjct: 366 K-SDVWSFGILLWEIYSFGRVPYPR 389

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 20/215 (9%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLR 56
               + K +G+G FG     RL      +  VA+K ++ G+          E     Q  
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYC 114
           HPNIIR + VV     + IV EY   G L  F R  +  +F+  +     + + SG+ Y 
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL 163

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYI---AP 168
             M   HRDL   N L++ +     K+ DFG  +  +L   P    +T G    I   +P
Sbjct: 164 SDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSP 219

Query: 169 EVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
           E ++ R++    +DVWS G+ L+ VM  G  P+ +
Sbjct: 220 EAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 92.1 bits (229), Expect = 8e-21
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 12/207 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E  +L K +G+G FG   +       + VA+K ++ G         E    K L+H  ++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 62  RFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +   VV T   + I+ E+ A G L  F +     +    +   F  Q+  G+++      
Sbjct: 247 KLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRREY 176
            HRDL+  N L+  S     KI DFG ++  +  +   +  G    I   APE ++   +
Sbjct: 306 IHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSF 362

Query: 177 DGKLADVWSCGVTLY-VMLVGAYPFED 202
             K +DVWS G+ L  ++  G  P+  
Sbjct: 363 TIK-SDVWSFGILLMEIVTYGRIPYPG 388

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 14/208 (6%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           E+  L+K++GSG FG V            VA+K I+ G   +    +E     +L HP +
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD--VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKL 65

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           ++F  V      + IV EY + G L  + R  +       +       +  G+++  S Q
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQ 124

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRRE 175
             HRDL   N L+D      +K+ DFG ++  +L  +  S+VGT   +   APEV    +
Sbjct: 125 FIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFK 181

Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFED 202
           Y  K +DVW+ G+ ++ V  +G  P++ 
Sbjct: 182 YSSK-SDVWAFGILMWEVFSLGKMPYDL 208

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 49/220 (22%), Positives = 85/220 (38%), Gaps = 33/220 (15%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLR 56
           E   L + +G G FG         +K  K  VA+K  ++   +D       E +  K L 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCH 115
           HP+I++   ++       I+ME    GEL   +  N           +  Q+   ++Y  
Sbjct: 72  HPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI--------- 166
           S+   HRD+ + N L+       +K+ DFG S+           +    Y          
Sbjct: 131 SINCVHRDIAVRNILVASPEC--VKLGDFGLSRY----------IEDEDYYKASVTRLPI 178

Query: 167 ---APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
              +PE ++ R +    +DVW   V ++ ++  G  PF  
Sbjct: 179 KWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 63/214 (29%), Positives = 95/214 (44%), Gaps = 17/214 (7%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKEL-VAMKYIERGHKIDANVA--REIINHKQL 55
                 K IG+G FG      L  +   KE+ VA+K ++ G+     V    E     Q 
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSY 113
            H NIIR + V+     + I+ EY   G L  F R    G FS  +     + + +G+ Y
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKY 162

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP-KSTVGTPAYI---APE 169
             +M   HRDL   N L++ +     K+ DFG S+          +T G    I   APE
Sbjct: 163 LANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220

Query: 170 VLSRREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
            +S R++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 221 AISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 88.8 bits (221), Expect = 2e-20
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 14/208 (6%)

Query: 2   EKYELMKDIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           +    +K++G+G FG V            VA+K I+ G   +     E      L H  +
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL 81

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           ++   V      + I+ EY A G L  + R     RF   +     + +   + Y  S Q
Sbjct: 82  VQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI---APEVLSRRE 175
             HRDL   N L++      +K+ DFG S+  +L     S+VG+   +    PEVL   +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197

Query: 176 YDGKLADVWSCGVTLY-VMLVGAYPFED 202
           +  K +D+W+ GV ++ +  +G  P+E 
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYER 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 88.1 bits (219), Expect = 4e-20
 Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 17/212 (8%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLR 56
           E+ EL + IG G FG       M  +N    VA+K  +            +E +  +Q  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYC 114
           HP+I++   V+       I+ME    GEL  F +              +  QL + ++Y 
Sbjct: 75  HPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYL 132

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGT--PA-YIAPEVL 171
            S +  HRD+   N L+  +    +K+ DFG S+  +  S          P  ++APE +
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 189

Query: 172 SRREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
           + R +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 190 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 13/210 (6%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLR 56
           E+ EL + IG G FG       M  +N    VA+K  +            +E +  +Q  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCH 115
           HP+I++   V+       I+ME    GEL   +              +  QL + ++Y  
Sbjct: 450 HPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG-TPA-YIAPEVLSR 173
           S +  HRD+   N L+  +    +K+ DFG S+     +  K++ G  P  ++APE ++ 
Sbjct: 509 SKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566

Query: 174 REYDGKLADVWSCGVTLY-VMLVGAYPFED 202
           R +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 567 RRFTSA-SDVWMFGVCMWEILMHGVKPFQG 595

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 72/363 (19%), Positives = 117/363 (32%), Gaps = 108/363 (29%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-----INHKQLR 56
            +Y +++ +G G+F    L  +   K+ VAMK ++           EI     + +    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 57  HPN--IIR-----FKEVVLTPTHLAIVMEYAAGGELFERIC--NAGRFSEDEARYFFQQL 107
            PN  ++      FK   +  TH+ +V E   G  L + I   N         +   QQ+
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQV 155

Query: 108 ISGVSYCHS-MQICHRDLKLENTLLD---------------------------------- 132
           + G+ Y H+  +I H D+K EN LL                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 133 -------------GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
                         +   ++KI D G   +  +H      + T  Y + EVL    Y+  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273

Query: 180 LADVWSCGVTLYVMLVGAYPFE--DQEDPKNFRKTISRIMAVQYKIP------------- 224
            AD+WS     + +  G Y FE    E+       I+ I+ +  K+P             
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 225 -----DYVHIS----------------------QDCRNLLSRIFVANPSRRITIKEIKSH 257
                D  HI+                          + L  +    P +R T  E   H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 258 PWF 260
           PW 
Sbjct: 393 PWL 395

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 52/220 (23%), Positives = 80/220 (36%), Gaps = 24/220 (10%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           +   L++ +G G FG         M N  +   VA+K +         +    E +   +
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------ 108
             H NI+R   V L      I+ME  AGG+L   +          +      L+      
Sbjct: 90  FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 109 -SGVSYCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYI 166
             G  Y       HRD+   N LL      R+ KI DFG ++   ++       G  A +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAML 207

Query: 167 -----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
                 PE      +  K  D WS GV L+ +  +G  P+
Sbjct: 208 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 85.8 bits (213), Expect = 4e-19
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 35/226 (15%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQL 55
           +++ L + +G G FG    A+L +   +   VA+K ++      +++    RE    K+ 
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 56  RHPNIIRFKEVVL------TPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQL 107
            HP++ +   V L            +++ +   G+L  F     A R  E+      Q L
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQTL 139

Query: 108 I-------SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 160
           +        G+ Y  S    HRDL   N +L       + + DFG S+   ++S      
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYYRQ 195

Query: 161 GTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
           G  + +     A E L+   Y    +DVW+ GVT++ +M  G  P+
Sbjct: 196 GCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 58/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
              + IG G+FG      L+ N   K   A+K + R   I        E I  K   HPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87

Query: 60  IIRFKEVVLTPTH-LAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           ++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ Y  S
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 171
            +  HRDL   N +LD      +K+ DFG ++             T A +     A E L
Sbjct: 147 KKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 172 SRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
             +++  K +DVWS GV L+ +M  GA P+
Sbjct: 205 QTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 86.0 bits (213), Expect = 6e-19
 Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 18/210 (8%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
              + IG G+FG      L+ N   K   A+K + R   I        E I  K   HPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151

Query: 60  IIRFKEVVLTPTH-LAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           ++    + L       +V+ Y   G+L  F R       +  +   F  Q+  G+ +  S
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEVL 171
            +  HRDL   N +LD      +K+ DFG ++             T A +     A E L
Sbjct: 211 KKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 172 SRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
             +++  K +DVWS GV L+ +M  GA P+
Sbjct: 269 QTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 85.1 bits (211), Expect = 9e-19
 Identities = 51/220 (23%), Positives = 80/220 (36%), Gaps = 24/220 (10%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           +   L++ +G G FG         M N  +   VA+K +         +    E +   +
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI------ 108
             H NI+R   V L      I++E  AGG+L   +          +      L+      
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 109 -SGVSYCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHSRPKSTVGTPAYI 166
             G  Y       HRD+   N LL      R+ KI DFG ++   ++       G  A +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGYYRKGGCAML 248

Query: 167 -----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
                 PE      +  K  D WS GV L+ +  +G  P+
Sbjct: 249 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 83.5 bits (207), Expect = 1e-18
 Identities = 37/222 (16%), Positives = 76/222 (34%), Gaps = 29/222 (13%)

Query: 2   EKYELMKDIGSGNFGV-------ARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-- 52
           E     + +G G F               +  +  V +K +++ H    N +        
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAAS 64

Query: 53  --KQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLI 108
              +L H +++    V +      +V E+   G L  + +  N    +        +QL 
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLA 123

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRL------KICDFGYSKSSLLHSRPKSTVGT 162
           + + +     + H ++  +N LL      +       K+ D G S + L     +  +  
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI-- 181

Query: 163 PAYIAPEVLS-RREYDGKLADVWSCGVTLY-VMLVGAYPFED 202
             ++ PE +   +  +    D WS G TL+ +   G  P   
Sbjct: 182 -PWVPPECIENPKNLNLA-TDKWSFGTTLWEICSGGDKPLSA 221

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 54/225 (24%), Positives = 85/225 (37%), Gaps = 34/225 (15%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQL 55
               L K +G G FG      L +   T   VA+K ++  +     +     E    K  
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 56  RHPNIIRFKEVVL-----TPTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLI 108
            HPN+IR   V +           +++ +   G+L  +       R          Q L+
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQTLL 150

Query: 109 -------SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG 161
                   G+ Y  +    HRDL   N +L       + + DFG SK   ++S      G
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYRQG 206

Query: 162 TPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
             A +     A E L+ R Y  K +DVW+ GVT++ +   G  P+
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 82.3 bits (204), Expect = 5e-18
 Identities = 45/222 (20%), Positives = 89/222 (40%), Gaps = 28/222 (12%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           EK  + +++G G+FG     VA+ +     +  VA+K +     +   +    E    K+
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL--FERICNAGRFSEDEAR--------YFF 104
               +++R   VV       ++ME    G+L  + R       +                
Sbjct: 85  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA 164
            ++  G++Y ++ +  HRDL   N ++  +    +KI DFG ++   ++       G   
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200

Query: 165 YI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
            +     +PE L    +    +DVWS GV L+ +  +   P+
Sbjct: 201 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 20/211 (9%)

Query: 5   ELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQLRHPN 59
              + IG G+FGV      +     +   A+K + R  ++    A  RE +  + L HPN
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 60  IIRFKEVVLT--PTHLAIVMEYAAGGEL--FERICNAGRFSEDEARYFFQQLISGVSYCH 115
           ++    ++L        +++ Y   G+L  F R       +  +   F  Q+  G+ Y  
Sbjct: 84  VLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYI-----APEV 170
             +  HRDL   N +LD S    +K+ DFG ++  L            A +     A E 
Sbjct: 142 EQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 171 LSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
           L    +  K +DVWS GV L+ ++  GA P+
Sbjct: 200 LQTYRFTTK-SDVWSFGVLLWELLTRGAPPY 229

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.0 bits (198), Expect = 3e-17
 Identities = 69/293 (23%), Positives = 112/293 (38%), Gaps = 45/293 (15%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQL 55
               L +++G G FG         +     K LVA+K ++        +  RE      L
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE---------RICNAGRFSEDEARYFFQQ 106
           +H +I++F  V      L +V EY   G+L +          I   G+  + +      Q
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134

Query: 107 LI-------SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 159
           ++       SG+ Y  S    HRDL   N L+       +KI DFG S+   ++S     
Sbjct: 135 MLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYR 190

Query: 160 VGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTI 213
           VG    +      PE +  R++  + +DVWS GV L+ +   G  P+    + +      
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249

Query: 214 S-RIMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL 264
             R++      P  V+ +   C           P +R+ IKEI      L  L
Sbjct: 250 QGRVLERPRVCPKEVYDVMLGCWQ-------REPQQRLNIKEIY---KILHAL 292

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 79.2 bits (196), Expect = 8e-17
 Identities = 52/230 (22%), Positives = 86/230 (37%), Gaps = 37/230 (16%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
            +    K +G+G FG      A  +   +    VA+K ++    +    A   E+     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------FERICNAGRFSEDEARY 102
           L  H NI+             ++ EY   G+L                +     +DE   
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 155
             + L+S       G+++  S    HRDL   N LL        KICDFG ++   + + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKND 198

Query: 156 PKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYP 199
               V   A +     APE +    Y  + +DVWS G+ L+ +  +G+ P
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 42/228 (18%), Positives = 85/228 (37%), Gaps = 34/228 (14%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
                M+++G   FG                + VA+K ++   +         E +   +
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARYFFQ 105
           L+HPN++    VV     L+++  Y + G+L            + +       ++     
Sbjct: 69  LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 106 QLI-------SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS 158
             +       +G+ Y  S  + H+DL   N L+       +KI D G  +   +++    
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYY 184

Query: 159 TVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
            +   + +     APE +   ++    +D+WS GV L+ V   G  P+
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 55/226 (24%), Positives = 88/226 (38%), Gaps = 32/226 (14%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQL 55
               L  ++G G FG         +  +  K LVA+K ++   +    +  RE      L
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------------FERICNAGRFSEDEA 100
           +H +I+RF  V      L +V EY   G+L                      G     + 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 101 RYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV 160
                Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     V
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSRD--IYSTDYYRV 216

Query: 161 GTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
           G    +      PE +  R++  + +DVWS GV L+ +   G  P+
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 76.9 bits (190), Expect = 5e-16
 Identities = 57/226 (25%), Positives = 86/226 (38%), Gaps = 37/226 (16%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQL- 55
              +    IG GNFG    AR+ +    +   A+K ++     D +     E+    +L 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARI-KKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 83

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARYFFQQ 106
            HPNII          +L + +EYA  G L          E        +   +    QQ
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 107 LI-------SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 159
           L+        G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++      
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVY-----V 196

Query: 160 VGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYP 199
             T   +     A E L+   Y    +DVWS GV L+ ++ +G  P
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 56/236 (23%), Positives = 89/236 (37%), Gaps = 42/236 (17%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           +   L K +G G FG      A  ++ +     VA+K ++             E    KQ
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------------FERICNAGRFSE 97
           + HP++I+          L +++EYA  G L                      ++     
Sbjct: 83  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 98  DEARYFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 150
           DE       LIS       G+ Y   M++ HRDL   N L+       +KI DFG S+  
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSR-- 198

Query: 151 LLHSRPKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
            ++        +   I     A E L    Y  + +DVWS GV L+ ++ +G  P+
Sbjct: 199 DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 52/236 (22%), Positives = 87/236 (36%), Gaps = 42/236 (17%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
              E ++DIG G FG      A  +       +VA+K ++     D      RE     +
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL-----------------FERICNAGRFSE 97
             +PNI++   V      + ++ EY A G+L                  +    A   S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 98  DEARYFFQQLI-------SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 150
                   + +       +G++Y    +  HRDL   N L+       +KI DFG S++ 
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN- 223

Query: 151 LLHSRPKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
            ++S           I      PE +    Y  + +DVW+ GV L+ +   G  P+
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 62/287 (21%), Positives = 107/287 (37%), Gaps = 43/287 (14%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
              +  K +G+G FG      A  +  ++    VA+K ++     D   A   E+     
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE-------RICNAGRFSEDEARYFFQQ 106
           L +H NI+           + ++ EY   G+L          +     F+   +    + 
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 107 LIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 159
           L+        G+++  S    HRD+   N LL  +     KI DFG ++   + +     
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLAR--DIMNDSNYI 221

Query: 160 VGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTI 213
           V   A +     APE +    Y  + +DVWS G+ L+ +  +G  P+        F K +
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280

Query: 214 SR--IMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSH 257
                MA     P  ++ I Q C           P+ R T ++I S 
Sbjct: 281 KDGYQMAQPAFAPKNIYSIMQACWA-------LEPTHRPTFQQICSF 320

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.5 bits (181), Expect = 7e-15
 Identities = 72/313 (23%), Positives = 121/313 (38%), Gaps = 48/313 (15%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKE--LVAMKYIERGHKIDANVA--REIINH 52
           +K  L K +G G FG      A  +     KE   VA+K ++             E+   
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARY 102
           K + +H NII           L +++EYA+ G L              +       E + 
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 155
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +++ 
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNI 210

Query: 156 PKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNF 209
                 T   +     APE L  R Y  + +DVWS GV ++ +  +G  P+      + F
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269

Query: 210 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 269
           +          +++    + + +   ++   + A PS+R T K++         L R LT
Sbjct: 270 KLLKEG-----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED------LDRILT 318

Query: 270 ETAQAIYYRKENP 282
            T    Y     P
Sbjct: 319 LTTNEEYLDLSQP 331

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 70/304 (23%), Positives = 119/304 (39%), Gaps = 48/304 (15%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKE--LVAMKYIERGHKIDANVA--REIINH 52
           +K  L K +G G FG      A  +     KE   VA+K ++             E+   
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140

Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARY 102
           K + +H NII           L +++EYA+ G L              +       E + 
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 155
            F+ L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +++ 
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNI 256

Query: 156 PKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNF 209
                 T   +     APE L  R Y  + +DVWS GV ++ +  +G  P+      + F
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315

Query: 210 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 269
           +          +++    + + +   ++   + A PS+R T K++         L R LT
Sbjct: 316 KLLKEG-----HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED------LDRILT 364

Query: 270 ETAQ 273
            T  
Sbjct: 365 LTTN 368

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 72.4 bits (178), Expect = 1e-14
 Identities = 59/268 (22%), Positives = 103/268 (38%), Gaps = 47/268 (17%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH---- 57
             Y++ + IG G+FGV     N    + VA+K+ E        +  E   +K L      
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           PN+  F +      H  +V++   G    +L   +C   +FS        +Q+++ V   
Sbjct: 69  PNVYYFGQ---EGLHNVLVIDL-LGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSI 122

Query: 115 HSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSLLH---SRPKSTVGTP 163
           H   + +RD+K +N L+   +   A  + + DFG  K      +  H      K+  GT 
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182

Query: 164 AYIAP-----EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA 218
            Y++         SRR+      D+ + G      L G+ P++  +   N +K   RI  
Sbjct: 183 RYMSINTHLGREQSRRD------DLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGE 235

Query: 219 VQYKIP----------DYVHISQDCRNL 236
            +   P          ++       RNL
Sbjct: 236 KKQSTPLRELCAGFPEEFYKYMHYARNL 263

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 66/323 (20%), Positives = 121/323 (37%), Gaps = 45/323 (13%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKE--LVAMKYIERGHKIDANVA--REIINH 52
           ++  L K +G G FG      A  +          VA+K ++             E+   
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128

Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL---------FERICNAGRFSEDEARY 102
           K + +H NII           L +++EYA+ G L              +       E + 
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 103 FFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 155
             + L+S       G+ Y  S +  HRDL   N L+  +    +KI DFG ++   +H  
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHHI 244

Query: 156 PKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNF 209
                 T   +     APE L  R Y  + +DVWS GV L+ +  +G  P+      + F
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303

Query: 210 RKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELT 269
           +          +++    + + +   ++   + A PS+R T K++      L  +    +
Sbjct: 304 KLLKEG-----HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV---EDLDRIVALTS 355

Query: 270 ETAQAIYYRKENPTFSLQSVEEI 292
                 Y+   +  + + + E +
Sbjct: 356 NQEMGYYHHHHHHDYDIPTTENL 378

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 36/230 (15%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           ++ +L K +G G FG      A  +    T   VA+K ++ G     + A   E+     
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 55  L-RHPNIIRFKEVVLTP-THLAIVMEYAAGGEL---------FERICNAGRFSEDEARYF 103
           +  H N++        P   L +++E+   G L                      +    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146

Query: 104 FQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP 156
            + LI        G+ +  S +  HRDL   N LL       +KICDFG ++   ++  P
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDP 202

Query: 157 KSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPF 200
                  A +     APE +  R Y  + +DVWS GV L+ +  +GA P+
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 28/216 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNI 60
            K+ L + IGSG+FG   L  N  T E VA+K  E        +  E   ++ L+    I
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 61  IRFKEVVLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
              +   +   +  +VM+   G    +LF   C+  + S         Q+I+ V + HS 
Sbjct: 66  PNVRWFGVEGDYNVLVMDL-LGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSK 122

Query: 118 QICHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSLLHSRP---KSTVGTPAYIAP 168
              HRD+K +N L+  G  A ++ I DFG +K     S+  H      K+  GT  Y + 
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182

Query: 169 EV-----LSRREYDGKLADVWSCGVTLYVMLVGAYP 199
                   SRR  D    D+ S G  L   L G+ P
Sbjct: 183 NTHLGIEQSRR--D----DLESLGYVLMYFLRGSLP 212

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.8 bits (174), Expect = 7e-14
 Identities = 71/315 (22%), Positives = 110/315 (34%), Gaps = 58/315 (18%)

Query: 2   EKYELMKDIGSGNFG-----VARLMRNKNTKELVAMKYIERGHKIDANVA--REIINHKQ 54
           E  E  K +GSG FG      A  +        VA+K ++         A   E+    Q
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGEL----------------FERICNAGRFSE 97
           L  H NI+           + ++ EY   G+L                           E
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 98  DEARYFFQQLIS-------GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 150
           D     F+ L+        G+ +       HRDL   N L+       +KICDFG ++  
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD- 221

Query: 151 LLHSRPKSTVGTPAYI-----APEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQE 204
            + S     V   A +     APE L    Y  K +DVWS G+ L+ +  +G  P+    
Sbjct: 222 -IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP 279

Query: 205 DPKNFRKTISR--IMAVQYKIPDYVH-ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL 261
              NF K I     M   +   + ++ I Q C          +  +R +   + S     
Sbjct: 280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWA-------FDSRKRPSFPNLTSF---- 328

Query: 262 KNLPRELTETAQAIY 276
             L  +L +  +A+Y
Sbjct: 329 --LGCQLADAEEAMY 341

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 70.1 bits (172), Expect = 8e-14
 Identities = 69/283 (24%), Positives = 108/283 (38%), Gaps = 55/283 (19%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNI 60
            +Y L + IGSG+FG   L  +    E VA+K  E        +  E   +K ++    I
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 61  IRFKEVVLTPTHLAIVMEYAAG---GELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
              +       +  +VME   G    +LF   C+  +FS         Q+IS + Y HS 
Sbjct: 68  PTIRWCGAEGDYNVMVMEL-LGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSK 124

Query: 118 QICHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSLLH---SRPKSTVGTPAYIAP 168
              HRD+K +N L+  G     + I DFG +K      +  H      K+  GT  Y + 
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184

Query: 169 -----EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED------------------ 205
                   SRR  D    D+ S G  L    +G+ P++  +                   
Sbjct: 185 NTHLGIEQSRR--D----DLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238

Query: 206 --------PKNFRKTISRIMAVQYKI-PDYVHISQDCRNLLSR 239
                   P  F   ++   ++++   PDY ++ Q  RNL  R
Sbjct: 239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 62/233 (26%), Positives = 95/233 (40%), Gaps = 38/233 (16%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH----P 58
            + + K IG GNFG  RL +N  T E VA+K +E        +  E   +KQL      P
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGG----ELFERICNAGRFSEDEARYFFQQLISGVSYC 114
            +  F        + A+V+E    G    +LF  +C+   FS         QLIS + Y 
Sbjct: 69  QVYYFGP---CGKYNAMVLELL--GPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYV 121

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSLLH---SRPKSTVGTP 163
           HS  + +RD+K EN L+        ++    DF  +K      +  H      KS  GT 
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181

Query: 164 AYIAP-----EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK 211
            Y++      +  SRR  D    D+ + G      L G+ P++  +      +
Sbjct: 182 RYMSINTHLGKEQSRR--D----DLEALGHMFMYFLRGSLPWQGLKADTLKER 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.9 bits (157), Expect = 6e-12
 Identities = 52/227 (22%), Positives = 71/227 (31%), Gaps = 59/227 (25%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN---------VAREIINH 52
           EK +  + IG G FG        +T   VA+K I        N         +  EII  
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 53  KQL---------RHPNIIRFKEVVL------------------------------TPTHL 73
           K+L         R    I    V                                    L
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 74  AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH-SMQICHRDLKLENTLLD 132
            IV+E+  GG   E++      S   A+    QL + ++    S++  HRDL   N LL 
Sbjct: 138 FIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 133 GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
                  K+      KSS +      + G    I    LSR E DG 
Sbjct: 197 --KTSLKKLHYTLNGKSSTIP-----SCGLQVSIIDYTLSRLERDGI 236

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 60.6 bits (148), Expect = 1e-10
 Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 17/107 (15%)

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-----GTPA 164
           G+++ H     HRD+K  N LLD +     KI DFG ++        ++ +     GT A
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLAR--ASEKFAQTVMTSRIVGTTA 200

Query: 165 YIAPEVLSRREYDGKL---ADVWSCGVTLYVMLVGAYPFEDQEDPKN 208
           Y+APE L      G++   +D++S GV L  ++ G    ++  +P+ 
Sbjct: 201 YMAPEALR-----GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 52/248 (20%), Positives = 90/248 (36%), Gaps = 52/248 (20%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           ++ L K IGSG FG+  L    N  E  A   ++  ++ +  +  E+  ++++   + I+
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 63  FKEVVLTPTHLAI-------------------VMEYAAGGELFERICNAGRFSEDEARYF 103
                    +L I                   VME   G +L +     G F +      
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQL 156

Query: 104 FQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRP-- 156
             +++  + Y H  +  H D+K  N LL      ++ + D+G S       +    +   
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216

Query: 157 -KSTVGTPAY--------IAPEVLSRREYDGKLADVWSCGVTLYVM---LVGAYPFED-Q 203
            K   GT  +        +A    SRR      +DV   G   Y M   L G  P+E   
Sbjct: 217 RKGHNGTIEFTSLDAHKGVAL---SRR------SDVEILG---YCMLRWLCGKLPWEQNL 264

Query: 204 EDPKNFRK 211
           +DP   + 
Sbjct: 265 KDPVAVQT 272

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.9 bits (135), Expect = 6e-09
 Identities = 34/233 (14%), Positives = 71/233 (30%), Gaps = 55/233 (23%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNT--------KELVAMKYIERGH---KIDANVAREII 50
            +++L       N G+       +T        K+  ++K ++        + N  +   
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100

Query: 51  NHKQLRHPNIIRFKEVVLTPT----------HLAIVMEYAAG---GELFERICNAGRFSE 97
              Q+     +    ++  PT          +  +V+    G       +        SE
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDV-SPKHVLSE 158

Query: 98  DEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLH- 153
                   +L+  + + H  +  H ++  EN  +D     ++ +  +G++     S  H 
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 154 ----SRPKSTVGTPAY--------IAPEVLSRREYDGKLADVWSCGVTLYVML 194
                      G   +          P   SRR      +D+ S G   Y ML
Sbjct: 219 AYVEGSRSPHEGDLEFISMDLHKGCGP---SRR------SDLQSLG---YCML 259

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 55.7 bits (135), Expect = 6e-09
 Identities = 38/93 (40%), Positives = 49/93 (52%), Gaps = 12/93 (12%)

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK-STV--GTPAYI 166
           G+ Y H+  I HRD+K  N LLD +  P  KI DFG SK      +   STV  GT  YI
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGTLGYI 208

Query: 167 APEVLSRREYDGKL---ADVWSCGVTLYVMLVG 196
            PE   +    G+L   +DV+S GV L+ +L  
Sbjct: 209 DPEYFIK----GRLTEKSDVYSFGVVLFEVLCA 237

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 56.0 bits (134), Expect = 9e-09
 Identities = 46/369 (12%), Positives = 115/369 (31%), Gaps = 79/369 (21%)

Query: 4   YELMKDIGSGNFG--VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
            + ++++   N+   ++ +   +    ++   YIE+  ++  N  +    +   R    +
Sbjct: 80  QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYL 138

Query: 62  RFKEVVLTPTHLAIVMEYAAGGE----LFERICNAGRFSEDEARYFFQQL-ISGVSYCHS 116
           + ++ +L       V+     G     +   +C + +    + +  F+   ++ +  C+S
Sbjct: 139 KLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LKNCNS 194

Query: 117 -------MQ-ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
                  +Q + ++      +  D S   +L+I         LL S+P         +  
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN----CLL-- 248

Query: 169 EVLSRREYDGKLADVWS----------C---------GVTLYVMLVGAYPFEDQEDPKNF 209
            VL          +V +          C          VT ++                 
Sbjct: 249 -VL-----L----NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298

Query: 210 RKTISR-IMAVQYKIPDYVHIS-QDCRNLLSRIFVANPSRRITI--KEIKSHP--W-FLK 262
                + ++        Y+    QD    +      NP RR++I  + I+     W   K
Sbjct: 299 TPDEVKSLLL------KYLDCRPQDLPREVLTT---NP-RRLSIIAESIRDGLATWDNWK 348

Query: 263 NLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIGGFGWGGEEDGDE 322
           ++  +   T          P    +  + ++     A +P  +   I    W    D  +
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI----WF---DVIK 401

Query: 323 KEEETDADE 331
            +     ++
Sbjct: 402 SDVMVVVNK 410

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 36/229 (15%), Positives = 74/229 (32%), Gaps = 49/229 (21%)

Query: 3   KYELMKDIGSGNFGV---ARLMRNKN--TKELVAMKYIERGHK---------IDANVARE 48
            +++   IG G FG    A +  +++  +     +K     +            A    +
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 49  IINHKQLRH------PNIIRF-KEVVLTPTHLAIVMEYAAG---GELFERICNAGRFSED 98
           I    + R       P             ++  ++M+   G    +++E      RFS  
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NA-KRFSRK 152

Query: 99  EARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLH 153
                  +++  + Y H  +  H D+K  N LL+     ++ + D+G +           
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212

Query: 154 SRP---KSTVGTPAYIAPEV-----LSRREYDGKLADVWSCGVTLYVML 194
                 +   GT  + + +       SRR       D+   G   Y M+
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRR------GDLEILG---YCMI 252

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 33/92 (35%), Positives = 42/92 (45%), Gaps = 20/92 (21%)

Query: 110 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV-----G 161
           G++Y H     +I HRD+K  N LLD        + DFG +K   L     + V     G
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTTAVRG 197

Query: 162 TPAYIAPEVLSRREYDGKL---ADVWSCGVTL 190
           T  +IAPE LS     GK     DV+  GV L
Sbjct: 198 TIGHIAPEYLST----GKSSEKTDVFGYGVML 225

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 34/115 (29%), Positives = 55/115 (47%), Gaps = 7/115 (6%)

Query: 103 FFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPKSTV 160
           +  Q+  G+ +  S +  HRDL   N LL       +KICDFG ++          K   
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDA 255

Query: 161 GTPA-YIAPEVLSRREYDGKLADVWSCGVTLY-VMLVGAYPFEDQEDPKNFRKTI 213
             P  ++APE +  R Y  + +DVWS GV L+ +  +GA P+   +  + F + +
Sbjct: 256 RLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	351
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.52
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.3
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.89
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.73
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.7
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.56
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.52
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.46
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.27
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.25
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.07
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.0
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.89
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.66
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.6
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.58
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.56
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.55
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.38
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.38
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.35
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.11
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.63
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.19
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.23
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.67
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.29

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=9.8e-69  Score=476.54  Aligned_cols=258  Identities=41%  Similarity=0.720  Sum_probs=213.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++++.||+|+||+||+|.+..+++.||+|++.+...    ....+.+|+.++++++|||||++++++.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            4789999999999999999999999999999999976432    235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||| +|+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+........
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL--NVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC--CEEECCSSCC---------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC--CEEEeecCCCeecCCCCcc
Confidence            9999 679999999999999999999999999999999999999999999999998765  4999999999866555556


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      .+.+||+.|||||++.+..+++.++|||||||++|+|++|++||...+.    ......+......+|.  .+|+++++|
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l  242 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI----PVLFKNISNGVYTLPK--FLSPGAAGL  242 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TSCHHHHHH
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence            6789999999999999988877779999999999999999999987543    3334445555555554  689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      |.+||++||.+|||++|+++||||+..+++.
T Consensus       243 i~~~L~~dP~~R~s~~eil~hpw~k~~~p~~  273 (275)
T 3hyh_A          243 IKRMLIVNPLNRISIHEIMQDDWFKVDLPEY  273 (275)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHCHHHHTTCCGG
T ss_pred             HHHHccCChhHCcCHHHHHcCcccccCCChh
Confidence            9999999999999999999999998776643

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-67  Score=476.17  Aligned_cols=255  Identities=30%  Similarity=0.538  Sum_probs=224.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||+||+|++..+++.||||++.+..    .....+.+|+.++++|+|||||+++++|.+++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999999997532    23356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC---C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---S  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~---~  154 (351)
                      |||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+.....   .
T Consensus       112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g--~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECCTTTTCC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC--CEEEEEcCCceecCCCCCcc
Confidence            9999999999999999999999999999999999999999999999999999998766  4999999999864322   2


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      ...+.+||+.|||||++.+..|+ .++|||||||++|+|++|++||...+.    ..+..++....+.+|.  .+|++++
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~  262 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNE----GLIFAKIIKLEYDFPE--KFFPKAR  262 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHTCCCCCT--TCCHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCCCc--ccCHHHH
Confidence            34567899999999999888875 559999999999999999999987543    3344455666666664  6899999


Q ss_pred             HHHHHhcccCCCCCCChHH------HhcCcccccCCC
Q 018734          235 NLLSRIFVANPSRRITIKE------IKSHPWFLKNLP  265 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~e------il~hp~~~~~~~  265 (351)
                      +||.+||++||.+|||++|      |++||||.....
T Consensus       263 dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw  299 (311)
T 4aw0_A          263 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW  299 (311)
T ss_dssp             HHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred             HHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence            9999999999999999988      589999976543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.6e-67  Score=478.94  Aligned_cols=257  Identities=26%  Similarity=0.485  Sum_probs=222.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +.|+++++||+|+||+||+|.+..+|+.||||++..... ....+.+|+.+++.++|||||+++++|.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            469999999999999999999999999999999975433 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  159 (351)
                      +||+|.+++.+ +++++..++.++.||+.||.|||++|||||||||+||||+.++  ++||+|||+|+..... ......
T Consensus       154 ~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          154 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC--CEEEecCcCceecCCCCCccccc
Confidence            99999998876 5799999999999999999999999999999999999998766  4999999999865433 344567


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-hccCCCCccCCCHhHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  238 (351)
                      +||+.|||||++.+..|+ .++|||||||++|||++|++||........+.    .+.. ....++.+..+|+++++||.
T Consensus       231 ~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~----~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK----MIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH----HHHcCCCCCCCccccCCHHHHHHHH
Confidence            899999999999888885 55999999999999999999998765433332    2222 22234555679999999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          239 RIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      +||++||.+|||+.|+|+||||++..++
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            9999999999999999999999876553

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-67  Score=482.36  Aligned_cols=260  Identities=29%  Similarity=0.521  Sum_probs=217.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |++|++++.||+|+||+||+|++..+|+.||||++.....   ....+.+|+.++++|+|||||++++++.+++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999999976532   2356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           78 EYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      |||+||+|.+++...  ..+++..++.|+.||+.||.|||++||+||||||+||||+.++  ++||+|||+|+...... 
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG--TVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC--CEEECSTTEESCCCHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC--CEEEcccccceeecCCcc
Confidence            999999999999754  4579999999999999999999999999999999999998766  49999999998543221 


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||+.|||||++.+..|+ .++|||||||++|+|++|++||...+...    .+.++....+. +.+..+|+++.
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~~~~~~-~~~~~~s~~~~  254 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKN----LVLKIISGSFP-PVSLHYSYDLR  254 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCC-CCCTTSCHHHH
T ss_pred             cccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHcCCCC-CCCccCCHHHH
Confidence            22345799999999999988875 45999999999999999999998765433    33344444432 34457899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCChhh
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL  268 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~~  268 (351)
                      +||.+||++||.+|||+.|+|+||||.+...+.+
T Consensus       255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~  288 (350)
T 4b9d_A          255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFL  288 (350)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHTTGGGTS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHHhhcCCCcCC
Confidence            9999999999999999999999999987655443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-65  Score=479.79  Aligned_cols=257  Identities=26%  Similarity=0.485  Sum_probs=222.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +.|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            469999999999999999999999999999999976433 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  159 (351)
                      .||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+||||+.++  ++||+|||+|+..... ......
T Consensus       231 ~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g--~vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          231 EGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG--RVKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             TTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC--CEEECCCTTCEECCSSCCCBCCC
T ss_pred             CCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEecCccceECCCCCcccccc
Confidence            99999998865 5699999999999999999999999999999999999998766  4999999999865433 344567


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-hccCCCCccCCCHhHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  238 (351)
                      +||+.|||||++.+..|+ .++|||||||++|||++|++||........+.    .+.. ....++.+..+|+++++||.
T Consensus       308 ~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~----~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK----MIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             EECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH----HHHcCCCCCCcccccCCHHHHHHHH
Confidence            899999999999888885 45999999999999999999998765433332    2222 22234555679999999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          239 RIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      +||+.||.+|||+.|+|+||||++..++
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence            9999999999999999999999876554

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.6e-66  Score=466.12  Aligned_cols=253  Identities=32%  Similarity=0.592  Sum_probs=213.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++.+..   .....+.+|+.++++++|||||++++++.+++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999884   468899999997643   223467889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~  154 (351)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+.... ..
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g--~vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG--HIKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS--CEEEESSEEEEC-----C
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC--CEEecccccceeccCCCc
Confidence            999999999999999999999999999999999999999999999999999999998766  499999999985433 33


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      ...+.+||+.|||||++.+..|+. ++|||||||++|+|++|++||...+...    .+..+......+|  ..+|+++.
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~  254 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQ-SADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTMILKAKLGMP--QFLSPEAQ  254 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHH
T ss_pred             cccccccCcccCCHHHhccCCCCC-CCcccchHHHHHHHHhCCCCCCCcCHHH----HHHHHHcCCCCCC--CcCCHHHH
Confidence            445678999999999999888865 4999999999999999999998765433    3444455555454  46899999


Q ss_pred             HHHHHhcccCCCCCCC-----hHHHhcCcccccC
Q 018734          235 NLLSRIFVANPSRRIT-----IKEIKSHPWFLKN  263 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps-----~~eil~hp~~~~~  263 (351)
                      +||.+||++||.+|||     ++|+++||||+..
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999999998     4799999999764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.5e-65  Score=456.73  Aligned_cols=253  Identities=23%  Similarity=0.394  Sum_probs=211.8

Q ss_pred             Ce-eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc----CCEEE
Q 018734            3 KY-ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT----PTHLA   74 (351)
Q Consensus         3 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~----~~~~~   74 (351)
                      || ++.+.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+.++++|+|||||+++++|.+    +..+|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            44 788899999999999999999999999999875432   23468899999999999999999999865    35689


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|  |+||||||+||||+.. .+++||+|||+|+.. .
T Consensus       106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~-~g~vKl~DFGla~~~-~  183 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLK-R  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST-TSCEEECCTTGGGGC-C
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC-CCCEEEEeCcCCEeC-C
Confidence            99999999999999999999999999999999999999999998  9999999999999742 235999999999743 2


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      .......+|||.|||||++.+ .|+ .++|||||||++|||+||++||........+   ...+.............+++
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~---~~~i~~~~~~~~~~~~~~~~  258 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHH---HHHHTTTCCCGGGGGCCCHH
T ss_pred             CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH---HHHHHcCCCCCCCCccCCHH
Confidence            333456789999999999865 454 5599999999999999999999876554333   23333332222233457889


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      +.+||.+||+.||++|||+.++|+||||++
T Consensus       259 ~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.6e-65  Score=462.94  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=214.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      +.|++.++||+|+||.||+|++..+|+.||||+++....    ..+|+.+++.|+|||||++++++.+++.+|||||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            568999999999999999999999999999999976533    2479999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC------
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR------  155 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~------  155 (351)
                      ||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.++. ++||+|||+|+.......      
T Consensus       134 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC-----------
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceec
Confidence            9999999999999999999999999999999999999999999999999986653 599999999985433221      


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC-CCccCCCHhHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-PDYVHISQDCR  234 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (351)
                      ....+||+.|||||++.+..|+. ++|||||||++|||++|++||........+..+..    ..... ..+..+++.+.
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDA-KVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGGGSCTTSCHHHH
T ss_pred             CCccccCccccCHHHHCCCCCCc-HHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCchhcCccCCHHHH
Confidence            23357999999999999888765 49999999999999999999987765544443332    22211 12346899999


Q ss_pred             HHHHHhcccCCCCCCChHHH-------------hcCcccccC
Q 018734          235 NLLSRIFVANPSRRITIKEI-------------KSHPWFLKN  263 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~ei-------------l~hp~~~~~  263 (351)
                      +||.+||++||.+|||+.|+             |+|||+.+.
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            99999999999999999997             679998764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-63  Score=464.49  Aligned_cols=261  Identities=28%  Similarity=0.437  Sum_probs=220.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEc------CCE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLT------PTH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~------~~~   72 (351)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+....   ...+.+|+.+|+.|+|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999999999999999765432   2457789999999999999999999764      367


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +|+|||||. |+|.+++.+.+.+++..++.+++||+.||.|||++|||||||||+|||++.++.  +||+|||+|+....
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~  210 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCT  210 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC--
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeeccc
Confidence            999999995 689999999999999999999999999999999999999999999999987664  99999999985432


Q ss_pred             -----CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc------
Q 018734          153 -----HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY------  221 (351)
Q Consensus       153 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------  221 (351)
                           .......+||++|||||++.+..+++.++||||+||++|||++|++||.+.+..+.+..+.........      
T Consensus       211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~  290 (398)
T 4b99_A          211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV  290 (398)
T ss_dssp             -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred             CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence                 223456789999999999988777777799999999999999999999987766665555443221110      


Q ss_pred             ----------CCCC---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          222 ----------KIPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       222 ----------~~~~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                                .+|.         +..+++++.+||.+||++||.+|||+.|+|+||||.+...
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                      0111         2347899999999999999999999999999999987543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.6e-62  Score=456.70  Aligned_cols=309  Identities=72%  Similarity=1.225  Sum_probs=245.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++++.||+|+||.||++++..+++.||+|++.........+.+|+.+++.++||||+++++++.+.+.+|+||||+.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            68999999999999999999999999999999998877777889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCccc
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVG  161 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~g  161 (351)
                      |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+++||+|||+++...........+|
T Consensus       100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~g  179 (361)
T 3uc3_A          100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  179 (361)
T ss_dssp             SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcC
Confidence            99999999988899999999999999999999999999999999999999877777799999999986555555566789


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhc
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIF  241 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  241 (351)
                      |+.|+|||++.+..++++++|||||||++|+|++|+.||........+...+..+....+.+|....+++.+.+||.+||
T Consensus       180 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  259 (361)
T 3uc3_A          180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIF  259 (361)
T ss_dssp             -CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHS
T ss_pred             CCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHc
Confidence            99999999998888877778999999999999999999998777777777788888888888887789999999999999


Q ss_pred             ccCCCCCCChHHHhcCcccccCCChhhHHHHHHhhhhccCCCCCCCCHHHHHHHHHHhCCCCCcccccCC
Q 018734          242 VANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEEAKVPPPVSRSIGG  311 (351)
Q Consensus       242 ~~~P~~Rps~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (351)
                      +.||.+|||+.++++||||.+..+......... ......+....++.+.+.....+...+....+....
T Consensus       260 ~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (361)
T 3uc3_A          260 VADPATRISIPEIKTHSWFLKNLPADLMNESNT-GSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDD  328 (361)
T ss_dssp             CSCTTTSCCHHHHHTSHHHHTTCCCC-------------------CCHHHHHHHHHHHTCC---------
T ss_pred             cCChhHCcCHHHHHhCcchhcCCchhhhccccc-cccccCCcccccCHHHHHHHHhhccCcccccccchh
Confidence            999999999999999999988776554322211 122233455667788888888887776655444333

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-61  Score=472.29  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=219.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHH---HHHHHHhcCCCCCcceEEEEEEcCCEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVA---REIINHKQLRHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~---~e~~~~~~l~hp~Iv~~~~~~~~~~~~   73 (351)
                      |++|++++.||+|+||.||+|++..+|+.||||++.+..    .......   .++.+++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            578999999999999999999999999999999997532    1112233   346677888999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+|||||.||+|..+|.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.++  ++||+|||+|+... .
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G--~vKL~DFGlA~~~~-~  344 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFS-K  344 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS-S
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC--CEEecccceeeecC-C
Confidence            99999999999999999999999999999999999999999999999999999999998766  49999999998543 3


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                      ....+.+|||.|||||++.+...++.++|||||||++|||++|++||....... ...+...+......+|.  .+|+++
T Consensus       345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~~a  421 (689)
T 3v5w_A          345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPEL  421 (689)
T ss_dssp             CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred             CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCHHH
Confidence            345667999999999999765444566999999999999999999997644322 23444455555555554  689999


Q ss_pred             HHHHHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 018734          234 RNLLSRIFVANPSRRIT-----IKEIKSHPWFLKNL  264 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps-----~~eil~hp~~~~~~  264 (351)
                      ++||.+||+.||.+|++     +++|++||||....
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence            99999999999999998     79999999997653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-61  Score=448.16  Aligned_cols=256  Identities=24%  Similarity=0.421  Sum_probs=207.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||+||+|+++   .+++.||+|++.... ....+.+|+.+++.+ +|||||+++++|.+.+++|+||
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm   99 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM   99 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence            57999999999999999999875   467899999886643 335688999999988 6999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC----
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH----  153 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~----  153 (351)
                      |||+||+|.+++.   .+++.+++.+++||+.||.|||++||+||||||+|||++.+. +++||+|||+|+.....    
T Consensus       100 E~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~  175 (361)
T 4f9c_A          100 PYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIEL  175 (361)
T ss_dssp             ECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGG
T ss_pred             eCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccc
Confidence            9999999999883   589999999999999999999999999999999999997652 35999999999743211    


Q ss_pred             -------------------------CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhH
Q 018734          154 -------------------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN  208 (351)
Q Consensus       154 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  208 (351)
                                               ......+||++|||||++.+...++.++||||+||++|+|++|+.||....+...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~  255 (361)
T 4f9c_A          176 LKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLT  255 (361)
T ss_dssp             GGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence                                     1123457999999999998876667779999999999999999999976554322


Q ss_pred             -HHHHHHHHH----------------------------------hh--------------ccCCCCccCCCHhHHHHHHH
Q 018734          209 -FRKTISRIM----------------------------------AV--------------QYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       209 -~~~~~~~~~----------------------------------~~--------------~~~~~~~~~~~~~~~~li~~  239 (351)
                       +..+.....                                  ..              ....+.+..+|+++.|||.+
T Consensus       256 ~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~  335 (361)
T 4f9c_A          256 ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDK  335 (361)
T ss_dssp             HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHH
T ss_pred             HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHH
Confidence             222211100                                  00              00112344688999999999


Q ss_pred             hcccCCCCCCChHHHhcCccccc
Q 018734          240 IFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      ||++||.+|||++|+|+||||++
T Consensus       336 lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          336 LLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HCcCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999975

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-61  Score=436.37  Aligned_cols=252  Identities=24%  Similarity=0.372  Sum_probs=198.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC--------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT--------   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~--------   71 (351)
                      ++|++++.||+|+||+||+|++..+++.||||++.....  ....+.+|+.++++|+|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            579999999999999999999999999999999875433  2356889999999999999999999987543        


Q ss_pred             ----EEEEEEeccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           72 ----HLAIVMEYAAGGELFERICNAGRF---SEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        72 ----~~~lv~e~~~~~~L~~~l~~~~~l---~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                          .+|+|||||.||+|.+++.....+   ++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~--~vKl~DF  162 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDF  162 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC--cEEEccC
Confidence                479999999999999999876553   4567899999999999999999999999999999998766  4999999


Q ss_pred             CCCcccCCCC-------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHH
Q 018734          145 GYSKSSLLHS-------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK  211 (351)
Q Consensus       145 g~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  211 (351)
                      |+|+......             .....+||+.|||||++.+..|+ .++|||||||++|||++   ||....   ....
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~---~~~~  235 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQM---ERVR  235 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCcc---HHHH
Confidence            9998543221             12345799999999999988875 45999999999999996   775421   1122


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+..+....+ .+.+...++.+.+||.+||+.||.+|||+.|+|+||||...
T Consensus       236 ~~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          236 TLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            2223322221 12233456788999999999999999999999999999764

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.5e-61  Score=469.75  Aligned_cols=260  Identities=28%  Similarity=0.582  Sum_probs=227.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      |++|++++.||+|+||.||+|.++.+|+.||+|++..... ....+.+|+.+|+.|+|||||+++++|.+++.+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            4789999999999999999999999999999999876543 335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |.||+|++++.. .+.+++.+++.+++||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+..........
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~  315 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  315 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEE
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceee
Confidence            999999999864 4689999999999999999999999999999999999999876556799999999987655555566


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCCHhHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNL  236 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  236 (351)
                      .+||+.|||||++.+..|+ .++|||||||++|+|++|++||.+.....    .+..+....+.++  .+..+|+++++|
T Consensus       316 ~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~dl  390 (573)
T 3uto_A          316 TTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSCDWNMDDSAFSGISEDGKDF  390 (573)
T ss_dssp             ECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCCCSGGGTTSCHHHHHH
T ss_pred             eEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            7899999999999988875 55999999999999999999998765433    3444555554443  345789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      |.+||+.||.+|||+.|+|+||||+....
T Consensus       391 i~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          391 IRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            99999999999999999999999986543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-59  Score=422.88  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=199.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +++++.+.||+|+||+||+++...   .||||+++....   ....+.+|+.++++++|||||++++++. ++.+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEE
Confidence            578899999999999999998654   599999875432   2356889999999999999999999875 456899999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC---C
Q 018734           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---S  154 (351)
Q Consensus        79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~---~  154 (351)
                      ||+||+|.++|... +++++..+..++.||+.||.|||+++||||||||+||||+.++.  +||+|||+|+.....   .
T Consensus       112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC--------
T ss_pred             cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCcce
Confidence            99999999999754 57999999999999999999999999999999999999987764  999999999854322   2


Q ss_pred             CCCCcccCCCccCcccccCCc--CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC----CccC
Q 018734          155 RPKSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP----DYVH  228 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  228 (351)
                      .....+||+.|||||++.+..  .++.++|||||||++|||+||+.||........+...+.    .....|    .+..
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~----~~~~~p~~~~~~~~  265 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG----RGYASPDLSKLYKN  265 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH----TTCCCCCSTTSCTT
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh----cCCCCCCccccccc
Confidence            234568999999999996532  235569999999999999999999987665444433322    222222    2346


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +++.+.+|+.+||+.||.+|||+.+|+++
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            78999999999999999999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-59  Score=424.27  Aligned_cols=246  Identities=26%  Similarity=0.389  Sum_probs=205.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|.+.+.||+|+||+||++...     .++..||||+++.... ....+.+|+.++++++|||||++++++.+++.+|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46899999999999999999875     3578999999976432 33568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 018734           76 VMEYAAGGELFERICNA-------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC  142 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~-------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~  142 (351)
                      |||||++|+|.++|.+.             ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.  +||+
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~  170 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIG  170 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEEC
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEEC
Confidence            99999999999999764             36999999999999999999999999999999999999987764  9999


Q ss_pred             ccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHh
Q 018734          143 DFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMA  218 (351)
Q Consensus       143 DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  218 (351)
                      |||+|+.......   ....+||+.|||||++.+..|+ .++|||||||++|||+| |+.||......+    .+..+..
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~----~~~~i~~  245 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNE----VIECITQ  245 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----HHHHHHH
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHc
Confidence            9999975433222   2345699999999999888875 45999999999999998 899998765433    2333333


Q ss_pred             hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHh
Q 018734          219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIK  255 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil  255 (351)
                      .. ..+.+..+|+++.+|+.+||+.||++|||+.+|+
T Consensus       246 ~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          246 GR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            22 2344457899999999999999999999999994

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.2e-59  Score=424.64  Aligned_cols=248  Identities=24%  Similarity=0.381  Sum_probs=202.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|.+.+.||+|+||+||+++..     .+++.||||++..... ....+.+|+.++++++|||||++++++.+...+|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            36888999999999999999865     3688999999976433 33568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEE
Q 018734           76 VMEYAAGGELFERICNA---------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLK  140 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~---------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vk  140 (351)
                      |||||++|+|.+++.+.               +++++.++..++.||+.||.|||+++||||||||+||||+.++.  +|
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~K  198 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VK  198 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EE
Confidence            99999999999998753               35899999999999999999999999999999999999987764  99


Q ss_pred             EeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHH
Q 018734          141 ICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRI  216 (351)
Q Consensus       141 L~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  216 (351)
                      |+|||+|+......   .....+||+.|||||++.+..++ .++|||||||++|||+| |+.||......+.+    ..+
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~----~~i  273 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI----DCI  273 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH----HHH
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHH----HHH
Confidence            99999998543322   22346799999999999888875 55999999999999998 89999876543332    222


Q ss_pred             HhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .. ....+.+..+++++.+|+.+||+.||++|||+.+|+++
T Consensus       274 ~~-g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          274 TQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HH-TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             Hc-CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            22 23344455789999999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-58  Score=419.36  Aligned_cols=248  Identities=21%  Similarity=0.358  Sum_probs=208.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      .++++.+.||+|+||+||++...     .+++.||||++.....  ....+.+|+.++++++|||||++++++.+++.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            46889999999999999999853     4678999999875432  3367899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 018734           75 IVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPR  138 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~  138 (351)
                      +|||||++|+|.++|...                ..+++..+..++.||+.||.|||+++||||||||+||||+.++.  
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--
Confidence            999999999999999653                35899999999999999999999999999999999999987764  


Q ss_pred             EEEeccCCCcccCCC---CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHH
Q 018734          139 LKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTIS  214 (351)
Q Consensus       139 vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  214 (351)
                      +||+|||+|+.....   ......+||+.|||||++.+..++ .++|||||||++|||+| |+.||......+    .+.
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~----~~~  258 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQD----VVE  258 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHH----HHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHH----HHH
Confidence            999999999854332   223456899999999999888875 45999999999999998 899998765433    222


Q ss_pred             HHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          215 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+.. ....|.+..+++.+.+|+.+||+.||.+|||+.+|+++
T Consensus       259 ~i~~-~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          259 MIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHc-CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3332 33345556789999999999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.2e-57  Score=413.13  Aligned_cols=256  Identities=41%  Similarity=0.710  Sum_probs=226.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            4689999999999999999999999999999999876432   2345779999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..........
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence            99999999999998899999999999999999999999999999999999999987664  9999999998665555556


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.....    ......+....+..|.  .+++++.+||
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~li  245 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KELRERVLRGKYRIPF--YMSTDCENLL  245 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCCCC--CCCHHHHHHH
Confidence            678999999999999888877779999999999999999999987553    3334444555555554  5899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCC
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      .+||+.||.+|||+.++++||||....
T Consensus       246 ~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          246 KRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999997643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-57  Score=419.78  Aligned_cols=249  Identities=22%  Similarity=0.362  Sum_probs=208.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCcc--cCHHHHHHHHHHhcCCC-CCcceEEEEEEcC-CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK--IDANVAREIINHKQLRH-PNIIRFKEVVLTP-TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~h-p~Iv~~~~~~~~~-~~   72 (351)
                      ++|++++.||+|+||+||+|.+..+     ++.||||++.....  ....+.+|+.++++++| ||||++++++..+ +.
T Consensus        64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~  143 (353)
T 4ase_A           64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  143 (353)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence            5799999999999999999997654     36899999876433  23568899999999976 8999999998664 57


Q ss_pred             EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 018734           73 LAIVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA  136 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~  136 (351)
                      +|+|||||++|+|.++|.+.                ..+++..+..++.||+.||.|||+++||||||||+|||++.++.
T Consensus       144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  223 (353)
T 4ase_A          144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  223 (353)
T ss_dssp             CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC
Confidence            89999999999999999753                34899999999999999999999999999999999999987764


Q ss_pred             CCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHH
Q 018734          137 PRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKT  212 (351)
Q Consensus       137 ~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~  212 (351)
                        +||+|||+|+.......   ....+||+.|||||++.+..|+ .++|||||||++|||+| |+.||........+...
T Consensus       224 --vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~  300 (353)
T 4ase_A          224 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  300 (353)
T ss_dssp             --EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred             --EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              99999999986443322   2345799999999999888875 55999999999999998 99999886654444333


Q ss_pred             HHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          213 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +    ......+.+..+++++.+||.+||+.||.+|||+.+|++|
T Consensus       301 i----~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          301 L----KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             H----HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H----HcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            2    2233444455789999999999999999999999999987

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4e-55  Score=402.83  Aligned_cols=255  Identities=34%  Similarity=0.605  Sum_probs=221.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++++.||+|+||.||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            578999999999999999999999999999999987532    2335678999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~  155 (351)
                      |||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.... ...
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC--CEEEeeccchhhcccCCCc
Confidence            99999999999999888999999999999999999999999999999999999998766  499999999985332 233


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|.  .+++.+.+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~  234 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFPR--TLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHH
Confidence            4556899999999999888775 45999999999999999999998754332    33334444444443  68999999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 018734          236 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       236 li~~~L~~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      ||.+||+.||.+||     ++.++++||||....
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            99999999999999     899999999997653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.1e-55  Score=405.68  Aligned_cols=258  Identities=32%  Similarity=0.588  Sum_probs=224.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc-------CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-------DANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++......       ...+.+|+.+++.++||||+++++++.+...+|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            5799999999999999999999999999999999764321       256889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~--~~vkL~DFg~a~~~~~  152 (351)
                      +||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  ..+||+|||++.....
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            99999999999999998889999999999999999999999999999999999999976552  2599999999986655


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHIS  230 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  230 (351)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.......    ....+....+.++  .+..++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          172 GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQE----TLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHHTTCCCCCHHHHTTSC
T ss_pred             CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhcCCCCCchhccCCC
Confidence            5555667899999999999877765 55999999999999999999998765433    3334444444433  235689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      +.+.+||.+||+.||.+|||+.++|+||||....
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            9999999999999999999999999999997543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.6e-55  Score=406.51  Aligned_cols=255  Identities=32%  Similarity=0.538  Sum_probs=216.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++++.||+|+||.||+|++..+++.||+|++.+..    .....+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            578999999999999999999999999999999987532    2234577899999887 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~  154 (351)
                      |||||.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.... ..
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g--~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG--HCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCC---
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC--CEEEccccceeecccCCc
Confidence            999999999999999989999999999999999999999999999999999999998766  499999999985332 23


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|.  .+++.+.
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~  252 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAILNDEVVYPT--WLHEDAT  252 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHH
Confidence            34456899999999999887775 45999999999999999999998765433    33444455555554  5899999


Q ss_pred             HHHHHhcccCCCCCCCh------HHHhcCcccccCC
Q 018734          235 NLLSRIFVANPSRRITI------KEIKSHPWFLKNL  264 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~------~eil~hp~~~~~~  264 (351)
                      +||.+||+.||.+||++      .++++||||....
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            99999999999999998      8999999997653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=7.5e-55  Score=408.52  Aligned_cols=258  Identities=28%  Similarity=0.518  Sum_probs=219.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++++.||+|+||.||+|++..+++.||+|++.+...    ....+.+|..+++++ +|||||++++++.+...+|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4689999999999999999999999999999999976432    224577888888776 89999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC-CCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~-~~~  154 (351)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++... ...
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC--CEEEeecceeeecccCCC
Confidence            999999999999999988999999999999999999999999999999999999998766  49999999998533 333


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh-----HHHHHHHHHHhhccCCCCccCC
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----NFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......     ........+......+|.  .+
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~  285 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SL  285 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TS
T ss_pred             ccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cC
Confidence            44567899999999999888875 55999999999999999999997543211     112233444445555554  68


Q ss_pred             CHhHHHHHHHhcccCCCCCCCh------HHHhcCcccccC
Q 018734          230 SQDCRNLLSRIFVANPSRRITI------KEIKSHPWFLKN  263 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~------~eil~hp~~~~~  263 (351)
                      ++.+.+||.+||+.||.+||++      .++++||||...
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            9999999999999999999985      799999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.5e-55  Score=403.92  Aligned_cols=257  Identities=45%  Similarity=0.811  Sum_probs=222.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC----cccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++...    ......+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            47899999999999999999999999999999998653    22345788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+ +|+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.........
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL--NVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC--CEEECCSSCTBTTTTSBTT
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC--CEEEEEeccceeccCCccc
Confidence            9999 789999998888999999999999999999999999999999999999998766  4999999999866555556


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||..........    .+....+..|  ..+++.+.+|
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~l  238 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----KVNSCVYVMP--DFLSPGAQSL  238 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----CCCSSCCCCC--TTSCHHHHHH
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----HHHcCCCCCc--ccCCHHHHHH
Confidence            677899999999999888877777999999999999999999998754322211    1111122223  3589999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      |.+||+.||.+|||+.++++||||....+.
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  268 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDPWFNVNLPD  268 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred             HHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence            999999999999999999999999876554

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-55  Score=403.65  Aligned_cols=258  Identities=27%  Similarity=0.494  Sum_probs=223.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++.++||||+++++++.+.+.+++|||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            37899999999999999999999999999999998766555567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           81 AGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      .|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++....+.+||+|||+++...........
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  163 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence            9999999997654 799999999999999999999999999999999999998754567999999999865444444556


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCCHhHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLL  237 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li  237 (351)
                      +||+.|+|||++.+..++ .++|||||||++|+|++|..||.......    ....+....+.++  .+..++.++.+||
T Consensus       164 ~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          164 FTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHH----HHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence            799999999999877664 55999999999999999999998765433    3333444444333  2346899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+||+.||.+|||+.++|+||||.+.
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999999765

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.9e-54  Score=389.36  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=213.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |++|++++.||+|+||.||++.+..+++.||+|++......   ...+.+|+.++++++||||+++++++.+.+.+++||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            68999999999999999999999999999999999764432   256789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CC
Q 018734           78 EYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~  155 (351)
                      ||+.+ +|...+. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  157 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRC  157 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccc
Confidence            99976 5555554 4678999999999999999999999999999999999999987664  999999999754322 23


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-------------
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-------------  222 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------  222 (351)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|..||............+.+.......             
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            3456799999999999877755667999999999999999888865554433332222221111000             


Q ss_pred             -----------CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          223 -----------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       223 -----------~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                                 ......+++.+.+||.+||+.||.+|||+.++|+||||.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                       011124788999999999999999999999999999998654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-54  Score=394.95  Aligned_cols=254  Identities=33%  Similarity=0.620  Sum_probs=221.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++++.||+|+||.||++++..+++.||+|++.+..    .....+.+|..+++.++||||+++++++.+...+|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            478999999999999999999999999999999987532    2335677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++...  ...
T Consensus        85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~Dfg~a~~~~--~~~  160 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVT  160 (318)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCB
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC--CEEEeecCcceecC--Ccc
Confidence            99999999999999988999999999999999999999999999999999999997665  49999999997532  233


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.......    ....+......+|.  .+++++.+|
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l  233 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNAELRFPP--FFNEDVKDL  233 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred             ccccCCccccCHhHhcCCCCCc-ccchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHHHH
Confidence            4568999999999998887754 4999999999999999999998765433    33344444444443  689999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccCCC
Q 018734          237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNLP  265 (351)
Q Consensus       237 i~~~L~~~P~~Rp-----s~~eil~hp~~~~~~~  265 (351)
                      |.+||+.||.+||     +++++++||||.....
T Consensus       234 i~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~  267 (318)
T 1fot_A          234 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW  267 (318)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             HHHHhccCHHHcCCCcCCCHHHHhcCccccCCCH
Confidence            9999999999999     8999999999986543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-55  Score=399.02  Aligned_cols=250  Identities=25%  Similarity=0.302  Sum_probs=191.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCC----EEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT----HLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~----~~~lv~   77 (351)
                      ++|.+.+.||+|+||+||+++.  +|+.||||++............|+..+.+++|||||++++++..++    .+|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            5799999999999999999987  4789999999765443333445666677899999999999997653    689999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM--------QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--------~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      |||++|+|.+++.+. .+++..+..++.|++.||.|||++        +|+||||||+||||+.++.  +||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence            999999999999764 689999999999999999999987        9999999999999987764  99999999975


Q ss_pred             cCCCC-----CCCCcccCCCccCcccccCCcC-----CCcchhHHHHHHHHHHHHcCCCCCCCCCC----------h-hH
Q 018734          150 SLLHS-----RPKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVGAYPFEDQED----------P-KN  208 (351)
Q Consensus       150 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~----------~-~~  208 (351)
                      .....     .....+||+.|||||++.+...     .+.++|||||||++|||+||.+||.....          . ..
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            43322     2234579999999999976431     23459999999999999999877643221          1 11


Q ss_pred             HHHHHHHHHhhccC--CCCcc---CCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          209 FRKTISRIMAVQYK--IPDYV---HISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       209 ~~~~~~~~~~~~~~--~~~~~---~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .......+.....+  +|...   ..+..+.+|+.+||+.||.+|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            22222222222222  12111   12346889999999999999999999986

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=8.7e-54  Score=387.46  Aligned_cols=258  Identities=25%  Similarity=0.437  Sum_probs=219.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   99 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence            589999999999999999999999999999999875443 3356789999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~  159 (351)
                      .|++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++  ++||+|||++....... .....
T Consensus       100 ~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          100 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             TTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC--CEEEeeCCCceecCCcccccCCc
Confidence            999999998765 689999999999999999999999999999999999997666  49999999987544332 23445


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      +||+.|+|||++.+..++. ++|||||||++|+|++|+.||.............   .......+....+++.+.+||.+
T Consensus       177 ~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~  252 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNR  252 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSCGGGSCHHHHHHHHH
T ss_pred             cCCcCccChhhhcCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCCCCCCccccCHHHHHHHHH
Confidence            7999999999998888754 5999999999999999999998765433332221   12222334445789999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCCh
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      ||+.||.+|||+.++++||||....+.
T Consensus       253 ~l~~dp~~Rps~~ell~h~~~~~~~~~  279 (297)
T 3fxz_A          253 CLEMDVEKRGSAKELLQHQFLKIAKPL  279 (297)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HccCChhHCcCHHHHhhChhhcccCcc
Confidence            999999999999999999999876553

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.7e-54  Score=397.13  Aligned_cols=258  Identities=29%  Similarity=0.520  Sum_probs=218.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++++.||+|+||.||++++..+++.||+|++.+....    ...+.+|..+++++ +||||+++++++.+...+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999865432    23467899999887 89999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC-CCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~-~~~  154 (351)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++... ...
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCGGGCBCSCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEEeccccccccCCCC
Confidence            999999999999999888999999999999999999999999999999999999997666  49999999998533 223


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh-----hHHHHHHHHHHhhccCCCCccCC
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----KNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......     .........+......+|.  .+
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~  242 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SL  242 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TS
T ss_pred             cccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CC
Confidence            34556899999999999887775 5599999999999999999999753221     1112233344444444443  68


Q ss_pred             CHhHHHHHHHhcccCCCCCCCh------HHHhcCcccccC
Q 018734          230 SQDCRNLLSRIFVANPSRRITI------KEIKSHPWFLKN  263 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~------~eil~hp~~~~~  263 (351)
                      +..+.+||.+||+.||.+||++      .++++||||...
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            9999999999999999999995      799999999754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-54  Score=399.71  Aligned_cols=255  Identities=33%  Similarity=0.566  Sum_probs=219.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++.+.||+|+||.||+|++..+++.||+|++.+..    .....+..|..+++.+ +||||+++++++.+...+|+
T Consensus        16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l   95 (345)
T 1xjd_A           16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   95 (345)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence            578999999999999999999999999999999997642    2334577888888766 99999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~  154 (351)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.... ..
T Consensus        96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A           96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--CEEEeEChhhhhcccCCC
Confidence            999999999999999888999999999999999999999999999999999999998766  499999999985432 23


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|.  .+++.+.
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  246 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRMDNPFYPR--WLEKEAK  246 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHH
T ss_pred             cccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHH----HHHHHHhCCCCCCc--ccCHHHH
Confidence            34566899999999999888775 55999999999999999999998765433    33333444444443  5899999


Q ss_pred             HHHHHhcccCCCCCCChH-HHhcCcccccCC
Q 018734          235 NLLSRIFVANPSRRITIK-EIKSHPWFLKNL  264 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~-eil~hp~~~~~~  264 (351)
                      +||.+||+.||.+||++. ++++||||....
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            999999999999999998 999999997653

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-54  Score=396.84  Aligned_cols=260  Identities=37%  Similarity=0.609  Sum_probs=221.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +++|++++.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            5799999999999999999999999999999999865432  23568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC---CC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SR  155 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~---~~  155 (351)
                      ||.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.....   ..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEECC
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC--CEEEEEeeccceeccCCcccc
Confidence            999999999998888899999999999999999999999999999999999998666  4999999999743222   22


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||..........   ..........+.+..+++.+.+
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY---SDWKEKKTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH---HHHHTTCTTSTTGGGSCHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHhcccccCCccccCCHHHHH
Confidence            3456799999999999888876777999999999999999999998765432222   1222333344555678999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ||.+||+.||.+|||+.++++||||.+...
T Consensus       241 li~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHccCChhhCcCHHHHhhChhhccccc
Confidence            999999999999999999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.5e-54  Score=400.57  Aligned_cols=256  Identities=33%  Similarity=0.612  Sum_probs=221.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            479999999999999999999999999999999976432   22467789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |+.|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+.+||+|||++..........
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~  188 (362)
T 2bdw_A          109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  188 (362)
T ss_dssp             CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence            999999999999888999999999999999999999999999999999999997653 2469999999998665554555


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--CCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (351)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.......    ....+....+.+  +.+..+++.+.+
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~  263 (362)
T 2bdw_A          189 GFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHR----LYAQIKAGAYDYPSPEWDTVTPEAKS  263 (362)
T ss_dssp             CSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred             cCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCcccccCCCHHHHH
Confidence            67899999999999887775 45999999999999999999998755432    333344444433  344578999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccccc
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      ||.+||+.||.+|||+.++|+||||..
T Consensus       264 li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          264 LIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999999964

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.1e-54  Score=401.52  Aligned_cols=258  Identities=26%  Similarity=0.494  Sum_probs=222.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++++.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++|||||++++++.+...+|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999986532    2235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++........
T Consensus        94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG--HVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTCCB
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC--CEEEeccceeeeccCCCce
Confidence            99999999999999988999999999999999999999999999999999999998766  4999999999866555556


Q ss_pred             CCcccCCCccCcccccCC---cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          157 KSTVGTPAYIAPEVLSRR---EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                      ...+||+.|+|||++.+.   .+ +.++|||||||++|+|++|+.||....... .......+.......|  ..+++.+
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p--~~~s~~~  247 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYP--SAWSQEM  247 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCC--TTSCHHH
T ss_pred             eccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCC--CcCCHHH
Confidence            677899999999999643   34 455999999999999999999997654322 2333333444433344  3689999


Q ss_pred             HHHHHHhcccCCCCCCC-hHHHhcCcccccCC
Q 018734          234 RNLLSRIFVANPSRRIT-IKEIKSHPWFLKNL  264 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps-~~eil~hp~~~~~~  264 (351)
                      .+||.+||+.||.+||+ +.++++||||....
T Consensus       248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~  279 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN  279 (384)
T ss_dssp             HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred             HHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence            99999999999999998 89999999997653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.2e-54  Score=409.63  Aligned_cols=256  Identities=33%  Similarity=0.611  Sum_probs=219.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++|||||++++++.+.+..|+|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            579999999999999999999999999999999876442   23457899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEeccCCCcccCCCCC-C
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSR-P  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~~~vkL~DFg~a~~~~~~~~-~  156 (351)
                      ||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||++........ .
T Consensus        91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~  170 (444)
T 3soa_A           91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW  170 (444)
T ss_dssp             CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred             eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence            99999999999999999999999999999999999999999999999999999753 235699999999975443322 3


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC--CCCccCCCHhHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCR  234 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  234 (351)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|.+||.......    ....+....+.  .+.+..+++.+.
T Consensus       171 ~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          171 FGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHR----LYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             ecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHH----HHHHHHhCCCCCCccccccCCHHHH
Confidence            456899999999999887775 45999999999999999999998765433    33334444443  344567899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      +||.+||+.||.+|||+.++|+||||..
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            9999999999999999999999999964

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.1e-54  Score=397.03  Aligned_cols=252  Identities=31%  Similarity=0.596  Sum_probs=220.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++++.||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999986532    2335678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+.|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...  ...
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFg~a~~~~--~~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVK--GRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS--SCB
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC--CEEEcccccceecc--CCc
Confidence            99999999999999888999999999999999999999999999999999999997766  49999999997543  233


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......    .....+......+|  ..+++.+.+|
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~~~~~~~p--~~~~~~~~~l  268 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIVSGKVRFP--SHFSSDLKDL  268 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC--TTCCHHHHHH
T ss_pred             ccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHH----HHHHHHHcCCCCCC--CCCCHHHHHH
Confidence            456899999999999888775 5599999999999999999999875543    23334444444444  3689999999


Q ss_pred             HHHhcccCCCCCCC-----hHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRIT-----IKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps-----~~eil~hp~~~~~  263 (351)
                      |.+||+.||.+||+     +.++++||||...
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            99999999999998     9999999999754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.3e-54  Score=396.73  Aligned_cols=255  Identities=31%  Similarity=0.530  Sum_probs=220.4

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++++.||+|+||.||+|++..+++.||+|++.+..    .....+..|..+++.+ +||||+++++++.+.+.+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            578999999999999999999999999999999987632    2335677899999888 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~  154 (351)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.... ..
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--cEEEEeCCcccccccCCc
Confidence            999999999999999888999999999999999999999999999999999999998766  499999999985332 23


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......    .....+......+|.  .+++.+.
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~  249 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYPK--SMSKEAV  249 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCCT--TSCHHHH
T ss_pred             ccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHH----HHHHHHHhCCCCCCC--CCCHHHH
Confidence            34556899999999999888775 5599999999999999999999875543    333444444544553  6899999


Q ss_pred             HHHHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 018734          235 NLLSRIFVANPSRRIT-----IKEIKSHPWFLKNL  264 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps-----~~eil~hp~~~~~~  264 (351)
                      +||.+||+.||.+||+     +.++++||||....
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            9999999999999995     69999999997643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-54  Score=393.91  Aligned_cols=258  Identities=34%  Similarity=0.626  Sum_probs=221.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ....+.+|+.+++.++||||+++++++.+...++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            479999999999999999999999999999999876432       2356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~--~~~vkL~DFg~a~~~~~  152 (351)
                      +||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ..++||+|||+++....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            9999999999999998888999999999999999999999999999999999999997655  22599999999986655


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHIS  230 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  230 (351)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||........    +..+......++  .+..++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQET----LANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHHTCCCCCHHHHTTSC
T ss_pred             CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHHhcCCCcCccccccCC
Confidence            5555667899999999999877765 459999999999999999999987654332    223333333332  234678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ..+.+||.+||+.||.+|||+.++|+||||....
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999999999999998654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.1e-53  Score=384.82  Aligned_cols=258  Identities=30%  Similarity=0.476  Sum_probs=211.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |++|++++.||+|+||.||++.+ .+++.||+|++.....   ....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            68999999999999999999999 5688999999865432   3367889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CC
Q 018734           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~  155 (351)
                      ||+.+ +|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCTTHHHHHCC----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEeECccccccCccccc
Confidence            99975 898888764 6799999999999999999999999999999999999997766  4999999998754322 22


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-CC----------
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IP----------  224 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~----------  224 (351)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.......... ++          
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            3445799999999999776545666999999999999999999998876555544444322111000 00          


Q ss_pred             ------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          225 ------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       225 ------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                                  ....+++.+.+||.+||+.||.+|||+.++++||||.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                        01247889999999999999999999999999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-53  Score=402.86  Aligned_cols=258  Identities=34%  Similarity=0.504  Sum_probs=219.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC----cccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+.    ......+.+|+.+++.++|||||++++++.+...+|+||
T Consensus        69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999998652    223345789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~  155 (351)
                      |||.||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......  .
T Consensus       149 E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g--~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          149 EYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             CCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSEEE
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC--CEEEeccceeEeeccCCccc
Confidence            99999999998875 4689999999999999999999999999999999999998766  49999999997543332  2


Q ss_pred             CCCcccCCCccCcccccCCcC---CCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 PKSTVGTPAYIAPEVLSRREY---DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      ....+||+.|+|||++.+...   .+.++|||||||++|+|++|+.||........+.+++...  ....+|....+++.
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~  303 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDISKE  303 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCCCCHH
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCcccccHH
Confidence            346689999999999976551   3456999999999999999999998766544444333221  23456666679999


Q ss_pred             HHHHHHHhcccCCCC--CCChHHHhcCcccccCC
Q 018734          233 CRNLLSRIFVANPSR--RITIKEIKSHPWFLKNL  264 (351)
Q Consensus       233 ~~~li~~~L~~~P~~--Rps~~eil~hp~~~~~~  264 (351)
                      +++||.+||+.+|.+  ||++.+|++||||....
T Consensus       304 ~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~  337 (410)
T 3v8s_A          304 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  337 (410)
T ss_dssp             HHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred             HHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence            999999999999988  99999999999998753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.7e-54  Score=411.49  Aligned_cols=257  Identities=40%  Similarity=0.740  Sum_probs=225.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|.+++.||+|+||.||+|.+..+|+.||+|++....    .....+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999999999999999999987532    2235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+.|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.........
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCB
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccc
Confidence            999999999999998889999999999999999999999999999999999999987664  999999999865555555


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||........    ...+....+..|  ..+++.+.+|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~L  246 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL----FKKICDGIFYTP--QYLNPSVISL  246 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH----HHHHHTTCCCCC--TTCCHHHHHH
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH----HHHHhcCCcCCC--ccCCHHHHHH
Confidence            6678999999999998888777779999999999999999999987655433    333344444444  3589999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      |.+||+.||.+|||+.++++||||.+..+
T Consensus       247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             HHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence            99999999999999999999999987654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-53  Score=388.18  Aligned_cols=260  Identities=28%  Similarity=0.466  Sum_probs=212.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +++|++++.||+|+||.||++.+.. ++.||+|++......   ...+.+|+.+++.++||||+++++++.+...+++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            4799999999999999999999964 889999998754332   256789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CC
Q 018734           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~  155 (351)
                      ||+.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ..
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~  175 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGLARAFGIPVRS  175 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEETTSCCC-
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC--CEEEccCcCceecCCCccc
Confidence            99975 787777654 4599999999999999999999999999999999999998766  4999999999754322 23


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-CC----------
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IP----------  224 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~----------  224 (351)
                      ....+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.......... ++          
T Consensus       176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  255 (311)
T 3niz_A          176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ  255 (311)
T ss_dssp             --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhh
Confidence            3445799999999999875555666999999999999999999998877766655554432211100 00          


Q ss_pred             -------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          225 -------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       225 -------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                                   ....+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                         0123678999999999999999999999999999997653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-53  Score=386.67  Aligned_cols=255  Identities=38%  Similarity=0.637  Sum_probs=212.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---------------------------cCHHHHHHHHHHh
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------------------------IDANVAREIINHK   53 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~e~~~~~   53 (351)
                      +++|++.+.||+|+||.||+|.+..+++.||+|++.....                           ....+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4789999999999999999999999999999999865431                           1245789999999


Q ss_pred             cCCCCCcceEEEEEEc--CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 018734           54 QLRHPNIIRFKEVVLT--PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLL  131 (351)
Q Consensus        54 ~l~hp~Iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll  131 (351)
                      .++||||+++++++.+  ...+|+||||+.+++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999999986  57899999999999997754 34579999999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEeccCCCcccCCCC-CCCCcccCCCccCcccccCCcC--CCcchhHHHHHHHHHHHHcCCCCCCCCCChhH
Q 018734          132 DGSPAPRLKICDFGYSKSSLLHS-RPKSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN  208 (351)
Q Consensus       132 ~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  208 (351)
                      +.++  ++||+|||+++...... ......||+.|+|||++.+...  .+.++|||||||++|+|++|+.||.....   
T Consensus       171 ~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---  245 (298)
T 2zv2_A          171 GEDG--HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI---  245 (298)
T ss_dssp             CTTS--CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH---
T ss_pred             CCCC--CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH---
Confidence            7765  49999999987543322 2244679999999999976543  35668999999999999999999976543   


Q ss_pred             HHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          209 FRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                       ......+.......+....+++.+.+||.+||+.||.+|||+.++++||||.+
T Consensus       246 -~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          246 -MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             -HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             -HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence             22333344445556666678999999999999999999999999999999953

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-53  Score=399.66  Aligned_cols=258  Identities=27%  Similarity=0.541  Sum_probs=221.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.+...+++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            579999999999999999999999999999999876533 2346889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           81 AGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      .|++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+++...........
T Consensus       131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~  210 (387)
T 1kob_A          131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  210 (387)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeee
Confidence            9999999987654 799999999999999999999999999999999999998665567999999999865444444456


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--CCccCCCHhHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLL  237 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li  237 (351)
                      +||+.|+|||++.+..++ .++|||||||++|+|++|..||........    +..+....+.+  +.+..+++.+.+||
T Consensus       211 ~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li  285 (387)
T 1kob_A          211 TATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVKRCDWEFDEDAFSSVSPEAKDFI  285 (387)
T ss_dssp             CSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             ccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCccccccCCHHHHHHH
Confidence            799999999999877764 559999999999999999999987654332    23333333332  33456899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCC
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      .+||+.||.+|||+.++|+||||....
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          286 KNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHcCCChhHCcCHHHHhhCccccCCc
Confidence            999999999999999999999997653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.9e-53  Score=392.60  Aligned_cols=259  Identities=34%  Similarity=0.593  Sum_probs=206.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++++++||||+++++++.....+++||||+.
T Consensus        53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            46999999999999999999999999999999987654 23467789999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEeccCCCcccCCCCCCCCcc
Q 018734           82 GGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTV  160 (351)
Q Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~-~~~~~vkL~DFg~a~~~~~~~~~~~~~  160 (351)
                      +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++...........+
T Consensus       132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  211 (349)
T 2w4o_A          132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC  211 (349)
T ss_dssp             SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccccccc
Confidence            9999999998888999999999999999999999999999999999999975 224569999999998654444445678


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--CCccCCCHhHHHHHH
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRNLLS  238 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~  238 (351)
                      ||+.|+|||++.+..++ .++|||||||++|+|++|+.||........   ....+.......  +.+..++..+.+||.
T Consensus       212 gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~li~  287 (349)
T 2w4o_A          212 GTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNCEYYFISPWWDEVSLNAKDLVR  287 (349)
T ss_dssp             -CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHH---HHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             CCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHH---HHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence            99999999999887765 459999999999999999999987655432   223333333332  334578999999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCCC
Q 018734          239 RIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      +||+.||.+|||+.++|+||||.....
T Consensus       288 ~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          288 KLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             HHccCChhhCcCHHHHhcCcccCCCcc
Confidence            999999999999999999999986543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.6e-53  Score=385.14  Aligned_cols=263  Identities=27%  Similarity=0.468  Sum_probs=203.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      .++|++++.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            3689999999999999999999999999999999875432  34678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           79 YAAGGELFERICNA------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        79 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |+. ++|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC--CEEECcCccceecCC
Confidence            997 5998888653      3589999999999999999999999999999999999998766  499999999975433


Q ss_pred             C-CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-------CCC
Q 018734          153 H-SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-------KIP  224 (351)
Q Consensus       153 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~  224 (351)
                      . ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.........       ..+
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            2 22345679999999999977554466699999999999999999999887665554444332211100       000


Q ss_pred             ---------------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          225 ---------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       225 ---------------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                                           ....++..+.+||.+||+.||.+|||+.++|+||||.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                 012468899999999999999999999999999999876543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-53  Score=403.07  Aligned_cols=261  Identities=27%  Similarity=0.513  Sum_probs=219.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||.||++++..+++.||+|++.+..    .....+.+|..+++.++||||+++++++.+...+|+||
T Consensus        74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999987522    22234788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      |||.||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+....... 
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG--HIRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSCE
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC--CEEEcchhhhhhcccCCCc
Confidence            99999999999987 57899999999999999999999999999999999999998766  499999999975433322 


Q ss_pred             -CCCcccCCCccCccccc-----CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc-cC
Q 018734          156 -PKSTVGTPAYIAPEVLS-----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY-VH  228 (351)
Q Consensus       156 -~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  228 (351)
                       ....+||+.|+|||++.     ...+ +.++|||||||++|||++|+.||......+.+..++...  ....+|.. ..
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~  308 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPTQVTD  308 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCSSCCC
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--ccccCCccccc
Confidence             23468999999999986     3344 556999999999999999999998866554444443222  12334433 45


Q ss_pred             CCHhHHHHHHHhcccCCCC--CCChHHHhcCcccccCCChh
Q 018734          229 ISQDCRNLLSRIFVANPSR--RITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~--Rps~~eil~hp~~~~~~~~~  267 (351)
                      +++++.+||.+||+.+|.+  |++++++++||||.......
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~  349 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDN  349 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTT
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHH
Confidence            8999999999999998888  99999999999998764433

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.7e-53  Score=394.74  Aligned_cols=255  Identities=31%  Similarity=0.545  Sum_probs=212.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHH-HhcCCCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIIN-HKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~-~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++++.||+|+||.||++++..+++.||+|++.+...    ....+.+|..+ ++.++||||+++++++.+.+.+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            3689999999999999999999999999999999976432    22345566665 577899999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC-CCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~-~~~  154 (351)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++... ...
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCBCGGGBCCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEeeCccccccccCCC
Confidence            999999999999999888999999999999999999999999999999999999998766  49999999998533 233


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.......    ....+......++  ..++..+.
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~i~~~~~~~~--~~~~~~~~  267 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDNILNKPLQLK--PNITNSAR  267 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHH----HHHHHHHSCCCCC--SSSCHHHH
T ss_pred             ccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHhcccCCC--CCCCHHHH
Confidence            44567899999999999887765 55999999999999999999998755433    3334444444444  36899999


Q ss_pred             HHHHHhcccCCCCCCCh----HHHhcCcccccCC
Q 018734          235 NLLSRIFVANPSRRITI----KEIKSHPWFLKNL  264 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~----~eil~hp~~~~~~  264 (351)
                      +||.+||+.||.+||++    .++++||||....
T Consensus       268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            99999999999999987    6999999997653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.4e-53  Score=408.99  Aligned_cols=257  Identities=37%  Similarity=0.638  Sum_probs=220.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC---cccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG---HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++...   ......+.+|+.++++++|||||++++++.+...+|+|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            5799999999999999999999999999999998643   2234578899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++.........
T Consensus       102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  181 (486)
T 3mwu_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (486)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccC
Confidence            99999999999888899999999999999999999999999999999999999643 23469999999998665555556


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc--CCCCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  235 (351)
                      ..+||+.|+|||++.+. + +.++|||||||++|+|++|++||........    +..+....+  ..|.+..+|+.+.+
T Consensus       182 ~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~  255 (486)
T 3mwu_A          182 DRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDI----LKRVETGKYAFDLPQWRTISDDAKD  255 (486)
T ss_dssp             CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCSCSGGGGGSCHHHHH
T ss_pred             CCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCCcccCCCCHHHHH
Confidence            67899999999999764 4 5569999999999999999999987654333    333333333  34556678999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ||.+||+.+|.+|||+.++|+||||++..
T Consensus       256 li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            99999999999999999999999997643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-53  Score=382.46  Aligned_cols=262  Identities=30%  Similarity=0.446  Sum_probs=213.4

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +++|++++.||+|+||.||++.+..+++.||+|++......   ...+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            68999999999999999999999999999999988664432   245778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~  156 (351)
                      ||+.+++|..++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||++...... ...
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  159 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDYY  159 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECC------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC--CEEEeeCCCchhccCccccc
Confidence            9999999999988888899999999999999999999999999999999999997665  4999999999754322 223


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hcc
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQY  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (351)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|+.||...........+......               ...
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (311)
T 4agu_A          160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV  239 (311)
T ss_dssp             ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred             CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence            45679999999999987555566699999999999999999999887665544433322110               000


Q ss_pred             CCCC----------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          222 KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       222 ~~~~----------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ..+.          +..++..+.+||.+||+.||.+|||+.++++||||.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            1111          135788999999999999999999999999999998653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-53  Score=398.45  Aligned_cols=261  Identities=28%  Similarity=0.411  Sum_probs=204.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCC-CCCcceEEEEEEcCC--EEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLR-HPNIIRFKEVVLTPT--HLA   74 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~--~~~   74 (351)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.....   ......+|+.+++.+. ||||+++++++...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            3789999999999999999999999999999999865432   2345778999999997 999999999997554  799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC--
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~--  152 (351)
                      +|||||. ++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+|+....  
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC--HVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEESSSCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC--CEEecCCcccccccccc
Confidence            9999997 589888866 5789999999999999999999999999999999999998766  499999999975322  


Q ss_pred             --------------------CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHH
Q 018734          153 --------------------HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT  212 (351)
Q Consensus       153 --------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  212 (351)
                                          .......+||++|+|||++.+....+.++|||||||++|+|++|++||.+......+..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                111234579999999999987555566799999999999999999999987765555544


Q ss_pred             HHHHHhhc-----------------------------------------cCCCCccCCCHhHHHHHHHhcccCCCCCCCh
Q 018734          213 ISRIMAVQ-----------------------------------------YKIPDYVHISQDCRNLLSRIFVANPSRRITI  251 (351)
Q Consensus       213 ~~~~~~~~-----------------------------------------~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~  251 (351)
                      +..+....                                         ........+++.+.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            42211000                                         0001112578899999999999999999999


Q ss_pred             HHHhcCcccccCCC
Q 018734          252 KEIKSHPWFLKNLP  265 (351)
Q Consensus       252 ~eil~hp~~~~~~~  265 (351)
                      .++|+||||.....
T Consensus       324 ~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          324 NDALKHPFVSIFHN  337 (388)
T ss_dssp             HHHTTSTTTTTTCC
T ss_pred             HHHhCCHHHHHhcC
Confidence            99999999976544

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-52  Score=381.49  Aligned_cols=258  Identities=25%  Similarity=0.412  Sum_probs=212.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc------ccCHHHHHHHHHHhcCC---CCCcceEEEEEEcCC-
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH------KIDANVAREIINHKQLR---HPNIIRFKEVVLTPT-   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~~~~l~---hp~Iv~~~~~~~~~~-   71 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++....      .......+|+.+++.++   ||||+++++++.... 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~   88 (308)
T 3g33_A            9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT   88 (308)
T ss_dssp             -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence            68999999999999999999999999999999986422      22356778888777764   999999999998765 


Q ss_pred             ----EEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccC
Q 018734           72 ----HLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG  145 (351)
Q Consensus        72 ----~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg  145 (351)
                          .+++||||+. ++|.+++.....  +++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg  165 (308)
T 3g33_A           89 DREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFG  165 (308)
T ss_dssp             SSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS--CEEECSCS
T ss_pred             CCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC--CEEEeeCc
Confidence                6899999996 599999987654  99999999999999999999999999999999999997666  49999999


Q ss_pred             CCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CCC
Q 018734          146 YSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIP  224 (351)
Q Consensus       146 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~  224 (351)
                      +++...........+||+.|+|||++.+..++. ++|||||||++|+|++|++||...........+......... .++
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  244 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYAT-PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  244 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCS-THHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSC
T ss_pred             cccccCCCcccCCccccccccCchHHcCCCCCc-hHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcc
Confidence            998665555556678999999999998888754 499999999999999999999887765555554443221110 000


Q ss_pred             --------------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          225 --------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       225 --------------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                          ....+++.+.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             chhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                                012478899999999999999999999999999999764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.3e-53  Score=386.14  Aligned_cols=253  Identities=32%  Similarity=0.562  Sum_probs=209.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++.+.||+|+||.||++++.   .+++.||+|++.+..     .....+.+|+.+++.++||||+++++++...+.+
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            68999999999999999999985   678999999987642     2234577899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESIHD  174 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS--CEEECCCSCC------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC--cEEEEeCCcccccccC
Confidence            99999999999999999888999999999999999999999999999999999999998665  4999999998753322


Q ss_pred             -CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          154 -SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       154 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                       ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......+|  ..++..
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~  247 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKT----IDKILKCKLNLP--PYLTQE  247 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHTCCCCC--TTSCHH
T ss_pred             CccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCC--CCCCHH
Confidence             233456799999999999887764 559999999999999999999987654332    333444444444  368999


Q ss_pred             HHHHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 018734          233 CRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      +.+||.+||+.||.+||     ++.++++||||...
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            99999999999999999     88999999999764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.9e-53  Score=403.63  Aligned_cols=254  Identities=35%  Similarity=0.606  Sum_probs=211.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC----cccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++++.||+|+||.||++.+..+++.||+|++...    ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999998753    22234567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HS  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~  154 (351)
                      |||+.|++|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++  .+||+|||+++.... ..
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS--CEEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC--CEEEccCCCceeccCCCc
Confidence            9999999999999988899999999999999999999998 9999999999999998766  499999999985332 23


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+......+|  ..+++.+.
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~~~~~~  377 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEEIRFP--RTLGPEAK  377 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHH
T ss_pred             ccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHH----HHHHHHhCCCCCC--ccCCHHHH
Confidence            34557899999999999888775 55999999999999999999998765432    2333344444444  36899999


Q ss_pred             HHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 018734          235 NLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       235 ~li~~~L~~~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      +||.+||+.||.+||     ++.++++||||...
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999999999     99999999999765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.2e-53  Score=391.83  Aligned_cols=255  Identities=32%  Similarity=0.591  Sum_probs=214.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc------ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH------KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....      .....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            47999999999999999999999999999999986421      123568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCccc
Q 018734           76 VMEYAAGGELFERICNA----GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSS  150 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~  150 (351)
                      |||||.|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||++...
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            99999999998877542    3589999999999999999999999999999999999997543 345999999999754


Q ss_pred             CCCCC-CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--Ccc
Q 018734          151 LLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYV  227 (351)
Q Consensus       151 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  227 (351)
                      ..... ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||....  .   .....+....+..+  .+.
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~--~---~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK--E---RLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH--H---HHHHHHHHTCCCCCHHHHT
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH--H---HHHHHHHcCCCCCCccccc
Confidence            43322 3456799999999999887775 55999999999999999999997642  1   22333333333322  234


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      .++..+.+||.+||+.||.+|||+.++|+||||..
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            68999999999999999999999999999999965

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.4e-53  Score=390.86  Aligned_cols=256  Identities=32%  Similarity=0.561  Sum_probs=216.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+....   ..+|+.++.++ +||||+++++++.+...+|+|||||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~   98 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELM   98 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCC
Confidence            4799999999999999999999999999999999765432   34688888777 7999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCCEEEeccCCCcccCCC-CCCC
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLLH-SRPK  157 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~--~~~vkL~DFg~a~~~~~~-~~~~  157 (351)
                      .||+|.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+|||+....  .+.+||+|||+++..... ....
T Consensus        99 ~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  178 (342)
T 2qr7_A           99 KGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM  178 (342)
T ss_dssp             CSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCcee
Confidence            9999999999988999999999999999999999999999999999999985432  235999999999854333 2334


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  235 (351)
                      ..+||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... .....+...+....+.++  .+..+++.+.+
T Consensus       179 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  256 (342)
T 2qr7_A          179 TPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKD  256 (342)
T ss_dssp             CSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHH
T ss_pred             ccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHHH
Confidence            56899999999999876664 459999999999999999999986432 223344455555555433  34568999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccccc
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      ||.+||+.||.+|||+.++++||||..
T Consensus       257 li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          257 LVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            999999999999999999999999954

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.3e-52  Score=375.05  Aligned_cols=259  Identities=32%  Similarity=0.605  Sum_probs=222.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++......   ...+.+|+.++++++||||+++++++...+..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            6899999999999999999999999999999998764322   2457789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~-~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |+.+++|.+.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++. +.+||+|||++..........
T Consensus        86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (284)
T 3kk8_A           86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH  165 (284)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCC
T ss_pred             cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcccc
Confidence            9999999999988889999999999999999999999999999999999999975542 459999999997665555555


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc--CCCCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  235 (351)
                      ...||+.|+|||++.+..++ .++|||||||++|+|++|+.||.........    ..+.....  ..+.+..+++.+.+
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T 3kk8_A          166 GFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLY----AQIKAGAYDYPSPEWDTVTPEAKS  240 (284)
T ss_dssp             CSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             CCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHH----HHHHhccccCCchhhcccCHHHHH
Confidence            67899999999999887775 4599999999999999999999876543322    22333333  33444578999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ||.+||+.||.+|||+.++++||||.....
T Consensus       241 li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          241 LIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            999999999999999999999999976543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.2e-53  Score=388.39  Aligned_cols=262  Identities=29%  Similarity=0.447  Sum_probs=210.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +++|++++.||+|+||.||++.+..+++.||+|++......   ...+.+|+.+++.++||||+++++++.+...+++||
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999998754332   245678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCCCEEEeccCCCcccCCC-
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS---PAPRLKICDFGYSKSSLLH-  153 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~---~~~~vkL~DFg~a~~~~~~-  153 (351)
                      ||+.+ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+   ..+.+||+|||+++..... 
T Consensus       113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            99975 999999998899999999999999999999999999999999999999532   2235999999998754322 


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-C------CCc
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-I------PDY  226 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~------~~~  226 (351)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.......... +      +.+
T Consensus       192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (329)
T 3gbz_A          192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDW  271 (329)
T ss_dssp             --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhh
Confidence            233445789999999999876655666999999999999999999998876655554444332111000 0      000


Q ss_pred             -----------------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          227 -----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       227 -----------------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                       ..+++.+.+||.+||+.||.+|||+.++|+||||...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          272 KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                             1167899999999999999999999999999999865

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.4e-53  Score=407.35  Aligned_cols=256  Identities=35%  Similarity=0.613  Sum_probs=218.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++++.||+|+||.||+|.+..++..||+|++....   .....+.+|+.+++.++|||||++++++.+...+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            37999999999999999999999999999999987643   234678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||.||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||++..........
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~  196 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK  196 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence            999999999998888999999999999999999999999999999999999997543 3469999999998665555556


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC--CCCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  235 (351)
                      ..+||+.|+|||++.+ .+ +.++|||||||++|+|++|++||.......    .+..+....+.  .+.+..+++.+.+
T Consensus       197 ~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          197 ERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQE----ILRKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             CCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             ccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCchhcccCCHHHHH
Confidence            6789999999999864 45 455999999999999999999998765433    33333344333  3445678999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ||.+||+.+|.+|||+.++|+||||.+.
T Consensus       271 li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          271 LIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHCCCChhhCccHHHHhcCcccccC
Confidence            9999999999999999999999999753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5e-53  Score=410.97  Aligned_cols=258  Identities=27%  Similarity=0.431  Sum_probs=221.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++++..+++.||+|++.+..    .....+.+|+.+++.++|||||++++++.+.+.+|+||
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  263 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL  263 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57999999999999999999999999999999986532    23356789999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           78 EYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||+.||+|..++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.......
T Consensus       264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTTCC
T ss_pred             EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--CeEEEecccceecccCcc
Confidence            99999999999987554  99999999999999999999999999999999999998766  499999999986554444


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+...+......++  ..+++++.+
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~d  418 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARS  418 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred             ccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHH
Confidence            4556899999999999887775 5599999999999999999999876543333344444444444444  468999999


Q ss_pred             HHHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 018734          236 LLSRIFVANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       236 li~~~L~~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      ||.+||+.||.+||     ++.++++||||....
T Consensus       419 LI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          419 LCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             HHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             HHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence            99999999999999     789999999997653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.8e-53  Score=387.22  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=208.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      |++|++++.||+|+||.||++.+..+++.||+|++......  ...+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            68999999999999999999999999999999998754322  1234579999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CC
Q 018734           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  156 (351)
Q Consensus        79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~  156 (351)
                      |+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...... ..
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC--CEEECSSSEEECC-------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC--CEEEccCcccccccCCcccc
Confidence            997 4888888765 4599999999999999999999999999999999999998766  49999999987543222 23


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc---------------
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------------  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  221 (351)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|+.||...........+.........               
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            34578999999999987555566699999999999999999999887655544443332211100               


Q ss_pred             CCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          222 KIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       222 ~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ..+         ....+++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            000         1124688999999999999999999999999999997653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.3e-53  Score=404.21  Aligned_cols=263  Identities=28%  Similarity=0.406  Sum_probs=197.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~   73 (351)
                      ++|++++.||+|+||.||+|.+..+++.||||++.....   ....+.+|+.+++.++|||||++++++...     ..+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            689999999999999999999999999999999876432   225678999999999999999999998443     579


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+||||+ +++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++  .+||+|||+|+.....
T Consensus       133 ~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC--SVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC--CEEECCCTTCBCTTSC
T ss_pred             EEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC--CEeecccccchhccCc
Confidence            9999998 569999999888899999999999999999999999999999999999998766  4999999999854321


Q ss_pred             C----------------------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc----------
Q 018734          154 S----------------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV----------  195 (351)
Q Consensus       154 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~----------  195 (351)
                      .                            .....+||++|+|||++......+.++|||||||++|||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                            22345789999999987555545666999999999999998          


Q ss_pred             -CCCCCCCCCC--------------------hhHHHHHHHHHHhh----------------ccC---------CCCccCC
Q 018734          196 -GAYPFEDQED--------------------PKNFRKTISRIMAV----------------QYK---------IPDYVHI  229 (351)
Q Consensus       196 -g~~pf~~~~~--------------------~~~~~~~~~~~~~~----------------~~~---------~~~~~~~  229 (351)
                       |+++|.+...                    ...+..+...+...                ...         ...+..+
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6777765431                    11111111110000                000         0112356


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      ++++.+||.+||+.||.+|||+.|+|+||||.......
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE  407 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence            89999999999999999999999999999998765543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-52  Score=376.94  Aligned_cols=255  Identities=29%  Similarity=0.522  Sum_probs=208.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||+|+||.||++.+..++..||+|++.....  ....+.+|+.+++.++||||+++++++.+...+++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            579999999999999999999999999999999876543  236788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEeccCCCcccCCCC
Q 018734           80 AAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        80 ~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +.+++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||++.......
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~  181 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE  181 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence            999999988854    3679999999999999999999999999999999999999643 23569999999998655555


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-CCCccCCCHhH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHISQDC  233 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (351)
                      ......||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.........    ......... ......+++.+
T Consensus       182 ~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  255 (285)
T 3is5_A          182 HSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ----QKATYKEPNYAVECRPLTPQA  255 (285)
T ss_dssp             -----CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCC--CCCCHHH
T ss_pred             cCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHH----hhhccCCcccccccCcCCHHH
Confidence            5566789999999999854 44 45699999999999999999999876533222    122211111 12223478999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      .+||.+||+.||.+|||+.++|+||||++
T Consensus       256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            99999999999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4e-53  Score=389.49  Aligned_cols=250  Identities=31%  Similarity=0.492  Sum_probs=217.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------IDANVAREIINHKQLRHPNIIRFKEVVLTPTH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~   72 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....         ....+.+|+.+++.++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            479999999999999999999999999999999876532         22356789999999999999999999999999


Q ss_pred             EEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           73 LAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        73 ~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      +++||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEeecccceECC
Confidence            99999999776 9999999988999999999999999999999999999999999999998765  49999999998655


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      ........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||......          .  .........+++
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~--~~~~~~~~~~~~  249 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------V--EAAIHPPYLVSK  249 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------T--TTCCCCSSCCCH
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------H--hhccCCCcccCH
Confidence            5555556689999999999988887677799999999999999999999753210          1  112233345899


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      .+.+||.+||+.||.+|||+.++++||||.+...
T Consensus       250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  283 (335)
T 3dls_A          250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN  283 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCccccCCcc
Confidence            9999999999999999999999999999987654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1e-52  Score=402.77  Aligned_cols=259  Identities=27%  Similarity=0.416  Sum_probs=207.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC------C
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------T   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~   71 (351)
                      +++|++++.||+|+||.||+|.+..+++.||||++.....   ....+.+|+.+++.++|||||++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            3689999999999999999999999999999999976432   235677999999999999999999999654      4


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      .+|+||||+.+ +|...+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++...
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAG  215 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCCC----
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC--CEEEEEEEeeeecC
Confidence            68999999976 57666643  489999999999999999999999999999999999998766  49999999998765


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc-----------
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-----------  220 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  220 (351)
                      ........+||++|+|||++.+..++. ++|||||||++|+|++|++||.+....+.+..++.......           
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCH-HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence            555566678999999999999887764 59999999999999999999998776665555544321100           


Q ss_pred             ----cCCCCccC---------------------CCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          221 ----YKIPDYVH---------------------ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       221 ----~~~~~~~~---------------------~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                          ...+.+..                     .++++.+||.+||+.||.+|||+.|+|+||||.....
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                00011000                     1467999999999999999999999999999986544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.3e-52  Score=403.16  Aligned_cols=258  Identities=27%  Similarity=0.408  Sum_probs=220.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.+...+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999987532    22356788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           78 EYAAGGELFERICNA----GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        78 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ||+.||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g--~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKAG  342 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC--CEEEeecceeeeccCC
Confidence            999999999998764    3699999999999999999999999999999999999998766  4999999999865433


Q ss_pred             CC-CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          154 SR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       154 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      .. ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+...+......+|  ..+++.
T Consensus       343 ~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~~  419 (543)
T 3c4z_A          343 QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPA  419 (543)
T ss_dssp             CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCHH
T ss_pred             CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCHH
Confidence            33 2345899999999999887775 4599999999999999999999876543333444455555444444  468999


Q ss_pred             HHHHHHHhcccCCCCCCC-----hHHHhcCcccccCC
Q 018734          233 CRNLLSRIFVANPSRRIT-----IKEIKSHPWFLKNL  264 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps-----~~eil~hp~~~~~~  264 (351)
                      +.+||.+||+.||.+||+     +.++++||||....
T Consensus       420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence            999999999999999996     58999999997653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.4e-53  Score=398.25  Aligned_cols=257  Identities=34%  Similarity=0.604  Sum_probs=206.4

Q ss_pred             CCeeEe-eeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHH-hcCCCCCcceEEEEEEc----CCEEEE
Q 018734            2 EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-KQLRHPNIIRFKEVVLT----PTHLAI   75 (351)
Q Consensus         2 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~-~~l~hp~Iv~~~~~~~~----~~~~~l   75 (351)
                      ++|.+. +.||+|+||.||++.+..+++.||||++...    ..+.+|+.++ +.++||||+++++++..    ...+|+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            578887 7899999999999999999999999998643    4577888876 55689999999999875    567999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccCC
Q 018734           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLL  152 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~~  152 (351)
                      |||||.||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+++....
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999999998754  599999999999999999999999999999999999998632 35699999999986554


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--CCccCCC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHIS  230 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  230 (351)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...............+....+.+  +.+..++
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  295 (400)
T 1nxk_A          217 HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  295 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred             CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence            4555667899999999999877775 459999999999999999999987543321111222333344433  3445789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..+.+||.+||+.||.+|||+.++++||||.+.
T Consensus       296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.5e-53  Score=407.57  Aligned_cols=258  Identities=35%  Similarity=0.609  Sum_probs=220.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc--------------ccCHHHHHHHHHHhcCCCCCcceEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--------------KIDANVAREIINHKQLRHPNIIRFKEVV   67 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~~~~l~hp~Iv~~~~~~   67 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....              .....+.+|+.+++.++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            58999999999999999999999999999999987643              2235688999999999999999999999


Q ss_pred             EcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEeccCC
Q 018734           68 LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA-PRLKICDFGY  146 (351)
Q Consensus        68 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~-~~vkL~DFg~  146 (351)
                      .+...+|+|||||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. .++||+|||+
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  195 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL  195 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence            999999999999999999999998889999999999999999999999999999999999999986643 3599999999


Q ss_pred             CcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--C
Q 018734          147 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--P  224 (351)
Q Consensus       147 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~  224 (351)
                      +............+||+.|+|||++.+ .+ +.++|||||||++|+|++|.+||.......    .+..+....+.+  +
T Consensus       196 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          196 SSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQD----IIKKVEKGKYYFDFN  269 (504)
T ss_dssp             CEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCHH
T ss_pred             CEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCcc
Confidence            986655555566789999999999864 45 455999999999999999999998765433    333334443332  3


Q ss_pred             CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      .+..+++.+.+||.+||++||.+|||+.++|+||||.+...
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            34578999999999999999999999999999999976543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-53  Score=396.54  Aligned_cols=259  Identities=25%  Similarity=0.447  Sum_probs=215.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||.||++++..+++.||+|++.+..    .....+.+|..++..++||||+++++++.+.+.+|+||
T Consensus        61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            68999999999999999999999999999999987532    12235778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      ||+.||+|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++....... 
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g--~vkL~DFGla~~~~~~~~~  218 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADGTV  218 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTSCE
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC--CEEEeechhheeccCCCcc
Confidence            999999999999875 4799999999999999999999999999999999999998766  499999999975433322 


Q ss_pred             -CCCcccCCCccCcccccC-------CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC-c
Q 018734          156 -PKSTVGTPAYIAPEVLSR-------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-Y  226 (351)
Q Consensus       156 -~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~  226 (351)
                       ....+||+.|+|||++..       ..+ +.++|||||||++|||++|+.||........+.++....  ....+|. .
T Consensus       219 ~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~  295 (412)
T 2vd5_A          219 RSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--EHLSLPLVD  295 (412)
T ss_dssp             ECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCC---
T ss_pred             ccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCcCCCccc
Confidence             234689999999999973       344 456999999999999999999998766544443333211  1223342 2


Q ss_pred             cCCCHhHHHHHHHhcccCCCCC---CChHHHhcCcccccCCCh
Q 018734          227 VHISQDCRNLLSRIFVANPSRR---ITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~R---ps~~eil~hp~~~~~~~~  266 (351)
                      ..+|+++++||.+||+ +|.+|   |+++++++||||......
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            4689999999999999 99998   599999999999865443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.1e-52  Score=381.22  Aligned_cols=260  Identities=31%  Similarity=0.584  Sum_probs=222.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....       ....+.+|+.+++.++||||+++++++.+...++
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            479999999999999999999999999999999876432       2356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~--~~vkL~DFg~a~~~~~  152 (351)
                      +||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  .++||+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~  171 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence            99999999999999998888999999999999999999999999999999999999976652  1599999999986555


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC--ccCCC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS  230 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  230 (351)
                      ........||+.|+|||++.+..++ .++|||||||++|+|++|..||........    +..+.......+.  +..++
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          172 GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQET----LANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCHHHHTTCC
T ss_pred             cccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhcccccChhhhcccC
Confidence            5555667899999999999877765 459999999999999999999987554332    2333333333321  24678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      ..+.+||.+||+.||.+|||+.++++||||......
T Consensus       247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~  282 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ  282 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence            999999999999999999999999999999765443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.3e-52  Score=391.00  Aligned_cols=260  Identities=23%  Similarity=0.385  Sum_probs=211.9

Q ss_pred             CCeeEeeeeccc--CceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSG--NFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++++.||+|  +||.||++.+..+++.||+|++......   ...+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  104 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV  104 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence            689999999999  9999999999999999999999764322   24577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC--
Q 018734           77 MEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL--  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~--  152 (351)
                      ||||.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.....  
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGCEECEETT
T ss_pred             EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccccceeecccc
Confidence            9999999999999875  6799999999999999999999999999999999999997666  499999998753221  


Q ss_pred             ------CCCCCCcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh-----
Q 018734          153 ------HSRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-----  219 (351)
Q Consensus       153 ------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----  219 (351)
                            .......+||+.|+|||++.+  ..+ +.++|||||||++|+|++|+.||........+...+......     
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  261 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS  261 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccc
Confidence                  122234579999999999987  345 455999999999999999999998766554443322111000     


Q ss_pred             -----------------------------------ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          220 -----------------------------------QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       220 -----------------------------------~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                                                         ....+....+++.+.+||.+||+.||.+|||+.++|+||||.+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                                               000122345788999999999999999999999999999997653

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.9e-53  Score=408.41  Aligned_cols=256  Identities=34%  Similarity=0.600  Sum_probs=221.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            47999999999999999999999999999999986542    23356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEeccCCCcccCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+++........
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  185 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM  185 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence            999999999999998999999999999999999999999999999999999999532 3346999999998765444444


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc--CCCCccCCCHhHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCR  234 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  234 (351)
                      ...+||+.|+|||++.+ .+ +.++|||||||++|+|++|++||........    +..+....+  ..|.+..+++.+.
T Consensus       186 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          186 KDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDI----LKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             HHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             ccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCCCCCCCcccccCCHHHH
Confidence            55679999999999976 44 4559999999999999999999987654333    333333333  3455667899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +||.+||+.+|.+|||+.++|+||||...
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.3e-52  Score=372.13  Aligned_cols=256  Identities=36%  Similarity=0.611  Sum_probs=218.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..++..||+|++..... ....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            479999999999999999999999999999999876433 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~-~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      .+++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+|||+.. +..+.+||+|||++............
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~  168 (277)
T 3f3z_A           89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK  168 (277)
T ss_dssp             CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhcc
Confidence            99999999998889999999999999999999999999999999999999932 12335999999999765555555667


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC--ccCCCHhHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLL  237 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li  237 (351)
                      .||+.|+|||++.+. + +.++|||||||++|+|++|+.||........    ...+.......+.  +..+++.+.+||
T Consensus       169 ~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (277)
T 3f3z_A          169 VGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEV----MLKIREGTFTFPEKDWLNVSPQAESLI  242 (277)
T ss_dssp             CSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred             CCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCCchhhhcCCHHHHHHH
Confidence            899999999998654 4 4559999999999999999999987654332    2233333333332  236889999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+||+.||.+|||+.++|+||||.+.
T Consensus       243 ~~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          243 RRLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHHccCChhhCcCHHHHhcCHHHhcc
Confidence            99999999999999999999999754

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-52  Score=384.56  Aligned_cols=259  Identities=33%  Similarity=0.610  Sum_probs=199.4

Q ss_pred             CCeeEe---eeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELM---KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~---~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.   +.||+|+||.||+|.+..+++.||+|++....  .....+|+.+++.+. ||||+++++++.+....|+||
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM--EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh--hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            467775   78999999999999999999999999986542  356778999999997 999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccCCC-CC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH-SR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~~~-~~  155 (351)
                      ||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++..... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999999999999999999999999999999999999999999999999999997543 225999999999754332 22


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh---hHHHHHHHHHHhhccCCCC--ccCCC
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYKIPD--YVHIS  230 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~  230 (351)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......   .........+....+.++.  +..++
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVS  244 (325)
T ss_dssp             ------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSC
T ss_pred             ccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCC
Confidence            3456799999999999887765 5599999999999999999999865431   1223344444444443332  24689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +.+.+||.+||+.||.+|||+.++++||||...
T Consensus       245 ~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          245 QEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            999999999999999999999999999999865

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.8e-52  Score=394.56  Aligned_cols=263  Identities=29%  Similarity=0.416  Sum_probs=208.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTP-----THL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~   73 (351)
                      ++|++++.||+|+||.||+|.+..+++.||||++......   ...+.+|+.+++.++||||+++++++...     ..+
T Consensus        26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            6899999999999999999999999999999999764332   35678999999999999999999999766     579


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+|+.....
T Consensus       106 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~--~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          106 YIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC--SVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEEC---
T ss_pred             EEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC--CEEEccCCCccccccc
Confidence            99999996 59999999888899999999999999999999999999999999999997765  4999999999854332


Q ss_pred             C-----------------------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcC-----------CCC
Q 018734          154 S-----------------------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-----------AYP  199 (351)
Q Consensus       154 ~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-----------~~p  199 (351)
                      .                       .....+||++|+|||++......+.++|||||||++|+|++|           .++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            1                       125568999999999976555556779999999999999984           444


Q ss_pred             CCCCCC-----------------hhHHHHHHHHH--------------------HhhccCCC-----CccCCCHhHHHHH
Q 018734          200 FEDQED-----------------PKNFRKTISRI--------------------MAVQYKIP-----DYVHISQDCRNLL  237 (351)
Q Consensus       200 f~~~~~-----------------~~~~~~~~~~~--------------------~~~~~~~~-----~~~~~~~~~~~li  237 (351)
                      |.+...                 ...+..+...+                    .......+     .+..+++.+.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence            433221                 11111111110                    00011111     1235899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      .+||+.||.+|||+.++|+||||.......
T Consensus       343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            999999999999999999999998765544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4e-52  Score=371.97  Aligned_cols=259  Identities=41%  Similarity=0.742  Sum_probs=213.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999999999999999999986532    2235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++  ++||+|||++.........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM--NAKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS--CEEECCCCGGGCCCC----
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC--CEEEeecccccccCCCcce
Confidence            99999999999999888999999999999999999999999999999999999997665  4999999998865544444


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....||+.|+|||++.+..+.+.++||||||+++|+|++|+.||.......    ....+.......|  ..++..+.++
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~--~~~~~~l~~l  241 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT----LFKKIRGGVFYIP--EYLNRSVATL  241 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH----HHHHhhcCcccCc--hhcCHHHHHH
Confidence            556799999999999887766667999999999999999999997754322    2223333333333  3578999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      |.+||+.||.+|||+.++++||||.+..+..
T Consensus       242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~  272 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIREHEWFKQDLPSY  272 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHTTCCGG
T ss_pred             HHHHccCChhhCCCHHHHHhChhhccCchhc
Confidence            9999999999999999999999998876543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-52  Score=391.10  Aligned_cols=259  Identities=26%  Similarity=0.394  Sum_probs=208.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcC------CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~   72 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++......   ...+.+|+.+++.++||||+++++++...      ..
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            5899999999999999999999999999999998654322   34677999999999999999999999765      35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++... 
T Consensus       105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~-  179 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQAD-  179 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECC-
T ss_pred             EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC--CEEEEeeecccccc-
Confidence            69999999 7899988876 5799999999999999999999999999999999999998765  49999999998543 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------  220 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------  220 (351)
                       ......+||++|+|||++.+....+.++|||||||++|+|++|+.||........+..+........            
T Consensus       180 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~  258 (367)
T 1cm8_A          180 -SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  258 (367)
T ss_dssp             -SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             -cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHH
Confidence             2345668999999999998744445669999999999999999999988766555544433211100            


Q ss_pred             ---------cCC----CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          221 ---------YKI----PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       221 ---------~~~----~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                               ...    ..+...++.+.+||.+||+.||.+|||+.++|+||||......
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          259 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                     000    0123568999999999999999999999999999999876443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=391.81  Aligned_cols=252  Identities=31%  Similarity=0.548  Sum_probs=210.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      .+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.++++++||||+++++++...+.+++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            678999999999999999999999999987643 2345688999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCC
Q 018734           86 FERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPA  164 (351)
Q Consensus        86 ~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~  164 (351)
                      .+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+..+++||+|||+++...........+||+.
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~  253 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPE  253 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCT
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCc
Confidence            9888654 469999999999999999999999999999999999999544445699999999986655555556689999


Q ss_pred             ccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCCHhHHHHHHHhcc
Q 018734          165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLLSRIFV  242 (351)
Q Consensus       165 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~  242 (351)
                      |+|||++.+..+ +.++|||||||++|+|++|+.||........+.    .+....+.++  .+..+++.+.+||.+||+
T Consensus       254 y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~~~li~~~L~  328 (373)
T 2x4f_A          254 FLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN----NILACRWDLEDEEFQDISEEAKEFISKLLI  328 (373)
T ss_dssp             TCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred             EeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence            999999977665 455999999999999999999998766544333    3333333332  235689999999999999


Q ss_pred             cCCCCCCChHHHhcCcccccC
Q 018734          243 ANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       243 ~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .||.+|||+.++|+||||...
T Consensus       329 ~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          329 KEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             SSGGGSCCHHHHHHSHHHHCH
T ss_pred             CChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.5e-52  Score=378.40  Aligned_cols=263  Identities=30%  Similarity=0.502  Sum_probs=211.6

Q ss_pred             CCeeEe-eeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++. +.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++++.+.+.+|+|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            579985 789999999999999999999999999976543 345688999999885 79999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEeccCCCcccCCCC---
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~-~~vkL~DFg~a~~~~~~~---  154 (351)
                      |+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||++.......   
T Consensus        92 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (316)
T 2ac3_A           92 KMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS  171 (316)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred             cCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence            9999999999998889999999999999999999999999999999999999976543 349999999987533211   


Q ss_pred             -----CCCCcccCCCccCcccccC-----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh-----------HHHHHH
Q 018734          155 -----RPKSTVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK-----------NFRKTI  213 (351)
Q Consensus       155 -----~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----------~~~~~~  213 (351)
                           .....+||+.|+|||++.+     ..+ +.++|||||||++|+|++|+.||.......           ......
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             ----------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             cccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                 1223469999999999865     334 455999999999999999999998754321           112233


Q ss_pred             HHHHhhccCCCC--ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          214 SRIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       214 ~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ..+......+|.  +..++..+.+||.+||+.||.+|||+.++++||||....+
T Consensus       251 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            344444444442  2458899999999999999999999999999999986543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.4e-52  Score=373.29  Aligned_cols=253  Identities=35%  Similarity=0.658  Sum_probs=214.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            578999999999999999999999999999999986532    2235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+.+++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||++.... ....
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~--~~~l~Dfg~~~~~~-~~~~  164 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAP-SSRR  164 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS--CEEECSCCEESCC------
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC--CEEEEeccccccCC-cccc
Confidence            99999999999999888999999999999999999999999999999999999997666  49999999886432 2233


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....||+.|+|||++.+..++ .++|||||||++|+|++|..||.......    ....+.......|  ..+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~l  237 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISRVEFTFP--DFVTEGARDL  237 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCC--TTSCHHHHHH
T ss_pred             cccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHH----HHHHHHhCCCCCC--CcCCHHHHHH
Confidence            456799999999999877765 45999999999999999999998754332    2333333343444  3588999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      |.+||+.+|.+|||+.++++||||...
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCC
Confidence            999999999999999999999999654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.2e-52  Score=371.71  Aligned_cols=260  Identities=36%  Similarity=0.608  Sum_probs=221.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            589999999999999999999999999999999865432  235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC---CCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SRP  156 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~---~~~  156 (351)
                      +.+++|.+++.....+++..++.++.|++.||.|||++||+||||||+||+++.++  ++||+|||++......   ...
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC--CEEEeeCCCccccCCCcchhcc
Confidence            99999999998878899999999999999999999999999999999999998665  4999999998743222   223


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...........   .........+.+..+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HhhhcccccCchhhcCHHHHHH
Confidence            4567999999999998877766679999999999999999999987654322221   2222223344455789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      |.+||+.||.+|||+.++++||||.+...+
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            999999999999999999999999877553

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.2e-52  Score=397.70  Aligned_cols=258  Identities=33%  Similarity=0.558  Sum_probs=206.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------IDANVAREIINHKQLRHPNIIRFKEVVLTPTH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~   72 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....         ....+.+|+.++++++||||+++++++. ...
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence            589999999999999999999999999999999875321         1124779999999999999999999985 456


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSL  151 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~  151 (351)
                      +|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++...
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~  293 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  293 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence            899999999999999998888999999999999999999999999999999999999997543 3459999999998665


Q ss_pred             CCCCCCCcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--CCcc
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYV  227 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  227 (351)
                      ........+||+.|+|||++.+  ....+.++|||||||++|+|++|+.||........+...+   ....+..  +.+.
T Consensus       294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i---~~~~~~~~~~~~~  370 (419)
T 3i6u_A          294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI---TSGKYNFIPEVWA  370 (419)
T ss_dssp             -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH---HTTCCCCCHHHHT
T ss_pred             CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH---hcCCCCCCchhhc
Confidence            5555566789999999999864  2223456999999999999999999998765443333322   2222222  1234


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       371 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            688999999999999999999999999999999754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5e-52  Score=389.06  Aligned_cols=256  Identities=26%  Similarity=0.413  Sum_probs=211.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEc------------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT------------   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~------------   69 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++......   ..+|+.+++.++|||||++++++..            
T Consensus         7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            6899999999999999999999999999999998765432   2379999999999999999999844            


Q ss_pred             --------------------------CCEEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 018734           70 --------------------------PTHLAIVMEYAAGGELFERIC----NAGRFSEDEARYFFQQLISGVSYCHSMQI  119 (351)
Q Consensus        70 --------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~i  119 (351)
                                                ...+++||||+.+ +|.+.+.    ....+++..++.++.||+.||.|||++||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence                                      3358999999975 7666554    45789999999999999999999999999


Q ss_pred             eecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCC
Q 018734          120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYP  199 (351)
Q Consensus       120 iH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  199 (351)
                      +||||||+|||++.. .+.+||+|||+++............||+.|+|||++.+....+.++|||||||++|+|++|+.|
T Consensus       163 ~H~Dikp~Nil~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  241 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSK-DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPL  241 (383)
T ss_dssp             ECSCCCGGGEEEETT-TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCccCHHHEEEcCC-CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCC
Confidence            999999999999732 2359999999998665566666778999999999998766456669999999999999999999


Q ss_pred             CCCCCChhHHHHHHHHHHhh-------------ccCCC----------CccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          200 FEDQEDPKNFRKTISRIMAV-------------QYKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       200 f~~~~~~~~~~~~~~~~~~~-------------~~~~~----------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      |......+.+..++......             ...+|          ....+++.+.+||.+||+.||.+|||+.++|+
T Consensus       242 f~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          242 FSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            99877666655554322110             00111          11247888999999999999999999999999


Q ss_pred             Cccccc
Q 018734          257 HPWFLK  262 (351)
Q Consensus       257 hp~~~~  262 (351)
                      ||||..
T Consensus       322 hp~f~~  327 (383)
T 3eb0_A          322 HPFFDH  327 (383)
T ss_dssp             SGGGHH
T ss_pred             CHHHHH
Confidence            999965

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-51  Score=382.14  Aligned_cols=262  Identities=24%  Similarity=0.391  Sum_probs=211.9

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc--------
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT--------   69 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--------   69 (351)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            4689999999999999999999999999999999865432   34568899999999999999999999977        


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           70 PTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        70 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      .+.+|+||||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~  172 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLAR  172 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCE
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--CEEEccchhcc
Confidence            4578999999975 777776654 5799999999999999999999999999999999999998766  49999999987


Q ss_pred             ccCC-----CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-
Q 018734          149 SSLL-----HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-  222 (351)
Q Consensus       149 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  222 (351)
                      ....     .......+||+.|+|||++.+....+.++|||||||++|+|++|++||...........+.......... 
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            5331     2223456799999999999876555667999999999999999999998876554444333222111110 


Q ss_pred             CCCcc-------------------------CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          223 IPDYV-------------------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       223 ~~~~~-------------------------~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ++...                         ..++.+.+||.+||+.||.+|||+.++|+||||.....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  320 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCC
Confidence            11100                         02677999999999999999999999999999976543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.1e-52  Score=387.08  Aligned_cols=256  Identities=23%  Similarity=0.412  Sum_probs=211.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-----CCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----HPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-----hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++............|+.+++.+.     ||||+++++++...+.+++|
T Consensus        35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv  114 (360)
T 3llt_A           35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLI  114 (360)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEE
T ss_pred             CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEE
Confidence            6899999999999999999999999999999999765555566778999998886     99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--------------------
Q 018734           77 MEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS--------------------  134 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~--------------------  134 (351)
                      |||+ +++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++..                    
T Consensus       115 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          115 FEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             ECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             EcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence            9999 889999998754  59999999999999999999999999999999999999751                    


Q ss_pred             ---CCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHH
Q 018734          135 ---PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK  211 (351)
Q Consensus       135 ---~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  211 (351)
                         ..+.+||+|||+++..  .......+||+.|+|||++.+..++. ++|||||||++|+|++|+.||........+..
T Consensus       194 ~~~~~~~~kl~DFG~a~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  270 (360)
T 3llt_A          194 YRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDV-SSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM  270 (360)
T ss_dssp             EEESCCCEEECCCTTCEET--TSCCCSCCSCGGGCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccCCCCEEEEeccCceec--CCCCcCccCcccccCcHHHcCCCCCC-ccchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence               2456999999999743  23345668999999999998888754 49999999999999999999987665443333


Q ss_pred             HHHHHHhh----------------------ccCCCCc------------------cCCCHhHHHHHHHhcccCCCCCCCh
Q 018734          212 TISRIMAV----------------------QYKIPDY------------------VHISQDCRNLLSRIFVANPSRRITI  251 (351)
Q Consensus       212 ~~~~~~~~----------------------~~~~~~~------------------~~~~~~~~~li~~~L~~~P~~Rps~  251 (351)
                      +.......                      ...+|..                  ...++.+.+||.+||+.||.+|||+
T Consensus       271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta  350 (360)
T 3llt_A          271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP  350 (360)
T ss_dssp             HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence            22211000                      0000100                  0123678899999999999999999


Q ss_pred             HHHhcCcccc
Q 018734          252 KEIKSHPWFL  261 (351)
Q Consensus       252 ~eil~hp~~~  261 (351)
                      .++|+||||+
T Consensus       351 ~elL~hp~f~  360 (360)
T 3llt_A          351 AELLKHKFLE  360 (360)
T ss_dssp             HHHTTSGGGC
T ss_pred             HHHhcCcccC
Confidence            9999999995

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.6e-51  Score=373.04  Aligned_cols=256  Identities=27%  Similarity=0.485  Sum_probs=215.9

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc-CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      |...+.||+|+||.||++.+..+|+.||||++...... ...+.+|+.+++.++||||+++++++...+..++||||+.|
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            78889999999999999999999999999998764433 35688999999999999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCCccc
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKSTVG  161 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~~~g  161 (351)
                      ++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||++....... .....+|
T Consensus       127 ~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~g  203 (321)
T 2c30_A          127 GALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG--RVKLSDFGFCAQISKDVPKRKSLVG  203 (321)
T ss_dssp             CBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSSSCCBCCCCS
T ss_pred             CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC--cEEEeeeeeeeecccCccccccccC
Confidence            999998864 5699999999999999999999999999999999999998665  49999999987543332 2345679


Q ss_pred             CCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CCCCccCCCHhHHHHHHHh
Q 018734          162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQDCRNLLSRI  240 (351)
Q Consensus       162 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~  240 (351)
                      |+.|+|||++.+..++. ++|||||||++|+|++|+.||.........    ..+..... .......+++.+.+||.+|
T Consensus       204 t~~y~aPE~~~~~~~~~-~~Dv~slG~il~el~~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          204 TPYWMAPEVISRSLYAT-EVDIWSLGIMVIEMVDGEPPYFSDSPVQAM----KRLRDSPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             CGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             CccccCHhhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence            99999999998777654 599999999999999999999876543322    22222211 2233446789999999999


Q ss_pred             cccCCCCCCChHHHhcCcccccCCChh
Q 018734          241 FVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       241 L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      |+.||.+|||+.++++||||.+...+.
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             ccCChhhCcCHHHHhcChhhccCCCcc
Confidence            999999999999999999998765443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.3e-52  Score=394.32  Aligned_cols=261  Identities=26%  Similarity=0.377  Sum_probs=213.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC------CCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL------RHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l------~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      .+|++++.||+|+||.||+|.+..+++.||||++.........+.+|+.+++.+      +|+||+++++++.....+++
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            579999999999999999999999999999999987655555677788777766      67899999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||++...  .
T Consensus       177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~--~  253 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--H  253 (429)
T ss_dssp             EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET--T
T ss_pred             EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec--C
Confidence            999995 69999987654  499999999999999999999999999999999999998776555999999998643  3


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc------------
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY------------  221 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------------  221 (351)
                      ......+||+.|+|||++.+..++ .++|||||||++|+|++|++||........+..+.........            
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  332 (429)
T 3kvw_A          254 QRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF  332 (429)
T ss_dssp             CCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHH
T ss_pred             CcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhc
Confidence            334556899999999999888875 5599999999999999999999887765555444432110000            


Q ss_pred             ----CCCC-------------------------------------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          222 ----KIPD-------------------------------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       222 ----~~~~-------------------------------------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                          ..|.                                     ....++.+.+||.+||++||.+|||+.|+|+||||
T Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~  412 (429)
T 3kvw_A          333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL  412 (429)
T ss_dssp             BCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTT
T ss_pred             cCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhh
Confidence                0000                                     00236789999999999999999999999999999


Q ss_pred             ccCCCh
Q 018734          261 LKNLPR  266 (351)
Q Consensus       261 ~~~~~~  266 (351)
                      ++..++
T Consensus       413 ~~~~~~  418 (429)
T 3kvw_A          413 RRRLPK  418 (429)
T ss_dssp             C-----
T ss_pred             ccCCCC
Confidence            887654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-51  Score=411.49  Aligned_cols=255  Identities=31%  Similarity=0.531  Sum_probs=222.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccC----cccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG----HKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++++.||+|+||.||++.+..+++.||||++.+.    ......+..|..++..+ +||||+++++++.+...+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999998753    23345677899999887 79999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC-CCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL-LHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~-~~~  154 (351)
                      ||||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++  ++||+|||+|+... ...
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS--CEEECCCTTCEECCCTTC
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC--cEEEeecceeeccccCCc
Confidence            999999999999999988999999999999999999999999999999999999998766  49999999998533 233


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||+.|+|||++.+..++ .++|||||||++|||++|++||......    .+...+......+|.  .+++++.
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~  570 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIMEHNVAYPK--SMSKEAV  570 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHSSCCCCCT--TSCHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHH----HHHHHHHhCCCCCCc--cCCHHHH
Confidence            34557899999999999888875 5599999999999999999999876543    334445555555554  6899999


Q ss_pred             HHHHHhcccCCCCCCCh-----HHHhcCcccccCC
Q 018734          235 NLLSRIFVANPSRRITI-----KEIKSHPWFLKNL  264 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~-----~eil~hp~~~~~~  264 (351)
                      +||.+||+.||.+||++     .+|++||||....
T Consensus       571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             HHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            99999999999999998     9999999997653

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-51  Score=379.42  Aligned_cols=261  Identities=29%  Similarity=0.451  Sum_probs=214.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +++|++++.||+|+||.||++.+..+++.||+|++......   ...+.+|+.+++.++||||+++++++...+.+++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            57999999999999999999999999999999998654332   244678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~  156 (351)
                      ||+.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++...... ...
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC----------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeecCCcccc
Confidence            9999988888888788899999999999999999999999999999999999997766  4999999998754332 223


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh---------------hcc
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA---------------VQY  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~  221 (351)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+......               ...
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            45679999999999987655566799999999999999999999887665554443322110               001


Q ss_pred             CCCC----------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          222 KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       222 ~~~~----------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..+.          +..+++.+.+||.+||+.||.+|||+.++|+||||+..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            1111          12578999999999999999999999999999999754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.4e-51  Score=370.96  Aligned_cols=258  Identities=33%  Similarity=0.545  Sum_probs=219.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----------cCHHHHHHHHHHhcCC-CCCcceEEEEEEc
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----------IDANVAREIINHKQLR-HPNIIRFKEVVLT   69 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~   69 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.....          ....+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            4789999999999999999999999999999999875431          1245678999999995 9999999999999


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           70 PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        70 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      ....++||||+.+++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhh
Confidence            9999999999999999999998889999999999999999999999999999999999999977664  99999999986


Q ss_pred             cCCCCCCCCcccCCCccCccccc------CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-
Q 018734          150 SLLHSRPKSTVGTPAYIAPEVLS------RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-  222 (351)
Q Consensus       150 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  222 (351)
                      ...........||+.|+|||++.      ...+ +.++|||||||++|+|++|+.||........    ...+...... 
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~  248 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----LRMIMSGNYQF  248 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCC
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHH----HHHHhcCCccc
Confidence            55555555668999999999985      2333 4569999999999999999999987554322    2233333333 


Q ss_pred             -CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          223 -IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       223 -~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                       .+.+..++..+.+||.+||+.||.+|||+.++++||||.+...
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence             3344568999999999999999999999999999999987654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-51  Score=383.98  Aligned_cols=254  Identities=32%  Similarity=0.567  Sum_probs=216.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---------CHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------DANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      ++|++.+.||+|+||.||+|.+..+|+.||||++......         ...+.+|+.+++.+ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            4699999999999999999999999999999998764321         24567899999998 7999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      ..|+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~--~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM--QIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEEEecCcccccC
Confidence            9999999999999999999888899999999999999999999999999999999999998665  49999999988665


Q ss_pred             CCCCCCCcccCCCccCcccccCC------cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--  223 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  223 (351)
                      ........+||+.|+|||++.+.      .+ +.++|||||||++|+|++|+.||.......    ....+....+..  
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~  326 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQIL----MLRMIMEGQYQFSS  326 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCH
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHhCCCCCCC
Confidence            55555667899999999998632      33 455999999999999999999998754332    222333333332  


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      +.+..++..+.+||.+||+.||.+|||+.++|+||||++
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            233568899999999999999999999999999999963

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-52  Score=385.26  Aligned_cols=259  Identities=32%  Similarity=0.532  Sum_probs=212.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc------ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH------KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....      .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            47999999999999999999999999999999986532      223568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 018734           76 VMEYAAGGELFERICN----------------------------------------AGRFSEDEARYFFQQLISGVSYCH  115 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~----------------------------------------~~~l~~~~~~~~~~qi~~aL~~lH  115 (351)
                      |||||.|++|.+++..                                        ...+++..++.++.||+.||.|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999998842                                        112467889999999999999999


Q ss_pred             HcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-----CCCCcccCCCccCcccccCC-cCCCcchhHHHHHHH
Q 018734          116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-----RPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVT  189 (351)
Q Consensus       116 ~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~i  189 (351)
                      ++||+||||||+|||++.++...+||+|||+++......     ......||+.|+|||++.+. ...+.++|||||||+
T Consensus       186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i  265 (345)
T 3hko_A          186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL  265 (345)
T ss_dssp             HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred             HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence            999999999999999987665579999999987532211     12455799999999999652 333556999999999


Q ss_pred             HHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC--CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          190 LYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       190 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      +|+|++|+.||...........    +......  .+.+..+++.+.+||.+||+.+|.+|||+.++|+||||.+..
T Consensus       266 l~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          266 LHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHH----HHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHHCCCCCCCCChHHHHHH----HHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            9999999999987665443333    2333322  334445899999999999999999999999999999997653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-52  Score=388.28  Aligned_cols=260  Identities=23%  Similarity=0.406  Sum_probs=198.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC------CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP------TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~   72 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            689999999999999999999999999999999876432   235677999999999999999999999754      56


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +|+||+++ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++... 
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~--~~kL~DFG~a~~~~-  183 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--ELKILDFGLARHTA-  183 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECC---------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC--CEEEeecccccccc-
Confidence            89999999 6799888865 6799999999999999999999999999999999999998766  49999999997532 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------------  220 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------  220 (351)
                       ......+||++|+|||++.+....+.++|||||||++|+|++|+.||........+..+........            
T Consensus       184 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          184 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             -ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence             2344568999999999998744455669999999999999999999988776555554443221100            


Q ss_pred             ----cCCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          221 ----YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       221 ----~~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                          ...+         .+...++.+.+||.+||+.||.+|||+.++|+||||.+...+.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~  322 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  322 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence                0001         0124678999999999999999999999999999998765543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.7e-51  Score=369.60  Aligned_cols=253  Identities=32%  Similarity=0.645  Sum_probs=217.9

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999986532    2235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++..... ...
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~-~~~  169 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG--ELKIADFGWSVHAPS-LRR  169 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC--CEEECCCTTCEECSS-SCB
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC--CEEEecccccccCcc-ccc
Confidence            99999999999999888999999999999999999999999999999999999997665  499999999864332 233


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....||+.|+|||++.+..++. ++|||||||++|+|++|..||........    ...+......+|  ..++..+.++
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~l  242 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDE-KVDLWCAGVLCYEFLVGMPPFDSPSHTET----HRRIVNVDLKFP--PFLSDGSKDL  242 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCC--TTSCHHHHHH
T ss_pred             ccccCCCCcCCHHHhccCCCCc-ccchhhHHHHHHHHHHCCCCCCCCCHhHH----HHHHhccccCCC--CcCCHHHHHH
Confidence            4567999999999998877754 49999999999999999999987554322    233333333333  4689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      |.+||+.+|.+|||+.++++||||...
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            999999999999999999999999654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2e-51  Score=374.34  Aligned_cols=249  Identities=21%  Similarity=0.285  Sum_probs=200.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC---HHHHHHHHHHhc-CCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQ-LRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~~~~-l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.++||+|+||+||+|.+..+++.||||++.......   .....|+..+.. .+||||+++++++...+.+|+||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999886543322   234455555444 48999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      ||+ +++|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence            999 66888887654 46999999999999999999999999999999999999977664  999999998866555555


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....||+.|+|||++.+ .+ +.++|||||||++|+|++|..||....   .    ...+............+++.+.+|
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGE---G----WQQLRQGYLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHH---H----HHHHTTTCCCHHHHTTSCHHHHHH
T ss_pred             cccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCcc---H----HHHHhccCCCcccccCCCHHHHHH
Confidence            56679999999999876 44 456999999999999999977765421   1    111222111111233578999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCccccc
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      |.+||+.||.+|||+.++|+||||++
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          285 LVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-51  Score=379.87  Aligned_cols=259  Identities=28%  Similarity=0.430  Sum_probs=211.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.....      ....+.+|+.+++.++||||+++++++......++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            689999999999999999999999999999999875322      13467899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-
Q 018734           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-  153 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-  153 (351)
                      ||||+.+ +|...+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++..... 
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECCCGGGSTTTSCC
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC--CEEEEecccceeccCCc
Confidence            9999976 888888664 4689999999999999999999999999999999999998765  4999999999864332 


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CCCC-------
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPD-------  225 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~-------  225 (351)
                      ......+||+.|+|||++.+....+.++|||||||++|+|++|.+||........+..+......... .++.       
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc
Confidence            23345679999999999977665566799999999999999999999887665555554443221110 0110       


Q ss_pred             --------------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          226 --------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       226 --------------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                    +..++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          247 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                          13457899999999999999999999999999999765

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.2e-51  Score=389.17  Aligned_cols=256  Identities=28%  Similarity=0.442  Sum_probs=210.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcC------CEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP------THLAIV   76 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~~~lv   76 (351)
                      +|++.+.||+|+||.||++.+..+++.||||++......   ..+|+.+++.++|||||++++++...      ..+++|
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            699999999999999999999999999999998764332   34799999999999999999998542      247799


Q ss_pred             EeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           77 MEYAAGGELFERIC----NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |||+.+ +|...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++....
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~  209 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVR  209 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhccc
Confidence            999976 6655553    3567999999999999999999999999999999999999985432 489999999986655


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh----------h---
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------V---  219 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----------~---  219 (351)
                      .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||......+.+.+++.....          .   
T Consensus       210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~  289 (420)
T 1j1b_A          210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT  289 (420)
T ss_dssp             TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred             CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            555666789999999999977644566699999999999999999999987766666555543211          0   


Q ss_pred             ccCCCC----------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          220 QYKIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       220 ~~~~~~----------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+.+|.          ...+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       290 ~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          290 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            111221          12468899999999999999999999999999999754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.7e-51  Score=374.47  Aligned_cols=257  Identities=23%  Similarity=0.406  Sum_probs=212.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-CCCcceEEEEEEc--CCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLT--PTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~--~~~~~lv~e   78 (351)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  ...+.+|+.+++.++ ||||+++++++..  ....++|||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            58999999999999999999999999999999987533  357889999999997 9999999999987  578999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |+.+++|..++..   +++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++..........
T Consensus       114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~~  189 (330)
T 3nsz_A          114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNV  189 (330)
T ss_dssp             CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCS
T ss_pred             ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCcccc
Confidence            9999999888753   899999999999999999999999999999999999975542 599999999986555555566


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHH-HHHHHHH---------HhhccC------
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF-RKTISRI---------MAVQYK------  222 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~---------~~~~~~------  222 (351)
                      ..||+.|+|||++.+....+.++|||||||++|+|++|+.||......... ..+....         ......      
T Consensus       190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (330)
T 3nsz_A          190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN  269 (330)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHH
T ss_pred             ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchh
Confidence            789999999999987555566799999999999999999999665443222 2111111         000000      


Q ss_pred             ----------------CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          223 ----------------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       223 ----------------~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                                      ......+++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          270 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                            011123789999999999999999999999999999998654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-52  Score=383.29  Aligned_cols=259  Identities=30%  Similarity=0.537  Sum_probs=216.4

Q ss_pred             CCCeeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCc-----ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGH-----KIDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      +++|++.+.||+|+||.||++++.   .+++.||||++....     .....+.+|+.+++.+ .||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            368999999999999999999984   578999999986532     2234566799999999 6999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      .+++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++...
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--cEEEeeCCCCeecc
Confidence            9999999999999999999888999999999999999999999999999999999999997765  49999999987532


Q ss_pred             CC--CCCCCcccCCCccCcccccCCc-CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          152 LH--SRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       152 ~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                      ..  ......+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........+...+.......  +..
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  288 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQE  288 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC--CTT
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC--Ccc
Confidence            22  2223457999999999997632 235669999999999999999999986554444444444444433333  346


Q ss_pred             CCHhHHHHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 018734          229 ISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      ++..+.+||.+||+.||.+||     ++.++++||||.+.
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            899999999999999999999     99999999999764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7e-52  Score=379.65  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=203.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC--------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT--------   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~--------   71 (351)
                      ++|++++.||+|+||.||+|.+..+++.||||++.....  ....+.+|+.++++++|||||++++++....        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            589999999999999999999999999999999875432  3356889999999999999999999985543        


Q ss_pred             -------------------------------------------------EEEEEEeccCCCChHHHHHhcCC---CCHHH
Q 018734           72 -------------------------------------------------HLAIVMEYAAGGELFERICNAGR---FSEDE   99 (351)
Q Consensus        72 -------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---l~~~~   99 (351)
                                                                       .+++|||||.+++|.+++.....   .++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999999987644   56667


Q ss_pred             HHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-------------CCCCCcccCCCcc
Q 018734          100 ARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-------------SRPKSTVGTPAYI  166 (351)
Q Consensus       100 ~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-------------~~~~~~~gt~~y~  166 (351)
                      ++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.....             ......+||+.|+
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            999999999999999999999999999999998665  5999999998754433             1223457999999


Q ss_pred             CcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCC
Q 018734          167 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPS  246 (351)
Q Consensus       167 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~  246 (351)
                      |||++.+..++ .++|||||||++|+|++|..|+.      ............... ..+...++.+.+||.+||+.||.
T Consensus       244 aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~------~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          244 SPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQM------ERVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             CHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHH------HHHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             ChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChh------HHHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCC
Confidence            99999887775 45999999999999999876642      112222222222111 11234578899999999999999


Q ss_pred             CCCChHHHhcCccccc
Q 018734          247 RRITIKEIKSHPWFLK  262 (351)
Q Consensus       247 ~Rps~~eil~hp~~~~  262 (351)
                      +|||+.++++||||.+
T Consensus       316 ~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          316 ERPEATDIIENAIFEN  331 (332)
T ss_dssp             GSCCHHHHHHSTTCCC
T ss_pred             cCCCHHHHhhchhhhc
Confidence            9999999999999964

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.1e-51  Score=372.79  Aligned_cols=257  Identities=34%  Similarity=0.608  Sum_probs=215.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.....+|+||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            479999999999999999999999999999999876543 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~-~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      .+++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||++.. +..+.+||+|||++..... ......
T Consensus        89 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~  167 (304)
T 2jam_A           89 SGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMSTA  167 (304)
T ss_dssp             CSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTHHH
T ss_pred             CCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Cccccc
Confidence            99999999988889999999999999999999999999999999999999932 2234599999999874322 222345


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC--CCCccCCCHhHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNLL  237 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li  237 (351)
                      .||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+....+.  .+.+..+++.+.+||
T Consensus       168 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~li  242 (304)
T 2jam_A          168 CGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKL----FEKIKEGYYEFESPFWDDISESAKDFI  242 (304)
T ss_dssp             HSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHCCCCCCTTTTTTSCHHHHHHH
T ss_pred             cCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHHcCCCCCCccccccCCHHHHHHH
Confidence            699999999999877664 559999999999999999999987654332    2333333332  233456899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccCC
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      .+||+.||.+|||+.++++||||....
T Consensus       243 ~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          243 CHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHcCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999999997653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.1e-52  Score=371.33  Aligned_cols=257  Identities=33%  Similarity=0.630  Sum_probs=215.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....       ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            479999999999999999999999999999999875422       2356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP--APRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~--~~~vkL~DFg~a~~~~~  152 (351)
                      +||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++  ..++||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999997654  23699999999986554


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHIS  230 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  230 (351)
                      ........||+.|+|||++.+..++ .++|||||||++|+|++|..||........    ...+.......+  .+..++
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQET----LTNISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCCHHHHTTCC
T ss_pred             CCcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHH----HHHhHhcccCCcchhcccCC
Confidence            4444556799999999999877765 459999999999999999999987654322    222333332222  124578


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..+.+||.+||+.||.+|||+.++++||||...
T Consensus       240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            899999999999999999999999999999653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-51  Score=368.78  Aligned_cols=254  Identities=30%  Similarity=0.548  Sum_probs=194.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....    .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            478999999999999999999999999999999986532    1235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-C
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~  154 (351)
                      |||+.+++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++  ++||+|||++...... .
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM--NIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC--CEEECCCTTCEECC----
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEEEeecceeeccCCCC
Confidence            9999999999999875 6799999999999999999999999999999999999997665  4999999998754322 2


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||..........    .+....+..  +..++..+.
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~  240 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVLADYEM--PSFLSIEAK  240 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCC--CTTSCHHHH
T ss_pred             cceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----HHhhcccCC--ccccCHHHH
Confidence            23345799999999999877664 45999999999999999999998755433221    122222222  335789999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +||.+||+.||.+|||+.++++||||.+.
T Consensus       241 ~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          241 DLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            99999999999999999999999999764

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.6e-51  Score=384.59  Aligned_cols=256  Identities=28%  Similarity=0.436  Sum_probs=208.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCC------EEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT------HLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~------~~~l   75 (351)
                      .+|++.+.||+|+||.||+|++..+++ ||+|++.......   .+|+.+++.++||||+++++++...+      .+++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~---~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK---NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC---CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH---HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            379999999999999999999988776 8888776543322   37999999999999999999996543      4889


Q ss_pred             EEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCCCEEEeccCCCccc
Q 018734           76 VMEYAAGGELFERIC----NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSS  150 (351)
Q Consensus        76 v~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~-~~~~~~vkL~DFg~a~~~  150 (351)
                      ||||+.++ +...+.    ....+++..++.++.||+.||.|||++||+||||||+|||++ .++  .+||+|||+++..
T Consensus       116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEEC
T ss_pred             EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccc
Confidence            99999764 433332    356799999999999999999999999999999999999997 444  5999999999876


Q ss_pred             CCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh----------hc
Q 018734          151 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA----------VQ  220 (351)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----------~~  220 (351)
                      .........+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..++.....          ..
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  272 (394)
T 4e7w_A          193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN  272 (394)
T ss_dssp             CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred             cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            66666667789999999999977665566799999999999999999999987766665555442211          11


Q ss_pred             c---CCCC----------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          221 Y---KIPD----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       221 ~---~~~~----------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      +   .+|.          ...+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            1   1111          123788999999999999999999999999999998643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.2e-51  Score=368.50  Aligned_cols=256  Identities=36%  Similarity=0.640  Sum_probs=219.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++...+.+++|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            579999999999999999999999999999999865432   33568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |+.+++|.+.+.....+++..++.++.||+.||.|||++|++||||||+||+++.++ ...+||+|||++..........
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~  181 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence            999999999998888999999999999999999999999999999999999997643 3469999999988655444445


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc--CCCCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KIPDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  235 (351)
                      ...||+.|+|||++.+. + +.++|||||||++|+|++|..||.......    ....+.....  ..+.+..+++.+.+
T Consensus       182 ~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          182 DRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYD----ILKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             cccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCchhhhhcCHHHHH
Confidence            56799999999998654 4 455999999999999999999998765432    2333333333  23444578999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +|.+||+.+|.+|||+.++++||||.+.
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.1e-51  Score=383.14  Aligned_cols=260  Identities=24%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCC-------EE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT-------HL   73 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-------~~   73 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++...........+++..++.++||||+++++++....       .+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            47899999999999999999999999999999998776665667778888889999999999999996543       38


Q ss_pred             EEEEeccCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEecC-CCCCCEEEeccCC
Q 018734           74 AIVMEYAAGGELFERI----CNAGRFSEDEARYFFQQLISGVSYCH--SMQICHRDLKLENTLLDG-SPAPRLKICDFGY  146 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~iiH~Dikp~NIll~~-~~~~~vkL~DFg~  146 (351)
                      ++||||+.+ +|...+    .....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++  ++||+|||+
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~  178 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGS  178 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTT
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCC
Confidence            899999976 554433    35667999999999999999999999  999999999999999975 44  599999999


Q ss_pred             CcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc------
Q 018734          147 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ------  220 (351)
Q Consensus       147 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------  220 (351)
                      ++............||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+........      
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            98766555556678999999999997766556679999999999999999999998766555554443211100      


Q ss_pred             -----c--C-------------CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          221 -----Y--K-------------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       221 -----~--~-------------~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                           .  .             .......++.+.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                 0  0             00111246789999999999999999999999999999765

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.3e-51  Score=381.26  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=213.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+.+++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            589999999999999999999999999999999876532  235678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      +.|++|.+++...+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.  +||+|||++..... .....
T Consensus       113 ~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~  189 (360)
T 3eqc_A          113 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  189 (360)
T ss_dssp             CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC---
T ss_pred             CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-ccccC
Confidence            99999999999888999999999999999999999985 9999999999999987664  99999999864322 23345


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHH----------------------------
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR----------------------------  210 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------------------------  210 (351)
                      ..||+.|+|||++.+..++ .++|||||||++|+|++|+.||..........                            
T Consensus       190 ~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (360)
T 3eqc_A          190 FVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG  268 (360)
T ss_dssp             -CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred             CCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence            6799999999999887764 55999999999999999999997654322111                            


Q ss_pred             ----------HHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          211 ----------KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       211 ----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                .....+............++..+.+||.+||+.||.+|||+.++|+||||...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                      11111121111111223478899999999999999999999999999999653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-51  Score=374.62  Aligned_cols=254  Identities=24%  Similarity=0.375  Sum_probs=210.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC--EEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~--~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++....  .+++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            579999999999999999999999999999999876432  2356779999999999999999999998765  789999


Q ss_pred             eccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCCCCCEEEeccCCCccc
Q 018734           78 EYAAGGELFERICNAGR---FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLL----DGSPAPRLKICDFGYSKSS  150 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll----~~~~~~~vkL~DFg~a~~~  150 (351)
                      ||+.+++|.+++.....   +++..++.++.||+.||.|||++||+||||||+|||+    +.++  .+||+|||+++..
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a~~~  166 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAAREL  166 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTCEEC
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCceec
Confidence            99999999999976543   9999999999999999999999999999999999998    4433  5999999999866


Q ss_pred             CCCCCCCCcccCCCccCccccc--------CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-
Q 018734          151 LLHSRPKSTVGTPAYIAPEVLS--------RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-  221 (351)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-  221 (351)
                      .........+||+.|+|||++.        +..+ +.++|||||||++|+|++|+.||............+..+..... 
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~  245 (319)
T 4euu_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (319)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred             CCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence            5555556678999999999986        3444 45599999999999999999999876655544444444443221 


Q ss_pred             ------------------CCCCc----cCCCHhHHHHHHHhcccCCCCCCChHHHhcCc
Q 018734          222 ------------------KIPDY----VHISQDCRNLLSRIFVANPSRRITIKEIKSHP  258 (351)
Q Consensus       222 ------------------~~~~~----~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp  258 (351)
                                        ..+..    ..++..+.+||.+||+.||.+|||++|+|+||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence                              11111    12445788999999999999999999999997

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.1e-51  Score=375.64  Aligned_cols=261  Identities=29%  Similarity=0.507  Sum_probs=213.6

Q ss_pred             CCeeEe-eeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|.+. +.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.+++.+. ||||+++++++.....+++|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            367887 899999999999999999999999999876432   2357889999999985 69999999999999999999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccCCC
Q 018734           77 MEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLLH  153 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~~~  153 (351)
                      |||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+++.....
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            9999999999988553  6799999999999999999999999999999999999997621 346999999999865554


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                      ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+..  ....+..+.+..+++.+
T Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~  264 (327)
T 3lm5_A          188 CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--VNVDYSEETFSSVSQLA  264 (327)
T ss_dssp             ------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTTTTTSCHHH
T ss_pred             cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh--cccccCchhhcccCHHH
Confidence            445567899999999999877765 459999999999999999999987654433322211  12223334445789999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      .+||.+||+.||.+|||+.++|+||||+....
T Consensus       265 ~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          265 TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             HHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            99999999999999999999999999976543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.2e-51  Score=366.89  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=207.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+..+..+ +||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            479999999999999999999999999999999876432   235677899999888 9999999999999999999999


Q ss_pred             eccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----------------C
Q 018734           78 EYAAGGELFERICNA----GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-----------------A  136 (351)
Q Consensus        78 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-----------------~  136 (351)
                      ||+++++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.++                 .
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999999764    6799999999999999999999999999999999999997432                 2


Q ss_pred             CCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH
Q 018734          137 PRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI  216 (351)
Q Consensus       137 ~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  216 (351)
                      ..+||+|||++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+....   ...    .+
T Consensus       171 ~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~----~~  240 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWH----EI  240 (289)
T ss_dssp             CCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHH----HH
T ss_pred             eEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHH----HH
Confidence            3599999999875432   2345699999999999876555567999999999999999988775432   111    12


Q ss_pred             HhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..... ......+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       241 ~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          241 RQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            22221 12234689999999999999999999999999999999765

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8e-51  Score=374.16  Aligned_cols=254  Identities=31%  Similarity=0.520  Sum_probs=218.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            589999999999999999999999999999999876432    2356778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~  156 (351)
                      ||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||++...... ...
T Consensus       121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC--CEEEeeccCceecccCcccc
Confidence            9999999999998888999999999999999999999999999999999999998765  4999999999754322 233


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+......++  ..+++.+.+|
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~l  271 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSIP--KHINPVAASL  271 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHHTCCCCC--TTSCHHHHHH
T ss_pred             cccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHH----HHHHhcCCCCCC--ccCCHHHHHH
Confidence            446799999999999887765 459999999999999999999987553322    233333344444  3688999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      |.+||+.||.+|||+.++++||||....
T Consensus       272 i~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          272 IQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHccCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999997653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.5e-50  Score=365.21  Aligned_cols=254  Identities=31%  Similarity=0.520  Sum_probs=218.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            589999999999999999999999999999999876432    2346778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~  156 (351)
                      ||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++  ++||+|||++...... ...
T Consensus        95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A           95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL--EVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCSTTCCB
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC--CEEEEeccCceecccCcccc
Confidence            9999999999998888999999999999999999999999999999999999998665  4999999998754322 223


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ....||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+.......|  ..+++.+.++
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~l  245 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKET----YLRIKKNEYSIP--KHINPVAASL  245 (294)
T ss_dssp             CCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCC--TTSCHHHHHH
T ss_pred             ccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhhccCCCc--cccCHHHHHH
Confidence            445799999999999877764 459999999999999999999987554322    223333333333  3688999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      |.+||+.||.+|||+.++++||||....
T Consensus       246 i~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          246 IQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHcccChhhCcCHHHHhhChheecCC
Confidence            9999999999999999999999997653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-51  Score=376.76  Aligned_cols=258  Identities=34%  Similarity=0.557  Sum_probs=210.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---------IDANVAREIINHKQLRHPNIIRFKEVVLTPTH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~   72 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....         ....+.+|+.+++.++||||+++++++.... 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            479999999999999999999999999999999865321         1235779999999999999999999997665 


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSL  151 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~  151 (351)
                      +|+||||+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||++....
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            899999999999999998888999999999999999999999999999999999999997644 3459999999987543


Q ss_pred             CCCCCCCcccCCCccCccccc--CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--Ccc
Q 018734          152 LHSRPKSTVGTPAYIAPEVLS--RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYV  227 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  227 (351)
                      .........||+.|+|||++.  +....+.++|||||||++|+|++|..||........+...+.   .......  .+.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~  245 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVWA  245 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH---HTCCCCCHHHHT
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH---hCccccCchhhh
Confidence            322223456999999999974  223335569999999999999999999987654433333222   2222211  123


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .++..+.+||.+||+.||.+|||+.++++||||...
T Consensus       246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            578999999999999999999999999999999764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.8e-50  Score=364.13  Aligned_cols=254  Identities=22%  Similarity=0.368  Sum_probs=210.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc----CCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT----PTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~----~~~~~   74 (351)
                      +.|++.+.||+|+||.||++.+..++..||+|++.....   ....+.+|+.+++.++||||+++++++..    ...++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            358999999999999999999999999999999875432   23457889999999999999999999865    35689


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEec-CCCCCCEEEeccCCCcccC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~-~~~~~~vkL~DFg~a~~~~  151 (351)
                      +||||+.+++|.+++...+.+++..++.++.||+.||.|||++|  |+||||||+|||++ .++  .+||+|||++....
T Consensus       106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKR  183 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCC
T ss_pred             EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCccccc
Confidence            99999999999999998889999999999999999999999999  99999999999997 344  59999999986432


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                       ........||+.|+|||++.+. + +.++|||||||++|+|++|+.||...........   .+.............++
T Consensus       184 -~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  257 (290)
T 1t4h_A          184 -ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             -TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCH
T ss_pred             -ccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH---HHhccCCccccCCCCCH
Confidence             2233445799999999998643 4 4569999999999999999999987655443322   22222222222335678


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+.+||.+||+.||.+|||+.++++||||++.
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            99999999999999999999999999999753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.4e-51  Score=379.50  Aligned_cols=260  Identities=27%  Similarity=0.439  Sum_probs=214.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~~   74 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.++++++||||+++++++...     ..+|
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            589999999999999999999999999999999875332  225678999999999999999999999765     4789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.......
T Consensus       107 iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          107 IVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGG
T ss_pred             EEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCC
Confidence            9999996 589888865 46999999999999999999999999999999999999977664  9999999997543222


Q ss_pred             C----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc----------
Q 018734          155 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ----------  220 (351)
Q Consensus       155 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------  220 (351)
                      .    ....+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+........          
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            1    24458999999999987666456669999999999999999999988776666555443211100          


Q ss_pred             ------cCCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          221 ------YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       221 ------~~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                            ...+         .+..+++.+.+||.+||+.||.+|||+.++|+||||.+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                  0001         01357889999999999999999999999999999987644

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.2e-51  Score=381.25  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=209.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCC--CCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLR--HPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~--hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++++.||+|+||.||++.+.. ++.||||++.....   ....+.+|+.+++.++  ||||+++++++...+.+|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            359999999999999999999876 88999999876432   2356789999999996  59999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--  154 (351)
                      || +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.   +.+||+|||+++......  
T Consensus       135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~---~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS---SCEEECCCSSSCCC------
T ss_pred             Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC---CeEEEEecCccccccCCCcc
Confidence            99 568899999999889999999999999999999999999999999999999963   359999999998543322  


Q ss_pred             -CCCCcccCCCccCcccccCC----------cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC
Q 018734          155 -RPKSTVGTPAYIAPEVLSRR----------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI  223 (351)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (351)
                       .....+||+.|+|||++.+.          ...+.++|||||||++|+|++|+.||.......   ..+..+.......
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~~  287 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEI  287 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSCC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccccC
Confidence             23456799999999998652          234566999999999999999999997654321   2233334334443


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      +.....+..+.+||.+||+.||.+|||+.++|+||||....
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            33445688999999999999999999999999999997654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8e-51  Score=375.36  Aligned_cols=256  Identities=26%  Similarity=0.382  Sum_probs=207.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCC--CCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRH--PNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~h--p~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++++.||+|+||.||++.+. +++.||+|++......   ...+.+|+.+++.++|  |||+++++++.....+|+|
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            57999999999999999999985 5889999998754332   2457889999999986  9999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      ||+ .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   +.+||+|||+++....... 
T Consensus        88 ~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~---~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             ECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCCC------
T ss_pred             EeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC---CcEEEeecccccccCccccc
Confidence            994 57899999999999999999999999999999999999999999999999963   3499999999985433222 


Q ss_pred             --CCCcccCCCccCcccccC----------CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC
Q 018734          156 --PKSTVGTPAYIAPEVLSR----------REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI  223 (351)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (351)
                        ....+||+.|+|||++.+          ....+.++|||||||++|+|++|+.||.......   ..+..+.......
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~  240 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEI  240 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHCTTSCC
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---HHHHHHhcCCccc
Confidence              235579999999999864          1333556999999999999999999997654321   2222333333333


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ......+..+.+||.+||+.||.+|||+.++|+||||.....
T Consensus       241 ~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            334456789999999999999999999999999999976543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.9e-51  Score=366.41  Aligned_cols=255  Identities=21%  Similarity=0.340  Sum_probs=195.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC---HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.......   ..+.++...++.++||||+++++++...+..++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e   86 (290)
T 3fme_A            7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME   86 (290)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred             HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence            68999999999999999999999999999999987643222   223344555788899999999999999999999999


Q ss_pred             ccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           79 YAAGGELFERIC----NAGRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        79 ~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+.+ +|.+++.    ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ++||+|||++......
T Consensus        87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLVDD  163 (290)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC---------
T ss_pred             hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccccc
Confidence            9975 8766664    356799999999999999999999998 999999999999997665  4999999999865555


Q ss_pred             CCCCCcccCCCccCccccc---CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          154 SRPKSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .......||+.|+|||++.   .....+.++|||||||++|+|++|+.||.........   +...............++
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  240 (290)
T 3fme_A          164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ---LKQVVEEPSPQLPADKFS  240 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH---HHHHHHSCCCCCCTTTSC
T ss_pred             ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH---HHHHhccCCCCcccccCC
Confidence            5555568999999999972   3333456699999999999999999999865433221   222222222222234689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      +.+.+||.+||+.||.+|||+.++++||||..
T Consensus       241 ~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            99999999999999999999999999999964

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.7e-50  Score=373.86  Aligned_cols=254  Identities=27%  Similarity=0.410  Sum_probs=212.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +|++++.||+|+||.||+|.+..+++.||+|++......    ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            599999999999999999999999999999998754322    2457899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           79 YAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        79 ~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      |+. |+|.+.+. ....+++..++.++.|++.||.|||++||+||||||+|||++.++  .+||+|||++.....   ..
T Consensus       135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~---~~  208 (348)
T 1u5q_A          135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---AN  208 (348)
T ss_dssp             CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS---BC
T ss_pred             cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecCC---CC
Confidence            997 57877775 456799999999999999999999999999999999999998765  499999999875432   24


Q ss_pred             CcccCCCccCccccc---CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          158 STVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      ..+||+.|+|||++.   ...+ +.++|||||||++|+|++|+.||..........    .+............+++.+.
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~  283 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPALQSGHWSEYFR  283 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCCCTTSCHHHH
T ss_pred             cccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH----HHHhcCCCCCCCCCCCHHHH
Confidence            567999999999985   3444 455999999999999999999998765433322    22222222223346889999


Q ss_pred             HHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      +||.+||+.+|.+|||+.++++||||....++.
T Consensus       284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~  316 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  316 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             HHHHHHcccChhhCcCHHHHhhChhhhccCCcc
Confidence            999999999999999999999999998765544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.2e-51  Score=379.64  Aligned_cols=258  Identities=28%  Similarity=0.427  Sum_probs=200.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC------
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPT------   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~------   71 (351)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            3689999999999999999999999999999999876432   2245778999999999999999999997664      


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      .+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~--~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAG  178 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCC-----
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC--CEEEEEeecccccc
Confidence            78999999975 7888875  3589999999999999999999999999999999999998765  49999999998654


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-------------
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------------  218 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------------  218 (351)
                      ........+||+.|+|||++.+..++. ++|||||||++|+|++|+.||........+..++.....             
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVILGMGYKE-NVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             cccccCCceecCCccCHHHhcCCCCCc-hHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            444445678999999999998877754 499999999999999999999887654444333221000             


Q ss_pred             --hccCCCCcc---------------------CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          219 --VQYKIPDYV---------------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       219 --~~~~~~~~~---------------------~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                        .....+.+.                     ..++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence              000001100                     0156789999999999999999999999999996543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.1e-51  Score=375.59  Aligned_cols=261  Identities=23%  Similarity=0.430  Sum_probs=218.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC------------------HHHHHHHHHHhcCCCCCcceE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID------------------ANVAREIINHKQLRHPNIIRF   63 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------~~~~~e~~~~~~l~hp~Iv~~   63 (351)
                      ++|++.+.||+|+||.||++.+  +++.||+|++.......                  ..+.+|+.+++.++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            6899999999999999999999  78999999987532211                  678899999999999999999


Q ss_pred             EEEEEcCCEEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCC
Q 018734           64 KEVVLTPTHLAIVMEYAAGGELFER------ICN--AGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGS  134 (351)
Q Consensus        64 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~  134 (351)
                      ++++.+.+.+++||||+.+++|.++      +..  ...+++..++.++.||+.||.|||+ +||+||||||+||+++.+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            9999999999999999999999988      655  5679999999999999999999999 999999999999999766


Q ss_pred             CCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCC-cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHH
Q 018734          135 PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI  213 (351)
Q Consensus       135 ~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  213 (351)
                      +  ++||+|||++...... ......||+.|+|||++.+. .+...++|||||||++|+|++|+.||........   ..
T Consensus       189 ~--~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~  262 (348)
T 2pml_X          189 G--RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE---LF  262 (348)
T ss_dssp             S--CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH---HH
T ss_pred             C--cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HH
Confidence            6  4999999998754322 33456799999999999877 4544369999999999999999999987665322   22


Q ss_pred             HHHHhhccCCCCc-----------------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChhhHH
Q 018734          214 SRIMAVQYKIPDY-----------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE  270 (351)
Q Consensus       214 ~~~~~~~~~~~~~-----------------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~~~~  270 (351)
                      ..+.......|..                 ..+++.+.+||.+||+.||.+|||+.++++||||.......+..
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~~  336 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLRE  336 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHHHH
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHHHH
Confidence            2333333333321                 46889999999999999999999999999999998765444433

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-50  Score=366.75  Aligned_cols=257  Identities=26%  Similarity=0.416  Sum_probs=210.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEc------CCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLT------PTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~------~~~~~   74 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.........+.+|+.+++++ +||||+++++++..      ...++
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            689999999999999999999999999999999987766677899999999998 79999999999976      46899


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.....
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~  181 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA--EVKLVDFGVSAQLDR  181 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCTTTC----
T ss_pred             EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC--CEEEeeCcCceecCc
Confidence            999999999999999764  5799999999999999999999999999999999999997665  499999999875432


Q ss_pred             C-CCCCCcccCCCccCccccc-----CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc
Q 018734          153 H-SRPKSTVGTPAYIAPEVLS-----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  226 (351)
Q Consensus       153 ~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (351)
                      . .......||+.|+|||++.     +..+ +.++|||||||++|+|++|+.||..........    .+..........
T Consensus       182 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~  256 (326)
T 2x7f_A          182 TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPAPRLKS  256 (326)
T ss_dssp             ---------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCSC
T ss_pred             CccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH----HhhcCccccCCc
Confidence            2 2234457999999999986     3344 455999999999999999999997765433222    222222222233


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ..++..+.+||.+||+.||.+|||+.++++||||.....
T Consensus       257 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          257 KKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             SCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             cccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            468899999999999999999999999999999987644

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-51  Score=374.57  Aligned_cols=253  Identities=25%  Similarity=0.355  Sum_probs=205.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCC----EE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPT----HL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~----~~   73 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.......    ..+.+|+.+++.++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            68999999999999999999999999999999997654333    35778999999999999999999987553    45


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++......
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~  169 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS  169 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCccccccc
Confidence            999999999999999998889999999999999999999999999999999999999987664  999999998754322


Q ss_pred             C----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--Ccc
Q 018734          154 S----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYV  227 (351)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  227 (351)
                      .    .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.............    ......+  ...
T Consensus       170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~  244 (311)
T 3ork_A          170 GNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----REDPIPPSARHE  244 (311)
T ss_dssp             ------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HCCCCCHHHHST
T ss_pred             ccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----cCCCCCcccccC
Confidence            1    22335699999999999887765 45999999999999999999998765433322221    1111111  123


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      .++..+.+||.+||+.||.+||++.+++.|+|+.
T Consensus       245 ~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          245 GLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            5889999999999999999999999999999984

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1e-50  Score=377.13  Aligned_cols=261  Identities=23%  Similarity=0.357  Sum_probs=203.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc------------CHHHHHHHHHHhcCCCCCcceEEEEEEc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI------------DANVAREIINHKQLRHPNIIRFKEVVLT   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~e~~~~~~l~hp~Iv~~~~~~~~   69 (351)
                      ++|++.+.||+|+||.||++.+.. ++.||+|++......            ...+.+|+.++++++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            689999999999999999999876 899999988653221            1568899999999999999999999843


Q ss_pred             -----CCEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 018734           70 -----PTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD  143 (351)
Q Consensus        70 -----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~D  143 (351)
                           ...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|
T Consensus       101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~D  177 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICD  177 (362)
T ss_dssp             CCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC
T ss_pred             ccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEe
Confidence                 347999999997 5888877654 46999999999999999999999999999999999999976664  99999


Q ss_pred             cCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc---
Q 018734          144 FGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---  220 (351)
Q Consensus       144 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---  220 (351)
                      ||++.............||+.|+|||++.+....+.++|||||||++|+|++|+.||...........+........   
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  257 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED  257 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence            99998655555556678999999999998745456669999999999999999999988765554444433211100   


Q ss_pred             -----------------cCCC------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          221 -----------------YKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       221 -----------------~~~~------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                                       ...+      .....++.+.+||.+||+.||.+|||+.++++||||.....+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                             0000      112467889999999999999999999999999999876543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2e-50  Score=370.76  Aligned_cols=258  Identities=25%  Similarity=0.382  Sum_probs=210.0

Q ss_pred             CCeeEeeeecccCceEEEEEEE-cCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCC------CcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYIERGHKIDANVAREIINHKQLRHP------NIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp------~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+ ..+++.||+|++.........+.+|+.+++.++|+      +|+++++++...+.++
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~   93 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC   93 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence            6899999999999999999998 56789999999977655556778899888887655      5999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----------------
Q 018734           75 IVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-----------------  135 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-----------------  135 (351)
                      +||||+ +++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++...                 
T Consensus        94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A           94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            999999 889999998765  689999999999999999999999999999999999997643                 


Q ss_pred             CCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR  215 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  215 (351)
                      .+++||+|||+++..  .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+...
T Consensus       173 ~~~~kl~Dfg~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  249 (339)
T 1z57_A          173 NPDIKVVDFGSATYD--DEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI  249 (339)
T ss_dssp             CCCEEECCCSSCEET--TSCCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred             CCCceEeeCcccccC--ccccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence            446999999998753  2334456899999999999887765 4599999999999999999999876654433322211


Q ss_pred             HHhhcc-----------------C---------------------CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          216 IMAVQY-----------------K---------------------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       216 ~~~~~~-----------------~---------------------~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ......                 .                     .......++.+.+||.+||+.||.+|||+.++++|
T Consensus       250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence            100000                 0                     00011234678899999999999999999999999


Q ss_pred             cccccC
Q 018734          258 PWFLKN  263 (351)
Q Consensus       258 p~~~~~  263 (351)
                      |||...
T Consensus       330 p~f~~~  335 (339)
T 1z57_A          330 PFFDLL  335 (339)
T ss_dssp             GGGGGG
T ss_pred             HHHHHH
Confidence            999753

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=361.58  Aligned_cols=258  Identities=26%  Similarity=0.424  Sum_probs=213.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+|+.+++.++||||+++++++...+.+|+||||+.
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  107 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCG  107 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCC
Confidence            57999999999999999999999999999999987643 34678899999999999999999999999999999999999


Q ss_pred             CCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCc
Q 018734           82 GGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  159 (351)
Q Consensus        82 ~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  159 (351)
                      +++|.+++. ....+++..++.++.||+.||.|||++|++||||||+||+++.++  ++||+|||++...... ......
T Consensus       108 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  185 (314)
T 3com_A          108 AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG--HAKLADFGVAGQLTDTMAKRNTV  185 (314)
T ss_dssp             TEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECBTTBSCBCCC
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC--CEEEeecccchhhhhhccccCcc
Confidence            999999987 456799999999999999999999999999999999999997665  4999999998754332 223445


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      .||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............   .......+.....++..+.+||.+
T Consensus       186 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~  261 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDFVKQ  261 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred             CCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHHHHHHH
Confidence            79999999999988776544 99999999999999999999876543222111   111112233344578999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCCh
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      ||+.||.+|||+.++++||||......
T Consensus       262 ~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          262 CLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             HTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             HccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.8e-50  Score=363.84  Aligned_cols=251  Identities=30%  Similarity=0.415  Sum_probs=204.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.......    ..+.+|+.+++.++||||+++++++...+.+|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            58999999999999999999999999999999986543322    46778999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--R  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~  155 (351)
                      ||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++  ++||+|||+++......  .
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK--TLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCSSSTTC-------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEEeCCCccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999997666  49999999997543322  2


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC---CCCccCCCHh
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK---IPDYVHISQD  232 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  232 (351)
                      ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||............+    .....   ......+++.
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  243 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI----QDSVPNVTTDVRKDIPQS  243 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH----SSCCCCHHHHSCTTSCHH
T ss_pred             cCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----hccCCCcchhcccCCCHH
Confidence            2345799999999999887765 44999999999999999999998765433222211    11110   1112458899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPW  259 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~  259 (351)
                      +.++|.+||+.||.+||+..+.+.+.|
T Consensus       244 l~~li~~~l~~dp~~R~~~~~~l~~~l  270 (294)
T 4eqm_A          244 LSNVILRATEKDKANRYKTIQEMKDDL  270 (294)
T ss_dssp             HHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred             HHHHHHHHhcCCHhHccccHHHHHHHH
Confidence            999999999999999996555555554

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.5e-50  Score=377.43  Aligned_cols=259  Identities=27%  Similarity=0.377  Sum_probs=210.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-CC-----CcceEEEEEEcCCEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HP-----NIIRFKEVVLTPTHLA   74 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-hp-----~Iv~~~~~~~~~~~~~   74 (351)
                      +++|++.+.||+|+||.||+|.+..+++.||||++.........+.+|+.+++.++ |+     +|+++++++...+.+|
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            47899999999999999999999999999999999865544556777888887775 44     4999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc
Q 018734           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCH--SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  150 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH--~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~  150 (351)
                      +||||+. ++|.+++...  ..+++..++.++.||+.||.|||  +.||+||||||+|||++.+..+.+||+|||+++..
T Consensus       133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            9999996 5999998765  45999999999999999999999  57999999999999997655556999999999754


Q ss_pred             CCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc---------
Q 018734          151 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------  221 (351)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  221 (351)
                      .  ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........+..+.........         
T Consensus       212 ~--~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  288 (382)
T 2vx3_A          212 G--QRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA  288 (382)
T ss_dssp             T--CCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred             c--cccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence            2  334567899999999999888775 5599999999999999999999987765555544432211000         


Q ss_pred             -----CCCC-------------------ccC-------------------------CCHhHHHHHHHhcccCCCCCCChH
Q 018734          222 -----KIPD-------------------YVH-------------------------ISQDCRNLLSRIFVANPSRRITIK  252 (351)
Q Consensus       222 -----~~~~-------------------~~~-------------------------~~~~~~~li~~~L~~~P~~Rps~~  252 (351)
                           ..|.                   ...                         .++.+.+||.+||+.||.+|||+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~  368 (382)
T 2vx3_A          289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY  368 (382)
T ss_dssp             HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence                 0000                   000                         013789999999999999999999


Q ss_pred             HHhcCcccccC
Q 018734          253 EIKSHPWFLKN  263 (351)
Q Consensus       253 eil~hp~~~~~  263 (351)
                      ++|+||||.+.
T Consensus       369 e~L~hp~f~~~  379 (382)
T 2vx3_A          369 YALQHSFFKKT  379 (382)
T ss_dssp             HHTTSGGGCC-
T ss_pred             HHhcCcccccC
Confidence            99999999765

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.8e-50  Score=375.67  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=207.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEE-----
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHL-----   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~-----   73 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++......   ...+.+|+.+++.++||||+++++++......     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            5899999999999999999999999999999998764332   35677999999999999999999999877654     


Q ss_pred             -EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           74 -AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        74 -~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                       |+||||+. ++|...+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++... 
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~-  195 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHAD-  195 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECSTTCC-----
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC--CEEEEecCcccccc-
Confidence             99999997 58877763  3599999999999999999999999999999999999997665  49999999987432 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh-------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------  219 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------  219 (351)
                       ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.......             
T Consensus       196 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          196 -AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             -cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence             334556799999999999874444566999999999999999999998876555444443321100             


Q ss_pred             ------ccCCC------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          220 ------QYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       220 ------~~~~~------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                            ....+      .+..+++.+.+||.+||+.||.+|||+.++|+||||....
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                  00000      1234689999999999999999999999999999997643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.1e-50  Score=380.85  Aligned_cols=256  Identities=24%  Similarity=0.385  Sum_probs=205.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC--------CCCcceEEEEEE----c
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR--------HPNIIRFKEVVL----T   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~--------hp~Iv~~~~~~~----~   69 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.+++.++        ||||+++++++.    .
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~  116 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN  116 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETT
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCC
Confidence            6899999999999999999999999999999999876555567889999998885        788999999997    5


Q ss_pred             CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCC-----------
Q 018734           70 PTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSP-----------  135 (351)
Q Consensus        70 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~-----------  135 (351)
                      ...+|+||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++           
T Consensus       117 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~  195 (397)
T 1wak_A          117 GTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT  195 (397)
T ss_dssp             EEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred             CceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence            56899999999 56777766554  4699999999999999999999998 999999999999997553           


Q ss_pred             ------------------------------------CCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCc
Q 018734          136 ------------------------------------APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK  179 (351)
Q Consensus       136 ------------------------------------~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  179 (351)
                                                          ..++||+|||++....  ......+||+.|+|||++.+..++. 
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-  272 (397)
T 1wak_A          196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSGYNT-  272 (397)
T ss_dssp             ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--BCSCSCCSCGGGCCHHHHHTSCCCT-
T ss_pred             HHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--ccCccCCCCCcccCChhhcCCCCCc-
Confidence                                                1259999999987543  2345568999999999998887754 


Q ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCChh------HHHHHHHHHHh--------hccC-----------------------
Q 018734          180 LADVWSCGVTLYVMLVGAYPFEDQEDPK------NFRKTISRIMA--------VQYK-----------------------  222 (351)
Q Consensus       180 ~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~--------~~~~-----------------------  222 (351)
                      ++|||||||++|+|++|+.||.......      .+..+......        ..+.                       
T Consensus       273 ~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (397)
T 1wak_A          273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFE  352 (397)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhH
Confidence            5999999999999999999998655321      11111111100        0000                       


Q ss_pred             -----CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          223 -----IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       223 -----~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                           .......+..+.+||.+||+.||.+|||+.++|+||||.
T Consensus       353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                 000112345788999999999999999999999999995

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.2e-51  Score=368.80  Aligned_cols=263  Identities=28%  Similarity=0.406  Sum_probs=192.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++....  .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   94 (303)
T 2vwi_A           15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL   94 (303)
T ss_dssp             CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred             hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence            68999999999999999999999999999999886542  2335677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           80 AAGGELFERICN--------AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        80 ~~~~~L~~~l~~--------~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      +.+++|.+++..        .+.+++..++.++.||+.||.|||++||+||||||+||+++.++  ++||+|||++....
T Consensus        95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG--SVQIADFGVSAFLA  172 (303)
T ss_dssp             CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC--CEEECCCHHHHHCC
T ss_pred             ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC--CEEEEeccchheec
Confidence            999999999864        45699999999999999999999999999999999999997665  49999999886433


Q ss_pred             CC------CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh-c---c
Q 018734          152 LH------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-Q---Y  221 (351)
Q Consensus       152 ~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~---~  221 (351)
                      ..      .......||+.|+|||++.+....+.++|||||||++|+|++|+.||................... .   .
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  252 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ  252 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC---
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccc
Confidence            22      112345799999999998764334566999999999999999999998876544433222110000 0   0


Q ss_pred             CCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          222 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       222 ~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      .......++..+.+||.+||+.||.+|||+.++++||||.+...+
T Consensus       253 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             --CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            011223578899999999999999999999999999999775443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.1e-50  Score=362.43  Aligned_cols=258  Identities=26%  Similarity=0.405  Sum_probs=209.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...+.+++||||+
T Consensus        19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            589999999999999999999999999999999876433 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCCCCC
Q 018734           81 AGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSRPKS  158 (351)
Q Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~~~~  158 (351)
                      .+++|..++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++  .+||+|||++..... ......
T Consensus        99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  176 (302)
T 2j7t_A           99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG--DIRLADFGVSAKNLKTLQKRDS  176 (302)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS--CEEECCCHHHHHHHHHHHC---
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC--CEEEEECCCCcccccccccccc
Confidence            99999988865 46799999999999999999999999999999999999997665  499999998753211 112234


Q ss_pred             cccCCCccCccccc-----CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CCCCccCCCHh
Q 018734          159 TVGTPAYIAPEVLS-----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KIPDYVHISQD  232 (351)
Q Consensus       159 ~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  232 (351)
                      ..||+.|+|||++.     +..+ +.++|||||||++|+|++|..||..........    .+..... .......++..
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  251 (302)
T 2j7t_A          177 FIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLL----KIAKSDPPTLLTPSKWSVE  251 (302)
T ss_dssp             --CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCSSGGGSCHH
T ss_pred             ccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH----HHhccCCcccCCccccCHH
Confidence            57999999999984     3444 456999999999999999999998765433222    2222221 22334567899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      +.++|.+||+.||.+|||+.++++||||......
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence            9999999999999999999999999999876543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=381.12  Aligned_cols=259  Identities=25%  Similarity=0.404  Sum_probs=192.1

Q ss_pred             CeeE-eeeecccCceEEEEEEEc--CCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEEEEEE
Q 018734            3 KYEL-MKDIGSGNFGVARLMRNK--NTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIVM   77 (351)
Q Consensus         3 ~y~~-~~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~~lv~   77 (351)
                      .|++ +++||+|+||.||+|.+.  .+++.||+|++.... ....+.+|+.+++.++|||||++++++..  ...+|+||
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            4666 458999999999999965  568899999987543 34578899999999999999999999954  67899999


Q ss_pred             eccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC--CCCCCEEEeccCC
Q 018734           78 EYAAGGELFERICNA---------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG--SPAPRLKICDFGY  146 (351)
Q Consensus        78 e~~~~~~L~~~l~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~--~~~~~vkL~DFg~  146 (351)
                      ||+. ++|.+.+...         ..+++..++.++.||+.||.|||++||+||||||+|||+..  ...+.+||+|||+
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence            9996 4887777532         24899999999999999999999999999999999999942  2234699999999


Q ss_pred             CcccCCC----CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh---------hHHHHHH
Q 018734          147 SKSSLLH----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---------KNFRKTI  213 (351)
Q Consensus       147 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---------~~~~~~~  213 (351)
                      ++.....    ......+||+.|+|||++.+....+.++|||||||++|+|++|++||......         ..+..++
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~  258 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF  258 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence            9754322    22344679999999999988665567799999999999999999999765431         2222222


Q ss_pred             HHHHhhccC-C-------------------------------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          214 SRIMAVQYK-I-------------------------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       214 ~~~~~~~~~-~-------------------------------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      ..+...... +                               ......++.+.+||.+||+.||.+|||+.++|+||||.
T Consensus       259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~  338 (405)
T 3rgf_A          259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL  338 (405)
T ss_dssp             HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhc
Confidence            211100000 0                               00011267899999999999999999999999999997


Q ss_pred             cC
Q 018734          262 KN  263 (351)
Q Consensus       262 ~~  263 (351)
                      +.
T Consensus       339 ~~  340 (405)
T 3rgf_A          339 ED  340 (405)
T ss_dssp             SS
T ss_pred             cC
Confidence            65

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=7e-50  Score=361.54  Aligned_cols=257  Identities=25%  Similarity=0.415  Sum_probs=205.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEc------------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT------------   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~------------   69 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.........+.+|+.+++.++||||+++++++..            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            47999999999999999999999999999999997655445678899999999999999999998865            


Q ss_pred             -CCEEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           70 -PTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        70 -~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                       ...+|+||||+.+++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~  163 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR--NVKIGDFGLA  163 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECCCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC--CEEEeeCcch
Confidence             357899999999999999998644 588999999999999999999999999999999999997666  4999999998


Q ss_pred             cccCCC---------------CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHH
Q 018734          148 KSSLLH---------------SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT  212 (351)
Q Consensus       148 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  212 (351)
                      ......               .......||+.|+|||++.+....+.++|||||||++|+|++   ||....   .....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---~~~~~  237 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---ERVNI  237 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch---hHHHH
Confidence            754321               122345799999999999876545666999999999999998   554321   22223


Q ss_pred             HHHHHhhccCCCC--ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          213 ISRIMAVQYKIPD--YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       213 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      ...+......+|.  ....+..+.++|.+||+.||.+|||+.++++||||......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD  293 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence            3333333333332  23456789999999999999999999999999999766443

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.4e-49  Score=358.94  Aligned_cols=255  Identities=28%  Similarity=0.431  Sum_probs=215.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++.....+++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            479999999999999999999999999999999876432  336788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~~~  158 (351)
                      +.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++  ++||+|||++....... ....
T Consensus       102 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          102 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG--EVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             CTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECBTTBCCBCC
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC--CEEEeecccceecCccccccCc
Confidence            999999998865 5799999999999999999999999999999999999997665  49999999987543322 2344


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS  238 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (351)
                      ..||+.|+|||++.+..++. ++|||||||++|+|++|+.||..........    .+... ........++..+.+||.
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDS-KADIWSLGITAIELARGEPPHSELHPMKVLF----LIPKN-NPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHS-CCCCCCSSCCHHHHHHHH
T ss_pred             cCCCcCccCHHHHhcCCCCc-hhhhHHHHHHHHHHccCCCCCCCcCHHHHHH----HhhcC-CCCCCccccCHHHHHHHH
Confidence            57999999999998877754 5999999999999999999998755432221    12111 112223468899999999


Q ss_pred             HhcccCCCCCCChHHHhcCcccccCCC
Q 018734          239 RIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       239 ~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      +||+.+|.+|||+.++++||||.....
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcCCC
Confidence            999999999999999999999976544

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.7e-50  Score=363.12  Aligned_cols=256  Identities=32%  Similarity=0.554  Sum_probs=210.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-----ccCHHHHHHHHHHhcCCCCCcceEEEEEE--cCCEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----KIDANVAREIINHKQLRHPNIIRFKEVVL--TPTHL   73 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~--~~~~~   73 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++....     .....+.+|+.+++.++||||+++++++.  ....+
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999999999999999987532     23356889999999999999999999984  44679


Q ss_pred             EEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           74 AIVMEYAAGGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      ++||||+.++ |.+.+..  ...+++..+..++.||+.||.|||++||+||||||+||+++.++  ++||+|||++....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~--~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG--TLKISALGVAEALH  160 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCTTCEECC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC--cEEeeccccccccC
Confidence            9999999875 7777665  45699999999999999999999999999999999999997665  49999999987543


Q ss_pred             CC---CCCCCcccCCCccCcccccCCc-CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCcc
Q 018734          152 LH---SRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV  227 (351)
Q Consensus       152 ~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (351)
                      ..   .......||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||......    .....+.......+  .
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~i~~~~~~~~--~  234 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLFENIGKGSYAIP--G  234 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCCCC--S
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHHHHhcCCCCCC--C
Confidence            22   1123456999999999997643 3355699999999999999999999875432    23333333433333  3


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      .+++.+.+||.+||+.||.+|||+.++++||||.+..+
T Consensus       235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            68999999999999999999999999999999987654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-49  Score=368.69  Aligned_cols=259  Identities=29%  Similarity=0.436  Sum_probs=209.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP-----THLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...     ...|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            689999999999999999999999999999999865332  234577999999999999999999988654     6799


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.......
T Consensus        91 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           91 IIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC--DLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECC---
T ss_pred             EEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC--cEEEEeccccccccccc
Confidence            9999996 589888876 5799999999999999999999999999999999999997665  49999999987543221


Q ss_pred             -----------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc---
Q 018734          155 -----------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---  220 (351)
Q Consensus       155 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---  220 (351)
                                 .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+........   
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence                       122347899999999987655556779999999999999999999988765444333322111100   


Q ss_pred             --------------cCCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          221 --------------YKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       221 --------------~~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                                    ...+         .+..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                          0000         0135789999999999999999999999999999997653

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-49  Score=362.05  Aligned_cols=258  Identities=28%  Similarity=0.422  Sum_probs=210.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-CCCcEEEEEEeccCcc---cCHHHHHHHHHHhcC---CCCCcceEEEEEE-----c
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-NTKELVAMKYIERGHK---IDANVAREIINHKQL---RHPNIIRFKEVVL-----T   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l---~hp~Iv~~~~~~~-----~   69 (351)
                      ++|++.+.||+|+||.||++.+. .+++.||+|++.....   ....+.+|+.+++.+   +||||+++++++.     .
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~   90 (326)
T 1blx_A           11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   90 (326)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence            58999999999999999999995 6789999999865322   223566777776665   8999999999987     5


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           70 PTHLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        70 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      ...+++||||+. ++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~--~~kl~Dfg~~  167 (326)
T 1blx_A           91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLA  167 (326)
T ss_dssp             EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--CEEECSCCSC
T ss_pred             CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC--CEEEecCccc
Confidence            578999999997 59999987754  499999999999999999999999999999999999997766  4999999999


Q ss_pred             cccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc-cCC---
Q 018734          148 KSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKI---  223 (351)
Q Consensus       148 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~---  223 (351)
                      +............||+.|+|||++.+..++ .++|||||||++|+|++|+.||........+..++....... ..+   
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  246 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccc
Confidence            765444444556799999999999887765 459999999999999999999988766555444443321100 000   


Q ss_pred             -----------------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          224 -----------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       224 -----------------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                       .....++..+.+||.+||+.||.+|||+.++++||||...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence                             0123578899999999999999999999999999999764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-49  Score=361.93  Aligned_cols=246  Identities=27%  Similarity=0.434  Sum_probs=199.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||+|+||.||++.+  +++.||+|++......   ...+.+|+.++++++||||+++++++.....+++|||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            5899999999999999999987  4778999998764432   2457789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           79 YAAGGELFERICNAGR---FSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+.+++|.+++...+.   +++..+..++.||+.||.|||++|  |+||||||+|||++.++  ++||+|||+++.....
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~--~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY--TVKVCDFGLSRLKAST  192 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC--CEEECCCC--------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC--cEEECCCCCCcccccc
Confidence            9999999999987654   999999999999999999999999  99999999999997765  4999999998753332


Q ss_pred             C-CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          154 S-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       154 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      . ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...+.......+....+++.
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  267 (309)
T 3p86_A          193 FLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQV----VAAVGFKCKRLEIPRNLNPQ  267 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHHHHHSCCCCCCCTTSCHH
T ss_pred             ccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCCCCCCccCCHH
Confidence            2 23456799999999999887775 459999999999999999999987654322    22222223333444578999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||.+||+.+|.+|||+.++++
T Consensus       268 l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          268 VAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.1e-51  Score=384.06  Aligned_cols=244  Identities=14%  Similarity=0.131  Sum_probs=196.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHH---HHHhcCCCCCcceEE-------EEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREI---INHKQLRHPNIIRFK-------EVV   67 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~---~~~~~l~hp~Iv~~~-------~~~   67 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.....    ....+.+|+   ..++.++|||||+++       +++
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            579999999999999999999999999999999874322    235677899   555666899999998       777


Q ss_pred             EcCC-----------------EEEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCeecC
Q 018734           68 LTPT-----------------HLAIVMEYAAGGELFERICNAGRFSE-------DEARYFFQQLISGVSYCHSMQICHRD  123 (351)
Q Consensus        68 ~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~l~~-------~~~~~~~~qi~~aL~~lH~~~iiH~D  123 (351)
                      .+.+                 ..|+||||+ +|+|.+++...+.+++       ..+..++.||+.||.|||++||+|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD  231 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  231 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            6654                 289999999 6799999987655555       78888999999999999999999999


Q ss_pred             CCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCC-----------cCCCcchhHHHHHHHHHH
Q 018734          124 LKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR-----------EYDGKLADVWSCGVTLYV  192 (351)
Q Consensus       124 ikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~il~e  192 (351)
                      |||+|||++.++  ++||+|||+++..  .......+| +.|+|||++.+.           .+ +.++|||||||++|+
T Consensus       232 ikp~NIll~~~~--~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il~e  305 (377)
T 3byv_A          232 LRPVDIVLDQRG--GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCGGGEEECTTC--CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEcCCC--CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHHHH
Confidence            999999998665  5999999999842  223345568 999999999876           55 566999999999999


Q ss_pred             HHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          193 MLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       193 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      |++|+.||.........          ....+....+++.+.+||.+||+.||.+|||+.++++||||.+
T Consensus       306 lltg~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          306 IWCADLPITKDAALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHSSCCC------CCS----------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHCCCCCcccccccch----------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999999764432211          1112233468999999999999999999999999999999964

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.3e-50  Score=369.46  Aligned_cols=256  Identities=31%  Similarity=0.544  Sum_probs=184.2

Q ss_pred             CCeeEee-eecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHH-HHHhcCCCCCcceEEEEEEc----CCEEEE
Q 018734            2 EKYELMK-DIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHPNIIRFKEVVLT----PTHLAI   75 (351)
Q Consensus         2 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~-~~~~~l~hp~Iv~~~~~~~~----~~~~~l   75 (351)
                      ++|++.+ .||+|+||.||++.+..+++.||+|++....    ...+++ ..++.++||||+++++++..    ...+++
T Consensus        28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  103 (336)
T 3fhr_A           28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI  103 (336)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence            6899965 6999999999999999999999999986643    233333 34567799999999999876    456899


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccCC
Q 018734           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSLL  152 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~~  152 (351)
                      ||||+.|++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+.+||+|||++.... 
T Consensus       104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~-  182 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT-  182 (336)
T ss_dssp             EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecc-
Confidence            999999999999998764  699999999999999999999999999999999999997533 3469999999987443 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc--cCCCCccCCC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ--YKIPDYVHIS  230 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  230 (351)
                      .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...............+....  ...+.+..++
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (336)
T 3fhr_A          183 QNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS  261 (336)
T ss_dssp             ---------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCC
T ss_pred             ccccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCC
Confidence            2233456799999999999777764 459999999999999999999977554332222222222222  2334445789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +.+.+||.+||+.||.+|||+.++++||||.+.
T Consensus       262 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            999999999999999999999999999999764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.4e-49  Score=366.75  Aligned_cols=256  Identities=25%  Similarity=0.403  Sum_probs=206.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCE------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTH------   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~------   72 (351)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|++......   ...+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            5899999999999999999999999999999998764322   3467789999999999999999999987653      


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +|+||||+. ++|.+.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++... 
T Consensus       104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~-  177 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC--ELKILDFGLARHAD-  177 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC--CEEECSTTCTTC---
T ss_pred             EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC--cEEEeecccccCCC-
Confidence            599999997 588777643  589999999999999999999999999999999999998765  49999999987532 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh-------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV-------------  219 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------  219 (351)
                       .......||+.|+|||++.+....+.++|||||||++|+|++|+.||........+..+.......             
T Consensus       178 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          178 -AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             -CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence             223456799999999999874444566999999999999999999998876544444333221100             


Q ss_pred             -------c----cC-CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          220 -------Q----YK-IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       220 -------~----~~-~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                             .    .. ...+..+++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                   0    00 011235789999999999999999999999999999997653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.8e-49  Score=360.95  Aligned_cols=248  Identities=24%  Similarity=0.365  Sum_probs=205.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            68999999999999999999999999999999875532 23456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC---
Q 018734           81 AGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---  156 (351)
Q Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~---  156 (351)
                      .+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++........   
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC--------
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceecccccccccc
Confidence            99999999987 567999999999999999999999999999999999999987654  999999998754322211   


Q ss_pred             ------------CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHH-HHHHHHHHhhccCC
Q 018734          157 ------------KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF-RKTISRIMAVQYKI  223 (351)
Q Consensus       157 ------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~  223 (351)
                                  ...+||+.|+|||++.+..++. ++|||||||++|+|++|..||......... ..........    
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----  242 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDE-KVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----  242 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCc-HHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----
Confidence                        1457999999999998877654 599999999999999999998764322110 0001111111    


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .....+++.+.++|.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            112357889999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-49  Score=364.30  Aligned_cols=251  Identities=31%  Similarity=0.507  Sum_probs=214.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------cCHHHHHHHHHHhcCC--CCCcceEEEEEEcCCE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLR--HPNIIRFKEVVLTPTH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~~~~l~--hp~Iv~~~~~~~~~~~   72 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....       ....+.+|+.+++.++  ||||+++++++...+.
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            589999999999999999999999999999999876432       1245668999999986  5999999999999999


Q ss_pred             EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCCCEEEeccCCCccc
Q 018734           73 LAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSKSS  150 (351)
Q Consensus        73 ~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~-~~~~~~vkL~DFg~a~~~  150 (351)
                      .++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++  .+||+|||+++..
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~  200 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALL  200 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCcccccc
Confidence            9999999976 89999999888999999999999999999999999999999999999997 333  5999999998754


Q ss_pred             CCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          151 LLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .. .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||....      .    +.....  .....++
T Consensus       201 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~----~~~~~~--~~~~~~~  267 (320)
T 3a99_A          201 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQV--FFRQRVS  267 (320)
T ss_dssp             CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCC--CCSSCCC
T ss_pred             cc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h----hhcccc--cccccCC
Confidence            32 233456799999999999877776677999999999999999999996521      1    111222  2234689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      +.+.+||.+||+.||.+|||+.++++||||.....+.
T Consensus       268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~  304 (320)
T 3a99_A          268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ  304 (320)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCcc
Confidence            9999999999999999999999999999998876543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-49  Score=360.13  Aligned_cols=261  Identities=27%  Similarity=0.383  Sum_probs=205.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEE------------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVL------------   68 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~------------   68 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            689999999999999999999999999999999875432 2356789999999999999999999873            


Q ss_pred             --cCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           69 --TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        69 --~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                        ....+|+||||+. ++|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++..+ +.+||+|||+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~  167 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGL  167 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTT
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCcc
Confidence              3468999999997 599888864 5789999999999999999999999999999999999997433 3599999999


Q ss_pred             CcccCCC----CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHH-----
Q 018734          147 SKSSLLH----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-----  217 (351)
Q Consensus       147 a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----  217 (351)
                      ++.....    .......+|+.|+|||++.+....+.++|||||||++|+|++|+.||...........+.....     
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  247 (320)
T 2i6l_A          168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE  247 (320)
T ss_dssp             CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred             ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence            8754322    2223456899999999987755556779999999999999999999988765444433322110     


Q ss_pred             -------------hhccCCC------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          218 -------------AVQYKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       218 -------------~~~~~~~------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                                   ......+      ....++..+.+||.+||+.||.+|||+.++++||||.....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence                         0000001      11357899999999999999999999999999999976543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-49  Score=368.06  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=208.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC-cEEEEEEeccCcccCHHHHHHHHHHhcCCCCC------cceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK-ELVAMKYIERGHKIDANVAREIINHKQLRHPN------IIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~------Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||+|.+..++ +.||+|++.........+.+|+.+++.++|++      ++.+++++...+.++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~   98 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC   98 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence            68999999999999999999998776 68999999876555567788999998887655      999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----------------C
Q 018734           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-----------------P  135 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-----------------~  135 (351)
                      +||||+ +++|.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||++..                 .
T Consensus        99 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A           99 IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             EEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence            999999 66777777654  369999999999999999999999999999999999999432                 2


Q ss_pred             CCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISR  215 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  215 (351)
                      .+.+||+|||+++..  .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........+..+...
T Consensus       178 ~~~~kl~Dfg~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (355)
T 2eu9_A          178 NTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI  254 (355)
T ss_dssp             CCCEEECCCTTCEET--TSCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             CCcEEEeecCccccc--cccccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            346999999998743  2334556899999999999887775 4599999999999999999999876654433332221


Q ss_pred             HHhhcc-----------------C---------------------CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          216 IMAVQY-----------------K---------------------IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       216 ~~~~~~-----------------~---------------------~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ......                 .                     .......+..+.+||.+||+.||.+|||+.++|+|
T Consensus       255 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            110000                 0                     00001124578899999999999999999999999


Q ss_pred             cccccCCC
Q 018734          258 PWFLKNLP  265 (351)
Q Consensus       258 p~~~~~~~  265 (351)
                      |||.+..+
T Consensus       335 p~f~~~~~  342 (355)
T 2eu9_A          335 PFFAGLTP  342 (355)
T ss_dssp             GGGGGCCH
T ss_pred             hhhcCCCh
Confidence            99987543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7.5e-51  Score=379.46  Aligned_cols=254  Identities=17%  Similarity=0.182  Sum_probs=189.0

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHH---HHHHhcCCCCCcceEE-------EEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVARE---IINHKQLRHPNIIRFK-------EVVL   68 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e---~~~~~~l~hp~Iv~~~-------~~~~   68 (351)
                      +|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|   +..++. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            59999999999999999999999999999999987543    22345667   455555 799988755       5554


Q ss_pred             cC-----------------CEEEEEEeccCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHcCCeecCC
Q 018734           69 TP-----------------THLAIVMEYAAGGELFERICNAG-RFSEDEA------RYFFQQLISGVSYCHSMQICHRDL  124 (351)
Q Consensus        69 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~------~~~~~qi~~aL~~lH~~~iiH~Di  124 (351)
                      .+                 ..+|+|||||. ++|.+++...+ .+++..+      ..++.||+.||.|||++||+||||
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi  220 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF  220 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence            33                 34899999998 79999997643 3444444      577799999999999999999999


Q ss_pred             CCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCCC
Q 018734          125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFED  202 (351)
Q Consensus       125 kp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~  202 (351)
                      ||+|||++.++  ++||+|||+++...  .......+|+.|+|||++.+  ..+ +.++|||||||++|+|++|+.||..
T Consensus       221 kp~NIll~~~~--~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~  295 (371)
T 3q60_A          221 TPDNLFIMPDG--RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFGL  295 (371)
T ss_dssp             SGGGEEECTTS--CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred             CHHHEEECCCC--CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999998765  49999999987442  22224567899999999976  445 5669999999999999999999987


Q ss_pred             CCChhHH--HH-HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          203 QEDPKNF--RK-TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       203 ~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .......  .. ...........++....+++.+.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          296 VTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             cCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            6322100  00 0000011233344455789999999999999999999999999999999653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.4e-49  Score=350.11  Aligned_cols=247  Identities=23%  Similarity=0.423  Sum_probs=209.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+.. ++.||+|++.........+.+|+.++++++||||+++++++.+.+..++||||+.
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            589999999999999999999875 6779999998776666789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC--CCCCC
Q 018734           82 GGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKS  158 (351)
Q Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~--~~~~~  158 (351)
                      +++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||+++.++  ++||+|||++......  .....
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC--CEEeccccccccccccccccccC
Confidence            99999999654 5689999999999999999999999999999999999997665  4999999998743322  12234


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||..........    .+.. ..........++.+.+++
T Consensus       167 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~li  240 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DIST-GFRLYKPRLASTHVYQIM  240 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHT-TCCCCCCTTSCHHHHHHH
T ss_pred             cccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHhc-CccCCCCCcCCHHHHHHH
Confidence            5578899999999877765 55999999999999999 999998765433222    2222 223334446799999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.+|.+|||+.++++|
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHH
Confidence            99999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-49  Score=370.57  Aligned_cols=260  Identities=23%  Similarity=0.364  Sum_probs=206.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-----------CCCcceEEEEEEcC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----------HPNIIRFKEVVLTP   70 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-----------hp~Iv~~~~~~~~~   70 (351)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.........+.+|+.++++++           ||||+++++++...
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            5899999999999999999999999999999999866555567788999888876           89999999999765


Q ss_pred             C----EEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCC----CCCCE
Q 018734           71 T----HLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGS----PAPRL  139 (351)
Q Consensus        71 ~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~----~~~~v  139 (351)
                      +    .+++|||++ +++|.+++...  ..+++..++.++.||+.||.|||++ ||+||||||+|||++..    ..+.+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~  177 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI  177 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceE
Confidence            4    789999999 88999999763  4599999999999999999999998 99999999999999532    22359


Q ss_pred             EEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh------hHHHHHH
Q 018734          140 KICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP------KNFRKTI  213 (351)
Q Consensus       140 kL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~  213 (351)
                      ||+|||++....  ......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......      ..+..+.
T Consensus       178 kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (373)
T 1q8y_A          178 KIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII  254 (373)
T ss_dssp             EECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred             EEcccccccccC--CCCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence            999999987543  233456899999999999888765 5599999999999999999999865421      1112221


Q ss_pred             HHHHhh------------------------------------ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          214 SRIMAV------------------------------------QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       214 ~~~~~~------------------------------------~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ......                                    ..........+..+.+||.+||+.||.+|||+.++|+|
T Consensus       255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence            111000                                    00001112345788999999999999999999999999


Q ss_pred             cccccCCC
Q 018734          258 PWFLKNLP  265 (351)
Q Consensus       258 p~~~~~~~  265 (351)
                      |||.+...
T Consensus       335 p~f~~~~~  342 (373)
T 1q8y_A          335 PWLKDTLG  342 (373)
T ss_dssp             GGGTTCTT
T ss_pred             hhhhcccC
Confidence            99987643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.4e-49  Score=360.40  Aligned_cols=256  Identities=21%  Similarity=0.363  Sum_probs=191.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc---EEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEE--
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHL--   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~--   73 (351)
                      ++|++.+.||+|+||.||+|.+..++.   .||+|++....   .....+.+|+.+++.++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            579999999999999999999987765   89999987643   2235688999999999999999999999877655  


Q ss_pred             ----EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 018734           74 ----AIVMEYAAGGELFERICNAG------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD  143 (351)
Q Consensus        74 ----~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~D  143 (351)
                          ++||||+.+++|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--~~kl~D  180 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--TVCVAD  180 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--CEEEee
Confidence                99999999999999986432      589999999999999999999999999999999999998765  499999


Q ss_pred             cCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhh
Q 018734          144 FGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAV  219 (351)
Q Consensus       144 Fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  219 (351)
                      ||+++.......   .....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||............    .. 
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~-  254 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL----IG-  254 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-
T ss_pred             ccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----hc-
Confidence            999975433222   2234578899999999877764 55999999999999999 99999887654433322    11 


Q ss_pred             ccCCCCccCCCHhHHHHHHHhcccCCCCCCC-------hHHHhcCcccccCCC
Q 018734          220 QYKIPDYVHISQDCRNLLSRIFVANPSRRIT-------IKEIKSHPWFLKNLP  265 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps-------~~eil~hp~~~~~~~  265 (351)
                      ....+....+++.+.+||.+||+.||.+|||       +++++.|||+.....
T Consensus       255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~  307 (323)
T 3qup_A          255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ  307 (323)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred             CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence            2233444578999999999999999999999       788899999876544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.4e-49  Score=349.82  Aligned_cols=247  Identities=26%  Similarity=0.411  Sum_probs=208.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+.. +..||+|++.........+.+|+.++++++||||+++++++......++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (268)
T 3sxs_A            8 EEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS   86 (268)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence            689999999999999999998874 6779999998776666788999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CCC
Q 018734           82 GGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKS  158 (351)
Q Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~~  158 (351)
                      +++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||++........  ...
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~  164 (268)
T 3sxs_A           87 NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL--CVKVSDFGMTRYVLDDQYVSSVG  164 (268)
T ss_dssp             TCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC--CEEECCTTCEEECCTTCEEECCS
T ss_pred             CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC--CEEEccCccceecchhhhhcccC
Confidence            999999997754 599999999999999999999999999999999999997766  499999999875432221  233


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...........    +.. ..........++.+.++|
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li  238 (268)
T 3sxs_A          165 TKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQ-GHRLYRPHLASDTIYQIM  238 (268)
T ss_dssp             CCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHT-TCCCCCCTTSCHHHHHHH
T ss_pred             CCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHc-CCCCCCCCcChHHHHHHH
Confidence            456778999999987777554 999999999999999 9999987654332222    222 222333345789999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.+|.+|||+.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          239 YSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=352.31  Aligned_cols=257  Identities=26%  Similarity=0.406  Sum_probs=207.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      +|.....||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            34445589999999999999999999999999876433 34668899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEeccCCCcccCCC-CCC
Q 018734           82 GGELFERICNAG---RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLH-SRP  156 (351)
Q Consensus        82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~-~~~~~vkL~DFg~a~~~~~~-~~~  156 (351)
                      +++|.+++....   .+++..++.++.||+.||.|||++||+||||||+||+++. ++  .+||+|||++...... ...
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~kl~Dfg~~~~~~~~~~~~  180 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCT  180 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC--CEEECCTTTCEESCC-----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC--CEEEeecccccccCCCCCcc
Confidence            999999987652   4679999999999999999999999999999999999976 43  5999999998754322 223


Q ss_pred             CCcccCCCccCcccccCCc-CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          157 KSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||..........   ............+..+++.+.+
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  257 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGMFKVHPEIPESMSAEAKA  257 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHHHHCCCCCCCTTSCHHHHH
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---HhhccccccccccccCCHHHHH
Confidence            4457999999999986543 23566999999999999999999997654432211   1111112222333468999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ||.+||+.||.+|||+.++++||||....
T Consensus       258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          258 FILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            99999999999999999999999997653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-49  Score=369.85  Aligned_cols=254  Identities=19%  Similarity=0.298  Sum_probs=207.9

Q ss_pred             CCeeEeeeecccCceEEEEEE-----EcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMR-----NKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++++.||+|+||.||++.     +..+++.||+|++.....  ....+.+|+.+++.++|||||++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            579999999999999999999     556788999999865322  2346788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCC
Q 018734           75 IVMEYAAGGELFERICNA-------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGY  146 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~  146 (351)
                      +|||||.||+|.+++...       ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            999999999999999764       3489999999999999999999999999999999999997443 23599999999


Q ss_pred             CcccC---CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccC
Q 018734          147 SKSSL---LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  222 (351)
Q Consensus       147 a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (351)
                      ++...   .........||+.|+|||++.+..++ .++|||||||++|+|++ |..||........    ...+.. ...
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~----~~~i~~-~~~  304 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEFVTS-GGR  304 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHHT-TCC
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHc-CCC
Confidence            87432   12233445789999999999877765 55999999999999998 9999987654322    222222 222


Q ss_pred             CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      .+....++..+.+||.+||+.+|.+|||+.+++++.++.
T Consensus       305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            333456889999999999999999999999999987653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.1e-49  Score=354.84  Aligned_cols=256  Identities=29%  Similarity=0.510  Sum_probs=210.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~~l   75 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.....   ....+.+|+.++++++||||+++++++..  ...+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            3689999999999999999999999999999999876432   23467899999999999999999998753  578999


Q ss_pred             EEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           76 VMEYAAGGELFERICNA----GRFSEDEARYFFQQLISGVSYCHSMQ-----ICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~-----iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||++|     |+||||||+||+++.++  ++||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~--~~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS--CEEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC--CEEEecCch
Confidence            99999999999998753    34999999999999999999999999     99999999999998665  499999999


Q ss_pred             CcccCCCCC-CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC
Q 018734          147 SKSSLLHSR-PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD  225 (351)
Q Consensus       147 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  225 (351)
                      +........ .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......    ....+..... .+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~~~~-~~~  236 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKF-RRI  236 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCC-CCC
T ss_pred             heeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHH----HHHHHhhccc-ccC
Confidence            874332211 1234699999999999887764 55999999999999999999998765322    2222333222 122


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      ...++..+.++|.+||+.+|.+|||+.++++|+|+.+..
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            336889999999999999999999999999999997654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.9e-49  Score=365.30  Aligned_cols=248  Identities=24%  Similarity=0.365  Sum_probs=206.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-------CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-------NTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      ++|++++.||+|+||.||+|.+.       .++..||+|++.....  ....+.+|+.+++.+ +||||+++++++...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            57999999999999999999875       3456799999876533  224688999999999 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      .+|+||||+.+|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC
Confidence            9999999999999999997653                478999999999999999999999999999999999997666


Q ss_pred             CCCEEEeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                        .+||+|||+++......   ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.......... 
T Consensus       241 --~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~-  316 (370)
T 2psq_A          241 --VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK-  316 (370)
T ss_dssp             --CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-
T ss_pred             --CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-
Confidence              49999999997543222   22334678899999999887765 55999999999999999 999998765433322 


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                         .+ ......+.+..++..+.+||.+||+.+|.+|||+.+++++
T Consensus       317 ---~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          317 ---LL-KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             ---HH-HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---HH-hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               11 2222334445689999999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=355.43  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=191.8

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC---HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID---ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      +++|++++.||+|+||.||++.+..+++.||+|++.......   ..+..+..+++.++||||+++++++...+.+++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            468999999999999999999999999999999987654322   22334445678889999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           78 EYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ++||+|||++........
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG--QIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS--CEEECCCTTC--------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC--CEEEEECCCchhccCCcc
Confidence            999 5555555443 56799999999999999999999995 999999999999997665  499999999876544444


Q ss_pred             CCCcccCCCccCcccccC----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-hccCCCCccCCC
Q 018734          156 PKSTVGTPAYIAPEVLSR----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKIPDYVHIS  230 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  230 (351)
                      .....||+.|+|||++..    ....+.++|||||||++|+|++|+.||.........   +..+.. .....+....++
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  257 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV---LTKVLQEEPPLLPGHMGFS  257 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH---HHHHHHSCCCCCCSSSCCC
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH---HHHHhccCCCCCCccCCCC
Confidence            455679999999999852    222345699999999999999999999875443222   222222 222344445689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      +.+.+||.+||+.||.+|||+.++++||||.+
T Consensus       258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            99999999999999999999999999999964

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6.7e-49  Score=359.89  Aligned_cols=247  Identities=25%  Similarity=0.372  Sum_probs=205.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc---EEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++.+..+++   .||+|++.....  ....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            589999999999999999999986554   599999876432  235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCSSCEECC----
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC--CEEECCCCcccccccCcc
Confidence            9999999999999754 5799999999999999999999999999999999999997665  499999999975433221


Q ss_pred             ----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          156 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                          .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||..........    .+ ......+....++
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~  280 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS----SV-EEGYRLPAPMGCP  280 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH----HH-HTTCCCCCCTTCC
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH----HH-HcCCCCCCCCCcC
Confidence                1223467889999999877765 45999999999999999 999998765433222    22 2234455556789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+.+||.+||+.||.+|||+.++++
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2e-49  Score=363.31  Aligned_cols=256  Identities=23%  Similarity=0.368  Sum_probs=186.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHH-HHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREII-NHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~-~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      .++|++++.||+|+||.||++.+..+++.||+|++.....  ....+..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            3689999999999999999999999999999999876432  2234555655 678889999999999999999999999


Q ss_pred             eccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           78 EYAAGGELFERICN-----AGRFSEDEARYFFQQLISGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        78 e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~-~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      ||+.+ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++  .+||+|||+++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLV  177 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT--EEEECCCSSSCC--
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC--CEEEccCCCceecc
Confidence            99975 88777653     56799999999999999999999998 999999999999998666  49999999998654


Q ss_pred             CCCCCCCcccCCCccCccccc----CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc---cCCC
Q 018734          152 LHSRPKSTVGTPAYIAPEVLS----RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ---YKIP  224 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~  224 (351)
                      .........||+.|+|||++.    +..+ +.++|||||||++|+|++|+.||.......   ..+..+....   ....
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             ----------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCC
T ss_pred             cccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCCCc
Confidence            444444557999999999983    3444 456999999999999999999997643211   1111111110   1111


Q ss_pred             CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          225 DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       225 ~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ....+++.+.+||.+||+.||.+|||+.++++||||...
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            123578999999999999999999999999999999643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-49  Score=360.62  Aligned_cols=247  Identities=32%  Similarity=0.530  Sum_probs=204.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------cCHHHHHHHHHHhcC----CCCCcceEEEEEEcC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQL----RHPNIIRFKEVVLTP   70 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~~~~l----~hp~Iv~~~~~~~~~   70 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....       ....+.+|+.+++++    +||||+++++++...
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~  110 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ  110 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence            589999999999999999999999999999999876432       122345688888887    899999999999999


Q ss_pred             CEEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCCCEEEeccCCCc
Q 018734           71 THLAIVMEY-AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD-GSPAPRLKICDFGYSK  148 (351)
Q Consensus        71 ~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~-~~~~~~vkL~DFg~a~  148 (351)
                      +..++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++  .+||+|||++.
T Consensus       111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~  188 (312)
T 2iwi_A          111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGA  188 (312)
T ss_dssp             --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCE
T ss_pred             CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhh
Confidence            999999999 78899999999888899999999999999999999999999999999999997 444  59999999987


Q ss_pred             ccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          149 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       149 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                      .... .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||....          .+......++  ..
T Consensus       189 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------~~~~~~~~~~--~~  255 (312)
T 2iwi_A          189 LLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------EILEAELHFP--AH  255 (312)
T ss_dssp             ECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHTCCCCC--TT
T ss_pred             hccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------HHhhhccCCc--cc
Confidence            5433 233456799999999999877776656999999999999999999996521          1122222333  46


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ++..+.+||.+||+.+|.+|||+.++++||||...
T Consensus       256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            89999999999999999999999999999999765

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-48  Score=349.24  Aligned_cols=247  Identities=22%  Similarity=0.378  Sum_probs=206.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++++.||+|+||.||++.+. ++..||+|++.........+.+|+.+++.++||||+++++++...+.+++||||+.
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  102 (283)
T 3gen_A           24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA  102 (283)
T ss_dssp             GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCT
T ss_pred             HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccC
Confidence            58999999999999999999887 46789999998776666789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC--CCCCC
Q 018734           82 GGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKS  158 (351)
Q Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~--~~~~~  158 (351)
                      +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++  ++||+|||++......  .....
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          103 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             TCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS--CEEECSTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC--CEEEccccccccccccccccccC
Confidence            9999999976 56799999999999999999999999999999999999997665  4999999998744322  12233


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||..........    .+.. ..........++.+.++|
T Consensus       181 ~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~~li  254 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQ-GLRLYRPHLASEKVYTIM  254 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----HHHT-TCCCCCCTTCCHHHHHHH
T ss_pred             CccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHH----HHhc-ccCCCCCCcCCHHHHHHH
Confidence            4578889999999877764 55999999999999998 999998765433222    2222 222333446789999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.+|.+|||+.++++|
T Consensus       255 ~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          255 YSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.9e-49  Score=365.15  Aligned_cols=249  Identities=23%  Similarity=0.382  Sum_probs=207.0

Q ss_pred             CCeeEeeeecccCceEEEEEE-----EcCCCcEEEEEEeccCccc--CHHHHHHHHHHhcC-CCCCcceEEEEEEcCC-E
Q 018734            2 EKYELMKDIGSGNFGVARLMR-----NKNTKELVAMKYIERGHKI--DANVAREIINHKQL-RHPNIIRFKEVVLTPT-H   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~-~   72 (351)
                      ++|++.+.||+|+||.||++.     +..+++.||+|++......  ...+.+|+.+++++ +|||||++++++...+ .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            689999999999999999999     5567789999999764332  24688999999999 7899999999998764 4


Q ss_pred             EEEEEeccCCCChHHHHHhcCC----------------------------------------------------------
Q 018734           73 LAIVMEYAAGGELFERICNAGR----------------------------------------------------------   94 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------   94 (351)
                      +++|||||.+|+|.+++.....                                                          
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            8999999999999999976543                                                          


Q ss_pred             --------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---CCCCcccCC
Q 018734           95 --------FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTP  163 (351)
Q Consensus        95 --------l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt~  163 (351)
                              +++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......   ......||+
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~  259 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN--VVKICDFGLARDIYKDPDYVRKGDARLPL  259 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC--cEEEEeccceeeecccccchhccccCCCc
Confidence                    89999999999999999999999999999999999997665  49999999997543222   223456899


Q ss_pred             CccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcc
Q 018734          164 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFV  242 (351)
Q Consensus       164 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  242 (351)
                      .|+|||++.+..++ .++|||||||++|+|++ |+.||........+...+.    .....+....+++.+.++|.+||+
T Consensus       260 ~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          260 KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----EGTRMRAPDYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             GGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----HTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             eeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH----cCCCCCCCCCCCHHHHHHHHHHcc
Confidence            99999999877765 55999999999999998 9999988765544433322    222334445689999999999999


Q ss_pred             cCCCCCCChHHHhcC
Q 018734          243 ANPSRRITIKEIKSH  257 (351)
Q Consensus       243 ~~P~~Rps~~eil~h  257 (351)
                      .+|.+|||+.++++|
T Consensus       335 ~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          335 GEPSQRPTFSELVEH  349 (359)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.5e-48  Score=353.89  Aligned_cols=255  Identities=26%  Similarity=0.384  Sum_probs=205.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCC--CCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLR--HPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~--hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++++.||+|+||.||++.+.. ++.||+|++.....   ....+.+|+.+++.++  ||||+++++++.....+++|
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             ceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            479999999999999999999865 88999999875432   2356788999999997  59999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      || +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.   +.+||+|||++........ 
T Consensus       107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC-------
T ss_pred             Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccCcccc
Confidence            99 557899999999889999999999999999999999999999999999999964   3599999999975433221 


Q ss_pred             --CCCcccCCCccCcccccCC----------cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC
Q 018734          156 --PKSTVGTPAYIAPEVLSRR----------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI  223 (351)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (351)
                        .....||+.|+|||++.+.          ...+.++|||||||++|+|++|+.||.......   .............
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~  259 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEI  259 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHCTTSCC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---HHHHHHHhccccc
Confidence              2345799999999998652          233556999999999999999999997654322   1222333333333


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      +.....+..+.++|.+||+.||.+|||+.++++||||....
T Consensus       260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            33345688999999999999999999999999999997653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.9e-48  Score=357.43  Aligned_cols=251  Identities=23%  Similarity=0.250  Sum_probs=205.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++......++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            579999999999999999999999999999999876543 34688999999999 9999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---CCEEEeccCCCcccCCCCC-
Q 018734           81 AGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA---PRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~---~~vkL~DFg~a~~~~~~~~-  155 (351)
                       +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   ..+||+|||+++....... 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~  166 (330)
T 2izr_A           88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK  166 (330)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCC
Confidence             8999999986 467999999999999999999999999999999999999976542   2399999999975432221 


Q ss_pred             -------CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC--c
Q 018734          156 -------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--Y  226 (351)
Q Consensus       156 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~  226 (351)
                             ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||....... .......+.......+.  .
T Consensus       167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~~  244 (330)
T 2izr_A          167 KHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADT-LKERYQKIGDTKRATPIEVL  244 (330)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSS-HHHHHHHHHHHHHHSCHHHH
T ss_pred             ccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCcccccccc-HHHHHHHHHhhhccCCHHHH
Confidence                   2456799999999999887764 55999999999999999999998764322 22233333222222221  1


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ....+.+.+++.+||+.+|.+||++++|++
T Consensus       245 ~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          245 CENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             TTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            112339999999999999999999999876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.2e-48  Score=351.31  Aligned_cols=252  Identities=24%  Similarity=0.397  Sum_probs=202.9

Q ss_pred             CCeeEeeeecccCceEEEEEE----EcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~   74 (351)
                      ++|++++.||+|+||.||+++    +..+++.||+|++..... ....+.+|+.+++.++||||+++++++...  ..++
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            689999999999999999998    667899999999876433 235678999999999999999999998653  5689


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           75 IVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      +||||+.+++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++  ++||+|||++......
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCSCC-----
T ss_pred             EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC--eEEEccCcccccccCC
Confidence            9999999999999997754 599999999999999999999999999999999999998765  4999999999754332


Q ss_pred             C----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----------hhHHHHHHHHHHh
Q 018734          154 S----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----------PKNFRKTISRIMA  218 (351)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~~~~~~~~  218 (351)
                      .    ......+|+.|+|||++.+..++ .++|||||||++|+|++|..||.....           .............
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  246 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence            2    12234578889999999877764 559999999999999999999864211           0111111222233


Q ss_pred             hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .....+.+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          247 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            33445556678999999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-47  Score=346.49  Aligned_cols=251  Identities=20%  Similarity=0.232  Sum_probs=206.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ...+.+|+..++.+ +||||+++++++......++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            579999999999999999999999999999999865433 34678899999999 7999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CCCEEEeccCCCcccCCCC--
Q 018734           81 AGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP---APRLKICDFGYSKSSLLHS--  154 (351)
Q Consensus        81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~---~~~vkL~DFg~a~~~~~~~--  154 (351)
                       +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++   ..++||+|||+++......  
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence             999999998754 599999999999999999999999999999999999997543   2349999999997543322  


Q ss_pred             ------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC---C
Q 018734          155 ------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---D  225 (351)
Q Consensus       155 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~  225 (351)
                            ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... ....+.......+   .
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~  245 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQSTPLREL  245 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHHHSCHHHH
T ss_pred             ccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhhccCccHHHH
Confidence                  2345579999999999987776 456999999999999999999998754322211 1112211111111   1


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...+++.+.+++.+||+.+|.+|||+.++++
T Consensus       246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            2357899999999999999999999999976

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.6e-48  Score=345.36  Aligned_cols=248  Identities=29%  Similarity=0.414  Sum_probs=197.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc-----CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-----DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      +++|++.+.||+|+||.||++.+.  ++.||+|++......     ...+.+|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            478999999999999999999985  788999998754322     2567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEecCC------CCCCEEEeccCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ---ICHRDLKLENTLLDGS------PAPRLKICDFGY  146 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---iiH~Dikp~NIll~~~------~~~~vkL~DFg~  146 (351)
                      ||||+.+++|.+++. ...+++..++.++.|++.||.|||++|   |+||||||+|||++..      ..+.+||+|||+
T Consensus        84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            999999999988885 457999999999999999999999999   8999999999999752      134699999999


Q ss_pred             CcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc
Q 018734          147 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  226 (351)
Q Consensus       147 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (351)
                      +..... .......||+.|+|||++.+..++ .++|||||||++|+|++|+.||........    ...........+..
T Consensus       163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~  236 (271)
T 3dtc_A          163 AREWHR-TTKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAV----AYGVAMNKLALPIP  236 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----HHHHHTSCCCCCCC
T ss_pred             cccccc-ccccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHhhhcCCCCCCCC
Confidence            875432 223356799999999999877664 559999999999999999999987654322    22233334444555


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+++.+.++|.+||+.+|.+|||+.+++++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            5789999999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.4e-49  Score=358.41  Aligned_cols=249  Identities=20%  Similarity=0.244  Sum_probs=197.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcC----CEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP----THLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~----~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++++.  ++.||+|++...........+|+.++++++|||||++++++...    ..+++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            58999999999999999999876  68999999976655555667789999999999999999999874    3589999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM----------QICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~----------~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      ||+.+|+|.+++... .+++..++.++.||+.||.|||++          ||+||||||+|||++.++  ++||+|||++
T Consensus       102 e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~kL~DFg~a  178 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TACIADFGLA  178 (322)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC--CEEECCCTTC
T ss_pred             ecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC--eEEEccCCcc
Confidence            999999999999764 589999999999999999999999          999999999999997665  4999999999


Q ss_pred             cccCCCC---CCCCcccCCCccCcccccCCcC----CCcchhHHHHHHHHHHHHcCCCCCCCCCChh------------H
Q 018734          148 KSSLLHS---RPKSTVGTPAYIAPEVLSRREY----DGKLADVWSCGVTLYVMLVGAYPFEDQEDPK------------N  208 (351)
Q Consensus       148 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~------------~  208 (351)
                      +......   .....+||+.|+|||++.+...    .+.++|||||||++|+|++|+.||.......            .
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            7543222   2334579999999999976422    2345899999999999999999997643211            1


Q ss_pred             HHHHHHHHHhhccCCCCccC------CCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          209 FRKTISRIMAVQYKIPDYVH------ISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .......... ....|....      .++.+.+||.+||+.||.+|||+.++++
T Consensus       259 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          259 LEDMQEVVVH-KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHHHTT-SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhhhhhhc-ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            1111111111 111221111      2345999999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-48  Score=361.02  Aligned_cols=248  Identities=24%  Similarity=0.358  Sum_probs=206.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-------CcEEEEEEeccCccc--CHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-------KELVAMKYIERGHKI--DANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      ++|++.+.||+|+||.||+|.+..+       +..||+|++......  ...+.+|+.+++.+ +|||||++++++...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            5899999999999999999997543       357999998765332  25688999999999 9999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      .+++||||+.+++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  228 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  228 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC
Confidence            9999999999999999998653                489999999999999999999999999999999999998765


Q ss_pred             CCCEEEeccCCCcccCCC---CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                        ++||+|||+++.....   .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.......    
T Consensus       229 --~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~----  301 (382)
T 3tt0_A          229 --VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----  301 (382)
T ss_dssp             --CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----
T ss_pred             --cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence              4999999999854332   223345688999999999887765 55999999999999999 999998765322    


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ....+ ......+....+++.+.+||.+||+.+|.+|||+.+++++
T Consensus       302 ~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          302 LFKLL-KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHH-HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHH-HcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22222 2222334445789999999999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-47  Score=344.05  Aligned_cols=249  Identities=26%  Similarity=0.408  Sum_probs=204.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc--------CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--------DANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++......        ...+.+|+.+++.++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6899999999999999999999999999999998654322        156889999999999999999999997666  


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCC---CCEEEeccCCC
Q 018734           74 AIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPA---PRLKICDFGYS  147 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~---~~vkL~DFg~a  147 (351)
                      ++||||+.+++|.+.+... ..+++..++.++.|++.||.|||++|  |+||||||+|||++.++.   ..+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            6999999999998888654 47999999999999999999999999  999999999999975442   23899999998


Q ss_pred             cccCCCCCCCCcccCCCccCcccccCC-cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc
Q 018734          148 KSSLLHSRPKSTVGTPAYIAPEVLSRR-EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  226 (351)
Q Consensus       148 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (351)
                      +...  .......||+.|+|||++... ...+.++|||||||++|+|++|+.||........  .....+.......+..
T Consensus       177 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  252 (287)
T 4f0f_A          177 QQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMIREEGLRPTIP  252 (287)
T ss_dssp             BCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHHHHHSCCCCCCC
T ss_pred             cccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHHHhccCCCCCCC
Confidence            7432  233456799999999998432 2235569999999999999999999987654332  1222223333334444


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+++.+.+||.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          253 EDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            578999999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=360.82  Aligned_cols=250  Identities=20%  Similarity=0.238  Sum_probs=198.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC---CCcEEEEEEeccCcc------------cCHHHHHHHHHHhcCCCCCcceEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHK------------IDANVAREIINHKQLRHPNIIRFKEV   66 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~------------~~~~~~~e~~~~~~l~hp~Iv~~~~~   66 (351)
                      ++|++.+.||+|+||.||+|.+..   ++..||+|++.....            ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999987   788999999876432            22346678888999999999999999


Q ss_pred             EEc----CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 018734           67 VLT----PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC  142 (351)
Q Consensus        67 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~  142 (351)
                      +..    ...+|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+++||+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~  195 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA  195 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence            987    78899999999 9999999988779999999999999999999999999999999999999987765579999


Q ss_pred             ccCCCcccCCCCC--------CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhH-HHHHH
Q 018734          143 DFGYSKSSLLHSR--------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKN-FRKTI  213 (351)
Q Consensus       143 DFg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~  213 (351)
                      |||+++.......        .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ .....
T Consensus       196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  274 (345)
T 2v62_A          196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAK  274 (345)
T ss_dssp             CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHH
T ss_pred             eCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHH
Confidence            9999975432211        134579999999999988766 4559999999999999999999965332222 22211


Q ss_pred             HHHHhhccCCCC-------ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          214 SRIMAVQYKIPD-------YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       214 ~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ....   ...+.       ...+++.+.++|.+||+.+|.+|||+.++++
T Consensus       275 ~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          275 TNLL---DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHH---HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             Hhhc---ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            1111   11111       1168899999999999999999999999976

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.4e-48  Score=352.71  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=206.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+.     .+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  102 (314)
T 2ivs_A           23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL  102 (314)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence            58999999999999999999983     4558999999876432  2256789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 018734           75 IVMEYAAGGELFERICNAGR------------------------FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTL  130 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIl  130 (351)
                      +||||+.+++|.+++.....                        +++..++.++.||+.||.|||++||+||||||+|||
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIl  182 (314)
T 2ivs_A          103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL  182 (314)
T ss_dssp             EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEE
Confidence            99999999999999986543                        899999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCh
Q 018734          131 LDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDP  206 (351)
Q Consensus       131 l~~~~~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  206 (351)
                      ++.++  ++||+|||++.......   ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||......
T Consensus       183 i~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          183 VAEGR--KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             EETTT--EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             EcCCC--CEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            98765  49999999987543222   12334578899999999877764 55999999999999999 99999876654


Q ss_pred             hHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .....     .......+.+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       260 ~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          260 RLFNL-----LKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GHHHH-----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHH-----hhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            33221     12222334445789999999999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.1e-48  Score=354.74  Aligned_cols=248  Identities=24%  Similarity=0.355  Sum_probs=206.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEE--EEEEeccCc--ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELV--AMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~v--aiK~~~~~~--~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++.+..++..+  |+|.+....  .....+.+|+.+++++ +||||+++++++...+.+|+|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999999888765  899886532  2335688999999999 899999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEE
Q 018734           77 MEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLK  140 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vk  140 (351)
                      |||+++++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+|
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~--~~k  182 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VAK  182 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC--eEE
Confidence            99999999999997654                699999999999999999999999999999999999997665  499


Q ss_pred             EeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhh
Q 018734          141 ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAV  219 (351)
Q Consensus       141 L~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  219 (351)
                      |+|||+++............+++.|+|||++.+..++ .++|||||||++|+|++ |+.||........    ... ...
T Consensus       183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~----~~~-~~~  256 (327)
T 1fvr_A          183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----YEK-LPQ  256 (327)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHH-GGG
T ss_pred             EcccCcCccccccccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHH----HHH-hhc
Confidence            9999998754444444555688999999999777664 55999999999999998 9999987654322    222 222


Q ss_pred             ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          220 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ....+....+++.+.+||.+||+.+|.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          257 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            23344445789999999999999999999999999875

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3e-48  Score=348.94  Aligned_cols=247  Identities=21%  Similarity=0.340  Sum_probs=211.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+..++..||+|++.........+.+|+.+++.++||||+++++++.....+++||||+.
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   92 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   92 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCC
Confidence            57999999999999999999999999999999998766666778899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CC
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~  157 (351)
                      +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++........  ..
T Consensus        93 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~~~~  170 (288)
T 3kfa_A           93 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  170 (288)
T ss_dssp             TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG--CEEECCCCGGGTSCSSSSEEET
T ss_pred             CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC--CEEEccCccceeccCCcccccc
Confidence            99999999864  4599999999999999999999999999999999999997665  499999999875433221  22


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.......... .    .......+....+++.+.+|
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~l  244 (288)
T 3kfa_A          171 GAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-L----LEKDYRMERPEGCPEKVYEL  244 (288)
T ss_dssp             TEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-H----HHTTCCCCCCTTCCHHHHHH
T ss_pred             CCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-H----HhccCCCCCCCCCCHHHHHH
Confidence            34578899999999877764 55999999999999999 999998765433222 1    22233444455789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      |.+||+.||.+|||+.++++
T Consensus       245 i~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          245 MRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999976

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.4e-48  Score=350.39  Aligned_cols=248  Identities=22%  Similarity=0.316  Sum_probs=199.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.......    ..+.+|+.+++.++||||+++++++...+.+|+|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999999999999999987654332    5678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--  154 (351)
                      |||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.......  
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC----------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccCccccccccc
Confidence            99999999999999888999999999999999999999999999999999999998665  49999999987543322  


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC--CCCccCCCHh
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQD  232 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  232 (351)
                      ......||+.|+|||++.+..++. ++|||||||++|+|++|+.||...... .    +.........  ......++..
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~  264 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATY-RADIYALTCVLYECLTGSPPYQGDQLS-V----MGAHINQAIPRPSTVRPGIPVA  264 (309)
T ss_dssp             ------CCGGGCCGGGTCC----C-CCHHHHHHHHHHHHHHSSCSSCSCHHH-H----HHHHHHSCCCCGGGTSTTCCTH
T ss_pred             cccccCCCcCccCHHHHcCCCCCc-hHhHHHHHHHHHHHHHCCCCCCCchHH-H----HHHHhccCCCCccccCCCCCHH
Confidence            223457999999999998777654 499999999999999999999764322 1    1111111111  1123468899


Q ss_pred             HHHHHHHhcccCCCCCC-ChHHHhc
Q 018734          233 CRNLLSRIFVANPSRRI-TIKEIKS  256 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rp-s~~eil~  256 (351)
                      +.++|.+||+.||.+|| +++++++
T Consensus       265 l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          265 FDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999999 7888765

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-48  Score=364.72  Aligned_cols=247  Identities=27%  Similarity=0.385  Sum_probs=206.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+.+|+||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            579999999999999999999999999999999875432  123577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC---
Q 018734           80 AAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---  155 (351)
Q Consensus        80 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---  155 (351)
                      +++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.......   
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~--~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECTTSEEECC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC--cEEECcCCCceecCCCceeec
Confidence            99999999997654 699999999999999999999999999999999999997665  499999999875322211   


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+++.|+|||++.+..++ .++|||||||++|||++ |..||........ .    .........+.+..+++.+.
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~l~  345 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQT-R----EFVEKGGRLPCPELCPDAVF  345 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-H----HHHHTTCCCCCCTTCCHHHH
T ss_pred             CCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-H----HHHHcCCCCCCCCCCCHHHH
Confidence            1223467789999999877764 45999999999999998 9999987654322 1    12223344555557899999


Q ss_pred             HHHHHhcccCCCCCCChHHHhc
Q 018734          235 NLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +||.+||+.||.+|||+.++++
T Consensus       346 ~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          346 RLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999975

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=6.7e-48  Score=343.17  Aligned_cols=244  Identities=17%  Similarity=0.290  Sum_probs=205.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTP--THLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~~l   75 (351)
                      +++|++.+.||+|+||.||++.+.  ++.||+|++.....   ....+.+|+.++++++||||+++++++.+.  ...++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            368999999999999999999985  78899999876432   234688999999999999999999999887  78899


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           76 VMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      ||||+.+++|.+++....  .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.  ++|+|||++..  
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~--  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFS--  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCT--
T ss_pred             eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceee--
Confidence            999999999999998765  4899999999999999999999999  999999999999987664  89998887653  


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCc--chhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCC
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGK--LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                        .......||+.|+|||++.+..+...  ++|||||||++|+|++|+.||.........    ..........+.+..+
T Consensus       163 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~  236 (271)
T 3kmu_A          163 --FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG----MKVALEGLRPTIPPGI  236 (271)
T ss_dssp             --TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH----HHHHHSCCCCCCCTTC
T ss_pred             --ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH----HHHHhcCCCCCCCCCC
Confidence              22344678999999999987665442  599999999999999999999876543322    2233333344444578


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ++.+.++|.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.9e-48  Score=357.80  Aligned_cols=252  Identities=14%  Similarity=0.218  Sum_probs=198.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCcc------------cCHHHHHHHHHHhcCCCCCcceEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-----KELVAMKYIERGHK------------IDANVAREIINHKQLRHPNIIRFK   64 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~------------~~~~~~~e~~~~~~l~hp~Iv~~~   64 (351)
                      ++|++.+.||+|+||.||++.+..+     ++.||+|++.....            .......++..++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4899999999999999999999765     57899999876432            123344566777888999999999


Q ss_pred             EEEEcC----CEEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 018734           65 EVVLTP----THLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRL  139 (351)
Q Consensus        65 ~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~v  139 (351)
                      +++...    ...|+||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++....+.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~  193 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV  193 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence            998764    5689999999 99999999876 67999999999999999999999999999999999999984445569


Q ss_pred             EEeccCCCcccCCCC--------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHH
Q 018734          140 KICDFGYSKSSLLHS--------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK  211 (351)
Q Consensus       140 kL~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  211 (351)
                      ||+|||+++......        .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........
T Consensus       194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~  272 (364)
T 3op5_A          194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR  272 (364)
T ss_dssp             EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred             EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence            999999996533221        11344699999999999887764 559999999999999999999986443333222


Q ss_pred             HHHHHHhhcc------CCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          212 TISRIMAVQY------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       212 ~~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..........      .++ ...++..+.+++.+||+.+|.+||++.+|++
T Consensus       273 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          273 DSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            2211111000      011 1357899999999999999999999999976

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.3e-48  Score=348.85  Aligned_cols=247  Identities=17%  Similarity=0.197  Sum_probs=203.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC-------cEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK-------ELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++.+.||+|+||.||++.+..++       ..||+|++..... ....+.+|+.+++.++||||+++++++...+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            68999999999999999999998877       4699999865433 345688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC------CEEEeccCC
Q 018734           74 AIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP------RLKICDFGY  146 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~------~vkL~DFg~  146 (351)
                      ++||||+.+++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++..      .+||+|||+
T Consensus        88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~  167 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI  167 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCS
T ss_pred             EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcc
Confidence            999999999999999987654 9999999999999999999999999999999999999766531      289999999


Q ss_pred             CcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc
Q 018734          147 SKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  226 (351)
Q Consensus       147 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (351)
                      +....   ......||+.|+|||++.+....+.++|||||||++|+|++|..|+............    .......+  
T Consensus       168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~----~~~~~~~~--  238 (289)
T 4fvq_A          168 SITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF----YEDRHQLP--  238 (289)
T ss_dssp             CTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTTCCCC--
T ss_pred             ccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH----hhccCCCC--
Confidence            86432   1233468999999999987454566799999999999999965554443333222221    12222223  


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ...++.+.+||.+||+.||.+|||+.++++|
T Consensus       239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3467899999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-47  Score=347.37  Aligned_cols=252  Identities=24%  Similarity=0.371  Sum_probs=204.4

Q ss_pred             CCeeEeeeecccCceEEEEEE----EcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEE
Q 018734            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP--THL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~   73 (351)
                      ++|++++.||+|+||.||+|.    +..+++.||+|++.....  ....+.+|+.+++.++||||+++++++...  ..+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            469999999999999999999    677899999999875432  236788999999999999999999999877  678


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           74 AIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      ++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++  ++||+|||++.....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIET  178 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCT
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECcccccccccC
Confidence            999999999999999954 46799999999999999999999999999999999999998766  499999999875443


Q ss_pred             CC----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCC----------ChhHHHHHHHHHHh
Q 018734          153 HS----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE----------DPKNFRKTISRIMA  218 (351)
Q Consensus       153 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~----------~~~~~~~~~~~~~~  218 (351)
                      ..    ......||+.|+|||++.+..++ .++|||||||++|+|++|..|+....          ........+.....
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            32    22345688899999999887765 55999999999999999999864321          01111112222233


Q ss_pred             hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .....+.+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            33445555678999999999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-48  Score=356.83  Aligned_cols=249  Identities=23%  Similarity=0.368  Sum_probs=207.6

Q ss_pred             CCeeEeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCc--ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++.+.||+|+||.||++.+     ..++..||+|++....  .....+.+|+.+++++ +||||+++++++...+.+
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            5799999999999999999997     3456789999987532  3346788999999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 018734           74 AIVMEYAAGGELFERICNAG-----------------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTL  130 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIl  130 (351)
                      ++||||+++++|.+++....                       .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  204 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  204 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEE
Confidence            99999999999999997653                       3789999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCh
Q 018734          131 LDGSPAPRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDP  206 (351)
Q Consensus       131 l~~~~~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  206 (351)
                      ++.++  .+||+|||++........   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||......
T Consensus       205 l~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          205 VTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             EETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             EcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            98665  499999999975433322   2234578899999999877764 55999999999999998 99999887655


Q ss_pred             hHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+...+    ......+....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       282 ~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          282 ANFYKLI----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             HHHHHHH----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHH----hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            4443332    2233444455689999999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.2e-48  Score=350.85  Aligned_cols=249  Identities=23%  Similarity=0.357  Sum_probs=209.5

Q ss_pred             CCeeEeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++.+.||+|+||.||++.+     ..+++.||+|++.....  ....+.+|+.+++++ +||||+++++++...+..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~  102 (313)
T 1t46_A           23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (313)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     45678999999876543  235688999999999 999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           74 AIVMEYAAGGELFERICNAG------------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      ++||||+.+++|.+++....                  .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~  182 (313)
T 1t46_A          103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (313)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC
Confidence            99999999999999997654                  489999999999999999999999999999999999998765


Q ss_pred             CCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                        .+||+|||++........   .....||+.|+|||++.+..++ .++|||||||++|+|++ |+.||...........
T Consensus       183 --~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  259 (313)
T 1t46_A          183 --ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (313)
T ss_dssp             --EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             --CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHH
Confidence              499999999875443322   2334578899999999877664 55999999999999998 9999988765544433


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+.    .....+....++..+.++|.+||+.||.+|||+.+++++
T Consensus       260 ~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          260 MIK----EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHH----HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhc----cCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            332    233334445689999999999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=367.88  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=205.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC--EEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT--HLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~--~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++....  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            579999999999999999999999999999999876432  2356779999999999999999999998764  789999


Q ss_pred             eccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec--CCCCCCEEEeccCCCcccCC
Q 018734           78 EYAAGGELFERICNAG---RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~--~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |||.+++|.+++....   .+++..++.++.||+.||.|||++||+||||||+|||+.  .++.+.+||+|||+++....
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~  168 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED  168 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence            9999999999997643   399999999999999999999999999999999999981  12233599999999986555


Q ss_pred             CCCCCCcccCCCccCcccccCC-------cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc----
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRR-------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY----  221 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  221 (351)
                      .......+||+.|+|||++.+.       ...+.++|||||||++|+|++|+.||............+..+.....    
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~  248 (396)
T 4eut_A          169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI  248 (396)
T ss_dssp             GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCC
T ss_pred             CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccc
Confidence            5555567899999999998652       22245599999999999999999999865544333344444333211    


Q ss_pred             ---------------CCCCc----cCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          222 ---------------KIPDY----VHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       222 ---------------~~~~~----~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                                     ..+..    ..++..+.++|.+||+.||.+||++.+++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                           11111    1234578899999999999999999998653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.1e-48  Score=345.15  Aligned_cols=246  Identities=25%  Similarity=0.354  Sum_probs=208.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEc------------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT------------   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~------------   69 (351)
                      ++|++++.||+|+||.||++.+..+++.||+|++....   ..+.+|+.+++.++||||+++++++..            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            47999999999999999999999999999999987643   457789999999999999999998864            


Q ss_pred             ----CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 018734           70 ----PTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICD  143 (351)
Q Consensus        70 ----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~D  143 (351)
                          ...+++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~D  165 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGD  165 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC--CEEECc
Confidence                34589999999999999999754  5799999999999999999999999999999999999998765  499999


Q ss_pred             cCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC
Q 018734          144 FGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI  223 (351)
Q Consensus       144 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (351)
                      ||++.............||+.|+|||++.+..++ .++|||||||++|+|++|..||...      ......+...  ..
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~--~~  236 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET------SKFFTDLRDG--II  236 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTT--CC
T ss_pred             chhheeccccccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhcc--cc
Confidence            9998866555555566899999999999887765 4599999999999999999887421      1122222211  12


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +  ..++..+.++|.+||+.||.+|||+.++++|++..+.
T Consensus       237 ~--~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          237 S--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             C--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             c--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            2  3578999999999999999999999999999876554

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6e-48  Score=355.52  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=205.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++++.||+|+||.||++.+.     .+++.||+|++.....  ....+.+|+.+++.++||||+++++++...+.+|
T Consensus        47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  126 (343)
T 1luf_A           47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC  126 (343)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence            58999999999999999999997     3458999999876432  2356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 018734           75 IVMEYAAGGELFERICNA------------------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTL  130 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIl  130 (351)
                      +||||+.+++|.+++...                        ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  206 (343)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEE
Confidence            999999999999999763                        56899999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeccCCCcccCCC---CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCh
Q 018734          131 LDGSPAPRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDP  206 (351)
Q Consensus       131 l~~~~~~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  206 (351)
                      ++.++  .+||+|||+++.....   .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||......
T Consensus       207 ~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~  283 (343)
T 1luf_A          207 VGENM--VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHE  283 (343)
T ss_dssp             ECGGG--CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ECCCC--eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence            98665  4999999998743222   222345689999999999877764 55999999999999999 99999876543


Q ss_pred             hHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .    ....+..... .+....++..+.+||.+||+.+|.+|||+.+++++
T Consensus       284 ~----~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          284 E----VIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             H----HHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H----HHHHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            2    2222222222 23334688999999999999999999999999874

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.5e-48  Score=345.90  Aligned_cols=247  Identities=24%  Similarity=0.381  Sum_probs=194.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC---CcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++.+..+   +..||+|++.....  ....+.+|+.+++.++||||+++++++. .+..|+|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            5899999999999999999998654   45799998875432  2356889999999999999999999984 5678999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+.+++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC------------
T ss_pred             EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccccCcccc
Confidence            99999999999997654 699999999999999999999999999999999999998665  499999999875433222


Q ss_pred             --CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                        .....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...........    +.. ....+....+++.
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~----i~~-~~~~~~~~~~~~~  245 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IEN-GERLPMPPNCPPT  245 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHT-TCCCCCCTTCCHH
T ss_pred             cccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHH----HHc-CCCCCCCCCCCHH
Confidence              2234578899999999877764 55999999999999996 9999987665443322    222 2233445578999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.++|.+||+.+|.+|||+.+++++
T Consensus       246 l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          246 LYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.2e-48  Score=353.39  Aligned_cols=247  Identities=21%  Similarity=0.322  Sum_probs=201.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcE----EEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKEL----VAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++++.||+|+||.||++.+..+++.    ||+|.+....  .....+.+|+.+++.++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            6899999999999999999999888876    6777665432  22245678999999999999999999886 456889


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      ||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS--QVQVADFGVADLLPPDD  169 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS--CEEECSCSGGGGSCCCT
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC--eEEECCCCcccccCccc
Confidence            99999999999999764 5799999999999999999999999999999999999997665  49999999998643332


Q ss_pred             C---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .   .....||+.|+|||++.+..++ .++|||||||++|+|++ |+.||..........    . .......+....++
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~-~~~~~~~~~~~~~~  243 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD----L-LEKGERLAQPQICT  243 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH----H-HHTTCBCCCCTTBC
T ss_pred             ccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH----H-HHcCCCCCCCCcCc
Confidence            2   2345688899999999877764 55999999999999999 999998765433222    1 12222334444678


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+.++|.+||+.+|.+|||+.+++++
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7e-48  Score=353.35  Aligned_cols=247  Identities=21%  Similarity=0.360  Sum_probs=199.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEE----EEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELV----AMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++.+.||+|+||.||++.+..+++.+    |+|.+....  .....+.+|+.++++++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            58999999999999999999998877654    777765432  23457889999999999999999999998765 778


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      |++|+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTHHHHHTTTC
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC--CEEEccCcceeEccCCc
Confidence            9999999999999876 45799999999999999999999999999999999999998766  49999999987543322


Q ss_pred             C---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .   .....||+.|+|||++.+..++ .++|||||||++|+|++ |+.||........ ..    ........+....++
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~----~~~~~~~~~~~~~~~  245 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SS----ILEKGERLPQPPICT  245 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HH----HHHTTCCCCCCTTBC
T ss_pred             ccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHH-HH----HHHcCCCCCCCccCC
Confidence            2   2234578899999999887765 55999999999999999 9999987654332 22    222233445555789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+.+++.+||+.+|.+|||+.+++++
T Consensus       246 ~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          246 IDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6e-48  Score=349.01  Aligned_cols=248  Identities=25%  Similarity=0.350  Sum_probs=193.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhc--CCCCCcceEEEEEEc----CCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--LRHPNIIRFKEVVLT----PTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~--l~hp~Iv~~~~~~~~----~~~~~l   75 (351)
                      ++|++.+.||+|+||.||++.+  +++.||+|++.....  ....+|.+++..  ++||||+++++++..    ...+++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~--~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc--hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            5899999999999999999988  588999999876433  344455555544  899999999998654    356899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH--------SMQICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH--------~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      ||||+.+|+|.+++.. ..+++..+..++.||+.||.|||        ++||+||||||+|||++.++  ++||+|||++
T Consensus        84 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a  160 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLA  160 (301)
T ss_dssp             EECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTC
T ss_pred             ehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC--CEEEeeCCCe
Confidence            9999999999999954 57999999999999999999999        99999999999999998665  4999999998


Q ss_pred             cccCCCCC-----CCCcccCCCccCcccccCCcCC-----CcchhHHHHHHHHHHHHcC----------CCCCCCCCChh
Q 018734          148 KSSLLHSR-----PKSTVGTPAYIAPEVLSRREYD-----GKLADVWSCGVTLYVMLVG----------AYPFEDQEDPK  207 (351)
Q Consensus       148 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~ell~g----------~~pf~~~~~~~  207 (351)
                      +.......     ....+||+.|+|||++.+....     +.++|||||||++|+|++|          ..||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            64322221     2344799999999999776332     2469999999999999999          88887654332


Q ss_pred             HHHHHHHHHHhhccCCCCcc------CCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          208 NFRKTISRIMAVQYKIPDYV------HISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ................+..+      ..++.+.+||.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            22222322222222222211      24467999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-47  Score=339.80  Aligned_cols=247  Identities=23%  Similarity=0.416  Sum_probs=208.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+. +++.||+|++.........+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            58999999999999999999987 46789999998776666788999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC--CCCCC
Q 018734           82 GGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPKS  158 (351)
Q Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~--~~~~~  158 (351)
                      +++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++  ++||+|||++......  .....
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG--CEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC--CEEEccccccccccccccccccc
Confidence            99999999765 5689999999999999999999999999999999999997665  4999999998754221  12234


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.........    ..+.. .........++..+.+++
T Consensus       165 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----~~i~~-~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----EDIST-GFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHT-TCCCCCCTTSCHHHHHHH
T ss_pred             ccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHH----HHHhc-CCcCCCCccCcHHHHHHH
Confidence            5678899999999877664 55999999999999999 89999876543322    22222 223333446789999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.+|.+|||+.+++++
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.4e-47  Score=363.45  Aligned_cols=242  Identities=24%  Similarity=0.392  Sum_probs=204.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCC-EEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT-HLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+.  ++.||||++.... ....+.+|+.++++++|||||++++++.... .+|+||||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            67999999999999999999886  6799999997654 4567899999999999999999999987664 799999999


Q ss_pred             CCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           81 AGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        81 ~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      .+|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....  ....
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~--~~~~  345 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASS--TQDT  345 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS--CEEECCCTTCEECC-------
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC--CEEEeeCCCcccccc--cccC
Confidence            99999999987654  79999999999999999999999999999999999998665  499999999874322  2233


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..+++.|+|||++.+..++ .++|||||||++|+|++ |+.||......+....    + ...+..+.+..+++.+.+||
T Consensus       346 ~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~p~~~~~~l~~li  419 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----V-EKGYKMDAPDGCPPAVYDVM  419 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH----H-HTTCCCCCCTTCCHHHHHHH
T ss_pred             CCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCcCCHHHHHHH
Confidence            4678999999999887765 45999999999999998 9999987665433322    2 22334455567899999999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 018734          238 SRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~  256 (351)
                      .+||+.||.+|||+.++++
T Consensus       420 ~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          420 KNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCChhHCcCHHHHHH
Confidence            9999999999999999975

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.4e-47  Score=345.85  Aligned_cols=252  Identities=27%  Similarity=0.392  Sum_probs=197.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            3689999999999999999999999999999999875322    234678899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |||+.+++|.+++..    ...+++..++.++.||+.||.|||++|++||||||+||+++.++  .+||+|||++.....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC--------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecC
Confidence            999999999998864    45699999999999999999999999999999999999997665  499999999875433


Q ss_pred             CC-CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          153 HS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       153 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      .. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||......  .......+....+.......++.
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CC--HHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchh--HHHHHHHhhcccCCCCcccccCH
Confidence            22 22345799999999999877764 5599999999999999999999764322  12233333333333222346889


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+.+||.+||+.||.+|||+.+++++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.1e-47  Score=370.89  Aligned_cols=247  Identities=21%  Similarity=0.345  Sum_probs=211.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+..++..||||++.........+.+|+.++++++|||||++++++.....+|+||||+.
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~  299 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT  299 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccC
Confidence            46899999999999999999999999999999998766556789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--CCC
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPK  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~~~  157 (351)
                      +|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......  ...
T Consensus       300 ~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~  377 (495)
T 1opk_A          300 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  377 (495)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG--CEEECCTTCEECCTTCCEECCT
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC--cEEEeecccceeccCCceeecC
Confidence            99999999864  4589999999999999999999999999999999999997665  49999999997543221  123


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+++.|+|||++.+..++ .++|||||||++|+|++ |..||......... .    .....+..+.+..+++.+.+|
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~l  451 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-E----LLEKDYRMERPEGCPEKVYEL  451 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-H----HHHTTCCCCCCTTCCHHHHHH
T ss_pred             CCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-H----HHHcCCCCCCCCCCCHHHHHH
Confidence            34567889999999877765 45999999999999999 99999876543322 2    222344455556789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      |.+||+.+|.+|||+.++++
T Consensus       452 i~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          452 MRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCcChhHCcCHHHHHH
Confidence            99999999999999999976

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-48  Score=356.52  Aligned_cols=249  Identities=12%  Similarity=0.172  Sum_probs=202.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC--------CcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcce-----------
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT--------KELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR-----------   62 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~-----------   62 (351)
                      ++|++.+.||+|+||.||++.+..+        ++.||+|++...    ..+.+|+.++++++||||++           
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            5899999999999999999999874        889999998754    36789999999999999987           


Q ss_pred             ----EEEEEEc-CCEEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           63 ----FKEVVLT-PTHLAIVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        63 ----~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                          +++++.. ...+|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~  196 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED  196 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence                6777765 78999999999 99999999876  7899999999999999999999999999999999999998765


Q ss_pred             CCCEEEeccCCCcccCCCC--------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCC-Ch
Q 018734          136 APRLKICDFGYSKSSLLHS--------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQE-DP  206 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~  206 (351)
                      ..++||+|||+++......        ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.... ..
T Consensus       197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~  275 (352)
T 2jii_A          197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTNCLPNT  275 (352)
T ss_dssp             EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence            3359999999997543221        12334799999999999877764 55999999999999999999998765 33


Q ss_pred             hHHHHHHHHHHhhccCCC----CccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          207 KNFRKTISRIMAVQYKIP----DYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.............++    .+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          276 EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            333333332222222111    12357899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-47  Score=351.79  Aligned_cols=249  Identities=24%  Similarity=0.410  Sum_probs=194.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhc--CCCCCcceEEEEEEcC----CEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--LRHPNIIRFKEVVLTP----THLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~--l~hp~Iv~~~~~~~~~----~~~~l   75 (351)
                      ++|++.+.||+|+||.||++.+.  ++.||+|++.....  ....+|..++..  ++||||+++++++...    ..+++
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  112 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL  112 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEE
Confidence            47999999999999999999886  78999999865433  334445555544  4999999999999877    78999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM--------QICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~--------~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      ||||+.+++|.+++... .+++..++.++.|++.||.|||++        ||+||||||+|||++.++  ++||+|||++
T Consensus       113 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfg~a  189 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLA  189 (337)
T ss_dssp             EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTTC
T ss_pred             EEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC--CEEEEeCCCc
Confidence            99999999999999664 689999999999999999999998        999999999999997665  4999999998


Q ss_pred             cccCCCCC-----CCCcccCCCccCcccccCCcCCCc-----chhHHHHHHHHHHHHcC----------CCCCCCCCChh
Q 018734          148 KSSLLHSR-----PKSTVGTPAYIAPEVLSRREYDGK-----LADVWSCGVTLYVMLVG----------AYPFEDQEDPK  207 (351)
Q Consensus       148 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwslG~il~ell~g----------~~pf~~~~~~~  207 (351)
                      +.......     ....+||+.|+|||++.+..+...     ++|||||||++|+|++|          +.||.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            64432222     234579999999999977665443     38999999999999999          77776543322


Q ss_pred             HHHHHHHHHHhhccCCCCc------cCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          208 NFRKTISRIMAVQYKIPDY------VHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ................+..      ..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            2222222222222111211      1345679999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-47  Score=351.84  Aligned_cols=254  Identities=19%  Similarity=0.294  Sum_probs=204.1

Q ss_pred             CCeeEeeeecccCceEEEEEE-----EcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMR-----NKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++++.||+|+||.||++.     +..+++.||+|++.....  ....+.+|+.++++++||||+++++++......|
T Consensus        30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (327)
T 2yfx_A           30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  109 (327)
T ss_dssp             GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence            589999999999999999999     556788999999865322  2346788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCC
Q 018734           75 IVMEYAAGGELFERICNAG-------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGY  146 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~  146 (351)
                      +||||+.+++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+
T Consensus       110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            9999999999999998653       489999999999999999999999999999999999997433 33599999998


Q ss_pred             CcccCCC---CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccC
Q 018734          147 SKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK  222 (351)
Q Consensus       147 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (351)
                      +......   .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||........    ...+... ..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~----~~~~~~~-~~  263 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV----LEFVTSG-GR  263 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----HHHHHTT-CC
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHH----HHHHhcC-CC
Confidence            8643222   222345689999999999877764 55999999999999998 9999987543322    2222222 22


Q ss_pred             CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      .+....++..+.++|.+||+.+|.+|||+.++++|.|+.
T Consensus       264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            333446889999999999999999999999999998764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.1e-48  Score=365.56  Aligned_cols=253  Identities=27%  Similarity=0.361  Sum_probs=193.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      +|.+.+.||+|+||.|+. ....+++.||||++.....  ....+|+.+++.+ +|||||++++++.+...+|+|||||.
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            589999999999998764 4445688999999865432  2356899999998 79999999999999999999999996


Q ss_pred             CCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCCCEEEeccCCCcccCCC----
Q 018734           82 GGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG---SPAPRLKICDFGYSKSSLLH----  153 (351)
Q Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~---~~~~~vkL~DFg~a~~~~~~----  153 (351)
                       ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.   ++..++||+|||+++.....    
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~  180 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF  180 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcce
Confidence             59999987654 4666678899999999999999999999999999999953   33346889999998754432    


Q ss_pred             CCCCCcccCCCccCcccccCC--cCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccC-CCCccCC
Q 018734          154 SRPKSTVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYK-IPDYVHI  229 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  229 (351)
                      ......+||+.|+|||++.+.  ...+.++|||||||++|+|++ |..||....... .. ..  ....... .......
T Consensus       181 ~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~-~~--~~~~~~~~~~~~~~~  256 (432)
T 3p23_A          181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-AN-IL--LGACSLDCLHPEKHE  256 (432)
T ss_dssp             -----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HH-HH--TTCCCCTTSCTTCHH
T ss_pred             eeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HH-HH--hccCCccccCccccc
Confidence            223446799999999999742  223456999999999999999 999996543221 11 11  1111111 1111223


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +..+.+||.+||+.||.+|||+.++++||||...
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            5568999999999999999999999999999653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-47  Score=357.10  Aligned_cols=247  Identities=24%  Similarity=0.381  Sum_probs=195.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEc---CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK---NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++.+.   .++..||+|++.....  ....+.+|+.++++++||||+++++++.....+++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            47999999999999999999887   5677899999876432  235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+++++|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.......
T Consensus       125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--VCKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred             EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC--CEEECcCccccccccCCc
Confidence            99999999999998754 699999999999999999999999999999999999997765  499999999875433221


Q ss_pred             ----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          156 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                          .....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.........    .. .......+....++
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~----~~-i~~~~~~~~~~~~~  276 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVI----KA-VDEGYRLPPPMDCP  276 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH----HH-HHTTEECCCCTTCB
T ss_pred             cceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HH-HHcCCCCCCCcccc
Confidence                1123467889999999877765 45999999999999998 99999876543222    22 22233455555788


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.+|+.+||+.+|.+||++.++++
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            99999999999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.9e-47  Score=343.08  Aligned_cols=248  Identities=23%  Similarity=0.358  Sum_probs=191.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++.+.||+|+||.||++.+..   .||+|++......   ...+.+|+.+++.++||||++++++. ....+++|||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            589999999999999999998754   4999998754332   24578999999999999999999965 5567899999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC---CC
Q 018734           79 YAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---HS  154 (351)
Q Consensus        79 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~---~~  154 (351)
                      |+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||++.....   ..
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~  177 (289)
T 3og7_A          100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEKSRWSGSH  177 (289)
T ss_dssp             CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC------------
T ss_pred             ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceeccccccccccc
Confidence            9999999999864 45699999999999999999999999999999999999998765  499999999874332   12


Q ss_pred             CCCCcccCCCccCccccc---CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          155 RPKSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                      ......||+.|+|||++.   +..+ +.++|||||||++|+|++|+.||............+...............+++
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (289)
T 3og7_A          178 QFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPK  256 (289)
T ss_dssp             ------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCH
T ss_pred             cccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCH
Confidence            223457999999999986   3333 456999999999999999999998876655444433321111111111235789


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhc
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .+.+||.+||+.+|.+|||+.++++
T Consensus       257 ~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          257 RMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.5e-47  Score=364.80  Aligned_cols=245  Identities=24%  Similarity=0.404  Sum_probs=206.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+.. +..||||++.........+.+|+.+++.++|||||++++++. ...+|+||||+.
T Consensus       188 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~  265 (454)
T 1qcf_A          188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA  265 (454)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence            579999999999999999999875 678999999876656678999999999999999999999986 567899999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC--CCCC
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPK  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~--~~~~  157 (351)
                      +|+|.+++...  ..++...+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.....  ....
T Consensus       266 ~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~~~~~~~~  343 (454)
T 1qcf_A          266 KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTARE  343 (454)
T ss_dssp             TCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC--CEEECSTTGGGGBCCHHHHTTC
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC--cEEEeeCCCceEcCCCceeccC
Confidence            99999999754  3689999999999999999999999999999999999998765  4999999999754322  1123


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+|+.|+|||++....++ .++|||||||++|||++ |+.||...........     ....+..+.+..+++.+.+|
T Consensus       344 ~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-----i~~~~~~~~~~~~~~~l~~l  417 (454)
T 1qcf_A          344 GAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-----LERGYRMPRPENCPEELYNI  417 (454)
T ss_dssp             SSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-----HHHTCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCHHHHHH
Confidence            34577889999999877764 55999999999999999 9999987654332222     22334556666789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      |.+||+.||.+|||+.+|++
T Consensus       418 i~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          418 MMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHH
Confidence            99999999999999999975

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5e-47  Score=347.73  Aligned_cols=246  Identities=21%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEE----EEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELV----AMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~v----aiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++++.||+|+||.||++.+..+++.|    |+|.+....  .....+.+|+.+++.++||||+++++++.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            68999999999999999999998888765    566554322  23467889999999999999999999998765 789


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      |++++.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ--HVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT--EEEECCTTC--------
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC--CEEEccCcceeEccCcc
Confidence            9999999999999876 45799999999999999999999999999999999999997766  49999999997543322


Q ss_pred             C---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||......... .    ........+....++
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~----~~~~~~~~~~~~~~~  245 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-S----ILEKGERLPQPPICT  245 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-H----HHHTTCCCCCCTTBC
T ss_pred             ccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-H----HHHcCCCCCCCccCC
Confidence            2   2234578899999999877765 55999999999999999 99999876554322 2    222333445556789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.++|.+||+.+|.+|||+.++++
T Consensus       246 ~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          246 IDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.9e-47  Score=350.31  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=207.5

Q ss_pred             CCeeEeeeecccCceEEEEEE----EcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEE--cCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVL--TPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~--~~~~~~   74 (351)
                      ++|++++.||+|+||.||++.    +..+++.||+|++..... ....+.+|+.++++++||||+++++++.  ....++
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            589999999999999999999    577899999999876533 2345889999999999999999999987  456799


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           75 IVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      +||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||++......
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA--HVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCGGGCEECCTT
T ss_pred             EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC--CEEEcccccceecccC
Confidence            99999999999999976 45699999999999999999999999999999999999998766  4999999998754322


Q ss_pred             C----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh----------HHHHHHHHHHhh
Q 018734          154 S----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK----------NFRKTISRIMAV  219 (351)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----------~~~~~~~~~~~~  219 (351)
                      .    ......||+.|+|||++.+..++ .++|||||||++|+|++|..||.......          .....+......
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE  259 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred             CccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence            2    22344688899999999877764 55999999999999999999986532110          001112222333


Q ss_pred             ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          220 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ....+....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            34455556789999999999999999999999999765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-47  Score=348.48  Aligned_cols=249  Identities=23%  Similarity=0.374  Sum_probs=206.0

Q ss_pred             CCeeEeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCccc--CHHHHHHHHHHhcC-CCCCcceEEEEEEcCC-E
Q 018734            2 EKYELMKDIGSGNFGVARLMRN-----KNTKELVAMKYIERGHKI--DANVAREIINHKQL-RHPNIIRFKEVVLTPT-H   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~-~   72 (351)
                      ++|++.+.||+|+||.||++.+     ..+++.||+|++......  ...+.+|+.+++++ +||||+++++++...+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            5899999999999999999985     456789999998765432  24678999999999 6899999999987654 5


Q ss_pred             EEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 018734           73 LAIVMEYAAGGELFERICNAGR----------------FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA  136 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~----------------l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~  136 (351)
                      +++||||+.+++|.+++.....                +++..++.++.||+.||.|||++||+||||||+||+++.++ 
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-  185 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-  185 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-
Confidence            9999999999999999987554                89999999999999999999999999999999999997665 


Q ss_pred             CCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHH
Q 018734          137 PRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKT  212 (351)
Q Consensus       137 ~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~  212 (351)
                       ++||+|||+++.......   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||........+...
T Consensus       186 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~  263 (316)
T 2xir_A          186 -VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  263 (316)
T ss_dssp             -CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             -CEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHH
Confidence             499999999875433222   2234688999999999877764 55999999999999998 99999876654443332


Q ss_pred             HHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          213 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.    .....+....+++.+.++|.+||+.+|.+|||+.++++|
T Consensus       264 ~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          264 LK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HH----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hc----cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22    122233344688999999999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.7e-47  Score=361.58  Aligned_cols=252  Identities=26%  Similarity=0.342  Sum_probs=192.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +.|.+.+.||+|+||+||.+. ..+|+.||||++....  ...+.+|+.+++.+ +|||||++++++.+...+|+|||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            356778999999999998654 4568999999986543  24577899999875 8999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----------CCCCEEEe
Q 018734           81 AGGELFERICNAGRF-------SEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-----------PAPRLKIC  142 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l-------~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-----------~~~~vkL~  142 (351)
                      . |+|.+++......       ++..+..++.||+.||.|||++||+||||||+|||++..           ...++||+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            5 5999999875433       233467899999999999999999999999999999753           23469999


Q ss_pred             ccCCCcccCCCCC-----CCCcccCCCccCcccccC------CcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHH
Q 018734          143 DFGYSKSSLLHSR-----PKSTVGTPAYIAPEVLSR------REYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFR  210 (351)
Q Consensus       143 DFg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  210 (351)
                      |||+++.......     ....+||+.|+|||++.+      ....+.++|||||||++|+|++ |+.||.......  .
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~  248 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--S  248 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--H
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--H
Confidence            9999985443221     234579999999999965      1334566999999999999999 999997654322  1


Q ss_pred             HHHHHHHhhccCCCCc-----cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          211 KTISRIMAVQYKIPDY-----VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       211 ~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                          .+.......+..     ..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       249 ----~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          249 ----NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             ----HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             ----HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence                122222232222     1345789999999999999999999999999999653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.4e-47  Score=348.96  Aligned_cols=248  Identities=24%  Similarity=0.364  Sum_probs=204.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-------CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-------NTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      ++|++.+.||+|+||.||++.+.       .++..||+|++.....  ....+.+|+.+++.+ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            68999999999999999999986       4567899999876432  234678999999999 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           72 HLAIVMEYAAGGELFERICNAG----------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      .+|+||||+.+++|.+++....                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC
Confidence            9999999999999999998654                389999999999999999999999999999999999997665


Q ss_pred             CCCEEEeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                        ++||+|||+++......   ......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.........  
T Consensus       195 --~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--  269 (334)
T 2pvf_A          195 --VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--  269 (334)
T ss_dssp             --CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH--
T ss_pred             --CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH--
Confidence              49999999987543222   22334678899999999877764 55999999999999999 99999876533222  


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                        ..+.. ....+....++..+.++|.+||+.+|.+|||+.+++++
T Consensus       270 --~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          270 --KLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             --HHHHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --HHHhc-CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              22222 22333445689999999999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-48  Score=354.83  Aligned_cols=252  Identities=20%  Similarity=0.228  Sum_probs=202.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+. +++.||+|++..... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  117 (321)
T 2qkw_B           39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM  117 (321)
T ss_dssp             CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred             hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence            68999999999999999999975 588999998876433 2356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--
Q 018734           81 AGGELFERICNAG----RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--  154 (351)
Q Consensus        81 ~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--  154 (351)
                      .+++|.+++....    .+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......  
T Consensus       118 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTELDQT  195 (321)
T ss_dssp             TTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSSSSCC
T ss_pred             CCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeeccccccccccccc
Confidence            9999999886543    589999999999999999999999999999999999997665  49999999987533221  


Q ss_pred             -CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHH--HHH-HHHHHhhccC--------
Q 018734          155 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF--RKT-ISRIMAVQYK--------  222 (351)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~-~~~~~~~~~~--------  222 (351)
                       ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.........  ... ..........        
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA  274 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred             ccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence             22344699999999999877765 4599999999999999999999765432211  111 1111111110        


Q ss_pred             CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .......+..+.+++.+||+.||.+|||+.+++++
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            01112245678999999999999999999999976

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.8e-48  Score=351.09  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=200.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCCCCCcceEEEEEE----cCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVL----TPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~----~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.    .....++|
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  108 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL  108 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence            57999999999999999999999999999999886533 23356789999999999999999999986    33588999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      |||+.+++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++.....
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~--~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG--QPVLMDLGSMNQACI  186 (317)
T ss_dssp             EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCSSCEESCE
T ss_pred             EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC--CEEEEecCcchhccc
Confidence            999999999998875    46799999999999999999999999999999999999997665  499999998864322


Q ss_pred             CCCC----------CCcccCCCccCcccccCCcC--CCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc
Q 018734          153 HSRP----------KSTVGTPAYIAPEVLSRREY--DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ  220 (351)
Q Consensus       153 ~~~~----------~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (351)
                      ....          ....||+.|+|||++.+...  .+.++|||||||++|+|++|+.||........   .........
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~  263 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQNQ  263 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---CHHHHHHCC
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---hhhHHhhcc
Confidence            1111          12357999999999875542  24569999999999999999999953110000   011112223


Q ss_pred             cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          221 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ...+....++..+.++|.+||+.||.+|||+.+++++
T Consensus       264 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          264 LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            4455556789999999999999999999999999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7e-47  Score=340.87  Aligned_cols=246  Identities=22%  Similarity=0.314  Sum_probs=200.9

Q ss_pred             CCeeEee-eecccCceEEEEEE--EcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMK-DIGSGNFGVARLMR--NKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~-~lG~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++.+ .||+|+||.||++.  ...+++.||+|++......   ...+.+|+.+++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            5799998 99999999999994  4667789999998765332   35688999999999999999999999 5667899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++........
T Consensus        95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEECCTTCS
T ss_pred             EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcceeeccCCC
Confidence            999999999999999988899999999999999999999999999999999999998765  499999999875433221


Q ss_pred             ----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          156 ----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       156 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                          .....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||........    ...+.. ....+....++
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~-~~~~~~~~~~~  246 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----TAMLEK-GERMGCPAGCP  246 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHHHT-TCCCCCCTTCC
T ss_pred             cccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHHc-CCCCCCCCCCC
Confidence                1223467899999999877764 55999999999999999 9999987654322    222222 22233345689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+.++|.+||+.||.+|||+.++++
T Consensus       247 ~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          247 REMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.9e-47  Score=349.81  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=208.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc-----EEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE-----LVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++.+.||+|+||.||++.+..+++     .||+|++.....  ....+.+|+.+++.+ +||||+++++++...+.+
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            579999999999999999999977664     799999876532  235688999999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 018734           74 AIVMEYAAGGELFERICNA--------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRL  139 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~v  139 (351)
                      ++||||+.+|+|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~--~~  203 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH--VA  203 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG--EE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC--eE
Confidence            9999999999999998653              3589999999999999999999999999999999999998665  49


Q ss_pred             EEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHH
Q 018734          140 KICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISR  215 (351)
Q Consensus       140 kL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  215 (351)
                      ||+|||++........   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||........+....  
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~--  280 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV--  280 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH--
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH--
Confidence            9999999975433222   2334578899999999877764 55999999999999998 999998766554443332  


Q ss_pred             HHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          216 IMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       216 ~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                        ......+.....++.+.+||.+||+.+|.+|||+.+++++
T Consensus       281 --~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          281 --KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             --HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence              2233444445678999999999999999999999999873

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2e-46  Score=338.21  Aligned_cols=249  Identities=22%  Similarity=0.222  Sum_probs=200.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEE-EEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEV-VLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~-~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ...+.+|+.+++.++|++++..+.. +......++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            689999999999999999999999999999999876543 3468899999999998876655544 46778899999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec---CCCCCCEEEeccCCCcccCCCCC-
Q 018734           81 AGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~---~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                       +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++   .++  .+||+|||++........ 
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCcccccccccc
Confidence             8999999974 45799999999999999999999999999999999999994   443  599999999875433322 


Q ss_pred             -------CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh---hHHHHHHHHHHhhccCCCC
Q 018734          156 -------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYKIPD  225 (351)
Q Consensus       156 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~  225 (351)
                             .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||......   ..+..+.......... ..
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~  242 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-VL  242 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-HH
T ss_pred             cccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-HH
Confidence                   2455799999999999887764 5599999999999999999999874322   2222222221111100 01


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...+++.+.+++.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            1357899999999999999999999999976

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.6e-47  Score=346.72  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=205.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+.     .+++.||+|++.....  ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            57999999999999999999876     4578899999876433  2245789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           75 IVMEYAAGGELFERICNA----------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                      +||||+.+++|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+||
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~~kl~Df  182 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--TVKIGDF  182 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--CEEECCT
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC--eEEECcC
Confidence            999999999999998652          4579999999999999999999999999999999999998765  4999999


Q ss_pred             CCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhc
Q 018734          145 GYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  220 (351)
Q Consensus       145 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (351)
                      |+++.......   .....||+.|+|||++.+..++ .++|||||||++|+|++ |..||........    ...+....
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~----~~~~~~~~  257 (322)
T 1p4o_A          183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFVMEGG  257 (322)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHHHTTC
T ss_pred             ccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHH----HHHHHcCC
Confidence            99875432221   2234678999999999877764 55999999999999999 8999987654322    22222222


Q ss_pred             cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          221 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                       ..+....++..+.+||.+||+.+|.+|||+.+++++
T Consensus       258 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          258 -LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             223345688999999999999999999999999986

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.9e-47  Score=344.88  Aligned_cols=237  Identities=33%  Similarity=0.595  Sum_probs=189.3

Q ss_pred             CCCeeEe-eeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHH-hcCCCCCcceEEEEEEc----CCEEE
Q 018734            1 MEKYELM-KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-KQLRHPNIIRFKEVVLT----PTHLA   74 (351)
Q Consensus         1 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~-~~l~hp~Iv~~~~~~~~----~~~~~   74 (351)
                      +++|.+. +.||+|+||.||++.+..+++.||+|++...    ....+|+.++ +.++||||+++++++..    ...++
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3678888 7899999999999999999999999998643    4677888887 66799999999999976    67899


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccC
Q 018734           75 IVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSL  151 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~  151 (351)
                      +||||+.+++|.+++....  .+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            9999999999999998754  699999999999999999999999999999999999998632 3469999999886321


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCC
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHI  229 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  229 (351)
                                           +..+ +.++|||||||++|+|++|+.||...............+.......+  .+..+
T Consensus       172 ---------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (299)
T 3m2w_A          172 ---------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  229 (299)
T ss_dssp             ---------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred             ---------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccC
Confidence                                 1223 45599999999999999999999765432211100011111111112  11457


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ++.+.+||.+||+.||.+|||+.++++||||.+.
T Consensus       230 ~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            8999999999999999999999999999999654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.2e-46  Score=337.10  Aligned_cols=245  Identities=22%  Similarity=0.373  Sum_probs=204.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++++.||+|+||.||++.+. ++..||+|++.........+.+|+.+++.++||||+++++++. .+..++||||+.
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   90 (279)
T 1qpc_A           13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (279)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCC
Confidence            58999999999999999999976 4678999999876655677899999999999999999999886 456899999999


Q ss_pred             CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--CCC
Q 018734           82 GGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPK  157 (351)
Q Consensus        82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~~~  157 (351)
                      +++|.+++....  .+++..+..++.|++.||.|||++||+||||||+||+++.++  .+||+|||++.......  ...
T Consensus        91 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~~  168 (279)
T 1qpc_A           91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL--SCKIADFGLARLIEDNEYTARE  168 (279)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECSSSCEECCT
T ss_pred             CCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC--CEEECCCcccccccCccccccc
Confidence            999999987543  699999999999999999999999999999999999997665  49999999987543322  123


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.........    ..+. .....+....++..+.++
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~l~~l  242 (279)
T 1qpc_A          169 GAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI----QNLE-RGYRMVRPDNCPEELYQL  242 (279)
T ss_dssp             TCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHH-TTCCCCCCTTCCHHHHHH
T ss_pred             CCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHH----HHHh-cccCCCCcccccHHHHHH
Confidence            34578899999999877664 55999999999999999 99999876543322    2222 223334445789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||+.+|.+|||+.++++
T Consensus       243 i~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          243 MRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccChhhCCCHHHHHH
Confidence            99999999999999999976

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-46  Score=344.57  Aligned_cols=248  Identities=24%  Similarity=0.360  Sum_probs=200.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC----cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK----ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++.+.||+|+||.||++.+..++    ..||+|++.....  ....+.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            57999999999999999999987553    4599999876432  23457899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      ||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~~~~  201 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP  201 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC--------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhcccc
Confidence            99999999999999764 6799999999999999999999999999999999999998665  49999999987543222


Q ss_pred             C----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCC
Q 018734          155 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       155 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                      .    .....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||........    ...+. .....+....+
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~----~~~~~-~~~~~~~~~~~  275 (333)
T 1mqb_A          202 EATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEV----MKAIN-DGFRLPTPMDC  275 (333)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHH-TTCCCCCCTTC
T ss_pred             ccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHH----HHHHH-CCCcCCCcccC
Confidence            1    1223468899999999877765 55999999999999998 9999987654322    22222 23344555578


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +..+.++|.+||+.+|.+||++.+++++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999999864

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-46  Score=339.44  Aligned_cols=246  Identities=22%  Similarity=0.231  Sum_probs=197.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEE-EEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEV-VLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~-~~~~~~~~lv~e~~   80 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++...... ..+.+|+.+++.++|++++..+.. +......++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            5899999999999999999999999999999987654332 357889999999998776665554 46778899999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCCCEEEeccCCCcccCCCC--
Q 018734           81 AGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLL---DGSPAPRLKICDFGYSKSSLLHS--  154 (351)
Q Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll---~~~~~~~vkL~DFg~a~~~~~~~--  154 (351)
                       +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++  .+||+|||+++......  
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCcccC
Confidence             8999999875 4579999999999999999999999999999999999999   4444  49999999997543322  


Q ss_pred             ------CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh---hHHHHHHHHHHhhccCCC-
Q 018734          155 ------RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP---KNFRKTISRIMAVQYKIP-  224 (351)
Q Consensus       155 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~-  224 (351)
                            ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......   ..+......    ....+ 
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~~  239 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----KMSTPI  239 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----HHHSCH
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----cccchh
Confidence                  2234579999999999988776 45599999999999999999999875432   222222221    11122 


Q ss_pred             --CccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          225 --DYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       225 --~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                        ....+++.+.+||.+||+.+|.+|||+.++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence              11357899999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8e-47  Score=338.16  Aligned_cols=243  Identities=24%  Similarity=0.392  Sum_probs=196.4

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcC-CEEEEEEec
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP-THLAIVMEY   79 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-~~~~lv~e~   79 (351)
                      +++|++.+.||+|+||.||++.+.  ++.||+|++.... ....+.+|+.+++.++||||+++++++... +.+++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            368999999999999999999875  7899999987643 446788999999999999999999997554 578999999


Q ss_pred             cCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           80 AAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      +.+++|.+++...+.  +++..+..++.|++.||.|||++|++||||||+||+++.++  ++||+|||++.....  ...
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~--~~~  172 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEASS--TQD  172 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC--cEEEeeccccccccc--ccc
Confidence            999999999976543  89999999999999999999999999999999999998665  499999999874322  223


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+++.|+|||++.+..++ .++|||||||++|+|++ |+.||..........    .+ ......+....+++.+.++
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~l~~l  246 (278)
T 1byg_A          173 TGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----RV-EKGYKMDAPDGCPPAVYEV  246 (278)
T ss_dssp             ---CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH----HH-TTTCCCCCCTTCCHHHHHH
T ss_pred             CCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HH-hcCCCCCCcccCCHHHHHH
Confidence            44688999999999877664 55999999999999998 999998765433222    12 1223334445789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      |.+||+.||.+|||+.++++
T Consensus       247 i~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          247 MKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999976

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=338.85  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=203.1

Q ss_pred             CCeeEee-eecccCceEEEEEEEc--CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMK-DIGSGNFGVARLMRNK--NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|.+.+ .||+|+||.||++.+.  .++..||+|++.....  ....+.+|+.+++.++||||+++++++ ..+.+++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4678877 9999999999999864  4678899999976432  335688999999999999999999999 45568999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      |||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++  .+||+|||++....... 
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeeeccCcc
Confidence            9999999999998654 5699999999999999999999999999999999999998665  49999999987543222 


Q ss_pred             ---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 ---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                         ......||+.|+|||++.+..++ .++|||||||++|+|++ |+.||..........    .+.. ....+.+..++
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~i~~-~~~~~~~~~~~  239 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQ-GKRMECPPECP  239 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHT-TCCCCCCTTCC
T ss_pred             eeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHhc-CCcCCCCCCcC
Confidence               12334578999999999877764 55999999999999998 999998766533222    2222 22233345789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHP  258 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp  258 (351)
                      +.+.++|.+||+.+|.+||++.+++++.
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999999863

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-46  Score=341.86  Aligned_cols=248  Identities=21%  Similarity=0.324  Sum_probs=195.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC---CCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCC----
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPT----   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~----   71 (351)
                      ++|++.+.||+|+||.||++.+..   ++..||+|++......   ...+.+|+.++++++||||+++++++....    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            579999999999999999998765   5568999998754322   245788999999999999999999997754    


Q ss_pred             -EEEEEEeccCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           72 -HLAIVMEYAAGGELFERIC------NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        72 -~~~lv~e~~~~~~L~~~l~------~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                       ..++||||+.+++|..++.      ....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+||
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kl~Df  191 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM--TVCVADF  191 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS--CEEECSC
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEEeec
Confidence             3599999999999999984      335699999999999999999999999999999999999998765  4999999


Q ss_pred             CCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhc
Q 018734          145 GYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQ  220 (351)
Q Consensus       145 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  220 (351)
                      |++.......   ......+++.|+|||++.+..++ .++|||||||++|+|++ |..||............    .. .
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~~-~  265 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL----LH-G  265 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HT-T
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH----Hc-C
Confidence            9987543322   12334578899999999877765 55999999999999999 89999876654433221    11 2


Q ss_pred             cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          221 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ...+....+++.+.++|.+||+.+|.+|||+.+++++
T Consensus       266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2334445788999999999999999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1e-46  Score=337.99  Aligned_cols=247  Identities=23%  Similarity=0.298  Sum_probs=201.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC---CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN---TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++.+..   ++..||+|++.....  ....+.+|+.+++.++||||+++++++.. +..|+|
T Consensus        12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v   90 (281)
T 3cc6_A           12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII   90 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred             cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence            689999999999999999998654   345699999876432  33568899999999999999999999865 456899


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++  ++||+|||++........
T Consensus        91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC-----
T ss_pred             EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCcccccccc
Confidence            9999999999999765 4599999999999999999999999999999999999998765  499999999875433221


Q ss_pred             --CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                        .....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||........... +    ......+....+++.
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~  242 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-L----EKGDRLPKPDLCPPV  242 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-H----HHTCCCCCCTTCCHH
T ss_pred             cccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-H----hcCCCCCCCCCCCHH
Confidence              2334578899999999777664 55999999999999998 9999987655433222 1    122234444568999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.++|.+||+.+|.+|||+.+++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-46  Score=336.47  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=200.4

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCc---EEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEE-EEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHL-AIV   76 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~-~lv   76 (351)
                      +|.+.+.||+|+||.||++.+..++.   .||+|++.....  ....+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46778999999999999999765544   799999876433  235678999999999999999999999776554 999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC---
Q 018734           77 MEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL---  152 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~---  152 (351)
                      |+|+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++....   
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF--TVKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEeCcCCCcccccCCcc
Confidence            999999999999976 45689999999999999999999999999999999999997665  499999999874322   


Q ss_pred             --CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          153 --HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       153 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                        ........+|+.|+|||.+.+..++ .++|||||||++|+|++|..||............+.    .....+....++
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~  254 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGRRLPQPEYCP  254 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTCCCCCCTTCC
T ss_pred             cccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCCCCCCCccch
Confidence              1223345689999999999877765 559999999999999996555544444333333222    222344455689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+.+++.+||+.+|.+|||+.++++
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.3e-46  Score=359.64  Aligned_cols=245  Identities=22%  Similarity=0.355  Sum_probs=201.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+.. +..||||++.........+.+|+.++++++||||+++++++.. ..+++||||+.
T Consensus       184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~  261 (452)
T 1fmk_A          184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  261 (452)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence            479999999999999999999976 4679999998765555678999999999999999999999866 67899999999


Q ss_pred             CCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CC
Q 018734           82 GGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  157 (351)
Q Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~  157 (351)
                      +|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.......  ..
T Consensus       262 ~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~~~~  339 (452)
T 1fmk_A          262 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  339 (452)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCTTC-----------
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC--CEEECCCccceecCCCceeccc
Confidence            9999999974  35699999999999999999999999999999999999997665  499999999975432221  22


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||......+..    ..+ ......+.+..+++.+.+|
T Consensus       340 ~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~----~~i-~~~~~~~~~~~~~~~l~~l  413 (452)
T 1fmk_A          340 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQV-ERGYRMPCPPECPESLHDL  413 (452)
T ss_dssp             ---CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHH-HTTCCCCCCTTSCHHHHHH
T ss_pred             CCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCCCCCCCCCCCHHHHHH
Confidence            34578899999999877764 55999999999999999 99999876543322    222 2334455556789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      |.+||+.+|.+|||+.++++
T Consensus       414 i~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          414 MCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHH
Confidence            99999999999999999976

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=340.43  Aligned_cols=244  Identities=29%  Similarity=0.485  Sum_probs=195.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+.  ++.||+|++.... ....+.+|+.++++++||||+++++++.+  ..++||||+.
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            58999999999999999999885  6789999986543 33568899999999999999999998764  4789999999


Q ss_pred             CCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           82 GGELFERICNAG---RFSEDEARYFFQQLISGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~---~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      +++|.+++....   .++...+..++.|++.||.|||+   +||+||||||+|||++.++. .+||+|||++....  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~--~~  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQ--TH  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC---------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccc--cc
Confidence            999999998765   37899999999999999999999   89999999999999976553 37999999987432  22


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||........  ....... .....+....++..+.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~l~~  235 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH-NGTRPPLIKNLPKPIES  235 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH-TTCCCCCBTTCCHHHHH
T ss_pred             cccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh-cCCCCCcccccCHHHHH
Confidence            3345799999999999877765 459999999999999999999986543321  1111111 22233444578999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcC
Q 018734          236 LLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +|.+||+.+|.+|||+.+++++
T Consensus       236 li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          236 LMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-46  Score=343.81  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=201.8

Q ss_pred             Ce-eEeeeecccCceEEEEEE----EcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcC--CEE
Q 018734            3 KY-ELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTP--THL   73 (351)
Q Consensus         3 ~y-~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~--~~~   73 (351)
                      +| ++++.||+|+||.||++.    +..+++.||+|++.....  ....+.+|+.+++.++||||+++++++.+.  ..+
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            45 999999999999998775    445789999999976532  235678999999999999999999999874  689


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ++||||+.+++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||++......
T Consensus       111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCGGGCEECCTT
T ss_pred             EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC--CEEECCcccccccccc
Confidence            9999999999999998765 489999999999999999999999999999999999997765  4999999998754333


Q ss_pred             C----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCCh----------hHHHHHHHHHHhh
Q 018734          154 S----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDP----------KNFRKTISRIMAV  219 (351)
Q Consensus       154 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------~~~~~~~~~~~~~  219 (351)
                      .    ......||+.|+|||++.+..++ .++|||||||++|+|++|..||......          ......+......
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence            2    12344688899999999877765 5599999999999999999999753211          0011112223333


Q ss_pred             ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          220 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ....+....+++.+.+||.+||+.+|.+|||+.++++
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            4445556678999999999999999999999999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=345.40  Aligned_cols=244  Identities=26%  Similarity=0.437  Sum_probs=183.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCC-CCCcceEEEEEE--------cCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLR-HPNIIRFKEVVL--------TPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~--------~~~   71 (351)
                      .+|++.+.||+|+||.||++.+..+++.||+|++..... ....+.+|+.+++++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            379999999999999999999999999999998855432 3356788999999996 999999999994        345


Q ss_pred             EEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           72 HLAIVMEYAAGGELFERICN---AGRFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                      .+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++  .+||+|||+
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS--CEEBCCCTT
T ss_pred             eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC--CEEEecCcc
Confidence            6899999995 688888764   567999999999999999999999999  99999999999998766  499999999


Q ss_pred             CcccCCCCC-------------CCCcccCCCccCccccc---CCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHH
Q 018734          147 SKSSLLHSR-------------PKSTVGTPAYIAPEVLS---RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFR  210 (351)
Q Consensus       147 a~~~~~~~~-------------~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  210 (351)
                      ++.......             .....||+.|+|||++.   +..+ +.++|||||||++|+|++|+.||.......   
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~---  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR---  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence            975433221             11446999999999983   3333 456999999999999999999997643321   


Q ss_pred             HHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          211 KTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                           +.......+.....+..+.+||.+||+.||.+|||+.++++|
T Consensus       261 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          261 -----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             ----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 222333445555678899999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.3e-47  Score=349.37  Aligned_cols=253  Identities=22%  Similarity=0.277  Sum_probs=199.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++.+.||+|+||.||++.+. +++.||+|++.....  ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            68999999999999999999865 588999999876432  234688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           80 AAGGELFERICNAG----RFSEDEARYFFQQLISGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        80 ~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +.+++|.+++....    .+++..++.++.|++.||.|||++   ||+||||||+|||++.++  ++||+|||++.....
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~  186 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF--EAVVGDFGLAKLMDY  186 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC--CEEECCCSSCEECCS
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC--CEEeccCccccccCc
Confidence            99999999997643    499999999999999999999999   999999999999998765  499999999975432


Q ss_pred             CCC--CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCC----CChhHHHHHHHHHHhhc------
Q 018734          153 HSR--PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQ----EDPKNFRKTISRIMAVQ------  220 (351)
Q Consensus       153 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~------  220 (351)
                      ...  .....||+.|+|||++.+..++ .++|||||||++|+|++|+.||...    .........+.......      
T Consensus       187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (326)
T 3uim_A          187 KDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV  265 (326)
T ss_dssp             SSSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred             ccccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence            222  2334699999999999877764 5599999999999999999999521    11111111111100000      


Q ss_pred             ---cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCc
Q 018734          221 ---YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHP  258 (351)
Q Consensus       221 ---~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp  258 (351)
                         .........+..+.+++.+||+.+|.+|||+.++++|-
T Consensus       266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence               00001112346799999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.7e-46  Score=340.43  Aligned_cols=252  Identities=24%  Similarity=0.399  Sum_probs=203.8

Q ss_pred             CCeeEeeeecccCceEEEEEE----EcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC--EEE
Q 018734            2 EKYELMKDIGSGNFGVARLMR----NKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPT--HLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~--~~~   74 (351)
                      ++|++++.||+|+||.||++.    +..+++.||+|++..... ....+.+|+.+++.++||||+++++++...+  .++
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            479999999999999999998    467899999999876433 2356889999999999999999999987654  789


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           75 IVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      +||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||++......
T Consensus       121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCSS
T ss_pred             EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC--cEEEecCcchhhcccc
Confidence            999999999999999875 4699999999999999999999999999999999999998665  4999999998754333


Q ss_pred             CC----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----------hhHHHHHHHHHHh
Q 018734          154 SR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQED-----------PKNFRKTISRIMA  218 (351)
Q Consensus       154 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----------~~~~~~~~~~~~~  218 (351)
                      ..    .....+++.|+|||++.+..++ .++|||||||++|+|++|..||.....           .......+.....
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  277 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             ccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence            22    2334578889999999877764 559999999999999999999864210           0111111222223


Q ss_pred             hccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          219 VQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       219 ~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .....+....++..+.+||.+||+.||.+|||+.++++
T Consensus       278 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          278 NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            33344555678999999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=348.90  Aligned_cols=242  Identities=15%  Similarity=0.175  Sum_probs=193.5

Q ss_pred             CCeeEeeeecccCceEEEEE-----EEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC---CCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLM-----RNKNTKELVAMKYIERGHKIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~---hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++.+.||+|+||.||+|     .+..+++.||+|++....  ...+.+|+.+++.++   |+||+++++++...+..
T Consensus        65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            57999999999999999999     467789999999987643  346777888888886   99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---------CCCCCE
Q 018734           74 AIVMEYAAGGELFERICN-----AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG---------SPAPRL  139 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~---------~~~~~v  139 (351)
                      |+|||||.+|+|.+++..     ...+++..++.++.||+.||.|||++||+||||||+|||++.         ...+.+
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~  222 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL  222 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence            999999999999999974     457999999999999999999999999999999999999976         113469


Q ss_pred             EEeccCCCcccC---CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHH
Q 018734          140 KICDFGYSKSSL---LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI  216 (351)
Q Consensus       140 kL~DFg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  216 (351)
                      ||+|||+|+...   ........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........        
T Consensus       223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~--------  293 (365)
T 3e7e_A          223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGEC--------  293 (365)
T ss_dssp             EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTEE--------
T ss_pred             EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCce--------
Confidence            999999996432   22223456799999999999888875 559999999999999999999965432110        


Q ss_pred             HhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          217 MAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                       .....++.. ..++.+.+++.+||+.+|.+|++..+.+.
T Consensus       294 -~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          294 -KPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             -EECSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             -eechhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence             001111111 24678899999999999999976555444

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=345.83  Aligned_cols=251  Identities=21%  Similarity=0.304  Sum_probs=187.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEc-----CCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT-----PTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~-----~~~~~l   75 (351)
                      +++|++++.||+|+||.||++.+  +++.||+|++............++..+..++||||+++++.+..     ...+++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            57999999999999999999977  57899999987654332233344444556899999999986542     236899


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEecCCCCCCEEEeccCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM---------QICHRDLKLENTLLDGSPAPRLKICDFGY  146 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---------~iiH~Dikp~NIll~~~~~~~vkL~DFg~  146 (351)
                      ||||+++|+|.+++.... +++..+..++.||+.||.|||++         ||+||||||+|||++.++  ++||+|||+
T Consensus        90 v~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG~  166 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFGL  166 (336)
T ss_dssp             EECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCTT
T ss_pred             EEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeeccc
Confidence            999999999999997654 48999999999999999999999         999999999999997665  599999999


Q ss_pred             CcccCCC---------CCCCCcccCCCccCcccccCC------cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHH--
Q 018734          147 SKSSLLH---------SRPKSTVGTPAYIAPEVLSRR------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNF--  209 (351)
Q Consensus       147 a~~~~~~---------~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--  209 (351)
                      ++.....         ......+||+.|+|||++.+.      ...+.++|||||||++|+|++|..||.........  
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            9754321         112345799999999999763      12234589999999999999997776543221110  


Q ss_pred             -----------HHHHHHHHhhccCCCCc-------cCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          210 -----------RKTISRIMAVQYKIPDY-------VHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       210 -----------~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                                 ..............+..       ...++.+.+||.+||+.||++|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                       01111111111111111       113447999999999999999999999964

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=7.1e-46  Score=335.19  Aligned_cols=247  Identities=22%  Similarity=0.291  Sum_probs=197.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC---CcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEE-EcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVV-LTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~-~~~~~~~l   75 (351)
                      .+|++.+.||+|+||.||++.+..+   ...||+|.+.....  ....+.+|+.++++++||||+++++++ ..++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            3699999999999999999997543   34689998876433  235678999999999999999999985 45568899


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      ||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCGG
T ss_pred             EEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECcccccccccccc
Confidence            9999999999999976 44689999999999999999999999999999999999997665  49999999987543221


Q ss_pred             -----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          155 -----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       155 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                           ......||+.|+|||++.+..++ .++|||||||++|+|++ |.+||...........    +... ........
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~  256 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQG-RRLLQPEY  256 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH----HHTT-CCCCCCTT
T ss_pred             hhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH----HhcC-CCCCCCcc
Confidence                 22345688899999999877765 55999999999999999 6666766554333222    1111 22233346


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +++.+.+++.+||+.+|.+|||+.++++
T Consensus       257 ~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          257 CPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7899999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.3e-47  Score=376.82  Aligned_cols=261  Identities=27%  Similarity=0.384  Sum_probs=206.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEc------CCE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLT------PTH   72 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~------~~~   72 (351)
                      +++|++.+.||+|+||.||++.+..+++.||+|++.....  ....+.+|+.+++.++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            3689999999999999999999999999999999875432  23567889999999999999999998765      677


Q ss_pred             EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEeccCCCc
Q 018734           73 LAIVMEYAAGGELFERICNAG---RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA-PRLKICDFGYSK  148 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~-~~vkL~DFg~a~  148 (351)
                      .++|||||.|++|.+++....   .+++..++.++.||+.||.|||++||+||||||+||+++.++. ..+||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            899999999999999998754   5899999999999999999999999999999999999986543 238999999998


Q ss_pred             ccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHH-----HHH-----Hh
Q 018734          149 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI-----SRI-----MA  218 (351)
Q Consensus       149 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-----~~~-----~~  218 (351)
                      ............||+.|+|||++.+..++. ++|||||||++|+|++|..||........+....     ...     ..
T Consensus       173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~-ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~  251 (676)
T 3qa8_A          173 ELDQGELCTEFVGTLQYLAPELLEQKKYTV-TVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT  251 (676)
T ss_dssp             BTTSCCCCCCCCSCCTTCSSCSSCCSCCST-THHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred             ccccccccccccCCcccCChHHhccCCCCc-hhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence            765555556678999999999998877755 4999999999999999999997643221110000     000     00


Q ss_pred             hccC----CCC----ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          219 VQYK----IPD----YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       219 ~~~~----~~~----~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                      ....    .+.    ...+++.+.+||.+||++||.+|||+.++++||||..
T Consensus       252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            0000    111    1225678999999999999999999999999999954

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-46  Score=337.70  Aligned_cols=248  Identities=28%  Similarity=0.444  Sum_probs=196.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-CCc--EEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-TKE--LVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++.+.||+|+||.||++.+.. +++  .||+|++....    .....+.+|+.+++.++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            589999999999999999998643 333  68999886542    22356789999999999999999999998765 88


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           75 IVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      +||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+||+++.++  .+||+|||++......
T Consensus        97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVKIGDFGLMRALPQN  174 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEECCC-
T ss_pred             eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEEEcccccccccccc
Confidence            999999999999998764 5699999999999999999999999999999999999998665  4999999998754332


Q ss_pred             CC----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          154 SR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       154 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                      ..    .....+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.......    ....+.......+....
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~  249 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRPED  249 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCCCCCCTT
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHH----HHHHHHccCCCCCCCcC
Confidence            21    2234578899999999877664 55999999999999999 999998765432    33334444444555567


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ++..+.++|.+||+.+|.+|||+.+++++
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            89999999999999999999999999873

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.1e-46  Score=336.62  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=198.2

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      |...+.||+|+||.||++.+  +++.||+|++.....     ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44558999999999999987  477999999865321     23568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           79 YAAGGELFERICN---AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        79 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |+.+++|.+++..   ...+++..+..++.||+.||.|||++||+||||||+||+++.++  .+||+|||++........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSCSS
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeecccccccccccc
Confidence            9999999999864   35699999999999999999999999999999999999997665  499999999875432221


Q ss_pred             ---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc--------CC-
Q 018734          156 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--------KI-  223 (351)
Q Consensus       156 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~-  223 (351)
                         .....||+.|+|||++.+. + +.++|||||||++|+|++|+.||...........+...+.....        .. 
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN  266 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred             cccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence               2345799999999998653 4 45599999999999999999999876544333333222221111        01 


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.....+..+.+++.+||+.+|.+|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1112345678999999999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1e-45  Score=340.41  Aligned_cols=249  Identities=24%  Similarity=0.300  Sum_probs=198.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhc--CCCCCcceEEEEEEcCC----EEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQ--LRHPNIIRFKEVVLTPT----HLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~--l~hp~Iv~~~~~~~~~~----~~~l   75 (351)
                      ++|++.+.||+|+||.||++.+  +++.||+|++....  ...+.+|..+++.  ++||||+++++++....    .+++
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            4799999999999999999998  48899999986543  3456778888776  79999999999998876    8999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH--------SMQICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH--------~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      ||||+.+++|.+++.+ ..+++..++.++.|++.||.|||        ++||+||||||+|||++.++  ++||+|||++
T Consensus       118 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~~  194 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLA  194 (342)
T ss_dssp             EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS--CEEECCCTTC
T ss_pred             EEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC--CEEEEECCCc
Confidence            9999999999999976 46899999999999999999999        89999999999999998766  4999999998


Q ss_pred             cccCCCC-----CCCCcccCCCccCcccccCCcCCC-----cchhHHHHHHHHHHHHcC----------CCCCCCCCChh
Q 018734          148 KSSLLHS-----RPKSTVGTPAYIAPEVLSRREYDG-----KLADVWSCGVTLYVMLVG----------AYPFEDQEDPK  207 (351)
Q Consensus       148 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~ell~g----------~~pf~~~~~~~  207 (351)
                      .......     ......||+.|+|||++.+.....     .++|||||||++|+|++|          ..||.......
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            7543332     234557999999999997653321     459999999999999999          78887654322


Q ss_pred             H-HHHHHHHHHhhccCCCCc-----cCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          208 N-FRKTISRIMAVQYKIPDY-----VHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       208 ~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      . .......+..........     ...+..+.+||.+||+.||.+|||+.++++|
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            1 222222222222221111     1233578999999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.5e-45  Score=351.22  Aligned_cols=249  Identities=22%  Similarity=0.244  Sum_probs=201.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC-CCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h-p~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++++.||+|+||.||++.+..+++.||||++..... ...+.+|+.+++.++| ++|..+..++......++||||+
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence            689999999999999999999999999999998776443 3458899999999987 56667777778888999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec---CCCCCCEEEeccCCCcccCCCCC-
Q 018734           81 AGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLD---GSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~---~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                       +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+   .++  .+||+|||+++....... 
T Consensus        86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTC
T ss_pred             -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCccc
Confidence             8999999975 56799999999999999999999999999999999999993   444  599999999975433221 


Q ss_pred             -------CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC---CC
Q 018734          156 -------PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI---PD  225 (351)
Q Consensus       156 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~  225 (351)
                             ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||........... +..+.......   ..
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~-~~~i~~~~~~~~~~~l  240 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK-YEKISEKKVATSIEAL  240 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH-HHHHHHHHHHSCHHHH
T ss_pred             cccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHH-HHHHhhccccccHHHH
Confidence                   2256799999999999887764 559999999999999999999987654322211 11111111111   11


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...++.++.+||.+||+.+|.+||++.+|++
T Consensus       241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             hcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            1357899999999999999999999998754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.7e-46  Score=361.62  Aligned_cols=245  Identities=22%  Similarity=0.358  Sum_probs=205.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||++.+.. +..||||++.........+.+|+.+++.++|||||++++++.. ..+|+||||+.
T Consensus       267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~  344 (535)
T 2h8h_A          267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS  344 (535)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence            579999999999999999999976 4679999998765555679999999999999999999999865 67899999999


Q ss_pred             CCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC--CCCC
Q 018734           82 GGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH--SRPK  157 (351)
Q Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~--~~~~  157 (351)
                      +|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.....  ....
T Consensus       345 ~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~~~~~  422 (535)
T 2h8h_A          345 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL--VCKVADFGLARLIEDNEYTARQ  422 (535)
T ss_dssp             TEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCTTSTTTCCCHHHHTTC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC--cEEEcccccceecCCCceeccc
Confidence            9999999974  35699999999999999999999999999999999999997665  4999999999754321  1123


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...++..|+|||++.+..++ .++|||||||++|+|++ |+.||......+.+    ..+ ...+..+....++..+.+|
T Consensus       423 ~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~----~~i-~~~~~~~~~~~~~~~l~~l  496 (535)
T 2h8h_A          423 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVL----DQV-ERGYRMPCPPECPESLHDL  496 (535)
T ss_dssp             STTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH----HHH-HTTCCCCCCTTCCHHHHHH
T ss_pred             CCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCCCCCCCCCCCHHHHHH
Confidence            34578899999999877764 55999999999999999 99999876543322    222 2334455556789999999


Q ss_pred             HHHhcccCCCCCCChHHHhc
Q 018734          237 LSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~  256 (351)
                      |.+||+.||.+|||+.+|++
T Consensus       497 i~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          497 MCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999976

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-46  Score=346.67  Aligned_cols=247  Identities=22%  Similarity=0.302  Sum_probs=192.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCC---CcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEE-cCCEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVL-TPTHLAIV   76 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~-~~~~~~lv   76 (351)
                      +|++.+.||+|+||.||++.+..+   +..||+|.+.....  ....+.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            478899999999999999987543   24689998865332  2356889999999999999999999865 45688999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      |||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...... 
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC-----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--CEEEeecccccccccccc
Confidence            9999999999999765 4589999999999999999999999999999999999997665  49999999997543221 


Q ss_pred             ----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCC
Q 018734          155 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHI  229 (351)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (351)
                          ......+|+.|+|||++.+..++ .++|||||||++|+|++ |.+||...........    +.. ....+.+..+
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~----~~~-~~~~~~p~~~  321 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQ-GRRLLQPEYC  321 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH----HHT-TCCCCCCTTC
T ss_pred             ccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH----HHc-CCCCCCCCCC
Confidence                12334578899999999877765 55999999999999999 7788876654433222    121 2223334468


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +..+.++|.+||+.+|.+|||+.+++++
T Consensus       322 ~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          322 PDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999864

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.1e-45  Score=364.22  Aligned_cols=240  Identities=22%  Similarity=0.328  Sum_probs=196.6

Q ss_pred             eeecccCceEEEEEEE--cCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRN--KNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||++.+  ..+++.||||++.....   ....+.+|+.++++++|||||++++++.. ..+++|||||.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4899999999999954  56678999999876433   23578899999999999999999999965 458899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC----CCCC
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS----RPKS  158 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~----~~~~  158 (351)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.++  .+||+|||+++......    ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC--CEEEEEcCCccccccCccccccccC
Confidence            99999999888999999999999999999999999999999999999998766  49999999987543222    1223


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..+|+.|+|||++.+..++ .++|||||||++|+|++ |+.||.........    ..+ ......+.+..+++.+.+||
T Consensus       532 ~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~----~~i-~~~~~~~~p~~~~~~l~~li  605 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----AML-EKGERMGCPAGCPREMYDLM  605 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHH-HTTCCCCCCTTCCHHHHHHH
T ss_pred             CCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHH-HcCCCCCCCCCCCHHHHHHH
Confidence            4578899999999877765 55999999999999998 99999876543322    222 22233444457899999999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 018734          238 SRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~  256 (351)
                      .+||+.||.+|||+.++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999975

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=360.04  Aligned_cols=245  Identities=25%  Similarity=0.375  Sum_probs=197.8

Q ss_pred             CeeEee-eecccCceEEEEEEEc--CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            3 KYELMK-DIGSGNFGVARLMRNK--NTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         3 ~y~~~~-~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++.+.+ .||+|+||.||++.+.  .++..||||++.....  ....+.+|+.+++.++|||||++++++.. ..+++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            345555 8999999999999775  3566799999976432  34678899999999999999999999976 5689999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           78 EYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        78 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      |||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....... 
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~~~~~  492 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKALGADDSY  492 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC-----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccccCCCce
Confidence            999999999998754 4699999999999999999999999999999999999998766  499999999985432221 


Q ss_pred             ---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          156 ---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       156 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                         .....+|+.|+|||++.+..++ .++|||||||++|||++ |+.||......+...    .+. .....+.+..+++
T Consensus       493 ~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----~i~-~~~~~~~p~~~~~  566 (613)
T 2ozo_A          493 YTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIE-QGKRMECPPECPP  566 (613)
T ss_dssp             ---------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH----HHH-TTCCCCCCTTCCH
T ss_pred             eeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCcCCH
Confidence               1223467899999999877765 55999999999999998 999998876544322    222 2233444557899


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhc
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .+.+||.+||+.+|.+||++.++++
T Consensus       567 ~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          567 ELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=336.81  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=199.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      .++|++.+.||+|+||.||++.+..   .||+|++.....   ....+.+|+.++++++||||+++++++.....+++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~  108 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT  108 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence            3689999999999999999999865   499999875322   2245678999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC----
Q 018734           78 EYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL----  152 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~----  152 (351)
                      ||+.|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.   +.+||+|||++.....    
T Consensus       109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~---~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN---GKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC--------
T ss_pred             ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC---CCEEEeecCCcccccccccc
Confidence            9999999999997755 6999999999999999999999999999999999999973   3599999999764321    


Q ss_pred             --CCCCCCcccCCCccCcccccCC--------cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC
Q 018734          153 --HSRPKSTVGTPAYIAPEVLSRR--------EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK  222 (351)
Q Consensus       153 --~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  222 (351)
                        ........||+.|+|||++.+.        ...+.++|||||||++|+|++|+.||........    ...+......
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~  261 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI----IWQMGTGMKP  261 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH----HHHHHTTCCC
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHhccCCCC
Confidence              1222334699999999998652        2235669999999999999999999987554322    2222222222


Q ss_pred             CCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          223 IPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       223 ~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ......++..+.++|.+||+.+|.+|||+.++++.
T Consensus       262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            22233578899999999999999999999999873

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.1e-47  Score=353.37  Aligned_cols=243  Identities=20%  Similarity=0.238  Sum_probs=190.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---------CHHHHHHHHHHhcCC---------CCCcceE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------DANVAREIINHKQLR---------HPNIIRF   63 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~~~~l~---------hp~Iv~~   63 (351)
                      ++|++.+.||+|+||.||+|++  +++.||||++......         ...+.+|+.+++.++         |||||++
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            5799999999999999999998  5799999999765321         156788988888775         8888888


Q ss_pred             EEEEE------------------------------cCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 018734           64 KEVVL------------------------------TPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY  113 (351)
Q Consensus        64 ~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~  113 (351)
                      .+++.                              ....+|+|||||.+|++.+.+.+ +.+++..++.++.||+.||.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            77653                              26789999999999987777644 578999999999999999999


Q ss_pred             HH-HcCCeecCCCCCcEEecCCCC------------------CCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCC
Q 018734          114 CH-SMQICHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR  174 (351)
Q Consensus       114 lH-~~~iiH~Dikp~NIll~~~~~------------------~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  174 (351)
                      || ++||+||||||+|||++.++.                  .++||+|||+|+....    ...+||+.|+|||++.+.
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~  252 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGD  252 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCC
T ss_pred             HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCC
Confidence            99 999999999999999987651                  1599999999985432    245899999999999866


Q ss_pred             cCCCcchhHHHHHHH-HHHHHcCCCCCCCCCChhHHHHHHHHHHh-hccCC----CCccCCCHhHHHHHHHhcccCCCCC
Q 018734          175 EYDGKLADVWSCGVT-LYVMLVGAYPFEDQEDPKNFRKTISRIMA-VQYKI----PDYVHISQDCRNLLSRIFVANPSRR  248 (351)
Q Consensus       175 ~~~~~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~li~~~L~~~P~~R  248 (351)
                      .  +.++||||||++ .+++++|..||.....   .......+.. .....    +.+..+++++.+||.+||++|    
T Consensus       253 ~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          253 G--DYQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             S--SHHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             C--ccceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            5  566999998777 7788899999843110   0111122221 11111    112347889999999999976    


Q ss_pred             CChHHHh-cCcccc
Q 018734          249 ITIKEIK-SHPWFL  261 (351)
Q Consensus       249 ps~~eil-~hp~~~  261 (351)
                       |+.++| +||||+
T Consensus       324 -sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 -SATDLLCQHSLFK  336 (336)
T ss_dssp             -SHHHHHHHCGGGC
T ss_pred             -CHHHHHhcCCCcC
Confidence             999999 999994

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-45  Score=348.52  Aligned_cols=244  Identities=15%  Similarity=0.113  Sum_probs=189.4

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHHHHHHHHhcCCC-CCc---------ce------
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVAREIINHKQLRH-PNI---------IR------   62 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~h-p~I---------v~------   62 (351)
                      .|++.+.||+|+||.||+|.+..+++.||||++.....    ....+.+|+.+++.++| +|+         +.      
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            48889999999999999999999999999999874322    24678899999999987 321         11      


Q ss_pred             ------EEEEEEc-----CCEEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 018734           63 ------FKEVVLT-----PTHLAIVMEYAAGGELFERICN-------AGRFSEDEARYFFQQLISGVSYCHSMQICHRDL  124 (351)
Q Consensus        63 ------~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Di  124 (351)
                            +...+..     ...++++|+++ +++|.+++..       ...+++..+..++.||+.||.|||++||+||||
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi  237 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL  237 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence                  1111111     12467888877 6799888841       234778889999999999999999999999999


Q ss_pred             CCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccc----------cCCcCCCcchhHHHHHHHHHHHH
Q 018734          125 KLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL----------SRREYDGKLADVWSCGVTLYVML  194 (351)
Q Consensus       125 kp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~DiwslG~il~ell  194 (351)
                      ||+|||++.++.  +||+|||+++.....  ....+| +.|+|||++          .+..+ +.++|||||||++|+|+
T Consensus       238 Kp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          238 RPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHHHH
Confidence            999999987765  999999998754322  445578 999999999          33334 45699999999999999


Q ss_pred             cCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          195 VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       195 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +|+.||.........          ...++....+++.+.+||.+||+.||.+||++.++++||||...
T Consensus       312 tg~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          312 CADLPNTDDAALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HSSCCCCTTGGGSCS----------GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HCCCCCCCcchhhhH----------HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            999999775432211          11123334688999999999999999999999999999999643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-44  Score=358.73  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=200.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC---CcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT---KELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||++.+..+   +..||+|.+.....  ....+.+|+.+++.++||||+++++++. ++..|+|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence            5799999999999999999998653   46799998865432  2356889999999999999999999984 4668999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      |||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.......
T Consensus       469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCCSCCC---
T ss_pred             EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCeecCCCcc
Confidence            99999999999998654 689999999999999999999999999999999999998765  499999999985433322


Q ss_pred             C--CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          156 P--KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       156 ~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      .  ....+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.........    ..+.. ....+.+..+++.
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~----~~i~~-~~~~~~~~~~~~~  620 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----GRIEN-GERLPMPPNCPPT  620 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHH-TCCCCCCTTCCHH
T ss_pred             eeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHc-CCCCCCCccccHH
Confidence            1  234577899999999877664 55999999999999997 99999876543322    22222 2233444578999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.+||.+||+.||.+|||+.++++
T Consensus       621 l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          621 LYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-44  Score=362.84  Aligned_cols=237  Identities=24%  Similarity=0.295  Sum_probs=195.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCE-----E
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTH-----L   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~-----~   73 (351)
                      ++|++.+.||+|+||.||++.+.. +++.||||++.....  ....+.+|+.++++++|||||++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999976 789999999865432  23457789999999999999999999987654     7


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+||||+.|++|.+.+..  .+++..+..++.||+.||.|||++||+||||||+|||++.+   .+||+|||+++.....
T Consensus       160 ~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC
T ss_pred             EEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC
Confidence            999999999999887755  79999999999999999999999999999999999999864   4999999998754322


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                         ...+||+.|+|||++.+..  +.++|||||||++|+|++|.+||........           . ........++.+
T Consensus       235 ---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------~-~~~~~~~~~~~l  297 (681)
T 2pzi_A          235 ---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------P-EDDPVLKTYDSY  297 (681)
T ss_dssp             ---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------C-TTCHHHHHCHHH
T ss_pred             ---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc-----------c-ccccccccCHHH
Confidence               4567999999999986654  5669999999999999999998865321100           0 000111246789


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+||.+||+.||.+||+..+.+.|+|+
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            999999999999999999999999886

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.9e-44  Score=319.72  Aligned_cols=222  Identities=15%  Similarity=0.123  Sum_probs=181.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++.+.||+|+||.||++.+..+++.||+|++.......    ..+.+|+..++.++||||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            58999999999999999999999999999999998765443    56889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      ||+.|++|.+++.+.  ....++..++.||+.||.|||++||+||||||+|||++.++.  +||+++|            
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~------------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA------------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC------------
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc------------
Confidence            999999999998553  366678999999999999999999999999999999987664  8988554            


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--CCccCCCHhHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYVHISQDCRN  235 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  235 (351)
                             |++|        .+.++|||||||++|+|++|+.||........+...... .......  .....+++.+.+
T Consensus       175 -------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~  238 (286)
T 3uqc_A          175 -------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPFQISA  238 (286)
T ss_dssp             -------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-TTSCBCCHHHHCTTSCHHHHH
T ss_pred             -------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-hccCCCChhhcccCCCHHHHH
Confidence                   3332        356699999999999999999999876542211000000 0000000  012358899999


Q ss_pred             HHHHhcccCCCCCCChHHHhc
Q 018734          236 LLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~  256 (351)
                      ||.+||+.||.+| |+.++++
T Consensus       239 li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          239 VAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             HHHHHHCTTSSCC-CHHHHHH
T ss_pred             HHHHHcccCCccC-CHHHHHH
Confidence            9999999999999 9999986

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3.4e-37  Score=301.39  Aligned_cols=226  Identities=13%  Similarity=0.045  Sum_probs=152.6

Q ss_pred             eecccCceEEEEEEEcCCCcEEEEEEeccCcc-----------cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEE
Q 018734            9 DIGSGNFGVARLMRNKNTKELVAMKYIERGHK-----------IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         9 ~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      .++.|+.|.+..++..-+|+.||+|++.+...           ...++.+|+.+|+++ .|+||+++++++.+++.+|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45677788777777777899999999976421           124588999999999 699999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~  155 (351)
                      |||++|++|.++|.+.+++++.   .++.||+.||.|+|++|||||||||+|||++.++  ++||+|||+|+..... ..
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg--~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ--HARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS--CEEECCCTTEESCC---CC
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC--CEEEeecccCeeCCCCCcc
Confidence            9999999999999999999875   4789999999999999999999999999998766  5999999999854433 23


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ..+.+||+.|||||++.+..  ...+|+||+|+++++|.++..+|.         ..   ..    ..+.   ....+..
T Consensus       396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~~---------~~---l~----~~~~---~~~~~~~  454 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNWL---------YA---VW----QEPV---ERWNFVL  454 (569)
T ss_dssp             SHHHHHHHHHHHHHHC-------------------CCCCTTHHHHH---------HH---HH----TSCG---GGCSHHH
T ss_pred             ccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchhH---------HH---hh----cCCC---CCCcHHH
Confidence            34568999999999997653  344899999999888766533321         00   00    1111   0112455


Q ss_pred             HHHHhcccCCCCCCChHHHhcCccc
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      +...++..+|..|+.......++|.
T Consensus       455 l~~~l~~~~~~~~~~~~~~~~~~~~  479 (569)
T 4azs_A          455 LLALFEKKAKLPSAEQQRGATEQWI  479 (569)
T ss_dssp             HHHHHHTGGGSCCGGGSSCCHHHHH
T ss_pred             HHHHHhCCCCCCCCChhhhccchhH
Confidence            6666666777777766655555553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=4.4e-31  Score=256.78  Aligned_cols=181  Identities=20%  Similarity=0.136  Sum_probs=139.1

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---------CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ..+.||+|+||.||++..  .++.+++|+.......         ...+.+|+.++++++||||+++..++......|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            456899999999999943  4678899876442211         23468999999999999999555555566677999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC-
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR-  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~-  155 (351)
                      |||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++.    ++||+|||+++....... 
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence            999999999999866        6789999999999999999999999999999986    499999999986533211 


Q ss_pred             -------CCCcccCCCccCcccccC--CcCCCcchhHHHHHHHHHHHHcCCCCCC
Q 018734          156 -------PKSTVGTPAYIAPEVLSR--REYDGKLADVWSCGVTLYVMLVGAYPFE  201 (351)
Q Consensus       156 -------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~  201 (351)
                             ....+||+.|||||++..  ..|. ..+|+||..+-..+.+.++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhccccC
Confidence                   124579999999999976  4554 34899999998888887777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=3.5e-27  Score=211.10  Aligned_cols=142  Identities=19%  Similarity=0.175  Sum_probs=114.3

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------------------cCHHHHHHHHHHhcCCCCCcceEE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------------------IDANVAREIINHKQLRHPNIIRFK   64 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~e~~~~~~l~hp~Iv~~~   64 (351)
                      |.+++.||+|+||.||++.+ .+++.||+|++.....                   ....+.+|+.+++.++|   +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence            55669999999999999999 7899999999864321                   12357899999999984   5555


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           65 EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        65 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                      +++.. +..|+||||++|++|.+ +.      ......++.|++.||.|||++||+||||||+|||++ ++  ++||+||
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DF  236 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDF  236 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEEC
Confidence            54433 45689999999999987 42      134567999999999999999999999999999998 44  5999999


Q ss_pred             CCCcccCCCCCCCCcccCCCccCccccc
Q 018734          145 GYSKSSLLHSRPKSTVGTPAYIAPEVLS  172 (351)
Q Consensus       145 g~a~~~~~~~~~~~~~gt~~y~aPE~~~  172 (351)
                      |+|+            .+..++|||.+.
T Consensus       237 G~a~------------~~~~~~a~e~l~  252 (282)
T 1zar_A          237 PQSV------------EVGEEGWREILE  252 (282)
T ss_dssp             TTCE------------ETTSTTHHHHHH
T ss_pred             CCCe------------ECCCCCHHHHHH
Confidence            9886            456689999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=2.7e-23  Score=183.55  Aligned_cols=135  Identities=14%  Similarity=0.116  Sum_probs=106.0

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcE--EEEEEeccCccc-------------------------CHHHHHHHHHHhcCC
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGHKI-------------------------DANVAREIINHKQLR   56 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~-------------------------~~~~~~e~~~~~~l~   56 (351)
                      |++.+.||+|+||.||+|.+..+|+.  ||||++......                         ...+.+|+.+++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            77899999999999999999777888  999987543111                         125778999999998


Q ss_pred             CCCc--ceEEEEEEcCCEEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCc
Q 018734           57 HPNI--IRFKEVVLTPTHLAIVMEYAAG-G----ELFERICNAGRFSEDEARYFFQQLISGVSYCH-SMQICHRDLKLEN  128 (351)
Q Consensus        57 hp~I--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH-~~~iiH~Dikp~N  128 (351)
                      |++|  ..++..    ...++||||+.+ |    +|.+....   .++..+..++.|++.||.||| ++||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8754  344443    245799999942 3    56555432   235578899999999999999 9999999999999


Q ss_pred             EEecCCCCCCEEEeccCCCcc
Q 018734          129 TLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus       129 Ill~~~~~~~vkL~DFg~a~~  149 (351)
                      ||++.    .++|+|||+|..
T Consensus       202 ILl~~----~~~liDFG~a~~  218 (258)
T 1zth_A          202 IMYID----KVYFIDMGQAVT  218 (258)
T ss_dssp             EEESS----SEEECCCTTCEE
T ss_pred             EEEcC----cEEEEECccccc
Confidence            99976    499999999863

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=4.7e-20  Score=169.82  Aligned_cols=134  Identities=16%  Similarity=0.122  Sum_probs=98.6

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---------------CH--------HHHHHHHHHhcCCCCCc
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---------------DA--------NVAREIINHKQLRHPNI   60 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------~~--------~~~~e~~~~~~l~hp~I   60 (351)
                      |++++.||.|+||.||+|.+. +|+.||||+++.....               ..        ...+|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            899999999999999999986 5889999987532110               00        12356677777755443


Q ss_pred             c--eEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC-
Q 018734           61 I--RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAP-  137 (351)
Q Consensus        61 v--~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~-  137 (351)
                      .  ..+++  ..  .++||||+.|++|..+.      .......++.||+.+|.+||++|||||||||.|||++.++.+ 
T Consensus       176 ~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            2  23332  22  26999999998885432      223456788999999999999999999999999999766532 


Q ss_pred             -------CEEEeccCCCc
Q 018734          138 -------RLKICDFGYSK  148 (351)
Q Consensus       138 -------~vkL~DFg~a~  148 (351)
                             .+.|+||+-+.
T Consensus       246 d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             CTTSEEEEEEECCCTTCE
T ss_pred             cccccccceEEEEeCCcc
Confidence                   37899999654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.52  E-value=7.1e-14  Score=123.09  Aligned_cols=138  Identities=18%  Similarity=0.130  Sum_probs=109.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ..|++...++.|+.+.||++...  +..+++|+..... .....+.+|+.+++.+. +..+.++++++...+..|+|||+
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            56888999999999999999854  5789999886532 22346888999998884 67788999999888999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-------------------------------------------  116 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-------------------------------------------  116 (351)
                      ++|.+|...+.     +......++.+++.+|..||+                                           
T Consensus        92 i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           92 ADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             cCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            99998876521     223345788899999999998                                           


Q ss_pred             ----------------cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 ----------------MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 ----------------~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                                      ..++|+|++|.|||++.+.  .+.|+||+.+.
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~  212 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence                            4589999999999997532  25699999664

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.38  E-value=2.2e-12  Score=113.05  Aligned_cols=133  Identities=12%  Similarity=0.112  Sum_probs=96.2

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC--cceEEEEEEcCCEEEEEEecc
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~--Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .|.+....+.|..+.||++.. .+|..+++|+....  ....+.+|+.+++.+.+.+  +.+++.+....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            456544444566689999965 34677999987654  2245778998888885544  556888888888899999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ------------------------------------------  118 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~------------------------------------------  118 (351)
                      +|.+|.  ..   ..+   ...++.+++..|..||+..                                          
T Consensus        98 ~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A           98 PGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             SSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             CCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence            998873  21   112   2356677777777777643                                          


Q ss_pred             ----------------CeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          119 ----------------ICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       119 ----------------iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                                      ++|+|++|.||+++++.  .+.|+||+.+.
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~liD~~~a~  213 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence                            99999999999997543  25699999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.30  E-value=7.8e-12  Score=115.17  Aligned_cols=139  Identities=14%  Similarity=0.234  Sum_probs=104.8

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEec--cCc--ccCHHHHHHHHHHhcCC--CCCcceEEEEEEcC---CEEEEE
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIE--RGH--KIDANVAREIINHKQLR--HPNIIRFKEVVLTP---THLAIV   76 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~e~~~~~~l~--hp~Iv~~~~~~~~~---~~~~lv   76 (351)
                      -++.|+.|.++.||++....  ..+++|+..  ...  .....+.+|+.+++.|.  +..+.+++.++.+.   +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            46789999999999998753  578888776  322  12346778999998886  45578888888766   458899


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS----------------------------------------  116 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~----------------------------------------  116 (351)
                      |||++|..+.+.  ....++......++.+++.+|..||+                                        
T Consensus       120 me~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          120 MEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             EECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            999999777431  12346788889999999999999997                                        


Q ss_pred             ------------------cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 ------------------MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 ------------------~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                                        ..++|+|++|.|||++.++...+.|+||+.+.
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                              35899999999999986543335899999876

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=2.7e-11  Score=108.92  Aligned_cols=183  Identities=17%  Similarity=0.129  Sum_probs=118.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-CCC--cceEEEEEEcCC---EEEEEEecc
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPN--IIRFKEVVLTPT---HLAIVMEYA   80 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-hp~--Iv~~~~~~~~~~---~~~lv~e~~   80 (351)
                      ++.++.|.+..||++.     ..+++|+.... .....+.+|..+++.+. +..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999874     35888875432 23356788999988773 332  344554443332   348899999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS--------------------------------------------  116 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--------------------------------------------  116 (351)
                      +|.+|.....  ..++..+...++.|++..|..||+                                            
T Consensus        99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            9988865433  346778888888899988888886                                            


Q ss_pred             --------------cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC---CCc---c---------cCCCccC
Q 018734          117 --------------MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP---KST---V---------GTPAYIA  167 (351)
Q Consensus       117 --------------~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~---~~~---~---------gt~~y~a  167 (351)
                                    ..++|+|++|.||+++.+....+.|+||+.+.........   ...   .         .......
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~  256 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD  256 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence                          1369999999999998642224789999987632111000   000   0         0001111


Q ss_pred             -cccccCCcCCCcchhHHHHHHHHHHHHcCCCCC
Q 018734          168 -PEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF  200 (351)
Q Consensus       168 -PE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  200 (351)
                       |+......   ...+.|++|.++|.+.+|..+|
T Consensus       257 ~~~~~~r~~---~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          257 IPTVLEKYR---MKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHH---HHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cHHHHHHHH---HHHHHHHHHHHHHHHHcCCHHH
Confidence             22221111   1158999999999999997776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.73  E-value=1.3e-07  Score=84.96  Aligned_cols=134  Identities=18%  Similarity=0.153  Sum_probs=90.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCC---CcceEEEEEE-cCCEEEEEEeccCC
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHP---NIIRFKEVVL-TPTHLAIVMEYAAG   82 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp---~Iv~~~~~~~-~~~~~~lv~e~~~~   82 (351)
                      ++.++.|....||.+     +..+++|+... ......+.+|..+++.+.+.   .+.+.+.+.. ..+..|+||++++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888888899988     45688887432 22335678999999988652   2456666664 45667899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSM---------------------------------------------  117 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---------------------------------------------  117 (351)
                      .++.....  ..++......++.++...|..||+.                                             
T Consensus        98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            88765321  1234555555555555555555532                                             


Q ss_pred             ---------------CCeecCCCCCcEEecCC-CCCCE-EEeccCCCc
Q 018734          118 ---------------QICHRDLKLENTLLDGS-PAPRL-KICDFGYSK  148 (351)
Q Consensus       118 ---------------~iiH~Dikp~NIll~~~-~~~~v-kL~DFg~a~  148 (351)
                                     .++|+|++|.||+++.+ ..+++ .|+||+.+.
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~  223 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA  223 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence                           35999999999999761 11234 799999775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.70  E-value=1.2e-07  Score=83.34  Aligned_cols=132  Identities=17%  Similarity=0.194  Sum_probs=93.4

Q ss_pred             eecccCce-EEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEEeccCCCChH
Q 018734            9 DIGSGNFG-VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELF   86 (351)
Q Consensus         9 ~lG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~   86 (351)
                      .+..|..| .||++.....+..+.+|+-....  ...+.+|...++.|. +--+.+++.++.+.+..|+||++++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~--~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV--ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETHH--HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCCC--HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            44556665 68999888778889999755432  245778888887774 223667888888889999999999998876


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------------
Q 018734           87 ERICNAGRFSEDEARYFFQQLISGVSYCHS--------------------------------------------------  116 (351)
Q Consensus        87 ~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--------------------------------------------------  116 (351)
                      +.....    ......+..++...|..||+                                                  
T Consensus       109 ~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          109 QVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             ccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            655331    12233455566666666663                                                  


Q ss_pred             --------cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 --------MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 --------~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                              ..++|+|++|.|||++.++  .+-|+||+.+.
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~--~~~viDwe~a~  222 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIFDEGK--LIGCIDVGRVG  222 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             hcccccCCcEEEcCCCCCCeEEEECCe--EEEEEECcccc
Confidence                    0268999999999997543  35699999765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.52  E-value=3.4e-07  Score=85.22  Aligned_cols=75  Identities=15%  Similarity=0.066  Sum_probs=48.7

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCc--------ccCHHHHHHHHHHhcCCC--CCc-ceEEEEEEcCCEEEE
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--------KIDANVAREIINHKQLRH--PNI-IRFKEVVLTPTHLAI   75 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~~~~l~h--p~I-v~~~~~~~~~~~~~l   75 (351)
                      .+.||.|.++.||++....+++.+++|......        ........|..+++.+..  |.. .+++.+  +....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            578999999999999876667789999754321        122456778888877632  333 355543  3444679


Q ss_pred             EEeccCCC
Q 018734           76 VMEYAAGG   83 (351)
Q Consensus        76 v~e~~~~~   83 (351)
                      |||++.|.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.27  E-value=7.6e-07  Score=81.46  Aligned_cols=80  Identities=8%  Similarity=0.060  Sum_probs=54.1

Q ss_pred             Eeeee-cccCceEEEEEEEcC------CCcEEEEEEeccCc---c-cCHHHHHHHHHHhcCC-C--CCcceEEEEEEcC-
Q 018734            6 LMKDI-GSGNFGVARLMRNKN------TKELVAMKYIERGH---K-IDANVAREIINHKQLR-H--PNIIRFKEVVLTP-   70 (351)
Q Consensus         6 ~~~~l-G~G~~g~V~~~~~~~------~~~~vaiK~~~~~~---~-~~~~~~~e~~~~~~l~-h--p~Iv~~~~~~~~~-   70 (351)
                      ..+.| +.|....+|++....      .+..+++|+.....   . ....+.+|..+++.|. +  -.+.+++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            34677 888889999887541      15678889765432   1 1245778888887774 2  3466777776554 


Q ss_pred             --CEEEEEEeccCCCCh
Q 018734           71 --THLAIVMEYAAGGEL   85 (351)
Q Consensus        71 --~~~~lv~e~~~~~~L   85 (351)
                        +..|+|||+++|.++
T Consensus       104 ~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             TTSSCEEEEECCCCBCC
T ss_pred             ccCCceEEEEecCCCCh
Confidence              356899999998654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.25  E-value=5.2e-06  Score=75.16  Aligned_cols=74  Identities=18%  Similarity=0.253  Sum_probs=42.3

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcC-----CCCCcceEE-E--EEEcCCEEEEEEe
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQL-----RHPNIIRFK-E--VVLTPTHLAIVME   78 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l-----~hp~Iv~~~-~--~~~~~~~~~lv~e   78 (351)
                      ++.|+.|..+.||++....  ..+++|+.....   ..+..|..+++.|     ..|.++... +  +....+..+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~~--~~~vlk~~~~~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDS--GAVCLKRIHRPE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETT--EEEEEEEECSCH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCC--CCEEEEecCCCH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            3567667788999998643  358899887532   2333445544443     335555410 0  1234678899999


Q ss_pred             ccCCCCh
Q 018734           79 YAAGGEL   85 (351)
Q Consensus        79 ~~~~~~L   85 (351)
                      |++|.++
T Consensus       112 ~i~G~~~  118 (346)
T 2q83_A          112 WIEGRPF  118 (346)
T ss_dssp             CCCCBCC
T ss_pred             eecCccC
Confidence            9998643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.07  E-value=9e-06  Score=72.52  Aligned_cols=74  Identities=14%  Similarity=0.126  Sum_probs=45.1

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCc-ceEEEEEEcCCEEEEEEecc-C
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEYA-A   81 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~I-v~~~~~~~~~~~~~lv~e~~-~   81 (351)
                      +.-++.|+.|....+|++      ..+++|+............+|..+++.+...++ .+++...  ...-+++++|+ +
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            444678988999999999      358888776532222234567777766642222 3555443  33346899999 6


Q ss_pred             CCCh
Q 018734           82 GGEL   85 (351)
Q Consensus        82 ~~~L   85 (351)
                      |.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.00  E-value=2.4e-05  Score=73.16  Aligned_cols=73  Identities=15%  Similarity=0.190  Sum_probs=43.3

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEecc-------C-cc--cCHHHHHHHHHHh-cCCCCCcceEEEEEEcCCEEE
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIER-------G-HK--IDANVAREIINHK-QLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~-~~--~~~~~~~e~~~~~-~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      -.+.||.|..+.||++..  +++.+++|....       . ..  ....+..|+..+. ......+.+++.+.  ....+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            357899999999999964  356799994221       1 00  1112233332222 11234556666665  45678


Q ss_pred             EEEecc-CC
Q 018734           75 IVMEYA-AG   82 (351)
Q Consensus        75 lv~e~~-~~   82 (351)
                      +|||++ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.89  E-value=0.00013  Score=65.39  Aligned_cols=76  Identities=16%  Similarity=0.086  Sum_probs=58.3

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC---CCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR---HPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~---hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      -.+.|+.|.+..+|++...  +..+++|+.....  ...+..|...++.|.   ...+.+++.+....+..|+|||+++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~~--~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE--VQTVFVKINERSY--RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS--SCEEEEEEEEGGG--HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEEC--CCeEEEEeCCccc--HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            3567899999999999863  5678889765432  345778888887773   35677888888888899999999998


Q ss_pred             CCh
Q 018734           83 GEL   85 (351)
Q Consensus        83 ~~L   85 (351)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.76  E-value=0.00038  Score=58.19  Aligned_cols=135  Identities=14%  Similarity=0.048  Sum_probs=86.4

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCcc
Q 018734           83 GELFERICN-AGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTV  160 (351)
Q Consensus        83 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~~  160 (351)
                      .+|.+.|+. +.+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.  |-+.+ +.+           ..
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s-----------~~   98 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AAD-----------DA   98 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-ccc-----------cc
Confidence            478888875 5689999999999999999887632 22234455678999977775  55442 111           01


Q ss_pred             cCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHh
Q 018734          161 GTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRI  240 (351)
Q Consensus       161 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  240 (351)
                      ....+.|||...  ...+.+.=|||||+++|.-+--..|=                       .....+|+.+..||..|
T Consensus        99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------------~eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------------NEERELSPPLEQLIDHM  153 (229)
T ss_dssp             --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------TEEECCCHHHHHHHHHH
T ss_pred             cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------ccchhhCHHHHHHHHHH
Confidence            233566888763  22334478999999999877422221                       12235899999999999


Q ss_pred             ccc-------------------------CCCCCCChHHHhc
Q 018734          241 FVA-------------------------NPSRRITIKEIKS  256 (351)
Q Consensus       241 L~~-------------------------~P~~Rps~~eil~  256 (351)
                      ..-                         .+..|+++++|++
T Consensus       154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             TTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             HhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            765                         3467888888875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.66  E-value=0.00012  Score=67.20  Aligned_cols=74  Identities=15%  Similarity=0.040  Sum_probs=44.4

Q ss_pred             eeeecccCceEEEEEEEcC--------CCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC-cceEEEEEEcCCEEEEEE
Q 018734            7 MKDIGSGNFGVARLMRNKN--------TKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~-Iv~~~~~~~~~~~~~lv~   77 (351)
                      .+.|+.|....+|++....        .+..+++|+.............|..+++.|...+ +.+++..+  .+  ++||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            4678888888999998653        1257888986553322223457777777764333 34666544  23  5899


Q ss_pred             eccCCCC
Q 018734           78 EYAAGGE   84 (351)
Q Consensus        78 e~~~~~~   84 (351)
                      +|++|.+
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998854

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.60  E-value=9.9e-05  Score=66.18  Aligned_cols=137  Identities=17%  Similarity=0.165  Sum_probs=75.1

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-----CCCcceEE-E--EEEcCCEEEEEEe
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----HPNIIRFK-E--VVLTPTHLAIVME   78 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-----hp~Iv~~~-~--~~~~~~~~~lv~e   78 (351)
                      .+.|+.|....+|++.... + .+++|+..... ....+..|+.+++.|.     -|.++... +  +....+..+++|+
T Consensus        27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESS-C-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCC-c-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            4667788888999998653 3 58889876531 2234556776666553     34444211 0  1123467889999


Q ss_pred             ccCCCChH-----------H---HHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHH----
Q 018734           79 YAAGGELF-----------E---RICNA-GRF--------SEDEARYF---------------FQQLISGVSYCHS----  116 (351)
Q Consensus        79 ~~~~~~L~-----------~---~l~~~-~~l--------~~~~~~~~---------------~~qi~~aL~~lH~----  116 (351)
                      +++|..+.           .   .+... ..+        ........               ...+...+..++.    
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            99985431           0   11110 011        10100000               0113444555553    


Q ss_pred             ---cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 ---MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 ---~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                         .+++|+|+++.|||++.+.  .+.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence               4689999999999997643  24799999664

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.58  E-value=0.00015  Score=66.67  Aligned_cols=138  Identities=14%  Similarity=0.132  Sum_probs=80.7

Q ss_pred             eeeecccCceEEEEEEEcC-------CCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC-cceEEEEEEcCCEEEEEEe
Q 018734            7 MKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~-Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++.|..|-...+|++....       .++.+++|+............+|..+++.|.--+ ..++++.+.+    .+||+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            3567778788899998753       3468999986432223345668988888774222 3456666543    28999


Q ss_pred             ccCCCChHH--------------HH---Hhc----C-CC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 018734           79 YAAGGELFE--------------RI---CNA----G-RF--SEDEARYFFQQLIS-------------------GVSYCH  115 (351)
Q Consensus        79 ~~~~~~L~~--------------~l---~~~----~-~l--~~~~~~~~~~qi~~-------------------aL~~lH  115 (351)
                      |++|.+|..              .|   ...    + ..  -..++..++.++-.                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999855421              11   111    1 11  24566666655422                   233333


Q ss_pred             H--------cCCeecCCCCCcEEecCC--CCCCEEEeccCCCc
Q 018734          116 S--------MQICHRDLKLENTLLDGS--PAPRLKICDFGYSK  148 (351)
Q Consensus       116 ~--------~~iiH~Dikp~NIll~~~--~~~~vkL~DFg~a~  148 (351)
                      +        ..++|+|+.+.||+++.+  ..+.+.|+||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            2        258999999999999765  12359999999765

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.56  E-value=0.00029  Score=63.26  Aligned_cols=75  Identities=8%  Similarity=0.036  Sum_probs=46.4

Q ss_pred             eeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC--cceEEEE-----EEcCCEEEEEEecc
Q 018734            8 KDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN--IIRFKEV-----VLTPTHLAIVMEYA   80 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~--Iv~~~~~-----~~~~~~~~lv~e~~   80 (351)
                      ..|+ |....||++... .|+.+++|+..........+..|..+++.|....  +++++..     ....+..+++|+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 777889988654 3557899987643223345667777776663211  2333322     22356778999999


Q ss_pred             CCCC
Q 018734           81 AGGE   84 (351)
Q Consensus        81 ~~~~   84 (351)
                      +|.+
T Consensus       110 ~G~~  113 (328)
T 1zyl_A          110 GGRQ  113 (328)
T ss_dssp             CCEE
T ss_pred             CCCC
Confidence            8844

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.55  E-value=0.00017  Score=67.58  Aligned_cols=73  Identities=12%  Similarity=0.144  Sum_probs=49.4

Q ss_pred             eeeecccCceEEEEEEEcC-------CCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCc-ceEEEEEEcCCEEEEEEe
Q 018734            7 MKDIGSGNFGVARLMRNKN-------TKELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~I-v~~~~~~~~~~~~~lv~e   78 (351)
                      ++.|+.|....+|++....       .+..+++|+.... .....+.+|..+++.|...++ .++++.+.  +  .+|++
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e  152 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  152 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence            4678888889999998753       2568899987432 111456688888887753333 56666553  2  28999


Q ss_pred             ccCCCC
Q 018734           79 YAAGGE   84 (351)
Q Consensus        79 ~~~~~~   84 (351)
                      |++|.+
T Consensus       153 ~l~G~~  158 (429)
T 1nw1_A          153 YIPSRP  158 (429)
T ss_dssp             CCCEEE
T ss_pred             EeCCcc
Confidence            998744

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.38  E-value=0.0013  Score=59.13  Aligned_cols=137  Identities=14%  Similarity=0.109  Sum_probs=68.9

Q ss_pred             eeeecccCceE-EEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC--CCcceEEEEEEcCCEEEEEEeccCCC
Q 018734            7 MKDIGSGNFGV-ARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PNIIRFKEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus         7 ~~~lG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h--p~Iv~~~~~~~~~~~~~lv~e~~~~~   83 (351)
                      .+.|+.|+... +|++... ++..+++|.......  ..+..|+.+++.+..  -.+.+++.+....+  +++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECT-TCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcC-CCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            45676665554 6677542 245677776443321  234456666665532  22445665543334  6899999776


Q ss_pred             ChHHHHHhc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHHH--
Q 018734           84 ELFERICNA--------------------------GRFSEDEAR-------Y-FF------------QQLISGVSYCH--  115 (351)
Q Consensus        84 ~L~~~l~~~--------------------------~~l~~~~~~-------~-~~------------~qi~~aL~~lH--  115 (351)
                      ++...+...                          +.+......       . +.            ..+...+..+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            665433211                          112222111       0 00            01112223331  


Q ss_pred             ----HcCCeecCCCCCcEEecCCC--CCCEEEeccCCCc
Q 018734          116 ----SMQICHRDLKLENTLLDGSP--APRLKICDFGYSK  148 (351)
Q Consensus       116 ----~~~iiH~Dikp~NIll~~~~--~~~vkL~DFg~a~  148 (351)
                          ...++|||+.+.||+++.+.  .+.+.|+||+.+.
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence                24699999999999997531  1358999999775

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.38  E-value=0.0012  Score=58.06  Aligned_cols=77  Identities=9%  Similarity=0.024  Sum_probs=52.5

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCC---CCcceEEEEEEcCCEEEEEEec
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRH---PNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~h---p~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ..-++.+|.|..+.||++.... |+.|.+|+...... ....+..|...|+.|.-   --+.+++...  .  -++|||+
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceEEEEe
Confidence            3456789999999999998764 77899998654332 22346788888887742   1244555442  2  3689999


Q ss_pred             cCCCCh
Q 018734           80 AAGGEL   85 (351)
Q Consensus        80 ~~~~~L   85 (351)
                      +.++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.35  E-value=0.0018  Score=61.10  Aligned_cols=75  Identities=15%  Similarity=0.085  Sum_probs=49.1

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCc-ceEEEEEEcCCEEEEEEeccCCCCh
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~I-v~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      ++.|+.|-...+|++.....+..+++|+............+|..+++.|...++ .++++++.  +.  +||+|++|.+|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCccC
Confidence            467888888999999886545788899875432222223578888888865444 46776662  32  59999988443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.11  E-value=0.0049  Score=55.66  Aligned_cols=30  Identities=23%  Similarity=0.472  Sum_probs=24.9

Q ss_pred             cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 ~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      ..++|+|+.+.||+++.++  .+.|+||+.+.
T Consensus       206 ~~~~HgD~~~~N~l~~~~~--~~~~iD~e~~~  235 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEE--SIYIIDWDEPM  235 (339)
T ss_dssp             CEEECSCCCGGGEEECGGG--CEEECCCSSCE
T ss_pred             ceeEeCCCCcCCEEEeCCC--eEEEEECCCCe
Confidence            3589999999999997544  38999998765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.19  E-value=0.039  Score=51.31  Aligned_cols=75  Identities=16%  Similarity=0.088  Sum_probs=48.1

Q ss_pred             eeeecccCceEEEEEEEcCC-------CcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC-cceEEEEEEcCCEEEEEEe
Q 018734            7 MKDIGSGNFGVARLMRNKNT-------KELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~-Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++.|..|-...+|++.....       ++.+++++............+|..+++.|.-.+ ..++++.+  .+  ++||+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            46677788889999987631       567899986543322223457888887774322 34555533  23  68999


Q ss_pred             ccCCCCh
Q 018734           79 YAAGGEL   85 (351)
Q Consensus        79 ~~~~~~L   85 (351)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.23  E-value=0.13  Score=47.32  Aligned_cols=30  Identities=40%  Similarity=0.616  Sum_probs=23.8

Q ss_pred             CeecCCCCCcEEecC----CCCCCEEEeccCCCc
Q 018734          119 ICHRDLKLENTLLDG----SPAPRLKICDFGYSK  148 (351)
Q Consensus       119 iiH~Dikp~NIll~~----~~~~~vkL~DFg~a~  148 (351)
                      ++|+|+.+.|||+..    +....+.++||-+|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            689999999999943    223459999999875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.67  E-value=3.2  Score=34.47  Aligned_cols=113  Identities=14%  Similarity=0.154  Sum_probs=75.6

Q ss_pred             CCCCcceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHcCCeecCCCCCcEEecCC
Q 018734           56 RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS-YCHSMQICHRDLKLENTLLDGS  134 (351)
Q Consensus        56 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~-~lH~~~iiH~Dikp~NIll~~~  134 (351)
                      .||++  -..+-.+++.+.+.++.-.++.-+..++   .++....++++.+|+.... ++  ..-+|--|+|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            67888  4555577788777777664444444553   4588888888888887665 44  445888999999999877


Q ss_pred             CCCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHH-HHHHHHHHHHcCCCCC
Q 018734          135 PAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVW-SCGVTLYVMLVGAYPF  200 (351)
Q Consensus       135 ~~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw-slG~il~ell~g~~pf  200 (351)
                      +.  +++.-.|+-.                -++|.-+      +. .|.| ++=|++..++.++..|
T Consensus       121 ~~--p~i~hRGi~~----------------~lpP~e~------~e-e~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          121 LE--PFFLHVGVKE----------------SLPPDEW------DD-ERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             CC--EEESCCEETT----------------TBSSCSC------CH-HHHHHHHHHHHHHHTTCSSCH
T ss_pred             Cc--EEEEEcCCcc----------------cCCCCCC------CH-HHHHHHHHHHHHHHHcCCCCH
Confidence            75  8888777532                2233321      12 2333 4567778888877776

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.29  E-value=1.8  Score=35.83  Aligned_cols=115  Identities=11%  Similarity=0.106  Sum_probs=76.4

Q ss_pred             CCCCcceEEEEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           56 RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        56 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      .||+.+.. .+-.+.+.+.+.++.-..+--+..+.   .++....++++.+|+....++  ..-+|--|+|+||+++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence            68998877 56667777766666544322233333   458888999999998877444  3448889999999998776


Q ss_pred             CCCEEEeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhH-HHHHHHHHHHHcCCCCCC
Q 018734          136 APRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADV-WSCGVTLYVMLVGAYPFE  201 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~  201 (351)
                      .  +++.-.|+-..                ++|..+      +. .|. -.+=|++..+++++..|.
T Consensus       117 ~--p~i~~RGik~~----------------l~P~~~------~e-e~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          117 L--PIAKTRGLQNV----------------VDPLPV------SE-AEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             C--EEESCCEETTT----------------BSCCCC------CH-HHHHHHHHHHHHHHHCTTCCHH
T ss_pred             C--EEEEEccCccC----------------CCCCCC------CH-HHHHHHHHHHHHHHHcCCCCHH
Confidence            5  88887775321                222211      12 233 346788888999888873

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	351
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-83
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-82
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-82
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-80
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-79
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-76
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	6e-75
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-75
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-74
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-74
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-73
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-73
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-73
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-72
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-70
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-69
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-68
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-67
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-67
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-65
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-63
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-62
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-60
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-60
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-60
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-59
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-59
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-59
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-58
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-58
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-58
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-57
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-56
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	7e-55
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-55
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-53
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-53
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-51
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-51
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-51
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-51
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-51
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-50
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-48
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-47
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-46
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-43
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-42
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-41
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-15

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  251 bits (643), Expect = 2e-83
 Identities = 97/270 (35%), Positives = 146/270 (54%), Gaps = 10/270 (3%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA--NVAREIINHKQLRHPN 59
           E ++L++ +G G +G  +L  N+ T+E VA+K ++    +D   N+ +EI  +K L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +++F           + +EY +GGELF+RI       E +A+ FF QL++GV Y H + I
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLSRREY 176
            HRD+K EN LLD      LKI DFG +     ++R +      GT  Y+APE+L RRE+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
             +  DVWSCG+ L  ML G  P+   + P +  +  S     +  +  +  I      L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239

Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
           L +I V NPS RITI +IK   W+ K L +
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPLKK 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  250 bits (639), Expect = 1e-82
 Identities = 92/267 (34%), Positives = 143/267 (53%), Gaps = 14/267 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLR 56
           +E +E+ + +G G FG   L R K +K ++A+K + +     A V     RE+     LR
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HPNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCHS
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
            ++ HRD+K EN LL  +    LKI DFG+S      SR  +  GT  Y+ PE++  R +
Sbjct: 125 KRVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           D K  D+WS GV  Y  LVG  PFE       +++T  RI  V++  PD   +++  R+L
Sbjct: 182 DEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPD--FVTEGARDL 234

Query: 237 LSRIFVANPSRRITIKEIKSHPWFLKN 263
           +SR+   NPS+R  ++E+  HPW   N
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWITAN 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (638), Expect = 8e-82
 Identities = 79/315 (25%), Positives = 140/315 (44%), Gaps = 12/315 (3%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           EKY + +D+G G FG+       ++K+    K+++        V +EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI-CNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
              E   +   L ++ E+ +G ++FERI  +A   +E E   +  Q+   + + HS  I 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
           H D++ EN +     +  +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183

Query: 181 ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLLS 238
            D+WS G  +YV+L G  PF      +  ++ I  IM  +Y   +  +  IS +  + + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 239 RIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSVEEITKIVEE 298
           R+ V     R+T  E   HPW  + + R  T+  + + +R+   T      +++  +V  
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIK---KDLNMVVSA 296

Query: 299 AKV-PPPVSRSIGGF 312
           A++      RS  G 
Sbjct: 297 ARISCGGAIRSQKGV 311

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  246 bits (628), Expect = 5e-80
 Identities = 75/291 (25%), Positives = 135/291 (46%), Gaps = 12/291 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           + Y++++++GSG FGV      K T  +   K+I   + +D   V  EI    QL HP +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQI 119
           I   +       + +++E+ +GGELF+RI     + SE E   + +Q   G+ + H   I
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGK 179
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R      
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLL 237
             D+W+ GV  YV+L G  PF  ++D     +T+  +    ++  +  +  +S + ++ +
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263

Query: 238 SRIFVANPSRRITIKEIKSHPWF---LKNLPRELTETAQAIYYRKENPTFS 285
             +    P +R+T+ +   HPW      NL   +  +      +K    ++
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYA 314

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  244 bits (624), Expect = 2e-79
 Identities = 82/310 (26%), Positives = 147/310 (47%), Gaps = 12/310 (3%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPN 59
           ++ Y++ +++G+G FGV   +  + T    A K++   H+ D   V +EI     LRHP 
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 84

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQ 118
           ++   +       + ++ E+ +GGELFE++ +   + SEDEA  + +Q+  G+ + H   
Sbjct: 85  LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV   +    
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNL 236
              D+WS GV  Y++L G  PF      +N  +T+  + +  + + D  +  IS+D ++ 
Sbjct: 205 Y-TDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 259

Query: 237 LSRIFVANPSRRITIKEIKSHPWFLK-NLPRELTETAQAIY--YRKENPTFSLQSVEEIT 293
           + ++ +A+P+ R+TI +   HPW    N P   ++   + Y   R    T      E + 
Sbjct: 260 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLP 319

Query: 294 KIVEEAKVPP 303
            +   +    
Sbjct: 320 PLGRISNYSS 329

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  234 bits (597), Expect = 7e-76
 Identities = 84/269 (31%), Positives = 139/269 (51%), Gaps = 6/269 (2%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQLRHPN 59
           + Y+    +G+G F    L  +K T++LVA+K I +      + ++  EI    +++HPN
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           I+   ++  +  HL ++M+  +GGELF+RI   G ++E +A     Q++  V Y H + I
Sbjct: 69  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128

Query: 120 CHRDLKLENTLLDGSPAP-RLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK EN L        ++ I DFG SK     S   +  GTP Y+APEVL+++ Y  
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 238
              D WS GV  Y++L G  PF D+ D K F + +      ++  P +  IS   ++ + 
Sbjct: 189 A-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE--YEFDSPYWDDISDSAKDFIR 245

Query: 239 RIFVANPSRRITIKEIKSHPWFLKNLPRE 267
            +   +P +R T ++   HPW   +   +
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDTALD 274

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 6e-75
 Identities = 76/272 (27%), Positives = 127/272 (46%), Gaps = 22/272 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH----KQLRH 57
           E ++  K +G G+F    L R   T    A+K +E+ H I  N    +        +L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P  ++          L   + YA  GEL + I   G F E   R++  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRR 174
            I HRDLK EN LL+      ++I DFG +K     S   R  S VGT  Y++PE+L+ +
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
                 +D+W+ G  +Y ++ G  PF       N      +I+ ++Y  P+        R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDFPE--KFFPKAR 238

Query: 235 NLLSRIFVANPSRRITIKE------IKSHPWF 260
           +L+ ++ V + ++R+  +E      +K+HP+F
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 6e-75
 Identities = 68/266 (25%), Positives = 124/266 (46%), Gaps = 9/266 (3%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-VAREIINHKQLRHPNI 60
           +KY   + IG G  G      +  T + VA++ +    +     +  EI+  ++ ++PNI
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           + + +  L    L +VMEY AGG L + +       E +     ++ +  + + HS Q+ 
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREYDGK 179
           HRD+K +N LL       +K+ DFG+          +ST VGTP ++APEV++R+ Y  K
Sbjct: 139 HRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 180 LADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
             D+WS G+    M+ G  P+ ++   +              ++ +   +S   R+ L+R
Sbjct: 197 -VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTPELQNPEKLSAIFRDFLNR 252

Query: 240 IFVANPSRRITIKEIKSHPWFLKNLP 265
               +  +R + KE+  H +     P
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKP 278

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  229 bits (585), Expect = 5e-74
 Identities = 73/273 (26%), Positives = 119/273 (43%), Gaps = 17/273 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRH 57
           + +  +++IG G+FG     R+    E+VA+K +    K       ++ +E+   ++LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           PN I+++   L      +VMEY  G        +     E E        + G++Y HS 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL---SRR 174
            + HRD+K  N LL       +K+ DFG +    + +   S VGTP ++APEV+      
Sbjct: 135 NMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDEG 189

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
           +YDGK  DVWS G+T   +     P  +     N    +  I   +       H S+  R
Sbjct: 190 QYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYFR 244

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
           N +       P  R T + +  H + L+  P  
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPT 277

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  228 bits (581), Expect = 8e-74
 Identities = 85/275 (30%), Positives = 133/275 (48%), Gaps = 20/275 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI----------ERGHKIDANVAREIIN 51
           E YE  + +G G   V R   +K T +  A+K I          E   ++     +E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 52  HKQLR-HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISG 110
            +++  HPNII+ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 111 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEV 170
           +   H + I HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 171 LSRREYD-----GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD 225
           +     D     GK  D+WS GV +Y +L G+ PF  ++     R  +S     Q+  P+
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 238

Query: 226 YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
           +   S   ++L+SR  V  P +R T +E  +HP+F
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (581), Expect = 1e-73
 Identities = 70/276 (25%), Positives = 121/276 (43%), Gaps = 12/276 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID-ANVAREIINHKQLRHPNI 60
           + +E++ ++G G FG     +NK T  L A K I+   + +  +   EI       HPNI
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 71

Query: 61  IRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-FSEDEARYFFQQLISGVSYCHSMQI 119
           ++  +      +L I++E+ AGG +   +    R  +E + +   +Q +  ++Y H  +I
Sbjct: 72  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
            HRDLK  N L        +K+ DFG S   +    R  S +GTP ++APEV+       
Sbjct: 132 IHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 179 KL----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
           +     ADVWS G+TL  M     P  +    +   K      +    +      S + +
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNFK 246

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTE 270
           + L +    N   R T  ++  HP+   +  + + E
Sbjct: 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRE 282

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 1e-73
 Identities = 73/303 (24%), Positives = 128/303 (42%), Gaps = 45/303 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
           + +E + ++G+GN GV   + +K +  ++A K I  E    I   + RE+    +   P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65

Query: 60  IIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ- 118
           I+ F     +   ++I ME+  GG L + +  AGR  E         +I G++Y      
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           I HRD+K  N L++      +K+CDFG S   L+ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 179 KLADVWSCGVTLYVMLVGAYPFE------------------------------------- 201
           + +D+WS G++L  M VG YP                                       
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 202 -DQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
            D   P    + +  I+            S + ++ +++  + NP+ R  +K++  H + 
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 261 LKN 263
            ++
Sbjct: 302 KRS 304

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (580), Expect = 6e-73
 Identities = 93/312 (29%), Positives = 155/312 (49%), Gaps = 17/312 (5%)

Query: 1   MEKYELMKD-IGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREI-INHKQLRHP 58
           ++ Y++    +G G  G    + NK T+E  A+K ++   K      RE+ ++ +  + P
Sbjct: 10  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR----REVELHWRASQCP 65

Query: 59  NIIRFKEVVLTP----THLAIVMEYAAGGELFERICNAG--RFSEDEARYFFQQLISGVS 112
           +I+R  +V          L IVME   GGELF RI + G   F+E EA    + +   + 
Sbjct: 66  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 113 YCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
           Y HS+ I HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL 185

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHI 229
              +YD    D+WS GV +Y++L G  PF             +RI   QY+ P+  +  +
Sbjct: 186 GPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244

Query: 230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFSLQSV 289
           S++ + L+  +    P++R+TI E  +HPW +++     T    +   +++   +     
Sbjct: 245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWE-DVK 303

Query: 290 EEITKIVEEAKV 301
           EE+T  +   +V
Sbjct: 304 EEMTSALATMRV 315

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 3e-72
 Identities = 90/270 (33%), Positives = 150/270 (55%), Gaps = 16/270 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-------VAREIINHKQ 54
           + Y+  +++GSG F V +  R K+T    A K+I++     +        + RE+   K+
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           ++HPN+I   EV    T + +++E  AGGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129

Query: 115 HSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           HS+QI H DLK EN +L     P PR+KI DFG +      +  K+  GTP ++APE+++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 189

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHIS 230
                   AD+WS GV  Y++L GA PF         ++T++ + AV Y+  D  + + S
Sbjct: 190 YEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFEDEYFSNTS 244

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
              ++ + R+ V +P +R+TI++   HPW 
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 6e-70
 Identities = 77/273 (28%), Positives = 135/273 (49%), Gaps = 23/273 (8%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
           E YE++  IG+G++G  + +R K+  +++  K ++ G   +A       E+   ++L+HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 59  NIIRFKEVVL--TPTHLAIVMEYAAGGELFERICNAGR----FSEDEARYFFQQLISGVS 112
           NI+R+ + ++  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 113 YCH-----SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYI 166
            CH        + HRDLK  N  LDG     +K+ DFG ++  +   S  K+ VGTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 167 APEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY 226
           +PE ++R  Y+ K +D+WS G  LY +     PF       + ++   +I   +++   Y
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFRRIPY 236

Query: 227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPW 259
              S +   +++R+       R +++EI  +P 
Sbjct: 237 -RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (552), Expect = 5e-69
 Identities = 82/267 (30%), Positives = 134/267 (50%), Gaps = 16/267 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-----KIDANVAREIINHKQL 55
           +E + L K +G G+FG   L   K T +  A+K +++        ++  +  + +     
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
            HP +        T  +L  VMEY  GG+L   I +  +F    A ++  ++I G+ + H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRR 174
           S  I +RDLKL+N LLD      +KI DFG  K ++L     +T  GTP YIAPE+L  +
Sbjct: 121 SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
           +Y+    D WS GV LY ML+G  PF      ++  +    I       P    + ++ +
Sbjct: 179 KYNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFYPR--WLEKEAK 231

Query: 235 NLLSRIFVANPSRRITIK-EIKSHPWF 260
           +LL ++FV  P +R+ ++ +I+ HP F
Sbjct: 232 DLLVKLFVREPEKRLGVRGDIRQHPLF 258

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 6e-68
 Identities = 83/279 (29%), Positives = 129/279 (46%), Gaps = 25/279 (8%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN-------VAREIINHKQL 55
           +Y++   +GSG FG        +    VA+K++E+    D         V  E++  K++
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 56  R--HPNIIRFKEVVLTPTHLAIVMEYAAGG-ELFERICNAGRFSEDEARYFFQQLISGVS 112
                 +IR  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           +CH+  + HRD+K EN L+D +    LK+ DFG     L  +      GT  Y  PE + 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIR 182

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
              Y G+ A VWS G+ LY M+ G  PFE  E+          I+  Q        +S +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSSE 230

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKN-LPRELTE 270
           C++L+       PS R T +EI++HPW     LP+E  E
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-67
 Identities = 60/266 (22%), Positives = 111/266 (41%), Gaps = 16/266 (6%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHPNI 60
            +   +IG G+F       +  T   VA   ++      +       E    K L+HPNI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 61  IRFKEVVLTPT----HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           +RF +   +       + +V E    G L   +           R + +Q++ G+ + H+
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 117 M--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
               I HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++APE+    
Sbjct: 131 RTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMY-EE 187

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
           +YD    DV++ G+ +  M    YP+ + ++     +   R+ +             + +
Sbjct: 188 KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVK 243

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWF 260
            ++      N   R +IK++ +H +F
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  211 bits (538), Expect = 7e-67
 Identities = 83/269 (30%), Positives = 143/269 (53%), Gaps = 20/269 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           ++ +++++ +G+G+FG   L+R+++     AMK +++   +          E +    + 
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HP IIR          + ++M+Y  GGELF  +  + RF    A+++  ++   + Y HS
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
             I +RDLK EN LLD +    +KI DFG++K   +     +  GTP YIAPEV+S + Y
Sbjct: 123 KDIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPY 178

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           +    D WS G+ +Y ML G  PF D     N  KT  +I+  + + P     ++D ++L
Sbjct: 179 NKS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRFPP--FFNEDVKDL 231

Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWF 260
           LSR+   + S+R+       +++K+HPWF
Sbjct: 232 LSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  209 bits (534), Expect = 1e-65
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 18/272 (6%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINH-------K 53
           M  + + + IG G FG     R  +T ++ AMK +++            +N         
Sbjct: 3   MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62

Query: 54  QLRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
               P I+       TP  L+ +++   GG+L   +   G FSE + R++  ++I G+ +
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            H+  + +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +
Sbjct: 123 MHNRFVVYRDLKPANILLD--EHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQK 179

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
                  AD +S G  L+ +L G  PF  Q   K+  +     + +  ++PD    S + 
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPD--SFSPEL 236

Query: 234 RNLLSRIFVANPSRRIT-----IKEIKSHPWF 260
           R+LL  +   + +RR+       +E+K  P+F
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 5e-63
 Identities = 85/270 (31%), Positives = 134/270 (49%), Gaps = 19/270 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLR 56
           M  ++ +K +G G FG   L+R K T    AMK + +   I     A+   E    +  R
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           HP +   K    T   L  VMEYA GGELF  +     F+E+ AR++  +++S + Y HS
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKSTVGTPAYIAPEVLSRRE 175
             + +RD+KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL   +
Sbjct: 124 RDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN 235
           Y     D W  GV +Y M+ G  PF +    ++  +    I+  + + P    +S + ++
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRFPR--TLSPEAKS 234

Query: 236 LLSRIFVANPSRRI-----TIKEIKSHPWF 260
           LL+ +   +P +R+       KE+  H +F
Sbjct: 235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-62
 Identities = 75/290 (25%), Positives = 118/290 (40%), Gaps = 32/290 (11%)

Query: 5   ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN------VAREIINHKQLRHP 58
           E +  +G G F      R+KNT ++VA+K I+ GH+ +A         REI   ++L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ 118
           NII   +     +++++V ++           N+   +    + +    + G+ Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 119 ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           I HRDLK  N LLD +    LK+ DFG +KS    +      V T  Y APE+L      
Sbjct: 121 ILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-------MAVQYKIPDYV--- 227
           G   D+W+ G  L  +L+         D     +    +             +PDYV   
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 228 ------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
                           D  +L+  +F+ NP  RIT  +     +F  N P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRP 287

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-60
 Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 16/275 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
            +  + + IGSG+FG     +       VA+K +         +     E+   ++ RH 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 59  NIIRFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSM 117
           NI+ F     T   LAIV ++  G  L+  +     +F   +     +Q   G+ Y H+ 
Sbjct: 65  NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVGTPAYIAPEVLSRR 174
            I HRDLK  N  L       +KI DFG +          + +   G+  ++APEV+  +
Sbjct: 124 SIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181

Query: 175 EYD--GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD 232
           + +     +DV++ G+ LY ++ G  P+ +  +       + R            +  + 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241

Query: 233 CRNLLSRIFVANPSRRITIKEIKSHPWFL-KNLPR 266
            + L++         R    +I +    L ++LP+
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-60
 Identities = 79/337 (23%), Positives = 133/337 (39%), Gaps = 42/337 (12%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRF 63
           Y   K IG+G+FGV    +  ++ ELVA+K + +  +      RE+   ++L H NI+R 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRL 78

Query: 64  KEVVLTP------THLAIVMEYAAGG---ELFERICNAGRFSEDEARYFFQQLISGVSYC 114
           +    +        +L +V++Y                        + +  QL   ++Y 
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRR 174
           HS  ICHRD+K +N LLD   A   K+CDFG +K  +      S + +  Y APE++   
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM-------------AVQY 221
                  DVWS G  L  +L+G   F          + I  +                ++
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257

Query: 222 KIPDY----------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
           K P                 +   L SR+    P+ R+T  E  +H +F      EL + 
Sbjct: 258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF-----DELRDP 312

Query: 272 AQAIYYRKENPTFSLQSVEEITKIVEEA-KVPPPVSR 307
              +   ++ P     + +E++     A  + PP +R
Sbjct: 313 NVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  193 bits (491), Expect = 2e-60
 Identities = 60/265 (22%), Positives = 102/265 (38%), Gaps = 14/265 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA----REIINHKQLRH 57
           ++YEL + +G G      L R+      VA+K +      D +      RE  N   L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 58  PNIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           P I+   +     T       IVMEY  G  L + +   G  +   A          +++
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFG--YSKSSLLHSRPKSTVGTPAYIAPEVL 171
            H   I HRD+K  N ++  + A ++         + S    ++  + +GT  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ 231
                D + +DV+S G  LY +L G  PF          + +           +   +S 
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE--GLSA 243

Query: 232 DCRNLLSRIFVANPSRRI-TIKEIK 255
           D   ++ +    NP  R  T  E++
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMR 268

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (492), Expect = 1e-59
 Identities = 75/269 (27%), Positives = 139/269 (51%), Gaps = 20/269 (7%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDAN----VAREIINHKQLR 56
           +++++ +K +G+G+FG   L+++K +    AMK +++   +          E    + + 
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
            P +++ +      ++L +VMEY AGGE+F  +   GRFSE  AR++  Q++    Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREY 176
           + + +RDLK EN L+D      +++ DFG++K      R  +  GTP  +APE++  + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGY 215

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL 236
           +    D W+ GV +Y M  G  PF          +   +I++ + + P   H S D ++L
Sbjct: 216 NKA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRFPS--HFSSDLKDL 268

Query: 237 LSRIFVANPSRRI-----TIKEIKSHPWF 260
           L  +   + ++R       + +IK+H WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 2e-59
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 30/293 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRH 57
           M+KYE ++ IG G +G     +N+ T E+VA+K +        + ++  REI   K+L+H
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
            NI+R  +V+ +   L +V E+             G    +  + F  QL+ G+ +CHS 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS-TVGTPAYIAPEVLSRREY 176
            + HRDLK +N L++ +    LK+ +FG +++  +  R  S  V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIM--------AVQYKIPDYV- 227
                D+WS G     +     P     D  +  K I R++            K+PDY  
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 228 ---------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP 265
                           ++   R+LL  +   NP +RI+ +E   HP+F    P
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-59
 Identities = 78/296 (26%), Positives = 137/296 (46%), Gaps = 31/296 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           ME ++ ++ IG G +GV    RNK T E+VA+K I        + +   REI   K+L H
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAA-GGELFERICNAGRFSEDEARYFFQQLISGVSYCHS 116
           PNI++  +V+ T   L +V E+     + F              + +  QL+ G+++CHS
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRRE 175
            ++ HRDLK +N L++      +K+ DFG +++  +  R  +  V T  Y APE+L   +
Sbjct: 121 HRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178

Query: 176 YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTI-------SRIMAVQYKIPDYV- 227
           Y     D+WS G     M+     F    +     +           +      +PDY  
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 228 ---------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
                           + +D R+LLS++   +P++RI+ K   +HP+F +++ + +
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPV 293

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-58
 Identities = 65/315 (20%), Positives = 121/315 (38%), Gaps = 53/315 (16%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRH 57
           + KYE +  IG G FG     R++ T + VA+K +   ++ +       REI   + L+H
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 58  PNIIRFKEVVLTPT--------HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLIS 109
            N++   E+  T           + +V ++              +F+  E +   Q L++
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 110 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPA 164
           G+ Y H  +I HRD+K  N L+       LK+ DFG ++      +   +R  + V T  
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 165 YIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP 224
           Y  PE+L      G   D+W  G  +  M   +   +        +  ++ I  +   I 
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG----NTEQHQLALISQLCGSIT 242

Query: 225 DYVH------------------------------ISQDCRNLLSRIFVANPSRRITIKEI 254
             V                                     +L+ ++ V +P++RI   + 
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

Query: 255 KSHPWFLKN-LPREL 268
            +H +F  + +P +L
Sbjct: 303 LNHDFFWSDPMPSDL 317

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  189 bits (481), Expect = 2e-58
 Identities = 61/295 (20%), Positives = 118/295 (40%), Gaps = 41/295 (13%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPN 59
            + Y+L++ +G G +       N    E V +K ++   K    + REI   + LR  PN
Sbjct: 34  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 91

Query: 60  IIRFKEVVLTPTH--LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           II   ++V  P     A+V E+    +  +        ++ + R++  +++  + YCHSM
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            I HRD+K  N ++D     +L++ D+G ++           V +  +  PE+L   +  
Sbjct: 149 GIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------------- 221
               D+WS G  L  M+    PF    D  +    I++++  +                 
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

Query: 222 ----------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                              +   +S +  + L ++   +   R+T +E   HP+F
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-58
 Identities = 61/260 (23%), Positives = 105/260 (40%), Gaps = 15/260 (5%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNI 60
           M++ +L++ IG G FG   L   +  K  VA+K I+      A    E     QLRH N+
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-FLAEASVMTQLRHSNL 62

Query: 61  IRFKEVVL-TPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSM 117
           ++   V++     L IV EY A G L + + + GR     D    F   +   + Y    
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
              HRDL   N L+        K+ DFG +K     S   +      + APE L  +++ 
Sbjct: 123 NFVHRDLAARNVLVSED--NVAKVSDFGLTK--EASSTQDTGKLPVKWTAPEALREKKFS 178

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            K +DVWS G+ L+ +         +   K+    + +    +   PD          ++
Sbjct: 179 TK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK--GYKMDAPD--GCPPAVYEVM 233

Query: 238 SRIFVANPSRRITIKEIKSH 257
              +  + + R +  +++  
Sbjct: 234 KNCWHLDAAMRPSFLQLREQ 253

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  187 bits (475), Expect = 6e-58
 Identities = 76/287 (26%), Positives = 124/287 (43%), Gaps = 30/287 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI---ERGHKIDANVAREIINHKQLRH 57
           MEKY  ++ IG G +GV    +N    E  A+K I   +    I +   REI   K+L+H
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
            NI++  +V+ T   L +V E+             G      A+ F  QL++G++YCH  
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST-VGTPAYIAPEVLSRREY 176
           ++ HRDLK +N L++      LKI DFG +++  +  R  +  + T  Y AP+VL   + 
Sbjct: 120 RVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 177 DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV--------- 227
                D+WS G     M+ G   F    +     +    +     K    V         
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 228 --------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF 260
                          + +   +LLS++   +P++RIT K+   H +F
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-57
 Identities = 81/347 (23%), Positives = 135/347 (38%), Gaps = 49/347 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYI--ERGHKIDANVAREIINHKQLRHPN 59
            +Y  +  IG G +G+     +   K  VA+K I             REI    + RH N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 60  IIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCH 115
           II   +++  PT        ++ +  G +L++ +      S D   YF  Q++ G+ Y H
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVL 171
           S  + HRDLK  N LL+ +    LKICDFG ++               V T  Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD------ 225
              +   K  D+WS G  L  ML     F      K++   ++ I+ +            
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPG----KHYLDQLNHILGILGSPSQEDLNCI 240

Query: 226 -----------------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK 262
                                  + +      +LL ++   NP +RI +++  +HP+  +
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300

Query: 263 NLPRELTETAQAIY-YRKENPTFSLQSVEEITKIVEEAKVPPPVSRS 308
                    A+A + +  E      + ++E+  I EE     P  RS
Sbjct: 301 YYDPSDEPIAEAPFKFDMELDDLPKEKLKEL--IFEETARFQPGYRS 345

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 2e-57
 Identities = 56/260 (21%), Positives = 104/260 (40%), Gaps = 13/260 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           +    +K++G+G FGV +  + +   + VA+K I+ G   +     E      L H  ++
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +   V      + I+ EY A G L   +     RF   +     + +   + Y  S Q  
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSRREYDG 178
           HRDL   N L++      +K+ DFG S+  L      S        +  PEVL   ++  
Sbjct: 123 HRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 179 KLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           K +D+W+ GV ++ +  +G  P+E   + +              ++      S+    ++
Sbjct: 181 K-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-----LRLYRPHLASEKVYTIM 234

Query: 238 SRIFVANPSRRITIKEIKSH 257
              +      R T K + S+
Sbjct: 235 YSCWHEKADERPTFKILLSN 254

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 73/275 (26%), Positives = 130/275 (47%), Gaps = 17/275 (6%)

Query: 1   MEKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGH-----KIDANVAREIINH 52
           +E +EL+K +G+G +G     R +   +T +L AMK +++       K   +   E    
Sbjct: 23  IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 53  KQLRH-PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
           + +R  P ++       T T L ++++Y  GGELF  +    RF+E E + +  +++  +
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
            + H + I +RD+KLEN LLD +    L          +    R     GT  Y+AP+++
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 172 SRREY-DGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
              +    K  D WS GV +Y +L GA PF    +  +  +   RI+  +   P    +S
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMS 260

Query: 231 QDCRNLLSRIFVANPSRRI-----TIKEIKSHPWF 260
              ++L+ R+ + +P +R+        EIK H +F
Sbjct: 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-55
 Identities = 77/333 (23%), Positives = 132/333 (39%), Gaps = 50/333 (15%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
             Y  ++ +GSG +G      +  T   VA+K + R  + +       RE+   K +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 59  NIIRFKEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVS 112
           N+I   +V          T   +VM +   G    ++    +  ED  ++   Q++ G+ 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 113 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLS 172
           Y H+  I HRDLK  N  ++      LKI DFG ++     S     V T  Y APEV+ 
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQED--------------PKNFRKTISRIMA 218
                 +  D+WS G  +  M+ G   F+  +               P  F + +    A
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 219 VQYKIPD-----------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
             Y                 + S    NLL ++ V +  +R+T  E  +HP+F       
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-----ES 306

Query: 268 LTETAQAIYYRKENPTFSLQSVEEITKIVEEAK 300
           L +T      +K + +F     +++ + ++E K
Sbjct: 307 LHDTEDEPQVQKYDDSF-----DDVDRTLDEWK 334

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 7e-55
 Identities = 58/271 (21%), Positives = 106/271 (39%), Gaps = 15/271 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E   L   +G G FG   +     T   VA+K ++ G        +E    K+LRH  ++
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE--RICNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           +   VV +   + IV EY + G L +  +          +      Q+ SG++Y   M  
Sbjct: 76  QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+  +     K+ DFG ++      ++  +       + APE      + 
Sbjct: 135 VHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 192

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            K +DVWS G+ L  +             +     + R     Y++P      +   +L+
Sbjct: 193 IK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHDLM 247

Query: 238 SRIFVANPSRRITIKEIKS--HPWFLKNLPR 266
            + +   P  R T + +++    +F    P+
Sbjct: 248 CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 9e-55
 Identities = 75/299 (25%), Positives = 122/299 (40%), Gaps = 38/299 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRN-KNTKELVAMKYIERGHKIDA---NVAREIINHKQL-- 55
           ++YE + +IG G +G     R+ KN    VA+K +      +    +  RE+   + L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 56  -RHPNIIRFKEVVLTP-----THLAIVMEYAAGGEL-FERICNAGRFSEDEARYFFQQLI 108
             HPN++R  +V         T L +V E+       +           +  +    QL+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
            G+ + HS ++ HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 169 EVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRI-MAVQYKIPDYV 227
           EVL +  Y     D+WS G     M      F    D     K +  I +  +   P  V
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 228 --------------------HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR 266
                                I +  ++LL +    NP++RI+     SHP+F ++L R
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF-QDLER 301

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 2e-54
 Identities = 55/259 (21%), Positives = 102/259 (39%), Gaps = 11/259 (4%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
            +   +++IGSG FG+  L    N  + VA+K I  G   + +   E     +L HP ++
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
           +   V L    + +V E+   G L +      G F+ +        +  G++Y     + 
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123

Query: 121 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           HRDL   N L+  +    +K+ DFG ++      ++    T     + +PEV S   Y  
Sbjct: 124 HRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 179 KLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLS 238
           K +DVWS GV ++ +        +        + IS      +++      S     +++
Sbjct: 182 K-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYKPRLASTHVYQIMN 236

Query: 239 RIFVANPSRRITIKEIKSH 257
             +   P  R     +   
Sbjct: 237 HCWKERPEDRPAFSRLLRQ 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (447), Expect = 9e-54
 Identities = 55/270 (20%), Positives = 102/270 (37%), Gaps = 14/270 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
               +   +G G +G       K     VA+K ++          +E    K+++HPN++
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGR--FSEDEARYFFQQLISGVSYCHSMQI 119
           +   V        I+ E+   G L + +    R   S     Y   Q+ S + Y      
Sbjct: 77  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL   N L+  +    +K+ DFG S+  +   ++          + APE L+  ++ 
Sbjct: 137 IHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            K +DVW+ GV L+ +           D     + + +     Y++       +    L+
Sbjct: 195 IK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYELM 249

Query: 238 SRIFVANPSRRITIKEIKSHPWFLKNLPRE 267
              +  NPS R +  EI       + + +E
Sbjct: 250 RACWQWNPSDRPSFAEIHQ---AFETMFQE 276

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 1e-53
 Identities = 69/269 (25%), Positives = 110/269 (40%), Gaps = 21/269 (7%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQ 54
           +   L++ +G G+FGV               VA+K ++           +  RE+     
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSY 113
           L H N+IR   VVLTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y
Sbjct: 68  LDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPE 169
             S +  HRDL   N LL       +KI DFG  +    +   +   +      A+ APE
Sbjct: 127 LESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 170 VLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH 228
            L  R +    +D W  GVTL+ M   G  P+       N  + + +I     ++P    
Sbjct: 185 SLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG----LNGSQILHKIDKEGERLPRPED 239

Query: 229 ISQDCRNLLSRIFVANPSRRITIKEIKSH 257
             QD  N++ + +   P  R T   ++  
Sbjct: 240 CPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 7e-53
 Identities = 68/338 (20%), Positives = 129/338 (38%), Gaps = 42/338 (12%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRHP 58
           E+Y+ +  +GSG +G      +  T   VA+K + R  +   +     RE+   K ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 59  NIIRFKEVVLTPTHLA-----IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSY 113
           N+I   +V      L       ++ +  G      I    + ++D  ++   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 114 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSR 173
            HS  I HRDLK  N  ++      LKI DFG ++           V T  Y APE++  
Sbjct: 137 IHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLN 192

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD-------- 225
             +  +  D+WS G  +  +L G   F   +     +  +  +     ++          
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 226 -----------------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPREL 268
                            ++  +    +LL ++ V +  +RIT  +  +H +F +    + 
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312

Query: 269 TETAQAIYYRKENPTFSLQSVEEITKIVEEAK--VPPP 304
              A       E+    +   + +    +E    VPPP
Sbjct: 313 EPVADPYDQSFESRDLLIDEWKSL--TYDEVISFVPPP 348

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 8e-53
 Identities = 55/265 (20%), Positives = 109/265 (41%), Gaps = 15/265 (5%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
           E  +L++ +G+G FG   +       + VA+K +++G         E    KQL+H  ++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 62  RFKEVVLTPTHLAIVMEYAAGGELFERI--CNAGRFSEDEARYFFQQLISGVSYCHSMQI 119
           R   VV T   + I+ EY   G L + +   +  + + ++      Q+  G+++      
Sbjct: 72  RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130

Query: 120 CHRDLKLENTLLDGSPAPRLKICDFGYSK--SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
            HRDL+  N L+        KI DFG ++      ++  +       + APE ++   + 
Sbjct: 131 IHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            K +DVWS G+ L  ++                + + R     Y++    +  ++   L+
Sbjct: 189 IK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQLM 243

Query: 238 SRIFVANPSRRITIKEIKS--HPWF 260
              +   P  R T   ++S    +F
Sbjct: 244 RLCWKERPEDRPTFDYLRSVLEDFF 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-51
 Identities = 56/309 (18%), Positives = 108/309 (34%), Gaps = 21/309 (6%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYI------ERGHKIDANVAREIINHKQLRH 57
           ++ +K +GSG FG           E V +             K +  +  E      + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 58  PNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSM 117
           P++ R   + LT T   I      G  L     +           +  Q+  G++Y    
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 118 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST---VGTPAYIAPEVLSRR 174
           ++ HRDL   N L+       +KI DFG +K      +            ++A E +  R
Sbjct: 131 RLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188

Query: 175 EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR 234
            Y  + +DVWS GVT++ ++       D          + +      ++P     + D  
Sbjct: 189 IYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----GERLPQPPICTIDVY 243

Query: 235 NLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIYYRKENPTFS-----LQSV 289
            ++ + ++ +   R   +E+      +   P+              +PT S     L   
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDE 303

Query: 290 EEITKIVEE 298
           E++  +V+ 
Sbjct: 304 EDMDDVVDA 312

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (433), Expect = 2e-51
 Identities = 57/279 (20%), Positives = 102/279 (36%), Gaps = 19/279 (6%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +Y L + IGSG+FG   L  +    E VA+K +E        +  E   +K ++    I 
Sbjct: 8   RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 63  -FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICH 121
             +       +  +VME             + +FS         Q+IS + Y HS    H
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 122 RDLKLENTLL-DGSPAPRLKICDFGYSK--------SSLLHSRPKSTVGTPAYIAPEVLS 172
           RD+K +N L+  G     + I DFG +K          + +   K+  GT  Y +     
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 173 RREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV---HI 229
             E   +  D+ S G  L    +G+ P++  +     +K   RI   +   P  V     
Sbjct: 187 GIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMSTPIEVLCKGY 244

Query: 230 SQDCRNLLSRIFVANPSRRIT---IKEIKSHPWFLKNLP 265
             +    L+         +     ++++  + +  +   
Sbjct: 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-51
 Identities = 55/266 (20%), Positives = 107/266 (40%), Gaps = 22/266 (8%)

Query: 8   KDIGSGNFGVARL--MRNKNTKELVAMKYIERGHKIDA---NVAREIINHKQLRHPNIIR 62
           K++GSGNFG  +    + K   + VA+K ++      A    +  E    +QL +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 63  FKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSKS----SLLHSRPKSTVGTPAYIAPEVLSRREYDG 178
           DL   N LL        KI DFG SK+       +           + APE ++  ++  
Sbjct: 132 DLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 179 KLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
           K +DVWS GV ++     G  P+   +  +     ++ ++    ++       ++  +L+
Sbjct: 190 K-SDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTAMLEKGERMGCPAGCPREMYDLM 243

Query: 238 SRIFVANPSRRITIKEIKS---HPWF 260
           +  +  +   R     ++    + ++
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYY 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-51
 Identities = 60/264 (22%), Positives = 112/264 (42%), Gaps = 16/264 (6%)

Query: 2   EKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERG--HKIDANVAREIINHKQLR 56
           E+ EL + IG G FG       M  +N    VA+K  +      +     +E +  +Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 57  HPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCH 115
           HP+I++   V+ T   + I+ME    GEL   +              +  QL + ++Y  
Sbjct: 67  HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 116 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST--VGTPAYIAPEVLSR 173
           S +  HRD+   N L+  +    +K+ DFG S+     +  K++       ++APE ++ 
Sbjct: 126 SKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 174 REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC 233
           R +    +DVW  GV ++ +L+            +    I        ++P   +     
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----GERLPMPPNCPPTL 238

Query: 234 RNLLSRIFVANPSRRITIKEIKSH 257
            +L+++ +  +PSRR    E+K+ 
Sbjct: 239 YSLMTKCWAYDPSRRPRFTELKAQ 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  170 bits (431), Expect = 3e-51
 Identities = 62/282 (21%), Positives = 113/282 (40%), Gaps = 28/282 (9%)

Query: 1   MEKYELMKDIGSGNFGV---ARLMRNKNTKELVAMKYIERGH--KIDANVAREIINHKQL 55
           +   ++ + IG+G FG      L      +  VA+K ++ G+  K   +   E     Q 
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARYFFQQLISGVSYC 114
            HPN+I  + VV   T + I+ E+   G L      N G+F+  +     + + +G+ Y 
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSLLHSRPKSTVGTPAYIAP 168
             M   HRDL   N L++ +     K+ DFG S+      S   ++          + AP
Sbjct: 145 ADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 169 EVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV 227
           E +  R++    +DVWS G+ ++ ++  G  P+ D  +               Y++P  +
Sbjct: 203 EAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-----YRLPPPM 256

Query: 228 HISQDCRNLLSRIFVANPSRRITIKEI-------KSHPWFLK 262
                   L+   +  + + R    +I         +P  LK
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 4e-51
 Identities = 62/264 (23%), Positives = 105/264 (39%), Gaps = 22/264 (8%)

Query: 10  IGSGNFGVARL--MRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFKE 65
           +G GNFG  R    R +  +  VA+K +++G +      + RE     QL +P I+R   
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 66  VVLTPTHLAIVMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDL 124
           V      L +VME A GG L + +                 Q+  G+ Y       HRDL
Sbjct: 77  VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135

Query: 125 KLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKL 180
              N LL      +  I DFG SK        ++   +      + APE ++ R++  + 
Sbjct: 136 AARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192

Query: 181 ADVWSCGVTLYVML-VGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR 239
           +DVWS GVT++  L  G  P++  + P+            + + P       +   L+S 
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMECPP--ECPPELYALMSD 247

Query: 240 IFVANPSRRITIKEIKS---HPWF 260
            ++     R     ++      ++
Sbjct: 248 CWIYKWEDRPDFLTVEQRMRACYY 271

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-50
 Identities = 57/291 (19%), Positives = 106/291 (36%), Gaps = 42/291 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKEL-----VAMKYIERGHKID--ANVAREIINHKQ 54
           E  E  K +GSG FG           +      VA+K ++          +  E+    Q
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI-----------------------C 90
           L  H NI+           + ++ EY   G+L   +                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 91  NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-- 148
           +    + ++   F  Q+  G+ +       HRDL   N L+       +KICDFG ++  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLARDI 214

Query: 149 -SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVML-VGAYPFEDQEDP 206
            S   +    +      ++APE L    Y  K +DVWS G+ L+ +  +G  P+      
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 257
            NF K    ++   +K+    + +++   ++   +  +  +R +   + S 
Sbjct: 274 ANFYK----LIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 5e-50
 Identities = 59/278 (21%), Positives = 102/278 (36%), Gaps = 28/278 (10%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGHKIDA--NVAREIINHKQL- 55
               +    IG GNFG     R K        A+K ++     D   + A E+    +L 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRFSEDE 99
            HPNII          +L + +EYA  G L + +                  A   S  +
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 100 ARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST 159
             +F   +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++ +    
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTMG 186

Query: 160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
                ++A E L+   Y    +DVWS GV L+ ++                + + +    
Sbjct: 187 RLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---- 241

Query: 220 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 257
            Y++   ++   +  +L+ + +   P  R +  +I   
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-48
 Identities = 53/260 (20%), Positives = 98/260 (37%), Gaps = 19/260 (7%)

Query: 10  IGSGNFGV---ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFK 64
           IG G+FG      L+ N   K   A+K + R   I   +    E I  K   HPN++   
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94

Query: 65  EVVL-TPTHLAIVMEYAAGGELFE-RICNAGRFSEDEARYFFQQLISGVSYCHSMQICHR 122
            + L +     +V+ Y   G+L           +  +   F  Q+  G+ +  S +  HR
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHR 154

Query: 123 DLKLENTLLDGSPAPRLKICDFGYSK-----SSLLHSRPKSTVGTPAYIAPEVLSRREYD 177
           DL   N +LD      +K+ DFG ++                     ++A E L  +++ 
Sbjct: 155 DLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212

Query: 178 GKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL 237
            K +DVWS GV L+ ++    P     +  +    + +      ++    +       ++
Sbjct: 213 TK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GRRLLQPEYCPDPLYEVM 267

Query: 238 SRIFVANPSRRITIKEIKSH 257
            + +      R +  E+ S 
Sbjct: 268 LKCWHPKAEMRPSFSELVSR 287

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 48/290 (16%), Positives = 94/290 (32%), Gaps = 21/290 (7%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
             Y++ + IG G+FGV     N    + VA+K+  R       +  E   +K L     I
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 62  -RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQIC 120
                      H  +V++               +FS        +Q+++ V   H   + 
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 121 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSLLHSRPKSTVGTPAYIAPE 169
           +RD+K +N L+    +     + + DFG  K          + +   K+  GT  Y++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 170 VLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYV-- 227
               RE   +  D+ + G      L G+ P++        ++   RI   +   P     
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQG-LKAATNKQKYERIGEKKQSTPLRELC 241

Query: 228 -HISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETAQAIY 276
               ++    +                ++        +   L  T    +
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG---LFSKVLERLNTTEDENF 288

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 2e-47
 Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 18/282 (6%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGH--KIDANVAREIINHKQL 55
                 K IG+G FG       K +       VA+K ++ G+  K   +   E     Q 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 56  RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYC 114
            H NIIR + V+     + I+ EY   G L + +    G FS  +     + + +G+ Y 
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 115 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSLLHSRPKSTVGTPAYIAPEV 170
            +M   HRDL   N L++ +     K+ DFG S+                    + APE 
Sbjct: 127 ANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 171 LSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS 230
           +S R++    +DVWS G+ ++ ++        +       K I+      +++P  +   
Sbjct: 185 ISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMDCP 239

Query: 231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTETA 272
                L+ + +    +RR    +I S    L   P  L   A
Sbjct: 240 SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLA 281

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 8e-47
 Identities = 57/287 (19%), Positives = 104/287 (36%), Gaps = 41/287 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKID--ANVAREIINHKQ 54
              E ++DIG G FG     R           +VA+K ++     D  A+  RE     +
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGR-------------------- 94
             +PNI++   V      + ++ EY A G+L E + +                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 95  ----FSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-- 148
                S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S+  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190

Query: 149 -SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK 207
            S+  +    +      ++ PE +    Y  + +DVW+ GV L+ +             +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHE 249

Query: 208 NFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
                +         +    +   +  NL+   +   P+ R +   I
Sbjct: 250 EVIYYVRD----GNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 9e-47
 Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 51/305 (16%)

Query: 1   MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVA---REIINHKQLRH 57
           +++Y+ +K IGSG  G+     +      VA+K + R  +   +     RE++  K + H
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 58  PNIIRFKEVVLTP------THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGV 111
            NII    V            + +VME                   +   Y   Q++ G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGI 132

Query: 112 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVL 171
            + HS  I HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 172 SRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH--- 228
               Y     D+WS G  +  M+     F  ++    + K I ++     +    +    
Sbjct: 191 LGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 229 ---------------------------------ISQDCRNLLSRIFVANPSRRITIKEIK 255
                                             +   R+LLS++ V +P++RI++ +  
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 256 SHPWF 260
            HP+ 
Sbjct: 310 QHPYI 314

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-46
 Identities = 54/299 (18%), Positives = 110/299 (36%), Gaps = 41/299 (13%)

Query: 2   EKYELMKDIGSGNFGV-----ARLMRNKNTKELVAMKYIERGHKID--ANVAREIINHKQ 54
            +    K +G+G FG      A  +   +    VA+K ++    +     +  E+     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 55  L-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERIC------------------NAGRF 95
           L  H NI+             ++ EY   G+L   +                   +    
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 96  SEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR 155
             ++   F  Q+  G+++  S    HRDL   N LL        KICDFG ++     S 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKNDSN 200

Query: 156 PKST---VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKT 212
                       ++APE +    Y  + +DVWS G+ L+ +              +    
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS---K 256

Query: 213 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPRELTET 271
             +++   +++    H   +  +++   + A+P +R T K+I      ++ + ++++E+
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI------VQLIEKQISES 309

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 66/292 (22%), Positives = 102/292 (34%), Gaps = 43/292 (14%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNII 61
               L + IG G FG   + R K   E VA+K      +       EI     LRH NI+
Sbjct: 3   RTIVLQESIGKGRFGE--VWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60

Query: 62  RFKEVV----LTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS- 116
            F         T T L +V +Y   G LF+ + N    + +          SG+++ H  
Sbjct: 61  GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHME 119

Query: 117 -------MQICHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSLLHSRPKSTVGTPA 164
                    I HRDLK +N L+  +      I D G      S +  +   P   VGT  
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 165 YIAPEVLSRREYDGKL-----ADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV 219
           Y+APEVL              AD+++ G+  + +          ED +     +      
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 220 QYKIPDYV----------------HISQDCRNLLSRIFVANPSRRITIKEIK 255
             ++   V                   +    ++   + AN + R+T   IK
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 2e-43
 Identities = 55/280 (19%), Positives = 104/280 (37%), Gaps = 32/280 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKNTKE-------LVAMKYI--ERGHKIDANVAREIINH 52
           ++  L K +G G FG   L       +        VA+K +  +   K  +++  E+   
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 53  KQL-RHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERI----------------CNAGRF 95
           K + +H NII           L +++EYA+ G L E +                    + 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 96  SEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRL-KICDFGYSKSSLLHS 154
           S  +      Q+  G+ Y  S +  HRDL   N L+      ++              + 
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIS 214
           +  +      ++APE L  R Y  + +DVWS GV L+ +             +   K + 
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 215 RIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEI 254
                 +++    + + +   ++   + A PS+R T K++
Sbjct: 252 E----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 2e-42
 Identities = 60/285 (21%), Positives = 111/285 (38%), Gaps = 36/285 (12%)

Query: 2   EKYELMKDIGSGNFGV-----ARLMRNKNTKELVAMKYIERGHKIDAN---VAREIINHK 53
           ++ +L K +G G FG      A  +    T   VA+K ++ G     +   ++   I   
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 54  QLRHPNIIRFKEVVLTP-THLAIVMEYAAGGELFERICNAGR----------------FS 96
              H N++        P   L +++E+   G L   + +                    +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 97  EDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLH 153
            +    +  Q+  G+ +  S +  HRDL   N LL       +KICDFG ++       +
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDPDY 190

Query: 154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKT 212
            R         ++APE +  R Y  + +DVWS GV L+ +    A P+   +  + F + 
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 213 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH 257
           +      + + PD  + + +    +   +   PS+R T  E+  H
Sbjct: 250 LKE--GTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  147 bits (372), Expect = 7e-42
 Identities = 57/326 (17%), Positives = 112/326 (34%), Gaps = 62/326 (19%)

Query: 3   KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIR 62
           +Y L++ +G G+F    L ++      VAMK +            EI   +++   +  +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 63  ---------------FKEVVLTPTHLAIVMEYAAGGEL-FERICNAGRFSEDEARYFFQQ 106
                          F        H+ +V E      L   +            +   +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 107 LISGVSYCHSMQ-ICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSLLHSRPKSTVGTP 163
           L+ G+ Y H    I H D+K EN L++   SP   ++I       +        +++ T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 164 AYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPF--EDQEDPKNFRKTISRIMAVQY 221
            Y +PEVL    +    AD+WS    ++ ++ G + F  ++          I++I+ +  
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 222 KIPDYV----------------------------------------HISQDCRNLLSRIF 241
           ++P Y+                                          +++  + LS + 
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 242 VANPSRRITIKEIKSHPWFLKNLPRE 267
             +P +R     + +HPW    L  E
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGME 338

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-41
 Identities = 53/285 (18%), Positives = 104/285 (36%), Gaps = 33/285 (11%)

Query: 2   EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKID--ANVAREIINHKQ 54
           EK  + +++G G+FG+      K       +  VA+K +     +        E    K+
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 55  LRHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRF----------SEDEARYFF 104
               +++R   VV       ++ME    G+L   + +              S  +     
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 105 QQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSLLHSRPKSTVG 161
            ++  G++Y ++ +  HRDL   N ++       +KI DFG ++    +  + +    + 
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 162 TPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY 221
              +++PE L    +    +DVWS GV L+ +   A         +   + +        
Sbjct: 198 PVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--GGLL 254

Query: 222 KIPDYVHISQDCRNLLSRIFVANPSRRITIKEI------KSHPWF 260
             PD  +       L+   +  NP  R +  EI      +  P F
Sbjct: 255 DKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 69.8 bits (170), Expect = 8e-15
 Identities = 28/202 (13%), Positives = 58/202 (28%), Gaps = 39/202 (19%)

Query: 4   YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERG-----------HKIDANVAREIINH 52
             + K +G G         ++   E   +K+ + G              D + +   I  
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 53  KQLRHPNIIRFKEVVLTPTH----LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLI 108
            +     + + + + +   +     A++ME               R   +        ++
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMIL 113

Query: 109 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAP 168
             V+  +   I H DL   N L+       + I DF  S                  +  
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE---VGEEGW----REILER 163

Query: 169 EVLS-----RREYDGKLADVWS 185
           +V +      R Y  +  D+ S
Sbjct: 164 DVRNIITYFSRTYRTE-KDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	351
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.62
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.16
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.13
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.49
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.32
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.51

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-67  Score=464.35  Aligned_cols=261  Identities=36%  Similarity=0.607  Sum_probs=224.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +++|++++.||+|+||+||+|.+..+++.||||++.....  ....+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            5789999999999999999999999999999999876432  23568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC---CC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---SR  155 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~---~~  155 (351)
                      ||.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+.....   ..
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~--~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECEETTEECC
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC--CEEEccchhheeeccCCcccc
Confidence            999999999998888999999999999999999999999999999999999998766  4999999999854322   22


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....+||+.|||||++.+..++++++|||||||++|+|++|++||...........   .........+.+..+|+++.+
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---HHHTTCTTSTTGGGSCHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH---HHhcCCCCCCccccCCHHHHH
Confidence            34568999999999999888877779999999999999999999977654333222   222233334455678999999


Q ss_pred             HHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          236 LLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       236 li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      ||.+||+.||.+|||++|+|+||||++.+.+
T Consensus       239 li~~~L~~dP~~R~t~~eil~hpwf~~~l~k  269 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKKDRWYNKPLKK  269 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             HHHHHcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence            9999999999999999999999999887654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-65  Score=454.33  Aligned_cols=253  Identities=35%  Similarity=0.672  Sum_probs=222.2

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      |++|++++.||+|+||+||+|.+..+++.||+|++.+..    .....+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            579999999999999999999999999999999986532    2345688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+... ....
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~~kl~DFG~a~~~~-~~~~  161 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG--ELKIADFGWSVHAP-SSRR  161 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCSCSCCC-CCCC
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC--CEeecccceeeecC-CCcc
Confidence            99999999999999989999999999999999999999999999999999999998765  49999999997543 3334


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|||||++.+..++ .++|||||||++|+|++|+.||...+.    ......+......+|.  .+|+++.+|
T Consensus       162 ~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~p~--~~s~~~~~l  234 (263)
T d2j4za1         162 TTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTY----QETYKRISRVEFTFPD--FVTEGARDL  234 (263)
T ss_dssp             EETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTTCCCCCT--TSCHHHHHH
T ss_pred             cccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCCCc--cCCHHHHHH
Confidence            556899999999999988875 459999999999999999999977543    2334445555555554  689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      |.+||++||.+|||+.|+|+||||..+
T Consensus       235 i~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         235 ISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            999999999999999999999999653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-64  Score=450.53  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=221.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++++.||+|+||+||+|.+..+|+.||||++..... ....+.+|+.++++++|||||++++++.+++.+|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            479999999999999999999999999999999876443 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCCc
Q 018734           81 AGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~~  159 (351)
                      .||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+..... ......
T Consensus       100 ~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1         100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             TTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCCBCCC
T ss_pred             CCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC--cEeeccchhheeecccccccccc
Confidence            99999988765 4699999999999999999999999999999999999997665  4999999999865433 334556


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLLSR  239 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (351)
                      +||+.|+|||++.+..++. ++|||||||++|+|++|+.||........+....   ......++.+..+|+.+++||.+
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGP-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             ccCCCccChhhhcCCCCCc-hhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH---hCCCCCCCCcccCCHHHHHHHHH
Confidence            7999999999999888754 5999999999999999999998765443332222   22233344556789999999999


Q ss_pred             hcccCCCCCCChHHHhcCcccccCCC
Q 018734          240 IFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       240 ~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                      ||+.||.+|||+.|+|+||||+...+
T Consensus       253 ~L~~dP~~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             HTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HccCChhHCcCHHHHhcCHhhCCCCC
Confidence            99999999999999999999976543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-64  Score=455.78  Aligned_cols=257  Identities=33%  Similarity=0.634  Sum_probs=207.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++++.||+|+||+||+|++..+++.||||++.+...  ....+.+|+.++++++|||||++++++.+++.+|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            469999999999999999999999999999999976432  234577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~-~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+.. +..+++||+|||+|+..........
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  168 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST  168 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeee
Confidence            999999999999999999999999999999999999999999999999999964 2345699999999986655555667


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC--CCCccCCCHhHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK--IPDYVHISQDCRNL  236 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  236 (351)
                      .+||+.|||||++.+..++. ++|||||||++|+|++|++||.......    ....+......  .+.+..+|+++.+|
T Consensus       169 ~~GT~~y~APE~~~~~~~~~-~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~l  243 (307)
T d1a06a_         169 ACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILLCGYPPFYDENDAK----LFEQILKAEYEFDSPYWDDISDSAKDF  243 (307)
T ss_dssp             ----CTTSCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             eeeCccccCcHHHcCCCCCc-HHHhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHhccCCCCCCccccCCCHHHHHH
Confidence            78999999999998888754 5999999999999999999998765433    33344444443  34456799999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      |.+||++||.+|||+.|+|+||||...
T Consensus       244 i~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         244 IRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.2e-64  Score=460.25  Aligned_cols=258  Identities=29%  Similarity=0.588  Sum_probs=224.9

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      |++|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+|+.++++++|||||++++++.+++.+|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            5789999999999999999999999999999999976543 235678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |+||+|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+..........
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence            99999999985 45679999999999999999999999999999999999999765556799999999986655555556


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCCHhHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNL  236 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  236 (351)
                      .+||+.|||||++.+..++ .++|||||||++|+|++|+.||...+..+    .+..+....+..+  .+..+|+++++|
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             ecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            7899999999999988875 55999999999999999999998765433    3334444444433  335689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      |.+||+.||.+|||++|+|+||||...
T Consensus       260 i~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-64  Score=455.85  Aligned_cols=257  Identities=27%  Similarity=0.443  Sum_probs=213.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      ++|++++.||+|+||+||+|++..+|+.||+|+++.....  ...+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus         6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            6899999999999999999999999999999999764332  35688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      |.||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++  ++||+|||+|+... .....+
T Consensus        86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~--~vkl~DFGla~~~~-~~~~~~  162 (322)
T d1s9ja_          86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVSGQLI-DSMANS  162 (322)
T ss_dssp             CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC--CEEECCCCCCHHHH-HHTC--
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC--CEEEeeCCCccccC-CCcccc
Confidence            9999999999998999999999999999999999997 5999999999999997766  49999999998543 233456


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHH---------------------------
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRK---------------------------  211 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---------------------------  211 (351)
                      .+||+.|||||++.+..|+.+ +|||||||++|||++|+.||...+.......                           
T Consensus       163 ~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T d1s9ja_         163 FVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG  241 (322)
T ss_dssp             -CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred             ccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence            789999999999999887655 9999999999999999999987543221110                           


Q ss_pred             -----------HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          212 -----------TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       212 -----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                                 ....+............+|.++.+||.+||+.||.+|||++|+|+||||++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence                       000001000000011236889999999999999999999999999999965

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-63  Score=450.68  Aligned_cols=254  Identities=34%  Similarity=0.603  Sum_probs=224.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      |++|++++.||+|+||.||+|++..+++.||||++.+..    .....+.+|+.++++++|||||++++++.+...+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            689999999999999999999999999999999997532    2335688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC-CCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL-HSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~-~~~  155 (351)
                      ||||+||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+.... ...
T Consensus        84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g--~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred             eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC--CEEEeecccccccccCCcc
Confidence            99999999999999999999999999999999999999999999999999999998765  599999999986443 334


Q ss_pred             CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHH
Q 018734          156 PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRN  235 (351)
Q Consensus       156 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (351)
                      ....+||+.|||||++.+..|+. ++|||||||++|+|++|++||...+..    .+...+......+|  ..+|+++++
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~-~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~~i~~~~~~~p--~~~s~~~~d  234 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGR-AVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIRFP--RTLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCT-THHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC--TTSCHHHHH
T ss_pred             cccceeCHHHhhhhhccCCCCCh-hhcccchhhHHHHHHHCCCCCCCcCHH----HHHHHHhcCCCCCC--ccCCHHHHH
Confidence            45678999999999999988854 599999999999999999999876543    33344444454454  468999999


Q ss_pred             HHHHhcccCCCCCCC-----hHHHhcCcccccC
Q 018734          236 LLSRIFVANPSRRIT-----IKEIKSHPWFLKN  263 (351)
Q Consensus       236 li~~~L~~~P~~Rps-----~~eil~hp~~~~~  263 (351)
                      ||.+||++||.+||+     +.++++||||.+.
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            999999999999995     8999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-63  Score=445.37  Aligned_cols=258  Identities=27%  Similarity=0.417  Sum_probs=219.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc-ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH-KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +.|++++.||+|+||.||+|++..+++.||+|++.... .....+.+|+.++++++|||||++++++.+++.+|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            35999999999999999999999999999999997643 33457889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCC
Q 018734           81 AGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKS  158 (351)
Q Consensus        81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~  158 (351)
                      +||+|..++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... .....
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCcccccc
Confidence            99999998765 457999999999999999999999999999999999999987664  999999998743222 22345


Q ss_pred             cccCCCccCcccccC-----CcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc-cCCCCccCCCHh
Q 018734          159 TVGTPAYIAPEVLSR-----REYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-YKIPDYVHISQD  232 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  232 (351)
                      .+||+.|||||++..     ..| +.++|||||||++|+|++|+.||......+.+..+    .... ..++.+..+|++
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~~s~~  244 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----AKSEPPTLAQPSRWSSN  244 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH----HHSCCCCCSSGGGSCHH
T ss_pred             cccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH----HcCCCCCCCccccCCHH
Confidence            689999999999843     333 45699999999999999999999887665544332    2222 234445678999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      +.+||.+||+.||.+|||+.|+|+||||+....+
T Consensus       245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~~~  278 (288)
T d2jfla1         245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK  278 (288)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCCCH
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            9999999999999999999999999999866544

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-63  Score=445.29  Aligned_cols=254  Identities=30%  Similarity=0.541  Sum_probs=218.5

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      ++|++++.||+|+||+||+|.+..+++.||||++.+..    .....+.+|+.++++++|||||++++++.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999999999999999987532    23356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC---C
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH---S  154 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~---~  154 (351)
                      |||+||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+|+.....   .
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCccc
Confidence            99999999999999999999999999999999999999999999999999999987664  999999999854322   2


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||+.|||||++.+..++ .++|||||||++|+|++|+.||...+..    ....++....+.+|.  .++++++
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~i~~~~~~~p~--~~s~~~~  238 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQKIIKLEYDFPE--KFFPKAR  238 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHTTCCCCCT--TCCHHHH
T ss_pred             ccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHH----HHHHHHHcCCCCCCc--cCCHHHH
Confidence            23456899999999999888875 5599999999999999999999875443    333445555555554  6899999


Q ss_pred             HHHHHhcccCCCCCCChHH------HhcCcccccCC
Q 018734          235 NLLSRIFVANPSRRITIKE------IKSHPWFLKNL  264 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~e------il~hp~~~~~~  264 (351)
                      +||.+||+.||.+|||++|      +++||||....
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~  274 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  274 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence            9999999999999999988      58899997643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.1e-63  Score=454.51  Aligned_cols=257  Identities=27%  Similarity=0.549  Sum_probs=224.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc-CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++++.||+|+||.||+|.+..+|+.||||++...... ...+.+|+.++++++|||||+++++|.+++.+|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999999999999999998765432 346778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           81 AGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      +||+|.+.+... .++++.+++.++.||+.||.|||++||+||||||+||||+....+++||+|||+|+...........
T Consensus       109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~  188 (352)
T d1koba_         109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT  188 (352)
T ss_dssp             CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEE
T ss_pred             CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeec
Confidence            999999887654 4699999999999999999999999999999999999998656667999999999876655555667


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCCHhHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHISQDCRNLL  237 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li  237 (351)
                      +||+.|||||++.+..++ .++|||||||++|+|++|+.||.+......    +..+......++  .+..+|+++.+||
T Consensus       189 ~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li  263 (352)
T d1koba_         189 TATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVKRCDWEFDEDAFSSVSPEAKDFI  263 (352)
T ss_dssp             CSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             cCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCcccccCCCHHHHHHH
Confidence            899999999999888875 459999999999999999999987654433    333444444433  3457899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+||++||.+|||+.|+|+||||+..
T Consensus       264 ~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         264 KNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.1e-63  Score=445.92  Aligned_cols=256  Identities=27%  Similarity=0.380  Sum_probs=218.8

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      +|++++.||+|+||+||+|++..+++.||||++.......    ..+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4999999999999999999999999999999997654322    457899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      ||.+|+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+....   ...
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~~Kl~DFG~a~~~~~---~~~  170 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---ANS  170 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS---BCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC--CEEEeecccccccCC---CCc
Confidence            999999988888888999999999999999999999999999999999999998765  499999999975432   345


Q ss_pred             cccCCCccCcccccCC--cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          159 TVGTPAYIAPEVLSRR--EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      .+||+.|||||++.+.  ..++.++|||||||++|+|++|+.||........    +..+.......+....+|+.+.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~s~~~~~l  246 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----LYHIAQNESPALQSGHWSEYFRNF  246 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----HHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH----HHHHHhCCCCCCCCCCCCHHHHHH
Confidence            6899999999998643  2234559999999999999999999987654333    333333333334445689999999


Q ss_pred             HHHhcccCCCCCCChHHHhcCcccccCCChh
Q 018734          237 LSRIFVANPSRRITIKEIKSHPWFLKNLPRE  267 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~hp~~~~~~~~~  267 (351)
                      |.+||+.||.+|||++++|+||||.+..++.
T Consensus       247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~  277 (309)
T d1u5ra_         247 VDSCLQKIPQDRPTSEVLLKHRFVLRERPPT  277 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHSCCCTT
T ss_pred             HHHHCcCChhHCcCHHHHHhCHHhcCCCCch
Confidence            9999999999999999999999998765543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-63  Score=444.92  Aligned_cols=257  Identities=34%  Similarity=0.637  Sum_probs=223.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+...       ....+.+|+.++++++|||||++++++.+.+.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            579999999999999999999999999999999865322       2356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA--PRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~--~~vkL~DFg~a~~~~~  152 (351)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  .++||+|||+|+....
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            99999999999999999889999999999999999999999999999999999999976553  3599999999987666


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC--CccCCC
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP--DYVHIS  230 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  230 (351)
                      ........||+.|+|||++.+..++ .++|||||||++|+|++|+.||......+    .+..+......++  .+..+|
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQE----TLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTTCCCCCHHHHTTSC
T ss_pred             CccccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHH----HHHHHHhcCCCCCchhcCCCC
Confidence            6666677899999999999887775 45999999999999999999998765433    3334444444433  234689


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +.+++||.+||+.||.+|||++++|+||||+..
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-63  Score=451.79  Aligned_cols=258  Identities=27%  Similarity=0.497  Sum_probs=227.3

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEecc
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      .+||++++.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.++|||||+++++|.+++.+|+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            47999999999999999999999999999999999876655567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCCc
Q 018734           81 AGGELFERICNAG-RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKST  159 (351)
Q Consensus        81 ~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~~  159 (351)
                      .||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.++..++||+|||+++...........
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~  163 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence            9999999998765 799999999999999999999999999999999999998776667999999999865544445566


Q ss_pred             ccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC--ccCCCHhHHHHH
Q 018734          160 VGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHISQDCRNLL  237 (351)
Q Consensus       160 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li  237 (351)
                      +||+.|+|||++.+..++ .++|||||||++|+|++|..||.......    ....+....+.++.  +..+|+++.+||
T Consensus       164 ~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         164 FTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQ----IIENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             ccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence            899999999999888775 55999999999999999999998765433    33444455544432  346899999999


Q ss_pred             HHhcccCCCCCCChHHHhcCcccccC
Q 018734          238 SRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      .+||+.||.+|||++|+|+||||.+.
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999765

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-62  Score=433.19  Aligned_cols=252  Identities=23%  Similarity=0.387  Sum_probs=210.8

Q ss_pred             Ce-eEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEc----CCEEE
Q 018734            3 KY-ELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLT----PTHLA   74 (351)
Q Consensus         3 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~----~~~~~   74 (351)
                      || ++.+.||+|+||+||+|.+..+++.||+|++.....   ....+.+|+.++++++|||||++++++.+    ...+|
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            45 788899999999999999999999999999875432   23467899999999999999999999865    35689


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||.|||+++  |+||||||+|||++.. .+.+||+|||+|+... 
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~-~~~~Kl~DFGla~~~~-  166 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLKR-  166 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST-TSCEEECCTTGGGGCC-
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC-CCCEEEeecCcceecc-
Confidence            99999999999999999899999999999999999999999998  9999999999999642 2359999999997432 


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      .......+||+.|||||++.+ .+ +.++|||||||++|+|++|+.||........+.   ..+.............+++
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIY---RRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH---HHHTTTCCCGGGGGCCCHH
T ss_pred             CCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH---HHHHcCCCCcccCccCCHH
Confidence            233345689999999999865 45 456999999999999999999998765544332   2333322222233457899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcCcccc
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSHPWFL  261 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~hp~~~  261 (351)
                      +.+||.+||++||++|||+.|+|+||||+
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999999999999995

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.9e-62  Score=441.97  Aligned_cols=253  Identities=33%  Similarity=0.627  Sum_probs=222.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      |++|++++.||+|+||+||+|++..+|+.||||++.+..    .....+.+|+.+++.++|||||++++++.+++.+|+|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            578999999999999999999999999999999987532    2335688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      ||||.||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+...  ...
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g--~vkL~DFG~a~~~~--~~~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVT  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCB
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC--CEEEecCccceEec--ccc
Confidence            99999999999999999999999999999999999999999999999999999998765  49999999998543  334


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|||||++.+..++. ++|||||||++|+|++|+.||...+...    ...++......+|  ..+++++.++
T Consensus       159 ~~~~Gt~~Y~APE~l~~~~y~~-~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~l  231 (316)
T d1fota_         159 YTLCGTPDYIAPEVVSTKPYNK-SIDWWSFGILIYEMLAGYTPFYDSNTMK----TYEKILNAELRFP--PFFNEDVKDL  231 (316)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCT-THHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred             ccccCcccccCHHHHcCCCCCc-hhhccccchhHHHHHhCCCCCCCcCHHH----HHHHHHcCCCCCC--CCCCHHHHHH
Confidence            5678999999999998888765 5999999999999999999998765433    3344445554444  3689999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccCC
Q 018734          237 LSRIFVANPSRRI-----TIKEIKSHPWFLKNL  264 (351)
Q Consensus       237 i~~~L~~~P~~Rp-----s~~eil~hp~~~~~~  264 (351)
                      |.+||++||.+|+     |++++|+||||++..
T Consensus       232 i~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         232 LSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             HHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence            9999999999996     899999999997754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8e-62  Score=432.56  Aligned_cols=256  Identities=32%  Similarity=0.515  Sum_probs=222.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc----------CHHHHHHHHHHhcCC-CCCcceEEEEEEcC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI----------DANVAREIINHKQLR-HPNIIRFKEVVLTP   70 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~   70 (351)
                      ++|++.+.||+|+||+||+|++..+++.||||++.+....          ...+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            7999999999999999999999999999999998764321          135778999999997 99999999999999


Q ss_pred             CEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCccc
Q 018734           71 THLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  150 (351)
Q Consensus        71 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~  150 (351)
                      +.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~  160 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQL  160 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEEC
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEc
Confidence            999999999999999999999999999999999999999999999999999999999999976664  999999999876


Q ss_pred             CCCCCCCCcccCCCccCcccccCC-----cCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc--CC
Q 018734          151 LLHSRPKSTVGTPAYIAPEVLSRR-----EYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY--KI  223 (351)
Q Consensus       151 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~  223 (351)
                      .........+||+.|+|||++.+.     ...+.++||||+||++|+|++|+.||........    ...+.....  ..
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~----~~~i~~~~~~~~~  236 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM----LRMIMSGNYQFGS  236 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCT
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH----HHHHHhCCCCCCC
Confidence            655556667899999999998532     2234569999999999999999999987654333    233343433  34


Q ss_pred             CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          224 PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       224 ~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      +.+..+|+++++||.+||++||.+|||++|+|+||||++.
T Consensus       237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            4556799999999999999999999999999999999764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-62  Score=434.52  Aligned_cols=251  Identities=29%  Similarity=0.518  Sum_probs=203.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEc--CCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLT--PTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--~~~~~lv   76 (351)
                      ++|++++.||+|+||.||+|++..+|+.||+|++......   ...+.+|+.++++++|||||++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6899999999999999999999999999999998765432   2457889999999999999999999865  4568999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEecCCCCCCEEEeccCCC
Q 018734           77 MEYAAGGELFERICN----AGRFSEDEARYFFQQLISGVSYCHSMQ-----ICHRDLKLENTLLDGSPAPRLKICDFGYS  147 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~-----iiH~Dikp~NIll~~~~~~~vkL~DFg~a  147 (351)
                      ||||+||+|.+++.+    ...+++..++.++.||+.||.|||++|     |+||||||+|||++.++  .+||+|||+|
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~--~vkl~DFG~a  161 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLA  161 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS--CEEECCHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC--cEEEeeccce
Confidence            999999999998864    467999999999999999999999976     99999999999998766  4999999999


Q ss_pred             cccCCCC-CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCc
Q 018734          148 KSSLLHS-RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDY  226 (351)
Q Consensus       148 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (351)
                      +...... .....+||+.|||||++.+..++ .++|||||||++|+|++|+.||...+..    .....+...... +.+
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~~i~~~~~~-~~~  235 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQK----ELAGKIREGKFR-RIP  235 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHTCCC-CCC
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHH----HHHHHHHcCCCC-CCC
Confidence            8644332 33457899999999999888775 5599999999999999999999875443    233334443332 233


Q ss_pred             cCCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          227 VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       227 ~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      ..+|+++.+||.+||+.||.+|||+.|+|+|||+
T Consensus       236 ~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            4689999999999999999999999999999995

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-61  Score=445.19  Aligned_cols=252  Identities=31%  Similarity=0.596  Sum_probs=221.4

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      |++|++++.||+|+||.||+|+++.+|+.||||++.+..    .....+.+|+.+++.++|||||++++++.+...+++|
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            579999999999999999999999999999999986532    2335688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCC
Q 018734           77 MEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRP  156 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~  156 (351)
                      |||+.||+|...+.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.++  ++||+|||+|+...  ...
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~--~~~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVK--GRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS--SCB
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeecc--ccc
Confidence            99999999999999989999999999999999999999999999999999999998765  59999999998543  334


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+||+.|||||++.+..++ .++|||||||++|+|++|+.||......    ....++.......|  ..+++++.+|
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~~~~~~p--~~~s~~~~~l  268 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPI----QIYEKIVSGKVRFP--SHFSSDLKDL  268 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHCCCCCC--TTCCHHHHHH
T ss_pred             ccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHH----HHHHHHhcCCCCCC--ccCCHHHHHH
Confidence            557899999999999988876 4599999999999999999999875432    33444444444444  4689999999


Q ss_pred             HHHhcccCCCCCC-----ChHHHhcCcccccC
Q 018734          237 LSRIFVANPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       237 i~~~L~~~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      |.+||++||.+|+     |++++++||||...
T Consensus       269 i~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            9999999999995     89999999999765

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-61  Score=447.21  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=216.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc----cCHHHH---HHHHHHhcCCCCCcceEEEEEEcCCEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK----IDANVA---REIINHKQLRHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~---~e~~~~~~l~hp~Iv~~~~~~~~~~~~   73 (351)
                      |++|++++.||+|+||.||+|++..+|+.||||++.+...    ....+.   +++.+++.++|||||++++++.+++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            6899999999999999999999999999999999864321    112233   346778888999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+|||||.||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+.... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g--~iKl~DFGla~~~~~-  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFSK-  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS--CEEECCCTTCEECSS-
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC--cEEEeeeceeeecCC-
Confidence            99999999999999999999999999999999999999999999999999999999998766  499999999985433 


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                      ......+||+.|||||++.....++.++|||||||++|+|++|+.||........ ...........  .+.+..+|+++
T Consensus       160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~--~~~~~~~s~~~  236 (364)
T d1omwa3         160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMA--VELPDSFSPEL  236 (364)
T ss_dssp             SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCC--CCCCSSSCHHH
T ss_pred             CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCC--CCCCCCCCHHH
Confidence            3445678999999999997655455669999999999999999999987654322 22332222222  33334789999


Q ss_pred             HHHHHHhcccCCCCCCC-----hHHHhcCcccccC
Q 018734          234 RNLLSRIFVANPSRRIT-----IKEIKSHPWFLKN  263 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps-----~~eil~hp~~~~~  263 (351)
                      ++||.+||++||.+|||     ++++++||||+..
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            99999999999999999     7999999999765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-62  Score=444.47  Aligned_cols=259  Identities=34%  Similarity=0.580  Sum_probs=216.4

Q ss_pred             CCCeeEee-eecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHh-cCCCCCcceEEEEEEc----CCEEE
Q 018734            1 MEKYELMK-DIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHK-QLRHPNIIRFKEVVLT----PTHLA   74 (351)
Q Consensus         1 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~-~l~hp~Iv~~~~~~~~----~~~~~   74 (351)
                      +++|++.. .||+|+||+||+|.+..+++.||||++...    ..+.+|+.++. .++|||||+++++|.+    ...+|
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            47899875 599999999999999999999999998653    46778998865 5589999999999875    46799


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEeccCCCcccC
Q 018734           75 IVMEYAAGGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP-APRLKICDFGYSKSSL  151 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~-~~~vkL~DFg~a~~~~  151 (351)
                      +|||||+||+|.+++.+.  ..+++.+++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+|+...
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence            999999999999999874  3699999999999999999999999999999999999997543 4569999999998766


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCC--ccCC
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPD--YVHI  229 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  229 (351)
                      ........+||+.|||||++.+..|+ .++|||||||++|+|++|++||...........+...+....+.+|.  +..+
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV  244 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred             CCCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence            66666778899999999999888775 45999999999999999999998766544444444444444444443  3468


Q ss_pred             CHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          230 SQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       230 ~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                      |+++.+||.+||+.||++|||+.|+|+||||.+..
T Consensus       245 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            99999999999999999999999999999997643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-60  Score=433.41  Aligned_cols=254  Identities=33%  Similarity=0.564  Sum_probs=218.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc----ccCHHHHHHHHHH-hcCCCCCcceEEEEEEcCCEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH----KIDANVAREIINH-KQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~~-~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      |++|++++.||+|+||+||+|.+..+++.||||++.+..    .....+..|..++ +.++|||||++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            789999999999999999999999999999999997532    2223456666665 47899999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-C
Q 018734           76 VMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~  154 (351)
                      |||||+||+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+..... .
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~--~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC--ceeccccchhhhcccccc
Confidence            999999999999999999999999999999999999999999999999999999998666  4999999999854433 3


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHH
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCR  234 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (351)
                      .....+||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.+...    ....+......+|  ..+|+.+.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~  231 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNH-SVDWWSFGVLLYEMLIGQSPFHGQDEEE----LFHSIRMDNPFYP--RWLEKEAK  231 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCc-hhhhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCC--ccCCHHHH
Confidence            334468999999999999888865 5999999999999999999998765433    3333444444444  36899999


Q ss_pred             HHHHHhcccCCCCCCChH-HHhcCcccccC
Q 018734          235 NLLSRIFVANPSRRITIK-EIKSHPWFLKN  263 (351)
Q Consensus       235 ~li~~~L~~~P~~Rps~~-eil~hp~~~~~  263 (351)
                      +||.+||++||.+|||+. ++++||||.+.
T Consensus       232 dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         232 DLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            999999999999999995 89999999763

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-60  Score=426.38  Aligned_cols=260  Identities=29%  Similarity=0.474  Sum_probs=215.6

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |++|++++.||+|+||+||+|.+..+++.||||++....   .....+.+|+.++++++|||||++++++.+++.+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            799999999999999999999999999999999986543   23567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-C
Q 018734           78 EYAAGGELFERI-C-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-S  154 (351)
Q Consensus        78 e~~~~~~L~~~l-~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~  154 (351)
                      |||.++ +...+ . ....+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+|+..... .
T Consensus        81 e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~--~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSTTHHHHHCCCSB
T ss_pred             eecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC--cceeccCCcceeccCCcc
Confidence            999764 44444 3 345699999999999999999999999999999999999998766  4999999999754332 3


Q ss_pred             CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC------------
Q 018734          155 RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK------------  222 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------  222 (351)
                      .....+||+.|+|||++....+.+.++|||||||++|+|++|+.||...+..+.+..+..........            
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK  237 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence            34456899999999999888887788999999999999999999998876555554444332111100            


Q ss_pred             --CCC---------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          223 --IPD---------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       223 --~~~---------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                        .+.         ...+|+++.+||.+||++||.+|||+.|+|+||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence              000         12467899999999999999999999999999999754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-61  Score=425.84  Aligned_cols=251  Identities=31%  Similarity=0.513  Sum_probs=215.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-------cCHHHHHHHHHHhcCC--CCCcceEEEEEEcCCE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-------IDANVAREIINHKQLR--HPNIIRFKEVVLTPTH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~~~~l~--hp~Iv~~~~~~~~~~~   72 (351)
                      +||++.+.||+|+||+||+|.+..+++.||||++.+...       ....+.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            589999999999999999999999999999999875321       1234668999999886  8999999999999999


Q ss_pred             EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           73 LAIVMEYAAG-GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        73 ~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      +|+||||+.+ +++..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+. +.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceecc
Confidence            9999999976 57888888888999999999999999999999999999999999999997543 359999999997543


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCH
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQ  231 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (351)
                       .......+||+.|+|||++.+..++++++|||||||++|+|++|+.||....          .+......++  ..+|+
T Consensus       163 -~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~--~~~s~  229 (273)
T d1xwsa_         163 -DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFR--QRVSS  229 (273)
T ss_dssp             -SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCS--SCCCH
T ss_pred             -cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCCC--CCCCH
Confidence             3334567899999999999888877777999999999999999999997521          1223333333  36899


Q ss_pred             hHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          232 DCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       232 ~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                      ++.+||.+||+.||.+|||++|+|+||||++...+
T Consensus       230 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence            99999999999999999999999999999876543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-60  Score=430.30  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=212.8

Q ss_pred             EeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc------cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEec
Q 018734            6 LMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK------IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      .++.||+|+||+||+|.+..+|+.||||++.....      ....+.+|+.++++++|||||++++++.+++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            46889999999999999999999999999865432      234688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-CCCCC
Q 018734           80 AAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-SRPKS  158 (351)
Q Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-~~~~~  158 (351)
                      |.++++..+......+++..++.+++||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... .....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence            998887777777778999999999999999999999999999999999999987664  999999999764433 23345


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-CC-------------
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-IP-------------  224 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-------------  224 (351)
                      .+||+.|+|||++.+...++.++|||||||++|+|++|.+||......+.+..+.......... .+             
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS  239 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence            6899999999999877666777999999999999999999998877666555554432211100 00             


Q ss_pred             --C------ccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          225 --D------YVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       225 --~------~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                        .      +..+++++.+||.+||+.||++|||+.|+|+||||+..
T Consensus       240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence              0      12467899999999999999999999999999999754

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-59  Score=420.42  Aligned_cols=259  Identities=29%  Similarity=0.432  Sum_probs=215.1

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |+||++++.||+|+||+||+|+++ +++.||||++....   .....+.+|+.++++++|||||++++++.+++..+++|
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            799999999999999999999996 67999999997643   23467889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~  156 (351)
                      +++.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|....... ..
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~  157 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY  157 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCcccc
Confidence            99988777777777888999999999999999999999999999999999999987664  9999999987543332 23


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccC-C------------
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYK-I------------  223 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~------------  223 (351)
                      ....|++.|+|||++.+..+.+.++|||||||++|+|++|+.||......+.+..+.......... .            
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            445799999999999887777788999999999999999999998876655554443322111000 0            


Q ss_pred             ----------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCccccc
Q 018734          224 ----------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLK  262 (351)
Q Consensus       224 ----------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~  262 (351)
                                .....+++.+.+||.+||++||++|||++|+|+||||++
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                      012346889999999999999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-58  Score=410.56  Aligned_cols=263  Identities=28%  Similarity=0.462  Sum_probs=221.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEE
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVM   77 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~   77 (351)
                      |+||++++.||+|+||+||+|++..+++.||||+++....   ....+.+|+.+++.++|||||++++++.+....++|+
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            7999999999999999999999999999999999865433   2356889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-CC
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-RP  156 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-~~  156 (351)
                      +++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||.|+...... ..
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccc
Confidence            99999999998888889999999999999999999999999999999999999987664  9999999998654433 33


Q ss_pred             CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc---------------
Q 018734          157 KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY---------------  221 (351)
Q Consensus       157 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  221 (351)
                      ....+++.|+|||++.+..+.+.++|||||||++|+|++|+.||....+.......+........               
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccc
Confidence            44568899999999988777677799999999999999999998766554443333322211100               


Q ss_pred             ---------CCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          222 ---------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       222 ---------~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                               .......+++.+.+||.+||++||.+|||++|+|+||||++..+
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                     00112346789999999999999999999999999999987544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-58  Score=417.16  Aligned_cols=259  Identities=27%  Similarity=0.387  Sum_probs=210.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-CcEEEEEEeccCc---ccCHHHHHHHHHHhcC---CCCCcceEEEEEEc-----
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-KELVAMKYIERGH---KIDANVAREIINHKQL---RHPNIIRFKEVVLT-----   69 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l---~hp~Iv~~~~~~~~-----   69 (351)
                      ++|++++.||+|+||+||+|++..+ ++.||||++....   .....+.+|+.+++.|   +|||||+++++|..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            6899999999999999999999755 6789999986532   2233566777776665   79999999999853     


Q ss_pred             CCEEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734           70 PTHLAIVMEYAAGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus        70 ~~~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      ...++++|||+.++.+..... ....+++..++.++.||+.||.|||++||+||||||+|||++..+.  +||+|||+++
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~  164 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLAR  164 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhh
Confidence            357899999998877654443 4456999999999999999999999999999999999999977664  9999999998


Q ss_pred             ccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhcc-CC----
Q 018734          149 SSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQY-KI----  223 (351)
Q Consensus       149 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~----  223 (351)
                      ...........+||+.|+|||++.+..++. ++|||||||++|||++|++||......+.+..+......... .+    
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~-~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYAT-PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  243 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCT-HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCCh-hehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccc
Confidence            766566666778999999999998888765 499999999999999999999887765555554433211000 00    


Q ss_pred             ----------------CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          224 ----------------PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       224 ----------------~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                      .....+++.+.+||.+||++||.+|||+.|+|+||||++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                            0123478899999999999999999999999999999753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-58  Score=413.60  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=213.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||+||+|.+..+++.||||+++......+.+.+|+.++++++|||||++++++.+++.+|+|||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            47899999999999999999999999999999998776666789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CC
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PK  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~  157 (351)
                      +|+|..++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++  ++||+|||+|+.......  ..
T Consensus        97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~--~~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG--CEEECCCCCTTTCCSSSSEEET
T ss_pred             CcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC--cEEEccccceeecCCCCceeec
Confidence            99999998754  5689999999999999999999999999999999999998776  499999999985433322  23


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ...||+.|+|||++.+..++ .++|||||||++|||++|..||....+...+.+.    .......+.+..+++.+.+||
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~----i~~~~~~~~~~~~~~~l~~li  249 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LEKDYRMERPEGCPEKVYELM  249 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH----HhcCCCCCCCccchHHHHHHH
Confidence            34589999999999888875 5599999999999999987777665554443332    333445555567999999999


Q ss_pred             HHhcccCCCCCCChHHHhc
Q 018734          238 SRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~  256 (351)
                      .+||+.||.+|||++++++
T Consensus       250 ~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         250 RACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-58  Score=420.25  Aligned_cols=257  Identities=28%  Similarity=0.416  Sum_probs=211.5

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcC------CEEEEE
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTP------THLAIV   76 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~------~~~~lv   76 (351)
                      +|+.+++||+|+||+||+|++..+++.||||++.+....   ..+|+.++++++|||||+++++|...      .++|+|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            599999999999999999999999999999999775433   34799999999999999999998543      468999


Q ss_pred             EeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           77 MEYAAGGELFER---ICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        77 ~e~~~~~~L~~~---l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      ||||+++.+...   ......+++..++.+++||+.||.|||++||+||||||+|||++.++. .+||+|||+++.....
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~  176 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRG  176 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTT
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCC
Confidence            999976543222   234567999999999999999999999999999999999999986643 4999999999876666


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-------------hc
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------------VQ  220 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------------~~  220 (351)
                      ......+||+.|+|||++.+...++.++|||||||++|||++|++||......+.+..+......             ..
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~  256 (350)
T d1q5ka_         177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  256 (350)
T ss_dssp             SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---C
T ss_pred             cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhh
Confidence            66677889999999999877665567799999999999999999999887765555444332111             00


Q ss_pred             cCCC----------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          221 YKIP----------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       221 ~~~~----------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ..++          ....+++++.+||.+||++||.+|||+.|+|+||||.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            0111          123478899999999999999999999999999999764

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.8e-57  Score=415.11  Aligned_cols=256  Identities=23%  Similarity=0.432  Sum_probs=213.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-CCCcceEEEEEEcC--CEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-HPNIIRFKEVVLTP--THLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~--~~~~lv~e   78 (351)
                      ++|+++++||+|+||+||+|++..+++.||||++....  ...+.+|+.+++.++ ||||++++++|...  ..+++|||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            68999999999999999999999999999999987643  356889999999995 99999999999754  56999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCCC
Q 018734           79 YAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKS  158 (351)
Q Consensus        79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~~  158 (351)
                      ||.+++|....   +.+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|+..........
T Consensus       113 ~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~~  188 (328)
T d3bqca1         113 HVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNV  188 (328)
T ss_dssp             CCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCCS
T ss_pred             ecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcccc
Confidence            99999987653   46999999999999999999999999999999999999975543 489999999987666666677


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhh----------c--------
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAV----------Q--------  220 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------~--------  220 (351)
                      .+||+.|+|||++.+....+.++||||+||++|+|++|+.||....+.......+......          .        
T Consensus       189 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  268 (328)
T d3bqca1         189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN  268 (328)
T ss_dssp             CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGG
T ss_pred             cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccc
Confidence            7899999999999887766677999999999999999999998766543322222211100          0        


Q ss_pred             --------------cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          221 --------------YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       221 --------------~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                                    ...+....+++++.+||.+||++||.+|||++|+|+||||+..
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                          0011223478899999999999999999999999999999763

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-58  Score=408.46  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=200.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc---cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEe
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK---IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e   78 (351)
                      ++|++++.||+|+||+||+++..   ..||||+++....   ....+.+|+.++++++|||||++++++. ...+++|||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            57999999999999999999754   3599999875432   2256789999999999999999999864 456899999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC---
Q 018734           79 YAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS---  154 (351)
Q Consensus        79 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~---  154 (351)
                      ||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+......   
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~--~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS--SEEECCCCCSCC--------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC--CEEEccccceeeccccCCcc
Confidence            99999999999754 5699999999999999999999999999999999999998766  49999999997543222   


Q ss_pred             CCCCcccCCCccCcccccCCc--CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          155 RPKSTVGTPAYIAPEVLSRRE--YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       155 ~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                      ......||+.|||||++.+..  ..+.++|||||||++|||+||+.||........+...+.+.............+++.
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  241 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA  241 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence            224457999999999986533  235669999999999999999999988766554443333211111111123457899


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.+||.+||+.||.+|||+.+|+++
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999976

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-58  Score=421.30  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=207.0

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCC------E
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPT------H   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~------~   72 (351)
                      ++|++++.||+|+||+||+|.+..+|+.||||++.+....   ...+.+|+.+++.++|||||+++++|...+      .
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            6899999999999999999999999999999999764332   246789999999999999999999997654      5


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCC
Q 018734           73 LAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLL  152 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~  152 (351)
                      +|+||||| +.+|...+ +.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..  
T Consensus        98 ~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~--  171 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQA--  171 (346)
T ss_dssp             CEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC--
T ss_pred             EEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceecc--
Confidence            79999999 55666655 4568999999999999999999999999999999999999987664  999999999854  


Q ss_pred             CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh--------------
Q 018734          153 HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA--------------  218 (351)
Q Consensus       153 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------  218 (351)
                      ....+..+||+.|+|||++.+..+.+.++|||||||++|+|++|++||........+.........              
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (346)
T d1cm8a_         172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA  251 (346)
T ss_dssp             CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHH
T ss_pred             CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhh
Confidence            334456789999999999988777677799999999999999999999887654444333221110              


Q ss_pred             -----h--ccCC----CCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCC
Q 018734          219 -----V--QYKI----PDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNL  264 (351)
Q Consensus       219 -----~--~~~~----~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~  264 (351)
                           .  ....    .....+++.+.+||.+||+.||.+|||+.|+|+||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                 0  0000    11235789999999999999999999999999999998653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-57  Score=412.10  Aligned_cols=261  Identities=24%  Similarity=0.369  Sum_probs=209.5

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCc---ccCHHHHHHHHHHhcCCCCCcceEEEEEEc--------
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGH---KIDANVAREIINHKQLRHPNIIRFKEVVLT--------   69 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~--------   69 (351)
                      ++||++++.||+|+||+||+|++..+|+.||||++....   .....+.+|+.++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            479999999999999999999999999999999986542   234678899999999999999999999865        


Q ss_pred             CCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           70 PTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        70 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      .+.+|+|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~  166 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARA  166 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeee
Confidence            3468999999988776666666778999999999999999999999999999999999999987664  99999999964


Q ss_pred             cCC-----CCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC-
Q 018734          150 SLL-----HSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI-  223 (351)
Q Consensus       150 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  223 (351)
                      ...     .......+||+.|+|||++.+...++.++|||||||++|+|++|++||...........+........... 
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            322     22334467999999999998776556679999999999999999999987665444433333221111000 


Q ss_pred             CCc-------------------------cCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccC
Q 018734          224 PDY-------------------------VHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKN  263 (351)
Q Consensus       224 ~~~-------------------------~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~  263 (351)
                      ...                         ...++.+.+||.+||++||++|||++|+|+||||+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            000                         0136788999999999999999999999999999753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=401.78  Aligned_cols=247  Identities=23%  Similarity=0.410  Sum_probs=200.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++++.||+|+||.||+|.+.+ ++.||||+++........+.+|+.++++++|||||++++++..++.+++|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            589999999999999999999874 6789999998776667789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CCC
Q 018734           82 GGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKS  158 (351)
Q Consensus        82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~~  158 (351)
                      +|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.  +||+|||+++.......  ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~  161 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTG  161 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC---------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceeecc
Confidence            99999988754 56899999999999999999999999999999999999987764  99999999985443322  234


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcC-CCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..||+.|+|||++.+..++ .++|||||||++|||+|+ .+||... ....+..   .+.. ....+.+...++++.+|+
T Consensus       162 ~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~~~~---~i~~-~~~~~~p~~~~~~l~~li  235 (263)
T d1sm2a_         162 TKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENR-SNSEVVE---DIST-GFRLYKPRLASTHVYQIM  235 (263)
T ss_dssp             ---CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSC-CHHHHHH---HHHH-TCCCCCCTTSCHHHHHHH
T ss_pred             eecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCC-CHHHHHH---HHHh-cCCCCCccccCHHHHHHH
Confidence            5799999999999888875 559999999999999995 5555443 3322222   2222 233444456899999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.||++|||+++|++|
T Consensus       236 ~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         236 NHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.8e-58  Score=407.07  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=202.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccC----HHHHHHHHHHhcCCCCCcceEEEEEEcCC----EE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKID----ANVAREIINHKQLRHPNIIRFKEVVLTPT----HL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~----~~   73 (351)
                      +||++.+.||+|+||.||+|.+..+++.||||++.......    ..+.+|+.+++.++|||||++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            68999999999999999999999999999999997654332    45789999999999999999999997653    48


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      |+|||||+|++|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  ++|+|||++......
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADS  164 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC--
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhccc
Confidence            999999999999999999999999999999999999999999999999999999999987765  999999988643322


Q ss_pred             ----CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCC--CCcc
Q 018734          154 ----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKI--PDYV  227 (351)
Q Consensus       154 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  227 (351)
                          ......+||+.|||||++.+..++ .++|||||||++|+|++|++||......+.+..    +.......  ....
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~  239 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ----HVREDPIPPSARHE  239 (277)
T ss_dssp             --------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHCCCCCGGGTSS
T ss_pred             cccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHH----HHhcCCCCCchhcc
Confidence                233456799999999999887775 459999999999999999999987654433332    22222221  2234


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHHhcCccc
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEIKSHPWF  260 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~  260 (351)
                      .+|+.+.+||.+||++||.+||+..+.+.|+|+
T Consensus       240 ~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         240 GLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            689999999999999999999954444445554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=403.02  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=208.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++++.||+|+||.||+|.+. +++.||||++.........+.+|+.++++++|||||++++++. ++.+|+|||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCC
Confidence            58999999999999999999986 4678999999876666678999999999999999999999875 456799999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--CCC
Q 018734           82 GGELFERICNA--GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPK  157 (351)
Q Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~~~  157 (351)
                      +|+|.+++...  .++++..+..++.||+.||.|||+++|+||||||+||||+.++.  +||+|||+|+......  ...
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCT
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCcccccc
Confidence            99999877543  36999999999999999999999999999999999999987664  9999999998643322  234


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ...||+.|||||++.+..++ .++|||||||++|||+||..|+..........   ..+. .....+.+..+++++.+|+
T Consensus       169 ~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~---~~i~-~~~~~~~p~~~~~~l~~li  243 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QNLE-RGYRMVRPDNCPEELYQLM  243 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred             ccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHH---HHHH-hcCCCCCcccChHHHHHHH
Confidence            56799999999999887775 55999999999999999655554443333222   2222 2334444557899999999


Q ss_pred             HHhcccCCCCCCChHHHhc--Ccccc
Q 018734          238 SRIFVANPSRRITIKEIKS--HPWFL  261 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~--hp~~~  261 (351)
                      .+||+.||++|||++++++  |+||.
T Consensus       244 ~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         244 RLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999988  77774

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=413.15  Aligned_cols=249  Identities=22%  Similarity=0.367  Sum_probs=209.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc-----EEEEEEeccC--cccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE-----LVAMKYIERG--HKIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++++.||+|+||+||+|++..+++     .||+|.+...  ......+.+|+.+++++ +|||||++++++.+.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            579999999999999999999876543     6999988653  23346788999999988 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 018734           74 AIVMEYAAGGELFERICNA-----------------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTL  130 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~-----------------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIl  130 (351)
                      |+|||||++|+|.+++...                       +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            9999999999999999754                       24889999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeccCCCcccCCCCCC---CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCCh
Q 018734          131 LDGSPAPRLKICDFGYSKSSLLHSRP---KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDP  206 (351)
Q Consensus       131 l~~~~~~~vkL~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  206 (351)
                      ++.++  ++||+|||+|+........   ....||+.|||||++.+..++ .++|||||||++|||++ |++||.+....
T Consensus       197 l~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         197 VTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             EETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             cccCC--eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            98776  4999999999865443322   345689999999999888775 55999999999999997 89999887665


Q ss_pred             hHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ..+.+.    .......+.+..+|+++.+||.+||+.||++|||+++|++|
T Consensus       274 ~~~~~~----~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         274 ANFYKL----IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHH----HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHH----HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            444433    33445556666789999999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-57  Score=411.62  Aligned_cols=259  Identities=30%  Similarity=0.546  Sum_probs=220.0

Q ss_pred             CCCeeEeeeecccCceEEEEEEE---cCCCcEEEEEEeccCc-----ccCHHHHHHHHHHhcCCC-CCcceEEEEEEcCC
Q 018734            1 MEKYELMKDIGSGNFGVARLMRN---KNTKELVAMKYIERGH-----KIDANVAREIINHKQLRH-PNIIRFKEVVLTPT   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~~~~l~h-p~Iv~~~~~~~~~~   71 (351)
                      |++|++++.||+|+||.||+|.+   ..+|+.||||++.+..     .....+.+|+.++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            57899999999999999999987   4478999999986532     233567789999999977 89999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      .++++|||+.+|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+|+...
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~--~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFV  180 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEESCSSEEEECC
T ss_pred             ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC--CEEEeeccchhhhc
Confidence            9999999999999999999999999999999999999999999999999999999999998765  49999999987543


Q ss_pred             CC--CCCCCcccCCCccCcccccCCc-CCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          152 LH--SRPKSTVGTPAYIAPEVLSRRE-YDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       152 ~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                      ..  .......||+.|+|||.+.+.. +.+.++|||||||++|+|++|+.||...........+..........+  +..
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~--~~~  258 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQE  258 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC--CTT
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC--ccc
Confidence            22  2234567999999999997654 345669999999999999999999988776666655555544443333  346


Q ss_pred             CCHhHHHHHHHhcccCCCCCC-----ChHHHhcCcccccC
Q 018734          229 ISQDCRNLLSRIFVANPSRRI-----TIKEIKSHPWFLKN  263 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rp-----s~~eil~hp~~~~~  263 (351)
                      +|+.+.+||.+||++||.+||     |++|+|+||||++.
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            899999999999999999999     48999999999753

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=419.62  Aligned_cols=259  Identities=24%  Similarity=0.403  Sum_probs=209.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcC-----CEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTP-----THL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~-----~~~   73 (351)
                      +||+++++||+|+||+||+|++..+|+.||||++.+....   ...+.+|+.++++++|||||++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            6899999999999999999999999999999999765432   24578999999999999999999999643     334


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           74 AIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      +++|+++.||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.  +|++|||++...  .
T Consensus        98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~--~  172 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT--D  172 (348)
T ss_dssp             CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CC--T
T ss_pred             EEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhccc--C
Confidence            566677789999998854 57999999999999999999999999999999999999987764  999999998743  3


Q ss_pred             CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhc-------------
Q 018734          154 SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQ-------------  220 (351)
Q Consensus       154 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  220 (351)
                      .......||+.|+|||++.+..+.+.++|||||||++|+|++|++||...+.......+........             
T Consensus       173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  252 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  252 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHH
T ss_pred             cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhh
Confidence            3345567999999999988877777779999999999999999999988765544444333221100             


Q ss_pred             ------cCCC------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          221 ------YKIP------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       221 ------~~~~------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                            ...+      .+..+++.+++||.+||+.||.+|||+.|+|+||||++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                  0000      02357899999999999999999999999999999987543

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=395.63  Aligned_cols=247  Identities=22%  Similarity=0.379  Sum_probs=213.1

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|+++++||+|+||+||+++.+ +++.||||+++........+.+|+.++++++|||||++++++.+++.+++||||+.
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            68999999999999999999985 67889999998877777889999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC--CCC
Q 018734           82 GGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR--PKS  158 (351)
Q Consensus        82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~--~~~  158 (351)
                      +|+|..++.. ...+++..+..++.|+++||.|||++||+||||||+|||++.++.  +||+|||+++.......  ...
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeecc
Confidence            9999888654 467999999999999999999999999999999999999987664  99999999975433322  234


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..||+.|+|||++.+..++ .++|||||||++|||+| |+.||......+.    ...+.. ....+.+...++.+.+||
T Consensus       161 ~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~----~~~i~~-~~~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSET----AEHIAQ-GLRLYRPHLASEKVYTIM  234 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----HHHHHT-TCCCCCCTTCCHHHHHHH
T ss_pred             cCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHH----HHHHHh-CCCCCCcccccHHHHHHH
Confidence            5699999999999888875 45999999999999998 8999987764332    223332 334555567899999999


Q ss_pred             HHhcccCCCCCCChHHHhcC
Q 018734          238 SRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||+.||++|||+++|++|
T Consensus       235 ~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHH
Confidence            99999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-56  Score=403.72  Aligned_cols=248  Identities=23%  Similarity=0.385  Sum_probs=198.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc---EEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE---LVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||+||+|.+..+++   .||||++.....  ....+.+|+.++++++|||||++++++..++.+++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            579999999999999999999986654   588998865433  234688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC
Q 018734           77 MEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR  155 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~  155 (351)
                      ||||++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+||||+.++.  +||+|||+|+.......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCC
Confidence            9999999999988764 57999999999999999999999999999999999999987664  99999999985433222


Q ss_pred             C------CCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          156 P------KSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       156 ~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                      .      ....||+.|||||++.+..++ .++|||||||++|||+| |+.||......+.    +..+ ......+.+..
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~----~~~i-~~~~~~~~~~~  257 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDV----INAI-EQDYRLPPPMD  257 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHH-HTTCCCCCCTT
T ss_pred             cceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHH----HHHH-HcCCCCCCCcc
Confidence            1      223589999999999888775 45999999999999998 8999987654322    2222 23345566667


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +++.+.+||.+||+.||.+|||+.+|+++
T Consensus       258 ~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999999999864

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=412.13  Aligned_cols=260  Identities=27%  Similarity=0.441  Sum_probs=207.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCC-----EEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPT-----HLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~-----~~~   74 (351)
                      +||++++.||+|+||+||+|.+..+++.||||++.....  ....+.+|+.++++++|||||++++++....     .+|
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            589999999999999999999999999999999975432  2346789999999999999999999997653     345


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC-
Q 018734           75 IVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH-  153 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~-  153 (351)
                      ++ +++.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+|+..... 
T Consensus        88 l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~--~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          88 LV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDH  163 (345)
T ss_dssp             EE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECCGGG
T ss_pred             EE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC--CEEEcccCceeeccCCC
Confidence            55 45668999999865 4799999999999999999999999999999999999998665  4999999998754322 


Q ss_pred             ---CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh------------
Q 018734          154 ---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA------------  218 (351)
Q Consensus       154 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------  218 (351)
                         ......+||+.|+|||++.....++.++||||+||++|+|++|+.||..................            
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence               22345679999999999977766677799999999999999999999876654443332221100            


Q ss_pred             ----hccCCC---------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCC
Q 018734          219 ----VQYKIP---------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLP  265 (351)
Q Consensus       219 ----~~~~~~---------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~  265 (351)
                          .....+         .+..+++.+.+||.+||+.||.+|||+.++|+||||.+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                000010         12357889999999999999999999999999999986644

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-57  Score=400.46  Aligned_cols=244  Identities=21%  Similarity=0.327  Sum_probs=198.9

Q ss_pred             eeecccCceEEEEEEEc--CCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccCC
Q 018734            8 KDIGSGNFGVARLMRNK--NTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAAG   82 (351)
Q Consensus         8 ~~lG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~~   82 (351)
                      +.||+|+||.||+|.+.  .+++.||||++......   ...+.+|+.++++++|||||++++++.++ ..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            47999999999999754  45678999998754332   35688999999999999999999998654 57899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC----CCC
Q 018734           83 GELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR----PKS  158 (351)
Q Consensus        83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~----~~~  158 (351)
                      |+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+.......    ...
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccc
Confidence            999999999999999999999999999999999999999999999999987664  99999999975433222    233


Q ss_pred             cccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          159 TVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       159 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ..||+.|||||++.+..++ .++|||||||++|||++ |++||......+    ....+. .....+.+..+|+++.+||
T Consensus       170 ~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----~~~~i~-~~~~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLE-KGERMGCPAGCPREMYDLM  243 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----HHHHHH-TTCCCCCCTTCCHHHHHHH
T ss_pred             cCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHH----HHHHHH-cCCCCCCCcccCHHHHHHH
Confidence            4699999999999887775 45999999999999998 899998765432    222222 2334455567899999999


Q ss_pred             HHhcccCCCCCCChHHHh---cCccc
Q 018734          238 SRIFVANPSRRITIKEIK---SHPWF  260 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil---~hp~~  260 (351)
                      .+||+.||.+|||+++|+   +|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999999984   55554

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=412.88  Aligned_cols=260  Identities=27%  Similarity=0.399  Sum_probs=200.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc---CHHHHHHHHHHhcCCCCCcceEEEEEEc------CC
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI---DANVAREIINHKQLRHPNIIRFKEVVLT------PT   71 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~~~~l~hp~Iv~~~~~~~~------~~   71 (351)
                      +++|+++++||+|+||+||+|.+..+|+.||||++.+....   ...+.+|+.++++++|||||+++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            47999999999999999999999999999999999765432   2457899999999999999999999964      37


Q ss_pred             EEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccC
Q 018734           72 HLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSL  151 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~  151 (351)
                      .+|+|||||.+ ++...+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +|++|||+++...
T Consensus        96 ~~~iv~Ey~~~-~l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~  170 (355)
T d2b1pa1          96 DVYLVMELMDA-NLCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEEECCSE-EHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----
T ss_pred             eeEEEEeccch-HHHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccc
Confidence            89999999966 455554  346899999999999999999999999999999999999987654  9999999988776


Q ss_pred             CCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHh-------------
Q 018734          152 LHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMA-------------  218 (351)
Q Consensus       152 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------------  218 (351)
                      ........+||+.|+|||++.+..++.+ +||||+||++|+|++|++||...+.......++.....             
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  249 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH
T ss_pred             cccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH
Confidence            6666677789999999999988777554 99999999999999999999877654444443322110             


Q ss_pred             -----hccCCC------------------CccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcccccCCCh
Q 018734          219 -----VQYKIP------------------DYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPWFLKNLPR  266 (351)
Q Consensus       219 -----~~~~~~------------------~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~~~~~~~~  266 (351)
                           ......                  .....++++.+||++||++||++|||++|+|+||||+.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~  320 (355)
T d2b1pa1         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP  320 (355)
T ss_dssp             HHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCH
T ss_pred             HHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCc
Confidence                 000000                  001136688999999999999999999999999999876543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-56  Score=397.43  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=204.7

Q ss_pred             CCeeEeee-ecccCceEEEEEEEcC--CCcEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKD-IGSGNFGVARLMRNKN--TKELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~-lG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|.+... ||+|+||.||+|.+..  ++..||||++.....  ....+.+|+.++++++|||||++++++.++ .+|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEE
Confidence            45777774 9999999999997754  455799999876433  235688999999999999999999998754 58899


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           77 MEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      ||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++  .+||+|||+|+...... 
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~--~~Kl~DFGla~~~~~~~~  164 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKALGADDS  164 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEECTTCSC
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC--ceeeccchhhhccccccc
Confidence            999999999998765 45799999999999999999999999999999999999998766  49999999998543322 


Q ss_pred             ---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 ---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                         ......||+.|||||++.+..++ .++|||||||++|||+| |+.||......+..    ..+.. ....+.+..+|
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~----~~i~~-~~~~~~p~~~~  238 (285)
T d1u59a_         165 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----AFIEQ-GKRMECPPECP  238 (285)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH----HHHHT-TCCCCCCTTCC
T ss_pred             ccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHH----HHHHc-CCCCCCCCcCC
Confidence               22345689999999999888775 45999999999999998 99999876654322    22222 23344456789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHH---hcCccc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEI---KSHPWF  260 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~ei---l~hp~~  260 (351)
                      +++.+||.+||+.+|++|||+.+|   |+|+|+
T Consensus       239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999999988   556665

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-56  Score=396.69  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=207.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEEEeccC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIVMEYAA   81 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   81 (351)
                      ++|++.+.||+|+||.||+|.+..+ +.||||++.........+.+|+.++++++|||||++++++. ++.+++|||||.
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence            6899999999999999999999875 56999999877666678999999999999999999999985 456899999999


Q ss_pred             CCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC--CCC
Q 018734           82 GGELFERICN--AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS--RPK  157 (351)
Q Consensus        82 ~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~--~~~  157 (351)
                      +|+|..++..  .+.+++.++..++.||+.||.|||++||+||||||+||||+.++.  +||+|||+|+......  ...
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----------
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCceeec
Confidence            9999888754  457999999999999999999999999999999999999987764  9999999998543222  223


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNLL  237 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  237 (351)
                      ...||+.|+|||++....++ .++|||||||++|||++|..||...........   .+. .....+....+++.+.+||
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~---~i~-~~~~~~~~~~~~~~l~~li  247 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---QVE-RGYRMPCPPECPESLHDLM  247 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHH-TTCCCCCCTTSCHHHHHHH
T ss_pred             cccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHH---HHH-hcCCCCCCcccCHHHHHHH
Confidence            45799999999999888875 559999999999999997666655444333322   222 2334555667899999999


Q ss_pred             HHhcccCCCCCCChHHHhc--CcccccC
Q 018734          238 SRIFVANPSRRITIKEIKS--HPWFLKN  263 (351)
Q Consensus       238 ~~~L~~~P~~Rps~~eil~--hp~~~~~  263 (351)
                      .+||+.||++|||+++|++  ++||...
T Consensus       248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         248 CQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            9999999999999999987  7888654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=387.65  Aligned_cols=248  Identities=23%  Similarity=0.319  Sum_probs=199.6

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC----cEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK----ELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++.+.||+|+||.||+|....++    ..||||++......  ...+.+|+.++++++|||||++++++.+...+++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            57999999999999999999987654    47999998754332  3467899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      |||||.++++...+... +.+++..+..++.||+.||.|||+++|+||||||+||||+.++.  +||+|||+|+......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC--------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCC
Confidence            99999999998887654 67999999999999999999999999999999999999987764  9999999998543322


Q ss_pred             C----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 R----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .    .....||+.|||||++.+..++. ++|||||||++|||++|..||........+..   . .....+.+.+..++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~-~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~---~-i~~~~~~~~~~~~~  239 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---A-INDGFRLPTPMDCP  239 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---H-HHTTCCCCCCTTCB
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCC-cccccccHHHHHHHHhCCCCccccCCHHHHHH---H-HhccCCCCCchhhH
Confidence            1    22346899999999998887754 59999999999999997666655444333222   2 22334555666789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ..+.+||.+||+.+|++|||+.+|++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-55  Score=389.18  Aligned_cols=247  Identities=24%  Similarity=0.380  Sum_probs=196.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC---cEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK---ELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++++.||+|+||.||+|.+..++   ..||||.+......  ...+.+|+.++++++|||||++++++. ++.+|+|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            58999999999999999999986543   56889988654332  356889999999999999999999985 5678999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC-
Q 018734           77 MEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS-  154 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~-  154 (351)
                      ||||.+|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+|+...... 
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC------------
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcc
Confidence            999999999988755 457999999999999999999999999999999999999987764  9999999998543322 


Q ss_pred             -CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHh
Q 018734          155 -RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQD  232 (351)
Q Consensus       155 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (351)
                       ......||+.|+|||++.+..++ .++|||||||++|||++ |.+||......+....    +.. ....+.+..+|+.
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~  237 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IEN-GERLPMPPNCPPT  237 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH----HHT-TCCCCCCTTCCHH
T ss_pred             eeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHH
Confidence             23345689999999999887775 45999999999999998 8999987765443332    222 2334556689999


Q ss_pred             HHHHHHHhcccCCCCCCChHHHhcC
Q 018734          233 CRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       233 ~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.+||.+||+.||.+|||+.+|++|
T Consensus       238 ~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         238 LYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-54  Score=391.28  Aligned_cols=247  Identities=20%  Similarity=0.353  Sum_probs=200.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCc----EEEEEEeccCc--ccCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKE----LVAMKYIERGH--KIDANVAREIINHKQLRHPNIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~l   75 (351)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|++....  .....+.+|+.++++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999999988776    57888876533  2345789999999999999999999999865 5677


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCC
Q 018734           76 VMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHS  154 (351)
Q Consensus        76 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~  154 (351)
                      +++++.+++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTC
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccccc
Confidence            8899999999888765 457999999999999999999999999999999999999987764  9999999998543332


Q ss_pred             C---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCC
Q 018734          155 R---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHIS  230 (351)
Q Consensus       155 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (351)
                      .   .....||+.|||||++.+..++ .++|||||||++|||+| |.+||....... +...+    ......+.+..++
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~~~i----~~~~~~~~p~~~~  239 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSIL----EKGERLPQPPICT  239 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-HHHHH----HHTCCCCCCTTBC
T ss_pred             ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-HHHHH----HcCCCCCCCcccC
Confidence            2   2334689999999999888775 55999999999999998 788987765433 22222    2234445556789


Q ss_pred             HhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          231 QDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       231 ~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.+.+|+.+||+.||.+|||+.+|+.|
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            999999999999999999999999987

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-54  Score=389.44  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=205.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcE--EEEEEeccCc--ccCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKEL--VAMKYIERGH--KIDANVAREIINHKQL-RHPNIIRFKEVVLTPTHLAIV   76 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~--~~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~~lv   76 (351)
                      ++|++.+.||+|+||.||+|.+..++..  ||||.+....  .....+.+|+.+++++ +|||||++++++.+.+.+|+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            6899999999999999999999888764  6778775432  2335688999999998 799999999999999999999


Q ss_pred             EeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEE
Q 018734           77 MEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLK  140 (351)
Q Consensus        77 ~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vk  140 (351)
                      ||||++|+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.  +|
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~k  167 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AK  167 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--eE
Confidence            9999999999999654                56999999999999999999999999999999999999987764  99


Q ss_pred             EeccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCC-CCCCCCCChhHHHHHHHHHHhh
Q 018734          141 ICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA-YPFEDQEDPKNFRKTISRIMAV  219 (351)
Q Consensus       141 L~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~  219 (351)
                      |+|||+|+............||+.|+|||.+.+..++ .++|||||||++|||++|. +||.......    +...+. .
T Consensus       168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~----~~~~i~-~  241 (309)
T d1fvra_         168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP-Q  241 (309)
T ss_dssp             ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGG-G
T ss_pred             EccccccccccccccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHH----HHHHHH-h
Confidence            9999999866555555566799999999999888875 4599999999999999975 5666544322    222222 2


Q ss_pred             ccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          220 QYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       220 ~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ....+.+..+++++.+||.+||+.||++|||+.+|+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            34455556789999999999999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=381.52  Aligned_cols=244  Identities=24%  Similarity=0.386  Sum_probs=197.7

Q ss_pred             CCCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEc-CCEEEEEEec
Q 018734            1 MEKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLAIVMEY   79 (351)
Q Consensus         1 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~-~~~~~lv~e~   79 (351)
                      +++|++++.||+|+||.||+|+.+  |+.||||+++.+. ..+.+.+|+.++++++|||||++++++.. .+.+|+||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            578999999999999999999985  6789999997643 34678999999999999999999998855 4668999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCCCC
Q 018734           80 AAGGELFERICNAG--RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPK  157 (351)
Q Consensus        80 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~~~  157 (351)
                      +++|+|.+++.+.+  .+++..+..++.||+.||.|||+++|+||||||+|||++.++.  +||+|||+++...  ....
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~--~~~~  158 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS--STQD  158 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecC--CCCc
Confidence            99999999986543  4899999999999999999999999999999999999987764  9999999987432  3334


Q ss_pred             CcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhHHHH
Q 018734          158 STVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDCRNL  236 (351)
Q Consensus       158 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (351)
                      ...+|+.|+|||++.+..++ .++|||||||++|||+| |++||......+....    +. .....+.+..+++.+.+|
T Consensus       159 ~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~----i~-~~~~~~~~~~~~~~~~~l  232 (262)
T d1byga_         159 TGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VE-KGYKMDAPDGCPPAVYEV  232 (262)
T ss_dssp             ---CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HT-TTCCCCCCTTCCHHHHHH
T ss_pred             cccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH----HH-cCCCCCCCccCCHHHHHH
Confidence            45789999999999887764 55999999999999998 7888876654333222    22 233445555789999999


Q ss_pred             HHHhcccCCCCCCChHHHhcC
Q 018734          237 LSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       237 i~~~L~~~P~~Rps~~eil~h  257 (351)
                      |.+||+.||.+|||+.+++++
T Consensus       233 i~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         233 MKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-54  Score=388.13  Aligned_cols=249  Identities=23%  Similarity=0.361  Sum_probs=195.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcC-CE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTP-TH   72 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~-~~   72 (351)
                      ++|++++.||+|+||.||+|.+..     +++.||||++.....  ....+.+|...+.++ +|||||.+++++..+ ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            579999999999999999999754     346899999875432  234566777777666 689999999988654 56


Q ss_pred             EEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 018734           73 LAIVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPA  136 (351)
Q Consensus        73 ~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~  136 (351)
                      +++|||||++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+||||+.++.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~  172 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV  172 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc
Confidence            89999999999999998653                24889999999999999999999999999999999999987664


Q ss_pred             CCEEEeccCCCcccCCCC---CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcC-CCCCCCCCChhHHHHH
Q 018734          137 PRLKICDFGYSKSSLLHS---RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKT  212 (351)
Q Consensus       137 ~~vkL~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~  212 (351)
                        +||+|||+|+......   .....+||+.|||||++.+..++ .++|||||||++|||++| .+||........+...
T Consensus       173 --~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~  249 (299)
T d1ywna1         173 --VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR  249 (299)
T ss_dssp             --EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHH
T ss_pred             --EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              9999999997543222   23446799999999999887775 559999999999999986 5678776655444433


Q ss_pred             HHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          213 ISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      +.    .....+.+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       250 ~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         250 LK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HH----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hh----cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            32    233344445689999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-54  Score=381.12  Aligned_cols=247  Identities=28%  Similarity=0.426  Sum_probs=196.7

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCC-C--cEEEEEEeccCcc----cCHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNT-K--ELVAMKYIERGHK----IDANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~~----~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++++.||+|+||.||+|..... +  ..||||++.....    ....+.+|+.++++++|||||++++++.+ ..++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5799999999999999999986433 2  3689998865432    22468899999999999999999999965 4678


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCC
Q 018734           75 IVMEYAAGGELFERICN-AGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLH  153 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~  153 (351)
                      +|||||.+++|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhcccC
Confidence            99999999999887654 457999999999999999999999999999999999999987764  999999999864333


Q ss_pred             CC----CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHHHHHHHHhhccCCCCccC
Q 018734          154 SR----PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVH  228 (351)
Q Consensus       154 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (351)
                      ..    .....||+.|+|||++.+..++ .++|||||||++|||+| |+.||...+..+    ....+.......+.+..
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~  239 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKEGERLPRPED  239 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHHHTSCCCCCCCTT
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHH----HHHHHHhCCCCCCCccc
Confidence            22    2334688899999999887765 55999999999999998 899998765433    34445555566666778


Q ss_pred             CCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          229 ISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       229 ~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +|+.+.+||.+||+.||++|||+.+|++
T Consensus       240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         240 CPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=382.85  Aligned_cols=247  Identities=24%  Similarity=0.358  Sum_probs=201.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCC-------cEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCC
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTK-------ELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPT   71 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~   71 (351)
                      ++|++++.||+|+||.||+|++..++       ..||||+++....  ....+.+|...+.++ +|||||++++++.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            68999999999999999999986654       4799999976543  235677888888777 8999999999999999


Q ss_pred             EEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           72 HLAIVMEYAAGGELFERICNA----------------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        72 ~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      .+++|||||.+|+|.+++...                ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            999999999999999999654                3589999999999999999999999999999999999998776


Q ss_pred             CCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                      .  +||+|||+++.......   .....||+.|+|||++.+..++ .++|||||||++|||++ |++||.......    
T Consensus       173 ~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~----  245 (299)
T d1fgka_         173 V--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----  245 (299)
T ss_dssp             C--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----
T ss_pred             C--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHH----
Confidence            4  99999999986543332   3345799999999999888775 55999999999999998 788887655432    


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      .... .......+.+..+++.+.+||.+||+.||++|||+.+|++
T Consensus       246 ~~~~-i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         246 LFKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHH-HHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHH-HHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            2222 2234445556678999999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-53  Score=382.27  Aligned_cols=247  Identities=23%  Similarity=0.354  Sum_probs=204.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCccc--CHHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHKI--DANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++++.||+|+||+||+|+..     .+++.||||++......  ...+.+|+.++++++||||+++++++...+..+
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~   92 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC   92 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence            57999999999999999999975     35678999998764332  356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 018734           75 IVMEYAAGGELFERICNAG------------------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTL  130 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIl  130 (351)
                      ++|||+.+|+|.+++....                        .+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL  172 (301)
T d1lufa_          93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL  172 (301)
T ss_dssp             EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceE
Confidence            9999999999999986432                        3789999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEeccCCCcccCCC---CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCC-CCCCCCCCh
Q 018734          131 LDGSPAPRLKICDFGYSKSSLLH---SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGA-YPFEDQEDP  206 (351)
Q Consensus       131 l~~~~~~~vkL~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~  206 (351)
                      ++.++.  +||+|||+|+.....   .......||+.|+|||++.+..++ .++|||||||++|||++|. +||......
T Consensus       173 ld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         173 VGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             ECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            987664  999999998754322   223346799999999999888876 5599999999999999985 577665443


Q ss_pred             hHHHHHHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          207 KNFRKTISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      +.    ...+.... ..+.+..+++++.+||.+||+.+|.+|||+.+|++
T Consensus       250 e~----~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         250 EV----IYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HH----HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH----HHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            32    23333332 33444578999999999999999999999999965

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=378.32  Aligned_cols=248  Identities=23%  Similarity=0.360  Sum_probs=206.9

Q ss_pred             CCeeEeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCcc--cCHHHHHHHHHHhcC-CCCCcceEEEEEEcCCEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNK-----NTKELVAMKYIERGHK--IDANVAREIINHKQL-RHPNIIRFKEVVLTPTHL   73 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~~~~l-~hp~Iv~~~~~~~~~~~~   73 (351)
                      ++|++++.||+|+||.||+|...     .+++.||||++.....  ....+.+|+.+++.+ +|||||++++++.+...+
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            58999999999999999999863     4667999999976443  234578999999998 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 018734           74 AIVMEYAAGGELFERICNAG------------------RFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSP  135 (351)
Q Consensus        74 ~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~  135 (351)
                      ++|||||++|+|.+++....                  .+++..+..++.||+.||.|||++|++||||||+|||++.++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            99999999999999987543                  589999999999999999999999999999999999998766


Q ss_pred             CCCEEEeccCCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHc-CCCCCCCCCChhHHHH
Q 018734          136 APRLKICDFGYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLV-GAYPFEDQEDPKNFRK  211 (351)
Q Consensus       136 ~~~vkL~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  211 (351)
                      .  +||+|||+++.......   ....+||+.|+|||++.+..++ .++|||||||++|||+| |.+||........+.+
T Consensus       183 ~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~  259 (311)
T d1t46a_         183 I--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK  259 (311)
T ss_dssp             E--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred             c--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            4  99999999985443222   2345799999999999877765 55999999999999998 5666666555444444


Q ss_pred             HHHHHHhhccCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          212 TISRIMAVQYKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ++    ......+....+++.+.+||.+||+.||.+|||+.+|++
T Consensus       260 ~i----~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         260 MI----KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HH----HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HH----hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            33    334444445578999999999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-52  Score=374.33  Aligned_cols=256  Identities=21%  Similarity=0.193  Sum_probs=199.3

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCC-cceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPN-IIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~-Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      +||++++.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.++|+| |+.+..++...+..++||||+
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~   85 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   85 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence            589999999999999999999999999999998876543 346789999999998765 556677778889999999999


Q ss_pred             CCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEeccCCCcccCCCC----
Q 018734           81 AGGELFERIC-NAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS-PAPRLKICDFGYSKSSLLHS----  154 (351)
Q Consensus        81 ~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~-~~~~vkL~DFg~a~~~~~~~----  154 (351)
                      . ++|...+. ....+++..+..++.|++.||+|||++||+||||||+|||++.. ....+||+|||+|+......    
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          86 G-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             C-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             C-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence            5 56655554 45679999999999999999999999999999999999998532 23469999999998543221    


Q ss_pred             ----CCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC---Ccc
Q 018734          155 ----RPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---DYV  227 (351)
Q Consensus       155 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~  227 (351)
                          .....+||+.|||||++.+..++ +++|||||||++|||++|+.||............... .......+   ...
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  242 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI-SEKKMSTPIEVLCK  242 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHH-HHHHHHSCHHHHTT
T ss_pred             eeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHh-hcccCCCChhHhcc
Confidence                22345799999999999888765 5599999999999999999999876544333222111 11111111   123


Q ss_pred             CCCHhHHHHHHHhcccCCCCCCChHHH---hcCcccc
Q 018734          228 HISQDCRNLLSRIFVANPSRRITIKEI---KSHPWFL  261 (351)
Q Consensus       228 ~~~~~~~~li~~~L~~~P~~Rps~~ei---l~hp~~~  261 (351)
                      .+|+++.+||.+||+.+|++||++.++   |+|+|..
T Consensus       243 ~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            588999999999999999999998754   5666543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-52  Score=377.98  Aligned_cols=248  Identities=21%  Similarity=0.302  Sum_probs=204.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCcccC--HHHHHHHHHHhcCCCCCcceEEEEEEcCCEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKN-----TKELVAMKYIERGHKID--ANVAREIINHKQLRHPNIIRFKEVVLTPTHLA   74 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~--~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~~~~   74 (351)
                      ++|++++.||+|+||.||+|.+..     ++..||||+++......  ..+.+|+.++++++|||||++++++..+..++
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            689999999999999999998753     35789999997643322  35789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           75 IVMEYAAGGELFERICNA----------GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        75 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                      +|||||.+|+|.+++...          ..++...+..++.|++.||.|||+++|+||||||+|||++.++.  +||+||
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DF  177 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDF  177 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCT
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeec
Confidence            999999999999987532          24689999999999999999999999999999999999987664  999999


Q ss_pred             CCCcccCCCCC---CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcC-CCCCCCCCChhHHHHHHHHHHhhc
Q 018734          145 GYSKSSLLHSR---PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVG-AYPFEDQEDPKNFRKTISRIMAVQ  220 (351)
Q Consensus       145 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~  220 (351)
                      |+|+.......   .....||+.|+|||.+.+..++ .++|||||||++|||++| .+||........    +..+... 
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~----~~~i~~~-  251 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFVMEG-  251 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHHHTT-
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHhC-
Confidence            99985433222   2334699999999999888775 459999999999999998 477766543322    2233332 


Q ss_pred             cCCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          221 YKIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       221 ~~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      ...+.+..+++.+.+||.+||+.+|++|||+.+|+++
T Consensus       252 ~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2344445789999999999999999999999999873

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=370.12  Aligned_cols=245  Identities=20%  Similarity=0.277  Sum_probs=196.4

Q ss_pred             EeeeecccCceEEEEEEEcCCC---cEEEEEEeccCcc--cCHHHHHHHHHHhcCCCCCcceEEEEEEc-CCEEEEEEec
Q 018734            6 LMKDIGSGNFGVARLMRNKNTK---ELVAMKYIERGHK--IDANVAREIINHKQLRHPNIIRFKEVVLT-PTHLAIVMEY   79 (351)
Q Consensus         6 ~~~~lG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~-~~~~~lv~e~   79 (351)
                      +.++||+|+||+||++.+..++   ..||||+++....  ....+.+|+.++++++|||||++++++.. ++.+++||||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            3578999999999999986543   3689999875332  23568999999999999999999998764 5789999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEeccCCCcccCCCCC---
Q 018734           80 AAGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSR---  155 (351)
Q Consensus        80 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~~~~~~~---  155 (351)
                      |++++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.  +||+|||+++.......   
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCT
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccc
Confidence            9999999988754 45788899999999999999999999999999999999987664  99999999985433222   


Q ss_pred             --CCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCCCccCCCHhH
Q 018734          156 --PKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIPDYVHISQDC  233 (351)
Q Consensus       156 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (351)
                        .....||+.|+|||.+.+..++ .++|||||||++|||++|..||........+   ...+... ...+.+..+++.+
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~---~~~i~~g-~~~~~p~~~~~~l  263 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYLLQG-RRLLQPEYCPDPL  263 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------C---HHHHHTT-CCCCCCTTCCHHH
T ss_pred             eecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHH---HHHHHcC-CCCCCcccCcHHH
Confidence              2234689999999999887775 5599999999999999988887764433222   2222222 2334445789999


Q ss_pred             HHHHHHhcccCCCCCCChHHHhcC
Q 018734          234 RNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       234 ~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .+||.+||+.||++|||+.||++|
T Consensus       264 ~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         264 YEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.7e-50  Score=362.67  Aligned_cols=251  Identities=20%  Similarity=0.226  Sum_probs=203.8

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC-CCcceEEEEEEcCCEEEEEEecc
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-PNIIRFKEVVLTPTHLAIVMEYA   80 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h-p~Iv~~~~~~~~~~~~~lv~e~~   80 (351)
                      ++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|++.++.|+| +||+.+++++......++||||+
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            589999999999999999999999999999998866433 3457889999999976 89999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCCCEEEeccCCCcccCCC---
Q 018734           81 AGGELFERICNA-GRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGS---PAPRLKICDFGYSKSSLLH---  153 (351)
Q Consensus        81 ~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~---~~~~vkL~DFg~a~~~~~~---  153 (351)
                       +++|.+.+... ..++...+..++.|++.||.|||++||+||||||+|||++..   ..+.+||+|||+|+.....   
T Consensus        84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (293)
T d1csna_          84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  162 (293)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccc
Confidence             68999888765 469999999999999999999999999999999999999642   2456999999999753321   


Q ss_pred             -----CCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChhHHHHHHHHHHhhccCCC---C
Q 018734          154 -----SRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTISRIMAVQYKIP---D  225 (351)
Q Consensus       154 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~  225 (351)
                           ......+||+.|||||++.+..++ .++|||||||++|+|++|+.||............ .++.......+   .
T Consensus       163 ~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~~l  240 (293)
T d1csna_         163 QHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPLREL  240 (293)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHSCHHHH
T ss_pred             cceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCCCChHHh
Confidence                 123345799999999999887765 5599999999999999999999865543332221 11111111111   1


Q ss_pred             ccCCCHhHHHHHHHhcccCCCCCCChHHHhc
Q 018734          226 YVHISQDCRNLLSRIFVANPSRRITIKEIKS  256 (351)
Q Consensus       226 ~~~~~~~~~~li~~~L~~~P~~Rps~~eil~  256 (351)
                      ...+|+++.+++..|+..+|++||+++.+.+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2357899999999999999999999887643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-51  Score=366.48  Aligned_cols=251  Identities=24%  Similarity=0.265  Sum_probs=190.4

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCcceEEEEEEcCC----EEEEEE
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRHPNIIRFKEVVLTPT----HLAIVM   77 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~Iv~~~~~~~~~~----~~~lv~   77 (351)
                      ++|.+.+.||+|+||.||+++.  +|+.||||++............|+..++.++|||||++++++.+.+    .+|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4789999999999999999986  4789999998765433333344555667889999999999997653    689999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeecCCCCCcEEecCCCCCCEEEeccCCCcc
Q 018734           78 EYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHS--------MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  149 (351)
Q Consensus        78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--------~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~~  149 (351)
                      |||++|+|..++.+. .+++..+..++.|++.||.|||+        +||+||||||+||||+.++  ++||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~--~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC--CeEEEecCcccc
Confidence            999999999999765 68999999999999999999996        5999999999999998766  499999999875


Q ss_pred             cCCCC-----CCCCcccCCCccCcccccCCcC-----CCcchhHHHHHHHHHHHHcCCCCCCCCCCh-----------hH
Q 018734          150 SLLHS-----RPKSTVGTPAYIAPEVLSRREY-----DGKLADVWSCGVTLYVMLVGAYPFEDQEDP-----------KN  208 (351)
Q Consensus       150 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~ell~g~~pf~~~~~~-----------~~  208 (351)
                      .....     .....+||+.|+|||++.+...     .+.++|||||||++|||+||..||......           ..
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            43322     2334679999999999866432     234589999999999999998887532211           11


Q ss_pred             HHHHHHHHHhhccCCCCcc-----CCCHhHHHHHHHhcccCCCCCCChHHHhcC
Q 018734          209 FRKTISRIMAVQYKIPDYV-----HISQDCRNLLSRIFVANPSRRITIKEIKSH  257 (351)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~~P~~Rps~~eil~h  257 (351)
                      .............+.+.+.     .....+.+|+.+||+.||.+|||+.||+++
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            1222222222222211111     122358899999999999999999999763

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.5e-49  Score=365.71  Aligned_cols=259  Identities=22%  Similarity=0.377  Sum_probs=197.0

Q ss_pred             CeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCC-----------CCCcceEEEEEEc--
Q 018734            3 KYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLR-----------HPNIIRFKEVVLT--   69 (351)
Q Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~-----------hp~Iv~~~~~~~~--   69 (351)
                      ||++++.||+|+||+||+|++..+|+.||||++++.......+.+|+.+++.++           |||||++++++..  
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            799999999999999999999999999999999876555566778888887764           5789999988754  


Q ss_pred             CCEEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCC----CCEEE
Q 018734           70 PTHLAIVMEYAAGGELFERI---CNAGRFSEDEARYFFQQLISGVSYCHS-MQICHRDLKLENTLLDGSPA----PRLKI  141 (351)
Q Consensus        70 ~~~~~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~iiH~Dikp~NIll~~~~~----~~vkL  141 (351)
                      ....++++.++..+......   .....+++..++.++.||+.||.|||+ .||+||||||+|||++..+.    ..++|
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl  173 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI  173 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence            45677777777665433322   234578999999999999999999998 89999999999999975443    24899


Q ss_pred             eccCCCcccCCCCCCCCcccCCCccCcccccCCcCCCcchhHHHHHHHHHHHHcCCCCCCCCCChh------HHHHHHHH
Q 018734          142 CDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKLADVWSCGVTLYVMLVGAYPFEDQEDPK------NFRKTISR  215 (351)
Q Consensus       142 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~  215 (351)
                      +|||.|...  .......+||+.|+|||++....++. ++||||+||++++|++|+.||.......      .....+..
T Consensus       174 ~dfg~s~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~  250 (362)
T d1q8ya_         174 ADLGNACWY--DEHYTNSIQTREYRSPEVLLGAPWGC-GADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  250 (362)
T ss_dssp             CCCTTCEET--TBCCCSCCSCGGGCCHHHHHTCCCCT-HHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             eeccccccc--ccccccccccccccChhhccccCCCc-cccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence            999998743  23445678999999999999888765 5999999999999999999997643211      11111111


Q ss_pred             HHh--------------------hcc----------------CCCCccCCCHhHHHHHHHhcccCCCCCCChHHHhcCcc
Q 018734          216 IMA--------------------VQY----------------KIPDYVHISQDCRNLLSRIFVANPSRRITIKEIKSHPW  259 (351)
Q Consensus       216 ~~~--------------------~~~----------------~~~~~~~~~~~~~~li~~~L~~~P~~Rps~~eil~hp~  259 (351)
                      +..                    ...                ........++.+.+||.+||++||.+|||++|+|+|||
T Consensus       251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~  330 (362)
T d1q8ya_         251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW  330 (362)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred             hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            000                    000                00011124578999999999999999999999999999


Q ss_pred             cccCC
Q 018734          260 FLKNL  264 (351)
Q Consensus       260 ~~~~~  264 (351)
                      |++..
T Consensus       331 f~~~~  335 (362)
T d1q8ya_         331 LKDTL  335 (362)
T ss_dssp             GTTCT
T ss_pred             cCCCC
Confidence            98543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=2.8e-27  Score=197.64  Aligned_cols=132  Identities=19%  Similarity=0.175  Sum_probs=106.0

Q ss_pred             eeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCccc-------------------CHHHHHHHHHHhcCCCCCcceEE
Q 018734            4 YELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHKI-------------------DANVAREIINHKQLRHPNIIRFK   64 (351)
Q Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~~~e~~~~~~l~hp~Iv~~~   64 (351)
                      |.++++||+|+||.||+|.+. +|+.||||+++.....                   .....+|+..+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            568999999999999999986 5889999987532110                   12344678889999999999988


Q ss_pred             EEEEcCCEEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecc
Q 018734           65 EVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARYFFQQLISGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF  144 (351)
Q Consensus        65 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~iiH~Dikp~NIll~~~~~~~vkL~DF  144 (351)
                      ++..    .+++|||+.+..+.       .++...+..++.|++.||.|||++||+||||||+|||++.++   ++|+||
T Consensus        81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF  146 (191)
T d1zara2          81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF  146 (191)
T ss_dssp             EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred             EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence            7642    26999999886543       245666788999999999999999999999999999998654   899999


Q ss_pred             CCCccc
Q 018734          145 GYSKSS  150 (351)
Q Consensus       145 g~a~~~  150 (351)
                      |+|...
T Consensus       147 G~a~~~  152 (191)
T d1zara2         147 PQSVEV  152 (191)
T ss_dssp             TTCEET
T ss_pred             CCcccC
Confidence            998643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.62  E-value=9e-08  Score=81.55  Aligned_cols=85  Identities=19%  Similarity=0.081  Sum_probs=59.2

Q ss_pred             CCeeEeeeecccCceEEEEEEEcCCCcEEEEEEeccCcc-cCHHHHHHHHHHhcCC-CCCcceEEEEEEcCCEEEEEEec
Q 018734            2 EKYELMKDIGSGNFGVARLMRNKNTKELVAMKYIERGHK-IDANVAREIINHKQLR-HPNIIRFKEVVLTPTHLAIVMEY   79 (351)
Q Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~~~~l~-hp~Iv~~~~~~~~~~~~~lv~e~   79 (351)
                      +.|++.+..+.++.+.||++..  .+..+.+|+...... ....+.+|...++.+. +--+.+++.+...++..++||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            5678777766566678998864  345677887654332 3345677888877663 32356777888888999999999


Q ss_pred             cCCCChHHH
Q 018734           80 AAGGELFER   88 (351)
Q Consensus        80 ~~~~~L~~~   88 (351)
                      ++|.++...
T Consensus        92 l~G~~~~~~  100 (263)
T d1j7la_          92 ADGVLCSEE  100 (263)
T ss_dssp             CSSEEHHHH
T ss_pred             ccccccccc
Confidence            999777543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.16  E-value=4.6e-06  Score=75.17  Aligned_cols=77  Identities=14%  Similarity=0.074  Sum_probs=47.5

Q ss_pred             eeeecccCceEEEEEEEcCCCcEEEEEEecc-------Cc-ccCHHHHHHHHHHhcCC--CC-CcceEEEEEEcCCEEEE
Q 018734            7 MKDIGSGNFGVARLMRNKNTKELVAMKYIER-------GH-KIDANVAREIINHKQLR--HP-NIIRFKEVVLTPTHLAI   75 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~-~~~~~~~~e~~~~~~l~--hp-~Iv~~~~~~~~~~~~~l   75 (351)
                      .+.||.|....||++.+..+++.|++|.-..       +. ....+...|...++.+.  .| .+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4679999999999999888888899996421       11 11234556777776552  23 34555544  3444568


Q ss_pred             EEeccCCCCh
Q 018734           76 VMEYAAGGEL   85 (351)
Q Consensus        76 v~e~~~~~~L   85 (351)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.13  E-value=3.5e-06  Score=70.91  Aligned_cols=74  Identities=12%  Similarity=0.063  Sum_probs=51.5

Q ss_pred             eecccCc-eEEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC--CCcceEEEEEEcCCEEEEEEeccCCCCh
Q 018734            9 DIGSGNF-GVARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH--PNIIRFKEVVLTPTHLAIVMEYAAGGEL   85 (351)
Q Consensus         9 ~lG~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h--p~Iv~~~~~~~~~~~~~lv~e~~~~~~L   85 (351)
                      .+..|.. +.||++.... +..+++|.......  ..+..|...++.|..  -.+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555654 5789888654 56688887554432  346677777776643  2356778888888899999999988655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.49  E-value=0.00014  Score=63.46  Aligned_cols=66  Identities=11%  Similarity=0.121  Sum_probs=43.7

Q ss_pred             EEEEEEEcCCCcEEEEEEeccCcccCHHHHHHHHHHhcCCC-----CCcceE--EEEEEcCCEEEEEEeccCCC
Q 018734           17 VARLMRNKNTKELVAMKYIERGHKIDANVAREIINHKQLRH-----PNIIRF--KEVVLTPTHLAIVMEYAAGG   83 (351)
Q Consensus        17 ~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~h-----p~Iv~~--~~~~~~~~~~~lv~e~~~~~   83 (351)
                      .||++.... |+.|++|+.+......+.+..|+..+..|..     +..+..  -..+...+..+.+++++.|.
T Consensus        37 ~vy~v~~~d-g~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          37 RVYQFQDED-RRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             EEEEECCTT-CCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             eeEEEEcCC-CCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            799998754 7789999877655555678888887766632     111111  11223457788999999873

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.32  E-value=0.00042  Score=61.96  Aligned_cols=74  Identities=14%  Similarity=0.160  Sum_probs=50.1

Q ss_pred             eeeecccCceEEEEEEEcCC-------CcEEEEEEeccCcccCHHHHHHHHHHhcCCCCCc-ceEEEEEEcCCEEEEEEe
Q 018734            7 MKDIGSGNFGVARLMRNKNT-------KELVAMKYIERGHKIDANVAREIINHKQLRHPNI-IRFKEVVLTPTHLAIVME   78 (351)
Q Consensus         7 ~~~lG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~e~~~~~~l~hp~I-v~~~~~~~~~~~~~lv~e   78 (351)
                      ++.|+.|-.=.+|++.....       .+.|.+++.... .......+|..+++.+.-.++ .++++++.+    ++|++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            46788788889999987642       356777776532 233456688888888753344 467777643    47999


Q ss_pred             ccCCCCh
Q 018734           79 YAAGGEL   85 (351)
Q Consensus        79 ~~~~~~L   85 (351)
                      |++|.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.51  E-value=0.0025  Score=54.67  Aligned_cols=30  Identities=23%  Similarity=0.335  Sum_probs=25.0

Q ss_pred             cCCeecCCCCCcEEecCCCCCCEEEeccCCCc
Q 018734          117 MQICHRDLKLENTLLDGSPAPRLKICDFGYSK  148 (351)
Q Consensus       117 ~~iiH~Dikp~NIll~~~~~~~vkL~DFg~a~  148 (351)
                      .|+||+|+.+.||+++++.  ..-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             cccccCCcchhhhhccccc--ceeEecccccc
Confidence            5799999999999998664  25799999764